FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Koh, A
   Carpenter, AW
   Slomberg, DL
   Schoenfisch, MH
AF Koh, Ahyeon
   Carpenter, Alexis W.
   Slomberg, Danielle L.
   Schoenfisch, Mark H.
TI Nitric Oxide-Releasing Silica Nanoparticle-Doped Polyurethane
   Electrospun Fibers
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE nitric oxide; controlled release; electrospun fiber; porous biomaterial;
   polyurethane
ID FOREIGN-BODY RESPONSE; IN-VIVO; BIOMEDICAL APPLICATIONS; SUBCUTANEOUS
   IMPLANTS; SILVER NANOPARTICLES; MEDICAL DEVICES; FABRICATION;
   NANOFIBERS; POLYMERS; DELIVERY
AB Electrospun polyurethane fibers doped with nitric oxide (NO)-releasing silica particles are presented as novel macromolecular scaffolds with prolonged NO-release and high porosity. Fiber diameter (119-614 nm) and mechanical strength (1.7-34.5 MPa of modulus) were varied by altering polyurethane type and concentration, as well as the NO-releasing particle composition, size, and concentration. The resulting NO-releasing electrospun nanofibers exhibited similar to 83% porosity with flexible plastic or elastomeric behavior. The use of N-diazeniumdiolate- or S-nitrosothiol-modified particles yielded scaffolds exhibiting a wide range of NO release totals and durations (7.5 nmol mg(-1)-0.12 mu mol mg(-1) and 7 h to 2 weeks, respectively). The application of NO-releasing porous materials as coatings for subcutaneous implants may improve tissue biocompatibility by mitigating the foreign body response and promoting cell integration.
C1 [Koh, Ahyeon; Carpenter, Alexis W.; Slomberg, Danielle L.; Schoenfisch, Mark H.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
RP Schoenfisch, MH (reprint author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.
EM schoenfisch@unc.edu
FU National Institutes of Health [EB000708]
FX This research was supported by the National Institutes of Health
   (EB000708). The authors thank Wesley L. Storm for assistance in
   measuring the surface areas of the fiber mats. We also thank Dr. Bin Sun
   and Dr. Daniel Riccio for synthesizing NO-releasing particles.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Barbe C, 2004, ADV MATER, V16, P1959, DOI 10.1002/adma.200400771
   Black J., 1998, HDB BIOMATERIAL PROP
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162
   Brune B, 2003, CELL DEATH DIFFER, V10, P864, DOI 10.1038/sj.cdd.4401261
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Carpenter AW, 2012, CHEM SOC REV, V41, P3742, DOI 10.1039/c2cs15273h
   Carpenter AW, 2011, ACS NANO, V5, P7235, DOI 10.1021/nn202054f
   Coneski PN, 2012, CHEM SOC REV, V41, P3753, DOI 10.1039/c2cs15271a
   Coneski PN, 2011, POLYM CHEM-UK, V2, P906, DOI 10.1039/c0py00269k
   Coneski PN, 2011, ACS APPL MATER INTER, V3, P426, DOI 10.1021/am101010e
   Coneski PN, 2010, BIOMACROMOLECULES, V11, P3208, DOI 10.1021/bm1006823
   Damodaran VB, 2012, J MATER CHEM, V22, P5990, DOI 10.1039/c2jm16554f
   Damodaran VB, 2011, J MATER CHEM, V21, P5870, DOI 10.1039/c1jm10315f
   Frost MC, 2005, J BIOMED MATER RES A, V72A, P409, DOI 10.1002/jbm.a.30275
   Frost MC, 2002, CURR OPIN CHEM BIOL, V6, P633, DOI 10.1016/S1367-5931(02)00371-X
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   HECK DE, 1992, J BIOL CHEM, V267, P21277
   Helton Kristen L, 2011, J Diabetes Sci Technol, V5, P647
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hetrick EM, 2007, BIOMATERIALS, V28, P1948, DOI 10.1016/j.biomaterials.2007.01.006
   Hong KH, 2007, POLYM ENG SCI, V47, P43, DOI 10.1002/pen.20660
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   Ignarro LJ, 2000, NITRIC OXIDE BIOL PA
   Jen MC, 2012, ADV FUNCT MATER, V22, P239, DOI 10.1002/adfm.201101707
   Jones ML, 2010, APPL MICROBIOL BIOT, V88, P401, DOI 10.1007/s00253-010-2733-x
   Koh A, 2011, BIOSENS BIOELECTRON, V28, P17, DOI 10.1016/j.bios.2011.06.005
   Koschwanez HE, 2008, J BIOMED MATER RES A, V87A, P792, DOI 10.1002/jbm.a.31824
   Kunzmann A, 2011, BBA-GEN SUBJECTS, V1810, P361, DOI 10.1016/j.bbagen.2010.04.007
   LANDON G, 1977, J MATER SCI, V12, P1605, DOI 10.1007/BF00542811
   Leung V, 2011, POLYM ADVAN TECHNOL, V22, P350, DOI 10.1002/pat.1813
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lu XF, 2009, SMALL, V5, P2349, DOI 10.1002/smll.200900445
   Lu Y, 2011, CHEM MATER, V23, P4227, DOI 10.1021/cm201628z
   Marxer SM, 2003, CHEM MATER, V15, P4193, DOI 10.1021/cm034347n
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092
   Moghe AK, 2008, POLYM REV, V48, P353, DOI 10.1080/15583720802022257
   Nablo BJ, 2005, BIOMATERIALS, V26, P4405, DOI 10.1016/j.biomaterials.2004.11.015
   Nichols SP, 2013, CHEM REV, V113, P2528, DOI 10.1021/cr300387j
   Nichols SP, 2012, BIOMATERIALS, V33, P6305, DOI 10.1016/j.biomaterials.2012.05.053
   Nichols SP, 2011, ANAL CHEM, V83, P1180, DOI 10.1021/ac103070t
   Reynolds MM, 2004, FREE RADICAL BIO MED, V37, P926, DOI 10.1016/j.freeradbiomed.2004.06.019
   Riccio DA, 2012, CHEM SOC REV, V41, P3731, DOI 10.1039/c2cs15272j
   Riccio DA, 2011, CHEM MATER, V23, P1727, DOI 10.1021/cm102510q
   Riccio DA, 2009, BIOMATERIALS, V30, P4494, DOI 10.1016/j.biomaterials.2009.05.006
   Robbins ME, 2004, LANGMUIR, V20, P10296, DOI 10.1021/la048368n
   Saino E., 2012, BIOMACROMOLECULES, V12, P1900
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Schaffer MR, 1996, J SURG RES, V63, P237, DOI 10.1006/jsre.1996.0254
   Shawon J, 2004, J MATER SCI, V39, P4605, DOI 10.1023/B:JMSC.0000034155.93428.ea
   Shin JH, 2008, CHEM MATER, V20, P239, DOI 10.1021/cm702526q
   Shin JH, 2007, J AM CHEM SOC, V129, P4612, DOI 10.1021/ja0674338
   Shin JH, 2006, ANALYST, V131, P609, DOI 10.1039/b600129g
   Skrzypchak AM, 2007, PERFUSION-UK, V22, P193, DOI 10.1177/0267659107080877
   Son WK, 2004, MACROMOL RAPID COMM, V25, P1632, DOI 10.1002/marc.200400323
   Stasko NA, 2006, J AM CHEM SOC, V128, P8265, DOI 10.1021/ja060875z
   Stasko NA, 2008, BIOMACROMOLECULES, V9, P834, DOI 10.1021/bm7011746
   Sun B, 2012, BIOMACROMOLECULES, V13, P3343, DOI 10.1021/bm301109c
   Tan SH, 2005, POLYMER, V46, P6128, DOI 10.1016/j.polymer.2005.05.068
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Vacanti NM, 2012, BIOMACROMOLECULES, V13, P3031, DOI 10.1021/bm300520u
   Wang N, 2013, BIOMATERIALS, V34, P888, DOI 10.1016/j.biomaterials.2012.10.049
   Williams DLH, 2003, ORG BIOMOL CHEM, V1, P441, DOI 10.1039/b209748f
   Wise D.L., 1996, HUMAN BIOMATERIALS A
   Wold KA, 2012, ACS APPL MATER INTER, V4, P3022, DOI 10.1021/am300383w
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   Yan Q., 2011, BIOSENS BIOELECTRON
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u
NR 74
TC 20
Z9 21
U1 6
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 28
PY 2013
VL 5
IS 16
BP 7956
EP 7964
DI 10.1021/am402044s
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 211AF
UT WOS:000323875800045
PM 23915047
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Santos, E
   Pedraz, JL
   Hernandez, RM
   Orive, G
AF Santos, Edorta
   Luis Pedraz, Jose
   Maria Hernandez, Rosa
   Orive, Gorka
TI Therapeutic cell encapsulation: Ten steps towards clinical translation
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE Cell encapsulation; Clinic; Cell therapy; Drug delivery; Stem cells
ID ALGINATE-BASED MICROCAPSULES; POLY-L-LYSINE; ALGINATE/CHITOSAN HYDROGEL
   MICROCAPSULES; PIGMENT EPITHELIAL-CELLS; CALCIUM-PHOSPHATE CEMENT;
   PANCREATIC-ISLET CELLS; CENTRAL-NERVOUS-SYSTEM; PORCINE SERTOLI-CELLS;
   FOREIGN-BODY REACTION; IN-VIVO
AB Since the conception of cell microencapsulation, many scientists bet on this biotechnology as they saw in it a promising alternative to protect transplanted cells from host immunoresponse. Some decades later, this initial enthusiasm is giving rise to a phase of certain conformism and lack of novel advances in the field. This perspective critically discusses current challenges needed to help this approach become a realistic clinical proposal. Alginate seems to be well established as the biomaterial of choice, but additional efforts are needed regarding current cross-linkers and coatings. Biofunctionalization of the matrices may provide the necessary biomimetic microenvironment to control cell behavior. Different alginate degradation rates would allow widening the applications of this biotechnology from drug delivery to cell delivery. In this sense, stem cells from stromal tissues could be the most suitable cell source due to their intrinsic hypoimmunogenicity, their immunomodulatory effects and their capacity to cell homing. The incorporation of suicide and reporter genes in the genome of enclosed cells may overcome some of the existing biosafety concerns. Administration and extraction by means of less invasive procedures also need to be developed to succeed in clinical translation. Finally, improving cost-effectiveness for the scale-up, together with establishing and fulfilling a series of strict regulatory aspects will be indispensable to make the final step to the clinic. (C) 2013 Elsevier B.V. All rights reserved.
C1 Univ Basque Country, Sch Pharm, Lab Pharmaceut, NanoBioCel Grp, Vitoria, Spain.
   Biomed Res Networking Ctr Bioengn Biomat & Nanome, Vitoria, Spain.
RP Orive, G (reprint author), Univ Basque Country, Sch Pharm, Lab Pharmaceut, Vitoria, Spain.
EM gorka.orive@ehu.es
RI SANTOS VIZCAINO, EDORTA/L-2796-2017; Hernandez, Rosa Maria/S-6332-2017
OI SANTOS VIZCAINO, EDORTA/0000-0001-7064-4563; PEDRAZ MUNOZ, JOSE
   LUIS/0000-0002-3938-2267; Hernandez, Rosa Maria/0000-0002-3947-409X
CR Acarregui A, 2013, BIOMACROMOLECULES, V14, P322, DOI 10.1021/bm301690a
   Acarregui A, 2012, BIODRUGS, V26, P283, DOI 10.2165/11632640-000000000-00000
   Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   AOTA S, 1991, J BIOL CHEM, V266, P15938
   Arifin DR, 2013, NMR BIOMED, V26, P850, DOI 10.1002/nbm.2894
   Arifin DR, 2012, BIOMATERIALS, V33, P4681, DOI 10.1016/j.biomaterials.2012.03.008
   Barnett BP, 2007, NAT MED, V13, P986, DOI 10.1038/nm1581
   Barnett BP, 2011, NAT PROTOC, V6, P1142, DOI 10.1038/nprot.2011.352
   Baroli B, 2006, J CHEM TECHNOL BIOT, V81, P491, DOI 10.1002/jctb.1468
   Barry FP, 2005, STEM CELLS DEV, V14, P252, DOI 10.1089/scd.2005.14.252
   Baruch L, 2006, BIOPOLYMERS, V82, P570, DOI 10.1002/bip.20509
   Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   Bistoni G, 2012, BIOMATERIALS, V33, P5333, DOI 10.1016/j.biomaterials.2012.04.020
   Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356
   Breger JC, 2009, J BIOMED MATER RES B, V91B, P755, DOI 10.1002/jbm.b.31452
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Catena R, 2010, J CONTROL RELEASE, V146, P93, DOI 10.1016/j.jconrel.2010.05.018
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   Chen HM, 2007, CELL BIOCHEM BIOPHYS, V47, P159, DOI 10.1385/CBB:47:1:159
   Chen WC, 2012, ACTA BIOMATER, V8, P2297, DOI 10.1016/j.actbio.2012.02.021
   Cheng DX, 2008, J BIOMED MATER RES A, V87A, P321, DOI 10.1002/jbm.a.31716
   Cheung CY, 2006, BIOCONJUGATE CHEM, V17, P1036, DOI 10.1021/bc060023o
   Cunningham JJ, 2012, NAT BIOTECHNOL, V30, P849, DOI 10.1038/nbt.2329
   De Castro M, 2009, J BIOMED MATER RES A, V91A, P1119, DOI 10.1002/jbm.a.32270
   de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018
   de Haan BJ, 2011, J BIOMED MATER RES A, V98A, P394, DOI 10.1002/jbm.a.33123
   de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345
   de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8
   de Vos P, 2002, J BIOMED MATER RES, V60, P252, DOI 10.1002/jbm.10060
   de Vos P, 2007, J BIOMED MATER RES A, V80A, P813, DOI 10.1002/jbm.a.30979
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039
   de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   Erceg S, 2009, STEM CELLS, V27, P78, DOI 10.1634/stemcells.2008-0543
   Fonseca KB, 2011, ACTA BIOMATER, V7, P1674, DOI 10.1016/j.actbio.2010.12.029
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   Fu XM, 2012, GENOME MED, V4, DOI 10.1186/gm354
   Garate A, 2012, THER DELIV, V3, P761, DOI 10.4155/TDE.12.53
   Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004
   Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6
   Godfrey KJ, 2012, DIABETIC MED, V29, P14, DOI 10.1111/j.1464-5491.2011.03433.x
   Goren A, 2010, FASEB J, V24, P22, DOI 10.1096/fj.09-131888
   Goto Y, 2008, BIOMACROMOLECULES, V9, P828, DOI 10.1021/bm701161d
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   Gross RE, 2011, LANCET NEUROL, V10, P509, DOI 10.1016/S1474-4422(11)70097-7
   Hang HL, 2010, LIVER INT, V30, P611, DOI 10.1111/j.1478-3231.2009.02197.x
   Haque T, 2005, BIOTECHNOL LETT, V27, P317, DOI 10.1007/s10529-005-0687-3
   Hasse C, 1997, LANCET, V350, P1296, DOI 10.1016/S0140-6736(05)62473-7
   Hastings CL, 2012, J CONTROL RELEASE, V161, P73, DOI 10.1016/j.jconrel.2012.04.033
   HAUTANEN A, 1989, J BIOL CHEM, V264, P1437
   He HY, 2013, J CONTROL RELEASE, V165, P226, DOI 10.1016/j.jconrel.2012.11.020
   Heile Anna, 2011, Dialogues Clin Neurosci, V13, P279
   Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hillberg AL, 2013, J BIOMED MATER RES B, V101B, P258, DOI 10.1002/jbm.b.32835
   Hillberg AL, 2009, BIOMATERIALS, V30, P4463, DOI 10.1016/j.biomaterials.2009.05.026
   Holland NB, 1998, NATURE, V392, P799
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Jeon O, 2012, BIOMATERIALS, V33, P3503, DOI 10.1016/j.biomaterials.2012.01.041
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Jin J, 2004, BIOMACROMOLECULES, V5, P162, DOI 10.1021/bm034286m
   Jin R, 2011, J CONTROL RELEASE, V152, P186, DOI 10.1016/j.jconrel.2011.01.031
   Karoubi G, 2009, BIOMATERIALS, V30, P5445, DOI 10.1016/j.biomaterials.2009.06.035
   Kauer TM, 2012, NAT NEUROSCI, V15, P197, DOI 10.1038/nn.3019
   Kedziorek DA, 2012, STEM CELLS, V30, P1286, DOI 10.1002/stem.1096
   Kershen RT, 2000, WORLD J UROL, V18, P51, DOI 10.1007/PL00007072
   Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002
   Knippenberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036857
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee KY, 2003, ADV MATER, V15, P1828, DOI 10.1002/adma.200305406
   Leinfelder U, 2003, BIOMATERIALS, V24, P4161, DOI 10.1016/S0142-9612(03)00299-0
   Leung A, 2010, BIOCHEM ENG J, V48, P337, DOI 10.1016/j.bej.2009.10.007
   Leung A, 2009, J BIOMED MATER RES A, V88A, P226, DOI 10.1002/jbm.a.31891
   Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Liu J, 2012, TISSUE ENG PT A, V18, P2303, DOI [10.1089/ten.tea.2011.0658, 10.1089/ten.TEA.2011.0658]
   Lohr M, 2001, LANCET, V357, P1591, DOI 10.1016/S0140-6736(00)04749-8
   Luca G, 2007, TISSUE ENG, V13, P641, DOI 10.1089/ten.2006.0137
   Luca G, 2013, J CONTROL RELEASE, V165, P75, DOI 10.1016/j.jconrel.2012.08.028
   Ludwig B, 2012, P NATL ACAD SCI USA, V109, P5022, DOI 10.1073/pnas.1201868109
   Lutolf MP, 2009, INTEGR BIOL, V1, P235, DOI 10.1039/b902243k
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Ma K, 2012, ACTA BIOMATER, V8, P3754, DOI 10.1016/j.actbio.2012.06.028
   Ma Y, 2013, J BIOMED MATER RES A, V101, P1265, DOI 10.1002/jbm.a.34418
   Ma Y, 2013, J BIOMED MATER RES A, V101, P1007, DOI 10.1002/jbm.a.34395
   Man Y, 2012, BIOMATERIALS, V33, P8802, DOI 10.1016/j.biomaterials.2012.08.054
   Mao Y, 2006, CELL COMMUN ADHES, V13, P267, DOI 10.1080/15419060601072215
   Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307
   Massoud TF, 2008, AM J NEURORADIOL, V29, P229, DOI 10.3174/ajnr.A0864
   McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87
   Montanucci P, 2011, BIOMATERIALS, V32, P9254, DOI 10.1016/j.biomaterials.2011.08.052
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Morch YA, 2008, BIOMACROMOLECULES, V9, P2360, DOI 10.1021/bm8003572
   Morch YA, 2007, BIOMACROMOLECULES, V8, P2809, DOI 10.1021/bm700502b
   Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d
   Murua A, 2009, BIOMATERIALS, V30, P3495, DOI 10.1016/j.biomaterials.2009.03.005
   Nafea EH, 2011, J CONTROL RELEASE, V154, P110, DOI 10.1016/j.jconrel.2011.04.022
   Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033
   Ochsenhirt SE, 2006, BIOMATERIALS, V27, P3863, DOI 10.1016/j.biomaterials.2005.12.012
   Olabisi RM, 2010, TISSUE ENG PT A, V16, P3727, DOI 10.1089/ten.TEA.2010.0234
   Orive G, 2003, INT J PHARMACEUT, V259, P57, DOI 10.1016/S0378-5173(03)00201-1
   Orive G, 2002, TRENDS BIOTECHNOL, V20, P382, DOI 10.1016/S0167-7799(02)02037-1
   Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7
   Orive G, 2009, J CONTROL RELEASE, V135, P203, DOI 10.1016/j.jconrel.2009.01.005
   Paek HJ, 2006, TISSUE ENG, V12, P1733, DOI 10.1089/ten.2006.12.1733
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Paul A, 2011, MOL BIOTECHNOL, V48, P116, DOI 10.1007/s12033-010-9352-8
   Prestwich GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004915
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Puicher EP, 2012, GENE THER, V19, P355, DOI 10.1038/gt.2011.94
   Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x
   Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941
   Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73
   Sakai A, 2007, CRYOLETTERS, V28, P151
   Sakai S, 2007, ACTA BIOMATER, V3, P495, DOI 10.1016/j.actbio.2006.12.002
   Sakai S, 2012, BIOMATERIALS, V33, P6721, DOI 10.1016/j.biomaterials.2012.06.027
   Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126
   Salmons B, 2010, CURR OPIN MOL THER, V12, P450
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Santos E, 2012, J CONTROL RELEASE, V158, P443, DOI 10.1016/j.jconrel.2011.09.079
   Santos E, 2013, BIOMATERIALS, V34, P1442, DOI 10.1016/j.biomaterials.2012.10.076
   Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005
   Santos E, 2010, ADV EXP MED BIOL, V670, P5
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Shoichet MS, 2000, ADV DRUG DELIVER REV, V42, P81, DOI 10.1016/S0169-409X(00)00055-7
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Sommer B, 2002, MOL THER, V6, P155, DOI 10.1006/mthe.2002.0646
   Studeny M, 2004, J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8
   Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479
   Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006
   Tam SK, 2011, J BIOMED MATER RES A, V98A, P40, DOI 10.1002/jbm.a.33047
   Tang M, 2012, ACTA BIOMATER, V8, P3436, DOI 10.1016/j.actbio.2012.05.016
   Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067
   Tendulkar S, 2012, BIOMED MICRODEVICES, V14, P461, DOI 10.1007/s10544-011-9623-6
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tobin SC, 2012, FEBS LETT, V586, P2874, DOI 10.1016/j.febslet.2012.07.024
   Tomicic MT, 2002, ONCOGENE, V21, P2141, DOI 10.1038/sj/onc/1205280
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Tuch BE, 2011, DIABETES-METAB RES, V27, P928, DOI 10.1002/dmrr.1274
   Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744
   Van Damme A, 2006, STEM CELLS, V24, P896, DOI 10.1634/stemcells.2003-0106
   van Hoogmoed CG, 2003, J BIOMED MATER RES A, V67A, P172, DOI 10.1002/jbm.a.10086
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wang N, 2009, J BIOTECHNOL, V144, P304, DOI 10.1016/j.jbiotec.2009.08.008
   Wang S., 2012, J HEMATOL ONCOL, V5
   Wikstrom J, 2012, EUR J PHARM SCI, V47, P520, DOI 10.1016/j.ejps.2012.06.014
   Williams DF, 2011, BIOMATERIALS, V32, P4195, DOI 10.1016/j.biomaterials.2011.02.025
   Wilson JL, 2013, BIOTECHNOL BIOENG, V110, P667, DOI 10.1002/bit.24802
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
   Wu YN, 2007, TISSUE ENG, V13, P649, DOI 10.1089/ten.2006.0075
   Xu Y, 2009, BIOMACROMOLECULES, V10, P267, DOI 10.1021/bm801279y
   Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005
   Yang C, 2012, J CONTROL RELEASE, V162, P612, DOI 10.1016/j.jconrel.2012.08.002
   Yang FP, 2012, BIOMATERIALS, V33, P5638, DOI 10.1016/j.biomaterials.2012.04.035
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zanin MP, 2012, J CONTROL RELEASE, V160, P3, DOI 10.1016/j.jconrel.2012.01.021
   Zanotti L, 2013, LEUKEMIA, V27, P500, DOI 10.1038/leu.2012.202
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
   Zheng JN, 2010, LANGMUIR, V26, P17156, DOI 10.1021/la1030203
   Zheng JN, 2012, LANGMUIR, V28, P13261, DOI 10.1021/la302615t
   Zheng MH, 2009, CYTOTHERAPY, V11, P326, DOI 10.1080/14653240802582091
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
   Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1
NR 194
TC 44
Z9 44
U1 1
U2 169
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 28
PY 2013
VL 170
IS 1
BP 1
EP 14
DI 10.1016/j.jconrel.2013.04.015
PG 14
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 173XZ
UT WOS:000321117600001
PM 23643824
DA 2018-10-20
ER

PT J
AU Miklas, JW
   Dallabrida, SM
   Reis, LA
   Ismail, N
   Rupnick, M
   Radisic, M
AF Miklas, Jason W.
   Dallabrida, Susan M.
   Reis, Lewis A.
   Ismail, Nesreen
   Rupnick, Maria
   Radisic, Milica
TI QHREDGS Enhances Tube Formation, Metabolism and Survival of Endothelial
   Cells in Collagen-Chitosan Hydrogels
SO PLOS ONE
LA English
DT Article
ID DESIGNED ANGIOPOIETIN-1 VARIANT; BIOMIMETIC SURFACTANT POLYMERS;
   IN-VIVO; LUMEN FORMATION; BLOOD-FLOW; PEPTIDE; ADHESION; MORPHOGENESIS;
   BIOMATERIALS; MIGRATION
AB Cell survival in complex, vascularized tissues, has been implicated as a major bottleneck in advancement of therapies based on cardiac tissue engineering. This limitation motivates the search for small, inexpensive molecules that would simultaneously be cardio-protective and vasculogenic. Here, we present peptide sequence QHREDGS, based upon the fibrinogen-like domain of angiopoietin-1, as a prime candidate molecule. We demonstrated previously that QHREDGS improved cardiomyocyte metabolism and mitigated serum starved apoptosis. In this paper we further demonstrate the potency of QHREDGS in its ability to enhance endothelial cell survival, metabolism and tube formation. When endothelial cells were exposed to the soluble form of QHREDGS, improvements in endothelial cell barrier functionality, nitric oxide production and cell metabolism (ATP levels) in serum starved conditions were found. The functionality of the peptide was then examined when conjugated to collagen-chitosan hydrogel, a potential carrier for in vivo application. The presence of the peptide in the hydrogel mitigated paclitaxel induced apoptosis of endothelial cells in a dose dependent manner. Furthermore, the peptide modified hydrogels stimulated tube-like structure formation of encapsulated endothelial cells. When integrin alpha v beta 3 or alpha 5 beta 1were antibody blocked during cell encapsulation in peptide modified hydrogels, tube formation was abolished. Therefore, the dual protective nature of the novel peptide QHREDGS may position this peptide as an appealing augmentation for collagen-chitosan hydrogels that could be used for biomaterial delivered cell therapies in the settings of myocardial infarction.
C1 [Miklas, Jason W.; Reis, Lewis A.; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Dallabrida, Susan M.; Ismail, Nesreen] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA.
   [Rupnick, Maria] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA.
   [Rupnick, Maria] Harvard Univ, Sch Med, Boston, MA USA.
   [Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
RP Radisic, M (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
EM m.radisic@utoronto.ca
FU NSERC [STPGP 381002-09, RGPIN 326982-10]; NSERC-CIHR [CHRPJ 385981-10];
   Discovery Accelerator Supplement [RGPAS 396125-10]; ORF GL2 grant;
   McLean Award
FX The authors wish to acknowledge the following funding sources: NSERC
   Strategic Grant (STPGP 381002-09), NSERC-CIHR Collaborative Health
   Research Grant (CHRPJ 385981-10), NSERC Discovery Grant (RGPIN
   326982-10) and Discovery Accelerator Supplement (RGPAS 396125-10), ORF
   GL2 grant and McLean Award (to MR). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639
   Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9
   BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135
   Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200
   Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200
   Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082
   Chiu LLY, 2010, MACROMOL BIOSCI, V10, P1286, DOI 10.1002/mabi.201000202
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Cho CH, 2005, CIRC RES, V97, P86, DOI 10.1161/01.RES.0000174093.64855.a6
   Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101
   Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101
   Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479
   Dallabrida Susan M, 2005, Circ Res, V96, pe8, DOI 10.1161/01.RES.0000158285.57191.60
   David S, 2011, ARTERIOSCL THROM VAS, V31, P2643, DOI 10.1161/ATVBAHA.111.233189
   Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109
   Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107
   DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013
   Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992
   FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664
   Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714
   Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019
   Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050
   Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338
   Harrison DG, 1997, J CLIN INVEST, V100, P2153, DOI 10.1172/JCI119751
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5
   Ismail NS, 2010, J INVEST DERMATOL, V130, P1307, DOI 10.1038/jid.2009.431
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24
   Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2
   Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mochizuki N, 2009, CIRC J, V73, P2183, DOI 10.1253/circj.CJ-09-0666
   Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9
   Noll G, 1998, EUR HEART J, V19, pC30
   Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584
   Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rask F, 2010, SOFT MATTER, V6, P5089, DOI 10.1039/c0sm00362j
   Rask F, 2010, J BIOMED MATER RES A, V95A, P105, DOI 10.1002/jbm.a.32808
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Rustad KC, 2010, ORGANOGENESIS, V6, P151, DOI 10.4161/org.6.3.12139
   Sagnella S, 2005, TISSUE ENG, V11, P226, DOI 10.1089/ten.2005.11.226
   Sagnella SM, 2004, BIOMATERIALS, V25, P1249, DOI 10.1016/S0142-9612(03)00634-3
   Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715
   Tinsley JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1285
   Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0
   van der Heijden M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023448
   Van Slyke P, 2009, TISSUE ENG PT A, V15, P1269, DOI 10.1089/ten.tea.2007.0400
   Wang X, 2012, J BIOMED MATER RES A, V100A, P794, DOI 10.1002/jbm.a.34026
   Zhang C, 2013, J BIOMEDICAL MAT R A
NR 55
TC 15
Z9 15
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 27
PY 2013
VL 8
IS 8
AR e72956
DI 10.1371/journal.pone.0072956
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 210FR
UT WOS:000323815200061
PM 24013716
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Pugno, NM
   Cranford, SW
   Buehler, MJ
AF Pugno, Nicola M.
   Cranford, Steven W.
   Buehler, Markus J.
TI Synergetic Material and Structure Optimization Yields Robust Spider Web
   Anchorages
SO SMALL
LA English
DT Article
DE adhesion; silk; biological materials; biomimetics; spider webs
ID ORB-WEAVING SPIDERS; DRAGLINE SILK; BIOMIMETIC MATERIALS; ATTACHMENT
   DEVICES; CAPTURE; EVOLUTION; ADHESION; BIOMATERIAL; MECHANICS;
   DIVERSIFICATION
AB Millions of years of evolution have adapted spider webs to achieve a range of properties, including the well-known capture of prey, with efficient use of materials. One feature that remains poorly understood is the attachment disc, a network of silk fibers that mechanically anchors a web to its environment. Experimental observations suggest that one possible attachment disc adheres to a substrate through multiple symmetrically branched structures composed of sub-micrometer scale silk fibers. Here, a theoretical model is used to explore the adaptation of the strength of attachment of such an anchorage, and complementary mesoscale simulations are applied to demonstrate a novel mechanism of synergetic material and structural optimization, such that the maximum anchorage strength can be achieved regardless of the initial anchor placement or material type. The optimal delamination (peeling) angle is facilitated by the inherent extensibility of silk, and is attained automatically during the process of delamination. This concept of self-optimizing peeling angle suggests that attachment discs do not require precise placement by the spider, irrespective of adhesion strength. Additional hierarchical branching of the anchorage increases efficiency, where both the delamination force and toughness modulus increase with a splitting of the cross-sectional area.
C1 [Pugno, Nicola M.] Univ Trento, Dept Civil Environm & Mech Engn, Lab Bioinspired & Graphene Nanomech, I-38123 Trento, Italy.
   [Cranford, Steven W.; Buehler, Markus J.] MIT, Ctr Mat Sci & Engn, Dept Civil & Environm Engn, Lab Atomist & Mol Mech, Cambridge, MA 02139 USA.
RP Pugno, NM (reprint author), Univ Trento, Dept Civil Environm & Mech Engn, Lab Bioinspired & Graphene Nanomech, Via Mesiano 77, I-38123 Trento, Italy.
EM nicola.pugno@unitn.it; mbuehler@MIT.EDU
RI Pugno, Nicola/C-2289-2014; Buehler, Markus/C-4580-2008
OI Buehler, Markus/0000-0002-4173-9659
FU European Research Council [279985]; NSF-MRSEC [DMR-0819762]; ONR
   [N000141010562]; AFOSR [FA9550-11-1-0199]; ARO [W911NF-09-1-0541]
FX N. M. Pugno and S. W. Cranford contributed equally to this work. NMP is
   supported by the European Research Council under the European Union's
   Seventh Framework Programme (FP7/20072013)/ ERC Grant agreement no
   279985 (Ideas Starting Grant BIHSNAM, 2012-2016). NMP and MJB
   acknowledge the support from the MIT-Italy program MITOR. MJB and SWC
   acknowledge support from a NSF-MRSEC grant (DMR-0819762) with additional
   support from ONR (N000141010562), AFOSR (FA9550-11-1-0199) and ARO
   (W911NF-09-1-0541). The authors thank J. Vanzo for discussion.
CR Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x
   AGNARSSON I, 2010, PLOS ONE, V5
   Aizenberg J, 2009, ADV MATER, V21, P387, DOI 10.1002/adma.200803699
   Aoyanagi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038102
   Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100
   Autumn K, 2000, NATURE, V405, P681
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Blamires S. J., 2012, PLOS ONE, V7
   Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378
   Bosia F., 2010, PHYS REV E, V82
   Boutry C, 2009, ZOOLOGY, V112, P451, DOI 10.1016/j.zool.2009.03.003
   Bratzel G, 2012, BIOPOLYMERS, V97, P408, DOI 10.1002/bip.21729
   Carpinteri A, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/47/474213
   CODDINGTON JA, 1989, J ARACHNOL, V17, P71
   Craig CL, 1999, INT J BIOL MACROMOL, V24, P109, DOI 10.1016/S0141-8130(99)00006-9
   CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x
   Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739
   Federle W, 2006, J EXP BIOL, V209, P2611, DOI 10.1242/jeb.02323
   Filippov A, 2011, J THEOR BIOL, V276, P126, DOI 10.1016/j.jtbi.2011.01.049
   FOSSEY SA, 1991, BIOPOLYMERS, V31, P1529, DOI 10.1002/bip.360311309
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   Gao HJ, 2004, P NATL ACAD SCI USA, V101, P7851, DOI 10.1073/pnas.0400757101
   Gay C, 1999, PHYS REV LETT, V82, P936, DOI 10.1103/PhysRevLett.82.936
   Geurts P, 2010, BIOMACROMOLECULES, V11, P3495, DOI 10.1021/bm101002w
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hansell MH, 2005, ANIMINAL ARCHITECTUR
   Keten S., 2010, J R SOC INTERFACE, V53, P1709
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Ko K. K., 2002, ADV FIBERS PLASTICS, V702, P17
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Lepore E., 2012, PLOS ONE, V7, P30500
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Moon Myung-Jin, 2006, Entomological Research, V36, P133, DOI 10.1111/j.1748-5967.2006.00023.x
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Opell BD, 1998, FUNCT ECOL, V12, P613, DOI 10.1046/j.1365-2435.1998.00222.x
   Opell BD, 2001, EVOL ECOL RES, V3, P567
   Perry DJ, 2010, BIOMACROMOLECULES, V11, P3000, DOI 10.1021/bm1007585
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Pugno NM, 2011, INT J FRACTURE, V171, P185, DOI 10.1007/s10704-011-9638-2
   Pugno NM, 2008, BIOSYSTEMS, V94, P218, DOI 10.1016/j.biosystems.2008.06.009
   Pugno NM, 2007, J PHYS CONDENS MAT, V19
   Sahni V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2099
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Tarakanova A, 2012, J R SOC INTERFACE, V9, P3240, DOI 10.1098/rsif.2012.0473
   Tarakanova A, 2012, JOM-US, V64, P214, DOI 10.1007/s11837-012-0250-3
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Tian Y, 2006, P NATL ACAD SCI USA, V103, P19320, DOI 10.1073/pnas.0608841103
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Varenberg M, 2010, SOFT MATTER, V6, P3269, DOI 10.1039/c003207g
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221
   Xiao SB, 2009, BIOPHYS J, V96, P3997, DOI 10.1016/j.bpj.2009.02.052
NR 58
TC 27
Z9 27
U1 0
U2 33
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1613-6810
EI 1613-6829
J9 SMALL
JI Small
PD AUG 26
PY 2013
VL 9
IS 16
BP 2747
EP 2756
DI 10.1002/smll.201201343
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 262MD
UT WOS:000327738600014
PM 23585296
DA 2018-10-20
ER

PT J
AU Ward, CL
   Corona, BT
   Yoo, JJ
   Harrison, BS
   Christ, GJ
AF Ward, Catherine L.
   Corona, Benjamin T.
   Yoo, James J.
   Harrison, Benjamin S.
   Christ, George J.
TI Oxygen Generating Biomaterials Preserve Skeletal Muscle Homeostasis
   under Hypoxic and Ischemic Conditions
SO PLOS ONE
LA English
DT Article
ID SATURATED LIFOR SOLUTION; PIG ISOLATED HEARTS; HYPERBARIC-OXYGEN; RAT
   DIAPHRAGM; IN-VITRO; COMPARTMENT SYNDROME; CARDIAC-MUSCLE; LIMB
   ISCHEMIA; LOW-FLOW; INJURY
AB Provision of supplemental oxygen to maintain soft tissue viability acutely following trauma in which vascularization has been compromised would be beneficial for limb and tissue salvage. For this application, an oxygen generating biomaterial that may be injected directly into the soft tissue could provide an unprecedented treatment in the acute trauma setting. The purpose of the current investigation was to determine if sodium percarbonate (SPO), an oxygen generating biomaterial, is capable of maintaining resting skeletal muscle homeostasis under otherwise hypoxic conditions. In the current studies, a biologically and physiologically compatible range of SPO (1-2 mg/mL) was shown to: 1) improve the maintenance of contractility and attenuate the accumulation of HIF1 alpha, depletion of intramuscular glycogen, and oxidative stress (lipid peroxidation) that occurred following similar to 30 minutes of hypoxia in primarily resting (duty cycle = 0.2 s train/120 s contraction interval <0.002) rat extensor digitorum longus (EDL) muscles in vitro (95% N-2-5% CO2, 37 degrees C); 2) attenuate elevations of rat EDL muscle resting tension that occurred during contractile fatigue testing (3 bouts of 25 100 Hz tetanic contractions; duty cycle = 0.2 s/2 s = 0.1) under oxygenated conditions in vitro (95% O-2-5% CO2, 37 degrees C); and 3) improve the maintenance of contractility (in vivo) and prevent glycogen depletion in rat tibialis anterior (TA) muscle in a hindlimb ischemia model (i.e., ligation of the iliac artery). Additionally, injection of a commercially available lipid oxygen-carrying compound or the components (sodium bicarbonate and hydrogen peroxide) of 1 mg/mL SPO did not improve EDL muscle contractility under hypoxic conditions in vitro. Collectively, these findings demonstrate that a biological and physiological concentration of SPO (1-2 mg/mL) injected directly into rat skeletal muscle (EDL or TA muscles) can partially preserve resting skeletal muscle homeostasis under hypoxic conditions.
C1 [Ward, Catherine L.; Corona, Benjamin T.; Yoo, James J.; Harrison, Benjamin S.; Christ, George J.] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.
RP Christ, GJ (reprint author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.
EM gchrist@wakehealth.edu
RI Yoo, James/L-4850-2017
FU Armed Forces Institute for Regenerative Medicine (AFIRM)
   [W81XWH-08-2-0032]; Telemedicine and Advanced Technology Research Center
   (TATRC) at the U.S. Army Medical Research and Materiel Command
   [W81XWH-07-1-0718]; National Institute of Arthritis and Musculoskeletal
   and Skin Diseases (NIAMS) of the National Institutes of Health
   [R01AR063808]
FX This study was supported, in part, by the Armed Forces Institute for
   Regenerative Medicine (AFIRM) (W81XWH-08-2-0032) and Telemedicine and
   Advanced Technology Research Center (TATRC) (W81XWH-07-1-0718) at the
   U.S. Army Medical Research and Materiel Command, as well as the National
   Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
   (R01AR063808) of the National Institutes of Health. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Barclay CJ, 2005, J MUSCLE RES CELL M, V26, P225, DOI 10.1007/s10974-005-9013-x
   Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4
   Bouachour G, 1996, J TRAUMA, V41, P333, DOI 10.1097/00005373-199608000-00023
   Bowersox J.C., 1986, J HYPERBARIC MED, V1, P141
   BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279
   Centis V, 2009, FRONT BIOSCI, V14, P665, DOI 10.2741/3272
   Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006
   Clausen T, 2011, EXP PHYSIOL, V96, P356, DOI 10.1113/expphysiol.2010.054999
   Corona BT, 2010, AM J PHYSIOL-CELL PH, V298, pC365, DOI 10.1152/ajpcell.00365.2009
   Corona BT, 2010, MUSCLE NERVE, V42, P270, DOI 10.1002/mus.21715
   Corona BT, 2013, BIOMATERIALS
   Criswell TL, 2012, AM J PATHOL, V180, P787, DOI 10.1016/j.ajpath.2011.10.012
   CROW MT, 1982, J GEN PHYSIOL, V79, P147, DOI 10.1085/jgp.79.1.147
   Dragas M, 2009, INJURY, V40, P815, DOI 10.1016/j.injury.2008.08.012
   Dutka T. L., 2012, PLOS ONE, V7
   Fernandez MR, INT ENDOD J, V43, P102
   Gage F, 2009, TRANSPL P, V41, P3571, DOI 10.1016/j.transproceed.2009.06.228
   Gifford Shaun M, 2011, Perspect Vasc Surg Endovasc Ther, V23, P81, DOI 10.1177/1531003511410356
   GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312
   Haapaniemi T, 1996, PLAST RECONSTR SURG, V97, P602, DOI 10.1097/00006534-199603000-00017
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Henke PK, 2009, SEMIN VASC SURG, V22, P34, DOI 10.1053/j.semvascsurg.2009.01.002
   Heunks LMA, 2001, AM J PHYSIOL-LUNG C, V281, pL1402
   Hill AV, 1928, P R SOC LOND B-CONTA, V109, P39
   HOFMANN WW, 1976, AM J PHYSIOL, V230, P34
   HOOD DA, 1986, AM J PHYSIOL, V250, pE449
   Hoppeler H, 2003, EXP PHYSIOL, V88, P109, DOI 10.1113/eph8802513
   HUDLICKA O, 1994, J APPL PHYSIOL, V77, P1317
   IDSTROM JP, 1985, AM J PHYSIOL, V248, pH40
   Kaneko J, 2000, J ENDODONT, V26, P25, DOI 10.1097/00004770-200001000-00006
   MATSUDA T, 1987, J TRAUMA, V27, P115, DOI 10.1097/00005373-198702000-00002
   MENDEZ J, 1960, METABOLISM, V9, P184
   MOHAN C, 1992, AM J SURG, V164, P194, DOI 10.1016/S0002-9610(05)81069-4
   Mohanraj P, 1998, J APPL PHYSIOL, V84, P1960
   Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279
   Myers RAM, 2000, INT ANESTHESIOL CLIN, V38, P139, DOI 10.1097/00004311-200001000-00009
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Olschewski P, 2010, CRYOBIOLOGY, V60, P337, DOI 10.1016/j.cryobiol.2010.03.005
   Ottenheijm CAC, 2006, AM J PHYSIOL-LUNG C, V290, pL127, DOI 10.1152/ajplung.00073.2005
   Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Regner KR, 2010, J SURG RES, V164, pE291, DOI 10.1016/j.jss.2010.08.033
   REN JM, 1992, AM J PHYSIOL, V263, pE1086
   SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206
   Satterfield CN, 1961, J CHEM ENG DATA, V6, P504
   SEGAL SS, 1985, AM J PHYSIOL, V248, pC265
   SINENSKY MC, 1995, TOXICOL LETT, V75, P101
   Skuk D, 2013, CELL TRANSP IN PRESS
   Skuk D, 2007, NEUROMUSCULAR DISORD, V17, P38, DOI 10.1016/j.nmd.2006.10.003
   Smith MA, 2006, RESP PHYSIOL NEUROBI, V151, P229, DOI 10.1016/j.resp.2005.12.011
   Stowe DF, 2008, J HEART LUNG TRANSPL, V27, P1008, DOI 10.1016/j.healun.2008.05.028
   Stowe DF, 2007, AM J PHYSIOL-HEART C, V293, pH895, DOI 10.1152/ajpheart.00149.2007
   Strauss MB, 2012, UNDERSEA HYPERBAR M, V39, P847
   TAKAHASHI F, 1987, PLAST RECONSTR SURG, V80, P582, DOI 10.1097/00006534-198710000-00018
   Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8
   Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf
   VESPER SJ, 1994, J HAZARD MATER, V36, P265, DOI 10.1016/0304-3894(94)85019-4
   Vidigal J, 2007, MICROSURG, V27, P252, DOI 10.1002/micr.20350
   Vinnakota KC, 2010, J PHYSIOL-LONDON, V588, P1961, DOI 10.1113/jphysiol.2009.185934
   Wattel F, 1998, ANAESTHESIA, V53, P63
   WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615
   Wright VP, 2005, J APPL PHYSIOL, V98, P1753, DOI 10.1152/japplphysiol.01022.2004
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391
   Zhu XP, 2005, AM J PHYSIOL-LUNG C, V288, pL16, DOI 10.1152/ajplung.00412.2003
NR 64
TC 19
Z9 20
U1 2
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 26
PY 2013
VL 8
IS 8
AR e72485
DI 10.1371/journal.pone.0072485
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 215RU
UT WOS:000324228800075
PM 23991116
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ueda, M
   Oliveira, RM
   Rossi, J
   Mello, CB
   Rangel, RCC
   Vieira, MS
AF Ueda, M.
   Oliveira, R. M.
   Rossi, J.
   Mello, C. B.
   Rangel, Rita C. C.
   Vieira, M. S.
TI Improvements of plasma immersion ion implantation (PIII) and deposition
   (PIII&D) processing for materials surface modification
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Plasma immersion ion implantation and deposition; Surface modification
   by PIII&D; High temperature PIII; ZnO, Ca, hydroxyapatite films; Cr film
   on SAE 1070 steel by glow discharge enhanced magnetron sputtering
AB Plasma immersion ion implantation (PIII) process is a three dimensional surface modification method that is quite mature and well known to the surface engineering community nowadays, especially to those working in the field of plasma materials interaction, aiming at both industrial and academic applications. More recently, deposition methods have been added to PIII, the PIII&D, opening possibilities of broader range of applications of these techniques. So, PIII&D is becoming a routine method of surface modification, with the advantage of pushing up the retained dose levels limited by the sputtering due to ion implantation. Therefore, well adherent, thick, three-dimensional films without stress are possible to be achieved, at relatively low cost, using PIII&D.
   In this paper, we will discuss about a few PIII and PIII&D experiments that have been performed recently to achieve surface improvements in different materials: 1 - high temperature nitrogen PIII in Ti6Al4V alloy in which a deep nitrogen rich treated layer resulted in surface improvements as increase of hardness, corrosion resistance and resistance to wear of the Ti alloy; 2 - nanostructures in ZnO films, obtained by PIII&D of vaporized & ionized Zn source; 3 - combined implantation and deposition of calcium for biomaterial activity of Ti alloy (PIII&D), allowing the growth of hydroxyapatite in a body solution; 4 - magnetron sputtering deposition of Cr that was enhanced by the glow discharge Ar plasma to allow implantation and deposition of Cr on SAE 1070 steel (PIII&D) resulting in surfaces with high resistance to corrosion; and 5 - implantation of nitrogen by ordinary PIII into this Cr film, which improved resistance to corrosion, while keeping the tribological properties as good as for the SAE 1070 steel surface. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Ueda, M.; Oliveira, R. M.; Rossi, J.; Mello, C. B.; Vieira, M. S.] INPE, Lab Associado Plasma, Sao Jose Dos Campos, SP, Brazil.
   [Mello, C. B.] UNESP, Fac Engn Guaratingueta, Jaboticabal, SP, Brazil.
   [Rangel, Rita C. C.] UNESP Sorocaba, Lab Tecnol Plasmas, Sorocaba, SP, Brazil.
RP Ueda, M (reprint author), INPE, Lab Associado Plasma, Sao Jose Dos Campos, SP, Brazil.
EM ueda@plasma.inpe.br
RI Mello, Carina/G-3332-2012
OI Mello, Carina/0000-0003-4673-9487
FU MCT - Ministry of Science and Technology; FAPESP; CNPq
FX Funding from MCT - Ministry of Science and Technology, and from FAPESP
   and CNPq Brazilian Funding Agencies, are acknowledged. GDOES
   measurements were performed by Dr. J.A. Garcia from Centro de Ingenieria
   Avanzada de Superficies, Cordovilla, Pamplona, Spain. Dr. G.S. Savonov
   from INPE, Brazil, performed the potentiodynamic tests for the corrosion
   resistance of the Ti alloy samples.
CR Anders A, 2000, HDB PLASMA IMMERSION, P2
   Baur K, 1999, SURF SCI, V436, P141, DOI 10.1016/S0039-6028(99)00645-7
   Chu PK, 2010, SURF COAT TECH, V204, P2853, DOI 10.1016/j.surfcoat.2010.01.045
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   Fouquet V, 2004, SURF COAT TECH, V186, P34, DOI 10.1016/j.surfcoat.2004.04.006
   Kong YC, 2001, APPL PHYS LETT, V78, P407, DOI 10.1063/1.1342050
   Kwok SCH, 2006, DIAM RELAT MATER, V15, P893, DOI 10.1016/j.diamond.2005.10.062
   Lai LW, 2008, MATER CHEM PHYS, V110, P393, DOI 10.1016/j.matchemphys.2008.02.029
   Lee C.Y., 2003, J SCI ENG, V6, P127
   Li ZW, 2007, THIN SOLID FILMS, V515, P3323, DOI 10.1016/j.tsf.2006.09.026
   Mantese JV, 1996, MRS BULL, V21, P52
   Mello CB, 2011, SURF COAT TECH, V205, pS151, DOI 10.1016/j.surfcoat.2011.01.030
   Oliveira RM, 2011, SURF COAT TECH, V205, pS111, DOI 10.1016/j.surfcoat.2011.03.029
   Oliveira RM, 2010, SURF COAT TECH, V204, P3009, DOI 10.1016/j.surfcoat.2010.03.014
   Oliveira RM, 2010, SURF COAT TECH, V204, P2981, DOI 10.1016/j.surfcoat.2010.03.009
   Oliveira R.M., SCT UNPUB
   Oliveira R.M., VACUUM IN PRESS
   Phan M.T., 2000, J MAT SCI MED, V11, P383
   Rangel R.C.C., EUR J APPL PHYSL, DOI DOI 10.1051/EPJAP/2011110173
   Sharma S., 2009, APP SUR SCI, V255, P5781
   Silva MM, 2007, NUCL INSTRUM METH B, V257, P722, DOI 10.1016/j.nimb.2007.01.135
   Ueda M, 2005, SURF COAT TECH, V200, P517, DOI 10.1016/j.surfcoat.2005.02.146
   Ueda M, 2002, SURF COAT TECH, V156, P71, DOI 10.1016/S0257-8972(02)00115-9
   Ueda M., SCT UNPUB
   Vanheusden K, 1996, J APPL PHYS, V79, P7983, DOI 10.1063/1.362349
   White WB., 1974, MINERALOGICAL SOC MO, P227
   Zhang Y., 2004, SEMIC SCI TECH, V6, P755
NR 27
TC 7
Z9 7
U1 1
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 25
PY 2013
VL 229
BP 97
EP 104
DI 10.1016/j.surfcoat.2012.06.057
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 200TT
UT WOS:000323094500020
DA 2018-10-20
ER

PT J
AU Avalos Vizcarra, I
   Emge, P
   Miermeister, P
   Chabria, M
   Konradi, R
   Vogel, V
   Moller, J
AF Avalos Vizcarra, Ima
   Emge, Philippe
   Miermeister, Philipp
   Chabria, Mamta
   Konradi, Rupert
   Vogel, Viola
   Moeller, Jens
TI Fluorescence-based in situ assay to probe the viability and growth
   kinetics of surface-adhering and suspended recombinant bacteria
SO BIOINTERPHASES
LA English
DT Article
DE Antimicrobial surfaces; Optical viability monitoring; Green fluorescent
   protein (GFP); SYTO (R) 9; Propidium iodide (PI)
ID ESCHERICHIA-COLI; GENE-EXPRESSION; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL
   ACTIVITY; BIOFILM FORMATION; PROPIDIUM IODIDE; TYPE-1 FIMBRIAE;
   FLOW-CYTOMETRY; CELL-ADHESION; PROTEIN
AB Bacterial adhesion and biofilm growth can cause severe biomaterial-related infections and failure of medical implants. To assess the antifouling properties of engineered coatings, advanced approaches are needed for in situ monitoring of bacterial viability and growth kinetics as the bacteria colonize a surface. Here, we present an optimized protocol for optical real-time quantification of bacterial viability. To stain living bacteria, we replaced the commonly used fluorescent dye SYTO (R) 9 with endogenously expressed eGFP, as SYTO (R) 9 inhibited bacterial growth. With the addition of nontoxic concentrations of propidium iodide (PI) to the culture medium, the fraction of live and dead bacteria could be continuously monitored by fluorescence microscopy as demonstrated here using GFP expressing Escherichia coli as model organism. The viability of bacteria was thereby monitored on untreated and bioactive dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride (DMOAC)-coated glass substrates over several hours. Pre-adsorption of the antimicrobial surfaces with serum proteins, which mimics typical protein adsorption to biomaterial surfaces upon contact with host body fluids, completely blocked the antimicrobial activity of the DMOAC surfaces as we observed the recovery of bacterial growth. Hence, this optimized eGFP/PI viability assay provides a protocol for unperturbed in situ monitoring of bacterial viability and colonization on engineered biomaterial surfaces with single-bacteria sensitivity under physiologically relevant conditions.
C1 [Avalos Vizcarra, Ima; Emge, Philippe; Chabria, Mamta; Vogel, Viola; Moeller, Jens] ETH, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, CH-8093 Zurich, Switzerland.
   [Miermeister, Philipp] Fraunhofer Inst Mfg Engn & Automat IPA, D-70569 Stuttgart, Germany.
   [Konradi, Rupert] BASF SE, Adv Mat & Syst Res, D-67056 Ludwigshafen, Germany.
RP Moller, J (reprint author), ETH, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, CH-8093 Zurich, Switzerland.
EM jens.moeller@hest.ethz.ch
RI Vogel, Viola/O-8025-2015; Moeller, Jens/F-5110-2011
OI Vogel, Viola/0000-0003-2898-7671; Moeller, Jens/0000-0002-7226-0675
FU BASF SE, Ludwigshafen, Germany; ETH Zurich
FX The authors thank Prof. Evgeni Sokurenko (University of Washington,
   Seattle, USA) for providing the E. coli AAEC191A strain and Dr. Peter
   Kaiser for help on Metamorph journals. We thank Mohammad Divandari and
   Dr. Edmondo M. Benetti for assistance with ellipsometry measurements and
   Markus Arnoldini and Prof. Martin Ackermann for providing the MG1655
   rpsm-GFP strain. We thank Prof. Marcus Textor for valuable discussions
   during the design of the assay. Funding from BASF SE, Ludwigshafen,
   Germany and ETH Zurich (V.V.) is gratefully acknowledged.
CR Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240
   Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06
   Asadishad B, 2011, ENVIRON SCI TECHNOL, V45, P8345, DOI 10.1021/es201496q
   Aspiras MB, 2000, APPL ENVIRON MICROB, V66, P4074, DOI 10.1128/AEM.66.9.4074-4083.2000
   AYALASANMARTIN J, 1989, MOL MICROBIOL, V3, P1745, DOI 10.1111/j.1365-2958.1989.tb00160.x
   Banning N, 2002, J APPL MICROBIOL, V93, P69, DOI 10.1046/j.1365-2672.2002.01670.x
   Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x
   Benoit MR, 2010, APPL ENVIRON MICROB, V76, P4136, DOI 10.1128/AEM.03065-09
   Berg CM, 1996, ECOSAL ESCHERICHIA C
   Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06
   BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x
   Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2
   Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006
   Charnley M, 2011, REACT FUNCT POLYM, V71, P329, DOI 10.1016/j.reactfunctpolym.2010.10.013
   Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Davey HM, 2011, APPL ENVIRON MICROB, V77, P5571, DOI 10.1128/AEM.00744-11
   Deligeorgiev Todor G., 2009, Recent Patents on Materials Science, V2, P1
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Green J-BD, 2010, BIOTECHNOL BIOENG, V108, P231
   ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859
   Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r
   KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1111/j.1574-6968.1993.tb05871.x
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kennedy D, 2011, APPL ENVIRON MICROB, V77, P4657, DOI 10.1128/AEM.00323-11
   Klibanov AM, 2007, J MATER CHEM, V17, P2479, DOI 10.1039/b702079a
   KUES U, 1989, MICROBIOL REV, V53, P491
   Lehtinen J, 2004, CYTOM PART A, V60A, P165, DOI 10.1002/cyto.a.20026
   Lenz AP, 2008, APPL ENVIRON MICROB, V74, P4463, DOI 10.1128/AEM.00710-08
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018083
   Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011
   Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399
   Neoh KG, 2011, ACS APPL MATER INTER, V3, P2808, DOI 10.1021/am200646t
   Parreira P, 2011, J BIOMED MATER RES A, V99A, P344, DOI 10.1002/jbm.a.33178
   Pei J, 2011, BIOMATERIALS, V32, P8968, DOI 10.1016/j.biomaterials.2011.08.034
   Pidhatika B, 2010, BIOMATERIALS, V31, P9462, DOI 10.1016/j.biomaterials.2010.08.033
   Postgate JR., 1969, METHOD MICROBIOL, V1, P611, DOI DOI 10.1016/S0580-9517(08)70149-1
   Reisner A, 2006, J BACTERIOL, V188, P3572, DOI 10.1128/JB.188.10.3572-3581.2006
   Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005
   Rodrigues DF, 2009, BIOFOULING, V25, P401, DOI 10.1080/08927010902833443
   Schiffman JD, 2011, ACS APPL MATER INTER, V3, P462, DOI 10.1021/am101043y
   Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069
   Strauber H, 2010, CYTOM PART A, V77A, P623, DOI 10.1002/cyto.a.20920
   SUMMERS DK, 1985, BIOESSAYS, V2, P209, DOI 10.1002/bies.950020506
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tombolini R, 1997, FEMS MICROBIOL ECOL, V22, P17, DOI 10.1111/j.1574-6941.1997.tb00352.x
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008
   Xie X, 2011, BIOMATERIALS, V32, P4347, DOI 10.1016/j.biomaterials.2011.02.063
   Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895
NR 51
TC 1
Z9 1
U1 0
U2 40
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD AUG 21
PY 2013
VL 8
AR 22
DI 10.1186/1559-4106-8-22
PG 9
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 227BQ
UT WOS:000325083100001
PM 24706134
OA Green Published
DA 2018-10-20
ER

PT J
AU Nair, KL
   Jagadeeshan, S
   Nair, SA
   Kumar, GSV
AF Nair, Lekha K.
   Jagadeeshan, Sankar
   Nair, Asha S.
   Kumar, G. S. Vinod
TI Folic Acid Conjugated delta-Valerolactone-Poly(ethylene glycol) Based
   Triblock Copolymer as a Promising Carrier for Targeted Doxorubicin
   Delivery
SO PLOS ONE
LA English
DT Article
ID DRUG-DELIVERY; FOLATE-RECEPTOR; CANCER-CELLS; ANTICANCER DRUGS; POLYMER
   MICELLES; IMAGING AGENTS; NANOPARTICLES; LIPOSOMES; EXPRESSION;
   APOPTOSIS
AB The aim of this study is to test the hypothesis that the newly synthesized poly(delta-valerolactone)/poly(ethylene glycol)/poly(delta-valerolactone) (VEV) copolymer grafted with folic acid would impart targetability and further enhance the anti-tumor efficacy of doxorubicin (DOX). Here, folic acid conjugated VEV (VEV-FOL) was synthesized by a modified esterification method and characterized using IR and NMR. DOX loaded VEV-FOL micelles were synthesized using a novel solvent evaporation method and were obtained with a mean diameter of 97 nm with high encapsulation efficiency and sustained in vitro release profile. Comparative studies of polymer micelles with and without folate for cellular uptake and cytotoxicity were done on folate receptor-positive breast cancer cell line, MDAMB231. The intracellular uptake tests showed significant increase in folate micellar uptake when compared to non-folate-mediated micelles. MTT assay followed by apoptosis assays clearly indicated that folate decorated micelles showed significantly better cytotoxicity (IC50 = 0.014 mu M) and efficiency to induce apoptosis than other treated groups. Moreover, a significant G2/M arrest was induced by DOX loaded VEV-FOL micelles at a concentration where free drug failed to show any activity. Thus, our results show that the folic acid-labeled VEV copolymer is a promising biomaterial with controlled and sustainable tumor targeting ability for anticancer drugs which can open new frontiers in the area of targeted chemotherapy.
C1 [Nair, Lekha K.; Jagadeeshan, Sankar; Nair, Asha S.; Kumar, G. S. Vinod] Rajiv Gandhi Ctr Biotechnol, Poojappura, Kerala, India.
RP Kumar, GSV (reprint author), Rajiv Gandhi Ctr Biotechnol, Poojappura, Kerala, India.
EM gsvinod@rgcb.res.in
FU Council of Scientific and Industrial Research, New Delhi, India
FX LNK sincerely acknowledges Council of Scientific and Industrial
   Research, New Delhi, India, for providing research fellowship and the
   authors' gratefully acknowledge National Institute of Interdisciplinary
   Sciences and Technology, Kerala, India, for NMR studies. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008
   BARLOGIE B, 1976, CANCER RES, V36, P1975
   Dilnawaz F, 2010, BIOMATERIALS, V31, P3694, DOI 10.1016/j.biomaterials.2010.01.057
   DiPaola RS, 2002, CLIN CANCER RES, V8, P3311
   Fritzer M, 1996, BIOCHEM PHARMACOL, V51, P489, DOI 10.1016/0006-2952(95)02225-2
   Gabizon A, 2003, CLIN CANCER RES, V9, P6551
   Jennifer S. B. A., 2000, ADV DRUG DELIVERY RE, V41, P147
   Justin BL, 2012, INT J CANCER, V131, pE781
   Kakudo T, 2004, BIOCHEMISTRY-US, V43, P5618, DOI 10.1021/bi035802w
   Kang KW, 2010, NANOMED-NANOTECHNOL, V6, P210, DOI 10.1016/j.nano.2009.12.006
   Kikuchi A, 1996, BIOCHEM BIOPH RES CO, V227, P666, DOI 10.1006/bbrc.1996.1566
   Kim SY, 2007, MACROMOL RES, V15, P646, DOI 10.1007/BF03218945
   KOOPMAN G, 1994, BLOOD, V84, P1415
   Lee K, 2010, BIOMATERIALS, V31, P6530, DOI 10.1016/j.biomaterials.2010.04.046
   Liu SQ, 2007, BIOMATERIALS, V28, P1423, DOI 10.1016/j.biomaterials.2006.11.013
   Liu YT, 2010, BIOMATERIALS, V31, P330, DOI 10.1016/j.biomaterials.2009.09.036
   Matteucci C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.58
   Meier R, 2010, RADIOLOGY, V255, P527, DOI 10.1148/radiol.10090050
   Nair KL, 2012, J APPL POLYM SCI, V124, P2030, DOI 10.1002/app.35229
   Nair K Lekha, 2011, Int J Nanomedicine, V6, P1685, DOI 10.2147/IJN.S20165
   Nair KL, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-42
   Nasongkla N, 2006, NANO LETT, V6, P2427, DOI 10.1021/nl061412u
   O'Loughlin C, 2000, EUR J CANCER, V36, P1149, DOI 10.1016/S0959-8049(00)00071-X
   Ohara Y, 2012, INT J CANCER, V131, P2402, DOI 10.1002/ijc.27502
   Park EK, 2005, BIOMATERIALS, V26, P1053, DOI 10.1016/j.biomaterials.2004.04.008
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Reddy JA, 2005, CURR PHARM BIOTECHNO, V6, P131, DOI 10.2174/1389201053642376
   Sapra Puja, 2005, Current Drug Delivery, V2, P369, DOI 10.2174/156720105774370159
   Shmeeda H, 2006, MOL CANCER THER, V5, P818, DOI 10.1158/1535-7163.MCT-05-0543
   Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9
   Tanaka K, 2010, INT J PHARMACEUT, V396, P229, DOI 10.1016/j.ijpharm.2010.06.028
   Tao XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049304
   Wang S, 1998, J CONTROL RELEASE, V53, P39, DOI 10.1016/S0168-3659(97)00236-8
   Wu J, 2006, INT J PHARM, V316, P148, DOI 10.1016/j.ijpharm.2006.02.027
   Zeng FQ, 2006, BIOCONJUGATE CHEM, V17, P399, DOI 10.1021/bc050350g
   Zhang ZP, 2007, BIOMATERIALS, V28, P1889, DOI 10.1016/j.biomaterials.2006.12.018
   Zhao HZ, 2008, INT J PHARMACEUT, V349, P256, DOI 10.1016/j.ijpharm.2007.07.040
   Zhao HZ, 2009, J BIOMED MATER RES A, V91A, P505, DOI 10.1002/jbm.a.32220
NR 38
TC 5
Z9 5
U1 1
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 21
PY 2013
VL 8
IS 8
AR e70697
DI 10.1371/journal.pone.0070697
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 218YW
UT WOS:000324470100032
PM 23990912
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Seo, HJ
   Lee, MH
   Kwon, BJ
   Kim, HL
   Lee, SJ
   Kim, BJ
   Wang, KK
   Kim, YR
   Park, JC
AF Seo, Hyok Jin
   Lee, Mi Hee
   Kwon, Byeong-Ju
   Kim, Hye-Lee
   Lee, Seung Jin
   Kim, Bong-Jin
   Wang, Kang-Kyun
   Kim, Yong-Rok
   Park, Jong-Chul
TI Plasma treatment induces internal surface modifications of electrospun
   poly(L-lactic) acid scaffold to enhance protein coating
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID GROWTH; CELLS; ADHESION; COLLAGEN; IMMOBILIZATION; PROLIFERATION;
   CHONDROCYTES; FABRICATION; FIBROBLAST; CHITOSAN
AB Advanced biomaterials should also be bioactive with regard to desirable cellular responses, such as selective protein adsorption and cell attachment, proliferation, and differentiation. To enhance cell-material interactions, surface modifications have commonly been performed. Among the various surface modification approaches, atmospheric pressure glow discharge plasma has been used to change a hydrophobic polymer surface to a hydrophilic surface. Poly(L-lactic acid) (PLLA)-derived scaffolds lack cell recognition signals and the hydrophobic nature of PLLA hinders cell seeding. To make PLLA surfaces more conducive to cell attachment and spreading, surface modifications may be used to create cell-biomaterial interfaces that elicit controlled cell adhesion and maintain differentiated phenotypes. In this study, (He) gaseous atmospheric plasma glow discharge was used to change the characteristics of a 3D-type polymeric scaffold from hydrophobic to hydrophilic on both the outer and inner surfaces of the scaffold and the penetration efficiency with fibronectin was investigated. Field-emission scanning electron microscope images showed that some grooves were formed on the PLLA fibers after plasma treatment. X-ray photoelectron spectroscopy data also showed chemical changes in the PLLA structure. After plasma treatment, -CN (285.76 eV) was increased in C1s and -NH2 (399.70 eV) was increased significantly and -N=CH (400.80 eV) and -NH3+ (402.05 eV) were newly appeared in N1s. These changes allowed fibronectin to penetrate into the PLLA scaffold; this could be observed by confocal microscopy. In conclusion, helium atmospheric pressure plasma treatment was effective in modifying the polymeric scaffold, making it hydrophilic, and this treatment can also be used in tissue engineering research as needed to make polymers hydrophilic. (C) 2013 AIP Publishing LLC.
C1 [Seo, Hyok Jin; Lee, Mi Hee; Kwon, Byeong-Ju; Kim, Hye-Lee; Park, Jong-Chul] Yonsei Univ, Coll Med, Dept Med Engn, Cellbiocontrol Lab, Seoul 120752, South Korea.
   [Seo, Hyok Jin; Lee, Mi Hee; Kwon, Byeong-Ju; Kim, Hye-Lee; Park, Jong-Chul] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
   [Lee, Seung Jin] Ewha Womans Univ, Coll Pharm, Dept Ind Pharm, Seoul 120750, South Korea.
   [Kim, Bong-Jin; Wang, Kang-Kyun; Kim, Yong-Rok] Yonsei Univ, Dept Chem, Seoul 120749, South Korea.
RP Park, JC (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, Cellbiocontrol Lab, Seoul 120752, South Korea.
EM parkjc@yuhs.ac
OI Wang, Kang-kyun/0000-0001-5116-8151
FU Ministry for Health & Welfare, Republic of Korea [A120878]
FX This study was supported by a grant of the Korea Healthcare technology
   R&D Project, Ministry for Health & Welfare, Republic of Korea (A120878).
CR Asher T, 2009, ELECTROCHIM ACTA, V54, P6053, DOI 10.1016/j.electacta.2009.02.089
   Bhati RS, 2001, J BIOMED MATER RES, V56, P74, DOI 10.1002/1097-4636(200107)56:1<74::AID-JBM1070>3.0.CO;2-M
   Cui WG, 2010, BIOMATERIALS, V31, P4620, DOI 10.1016/j.biomaterials.2010.02.050
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   He FP, 2013, COLLOID SURFACE B, V103, P209, DOI 10.1016/j.colsurfb.2012.10.018
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   LINDBERG B, 1983, J COLLOID INTERF SCI, V95, P308, DOI 10.1016/0021-9797(83)90190-X
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Meneghello G., 2009, J MEMBR SCI, V344
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   RAIZER YP, 1991, GAS DISCHARGE PHYS, P52
   Safinia L, 2008, J BIOMED MATER RES A, V87A, P632, DOI 10.1002/jbm.a.31731
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Shim IK, 2010, J BIOMED MATER RES B, V95B, P150, DOI 10.1002/jbm.b.31695
   Shin YM, 2010, MACROMOL RES, V18, P472, DOI 10.1007/s13233-010-0507-z
   Tendero C, 2006, SPECTROCHIM ACTA B, V61, P2, DOI 10.1016/j.sab.2005.10.003
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wu SR, 1996, J APPL POLYM SCI, V62, P1347, DOI 10.1002/(SICI)1097-4628(19961128)62:9<1347::AID-APP5>3.0.CO;2-H
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang SJ, 2007, PLASMA CHEM PLASMA P, V27, P23, DOI 10.1007/s11090-006-9041-3
   Yildirim ED, 2008, PLASMA PROCESS POLYM, V5, P58, DOI 10.1002/ppap.200700041
   Zhang W, 2008, ACTA BIOMATER, V4, P2028, DOI 10.1016/j.actbio.2008.05.012
   Zhu HG, 2004, J BIOMED MATER RES B, V71B, P159, DOI 10.1002/jbm.b.30080
NR 26
TC 2
Z9 2
U1 2
U2 53
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD AUG 21
PY 2013
VL 114
IS 7
AR 073304
DI 10.1063/1.4818914
PG 6
WC Physics, Applied
SC Physics
GA 206HV
UT WOS:000323510900009
DA 2018-10-20
ER

PT J
AU Ravichandran, R
   Venugopal, JR
   Sundarrajan, S
   Mukherjee, S
   Sridhar, R
   Ramakrishna, S
AF Ravichandran, Rajeswari
   Venugopal, Jayarama Reddy
   Sundarrajan, Subramanian
   Mukherjee, Shayanti
   Sridhar, Radhakrishnan
   Ramakrishna, Seeram
TI Expression of cardiac proteins in neonatal cardiomyocytes on
   PGS/fibrinogen core/shell substrate for Cardiac tissue engineering
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Article
DE Cardiomyocytes; Core/shell fibers; Myocardial infarction; Cardiac tissue
   engineering
ID MYOCARDIAL-INFARCTION; SKELETAL MYOBLASTS; FIBRIN SEALANT;
   HEART-FAILURE; STEM-CELLS; TRANSPLANTATION; SCAFFOLD; GRAFTS; MATRIX;
   BIOMATERIALS
AB Background: Heart failure due to myocardial infarction remains the leading cause of death worldwide owing to the inability of myocardial tissue regeneration. The aim of this study is to develop a core/shell fibrous cardiac patch having desirable mechanical properties and biocompatibility to engineer the infarcted myocardium.
   Method: We fabricated poly(glycerol sebacate)/fibrinogen (PGS/fibrinogen) core/shell fibers with core as elastomeric PGS provides suitable mechanical properties comparable to that of native tissue and shell as fibrinogen to promote cell-biomaterial interactions. The PGS/fibrinogen core/shell fibers and fibrinogen nanofibers were characterized by SEM, contact angle and tensile testing to analyze the fiber morphology, wettability, and mechanical properties of the scaffold. The cell-scaffold interactions were analyzed using isolated neonatal cardiomyocytes for cell proliferation, confocal analysis for the expression of marker proteins alpha-actinin, Troponin-T, beta-myosin heavy chain and connexin 43 and SEM analysis for cell morphology.
   Results: We observed PGS/fibrinogen core/shell fibers had a Young's modulus of about 3.28 +/- 1.7 MPa, which was comparable to that of native myocardium. Neonatal cardiomyocytes cultured on these scaffolds showed normal expression of cardiac specific marker proteins alpha-actinin, Troponin, beta-myosin heavy chain and connexin 43 to prove PGS/fibrinogen core/shell fibers have potential for cardiac tissue engineering.
   Conclusion: Results indicated that neonatal cardiomyocytes formed predominant gap junctions and expressed cardiac specific marker proteins on PGS/fibrinogen core/shell fibers compared to fibrinogen nanofibers, indicating PGS/fibrinogen core/shell fibers may serve as a suitable cardiac patch for the regeneration of infarcted myocardium. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Ravichandran, Rajeswari; Venugopal, Jayarama Reddy; Sundarrajan, Subramanian; Mukherjee, Shayanti; Sridhar, Radhakrishnan; Ramakrishna, Seeram] Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Fac Engn, Healthcare & Energy Mat Lab, Singapore 117576, Singapore.
   [Ravichandran, Rajeswari; Sundarrajan, Subramanian; Sridhar, Radhakrishnan; Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Venugopal, JR (reprint author), Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Fac Engn, Block E3,05-12,2 Engn Dr 3, Singapore 117576, Singapore.
EM nnijrv@nus.edu.sg; seeram@nus.edu.sg
RI Radhakrishnan, Sridhar/B-7439-2013; Subramanian, Sundarrajan/E-8022-2011
OI Radhakrishnan, Sridhar/0000-0002-5068-3175; Jayarama Reddy,
   Venugopal/0000-0001-5867-8007
FU NRF-Technion [R-398-001-065-592]; Ministry of Education
   [R-265-000-318-112]; NUSNNI, National University of Singapore, Singapore
FX This study was supported by the NRF-Technion (R-398-001-065-592),
   Ministry of Education (R-265-000-318-112) and NUSNNI, National
   University of Singapore, Singapore.
CR Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9
   Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc
   Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023
   Braunwald E, 2000, CIRCULATION, V102, P14
   Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9
   Crisostomo PR, 2007, SHOCK, V28, P375, DOI 10.1097/shk.0b013e318058a817
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Dib N, 2002, J ENDOVASC THER, V9, P313, DOI 10.1583/1545-1550(2002)009<0313:ETOASM>2.0.CO;2
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   EISENBERG E, 1980, ANNU REV PHYSIOL, V42, P293, DOI 10.1146/annurev.ph.42.030180.001453
   ElOakley RM, 1996, J HEART LUNG TRANSPL, V15, P255
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   ERLEBACHER JA, 1984, J AM COLL CARDIOL, V4, P201, DOI 10.1016/S0735-1097(84)80203-X
   Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   HUNT SA, 2006, J AM COLL CARDIOL, V47, P1503
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Li RK, 1996, CIRC RES, V78, P283, DOI 10.1161/01.RES.78.2.283
   Li YS, 2007, CHINESE MED J-PEKING, V120, P2022
   Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1
   Mayer JE, 1997, CURR OPIN CARDIOL, V12, P528, DOI 10.1097/00001573-199711000-00005
   OLIVETTI G, 1990, CIRC RES, V67, P23, DOI 10.1161/01.RES.67.1.23
   Ozawa T, 2002, CIRCULATION, V106, pI176, DOI 10.1161/01.cir.0000032901.55215.cc
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Ravichandran R., 2010, TISSUE ENG PART A, V17, P1363
   Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Robinson KA, 2005, CIRCULATION, V112, pI135
   ROUSOU J, 1989, J THORAC CARDIOV SUR, V97, P194
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   Smits AM, 2005, J CELL MOL MED, V9, P25, DOI 10.1111/j.1582-4934.2005.tb00334.x
   Tang YL, 2005, METH MOLEC MED, V112, P193
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WARREN SE, 1988, J AM COLL CARDIOL, V11, P12, DOI 10.1016/0735-1097(88)90159-3
   Xing Yu, 2003, Fa Yi Xue Za Zhi, V19, P242
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 45
TC 43
Z9 46
U1 0
U2 36
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD AUG 20
PY 2013
VL 167
IS 4
BP 1461
EP 1468
DI 10.1016/j.ijcard.2012.04.045
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 206ZV
UT WOS:000323566800073
PM 22564386
DA 2018-10-20
ER

PT J
AU Awojoodu, AO
   Ogle, ME
   Sefcik, LS
   Bowers, DT
   Martin, K
   Brayman, KL
   Lynch, KR
   Peirce-Cottler, SM
   Botchwey, E
AF Awojoodu, Anthony O.
   Ogle, Molly E.
   Sefcik, Lauren S.
   Bowers, Daniel T.
   Martin, Kyle
   Brayman, Kenneth L.
   Lynch, Kevin R.
   Peirce-Cottler, Shayn M.
   Botchwey, Edward
TI Sphingosine 1-phosphate receptor 3 regulates recruitment of
   anti-inflammatory monocytes to microvessels during implant
   arteriogenesis
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE sphingolipid; microvascular remodeling; biomaterials; immunomodulation;
   tissue engineering
ID COLLATERAL CAPILLARY ARTERIALIZATION; ENDOTHELIAL GROWTH-FACTOR;
   PROGENITOR CELLS; SKELETAL-MUSCLE; ACTIVATION; BLOOD; MACROPHAGES;
   SPHINGOSINE-1-PHOSPHATE; MOBILIZATION; FRACTALKINE
AB Endothelial cells play significant roles in conditioning tissues after injury by the production and secretion of angiocrine factors. At least two distinct subsets of monocytes, CD45(+)CD11b(+)Gr1(+)Ly6C(+) inflammatory and CD45(+)CD11b(+)Gr1(-)Ly6C(-) anti-inflammatory monocytes, respond differentially to these angiocrine factors and promote pathogen/debris clearance and arteriogenesis/tissue regeneration, respectively. We demonstrate here that local sphingosine 1-phosphate receptor 3 (S1P(3)) agonism recruits anti-inflammatory monocytes to remodeling vessels. Poly(lactic-co-glycolic acid) thin films were used to deliver FTY720, an S1P(1/3) agonist, to inflamed and ischemic tissues, which resulted in a reduction in proinflammatory cytokine secretion and an increase in regenerative cytokine secretion. The altered balance of cytokine secretion results in preferential recruitment of anti-inflammatory monocytes from circulation. The chemotaxis of these cells, which expressmore S1P(3) than inflammatory monocytes, toward SDF-1 alpha was also enhanced with FTY720 treatment, but not in S1P(3) knockout cells. FTY720 delivery enhanced arteriolar diameter expansion and increased length density of the local vasculature. This work establishes a role for S1P receptor signaling in the local conditioning of tissues by angiocrine factors that preferentially recruit regenerative monocytes that can enhance healing outcomes, tissue regeneration, and biomaterial implant functionality.
C1 [Awojoodu, Anthony O.; Ogle, Molly E.; Botchwey, Edward] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Sefcik, Lauren S.] Lafayette Coll, Dept Chem & Biomol Engn, Easton, PA 18042 USA.
   [Bowers, Daniel T.; Martin, Kyle; Peirce-Cottler, Shayn M.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.
   [Brayman, Kenneth L.] Univ Virginia, Dept Surg, Charlottesville, VA 22903 USA.
   [Lynch, Kevin R.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22903 USA.
RP Botchwey, E (reprint author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
EM edward.botchwey@bme.gatech.edu
OI Martin, Kyle/0000-0002-6161-9611
FU National Institutes of Health [1R01DE019935-01, 1R01AR056445-01A2,
   T32GM-008715]; National Science Foundation [NSF0933643]
FX We thank Dr. Richard Price, Dr. Caitlin Burke, and Anthony Bruce for
   assistance with creating chimeric and transgenic mice; Dr. Klaus Ley (La
   Jolla Institute for Allergy) for providing the CX3CR1-eGFP mice; Blair
   Hu, Carol Bampo, and Cheryl Lau for experimental assistance; and Claire
   Segar for critical review of manuscript. We are grateful for the
   assistance provided by the University of Virginia School of Medicine
   Flow Cytometry Core and Research Histology Core. This work was supported
   in part by National Institutes of Health Grants 1R01DE019935-01,
   1R01AR056445-01A2, and T32GM-008715 and National Science Foundation
   Grant NSF0933643.
CR Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Bruce AC, 2012, MICROCIRCULATION, V19, P143, DOI 10.1111/j.1549-8719.2011.00138.x
   Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083
   Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413
   Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2
   Golan K, 2012, BLOOD, V119, P2478, DOI 10.1182/blood-2011-06-358614
   Goldman D, 2000, J THEOR BIOL, V206, P181, DOI 10.1006/jtbi.2000.2113
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Greaves DR, 2001, ARTERIOSCL THROM VAS, V21, P923, DOI 10.1161/01.ATV.21.6.923
   Hur J, 2013, BIOMATERIALS, V34, P1929, DOI 10.1016/j.biomaterials.2012.11.015
   Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028
   Kimura T, 2004, BLOOD, V103, P4478, DOI 10.1182/blood-2003-03-0875
   Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989
   Mac Gabhann F, 2010, MICROCIRCULATION, V17, P333, DOI 10.1111/j.1549-8719.2010.00034.x
   Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189
   Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804
   Retzlaff S, 2002, ONCOL REP, V9, P525
   Ruitenberg MJ, 2008, J NEUROIMMUNOL, V205, P80, DOI 10.1016/j.jneuroim.2008.09.010
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Sefcik LS, 2011, TISSUE ENG PT A, V17, P617, DOI [10.1089/ten.tea.2010.0404, 10.1089/ten.TEA.2010.0404]
   Shantsila E, 2013, THROMB HAEMOSTASIS, V109, P255, DOI 10.1160/TH12-06-0395
   Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477
   Takuwa Yoh, 2010, World J Biol Chem, V1, P298, DOI 10.4331/wjbc.v1.i10.298
   Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70
   Weigert A, 2007, MOL BIOL CELL, V18, P3810, DOI 10.1091/mbc.E06-12-1096
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001
   Yun HJ, 2003, J KOREAN MED SCI, V18, P679, DOI 10.3346/jkms.2003.18.5.679
   Zhu R, 2007, J MED CHEM, V50, P6428, DOI 10.1021/jm7010172
NR 34
TC 56
Z9 58
U1 0
U2 12
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 20
PY 2013
VL 110
IS 34
BP 13785
EP 13790
DI 10.1073/pnas.1221309110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 203DU
UT WOS:000323271400035
PM 23918395
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Hu, X
   Tang-Schomer, MD
   Huang, WW
   Xia, XX
   Weiss, AS
   Kaplan, DL
AF Hu, Xiao
   Tang-Schomer, Min D.
   Huang, Wenwen
   Xia, Xiao-Xia
   Weiss, Anthony S.
   Kaplan, David L.
TI Charge-Tunable Autoclaved Silk-Tropoelastin Protein Alloys That Control
   Neuron Cell Responses
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE charges; silk fibroins; elastins; cortical neurons; tissue engineering
ID FIBROUS PROTEINS; BIOMATERIALS; ELASTICITY; POLYMERS; STEM;
   DIFFERENTIATION; REGENERATION; SPECTROSCOPY; ADHESION; FEATURES
AB Tunable protein composites are important for constructing extracellular matrix mimics of human nerve tissues with control of charge, structural, and mechanical properties. Molecular interaction mechanisms between silk fibroin protein and recombinant human tropoelastin, based on charge, are utilized to generate a new group of multifunctional protein alloys with different net charges. These new biomaterials are then utilized as a biomaterial platform to control neuron cell response. With a +38 net charge in water, tropoelastin molecules provide extraordinary elasticity and selective interactions with cell surface integrins. In contrast, negatively charged silk fibroin protein (net charge -36) provides remarkable toughness and stiffness with morphologic stability in material formats via autoclaving-induced beta-sheet crystal physical crosslinks. The combination of these properties in alloy format extends the versatility of both structural proteins, providing a new biocompatible, biodegradable, and charge-tunable biomaterial platform for neural repair. The data point to these protein alloys as an alternative to commonly used charged synthetic polymers, particularly with regard to the versatility of material formats (e.g., gels, sponges, films, fibers). The results also provide a practical example of physically designed protein materials with control of net charge to direct biological outcomes, in this case for neuronal tissue engineering.
C1 [Hu, Xiao; Tang-Schomer, Min D.; Huang, Wenwen; Xia, Xiao-Xia; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
RP Hu, X (reprint author), Rowan Univ, Dept Phys & Astron, Glassboro, NJ 08028 USA.
EM david.kaplan@tufts.edu
RI Xia, Xiaoxia/C-6614-2013; Huang, Wenwen/H-5352-2018; Hu,
   Xiao/F-2403-2012
OI Xia, Xiaoxia/0000-0001-8375-1616; Huang, Wenwen/0000-0001-8175-9083; Hu,
   Xiao/0000-0002-2579-2820; WEISS, ANTHONY/0000-0002-8106-4836
FU NIH [AR005593, P41 EB002520, EB014283]; Air Force Office of Scientific
   Research, DARPA [W911NF-11-1-0079]; AFIRM; Australian Research Council;
   National Health and Medical Research Council; Defense Health Foundation
FX The authors thank the NIH (AR005593, P41 EB002520, EB014283), the Air
   Force Office of Scientific Research, DARPA (W911NF-11-1-0079), and AFIRM
   for support of this research. A. S. W. acknowledges grants support from
   the Australian Research Council, the National Health and Medical
   Research Council and the Defense Health Foundation.
CR Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Annabi N, 2010, BIOMATERIALS, V31, P1655, DOI 10.1016/j.biomaterials.2009.11.051
   Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   Gustafson JA, 2010, ADV DRUG DELIVER REV, V62, P1509, DOI 10.1016/j.addr.2010.04.006
   Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f
   Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p
   Hwang W, 2009, LANGMUIR, V25, P12682, DOI 10.1021/la9015993
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624
   Lakard S, 2004, BIOELECTROCHEMISTRY, V62, P19, DOI 10.1016/j.bioelechem.2003.03.009
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Liu BF, 2006, COLLOID SURFACE B, V53, P175, DOI 10.1016/j.colsurfb.2006.08.018
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   Nojehdehian H, 2010, INT J ARTIF ORGANS, V33, P721, DOI 10.5301/IJAO.2010.5981
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Pyda M, 2008, MACROMOLECULES, V41, P4786, DOI 10.1021/ma8003357
   Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g
   Reguera J, 2004, J AM CHEM SOC, V126, P13212, DOI 10.1021/ja047417f
   Rhovski V. B., 1998, EUR J BIOCHEM, V258, P1
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Teng WB, 2009, BIOMACROMOLECULES, V10, P3028, DOI 10.1021/bm900651g
   Toonkool P, 2001, J BIOL CHEM, V276, P28042, DOI 10.1074/jbc.M103391200
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   WONG PFC, 2006, APPL PHYS A, V82, P223
   Yu L, 2010, BIOMACROMOLECULES, V11, P2766, DOI 10.1021/bm1008316
NR 44
TC 27
Z9 27
U1 3
U2 62
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG 19
PY 2013
VL 23
IS 31
BP 3875
EP 3884
DI 10.1002/adfm.201202685
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 258XE
UT WOS:000327491200005
PM 25093018
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Giussi, JM
   Blaszczyk-Lezak, I
   Allegretti, PE
   Cortizo, MS
   Mijangos, C
AF Giussi, Juan M.
   Blaszczyk-Lezak, Iwona
   Allegretti, Patricia E.
   Susana Cortizo, M.
   Mijangos, Carmen
TI Tautomerizable styrenic copolymers confined in AAO templates
SO POLYMER
LA English
DT Article
DE Tautomeric copolymers; AAO templates; Nanostructured scaffolds
ID POLYMER-BASED NANORODS; ALUMINA NANOPORES; NANOTUBES; ARRAYS;
   NANOFIBERS; DYNAMICS; SENSORS
AB The aim of this work is to prepare new keto-enol tautomerizable polystyrene copolymer nanofibers, by infiltrating the polymer into nanoporous anodized aluminum oxide (AAO) nanocavities, and to examine the influence of confinement effects on the polymer properties of nanostructured polymers in comparison to the bulk. The interest of this work lies, on the one side, on the presence of tautomeric groups that could lead to discriminate against specific substrates and, therefore, could make them interesting in biomedicine. And, on the other hand, on the topographic characteristic of oriented nanofibrous structures that could be convenient for cell regeneration.
   In this work nanostructured keto-enol tautomerizable polystyrene copolymer nanofibers, i.e. Styrene-co-2-methyl-3-oxo-5-phenyl-4-pentenonitrile (St-co-MOP) of different chemical composition, have been prepared under soft infiltration conditions of the polymer into AAO templates. For all compositions, SEM images show stacked nanofibers reproducing the dimensions of AAO nanopores and Raman confocal spectroscopy of the samples, confirms the homogenous chemical distribution of nanofibers through all the length of AAO pores. The glass transition temperature values for St-co-MOP copolymer nanofibers inside AAO nanocavities determined by differential scanning calorimetry are higher than those corresponding to the bulk copolymers. From thermograms of nanofibers obtained by thermo gravimetric analysis (TGA), in an air atmosphere, the existence of two thermal peaks is observed, the second one probably caused by the presence of tautomeric forms in the copolymers. Moreover, the elastics moduli found for the bulk copolymers are consistent with their employment for building extracellular matrices.
   In summary, this study clearly demonstrates the feasibility of producing nanofibers from styrene-co-2-methyl-3-oxo-5-phenyl-4-pentenonitrile (St-co-MOP) tautomeric polymers with a high degree of homogeneity and appropriate thermal and mechanical properties. Furthermore, preliminary results for tautomeric copolymers do not show cytotoxic effects, indicating that the obtained nanostructured copolymer combines several relevant properties required for its future applications as a biomaterial for cell scaffolds. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Giussi, Juan M.; Blaszczyk-Lezak, Iwona; Mijangos, Carmen] CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
   [Giussi, Juan M.; Allegretti, Patricia E.; Susana Cortizo, M.] UNLP, Fac Ciencias Exactas, Lab Estudio Compuestos Organ LADECOR, RA-1900 La Plata, Buenos Aires, Argentina.
   [Giussi, Juan M.; Susana Cortizo, M.] UNLP, Fac Ciencias Exactas, CCT La Plata, Inst Invest Fisicoquim Teor & Aplicadas INIFTA, RA-1900 La Plata, Buenos Aires, Argentina.
RP Mijangos, C (reprint author), CSIC, Inst Ciencia & Tecnol Polimeros, Juan Cierva 3, E-28006 Madrid, Spain.
EM cmijangos@ictp.csic.es
RI MIJANGOS, CARMEN/M-1890-2014
OI MIJANGOS, CARMEN/0000-0003-3347-3181
FU CSIC; MICINN [MAT2011-24797, PRI-PIBAR-2011-1400]
FX J.M. Giussi would like to thank La Plata National University and CONICET
   from Argentina and CSIC from Spain by the help granted for the
   collaboration. I. Blaszczyk-Lezak acknowledges support from CSIC for a
   JAE postdoctoral fellowship. Financial support from the MICINN,
   MAT2011-24797 and PRI-PIBAR-2011-1400 is also acknowledged.
CR Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Benner SA, 2004, SCIENCE, V306, P625, DOI 10.1126/science.1101104
   Blaszczyk-Lezak I, 2011, IND ENG CHEM RES, V50, P10883, DOI 10.1021/ie200826x
   Chen D, 2011, MACROMOLECULES, V44, P8020, DOI 10.1021/ma2015276
   Chen D, 2009, MACROMOL RAPID COMM, V30, P377, DOI 10.1002/marc.200800730
   Cortizo AM, 2012, J BIOMATER TISS ENG, V2, P125, DOI 10.1166/jbt.2012.1039
   Demetriou M, 2012, J POLYM SCI POL CHEM, V50, P52, DOI 10.1002/pola.24977
   Dersch R, 2005, POLYM ADVAN TECHNOL, V16, P276, DOI 10.1002/pat.568
   Du Y, 1999, APPL PHYS LETT, V74, P2951, DOI 10.1063/1.123976
   Duran H, 2011, NANO LETT, V11, P1671, DOI 10.1021/nl200153c
   Efremov MY, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085703
   Feng XD, 2009, MACROMOLECULES, V42, P569, DOI 10.1021/ma8024283
   Gallardo A, 2007, J RAMAN SPECTROSC, V38, P880, DOI 10.1002/jrs.1736
   Gauglitz G., 2003, HDB SPECTROSCOPY
   Giussi JM, 2012, J POLYM SCI POL CHEM, V50, P4161, DOI 10.1002/pola.26238
   Grimm S, 2010, J MATER CHEM, V20, P3171, DOI 10.1039/b926432a
   Hernandez-Velez H., 2005, THIN SOLID FILMS, V495, P51
   Jia HF, 2002, BIOTECHNOL PROGR, V18, P1027, DOI 10.1021/bp020042m
   Kim BC, 2005, NANOTECHNOLOGY, V16, pS382, DOI 10.1088/0957-4484/16/7/011
   Krutyeva M, 2009, J CHEM PHYS, V131
   Laslau C, 2010, PROG POLYM SCI, V35, P1403, DOI 10.1016/j.progpolymsci.2010.08.002
   Lee DY, 2012, SOFT MATTER, V8, P4905, DOI 10.1039/c2sm07319f
   Maiz J, 2010, CHEM PHYS LETT, V484, P290, DOI 10.1016/j.cplett.2009.11.063
   Martin J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/17/175304
   Martin J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.197801
   Martin J, 2012, POLYMER, V53, P1149, DOI 10.1016/j.polymer.2012.01.028
   Martin J, 2009, J NANOSCI NANOTECHNO, V9, P5898, DOI 10.1166/jnn.2009.1299
   Martin J, 2009, MACROMOLECULES, V42, P5395, DOI 10.1021/ma900754v
   Martin J, 2009, LANGMUIR, V25, P1181, DOI 10.1021/la803127w
   Masuda H, 1998, JPN J APPL PHYS 2, V37, pL1090, DOI 10.1143/JJAP.37.L1090
   Masuda S, 1996, PROG POLYM SCI, V21, P557, DOI 10.1016/0079-6700(95)00025-9
   Mei SL, 2011, MACROMOLECULES, V44, P1615, DOI 10.1021/ma102573p
   Michell RM, 2012, MACROMOLECULES, V45, P1517, DOI 10.1021/ma202327f
   Mohamed NA, 1997, POLYM DEGRAD STABIL, V56, P317, DOI 10.1016/S0141-3910(96)00192-9
   Ozaydin-Ince G, 2011, SOFT MATTER, V7, P638, DOI 10.1039/c0sm00922a
   Palacios R, 2009, PHYS STATUS SOLIDI C, V6, P1584, DOI 10.1002/pssc.200881057
   Pinto NJ, 2003, APPL PHYS LETT, V83, P4244, DOI 10.1063/1.1627484
   Richter S, 2005, APPL PHYS LETT, V87, P1
   Roghani-Mamaqani H, 2011, AICHE J, V57, P1873, DOI 10.1002/aic.12395
   Shin K, 2007, NAT MATER, V6, P961, DOI 10.1038/nmat2031
   Steinhart M, 2004, ANGEW CHEM INT EDIT, V43, P1334, DOI 10.1002/anie.200300614
   Tress M, 2010, MACROMOLECULES, V43, P9937, DOI 10.1021/ma102031k
   Vazquez M, 2004, J APPL PHYS, V95, P6642, DOI 10.1063/1.1687539
   Wang B, 2011, J MECH BEHAV BIOMED, V4, P600, DOI 10.1016/j.jmbbm.2011.01.008
NR 44
TC 12
Z9 12
U1 1
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD AUG 16
PY 2013
VL 54
IS 18
BP 5050
EP 5057
DI 10.1016/j.polymer.2013.06.040
PG 8
WC Polymer Science
SC Polymer Science
GA 202SP
UT WOS:000323240200035
DA 2018-10-20
ER

PT J
AU Kwak, KA
   Kim, YH
   Kim, M
   Lee, BT
   Song, HY
AF Kwak, Kyung-A.
   Kim, Young-Hee
   Kim, Minsung
   Lee, Byong-Taek
   Song, Ho-Yeon
TI Bio-functionalization of polycaprolactone infiltrated BCP scaffold with
   silicon and fibronectin enhances osteoblast activity in vitro
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE BCP; Polycaprolactone; Silicon; Fibronectin; Osteoblast activity
ID CHONDROCYTE ADHESION; CELL ATTACHMENT; GENE-EXPRESSION; DIFFERENTIATION;
   FABRICATION; COLLAGEN; DESIGN; NANOPARTICLES; PROLIFERATION; CERAMICS
AB The surface property of a biomaterial plays a fundamental role in cell attachment, proliferation, differentiation, resorption, and biomolecular expression. In this study, the surface of a polycaprolactone-infiltrated biphasic calcium phosphate scaffold was biofunctionalized by silicon (Si) and fibronectin (FN) coating to evaluate the osteoblast-like cells activity in vitro. The surfaces of all scaffolds were characterized by scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS), whereas the presence of the functional group was determined by Fourier-transform infrared spectroscopy (FT-IR). Coomassie brilliant blue staining was applied to confirm the presence of FN on the scaffold surface. The in vitro bioactivity of the osteoblast-like cells was determined by one cell morphology and proliferation assay at 3, 7, and 14 days by SEM. Cell viability assay by MTT showed higher cell viability rate on coated scaffolds than in those coated with Si only or non-coated surfaces. The mRNA expressions of alkaline phosphatase (ALP) and osteocalcin (OC) were determined using RT-PCR and the expressions of osteopontin (OPN), type I collagen, and osteocalcin (OC) proteins were determined using Western blot. Thus the expression of genes and proteins further confirmed both early and intermediate phases of osteoblast-like cell activity which was found increased by Si-and Fn coating on PCL infiltrated BCP surfaces. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Kwak, Kyung-A.; Kim, Young-Hee; Song, Ho-Yeon] Soonchunhyang Univ, Sch Med, Dept Microbiol & Immunol, Cheonan 330090, Chungnum, South Korea.
   [Kim, Minsung; Lee, Byong-Taek] Soonchunhyang Univ, Sch Med, Dept Biomed Engn & Mat, Cheonan 330090, Chungnum, South Korea.
RP Song, HY (reprint author), Soonchunhyang Univ, Sch Med, Dept Microbiol & Immunol, Cheonan 330090, Chungnum, South Korea.
EM songmic@sch.ac.kr
CR An YQ, 2007, J COLLOID INTERF SCI, V311, P507, DOI 10.1016/j.jcis.2007.02.084
   Bahar H, 2007, CRIT REV EUKAR GENE, V17, P87, DOI 10.1615/CritRevEukarGeneExpr.v17.i2.10
   Byun IS, 2010, J MATER SCI-MATER M, V21, P1937, DOI 10.1007/s10856-010-4061-1
   Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7
   Connel D.M, 1973, BIOLOGIC APATITES, P68
   Cottam E, 2009, MED ENG PHYS, V31, P221, DOI 10.1016/j.medengphy.2008.07.005
   de Jong WF, 1926, RECL TRAV CHIM PAY-B, V45, P445
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Fu Y, 2002, MACROMOL RAPID COMM, V23, P256, DOI 10.1002/1521-3927(20020301)23:4<256::AID-MARC256>3.0.CO;2-5
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.3.CO;2-3
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Kim M, 2010, KOREAN J MAT RES, V20, P331
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   Le Geros R.Z., 1993, AN INTRODUCTION TO B
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Li DJ, 2002, NUCL INSTRUM METH B, V192, P393, DOI 10.1016/S0168-583X(02)00490-1
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Makita N, 2008, GENE, V413, P8, DOI 10.1016/j.gene.2007.12.025
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Riboh JC, 2003, J PHYS CHEM B, V107, P1772, DOI 10.1021/jp022130v
   Santo VE, 2010, J SUPERCRIT FLUID, V54, P320, DOI 10.1016/j.supflu.2010.05.021
   SOMERMAN MJ, 1989, MATRIX, V9, P49, DOI 10.1016/S0934-8832(89)80018-6
   Sun JY, 2009, BIOMED PHARMACOTHER, V63, P650, DOI 10.1016/j.biopha.2009.01.007
   Sun LY, 2009, MAT SCI ENG C-MATER, V29, P1829, DOI 10.1016/j.msec.2009.02.011
   Tsai WB, 2006, J MATER SCI-MATER M, V17, P337, DOI 10.1007/s10856-006-8234-x
   von Walter M, 2005, BIOMATERIALS, V26, P2813, DOI 10.1016/j.biomaterials.2004.07.066
   Wang XD, 2001, J ORTHOPAED RES, V19, P1021, DOI 10.1016/S0736-0266(01)00047-X
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yamada M, 2003, BIOL TRACE ELEM RES, V95, P113, DOI 10.1385/BTER:95:2:113
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 40
TC 6
Z9 6
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 15
PY 2013
VL 279
BP 13
EP 22
DI 10.1016/j.apsusc.2013.03.039
PG 10
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 169GB
UT WOS:000320766500003
DA 2018-10-20
ER

PT J
AU Dawson, JI
   Oreffo, ROC
AF Dawson, Jonathan I.
   Oreffo, Richard O. C.
TI Clay: New Opportunities for Tissue Regeneration and Biomaterial Design
SO ADVANCED MATERIALS
LA English
DT Article
DE clay materials; nanoparticles; nanocomposites; drug delivery; tissue
   regeneration
ID DRUG-RELEASE BEHAVIOR; LAYERED SILICATE NANOCOMPOSITES; SEPIOLITE
   COLLAGEN COMPLEX; MESENCHYMAL STEM-CELLS; CROSS-LINKED PEO; IN-VITRO;
   MECHANICAL-PROPERTIES; POLYURETHANE NANOCOMPOSITES; OSTEOGENIC
   DIFFERENTIATION; MOLECULAR CHARACTERISTICS
AB Seminal recent studies that have shed new light on the remarkable properties of clay interactions suggest unexplored opportunities for biomaterial design and regenerative medicine. Here, recent conceptual and technological developments in the science of clay interactions with biomolecules, polymers, and cells are examined, focusing on the implications for tissue engineering and regenerative strategies. Pioneering studies demonstrating the utility of clay for drug-delivery and scaffold design are reviewed and areas for future research and development highlighted.
C1 [Dawson, Jonathan I.; Oreffo, Richard O. C.] Univ Southampton, Inst Dev Sci, Southampton SO16 6YD, Hants, England.
RP Dawson, JI (reprint author), Univ Southampton, Inst Dev Sci, Southampton SO16 6YD, Hants, England.
EM jid@soton.ac.uk; roco@soton.ac.uk
RI Oreffo, Richard/A-4615-2011
OI Oreffo, Richard/0000-0001-5995-6726
FU Wessex Medical Research; Rosetrees Trust; BBSRC [LOLA BB/G010579]; EU
   Framework 7 (BIODESIGN); Biotechnology and Biological Sciences Research
   Council [BB/G010579/1]
FX The authors would like to thank the members of the Bone and Joint
   research group for useful discussions. J.I.D. and R.O.C.O. are grateful
   recipients of funding from Wessex Medical Research, Rosetrees Trust,
   BBSRC (LOLA BB/G010579) and EU Framework 7 (BIODESIGN).
CR Aguzzi C, 2007, APPL CLAY SCI, V36, P22, DOI 10.1016/j.clay.2006.06.015
   Akhilesh K., 2011, NANOBIOMATERIALS HDB
   Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Alam HB, 2005, MIL MED, V170, P63, DOI 10.7205/MILMED.170.1.63
   Ambre A. H., 2010, J NANOTECHNOL ENG ME, V1
   Ambre A, 2011, MAT SCI ENG C-MATER, V31, P1017, DOI 10.1016/j.msec.2011.03.001
   Baek M, 2012, J NANOMATER, DOI 10.1155/2012/469372
   Baek M, 2012, MOL CELL TOXICOL, V8, P95, DOI 10.1007/s13273-012-0012-x
   Baker KC, 2011, ACTA BIOMATER, V7, P3382, DOI 10.1016/j.actbio.2011.05.014
   Baker SE, 2007, CHEM MATER, V19, P4390, DOI 10.1021/cm071457b
   Bongio M, 2010, J MATER CHEM, V20, P8747, DOI 10.1039/c0jm00795a
   Cai P, 2006, ENVIRON SCI TECHNOL, V40, P2971, DOI 10.1021/es0522985
   Campbell K, 2008, INT J PHARMACEUT, V363, P126, DOI 10.1016/j.ijpharm.2008.06.027
   Carey BJ, 2011, ACS NANO, V5, P2715, DOI 10.1021/nn103104g
   Carraway JW, 2008, RESUSCITATION, V78, P230, DOI 10.1016/j.resuscitation.2008.02.019
   Carretero MI, 2006, DEV CLAY SCI, V1, P717, DOI 10.1016/S1572-4352(05)01024-X
   Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0
   Chang CW, 2010, SOFT MATTER, V6, P5157, DOI 10.1039/c0sm00067a
   Chen MW, 2012, INT J NANOMED, V7, P4285, DOI 10.2147/IJN.S33083
   Chen QZ, 2011, J MECH BEHAV BIOMED, V4, P1805, DOI 10.1016/j.jmbbm.2011.05.038
   Chen RF, 2008, MAT SCI ENG C-BIO S, V28, P218, DOI 10.1016/j.msec.2006.12.008
   Chung J. H. Y., 2011, EXPERT OPIN DRUG DEL, V8, P1
   Cypes SH, 2003, J CONTROL RELEASE, V90, P163, DOI 10.1016/S0168-3659(03)00133-0
   Da Silva GR, 2009, J DRUG TARGET, V17, P374, DOI 10.1080/10611860902839510
   Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001
   Darder M, 2003, CHEM MATER, V15, P3774, DOI 10.1021/cm0343047
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   Dawson JI, 2011, ADV MATER, V23, P3304, DOI 10.1002/adma.201100968
   Demaneche S, 2001, APPL ENVIRON MICROB, V67, P293, DOI 10.1128/AEM.67.1.293-299.2001
   Depan D, 2009, ACTA BIOMATER, V5, P93, DOI 10.1016/j.aetbio.2008.08.007
   Droy-Lefaix MT, 2006, DEV CLAY SCI, V1, P743, DOI 10.1016/S1572-4352(05)01025-1
   Drummy LF, 2010, ACS APPL MATER INTER, V2, P1492, DOI 10.1021/am1001184
   Dutta S, 2009, BIORESOURCE TECHNOL, V100, P6391, DOI 10.1016/j.biortech.2009.06.029
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Ferris J. P., 1996, NATURE, P381
   Fornes TD, 2003, POLYMER, V44, P4993, DOI 10.1016/S0032-3861(03)00471-3
   Franchi M, 2005, GENE, V346, P205, DOI 10.1016/j.gene.2004.11.002
   Franchi M, 1999, ORIGINS LIFE EVOL B, V29, P297, DOI 10.1023/A:1006557832574
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Frydrych M, 2011, J MATER CHEM, V21, P9103, DOI 10.1039/c1jm10788g
   Fukasawa M, 2010, MACROMOLECULES, V43, P4370, DOI 10.1021/ma100419c
   Gaharwar A. K., 2011, NANOBIOMATERIALS HDB, P1
   Gaharwar AK, 2012, MACROMOL BIOSCI, V12, P779, DOI 10.1002/mabi.201100508
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P4139, DOI 10.1016/j.actbio.2011.07.023
   Gaharwar AK, 2011, MACROMOL RAPID COMM, V32, P50, DOI 10.1002/marc.201000556
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P568, DOI 10.1016/j.actbio.2010.09.015
   Gaharwar AK, 2010, ACS APPL MATER INTER, V2, P3119, DOI 10.1021/am100609t
   Gaharwar AK, 2010, ADV FUNCT MATER, V20, P429, DOI 10.1002/adfm.200901606
   Han HK, 2011, ACS APPL MATER INTER, V3, P2564, DOI 10.1021/am200406k
   Haraguchi K, 2002, MACROMOLECULES, V35, P10162, DOI 10.1021/ma021301r
   Haraguchi K, 2006, MACROMOLECULES, V39, P1898, DOI 10.1021/ma052468y
   Haraguchi K, 2012, J STEM CELLS REGEN, V8, pP2
   Haraguchi K, 2003, MACROMOLECULES, V36, P5732, DOI 10.1021/ma034366i
   Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9
   Haraguchi K, 2006, BIOMACROMOLECULES, V7, P3267, DOI 10.1021/bm060549b
   Haraguchi K, 2006, ADV MATER, V18, P2250, DOI 10.1002/adma.200600143
   Haraguchi K, 2011, MACROMOL RAPID COMM, V32, P1253, DOI 10.1002/marc.201100248
   Haraguchi K, 2010, MACROMOL RAPID COMM, V31, P718, DOI 10.1002/marc.200900819
   Haroun AA, 2009, J MATER SCI-MATER M, V20, P2527, DOI 10.1007/s10856-009-3818-x
   Heinz H, 2012, CLAY MINER, V47, P205, DOI 10.1180/claymin.2012.047.2.05
   Heinz H, 2010, J COMPUT CHEM, V31, P1564, DOI 10.1002/jcc.21421
   HERRERA JI, 1995, BIOMATERIALS, V16, P625, DOI 10.1016/0142-9612(95)93860-G
   Hoon L. J., 2003, BIOMATERIALS, V24, P2773
   Hua SB, 2010, APPL CLAY SCI, V50, P112, DOI 10.1016/j.clay.2010.07.012
   Huang WH, 2003, CHEM COMMUN, P1458, DOI 10.1039/b303134a
   Carretero MI, 2010, APPL CLAY SCI, V47, P171, DOI 10.1016/j.clay.2009.10.016
   Carretero MI, 2009, APPL CLAY SCI, V46, P73, DOI 10.1016/j.clay.2009.07.017
   Istrate OM, 2012, J APPL POLYM SCI, V125, pE102, DOI 10.1002/app.36336
   Joshi GV, 2009, INT J PHARMACEUT, V374, P53, DOI 10.1016/j.ijpharm.2009.03.004
   Jung H, 2008, INT J PHARM, V349, P283, DOI 10.1016/j.ijpharrn.2007.08.008
   Katti KS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034122
   Kawase M, 2004, BIOL PHARM BULL, V27, P2049, DOI 10.1248/bpb.27.2049
   KHANNA M, 1992, APPL ENVIRON MICROB, V58, P1930
   KHANNA M, 1998, SCI SOILS, V3, P1
   Killeen D., 2012, MAT SCI ENG C, P32
   Kingham EJ, 2011, BONE, V48, pS108, DOI 10.1016/j.bone.2011.03.177
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Koo CM, 2003, MACROMOLECULES, V36, P2748, DOI 10.1021/ma021377n
   Kotobuki N, 2013, J BIOMED MATER RES A, V101, P537, DOI 10.1002/jbm.a.34355
   Krikorian V, 2003, CHEM MATER, V15, P4317, DOI 10.1021/cm034369+
   Kulangara K, 2009, SOFT MATTER, V5, P4072, DOI 10.1039/b910132m
   Lagaly G, 2006, DEV CLAY SCI, V1, P141, DOI 10.1016/S1572-4352(05)01005-6
   Lee J, 2006, J MATER CHEM, V16, P3558, DOI 10.1039/b605797g
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee WF, 2004, J APPL POLYM SCI, V94, P74, DOI 10.1002/app.20730
   Lee WF, 2004, J APPL POLYM SCI, V91, P2934, DOI 10.1002/app.13499
   Lee WF, 2003, J APPL POLYM SCI, V89, P3652, DOI 10.1002/app.12624
   Lewkowitz-Shpuntoff HM, 2009, BIOMATERIALS, V30, P8, DOI 10.1016/j.biomaterials.2008.09.015
   Li PR, 2010, ACS APPL MATER INTER, V2, P1608, DOI 10.1021/am1001162
   Lin FH, 2006, BIOMATERIALS, V27, P3333, DOI 10.1016/j.biomaterials.2005.12.029
   Liu D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/055008
   Liu KH, 2008, ACTA BIOMATER, V4, P1038, DOI 10.1016/j.actbio.2008.01.012
   Liu MX, 2012, COLLOID POLYM SCI, V290, P895, DOI 10.1007/s00396-012-2588-z
   LIZARBE MA, 1987, BIOMATERIALS, V8, P35, DOI 10.1016/0142-9612(87)90025-1
   Lordan S, 2012, CELL BIOL INT, V36, P57, DOI 10.1042/CBI20100587
   Lordan S, 2011, J APPL TOXICOL, V31, P27, DOI 10.1002/jat.1564
   Lu CS, 2007, COMPOS SCI TECHNOL, V67, P2895, DOI 10.1016/j.compscitech.2007.05.008
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MARKS SC, 1988, AM J ANAT, V183, P1, DOI 10.1002/aja.1001830102
   Mehta G, 2007, ADV FUNCT MATER, V17, P2701, DOI 10.1002/adfm.200700016
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Miyazaki S, 2007, MACROMOLECULES, V40, P4287, DOI 10.1021/ma070104v
   Murray HH, 2000, APPL CLAY SCI, V17, P207, DOI 10.1016/S0169-1317(00)00016-8
   Nanda R, 2011, CARBOHYD POLYM, V83, P988, DOI 10.1016/j.carbpol.2010.09.009
   Nennemann A, 2001, APPL CLAY SCI, V18, P285, DOI 10.1016/S0169-1317(01)00025-4
   Nitya G, 2012, J MATER SCI-MATER M, V23, P1749, DOI 10.1007/s10856-012-4647-x
   OLMO N, 1987, BIOMATERIALS, V8, P67, DOI 10.1016/0142-9612(87)90033-0
   Ozkoc G, 2010, POLYM COMPOSITE, V31, P674, DOI 10.1002/pc.20846
   Park JK, 2008, INT J PHARM, V359, P198, DOI 10.1016/j.ijpharm.2008.04.012
   Patel HA, 2011, APPL CLAY SCI, V51, P126, DOI 10.1016/j.clay.2010.11.013
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   Patwardhan SV, 2012, J AM CHEM SOC, V134, P6244, DOI 10.1021/ja211307u
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Pereira IM, 2009, J APPL POLYM SCI, V114, P254, DOI 10.1002/app.30404
   Perez CJ, 2007, POLYM INT, V56, P686, DOI 10.1002/pi.2192
   Perotti G. F., 2011, POLYMER, P52
   Pietramellara G, 2001, BIOL FERT SOILS, V33, P402, DOI 10.1007/s003740100341
   Podsiadlo P, 2008, J PHYS CHEM B, V112, P14359, DOI 10.1021/jp801492n
   Popryadukhin P., 2012, CELL TISSUE BIOL, V6, P82
   Pusateri AE, 2004, J TRAUMA, V57, P555, DOI 10.1097/01.TA.0000136155.97758.CD
   Qi RL, 2012, J BIOMAT SCI-POLYM E, V23, P299, DOI 10.1163/092050610X550340
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Reijnders L, 2012, J MATER SCI, V47, P5061, DOI 10.1007/s10853-012-6288-3
   Ren HY, 2011, MACROMOLECULES, V44, P8516, DOI 10.1021/ma201272j
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rueda L, 2011, J BIOMED MATER RES A, V97A, P480, DOI 10.1002/jbm.a.33075
   Ruiz-Hitzky E, 2010, J MATER CHEM, V20, P9306, DOI 10.1039/c0jm00432d
   Sairaku A, 2011, J INTERV CARD ELECTR, V31, P157, DOI 10.1007/s10840-011-9552-6
   Schexnailder PJ, 2010, MACROMOL BIOSCI, V10, P1416, DOI 10.1002/mabi.201000053
   Schloesing T., 1874, CR HEBD ACAD SCI, V78, P1276
   Sharma AK, 2010, MUTAT RES-GEN TOX EN, V700, P18, DOI 10.1016/j.mrgentox.2010.04.021
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Sposito G, 1999, P NATL ACAD SCI USA, V96, P3358, DOI 10.1073/pnas.96.7.3358
   Stevens MM, 2010, SOFT MATTER, V6, P4962, DOI 10.1039/c0sm90029j
   Styan KE, 2008, J BIOMED MATER RES A, V86A, P571, DOI 10.1002/jbm.a.31667
   TAKEZAWA T, 1990, BIO-TECHNOL, V8, P854, DOI 10.1038/nbt0990-854
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Thatiparti TR, 2010, J BIOMED MATER RES B, V92B, P111, DOI 10.1002/jbm.b.31496
   Theng BKG, 2012, DEV CLAY SCI, V4, P245, DOI 10.1016/B978-0-444-53354-8.00008-6
   Theng BKG, 2012, DEV CLAY SCI, V4, P201, DOI 10.1016/B978-0-444-53354-8.00007-4
   Theng BKG, 2012, DEV CLAY SCI, V4, P3, DOI 10.1016/B978-0-444-53354-8.00001-3
   Trabattoni D, 2012, INT J CARDIOL, V156, P53, DOI 10.1016/j.ijcard.2010.10.030
   Ul-Islam M, 2012, CARBOHYD POLYM, V89, P1189, DOI 10.1016/j.carbpol.2012.03.093
   Verma N., 2012, J NANOPART RES, V14, P1, DOI DOI 10.1007/S11051-012-1137-5
   Viseras C, 2008, MATER SCI TECH-LOND, V24, P1020, DOI 10.1179/174328408X341708
   Viseras C, 2010, APPL CLAY SCI, V48, P291, DOI 10.1016/j.clay.2010.01.007
   Wang J., 2012, ANGEW CHEM, V124, P4754
   Wang JF, 2012, ANGEW CHEM INT EDIT, V51, P4676, DOI 10.1002/anie.201200267
   Wang MC, 2012, ACS APPL MATER INTER, V4, P338, DOI 10.1021/am2014103
   Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693
   Wang Q, 2009, CARBOHYD POLYM, V78, P731, DOI 10.1016/j.carbpol.2009.06.010
   Wang XY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/37/375102
   Wang XY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/6/065707
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Williams D, 2011, JOM-US, V63, P51, DOI 10.1007/s11837-011-0067-5
   Wu CJ, 2011, MACROMOLECULES, V44, P8215, DOI 10.1021/ma200562k
   Wu CJ, 2010, MATERIALS, V3, P2986, DOI 10.3390/ma3052986
   Wu CJ, 2009, MACROMOL RAPID COMM, V30, P1492, DOI 10.1002/marc.200900163
   Xu RJ, 2001, MACROMOLECULES, V34, P337, DOI 10.1021/ma0013657
   Xu W, 2008, SMALL, V4, P662, DOI 10.1002/smll.200701231
   Yuan Q, 2010, ACTA BIOMATER, V6, P1140, DOI 10.1016/j.actbio.2009.08.027
   Zheng JP, 2002, J APPL POLYM SCI, V86, P1189, DOI 10.1002/app.11062
   Zheng JP, 2007, REACT FUNCT POLYM, V67, P780, DOI 10.1016/j.reactfunctpolym.2006.12.002
   Zhou WY, 2010, J BIOMED MATER RES A, V93A, P1574, DOI 10.1002/jbm.a.32656
   Zhu MF, 2006, MACROMOL RAPID COMM, V27, P1023, DOI 10.1002/marc.200600159
   Zhuang H, 2007, J MATER SCI-MATER M, V18, P951, DOI 10.1007/s10856-006-0093-y
   Zia KM, 2011, INT J BIOL MACROMOL, V49, P1131, DOI 10.1016/j.ijbiomac.2011.09.010
NR 169
TC 86
Z9 88
U1 12
U2 154
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD AUG 14
PY 2013
VL 25
IS 30
BP 4069
EP 4086
DI 10.1002/adma.201301034
PG 18
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 261QY
UT WOS:000327680900001
PM 23722321
OA Green Published
DA 2018-10-20
ER

PT J
AU Rodrigues, NFM
   Santana, SAA
   Bezerra, CWB
   Silva, HAS
   Melo, JCP
   Vieira, AP
   Airoldi, C
   Silva, EC
AF Rodrigues, Nubia F. M.
   Santana, Sirlane A. A.
   Bezerra, Cicero W. B.
   Silva, Hildo A. S.
   Melo, Julio C. P.
   Vieira, Adriana P.
   Airoldi, Claudio
   Silva Filho, Edson C.
TI New Chemical Organic Anhydride Immobilization Process Used on Banana
   Pseudostems: A Biopolymer for Cation Removal
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID LOW-COST ADSORBENTS; AQUEOUS-SOLUTIONS; ORBIGNYA-SPECIOSA; HEAVY-METALS;
   DYE REMOVAL; ADSORPTION; COPPER; SORPTION; MESOCARP; WASTE
AB Maleic and phthalic anhydrides were chemically incorporated onto the banana pseudostem biopolymeric structure through reaction without solvent at the fusion temperatures of the reagents. The new biomaterials showed unequivocal success for these proposed reactions and demonstrated abilities to remove cations from aqueous solutions. Phthalic anhydride pendant chains bonded to biopolymeric structure showed high performance for cation sorption at short times, 60-180 min, to give the maximum sorption capacities of 0.52, 0.54, and 0.59 mmol g(-1) for copper, cobalt, and nickel, respectively. Identically, maleic anhydride chains gave 0.27, 0.32, and 0.20 mmol g(-1) for the same sequence of cations. The equilibrium data were best represented by the Langmuir model in a linear regression and by the Freundlich model in nonlinear regression procedures. These new biopolymers are promising for ecosystem remediation with advantages in using biopolymers based on a natural, cheap, and abundant raw biomaterial.
C1 [Rodrigues, Nubia F. M.; Santana, Sirlane A. A.; Bezerra, Cicero W. B.; Silva, Hildo A. S.] Univ Fed Maranhao, Chem Dept CCET, BR-65080540 Sao Luis, MA, Brazil.
   [Melo, Julio C. P.; Vieira, Adriana P.; Airoldi, Claudio] Univ Estadual Campinas, Inst Chem, UNICAMP, BR-13084971 Campinas, SP, Brazil.
   [Silva Filho, Edson C.] Univ Fed Piaui, Interdisciplinay Lab Adv Mat, CCN, BR-64049550 Teresina, PI, Brazil.
RP Santana, SAA (reprint author), Univ Fed Maranhao, Chem Dept CCET, Av Portugueses S-N,Campus Bacanga, BR-65080540 Sao Luis, MA, Brazil.
EM sirlane@ufma.br
RI Vieira, Adriana/D-8303-2012; Bezerra, Cicero/G-3171-2014
OI Bezerra, Cicero/0000-0001-9058-9469; Silva Filho,
   Edson/0000-0003-0988-2970; Vieira, Adriana Pires/0000-0002-2806-2604
FU CAPES
FX The authors are indebted to CAPES for financial support and for a
   fellowship to NFMR.
CR Abdulfatai Jimoh, 2013, Applied Mechanics and Materials, V248, P310, DOI 10.4028/www.scientific.net/AMM.248.310
   Ahmadi MA, 2012, IND ENG CHEM RES, V51, P9894, DOI 10.1021/ie300269c
   Al-Asheh S, 2000, CHEMOSPHERE, V41, P659, DOI 10.1016/S0045-6535(99)00497-X
   Ali M, 2001, ADV ENVIRON RES, V5, P175, DOI 10.1016/S1093-0191(00)00055-1
   Allen SJ, 2005, J COLLOID INTERF SCI, V286, P101, DOI 10.1016/j.jcis.2004.12.043
   Anirudhan TS, 2012, J CHEM TECHNOL BIOT, V87, P714, DOI 10.1002/jctb.3700
   Annadurai G, 2003, WATER SCI TECHNOL, V47, P185
   Azizian S, 2004, J COLLOID INTERF SCI, V276, P47, DOI 10.1016/j.jcis.2004.03.048
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Banat IM, 1996, BIORESOURCE TECHNOL, V58, P217, DOI 10.1016/S0960-8524(96)00113-7
   Clarkson PM, 2008, ACCOUNT ORG SOC, V33, P303, DOI 10.1016/j.aos.2007.05.003
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Djilani C, 2012, CHEM ENG J, V189, P203, DOI 10.1016/j.cej.2012.02.059
   Fernandez N. B., 2012, J APPL POLYM SCI, V125, P262
   Fonseca M.G., 2003, COLLOID SURF A, V227, P85
   Gallego-Alvarez I, 2012, ECOL INDIC, V23, P250, DOI 10.1016/j.ecolind.2012.03.024
   Ghaedi M, 2007, J HAZARD MATER, V147, P226, DOI 10.1016/j.jhazmat.2006.12.070
   Gimbert F, 2008, J HAZARD MATER, V157, P34, DOI 10.1016/j.jhazmat.2007.12.072
   Guo L, 2009, IND ENG CHEM RES, V48, P10657, DOI 10.1021/ie9010782
   Gupta N, 2012, J INDIAN CHEM SOC, V89, P891
   Hasanah A. N., 2012, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V3, P1171
   Ho Y.S., 2004, CARBON, V42, P2113
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Jha R., 2012, POLLUT RES, V31, P277
   Julinova M, 2012, J ENVIRON MANAGE, V94, P13, DOI 10.1016/j.jenvman.2011.09.006
   Kakitani T, 2006, J ENVIRON QUAL, V35, P912, DOI 10.2134/jeq2005.0318
   Khin MM, 2012, ENERG ENVIRON SCI, V5, P8075, DOI 10.1039/c2ee21818f
   Liu C, 2012, BIORESOURCE TECHNOL, V119, P349, DOI 10.1016/j.biortech.2012.06.004
   Melo J. C. P., 2010, CARBOHYD RES, V345, P1914
   Melo J.C.P., 2009, COLLOID SURF A, V346, P138, DOI DOI 10.1016/J.C0LSURFA.2009.06.006
   Melo JCP, 2011, THERMOCHIM ACTA, V524, P29, DOI 10.1016/j.tca.2011.06.007
   Perez-Marin AB, 2007, J HAZARD MATER, V139, P122, DOI 10.1016/j.jhazmat.2006.06.008
   Rengaraj S, 2004, KOREAN J CHEM ENG, V21, P187, DOI 10.1007/BF02705397
   Repo E, 2010, CHEM ENG J, V161, P73, DOI 10.1016/j.cej.2010.04.030
   Santana S. A. A., 2010, J THERM ANAL CALORIM, V100, P315
   Silva Filho E. C., 2011, GLOB J PHYS CHEM, V2, P277
   Silva Filho EC, 2011, SEP SCI TECHNOL, V46, P2566
   Silva Filho EC, 2009, J COLLOID INTERF SCI, V340, P8
   Silva Filho EC, 2006, CARBOHYD RES, V341, P2842
   Silva Filho EC, 2011, J THERM ANAL CALORIM, V106, P369
   Sousa KS, 2009, CARBOHYD RES, V344, P1716, DOI 10.1016/j.carres.2009.05.028
   Vieira AP, 2011, CHEM ENG J, V173, P334, DOI 10.1016/j.cej.2011.07.043
   Vieira AP, 2011, J BRAZIL CHEM SOC, V22, P21, DOI 10.1590/S0103-50532011000100003
   Vieira AP, 2010, CHEM ENG J, V161, P99, DOI 10.1016/j.cej.2010.04.036
   Vieira AP, 2009, J HAZARD MATER, V166, P1272, DOI 10.1016/j.jhazmat.2008.12.043
   Wu FC, 2001, WATER RES, V35, P613, DOI 10.1016/S0043-1354(00)00307-9
   Zheng YA, 2010, IND ENG CHEM RES, V49, P6034, DOI 10.1021/ie9016336
NR 47
TC 5
Z9 5
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD AUG 14
PY 2013
VL 52
IS 32
BP 11007
EP 11015
DI 10.1021/ie303409b
PG 9
WC Engineering, Chemical
SC Engineering
GA 202SW
UT WOS:000323240900016
DA 2018-10-20
ER

PT J
AU Kisiel, M
   Klar, AS
   Martino, MM
   Ventura, M
   Hilborn, J
AF Kisiel, Marta
   Klar, Agnieszka S.
   Martino, Mikael M.
   Ventura, Manuela
   Hilborn, Jons
TI Evaluation of Injectable Constructs for Bone Repair with a Subperiosteal
   Cranial Model in the Rat
SO PLOS ONE
LA English
DT Article
AB While testing regenerative medicine strategies, the use of animal models that match the research questions and that are related to clinical translation is crucial. During the initial stage of evaluating new strategies for bone repair, the main goal is to state whether the strategies efficiently induce the formation of new bone tissue at an orthotopic site. Here, we present a subperiosteal model in rat calvaria that allow the evaluation of a broad range of approaches including bone augmentation, replacement and regeneration. The model is a fast to perform, minimally invasive, and has clearly defined control groups. The procedure enables to evaluate the outcomes quantitatively using micro-computed tomography and qualitatively by histology and immunohistochemistry. We established this new model, using bone morphogenetic protein-2 as an osteoinductive factor and hyaluronic acid hydrogel as injectable biomaterial. We showed that this subperiosteal cranial model offers a minimally invasive and promising solution for a rapid initial evaluation of injectables for bone repair. We believe that this approach could be a powerful platform for orthopedic research and regenerative medicine.
C1 [Kisiel, Marta; Hilborn, Jons] Uppsala Univ, Div Polymer Chem, Dept Chem Angstrom, Sci Life Lab, Uppsala, Sweden.
   [Kisiel, Marta] Univ Hosp Akademiska, Fac Med, Uppsala, Sweden.
   [Klar, Agnieszka S.] Univ Childrens Hosp, Dept Surg, Tissue Biol Res Unit, Zurich, Switzerland.
   [Martino, Mikael M.] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr IFReC, Osaka, Japan.
   [Ventura, Manuela] Radboud Univ Nijmegen, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands.
RP Hilborn, J (reprint author), Uppsala Univ, Div Polymer Chem, Dept Chem Angstrom, Sci Life Lab, Uppsala, Sweden.
EM jons.hilborn@kemi.uu.se
RI Martino, Mikael/N-9345-2013
OI Martino, Mikael/0000-0002-5012-4605; Hilborn, Jons/0000-0001-6947-9601
FU Marie Curie ITN
FX The study was supported by Marie Curie ITN. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Auer JA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-72
   Barger-Lux M. J., 2002, TOP MAGN RESON IMAG, V13, P297
   Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289
   Boden SD, 2000, TISSUE ENG, V6, P383, DOI 10.1089/107632700418092
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Docherty-Skogh AC, 2010, PLAST RECONSTR SURG, V125, P1383, DOI 10.1097/PRS.0b013e3181d629dc
   Drosse I, 2008, TISSUE ENG PART C-ME, V14, P79, DOI 10.1089/tec.2007.0234
   Einhorn TA, 1999, CLIN ORTHOP RELAT R, pS59, DOI 10.1097/00003086-199910001-00007
   ELLENDER G, 1988, J ANAT, V158, P173
   Emans PJ, 2005, TISSUE ENG, V11, P369, DOI 10.1089/ten.2005.11.369
   Eryilmaz T, 2011, J CRANIOFAC SURG, V22, P1888, DOI 10.1097/SCS.0b013e31822e86a3
   Fujimoto R, 1999, J BONE MINER METAB, V17, P11, DOI 10.1007/s007740050057
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007
   Hulsart-Billstrom G, 2012, J TISSUE ENG REGEN M
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kisiel M, 2012, J CONTROL RELEASE
   Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015
   Kisiel M, 2012, J CONTROL RELEASE, V162, P646, DOI 10.1016/j.jconrel.2012.08.004
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Mahomed AA, 2007, J LAPAROENDOSC ADV S, V17, P375, DOI 10.1089/lap.2006.0077
   Manes S, 2000, IUBMB LIFE, V49, P89
   Martinez-Sanz E, 2012, J TISSUE ENG REGEN M
   Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]
   Neyt J G, 1998, Iowa Orthop J, V18, P118
   Perilli E, 2007, J MICROSC-OXFORD, V225, P192, DOI 10.1111/j.1365-2818.2007.01731.x
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018
   Rowan A N, 1980, Dev Biol Stand, V45, P175
   Russell AJ, 2005, TISSUE ENG, V11, pVII, DOI 10.1089/ten.2005.11.vii
   Ryzewicz M, 2009, J BONE JOINT SURG BR, V91B, P522, DOI 10.1302/0301-620X.91B4.21399
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   SCHIMANDLE JH, 1994, SPINE, V19, P1998, DOI 10.1097/00007632-199409000-00023
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967
   Viateau V, 2007, J ORTHOP RES, V25, P741, DOI 10.1002/jor.20352
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   Yamada Y, 2008, TISSUE ENG PT A, V14, P1699, DOI 10.1089/ten.tea.2007.0189
   Zhu SJ, 2006, ORAL SURG ORAL MED O, V101, P166, DOI 10.1016/j.tripleo.2005.04.006
NR 44
TC 10
Z9 10
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 13
PY 2013
VL 8
IS 8
AR e71683
DI 10.1371/journal.pone.0071683
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 201BN
UT WOS:000323115800075
PM 23967235
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hamilton, PT
   Jansen, MS
   Ganesan, S
   Benson, RE
   Hyde-DeRuyscher, R
   Beyer, WF
   Gile, JC
   Nair, SA
   Hodges, JA
   Gron, H
AF Hamilton, Paul T.
   Jansen, Michelle S.
   Ganesan, Sathya
   Benson, R. Edward
   Hyde-DeRuyscher, Robin
   Beyer, Wayne F.
   Gile, Joseph C.
   Nair, Shrikumar A.
   Hodges, Jonathan A.
   Gron, Hanne
TI Improved Bone Morphogenetic Protein-2 Retention in an Injectable
   Collagen Matrix Using Bifunctional Peptides
SO PLOS ONE
LA English
DT Article
ID OSTEOGENIC FACTORS; DELIVERY; REGENERATION; FRACTURES; LIBRARIES; REPAIR
AB To promote healing of many orthopedic injuries, tissue engineering approaches are being developed that combine growth factors such as Bone Morphogenetic Proteins (BMP) with biomaterial carriers. Although these technologies have shown great promise, they still face limitations. We describe a generalized approach to create target-specific modular peptides that bind growth factors to implantable biomaterials. These bifunctional peptide coatings provide a novel way to modulate biology on the surface of an implant. Using phage display techniques, we have identified peptides that bind with high affinity to BMP-2. The peptides that bind to BMP-2 fall into two different sequence clusters. The first cluster of peptide sequences contains the motif W-X-X-F-X-X-L (where X can be any amino acid) and the second cluster contains the motif F-P-L-K-G. We have synthesized bifunctional peptide linkers that contain BMP-2 and collagen-binding domains. Using a rat ectopic bone formation model, we have injected rhBMP-2 into a collagen matrix with or without a bifunctional BMP-2: collagen peptide (BC-1). The presence of BC-1 significantly increased osteogenic cellular activity, the area of bone formed, and bone maturity at the site of injection. Our results suggest that bifunctional peptides that can simultaneously bind to a growth factor and an implantable biomaterial can be used to control the delivery and release of growth factors at the site of implantation.
C1 [Hamilton, Paul T.] N Carolina State Univ, Dept Microbiol, Raleigh, NC 27695 USA.
   [Jansen, Michelle S.; Ganesan, Sathya; Nair, Shrikumar A.; Hodges, Jonathan A.] Affinergy LLC, Res Triangle Pk, NC USA.
   [Benson, R. Edward] GlaxoSmithKline, Platform Technol & Sci, Res Triangle Pk, NC USA.
   [Hyde-DeRuyscher, Robin] Biogen Idec Inc, Mfg Sci, Res Triangle Pk, NC USA.
   [Beyer, Wayne F.] QNS Grp LLC, Durham, NC USA.
   [Gile, Joseph C.] Gile Surg Support, Bangor, ME USA.
   [Gron, Hanne] Novo Nordisk, Haemophilia Biochem, Malov, Denmark.
RP Hodges, JA (reprint author), Affinergy LLC, Res Triangle Pk, NC USA.
EM jhodges@affinergy.com
OI Hamilton, Paul/0000-0003-4028-424X
FU National Institutes of Arthritis and Musculoskeletal and Skin Disease,
   General Medicine, and Dental and Craniofacial Research of the National
   Institutes of Health (NIH) [R43AR053387, R43AR051264, R44GM077753,
   R44DE018071]
FX The work was supported in part by the National Institutes of Arthritis
   and Musculoskeletal and Skin Disease, General Medicine, and Dental and
   Craniofacial Research of the National Institutes of Health (NIH) under
   award numbers R43AR053387, R43AR051264, R44GM077753 and R44DE018071. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the NIH.
CR Andrade FK, 2010, J BIOMED MATER RES A, V92A, P9, DOI 10.1002/jbm.a.32284
   [Anonymous], 2000, MUSC INJ REP INC RIS
   Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010
   Epstein Nancy E, 2011, Surg Neurol Int, V2, P10, DOI 10.4103/2152-7806.76147
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Gron H, 2008, METHODS COMPOSITIONS
   Hyde-DeRuyscher R, 2000, CHEM BIOL, V7, P17, DOI 10.1016/S1074-5521(00)00062-4
   Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007
   Lee J. S., 2009, ANGEW CHEM, V121, P6384
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970
   Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Pertile R, 2012, BIOTECHNOL PROGR, V28, P526, DOI 10.1002/btpr.1501
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Seeherman H, 2001, J BONE JOINT SURG AM, V83A, pS79
   SPARKS AB, 1995, METHOD ENZYMOL, V255, P498
   Sparks Andrew B., 1996, P227, DOI 10.1016/B978-012402380-2/50015-0
NR 24
TC 9
Z9 10
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 8
PY 2013
VL 8
IS 8
AR e70715
DI 10.1371/journal.pone.0070715
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 201ER
UT WOS:000323124000025
PM 23950987
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Leal-Egana, A
   Diaz-Cuenca, A
   Boccaccini, AR
AF Leal-Egana, Aldo
   Diaz-Cuenca, Aranzazu
   Boccaccini, Aldo R.
TI Tuning of Cell-Biomaterial Anchorage for Tissue Regeneration
SO ADVANCED MATERIALS
LA English
DT News Item
DE cell-matrix anchorage; spatiotemporal tuning; cell adhesion; tunable
   biomaterials; tissue engineering
ID COLLAGEN-BINDING; STEM-CELLS; IN-VITRO; MATRIX ELASTICITY; ADHESION;
   DIFFERENTIATION; PROLIFERATION; HYDROGELS; SURFACES; MECHANOTRANSDUCTION
AB Which mechanisms mediate cell attachment to biomaterials? What role does the surface charge or wettability play on cell-material anchorage? What are the currently investigated strategies to modify cell-matrix adherence spatiotemporally? Considering the development of scaffolds made of biocompatible materials to temporarily replace the structure and/or function of the extracellular matrix, focus is given to the analysis of the specific (i.e., cell adhesive peptide sequences) and unspecific (i.e., surface charge, wettability) mechanisms mediating cell-matrix interactions. Furthermore, because natural tissue regeneration is characterized by the dynamic attachment/detachment of different cell populations, the design of advanced scaffolds for tissue engineering, based in the spatiotemporal tuning of cell-matrix anchorage is discussed.
C1 [Leal-Egana, Aldo; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, D-91058 Erlangen, Germany.
   [Leal-Egana, Aldo] CEA Grenoble, DSV, iRTSV, Lab Phys Cytoskeleton & Morphogenesis,LPCV, F-38054 Grenoble, France.
   [Diaz-Cuenca, Aranzazu] Univ Seville, CSIC, Ctr Mixto, ICMS, Seville 41092, Spain.
   [Diaz-Cuenca, Aranzazu] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Zaragoza 50018, Aragon, Spain.
RP Leal-Egana, A (reprint author), Univ Erlangen Nurnberg, Inst Biomat, Cauerstr 6, D-91058 Erlangen, Germany.
EM aldoleal@yahoo.com
RI Boccaccini, Aldo/C-7905-2013; Diaz-Cuenca, Aranzazu/M-3019-2013
OI Diaz-Cuenca, Aranzazu/0000-0002-5790-4452
CR Afanasenkau D, 2012, LANGMUIR, V28, P13387, DOI 10.1021/la302500r
   Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073
   Allon AA, 2012, J BIOMED MATER RES A, V100A, P2168, DOI 10.1002/jbm.a.34144
   Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104
   [Anonymous], 2012, NAT PHYS, V8, P583
   Arima Y, 2012, ADV POLYM SCI, V247, P167, DOI 10.1007/12_2011_161
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Bell BF, 2011, CLIN ORAL IMPLAN RES, V22, P865, DOI 10.1111/j.1600-0501.2010.02074.x
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Buske P., 2011, PLOS COMPUT BIOL, V7
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   Chen I. H., 2012, BIOMATERIALS, V33, P1336
   Choi YJ, 2012, BIOCHEM BIOPH RES CO, V419, P326, DOI 10.1016/j.bbrc.2012.02.022
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Davila J, 2012, J AM CHEM SOC, V134, P83, DOI 10.1021/ja208970b
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   Diaz-Cuenca A., 2013, J BIOMED MAT RES A, V101A, P1026
   Dou XQ, 2012, SOFT MATTER, V8, P9539, DOI 10.1039/c2sm26442k
   DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112
   Elloumi-Hannachi I, 2010, J INTERN MED, V267, P54, DOI 10.1111/j.1365-2796.2009.02185.x
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513
   Fukuda J, 2011, BIOMATERIALS, V32, P6663, DOI 10.1016/j.biomaterials.2011.05.068
   Gautrot J. E., 2012, NAT MAT, V11, P642
   Hanein D, 2012, CURR OPIN CELL BIOL, V24, P134, DOI 10.1016/j.ceb.2011.12.001
   Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Hsia H., 2009, PLAST RECONSTR SURG, V127, P2312
   Imen EH, 2009, J BIOTECHNOL, V139, P19, DOI 10.1016/j.jbiotec.2008.09.011
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001
   Kim BS, 2011, PROG POLYM SCI, V36, P238, DOI 10.1016/j.progpolymsci.2010.10.001
   Kim J, 2012, TISSUE ENG PART C-ME, V18, P913, DOI [10.1089/ten.tec.2011.0731, 10.1089/ten.TEC.2011.0731]
   Kinney MA, 2013, TRENDS BIOTECHNOL, V31, P78, DOI 10.1016/j.tibtech.2012.11.001
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kolesnikova, 2012, ACS NANO, V11, P9585
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lai YX, 2010, BIOMATERIALS, V31, P4809, DOI 10.1016/j.biomaterials.2010.02.064
   Lam MT, 2008, BIOMATERIALS, V29, P1705, DOI 10.1016/j.biomaterials.2007.12.010
   Lamb B., 2012, J AM CHEM SOC, V133, P8870
   Lavanant L, 2010, MACROMOL BIOSCI, V10, P101, DOI 10.1002/mabi.200900205
   Leal-Egana A, 2012, J MATER CHEM, V22, P14330, DOI 10.1039/c2jm31174g
   Leal-Egana A, 2012, J MECH BEHAV BIOMED, V9, P113, DOI 10.1016/j.jmbbm.2012.01.013
   Leal-Egana A, 2012, ADV ENG MATER, V14, pB67, DOI 10.1002/adem.201180072
   Leal-Egana A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-24
   Lutolf MP, 2012, NATURE, V482, P477, DOI 10.1038/482477a
   Mandal K., 2012, PLOS ONE, V7
   Margadant F., 2011, PLOS BIOL, P9
   McNiven MA, 2013, TRENDS CELL BIOL, V23, P16, DOI 10.1016/j.tcb.2012.08.009
   Mendoza-Palomares C, 2012, ACS NANO, V6, P483, DOI 10.1021/nn203817t
   Mertz D, 2009, NAT MATER, V8, P731, DOI [10.1038/NMAT2504, 10.1038/nmat2504]
   Mohammed FF, 2005, TRENDS CELL BIOL, V15, P555, DOI 10.1016/j.tcb.2005.08.009
   Monemdjou R, 2012, ARTHRITIS RHEUM-US, V64, P1551, DOI 10.1002/art.33490
   Moses PJ, 2013, J ENDODONT, V39, P39, DOI 10.1016/j.joen.2012.06.002
   Nakayama M, 2012, MACROMOL BIOSCI, V12, P751, DOI 10.1002/mabi.201200018
   Opolka A, 2012, ARTHRITIS RHEUM-US, V64, P729, DOI 10.1002/art.33449
   Patel PR, 2012, BIOMACROMOLECULES, V13, P2546, DOI 10.1021/bm300795y
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591
   Salber J, 2007, SMALL, V3, P1023, DOI 10.1002/smll.200600596
   Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f
   Shahal, 2012, BIOINTERPHASES, V7, P23
   Sharapova NE, 2009, MOL GENET MICROBIOL+, V24, P150, DOI 10.3103/S0891416809030082
   Stromblad S., 2008, CELL CYCLE, V7, P984
   van der Wijk B., 2012, PLOS ONE, V7
   Vignaud, 2012, J CELL SCI, V125, P2134
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Wang I., 2011, LAB CHIP, V11, P2231
   Wang YJ, 2012, J MATER CHEM, V22, P4652, DOI 10.1039/c2jm13983a
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   Wojciechowski JC, 2008, BRIT J HAEMATOL, V140, P673, DOI 10.1111/j.1365-2141.2007.06967.x
   Young JL, 2011, BIOMATERIALS, V32, P1002, DOI 10.1016/j.biomaterials.2010.10.020
   Zha ZB, 2011, ADV MATER, V23, P3435, DOI 10.1002/adma.201101516
   Zhou HZ, 2012, TISSUE ENG PT A, V18, P1583, DOI [10.1089/ten.tea.2011.0604, 10.1089/ten.TEA.2011.0604]
   Zhu H, 2008, COLLOID SURFACE B, V64, P260, DOI 10.1016/j.colsurfb.2008.02.010
NR 82
TC 28
Z9 28
U1 6
U2 79
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD AUG 7
PY 2013
VL 25
IS 29
BP 4049
EP 4057
DI 10.1002/adma.201301227
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 261VJ
UT WOS:000327692400019
PM 24063035
DA 2018-10-20
ER

PT J
AU Luo, YC
   Teng, Z
   Wang, TTY
   Wang, Q
AF Luo, Yangchao
   Teng, Zi
   Wang, Thomas T. Y.
   Wang, Qin
TI Cellular Uptake and Transport of Zein Nanoparticles: Effects of Sodium
   Caseinate
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE zein; sodium caseinate; nanoparticles; cell uptake; Caco-2 monolayer;
   coumarin 6
ID DRUG-DELIVERY; CONTROLLED-RELEASE; CACO-2 MONOLAYERS; CORN PROTEIN;
   ENCAPSULATION; CELLS; SYSTEMS; CYTOTOXICITY; PERMEABILITY; BIOMATERIAL
AB Cellular evaluation of zein nanoparticles has not been studied systematically due to their poor redispersibility. Caseinate (CAS)-stabilized zein nanoparticles have been recently developed with better redispersibility in salt solutions. In this study, zein CAS nanoparticles were prepared with different zein/CAS mass ratios. The prepared nanoparticles demonstrated good stabilities to maintain particle size (120-140 nm) in cell culture medium and HBSS buffer at 37 degrees C. The nanoparticles showed no cytotoxicity for Caco-2 cells for 72 h. CAS not only significantly enhanced cell uptake of zein nanoparticles in a concentration- and time-dependent manner but also remarkably improved epithelial transport through Caco-2 cell monolayer. The cell uptake of zein-CAS nanoparticles indicated an energy-dependent endocytosis process as evidenced by cell uptake under blocking conditions, that is, 4 degrees C, sodium azide, and colchicine. Fluorescent microscopy clearly showed the internalization of zein-CAS nanoparticles. This study may shed some light on the cellular evaluations of hydrophobic protein nanoparticles.
C1 [Luo, Yangchao; Teng, Zi; Wang, Qin] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.
   [Wang, Thomas T. Y.] ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD 20705 USA.
RP Wang, Q (reprint author), Univ Maryland, Dept Nutr & Food Sci, 0112 Skinner Bldg, College Pk, MD 20742 USA.
EM wangqin@umd.edu
RI Luo, Yangchao/I-2689-2012; Teng, Zi/G-5747-2013
OI Luo, Yangchao/0000-0002-0001-1194; Teng, Zi/0000-0002-6029-7024
FU Maryland NanoCenter at the University of Maryland
FX We appreciate support from the Maryland NanoCenter at the University of
   Maryland. We also acknowledge help and valuable advice from Haiqiu Huang
   in cell culture experiments and help from Caroline Rocourt in
   fluorescence microscope operations.
CR Anarjan N, 2011, J AGR FOOD CHEM, V59, P8733, DOI 10.1021/jf201314u
   Arcan I, 2011, FOOD RES INT, V44, P550, DOI 10.1016/j.foodres.2010.11.034
   Chen LY, 2009, BIOMACROMOLECULES, V10, P3327, DOI 10.1021/bm900989y
   Chen LY, 2006, TRENDS FOOD SCI TECH, V17, P272, DOI 10.1016/j.tifs.2005.12.011
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   Dausend J, 2008, MACROMOL BIOSCI, V8, P1135, DOI 10.1002/mabi.200800123
   Dickinson E, 1997, J DAIRY SCI, V80, P2607, DOI 10.3168/jds.S0022-0302(97)76218-0
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Dong YC, 2005, BIOMATERIALS, V26, P6068, DOI 10.1016/j.biomaterials.2005.03.021
   El-Sayed M, 2002, J CONTROL RELEASE, V81, P355, DOI 10.1016/S0168-3659(02)00087-1
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Elzoghby AO, 2011, J CONTROL RELEASE, V153, P206, DOI 10.1016/j.jconrel.2011.02.010
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Hafner A, 2009, INT J PHARMACEUT, V381, P205, DOI 10.1016/j.ijpharm.2009.07.001
   Harush-Frenkel O, 2008, BIOMACROMOLECULES, V9, P435, DOI 10.1021/bm700535p
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303
   Jahanshahi M, 2008, AFR J BIOTECHNOL, V7, P4926
   Lai LF, 2011, INT J PHARMACEUT, V404, P317, DOI 10.1016/j.ijpharm.2010.11.025
   Li KK, 2012, J AGR FOOD CHEM, V60, P11592, DOI 10.1021/jf302752v
   Liu CJ, 2011, SOFT MATTER, V7, P11526, DOI 10.1039/c1sm06388j
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Liu Y, 2010, INT J PHARMACEUT, V397, P155, DOI 10.1016/j.ijpharm.2010.06.030
   Loh JW, 2012, TOXICOL APPL PHARM, V262, P273, DOI 10.1016/j.taap.2012.04.037
   Loh JW, 2010, TOXICOL APPL PHARM, V249, P148, DOI 10.1016/j.taap.2010.08.029
   Luo YC, 2012, J AGR FOOD CHEM, V60, P836, DOI 10.1021/jf204194z
   Luo YC, 2011, COLLOID SURFACE B, V85, P145, DOI 10.1016/j.colsurfb.2011.02.020
   Luo YC, 2010, CARBOHYD POLYM, V82, P942, DOI 10.1016/j.carbpol.2010.06.029
   MaHam A, 2009, SMALL, V5, P1706, DOI 10.1002/smll.200801602
   Pan K, 2013, J AGR FOOD CHEM, V61, P6036, DOI 10.1021/jf400752a
   Patel AR, 2010, J AGR FOOD CHEM, V58, P12497, DOI 10.1021/jf102959b
   Pisal DS, 2008, INT J PHARM, V350, P113, DOI 10.1016/j.ijpharm.2007.08.033
   Podaralla S, 2012, MOL PHARMACEUT, V9, P2778, DOI 10.1021/mp2006455
   Shi K., 2010, J AGR FOOD CHEM, V59, P56
   Teng Z, 2013, BIOMACROMOLECULES, V14, P2848, DOI 10.1021/bm4006886
   Teng Z, 2013, FOOD CHEM, V141, P524, DOI 10.1016/j.foodchem.2013.03.043
   Teng Z, 2012, J AGR FOOD CHEM, V60, P2712, DOI 10.1021/jf205238x
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   Villarroel P, 2011, EUR J NUTR, V50, P637, DOI 10.1007/s00394-011-0173-8
   Weber C, 2000, INT J PHARM, V194, P91, DOI 10.1016/S0378-5173(99)00370-1
   Win K. Yin, 2005, BIOMATERIALS, V26, P2713
   Wu YP, 2012, LWT-FOOD SCI TECHNOL, V48, P283, DOI 10.1016/j.lwt.2012.03.027
   Xu HL, 2011, J MATER CHEM, V21, P18227, DOI 10.1039/c1jm11163a
   Zhang BC, 2011, FOOD CHEM, V124, P210, DOI 10.1016/j.foodchem.2010.06.019
   Zhang BC, 2010, BIOMACROMOLECULES, V11, P2366, DOI 10.1021/bm100488x
   Zhang Y., 2013, FOOD CHEM, DOI [10.1016/j.foodchem.2013.07.058, DOI 10.1016/J.F00DCHEM.2013.07.058]
   Zhang ZP, 2012, BIOMATERIALS, V33, P4889, DOI 10.1016/j.biomaterials.2012.03.046
   Zhang ZP, 2006, BIOMATERIALS, V27, P4025, DOI 10.1016/j.biomaterials.2006.03.006
   Zhong QX, 2009, FOOD HYDROCOLLOID, V23, P2380, DOI 10.1016/j.foodhyd.2009.06.015
NR 49
TC 60
Z9 62
U1 3
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD AUG 7
PY 2013
VL 61
IS 31
BP 7621
EP 7629
DI 10.1021/jf402198r
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 199UH
UT WOS:000323020500027
PM 23859760
DA 2018-10-20
ER

PT J
AU Forget, A
   Christensen, J
   Ludeke, S
   Kohler, E
   Tobias, S
   Matloubi, M
   Thomann, R
   Shastri, VP
AF Forget, Aurelien
   Christensen, Jon
   Luedeke, Steffen
   Kohler, Esther
   Tobias, Simon
   Matloubi, Maziar
   Thomann, Ralf
   Shastri, V. Prasad
TI Polysaccharide hydrogels with tunable stiffness and provasculogenic
   properties via alpha-helix to beta-sheet switch in secondary structure
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE extracellular matrix; vascular biology; angiogenesis; cell carrier;
   regenerative medicine
ID IN-VITRO; AGAROSE-GEL; MATRIX; MORPHOGENESIS; IMPLANTATION; INTEGRIN;
   PHOTOPOLYMERIZATION; MICROENVIRONMENTS; VASCULOGENESIS; BIOMATERIALS
AB Mechanical aspects of the cellular environment can influence cell function, and in this context hydrogels can serve as an instructive matrix. Here we report that physicochemical properties of hydrogels derived from polysaccharides (agarose, kappa-carrageenan) having an alpha-helical backbone can be tailored by inducing a switch in the secondary structure from alpha-helix to beta-sheet through carboxylation. This enables the gel modulus to be tuned over four orders of magnitude (G' 6 Pa-3.6 x 10(4) Pa) independently of polymer concentration and molecular weight. Using carboxylated agarose gels as a screening platform, we demonstrate that soft-carboxylated agarose provides a unique environment for the polarization of endothelial cells in the presence of soluble and bound signals, which notably does not occur in fibrin and collagen gels. Furthermore, endothelial cells organize into freestanding lumens over 100 mu m in length. The finding that a biomaterial can modulate soluble and bound signals provides impetus for exploring mechanobiology paradigms in regenerative therapies.
C1 [Forget, Aurelien; Christensen, Jon; Kohler, Esther; Tobias, Simon; Matloubi, Maziar; Thomann, Ralf; Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, D-79104 Freiburg, Germany.
   [Forget, Aurelien; Christensen, Jon; Kohler, Esther; Shastri, V. Prasad] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany.
   [Luedeke, Steffen] Univ Freiburg, Inst Pharmaceut Sci, D-79104 Freiburg, Germany.
RP Shastri, VP (reprint author), Univ Freiburg, Inst Macromol Chem, D-79104 Freiburg, Germany.
EM prasad.shastri@gmail.com
OI Ludeke, Steffen/0000-0003-1498-5552; Forget,
   Aurelien/0000-0002-3305-3980
FU excellence initiative of the German Federal and State Governments [EXC
   294]; University of Freiburg
FX The authors thank Drs. Daniel Vonwil and Christopher Pino for valuable
   suggestions, Dr. Christian Friedrich for providing access to the
   rheology instrument, and Prof. Roland Nitschke for help with confocal
   imaging. This work was supported by the excellence initiative of the
   German Federal and State Governments Grant EXC 294 (Centre for
   Biological Signaling Studies) and the University of Freiburg.
CR Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799
   Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043
   Araki J, 1999, J WOOD SCI, V45, P258, DOI 10.1007/BF01177736
   Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4
   Arndt ER, 1997, CARBOHYD RES, V303, P73, DOI 10.1016/S0008-6215(97)00138-9
   ARNOTT S, 1974, J MOL BIOL, V90, P269, DOI 10.1016/0022-2836(74)90372-6
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711
   Cao X, 2002, J BIOMAT SCI-POLYM E, V13, P623, DOI 10.1163/156856202320269120
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   DJABOUROV M, 1989, MACROMOLECULES, V22, P180, DOI 10.1021/ma00191a035
   Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Emans PJ, 2010, P NATL ACAD SCI USA, V107, P3418, DOI 10.1073/pnas.0907774107
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fernandez-Cossio S, 2007, PLAST RECONSTR SURG, V120, P1161, DOI 10.1097/01.prs.0000279475.99934.71
   Ganesh S, 2003, BIOPOLYMERS, V70, P336, DOI 10.1002/bip.10474
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI [10.1016/S0076-6879(08)021105-3, 10.1016/S0076-6879(08)02005-3]
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   Lafleur MA, 2002, J CELL SCI, V115, P3427
   LAHAYE M, 1991, HYDROBIOLOGIA, V221, P137, DOI 10.1007/BF00028370
   LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242
   MYER YP, 1969, MACROMOLECULES, V2, P624, DOI 10.1021/ma60012a012
   Oguey D, 2000, GENE THER, V7, P1292, DOI 10.1038/sj.gt.3301236
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rugge A, 2002, LANGMUIR, V18, P7057, DOI 10.1021/la025710s
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Selmi TAS, 2007, TECH KNEE SURG, V6, P253, DOI [10.1097/BTK.0b013e318148b797aB, DOI 10.1097/BTK.0B013E318148B797AB]
   Shastri VP, 2012, DRUG DELIV TRANSL RE, V2, P293, DOI 10.1007/s13346-012-0100-4
   Shastri VP, 2009, ADV MATER, V21, P3246, DOI [10.1002/adma.200900608, 10.1002/adma.200990155]
   Shiokawa S, 1999, BIOL REPROD, V60, P1468, DOI 10.1095/biolreprod60.6.1468
   Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Takahiro F, 2010, MEASUREMENT, V16, P1
   Tamura H, 2006, CELLULOSE, V13, P357, DOI 10.1007/s10570-006-9058-z
   Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252
   vandenAkker CC, 2011, J AM CHEM SOC, V133, P18030, DOI 10.1021/ja206513r
   Whitley D, 1999, J VASC SURG, V29, P748, DOI 10.1016/S0741-5214(99)70329-0
   Woody RW, 2012, COMPREHENSIVE CHIROP, P475
NR 50
TC 34
Z9 35
U1 1
U2 59
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 6
PY 2013
VL 110
IS 32
BP 12887
EP 12892
DI 10.1073/pnas.1222880110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 196JQ
UT WOS:000322771100025
PM 23886665
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Ahtiainen, K
   Mauno, J
   Ella, V
   Hagstrom, J
   Lindqvist, C
   Miettinen, S
   Ylikomi, T
   Kellomaki, M
   Seppanen, R
AF Ahtiainen, Katja
   Mauno, Jari
   Ella, Ville
   Hagstrom, Jaana
   Lindqvist, Christian
   Miettinen, Susanna
   Ylikomi, Timo
   Kellomaki, Minna
   Seppanen, Riitta
TI Autologous adipose stem cells and polylactide discs in the replacement
   of the rabbit temporomandibular joint disc
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE temporomandibular joint disc; biodegradable replacement; discectomy;
   tissue engineering; polylactide; adipose stem cell
ID AURICULAR CARTILAGE GRAFTS; LONG-TERM EVALUATION; CRANIOMANDIBULAR
   JOINT; INTERNAL DERANGEMENT; FOLLOW-UP; TMJ DISC; EXTRACELLULAR-MATRIX;
   ARTICULAR-CARTILAGE; MANDIBULAR CONDYLE; SURGICAL INDUCTION
AB The temporomandibular joint (TMJ) disc lacks functional replacement after discectomy. We investigated tissue-engineered bilayer polylactide (PLA) discs and autologous adipose stem cells (ASCs) as a potential replacement for the TMJ disc. These ASC discs were pre-cultured either in control or in differentiation medium, including transforming growth factor (TGF)-beta 1 for one week. Prior to implantation, expression of fibrocartilaginous genes was measured by qRT-PCR. The control and differentiated ASC discs were implanted, respectively, in the right and left TMJs of rabbits for six (n = 5) and 12 months (n = 5). Thereafter, the excised TMJ areas were examined with cone beam computed tomography (CBCT) and histology. No signs of infection, inflammation or foreign body reactions were detected at histology, whereas chronic arthrosis and considerable condylar hypertrophy were observed in all operated joints at CBCT. The left condyle treated with the differentiated ASC discs appeared consistently smoother and more sclerotic than the right condyle. The ASC disc replacement resulted in dislocation and morphological changes in the rabbit TMJ. The ASC discs pre-treated with TGF-beta 1 enhanced the condylar integrity. While adverse tissue reactions were not shown, the authors suggest that with improved attachment and design, the PLA disc and biomaterial itself would hold potential for TMJ disc replacement.
C1 [Ahtiainen, Katja; Ylikomi, Timo] Univ Tampere, Dept Cell Biol, Sch Med, Tampere 33014, Finland.
   [Ahtiainen, Katja; Miettinen, Susanna; Seppanen, Riitta] Univ Tampere, Inst Biomed Technol, Tampere 33014, Finland.
   [Ylikomi, Timo] Univ Tampere, Sch Med, Finnish Ctr Alternat Methods, FICAM, Tampere 33014, Finland.
   [Ahtiainen, Katja; Ella, Ville; Miettinen, Susanna; Kellomaki, Minna; Seppanen, Riitta] BioMediTech, Tampere 33520, Finland.
   [Ahtiainen, Katja; Miettinen, Susanna] Tampere Univ Hosp, Sci Ctr, Tampere 33521, Finland.
   [Ylikomi, Timo] Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland.
   [Seppanen, Riitta] Tampere Univ Hosp, Dept Eye Ear & Oral Dis, Tampere 33521, Finland.
   [Mauno, Jari; Lindqvist, Christian] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Surg, Helsinki 00029, Finland.
   [Hagstrom, Jaana] Univ Helsinki, Cent Hosp, HusLab, Dept Pathol, Helsinki 00029, Finland.
   [Ella, Ville; Kellomaki, Minna; Seppanen, Riitta] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland.
   [Hagstrom, Jaana] Univ Helsinki, Dept Pathol & Oral Pathol, FIN-00014 Helsinki, Finland.
   [Lindqvist, Christian] Univ Helsinki, Inst Dent, FIN-00014 Helsinki, Finland.
RP Mauno, J (reprint author), Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Surg, Haartmaninkatu 3, Helsinki 00029, Finland.
EM jari.mauno@hus.fi
RI Kellomaki, Minna/G-6190-2010; Hagstrom, Jaana/G-1468-2018
OI Kellomaki, Minna/0000-0003-4321-1820; Hagstrom,
   Jaana/0000-0001-6079-7881; Miettinen, Susanna/0000-0002-0647-9556
FU Pirkanmaa Hospital District [9J069, 9M058]; Helsinki University Central
   Hospital [TYH 2010232]; University of Tampere; Finnish Cultural
   Foundation; National Doctoral Programme of Musculoskeletal Disorders and
   Biomaterials
FX The authors thank Ms Miia Juntunen, Mrs Hilkka Makinen and Mrs Mirja
   Hypponen for expert technical assistance. Histola Research Limited is
   acknowledged for preparing the histological sections and staining. The
   work was financially supported by the competitive research funding of
   the Pirkanmaa Hospital District (9J069, 9M058), Helsinki University
   Central Hospital (TYH 2010232), the University of Tampere and the
   Finnish Cultural Foundation and National Doctoral Programme of
   Musculoskeletal Disorders and Biomaterials.
CR ALI AM, 1995, J ORAL MAXIL SURG, V53, P544, DOI 10.1016/0278-2391(95)90068-3
   Ali AM, 1996, J ORAL MAXIL SURG, V54, P992, DOI 10.1016/S0278-2391(96)90399-7
   ALI AM, 1995, ARCH ORAL BIOL, V40, P473, DOI 10.1016/0003-9969(95)00005-A
   Ali AM, 1996, J ORAL PATHOL MED, V25, P78, DOI 10.1111/j.1600-0714.1996.tb00197.x
   Allen KD, 2008, J DENT RES, V87, P180, DOI 10.1177/154405910808700205
   Allen KD, 2006, TISSUE ENG, V12, P1183, DOI 10.1089/ten.2006.12.1183
   Allen KD, 2007, TISSUE ENG, V13, P101, DOI 10.1089/ten.2006.0094
   Almarza AJ, 2005, ANN BIOMED ENG, V33, P943, DOI 10.1007/s10439-005-3311-8
   Almarza AJ, 2004, TISSUE ENG, V10, P1787, DOI 10.1089/ten.2004.10.1787
   Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   Anderson DEJ, 2008, ANN BIOMED ENG, V36, P1992, DOI 10.1007/s10439-008-9572-2
   AXELSSON S, 1992, ACTA ODONTOL SCAND, V50, P273, DOI 10.3109/00016359209012773
   BERMEJO A, 1993, ORAL SURG ORAL MED O, V75, P18, DOI 10.1016/0030-4220(93)90399-O
   Brown BN, 2012, J ORAL MAXIL SURG, V70, P2656, DOI 10.1016/j.joms.2011.12.030
   Brown BN, 2011, J ORAL MAXIL SURG, V69, pE488, DOI 10.1016/j.joms.2011.02.130
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Detamore MS, 2006, J ORAL MAXIL SURG, V64, P243, DOI 10.1016/j.joms.2005.10.009
   Detamore MS, 2005, ANN BIOMED ENG, V33, P383, DOI 10.1007/s10439-005-1741-y
   Detamore MS, 2005, MATRIX BIOL, V24, P45, DOI 10.1016/j.matbio.2004.11.006
   Detamore MS, 2003, TISSUE ENG, V9, P1065, DOI 10.1089/10763270360727991
   Dimitroulis G, 2006, J ORAL MAXIL SURG, V64, P1075, DOI 10.1016/j.joms.2006.03.011
   Dimitroulis G, 2005, J ORAL MAXIL SURG, V63, P173, DOI 10.1016/j.joms.2004.06.051
   Dimitroulis G, 2011, INT J ORAL MAX SURG, V40, P561, DOI 10.1016/j.ijom.2010.11.020
   Dimitroulis G, 2011, J ORAL MAXIL SURG, V69, P439, DOI 10.1016/j.joms.2010.07.021
   Dolwick M Franklin, 2007, Dent Clin North Am, V51, P195, DOI 10.1016/j.cden.2006.10.003
   Dolwick MF, 1997, ORAL SURG ORAL MED O, V83, P150, DOI 10.1016/S1079-2104(97)90106-2
   ERIKSSON L, 1985, J ORAL MAXIL SURG, V43, P263, DOI 10.1016/0278-2391(85)90284-8
   Eriksson L, 2001, J ORAL MAXIL SURG, V59, P750, DOI 10.1053/joms.2001.24288
   ESTABROOKS LN, 1990, ORAL SURG ORAL MED O, V70, P381, DOI 10.1016/0030-4220(90)90164-N
   FEINBERG SE, 1995, J ORAL MAXIL SURG, V53, P535, DOI 10.1016/0278-2391(95)90066-7
   Giurea A, 2003, J ORTHOPAED RES, V21, P584, DOI 10.1016/S0736-0266(02)00263-2
   Grimaud E, 2002, CYTOKINE GROWTH F R, V13, P241, DOI 10.1016/S1359-6101(02)00004-7
   Haimi S, 2009, TISSUE ENG PT A, V15, P1473, DOI 10.1089/ten.tea.2008.0241
   Hattori H, 2006, J BIOMED MATER RES B, V76B, P230, DOI 10.1002/jbm.b.30357
   Hildner F, 2011, J TISSUE ENG REGEN M, V5, pE36, DOI 10.1002/term.386
   HINTON RJ, 1992, J DENT RES, V71, P1292, DOI 10.1177/00220345920710060501
   Hoben GM, 2008, STEM CELLS, V26, P422, DOI 10.1634/stemcells.2007-0641
   Hoben GM, 2009, STEM CELLS DEV, V18, P283, DOI 10.1089/scd.2008.0024
   Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969
   Ingawale S, 2009, ANN BIOMED ENG, V37, P976, DOI 10.1007/s10439-009-9659-4
   Johns DE, 2008, J DENT RES, V87, P548
   Johns DE, 2007, CELLS TISSUES ORGANS, V185, P246, DOI 10.1159/000102173
   Kalpakci KN, 2011, J DENT RES, V90, P193, DOI 10.1177/0022034510381501
   Kalpakci KN, 2011, ACTA BIOMATER, V7, P1710, DOI 10.1016/j.actbio.2010.12.015
   Landesberg R, 1996, ARCH ORAL BIOL, V41, P761, DOI 10.1016/S0003-9969(96)00068-4
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612
   Maenpaa K, 2010, J R SOC INTERFACE, V7, P177, DOI 10.1098/rsif.2009.0117
   Mercuri LG, 2004, J ORAL MAXIL SURG, V62, P1088, DOI 10.1016/j.joms.2003.10.012
   Mercuri LG, 2007, J ORAL MAXIL SURG, V65, P1140, DOI 10.1016/j.joms.2006.10.006
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   MEYER RA, 1988, J ORAL MAXIL SURG, V46, P948, DOI 10.1016/0278-2391(88)90332-1
   Mills David K., 1994, Journal of Orofacial Pain, V8, P136
   MILLS DK, 1994, J ORAL MAXIL SURG, V52, P1279, DOI 10.1016/0278-2391(94)90051-5
   Miloro M, 2010, J ORAL MAXIL SURG, V68, P782, DOI 10.1016/j.joms.2009.09.091
   Minarelli AM, 1997, J ORAL REHABIL, V24, P835, DOI 10.1046/j.1365-2842.1997.00595.x
   NAKANO T, 1989, ARCH ORAL BIOL, V34, P749, DOI 10.1016/0003-9969(89)90082-4
   Nakano T, 1996, ARCH ORAL BIOL, V41, P845, DOI 10.1016/S0003-9969(96)00040-4
   Olivos-Meza A, 2010, OSTEOARTHR CARTILAGE, V18, P1183, DOI 10.1016/j.joca.2010.06.003
   POGREL MA, 1990, J ORAL MAXIL SURG, V48, P14, DOI 10.1016/0278-2391(90)90173-Y
   PUELACHER WC, 1994, J ORAL MAXIL SURG, V52, P1172, DOI 10.1016/0278-2391(94)90538-X
   Revell CM, 2008, ANN BIOMED ENG, V36, P1441, DOI 10.1007/s10439-008-9524-x
   Roelen Bernard A J, 2003, J Orthop Sci, V8, P740, DOI 10.1007/s00776-003-0702-2
   Sandler NA, 1997, J ORAL MAXIL SURG, V55, P1014, DOI 10.1016/S0278-2391(97)90082-3
   Sandor GK, 2013, J ORAL MAXIL SURG, V71, P938, DOI 10.1016/j.joms.2012.11.014
   SAVALLE WPM, 1990, ANAT REC, V227, P159, DOI 10.1002/ar.1092270204
   Smith DM, 2011, PLAST RECONSTR SURG, V128, P1053, DOI 10.1097/PRS.0b013e31822b65e4
   Springer ING, 2001, BIOMATERIALS, V22, P2569, DOI 10.1016/S0142-9612(01)00148-X
   Su-Gwan K, 2001, INT J ORAL MAX SURG, V30, P189, DOI 10.1054/ijom.2001.0047
   Supronowicz P, 2011, TISSUE ENG PT A, V17, P789, DOI 10.1089/ten.TEA.2010.0357
   TAKAKU S, 1994, J ORAL MAXIL SURG, V52, P722, DOI 10.1016/0278-2391(94)90486-3
   Takatsuka S, 1996, J ORAL MAXIL SURG, V54, P1216, DOI 10.1016/S0278-2391(96)90355-9
   Thesleff T, 2011, NEUROSURGERY, V68, P1535, DOI 10.1227/NEU.0b013e31820ee24e
   THOMAS M, 1991, J ORAL MAXIL SURG, V49, P854, DOI 10.1016/0278-2391(91)90015-E
   THYNE GM, 1992, J ORAL MAXIL SURG, V50, P979, DOI 10.1016/0278-2391(92)90059-9
   TOLVANEN M, 1988, BRIT J ORAL MAX SURG, V26, P311, DOI 10.1016/0266-4356(88)90049-6
   Tucker M R, 1996, Atlas Oral Maxillofac Surg Clin North Am, V4, P75
   TUCKER MR, 1986, J ORAL MAXIL SURG, V44, P781, DOI 10.1016/0278-2391(86)90153-9
   WEIJS WA, 1981, NETH J ZOOL, V31, P99
   WESTESSON PL, 1987, ORAL SURG ORAL MED O, V63, P143, DOI 10.1016/0030-4220(87)90302-1
   WILKES CH, 1991, ARCH OTOLARYNGOL, V117, P64
   Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 84
TC 11
Z9 11
U1 1
U2 12
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD AUG 6
PY 2013
VL 10
IS 85
AR 20130287
DI 10.1098/rsif.2013.0287
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 167DL
UT WOS:000320610700008
PM 23720535
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Hutten, M
   Erhacrt, F
   Zimmermann, H
   Reich, U
   Esser, KH
   Lenarz, T
   Scheper, V
AF Huetten, Mareike
   Erhacrt, Friederike
   Zimmermann, Heiko
   Reich, Uta
   Esser, Karl-Heinz
   Lenarz, Thomas
   Scheper, Verena
TI UHV-Alginate as Matrix for Neurotrophic Factor Producing Cells-A Novel
   Biomaterial for Cochlear Implant Optimization to Preserve Inner Ear
   Neurons From Degeneration
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE Brain-derived neurotrophic factor; Cell-based therapy; Cochlear implant;
   Local drug delivery; Spiral ganglion neuron
ID SPIRAL GANGLION-CELLS; TERM IMMUNOISOLATED TRANSPLANTATION;
   SENSORINEURAL HEARING-LOSS; AUDITORY NEURONS; IN-VIVO; DRUG-DELIVERY;
   SURVIVAL; BRAIN; MICROCAPSULES; BDNF
AB Hypothesis: Ultra high viscous (UHV-) alginate is a suitable matrix for brain-derived neurotrophic factor (BDNF) producing cells, enabling cell survival and BDNF release out of the matrix and subsequent protection of auditory neuronal cells.
   Background: Cochlear implant (CI) target cells, spiral ganglion cells (SGC), undergo a progressive degeneration. BDNF prevents SGC from degeneration but has to be delivered locally to the inner ear for months. A permanent growth factor application may be realized via a cell-based drug delivery system. Encapsulation of this delivery system into a matrix could avoid immune response of the recipient, migration, and uncontrolled proliferation of the cells.
   Methods: NIH3T3-fibroblasts producing endogenous BDNF were incorporated in UHV-alginate. The survival of the cells in the alginate was examined by cell counts of cryogenic slices, and the BDNF production was determined by performing ELISA. The supernatant of the alginate-cell culture was added to primary SGC culture, and the neuroprotective effect of the produced BDNF was observed performing SGC counts.
   Results: BDNF-producing cells cultivated in UHV-alginate survived for up to 30 days, which was the latest time point observed. The BDNF concentration in cell culture medium, produced from in UHV-alginate incorporated fibroblasts and released out of the alginate matrix into the medium, was significantly increased after 30 days of cultivation. Supernatant of 7 days incubated UHV-alginate containing NIH3T3/BDNF cells significantly increased the SGC survival in vitro.
   Conclusion: This study demonstrates UHV-alginate to be a suitable scaffold for BDNF-producing fibroblasts. UHV-alginates are a promising biomaterial for cochlear implant biofunctionalization.
C1 [Huetten, Mareike; Reich, Uta; Lenarz, Thomas; Scheper, Verena] Hannover Med Sch, Dept Otolaryngol Head & Neck Surg, D-30625 Hannover, Germany.
   [Huetten, Mareike; Esser, Karl-Heinz] Univ Vet Med Hannover, Inst Zool, Hannover, Germany.
   [Erhacrt, Friederike] Fraunhofer Inst Biomed Tech, St Ingbert, Germany.
   [Zimmermann, Heiko] Univ Saarland, Lehrstuhl Mol Zellulare Biotechnol Nanotechnol, St Ingbert, Germany.
   [Reich, Uta] Charite, Dept Otorhinolaryngol, D-13353 Berlin, Germany.
RP Scheper, V (reprint author), Hannover Med Sch, Dept Otolaryngol Head & Neck Surg, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM scheper.verena@mh-hannover.de
OI Ehrhart, Friederike/0000-0002-7770-620X
FU German Research Foundation, Excellence Academy for Medicine
   Technology-Adaptive Implants; European Community [NMP4-CT-2006-026556]
FX This study was supported by the German Research Foundation, Excellence
   Academy for Medicine Technology-Adaptive Implants and by the European
   Community 6th Framework Programme on Research, Technological Development
   and Demonstration (Nanotechnology based Drug Delivery. Contract Number:
   NMP4-CT-2006-026556, Project acronym: NANOEAR).
CR Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2
   Borenstein JT, 2011, EXPERT OPIN DRUG DEL, V8, P1161, DOI 10.1517/17425247.2011.588207
   Braccini I, 1999, CARBOHYD RES, V317, P119, DOI 10.1016/S0008-6215(99)00062-2
   Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270
   Chikar JA, 2012, BIOMATERIALS, V33, P1982, DOI 10.1016/j.biomaterials.2011.11.052
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Garnham C, 2005, Cochlear Implants Int, V6 Suppl 1, P12, DOI 10.1179/cim.2005.6.Supplement-1.12
   Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542
   Gillespie LN, 2005, EUR J NEUROSCI, V22, P2123, DOI 10.1111/j.1460-9568.2005.04430.x
   Heiligenstein S, 2011, J GENE MED, V13, P230, DOI 10.1002/jgm.1557
   KUHTREIBER WM, 1999, CELL ENCAPSULATION T
   Lanza RP, 1996, NAT BIOTECHNOL, V14, P1107, DOI 10.1038/nbt0996-1107
   NADOL JB, 1988, ANNU REV MED, V39, P491, DOI 10.1146/annurev.med.39.1.491
   Noushi F, 2005, OTOL NEUROTOL, V26, P528, DOI 10.1097/01.mao.0000169780.84588.a5
   Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V
   Schneider S, 2005, DIABETES, V54, P687, DOI 10.2337/diabetes.54.3.687
   Shepherd RK, 2005, J COMP NEUROL, V486, P145, DOI 10.1002/cne.20564
   Skinner SJM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065001
   Storz H, 2009, CARBOHYD RES, V344, P985, DOI 10.1016/j.carres.2009.02.016
   Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003
   Tusi SK, 2011, BIOMATERIALS, V32, P5438, DOI 10.1016/j.biomaterials.2011.04.024
   Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7
   Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007
   Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008
   Wise AK, 2011, NEUROTHERAPEUTICS, V8, P774, DOI 10.1007/s13311-011-0070-0
   Zimmermann H, 2007, APPL PHYS A-MATER, V89, P909, DOI 10.1007/s00339-007-4270-8
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
   Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1
   Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x
NR 29
TC 2
Z9 2
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1531-7129
EI 1537-4505
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD AUG
PY 2013
VL 34
IS 6
BP 1127
EP 1133
PG 7
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 301GU
UT WOS:000330521600033
PM 23512074
DA 2018-10-20
ER

PT J
AU He, JK
   Mao, M
   Liu, YX
   Shao, JY
   Jin, ZM
   Li, DC
AF He, Jiankang
   Mao, Mao
   Liu, Yaxiong
   Shao, Jinyou
   Jin, Zhongmin
   Li, Dichen
TI Fabrication of Nature-Inspired Microfluidic Network for Perfusable
   Tissue Constructs
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE biomaterial hydrogel; leaf venation; microfluidic network; tissue
   engineering
ID 3-DIMENSIONAL MICROVASCULAR NETWORKS; VASCULAR NETWORKS; MATRIX;
   STRATEGIES; SCAFFOLDS; COLLAGEN; ENGINEER
C1 [He, Jiankang; Mao, Mao; Liu, Yaxiong; Shao, Jinyou; Jin, Zhongmin; Li, Dichen] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Shaanxi, Peoples R China.
RP He, JK (reprint author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Shaanxi, Peoples R China.
EM jiankanghe@mail.xjtu.edu.cn; dcli@mail.xjtu.edu.cn
RI Shao, Jinyou/N-3185-2014
FU Fundamental Research Funds for the Central Universities; National
   Natural Science Foundation [51105298]; National High Technology Research
   and Development Program of China [2009AA043801]
FX This work was supported by the Fundamental Research Funds for the
   Central Universities, the National Natural Science Foundation (51105298)
   and the National High Technology Research and Development Program
   (2009AA043801) of China. We would like to thank Dr. Jiuhong Wang and Mr.
   Jicheng Li for their kind help in the preparation of silicon mold.
CR Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Bellan LM, 2012, ADV HEALTHC MATER, V1, P164, DOI 10.1002/adhm.201100052
   Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Hansen C.J., 2009, ADV MATER, V21, P1, DOI DOI 10.1002/ADMA.200900588
   Hoganson DM, 2010, TISSUE ENG PT A, V16, P1469, DOI [10.1089/ten.tea.2009.0118, 10.1089/ten.TEA.2009.0118]
   Huang JH, 2009, ADV MATER, V21, P3567, DOI 10.1002/adma.200900584
   Jeong JH, 2012, ADV MATER, V24, P58, DOI 10.1002/adma.201103207
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   McCulloh KA, 2003, NATURE, V421, P939, DOI 10.1038/nature01444
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Schnepp Z, 2010, ANGEW CHEM INT EDIT, V49, P6564, DOI 10.1002/anie.201001626
   Therriault D, 2005, ADV MATER, V17, P395, DOI 10.1002/adma.200400481
   Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863
   Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625
   Wu W, 2010, SOFT MATTER, V6, P739, DOI 10.1039/b918436h
   Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109
NR 28
TC 29
Z9 29
U1 7
U2 60
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD AUG
PY 2013
VL 2
IS 8
BP 1108
EP 1113
DI 10.1002/adhm.201200404
PG 6
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 267XA
UT WOS:000328130400005
PM 23554383
DA 2018-10-20
ER

PT J
AU Pereira, KKY
   Alves, OC
   Novaes, AB
   de Oliveira, FS
   Yi, JH
   Zaniquelli, O
   Wolf-Brandstetter, C
   Scharnweber, D
   Variola, F
   Nanci, A
   Rosa, AL
   de Oliveira, PT
AF Pereira, Karina K. Y.
   Alves, Olivia C.
   Novaes, Arthur B., Jr.
   de Oliveira, Fabiola S.
   Yi, Ji-Hyun
   Zaniquelli, Osvaldo
   Wolf-Brandstetter, Cornelia
   Scharnweber, Dieter
   Variola, Fabio
   Nanci, Antonio
   Rosa, Adalberto L.
   de Oliveira, Paulo T.
TI Progression of Osteogenic Cell Cultures Grown on Microtopographic
   Titanium Coated With Calcium Phosphate and Functionalized With a Type I
   Collagen-Derived Peptide
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Calcium phosphates; cells; cultured; collagen; osteoblasts; peptides;
   titanium
ID OSTEOBLAST DIFFERENTIATION; IMPLANT SURFACE; BONE-FORMATION; MATRIX
   MINERALIZATION; DENTAL IMPLANTS; GENE-EXPRESSION; ADHESION; VITRO;
   PHENOTYPE; COATINGS
AB Background: The functionalization of metallic surfaces aims at promoting the cellular response at the biomaterial-tissue interface. This study investigates the effects of the functionalization of titanium (Ti) microtopography with a calcium phosphate (CaP) coating with and without peptide 15 (P-15), a synthetic peptide analog of the cell-binding domain of collagen I, on the in vitro progression of osteogenic cells.
   Methods: Sandblasting and acid etching (SBAE; control) Ti microtopography was coated with CaP, enabling the loading of two concentrations of P-15: 20 or 200 mg/mL. A machined Ti was also examined. Rat calvarial osteogenic cells were cultured on Ti disks with the surfaces mentioned above for periods up to 21 days (n = 180 per group).
   Results: CaP coating exhibited a submicron-scale needle-shaped structure. Although all surfaces were hydrophobic at time zero, functionalization increased hydrophilicity at equilibrium. Microtopographies exhibited a lower proportion of well-spread cells at 4 hours of culture and cells with long cytoplasmic extensions at day 3; modified SBAE supported higher cell viability and larger extracellular osteopontin (OPN) accumulation. For SBAE and modified SBAE, real-time polymerase chain reaction showed the following results: 1) lower levels for runt-related transcription factor 2 at 7 days and for bone sialoprotein at days 7 and 10 as well as higher OPN levels at days 7 and 10 compared to machined Ti; and 2) higher alkaline phosphatase levels at day 10 compared to day 7. At 14 and 21 days, modified SBAE supported higher proportions of red-dye-stained areas (calcium content).
   Conclusion: Addition of a CaP coating to SBAE Ti by itself may affect key events of in vitro osteogenesis, ultimately resulting in enhanced matrix mineralization; additional P-15 functionalization has only limited synergistic effects.
C1 [Pereira, Karina K. Y.; Alves, Olivia C.; Novaes, Arthur B., Jr.; de Oliveira, Fabiola S.; Zaniquelli, Osvaldo; Rosa, Adalberto L.; de Oliveira, Paulo T.] Univ Sao Paulo, Sch Dent Ribeirao Preto, BR-14040904 Sao Paulo, Brazil.
   [Yi, Ji-Hyun; Nanci, Antonio] Univ Montreal, Lab Study Calcified Tissues & Biomat, Montreal, PQ, Canada.
   [Wolf-Brandstetter, Cornelia; Scharnweber, Dieter] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, Dresden, Germany.
   [Variola, Fabio] Univ Ottawa, Fac Engn, Ottawa, ON, Canada.
RP de Oliveira, PT (reprint author), Univ Sao Paulo, Dept Morphol, Sch Dent Ribeirao Preto, Av Cafe S-N, BR-14040904 Sao Paulo, Brazil.
EM tambasco@usp.br
RI Oliveira, Fabiola/J-6915-2014; novaes, arthur/O-2945-2013; Rosa,
   Adalberto/A-6314-2008; Tambasco de Oliveira, Paulo/F-9749-2010
OI Oliveira, Fabiola/0000-0003-0855-5118; Rosa,
   Adalberto/0000-0002-6495-2778; Tambasco de Oliveira,
   Paulo/0000-0002-6662-0486; Variola, Fabio/0000-0002-5519-6915;
   Scharnweber, Dieter/0000-0003-0369-5189
FU State of Sao Paulo Research Foundation [2008/54027-9]; National Council
   of Scientific and Technological Development; Canadian Institutes of
   Health Research; Natural Sciences and Engineering Research Council of
   Canada; Coordination for the Improvement of Higher Education Personnel,
   Brasilia, DF, Brazil; State of Sao Paulo Research Foundation; DENTSPLY
   Friadent, Mannheim, Germany
FX This study was supported by State of Sao Paulo Research Foundation Grant
   2008/54027-9 and the National Council of Scientific and Technological
   Development. AN acknowledges support from Canadian Institutes of Health
   Research and Natural Sciences and Engineering Research Council of
   Canada. KKYP was the recipient of a master's fellowship from The
   Coordination for the Improvement of Higher Education Personnel,
   Brasilia, DF, Brazil. OCA was the recipient of an internship scholarship
   from the State of Sao Paulo Research Foundation. The MPIIIB10-1 and
   WVID1-9C5 antibodies, developed by M. Solursh and A. Franzen, University
   of Iowa, Iowa City, Iowa, were obtained from the Developmental Studies
   Hybridoma Bank (University of Iowa, Iowa City, Iowa). The authors thank
   Roger R. Fernandes and Larissa M.S. de Castro-Raucci (University of Sao
   Paulo, Ribeirao Preto, Sao Paulo, Brazil) for their technical
   assistance; Murilo Crovace (Federal University of Sao Carlos, Sao
   Carlos, Sao Paulo, Brazil) for the FTIR analysis; and Sylvia Zalzal
   (University of Montreal, Montreal, Quebec) for the SEM imaging. Drs.
   Scharnweber and Wolf-Brandstetter report financial support from DENTSPLY
   Friadent, Mannheim, Germany for the development of the coating process.
   Drs. Pereira, Alves, Novaes Jr., F.S. de Oliveira, Yi, Zaniquelli,
   Variola, Nanci, Rosa, and P.T. de Oliveira report no conflicts of
   interest related to this study.
CR Adamson AW, 1997, PHYS CHEM SURFACES, P347
   Beutner R, 2010, J R SOC INTERFACE, V7, pS93, DOI 10.1098/rsif.2009.0418.focus
   da Silva RAB, 2008, J ENDODONT, V34, P1485, DOI 10.1016/j.joen.2008.08.031
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   Bornstein MM, 2009, INT J ORAL MAX IMPL, V24, P12
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   de Assis AF, 2009, CLIN ORAL IMPLAN RES, V20, P240, DOI 10.1111/j.1600-0501.2008.01641.x
   de Oliva MA, 2009, J HISTOCHEM CYTOCHEM, V57, P265, DOI 10.1369/jhc.2008.952713
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Gomar F, 2007, INT ORTHOP, V31, P93, DOI 10.1007/s00264-006-0087-x
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kirmizidis G, 2009, TISSUE ENG PT A, V15, P1427, DOI 10.1089/ten.tea.2008.0137
   Kizuki T, 2010, ACTA BIOMATER, V6, P2836, DOI 10.1016/j.actbio.2010.01.007
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lutz R, 2013, CLIN ORAL IMPLAN RES, V24, P781, DOI 10.1111/j.1600-0501.2012.02455.x
   Lutz R, 2010, CLIN ORAL IMPLAN RES, V21, P726, DOI 10.1111/j.1600-0501.2009.01904.x
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Meirelles L, 2008, J BIOMED MATER RES A, V87A, P299, DOI 10.1002/jbm.a.31744
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Mendonca G, 2010, J BIOMED MATER RES A, V94A, P169, DOI 10.1002/jbm.a.32701
   Morra M, 2006, J BIOMED MATER RES A, V78A, P449, DOI 10.1002/jbm.a.30783
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011
   Roessler S, 2001, J MATER SCI-MATER M, V12, P871, DOI 10.1023/A:1012807621414
   Rosa AL, 2009, CLIN ORAL IMPLAN RES, V20, P472, DOI 10.1111/j.1600-0501.2008.01662.x
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   Schouten C, 2009, CLIN ORAL IMPLAN RES, V20, P421, DOI 10.1111/j.1600-0501.2008.01657.x
   Fo HOS, 2007, CLIN ORAL IMPLAN RES, V18, P333, DOI 10.1111/j.1600-0501.2006.01313.x
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979
   Susin C, 2010, J CLIN PERIODONTOL, V37, P574, DOI 10.1111/j.1600-051X.2010.01554.x
   Tosatti S, 2004, J BIOMED MATER RES A, V68A, P458, DOI 10.1002/jbm.a.20082
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Vetrone F, 2009, NANO LETT, V9, P659, DOI 10.1021/nl803051f
   Wieland M, 2005, BIOMATERIALS, V26, P1119, DOI 10.1016/j.biomaterials.2004.04.020
   Wikesjo UME, 2008, J CLIN PERIODONTOL, V35, P992, DOI 10.1111/j.1600-051X.2008.01322.x
   Yang GL, 2010, J ORAL MAXIL SURG, V68, P420, DOI 10.1016/j.joms.2009.09.014
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 50
TC 5
Z9 6
U1 0
U2 8
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD AUG
PY 2013
VL 84
IS 8
BP 1199
EP 1210
DI 10.1902/jop.2012.120072
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 275NW
UT WOS:000328685100019
PM 23088527
DA 2018-10-20
ER

PT J
AU Pal, S
   Kundu, J
   Talukdar, S
   Thomas, T
   Kundu, SC
AF Pal, Shilpa
   Kundu, Joydip
   Talukdar, Sarmistha
   Thomas, Tintu
   Kundu, Subhas C.
TI An Emerging Functional Natural Silk Biomaterial from the only
   Domesticated Non-mulberry Silkworm Samia ricini
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterial; eri; fibroin; Samia ricini; silk
ID TISSUE ENGINEERING APPLICATIONS; BOMBYX-MORI; FIBROIN PROTEIN; FILMS;
   DISSOLUTION; FABRICATION; MATRICES; METHANOL
AB Mulberry silk fibroin is a widely used biomaterial and recent work on non-mulberry silk fibroin also suggests it may have similar uses. We expect silk fibroin from the only domesticated non-mulberry eri silkworm, Samia ricini, to possess useful properties as a biomaterial. Eri silk gland fibroin is a heterodimeric protein of approximately 450kDa. Cytocompatibility evaluation with fibroblasts and osteoblast-like cells shows good cell attachment, viability and proliferation. The matrices, which have high thermal stability and good swellability, are also haemocompatible. Eri silk production is cost effective as no agronomic practices are required for their host plant cultivation. This fibroin provide new opportunities as an alternative natural functional biomaterial in various biomedical applications.
C1 [Pal, Shilpa; Kundu, Joydip; Talukdar, Sarmistha; Thomas, Tintu; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology (NER Programme) and its Bioinformatics
   facilities; Department of Science and Technology, Government of India,
   New Delhi
FX The authors are grateful to Professor Chandra P. Sharma and Dr. M. R.
   Rekha of Sree Chitra Tirunal Institute for Medical Sciences and
   Technology, Trivandrum, for scientific discussions, protocols and
   training for blood compatibility experiments; Dr. Tuli Dey for her
   comments to improve the manuscript; Dr. Milli Banerjee, Deputy Director,
   Directorate of Textile (Sericulture) and Mr. Mrinal Dey of State
   Ericulture Farm, Jalpaiguri, West Bengal State of India for providing
   the live 5th instar eri silkworms from time to time. This work was
   financially supported by the Department of Biotechnology (NER Programme)
   and its Bioinformatics facilities and the Department of Science and
   Technology, Government of India, New Delhi.
CR Ahmad S. E., 2004, DNA CELL BIOL, V23, P149
   Alessandrino A, 2008, ENG LIFE SCI, V8, P219, DOI 10.1002/elsc.200700067
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Datta A, 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI 10.1016/S0965-1748(01)00049-2
   Dutta S, 2013, BIOPOLYMERS, V99, P326, DOI 10.1002/bip.22168
   Khatiwala C.B., 2006, AM J PHYSIOL-CELL PH, V290, P1640
   Kommireddy DS, 2006, BIOMATERIALS, V27, P4296, DOI 10.1016/j.biomaterials.2006.03.042
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Kweon H, 2001, J APPL POLYM SCI, V82, P750, DOI 10.1002/app.1901
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Mai-ngam K, 2011, J BIOMAT SCI-POLYM E, V22, P2001, DOI 10.1163/092050610X530964
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Mossman T., 1989, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Peigler R. S., 2003, REVISION SILKMOTH GE, P66
   Rekha MR, 2009, BIOMATERIALS, V30, P6655, DOI 10.1016/j.biomaterials.2009.08.029
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Seib FP, 2012, BIOMATERIALS, V33, P1017, DOI 10.1016/j.biomaterials.2011.10.063
   Tanaka C, 2008, MACROMOLECULES, V41, P796, DOI 10.1021/ma7021875
   Tanaka T, 2002, J THERM ANAL CALORIM, V70, P825, DOI 10.1023/A:1022256203778
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   Thomas JJ, 2010, COLLOID SURFACE B, V81, P195, DOI 10.1016/j.colsurfb.2010.07.015
   Towbin H., 1979, P NATL ACAD SCI USA, V76, P4872
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yamamoto K, 2007, BIOMATERIALS, V28, P1838, DOI 10.1016/j.biomaterials.2006.11.045
   Yamauchi K, 2010, SOLID STATE NUCL MAG, V38, P27, DOI 10.1016/j.ssnmr.2010.06.002
   YANG JT, 1986, METHOD ENZYMOL, V130, P208
   Yaowalak S, 2009, Journal of Applied Sciences, V9, P2992, DOI 10.3923/jas.2009.2992.2995
   Zhu ZH, 2009, MATER CHEM PHYS, V117, P430, DOI 10.1016/j.matchemphys.2009.06.028
NR 39
TC 15
Z9 15
U1 1
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG
PY 2013
VL 13
IS 8
BP 1020
EP 1035
DI 10.1002/mabi.201300013
PG 16
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 262ME
UT WOS:000327738700003
PM 23733347
DA 2018-10-20
ER

PT J
AU Lu, HB
   Wan, L
   Zhang, XY
   Rong, MD
   Guo, ZH
   Zhou, L
AF Lu Haibin
   Wan Lei
   Zhang Xueyang
   Rong Mingdeng
   Guo Zehong
   Zhou Lei
TI Effects of Hydrocarbons Contamination on Initial Responses of
   Osteoblast-like Cells on Acid-Etched Titanium Surface
SO RARE METAL MATERIALS AND ENGINEERING
LA English
DT Article
DE hydrocarbons contamination; cellular responses; titanium surface;
   acid-etched
ID BIOMATERIAL; ADHESION; BONE; STERILIZATION; INTEGRATION; ROUGHNESS;
   IMPLANTS
AB The purpose of this study is to investigate the initial cellular responses on acid-etched titanium surface with different degrees of hydrocarbons contamination in the atmosphere, with reference to cell adhesion and proliferation in vitro. Acid-etched surfaces were prepared and divided into 4 groups, which were stored in sealed containers for different durations. Scanning electron microscopy, Optical profiler, X-ray photoelectron spectroscopy (XPS) and contact angle measurements were used to examine surface characterization. MG63 osteoblast-like cells were cultured on these discs, and cell attachment and cell proliferation were analyzed. The results of Scanning electron microscope and Optical Profiler analysis show that the titanium discs used in this experiment share the same surface topography; however, X-ray photoelectron spectroscopy (XPS) examination show that the carbon atomic percentage presented on titanium surface increases with prolonging of storage time, from 25.99% to 48.16%. In addition, the surface changes from being hydrophilic to hydrophobic as the storage time increases. Cell attachment and cell proliferation show better results on the new titanium surface (P<0.05), and the morphology of cells on the new surface also spread wider and better, compared with all the old surfaces. Hydrocarbons contamination on titanium surface significantly affects the bioactivity of acid-etched surfaces. More efforts are needed to improve the storage methods in order to maintain the bioactivity of titanium implant.
C1 [Lu Haibin; Wan Lei; Zhang Xueyang; Rong Mingdeng; Guo Zehong; Zhou Lei] Southern Med Univ, Guangdong Prov Stomatol Hosp, Guangzhou 510280, Guangdong, Peoples R China.
RP Zhou, L (reprint author), Southern Med Univ, Guangdong Prov Stomatol Hosp, Guangzhou 510280, Guangdong, Peoples R China.
EM luhaibin-1985@hotmail.com; zho668@263.net
FU National Natural Science Foundation of China [50824001]
FX National Natural Science Foundation of China (50824001)
CR An YH, 2005, INT J ARTIF ORGANS, V28, P1126
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   APARICIO C, 1992, International Journal of Oral and Maxillofacial Implants, V7, P94
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Faghihi S, 2007, BIOMATERIALS, V28, P3887, DOI 10.1016/j.biomaterials.2007.05.010
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Klauber C, 1990, Int J Oral Maxillofac Implants, V5, P264
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Mata A, 2003, IEEE T NANOBIOSCI, V2, P287, DOI 10.1109/TNB.2003.820268
   Park J H, 2011, ACTA BIOMATER, V7, P2751
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   Zhao LZ, 2010, BIOMATERIALS, V31, P2055, DOI 10.1016/j.biomaterials.2009.11.103
NR 17
TC 1
Z9 1
U1 0
U2 3
PU NORTHWEST INST NONFERROUS METAL RESEARCH
PI SHAANXI
PA C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI
   710016, PEOPLES R CHINA
SN 1002-185X
J9 RARE METAL MAT ENG
JI Rare Metal Mat. Eng.
PD AUG
PY 2013
VL 42
IS 8
BP 1558
EP 1562
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 275HP
UT WOS:000328667200004
DA 2018-10-20
ER

PT J
AU Filardo, G
   Kon, E
   Di Martino, A
   Busacca, M
   Altadonna, G
   Marcacci, M
AF Filardo, Giuseppe
   Kon, Elizaveta
   Di Martino, Alessandro
   Busacca, Maurizio
   Altadonna, Giulio
   Marcacci, Maurilio
TI Treatment of Knee Osteochondritis Dissecans With a Cell-Free Biomimetic
   Osteochondral Scaffold Clinical and Imaging Evaluation at 2-Year
   Follow-up
SO AMERICAN JOURNAL OF SPORTS MEDICINE
LA English
DT Article
DE osteochondritis dissecans; OCD; biomimetic scaffold; osteochondral
   regeneration; knee
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; BILAYER COLLAGEN MEMBRANE;
   COMPOSITE MULTILAYERED BIOMATERIAL; LONG-TERM; CARTILAGE REPAIR; SHEEP
   MODEL; BONE-GRAFT; LESIONS; REGENERATION; MANAGEMENT
AB Background: Osteochondritis dissecans (OCD) is an acquired lesion of the subchondral bone that may result in separation and instability of the overlying articular cartilage. Unstable lesions must be treated surgically to reestablish the joint surface as anatomically as possible.
   Hypothesis/Purpose: The aim of this study was to evaluate the potential of a biomimetic osteochondral scaffold to treat OCD by analyzing the results obtained at 2-year follow-up. The hypothesis was that this scaffold, which was developed to treat the entire osteochondral unit, might restore the articular surface and improve symptoms and function in patients affected by knee OCD.
   Study Design: Case series; Level of evidence, 4.
   Methods: Twenty-seven consecutive patients (19 men, 8 women; age [mean SD], 25.5 7.7 years) who were affected by symptomatic knee OCD of the femoral condyles (average defect size 3.4 +/- 2.2 cm(2)), grade 3 or 4 on the International Cartilage Repair Society (ICRS) scale, were enrolled and treated with the implantation of a 3-layer collagen-hydroxyapatite scaffold. Patients were prospectively evaluated by subjective and objective International Knee Documentation Committee (IKDC) and Tegner scores preoperatively and at 1- and 2-year follow-up. An MRI was also performed at the 2 follow-up times.
   Results: A statistically significant improvement in all clinical scores was obtained at 1 year, and a further improvement was found the following year. At the 2-year follow-up, the IKDC subjective score had increased from 48.4 +/- 17.8 preoperatively to 82.3 +/- 12.2, the IKDC objective evaluation from 40% to 85% of normal knees, and the Tegner score from 2.4 +/- 1.7 to 4.5 +/- 1.6. The MRI evaluations showed good defect filling and implant integration but also inhomogeneous regenerated tissue and subchondral bone changes in most patients at both follow-up times. No correlation between the MOCART (magnetic resonance observation of cartilage repair tissue) score and clinical outcome was found.
   Conclusion: This biomimetic osteochondral scaffold seems to be a valid treatment option for knee OCD, showing a good clinical outcome at 2-year follow-up. Moreover, the improvement was not correlated with lesion size, so large lesions can benefit from this implant. Less favorable findings were obtained with MRI evaluation.
C1 [Filardo, Giuseppe; Kon, Elizaveta; Di Martino, Alessandro; Busacca, Maurizio; Altadonna, Giulio; Marcacci, Maurilio] Rizzoli Orthopaed Inst, I-40136 Bologna, Italy.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Biomech Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
OI Filardo, Giuseppe/0000-0002-8136-0977
CR Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P330, DOI 10.1302/0301-620X.87B3.15552
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   CAHILL BR, 1989, AM J SPORT MED, V17, P601, DOI 10.1177/036354658901700502
   Chambers Henry G, 2012, J Bone Joint Surg Am, V94, P1322, DOI 10.2106/JBJS.9414ebo
   Cole BJ, 2012, AM J SPORT MED, V40, P2015, DOI 10.1177/0363546512453292
   DeSmet AA, 1997, SKELETAL RADIOL, V26, P463
   Detterline Alvin J, 2008, J Knee Surg, V21, P106
   Filardo G, 2012, CARTILAGE, V3, P288, DOI 10.1177/1947603512436371
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Filardo G, 2012, KNEE, V19, P658, DOI 10.1016/j.knee.2011.08.007
   Filardo G, 2011, AM J SPORT MED, V39, P2153, DOI 10.1177/0363546511415658
   Gomoll AH, 2009, AM J SPORT MED, V37, p20S, DOI 10.1177/0363546509348477
   Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011
   ICRS Cartilage Injury Evaluation Package, 2000, ICRS CART INJ EV PAC
   Kocher MS, 2006, AM J SPORT MED, V34, P1181, DOI 10.1177/0363546506290127
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2012, J BONE JOINT SURG AM, V94
   Kon E, 2012, J KNEE SURG, V25, P17, DOI 10.1055/s-0031-1299651
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-220
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, AM J SPORT MED, V37, p156S, DOI 10.1177/0363546509351649
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256
   Kramer J, 2006, CELL MOL LIFE SCI, V63, P616, DOI 10.1007/s00018-005-5527-z
   Krishnan SP, 2006, J BONE JOINT SURG BR, V88B, P203, DOI 10.1302/0301-620X.88B2.17009
   Lim HC, 2012, J BONE JOINT SURG BR, V94B, P185, DOI 10.1302/0301-620X.94B2.27212
   Linden B, 1976, ACTA ORTHOP SCAND, V47, P666
   Marlovits S, 2006, EUR J RADIOL, V57, P1, DOI 10.1016/j.ejrad.2005.08.004
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Maus U, 2008, Z ORTHOP UNFALLCHIR, V146, P31, DOI 10.1055/s-2007-989353
   Moriya T, 2007, J ORTHOP SCI, V12, P265, DOI 10.1007/s00776-007-1111-8
   Ochs BG, 2007, Z ORTHOP UNFALLCHIR, V145, P146, DOI 10.1055/s-2007-965167
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Shirazi R, 2009, J BIOMECH, V42, P2458, DOI 10.1016/j.jbiomech.2009.07.022
   Steinhagen J, 2010, INT ORTHOP, V34, P819, DOI 10.1007/s00264-009-0841-y
   Stone KR, 2006, ARTHROSCOPY, V22, P291, DOI 10.1016/j.arthro.2005.12.051
   TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43
   Teo BJX, 2013, CLIN ORTHOP RELAT R, V471, P1152, DOI 10.1007/s11999-012-2338-z
   Trinh TQ, 2012, KNEE SURG SPORT TR A, V20, P2419, DOI 10.1007/s00167-012-1917-6
   Vasiliadis HS, 2010, AM J SPORT MED, V38, P943, DOI 10.1177/0363546509358266
   Vijayan S, 2012, J BONE JOINT SURG BR, V94B, P488, DOI 10.1302/0301-620X.94B4.27117
NR 46
TC 52
Z9 53
U1 0
U2 17
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0363-5465
EI 1552-3365
J9 AM J SPORT MED
JI Am. J. Sports Med.
PD AUG
PY 2013
VL 41
IS 8
BP 1786
EP 1793
DI 10.1177/0363546513490658
PG 8
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 235HN
UT WOS:000325708000010
PM 23761684
DA 2018-10-20
ER

PT J
AU Chan, DD
   Toribio, D
   Neu, CP
AF Chan, Deva D.
   Toribio, David
   Neu, Corey P.
TI Displacement smoothing for the precise MRI-based measurement of strain
   in soft biological tissues
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE DENSE MRI; displacement encoding; displacement and strain precision;
   soft tissue deformation; smoothing filter
ID CARTILAGE DEFORMATION; ARTICULAR-CARTILAGE; STIMULATED ECHOES; FIELDS;
   MUSCLE; DENSE
AB Displacement and strain are fundamental quantities that describe the normal and pathological mechanical function of soft biological materials. Non-invasive imaging techniques, including displacement-encoded magnetic resonance imaging (MRI), enable the direct calculation of biomaterial displacements during the application of extrinsic mechanical forces. However, because strain is derived from measured MRI-based displacements, data processing must be accomplished to minimise the propagation and amplification of errors. Here, we evaluate smoothing methods (including averaging filters, splines, finite impulse response filters and wavelets) that enable the calculation of strain in biomaterials from MRI-based displacements for minimal error, defined in terms of bias and precision. Displacement and strain precisions were improved using all smoothing methods studied. Precision generally increased with the number of smoothing iterations (i.e. repeated applications) of a chosen smoothing method. The bias depended on the smoothing method and tended to increase with the number of smoothing iterations. A Gaussian filter characterised complex and heterogeneous strain fields with maximum precision and minimum bias. The results suggest that the optimal choice of smoothing method to compute strain for a given biomaterial or tissue application depends on a careful consideration of trade-offs between the improved precision (with increased data smoothing) and the trending increase in bias.
C1 [Chan, Deva D.; Toribio, David; Neu, Corey P.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
RP Neu, CP (reprint author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
EM cpneu@purdue.edu
OI Chan, Deva/0000-0003-1508-1045
FU NSF CMMI/BMMB [1100554]
FX Funding for this research was provided in part by NSF CMMI/BMMB 1100554.
CR AKAY M, 1995, ANN BIOMED ENG, V23, P531, DOI 10.1007/BF02584453
   Aletras AH, 2001, MAGNET RESON MED, V46, P523, DOI 10.1002/mrm.1223
   Aletras AH, 1999, J MAGN RESON, V137, P247, DOI 10.1006/jmre.1998.1676
   Avril S, 2008, EUR J COMPUT MECH, V17, P857
   Cai J, 2007, INT J RADIAT ONCOL, V68, P650, DOI 10.1016/j.ijrobp.2007.02.011
   Chan DD, 2011, SPINE, V36, P1438, DOI 10.1097/BRS.0b013e3181f8be52
   Chan DD, 2009, MAGN RESON MED, V61, P989, DOI 10.1002/mrm.21927
   Geers MGD, 1996, INT J SOLIDS STRUCT, V33, P4293, DOI 10.1016/0020-7683(95)00240-5
   Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4
   McVeigh ER, 1996, MAGN RESON IMAGING, V14, P137, DOI 10.1016/0730-725X(95)02009-I
   Neu CP, 2009, J TISSUE ENG REGEN M, V3, P477, DOI 10.1002/term.188
   Neu CP, 2008, MAGN RESON MED, V59, P149, DOI 10.1002/mrm.21464
   Neu CP, 2005, MAGNET RESON MED, V54, P1290, DOI 10.1002/mrm.20669
   Neu CP, 2005, MAGNET RESON MED, V53, P321, DOI 10.1002/mrm.20343
   Nucifora G, 2010, AM J CARDIOL, V106, P1404, DOI 10.1016/j.amjcard.2010.06.072
   Pan B, 2009, OPT LASER ENG, V47, P865, DOI 10.1016/j.optlaseng.2008.10.014
   SETTON LA, 1994, J ORTHOPAED RES, V12, P451, DOI 10.1002/jor.1100120402
   Suki B, 2011, PULM PHARM IN PRESS
   YOUNG AA, 1993, RADIOLOGY, V188, P101, DOI 10.1148/radiology.188.1.8511281
   Zhou HH, 2007, J MAGN RESON IMAGING, V25, P175, DOI 10.1002/jmri.20783
NR 20
TC 4
Z9 4
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PD AUG 1
PY 2013
VL 16
IS 8
BP 852
EP 860
DI 10.1080/10255842.2011.641178
PG 9
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA 220UM
UT WOS:000324612400005
PM 22292493
DA 2018-10-20
ER

PT J
AU Krokstad, S
   Langhammer, A
   Hveem, K
   Holmen, TL
   Midthjell, K
   Stene, TR
   Bratberg, G
   Heggland, J
   Holmen, J
AF Krokstad, S.
   Langhammer, A.
   Hveem, K.
   Holmen, T. L.
   Midthjell, K.
   Stene, T. R.
   Bratberg, G.
   Heggland, J.
   Holmen, J.
TI Cohort Profile: The HUNT Study, Norway
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
ID NORD-TRONDELAG HEALTH; POPULATION-BASED COHORT; ISCHEMIC-HEART-DISEASE;
   BONE-MINERAL DENSITY; 10-YEAR FOLLOW-UP; BLOOD-PRESSURE; SUSCEPTIBILITY
   LOCI; EDUCATIONAL-LEVEL; COUNTY POPULATION; PHYSICAL-ACTIVITY
AB The HUNT Study includes large total population-based cohorts from the 1980ies, covering 125 000 Norwegian participants; HUNT1 (1984-86), HUNT2 (1995-97) and HUNT3 (2006-08). The study was primarily set up to address arterial hypertension, diabetes, screening of tuberculosis, and quality of life. However, the scope has expanded over time. In the latest survey a state of the art biobank was established, with availability of biomaterial for decades ahead. The three population based surveys now contribute to important knowledge regarding health related lifestyle, prevalence and incidence of somatic and mental illness and disease, health determinants, and associations between disease phenotypes and genotypes. Every citizen of Nord-Tr circle divide ndelag County in Norway being 20 years or older, have been invited to all the surveys for adults. Participants may be linked in families and followed up longitudinally between the surveys and in several national health- and other registers covering the total population. The HUNT Study includes data from questionnaires, interviews, clinical measurements and biological samples (blood and urine). The questionnaires included questions on socioeconomic conditions, health related behaviours, symptoms, illnesses and diseases. Data from the HUNT Study are available for researchers who satisfy some basic requirements (www.ntnu.edu/hunt), whether affiliated in Norway or abroad.
RP Krokstad, S (reprint author), Fac Med NTNU, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Forskningsveien 2, N-7600 Levanger, Norway.
EM steinar.krokstad@ntnu.no
CR Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019
   Dale AC, 2007, EUR HEART J, V28, P2924, DOI 10.1093/eurheartj/ehm447
   Dalen H, 2011, J AM SOC ECHOCARDIOG, V24, P322, DOI 10.1016/j.echo.2010.12.010
   Droyvold WB, 2005, J INTERN MED, V257, P338, DOI 10.1111/j.1365-2796.2005.01458.x
   Ellekjaer H, 2000, STROKE, V31, P14, DOI 10.1161/01.STR.31.1.14
   Engum A, 2005, J PSYCHOSOM RES, V59, P263, DOI 10.1016/j.jpychores.2005.04.002
   Ernstsen L, 2010, SCAND J PUBLIC HEALT, V38, P678, DOI 10.1177/1403494810380300
   Esping-Andersen G, 1990, 3 WORLDS WELFARE CAP
   Forsmo S, 2008, AM J EPIDEMIOL, V167, P406, DOI 10.1093/aje/kwm320
   Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013
   Hagen K, 2002, J NEUROL NEUROSUR PS, V72, P463
   Hagen K, 2008, PHARMACOEPIDEM DR S, V17, P372, DOI 10.1002/pds.1567
   Hagen K, 2010, J HEADACHE PAIN, V11, P67, DOI 10.1007/s10194-009-0174-7
   HOLMEN J, 1991, BRIT MED J, V302, P219, DOI 10.1136/bmj.302.6770.219
   HOLMEN J, 1990, Tidsskrift for den Norske Laegeforening, V110, P1973
   Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19
   Holst D, 2007, NOR TANNIEGEFOREN TI, V117, P804
   Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885
   Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183
   Krokstad S, 2002, J EPIDEMIOL COMMUN H, V56, P375, DOI 10.1136/jech.56.5.375
   Langhammer A, 2001, EUR RESPIR J, V18, P770, DOI 10.1183/09031936.01.00255301
   Langhammer A, 2007, RESP MED, V101, P1744, DOI 10.1016/j.rmed.2007.02.018
   Lund-Larsen P., 1997, NOR J EPIDEMIOL, V7, P235
   Midthjell K, 1999, DIABETES CARE, V22, P1813, DOI 10.2337/diacare.22.11.1813
   MOUM T, 1992, Tidsskrift for den Norske Laegeforening, V112, P18
   Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x
   Nilsen SM, 2010, EUR J PUBLIC HEALTH, V20, P299, DOI 10.1093/eurpub/ckp137
   Pettersen E, 2010, DIABETES, V59, P302, DOI 10.2337/db09-0923
   Petursson H, 2009, J EVAL CLIN PRACT, V15, P103, DOI 10.1111/j.1365-2753.2008.00962.x
   Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723
   Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788
   Sivertsen B, 2011, AM J EPIDEMIOL, V174, P147, DOI 10.1093/aje/kwr052
   Sjodahl K, 2008, CANCER EPIDEM BIOMAR, V17, P135, DOI 10.1158/1055-9965.EPI-07-0704
   Skalicka V, 2009, INT J EPIDEMIOL, V38, P1272, DOI 10.1093/ije/dyp262
   Skolbekken J., 2005, CRITICAL PUBLIC HLTH, V15, P335, DOI DOI 10.1080/09581590500523319
   SKOLBEKKEN JA, 1995, SOC SCI MED, V40, P291, DOI 10.1016/0277-9536(94)00262-R
   Stordal E, 2001, ACTA PSYCHIAT SCAND, V104, P210, DOI 10.1034/j.1600-0447.2001.00130.x
   Svebak S, 2010, INT J PSYCHIAT MED, V40, P125, DOI 10.2190/PM.40.2.a
   Ursin LO, 2008, THEOR MED BIOETH, V29, P267, DOI 10.1007/s11017-008-9079-8
   Ursin LO, 2009, MED HEALTH CARE PHIL, V12, P17, DOI 10.1007/s11019-008-9144-0
   VATTEN LJ, 1995, EPIDEMIOLOGY, V6, P70, DOI 10.1097/00001648-199501000-00014
   Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609
   Westin S, 2005, BRIT MED J, V330, P1461, DOI 10.1136/bmj.330.7506.1461
NR 43
TC 270
Z9 270
U1 4
U2 21
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD AUG
PY 2013
VL 42
IS 4
BP 968
EP 977
DI 10.1093/ije/dys095
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 228EG
UT WOS:000325167800009
PM 22879362
OA Bronze
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Mintzer, JL
   Kronenthal, CJ
   Kelly, V
   Seneca, M
   Butler, G
   Fecenko-Tacka, K
   Altamuro, D
   Madore, SJ
AF Mintzer, Joseph L.
   Kronenthal, Courtney J.
   Kelly, Victoria
   Seneca, Michael
   Butler, Gary
   Fecenko-Tacka, Karen
   Altamuro, Donna
   Madore, Steven J.
TI Preparedness for a Natural Disaster: How Coriell Planned for Hurricane
   Sandy
SO BIOPRESERVATION AND BIOBANKING
LA English
DT Article
AB When a biological specimen is donated to a biobank such as the nonprofit Coriell Institute for Medical Research, regardless of whether that submission is sent directly or through a physician, scientist, foundation, or patient-centered advocacy organization, the donor expects their biomaterial to be processed effectively and stored in proper conditions until distribution to researchers answering scientific questions. The donor and scientific researchers rarely, if ever, consider what might happen to those specimens if the biobank experiences an adverse event, such as a disaster that compromises its business operations, including handling of samples. Management of biomaterials is not simply a laboratory process; their long-term survival is dependent on both the laboratory preparation and the infrastructure designed for maintenance, safety, and security. Coriell Institute has documented disaster preparedness plans since its inception in 1953, and currently manages hundreds of thousands of cell lines and DNA samples under ISO 9001 quality management standards, complete with a robust Emergency Operations Plan. The Institute's recent approach to preparing for Hurricane Sandy, a Category 1 hurricane that struck the East Coast of the United States in late October 2012, was two-fold. It included the validation of its long-term strategies focused on emergency back-up systems, communication solutions, and employee training, and implementation of short-term tactics such as confirming on-call emergency response personnel and safe storage options for working biomaterials and reagents. The purpose of this article is to review several best practices in use at Coriell Institute associated with disaster planning and to identify and evaluate the effectiveness of those elements in coping with Hurricane Sandy.
C1 [Mintzer, Joseph L.; Kronenthal, Courtney J.; Kelly, Victoria; Seneca, Michael; Butler, Gary; Fecenko-Tacka, Karen; Altamuro, Donna; Madore, Steven J.] Coriell Inst Med Res, Camden, NJ 08103 USA.
RP Mintzer, JL (reprint author), Coriell Inst Med Res, 403 Haddon Ave, Camden, NJ 08103 USA.
EM jmintzer@coriell.org
CR Eiseman E, 2003, RAND SCI TECHNOLOGY
   Fontevecchia A, 2012, DESPITE 50B DAMAGES
   Garnett JD, 2009, JHSEM, V7, P1
   Mayer B, 2008, JCCM, V16, P13
   Perry SC, 2001, J SMALL BUS MANAGE, V39, P201, DOI 10.1111/1540-627X.00019
   Perz M, 2014, BIOPRESERV BIOBANK, V12, P222
   Petinaux B, 2009, PREHOSPITAL DISASTER, V24, P372, DOI 10.1017/S1049023X00007160
   Stirling S, 2012, HURRICANE SANDY UPDA
   The Federal Emergency Management Agency (FEMA), 2013, READ BUS PREP PLAN S
   Webb G. R., 2000, NAT HAZARDS REV, V1, P83, DOI DOI 10.1061/(ASCE)1527-6988(2000)1:2(83)
NR 10
TC 5
Z9 5
U1 1
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1947-5535
J9 BIOPRESERV BIOBANK
JI Biopreserv. Biobank.
PD AUG 1
PY 2013
VL 11
IS 4
BP 216
EP 220
DI 10.1089/bio.2013.0035
PG 5
WC Cell Biology; Chemistry, Applied; Medical Laboratory Technology
SC Cell Biology; Chemistry; Medical Laboratory Technology
GA 224GG
UT WOS:000324870300006
PM 24845588
DA 2018-10-20
ER

PT J
AU Fukushima, Y
   Katsumata, K
   Zhu, SL
   Xie, GQ
   Niinomi, M
   Okada, K
   Matsushita, N
AF Fukushima, Yuriko
   Katsumata, Ken-ichi
   Zhu Shengli
   Xie Guoqiang
   Niinomi, Mitsuo
   Okada, Kiyoshi
   Matsushita, Nobuhiro
TI Solution Process for Synthesizing Bioactive Nano-Mesh Layer on Ti-Based
   Bulk Metallic Glasses
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Designing, Processing and Properties of
   Advanced Engineering Materials (ISAEM)
CY NOV 05-08, 2012
CL Toyohashi, JAPAN
SP Japan Soc Promot Sci, 176th Comm Proc Created Mat Funct
DE biomaterial; nanostructure; bulk metallic glasses; titanium alloy;
   hydroxyapatite
ID AMORPHOUS-ALLOYS; STRENGTH
AB Ti based Bulk Metallic Glasses (BMGs) were treated by Hydrothermal (H), Electrochemical (E) and Hydrothermal-Electrochemical (H-E) processes in NaOH solution and all of these processes enabled fabrication of titanate nano-mesh structures on their surfaces. XPS data suggested that the amount of cytotoxic Cu was drastically decreased for the samples treated by H-E process. Specimens having nano-mesh structures on their surface were immersed in Simulated Body Fluid (SBF) for 12 days. The results of the SBF test supported the fact that nano-mesh structures fabricated by these three methods have bioactivity. However, only the specimen treated by H-E process exhibited very good adhesion performance between the induced hydroxyapatite layer and substrate with intermediated titanate nanomesh layer. These results indicated that the H-E process was the best among three to fabricate a low cytotoxic bioactive nano-mesh layer on Ti-based BMG which enabled to induce hydroxyapatite layer with strong adhesion.
C1 [Fukushima, Yuriko; Katsumata, Ken-ichi; Okada, Kiyoshi; Matsushita, Nobuhiro] Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan.
   [Zhu Shengli; Xie Guoqiang; Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Matsushita, N (reprint author), Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan.
EM matsushita@msl.titech.ac.jp
RI Okada, Kiyoshi/E-3916-2014; Niinomi, Mitsuo/B-5965-2011; Xie,
   Guoqiang/A-8619-2011; Katsumata, Ken-ichi/E-4576-2014; Zhu,
   Shengli/D-5281-2009; Matsushita, Nobuhiro/F-9416-2014; Katsumata,
   Ken-ichi/O-1999-2013
OI Katsumata, Ken-ichi/0000-0002-3841-5354; Zhu,
   Shengli/0000-0002-0190-2626; Katsumata, Ken-ichi/0000-0003-2774-4002
CR AMIYA K, 1994, MAT SCI ENG A-STRUCT, V179, P692, DOI 10.1016/0921-5093(94)90294-1
   Buzzi S, 2006, INTERMETALLICS, V14, P729, DOI 10.1016/j.intermet.2005.11.003
   Gao XP, 2004, J PHYS CHEM B, V108, P2868, DOI 10.1021/jp036821i
   INOUE A, 1994, MATER LETT, V19, P131, DOI 10.1016/0167-577X(94)90057-4
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Ma MZ, 2004, MAT SCI ENG A-STRUCT, V386, P326, DOI 10.1016/j.msea.2004.07.054
   Morrison ML, 2007, J NON-CRYST SOLIDS, V353, P2115, DOI 10.1016/j.jnoncrysol.2007.03.012
   Park JM, 2004, MATER TRANS, V45, P595, DOI 10.2320/matertrans.45.595
   Pouraix M., 1974, ATLAS ELECTROCHEMICA, P215
   Sugiyama N, 2009, ACTA BIOMATER, V5, P1367, DOI 10.1016/j.actbio.2008.10.014
   Wang WH, 2004, MAT SCI ENG R, V44, P45, DOI 10.1016/j.mser.2004.03.001
   Yoshimura M, 2008, MATER SCI ENG B-ADV, V148, P2, DOI 10.1016/j.mseb.2007.09.080
   Zarate RA, 2007, J PHYS CHEM SOLIDS, V68, P628, DOI 10.1016/j.jpcs.2007.02.011
   Zhu SL, 2007, MATER TRANS, V48, P2445, DOI 10.2320/matertrans.MRA2007086
NR 15
TC 3
Z9 3
U1 0
U2 25
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2013
VL 54
IS 8
BP 1343
EP 1346
DI 10.2320/matertrans.MF201312
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 227OJ
UT WOS:000325122900019
OA Bronze
DA 2018-10-20
ER

PT J
AU Chen, HH
   Lin, SB
   Hsu, CP
   Chen, LC
AF Chen, Hui-Huang
   Lin, Shih-Bin
   Hsu, Chieh-Ping
   Chen, Li-Chen
TI Modifying bacterial cellulose with gelatin peptides for improved
   rehydration
SO CELLULOSE
LA English
DT Article
DE Bacterial cellulose; Gelatin; Hydrolyze; Rehydration
ID COMPOSITES; RELEASE
AB Bacterial cellulose (BC) is a nanoscale and useful biomaterial with a fine fiber network and high water holding capacity. However, dried BC exhibits poor rehydration ability. The present study investigated the rehydration ability of composites of hydrolyzed gelatin peptides (HGP) and hydroxypropylmethyl cellulose-modified BC (HBC). The HGP with molecular weights < 9 kDa were obtained by hydrolyzing gelatin with a combination of 1 % alcalase and 1.5 % pronase E at 50 A degrees C for 2 h. The HGP/HBC nanocomposites exhibited higher rehydration ratios than composites prepared with gelatin. According to SEM images, gelatin and HGP successfully penetrated the cellulose network in composite films prepared using both immersion and adsorption (DA) methods. The high hydrophilic property of HGP resulted in a rehydration ratio of approximately 180 % at a HGP/HBC ratio of 4.5:1 (W/W) in DA composites. The 1 min rehydrated HGP/HBC composites possessed similar mechanical properties to the original wet type composites. Overall, results indicated that the HGP/HBC composites prepared using the DA method demonstrated the highest rehydration ability among the composite films evaluated.
C1 [Chen, Hui-Huang; Lin, Shih-Bin; Hsu, Chieh-Ping; Chen, Li-Chen] Natl Ilan Univ, Dept Food Sci, Ilan, Taiwan.
RP Chen, LC (reprint author), Natl Ilan Univ, Dept Food Sci, 1 Sec 1,Shen Nung Rd, Ilan, Taiwan.
EM ywchen@niu.edu.tw
FU National Science Council [NSC 97-2313-B-197- 003-MY3, NSC
   100-2120-S-197-001-NM]
FX The authors would like to thank the National Science Council (NSC
   97-2313-B-197- 003-MY3 and NSC 100-2120-S-197-001-NM) for financial
   support for this study.
CR Aspmo SI, 2005, PROCESS BIOCHEM, V40, P1957, DOI 10.1016/j.procbio.2004.07.011
   Bodhibukkana C, 2006, J CONTROL RELEASE, V113, P43, DOI 10.1016/j.jconrel.2006.03.007
   Brown Jr RM, 1992, P 9 INT BIOL S EXP L, P76
   Chang ST, 2012, FOOD HYDROCOLLOID, V27, P137, DOI 10.1016/j.foodhyd.2011.08.004
   George J, 2008, J APPL POLYM SCI, V108, P1845, DOI 10.1002/app.27802
   HAIGLER CH, 1982, J CELL BIOL, V94, P64, DOI 10.1083/jcb.94.1.64
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Horwitz W, 1984, OFF METH AN, P161
   Huang HC, 2010, BIORESOURCE TECHNOL, V101, P6084, DOI 10.1016/j.biortech.2010.03.031
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lai CH, 2005, THESIS NATL TAIWAN O
   Leane MM, 2004, INT J PHARM, V271, P241, DOI 10.1016/j.ijpharm.2003.11.023
   Lin SB, 2009, FOOD HYDROCOLLOID, V23, P2195, DOI 10.1016/j.foodhyd.2009.05.011
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   OKIYAMA A, 1992, FOOD HYDROCOLLOID, V6, P471, DOI 10.1016/S0268-005X(09)80032-5
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Schrecker ST, 2005, BIOTECHNOL LETT, V27, P1435, DOI 10.1007/s10529-005-1465-y
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   Yan ZY, 2008, CARBOHYD RES, V343, P73, DOI 10.1016/j.carres.2007.10.024
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
NR 21
TC 10
Z9 10
U1 1
U2 37
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
J9 CELLULOSE
JI Cellulose
PD AUG
PY 2013
VL 20
IS 4
BP 1967
EP 1977
DI 10.1007/s10570-013-9931-5
PG 11
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 195AE
UT WOS:000322673000036
DA 2018-10-20
ER

PT J
AU Akar, ST
   Yilmazer, D
   Celik, S
   Balk, YY
   Akar, T
AF Akar, Sibel Tunali
   Yilmazer, Dilek
   Celik, Sema
   Balk, Yasemin Yetimoglu
   Akar, Tamer
TI On the utilization of a lignocellulosic waste as an excellent dye
   remover: Modification, characterization and mechanism analysis
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Modified sugar beet pulp; Biosorption; Dye; Mechanism; Kinetics;
   Equilibrium
ID SUGAR-BEET PULP; AQUEOUS-SOLUTIONS; EQUILIBRIUM ISOTHERM;
   METHYLENE-BLUE; OLIVE POMACE; METAL-IONS; LEAD IONS; AZO DYES;
   BIOSORPTION; SORPTION
AB Biosorption potential of sugar beet pulp was significantly improved via grafting by quaternary ammonium salt. Initial pH, biosorbent dosage, contact time, temperature and flow rate were investigated as design parameters. A higher biosorption yield, shorter period of equilibrium time and lower amount of biosorbent were recorded as the main characteristics for batch mode decolorization. The pseudo-second-order model better fitted the kinetic data while Langmuir isotherm model is found to be best represent the biosorption equilibrium. Thermodynamic findings indicated that the nature of Reactive Red 2 (RR2) biosorption is endothermic and spontaneous. The modified sugar beet pulp was also successfully used in dynamic flow mode removal of RR2. Recovery of biosorbed RR2 from the modified biomaterial was investigated in alkaline solutions and good values were observed. IR, SEM, AFM, EDX, potentiometric titration and zeta potential studies were used to characterize the biosorbent structure in addition to real sample application of modified biomaterial. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Akar, Sibel Tunali; Akar, Tamer] Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
   [Yilmazer, Dilek; Celik, Sema; Balk, Yasemin Yetimoglu] Eskisehir Osmangazi Univ, Grad Sch Nat & Appl Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
RP Akar, ST (reprint author), Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
EM stunali@ogu.edu.tr
FU Commission of Scientific Research Projects of Eskisehir Osmangazi
   University (ESOGU) [201219009]; ESOGU
FX This work was supported by the Commission of Scientific Research
   Projects of Eskisehir Osmangazi University (ESOGU) with the project
   number 201219009. The authors gratefully acknowledge for financial
   support by ESOGU.
CR Acheampong MA, 2013, J IND ENG CHEM, V19, P841, DOI 10.1016/j.jiec.2012.10.029
   Akar ST, 2011, CHEM ENG J, V168, P125, DOI 10.1016/j.cej.2010.12.049
   Akar T, 2009, J HAZARD MATER, V166, P1217, DOI 10.1016/j.jhazmat.2008.12.029
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aksu Z, 2006, J HAZARD MATER, V137, P418, DOI 10.1016/j.jhazmat.2006.02.019
   Aloma I, 2012, J TAIWAN INST CHEM E, V43, P275, DOI 10.1016/j.jtice.2011.10.011
   Asgher M, 2012, ECOL ENG, V38, P79, DOI 10.1016/j.ecoleng.2011.10.004
   Blazquez G, 2010, CHEM ENG J, V160, P615, DOI 10.1016/j.cej.2010.03.085
   Bulgariu D, 2013, BIORESOURCE TECHNOL, V129, P374, DOI 10.1016/j.biortech.2012.10.142
   Calero M, 2009, J HAZARD MATER, V171, P886, DOI 10.1016/j.jhazmat.2009.06.082
   Castro L, 2011, PROCESS BIOCHEM, V46, P1076, DOI 10.1016/j.procbio.2011.01.025
   Chu KH, 2004, CHEM ENG J, V97, P233, DOI 10.1016/S1385-8947(03)00214-6
   Dinand E, 1999, FOOD HYDROCOLLOID, V13, P275, DOI 10.1016/S0268-005X(98)00084-8
   Dronnet VM, 1997, CARBOHYD POLYM, V34, P73, DOI 10.1016/S0144-8617(97)00055-6
   Dubinin M, 1947, CHEM ZENTR, V1, P875
   Farooq U, 2010, BIORESOURCE TECHNOL, V101, P5043, DOI 10.1016/j.biortech.2010.02.030
   Freundlich H., 1906, ABSORPTION LOSUNGEN, P98
   Gerente C, 2000, REACT FUNCT POLYM, V46, P135, DOI 10.1016/S1381-5148(00)00047-X
   Ghasemi M, 2011, J HAZARD MATER, V189, P141, DOI 10.1016/j.jhazmat.2011.02.011
   Goertzen SL, 2010, CARBON, V48, P1252, DOI 10.1016/j.carbon.2009.11.050
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Hameed BH, 2008, J HAZARD MATER, V158, P499, DOI 10.1016/j.jhazmat.2008.01.098
   Han RP, 2006, J HAZARD MATER, V137, P1569, DOI 10.1016/j.jhazmat.2006.04.045
   Hassan ML, 2010, J APPL POLYM SCI, V117, P2205, DOI 10.1002/app.32063
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Hu C, 2003, APPL CATAL B-ENVIRON, V42, P47, DOI 10.1016/S0926-3373(02)00214-X
   Jain M, 2013, BIORESOURCE TECHNOL, V129, P242, DOI 10.1016/j.biortech.2012.11.036
   Lagergren S, 1989, HANDLINGAR, V24, P1
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Malekbala MR, 2012, CHEM ENG RES DES, V90, P704, DOI 10.1016/j.cherd.2011.09.010
   Muhamad H, 2010, CHEM ENG J, V158, P369, DOI 10.1016/j.cej.2009.12.042
   Niu H, 2003, HYDROMETALLURGY, V71, P209, DOI 10.1016/S0304-386X(03)00158-0
   Padmavathy V, 2008, BIORESOURCE TECHNOL, V99, P3100, DOI 10.1016/j.biortech.2007.05.070
   Pagnanelli F, 2005, WATER RES, V39, P1639, DOI 10.1016/j.watres.2005.01.019
   Pandey KK, 2003, INT BIODETER BIODEGR, V52, P151, DOI 10.1016/S0964-8305(03)00052-0
   Pehlivan E, 2008, BIORESOURCE TECHNOL, V99, P3520, DOI 10.1016/j.biortech.2007.07.052
   Puranik PR, 1997, J BIOTECHNOL, V55, P113, DOI 10.1016/S0168-1656(97)00067-9
   Shen XE, 2009, J COLLOID INTERF SCI, V330, P1, DOI 10.1016/j.jcis.2008.10.023
   Solis M, 2012, PROCESS BIOCHEM, V47, P1723, DOI 10.1016/j.procbio.2012.08.014
   Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003
   Sun RC, 1998, CARBOHYD POLYM, V36, P293, DOI 10.1016/S0144-8617(97)00255-5
   Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011
   Tunali S, 2007, J ENVIRON SCI HEAL A, V42, P591, DOI 10.1080/10934520701244359
   Turquois T, 1999, FOOD HYDROCOLLOID, V13, P255, DOI 10.1016/S0268-005X(99)00007-7
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
   Vucurovic VM, 2012, IND CROP PROD, V39, P128, DOI 10.1016/j.indcrop.2012.02.002
   Vucurovic VM, 2012, J TAIWAN INST CHEM E, V43, P108, DOI 10.1016/j.jtice.2011.06.008
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yeddou-Mezenner N, 2010, DESALINATION, V262, P251, DOI 10.1016/j.desal.2010.06.023
   Yoo SD, 1999, BIORESOURCE TECHNOL, V70, P105, DOI 10.1016/S0960-8524(99)00013-9
NR 51
TC 15
Z9 16
U1 1
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD AUG 1
PY 2013
VL 229
BP 257
EP 266
DI 10.1016/j.cej.2013.06.009
PG 10
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 217GZ
UT WOS:000324349200031
DA 2018-10-20
ER

PT J
AU Miyazaki, T
   Kuramoto, A
   Hirakawa, A
   Shirosaki, Y
   Ohtsuki, C
AF Miyazaki, Toshiki
   Kuramoto, Akimasa
   Hirakawa, Atsuhide
   Shirosaki, Yuki
   Ohtsuki, Chikara
TI Biomineralization on chemically synthesized collagen containing
   immobilized poly-gamma-glutamic acid
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Chemically synthesized collagen; Poly-gamma-glutamic acid; Simulated
   body fluid (SBF); Apatite; Calcite
ID BINARY POLY(ACRYLIC ACID); SIMULATED BODY-FLUID; POLYGLUTAMIC ACID;
   APATITE FORMATION; BIOCERAMICS; DEPENDENCE
AB Chemically synthesized collagen with a triple helix structure similar to that of natural collagen is attractive as a safe biomaterial. Hybrids of chemically synthesized collagen and apatite are proposed for novel bone substitutes. However their apatite-forming ability in simulated body fluid is still quite low. We examined acceleration of apatite formation on collagen by immobilized poly-gamma-glutamic acid (PGA), which has excellent apatite-forming ability. Apatite was formed within 3 days when collagen was treated with PGA solutions containing an appropriate amount of CaCl2. A mixture of apatite and calcite was formed at high CaCl2 concentration. The present results indicate the possibility of preparing hybrid materials, with tailored mechanical and biological properties, based on chemically synthesized collagen.
C1 [Miyazaki, Toshiki; Kuramoto, Akimasa; Hirakawa, Atsuhide] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan.
   [Shirosaki, Yuki] Kyushu Inst Technol, Frontier Res Acad Young Researchers, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan.
   [Ohtsuki, Chikara] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.
RP Miyazaki, T (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.
EM tmiya@life.kyutech.ac.jp
RI Ohtsuki, Chikara/E-4973-2010
OI Ohtsuki, Chikara/0000-0002-6474-1540
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   (MEXT) [2206]
FX This study was supported by a Grant-in-Aid for Scientific Research on
   Innovative Areas of "Fusion Materials: Creative Development of Materials
   and Exploration of Their Function through Molecular Control" (No. 2206)
   from the Ministry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT).
CR CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   DEAN JA, 1999, LANGES HDB CHEM
   GIRIJA EK, 2002, CHEM LETT 0705, P702
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Iafisco M, 2010, ADV ENG MATER, V12, pB218, DOI 10.1002/adem.201080003
   Kamitakahara M, ARCH BIOCERAMICS RES, P210
   Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E
   Kishimoto T, 2005, BIOPOLYMERS, V79, P163, DOI 10.1002/bip.20348
   Koh MY, 2011, J BIOMATER APPL, V25, P581, DOI 10.1177/0885328209357111
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kotachi A, 2004, CHEM MATER, V16, P3191, DOI 10.1021/cm049832c
   Kumar R, 2010, MATER RES BULL, V45, P1603, DOI 10.1016/j.materresbull.2010.07.017
   Miura T, 2006, CRYST GROWTH DES, V6, P612, DOI 10.1021/cg0502237
   Miyazaki T, 2003, J MATER SCI-MATER M, V14, P569, DOI 10.1023/A:1024000821368
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Olszta MJ, 2004, CHEM MATER, V16, P2355, DOI 10.1021/cm035161r
   Oudadesse H, 2004, INSTRUM SCI TECHNOL, V32, P545, DOI 10.1081/CI-200029803
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   PARK JB, 1992, BIOMATERIALS INTRO
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   Sugino A, 2008, J MATER SCI-MATER M, V19, P2269, DOI 10.1007/s10856-007-3327-8
   Suzawa Y, 2010, J BIOMED MATER RES A, V93A, P965, DOI 10.1002/jbm.a.32518
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Tanihara M, 2008, J BIOMED MATER RES A, V85A, P133, DOI 10.1002/jbm.a.31496
NR 26
TC 4
Z9 4
U1 2
U2 23
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD AUG
PY 2013
VL 32
IS 4
BP 544
EP 549
DI 10.4012/dmj.2012-324
PG 6
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 224OO
UT WOS:000324898100003
PM 23903634
OA Bronze
DA 2018-10-20
ER

PT J
AU Moon, YH
   Yoon, MK
   Moon, JS
   Kang, JH
   Kim, SH
   Yang, HS
   Kim, MS
AF Moon, Yeon-Hee
   Yoon, Mi-Kyeong
   Moon, Jung-Sun
   Kang, Jee-Hae
   Kim, Sun-Hun
   Yang, Hong-Seo
   Kim, Min-Seok
TI Focal adhesion linker proteins expression of fibroblast related to
   adhesion in response to different transmucosal abutment surfaces
SO JOURNAL OF ADVANCED PROSTHODONTICS
LA English
DT Article
DE Transmucosal abutment; Focal adhesion linker proteins; Gingival
   fibroblast; Adhesion
ID MODIFIED DENTAL IMPLANTS; OSTEOBLAST-LIKE CELLS; TITANIUM SURFACE;
   BIOMATERIAL SURFACES; ELECTRON-MICROSCOPY; IN-VITRO; ATTACHMENT;
   PROLIFERATION; ROUGHNESS; GROWTH
AB PURPOSE. To evaluate adherence of human gingival fibroblasts (HGFs) to transmucosal abutment of dental implant with different surface conditions with time and to investigate the roles of focal adhesion linker proteins (FALPs) involved in HGFs adhesion to abutment surfaces. MATERIALS AND METHODS. Morphologies of cultured HGFs on titanium and ceramic discs with different surface were observed by scanning electron microscopy. Biocompatibility and focal adhesion were evaluated by ultrasonic wave application and cell viability assay. FALPs expression levels were assessed by RT-PCR and western blot. RESULTS. There seemed to be little difference in biocompatibility and adhesion strength of HGFs depending on the surface conditions and materials. In all experimental groups, the number of cells remaining on the disc surface after ultrasonic wave application increased more than 2 times at 3 days after seeding compared to 1-day cultured cells and this continued until 7 days of culture. FALPs expression levels, especially of vinculin and paxillin, also increased in 5-day cultured cells compared to 1-day cultured fibroblasts on the disc surface. CONCLUSION. These results might suggest that the strength of adhesion of fibroblasts to transmucosal abutment surfaces increases with time and it seemed to be related to expressions of FALPs.
C1 [Moon, Yeon-Hee; Yoon, Mi-Kyeong; Moon, Jung-Sun; Kang, Jee-Hae; Kim, Sun-Hun; Yang, Hong-Seo; Kim, Min-Seok] Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Kwangju 500757, South Korea.
RP Kim, MS (reprint author), Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Kwangju 500757, South Korea.
EM greatone@chonnam.ac.kr
FU National Research Foundation of Korea; Korean Government
   [KRF-2010-002598]
FX This study was supported by National Research Foundation of Korea Grant
   funded by the Korean Government (KRF-2010-002598).
CR Abrahamsson I, 1998, J CLIN PERIODONTOL, V25, P721, DOI 10.1111/j.1600-051X.1998.tb02513.x
   Alenghat FJ, 2000, BIOCHEM BIOPH RES CO, V277, P93, DOI 10.1006/bbrc.2000.3636
   AMBROSE E. J., 1961, EXPTL CELL RES SUPPL, V8, P54, DOI 10.1016/0014-4827(61)90340-8
   An N, 2012, DENT MATER, V28, P1207, DOI 10.1016/j.dental.2012.08.007
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Arvidson K, 1996, CLIN ORAL IMPLAN RES, V7, P1, DOI 10.1034/j.1600-0501.1996.070101.x
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x
   Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319
   Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357
   Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   CRAIG RG, 1990, J DENT RES, V69, P1539, DOI 10.1177/00220345900690081801
   Derhami K, 2000, J BIOMED MATER RES, V52, P315, DOI 10.1002/1097-4636(200011)52:2<315::AID-JBM10>3.0.CO;2-2
   FERNANDEZ JLR, 1992, CELL MOTIL CYTOSKEL, V22, P127, DOI 10.1002/cm.970220206
   FERNANDEZ JLR, 1993, J CELL BIOL, V122, P1285
   GARROD DR, 1993, BRIT MED J, V306, P703, DOI 10.1136/bmj.306.6879.703
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Groessner-Schreiber B, 2003, J BIOMED MATER RES A, V64A, P591, DOI 10.1002/jbm.a.10417
   Grossner-Schreiber B, 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI 10.1111/j.1600-0501.2006.01277.x
   GROVER A, 1987, DEV BIOL, V120, P1, DOI 10.1016/0012-1606(87)90098-4
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   LISTGARTEN MA, 1992, J DENT RES, V71, P364, DOI 10.1177/00220345920710020401
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Meredith DO, 2005, J BIOMED MATER RES A, V75A, P541, DOI 10.1002/jbm.a.30457
   Owen G Rh, 2005, Eur Cell Mater, V9, P85
   Palma-Carrio C, 2011, MED ORAL PATOL ORAL, V16, pC1043, DOI 10.4317/medoral.17125
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Raisanen L, 2000, J BIOMED MATER RES, V49, P79
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Richards RG, 2001, CELL BIOL INT, V25, P1237, DOI 10.1006/cbir.2001.0807
   Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659
NR 39
TC 4
Z9 5
U1 2
U2 5
PU KOREAN ACAD PROSTHODONTICS
PI SEOUL
PA #705 KOREA SCIENCE & TECHNOLOGY CENTER, 22 TAHRANNO 7 GIL, GANGNAMGU,
   SEOUL, 135-703, SOUTH KOREA
SN 2005-7806
EI 2005-7814
J9 J ADV PROSTHODONT
JI J. Adv. Prosthodont.
PD AUG
PY 2013
VL 5
IS 3
BP 341
EP 350
DI 10.4047/jap.2013.5.3.341
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 221LU
UT WOS:000324661200017
PM 24049577
OA Green Published
DA 2018-10-20
ER

PT J
AU Radisic, M
   Christman, KL
AF Radisic, Milica
   Christman, Karen L.
TI Materials Science and Tissue Engineering: Repairing the Heart
SO MAYO CLINIC PROCEEDINGS
LA English
DT Article
ID EMBRYONIC STEM-CELLS; INFARCTED RAT HEARTS; CARDIOVASCULAR PROGENITOR
   CELLS; VASCULARIZED CARDIAC-MUSCLE; MESENCHYMAL STROMAL CELLS;
   RANDOMIZED PHASE-1 TRIAL; FIBROBLAST-GROWTH-FACTOR;
   MYOCARDIAL-INFARCTION; IN-VITRO; FUNCTIONAL-INTEGRATION
AB Heart failure after a myocardial infarction continues to be a leading killer in the Western world. Currently, there are no therapies that effectively prevent or reverse the cardiac damage and negative left ventricular remodeling process that follows a myocardial infarction. Because the heart has limited regenerative capacity, there has been considerable effort to develop new therapies that could repair and regenerate the myocardium. Although cell transplantation alone was initially studied, more recently, tissue engineering strategies using biomaterial scaffolds have been explored. In this review, we cover the different approaches to engineering the myocardium, including cardiac patches, which are in vitro-engineered constructs of functional myocardium, and injectable scaffolds, which can either encourage endogenous repair and regeneration or act as vehicles to support the delivery of cells and other therapeutics. (C) 2013 Mayo Foundation for Medical Education and Research
C1 [Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
   [Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, 2880 Torrey Pines Scenic Dr, La Jolla, CA 92037 USA.
EM m.radisic@utoronto.ca; christman@eng.ucsd.edu
FU Ontario Research Fund-Global Leadership Round in Genomics and Life
   Sciences grant [ORF-GL2]; Natural Sciences and Engineering Research
   Council of Canada (NSERC) Strategic grant STPGP [381002-09];
   NSERC-Canadian Institutes of Health Research Collaborative Health
   Research grant CHRPJ [385981-10]; NSERC Discovery grant RGPIN
   [326982-10]; Discovery Accelerator Supplement RGPAS [396125-10];
   National Institutes of Health (the Common Fund); National Institutes of
   Health (the National Heart, Lung, and Blood Institute); Wallace H.
   Coulter Foundation; American Heart Association
FX Radisic Lab is supported by Ontario Research Fund-Global Leadership
   Round in Genomics and Life Sciences grant ORF-GL2, Natural Sciences and
   Engineering Research Council of Canada (NSERC) Strategic grant STPGP
   381002-09, NSERC-Canadian Institutes of Health Research Collaborative
   Health Research grant CHRPJ 385981-10, NSERC Discovery grant RGPIN
   326982-10, and Discovery Accelerator Supplement RGPAS 396125-10.
   Christman Lab is supported by the National Institutes of Health (the
   Common Fund and the National Heart, Lung, and Blood Institute), the
   Wallace H. Coulter Foundation, and the American Heart Association.
CR Asakawa N, 2010, BIOMATERIALS, V31, P3903, DOI 10.1016/j.biomaterials.2010.01.105
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Boateng SY, 2003, AM J PHYSIOL-CELL PH, V285, pC171, DOI 10.1152/ajpcell.00013.2003
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.tea.2011.0341, 10.1089/ten.TEA.2011.0341]
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Chiu LLY, 2011, TISSUE ENG PT A, V17, P1465, DOI 10.1089/ten.tea.2007.0244
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Didie M, 2013, J CLIN INVEST, V123, P1285, DOI 10.1172/JCI66854
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Eschenhagen T, 1997, FASEB J, V11, P683
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545
   Godbey WT, 2002, ANN NY ACAD SCI, V961, P10, DOI 10.1111/j.1749-6632.2002.tb03041.x
   Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]
   Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Iyer RK, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035002
   Iyer RK, 2011, CURR OPIN BIOTECH, V22, P706, DOI 10.1016/j.copbio.2011.04.004
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   Johnson T.D., 2012, EXPERT OPIN DRUG DEL, V10, P59
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002
   Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Kofidis T, 2005, CIRCULATION, V112, P1173
   Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077
   Kurobe H, 2012, STEM CELL TRANSL MED, V1, P566, DOI 10.5966/sctm.2012-0044
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laham RJ, 2000, J AM COLL CARDIOL, V36, P2132, DOI 10.1016/S0735-1097(00)00988-8
   Laham RJ, 1999, DRUG METAB DISPOS, V27, P821
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215
   Leor J., 2000, CIRCULATION S3, V102, P11156
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Leung BM, 2010, TISSUE ENG PT A, V16, P3207, DOI [10.1089/ten.tea.2009.0746, 10.1089/ten.TEA.2009.0746]
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li ZQ, 2012, ACTA BIOMATER, V8, P3586, DOI 10.1016/j.actbio.2012.06.024
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Liau B, 2011, BIOMATERIALS, V32, P9180, DOI 10.1016/j.biomaterials.2011.08.050
   Lieu DK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P191, DOI 10.1161/CIRCEP.111.973420
   Lin X, 2013, CELL TISSUE RES, V352, P523, DOI 10.1007/s00441-013-1576-z
   Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lundy SD, 2013, STEM CELLS DEV
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   McManus DD, 2009, J AM SOC ECHOCARDIOG, V22, P190, DOI 10.1016/j.echo.2008.11.005
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Miyagawa S, 2005, TRANSPLANTATION, V80, P1586, DOI 10.1097/01.tp.0000181163.69108.dd
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679
   NAG AC, 1980, CYTOBIOS, V28, P41
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Naito H, 2006, CIRCULATION, V114, P172, DOI DOI 10.1161/CIRCULATIONAHA.105.001560
   Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005
   Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Parratt JR, 1997, AM J CARDIOL, V80, pA124, DOI 10.1016/S0002-9149(97)00467-0
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329
   Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4
   Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397
   Schoen FJ, 2011, CURR OPIN BIOTECH, V22, P698, DOI 10.1016/j.copbio.2011.01.004
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406
   Shah AM, 1997, CIRC RES, V80, P688, DOI 10.1161/01.RES.80.5.688
   Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106
   Stamm C, 2009, HEART LUNG CIRC, V18, P245, DOI 10.1016/j.hlc.2008.10.014
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Stevens KR, 2009, TISSUE ENG PT A, V15, P1211, DOI 10.1089/ten.tea.2008.0151
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552
   Sussman MA, 2002, CIRC RES, V91, P888, DOI 10.1161/01.RES.0000031680.43270.F8
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tandon N, 2011, J TISSUE ENG REGEN M, V5, pE115, DOI 10.1002/term.377
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2
   Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894
   Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855
   Young JL, 2011, BIOMATERIALS, V32, P1002, DOI 10.1016/j.biomaterials.2010.10.020
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
   Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
NR 132
TC 42
Z9 44
U1 1
U2 73
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-6196
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD AUG
PY 2013
VL 88
IS 8
BP 884
EP 898
DI 10.1016/j.mayocp.2013.05.003
PG 15
WC Medicine, General & Internal
SC General & Internal Medicine
GA 217CE
UT WOS:000324333400019
PM 23910415
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wang, YP
   Ouyang, YM
   He, YH
   Chen, DY
   Jiang, Y
   Mao, L
   Niu, JL
   Zhang, J
   Yuan, GY
AF Wang YongPing
   Ouyang YuanMing
   He YaoHua
   Chen DaoYun
   Jiang Yao
   Mao Lin
   Niu JiaLin
   Zhang Jian
   Yuan GuangYin
TI Biocompatibility of Mg-Nd-Zn-Zr alloy with rabbit blood
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE magnesium alloy; hemocompatibility; blood cell aggregation; platelet
   adhesion; protein adsorption
ID MAGNESIUM; BIOMATERIALS; BEHAVIOR; DEGRADATION; CORROSION; ADHESION;
   IMPLANTS
AB In this study, in vitro blood biocompatibility of Mg-Nd-Zn-Zr (JDBM) alloy was investigated to determine its suitability as a degradable medical biomaterial. Blood biocompatibility was assessed by blood cell aggregation, platelet adhesion, and protein adsorption. A titanium alloy was used as control. The results showed that the JDBM alloy did not induce significant blood cell aggregation, platelet adhesion, and protein adsorption comparison with the titanium alloy (P > 0.05). Our data indicate that the JDBM alloy has excellent in vitro blood compatibility, and thus can be considered as a potential degradable biomaterial for medical applications with respect to hemocompatibility.
C1 [Wang YongPing] Lanzhou Univ, Hosp 1, Dept Orthopaed, Lanzhou 730000, Peoples R China.
   [Wang YongPing; Ouyang YuanMing; He YaoHua; Chen DaoYun; Jiang Yao] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.
   [Mao Lin; Niu JiaLin; Zhang Jian; Yuan GuangYin] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, Natl Engn Res Ctr Light Alloys Net Forming, Shanghai 200240, Peoples R China.
RP Jiang, Y (reprint author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.
EM jiangyao195106@163.com; gyyuan@sjtu.edu.cn
FU Major Basic Research Project of Shanghai Science and Technology
   Commission [11DJ1400304, 11DJ1400301]; National Natural Science
   Foundation of China [81071452, 81271961, 81271998]
FX This work was supported by Major Basic Research Project of Shanghai
   Science and Technology Commission (11DJ1400304, 11DJ1400301) and the
   National Natural Science Foundation of China (81071452, 81271961 and
   81271998).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   ITO Y, 1990, J BIOMED MATER RES, V24, P227, DOI 10.1002/jbm.820240209
   Johnson G, 2013, J BIOMATER APPL, V27, P925, DOI 10.1177/0885328211428525
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   Sharma CP, 2001, J BIOMATER APPL, V15, P359, DOI 10.1106/YY8L-M4DD-AGW1-QAGU
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wang YP, 2012, CHINESE SCI BULL, V57, P2163, DOI 10.1007/s11434-012-5066-6
   Wang YP, 2012, INT J MOL MED, V29, P178, DOI 10.3892/ijmm.2011.815
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001
   Zhang XB, 2012, J MECH BEHAV BIOMED, V9, P153, DOI 10.1016/j.jmbbm.2012.02.002
NR 18
TC 2
Z9 2
U1 1
U2 39
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD AUG
PY 2013
VL 58
IS 23
BP 2903
EP 2908
DI 10.1007/s11434-013-5883-2
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 204CR
UT WOS:000323343100018
OA Bronze
DA 2018-10-20
ER

PT J
AU Higgins, AM
   Banik, BL
   Brown, JL
AF Higgins, Andrew M.
   Banik, Brittany L.
   Brown, Justin L.
TI Nanotopography Sensing Through Intracellular Signaling and
   Mechanotransduction with an Emphasis on Bone
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Review
DE Nanotopography; Mechanotransduction; Curvature Sensing; Growth Factor
   Signaling; Ion Signaling; Stretch Signaling; Integrin Signaling;
   Cadherin Signaling
ID MESENCHYMAL STEM-CELLS; CADHERIN-MEDIATED ADHESIONS; MEMBRANE CURVATURE;
   BAR DOMAINS; MECHANICAL STRETCH; FOCAL ADHESION; OSTEOBLAST
   DIFFERENTIATION; AMPHIPATHIC HELICES; INTEGRIN ADHESOME; STRESS FIBERS
AB Synthetic substrates have demonstrated efficacy over numerous cell phenotypes from morphology to proliferation and differentiation. This becomes especially true when the substrate's topography approaches the nanoscale. Nanotopography, structures ranging from 10(1) nm-10(3) nm as defined in the context of this review, can have a significant impact on cell signaling. The signaling mechanisms that are impacted by nanotopography are described within this article. Background material on nanotopography and mechanobiology will be briefly discussed, followed by a detailed discussion of the membrane-related signaling mechanisms, specifically, mechanisms related to membrane stretching, growth factors, ions, and curvature sensing. The role of cell-surface and cell-cell anchoring proteins, integrins and cadherins respectively, in topography sensing is discussed with respect to their ability to act as topography sensors. Developing an understanding of nanotopography's ability to influence cell signaling leading to phenotype shift is of great importance because it enables development of future generations of biomaterial substrates capable of targeted control over cellular signaling leading to directed cell phenotype.
C1 [Higgins, Andrew M.; Banik, Brittany L.; Brown, Justin L.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA.
RP Brown, JL (reprint author), Penn State Univ, Dept Bioengn, Hallowell Bldg, University Pk, PA 16802 USA.
RI Brown, Justin/N-4775-2015
OI Brown, Justin/0000-0001-9401-6094
CR Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121
   Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261
   Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004
   Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714
   Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108
   Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]
   Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955067402003733
   Brown JL, 2010, J BIOMED MATER RES A, V95A, P1150, DOI 10.1002/jbm.a.32934
   Chan LY, 2013, BIOMATERIALS, V34, P382, DOI 10.1016/j.biomaterials.2012.09.033
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Chifflet S., 2012, INT J CELL BIOL, V2012
   Childress P, 2011, CALCIFIED TISSUE INT, V89, P74, DOI 10.1007/s00223-011-9496-y
   Childress P, 2010, BONE, V46, P259, DOI 10.1016/j.bone.2009.09.014
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   Clemente CFMZ, 2005, AM J PHYSIOL-REG I, V289, pR862, DOI 10.1152/ajpregu.00348.2004
   Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017
   Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036
   Curtis ASG, 2006, NANOMEDICINE-UK, V1, P67, DOI 10.2217/17435889.1.1.67
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010
   Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223
   Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105
   Hamamura K, 2010, CELL BIOL INT, V34, P1005, DOI 10.1042/CBI20100069
   Harjanto D, 2010, ORG BIOMOL CHEM, V8, P299, DOI 10.1039/b913064k
   Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213
   Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053
   Heydarkhan-Hagvall S, 2007, CELL COMMUN ADHES, V14, P181, DOI 10.1080/15419060701755594
   Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057
   Holthuis JCM, 2003, DEV CELL, V5, P821, DOI 10.1016/S1534-5807(03)00366-6
   Hong SY, 2010, MOL CELL BIOCHEM, V335, P263, DOI 10.1007/s11010-009-0276-1
   Hu J, 2008, BIOMATERIALS, V29, P3815, DOI 10.1016/j.biomaterials.2008.06.015
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4
   Jaiswal D, 2012, J BIOMED MATER RES A, V100A, P2921, DOI 10.1002/jbm.a.34234
   Janssen H, 2006, EXP CELL RES, V312, P1194, DOI 10.1016/j.yexcr.2006.02.001
   Jiang JJ, 2013, ADV HEALTHC MATER, V2, P25, DOI 10.1002/adhm.201200169
   Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200
   Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200
   Kim E. Y., 2010, HDB METALLOPROTEINS, V5, P1
   Kulangara K, 2009, SOFT MATTER, V5, P4072, DOI 10.1039/b910132m
   Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044
   Leckband DE, 2011, CURR OPIN CELL BIOL, V23, P523, DOI 10.1016/j.ceb.2011.08.003
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Liao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042709
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Lionetti V, 2011, STEM CELLS DEV, V20, P561, DOI 10.1089/scd.2010.0389
   Lutz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025459
   Mahmood TA, 2004, EXP CELL RES, V301, P179, DOI 10.1016/j.yexcr.2004.07.027
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611
   Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795
   NARUSE K, 1993, AM J PHYSIOL, V264, pC1037
   Nava M. M., 2012, J BIOMEDICINE BIOTEC, V2012, P1
   Ott CE, 2009, J BONE MINER RES, V24, P1247, DOI [10.1359/jbmr.090206, 10.1359/JBMR.090206]
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241
   Rani VVD, 2012, ACTA BIOMATER, V8, P1976, DOI 10.1016/j.actbio.2012.01.021
   Robling AG, 2009, J CELL PHYSIOL, V219, P734, DOI 10.1002/jcp.21717
   SACHS F, 1991, MOL CELL BIOCHEM, V104, P57
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077
   Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330
   Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Su B, 2013, ONCOGENE, V32, P2016, DOI 10.1038/onc.2012.218
   Su FC, 2011, J MED BIOL ENG, V31, P233, DOI 10.5405/jmbe.944
   Tsuruma A, 2008, COLLOID SURFACE A, V313, P536, DOI 10.1016/j.colsurfa.2007.05.079
   Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014
   Wheeldon I, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/212001
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200
   Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058
   Yamazaki T, 1998, CIRC RES, V82, P430, DOI 10.1161/01.RES.82.4.430
   Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858
   Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183
   Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060
NR 98
TC 2
Z9 2
U1 2
U2 39
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD AUG
PY 2013
VL 3
IS 4
SI SI
BP 396
EP 408
DI 10.1166/jbt.2013.1104
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 210WX
UT WOS:000323866900005
DA 2018-10-20
ER

PT J
AU Simka, W
   Sowa, M
   Socha, RP
   Maciej, A
   Michalska, J
AF Simka, Wojciech
   Sowa, Maciej
   Socha, Robert P.
   Maciej, Artur
   Michalska, Joanna
TI Anodic oxidation of zirconium in silicate solutions
SO ELECTROCHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Surface Imaging/Spectroscopy at the
   Solid/Liquid Interface (ISSIS)
CY MAY 27-JUN 01, 2012
CL Polish Acad Sci, J Haber Inst Catalysis & Surface Chem, Krakow, POLAND
SP Univ Warsaw, Fac Chem, Electrochem Soc, Shim Pol, KGHM, ECOREN, Azoty Tarnow, nLab
HO Polish Acad Sci, J Haber Inst Catalysis & Surface Chem
DE Zirconium; Plasma electrolytic oxidation; Corrosion; Silicate solutions
ID PLASMA ELECTROLYTIC OXIDATION; CORROSION-RESISTANCE; BIOMEDICAL
   APPLICATION; TITANIUM BIOMATERIAL; RINGERS SOLUTION; OXIDE-FILM; ALLOYS;
   TI-6AL-4V; TI-13NB-13ZR; COATINGS
AB Herein, a study of the surface modification of zirconium by anodic oxidation is reported. The oxidation process was carried out in a solution containing K2SiO3 and KOH. The anodization was conducted at voltages of 100, 200 and 400 V. It was found that the morphology of the surface did not change during the oxidation of the zirconium at 100 and 200 V. The application of 400 V resulted in the incorporation of silicon into the formed oxide layer and a significant modification of the surface morphology. The obtained coatings are typical of coating produced during an electrolytic plasma oxidation process and contain a considerable amount of silicon. The anodic oxidation of zirconium leads to a significant improvement in the corrosion resistance of the material in the presence of Ringer's physiological solution. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Simka, Wojciech; Sowa, Maciej; Maciej, Artur] Silesian Tech Univ, Fac Chem, PL-44100 Gliwice, Poland.
   [Socha, Robert P.] Jerzy Haber Inst Catalysis & Surface Chem PAS, PL-30239 Krakow, Poland.
   [Michalska, Joanna] Silesian Tech Univ, Fac Mat Sci & Met, PL-40019 Katowice, Poland.
RP Simka, W (reprint author), Silesian Tech Univ, Fac Chem, B Krzywoustego St 6, PL-44100 Gliwice, Poland.
EM wojciech.simka@polsl.pl
RI Socha, Robert/J-4307-2012
OI Socha, Robert/0000-0003-4072-2393; Simka, Wojciech/0000-0002-2648-5523
CR Assis SL, 2007, MATER CORROS, V58, P329, DOI 10.1002/maco.200604027
   Blackwood DJ, 2009, MAT SCI ENG C-BIO S, V29, P1233, DOI 10.1016/j.msec.2008.10.015
   BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   Cheng S, 2011, CERAM INT, V37, P1761, DOI 10.1016/j.ceramint.2011.03.006
   Cheng Y, 2012, SURF COAT TECH, V206, P3230, DOI 10.1016/j.surfcoat.2012.01.011
   Cheng YL, 2011, ELECTROCHIM ACTA, V56, P8467, DOI 10.1016/j.electacta.2011.07.034
   DAVIES JA, 1965, J ELECTROCHEM SOC, V112, P675, DOI 10.1149/1.2423662
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Guo WY, 2009, MATER CHEM PHYS, V113, P816, DOI 10.1016/j.matchemphys.2008.08.043
   Ha JY, 2011, SURF COAT TECH, V205, P4948, DOI 10.1016/j.surfcoat.2011.04.079
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2012, SURF COAT TECH, V206, P4027, DOI 10.1016/j.surfcoat.2012.03.083
   Hu HJ, 2010, SURF COAT TECH, V204, P3265, DOI 10.1016/j.surfcoat.2010.03.028
   Huang P, 2005, MATER LETT, V59, P185, DOI 10.1016/j.matlet.2004.09.045
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Krzakala A, 2013, ELECTROCHIM ACTA, V104, P407, DOI 10.1016/j.electacta.2012.07.075
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   Li J, 2006, APPL SURF SCI, V252, P7436, DOI 10.1016/j.apsusc.2005.08.091
   Mamun A, 2001, ELECTROCHIM ACTA, V46, P3343, DOI 10.1016/S0013-4686(01)00544-8
   Matykina E, 2010, SURF COAT TECH, V204, P2142, DOI 10.1016/j.surfcoat.2009.11.042
   MEISTERJAHN P, 1987, J ELECTROANAL CHEM, V217, P159, DOI 10.1016/0022-0728(87)85072-6
   Miller P. D., 1958, WEAR, V2, P133, DOI DOI 10.1016/0043-1648(58)90428-9
   Monfort F, 2007, CORROS SCI, V49, P672, DOI 10.1016/j.corsci.2006.05.046
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Muratore F, 2011, ELECTROCHIM ACTA, V58, P389, DOI 10.1016/j.electacta.2011.09.062
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Narayanan R, 2008, CORROS SCI, V50, P1521, DOI 10.1016/j.corsci.2008.02.023
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P2068, DOI 10.1016/j.electacta.2005.07.015
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Rath PC, 2012, CERAM INT, V38, P3209, DOI 10.1016/j.ceramint.2011.12.026
   Robin A, 2008, MATER CORROS, V59, P929, DOI 10.1002/maco.200805014
   Simka W, 2011, ELECTROCHIM ACTA, V56, P9831, DOI 10.1016/j.electacta.2011.08.049
   Simka W, 2011, ELECTROCHIM ACTA, V56, P8962, DOI 10.1016/j.electacta.2011.07.129
   Simka W, 2010, ELECTROCHIM ACTA, V55, P2437, DOI 10.1016/j.electacta.2009.11.097
   Simka W, 2009, ELECTROCHIM ACTA, V54, P6983, DOI 10.1016/j.electacta.2009.07.010
   SOUTHWORTH P, 1988, CORROS SCI, V28, P1139, DOI 10.1016/0010-938X(88)90124-2
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Strzala A, 2012, ACTA PHYS POL A, V121, P561, DOI 10.12693/APhysPolA.121.561
   Sulka GD, 2011, ELECTROCHIM ACTA, V56, P4972, DOI 10.1016/j.electacta.2011.03.126
   Szewczenko J, 2010, MATERIALWISS WERKST, V41, P360, DOI 10.1002/mawe.201000610
   Szewczenko J, 2012, LECT N BIOINFORMAT, V7339, P398
   Szewczenko J, 2011, PRZ ELEKTROTECHNICZN, V87, P177
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Xue WB, 2010, MATER CHEM PHYS, V120, P656, DOI 10.1016/j.matchemphys.2009.12.012
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
NR 53
TC 36
Z9 36
U1 2
U2 32
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD AUG 1
PY 2013
VL 104
BP 518
EP 525
DI 10.1016/j.electacta.2012.10.130
PG 8
WC Electrochemistry
SC Electrochemistry
GA 180NF
UT WOS:000321601200063
DA 2018-10-20
ER

PT J
AU Lin, MY
   Manzano, G
   Gupta, R
AF Lin, Michael Y.
   Manzano, Givenchy
   Gupta, Ranjan
TI Nerve Allografts and Conduits in Peripheral Nerve Repair
SO HAND CLINICS
LA English
DT Article
DE Nerve conduit; Allograft; Peripheral nerve injury; Peripheral nerve
   repair
ID PROSPECTIVE CLINICAL-EVALUATION; MESENCHYMAL STEM-CELLS; RAT
   SCIATIC-NERVE; SCHWANN-CELLS; AXONAL REGENERATION; NEUROTROPHIC FACTORS;
   FUNCTIONAL RECOVERY; POLYGLYCOLIC ACID; VEIN CONDUITS; MEDIAN-NERVE
AB Since the last update on nerve conduits and allograft in 2000, investigations have established the efficacy of these alternatives to autograft in the repair of small sensory neural gaps. However, limited insights into the biology of the regenerating nerve continue to preclude intelligent conduit design. Ongoing discoveries in neuroscience and biomaterial engineering hold promise for the eventual development of allograft and conduits with potential of surpassing nerve autografts in clinical efficacy. In this review, we summarize the history, recent advances, and emerging developments in nerve conduits and allograft.
C1 [Lin, Michael Y.; Manzano, Givenchy; Gupta, Ranjan] Univ Calif Irvine, Dept Orthopaed Surg, Gillespie Neurosci Res Facil 2226, Irvine, CA 92697 USA.
RP Gupta, R (reprint author), Univ Calif Irvine, Dept Orthopaed Surg, Gillespie Neurosci Res Facil 2226, Irvine, CA 92697 USA.
EM ranjang@uci.edu
CR Albert E., 1885, EINIGE OPERATIONEN N, V26, P1285
   ANDERSON PN, 1986, J ANAT, V147, P73
   Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979
   Asplund M, 2009, NEUROEPIDEMIOLOGY, V32, P217, DOI 10.1159/000197900
   Atchabahian A, 1998, RESTOR NEUROL NEUROS, V13, P129
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Battiston B, 2000, MICROSURG, V20, P32, DOI 10.1002/(SICI)1098-2752(2000)20:1<32::AID-MICR6>3.0.CO;2-D
   Berrocal YA, J NEUROSURG IN PRESS
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Brandt J, 2002, SCAND J PLAST RECONS, V36, P2, DOI 10.1080/028443102753478309
   Brandt J, 1999, J HAND SURG-BRIT EUR, V24B, P284, DOI 10.1054/jhsb.1999.0074
   Brooke R, 2004, J NEUROSCI RES, V40, P318
   Brooks DN, 2012, MICROSURG, V32, P1, DOI 10.1002/micr.20975
   BRUNELLI GA, 1993, MICROSURG, V14, P247, DOI 10.1002/micr.1920140407
   Bunger O, 1891, BEITR PATHOL ANAL, V10, P312
   Bushnell BD, 2008, J HAND SURG-AM, V33A, P1081, DOI 10.1016/j.jhsa.2008.03.015
   Chang CJ, 2004, ULTRASOUND MED BIOL, V30, P1079, DOI 10.1016/j.ultrasmedbio.2004.06.005
   Chao T, 2013, ANN NEUROL, V73, P210, DOI 10.1002/ana.23781
   Chiriac S, 2012, J HAND SURG-EUR VOL, V37E, P342, DOI 10.1177/1753193411422685
   CHIU DTW, 1990, PLAST RECONSTR SURG, V86, P928, DOI 10.1097/00006534-199011000-00015
   Cho MS, 2012, J HAND SURG-AM, V37A, P2340, DOI 10.1016/j.jhsa.2012.08.028
   CLARK WL, 1992, J HAND SURG-AM, V17A, P677, DOI 10.1016/0363-5023(92)90316-H
   CRUZ NI, 1986, PLAST RECONSTR SURG, V78, P369, DOI 10.1097/00006534-198609000-00015
   Dai LG, 2012, CELL TRANSPLANT
   DALY P J, 1985, Journal of Reconstructive Microsurgery, V2, P45, DOI 10.1055/s-2007-1007044
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   DANIELSEN N, 1994, BRAIN RES, V666, P250, DOI 10.1016/0006-8993(94)90779-X
   DANILOFF JK, 1986, J CELL BIOL, V103, P929, DOI 10.1083/jcb.103.3.929
   DAVIS L, 1945, SURG GYNECOL OBSTET, V80, P35
   Dellon AL, 2006, J HAND SURG-AM, V31A, P1495, DOI 10.1016/j.jhsa.2006.07.003
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Dubuisson AS, 1997, EXP NEUROL, V148, P378, DOI 10.1006/exnr.1997.6667
   Dudanova I, 2013, TRENDS NEUROSCI, V36, P295, DOI 10.1016/j.tins.2013.01.007
   EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x
   Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002
   El-Barrany WG, 1999, SURG RADIOL ANAT, V21, P95, DOI 10.1007/s00276-999-0095-9
   Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   Fujimura J, 2005, BIOCHEM BIOPH RES CO, V333, P116, DOI 10.1016/j.bbrc.2005.05.096
   GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164
   Gu JH, 2012, J TISSUE ENG REGEN M, V6, P163, DOI 10.1002/term.407
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hall H, 2007, CURR PHARM DESIGN, V13, P3597, DOI 10.2174/138161207782794158
   Hernandez-Cortes P, 2010, MICROSURG, V30, P414, DOI 10.1002/micr.20730
   Hobson MI, 2002, ANN ROY COLL SURG, V84, P47
   Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI 10.1089/ten.TEA.2009.0017
   Huang AHC, 2008, STEM CELLS, V26, P2654, DOI 10.1634/stemcells.2008-0285
   Isaacs J, 2010, J HAND SURG-AM, V35A, P491, DOI 10.1016/j.jhsa.2009.12.009
   Jin J, 2012, REGEN MED, V7, P799, DOI [10.2217/RME.12.87, 10.2217/rme.12.87]
   Johnson PJ, 2011, J RECONSTR MICROSURG, V27, P83, DOI 10.1055/s-0030-1267834
   Jubran M, 2003, EXP NEUROL, V181, P204, DOI 10.1016/S0014-4886(03)00041-4
   Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015
   Kalbermatten DF, 2009, J RECONSTR MICROSURG, V25, P27, DOI 10.1055/s-0028-1090619
   Karabekmez Furkan E, 2009, Hand (N Y), V4, P245, DOI 10.1007/s11552-009-9195-6
   Kemp SWP, 2009, TISSUE ENG PT A, V15, P1975, DOI 10.1089/ten.tea.2008.0338
   KERNS JM, 1993, EXP NEUROL, V122, P28, DOI 10.1006/exnr.1993.1104
   Konofaos P, 2013, J RECONSTR MICROSURG, V29, P149, DOI 10.1055/s-0032-1333316
   KOSHIMA I, 1985, ANN PLAS SURG, V14, P235, DOI 10.1097/00000637-198503000-00008
   Kosutic D, 2009, J PLAST RECONSTR AES, V62, P553, DOI 10.1016/j.bjps.2008.12.002
   Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131
   LASSNER F, 1995, MICROSURG, V16, P4, DOI 10.1002/micr.1920160104
   LEE HK, 1993, INT ORTHOP, V17, P193
   Lee S K, 2000, J Am Acad Orthop Surg, V8, P243
   LEVINTHAL R, 1978, J NEUROSURG, V48, P428, DOI 10.3171/jns.1978.48.3.0428
   Liu BS, 2012, J TISSUE ENG REGEN M
   Lohmeyer JA, 2009, J RECONSTR MICROSURG, V25, P55, DOI 10.1055/s-0028-1103505
   LUNDBORG G, 1991, SCAND J PLAST RECONS, V25, P79, DOI 10.3109/02844319109034927
   Lundborg G, 1997, J HAND SURG-AM, V22A, P99, DOI 10.1016/S0363-5023(05)80188-1
   LUNDBORG G, 1994, J RECONSTR MICROSURG, V10, P345, DOI 10.1055/s-2007-1006604
   LUNDBORG G, 1994, J HAND SURG-BRIT EUR, V19B, P273, DOI 10.1016/0266-7681(94)90068-X
   Lundborg G, 2004, NERVE INJURY REPAIR
   Luo Y X, 1989, J Tongji Med Univ, V9, P103
   LUX P, 1988, PLAST RECONSTR SURG, V82, P133, DOI 10.1097/00006534-198882010-00024
   Mackinnon SE, 2001, PLAST RECONSTR SURG, V107, P1419, DOI 10.1097/00006534-200105000-00016
   MACKINNON SE, 1987, PLAST RECONSTR SURG, V79, P436, DOI 10.1097/00006534-198703000-00023
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Madduri S, 2010, J CONTROL RELEASE, V143, P168, DOI 10.1016/j.jconrel.2009.12.017
   McGrath AM, 2012, NEUROSCI LETT, V516, P171, DOI 10.1016/j.neulet.2012.03.041
   McLeod M, 2006, EUR J NEUROSCI, V24, P361, DOI 10.1111/j.1460-9568.2006.04919.x
   Meek MF, 2006, J RECONSTR MICROSURG, V22, P149, DOI 10.1055/s-2006-939959
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45
   MIDHA R, 1994, J NEUROPATH EXP NEUR, V53, P316, DOI 10.1097/00005072-199405000-00013
   MIDHA R, 1993, TRANSPLANT P, V25, P532
   Moore AM, 2011, MUSCLE NERVE, V44, P221, DOI 10.1002/mus.22033
   Moore AM, 2010, J HAND SURG-AM, V35A, P2008, DOI 10.1016/j.jhsa.2010.08.016
   Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3
   Neubauer D, 2007, EXP NEUROL, V207, P163, DOI 10.1016/j.expneurol.2007.06.006
   Nishimura MT, 2008, J RECONSTR MICROSURG, V24, P327, DOI 10.1055/s-2008-1080535
   Nishiura Y, 2004, TISSUE ENG, V10, P157, DOI 10.1089/107632704322791808
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Nosrat IV, 2004, EUR J NEUROSCI, V19, P2388, DOI 10.1111/j.1460-9568.2004.03314.x
   Oliveira JT, 2010, NEUROSCIENCE, V170, P1295, DOI 10.1016/j.neuroscience.2010.08.042
   Pettersson J, 2010, J PLAST RECONSTR AES, V63, P1893, DOI 10.1016/j.bjps.2009.11.024
   Platt H, 1920, BRIT J SURG, V7, P384
   Rafijah G, 2013, J HAND SURG-AM, V38A, P847, DOI 10.1016/j.jhsa.2013.01.044
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Rinker B, 2011, J HAND SURG-AM, V36A, P775, DOI 10.1016/j.jhsa.2011.01.030
   Rosson GD, 2009, MICROSURG, V29, P107, DOI 10.1002/micr.20580
   Roy J, 2013, LAB CHIP, V13, P498, DOI 10.1039/c2lc41002h
   SALONEN V, 1988, ACTA NEUROPATHOL, V75, P331, DOI 10.1007/BF00687785
   Sameem M, 2011, PLAST RECONSTR SURG, V127, P2381, DOI 10.1097/PRS.0b013e3182131cf5
   Santiago LY, 2009, CELL TRANSPLANT, V18, P145, DOI 10.3727/096368909788341289
   Saray A, 2002, J RECONSTR MICROSURG, V18, P281, DOI 10.1055/s-2002-30184
   Serel S, 2010, ANN PLAS SURG, V64, P323, DOI 10.1097/SAP.0b013e3181a7308a
   Settergren C R, 1984, J Reconstr Microsurg, V1, P95, DOI 10.1055/s-2007-1007060
   SHIBATA M, 1988, J HAND SURG-AM, V13A, P358, DOI 10.1016/S0363-5023(88)80008-X
   SIIRONEN J, 1992, LAB INVEST, V67, P80
   TANG JB, 1995, J RECONSTR MICROSURG, V11, P21, DOI 10.1055/s-2007-1006506
   TANG JB, 1993, MICROSURG, V14, P404, DOI 10.1002/micr.1920140611
   Taras JS, 2011, J HAND SURG-AM, V36A, P1441, DOI 10.1016/j.jhsa.2011.06.009
   Tark KC, 2001, J RECONSTR MICROSURG, V17, P109
   Temple CLF, 2004, J RECONSTR MICROSURG, V20, P645, DOI 10.1055/s-2004-861525
   Thomsen L, 2010, CHIR MAIN, V29, P255, DOI 10.1016/j.main.2010.07.004
   TRUMBLE TE, 1992, J NEURAL TRANSP PLAS, V3, P39, DOI 10.1155/NP.1992.39
   WALTON RL, 1989, PLAST RECONSTR SURG, V84, P944, DOI 10.1097/00006534-198912000-00013
   Wangensteen Kirk J, 2010, Hand (N Y), V5, P273, DOI 10.1007/s11552-009-9245-0
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Weiss P, 1944, J EXP ZOOL, V95, P233, DOI 10.1002/jez.1400950205
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   Wolford Larry M, 2003, Proc (Bayl Univ Med Cent), V16, P152
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   WREDE L, 1909, DEUT MED WOCHENSCHR, V35, P1125
   Xie JW, 2008, MACROMOL RAPID COMM, V29, P1775, DOI 10.1002/marc.200800381
   Xu YF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-21
   Yin Q, 2001, MUSCLE NERVE, V24, P345, DOI 10.1002/1097-4598(200103)24:3<345::AID-MUS1004>3.3.CO;2-G
   ZALEWSKI AA, 1980, J NEUROSURG, V52, P557, DOI 10.3171/jns.1980.52.4.0557
   Zavan B, 2010, DISCOV MED, V10, P37
   Zhan XD, 2012, NANOMEDICINE, V9, P305
   Zheng L, 2010, J MATER SCI-MATER M, V21, P1713, DOI 10.1007/s10856-010-4003-y
   Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.0.CO;2-C
NR 134
TC 33
Z9 37
U1 1
U2 42
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-0712
EI 1558-1969
J9 HAND CLIN
JI Hand Clin.
PD AUG
PY 2013
VL 29
IS 3
BP 331
EP +
DI 10.1016/j.hcl.2013.04.003
PG 19
WC Orthopedics
SC Orthopedics
GA 207TR
UT WOS:000323627800003
PM 23895714
DA 2018-10-20
ER

PT J
AU Yu, XF
   Zou, YQ
   Horte, S
   Janzen, J
   Kizhakkedathu, JN
   Brooks, DE
AF Yu, Xifei
   Zou, Yuquan
   Horte, Sonja
   Janzen, Johan
   Kizhakkedathu, Jayachandran N.
   Brooks, Donald E.
TI Thermal Reversal of Polyvalent Choline Phosphate, a Multivalent
   Universal Biomembrane Adhesive
SO BIOMACROMOLECULES
LA English
DT Article
AB Multivalent macromolecular associations are widely observed in biological systems and are increasingly being utilized in bioengineering, nanomedicine, and biomaterial applications. Control over such associations usually demands an ability to reverse the multivalent binding. While in principle this can be done with binding site competitive inhibitors, dissociation is difficult in practice due to limited site accessibility when the macromolecule is bound. We demonstrate here efficient binding reversal of multivalent linear copolymers that adhere to any mammalian cell via the universal mechanism based on choline phosphate (CP) groups binding to phosphatidyl choline (PC)-containing biomembranes. Using a smart linear polymer exhibiting a lower critical solution temperature (LCST), we take advantage of the thermal contraction of the polymer above the LCST, which reduces accessibility of the CP groups to cell membrane PC lipids. The polymer construct can then desorb from the cell surface, reversing all effects of multivalent polymer adhesion on the cell.
C1 [Yu, Xifei; Zou, Yuquan; Horte, Sonja; Janzen, Johan; Kizhakkedathu, Jayachandran N.; Brooks, Donald E.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada.
   [Yu, Xifei; Zou, Yuquan; Horte, Sonja; Janzen, Johan; Kizhakkedathu, Jayachandran N.; Brooks, Donald E.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada.
   [Kizhakkedathu, Jayachandran N.; Brooks, Donald E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada.
RP Brooks, DE (reprint author), Univ British Columbia, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.
EM don.brooks@ubc.ca
OI Brooks, Donald/0000-0002-7946-4320
FU CIHR; Canadian Blood Services, Health Canada; CFI; Michael Smith
   Foundation for Health Research (MSFHR); MSFHR
FX Financial support from the CIHR, Canadian Blood Services, Health Canada,
   CFI, and the Michael Smith Foundation for Health Research (MSFHR) are
   gratefully acknowledged. J.N.K. acknowledges a Career Investigator
   Scholar award from MSFHR.
CR AOSHIMA S, 1992, J POLYM SCI POL CHEM, V30, P2407, DOI 10.1002/pola.1992.080301115
   Aplin AE, 1998, PHARMACOL REV, V50, P197
   Chee CK, 2001, POLYMER, V42, P5079, DOI 10.1016/S0032-3861(00)00821-1
   Cloninger MJ, 2002, CURR OPIN CHEM BIOL, V6, P742, DOI 10.1016/S1367-5931(02)00400-3
   Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3
   FERRELL JE, 1985, BIOCHEMISTRY-US, V24, P2849, DOI 10.1021/bi00333a006
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Han S, 2003, MACROMOLECULES, V36, P8312, DOI 10.1021/ma0347971
   Hoffman AS, 2004, MACROMOL SYMP, V207, P139, DOI 10.1002/masy.200450314
   Huskens J, 2004, J AM CHEM SOC, V126, P6784, DOI 10.1021/ja049085k
   Iglic A, 1998, EUR BIOPHYS J BIOPHY, V27, P335, DOI 10.1007/s002490050140
   Jakab K, 2004, P NATL ACAD SCI USA, V101, P2864, DOI 10.1073/pnas.0400164101
   KATO M, 1995, MACROMOLECULES, V28, P1721, DOI 10.1021/ma00109a056
   Kiessling LL, 2000, CURR OPIN CHEM BIOL, V4, P696, DOI 10.1016/S1367-5931(00)00153-8
   Kim MR, 2002, BIOTECHNOL PROGR, V18, P495, DOI 10.1021/bp020287z
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836
   Liu ZH, 2010, BIOMATERIALS, V31, P3364, DOI 10.1016/j.biomaterials.2010.01.021
   Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706
   Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
   MELLMAN I, 1984, J CELL BIOL, V98, P1170, DOI 10.1083/jcb.98.4.1170
   MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   Oliveira MB, 2011, BIOTECHNOL PROGR, V27, P897, DOI 10.1002/btpr.618
   OSBORNE SL, 1948, JAMA-J AM MED ASSOC, V137, P1036, DOI 10.1001/jama.1948.82890460002007
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975
   WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   Yu XF, 2006, POLYMER, V47, P1538, DOI 10.1016/j.polymer.2006.01.005
   Yu XF, 2007, POLYMER, V48, P2489, DOI 10.1016/j.polymer.2007.02.032
   Yu XF, 2012, NAT MATER, V11, P468, DOI [10.1038/NMAT3272, 10.1038/nmat3272]
   Yu XF, 2007, J POLYM SCI POL CHEM, V45, P147, DOI 10.1002/pola.21814
   Zou YQ, 2009, MACROMOLECULES, V42, P3258, DOI 10.1021/ma8025699
NR 36
TC 18
Z9 18
U1 3
U2 52
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD AUG
PY 2013
VL 14
IS 8
BP 2611
EP 2621
DI 10.1021/bm400466e
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 201LS
UT WOS:000323143700019
PM 23745838
DA 2018-10-20
ER

PT J
AU Sobczak-Kupiec, A
   Wzorek, Z
   Kijkowska, R
   Kowalski, Z
AF Sobczak-Kupiec, Agnieszka
   Wzorek, Zbigniew
   Kijkowska, Regina
   Kowalski, Zygmunt
TI Effect of calcination conditions of pork bone sludge on behaviour of
   hydroxyapatite in simulated body fluid
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE Natural hydroxyapatite; simulated body fluid; incubation; biomaterial;
   pH changes; rotary calcining kiln; chamber oven
ID PHOSPHATE CERAMIC COMPOSITION; NATURAL HYDROXYAPATITE; BOVINE BONE;
   NANOCRYSTALLINE HYDROXYAPATITE; TRICALCIUM PHOSPHATE; APATITE STRUCTURE;
   INVITRO BEHAVIOR; CORTICAL BONE; STABILITY; DECOMPOSITION
AB The paper presents in vitro (in SBF) behaviour of hydroxyapatite (HAp) obtained from pork bone sludge from meat plant via two essentially different calcination methods using a stationary, electrically heated chamber oven and enlarged laboratory scale rotary kiln designed by the authors, heated by gas combustion methods enabling application of different set of physical parameters such as temperature, holding time-differing according to type of the kiln. HAp ceramic discs, after 62-days of incubation in SBF at 37 A degrees C, characterized by X-ray diffraction (XRD), FTIR, SEM and EDS methods, underwent changes recorded by: (i) a reduction in Ca/P molar ratio in all the investigated materials resulting from modification in phase composition and (ii) weight increase in the investigated disc-samples, resulting from a precipitation of newly formed phase as an admixture of primary HPO-free HAp. They were: secondary (with HPO incorporated) HAp and chlorapatite in all the samples, while in addition to the listed above, beta -tricalcium phosphate was formed on the discs made of HAp from stationary chamber oven, but not from rotary kiln. The new phases were formed in agglomerates on the surface of the investigated ceramic discs and in their pores. The results obtained proved that calcination conditions of pork bone sludge (temperature 750-950 A degrees C, time and type of the applied kiln) under which hydroxyapatite (HAp) powders were obtained had an impact on its different behaviour in SBF, nevertheless, indicating a potential ability of the material to form a new biologically relevant interface with hard tissue and suitability for further investigations intended for medical grafting.
C1 [Sobczak-Kupiec, Agnieszka; Wzorek, Zbigniew; Kowalski, Zygmunt] Cracow Univ Technol, Inst Inorgan Chem & Technol, PL-31155 Krakow, Poland.
   [Kijkowska, Regina] Alfred Meissner Higher Sch Dent Engn & Humanities, PL-43450 Ustron, Poland.
RP Sobczak-Kupiec, A (reprint author), Cracow Univ Technol, Inst Inorgan Chem & Technol, Warszawska 24, PL-31155 Krakow, Poland.
EM asobczak@chemia.pk.edu.pl
RI Sobczak-Kupiec, Agieszka/N-2799-2013; Wzorek, Zbigniew/D-3671-2013
OI Wzorek, Zbigniew/0000-0001-9077-4699; Kowalski,
   Zygmunt/0000-0003-2884-710X; Sobczak-Kupiec,
   Agnieszka/0000-0003-0005-6146
FU National Centre for Science, Poland
FX The research was supported by the National Centre for Science, Poland.
CR Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Benhayoune H, 2000, BIOMATERIALS, V21, P235, DOI 10.1016/S0142-9612(99)00138-6
   BERRY EE, 1967, J INORG NUCL CHEM, V29, P317, DOI 10.1016/0022-1902(67)80033-2
   Brandt J, 2008, KEY ENG MATER, V361-363, P35, DOI 10.4028/www.scientific.net/KEM.361-363.35
   Daculsi G, 2008, KEY ENG MAT T TECH P, V361-363, P27
   De Champos M, 2002, KEY ENG MAT T TECH P, V218-220, P171
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P100
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3
   Funayama T., 2009, BIOCERAMICS, V22, P765
   Gibson R I, 2000, J MATER SCI-MATER M, V11, P533
   Goller G, 2006, J SOL-GEL SCI TECHN, V37, P111, DOI 10.1007/s10971-006-6428-9
   Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Hsu YH, 2005, KEY ENG MAT, V284-286, P305, DOI 10.4028/www.scientific.net/KEM.284-286.305
   HULBERT SF, 1990, BIOCERAMICS, V3, P1
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P837, DOI 10.1016/j.msec.2006.09.036
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kim YG, 2008, APPL SURF SCI, V255, P589, DOI 10.1016/j.apsusc.2008.06.089
   Knychalska-Karwan Zofia, 1998, Frontiers of Medical and Biological Engineering, V8, P239
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P232
   LeGeros R Z, 1995, CONNECTIVE TISSUE RE, V31, P1
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   LeGeros R Z, 1974, ARCH ORAL BIOL, V20, P63
   LEGEROS RZ, 1968, B SOC CHIM FR, P1712
   LeGeros RZ, 2006, KEY ENG MAT, V309-311, P697, DOI 10.4028/www.scientific.net/KEM.309-311.697
   LEGEROS RZ, 1975, C INT CNRS, V230, P105
   LEGEROS RZ, 1989, MAGNESIUM HLTH DIS, P11
   LeGeros RZ, 1971, ADV XRAY ANALYSIS, V14, P57
   Li SH, 2002, KEY ENG MATER, V218-2, P25, DOI 10.4028/www.scientific.net/KEM.218-220.25
   Li YB, 2007, ACTA BIOMATER, V3, P251, DOI 10.1016/j.actbio.2006.07.003
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Medvecky L, 2006, COLLOID SURFACE A, V281, P221, DOI 10.1016/j.colsurfa.2006.02.042
   Milev A, 2003, MATER LETT, V57, P1960, DOI 10.1016/S0167-577X(02)01112-6
   Mohammadi Z, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015006
   Mostafa NY, 2005, MATER CHEM PHYS, V94, P333, DOI 10.1016/j.matchemphys.2005.05.011
   Murugan R, 2004, BIOMATERIALS, V25, P3073, DOI 10.1016/j.biomaterials.2003.09.089
   Murugan R, 2003, B MATER SCI, V26, P523, DOI 10.1007/BF02707351
   Nishihara K., 1990, BIOCERAMICS, V3, P255
   Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001
   Orlovskii VP, 2002, INORG MATER+, V38, P973, DOI 10.1023/A:1020585800572
   Pena J, 2003, J EUR CERAM SOC, V23, P1687, DOI 10.1016/S0955-2219(02)00369-2
   Posner A. S., 1984, Phosphate Minerals, P330
   Posner A S, 1980, 2 INT C PHOSPH COMP, P25
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Rajabi-Zamani AH, 2008, MAT SCI ENG C-BIO S, V28, P1326, DOI 10.1016/j.msec.2008.02.001
   Raynaud S, 2002, BIOMATERIALS, V23, P1081, DOI 10.1016/S0142-9612(01)00220-4
   RAYNAUD S, 1998, BIOCERAMICS, V11, P109
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Ruixue S, 2006, MATER CHARACT, V56, P250
   Salms G, 2009, BIOCERAMICS, V22, P141
   Shih WJ, 2006, MAT SCI ENG C-BIO S, V26, P1434, DOI 10.1016/j.msec.2005.08.005
   Slosarczyk A, 1997, B CERAMICZNY, V51
   Sobczak A, 2010, ENVIRONMENTAL ENGINEERING III, P307, DOI 10.1201/b10566-50
   Sobczak A, 2010, PRZEM CHEM, V89, P1073
   Sobczak A, 2009, ACTA BIOENG BIOMECH, V11, P23
   Sobczak-Kupiec A, 2012, CERAM INT, V38, P641, DOI 10.1016/j.ceramint.2011.06.065
   Sopyan I., 2007, SCI TECHNOL ADV MAT, V8, P116
   Suetsugu Y, 1997, BIOCERAMICS, V10, P249
   Swieciki Z, 1992, BIOCERAMIKA DLA ORTO
   Veiderma M, 2005, J ORGANOMET CHEM, V690, P2638, DOI 10.1016/j.jorganchem.2004.11.022
   Wang T, 2004, MATER LETT, V58, P3025, DOI 10.1016/j.matlet.2004.05.033
   Yang Z, 2008, KEY ENG MATER, V361-363, P459, DOI 10.4028/www.scientific.net/KEM.361-363.459
   Younesi M, 2010, J MATER ENG PERFORM, V20, P1484
NR 70
TC 6
Z9 6
U1 1
U2 28
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD AUG
PY 2013
VL 36
IS 4
BP 755
EP 764
DI 10.1007/s12034-013-0482-z
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 203GF
UT WOS:000323278900038
DA 2018-10-20
ER

PT J
AU Kim, DG
   Huja, SS
   Tee, BC
   Larsen, PE
   Kennedy, KS
   Chien, HH
   Lee, JW
   Wen, HB
AF Kim, Do-Gyoon
   Huja, Sarandeep S.
   Tee, Boon Ching
   Larsen, Peter E.
   Kennedy, Kelly S.
   Chien, Hua-Hong
   Lee, Jin Whan
   Wen, Hai Bo
TI Bone Ingrowth and Initial Stability of Titanium and Porous Tantalum
   Dental Implants: A Pilot Canine Study
SO IMPLANT DENTISTRY
LA English
DT Article
DE porous tantalum; bone ingrowth; osseointegration
ID FINITE-ELEMENT-ANALYSIS; TOTAL HIP-ARTHROPLASTY; STRESS-DISTRIBUTION;
   LOADED IMPLANTS; MICROMOTION; BIOMATERIAL; INTEGRATION; INTERFACE;
   SURFACES; DESIGN
AB Purpose: To investigate if a dental implant system with a midsection covered by 3-dimensionally porous tantalum material would exhibit stability comparable with a traditional threaded titanium alloy implant system and whether bone would grow into the porous section.Methods: Three experimental and 3 control implants were placed in the individual mandibles of 8 dogs. Resonance frequency analysis assessed implant stability at 0, 2, 4, 8, and 12 weeks of healing. Histomorphometric and backscattered scanning electron microscopic analyses examined the presence of bone ingrowth into the experimental implant's porous section and bone-to-implant contact along the titanium surfaces of both implants.Results: Implant stability did not significantly differ during 0 to 12 weeks of healing. Progressive tissue mineralization developed inside porous sections from weeks 2 to 12. Porous implants exhibited a combination of progressive osseointegration along their titanium surfaces and bone ingrowth inside their porous tantalum sections.Conclusions: Cortical and apical implant threads, combined with the porous section, were able to stabilize the experimental implant to the same degree as the fully threaded control implant.
C1 [Kim, Do-Gyoon; Tee, Boon Ching] Ohio State Univ, Div Orthodont, Coll Dent, Columbus, OH 43210 USA.
   [Huja, Sarandeep S.] Univ Kentucky, Coll Dent, Div Orthodont, Lexington, KY USA.
   [Larsen, Peter E.; Kennedy, Kelly S.] Ohio State Univ, Div Oral & Maxillofacial Surg, Coll Dent, Columbus, OH 43210 USA.
   [Chien, Hua-Hong] Ohio State Univ, Div Periodontol, Coll Dent, Columbus, OH 43210 USA.
   [Lee, Jin Whan] Zimmer Dent Inc, Dent Res, Carlsbad, CA USA.
   [Wen, Hai Bo] Zimmer Dent Inc, Dent Res & Clin Affairs, Carlsbad, CA USA.
RP Kim, DG (reprint author), Ohio State Univ, Div Orthodont, Coll Dent, 4088 Postle Hall,305 W 12th Ave, Columbus, OH 43210 USA.
EM kim.2508@osu.edu
RI Kim, Dogyoon/D-5543-2012; Huja, Sarandeep/I-6234-2016
OI Huja, Sarandeep/0000-0002-4617-5055
FU Zimmer Dental, Inc.
FX This study was supported by a research grant from Zimmer Dental, Inc.
   The authors thank Dr. Lisa M. Lee, Dr. Kevin C. Harrison, AnRedrew M.
   D'Atri, Hye Ri Lee, Nari Kim, and Michael M. Warner, MA, for their
   assistance.
CR Abrahamsson I, 2009, CLIN ORAL IMPLAN RES, V20, P207, DOI 10.1111/j.1600-0501.2009.01783.x
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   BOYCE TM, 1990, SCANNING MICROSCOPY, V4, P591
   Brunski J B, 1999, Adv Dent Res, V13, P99
   DEPORTER DA, 1986, J DENT RES, V65, P1064, DOI 10.1177/00220345860650080501
   Ersanli S, 2005, J PERIODONTOL, V76, P1066, DOI 10.1902/jop.2005.76.7.1066
   Fazel A, 2009, CLIN IMPLANT DENT R, V11, P267, DOI 10.1111/j.1708-8208.2008.00121.x
   Fazel A, 2009, IMPLANT DENT, V18, P345, DOI 10.1097/ID.0b013e31819cd938
   Freitas AC, 2012, CLIN ORAL IMPLAN RES, V23, P113, DOI 10.1111/j.1600-0501.2010.02142.x
   Huja SS, 2006, ANAT REC PART A, V288A, P1243, DOI 10.1002/ar.a.20396
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kawahara Haruyuki, 2003, Implant Dent, V12, P61
   Kim DG, 2001, THESIS RENSSELAER PO
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Ormianer Z, 2013, INT J ORAL MAXILLOF, V27, P442
   Ormianer Z, 2012, IMPLANT DENT, V21, P350, DOI 10.1097/ID.0b013e31825feb16
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   PILLIAR RM, 1991, J DENT RES, V70, P1338, DOI 10.1177/00220345910700100501
   Roschger P, 2003, BONE, V32, P316, DOI 10.1016/S8756-3282(02)00973-0
   Scarano A, 2006, CLIN IMPLANT DENT R, V8, P218, DOI 10.1111/j.1708-8208.2006.00022.x
   Shiigai Tatsuo, 2007, J Oral Implantol, V33, P13, DOI 10.1563/0-832.1
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P47, DOI 10.1002/jbm.820270107
   Stavropoulos A, 2008, CLIN ORAL IMPLAN RES, V19, P55, DOI 10.1111/j.1600-0501.2007.01422.x
   Svehla M, 2000, J BIOMED MATER RES, V51, P15, DOI 10.1002/(SICI)1097-4636(200007)51:1<15::AID-JBM3>3.0.CO;2-9
   Todisco Marzio, 2006, J Oral Implantol, V32, P153, DOI 10.1563/812.1
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   WEISS MB, 1981, J PROSTHET DENT, V46, P646, DOI 10.1016/0022-3913(81)90073-1
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
NR 32
TC 22
Z9 28
U1 1
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD AUG
PY 2013
VL 22
IS 4
BP 399
EP 405
DI 10.1097/ID.0b013e31829b17b5
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 193WO
UT WOS:000322592400021
PM 23823737
DA 2018-10-20
ER

PT J
AU Lim, SY
   Hernandez, D
   Dusting, GJ
AF Lim, Shiang Y.
   Hernandez, Damian
   Dusting, Gregory J.
TI Growing Vascularized Heart Tissue From Stem Cells
SO JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
LA English
DT Review
DE cardiac engineering; vascular engineering; pluripotent stem cell; adult
   stem cell; myocardial infarction
ID ENDOTHELIAL PROGENITOR CELLS; SHEET MANIPULATION TECHNIQUE; RANDOMIZED
   PHASE-1 TRIAL; CARDIAC TISSUE; MYOCARDIAL-INFARCTION; IN-VIVO; MYOBLAST
   TRANSPLANTATION; GROWTH-FACTOR; REGENERATION; ANGIOGENESIS
AB The promise of stem cells to repair the heart after damage or heart attack has not been realized because most such cells are lost after transplantation. A new approach is to grow substantial viable pieces of cardiac tissue from human stem cells by cardiac tissue engineering. Such constructs must be fully vascularized and perfused to ensure the viability of clinically relevant volumes of tissue. This requires careful choice of cells, culture conditions, a biomaterial to act as scaffold, and crucial strategies for vascularization. Autologous stem cells with high plasticity, which would avoid the need for antirejection therapies after transplantation, are an attractive source of both cardiomyocytes and vascular cells. Most stem cells also have inherent paracrine activity, releasing cytoprotective factors and growth-promoting cytokines that can further stimulate tissue regeneration and neovascularization through recruitment of endogenous stem and progenitor cells. Current advances for growing vascularized and functional cardiac constructs with human stem cells are described, bringing us a step closer to the engineering of complex cardiac tissues such as pacemaker, conducting tissue, or contractile myocardial flaps ideal for transplantation. From studies in rats successful transplantation of thin constructs to the ventricle has been reported, but there remain further issues to resolve before larger human constructs will be available to test in the clinic.
C1 [Lim, Shiang Y.; Dusting, Gregory J.] Univ Melbourne, Dept Surg, East Melbourne, Vic 3002, Australia.
   [Hernandez, Damian] Univ Melbourne, Dept Med, East Melbourne, Vic 3002, Australia.
   [Dusting, Gregory J.] Univ Melbourne, Ctr Eye Res Australia, East Melbourne, Vic 3002, Australia.
RP Dusting, GJ (reprint author), Univ Melbourne, Ctr Eye Res Australia, 1-32 Gisborne St, East Melbourne, Vic 3002, Australia.
EM dusting@unimelb.edu.au
OI Hernandez de Santiago, Hector Damian/0000-0001-8990-6607
FU National Heart Foundation; National Health and Medical Research Council
   of Australia; JR and JO Wicking Trust; Victorian State Government's
   Department of Innovation, Industry, and Regional Development's
   Operational Infrastructure Support Program
FX Supported by National Heart Foundation and National Health and Medical
   Research Council of Australia for project grant, Principal Research
   Fellow to G. J. Dusting, and Melbourne International Research
   Scholarship to D. Hernandez. Support is also provided by the JR and JO
   Wicking Trust and the Victorian State Government's Department of
   Innovation, Industry, and Regional Development's Operational
   Infrastructure Support Program.
CR Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006
   Boudoulas KD, 2009, DIS MODEL MECH, V2, P344, DOI 10.1242/dmm.000240
   Caccamo Marco, 2011, Curr Heart Fail Rep, V8, P91, DOI 10.1007/s11897-011-0050-z
   Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273
   Choi YS, 2010, J CELL MOL MED, V14, P878, DOI 10.1111/j.1582-4934.2010.01009.x
   Choi YS, 2010, BIOMATERIALS, V31, P2236, DOI 10.1016/j.biomaterials.2009.11.097
   Das M, 2008, IUBMB LIFE, V60, P199, DOI 10.1002/iub.31
   Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z
   Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283
   DiMuzio P, 2007, J VASC SURG, V45, p99A, DOI 10.1016/j.jvs.2007.02.046
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Faucherre A, 2012, INT J CARDI IN PRESS
   Furuta A, 2006, CIRC RES, V98, P705, DOI 10.1161/01.RES.0000209515.59115.70
   Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1
   Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6
   Giraud MN, 2007, TISSUE ENG, V13, P1825, DOI 10.1089/ten.2006.0110
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004
   Haraguchi Y., 2011, CARDIOL RES PRACT, V2011
   Herrmann JL, 2011, J SURG RES, V166, P138, DOI 10.1016/j.jss.2010.05.057
   Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674
   Hsiao ST, 2013, STEM CELLS IN PRESS
   Iyer RK, 2011, CURR OPIN BIOTECH, V22, P706, DOI 10.1016/j.copbio.2011.04.004
   Janssens S, 2010, ANNU REV MED, V61, P287, DOI 10.1146/annurev.med.051508.215152
   Kanashiro-Takeuchi RM, 2011, J MOL CELL CARDIOL, V51, P619, DOI 10.1016/j.yjmcc.2011.05.015
   Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343
   Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853
   Krawiec JT, 2012, BIOMATERIALS, V33, P3388, DOI 10.1016/j.biomaterials.2012.01.014
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laschke MW, 2009, TISSUE ENG PART B-RE, V15, P455, DOI 10.1089/ten.TEB.2009.0252
   Lian QZ, 2010, THROMB HAEMOSTASIS, V104, P194, DOI 10.1160/TH09-12-0839
   Lim SY, 2011, ADVANCES IN REGENERATIVE MEDICINE, P89
   Lim SY, 2012, TISSUE ENG PT A, V18, P2210, DOI [10.1089/ten.TEA.2011.0719, 10.1089/ten.tea.2011.0719]
   Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7
   Liu JF, 2012, STEM CELLS DEV, V21, P2095, DOI 10.1089/scd.2012.0031
   Lokmic Z, 2008, TISSUE ENG PART B-RE, V14, P87, DOI 10.1089/teb.2007.0299
   Lokmic Z, 2007, FASEB J, V21, P511, DOI 10.1096/fj.06-6614com
   Lu YX, 2001, CIRCULATION, V104, P594, DOI 10.1161/hc3101.092215
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Matsuura K, 2011, BIOMATERIALS, V32, P7355, DOI 10.1016/j.biomaterials.2011.05.042
   Maulik N, 2004, ANTIOXID REDOX SIGN, V6, P413, DOI 10.1089/152308604322899486
   Mehta A, 2011, CARDIOVASC RES, V91, P577, DOI 10.1093/cvr/cvr132
   Metzele R, 2011, FASEB J, V25, P830, DOI 10.1096/fj.09-153221
   Miniati DN, 2002, ANNU REV MED, V53, P189, DOI 10.1146/annurev.med.53.082901.104050
   Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005
   Mohsin S, 2011, CIRC RES, V109, P1415, DOI 10.1161/CIRCRESAHA.111.243071
   Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379
   Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218
   Murry CE, 2002, J CARD FAIL, V8, pS532, DOI 10.1054/jcaf.2002.129268
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946
   Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z
   Nesselmann Catharina, 2010, Ther Adv Cardiovasc Dis, V4, P27, DOI 10.1177/1753944709353338
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Palpant NJ, 2010, CURR STEM CELL RES T, V5, P145
   Penn MS, 2008, CIRC RES, V102, P1471, DOI 10.1161/CIRCRESAHA.108.175174
   Pouzet B, 2001, ANN THORAC SURG, V71, P844, DOI 10.1016/S0003-4975(00)01785-9
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rangappa S, 2010, J CARDIOVASC PHARM T, V15, P338, DOI 10.1177/1074248410376382
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Streckfuss-Bomeke K., 2012, EUR HEART J IN PRESS
   Suzuki R, 2009, BIOCHEM BIOPH RES CO, V387, P353, DOI 10.1016/j.bbrc.2009.07.024
   Tee R, 2012, TISSUE ENG PT A, V18, P1992, DOI [10.1089/ten.tea.2012.0151, 10.1089/ten.TEA.2012.0151]
   Tee R, 2010, ANZ J SURG, V80, P683, DOI 10.1111/j.1445-2197.2010.05435.x
   Tilkorn DJ, 2010, TISSUE ENG PT A, V16, P165, DOI [10.1089/ten.tea.2009.0075, 10.1089/ten.TEA.2009.0075]
   Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018
   van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Xu SJ, 2012, J CARDIOVASC PHARM, V59, P387, DOI 10.1097/FJC.0b013e3182440338
   Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zimmet H, 2012, EUR J HEART FAIL, V14, P91, DOI 10.1093/eurjhf/hfr148
   Zvibel I, 2002, CELL TRANSPLANT, V11, P621, DOI 10.3727/000000002783985404
NR 86
TC 3
Z9 3
U1 3
U2 40
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0160-2446
J9 J CARDIOVASC PHARM
JI J. Cardiovasc. Pharmacol.
PD AUG
PY 2013
VL 62
IS 2
BP 122
EP 129
DI 10.1097/FJC.0b013e31829372fc
PG 8
WC Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy
SC Cardiovascular System & Cardiology; Pharmacology & Pharmacy
GA 202JE
UT WOS:000323209800002
PM 23924689
DA 2018-10-20
ER

PT J
AU Hidi, IJ
   Melinte, G
   Stefan, R
   Bindea, M
   Baia, L
AF Hidi, I. J.
   Melinte, G.
   Stefan, R.
   Bindea, M.
   Baia, L.
TI The study of the structure and bioactivity of the B2O3 center dot Na2O
   center dot P2O5 system
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE biomaterial; borophosphate; Raman; IR; SEM
ID SODIUM BOROPHOSPHATE GLASSES; IN-VITRO EVALUATION; BORATE GLASSES;
   CONTROLLABLE DEGRADATION; RAMAN-SCATTERING; CALCIUM HYDROXYAPATITE;
   PHOSPHATE-GLASSES; SCAFFOLDS; LITHIUM; SILICATE
AB In this study, we have investigated calcium and silicate-free samples over a wide compositional range in the xB(2)O(3)center dot 30 Na2O center dot(70-x)P2O5 system, with 0 <= x <= 70 mol%, in order to determine the influence of the chemical composition on their structure and bioactive response in simulated body fluid. Information related to the chemical structures present in the network was obtained by means of Raman and infrared spectroscopy. For samples containing small amounts of P2O5, boron structures are preponderant. Upon increasing the phosphorus content, the samples' network is based on phosphate chains linked by boron groups through 'P-O-B' bridges. For high concentration of P2O5, the Q(3) units form three-dimensional network, whereas Q(2) units assist the chain formation. Regarding the in vitro assessment of bioactivity, the clear print of PO4 asymmetric bending vibrations of apatite-like layer in the 540-680 cm(-1) spectral domain, the scanning electron micrographs and energy dispersive x-ray analysis spectra demonstrate that the studied borophosphate samples exhibit good bioactive response only for certain chemical compositions. More exactly, the highest bioactivity is obtained for 30% and 20% B2O3 (mol%) after 3 and 11 days of immersion, respectively. Therefore, the samples with 20-30 mol% boron content are valuable candidates that can be used as materials for tissue engineering applications. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Hidi, I. J.; Melinte, G.; Baia, L.] Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania.
   [Hidi, I. J.; Melinte, G.; Baia, L.] Univ Babes Bolyai, Inst Interdisciplinary Res Bionanosci, Cluj Napoca 400084, Romania.
   [Stefan, R.; Bindea, M.] Univ Agr Sci & Vet Med, Fac Vet Med, Cluj Napoca 400372, Romania.
RP Stefan, R (reprint author), Univ Agr Sci & Vet Med, Fac Vet Med, Calea Manastur 3-5, Cluj Napoca 400372, Romania.
EM rstefan@usamvcluj.ro
RI Stefan, Marius/C-4918-2011; Baia, Lucian/B-9711-2011
OI Baia, Lucian/0000-0003-3196-4868
FU Romanian National University Research Council - CNCSIS [PNII Idei
   PCCE-129/2008]
FX This research was accomplished in the framework of PNII Idei
   PCCE-129/2008 project granted by the Romanian National University
   Research Council - CNCSIS.
CR Almeida AFL, 2001, INT J INORG MATER, V3, P829, DOI 10.1016/S1466-6049(01)00172-6
   Aronne A, 2003, J NON-CRYST SOLIDS, V324, P208, DOI 10.1016/S0022-3093(03)00263-1
   ASSIH T, 1988, J MATER SCI, V23, P3326, DOI 10.1007/BF00551313
   Baia L, 2007, VIB SPECTROSC, V43, P313, DOI 10.1016/j.vibspec.2006.03.006
   Baia L, 2006, CHEM PHYS, V327, P63, DOI 10.1016/j.chemphys.2006.03.036
   Baia L, 2002, J NON-CRYST SOLIDS, V303, P379, DOI 10.1016/S0022-3093(02)01042-6
   BAIDOC SC, 2008, ANN U ORADEA, V18, P5
   BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8
   Carta D, 2008, J NON-CRYST SOLIDS, V354, P3671, DOI 10.1016/j.jnoncrysol.2008.04.009
   Carta D, 2007, J NON-CRYST SOLIDS, V353, P1141, DOI 10.1016/j.jnoncrysol.2006.12.093
   Christensen R, 2012, J NON-CRYST SOLIDS, V358, P583, DOI 10.1016/j.jnoncrysol.2011.10.018
   Christensen R, 2012, J NON-CRYST SOLIDS, V358, P826, DOI 10.1016/j.jnoncrysol.2011.12.068
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   DUCEL JF, 1993, MATER LETT, V18, P69, DOI 10.1016/0167-577X(93)90059-7
   DUCEL JF, 1993, PHYS CHEM GLASSES, V34, P212
   DUCEL JF, 1994, MAT SCI ENG B-SOLID, V27, P159, DOI 10.1016/0921-5107(94)90137-6
   DUCEL JF, 1992, MATER LETT, V13, pL27
   DWIVEDI BP, 1993, J PHYS CHEM SOLIDS, V54, P621, DOI 10.1016/0022-3697(93)90242-J
   DWIVEDI BP, 1995, J PHYS CHEM SOLIDS, V56, P39, DOI 10.1016/0022-3697(94)00130-8
   Fu HL, 2009, MAT SCI ENG C-MATER, V29, P2275, DOI 10.1016/j.msec.2009.05.013
   Fu QA, 2010, J BIOMED MATER RES A, V95A, P164, DOI 10.1002/jbm.a.32824
   Fu QA, 2010, J BIOMED MATER RES A, V95A, P172, DOI 10.1002/jbm.a.32823
   GARRIGOULAGRANGE C, 1985, CAN J CHEM, V63, P1436, DOI 10.1139/v85-247
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   Hudgens JJ, 1998, J NON-CRYST SOLIDS, V223, P21, DOI 10.1016/S0022-3093(97)00347-5
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   KAMITSOS EI, 1989, PHYS CHEM GLASSES, V30, P229
   Kim NJ, 2010, ELECTRON MATER LETT, V6, P103, DOI 10.3365/eml.2010.09.103
   Krishnan K., 1963, P INDIAN ACAD SCI A, V57, P103
   Kumar S, 2004, J SOLID STATE CHEM, V177, P1723, DOI 10.1016/j.jssc.2003.12.034
   Liang W, 2008, J NON-CRYST SOLIDS, V354, P1690, DOI 10.1016/j.jnoncrysol.2007.10.003
   Liang W, 2011, J NON-CRYST SOLIDS, V357, P958, DOI 10.1016/j.jnoncrysol.2010.07.068
   Liu X, 2010, J MATER SCI-MATER M, V21, P575, DOI 10.1007/s10856-009-3897-8
   MANUPRIYA KS, 2007, J AM CERAM SOC, V90, P467
   Marion NW, 2005, MECH ADV MATER STRUC, V12, P239, DOI 10.1080/15376490590928615
   MEERA BN, 1993, J NON-CRYST SOLIDS, V159, P1, DOI 10.1016/0022-3093(93)91277-A
   Qiu D, 2008, MATER CHEM PHYS, V111, P455, DOI 10.1016/j.matchemphys.2008.04.045
   Qiu D, 2010, J NON-CRYST SOLIDS, V356, P490, DOI 10.1016/j.jnoncrysol.2009.12.016
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rinke MT, 2011, PHYS CHEM CHEM PHYS, V13, P6552, DOI 10.1039/c0cp01590c
   Saranti A, 2006, J NON-CRYST SOLIDS, V352, P390, DOI 10.1016/j.jnoncrysol.2006.01.042
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Schwarz J, 2004, J OPTOELECTRON ADV M, V6, P737
   Takebe H, 2006, J NON-CRYST SOLIDS, V352, P709, DOI 10.1016/j.jnoncrysol.2005.11.066
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Yao AH, 2007, J AM CERAM SOC, V90, P303, DOI 10.1111/j.1551-2916.2006.01358.x
   Zheng K, 2012, J NON-CRYST SOLIDS, V358, P387, DOI 10.1016/j.jnoncrysol.2011.10.004
   Zielniok D, 2007, CHEM MATER, V19, P3162, DOI 10.1021/cm0628092
NR 49
TC 14
Z9 14
U1 2
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD AUG
PY 2013
VL 44
IS 8
BP 1187
EP 1194
DI 10.1002/jrs.4330
PG 8
WC Spectroscopy
SC Spectroscopy
GA 201ZD
UT WOS:000323180700016
DA 2018-10-20
ER

PT J
AU Oprenyeszk, F
   Chausson, M
   Maquet, V
   Dubuc, JE
   Henrotin, Y
AF Oprenyeszk, F.
   Chausson, M.
   Maquet, V.
   Dubuc, J. -E.
   Henrotin, Y.
TI Protective effect of a new biomaterial against the development of
   experimental osteoarthritis lesions in rabbit: a pilot study evaluating
   the intra-articular injection of alginate-chitosan beads dispersed in an
   hydrogel
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE Osteoarthritis; Alginate; Chitosan; Hydrogel; Rabbit
ID EVIDENCE BASED RECOMMENDATIONS; EULAR-STANDING-COMMITTEE; KNEE
   OSTEOARTHRITIS; OARSI RECOMMENDATIONS; ARTICULAR-CARTILAGE; TASK-FORCE;
   MANAGEMENT; HIP; PROGRESSION; ARTHRITIS
AB Objective: This study aimed to evaluate the structural benefit of a new biomaterial composed of alginate-chitosan (AC) beads dispersed in a hydrogel (H) derived from chitosan on the development of osteoarthritis (OA) in rabbit.
   Design: OA was induced by the surgical transection of the anterior cruciate ligament in rabbits. Animals received a single intra-articular injection (900 mu l) of AC beads in H hydrogel, H hydrogel alone or saline a week after surgery. OA development was followed by X-rays. Blood samples were collected throughout the study to measure biological markers (Prostaglandins E-2 - PGE(2) and C reactive protein - CRP). Macroscopic observation and histological evaluation of articular cartilage and synovial membrane were performed 6 weeks after surgery.
   Results: AC beads in H hydrogel prevented from the development of OA based on the reduction of the Kellgren & Lawrence (K&L) score. It also significantly reduced the histological score of cartilage lesion severity. This effect was homogenous on every joint compartment. It was due to a significant effect on cartilage structure and cellularity scores. The injection of AC beads in H hydrogel also tended to reduce the synovial membrane inflammation. No significant variation of biological markers was noted.
   Conclusions: The present pilot study provides interesting and promising results for the use of AC beads in H hydrogel in animal. It indeed prevented the development of OA cartilage lesions without inflammatory signs. The potencies of this biomaterial to protect OA joint should be further documented. It could then represent a new alternative for viscosupplementation in human OA management. (C) 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 [Oprenyeszk, F.; Henrotin, Y.] Univ Liege, Bone & Cartilage Res Unit, CHU Sart Tilman, Liege, Belgium.
   [Chausson, M.; Maquet, V.] Parc Ind Haut Sarts, KitoZyme SA, Herstal, Belgium.
   [Dubuc, J. -E.] Clin Univ St Luc, Dept Orthopaed, B-1200 Brussels, Belgium.
   [Henrotin, Y.] Princess Paola Hosp, Phys Therapy & Rehabil Dept, Vivalia, Marche En Famen, Belgium.
RP Henrotin, Y (reprint author), CHU Sart Tilman, Inst Pathol, Bone & Cartilage Res Unit, Level 5, B-4000 Liege, Belgium.
EM frederic.oprenyeszk@ulg.ac.be; m.chausson@kitozyme.com;
   v.maquet@kitozyme.com; jean-emile.dubuc@uclouvain.be;
   yhenrotin@ulg.ac.be
FU L'Interface Entreprises-University of Liege: Fonds de Maturation-projet
   CARTIMAT
FX This work was supported in its entirety by "L'Interface
   Entreprises-University of Liege: Fonds de Maturation-projet CARTIMAT".
CR Altman RD, 2000, ARTHRITIS RHEUM, V43, P1905
   Brandt KD, 2000, ARTHRITIS RHEUM, V43, P1192, DOI 10.1002/1529-0131(200006)43:6<1192::AID-ANR2>3.0.CO;2-L
   Chen WP, 2010, MOL BIOL REP, V37, P3967, DOI 10.1007/s11033-010-0055-9
   Guo H, 2011, JOINT BONE SPINE, V78, P604, DOI 10.1016/j.jbspin.2011.01.009
   Hao T, 2010, OSTEOARTHR CARTILAGE, V18, P257, DOI 10.1016/j.joca.2009.08.007
   Hashizume M, 2010, MOD RHEUMATOL, V20, P432, DOI 10.1007/s10165-010-0299-1
   Hayashi M, 2010, J ORTHOP RES, V28, P1502, DOI 10.1002/jor.21165
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Jiang DH, 2010, INT J MOL SCI, V11, P4106, DOI 10.3390/ijms11104106
   Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742
   Jubb RW, 2003, INT J CLIN PRACT, V57, P467
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Laverty S, 2010, OSTEOARTHR CARTILAGE, V18, pS53, DOI 10.1016/j.joca.2010.05.029
   Lin HD, 2012, RHEUMATOL INT, V32, P759, DOI 10.1007/s00296-010-1629-5
   Lo YJ, 2007, RHEUMATOL INT, V27, P1099, DOI 10.1007/s00296-007-0346-1
   Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453
   Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Ohta N, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-98
   Oprenyeszk F, 2013, NEW ALGINATE C UNPUB
   Papaioannou NA, 2004, CONTEMP TOP LAB ANIM, V43, P22
   Park KM, 2009, ACTA BIOMATER, V5, P1956, DOI 10.1016/j.actbio.2009.01.040
   Patchornik S, 2012, ADV ORTHOP, V2012
   Pham T, 2004, ANN RHEUM DIS, V63, P1611, DOI 10.1136/ard.2003.019703
   Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129
   Qin Yimin, 2004, Med Device Technol, V15, P34
   Ravina M, 2010, PHARM RES-DORDR, V27, P2544, DOI 10.1007/s11095-010-0263-y
   Saito M, 2009, CLIN EXP RHEUMATOL, V27, P201
   Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shikhman AR, 2005, ANN RHEUM DIS, V64, P89, DOI 10.1136/ard.2003.019406
   Stark Y, 2006, EXP TOXICOL PATHOL, V57, P305, DOI 10.1016/j.etp.2005.10,005
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   VIGNON E, 1983, ANN RHEUM DIS, V42, P82, DOI 10.1136/ard.42.1.82
   Waddell DD, 2007, J MANAGE CARE PHARM, V13, P113, DOI 10.18553/jmcp.2007.13.2.113
   Yoshioka M, 1996, OSTEOARTHR CARTILAGE, V4, P87, DOI 10.1016/S1063-4584(05)80318-8
   Yun K, 2008, J BIOSCI BIOENG, V105, P122, DOI 10.1263/jbb.105.122
   Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013
   Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014
   Zhang W, 2007, ANN RHEUM DIS, V66, P377, DOI 10.1136/ard.2006.062091
   Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886
   Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013
   Zhang YQ, 2008, RHEUM DIS CLIN N AM, V34, P515, DOI 10.1016/j.rdc.2008.05.007
   Zhang Z, 2012, J NANOTECHNOL, V2012
NR 45
TC 13
Z9 15
U1 3
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
EI 1522-9653
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD AUG
PY 2013
VL 21
IS 8
BP 1099
EP 1107
DI 10.1016/j.joca.2013.04.017
PG 9
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 196VU
UT WOS:000322806300011
PM 23680875
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Kar, S
   Talukdar, S
   Pal, S
   Nayak, S
   Paranjape, P
   Kundu, SC
AF Kar, Subrata
   Talukdar, Sarmistha
   Pal, Shilpa
   Nayak, Sunita
   Paranjape, Pallavi
   Kundu, S. C.
TI Silk Gland Fibroin from Indian Muga Silkworm Antheraea assama as
   Potential Biomaterial
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE muga silkworm; fibroin; film; crystallinity; biomaterial
ID TISSUE ENGINEERING APPLICATIONS; NON-MULBERRY; 3D SCAFFOLDS; PROTEIN;
   GENE; FABRICATION; ADHESION; YAMAMAI; SERICIN; CELLS
AB There is an increasing demand for new versatile biomaterials. Silk is reported by many researchers as an ideal biomaterial for different biomedical applications. Most of the studies are carried out on mulberry silk Bombyx mori, however silk from Indian non-mulberry silkworms are relatively unexplored. In this report we fabricate 2D matrices from the regenerated aqueous silk fibroin protein of the glands of non-mulberry Indian muga silkworm Antheraea assama (assamensis). Its biochemical, biophysical characteristics and its cytocompatibility for biomedical uses are evaluated. The properties of this muga gland fibroin are compared with silk gland fibroin from non-mulberry Indian tropical tasar silkworm Antheraea mylitta and with the fibroin from the cocoon of mulberry silkworm Bombyx mori. The gland fibroin of Antheraea assama is observed to consist of two polypeptides of approximately 250 kDa each linked by disulfide bond. Fourier transformed infrared spectroscopy and X-ray diffraction studies indicate random coil structure of dissolved fibroin solution. The alpha-helical structure in 2D films changed to beta-sheets upon ethanol treatment, imparting crystallinity and insolubility. The fibroin film is found to be the least hydrophilic, followed by B. mori and A. mylitta silk. Biocompatibility of the films from all three species is investigated through the cell attachment and spreading study of MG-63 human osteoblast-like cells. The cytocompatibility of non-mulberry fibroin matrices are comparable with that of standard tissue culture plates. The results indicate that the non-mulberry Indian muga silk gland fibroin is also suitable matrix as a natural biomaterial for tissue engineering applications.
C1 [Kar, Subrata; Talukdar, Sarmistha; Pal, Shilpa; Nayak, Sunita; Paranjape, Pallavi; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
FU Department of Biotechnology (NER programme); Indo-Russia Biotechnology
   Programme of the Department of Science and Technology, Govt. of India
FX This work was supported by the Department of Biotechnology (NER
   programme) and Indo-Russia Biotechnology Programme of the Department of
   Science and Technology, Govt. of India. We are grateful to Dr. Monoj K.
   Baidya (Deputy Director), Dr. Narayan Biswas, and Mr. Ram Kumar Saha of
   Central Silk Board, Coochbehar, and also Dr. Milli Banerjee and Mr.
   Mrinal Kanti Dey, Department of Textile (Sericulture division), West
   Bengal, India for providing us live 5th instar larvae of muga silkworms.
   We are thankful to the Sericulture Directorate, Midnapore, West Bengal,
   India for providing Indian Tropical tasar 5th instar larvae and fresh
   mulberry cocoons for our work.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Ahmad R, 2004, DNA CELL BIOL, V23, P149, DOI 10.1089/104454904322964742
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   Devi D, 2011, J TEXT I, V102, P527, DOI 10.1080/00405000.2010.498172
   Du CL, 2009, MAT SCI ENG C-BIO S, V29, P62, DOI 10.1016/j.msec.2008.05.010
   Dutta S, 2013, BIOPOLYMERS, V99, P326, DOI 10.1002/bip.22168
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hwang JS, 2001, BIOTECHNOL LETT, V23, P1321, DOI 10.1023/A:1010542011150
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kasoju N, 2010, ADV ENG MATER, V12, pB139, DOI 10.1002/adem.200980055
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346
   MAGOSHI J, 1975, J APPL POLYM SCI, V19, P1013, DOI 10.1002/app.1975.070190410
   Mahendran B, 2006, J GENET, V85, P31, DOI 10.1007/BF02728967
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   Mori H, 2000, J Biotechnol, V74, P95
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Padamwar MN, 2004, J SCI IND RES INDIA, V63, P323
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   Reddy R. M., 2011, Trends in Applied Sciences Research, V6, P89
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Saxena U, 2010, APPL BIOCHEM BIOTECH, V162, P1122, DOI 10.1007/s12010-010-8923-2
   Sezutsu H, 2000, J MOL EVOL, V51, P329, DOI 10.1007/s002390010095
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Suzuki N, 2004, BIOFACTORS, V21, P329, DOI 10.1002/biof.552210164
   Talukdar B., 2011, INT J PURE APPL SCI, V7, P81
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Zheng ZH, 2010, J APPL POLYM SCI, V116, P461, DOI 10.1002/app.31522
NR 41
TC 13
Z9 13
U1 0
U2 28
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD AUG
PY 2013
VL 10
IS 4
BP 200
EP 210
DI 10.1007/s13770-012-0008-6
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 200PZ
UT WOS:000323082700007
DA 2018-10-20
ER

PT J
AU Chan, RN
   Stoner, BR
   Thompson, JY
   Scattergood, RO
   Piascik, JR
AF Chan, Ryan N.
   Stoner, Brian R.
   Thompson, Jeffrey Y.
   Scattergood, Ronald O.
   Piascik, Jeffrey R.
TI Fracture toughness improvements of dental ceramic through use of
   yttria-stabilized zirconia (YSZ) thin-film coatings
SO DENTAL MATERIALS
LA English
DT Article
DE Dental material; Fracture toughness; Thin film; Zirconia; All-ceramic;
   Failure; Stress
ID FLEXURAL STRENGTH; PORCELAIN; STRESS; BIOMATERIAL; RELAXATION;
   DEPOSITION; CRACKS; MODEL; GLASS
AB Objectives. The aim of this study was to evaluate strengthening mechanisms of yttria-stabilized zirconia (YSZ) thin film coatings as a viable method for improving fracture toughness of all-ceramic dental restorations.
   Methods. Bars (2 mm x 2 mm x 15 mm, n = 12) were cut from porcelain (ProCAD, Ivoclar-Vivadent) blocks and wet-polished through 1200-grit using SiC abrasive. A Vickers indenter was used to induce flaws with controlled size and geometry. Depositions were performed via radio frequency magnetron sputtering (5 mT, 25 degrees C, 30:1 Ar/O-2 gas ratio) with varying powers of substrate bias. Film and flaw properties were characterized by optical microscopy, scanning electron microscopy (SEM), and X-ray diffraction (XRD). Flexural strength was determined by three-point bending. Fracture toughness values were calculated from flaw size and fracture strength.
   Results. Data show improvements in fracture strength of up to 57% over unmodified specimens. XRD analysis shows that films deposited with higher substrate bias displayed a high %monoclinic volume fraction (19%) compared to non-biased deposited films (87%), and resulted in increased film stresses and modified YSZ microstructures. SEM analysis shows critical flaw sizes of 67 +/- 1 mu m leading to fracture toughness improvements of 55% over unmodified specimens.
   Significance. Data support surface modification of dental ceramics with YSZ thin film coatings to improve fracture toughness. Increase in construct strength was attributed to increase in compressive film stresses and modified YSZ thin film microstructures. It is believed that this surface modification may lead to significant improvements and overall reliability of all-ceramic dental restorations. (c) 2013 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Chan, Ryan N.; Scattergood, Ronald O.; Piascik, Jeffrey R.] N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   [Chan, Ryan N.; Stoner, Brian R.; Piascik, Jeffrey R.] RTI Int, Ctr Mat & Elect Technol, Res Triangle Pk, NC 27709 USA.
   [Thompson, Jeffrey Y.] Nova SE Univ, Sect Prosthodont, Ft Lauderdale, FL 33328 USA.
RP Piascik, JR (reprint author), RTI Int, Ctr Mat & Elect Technol, POB 12194,3040 Cornwallis Rd RTP, Res Triangle Pk, NC 27709 USA.
EM jpiascik@rti.org
FU NIH-NIDCR [NIH-2RO1DE013511-10]
FX This work is supported through NIH-NIDCR grant number
   NIH-2RO1DE013511-10.
CR Aboushelib MN, 2010, J PROSTHET DENT, V104, P98, DOI 10.1016/S0022-3913(10)60100-X
   Ai X, 1998, MAT SCI ENG A-STRUCT, V248, P125, DOI 10.1016/S0921-5093(98)00502-4
   Albakry M, 2004, J DENT, V32, P91, DOI 10.1016/j.jdent.2003.08.006
   AMOR SB, 1998, MAT SCI ENG B-SOLID, V57, P28
   [Anonymous], 2008, ANN BOOK ASTM STAND, P1, DOI [DOI 10.1520/D7334-08, 10.1520/D0695-15.2]
   Anusavice K J, 1992, Adv Dent Res, V6, P82
   ASTM, 2010, ANN BOOK ASTM STAND, P1, DOI DOI 10.1520/D4404-10
   Barsoum M. W., 2003, FUND CERAM, P356
   Cattell MJ, 1997, J DENT, V25, P409, DOI 10.1016/S0300-5712(96)00059-0
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Curtis AR, 2006, J DENT, V34, P195, DOI 10.1016/j.jdent.2005.06.006
   de Jager N, 2000, DENT MATER, V16, P381, DOI 10.1016/S0109-5641(00)00030-0
   KELLY JR, 1995, J DENT RES, V74, P1253, DOI 10.1177/00220345950740060301
   Kelly JR, 1997, ANNU REV MATER SCI, V27, P443, DOI 10.1146/annurev.matsci.27.1.443
   KNOTEK O, 1991, SURF COAT TECH, V46, P265, DOI 10.1016/0257-8972(91)90169-W
   LAWN BR, 1980, J MATER SCI, V15, P1207, DOI 10.1007/BF00551810
   LAWN BR, 1975, J MATER SCI, V10, P2016, DOI 10.1007/BF00557479
   MECHOLSKY JJ, 1974, J AM CERAM SOC, V57, P440, DOI 10.1111/j.1151-2916.1974.tb11377.x
   NARAYANASWAMY OS, 1978, J AM CERAM SOC, V61, P146, DOI 10.1111/j.1151-2916.1978.tb09259.x
   Piascik JR, 2007, J MATER RES, V22, P1105, DOI 10.1557/JMR.2007.0128
   Piascik JR, 2006, J VAC SCI TECHNOL, V24, P4
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   REKHSON SM, 1993, J AM CERAM SOC, V76, P1113, DOI 10.1111/j.1151-2916.1993.tb03728.x
   Rekow ED, 2011, J DENT RES, V90, P937, DOI 10.1177/0022034510391795
   Ruddell D, 1999, J BIOMEDICAL MAT RES, V51, P316
   Ruddell DE, 2003, THIN SOLID FILMS, V445, P14, DOI 10.1016/j.tsf.2003.07.009
   SAKAGUCHI RL, 1992, DENT MATER, V8, P131, DOI 10.1016/0109-5641(92)90068-N
   Scherrer SS, 1999, DENT MATER, V15, P342, DOI 10.1016/S0109-5641(99)00055-X
   SEGHI RR, 1995, J PROSTHET DENT, V74, P145, DOI 10.1016/S0022-3913(05)80177-5
   Smith RL, 2012, FRACTOGRAPHY GLASS 6, V230, P265
   STANGEL I, 1987, J DENT RES, V66, P1460, DOI 10.1177/00220345870660091001
   TAIRA M, 1990, J ORAL REHABIL, V17, P551, DOI 10.1111/j.1365-2842.1990.tb01426.x
   Taskonak B, 2005, BIOMATERIALS, V26, P3235, DOI 10.1016/j.biomaterials.2004.08.025
   Teixeira EC, 2009, P I MECH ENG H, V223, P897, DOI 10.1243/09544119JEIM543
   Teixeira EC, 2007, J BIOMED MATER RES B, V83B, P459, DOI 10.1002/jbm.b.30855
   Thompson CV, 2000, ANNU REV MATER SCI, V30, P159, DOI 10.1146/annurev.matsci.30.1.159
   THOMPSON JY, 1994, J DENT RES, V73, P1824, DOI 10.1177/00220345940730120601
   THORNTON JA, 1986, J VAC SCI TECHNOL A, V4, P3059, DOI 10.1116/1.573628
   Wang JH, 1994, THIN SOLID FILMS, V250, P132
   WIEDERHORN SM, 1984, ANNU REV MATER SCI, V14, P373
   Yilmaz H, 2007, J PROSTHET DENT, V98, P120, DOI 10.1016/S0022-3913(07)60045-6
   Zhou J, 2007, J MATER SCI-MATER M, V18, P71, DOI 10.1007/s10856-006-0664-y
NR 42
TC 5
Z9 7
U1 3
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD AUG
PY 2013
VL 29
IS 8
BP 881
EP 887
DI 10.1016/j.dental.2013.05.003
PG 7
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 186SA
UT WOS:000322063500013
PM 23764025
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Miller, R
   Davies, NH
   Kortsmit, J
   Zilla, P
   Franz, T
AF Miller, Renee
   Davies, Neil H.
   Kortsmit, Jeroen
   Zilla, Peter
   Franz, Thomas
TI Outcomes of myocardial infarction hydrogel injection therapy in the
   human left ventricle dependent on injectate distribution
SO INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING
LA English
DT Article
DE myocardial infarction; heart failure; adverse remodelling;
   intra-myocardial injectate; myocardial stress; finite element analysis
ID ELEMENT STRESS-ANALYSIS; ACTIVE CONTRACTION; CARDIAC-MUSCLE; FAILING
   HEART; MODEL; MECHANICS; STRAIN; CELL; EXPANSION; ANEURYSM
AB Myocardial infarction therapies involving biomaterial injections have shown benefits in inhibiting progression towards heart failure. However, the underlying mechanisms remain unclear. A finite element model of the human left ventricle was developed from magnetic resonance images. An anteroapical infarct was represented at acute (AI) and fibrotic (FI) stage. Hydrogel injections in the infarct region were modelled with layered (L) and bulk (B) distribution. In the FI, injectates reduced end-systolic myofibre stresses from 291.6% to 117.6% (FI-L) and 115.3% (FI-B) of the healthy value, whereas all AI models exhibited sub-healthy stress levels (AI: 90.9%, AI-L: 20.9%, AI-B: 30.5%). Reduction in end-diastolic infarct stress were less pronounced for both FI (FI: 294.1%, FI-L: 176.5%, FI-B: 188.2%) and AI (AI: 94.1%, AI-L: 35.3%, AI-B: 41.2%). In the border zone, injectates reduced end-systolic fibre stress by 8-10% and strain from positive (AI) and zero (FI) to negative. Layered and bulk injectates increased ejection fraction by 7.4% and 8.4% in AI and 14.1% and 13.7% in FI. The layered injectate had a greater impact on infarct stress and strain at acute stage, whereas the bulk injectate exhibited greater benefits at FI stage. These findings were confirmed by our previous in vivo results. Copyright (C) 2013 John Wiley & Sons, Ltd.
C1 [Miller, Renee; Davies, Neil H.; Kortsmit, Jeroen; Zilla, Peter; Franz, Thomas] Univ Cape Town, Chris Barnard Div Cardiothorac Surg, Cardiovasc Res Unit, ZA-7935 Observatory, South Africa.
   [Franz, Thomas] Univ Cape Town, Res Off, PERC, Mowbray, South Africa.
   [Franz, Thomas] Univ Cape Town, Ctr Res Computat & Appl Mech, ZA-7700 Rondebosch, South Africa.
   [Franz, Thomas] Ctr High Performance Comp, Johannesburg, South Africa.
RP Franz, T (reprint author), Univ Cape Town, Fac Hlth Sci, Cardiovasc Res Unit, Private Bag X3, ZA-7935 Observatory, South Africa.
EM thomas.franz@uct.ac.za
OI Franz, Thomas/0000-0002-1504-3842
FU National Research Foundation (NRF) of South Africa; Whitaker Foundation;
   Institute for International Education; Claude Leon Foundation
FX The authors would like to thank Prof Ernesta Meintjes and Dr Bruce
   Spottiswoode from the UCT/MRC Medical Imaging Research Unit, Department
   of Human Biology, University of Cape Town, for providing the MRI data
   and advice on data processing, and Dr Roy Kerckhoffs, Chris Villongco
   and Jeff Van Dorn from the Cardiac Mechanics Research Group, University
   of California in San Diego for support and advice with cardiac modelling
   using Continuity. This study was in part supported financially by the
   National Research Foundation (NRF) of South Africa. Any opinion,
   findings and conclusions or recommendations expressed in this
   publication are those of the authors, and therefore, the NRF does not
   accept any liability in regard thereto. RM acknowledges a Whitaker
   Fellowship of the Whitaker Foundation and the Institute for
   International Education. JK acknowledges a postdoctoral fellowship of
   the Claude Leon Foundation.
CR AHA, 2008, HEART DIS STROK STAT
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Doll S, 2000, J APPL MECH-T ASME, V67, P17, DOI 10.1115/1.321146
   Guccione JM, 2003, ANN THORAC SURG, V76, P1171, DOI 10.1016/S0003-4975(03)00731-8
   GUCCIONE JM, 1995, J BIOMECH, V28, P1167, DOI 10.1016/0021-9290(94)00174-3
   GUCCIONE JM, 1993, J BIOMECH ENG-T ASME, V115, P72, DOI 10.1115/1.2895473
   GUCCIONE JM, 1993, J BIOMECH ENG-T ASME, V115, P82, DOI 10.1115/1.2895474
   Heiberg E, 2005, SCAND CARDIOVASC J, V39, P267, DOI 10.1080/14017430500340543
   Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Kerckhoffs RCP, 2009, MED IMAGE ANAL, V13, P362, DOI 10.1016/j.media.2008.06.013
   Kofidis Lebl DR, 2005, CIRCULATION, V112, pI173
   Kortsmit J, 2012, COMPUTER METHODS BIO, DOI [10.1080/10255842.2012.656611, DOI 10.1080/10255842.2012.656611]
   Kortsmit J, 2013, ADV BIOMECHANICS APP
   Liu C. H., 1994, Engineering Computations, V11, P111
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Niederer SA, 2012, J PHYSIOL-LONDON, V590, P1331, DOI 10.1113/jphysiol.2011.225045
   Nordsletten D, 2011, INT J NUMER METH BIO, V27, P1017, DOI 10.1002/cnm.1405
   OMENS JH, 1991, AM J PHYSIOL, V261, pH918
   Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Rijnsburger W, 1980, CIRC RES, V46, P703
   Rohmer D, 2007, INVEST RADIOL, V42, P777, DOI 10.1097/RLI.0b013e3181238330
   Schlosser Pagonidis K, 2005, AM J ROENTGENOL, V184, P765
   Sermesant M, 2010, PATIENT SPECIFIC MOD, P765
   Smith NP, 2002, CHAOS SOLITON FRACT, V13, P1613, DOI 10.1016/S0960-0779(01)00170-9
   Sun K, 2009, J BIOMECHANICAL ENG, V131
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   TERKEURS HED, 1983, CARDIAC METABOLISM, P73
   Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716
   Usyk, 2003, J ELECTROCARDIOL, V36, P57
   Vetter FJ, 2000, ANN BIOMED ENG, V28, P781, DOI 10.1114/1.1289469
   Walker JC, 2005, AM J PHYSIOL-HEART C, V289, pH692, DOI 10.1152/ajpheart.01226.2004
   Walker JC, 2008, J THORAC CARDIOV SUR, V135, P1094, DOI 10.1016/j.jtcvs.2007.11.038
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wenk JF, 2009, J BIOMECHANICAL ENG, V131
   Wenk JF, 2011, ANN THORAC SURG, V92, P935, DOI 10.1016/j.athoracsur.2011.04.089
   World Health Organization, 2008, ATLAS HEART DIS STRO
NR 42
TC 8
Z9 9
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-7939
J9 INT J NUMER METH BIO
JI Int. J. Numer. Meth. Biomed.
PD AUG
PY 2013
VL 29
IS 8
BP 870
EP 884
DI 10.1002/cnm.2551
PG 15
WC Engineering, Biomedical; Mathematical & Computational Biology;
   Mathematics, Interdisciplinary Applications
SC Engineering; Mathematical & Computational Biology; Mathematics
GA 195AT
UT WOS:000322674500004
PM 23640777
DA 2018-10-20
ER

PT J
AU Steele, TWJ
   Huang, CL
   Nguyen, E
   Sarig, U
   Kumar, S
   Widjaja, E
   Loo, JSC
   Machluf, M
   Boey, F
   Vukadinovic, Z
   Hilfiker, A
   Venkatraman, SS
AF Steele, Terry W. J.
   Huang, Charlotte L.
   Evelyne Nguyen
   Sarig, Udi
   Kumar, Saranya
   Widjaja, Effendi
   Loo, Joachim S. C.
   Machluf, Marcelle
   Boey, Freddy
   Vukadinovic, Zlata
   Hilfiker, Andreas
   Venkatraman, Subbu S.
TI Collagen-cellulose composite thin films that mimic soft-tissue and allow
   stem-cell orientation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; BAND-TARGET ENTROPY; HUMAN
   ENDOTHELIAL-CELLS; IN-VITRO; RAMAN MICROSCOPY; BLOOD-VESSEL; UROTHELIAL
   CELLS; VASCULAR TISSUE; EDIBLE FILMS; WALL REPAIR
AB Mechanical properties of collagen films are less than ideal for biomaterial development towards musculoskeletal repair or cardiovascular applications. Herein, we present a collagen-cellulose composite film (CCCF) compared against swine small intestine submucosa in regards to mechanical properties, cell growth, and histological analysis. CCCF was additionally characterized by FE-SEM, NMR, mass spectrometry, and Raman Microscopy to elucidate its physical structure, collagen-cellulose composition, and structure activity relationships. Mechanical properties of the CCCF were tested in both wet and dry environments, with anisotropic stress-strain curves that mimicked soft-tissue. Mesenchymal stem cells, human umbilical vein endothelial cells, and human coronary artery smooth muscle cells were able to proliferate on the collagen films with specific cell orientation. Mesenchymal stem cells had a higher proliferation index and were able to infiltrate CCCF to a higher degree than small intestine submucosa. With the underlying biological properties, we present a collagen-cellulose composite film towards forthcoming biomaterial-related applications.
C1 [Steele, Terry W. J.; Huang, Charlotte L.; Evelyne Nguyen; Sarig, Udi; Kumar, Saranya; Loo, Joachim S. C.; Boey, Freddy; Venkatraman, Subbu S.] Nanyang Technol Univ, Div Mat Technol Mat & Sci Engn, Singapore 639798, Singapore.
   [Sarig, Udi; Machluf, Marcelle] Technion Israel Inst Technol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel.
   [Widjaja, Effendi] ASTAR, Inst Chem & Engn Sci, Singapore 627833, Singapore.
   [Vukadinovic, Zlata; Hilfiker, Andreas] HBZ, Leibniz Res Labs Biotechnol & Artificial Organs L, Dept Cardiothorac Transplantat & Vasc Surg, Hannover Med Sch MHH, D-30625 Hannover, Germany.
RP Steele, TWJ (reprint author), Nanyang Technol Univ, Div Mat Technol Mat & Sci Engn, N4-1-01-30,50 Nanyang Ave, Singapore 639798, Singapore.
EM wjsteele@ntu.edu.sg; huan0193@e.ntu.edu.sg; ebnguyen@e.ntu.edu.sg;
   udsa@tx.technion.ac.il; kuma0022@e.ntu.edu.sg;
   effendi_widjaja@ices.a-star.edu.sg; joachimloo@ntu.edu.sg;
   machlufm@tx.technion.ac.il; mycboey@ntu.edu.sg;
   Vukadinovic.Zlata@mh-hannover.de; hilfiker.andres@mh-hannover.de;
   assubbu@ntu.edu.sg
RI Steele, Terry/B-7162-2012; Venkatraman, Subramanian/A-2228-2011; Boey,
   Freddy Yin Chiang/G-2618-2017; Loo, Say Chye Joachim/A-2234-2011
OI Steele, Terry/0000-0001-8596-9619; Venkatraman,
   Subramanian/0000-0002-8693-1070; Loo, Say Chye
   Joachim/0000-0001-5300-1275; Sarig, Udi/0000-0001-5260-4023
FU Singapore National Research Foundation [NRF2010NRF-POC002-019, NRF 2007
   NRF-CRP 002-12]; CREATE program: The Regenerative Medicine Initiative in
   Cardiac Restoration Therapy Research
FX The authors acknowledge and appreciate the help and support rendered by
   Final Year Project Student, Wang Qianying Dione. This research was most
   generously supported by the Singapore National Research Foundation under
   parts of the following programs: NRF2010NRF-POC002-019, NRF 2007 NRF-CRP
   002-12, and the CREATE program: The Regenerative Medicine Initiative in
   Cardiac Restoration Therapy Research.
CR Anamelechi CC, 2009, LANGMUIR, V25, P5725, DOI 10.1021/la803963r
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   [Anonymous], 2001, STELPRDC5066975 USDA
   Atalla RH., 1975, RAMAN SPECTRAL STU 1
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Bilbao-Sainz C, 2010, J AGR FOOD CHEM, V58, P3753, DOI 10.1021/jf9033128
   Brusselaers N, 2010, J TRAUMA, V68, P490, DOI 10.1097/TA.0b013e3181c9c074
   Cagri A, 2004, J FOOD PROTECT, V67, P833, DOI 10.4315/0362-028X-67.4.833
   Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019
   CANHAM PB, 1991, CONNECT TISSUE RES, V26, P121, DOI 10.3109/03008209109152168
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Chajra H, 2008, BIO-MED MATER ENG, V18, pS33
   CHAN D, 1990, BIOCHEM J, V269, P175, DOI 10.1042/bj2690175
   Chen HL, 2008, ARTIF CELL BLOOD SUB, V36, P372, DOI 10.1080/10731190802239057
   Dai W., 2007, REBUILDING INFARCTED, P55
   Dai WD, 2009, REGEN MED, V4, P387, DOI 10.2217/RME.09.2
   DAVIES JED, 1990, CHEM PHYS LIPIDS, V56, P223, DOI 10.1016/0009-3084(90)90106-2
   de Mesquita JP, 2011, SOFT MATTER, V7, P4405, DOI 10.1039/c0sm01168a
   Ding QX, 2003, PROTEOMICS, V3, P1313, DOI 10.1002/pmic.200300452
   Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]
   Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021
   Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041
   Filova E, 2009, PHYSIOL RES, V58, pS141
   Floren MG, 2004, INVEST RADIOL, V39, P264, DOI 10.1097/01.rli.0000117881.42422.72
   Galois L, 2004, BIORHEOLOGY, V41, P433
   Garvin K, 2005, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000175720.99118.fe
   Godbey WT, 2004, BIOMATERIALS, V25, P2799, DOI 10.1016/j.biomaterials.2003.09.056
   Goren A, 2009, FASEB J, V24, P22, DOI DOI 10.1096/FJ.09-131888
   Ha TT, 2001, T ASAE, V44, P1223
   Hata H, 2010, EUR J CARDIO-THORAC, V38, P450, DOI 10.1016/j.ejcts.2010.02.009
   HENRICKSON RL, 1984, CRC CR REV FOOD SCI, V20, P159, DOI 10.1080/10408398409527388
   Hirai J, 1996, CELL TRANSPLANT, V5, P93, DOI 10.1016/0963-6897(95)02002-0
   HOOD LL, 1987, ADV MEAT RES
   Huang ZW, 2005, PHOTOCHEM PHOTOBIOL, V81, P1219, DOI 10.1562/2005-02-24-RA-449
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jorge-Herrero E, 2010, ARTIF ORGANS, V34, pE168, DOI 10.1111/j.1525-1594.2009.00978.x
   Kaab MJ, 1998, J ANAT, V193, P23, DOI 10.1046/j.1469-7580.1998.19310023.x
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kamenskiy AV, 2012, J SURG RES, V176, P329, DOI 10.1016/j.jss.2011.09.058
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   L'Heureux N, 1998, FASEB J, V12, P47
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Luo HL, 2008, MATER CHEM PHYS, V110, P193, DOI 10.1016/j.matchemphys.2008.01.040
   McGuigan AP, 2008, BIOMATERIALS, V29, P2453, DOI 10.1016/j.biomaterials.2008.02.010
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Muller-Ehmsen J, 2006, J MOL CELL CARDIOL, V41, P876, DOI 10.1016/j.yjmcc.2006.07.023
   Osburn W., 2002, COLLAGEN CASINGS PRO
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z
   Park SN, 2007, J MATER SCI-MATER M, V18, P475, DOI 10.1007/s10856-007-2007-z
   Penkova R, 1999, FOOD CHEM, V66, P483, DOI 10.1016/S0308-8146(99)00097-7
   PINNELL SR, 1987, ARCH DERMATOL, V123, P1684, DOI 10.1001/archderm.123.12.1684
   Polomska M, 2010, ACTA PHYS POL A, V118, P136
   Prendergast PJ, 2003, J BIOMECH ENG-T ASME, V125, P692, DOI 10.1115/1.1613674
   Punchard MA, 2009, ANN BIOMED ENG, V37, P1322, DOI 10.1007/s10439-009-9701-6
   QUTEISH D, 1990, J BIOMED MATER RES, V24, P749, DOI 10.1002/jbm.820240609
   Schulz JT, 2000, ANNU REV MED, V51, P231, DOI 10.1146/annurev.med.51.1.231
   Seah RKH, 2009, ANAL CHEM, V81, P1442, DOI 10.1021/ac802234t
   Steele TWJ, 2011, ACTA BIOMATER, V7, P1973, DOI 10.1016/j.actbio.2011.02.002
   Su Y, 2007, BRAIN RES, V1145, P41, DOI 10.1016/j.brainres.2007.01.138
   Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426
   Tan WJ, 2005, BIOMATERIALS, V26, P891, DOI 10.1016/j.biomaterials.2004.03.041
   Tang SQ, 2007, BIOMED MATER, V2, pS129, DOI 10.1088/1748-6041/2/3/S09
   Tranquillo RT, 2002, ANN NY ACAD SCI, V961, P251, DOI 10.1111/j.1749-6632.2002.tb03094.x
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Widjaja E, 2003, ANAL CHEM, V75, P4499, DOI 10.1021/ac0263622
   Widjaja E, 2008, J PHARMACEUT BIOMED, V46, P274, DOI 10.1016/j.jpba.2007.09.023
   Widjaja E, 2008, ANAL CHEM, V80, P729, DOI 10.1021/ac701940k
   Woods AM, 2004, BIOMATERIALS, V25, P515, DOI 10.1016/S0142-9612(03)00552-0
   Xu B, 2011, J PROTEOMICS, V74, P1022, DOI 10.1016/j.jprot.2011.03.001
   Yang L, 1999, J ORTHOPAED RES, V17, P755, DOI 10.1002/jor.1100170521
   Yazdani SK, 2009, J VASC INTERV RADIOL, V20, P101, DOI 10.1016/j.jvir.2008.09.025
   Zhang F, 2003, PLAST RECONSTR SURG, V112, P565, DOI 10.1097/01.PRS.0000070966.74429.03
   Zhang H, 2007, J THORAC CARDIOV SUR, V134, P1234, DOI 10.1016/j.jtcvs.2007.07.019
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
NR 75
TC 13
Z9 14
U1 1
U2 31
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2013
VL 24
IS 8
BP 2013
EP 2027
DI 10.1007/s10856-013-4940-3
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 184TB
UT WOS:000321915300019
PM 23670603
DA 2018-10-20
ER

PT J
AU Enea, D
   Gwynne, J
   Kew, S
   Arumugam, M
   Shepherd, J
   Brooks, R
   Ghose, S
   Best, S
   Cameron, R
   Rushton, N
AF Enea, Davide
   Gwynne, Jessica
   Kew, Simon
   Arumugam, Meera
   Shepherd, Jennifer
   Brooks, Roger
   Ghose, Siddhartha
   Best, Serena
   Cameron, Ruth
   Rushton, Neil
TI Collagen fibre implant for tendon and ligament biological augmentation.
   In vivo study in an ovine model
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article
DE Tissue engineering; Collagen fibre; Augmentation; Collagen crosslinking;
   Tendon repair
ID ANTERIOR CRUCIATE LIGAMENT; TISSUE ENGINEERING APPLICATIONS;
   CROSS-LINKING; PATELLAR TENDON; ACHILLES-TENDON; RECONSTRUCTION;
   SCAFFOLD; REGENERATION; REPAIR; PROSTHESIS
AB Although most in vitro studies indicate that collagen is a suitable biomaterial for tendon and ligament tissue engineering, in vivo studies of implanted collagen for regeneration of these tissues are still lacking. The objectives of this study were the following: (1) to investigate the regeneration of the central third of the ovine patellar tendon using implants made of an open array of collagen fibres (reconstituted, extruded bovine collagen); and (2) to compare two collagen crosslinking chemistries: carbodiimide and carbodiimide associated with ethyleneglycoldiglycidylether.
   Forty-eight Welsh Mountain sheep were operated on their right hind leg. The central third of patellar tendon was removed and substituted with carbodiimide (n = 16) and carbodiimide-ethyleneglycoldiglycidylether-crosslinked implants (n = 16). In the control group the defect was left empty (n = 16). The central third of contralateral unoperated tendons was used as positive controls. Half of the sheep in each group were killed at 3- and 6-month time points. After proper dissection, tendon sub-units (medial, central and lateral) were tested to failure (n = 6 for each group), whilst 2 non-dissected samples were used for histology.
   Both the implants had significantly lower stress to failure and modulus with respect to native tendon at both 3- and at 6-month time points. The implants did not statistically differ in stress to failure, whilst carbodiimide-crosslinked implants had significantly higher modulus than carbodiimide-ethyleneglycoldiglycidylether-crosslinked implants both at 3 and at 6 months. Histology showed carbodiimide-crosslinked implants to have a better integration with the native tendon than carbodiimide-ethyleneglycoldiglycidylether-crosslinked implants. Carbodiimide-crosslinked implants appeared partially resorbed and showed increased tissue ingrowth with respect to carbodiimide-ethyleneglycoldiglycidylether-crosslinked implants.
   To deliver collagen implants as an open array of fibres allows optimal tendon-implant integration and good ingrowth of regenerated tissue. In the present study the resorption rate of both the examined implants was too low due to the high level of crosslinking. This led to only minor substitution of the implant with regenerated tissue, which in turn produced a low-strength implanted region. Further studies are needed to find the right balance between strength and resorption rate of collagen fibres.
C1 [Enea, Davide; Arumugam, Meera; Brooks, Roger; Rushton, Neil] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
   [Enea, Davide] Polytech Univ Marche, Osped Riuniti Ancona, Clin Ortoped, I-60126 Ancona, Italy.
   [Gwynne, Jessica; Shepherd, Jennifer; Best, Serena; Cameron, Ruth] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   [Kew, Simon; Ghose, Siddhartha] Tigenix Ltd Labs, Cambridge CB4 0WZ, England.
RP Enea, D (reprint author), Univ Cambridge, Addenbrookes Hosp, Dept Surg, Orthopaed Res Unit, Box 180,Hills Rd, Cambridge CB2 2QQ, England.
EM davidenea@tiscali.it
OI Shepherd, Jennifer/0000-0002-3790-0323; Cameron,
   Ruth/0000-0003-1573-4923
FU Technology Strategy Board [DT/F006977/1]; National Institute for Health
   Research; Engineering and Physical Sciences Research Council
   [DT/F006977/1]
FX The authors gratefully acknowledge the founding support of the
   Technology Strategy Board (grant number DT/F006977/1) and of the
   National Institute for Health Research. The authors would like to thank
   Dr. Andrew Rayment for his help with mechanical testing, Dr. Ben Ting
   Yiu Wong for his help with the surgery and Dr. Jeremy Skepper for his
   help with the histology sample preparation. Dr D. Enea gratefully
   acknowledges Prof F. Greco and Dr A. Gigante (Clinica Ortopedica,
   Polytechnic University of Marche) for their helpfulness and support.
CR Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   BROOKS P, 2009, ORTHOPEDICS, V32, P9, DOI DOI 10.3928/01477447-20090728-27
   Cao YL, 2002, PLAST RECONSTR SURG, V110, P1280, DOI 10.1097/01.PRS.0000025290.49889.4D
   Caruso AB, 2004, J BIOMED MATER RES A, V69A, P164, DOI 10.1002/jbm.a.20136
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V44, P146, DOI 10.1002/bit.260440121
   Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   Enea D, 2011, J MATER SCI-MATER M, V22, P1569, DOI 10.1007/s10856-011-4336-1
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Gigante A, 2009, J ORTHOP RES, V27, P826, DOI 10.1002/jor.20812
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   JACKSON DW, 1993, AM J SPORT MED, V21, P176, DOI 10.1177/036354659302100203
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   LaPrade RF, 1997, AM J SPORT MED, V25, P779, DOI 10.1177/036354659702500609
   Legnani C, 2010, INT ORTHOP, V34, P465, DOI 10.1007/s00264-010-0963-2
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Maffulli Nicola, 2007, Foot Ankle Clin, V12, P583, DOI 10.1016/j.fcl.2007.07.007
   Maffulli N, 2011, MED SPORT SCI, V56, P187, DOI 10.1159/000321078
   Miyashita H, 1997, ARCH ORTHOP TRAUM SU, V116, P454, DOI 10.1007/s004020050162
   Nho SJ, 2010, AM J SPORT MED, V38, P619, DOI 10.1177/0363546509343199
   NOYES FR, 1976, J BONE JOINT SURG AM, V58, P1074, DOI 10.2106/00004623-197658080-00006
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Reinhardt KR, 2010, ORTHOP CLIN N AM, V41, P249, DOI 10.1016/j.ocl.2009.12.009
   Shelton W R, 1998, J Am Acad Orthop Surg, V6, P169
   Spindler KR, 2004, AM J SPORT MED, V32, P1986, DOI 10.1177/0363546504271211
   Tohyama H, 2003, CLIN BIOMECH, V18, P765, DOI 10.1016/S0268-0033(03)00055-X
   Ventura A, 2010, KNEE, V17, P108, DOI 10.1016/j.knee.2009.07.013
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
NR 33
TC 23
Z9 23
U1 1
U2 32
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
EI 1433-7347
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD AUG
PY 2013
VL 21
IS 8
BP 1783
EP 1793
DI 10.1007/s00167-012-2102-7
PG 11
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 190KK
UT WOS:000322338500009
PM 22714976
DA 2018-10-20
ER

PT J
AU Kesselman, D
   Kossover, O
   Mironi-Harpaz, I
   Seliktar, D
AF Kesselman, Dafna
   Kossover, Olga
   Mironi-Harpaz, Iris
   Seliktar, Dror
TI Time-dependent cellular morphogenesis and matrix stiffening in
   proteolytically responsive hydrogels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Fibrinogen; Mechanics; Poly(ethylene glycol); Tissue engineering
ID TISSUE ENGINEERING APPLICATIONS; CROSS-LINKING; FIBRINOGEN; MIGRATION;
   CARDIOMYOCYTES; ENCAPSULATION; REGENERATION; FIBROBLASTS; DEGRADATION;
   SCAFFOLDS
AB Mesenchymal stromal cells residing in proteolytically responsive hydrogel scaffolds were subjected to changes in mechanical properties associated with their own three-dimensional (3-D) morphogenesis. In order to investigate this relationship the current study documents the transient degradation and restructuring of fibroblasts seeded in hydrogel scaffolds undergoing active cell-mediated reorganization over 7 days in culture. A semi-synthetic proteolytically degradable polyethylene glycol-fibrinogen (PF) hydrogel matrix and neonatal human dermal fibroblasts (NHDF) were used. Rheology (in situ and ex situ) measured stiffening of the gels and confocal laser scanning microscopy (CLSM) measured cell morphogenesis within the gels. The assumption that the matrix modulus systematically decreases as cells locally begin to enzymatically disassemble the PF hydrogel to become spindled in the material was not supported by the bulk mechanical property measurements. Instead, the PF hydrogels exhibited cell-mediated stiffening concurrent with their dynamic morphogenesis, as indicated by a four-fold increase in storage modulus after 1 week in culture. Fibrin hydrogels, which were used as the control biomaterial, proved similarly adaptive to cell-mediated remodeling only in the presence of the exogenous serine protease inhibitor aprotinin. Acellular and non-viable hydrogels also served as control groups to verify that transient matrix remodeling was entirely associated with cell-mediated events, including collagen deposition, cell-mediated proteolysis, and the formation of multicellular networks within the hydrogel constructs. The fact that cell network formation and collagen deposition both paralleled transient stiffening of the PF hydrogels, further reinforces the notion that cells actively balance between proteolysis and ECM synthesis when remodeling proteolytically responsive hydrogel scaffolds. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kesselman, Dafna; Kossover, Olga; Mironi-Harpaz, Iris; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
FU US-Israel Binational Science Foundation [2007366]; EU
FX This research was partially supported by US-Israel Binational Science
   Foundation grant no. 2007366 and EU FP7 large-scale cooperation grant
   ANGIOSCAFF.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Appelman TP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003314
   Appelman TP, 2011, BIOMATERIALS, V32, P1508, DOI 10.1016/j.biomaterials.2010.10.017
   Appelman TP, 2009, BIOMATERIALS, V30, P518, DOI 10.1016/j.biomaterials.2008.09.063
   Appelman TP, 2011, J BIOMECH ENG, V4, P133
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Dikovsky D, 2010, ADV ENG MATER, V12, pB200, DOI 10.1002/adem.200980054
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Frisman I, 2011, BIOMATERIALS, V32, P7839, DOI 10.1016/j.biomaterials.2011.06.078
   Frisman I, 2010, ACTA BIOMATER, V6, P2518, DOI 10.1016/j.actbio.2009.07.015
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hunt NC, 2010, ACTA BIOMATER, V6, P3649, DOI 10.1016/j.actbio.2010.03.026
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   Raeber GP, 2007, ACTA BIOMATER, V3, P615, DOI 10.1016/j.actbio.2007.03.013
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Sarig-Nadir O, 2008, TISSUE ENG PT A, V14, P401, DOI 10.1089/tea.2007.0029
   Schwartz MP, 2010, INTEGR BIOL-UK, V2, P32, DOI 10.1039/b912438a
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205
NR 34
TC 11
Z9 11
U1 2
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2013
VL 9
IS 8
BP 7630
EP 7639
DI 10.1016/j.actbio.2013.04.030
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 188QD
UT WOS:000322207700003
PM 23624218
DA 2018-10-20
ER

PT J
AU El Habnouni, S
   Lavigne, JP
   Darcos, V
   Porsio, B
   Garric, X
   Coudane, J
   Nottelet, B
AF El Habnouni, Sarah
   Lavigne, Jean-Philippe
   Darcos, Vincent
   Porsio, Barbara
   Garric, Xavier
   Coudane, Jean
   Nottelet, Benjamin
TI Toward potent antibiofilm degradable medical devices: A generic method
   for the antibacterial surface modification of polylactide
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Surface modification; Polylactide; Antibacterial; Biocompatibility;
   Biofilm
ID TRANSFER RADICAL POLYMERIZATION; URINARY-TRACT-INFECTION; CLICK
   CHEMISTRY; CHEMICAL-MODIFICATION; CATIONIC SURFACES; FUNCTIONALIZATION;
   ANTIBIOTICS; MESH; BIOMATERIALS; COPOLYESTER
AB The effects of biomaterials on their environment must be carefully modulated in most biomedical applications. Among other approaches, this modulation can be obtained through the modification of the biomaterial surface. This paper proposes a simple and versatile strategy to produce non-leaching antibacterial polylactide (PLA) surfaces without any degradation of the polyester chains. The method is based on a one-pot procedure that provides a "clickable" PLA surface via anionic activation which is then functionalized with an antibacterial quaternized poly(2-(dimethylamino)ethyl methacrylate) (QPDMAEMA) by covalent immobilization on the surface. The anti-adherence and antibiofilm activities of modified PLA surfaces are assessed for different QPDMAEMA molecular weights and different quaternization agents. Antibacterial PLA surfaces are shown to be very active against Gram-negative and Gram-positive strains, with adherence reduction factors superior to 99.999% and a marked reduction in biofilm on the most potent surfaces. In addition to this substantial antibacterial activity, the proposed PLA surfaces are also cytocompatible, as demonstrated through the proliferation of L929 fibroblasts. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [El Habnouni, Sarah; Darcos, Vincent; Porsio, Barbara; Garric, Xavier; Coudane, Jean; Nottelet, Benjamin] Univ Montpellier 2, Univ Montpellier 1, UMR CNRS 5247, Fac Pharm,Artificial Biopolymers Grp,IBMM, F-34093 Montpellier, France.
   [Lavigne, Jean-Philippe] Univ Montpellier I, UFR Med Site Nimes, INSERM U1047, CS 83021, F-30908 Nimes 2, France.
RP Nottelet, B (reprint author), Univ Montpellier 2, Univ Montpellier 1, UMR CNRS 5247, Fac Pharm,Artificial Biopolymers Grp,IBMM, 15 Av C Flahault, F-34093 Montpellier, France.
EM benjamin.nottelet@univ-montp1.fr
RI Lavigne, Jean-Philippe/E-1756-2014; Nottelet, Benjamin/M-5604-2014
OI Lavigne, Jean-Philippe/0000-0002-9484-0304; Nottelet,
   Benjamin/0000-0002-8577-9273
FU French Ministry of Education and Research; Erasmus program
FX The authors wish to thank the French Ministry of Education and Research
   for S.E.H.'s fellowship, the Erasmus program for B.P.'s fellowship,
   Valerie Flaud for the XPS analyses, Michel Ramona for the AFM analyses
   and Sylvie Hunger and Cedric Paniagua for the NMR characterizations.
CR AFNOR, 2009, 1099352009 AFNOR ISO
   Agut W, 2007, MACROMOLECULES, V40, P5653, DOI 10.1021/ma070579m
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Birch C, 2005, BEST PRACT RES CL OB, V19, P979, DOI 10.1016/j.bpobgyn.2005.08.013
   Bliziotis IA, 2006, INFECTION, V34, P46, DOI 10.1007/s15010-006-4140-x
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Danese PN, 2002, CHEM BIOL, V9, P873, DOI 10.1016/S1074-5521(02)00192-8
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   El Habnouni S, 2011, ADV FUNCT MATER, V21, P3321, DOI 10.1002/adfm.201100412
   Ferreira FA, 2012, J MICROBIOL METH, V88, P393, DOI 10.1016/j.mimet.2012.01.007
   Gabrielska J, 1994, TENSIDE SURFACT DET, V31, P296
   GILBERT P, 1985, LETT APPL MICROBIOL, V1, P101, DOI 10.1111/j.1472-765X.1985.tb01498.x
   Goldstein H., 1999, HERNIA, V3, P23
   Guillaume O, 2011, ACTA BIOMATER, V7, P3390, DOI 10.1016/j.actbio.2011.05.009
   Gutierrez-Villarreal MH, 2008, J APPL POLYM SCI, V110, P163, DOI 10.1002/app.28000
   Huang JY, 2008, LANGMUIR, V24, P6785, DOI 10.1021/la8003933
   IKEDA T, 1984, ANTIMICROB AGENTS CH, V26, P139, DOI 10.1128/AAC.26.2.139
   Ishihara K, 2010, J PHOTOPOLYM SCI TEC, V23, P161, DOI 10.2494/photopolymer.23.161
   KANAZAWA A, 1994, J APPL POLYM SCI, V52, P641, DOI 10.1002/app.1994.070520507
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kingshott P, 2011, CURR OPIN CHEM BIOL, V15, P667, DOI 10.1016/j.cbpa.2011.07.012
   Kiss E, 2010, LANGMUIR, V26, P1440, DOI 10.1021/la903373g
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Lenoir S, 2006, J POLYM SCI POL CHEM, V44, P1214, DOI 10.1002/pola.21229
   Lepretre S, 2009, BIOMATERIALS, V30, P6086, DOI 10.1016/j.biomaterials.2009.07.045
   Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557
   Milovic NM, 2005, BIOTECHNOL BIOENG, V90, P715, DOI 10.1002/bit.20454
   Mishra B, 2012, INT J CLIN PRACT, V66, P493, DOI 10.1111/j.1742-1241.2012.02906.x
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Niska JA, 2012, ANTIMICROB AGENTS CH, V56, P2590, DOI 10.1128/AAC.06291-11
   Nottelet B, 2007, BIOMACROMOLECULES, V8, P2594, DOI 10.1021/bm700449c
   Nottelet B, 2008, MACROMOL RAPID COMM, V29, P743, DOI 10.1002/marc.200800037
   Nottelet B, 2006, BIOMATERIALS, V27, P4948, DOI 10.1016/j.biomaterials.2006.05.032
   Palermo EF, 2009, BIOMACROMOLECULES, V10, P1416, DOI 10.1021/bm900044x
   Riva R, 2008, POLYMER, V49, P2023, DOI 10.1016/j.polymer.2008.03.008
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Ronco E, 2011, NEUROREHAB NEURAL RE, V25, P351, DOI 10.1177/1545968310383432
   Roy D, 2008, BIOMACROMOLECULES, V9, P91, DOI 10.1021/bm700849j
   Shameli K, 2010, INT J NANOMED, V5, P573
   Teo EY, 2011, BIOMATERIALS, V32, P279, DOI 10.1016/j.biomaterials.2010.08.089
   Timofeeva L, 2011, APPL MICROBIOL BIOT, V89, P475, DOI 10.1007/s00253-010-2920-9
   Walsh CA, 2011, NEUROUROL URODYNAM, V30, P32, DOI 10.1002/nau.20927
   Wang HW, 2011, COLLOID SURFACE B, V83, P355, DOI 10.1016/j.colsurfb.2010.12.009
   Wang SG, 2005, ANAL BIOANAL CHEM, V381, P547, DOI 10.1002/s00216-004-27712
   Xu FJ, 2011, MACROMOLECULES, V44, P2371, DOI 10.1021/ma200160h
   Xu FJ, 2010, BIOMATERIALS, V31, P3139, DOI 10.1016/j.biomaterials.2010.01.032
   Xu XL, 2010, J APPL POLYM SCI, V118, P588, DOI 10.1002/app.32415
   Yao F, 2008, J MEMBRANE SCI, V319, P149, DOI 10.1016/j.memsci.2008.03.049
   Zhang X, 1998, MACROMOLECULES, V31, P5167, DOI 10.1021/ma980477j
NR 52
TC 13
Z9 13
U1 7
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2013
VL 9
IS 8
BP 7709
EP 7718
DI 10.1016/j.actbio.2013.04.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 188QD
UT WOS:000322207700011
PM 23603533
DA 2018-10-20
ER

PT J
AU Li, Q
   Niinomi, M
   Hieda, J
   Nakai, M
   Cho, K
AF Li, Qiang
   Niinomi, Mitsuo
   Hieda, Junko
   Nakai, Masaaki
   Cho, Ken
TI Deformation-induced omega phase in modified Ti-29Nb-13Ta-4.6Zr alloy by
   Cr addition
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterial; Titanium alloy; Springback; Deformation-induced; Young's
   modulus
ID SPINAL FIXATION APPLICATIONS; CHANGEABLE YOUNGS MODULUS; BIOMEDICAL
   APPLICATIONS; TITANIUM-ALLOYS; MECHANICAL-PROPERTIES; BETA-PHASE; TI-NB;
   IMPLANTS; BEHAVIOR; FATIGUE
AB For spinal-fixation applications, implants should have a high Young's modulus to reduce springback during operations, though a low Young's modulus is required to prevent stress shielding for patients after surgeries. In the present study, Ti-29Nb-13Ta-4.6Zr alloy (TNTZ) with a low Young's modulus was modified by adding Cr to obtain a higher deformation-induced Young's modulus in order to satisfy these contradictory requirements. Two newly designed alloys, TNTZ-8Ti-2Cr and TNTZ-16Ti-4Cr, possess more stable beta phases than TNTZ. These alloys consist of single beta phases and exhibit relatively low Young's moduli of <65 GPa after solution treatment. However, after cold rolling, they exhibit higher Young's moduli owing to a deformation-induced omega-phase transformation. These modified TNTZ alloys show significantly less springback than the original TNTZ alloy based on tensile and bending loading-unloading tests. Thus, the Cr-added TNTZ alloys are beneficial for spinal-fixation applications. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Li, Qiang; Niinomi, Mitsuo; Hieda, Junko; Nakai, Masaaki; Cho, Ken] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Hieda, J (reprint author), Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM hieda@imr.tohoku.ac.jp
RI Niinomi, Mitsuo/B-5965-2011; Li, Qiang/D-1830-2013; Nakai,
   Masaaki/C-1919-2009
OI Li, Qiang/0000-0002-1990-8233; 
FU New Energy and Industrial Technology Development Organization (NEDO) of
   Japan; Japan Society for the Promotion of Science [24246111, 24656401];
   Global COE program "Materials Integration International Center of
   Education and Research, Tohoku University," Ministry of Education,
   Culture, Sports, Science and Technology (MEXT) of Japan; Tohoku Leading
   Women's JUMP UP Project, Tohoku University; MEXT; Advanced Research
   Center of Metallic Glasses, Institute for Materials Research, Tohoku
   University
FX This study was supported in part by the Industrial Technology Research
   Grant Program in 2009 from the New Energy and Industrial Technology
   Development Organization (NEDO) of Japan; a Grant-in-Aid for Scientific
   Research from the Japan Society for the Promotion of Science (Grant
   Number 24246111 and Grant Number 24656401) and the Global COE program
   "Materials Integration International Center of Education and Research,
   Tohoku University," Ministry of Education, Culture, Sports, Science and
   Technology (MEXT) of Japan; the Tohoku Leading Women's JUMP UP Project,
   Tohoku University; the inter-university cooperative research program
   "Innovative Research for Biosis-Abiosis Intelligent Interface," MEXT;
   and the cooperative research program of the Advanced Research Center of
   Metallic Glasses, Institute for Materials Research, Tohoku University.
CR Baker C., 1971, Metal Science Journal, V5, P92
   Ban S, 1998, BIOMATERIALS, V19, P1245, DOI 10.1016/S0142-9612(98)00032-5
   Boyer R., 1994, MAT PROPERTIES HDB T, p[10, 490]
   Domingo JL, 2002, BIOL TRACE ELEM RES, V88, P97, DOI 10.1385/BTER:88:2:097
   FAN ZY, 1993, SCRIPTA METALL MATER, V29, P1427, DOI 10.1016/0956-716X(93)90331-L
   HANADA S, 1980, METALL TRANS A, V11, P1447, DOI 10.1007/BF02653501
   HANADA S, 1986, J MATER SCI, V21, P4131, DOI 10.1007/BF01106518
   HANADA S, 1985, METALL TRANS A, V16, P789, DOI 10.1007/BF02814829
   HANADA S, 1987, METALL TRANS A, V18, P265, DOI 10.1007/BF02646160
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   KUAN TS, 1975, METALL TRANS A, V6, P1767, DOI 10.1007/BF02642306
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Matsumoto H, 2006, METALL MATER TRANS A, V37A, P3239, DOI 10.1007/BF02586159
   Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008
   Nakai M, 2011, MATER LETT, V65, P688, DOI 10.1016/j.matlet.2010.11.006
   Narita K, 2010, ADV MATER RES-SWITZ, V89-91, P400, DOI 10.4028/www.scientific.net/AMR.89-91.400
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2009, MATER TRANS, V50, P1704, DOI 10.2320/matertrans.MF200922
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   PILLIAR RM, 1991, BIOMATERIALS, V12, P95, DOI 10.1016/0142-9612(91)90185-D
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Semlitsch M., 1986, TITAN, V2, P721
   Steib JP, 2004, SPINE, V29, P193, DOI 10.1097/01.BRS.0000107233.99835.A4
   Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Zhao XL, 2011, ACTA BIOMATER, V7, P3230, DOI 10.1016/j.actbio.2011.04.019
   Zhao XF, 2012, ACTA BIOMATER, V8, P2392, DOI 10.1016/j.actbio.2012.02.010
   Zhao XF, 2012, ACTA BIOMATER, V8, P1990, DOI 10.1016/j.actbio.2012.02.004
NR 35
TC 20
Z9 20
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2013
VL 9
IS 8
BP 8027
EP 8035
DI 10.1016/j.actbio.2013.04.032
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 188QD
UT WOS:000322207700043
PM 23624220
DA 2018-10-20
ER

PT J
AU Neill, JSA
   Lineaweaver, WC
AF Neill, James S. A.
   Lineaweaver, William C.
TI Tissue Response to Bovine Fetal Collagen Extracellular Matrix in
   Full-Thickness Skin Wounds
SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
DE Dermal substitute; Histology; Dermatopathology; Wound healing; Bovine
   fetal collagen
AB Objectives: To present the findings of the biological response and assimilation of bovine fetal collagen (BFC) as observed in biopsy specimens taken after implant.
   Methods: The biopsy specimens were from 9 patients with full-thickness skin wounds who received the BFC biomaterial in the first stage of a 2-stage reconstruction. Biopsy specimens were taken at the second stage of skin grafting from the wound margins.
   Results: The response to the BFC included neovascularization and infiltration of the collagen matrix with fibroblasts. The acellular matrix had the tinctural properties of devitalized tissue, which may be mistaken for coagulative necrosis if one is unaware of the biomaterial implant.
   Conclusions: The characteristics of BFC histology should be recognized by pathologists involved in patients treated for reconstruction and wound care.
C1 [Neill, James S. A.] Ameripath, Flowood, MS 39232 USA.
   [Lineaweaver, William C.] Joseph M Still Burn & Reconstruct Ctr, Brandon, MS USA.
RP Neill, JSA (reprint author), Ameripath, 1033 N Flowood Dr, Flowood, MS 39232 USA.
EM jneill@ameripath.com
CR Agren Magnus S, 2007, Int J Low Extrem Wounds, V6, P82, DOI 10.1177/1534734607301394
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Hackum DJ, 2002, SURG INFECT, V3, pS1
   Karr JC, 2011, ADV SKIN WOUND CARE, V24, P119, DOI 10.1097/01.ASW.0000395038.28398.88
   Landsman Adam, 2009, Clin Podiatr Med Surg, V26, P525, DOI 10.1016/j.cpm.2009.08.012
   Neill J, 2012, ANN PLAS SURG, V68, P451, DOI 10.1097/SAP.0b013e31824189ed
   Shores Jaimie T, 2007, Adv Skin Wound Care, V20, P493, DOI 10.1097/01.ASW.0000288217.83128.f3
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Winitphakdeedecha R, 2008, J DRUGS DERMATOL, V7, P781
NR 10
TC 4
Z9 4
U1 0
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9173
EI 1943-7722
J9 AM J CLIN PATHOL
JI Am. J. Clin. Pathol.
PD AUG
PY 2013
VL 140
IS 2
BP 248
EP 252
DI 10.1309/AJCPMF3B9XJAKXKM
PG 5
WC Pathology
SC Pathology
GA 187VM
UT WOS:000322149600017
PM 23897262
OA Bronze
DA 2018-10-20
ER

PT J
AU Bennett, JA
   Mikheenko, IP
   Deplanche, K
   Shannon, IJ
   Wood, J
   Macaskie, LE
AF Bennett, J. A.
   Mikheenko, I. P.
   Deplanche, K.
   Shannon, I. J.
   Wood, J.
   Macaskie, L. E.
TI Nanoparticles of palladium supported on bacterial biomass: New re-usable
   heterogeneous catalyst with comparable activity to homogeneous colloidal
   Pd in the Heck reaction
SO APPLIED CATALYSIS B-ENVIRONMENTAL
LA English
DT Article
DE BioPd; Biogenic nanopartides; Desulfovibrio desulfuricans; Heck
   coupling; Palladium catalyst
ID COUPLING REACTIONS; ESCHERICHIA-COLI; SUZUKI REACTIONS;
   AQUEOUS-SOLUTION; IONIC LIQUID; EFFICIENT; GENERATION; REDUCTION;
   PARTICLES; CHEMISTRY
AB The Heck coupling of iodobenzene with ethyl acrylate or styrene was used to assess the catalytic properties of biogenic nanoparticles of palladium supported upon the surface of bacterial biomass (bioPd), this approach combining advantages of both homogeneous and heterogeneous catalysts. The biomaterial was comparably active or superior to colloidal Pd in the Heck reaction, giving a final conversion of 85% halide and initial rate of 0.17 mmol/min for the coupling of styrene and iodobenzene compared to a final conversion of 70% and initial rate of 0.15 mmol/min for a colloidal Pd catalyst under the same reaction conditions at 0.5 mol.% catalyst loading. It was easily separated from the products under gravity or by filtration for reuse with low loss or agglomeration. When compared to two alternative palladium catalysts, commercial 5% Pd/C and tetraalkylammonium-stabilised palladium clusters, the bioPd was successfully reused in six sequential alkylations with only slight decreases in the rate of reaction as compared to virgin catalyst (initial rate normalised for g Pd decreased by 5% by the 6th run with bioPd catalyst cf. a decrease of 95% for Pd/C). A re-usable Pd-catalyst made cheaply from bacteria left over from other processes would impact on both conservation of primary sources via reduced metal losses in industrial application and the large environmental demand of primary processing from ores. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
C1 [Bennett, J. A.; Wood, J.] Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.
   [Mikheenko, I. P.; Deplanche, K.; Macaskie, L. E.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
   [Shannon, I. J.] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England.
RP Macaskie, LE (reprint author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
EM L.E.Macaskie@bham.ac.uk
OI Deplanche, Kevin/0000-0002-2068-8637; Mikheenko,
   Iryna/0000-0001-6361-6740
FU EPSRC [EP/D05768X/1, EP/1007806/1]; BBSRC [BB/E003788/1]; Biotechnology
   and Biological Sciences Research Council [BB/E003788/1]; Engineering and
   Physical Sciences Research Council [EP/D05768X/1, EP/H029567/1,
   EP/I007806/1]
FX This study was supported by EPSRC (grant nos. EP/D05768X/1 and
   EP/1007806/1) and BBSRC (grant no. BB/E003788/1). The authors greatly
   acknowledge the assistance with of Dr. Yu Chen in HRTEM.
CR Antolini A., 2008, APPL CATAL B-ENVIRON, V88, P1
   Attard G, 2012, LANGMUIR, V28, P5267, DOI 10.1021/la204495z
   AUGUSTINE RL, 1995, J MOL CATAL A-CHEM, V95, P277, DOI 10.1016/1381-1169(94)00021-2
   Beauregard DA, 2010, BIOTECHNOL BIOENG, V107, P11, DOI 10.1002/bit.22791
   Benkhaled M, 2006, APPL CATAL A-GEN, V312, P1, DOI 10.1016/j.apcata.2006.06.011
   Beveridge TJ, 1999, J BACTERIOL, V181, P4725
   Bolliger JL, 2008, CHEM-EUR J, V14, P7969, DOI 10.1002/chem.200800441
   Cassol CC, 2005, J AM CHEM SOC, V127, P3298, DOI 10.1021/ja0430043
   Chariot G., 1978, DOSAGES ABSORPTIOMET, P380
   Colacot TJ, 2008, TOP CATAL, V48, P91, DOI 10.1007/s11244-008-9055-6
   Creamer NJ, 2007, CATAL TODAY, V128, P80, DOI 10.1016/j.cattod.2007.04.014
   Creamer NJ, 2006, BIOTECHNOL LETT, V28, P1475, DOI 10.1007/s10529-006-9120-9
   Cypryk M, 2010, J MOL CATAL A-CHEM, V319, P30, DOI 10.1016/j.molcata.2009.11.016
   De Corte S, 2012, MICROB BIOTECHNOL, V5, P5, DOI 10.1111/j.1751-7915.2011.00265.x
   De Vargas I., 2005, P 16 INT BIOH S CAP, P605
   de Vries AHM, 2003, ORG LETT, V5, P3285, DOI 10.1021/ol035184b
   de Vries JG, 2006, DALTON T, P421, DOI 10.1039/b506276b
   Denicourt-Nowicki A, 2008, CATAL COMMUN, V10, P68, DOI 10.1016/j.catcom.2008.07.023
   Deplanche K, 2012, J R SOC INTERFACE, V9, P1705, DOI 10.1098/rsif.2012.0003
   Deplanche K, 2011, NANOMATERIALS, P279
   Dieguez M, 2008, ADV SYNTH CATAL, V350, P2583, DOI 10.1002/adsc.200800424
   Durand J., 2008, EUR J INORG CHEM, V23, P3577
   Durand J, 2008, MAGN RESON CHEM, V46, P739, DOI 10.1002/mrc.2244
   Favier I, 2011, CURR ORG CHEM, V15, P3127, DOI 10.2174/138527211797247950
   Garcia-Martinez J, 2008, ADV MATER, V20, P288, DOI 10.1002/adma.200602977
   Gniewk A., 2007, J CATAL, V254, P121
   Humphries AC, 2006, BIOTECHNOL BIOENG, V94, P81, DOI 10.1002/bit.20814
   Jansat S, 2009, CHEMCATCHEM, V1, P244, DOI 10.1002/cctc.200900127
   Klug H. P., 1974, XRAY DIFFRACTION PRO
   Kohler K, 2002, CHEM-EUR J, V8, P622, DOI 10.1002/1521-3765(20020201)8:3<622::AID-CHEM622>3.0.CO;2-0
   Li Y, 2002, LANGMUIR, V18, P4921, DOI 10.1021/la011469q
   Liu Y, 2006, CATAL COMMUN, V7, P985, DOI 10.1016/j.catcom.2006.05.002
   Macaskie L.E., 2012, J CHEM TECHNOL BIOTE
   Macaskie L. E., 2011, COMPREHENSIVE BIOTEC, P719
   Mikheenko IP, 2008, APPL ENVIRON MICROB, V74, P6144, DOI 10.1128/AEM.02538-07
   Mikheenko I.P., 2001, BIOHYDROMETALLURGY F, P525
   MIKHEENKO IP, 2004, THESIS U BIRMINGHAM
   Murray A. J., 2012, MIN ENG IN PRESS
   Orozco RL, 2010, BIOTECHNOL LETT, V32, P1837, DOI 10.1007/s10529-010-0383-9
   Phan NTS, 2006, ADV SYNTH CATAL, V348, P609, DOI 10.1002/adsc.200505473
   Prockl SS, 2004, ANGEW CHEM INT EDIT, V43, P1881, DOI 10.1002/anie.200353473
   Pryjomska-Ray I, 2006, J MOL CATAL A-CHEM, V257, P3, DOI 10.1016/j.molcata.2006.03.064
   REETZ MT, 1995, SCIENCE, V267, P367, DOI 10.1126/science.267.5196.367
   Reetz MT, 1999, ADV MATER, V11, P773, DOI 10.1002/(SICI)1521-4095(199906)11:9<773::AID-ADMA773>3.0.CO;2-1
   Rodriguez-Perez L, 2011, CHEMCATCHEM, V3, P749, DOI 10.1002/cctc.201000321
   Sheloumov A.M., 2008, EUROPEAN J INORGANIC, V4, P572
   Shin JY, 2007, CHEM COMMUN, P5238, DOI 10.1039/b711237h
   Thathagar MB, 2006, ANGEW CHEM INT EDIT, V45, P2886, DOI 10.1002/anie.200504321
   Wood J., 2011, P HYBR MAT 2011 2 IN
   Zhang JZ, 2008, ADV SYNTH CATAL, V350, P2065, DOI 10.1002/adsc.200800304
NR 50
TC 37
Z9 37
U1 5
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-3373
J9 APPL CATAL B-ENVIRON
JI Appl. Catal. B-Environ.
PD AUG-SEP
PY 2013
VL 140
BP 700
EP 707
DI 10.1016/j.apcatb.2013.04.022
PG 8
WC Chemistry, Physical; Engineering, Environmental; Engineering, Chemical
SC Chemistry; Engineering
GA 185ST
UT WOS:000321991300076
OA Other Gold
DA 2018-10-20
ER

PT J
AU Cheng, SH
   Fan, FY
   Xu, Y
   Li, S
   Zhu, PW
   Li, HD
   Liu, JS
AF Cheng Shao-heng
   Fan Feng-yang
   Xu Yang
   Li Shuo
   Zhu Pin-wen
   Li Hong-dong
   Liu Jun-song
TI Improving performance of inoculating alloy wires by coating a boron
   nitride layer
SO CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
LA English
DT Article
DE Inoculating alloy wire; Boron nitride layer; Magnetron sputtering;
   Self-cleaning; Organism transferring
ID REDUCE; NANOTUBES; ADHESION; SURFACES; POLYMER; FILMS
AB The paper reports the deposition(by magnetron sputtering) and properties of polycrystalline boron nitride (BN) layers on commercial inoculating alloy wires. As is characterized by means of Fourier transform infrared(FTIR) spectroscopy, electron energy dispersive X-ray(EDX) spectroscopy and scanning electron microscopy(SEM), the thin BN layers consist of hexagonal and orthorhombic BN phases and are smooth without cracks. Organism transferring-circles experiments reveal that the adhesion between the BN layer and alloy wire is very good after tens of cycles. It is demonstrated that the BN layers covered wires are biomaterial lubricious and self-cleaning. As a result, BN layer would effectively enhance the function and efficiency of inoculating alloy wires, which could be widely applied to bio-experimentation and biomedicine apparatuses.
C1 [Cheng Shao-heng; Fan Feng-yang; Xu Yang; Li Shuo; Zhu Pin-wen; Li Hong-dong; Liu Jun-song] Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China.
RP Li, HD (reprint author), Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China.
EM hdli@jlu.edu.cn; jsliu@jlu.edu.cn
FU National Natural Science Foundation of China [51072066, 50772041];
   Specialized Research Fund for the Doctoral Program of Higher Education
   of China [20100061110083]; New Century Excellent Talents in Universities
   of China [NCET-06-0303]
FX Supported by the National Natural Science Foundation of China(Nos.
   51072066, 50772041), the Specialized Research Fund for the Doctoral
   Program of Higher Education of China(No. 20100061110083) and the New
   Century Excellent Talents in Universities of China(No. NCET-06-0303).
CR Boinovich LB, 2012, LANGMUIR, V28, P1206, DOI 10.1021/la204429z
   Chen X, 2009, J AM CHEM SOC, V131, P890, DOI 10.1021/ja807334b
   Edmiston CE, 2006, J AM COLL SURGEONS, V203, P481, DOI 10.1016/j.jamcollsurg.2006.06.026
   Eichler J, 2008, J EUR CERAM SOC, V28, P1105, DOI 10.1016/j.jeurceramsoc.2007.09.005
   Haubner R, 2002, STRUCT BOND, V102, P1
   Jacobson N, 1999, J AM CERAM SOC, V82, P393
   Katarzyna K., 2008, J MATER SCI-MATER M, V19, P2301
   Lahiri D, 2011, J MECH BEHAV BIOMED, V4, P44, DOI 10.1016/j.jmbbm.2010.09.005
   Marmieri G, 1996, J BIOMED MATER RES, V33, P29, DOI 10.1002/(SICI)1097-4636(199621)33:1<29::AID-JBM5>3.3.CO;2-M
   MCNEILL IC, 1985, POLYM DEGRAD STABIL, V11, P309, DOI 10.1016/0141-3910(85)90035-7
   Parkin IP, 2005, J MATER CHEM, V15, P1689, DOI 10.1039/b412803f
   Patel JD, 2005, J BIOMED MATER RES A, V73A, P359, DOI 10.1002/jbm.a.30302
   Rojas IA, 2000, J CONTROL RELEASE, V63, P175, DOI 10.1016/S0168-3659(99)00195-9
   SANJURJO JA, 1983, PHYS REV B, V28, P4579, DOI 10.1103/PhysRevB.28.4579
   SHANKEL D M, 1968, American Biology Teacher, V30, P461
   WANG JL, 2010, CHEM J CHINESE U, V31, P239
   Yang XX, 2010, J CRYST GROWTH, V312, P3434, DOI 10.1016/j.jcrysgro.2010.08.031
   Yang XX, 2009, J CRYST GROWTH, V311, P3716, DOI 10.1016/j.jcrysgro.2009.04.041
   Zhao YN, 1998, CHEM J CHINESE U, V19, P1136
NR 19
TC 1
Z9 1
U1 0
U2 28
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 1005-9040
J9 CHEM RES CHINESE U
JI Chem. Res. Chin. Univ.
PD AUG
PY 2013
VL 29
IS 4
BP 816
EP 819
DI 10.1007/s40242-013-2379-1
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 188NQ
UT WOS:000322200100041
DA 2018-10-20
ER

PT J
AU Rivadeneira, J
   Audisio, MC
   Boccaccini, AR
   Gorustovich, AA
AF Rivadeneira, J.
   Carina Audisio, M.
   Boccaccini, A. R.
   Gorustovich, A. A.
TI In vitro antistaphylococcal effects of a novel 45S5
   bioglass/agar-gelatin biocomposite films
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE antibacterial activity; bioactive glass; biocomposites; biopolymers
ID TISSUE-ENGINEERING APPLICATIONS; BIOACTIVE GLASS PARTICLES;
   STAPHYLOCOCCUS-EPIDERMIDIS; BACTERIAL ADHESION; PARTICULATE BIOGLASS(R);
   ANTIBACTERIAL ACTIVITY; HYBRID SCAFFOLDS; GELATIN; INFECTIONS;
   ATTACHMENT
AB Aims: To assess the antibacterial efficacy of new composite materials developed from microparticles of 45S5 bioactive glass (BG) and agar-gelatin films.
   Methods and Results: In vitro antibacterial activity was evaluated against Staphylococcus spp. because of the importance of this pathogen in damaged tissues and in failures associated with biomaterial implants. To our knowledge, this is the first paper reporting on the suitable combination of BG and agar-gelatin for bioactive and antibacterial films. Bacterial suspensions up or below 10(5) CFU ml(-1) reflecting situations of wound infection and of noninfection, respectively, were prepared and then put in contact with the biomaterials at 37 degrees C. After 24 and 48 h of incubation, the pH value was measured and the staphylococci strains viability was determined by counting in Mueller-Hinton agar plates. Moreover, the biomaterials were prepared for observation under scanning electron microscopy (SEM). Biocomposites (BCs) showed a strong antibacterial effect against all staphylococci strains tested. Some differences were found depending on the strain, the inoculum size and the contact time. This effect was correlated with an alkalinization of the media. By SEM analyses, no bacterial presence was observed on the surface of BCs in any of the cell concentrations tested at any time.
   Conclusions: Overall, the coating of 45S5 BG on agar-gelatin films promoted BCs with strong antistaphylococcal activity. The effect was efficient under bacterial concentration up or below 10(5) CFU ml (1). Additionally, none of the strains were found on BCs surfaces.
   Significance and Impact of Study: 45S5 bioglass/agar-gelatin biocomposite films are reported for the first time. The results suggest a potential application as wound dressing.
C1 [Rivadeneira, J.; Gorustovich, A. A.] Univ Buenos Aires, Inst Tecnol Ciencias Ingn, Consejo Nacl Invest Cient & Tecn INTECIN UBA CONI, Grp Interdisciplinario Mat,Univ Catolica Salta IE, Salta, Argentina.
   [Carina Audisio, M.] Univ Nacl Salta UNSa, Inst Invest Ind Quim, Consejo Nacl Invest Cient & Tecn INIQUI CONICET, Salta, Argentina.
   [Boccaccini, A. R.] Univ Erlangen Nurnberg, Inst Biomat, D-91054 Erlangen, Germany.
RP Rivadeneira, J (reprint author), Univ Buenos Aires, Inst Tecnol Ciencias Ingn, Consejo Nacl Invest Cient & Tecn INTECIN UBA CONI, Grp Interdisciplinario Mat,Univ Catolica Salta IE, Campo Castanares S-N, Salta, Argentina.
EM jrivadeneira@conicet.gov.ar
RI Boccaccini, Aldo/C-7905-2013
FU Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET
   [PIP0184]
FX This work was supported by the Consejo Nacional de Investigaciones
   Cientificas y Tecnicas, CONICET (PIP0184 to A. A. G). The authors
   declare no conflict of interest related to this work.
CR Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538
   Allan I, 2002, CLIN ORAL IMPLAN RES, V13, P53, DOI 10.1034/j.1600-0501.2002.130106.x
   Allan I, 2001, BIOMATERIALS, V22, P1683, DOI 10.1016/S0142-9612(00)00330-6
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
   Campoccia D, 2008, BIOMATERIALS, V29, P4108, DOI 10.1016/j.biomaterials.2008.07.006
   Campoccia D, 2009, J BIOMED MATER RES A, V88A, P654, DOI 10.1002/jbm.a.31754
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015
   Dass CL, 2009, J SURG RES, V156, P57, DOI 10.1016/j.jss.2009.03.067
   Day RM, 2005, J BIOMED MATER RES A, V75A, P778, DOI 10.1002/jbm.a.30433
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   Denkbas EB, 2004, J BIOMATER APPL, V18, P291, DOI 10.1177/0885328204041510
   Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004
   Gentile P, 2010, J BIOMAT SCI-POLYM E, V21, P1207, DOI 10.1163/092050609X12481751806213
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   Gorriti MF, 2009, ADV ENG MATER, V11, pB67, DOI 10.1002/adem.200900081
   Gorustovich AA, 2006, BIOMED MATER, V1, P100, DOI 10.1088/1748-6041/1/3/002
   Gorustovich AA, 2010, J BIOMED MATER RES A, V92A, P232, DOI 10.1002/jbm.a.32355
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611
   Hong Z, 2009, J BIOMED MATER RES A, V88A, P304, DOI 10.1002/jbm.a.31848
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5
   Ignatova M, 2008, J BIOMAT SCI-POLYM E, V19, P373, DOI 10.1163/156856208783721056
   Itokazu M, 1997, J MED MICROBIOL, V46, P779, DOI 10.1099/00222615-46-9-779
   Jacobsen F, 2011, ANTIMICROB AGENTS CH, V55, P2325, DOI 10.1128/AAC.01071-10
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Ketonis C, 2010, CLIN ORTHOP RELAT R, V468, P2113, DOI 10.1007/s11999-010-1322-8
   Krimmer V, 1999, J CLIN MICROBIOL, V37, P2667
   Lin C, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045017
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Madhumathi K, 2010, J MATER SCI-MATER M, V21, P807, DOI 10.1007/s10856-009-3877-z
   Marelli B, 2010, BIOMACROMOLECULES, V11, P1470, DOI 10.1021/bm1001087
   McWhirter MJ, 2002, COLLOID SURFACE B, V26, P365, DOI 10.1016/S0927-7765(02)00017-6
   Misra SK, 2010, BIOMATERIALS, V31, P2806, DOI 10.1016/j.biomaterials.2009.12.045
   Moosvi SR, 2009, ACTA BIOMATER, V5, P76, DOI 10.1016/j.actbio.2008.08.003
   O'Meara S, 2006, DIABETIC MED, V23, P341, DOI 10.1111/j.1464-5491.2006.01830.x
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Pratten J, 2004, J BIOMATER APPL, V19, P47, DOI 10.1177/0885328204043200
   Raja AF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-54
   Robson MC, 1999, AM J SURG, V178, P399, DOI 10.1016/S0002-9610(99)00208-1
   Rosellini E, 2009, J BIOMED MATER RES A, V91A, P447, DOI 10.1002/jbm.a.32216
   Sakai S, 2007, J BIOSCI BIOENG, V103, P22, DOI 10.1263/jbb.103.22
   Saxena A, 2011, INT J PHARM INVESTIG, V1, P93, DOI 10.4103/2230-973X.82407
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x
   Shome A, 2011, SOFT MATTER, V7, P3011, DOI 10.1039/c0sm01087a
   Stoor P, 1999, J BIOMED MATER RES, V48, P869, DOI 10.1002/(SICI)1097-4636(1999)48:6<869::AID-JBM16>3.3.CO;2-Y
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Vallet-Regi M, 2006, J MATER SCI-MATER M, V17, P1011, DOI 10.1007/s10856-006-0437-7
   van den Bosch E, 2003, INT J BIOL MACROMOL, V32, P129, DOI 10.1016/S0141-8130(03)00046-1
   Verma P, 2009, J TISSUE ENG REGEN M, V3, P368, DOI 10.1002/term.172
   Verma V, 2007, BIOTECHNOL BIOENG, V96, P392, DOI 10.1002/bit.21111
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   Waltimo T, 2009, J DENT RES, V88, P235, DOI 10.1177/0022034508330315
   Xie ZP, 2008, J ANTIMICROB CHEMOTH, V62, P1162, DOI 10.1093/jac/dkn336
   Zehnder M, 2006, INT ENDOD J, V39, P952, DOI 10.1111/j.1365-2591.2006.01173.x
NR 65
TC 14
Z9 14
U1 1
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD AUG
PY 2013
VL 115
IS 2
BP 604
EP 612
DI 10.1111/jam.12254
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 184MR
UT WOS:000321894900029
PM 23679823
OA Bronze
DA 2018-10-20
ER

PT J
AU Opell, BD
   Karinshak, SE
   Sigler, MA
AF Opell, Brent D.
   Karinshak, Shannon E.
   Sigler, Mary A.
TI Environmental response and adaptation of glycoprotein glue within the
   droplets of viscous prey capture threads from araneoid spider orb-webs
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Araneoidea; Argiope aurantia; biomaterial; glycoprotein; hygroscopic;
   Neoscona crucifera
ID NEPHILA-CLAVIPES ARANEAE; WEAVING SPIDERS; CHEMICAL-COMPOSITION;
   EVOLUTION; SILK; ARANEIDAE; HUMIDITY; SUPERCONTRACTION; ADHESION;
   ARGIOPE
AB Viscous threads that form the prey capture spiral of araneoid orb-webs retain insects that strike the web, giving a spider more time to locate and subdue them. The viscoelastic glycoprotein glue responsible for this adhesion forms the core of regularly spaced aqueous droplets, which are supported by protein axial fibers. Glycoprotein extensibility both facilitates the recruitment of adhesion from multiple droplets and dissipates the energy generated by insects struggling to free themselves from the web. Compounds in the aqueous material make the droplets hygroscopic, causing an increase in both droplet volume and extensibility as humidity ( RH) rises. We characterized these humidity-mediated responses at 20%, 37%, 55%, 72% and 90% RH in two large orbweavers, Argiope aurantia, which is found in exposed habitats, and Neoscona crucifera, which occupies forests and forest edges. The volume-specific extension of A. aurantia glycoprotein reached a maximum value at 55% RH and then declined, whereas that of N. crucifera increased exponentially through the RH range. As RH increased, the relative stress on droplet filaments at maximum extension, as gauged by axial line deflection, decreased in a linear fashion in A. aurantia, but in N. crucifer increased logarithmically, indicating that N. crucifera threads are better equipped to dissipate energy through droplet elongation. The greater hygroscopicity of A. aurantia threads equips them to function in lower RH environments and during the afternoon when RH drops, but their performance is diminished during the high RH of the morning hours. In contrast, the lower hygroscopicity of N. crucifera threads optimizes their performance for intermediate and high RH environments and during the night and morning. These interspecific differences support the hypothesis that viscous capture threads are adapted to the humidity regime of an orbweavers habitat.
C1 [Opell, Brent D.; Karinshak, Shannon E.; Sigler, Mary A.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.
RP Opell, BD (reprint author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.
EM bopell@vt.edu
OI Speight, Shannon/0000-0002-2079-0973
FU State Council for Higher Education for Virginia
FX Funds from the State Council for Higher Education for Virginia provided
   the digital camera used in this study.
CR Adams MR, 2000, J INSECT BEHAV, V13, P299, DOI 10.1023/A:1007771332721
   Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x
   Agnarsson I, 2009, ZOOLOGY, V112, P325, DOI 10.1016/j.zool.2008.11.003
   Blackledge TA, 2006, ETHOLOGY, V112, P1194, DOI 10.1111/j.1439-0310.2006.01277.x
   Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944
   Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357
   Boutry C, 2010, J EXP BIOL, V213, P3505, DOI 10.1242/jeb.046110
   Carrel JE, 2008, FLA ENTOMOL, V91, P332, DOI 10.1653/0015-4040(2008)91[332:TEOSOF]2.0.CO;2
   Chacon P., 1980, Bulletin of the British Arachnological Society, V5, P29
   Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w
   CODDINGTON JA, 1989, J ARACHNOL, V17, P71
   DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001
   EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055
   Edwards G. B., 1984, ENTOMOLOGY CIRCULAR, V266, P1
   Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097
   ENDERS F, 1977, ANIM BEHAV, V25, P694, DOI 10.1016/0003-3472(77)90119-1
   FISCHER FG, 1960, H-S Z PHYSIOL CHEM, V320, P92, DOI 10.1515/bchm2.1960.320.1.92
   Gosline J. M., 1993, POLYM ADVAN TECHNOL, V544, p[717, 328], DOI [10.1002/pat.1995.220061107, DOI 10.1002/PAT.1995.220061107]
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Higgins LE, 2001, J ARACHNOL, V29, P82, DOI 10.1636/0161-8202(2001)029[0082:VITCCO]2.0.CO;2
   Opell BD, 2010, J EXP BIOL, V213, P339, DOI 10.1242/jeb.036947
   Opell BD, 2007, J EXP BIOL, V210, P2352, DOI 10.1242/jeb.004952
   Opell BD, 2007, J EXP BIOL, V210, P553, DOI 10.1242/jeb.02682
   Opell BD, 2011, J EXP BIOL, V214, P2988, DOI 10.1242/jeb.055996
   Opell BD, 2011, J EXP ZOOL PART A, V315A, P376, DOI 10.1002/jez.684
   Opell BD, 2009, J EXP BIOL, V212, P3026, DOI 10.1242/jeb.030064
   Peters H. M., 1986, ECOPHYSIOLOGY SPIDER, P187
   Puthoff JB, 2010, J EXP BIOL, V213, P3699, DOI 10.1242/jeb.047654
   Rasband WS, 1997, IMAGEJ
   ROSE GD, 1993, ANNU REV BIOPH BIOM, V22, P381, DOI 10.1146/annurev.bb.22.060193.002121
   Sahni V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00041
   Sahni V, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1019
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   TILLINGHAST EK, 1993, MATER RES SOC SYMP P, V292, P9
   TILLINGHAST EK, 1984, J ARACHNOL, V12, P69
   Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147
   TOWNLEY MA, 1991, J EXP ZOOL, V259, P154, DOI 10.1002/jez.1402590203
   VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   WORK RW, 1981, J ARACHNOL, V9, P299
   YOUNG OP, 1990, J ARACHNOL, V18, P1
NR 41
TC 22
Z9 22
U1 0
U2 23
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
J9 J EXP BIOL
JI J. Exp. Biol.
PD AUG
PY 2013
VL 216
IS 16
BP 3023
EP 3034
DI 10.1242/jeb.084822
PG 12
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 188TL
UT WOS:000322216600010
PM 23619400
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Sarkar, D
   Swain, SK
   Adhikari, S
   Reddy, BS
   Maiti, HS
AF Sarkar, Debasish
   Swain, Sanjaya Kumar
   Adhikari, Sangeeta
   Reddy, B. Sambi
   Maiti, Himadri Sekhar
TI Synthesis, mechanical properties and bioactivity of nanostructured
   zirconia
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nanopowders; Zirconia; Bioimplant; Hydroxyapatite
ID SURFACE CHARACTERIZATION; FRACTURE-TOUGHNESS; TRANSFORMATION; CERAMICS;
   HYDROXYAPATITE; BIOMATERIAL; NANOPOWDER; POWDERS
AB Yttria stabilized zirconia 3Y - TZP nanopowders (10-30 nm) are prepared through direct precursor calcination of mixed zirconium oxychloride and yttrium nitrate solutions at 600 degrees C for 2 h. Cuboid(50 x 25 x 20 mm(3)) zirconia blanks are fabricated through centrifuge casting and followed by sintering at 1350 degrees C for 2 h. Sintered zirconia blanks exhibit 24% volume shrinkage and 98% relative density with average grain size of 250 nm. Vickers hardness and indented fracture toughness of sintered blanks are measured as 13.5 GPa and 3.5 MPa.m(1/2), respectively. Bioactivity of nanostructured zirconia originates after four weeks incubation in simulated body fluid solution. An optimum time is required for the deposition of hydroxyapatite nanoparticles on stress-induced nucleation site of nanostructured zirconia. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Sarkar, Debasish; Swain, Sanjaya Kumar; Adhikari, Sangeeta; Reddy, B. Sambi; Maiti, Himadri Sekhar] Natl Inst Technol, Dept Ceram Engn, Rourkela, Orissa, India.
RP Sarkar, D (reprint author), Natl Inst Technol, Dept Ceram Engn, Rourkela, Orissa, India.
EM dsarkar@nitrkl.ac.in; hsmaiti2009@gmail.com
RI Sarkar, Debasish/O-9418-2018
OI Sarkar, Debasish/0000-0002-6712-0520
CR Basu B, 2005, INT MATER REV, V50, P239, DOI 10.1179/174328005X41113
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Cottom BA, 1996, SCRIPTA MATER, V34, P809, DOI 10.1016/1359-6462(95)00587-0
   Guazzato M, 2004, DENT MATER, V20, P449, DOI 10.1016/j.dental.2003.05.002
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   MAITI HS, 1972, J AM CERAM SOC, V55, P317, DOI 10.1111/j.1151-2916.1972.tb11294.x
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   PAPARAZZO E, 1987, J VAC SCI TECHNOL A, V5, P1226, DOI 10.1116/1.574777
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ray JC, 2006, J IND ENG CHEM, V12, P142
   Sarkar D, 2007, COMPOS PART A-APPL S, V38, P124, DOI 10.1016/j.composites.2006.01.005
   Sarkar D, 2007, CERAM INT, V33, P1275, DOI 10.1016/j.ceramint.2006.05.002
   Sarkar D, 2011, J AM CERAM SOC, V94, P213, DOI 10.1111/j.1551-2916.2010.04049.x
   Sarkar D, 2009, J AM CERAM SOC, V92, P2877, DOI 10.1111/j.1551-2916.2009.03316.x
   SUBBARAO EC, 1974, PHYS STATUS SOLIDI A, V21, P9, DOI 10.1002/pssa.2210210102
   Swain SK, 2011, MAT SCI ENG C-MATER, V31, P1240, DOI 10.1016/j.msec.2010.11.014
   Tan QQ, 2003, MATER CHEM PHYS, V80, P615, DOI 10.1016/S0254-0584(03)00103-2
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Uchida M., 2001, J AM CERAM SOC, V84, P204
   Zalga A., 2011, MAT SC MEDZIAGOTYRA, V17, P91
   Zinelis S, 2010, DENT MATER, V26, P295, DOI 10.1016/j.dental.2009.11.079
NR 21
TC 8
Z9 8
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2013
VL 33
IS 6
BP 3413
EP 3417
DI 10.1016/j.msec.2013.04.036
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA 172AT
UT WOS:000320973000040
PM 23706228
DA 2018-10-20
ER

PT J
AU Nagiah, N
   Madhavi, L
   Anitha, R
   Srinivasan, NT
   Sivagnanam, UT
AF Nagiah, Naveen
   Madhavi, Lakshmi
   Anitha, R.
   Srinivasan, Natarajan Tirupattur
   Sivagnanam, Uma Tirichurapalli
TI Electrospinning of poly (3-hydroxybutyric acid) and gelatin blended thin
   films: fabrication, characterization, and application in skin
   regeneration
SO POLYMER BULLETIN
LA English
DT Article
DE Electrospinning; Composites; Thin film; Biomaterial; Skin regeneration
ID NANOFIBERS; SCAFFOLDS; FIBERS; COLLAGEN; BLOOD
AB A tissue engineering scaffold should mimic the structure and biological function of native extracellular matrix proteins. Electrospinning is a simple and versatile method to produce ultrathin fibers for tissue engineering. Blended submicron fibers of poly (3-hydroxybutyric acid) and gelatin were electrospun using 1,1,1,3,3,3 hexafluoro-2-propanol as solvent. Cross linking of fibers was achieved using glutaraldehyde, and the resultant fibers were tested and analyzed using scanning electron microscopy (SEM), differential scanning calorimetry, thermogravimetric analysis, X-ray diffraction, and Fourier transformed infrared spectroscopy (FTIR).The fibers were found to exhibit good tensile strength. Degradation studies were performed and analyzed using SEM and FTIR and proved the stability of fibers for tissue engineering applications. The fibrous scaffold supported the growth and rapid proliferation of human dermal fibroblasts and keratinocytes with normal morphology, thus proving its reliability in using it as a potential scaffold for skin regeneration.
C1 [Nagiah, Naveen; Sivagnanam, Uma Tirichurapalli] Cent Leather Res Inst, Bioprod Lab, Chennai 600020, Tamil Nadu, India.
   [Madhavi, Lakshmi; Anitha, R.] CavinKare Res Ctr, Chennai, Tamil Nadu, India.
   [Srinivasan, Natarajan Tirupattur] Indian Inst Technol, Dept Phys, Conducting Polymers Lab, Madras 600036, Tamil Nadu, India.
RP Sivagnanam, UT (reprint author), Cent Leather Res Inst, Bioprod Lab, Chennai 600020, Tamil Nadu, India.
EM tsn@physics.iitm.ac.in; suma67@gmail.com
RI Tirichurapalli Sivagnanam, uma/E-1325-2017
OI Tirichurapalli Sivagnanam, uma/0000-0002-1401-2569
FU CSIR, Government of India
FX We are grateful to Dr A. B. Mandal, Director, CLRI, Chennai, for his
   kind permission to publish this work. Author N. Naveen acknowledges
   CSIR, Government of India for the financial assistance in the form of
   Senior Research Fellowship. We sincerely thank Dr. Mary Babu, Kanchi
   Kamakotti Child Trust Hospital, Chennai for her guidance through the
   work. We sincerely thank The Director, CTDT, Anna University for their
   helping us in availing the SEM facility.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bergo P, 2007, FOOD HYDROCOLLOID, V21, P1285, DOI 10.1016/j.foodhyd.2006.09.014
   Bit NL, 2012, J BIOMED MATER RES A, V100A, P1751
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Hashim DM, 2010, FOOD CHEM, V118, P856, DOI 10.1016/j.foodchem.2009.05.049
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Kim GM, 2007, J APPL POLYM SCI, V103, P1860, DOI 10.1002/app.25348
   Kim MS, 2010, MACROMOL BIOSCI, V10, P91, DOI 10.1002/mabi.200900168
   Kristin S, 2009, BIOMACROMOLECULES, V10, P1675
   LALEH GM, 2008, BIOMATERIALS, V29, P4532
   Laura AS, 2004, COLLOID SURFACE B, V39, P125
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Li XT, 2008, BIOMATERIALS, V29, P3720, DOI 10.1016/j.biomaterials.2008.06.004
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Meng ZX, 2011, COLLOID SURFACE B, V84, P97, DOI 10.1016/j.colsurfb.2010.12.022
   Mirko N, 2002, J BIOMED MATER RES, V59, P632
   Mustafa K., 2000, APPL ENVIRON MICROB, V66, P3415
   Muyonga JH, 2004, FOOD CHEM, V86, P325, DOI 10.1016/j.foodchem.2003.09.038
   Naveen N, 2010, ADV ENG MATER, V12, pB380, DOI 10.1002/adem.200980067
   Naveen N, 2012, ADV ENG MATER, V14, pB138
   Panprung S., 2008, NANOTECHNOLOGY, V19
   Pim-on R., 2008, POLYMER, V49, P4723
   Piras AM, 2008, J BIOACT COMPAT POL, V23, P423, DOI 10.1177/0883911508093357
   ShA Ashraf, 2010, BIOMACROMOLECULES, V11, P3413
   Sill Travis J, 2008, BIOMATERIALS, V29, P1989
   Theron SA, 2004, POLYMER, V45, P2017, DOI 10.1016/j.polymer.2004.01.024
   WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
   YIN G, 2009, J APPL POLYM SCI, V111, P1471
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhang YZ, 2006, NANOTECHNOLOGY, V17, P901, DOI 10.1088/0957-4484/17/3/047
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 38
TC 20
Z9 21
U1 0
U2 44
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
J9 POLYM BULL
JI Polym. Bull.
PD AUG
PY 2013
VL 70
IS 8
BP 2337
EP 2358
DI 10.1007/s00289-013-0956-6
PG 22
WC Polymer Science
SC Polymer Science
GA 184VM
UT WOS:000321921800014
DA 2018-10-20
ER

PT J
AU Mitra, T
   Sailakshmi, G
   Gnanamani, A
   Mandal, AB
AF Mitra, Tapas
   Sailakshmi, G.
   Gnanamani, A.
   Mandal, A. B.
TI Exploring the dual role of alpha,omega-di-carboxylic acids in the
   preparation of collagen based biomaterial
SO JOURNAL OF POROUS MATERIALS
LA English
DT Article
DE Dicarboxylic acid; Porous membrane; Thermal stability; Mechanical
   stability
ID I COLLAGEN; PEPTIDES
AB Di-carboxylic acids (DCAs), a precursor for many polyamides and polyester preparations, may also find applications in the preparation of high-performance biopolymer material for tissue engineering research. In the present study, collagen, a natural biopolymer when mixed with the chosen DCAs, through ionic interaction between R-COO- and -NH3 (+), dissolution as well as stabilization of collagen was achieved, which obviates the use of carbodiimide activation of -COOH groups of DCA. The DCA engineered collagen biopolymer material obtained in the form of 3D scaffolds was subjected to evaluate its high performance through in vitro and in vivo studies. Results on FT-IR, CD, TGA, DSC, SEM, mechanical properties, docking simulation studies and binding energy calculations explored the interactions and the in vitro cytotoxicity assays and in vivo wound healing studies explored and authenticated the performance of the DCA engineered biopolymer material and suggested the option for tissue engineering research.
C1 [Mitra, Tapas; Sailakshmi, G.; Gnanamani, A.; Mandal, A. B.] Cent Leather Res Inst CSIR, Div Microbiol, Madras 20, Tamil Nadu, India.
RP Gnanamani, A (reprint author), Cent Leather Res Inst CSIR, Div Microbiol, Madras 20, Tamil Nadu, India.
EM gnanamani3@gmail.com
RI Mandal, Asit Baran/B-9977-2009
OI Mitra, Tapas/0000-0003-0813-7389
FU CSIR, New Delhi
FX One of the authors Mr. Tapas Mitra acknowledges CSIR, New Delhi for the
   financial assistance provided in the form of CSIR-SRF. The authors wish
   to thank Dr. Swaraj Sinha and Dr. Suvro Chatterjee, Au-KBC research
   centre, MIT Campus, Anna University, Chennai for their help and
   extending the lab facility to perform cell lines studies.
CR [Anonymous], 2009, ACD CHEMSKETCH VERS
   Barrett DG, 2010, SOFT MATTER, V6, P5026, DOI 10.1039/c0sm00476f
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Everaerts F., 2007, J BIOMED MATER RES A, V85, P547, DOI DOI 10.1002/JBM.A.31524
   Huf S, 2011, EUR J LIPID SCI TECH, V113, P548, DOI 10.1002/ejlt.201000112
   Kim E.S., 2001, FIBER POLYM, V2, P64, DOI DOI 10.1007/BF02875260
   Kumar A, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70202-9
   Lilius H, 1996, TOXICOL IN VITRO, V10, P341, DOI 10.1016/0887-2333(96)00015-X
   Lin YK, 2006, FOOD CHEM, V99, P244, DOI 10.1016/j.foodchem.2005.06.053
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   Majumder S, 2011, J CELL BIOCHEM, V112, P1898, DOI 10.1002/jcb.23110
   Meyer D.C., 2007, CHEM SOC REV, V36, P1705, DOI [10.1039/b513441m, DOI 10.1039/B513441M]
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Nam K, 2008, MACROMOL BIOSCI, V8, P32, DOI 10.1002/mabi.200700206
   Nomura Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1919, DOI 10.1271/bbb.61.1919
   Pavia D..L.G., 2001, INTRO SPECTROSCOPY
   Sacca B, 2002, J MOL BIOL, V324, P309, DOI 10.1016/S0022-2836(02)01065-3
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Sokolsky-Papkov M, 2011, POLYM ADVAN TECHNOL, V22, P502, DOI 10.1002/pat.1541
   Tripathi A, 2011, MACROMOL BIOSCI, V11, P22, DOI 10.1002/mabi.201000286
   Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h
   VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wong S.S., 1991, CHEM PROTEIN CONJUGA, DOI [10.1021/bk-1993-0516, DOI 10.1021/BK-1993-0516]
NR 27
TC 2
Z9 3
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-2224
J9 J POROUS MAT
JI J. Porous Mat.
PD AUG
PY 2013
VL 20
IS 4
BP 647
EP 661
DI 10.1007/s10934-012-9638-2
PG 15
WC Chemistry, Applied; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 174BG
UT WOS:000321127100009
DA 2018-10-20
ER

PT J
AU Wu, M
   Ni, CH
   Yao, BL
   Zhu, CP
   Huang, B
   Zhang, LP
AF Wu, Min
   Ni, Caihua
   Yao, Bolong
   Zhu, Changping
   Huang, Bo
   Zhang, Liping
TI Covalently cross-linked and hydrophobically modified alginic acid
   hydrogels and their application as drug carriers
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
ID SALT MEDIA; GEL BEADS; RELEASE; SURFACTANTS; DERIVATIVES
AB Covalently crosslinked and hydrophobically modified alginate hydrogels were prepared through esterification of alginic acid (ALG-H) with 1,10-decanediol that functioned as a crosslinking agent and hydrophobic component. The preparation was accomplished with one step and was carried out in N,N-dimethylformamide solution at a reduced pressure for removing the water produced. The characterization results confirmed the esterification of the products. The modified alginate hydrogels could be used as drug delivery vehicles for controlled release. The drug release study revealed that compared with a calcium alginate hydrogel the modified hydrogels possessed improved loading rate and encapsulation efficiency for the hydrophobic drug(ibuprofen), and a remarkable sustained release behavior was observed. The release kinetics was close to zero order, a desirable drug release pattern. The modified alginate hydrogels were nontoxic and were potentially applicable as a promising biomaterial. POLYM. ENG. SCI., 2013. (c) 2012 Society of Plastics Engineers
C1 [Wu, Min; Ni, Caihua; Yao, Bolong; Zhang, Liping] Jiangnan Univ, Sch Chem & Mat Engn, Key Lab Food Colloids & Biotechnol, Minist Educ, Wuxi 214122, Peoples R China.
   [Zhu, Changping; Huang, Bo] Hohai Univ, Coll Comp & Informat Engn, State Key Lab Hydrol Water Resources & Hydraul En, Changzhou, Peoples R China.
RP Ni, CH (reprint author), Hohai Univ, Coll Comp & Informat Engn, State Key Lab Hydrol Water Resources & Hydraul En, Changzhou, Peoples R China.
EM nicaihua2000@163.com
FU Science and Technology Support Program of Jiangsu Province [BE2012017];
   National Natural Science Foundation of China [11274092]; State Key
   Laboratory of Hydrology-Water Resources and Hydraulic Engineering, Hohai
   University [2010490911]
FX Contract grant sponsor: Science and Technology Support Program of
   Jiangsu Province; contract grant number: BE2012017; contract grant
   sponsor: National Natural Science Foundation of China; contract grant
   number: 11274092; contract grant sponsor: State Key Laboratory of
   Hydrology-Water Resources and Hydraulic Engineering, Hohai University;
   contract grant number: 2010490911.
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Babak VG, 2000, J COLLOID INTERF SCI, V225, P505, DOI 10.1006/jcis.2000.6788
   Broderick E, 2006, J COLLOID INTERF SCI, V298, P154, DOI 10.1016/j.jcis.2005.12.026
   Bu HT, 2004, BIOMACROMOLECULES, V5, P1470, DOI 10.1021/bm049947+
   Chan AW, 2009, BIOMACROMOLECULES, V10, P609, DOI 10.1021/bm801316z
   Colinet I, 2009, CARBOHYD POLYM, V77, P743, DOI 10.1016/j.carbpol.2009.03.019
   Colinet I, 2009, CARBOHYD POLYM, V75, P454, DOI 10.1016/j.carbpol.2008.08.002
   De Boisseson MR, 2004, J COLLOID INTERF SCI, V273, P131, DOI 10.1016/j.jcis.2003.12.064
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Kang HA, 2002, J CHEM TECHNOL BIOT, V77, P205, DOI 10.1002/jctb.550
   Laurienzo P, 2005, CARBOHYD POLYM, V62, P274, DOI 10.1016/j.carbpol.2005.08.005
   Leonard M, 2004, J CONTROL RELEASE, V98, P395, DOI 10.1016/j.jconrel.2004.05.009
   Li L, 1999, THERMOCHIM ACTA, V342, P53, DOI 10.1016/S0040-6031(99)00305-6
   Pelletier S, 2000, CARBOHYD POLYM, V43, P343, DOI 10.1016/S0144-8617(00)00188-0
   Rousseau I, 2004, EUR POLYM J, V40, P2709, DOI 10.1016/j.eurpolymj.2004.07.022
   Sriamornsak P, 2011, CARBOHYD POLYM, V84, P1208, DOI 10.1016/j.carbpol.2010.12.065
   Walewijk A, 2008, FOOD HYDROCOLLOID, V22, P91, DOI [10.1016/j.foodhyd.2007.05.005, 10.1016/j.foodliyd.2007.05.005]
   Xiao CM, 2006, J APPL POLYM SCI, V102, P4850, DOI 10.1002/app.24826
   Yao BL, 2010, BIOPROC BIOSYST ENG, V33, P457, DOI 10.1007/s00449-009-0349-2
NR 19
TC 5
Z9 5
U1 2
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0032-3888
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PD AUG
PY 2013
VL 53
IS 8
BP 1583
EP 1589
DI 10.1002/pen.23415
PG 7
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 183NB
UT WOS:000321821700001
DA 2018-10-20
ER

PT J
AU Heard, AJ
   Socrate, S
   Burke, KA
   Norwitz, ER
   Kaplan, DL
   House, MD
AF Heard, Asha J.
   Socrate, Simona
   Burke, Kelly A.
   Norwitz, Errol R.
   Kaplan, David L.
   House, Michael D.
TI Silk-Based Injectable Biomaterial as an Alternative to Cervical
   Cerclage: An In Vitro Study
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE cerclage; cervix; injectable biomaterial; silk; preterm birth
ID PRETERM BIRTH; CONTROLLED-TRIAL; FIBROIN; WOMEN; DELIVERY; TISSUE; RISK;
   PROGESTERONE; SPECTROSCOPY; SCAFFOLDS
AB Objective:
   New therapies to prevent preterm birth are needed. Our objective was to study an injectable biomaterial for human cervical tissue as an alternative to cervical cerclage.
   Study Design:
   Human cervical tissue specimens were obtained from premenopausal gynecological hysterectomies for benign indications. A 3-part biomaterial was formulated, consisting of silk protein solution blended with a 2-part polyethylene glycol gelation system. The solutions were injected into cervical tissue and the tissue was evaluated for mechanical properties, swelling, cytocompatibility, and histology.
   Results:
   The stiffness of cervical tissue more than doubled after injection (P = .02). Swelling properties of injected tissue were no different than native tissue controls. Cervical fibroblasts remained viable for at least 48 hours when cultured on the biomaterial.
   Conclusions:
   We report a silk-based, biocompatible, injectable biomaterial that increased the stiffness of cervical tissue compared to uninjected controls. Animal studies are needed to assess this biomaterial in vivo.
C1 [Heard, Asha J.; Norwitz, Errol R.; House, Michael D.] Tufts Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Boston, MA 02111 USA.
   [Socrate, Simona] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Burke, Kelly A.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Medford, MA 02155 USA.
   Tufts Med Ctr, Boston, MA 02111 USA.
   MIT, Cambridge, MA 02139 USA.
RP House, MD (reprint author), Tufts Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, 800 Washington St,Box 360, Boston, MA 02111 USA.
EM mhouse@tuftsmedicalcenter.org
FU Reproductive Scientist Development Program (NICHD); March of Dimes Birth
   Defects Foundation; Tissue Engineering Resource Center (TERC) from the
   National Institute of Biomedical Imaging and Bioengineering [EB002520]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article:
   Reproductive Scientist Development Program (NICHD), March of Dimes Birth
   Defects Foundation, Tissue Engineering Resource Center (TERC) from the
   National Institute of Biomedical Imaging and Bioengineering (EB002520).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Berghella V, 2005, OBSTET GYNECOL, V106, P181, DOI 10.1097/01.AOG.0000168435.17200.53
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Daskalakis G, 2006, OBSTET GYNECOL, V107, P221, DOI 10.1097/01.AOG.0000187896.04535.e6
   Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815
   Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017
   House M, 2006, ULTRASOUND OBST GYN, V28, P745, DOI 10.1002/uog.3850
   House M, 2010, TISSUE ENG PT A, V16, P2101, DOI [10.1089/ten.tea.2009.0457, 10.1089/ten.TEA.2009.0457]
   House M, 2009, SEMIN PERINATOL, V33, P300, DOI 10.1053/j.semperi.2009.06.002
   Hu X, 2011, BIOMATERIALS, V31, P8121
   Hu X, 2010, BIOMACROMOLECULES
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004
   Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904
   Institute of Medicine, 2006, PRETERM BIRTH CAUSES
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Landy HJ, 2011, OBSTET GYNECOL, V117, P627, DOI 10.1097/AOG.0b013e31820afaf2
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1
   Mathews T J, 2010, Natl Vital Stat Rep, V58, P1
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Myers KM, 2008, ACTA BIOMATER, V4, P104, DOI 10.1016/j.actbio.2007.04.009
   Myers KM, 2010, J BIOMECH ENG, V132
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   OSMERS R, 1993, OBSTET GYNECOL, V81, P88
   Owen J, 2001, JAMA-J AM MED ASSOC, V286, P1340, DOI 10.1001/jama.286.11.1340
   Owen J, 2009, AM J OBSTET GYNECOL, V201, pe371
   Pereira L, 2007, AM J OBSTET GYNECOL, V197
   Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1
   Serban MA, 2011, J BIOMED MATER RES A, V98A, P567, DOI 10.1002/jbm.a.33149
   Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x
   Straach KJ, 2005, GLYCOBIOLOGY, V15, P55, DOI 10.1093/glycob/cwh137
   To MS, 2004, LANCET, V363, P1849, DOI 10.1016/S0140-6736(04)16351-4
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yucel T, 2010, J STRUCT BIOL, V170, P406, DOI 10.1016/j.jsb.2009.12.012
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
NR 38
TC 8
Z9 8
U1 1
U2 21
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
J9 REPROD SCI
JI Reprod. Sci.
PD AUG
PY 2013
VL 20
IS 8
BP 929
EP 936
DI 10.1177/1933719112468952
PG 8
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 183OF
UT WOS:000321825500009
PM 23271162
OA Green Published
DA 2018-10-20
ER

PT J
AU Danielson, J
   Karlbom, U
   Wester, T
   Graf, W
AF Danielson, J.
   Karlbom, U.
   Wester, T.
   Graf, W.
TI Efficacy and quality of life 2 years after treatment for faecal
   incontinence with injectable bulking agents
SO TECHNIQUES IN COLOPROCTOLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons /
   General Surgery Resident's Forum
CY APR 27-MAY 01, 2013
CL Phoenix, AZ
SP Amer Soc Colon & Rectal Surg
DE Anal incontinence; Treatment; Injection therapy; NASHA/Dx
ID SILICONE BIOMATERIAL; HYALURONIC-ACID; VESICOURETERAL REFLUX;
   DEXTRANOMER; INJECTION; IMPLANTS; GEL
AB Stabilized non-animal hyaluronic acid/dextranomer (NASHA(A (R)) Dx) gel as injectable bulking therapy has been shown to decrease symptoms of faecal incontinence, but the durability of treatment and effects and influence on quality of life (QoL) is not known. The aim of this study was to assess the effects on continence and QoL and to evaluate the relationship between QoL and efficacy up to 2 years after treatment.
   Thirty-four patients (5 males, mean age 61, range 34-80) were injected with 4 x 1 ml NASHA Dx in the submucosal layer. The patients were followed for 2 years with registration of incontinence episodes, bowel function and QoL questionnaires.
   Twenty-six patients reported sustained improvement after 24 months. The median number of incontinence episodes before treatment was 22 and decreased to 10 at 12 months (P = 0.0004) and to 7 at 24 months (P = 0.0026). The corresponding Miller incontinence scores were 14, 11 (P = 0.0078) and 10.5 (P = 0.0003), respectively. There was a clear correlation between the decrease in the number of leak episodes and the increase in the SF-36 Physical Function score but only patients with more than 75 % improvement in the number of incontinence episodes had a significant improvement in QoL at 24 months.
   Anorectal injection of NASHA Dx gel induces improvement of incontinence symptoms for at least 2 years. The treatment has a potential to improve QoL. A 75 % decrease in incontinence episodes may be a more accurate threshold to indicate a successful incontinence treatment than the more commonly used 50 %.
C1 [Danielson, J.; Karlbom, U.; Graf, W.] Uppsala Univ, Inst Surg Sci, Uppsala, Sweden.
   [Danielson, J.] Uppsala Univ, Inst Womens & Childrens Hlth, Uppsala, Sweden.
   [Danielson, J.] Akad Sjukhuset, Dept Pediat Surg, S-75185 Uppsala, Sweden.
   [Karlbom, U.; Graf, W.] Akad Sjukhuset, Dept Surg, S-75185 Uppsala, Sweden.
   [Wester, T.] Karolinska Univ Hosp, Dept Pediat Surg, Stockholm, Sweden.
   [Wester, T.] Karolinska Inst, Stockholm, Sweden.
RP Danielson, J (reprint author), Akad Sjukhuset, Dept Pediat Surg, S-75185 Uppsala, Sweden.
EM johan.danielsson@akademiska.se
OI Danielson, Johan/0000-0002-5071-3127
FU Q-Med AB (Uppsala, Sweden)
FX The study was supported by a grant from Q-Med AB (Uppsala, Sweden),
   which also provided Solesta (R) for the study.
CR Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Chapple CR, 2005, EUR UROL, V48, P488, DOI 10.1016/j.eururo.2005.05.007
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   de la Portilla F, 2009, TECH COLOPROCTOL, V13, P195, DOI 10.1007/s10151-009-0502-6
   Gourcerol G, 2007, DIS COLON RECTUM, V50, P3, DOI 10.1007/s10350-006-0746-4
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Gustafsson U M, 2001, Colorectal Dis, V3, P189, DOI 10.1046/j.1463-1318.2001.00241.x
   Hussain ZI, 2011, BRIT J SURG, V98, P1526, DOI 10.1002/bjs.7645
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   MILLER R, 1988, BRIT J SURG, V75, P101, DOI 10.1002/bjs.1800750204
   Osterberg A, 1996, SCAND J GASTROENTERO, V31, P575, DOI 10.3109/00365529609009130
   Ratto C, 2011, BRIT J SURG, V98, P1644, DOI 10.1002/bjs.7699
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Stenberg A, 1999, SCAND J UROL NEPHROL, V33, P355
   Stenberg A, 2003, J UROLOGY, V169, P1109, DOI 10.1097/01.ju.0000053013.49676.89
   Sullivan M, 2002, SF 36 HALSOENKAT SVE
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   Yu RN, 2006, PEDIATRICS, V118, P698, DOI 10.1542/peds.2006-0178
NR 20
TC 9
Z9 10
U1 0
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1123-6337
EI 1128-045X
J9 TECH COLOPROCTOL
JI Tech. Coloproctology
PD AUG
PY 2013
VL 17
IS 4
BP 389
EP 395
DI 10.1007/s10151-012-0949-8
PG 7
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 184TF
UT WOS:000321915700010
PM 23224913
DA 2018-10-20
ER

PT J
AU Shukla, SK
   Mishra, AK
   Arotiba, OA
   Mamba, BB
AF Shukla, Sudheesh K.
   Mishra, Ajay K.
   Arotiba, Omotayo A.
   Mamba, Bhekie B.
TI Chitosan-based nanomaterials: A state-of-the-art review
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Review
DE Nanomaterials; Nanocomposites; Chitosan; Water-treatment;
   Electrochemical; Biosensor
ID TISSUE ENGINEERING APPLICATIONS; CONTROLLED DRUG-DELIVERY;
   ELECTROCHEMICALLY DEPOSITED NANOCOMPOSITE; WATER-SOLUBLE CHITIN; GLUCOSE
   BIOSENSOR; CONTROLLED-RELEASE; CARBON NANOTUBES; BIOMEDICAL
   APPLICATIONS; GOLD NANOPARTICLES; POLYMER BLENDS
AB This manuscript briefly reviews the extensive research as well as new developments on chitosan based nanomaterials for various applications. Chitosan is a biocompatible and biodegradable polymer having immense structural possibilities for chemical and mechanical modification to generate novel properties and functions in different fields especially in the biomedical field. Over the last era, research in functional biomaterials such as chitosan has led to the development of new drug delivery system and superior regenerative medicine, currently one of the most quickly growing fields in the area of health science. Chitosan is known as a biomaterial due to its biocompatibility, biodegradability, and non-toxic properties. These properties clearly point out that chitosan has greater potential for future development in different fields of science namely drug delivery, gene delivery, cell imaging, sensors and also in the treatment as well as diagnosis of some diseases like cancer. Chitosan based nanomaterials have superior physical and chemical properties such as high surface area, porosity, tensile strength, conductivity, photo-luminescent as well as increased mechanical properties as comparison to pure chitosan. This review highlights the recent research on different aspect of chitosan based nanomaterials, including their preparation and, application. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Shukla, Sudheesh K.; Mishra, Ajay K.; Arotiba, Omotayo A.; Mamba, Bhekie B.] Univ Johannesburg, Dept Appl Chem, ZA-2028 Johannesburg, South Africa.
RP Mishra, AK (reprint author), Univ Johannesburg, Dept Appl Chem, POB 17011, ZA-2028 Johannesburg, South Africa.
EM amishra@uj.ac.za
RI Mamba, Bhekie/P-4940-2014; Mishra, Ajay/A-4668-2015; Arotiba,
   Omotayo/B-4946-2011
OI Mamba, Bhekie/0000-0003-2534-2579; Mishra, Ajay/0000-0002-3743-8669;
   Arotiba, Omotayo/0000-0002-8227-8684; Mishra, Ajay/0000-0002-4727-0943
CR Aberg A.M., 2004, AGR FOOD CHEM, V52, P788
   Abolhasani MM, 2010, J POLYM SCI POL PHYS, V48, P251, DOI 10.1002/polb.21857
   Agrawal P., 2009, ADV DRUG DELIV REV, V62, P42
   Al-Remawi M.M., 2012, AM J APPL SCI, V9, P1091
   Alaejos MS, 2004, CHEM REV, V104, P3239, DOI 10.1021/cr0304471
   Andersson M, 2003, INT J PHARM, V257, P305, DOI 10.1016/S0378-5173(03)00131-5
   Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Aoi K, 2002, MACROMOL CHEM PHYS, V203, P2650, DOI 10.1002/macp.200290040
   Aranaz I, 2009, CURR CHEM BIOL, V3, P203, DOI DOI 10.2174/187231309788166415
   Avadi MR, 2003, J BIOACT COMPAT POL, V18, P469, DOI 10.1177/0883911503040432
   Avadi MR, 2004, EUR POLYM J, V40, P1355, DOI 10.1016/j.europolymj.2004.02.015
   Averous L, 2000, J APPL POLYM SCI, V76, P1117, DOI 10.1002/(SICI)1097-4628(20000516)76:7<1117::AID-APP16>3.0.CO;2-W
   Bagheri-Khoulenjani S, 2009, CARBOHYD POLYM, V78, P773, DOI 10.1016/j.carbpol.2009.06.020
   Banerjee T, 2002, INT J PHARM, V243, P93, DOI 10.1016/S0378-5173(02)00267-3
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   BERSCHT PC, 1994, BIOMATERIALS, V15, P593, DOI 10.1016/0142-9612(94)90209-7
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   Boucard N, 2005, BIOMACROMOLECULES, V6, P3227, DOI 10.1021/bm050653d
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Chauhan N, 2012, INT J BIOL MACROMOL, V51, P879, DOI 10.1016/j.ijbiomac.2012.08.008
   Che X, 2011, COLLOID SURFACE B, V84, P454, DOI 10.1016/j.colsurfb.2011.01.041
   Chen TH, 2000, BIOTECHNOL BIOENG, V70, P564, DOI 10.1002/1097-0290(20001205)70:5<564::AID-BIT11>3.0.CO;2-W
   Chouwatat P., 2010, J MET MAT MINER, V20, P41
   Chung YC, 2003, BIORESOURCE TECHNOL, V88, P179, DOI 10.1016/S0960-8524(03)00002-6
   Conti B., 1998, P INT S CONTR REL BI, V25, P822
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   Croisier F., 2013, EUR POLYM J, DOI DOI 10.1016/J.EURP0LYMJ.2012.12.009
   Dai H, 2010, BIOSENS BIOELECTRON, V25, P1414, DOI 10.1016/j.bios.2009.10.042
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   de la Torre PM, 2003, BIOMATERIALS, V24, P1499
   De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495
   Devlieghere F, 2004, FOOD MICROBIOL, V21, P703, DOI 10.1016/j.fm.2004.02.008
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   Edwards W, 1999, ENZYME MICROB TECH, V24, P209, DOI 10.1016/S0141-0229(98)00110-0
   Edwards W, 1999, ENZYME MICROB TECH, V25, P769, DOI 10.1016/S0141-0229(99)00116-7
   Eidelman N, 2004, J RES NATL INST STAN, V109, P219, DOI 10.6028/jres.109.014
   El-hefian EA, 2010, MAEJO INT J SCI TECH, V4, P210
   Evans JR, 2002, WATER RES, V36, P3219, DOI 10.1016/S0043-1354(02)00044-1
   Faraday M., 1857, PHILOS T ROY SOC LON, V147, P145, DOI DOI 10.1098/RSTL.1857.0011
   Fernandez-Urrusuno R, 1999, PHARMACEUT RES, V16, P1576, DOI 10.1023/A:1018908705446
   Fernandez-Urrusuno R, 1999, STP PHARMA SCI, V9, P429
   Fierro S, 2008, BIORESOURCE TECHNOL, V99, P1274, DOI 10.1016/j.biortech.2007.02.043
   Gandhi MR, 2010, INT J BIOL MACROMOL, V47, P146, DOI 10.1016/j.ijbiomac.2010.05.008
   Ganza-Gonzalez A, 1999, EUR J PHARM BIOPHARM, V48, P149, DOI 10.1016/S0939-6411(99)00040-5
   GIBSON HW, 1980, MACROMOLECULES, V13, P34, DOI 10.1021/ma60073a007
   Giunchedi P, 1998, BIOMATERIALS, V19, P157, DOI 10.1016/S0142-9612(97)00181-6
   Gonzalez-Rodriguez ML, 2002, INT J PHARM, V232, P225, DOI 10.1016/S0378-5173(01)00915-2
   Grizzuti N, 2000, J RHEOL, V44, P149, DOI 10.1122/1.551073
   Guibal E, 2005, PROG POLYM SCI, V30, P71, DOI 10.1016/j.progpolymsci.2004.12.001
   Ham-Pichavant F, 2005, CARBOHYD POLYM, V61, P259, DOI 10.1016/j.carbpol.2005.01.020
   He P, 1999, INT J PHARM, V187, P53, DOI 10.1016/S0378-5173(99)00125-8
   HIRANO S, 1990, PROGRESS IN BIOMEDICAL POLYMERS, P283
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Hoppe-Seiler F., 1994, BER DTSCH CHEM GES, V27, P3329
   Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2
   Jaworska M, 2003, POLYM INT, V52, P206, DOI 10.1002/pi.1160
   Jaworska M, 2003, POLYM INT, V52, P198, DOI 10.1002/pi.1159
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   Jayakumar R, 2006, J BIOACT COMPAT POL, V21, P327, DOI 10.1177/0883911506066929
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jayakumar R, 2010, CARBOHYD POLYM, V79, P1, DOI 10.1016/j.carbpol.2009.08.026
   Jayakumar R, 2009, INT J BIOL MACROMOL, V45, P135, DOI 10.1016/j.ijbiomac.2009.04.016
   Jayakumar R, 2008, MACROMOL SYMP, V264, P163, DOI 10.1002/masy.200850426
   Jenkins DW, 2001, CHEM REV, V101, P3245, DOI 10.1021/cr000257f
   Kang XH, 2009, BIOSENS BIOELECTRON, V25, P901, DOI 10.1016/j.bios.2009.09.004
   Kaushik A, 2009, SENSOR ACTUAT B-CHEM, V138, P572, DOI 10.1016/j.snb.2009.02.005
   Khoo CGL, 2003, EUR J PHARM BIOPHARM, V55, P47, DOI 10.1016/S0939-6411(02)00155-8
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kolhe P, 2003, BIOMACROMOLECULES, V4, P173, DOI 10.1021/bm025689+
   Kolodynska D, 2011, CHEM ENG J, V173, P520, DOI 10.1016/j.cej.2011.08.025
   Krouse S.A., 1987, MACROMOLECULES, V20, P904
   Kulys J., 2008, OPEN NANOSCI J, V2, P34
   Kumar G, 1999, BIOTECHNOL BIOENG, V63, P154, DOI 10.1002/(SICI)1097-0290(19990420)63:2<154::AID-BIT4>3.3.CO;2-I
   KURITA K, 1986, J APPL POLYM SCI, V31, P1169, DOI 10.1002/app.1986.070310502
   Kurita K, 1998, POLYM DEGRAD STABIL, V59, P117, DOI 10.1016/S0141-3910(97)00160-2
   KURITA K, 1988, POLYM J, V20, P1083, DOI 10.1295/polymj.20.1083
   Kurita K, 2002, BIOMACROMOLECULES, V3, P147, DOI 10.1021/bm0101320
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Kurita K., 1996, CHITIN CHITOSAN GRAF, V2
   Kyzas GZ, 2009, CHEM ENG J, V152, P440, DOI 10.1016/j.cej.2009.05.005
   Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Li HB, 2011, DESALINATION, V278, P397, DOI 10.1016/j.desal.2011.05.056
   Li J, 2002, ANAL CHEM, V74, P3336, DOI 10.1021/ac015653s
   Lin YH, 2007, BIOMACROMOLECULES, V8, P146, DOI 10.1021/bm0607776
   Luo XL, 2005, CHEM COMMUN, P2169, DOI 10.1039/b419197h
   Madhumathi K, 2010, J MATER SCI-MATER M, V21, P807, DOI 10.1007/s10856-009-3877-z
   Madhumathi K, 2009, INT J BIOL MACROMOL, V44, P1, DOI 10.1016/j.ijbiomac.2008.09.013
   Marsano E, 2005, POLYMER, V46, P1595, DOI 10.1016/j.polymer.2004.12.017
   MECLEAN S, 1998, EUR J PHARM SCI, V6, P153
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Mi FL, 1999, J APPL POLYM SCI, V74, P1868, DOI 10.1002/(SICI)1097-4628(19991114)74:7<1868::AID-APP32>3.0.CO;2-N
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   Mourya V.K., 2010, ADV MAT LETT, V1, P11, DOI DOI 10.5185/AMLETT.2010.3108
   Muzzarelli C, 2003, CARBOHYD RES, V338, P2247, DOI 10.1016/S0008-6215(03)00373-2
   Muzzarelli C, 2002, TRENDS GLYCOSCI GLYC, V14, P223, DOI 10.4052/tigg.14.223
   Muzzarelli RAA, 2005, ADV POLYM SCI, V186, P151, DOI 10.1007/b136820
   Nagahama H, 2008, CARBOHYD POLYM, V73, P456, DOI 10.1016/j.carbpol.2007.12.011
   Nagahama H, 2008, CARBOHYD POLYM, V73, P295, DOI 10.1016/j.carbpol.2007.11.034
   Ng JCY, 2002, J COLLOID INTERF SCI, V255, P64, DOI 10.1006/jcis.2002.8664
   Ng LT, 2005, CARBOHYD POLYM, V60, P523, DOI 10.1016/j.carbpol.2005.03.009
   Norouzi P, 2010, INT J ELECTROCHEM SC, V5, P1434
   Northcott KA, 2005, CHEM ENG SCI, V60, P6835, DOI 10.1016/j.ces.2005.05.049
   Ohya Y, 2000, STP PHARMA SCI, V10, P77
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Pan Y, 2002, INT J PHARM, V249, P139, DOI 10.1016/S0378-5173(02)00486-6
   Park SY, 2001, FOOD HYDROCOLLOID, V15, P499, DOI 10.1016/S0268-005X(01)00055-8
   Paul W, 2000, STP PHARMA SCI, V10, P5
   Payne GF, 1996, POLYMER, V37, P4643, DOI 10.1016/0032-3861(96)00338-2
   PETER MG, 2000, ADV CHITIN SCI, V4
   Pospisil J, 1999, POLYM DEGRAD STABIL, V65, P405, DOI 10.1016/S0141-3910(99)00029-4
   Prabaharan M, 2007, REACT FUNCT POLYM, V67, P43, DOI 10.1016/j.reactfunctpolym.2006.09.001
   Prabaharan M, 2006, CARBOHYD POLYM, V63, P153, DOI 10.1016/j.carbpol.2005.08.051
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Prabaharan M, 2008, J BIOMATER APPL, V23, P5, DOI 10.1177/0885328208091562
   Prion E., 1997, LANGMUIR, V13, P1653
   Pumera M, 2007, SENSOR ACTUAT B-CHEM, V123, P1195, DOI 10.1016/j.snb.2006.11.016
   Qiu JD, 2009, BIOSENS BIOELECTRON, V24, P2920, DOI 10.1016/j.bios.2009.02.029
   Qu X, 1999, J APPL POLYM SCI, V74, P3193, DOI 10.1002/(SICI)1097-4628(19991220)74:13<3193::AID-APP23>3.0.CO;2-V
   Ravi Kumar M. N. V., 2004, CHEM REV, V104, P6017
   RAVIKUMAR MNV, 2000, REACT FUNCT POLYM, V46, P1
   Rege PR, 2003, INT J PHARM, V252, P41, DOI 10.1016/S0378-5173(02)00604-X
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   ROBERTS G. A. F, 1992, CHITIN CHEM, V1st, P1
   Safavi A, 2011, BIOSENS BIOELECTRON, V26, P2547, DOI 10.1016/j.bios.2010.11.002
   Sandri G, 2007, EUR J PHARM BIOPHARM, V65, P68, DOI 10.1016/j.ejpb.2006.07.016
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Sebastien F, 2006, CARBOHYD POLYM, V65, P185, DOI 10.1016/j.carbpol.2006.01.006
   Shan CS, 2010, BIOSENS BIOELECTRON, V25, P1070, DOI 10.1016/j.bios.2009.09.024
   Shi XY, 2002, BIOMATERIALS, V23, P4469, DOI 10.1016/S0142-9612(02)00165-5
   Shukla SK, 2012, TALANTA, V99, P283, DOI 10.1016/j.talanta.2012.05.052
   Shukla SK, 2011, ADV MATER RES-SWITZ, V306-307, P82, DOI 10.4028/www.scientific.net/AMR.306-307.82
   Shukla S.K., 2013, AMORPHOUS MAT NEW RE, P83
   Sinkowska A., 2005, POLYM DEGRADATION ST, V88, P261
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Strobl G., 1996, PHYS POLYM CONCEPT U
   SUDARSHAN NR, 1992, FOOD BIOTECHNOL, V6, P257, DOI 10.1080/08905439209549838
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun LP, 2006, CARBOHYD POLYM, V66, P168, DOI 10.1016/j.carbpol.2006.02.036
   Suntornsuk W, 2002, PROCESS BIOCHEM, V37, P727, DOI 10.1016/S0032-9592(01)00265-5
   Sureshkumar P. R., 2011, INT J COMPREHENSIVE, V2, P1
   Teles FRR, 2008, MAT SCI ENG C-BIO S, V28, P1530, DOI 10.1016/j.msec.2008.04.010
   Tiwari A, 2007, EXPRESS POLYM LETT, V1, P308, DOI 10.3144/expresspolymlett.2007.44
   Tiwari A, 2009, EXPRESS POLYM LETT, V3, P553, DOI 10.3144/expresspolymlett.2009.69
   Tiwari AD, 2011, INT J BIOL MACROMOL, V48, P682, DOI 10.1016/j.ijbiomac.2011.02.008
   Tiwari A, 2008, ELECTROANAL, V20, P2119, DOI 10.1002/elan.200804296
   Tiwari A, 2008, ELECTROANAL, V20, P1775, DOI 10.1002/elan.200804237
   Tiwari A, 2011, ANAL METHODS-UK, V3, P217, DOI 10.1039/c0ay00574f
   Tiwari A, 2009, J INORG ORGANOMET P, V19, P361, DOI 10.1007/s10904-009-9280-x
   Tiwari A, 2009, INT J BIOL MACROMOL, V44, P408, DOI 10.1016/j.ijbiomac.2009.03.002
   Tiwari A, 2009, TALANTA, V77, P1217, DOI 10.1016/j.talanta.2008.08.029
   Tobio M, 2000, COLLOID SURFACE B, V18, P315, DOI 10.1016/S0927-7765(99)00157-5
   Tucker CL, 2002, ANNU REV FLUID MECH, V34, P177, DOI 10.1146/annurev.fluid.34.082301.144051
   URAGAMI T, 1983, J APPL POLYM SCI, V28, P1361, DOI 10.1002/app.1983.070280410
   Valev R., 2003, NATURE, V419, P887
   Vitalia L, 2008, INT J BIOL MACROMOL, V42, P152, DOI 10.1016/j.ijbiomac.2007.10.020
   Wang L, 2008, BIORESOURCE TECHNOL, V99, P1403, DOI 10.1016/j.biortech.2007.01.063
   Wang SF, 2008, BIOSENS BIOELECTRON, V23, P1781, DOI 10.1016/j.bios.2008.02.014
   Xu YM, 2003, INT J PHARM, V250, P215, DOI 10.1016/S0378-5173(02)00548-3
   Yamomoto H., 2000, STP PHARMA SCI, V10, P63
   Yang J, 2008, J BIOMED MATER RES B, V84B, P131, DOI 10.1002/jbm.b.30853
   Yang SC, 2000, COLLOID POLYM SCI, V278, P285, DOI 10.1007/s003960050516
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Yu L, 2006, PROG POLYM SCI, V31, P576, DOI 10.1016/j.progpolymsci.2006.03.002
   Yuwei C., 2011, CHEM ENG J, V168, P286, DOI DOI 10.1016/J.CEJ.2011.01.006
   Zeng Q, 2011, BIOSENS BIOELECTRON, V26, P3456, DOI 10.1016/j.bios.2011.01.024
   Zhai XR, 2006, ANAL LETT, V39, P913, DOI 10.1080/00032710600614057
   Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhang MG, 2011, ELECTROANAL, V23, P1856, DOI 10.1002/elan.201100078
   Zhang YY, 2008, J APPL POLYM SCI, V107, P891, DOI 10.1002/app.26402
   Zhao L, 2006, CARBOHYD POLYM, V64, P473, DOI 10.1016/j.carbpol.2005.12.014
   Zou YJ, 2008, BIOSENS BIOELECTRON, V23, P1010, DOI 10.1016/j.bios.2007.10.009
NR 181
TC 228
Z9 231
U1 27
U2 545
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2013
VL 59
BP 46
EP 58
DI 10.1016/j.ijbiomac.2013.04.043
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 175KG
UT WOS:000321229000006
PM 23608103
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Baysal, K
   Aroguz, AZ
   Adiguzel, Z
   Baysal, BM
AF Baysal, Kemal
   Aroguz, Ayse Z.
   Adiguzel, Zelal
   Baysal, Bahattin M.
TI Chitosan/alginate crosslinked hydrogels: Preparation, characterization
   and application for cell growth purposes
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan; Hydrogel; Alginate; Tissue engineering; Biopolymer
ID BIOMEDICAL APPLICATIONS; CHITOSAN-ALGINATE; DRUG-RELEASE; SCAFFOLDS;
   POLYCAPROLACTONE; GEL; FIBERS
AB Chitosan hydrogels may be formed by various mechanisms. In this study, we aimed to form hybrid polymer networks of chitosan with alginate using a crosslinker which enabled the covalent binding of the two macromolecules. The structural and thermal characterization of these hydrogels was performed by using Fourier transform infrared (FTIR) and differential scanning calorimeter (DSC). The morphological analysis of the crosslinked material was investigated by scanning electron microscopy (SEM) and a scanning probe microscope with atomic force microscope (AFM) attachment. The swelling properties of these gels were analyzed in water and in phosphate buffered saline (PBS) solution. The presence of alginate in a chitosan/alginate hydrogel was shown to support the hydrogel stability. Compared to chitosan/alginate (1/2) hydrogel prepared with 1 wt% DCC, the swelling of chitosan/alginate (1/2) hydrogels prepared with 3 wt% DCC was limited. To measure the degree of cell proliferation, the hydrogels were seeded with L929 mouse fibroblasts and cell numbers measured by neutral red uptake assay. The cell attachment was also followed by (SEM) photography. It was observed that chitosan/alginate (1/2) hydrogels with 1 wt% (DCC) provides a better environment for cell attachment and proliferation. This study presents functional hydrogel formation by crosslinked chitosan and alginate, a novel biomaterial which also supports cell growth. (C) 2013 Published by Elsevier B.V.
C1 [Baysal, Kemal; Adiguzel, Zelal; Baysal, Bahattin M.] TUBITAK, Marmara Res Ctr, Genet Engn & Biotechnol Inst, TR-41470 Gebze, Turkey.
   [Baysal, Kemal] Dokuz Eylul Univ, Fac Med, Dept Biochem, TR-35340 Inciralti Izmir, Turkey.
   [Aroguz, Ayse Z.] Istanbul Univ, Fac Engn, Dept Chem, TR-34320 Avcilar, Turkey.
   [Baysal, Bahattin M.] Bogazici Univ, Dept Chem Engn, TR-81815 Bebek, Turkey.
RP Baysal, BM (reprint author), Bogazici Univ, Dept Chem Engn, TR-81815 Bebek, Turkey.
EM bmbaysal@hotmail.com
FU TUBA-Turkish Academy of Sciences
FX B.M. Baysal acknowledges support from TUBA-Turkish Academy of Sciences.
CR Aroguz AZ, 2011, J APPL POLYM SCI, V119, P2885, DOI 10.1002/app.33074
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Florczyk SJ, 2011, J BIOMED MATER RES A, V98A, P614, DOI 10.1002/jbm.a.33153
   Hoemann CD, 2007, J BIOMED MATER RES A, V83A, P521, DOI 10.1002/jbm.a.31365
   Hyland LL, 2011, BIOPOLYMERS, V95, P840, DOI 10.1002/bip.21687
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   Jin HH, 2008, MATER LETT, V62, P1630, DOI 10.1016/j.matlet.2007.09.043
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Ma LH, 2007, J APPL POLYM SCI, V106, P394, DOI 10.1002/app.26463
   Mi FL, 2000, CARBOHYD POLYM, V41, P389, DOI 10.1016/S0144-8617(99)00104-6
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Rinaudo M., 2007, POLYM INT, V430, P397
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Sarasam AR, 2007, MACROMOL BIOSCI, V7, P1160, DOI 10.1002/mabi.200700001
   Sarmento B., 2011, INT J CARBOHYDRATE C, P1
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
NR 24
TC 27
Z9 30
U1 4
U2 183
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2013
VL 59
BP 342
EP 348
DI 10.1016/j.ijbiomac.2013.04.073
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 175KG
UT WOS:000321229000048
PM 23664939
DA 2018-10-20
ER

PT J
AU Gustavsson, J
   Planell, J
   Engel, E
AF Gustavsson, J.
   Planell, J.
   Engel, E.
TI Ion-selective electrodes to monitor osteoblast-like cellular influence
   on the extracellular concentration of calcium
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE ion-selective electrode; extracellular ions; tissue engineering;
   osteoblasts; Saos-2; MG63; mineralization; sensor
ID OSTEOSARCOMA CELLS; BONE-FORMATION; SAOS-2 CELLS; IN-VITRO; PERFUSION
   BIOREACTOR; MATRIX DEPOSITION; SENSING RECEPTOR; ENGINEERED BONE;
   GENE-EXPRESSION; LINE SAOS-2
AB In bone tissue engineering, the composition of the ionic extracellular environment (IEE) can determine both cellular fate and a biomaterial's development and performance. Therefore, precise control of the IEE and a perfect understanding of the dynamic changes that it can be subject to due to cellular activity is highly desired. To achieve this, we initially monitored how two standard osteoblast-like cell models that expressed either high or low alkaline phosphatase activity - SAOS-2 and MG63 cells, respectively - affected the extracellular concentrations of calcium and phosphate during long-term cultures. It was observed that cellular influence on the IEE varied greatly between the two models and could be linked to the capacity of cells to deposit calcium in the extracellular matrix. Miniaturized ion-selective electrodes that could allow for real-time monitoring of calcium in a minimally invasive way were then constructed. The electrodes were characterized in standard in vitro cell culture environments, prior to being successfully applied for periods of 24h, to record the dynamics of cell-induced deposition of calcium in the extracellular matrix, while using osteogenic media of either high or low concentrations of phosphate. As a result, this study provides the background and technological means for the non-destructive evaluation of the IEE in vitro and allows for the optimization and development of better models of bone tissue construction. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Gustavsson, J.; Planell, J.; Engel, E.] Inst Bioengn Catalonia IBEC, Barcelona 08028, Spain.
   [Gustavsson, J.; Planell, J.; Engel, E.] Tech Univ Catalonia UPC, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn Grp, Barcelona 08028, Spain.
   [Gustavsson, J.; Planell, J.; Engel, E.] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza 50018, Spain.
RP Engel, E (reprint author), Tech Univ Catalonia UPC, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn Grp, Av Diagonal 647, Barcelona 08028, Spain.
EM elisabeth.engel@upc.edu
RI Engel, Elisabeth/D-4365-2014
OI Engel, Elisabeth/0000-0003-4855-8874
FU European Commission [NMP3-CT-2005-013912, NMP-LA-2008-214402];
   Generalitat de Catalunya; CIBER-BBN
FX Funding was obtained from the European Commission for projects
   NMP3-CT-2005-013912 (SmartCap) and NMP-LA-2008-214402 (AngioScaff). J.G.
   acknowledges FI grant from Generalitat de Catalunya and funding from
   CIBER-BBN. J.G. would also like to thank Prof. M. Boutelle and Prof. D.
   O'Hare at Imperial College, London, for their kind introduction to
   sensor development. Philipp Schuler is greatly acknowledged for
   assisting in the fabrication of the electronic measurement setup.
CR Acosta MA, 2009, BIOMATERIALS, V30, P3068, DOI 10.1016/j.biomaterials.2009.02.021
   Aguirre A, 2010, BIOCHEM BIOPH RES CO, V393, P156, DOI 10.1016/j.bbrc.2010.01.109
   Ahlstrom M, 2008, BONE, V42, P483, DOI 10.1016/j.bone.2007.10.025
   Allori AC, 2008, TISSUE ENG PART B-RE, V14, P259, DOI 10.1089/ten.teb.2008.0082
   Ammann D. A. A., 1986, ION SELECTIVE MICROE
   Arnett T, 1998, METHODS BONE BIOL
   Bagnaninchi PO, 2007, TISSUE ENG, V13, P313
   Bakker E, 1997, ELECTROANAL, V9, P7, DOI 10.1002/elan.1140090103
   Balint E, 2001, BONE, V28, P21, DOI 10.1016/S8756-3282(00)00426-9
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205
   CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033
   CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Eklou-Kalonji E, 1998, CELL TISSUE RES, V292, P163, DOI 10.1007/s004410051046
   Engel E, 2008, TISSUE ENG PT A, V14, P1341, DOI 10.1089/ten.tea.2007.0287
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Generelli S, 2008, LAB CHIP, V8, P1210, DOI 10.1039/b801042k
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Gustavsson J, 2011, ACTA BIOMATER, DOI 10.1016/j.actbio.2011.10.002
   Habel B, 1998, EUR BIOPHYS J BIOPHY, V27, P411, DOI 10.1007/s002490050149
   Hamlin NJ, 2004, CALCIFIED TISSUE INT, V75, P231, DOI 10.1007/s00223-004-0190-1
   Hausser HJ, 2005, BIOCHEM BIOPH RES CO, V333, P216, DOI 10.1016/j.bbrc.2005.05.097
   Hempel U, 2004, J BIOMED MATER RES B, V71B, P130, DOI 10.1002/jbm.b.30082
   Hirose M, 2003, KEY ENG MATER, V15, P240
   Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004
   Janssen FW, 2006, BIOMATERIALS, V27, P315, DOI 10.1016/j.biomaterials.2005.07.044
   Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335
   JUKKOLA A, 1993, J BONE MINER RES, V8, P651
   Karp FB, 2008, IEEE SENS J, V8, P104, DOI 10.1109/JSEN.2007.912550
   Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352
   KHOUJA HI, 1990, BONE, V11, P385, DOI 10.1016/8756-3282(90)90131-H
   Kim MM, 2007, BIOORG MED CHEM LETT, V17, P1938, DOI 10.1016/j.bmcl.2007.01.030
   Kivlehan F, 2007, ANAL CHIM ACTA, V585, P154, DOI 10.1016/j.aca.2006.11.078
   Lin KI, 1998, BIOCHEM BIOPH RES CO, V249, P325, DOI 10.1006/bbrc.1998.9124
   Lorget F, 2000, BIOCHEM BIOPH RES CO, V268, P899, DOI 10.1006/bbrc.2000.2229
   Mason C, 2007, TISSUE ENG, V13, P301, DOI 10.1089/ten.2006.0177
   Mather ML, 2007, REGEN MED, V2, P145, DOI 10.2217/174607451.2.2.145
   MCQUILLAN DJ, 1995, BONE, V16, P415
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   O'Neill CA, 2000, CALCIFIED TISSUE INT, V67, P53, DOI 10.1007/s00223001097
   Pancrazio JJ, 2007, BIOSENS BIOELECTRON, V22, P2803, DOI 10.1016/j.bios.2006.12.023
   Radin S, 2005, J BIOMED MATER RES A, V73A, P21, DOI 10.1002/jbm.a.30241
   Radomska A, 2008, BIOSENS BIOELECTRON, V24, P435, DOI 10.1016/j.bios.2008.04.026
   RODAN SB, 1987, CANCER RES, V47, P4961
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420
   Starly B, 2007, ANN BIOMED ENG, V36, P30
   STINSON RA, 1993, CLIN CHIM ACTA, V221, P105, DOI 10.1016/0009-8981(93)90025-Y
   Sun JY, 2009, ACTA BIOMATER, V5, P1284, DOI 10.1016/j.actbio.2008.10.011
   SUZUKI K, 1995, ANAL CHEM, V67, P324, DOI 10.1021/ac00098a016
   Suzuki T, 1997, J BIOMED MATER RES, V34, P507, DOI 10.1002/(SICI)1097-4636(19970315)34:4<507::AID-JBM11>3.3.CO;2-P
   Takagishi Y, 2006, TISSUE ENG, V12, P927, DOI 10.1089/ten.2006.12.927
   Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992
   Vojinovic V, 2006, SENSOR ACTUAT B-CHEM, V114, P1083, DOI 10.1016/j.snb.2005.07.059
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 58
TC 1
Z9 1
U1 1
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD AUG
PY 2013
VL 7
IS 8
BP 609
EP 620
DI 10.1002/term.550
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 186BG
UT WOS:000322015800002
PM 22539232
DA 2018-10-20
ER

PT J
AU Chebil, S
   Miodek, A
   Ambike, V
   Sauriat-Dorizon, H
   Policar, C
   Korri-Youssoufi, H
AF Chebil, S.
   Miodek, A.
   Ambike, V.
   Sauriat-Dorizon, H.
   Policar, C.
   Korri-Youssoufi, H.
TI Polypyrrole functionalized with new copper complex as platform for
   His-tag antibody immobilization and direct antigen detection
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Review
DE Complex of copper(II); Polypyrrole; Histidine-tag antibody; Redox
   marker; Electrochemical detection; D-dimer
ID ION AFFINITY-CHROMATOGRAPHY; CONDUCTING POLYMERS; DNA HYBRIDIZATION;
   ELECTROCHEMICAL DETECTION; PROTEIN IMMOBILIZATION; CU(II) IONS;
   PURIFICATION; BINDING; LIGAND; STRATEGIES
AB A biomaterial based on a copper complex covalently attached to a polypyrrole backbone was designed for monitoring a glycoprotein, D-dimer, used as a marker of the deep vein thrombosis (DVT) condition. For this purpose a new copper complex has been developed based on the ligand N-(2-hydroxybenzyl)-N'-(6-aminohexyl)- N,N'-bis[2-(N-methylimidazolyl) methyl] ethane-1,2-diamine (3) that is able to coordinate copper ions through two imidazole, two amine and one phenolato moieties-this coordination sphere will be labeled enPI2. The complex conjugated with a polypyrrole layer allows the His-tag antibody immobilization onto the conducting polymer substrate and immunosensor evaluation. The biomaterial shows a remarkable variation in redox activity of the Cu(II) complex after the D-dimer interaction. The redox activity of the [(enPi2) Cu(II)] complex decreases after the antigen interaction providing a linear response between 0.01 and 500 ng mL(-1) with a detection limit of 10 pg mL(-1). The chemical structure of copper complex demonstrates the ability to avoid non specific-interaction leading to anti fouling surface. Such biolayer architecture offers high measurement stability over time and the biomaterial could be stocked for several weeks without any modification of the electrochemical properties. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Chebil, S.; Miodek, A.; Ambike, V.; Sauriat-Dorizon, H.; Korri-Youssoufi, H.] CNRS, ICMMO, UMR 8182, F-91405 Orsay, France.
   [Chebil, S.; Miodek, A.; Ambike, V.; Sauriat-Dorizon, H.; Korri-Youssoufi, H.] Univ Paris 11, ICMMO, F-91405 Orsay, France.
   [Policar, C.] Univ Paris 06, Dept Chim ENS, LBM, UMR7203, F-75231 Paris, France.
RP Korri-Youssoufi, H (reprint author), Univ Paris 11, CNRS, ICMMO, UMR 8182, Bat 420, F-91405 Orsay, France.
EM hafsa.korri-youssoufi@u-psud.fr
OI Policar, Clotilde/0000-0003-0255-1650; Korri-Youssoufi,
   Hafsa/0000-0002-5858-5385
FU European Community [53086]; CEFIPRA
FX The authors are grateful to the financial support of the European
   Community Sixth Framework Program through a STREP grant to the DVT-IMP
   Consortium, Contract No. 53086, Wyeth Company for providing the His-tag
   D-dimer antibody, and CEFIPRA for VA's post-doctoral fellowship.
CR Ahuja T, 2007, BIOMATERIALS, V28, P791, DOI 10.1016/j.biomaterials.2006.09.046
   Arnold F. H., 1991, NAT BIOTECHNOL, V9, P151
   Bayramoglu G, 2006, SEP PURIF TECHNOL, V50, P229, DOI 10.1016/j.seppur.2005.11.030
   BELEW M, 1990, J CHROMATOGR, V516, P333, DOI 10.1016/S0021-9673(01)89275-X
   Berggren C, 2001, ELECTROANAL, V13, P173, DOI 10.1002/1521-4109(200103)13:3<173::AID-ELAN173>3.0.CO;2-B
   Briggs D., 1990, PRACTICAL SURFACE AN, V1
   Chebil S, 2010, BIOSENS BIOELECTRON, V26, P736, DOI 10.1016/j.bios.2010.06.048
   Cisnetti F, 2007, EUR J INORG CHEM, P4472, DOI 10.1002/ejic.200601236
   Darain F, 2004, BIOSENS BIOELECTRON, V20, P857, DOI 10.1016/j.bios.2004.03.028
   Fuentes M, 2007, BIOMACROMOLECULES, V8, P703, DOI 10.1021/bm060992m
   Graham B, 2011, J CHROMATOGR B, V879, P844, DOI 10.1016/j.jchromb.2011.02.029
   Griffin M., 1999, Molecular Physics Reports, V26, P60
   Grosjean L, 2005, ANAL BIOCHEM, V347, P193, DOI 10.1016/j.ab.2005.09.033
   Haddour N, 2005, J AM CHEM SOC, V127, P5752, DOI 10.1021/ja050390v
   Hafaid I, 2010, SENSOR ACTUAT B-CHEM, V144, P323, DOI 10.1016/j.snb.2009.08.058
   Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003
   Jiang W, 2009, BIOTECHNOL BIOENG, V103, P747, DOI 10.1002/bit.22302
   Job P, 1928, ANN CHIM FRANCE, V9, P113
   Khan F, 2006, ANAL CHEM, V78, P3072, DOI 10.1021/ac060184l
   Korri-Youssoufi H, 2001, SYNTHETIC MET, V119, P265, DOI 10.1016/S0379-6779(00)01509-5
   Korri-Youssoufi H, 2001, BIOMACROMOLECULES, V2, P58, DOI 10.1021/bm0000440
   Korri-Youssoufi H, 2001, MAT SCI ENG C-BIO S, V15, P307, DOI 10.1016/S0928-4931(01)00233-8
   KorriYoussoufi H, 1997, J AM CHEM SOC, V119, P7388, DOI 10.1021/ja964261d
   Kowalik-Jankowska T, 2009, J INORG BIOCHEM, V103, P135, DOI 10.1016/j.jinorgbio.2008.09.013
   Kozlowski H, 1999, COORDIN CHEM REV, V184, P319, DOI 10.1016/S0010-8545(98)00261-6
   Kronina VV, 1999, J CHROMATOGR A, V852, P261, DOI 10.1016/S0021-9673(99)00753-0
   Kurunczi S, 2013, SENSOR ACTUAT B-CHEM, V181, P71, DOI 10.1016/j.snb.2012.12.097
   Le HQA, 2010, ANAL CHIM ACTA, V674, P1, DOI 10.1016/j.aca.2010.06.008
   Livache T, 1998, CLIN CHIM ACTA, V278, P171, DOI 10.1016/S0009-8981(98)00143-0
   MCLACHLAN GA, 1995, INORG CHEM, V34, P254, DOI 10.1021/ic00105a041
   Muir BW, 2007, ANAL BIOCHEM, V363, P97, DOI 10.1016/j.ab.2007.01.015
   Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326
   PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001
   PETERS T, 1967, J BIOL CHEM, V242, P1574
   PORATH J, 1983, BIOCHEMISTRY-US, V22, P1621, DOI 10.1021/bi00276a015
   Prieto-Simon B, 2008, PROTEIN PEPTIDE LETT, V15, P757, DOI 10.2174/092986608785203791
   Pumera M, 2007, SENSOR ACTUAT B-CHEM, V123, P1195, DOI 10.1016/j.snb.2006.11.016
   Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b
   Samanta D, 2011, CHEM SOC REV, V40, P2567, DOI 10.1039/c0cs00056f
   Belluzo MS, 2008, SENSORS-BASEL, V8, P1366
   Stanczak P, 2007, FEBS LETT, V581, P4544, DOI 10.1016/j.febslet.2007.08.043
   STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F
   Stora T, 1997, LANGMUIR, V13, P5211, DOI 10.1021/la970504j
   Tlili C, 2005, TALANTA, V68, P131, DOI 10.1016/j.talanta.2005.04.069
   Wang J, 1999, CHEM-EUR J, V5, P1681, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1681::AID-CHEM1681>3.0.CO;2-U
NR 45
TC 8
Z9 8
U1 0
U2 76
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD AUG
PY 2013
VL 185
BP 762
EP 770
DI 10.1016/j.snb.2013.05.024
PG 9
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 179HD
UT WOS:000321509600102
DA 2018-10-20
ER

PT J
AU Hwang, NS
   Varghese, S
   Lee, HJ
   Zhang, ZJ
   Elisseeff, J
AF Hwang, Nathaniel S.
   Varghese, Shyni
   Lee, H. Janice
   Zhang, Zijun
   Elisseeff, Jennifer
TI Biomaterials Directed In Vivo Osteogenic Differentiation of Mesenchymal
   Cells Derived from Human Embryonic Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MARROW STROMAL CELL; WNT/BETA-CATENIN; BONE-MARROW; HUMAN BLASTOCYSTS;
   GENE-EXPRESSION; TISSUE; SCAFFOLDS; DERIVATION; VITRO; CARTILAGE
AB Spontaneous differentiation of human embryonic stem cells (hESCs) is generally inefficient and leads to a heterogeneous population of differentiated and undifferentiated cells, limiting the potential use of hESCs for cell-based therapy and studies of specific differentiation programs. Here, we demonstrate biomaterial-dependent commitment of a mesenchymal cell population derived from hESCs toward the osteogenic lineage in vivo. In skeletal development, bone formation from condensing mesenchymal cells involves two distinct pathways: endochondral and intramembraneous bone formation. In this study, we demonstrate that the hESC-derived mesenchymal cells differentiate and regenerate in vivo bone tissues through two different pathways depending upon the local cues present in a scaffold microenvironment. Hydroxyapatite (HA) was incorporated into biodegradable poly(lactic-co-glycolic acid)/poly(L-lactic acid) (PLGA/PLLA) scaffolds to enhance bone formation. The HA microenvironment stabilized the beta-catenin and upregulated Runx2, resulting in faster bone formation through intramembraneous ossification. hESC-derived mesenchymal cells seeded on the PLGA/PLLA scaffold without HA, however, showed minimal levels Runx2, and differentiated via endochondral ossification, as evidenced by formation of cartilaginous tissue, followed by calcification and increased blood vessel invasion. These results indicate that the ossification mechanisms of the hESC-derived mesenchymal stem cells can be regulated by the scaffold-mediated microenvironments, and bone tissue can be formed.
C1 [Hwang, Nathaniel S.] Seoul Natl Univ, Sch Chem & Biol Engn, Inst Chem Proc, Seoul 151744, South Korea.
   [Hwang, Nathaniel S.] Seoul Natl Univ, Interdisciplinary Program Bioengn, Seoul 151744, South Korea.
   [Hwang, Nathaniel S.] Seoul Natl Univ, Bio MAX Inst, Seoul 151744, South Korea.
   [Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Lee, H. Janice; Elisseeff, Jennifer] Johns Hopkins Univ, Wilmer Eye Inst, Dept Biomed Engn, Baltimore, MD 21218 USA.
   [Zhang, Zijun] St Louis Univ, Dept Orthopaed Surg, St Louis, MO 63103 USA.
RP Hwang, NS (reprint author), Seoul Natl Univ, Sch Chem & Biol Engn, 1 Gwank Ro, Seoul 151744, South Korea.
EM nshwang@snu.ac.kr
FU NIDCR [R01DE016887]; Basic Science Research Program through the National
   Research Foundation of Korea [0458-20120013]
FX This work was supported by funding from the NIDCR R01DE016887 and the
   Basic Science Research Program through the National Research Foundation
   of Korea (Grant Number 0458-20120013). We also gratefully acknowledge
   J.M. McCaffery and E. Perkins of the Integrated Imaging Facility (JHU
   Department of Biology) for help with electron microscopy.
CR Ambrosio AMA, 2001, J BIOMED MATER RES, V58, P295, DOI 10.1002/1097-4636(2001)58:3<295::AID-JBM1020>3.3.CO;2-#
   Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161
   Brown SE, 2009, CELLS TISSUES ORGANS, V189, P256, DOI 10.1159/000151746
   Chen WC, 2013, TISSUE ENG PT A, V19, P915, DOI [10.1089/ten.tea.2012.0172, 10.1089/ten.TEA.2012.0172]
   Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016
   Domev H, 2012, TISSUE ENG PT A, V18, P2290, DOI [10.1089/ten.tea.2011.0371, 10.1089/ten.TEA.2011.0371]
   Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295
   Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   Gerber HP, 1999, NAT MED, V5, P623
   Heng BC, 2004, J BONE MINER RES, V19, P1379, DOI 10.1359/JBMR.040714
   Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013
   Holland TA, 2006, ADV BIOCHEM ENG BIOT, V102, P161, DOI 10.1007/b137205
   Huang YX, 2008, J BIOMATER APPL, V22, P409, DOI 10.1177/0885328207077632
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje
   KIM HN, 2012, ADV DRUG DELIV REV, DOI DOI 10.1016/J.ADDR
   Kolpakova E, 2005, DEV CELL, V8, P626, DOI 10.1016/j.devcel.2005.04.008
   Lee EJ, 2010, TISSUE ENG PT A, V16, P705, DOI 10.1089/ten.tea.2008.0596
   Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420
   Luklinska ZB, 2003, J MICROSC-OXFORD, V211, P121, DOI 10.1046/j.1365-2818.2003.01204.x
   Mankani MH, 2008, TISSUE ENG PT A, V14, P1949, DOI 10.1089/ten.tea.2007.0348
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648
   Ren J, 2007, J BIOMAT SCI-POLYM E, V18, P505, DOI 10.1163/156856207780852578
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105
   Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
   YAMASHITA A, PLOS ONE, V5, pE9663
NR 43
TC 25
Z9 26
U1 2
U2 27
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2013
VL 19
IS 15-16
BP 1723
EP 1732
DI 10.1089/ten.tea.2013.0064
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 172XJ
UT WOS:000321039800008
PM 23510052
OA Green Published
DA 2018-10-20
ER

PT J
AU Murab, S
   Chameettachal, S
   Bhattacharjee, M
   Das, S
   Kaplan, DL
   Ghosh, S
AF Murab, Sumit
   Chameettachal, Shibu
   Bhattacharjee, Maumita
   Das, Sanskrita
   Kaplan, David L.
   Ghosh, Sourabh
TI Matrix-Embedded Cytokines to Simulate Osteoarthritis-Like Cartilage
   Microenvironments
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID HUMAN ARTICULAR-CARTILAGE; FIBROBLAST-GROWTH-FACTOR;
   NECROSIS-FACTOR-ALPHA; KNEE OSTEOARTHRITIS; EXTRACELLULAR-MATRIX;
   THERAPEUTIC TARGETS; FOCAL ADHESIONS; IN-VITRO; CHONDROCYTES; EXPRESSION
AB In vivo, cytokines noncovalently bind to the extracellular matrix (ECM), to facilitate intimate interactions with cellular receptors and potentiate biological activity. Development of a biomaterial that simulates this type of physiological binding and function is an exciting proposition for designing controlled advanced delivery systems for simulating in vivo conditions in vitro. We have decorated silk protein with sulfonated moieties through diazonium coupling reactions to noncovalently immobilize pro-inflammatory cytokines interleukin-1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF-alpha) in such a biomimetic manner. After adsorption of the cytokines to the diazonium-modified silk matrix, constant release of cytokines up to at least 3 days was demonstrated, as an initial step to simulate an osteoarthritic (OA) microenvironment in vitro. Matrix-embedded cytokines induced the formation of multiple elongated processes in chondrocytes in vitro, akin to what is seen in OA cartilage in vivo. Gene expression profiles with this in vitro tissue model of OA showed significant similarities to profiles from explanted OA cartilage tissues collected from patients who underwent total knee replacement surgery. The common markers of OA, including COL, MMP, TIMP, ADAMTS, and metallothioneins, were upregulated at least 35-fold in the in vitro model when compared to the control-non-OA in vitro generated tissue-engineered cartilage. The microarray data were validated by reverse transcriptase-polymerase chain reaction. Mechanistically, protein interaction studies indicated that TNF-alpha and IL-1 beta synergistically controlled the equilibrium between MMPs and their inhibitors, TIMPs, resulting in ECM degradation through the MAPK pathway. This study offers a promising initial step toward establishing a relevant in vitro OA disease model, which can be further modified to assess signaling mechanisms, responses to cell or drug treatments and patient-specific features.
C1 [Murab, Sumit; Chameettachal, Shibu; Bhattacharjee, Maumita; Das, Sanskrita; Ghosh, Sourabh] Indian Inst Technol Delhi, Dept Text Technol, New Delhi 110016, India.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Boston, MA 02111 USA.
RP Ghosh, S (reprint author), Indian Inst Technol Delhi, Dept Text Technol, New Delhi 110016, India.
EM ghoshsourabh@yahoo.com
FU Department of Biotechnology, Government of India; Indo-US Science and
   Technology Forum
FX This study was supported by a grant from the Department of
   Biotechnology, Government of India, and a travel grant to S.G. from
   Indo-US Science and Technology Forum. We also thank the NIH Tissue
   Engineering Resource Center for help with this study (EB002520).
CR Aigner T, 2004, REJUV RES, V7, P134, DOI 10.1089/1549168041552964
   Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H
   AIGNER T, 1993, VIRCHOWS ARCH B, V63, P205, DOI 10.1007/BF02899263
   ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565
   Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359
   ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042
   Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010
   Barthelmes K, 2011, J AM CHEM SOC, V133, P808, DOI 10.1021/ja104983t
   Beg OU, 1998, J PROTEIN CHEM, V17, P807, DOI 10.1023/A:1020730418999
   BLUTEAU G, 2002, BIORHEOLOGY, V39, P24
   Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139
   Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099
   BREW CJ, 2008, ANN RHEUM DIS, V69, P234
   Bush PG, 2003, OSTEOARTHR CARTILAGE, V11, P242, DOI 10.1053/S1063-4584-(02)00369-2
   Calamia V, 2011, J PROTEOME RES, V10, P3701, DOI 10.1021/pr200331k
   El-Bikai R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3173
   Fernandes JC, 2002, BIORHEOLOGY, V39, P237
   Fosang AJ, 2008, NAT CLIN PRACT RHEUM, V4, P420, DOI 10.1038/ncprheum0841
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Goldring M B, 2000, Curr Rheumatol Rep, V2, P459, DOI 10.1007/s11926-000-0021-y
   Haudenschild DR, 2011, J ORTHOP RES, V29, P20, DOI 10.1002/jor.21198
   Haywood L, 2003, ARTHRITIS RHEUM, V48, P2173, DOI 10.1002/art.11094
   Holloway I, 2004, OSTEOARTHR CARTILAGE, V12, P17, DOI 10.1016/j.joca.2003.09.001
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Hunter DJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2314
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Jeffrey JE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2346
   Jones ARC, 2007, EUR CELLS MATER, V13, P40, DOI 10.22203/eCM.v013a04
   Kenig M, 2008, J CHROMATOGR B, V867, P119, DOI 10.1016/j.jchromb.2008.03.023
   Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496
   Lambrecht S, 2008, OSTEOARTHR CARTILAGE, V16, P163, DOI 10.1016/j.joca.2007.06.005
   Li Y, 2007, OSTEOARTHR CARTILAGE, V15, P1101, DOI 10.1016/j.joca.2007.04.013
   Little CB, 2007, J CLIN INVEST, V117, P1627, DOI 10.1172/JCI30765
   Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059
   LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084
   Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005
   Lorenzo P, 2004, MATRIX BIOL, V23, P381, DOI 10.1016/j.matbio.2004.07.007
   Lotz M, 1995, J Rheumatol Suppl, V43, P104
   MALEMUD CJ, 2005, CURR REV RHEUMATOL, V1, P131, DOI DOI 10.2174/1573397054023146
   Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172
   McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109
   Mi FL, 2006, J BIOMED MATER RES A, V76A, P1, DOI 10.1002/jbm.a.30298
   Miyaki S, 2009, ARTHRITIS RHEUM, V60, P2723, DOI 10.1002/art.24745
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Musumeci G, 2011, HISTOL HISTOPATHOL, V26, P1265, DOI 10.14670/HH-26.1265
   OLLIVIERRE F, 1986, BIOCHEM BIOPH RES CO, V141, P904, DOI 10.1016/S0006-291X(86)80128-0
   Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918
   Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F
   Peters HC, 2011, TISSUE ENG PT A, V17, P2017, DOI [10.1089/ten.tea.2010.0601, 10.1089/ten.TEA.2010.0601]
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Pritzker KPH, 2011, NAT REV RHEUMATOL, V7, P444, DOI 10.1038/nrrheum.2011.104
   Recklies AD, 1998, ARTHRITIS RHEUM, V41, P997, DOI 10.1002/1529-0131(199806)41:6<997::AID-ART6>3.0.CO;2-G
   Richardson DW, 2000, AM J VET RES, V61, P624, DOI 10.2460/ajvr.2000.61.624
   Riyazi N, 2005, ARTHRITIS RHEUM, V52, P1443, DOI 10.1002/art.21014
   Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369
   SANDY JD, 1984, ARTHRITIS RHEUM, V27, P388, DOI 10.1002/art.1780270405
   Santangelo KS, 2011, OSTEOARTHR CARTILAGE, V19, P439, DOI 10.1016/j.joca.2011.01.004
   Smith MD, 1997, J RHEUMATOL, V24, P365
   Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442
   Sun L, 2011, BIOMATERIALS, V32, P5581, DOI 10.1016/j.biomaterials.2011.04.028
   Takahashi H, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3157
   Tiku ML, 2000, J BIOL CHEM, V275, P20069, DOI 10.1074/jbc.M907604199
   Towle CA, 1997, OSTEOARTHR CARTILAGE, V5, P293, DOI 10.1016/S1063-4584(97)80008-8
   Valdes AM, 2007, ARTHRITIS RHEUM, V56, P137, DOI 10.1002/art.22301
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W
   Yudoh K, 2005, ARTHRITIS RES THER, V7, pR380, DOI 10.1186/ar1499
NR 67
TC 14
Z9 14
U1 1
U2 24
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2013
VL 19
IS 15-16
BP 1733
EP 1753
DI 10.1089/ten.tea.2012.0385
PG 21
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 172XJ
UT WOS:000321039800009
PM 23470228
OA Green Published
DA 2018-10-20
ER

PT J
AU Zeng, XW
   Tao, W
   Mei, L
   Huang, LG
   Tan, CY
   Feng, SS
AF Zeng, Xiaowei
   Tao, Wei
   Mei, Lin
   Huang, Laigiang
   Tan, Chunyan
   Feng, Si-Shen
TI Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E
   TPGS copolymer for docetaxel delivery to cervical cancer
SO BIOMATERIALS
LA English
DT Article
DE Anticancer drugs; Cancer nanotechnology; Controlled release; Drug
   delivery; Molecular biomaterials; Nanomedicine
ID DRUG-DELIVERY; MULTIDRUG-RESISTANCE; LOADED NANOPARTICLES;
   CONTROLLED-RELEASE; BLOCK-COPOLYMERS; CELLULAR UPTAKE; ORAL DELIVERY;
   BREAST-CANCER; SUCCINATE; POLYMERS
AB We developed a system of nanoparticles (NPs) of cholic acid functionalized, star-shaped block copolymer consisting of PLGA and vitamin E TPGS for sustained and controlled delivery of docetaxel for treatment of cervical cancer, which demonstrated superior in vitro and in vivo performance in comparison with the drug-loaded PLGA NPs and the linear PLGA-b-TPGS copolymer NPs. The star-shaped block copolymer CA-PLGA-b-TPGS of three branch arms was synthesized through the core-first approach and characterized by H-1 NMR, GPC and TGA. The drug- or coumarin 6-loaded NPs were prepared by a modified nanoprecipitation technique and then characterized in terms of size and size distribution, surface morphology and surface charge, drug encapsulation efficiency, in vitro release profile and physical state of the encapsulated drug. The CA-PLGA-b-TPGS NPs were found to have the highest cellular uptake efficiency, the highest antitumor efficacy compared with PLGA-b-TPGS NPs and PLGA NPs. The results suggest that such a star-shaped copolymer CA-PLGA-b-TPGS could be used as a new molecular biomaterial for drug delivery of high efficiency. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Zeng, Xiaowei; Tao, Wei; Mei, Lin; Huang, Laigiang; Tan, Chunyan; Feng, Si-Shen] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Zeng, Xiaowei; Tao, Wei; Mei, Lin; Huang, Laigiang; Tan, Chunyan; Feng, Si-Shen] Tsinghua Univ, Shenzhen Grad Sch, Minist Prov Jointly Construct Base State Key Lab, Shenzhen Key Lab Gene & Antibody Therapy, Shenzhen 518055, Peoples R China.
   [Zeng, Xiaowei; Tao, Wei; Mei, Lin; Huang, Laigiang; Tan, Chunyan; Feng, Si-Shen] Tsinghua Univ, Shenzhen Grad Sch, Div Life & Hlth Sci, Shenzhen 518055, Peoples R China.
   [Feng, Si-Shen] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
RP Mei, L (reprint author), Tsinghua Univ, Shenzhen Grad Sch, Div Life & Hlth Sci, Shenzhen 518055, Peoples R China.
EM mei.lin@sz.tsinghua.edu.cn; chefss@nus.edu.sg
RI Tan, Chunyan/F-2785-2012; Zeng, Xiaowei/A-6506-2015
OI Tan, Chunyan/0000-0002-4263-2175; Tao, Wei/0000-0002-4277-3728
FU National Natural Science Foundation of China [31270019, 51203085,
   30900291]; China Postdoctoral Science Foundation [2012M520242]; Natural
   Science Foundation of Guangdong Province [S2012040006820,
   S2012010010046]; Shenzhen Municipal Program for Building State and
   Shenzhen Key Laboratories [CXB201005260070A, CXB201104220043A]; Science,
   Technology & Innovation Commission of Shenzhen Municipality
   [JCYJ20120616213729920, KQC201105310021A, JCYJ2012061419193 6420,
   JC201005270308A]; Program for New Century Excellent Talents in
   University [NCET-11-0275]
FX The authors are grateful for financial support from the National Natural
   Science Foundation of China (No. 31270019, 51203085, 30900291), China
   Postdoctoral Science Foundation (No. 2012M520242), Natural Science
   Foundation of Guangdong Province (No. S2012040006820, S2012010010046),
   Shenzhen Municipal Program for Building State and Shenzhen Key
   Laboratories (No. CXB201005260070A, CXB201104220043A), Science,
   Technology & Innovation Commission of Shenzhen Municipality (No.
   JCYJ20120616213729920, KQC201105310021A, JCYJ2012061419193 6420,
   JC201005270308A) and Program for New Century Excellent Talents in
   University (NCET-11-0275).
CR Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Baimark Y, 2012, J APPL POLYM SCI, V124, P3871, DOI 10.1002/app.35473
   Cai C, 2006, J POLYM SCI A, V44, P2034
   Chen MC, 2011, BIOMATERIALS, V32, P9826, DOI 10.1016/j.biomaterials.2011.08.087
   Claesson H, 2002, POLYMER, V43, P3511, DOI 10.1016/S0032-3861(02)00073-3
   Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045
   Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f
   Guo JW, 2011, BIOMATERIALS, V32, P8010, DOI 10.1016/j.biomaterials.2011.07.004
   Huang LQ, 2011, INTEGR BIOL-UK, V3, P993, DOI 10.1039/c1ib00026h
   Hubbell JA, 2012, SCIENCE, V337, P303, DOI 10.1126/science.1219657
   Koyama Y, 2001, J CONTROL RELEASE, V77, P357, DOI 10.1016/S0168-3659(01)00521-1
   Lapienis G, 2009, PROG POLYM SCI, V34, P852, DOI 10.1016/j.progpolymsci.2009.04.006
   Lapienis G, 2009, POLYMER, V50, P77, DOI 10.1016/j.polymer.2008.10.034
   Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350
   Liu Q, 2012, INT J PHARMACEUT, V430, P350, DOI 10.1016/j.ijpharm.2012.04.008
   Ma YD, 2011, INT J NANOMED, V6, P2679, DOI 10.2147/IJN.S25251
   Ma YD, 2010, POLYMER, V51, P5952, DOI 10.1016/j.polymer.2010.10.029
   Ma YD, 2010, NANOSCALE RES LETT, V5, P1161, DOI 10.1007/s11671-010-9620-3
   Maglio G, 2004, MACROMOL RAPID COMM, V25, P1139, DOI 10.1002/marc.200400113
   Mehnert W, 2012, ADV DRUG DELIVER REV, V64, P83, DOI 10.1016/j.addr.2012.09.021
   Mei L, 2009, NANOSCALE RES LETT, V4, P1530, DOI 10.1007/s11671-009-9431-6
   Mi Y, 2012, BIOMATERIALS, V33, P7519, DOI 10.1016/j.biomaterials.2012.06.100
   Mi Y, 2011, BIOMATERIALS, V32, P4058, DOI 10.1016/j.biomaterials.2011.02.022
   Mu L, 2003, J CONTROL RELEASE, V86, P33, DOI 10.1016/S0168-3659(02)00320-6
   Muthu MS, 2012, BIOMATERIALS, V33, P3494, DOI 10.1016/j.biomaterials.2012.01.036
   Nabid MR, 2011, POLYMER, V52, P2799, DOI 10.1016/j.polymer.2011.04.054
   Cuong NV, 2012, J MATER CHEM, V22, P1006, DOI 10.1039/c1jm13588k
   Ouyang CP, 2012, POLYM BULL, V68, P27, DOI 10.1007/s00289-011-0516-x
   Park S, 2013, BIOMATERIALS, V34, P598, DOI 10.1016/j.biomaterials.2012.10.004
   Park SY, 2003, MACROMOLECULES, V36, P4115, DOI 10.1021/ma021639l
   Park W, 2012, BIOMATERIALS, V33, P8848, DOI 10.1016/j.biomaterials.2012.08.042
   Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Ren TB, 2011, SOFT MATTER, V7, P2329, DOI 10.1039/c1sm05020f
   Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(07)61416-0
   Schubert S, 2011, SOFT MATTER, V7, P1581, DOI 10.1039/c0sm00862a
   Sonaje K, 2009, BIOMATERIALS, V30, P2329, DOI 10.1016/j.biomaterials.2008.12.066
   Thamake SI, 2012, BIOMATERIALS, V33, P7164, DOI 10.1016/j.biomaterials.2012.06.026
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tomasina J, 2013, BIOMATERIALS, V34, P1073, DOI 10.1016/j.biomaterials.2012.10.055
   Valencia PM, 2011, BIOMATERIALS, V32, P6226, DOI 10.1016/j.biomaterials.2011.04.078
   Vivero-Escoto JL, 2012, BIOMATERIALS, V31, P1325
   Wang JL, 2012, BIOMATERIALS, V33, P6877, DOI 10.1016/j.biomaterials.2012.06.019
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050
   Wu QH, 2012, REACT FUNCT POLYM, V72, P372, DOI 10.1016/j.reactfunctpolym.2012.04.004
   Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022
   Yan F, 2010, NANOMED-NANOTECHNOL, V6, P170, DOI 10.1016/j.nano.2009.05.004
   Zhang CN, 2012, BIOMATERIALS, V33, P2187, DOI 10.1016/j.biomaterials.2011.11.045
   Zhang XJ, 2010, MACROMOLECULES, V43, P6671, DOI 10.1021/ma100653u
   Zhang YQ, 2010, ACTA BIOMATER, V6, P2045, DOI 10.1016/j.actbio.2009.11.035
   Zhang ZP, 2012, NANOMEDICINE-UK, V7, P1645, DOI [10.2217/NNM.12.117, 10.2217/nnm.12.117]
   Zhang ZP, 2012, BIOMATERIALS, V33, P4889, DOI 10.1016/j.biomaterials.2012.03.046
   Zhang ZP, 2006, BIOMATERIALS, V27, P4025, DOI 10.1016/j.biomaterials.2006.03.006
   Zhu ZS, 2010, J CONTROL RELEASE, V142, P438, DOI 10.1016/j.jconrel.2009.11.002
   Zou T, 2007, J BIOMED MATER RES B, V82B, P400, DOI 10.1002/jbm.b.30745
NR 55
TC 141
Z9 148
U1 10
U2 181
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2013
VL 34
IS 25
BP 6058
EP 6067
DI 10.1016/j.biomaterials.2013.04.052
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 171DU
UT WOS:000320906100007
PM 23694904
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Moschakis, T
AF Moschakis, Thomas
TI Microrheology and particle tracking in food gels and emulsions
SO CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
LA English
DT Review
DE Particle tracking microrheology; Video microscopy; Viscoelasticity;
   Heterogeneity; Emulsions; Gelation
ID ATOMIC-FORCE MICROSCOPY; DIFFUSING WAVE SPECTROSCOPY; COLLOIDAL
   GLASS-TRANSITION; PROTEIN-LAYER FORMATION; PEG-HEPARIN HYDROGELS;
   BETA-GLUCAN SOLUTIONS; COMPLEX FLUIDS; BIOMATERIAL HYDROGELATORS;
   DYNAMICAL HETEROGENEITIES; 2-POINT MICRORHEOLOGY
AB Particle tracking microrheology, an emerging experimental technique, which utilizes the Brownian motion of embedded particles to probe local dynamics of soft materials, is presented. Particle tracking microrheology is a powerful technique that enables the measurement of viscoelastic responses in small sample volumes, which are inaccessible to macrorheology and to spatially map structural heterogeneities at a microlevel. Therefore, particle tracking microrheology has considerable potential in food emulsions and gels, since these systems are commonly inhomogeneous. Recent advances and achievements are discussed, including the basic principles, operating regimes and limitations of the technique. The application of the technique in the field of food gels and emulsions to study the evolving dynamics of inhomogeneous at microscale length systems and during sol-gel transition is highlighted. (c) 2013 Elsevier Ltd. All rights reserved.
C1 Aristotle Univ Thessaloniki, Sch Agr, Dept Food Sci & Technol, GR-54124 Thessaloniki, Greece.
RP Moschakis, T (reprint author), Aristotle Univ Thessaloniki, Sch Agr, Dept Food Sci & Technol, GR-54124 Thessaloniki, Greece.
EM tmoschak@agro.auth.gr
RI Moschakis, Thomas/A-7509-2012
OI Moschakis, Thomas/0000-0003-1401-1352
CR Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268
   ADOLF D, 1990, MACROMOLECULES, V23, P3700, DOI 10.1021/ma00217a026
   Alexander M, 2007, CURR OPIN COLLOID IN, V12, P179, DOI 10.1016/j.cocis.2007.07.008
   Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6
   Aufderhorst-Roberts A, 2012, SOFT MATTER, V8, P5940, DOI 10.1039/c2sm25158b
   Balakrishnan G, 2011, BIOMACROMOLECULES, V12, P450, DOI 10.1021/bm101238r
   Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5
   Benmouna F, 2004, LANGMUIR, V20, P188, DOI 10.1021/la0355794
   Breedveld V, 2003, J MATER SCI, V38, P4461, DOI 10.1023/A:1027321232318
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Caggioni M, 2007, J RHEOL, V51, P851, DOI 10.1122/1.2751385
   Cang H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2204652
   Cardinaux F, 2007, ROY SOC CH, P319, DOI 10.1039/9781847557698-00319
   Chae BS, 2005, LANGMUIR, V21, P3084, DOI 10.1021/la0480890
   Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023
   Cohen I, 2010, J FOOD ENG, V100, P366, DOI 10.1016/j.jfoodeng.2010.04.023
   Corredig M, 2008, TRENDS FOOD SCI TECH, V19, P67, DOI 10.1016/j.tifs.2007.07.014
   Corrigan AM, 2009, LANGMUIR, V25, P8599, DOI 10.1021/la804208q
   Crater JS, 2010, MACROMOL BIOSCI, V10, P1473, DOI 10.1002/mabi.201000137
   CRICK FHC, 1950, EXP CELL RES, V1, P37, DOI 10.1016/0014-4827(50)90048-6
   Crielaard BJ, 2011, J CONTROL RELEASE, V156, P307, DOI 10.1016/j.jconrel.2011.07.023
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888
   Crocker JC, 2012, SOFTWARE PACKAGE PAR
   Crocker JC, 2007, METHOD CELL BIOL, V83, P141, DOI 10.1016/S0091-679X(07)83007-X
   Cucheval ASB, 2009, LANGMUIR, V25, P11827, DOI 10.1021/la901424w
   Dasgupta BR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021504
   Dasgupta BR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051505
   DICKINSON E, 1992, INTRO FOOD COLLOIDS
   Dickinson E, 2007, ROY SOC CH, P305, DOI 10.1039/9781847557698-00303
   Doliwa B, 1998, PHYS REV LETT, V80, P4915, DOI 10.1103/PhysRevLett.80.4915
   Duits MHG, 2009, PHYS REV E, V79, P05910
   Evans RML, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.012501
   FREUNDLICH H, 1922, Z PHYS CHEM, V104, P233
   Gardel M., 2005, MICROSCALE DIAGNOSTI, P1, DOI DOI 10.1007/3-540-26449-3_1
   Gunning AP, 2010, FOOD TECHNOL-CHICAGO, V64, P32
   Hasnain IA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031901
   Heinemann C, 2004, CARBOHYD POLYM, V55, P155, DOI 10.1016/j.carbpol.2003.09.003
   Horne DS, 2002, CURR OPIN COLLOID IN, V7, P456, DOI 10.1016/S1359-0294(02)00082-1
   Horne DS, 1998, INT DAIRY J, V8, P171, DOI 10.1016/S0958-6946(98)00040-5
   Houghton HA, 2008, EUR PHYS J E, V25, P119, DOI 10.1140/epje/i2007-10269-1
   Hurley MM, 1996, J CHEM PHYS, V105, P10521, DOI 10.1063/1.472941
   Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290
   Kimura Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.041005
   Kob W, 1997, PHYS REV LETT, V79, P2827, DOI 10.1103/PhysRevLett.79.2827
   Koenig GM, 2009, NANO LETT, V9, P2794, DOI 10.1021/nl901498d
   KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0
   Larsen T, 2008, KOREA-AUST RHEOL J, V20, P165
   Larsen TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146001
   Larsen TH, 2008, AIP CONF PROC, V1027, P1090, DOI 10.1063/1.2964477
   Larsen TH, 2009, MACROMOLECULES, V42, P8443, DOI 10.1021/ma901423n
   Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101
   Lee MH, 2011, SOFT MATTER, V7, P7635, DOI 10.1039/c1sm05235g
   Lee MH, 2010, LANGMUIR, V26, P2650, DOI 10.1021/la902881f
   Levine AJ, 2000, PHYS REV LETT, V85, P1774, DOI 10.1103/PhysRevLett.85.1774
   Liu J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.118104
   Loudet JC, 2004, SCIENCE, V306, P1525, DOI 10.1126/science.1102864
   Macierzanka A, 2012, LANGMUIR, V28, P17349, DOI 10.1021/la302194q
   Macierzanka A, 2011, SOFT MATTER, V7, P8077, DOI 10.1039/c1sm05888f
   MacKintosh FC, 1999, CURR OPIN COLLOID IN, V4, P300, DOI 10.1016/S1359-0294(99)90010-9
   Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9
   Maier T, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011501
   Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4
   Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094
   MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250
   Massiera G, 2007, BIOPHYS J, V93, P3703, DOI 10.1529/biophysj.107.111641
   Mcclements D.J., 1999, FOOD EMULSIONS PRINC
   McGrath JL, 2000, BIOPHYS J, V79, P3258, DOI 10.1016/S0006-3495(00)76558-1
   Morris VJ, 2011, J SCI FOOD AGR, V91, P2117, DOI 10.1002/jsfa.4501
   Morris VJ, 2001, LEBENSM-WISS TECHNOL, V34, P3, DOI 10.1006/fstl.2000.0706
   Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u
   Moschakis T, 2005, J COLLOID INTERF SCI, V284, P714, DOI 10.1016/j.jcis.2004.10.036
   Moschakis T, 2006, LANGMUIR, V22, P4710, DOI 10.1021/la0533258
   Moschakis T, 2012, J COLLOID INTERF SCI, V375, P50, DOI 10.1016/j.jcis.2012.02.048
   Moschakis T, 2010, J COLLOID INTERF SCI, V345, P278, DOI 10.1016/j.jcis.2010.02.005
   Mukhopadhyay A, 2001, CURR OPIN COLLOID IN, V6, P423, DOI 10.1016/S1359-0294(01)00119-4
   Murray CA, 1996, ANNU REV PHYS CHEM, V47, P421, DOI 10.1146/annurev.physchem.47.1.421
   Nayebzadeh K, 2006, LANGMUIR, V22, P8873, DOI 10.1021/la060419o
   Oppong FK, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021405
   Pashkovski EE, 2003, LANGMUIR, V19, P3589, DOI 10.1021/la020687e
   Pawley J.B., 2006, HDB BIOL CONFOCAL MI
   Prasad V, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.176001
   Prasad V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178302
   Prasad V, 2007, J PHYS CONDENS MATT, V19
   Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7
   Rich JP, 2011, J RHEOL, V55, P273, DOI 10.1122/1.3532979
   Savin T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041106
   Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]
   Savin T, 2007, SOFT MATTER, V3, P1194, DOI 10.1039/b700434f
   Schultz K, 2008, AIP CONF PROC, V1027, P1096, DOI 10.1063/1.2964479
   Schultz KM, 2012, SOFT MATTER, V8, P6198, DOI 10.1039/c2sm25187f
   Schultz KM, 2011, BIOMACROMOLECULES, V12, P4178, DOI 10.1021/bm201214r
   Schultz KM, 2009, MACROMOLECULES, V42, P5310, DOI 10.1021/ma900766u
   Schultz KM, 2009, SOFT MATTER, V5, P740, DOI 10.1039/b818178k
   Solomon MJ, 2001, CURR OPIN COLLOID IN, V6, P430, DOI 10.1016/S1359-0294(01)00111-X
   Tripathy S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3194752
   Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8
   Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812
   Valentine MT, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061506
   Veerman C, 2006, MACROMOLECULES, V39, P6608, DOI 10.1021/ma0609331
   Velegol D, 2001, BIOPHYS J, V81, P1786, DOI 10.1016/S0006-3495(01)75829-8
   Vincent RR, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031909
   Wagner J, 2011, J FOOD ENG, V105, P530, DOI 10.1016/j.jfoodeng.2011.03.017
   Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04
   Weeks ER, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.095704
   Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627
   Weeks ER, 2002, CHEM PHYS, V284, P361, DOI 10.1016/S0301-0104(02)00667-5
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Winter HH, 1997, ADV POLYM SCI, V134, P165
   Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724
   Wong IY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178101
   Xu JY, 2007, FOOD CHEM, V103, P1192, DOI 10.1016/j.foodchem.2006.10.024
   Xu JY, 2002, BIOMACROMOLECULES, V3, P92, DOI 10.1021/bm015586b
   Yu Y, 2011, J PHYS CHEM B, V115, P2748, DOI 10.1021/jp109146s
   Yu Y, 2009, MOL CRYST LIQ CRYST, V507, P18, DOI 10.1080/15421400903048024
NR 115
TC 39
Z9 39
U1 8
U2 133
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1359-0294
J9 CURR OPIN COLLOID IN
JI Curr. Opin. Colloid Interface Sci.
PD AUG
PY 2013
VL 18
IS 4
BP 311
EP 323
DI 10.1016/j.cocis.2013.04.011
PG 13
WC Chemistry, Physical
SC Chemistry
GA 177WR
UT WOS:000321406600008
DA 2018-10-20
ER

PT J
AU Uhrig, BA
   Boerckel, JD
   Willett, NJ
   Li, MTA
   Huebsch, N
   Guldberg, RE
AF Uhrig, Brent A.
   Boerckel, Joel D.
   Willett, Nick J.
   Li, Mon-Tzu A.
   Huebsch, Nathaniel
   Guldberg, Robert E.
TI Recovery from hind limb ischemia enhances rhBMP-2-mediated segmental
   bone defect repair in a rat composite injury model
SO BONE
LA English
DT Article
DE Composite injury model; Bone defect; Ischemia; Bone regeneration;
   Vascularization; Bone morphogenetic protein
ID SMOOTH-MUSCLE-CELLS; MORPHOGENETIC PROTEINS; DISTRACTION OSTEOGENESIS;
   FUNCTIONAL REPAIR; TIBIAL FRACTURES; VASCULAR INJURY; SPINAL-FUSION;
   MOUSE MODEL; ANGIOGENESIS; GROWTH
AB Although severe extremity trauma is often inclusive of skeletal and vascular damage in combination, segmental bone defect repair with concomitant vascular injury has yet to be experimentally investigated. To this end, we developed a novel rat composite limb injury model by combining a critically-sized segmental bone defect with surgically-induced hind limb ischemia (HLI). Unilateral 8 mm femoral defects were created alone (BD) or in combination with HLI (BD + HLI), and all defects were treated with rhBMP-2 via a hybrid biomaterial delivery system. Based on reported clinical and experimental observations on the importance of vascular networks in bone repair, we hypothesized that HLI would impair bone regeneration. Interestingly, the BD + HLI group displayed improved radiographic bridging, and quantitative micro-CT analysis revealed enhanced bone regeneration as early as week 4 (p < 0.01) that was sustained through week 12 (p < 0.001) and confirmed histologically. This effect was observed in two independent studies and at two different doses of rhBMP-2. Micro-CT angiography was used to quantitatively evaluate vascular networks at week 12 in both the thigh and the regenerated bone defect. No differences were found between groups in total blood vessel volume in the thigh, but clear differences in morphology were present as the BD + HLI group possessed a more interconnected network of smaller diameter vessels (p < 0.001). Accordingly, while the overall thigh vessel volume was comparable between groups, the contributions to vessel volume based on vessel diameter differed significantly. Despite this evidence of a robust neovascular response in the thigh of the BD + HLI group, differences were not observed between groups for bone defect blood vessel volume or morphology. In total, our results demonstrate that a transient ischemic insult and the subsequent recovery response to HLI significantly enhanced BMP-2-mediated segmental bone defect repair, providing additional complexity to the relationship between vascular tissue networks and bone healing. Ultimately, a better understanding of the coupling mechanisms may reveal important new strategies for promoting bone healing in challenging clinical scenarios. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Uhrig, Brent A.; Boerckel, Joel D.; Willett, Nick J.; Li, Mon-Tzu A.; Guldberg, Robert E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Uhrig, Brent A.; Boerckel, Joel D.; Willett, Nick J.; Li, Mon-Tzu A.; Guldberg, Robert E.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA USA.
   [Huebsch, Nathaniel] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Huebsch, Nathaniel] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.
RP Guldberg, RE (reprint author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, 315 Ferst Dr NW, Atlanta, GA 30332 USA.
EM robert.guldberg@me.gatech.edu
RI Boerckel, Joel/A-7223-2015
OI Huebsch, Nathaniel/0000-0002-3329-0214
FU Armed Forces Institute of Regenerative Medicine (AFIRM)
FX This work was supported by the Armed Forces Institute of Regenerative
   Medicine (AFIRM). The authors would like to thank Dr. David Mooney for
   useful discussions regarding preparation of the RGD-modified alginate,
   Dr. Natalia Landazuri for assistance with adapting the hind limb
   ischemia surgery technique, and Dr. Laura O'Farrell for veterinary
   assistance. Additional thanks to Hazel Stevens, Angela Lin, Ashley
   Allen, Dr. Tamim Diab, Christopher Dosier, Taran Lundgren, Lauren
   Priddy, and Tanushree Thote for their assistance during surgeries.
CR Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877
   Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P2384, DOI 10.1097/00006534-200206000-00033
   Brinker MR, 1997, J TRAUMA, V42, P11, DOI 10.1097/00005373-199701000-00004
   Buschmann I, 2003, MICROCIRCULATION, V10, P371, DOI 10.1038/sj.mn.7800199
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Caplan AI, 2011, J ORTHOP RES, V29, P1795, DOI 10.1002/jor.21462
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Clarkin CE, 2013, CELL BIOCHEM FUNCT, V31, P1, DOI 10.1002/cbf.2911
   Corcoran HA, 2009, J CARDIOVASC PHARM, V53, P446, DOI 10.1097/FJC.0b013e3181a6aa62
   Couffinhal T, 1998, AM J PATHOL, V152, P1667
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Devine John G, 2012, Evid Based Spine Care J, V3, P35, DOI 10.1055/s-0031-1298616
   DICKSON K, 1994, CLIN ORTHOP RELAT R, P189
   Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003
   Duvall CL, 2008, ARTERIOSCL THROM VAS, V28, P290, DOI 10.1161/ATVBAHA.107.158485
   Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Even J, 2012, J AM ACAD ORTHOP SUR, V20, P547, DOI 10.5435/JAAOS-20-09-547
   Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1
   Gerber HP, 1999, NAT MED, V5, P623
   Glass GE, 2009, J PLAST RECONSTR AES, V62, P571, DOI [10.1016/j.bjps.2008.11.117, 10.1016/j.bjps.2007.11.047]
   Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010
   Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0
   Ikeda K, 2012, BIOCHEM BIOPH RES CO, V425, P39, DOI 10.1016/j.bbrc.2012.07.045
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kase T, 1998, ARCH ORTHOP TRAUM SU, V117, P273, DOI 10.1007/s004020050245
   Kempen DHR, 2010, TISSUE ENG PART B-RE, V16, P551, DOI 10.1089/ten.teb.2010.0176
   Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657
   Langenfeld EM, 2004, MOL CANCER RES, V2, P141
   Lu CY, 2007, J ORTHOP RES, V25, P51, DOI 10.1002/jor.20264
   Lu CY, 2010, J ORTHOP RES, V28, P687, DOI 10.1002/jor.21033
   Lyle AN, 2012, ARTERIOSCL THROM VAS, V32, P1383, DOI 10.1161/ATVBAHA.112.248922
   Matsubara H, 2012, BONE, V51, P168, DOI 10.1016/j.bone.2012.02.017
   Morgan EF, 2012, BONE, V51, P535, DOI 10.1016/j.bone.2012.05.008
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nauth A, 2011, J ORTHOP TRAUMA, V25, P462, DOI 10.1097/BOT.0b013e318224caf0
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Schaper W, 2003, ARTERIOSCL THROM VAS, V23, P1143, DOI 10.1161/01.ATV.0000069625.11230.96
   Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]
   SEIFERT FC, 1985, J CARDIOVASC SURG, V26, P502
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507
   Towler DA, 2007, J CLIN INVEST, V117, P1477, DOI 10.1172/JCI32518
   Trion A, 2004, AM HEART J, V147, P808, DOI 10.1016/j.ahj.2003.10.047
   Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105
   Willett NJ, 2013, TISSUE ENG PART C-ME, V19, P316, DOI [10.1089/ten.tec.2012.0290, 10.1089/ten.TEC.2012.0290]
NR 54
TC 13
Z9 13
U1 2
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD AUG
PY 2013
VL 55
IS 2
BP 410
EP 417
DI 10.1016/j.bone.2013.04.027
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 171AK
UT WOS:000320896600019
PM 23664918
DA 2018-10-20
ER

PT J
AU Dewi, AH
   Ana, ID
   Wolke, J
   Jansen, J
AF Dewi, Anne Handrini
   Ana, Ika Dewi
   Wolke, Joop
   Jansen, John
TI Behavior of plaster of Paris-calcium carbonate composite as bone
   substitute. A study in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium sulfate; calcium carbonate; bone substitute; degradation; bone
   formation
ID TIBIAL DEFECT MODEL; GRAFT SUBSTITUTE; IN-VIVO; PHOSPHATE CEMENTS;
   SULFATE; BIOACTIVITY; DELIVERY
AB Calcium sulfate, also known as plaster of Paris (POP), is probably the oldest biomaterial used for bone grafting and considered to be a fast degradable material that allows complete resorption before the bone defect area is completely filled by new bone. The aim of this study was to investigate the possibility to combine POP with calcium carbonate in order to increase the the osteoconductivity of this material. Twenty four male Sprague Dawley rats, 5-months-old and weighing 300-350 g, were used in the study. Various treatment groups were created by the implantation of cylindrical samples of POP-100, POP-075 and POP-050 into the femoral condyles. After 1 and 4 weeks of implantation, rats were sacrificed and the implanted areas and the surrounding tissue were retrieved for histological analysis. The study was completed by an in vitro experiment, which included the soaking of the experimental materials into simulated body fluid. The results indicated that the composites were appropriate to be used as bone grafting material. The incorporation of CaCO3 into POP did decrease the degradation rate of the cements and induced faster bone formation, thus provides promising properties to this material. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Dewi, Anne Handrini; Ana, Ika Dewi] Gadjah Mada Univ, Fac Dent, Dept Dent Biomed Sci, Yogyakarta 55281, Indonesia.
   [Wolke, Joop; Jansen, John] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, J (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Wolke, J.G.C./L-4768-2015; Jansen, John/H-8055-2014
FU DGHE of The Republic of Indonesia Scholarship
FX Contract grant sponsors: DGHE of The Republic of Indonesia Scholarship
CR Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   Blom EJ, 2002, J BIOMED MATER RES, V59, P265, DOI 10.1002/jbm.1241
   Bodde EWH, 2007, J BIOMED MATER RES B, V83B, P161, DOI 10.1002/jbm.b.30780
   Bohner M, 2004, BIOMATERIALS, V25, P741, DOI 10.1016/S0142-9612(03)00573-8
   Cirotteau Y., 2001, EUR J ORTHOP SURG TR, V11, P149
   Combes C, 2006, BIOMATERIALS, V27, P1945, DOI 10.1016/j.biomaterials.2005.09.026
   Cvetkovic J, 1997, J MOL STRUCT, V408, P463, DOI 10.1016/S0022-2860(96)09721-9
   De Leonardis D, 1999, INT J ORAL MAX IMPL, V14, P869
   Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005
   Elliott J.C., 1994, STUDIES INORGANIC CH, V18, P191
   Hamed SED, 1981, BRIT CERAM TRANS J, V80, P56
   Hu GF, 2010, J POROUS MAT, V17, P605, DOI 10.1007/s10934-009-9330-3
   Huan Z, 2007, ACTA BIOMATER, V3, P952, DOI 10.1016/j.actbio.2007.05.003
   Iezzi Giovanna, 2007, J Oral Implantol, V33, P89, DOI 10.1563/0.808.1
   Jamali A, 2002, CALCIFIED TISSUE INT, V71, P172, DOI 10.1007/s00223-001-1087-x
   Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448
   Kittle E, 2001, PHYS CHEM MINER, V28, P630
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lewry JL, 1994, J MATER SCI, V29, P6085
   Lucas A, 2001, INT J INORG MATER, V3, P87, DOI 10.1016/S1466-6049(00)00058-1
   Matsuya S, 2007, J MATER SCI-MATER M, V18, P1361, DOI 10.1007/s10856-007-0123-4
   Mazor Z, 2011, J ORAL IMPLANTOL, V37, P287, DOI 10.1563/AAID-JOI-D-10-00006.1
   MIRTCHI AA, 1990, BIOMATERIALS, V11, P83, DOI 10.1016/0142-9612(90)90121-6
   Nillson M, 2002, J BIOMED MATER RES, V61, P600
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Orsini G, 2004, INT J ORAL MAXILLOF, V24, P901
   Pecora G, 1997, Dent Clin North Am, V41, P585
   Peters CL, 2006, J BIOMED MATER RES A, V76A, P456, DOI 10.1002/jbm.a.30569
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   RAWLINGS CE, 1988, J NEUROSURG, V69, P269, DOI 10.3171/jns.1988.69.2.0269
   Ricci JL, 2000, BONE ENG, P332
   Sacrano A, 2007, IMPLANT DENT, V16, P195
   Singh NB, 2007, PROG CRYST GROWTH CH, V53, P57, DOI 10.1016/j.pcrysgrow.2007.01.002
   Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014
   Thomas MV, 2008, J BIOMED MATER RES B, V88B, P597
   Vratislav T, 2012, J THERM ANAL CALORIM, V109, P57
   Walsh WR, 2003, CLIN ORTHOP RELAT R, P228, DOI 10.1097/01.blo.0000030062.92399.6a
   Wang ML, 2007, SPINE J, V7, P466, DOI 10.1016/j.spinee.2006.06.400
   Wu YC, 2009, J MATER SCI-MATER M, V20, P1273, DOI 10.1007/s10856-009-3695-3
NR 40
TC 10
Z9 11
U1 1
U2 36
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2013
VL 101
IS 8
BP 2143
EP 2150
DI 10.1002/jbm.a.34513
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169KD
UT WOS:000320778000001
PM 23239628
DA 2018-10-20
ER

PT J
AU Dicesare, P
   Fox, WM
   Hill, MJ
   Krishnan, GR
   Yang, SY
   Sarkar, D
AF Dicesare, Patrick
   Fox, Wade M.
   Hill, Michael J.
   Krishnan, G. Rajesh
   Yang, Shuying
   Sarkar, Debanjan
TI Cell-material interactions on biphasic polyurethane matrix
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mesenchymal stem cell; polyurethane; cell-matrix interaction; cellular
   organization
ID MESENCHYMAL STEM-CELLS; MODEL SEGMENTED POLYURETHANES; TYROSINE-BASED
   POLYURETHANES; FOCAL ADHESIONS; BIODEGRADABLE POLYURETHANES; BIOMATERIAL
   APPLICATIONS; REGENERATIVE MEDICINE; HARD SEGMENTS; DIFFERENTIATION;
   ELASTOMERS
AB Cell-matrix interaction is a key regulator for controlling stem cell fate in regenerative tissue engineering. These interactions are induced and controlled by the nanoscale features of extracellular matrix and are mimicked on synthetic matrices to control cell structure and functions. Recent studies have shown that nanostructured matrices can modulate stem cell behavior and exert specific role in tissue regeneration. In this study, we have demonstrated that nanostructured phase morphology of synthetic matrix can control adhesion, proliferation, organization and migration of human mesenchymal stem cells (MSCs). Nanostructured biodegradable polyurethanes (PU) with segmental composition exhibit biphasic morphology at nanoscale dimensions and can control cellular features of MSCs. Biodegradable PU with polyester soft segment and hard segment composed of aliphatic diisocyanates and dipeptide chain extender were designed to examine the effect polyurethane phase morphology. By altering the polyurethane composition, morphological architecture of PU was modulated and its effect was examined on MSC. Results show that MSCs can sense the nanoscale morphology of biphasic polyurethane matrix to exhibit distinct cellular features and, thus, signifies the relevance of matrix phase morphology. The role of nanostructured phases of a synthetic matrix in controlling cell-matrix interaction provides important insights for regulation of cell behavior on synthetic matrix and, therefore, is an important tool for engineering tissue regeneration. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Dicesare, Patrick; Sarkar, Debanjan] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   [Fox, Wade M.; Hill, Michael J.; Krishnan, G. Rajesh; Sarkar, Debanjan] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.
   [Yang, Shuying] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA.
RP Sarkar, D (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM debanjan@buffalo.edu
RI Yang, Shuying/G-4599-2011; Sarkar, Debanjan/C-6093-2017
OI Sarkar, Debanjan/0000-0002-6666-3152; Hill, Michael/0000-0001-9429-8060
FU University at Buffalo Foundation (UBF)
FX Contract grant sponsor: University at Buffalo Foundation (UBF)
CR Acharya C, 2008, BIOMATERIALS, V29, P4665, DOI 10.1016/j.biomaterials.2008.08.033
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   D'Arlas BF, 2008, POLYM ENG SCI, V48, P519, DOI 10.1002/pen.20983
   Dalby MJ, 2007, INT J NANOMED, V2, P373
   Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   ESTES GM, 1971, MACROMOLECULES, V4, P452, DOI 10.1021/ma60022a018
   Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Giannona S, 2007, J NANOSCI NANOTECHNO, V7, P1679, DOI 10.1166/jnn.2007.454
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P497, DOI 10.1163/156856294X00464
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Hernandez R, 2008, MACROMOLECULES, V41, P9767, DOI 10.1021/ma8014454
   Huang NF, 2010, ACTA BIOMATER, V6, P4614, DOI 10.1016/j.actbio.2010.06.033
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   LEE HS, 1987, MACROMOLECULES, V20, P2089, DOI 10.1021/ma00175a008
   Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038
   Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Mishra A, 2010, J PHYS CHEM B, V114, P5292, DOI 10.1021/jp100599u
   Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473
   PETROVIC ZS, 1991, PROG POLYM SCI, V16, P695, DOI 10.1016/0079-6700(91)90011-9
   Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pompe T, 2005, BIOPHYS J, V88, P527, DOI [10.1529/biophysj.104.048074, 10.1529/biophysj.104.049074]
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Shah PN, 2011, J BIOMATER APPL
   Shan-hui Hsu C-AC, 2007, J MED BIOL ENG, V27, P15
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   SPECKHARD TA, 1985, POLYMER, V26, P70, DOI 10.1016/0032-3861(85)90058-8
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sun YY, 2012, J ELECTRON MATER, V41, P519, DOI 10.1007/s11664-011-1800-0
   Tang ZG, 2004, BIOMATERIALS, V25, P4741, DOI 10.1016/j.biomaterials.2003.12.003
   Ulin J, 2004, EUR POLYM J, V40, P1857
   VANBOGART JWC, 1983, J POLYM SCI POL PHYS, V21, P65, DOI 10.1002/pol.1983.180210106
   Waletzko RS, 2009, MACROMOLECULES, V42, P2041, DOI 10.1021/ma8022052
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Yilgor I, 2006, POLYMER, V47, P4105, DOI 10.1016/j.polymer.2006.02.027
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
NR 61
TC 10
Z9 10
U1 0
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2013
VL 101
IS 8
BP 2151
EP 2163
DI 10.1002/jbm.a.34515
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169KD
UT WOS:000320778000002
PM 23255285
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Salem, SA
   Hwei, NM
   Bin Saim, A
   Ho, CCK
   Sagap, I
   Singh, R
   Yusof, MR
   Zainuddin, ZM
   Idrus, RBH
AF Salem, Salah Abood
   Hwei, Ng Min
   Bin Saim, Aminuddin
   Ho, Christopher C. K.
   Sagap, Ismail
   Singh, Rajesh
   Yusof, Mohd Reusmaazran
   Zainuddin, Zulkifili Md
   Idrus, Ruszymah Bt. Hj
TI Polylactic-co-glycolic acid mesh coated with fibrin or collagen and
   biological adhesive substance as a prefabricated, degradable,
   biocompatible, and functional scaffold for regeneration of the urinary
   bladder wall
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PLGA; collagen; fibrin; combosite scaffold; regeneration of urinary
   bladder wall
ID TISSUE; CELLS; BIOMATERIALS; REPAIR
AB The chief obstacle for reconstructing the bladder is the absence of a biomaterial, either permanent or biodegradable, that will function as a suitable scaffold for the natural process of regeneration. In this study, polylactic-co-glycolic acid (PLGA) plus collagen or fibrin was evaluated for its suitability as a scaffold for urinary bladder construct. Human adipose-derived stem cells (HADSCs) were cultured, followed by incubation in smooth muscle cells differentiation media. Differentiated HADSCs were then seeded onto PLGA mesh supported with collagen or fibrin. Evaluation of cell-seeded PLGA composite immersed in culture medium was performed under a light and scanning microscope. To determine if the composite is compatible with the urodynamic properties of urinary bladder, porosity and leaking test was performed. The PLGA samples were subjected to tensile testing was pulled until PLGA fibers break. The results showed that the PLGA composite is biocompatible to differentiated HADSCs. PLGA-collagen mesh appeared to be optimal as a cell carrier while the three-layered PLGA-fibrin composite is better in relation to its leaking/ porosity property. A biomechanical test was also performed for three-layered PLGA with biological adhesive and three-layered PLGA alone. The tensile stress at failure was 30.82 +/- 3.80 (MPa) and 34.36 +/- 2.57 (MPa), respectively. Maximum tensile strain at failure was 19.42 +/- 2.24 (mm) and 23.06 +/- 2.47 (mm), respectively. Young's modulus was 0.035 +/- 0.0083 and 0.043 +/- 0.012, respectively. The maximum load at break was 58.55 +/- 7.90 (N) and 65.29 +/- 4.89 (N), respectively. In conclusion, PLGA-Fibrin fulfils the criteria as a scaffold for urinary bladder reconstruction. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Salem, Salah Abood; Ho, Christopher C. K.; Sagap, Ismail; Zainuddin, Zulkifili Md] UKM Med Ctr, Dept Surg, Kuala Lumpur, Malaysia.
   [Salem, Salah Abood; Hwei, Ng Min; Ho, Christopher C. K.; Zainuddin, Zulkifili Md; Idrus, Ruszymah Bt. Hj] UKM Med Ctr, Tissue Engn Ctr, Kuala Lumpur, Malaysia.
   [Bin Saim, Aminuddin] Ampang Putri Specialist Hosp, Dept ENT, Kuala Lumpur, Malaysia.
   [Singh, Rajesh] UKM Med Ctr, Dept Orthoped, Kuala Lumpur, Malaysia.
   [Yusof, Mohd Reusmaazran] Agensi Nuklear Malaysia, Bangi 43000, Selangor, Malaysia.
   [Idrus, Ruszymah Bt. Hj] UKM Med Ctr, Dept Physiol, Kuala Lumpur, Malaysia.
RP Idrus, RBH (reprint author), UKM Med Ctr, Tissue Engn Ctr, Kuala Lumpur, Malaysia.
EM ruszyidrus@gmail.com
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Alberts B., 1994, MOL BIOL CELL, P971
   [Anonymous], 2001 ANN REP US ORG
   Astete CE, 2006, J BIOMAT SCI-POLYM E, V17, P247, DOI 10.1163/156856206775997322
   Atala A., 1997, TISSUE ENG, P49
   Atala A, 2008, PEDIATR RES, V63, P569, DOI 10.1203/PDR.0b013e3181660639
   David Heeley. Sensor Product Division Pheonix Arizona, 2014, UNDERSTANDING PRESSU
   Eberli D, 2007, INT J IMPOT RES, V19, P602, DOI 10.1038/sj.ijir.3901587
   Kim BS, 1998, J BIOMED MATER RES, V41, P322, DOI 10.1002/(SICI)1097-4636(199808)41:2<322::AID-JBM18>3.0.CO;2-M
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z
   Ruszymah B H I, 2004, Med J Malaysia, V59 Suppl B, P30
   Walter JR, 1985, T AM OPHTHAL SOC, V82, P187
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 16
TC 12
Z9 14
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2013
VL 101
IS 8
BP 2237
EP 2247
DI 10.1002/jbm.a.34518
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169KD
UT WOS:000320778000011
PM 23349110
DA 2018-10-20
ER

PT J
AU Hulsart-Billstrom, G
   Xia, W
   Pankotai, E
   Weszl, M
   Carlsson, E
   Forster-Horvath, C
   Larsson, S
   Engqvist, H
   Lacza, Z
AF Hulsart-Billstroem, Gry
   Xia, Wei
   Pankotai, Eszter
   Weszl, Miklos
   Carlsson, Elin
   Forster-Horvath, Csaba
   Larsson, Sune
   Engqvist, Hakan
   Lacza, Zsombor
TI Osteogenic potential of Sr-doped calcium phosphate hollow spheres in
   vitro and in vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium phosphate; strontium; bone substitutes; biomaterial; vertebral
   defect; hollow spheres; in vivo
ID BONE-FORMATION; STRONTIUM; MINERALIZATION; OSTEOBLAST; RATS;
   DIFFERENTIATION; PROLIFERATION; OSTEOPOROSIS; RESORPTION; DELIVERY
AB Treatment of osteoporotic fractures with conventional surgical methods is associated with a high rate of complications. Intense search for new treatment options includes development of specific biomaterials aimed to be part of the surgical armamentarium. Strontium doped calcium phosphate spheres (SrCPS) is a new material that might be of interest due to the influence on osteoclast and osteoblast activity. In the present study, we successfully constructed hollow spherical SrCPS particles with a diameter of approximate to 700 nm and shell thickness of approximate to 150 nm. The Sr content was about 20 wt %. Cell viability and cytotoxicity were investigated in vitro with concentrations from 0 to 1000 g/mL of SrCPS in medium extract in a day chase study. The in vivo biocompatibility was tested in a delayed bone-healing model in a rat vertebral defect by histology, CT, and nanoSPECT. The SrCPS showed no toxicity in vitro with comparable cell number in all concentrations. Increased metabolism was seen in the cell viability study in cells exposed to 400 and 600 g/mL. SPECT showed good biocompatibility with no local adverse effects and an increased osteoblast activity as compared to adjacent vertebra. SrCPS implantation induced bone formation and resulted in complete resorption and defect consolidation. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Hulsart-Billstroem, Gry; Carlsson, Elin; Larsson, Sune] Uppsala Univ, Dept Orthoped, SE-75185 Uppsala, Sweden.
   [Xia, Wei; Engqvist, Hakan] Uppsala Univ, Dept Engn Sci, Div Mat Med, SE-75121 Uppsala, Sweden.
   [Xia, Wei] VINN Excellence Ctr Biomat & Cell Therapy, BIOMATCELL, SE-40530 Gothenburg, Sweden.
   [Pankotai, Eszter; Weszl, Miklos; Lacza, Zsombor] Semmelweis Univ, Dept Human Physiol & Clin Expt Res, H-1094 Budapest, Hungary.
   [Forster-Horvath, Csaba; Lacza, Zsombor] Semmelweis Univ, Dept Orthoped, H-1113 Budapest, Hungary.
RP Hulsart-Billstrom, G (reprint author), Uppsala Univ, Dept Orthoped, SE-75185 Uppsala, Sweden.
EM gry.hulsart@surgsci.uu.se
OI Forster-Horvath MD PhD, Csaba/0000-0002-9546-6772; Engqvist,
   Hakan/0000-0001-9529-650X
FU BIOMATCELL; Biodesign; VINN Excellence Center of Biomaterials; Cell
   Therapy; TET-SIN-CELLTHER [TAMOP-4.2.1/B09/1/KMR-2010-0001, OTKA 83803];
   Bolyai; Oveges
FX Contract grant sponsors: BIOMATCELL, Biodesign, VINN Excellence Center
   of Biomaterials, Cell Therapy; Contract grant sponsors:
   TET-SIN-CELLTHER; contract grant numbers:
   TAMOP-4.2.1/B09/1/KMR-2010-0001, OTKA 83803 Contract grant sponsors:
   Bolyai and Oveges
CR Aberg J, 2011, INT J BIOMATER, V2011
   Albee FH, 1920, ANN SURG, V71, P32
   BROWN WE, 1983, J DENT RES, V62, P672
   BROWN WE, 1985, Patent No. 4518430
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Cerroni L, 2002, BIOMOL ENG, V19, P119, DOI 10.1016/S1389-0344(02)00027-8
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Emoto M, 2010, CANCER SCI, V101, P984, DOI 10.1111/j.1349-7006.2009.01479.x
   Ferraz MP, 2007, J BIOMED MATER RES A, V81A, P994, DOI 10.1002/jbm.a.31151
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   GRYNPAS MD, 1990, BONE, V11, P313, DOI 10.1016/8756-3282(90)90086-E
   Grynpas MD, 1996, BONE, V18, P253, DOI 10.1016/8756-3282(95)00484-X
   Labbaf S, 2011, BIOMATERIALS, V32, P1010, DOI 10.1016/j.biomaterials.2010.08.082
   Larsson S, 2010, J ORTHOP TRAUMA, V24, pS41, DOI 10.1097/BOT.0b013e3181cec472
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Marie PJ, 2005, CURR OPIN PHARMACOL, V5, P633, DOI 10.1016/j.coph.2005.05.005
   MARIE PJ, 1986, METABOLISM, V35, P547, DOI 10.1016/0026-0495(86)90013-2
   MARIE PJ, 1985, MINER ELECTROL METAB, V11, P5
   Mizushima Y, 2006, J CONTROL RELEASE, V110, P260, DOI 10.1016/j.jconrel.2005.09.051
   Ni GX, 2011, J MATER SCI-MATER M, V22, P961, DOI 10.1007/s10856-011-4264-0
   Olton D, 2007, BIOMATERIALS, V28, P1267, DOI 10.1016/j.biomaterials.2006.10.026
   Panzavolta S, 2008, J BIOMED MATER RES A, V84A, P965, DOI 10.1002/jbm.a.31412
   Rokita E, 1999, NUCL INSTRUM METH B, V158, P412, DOI 10.1016/S0168-583X(99)00361-4
   Su Y, 2005, J BONE MINER RES, V7, pS306
   Takaoka S, 2010, HORM METAB RES, V42, P627, DOI 10.1055/s-0030-1255091
   Tang RK, 2004, ANGEW CHEM INT EDIT, V43, P2697, DOI 10.1002/anie.200353652
   Tian M, 2009, J MATER SCI-MATER M, V20, P1505, DOI 10.1007/s10856-009-3713-5
   Tomoda K, 2010, COLLOID SURFACE B, V76, P226, DOI 10.1016/j.colsurfb.2009.10.039
   Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x
   Xia W, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/30/305610
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
NR 36
TC 12
Z9 12
U1 1
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2013
VL 101
IS 8
BP 2322
EP 2331
DI 10.1002/jbm.a.34526
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169KD
UT WOS:000320778000020
PM 23359485
DA 2018-10-20
ER

PT J
AU Mobini, S
   Hoyer, B
   Solati-Hashjin, M
   Lode, A
   Nosoudi, N
   Samadikuchaksaraei, A
   Gelinsky, M
AF Mobini, Sahba
   Hoyer, Birgit
   Solati-Hashjin, Mehran
   Lode, Anja
   Nosoudi, Nasim
   Samadikuchaksaraei, Ali
   Gelinsky, Michael
TI Fabrication and characterization of regenerated silk scaffolds
   reinforced with natural silk fibers for bone tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; natural silk fiber; fibroin; reinforcement;
   human mesenchymal stem cells
ID BOMBYX-MORI SILK; FIBROIN SCAFFOLDS; IN-VITRO; FIBROIN/CHITOSAN
   SCAFFOLD; MECHANICAL-PROPERTIES; MINERALIZED COLLAGEN; COMPOSITE
   SCAFFOLDS; DEGRADATION; FILMS; BIOMATERIAL
AB We introduce a novel Bombyx mori silk-based composite material developed for bone tissue engineering. Three-dimensional scaffolds were fabricated by embedding of natural degummed silk fibers in a matrix of regenerated fibroin, followed by freeze-drying. Different ratios of fibers to fibroin were investigated with respect to their influence on mechanical and biological properties. For all scaffold types, an interconnected porous structure suitable for cell penetration was proven by scanning electron microscopy. Compressive tests, carried out in static and cyclic mode under dry as well as wet conditions, revealed a strong impact of fiber reinforcement on compressive modulus and compressive stress. Cell culture experiments with human mesenchymal stem cells demonstrated that the fiber/fibroin composite scaffolds support cell attachment, proliferation, as well as differentiation along the osteoblastic lineage. Considering the excellent mechanical and biological properties, novel fiber/fibroin scaffolds appear to be an interesting structure for prospect studies in bone tissue engineering. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2013.
C1 [Mobini, Sahba] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran.
   [Mobini, Sahba; Hoyer, Birgit; Lode, Anja; Nosoudi, Nasim; Gelinsky, Michael] Univ Hosp Carl Gustav Carus, Ctr Translat Bone Joint & Soft Tissue Res, Dresden, Germany.
   [Mobini, Sahba; Hoyer, Birgit; Lode, Anja; Nosoudi, Nasim; Gelinsky, Michael] Tech Univ Dresden, Fac Med, D-01062 Dresden, Germany.
   [Mobini, Sahba; Solati-Hashjin, Mehran] Amirkabir Univ Technol, Dept Biomed Engn, Tehran, Iran.
   [Samadikuchaksaraei, Ali] Univ Tehran Med Sci, Cellular & Mol Res Ctr, Dept Med Biotechnol, Tehran, Iran.
   [Samadikuchaksaraei, Ali] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Biol Syst Engn Lab, London SW7 2AZ, England.
RP Solati-Hashjin, M (reprint author), Amirkabir Univ Technol, Dept Biomed Engn, Tehran, Iran.
EM solati@aut.ac.ir
RI Solati-Hashjin, Mehran/A-5535-2010; Samadikuchaksaraei, Ali/B-5158-2008
OI Solati-Hashjin, Mehran/0000-0002-1187-1237; Samadikuchaksaraei,
   Ali/0000-0002-2108-9927; Mobini, Sahba/0000-0003-2756-8694; Gelinsky,
   Michael/0000-0001-9075-5121
FU German Academic Exchange Service (DAAD, Germany)
FX Contract grant sponsor: German Academic Exchange Service (DAAD, Germany)
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   Buhler M, 2008, COMPOS SCI TECHNOL, V68, P820, DOI 10.1016/j.compscitech.2007.08.028
   Buhler M, 2008, COMPOS PART A-APPL S, V39, P1779, DOI 10.1016/j.compositesa.2008.05.020
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   De Santis R, 2004, COMPOS SCI TECHNOL, V64, P861, DOI 10.1016/j.compscitech.2003.09.008
   Doll B, 2005, BONE TISSUE ENGINEERING, P27
   Garcia-Fuentes M, 2008, BIOMATERIALS, V29, P633, DOI 10.1016/j.biomaterials.2007.10.024
   Gelinsky M, 2011, STEM CELL ENGINEERING: PRINCIPLES AND APPLICATIONS, P383, DOI 10.1007/978-3-642-11865-4_17
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gibson LJ, 1988, CELLULAR SOLIDS STRU
   Hamlehkhan Azhang, 2012, Key Engineering Materials, V493-494, P909, DOI 10.4028/www.scientific.net/KEM.493-494.909
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Heinemann S., 2010, NANOCOMPOSITES LIFE, P405
   Hofmann S, 2006, CULTURE CELLS TISSUE, P331
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Iridag Y, 2006, J APPL POLYM SCI, V100, P4260, DOI 10.1002/app.23810
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Kanungo BP, 2008, ACTA BIOMATER, V4, P490, DOI 10.1016/j.actbio.2008.01.003
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Ki CS, 2009, POLYMER, V50, P4618, DOI 10.1016/j.polymer.2009.02.017
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kweon H, 2001, J APPL POLYM SCI, V82, P750, DOI 10.1002/app.1901
   Lee KG, 2004, J APPL POLYM SCI, V93, P2174, DOI 10.1002/app.20714
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   Park J., 2010, BIOMATERIALS INTRO
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Shubhra QTH, 2011, RADIAT PHYS CHEM, V80, P1228, DOI 10.1016/j.radphyschem.2011.04.010
   Shubhra QTH, 2011, MATER LETT, V65, P333, DOI 10.1016/j.matlet.2010.09.059
   Silber G, 2010, J MECH, V26, P327, DOI 10.1017/S1727719100003889
   Stuart B.H., 2004, INFRARED SPECTROSCOP
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Teh K, 2007, J BIOMECH, V40, pS119
   Toh SL, 2006, KEY ENG MATER, V326-328, P727, DOI 10.4028/www.scientific.net/KEM.326-328.727
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wongpanit P, 2007, EUR POLYM J, V43, P4123, DOI 10.1016/j.eurpolymj.2007.07.004
   Xiong SY, 2011, ADV MATER RES-SWITZ, V197-198, P27, DOI 10.4028/www.scientific.net/AMR.197-198.27
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
   Zhu ZH, 2008, EXPRESS POLYM LETT, V2, P885, DOI 10.3144/expresspolymlett.2008.103
NR 60
TC 41
Z9 41
U1 2
U2 82
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2013
VL 101
IS 8
BP 2392
EP 2404
DI 10.1002/jbm.a.34537
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169KD
UT WOS:000320778000027
PM 23436754
DA 2018-10-20
ER

PT J
AU Dreifke, MB
   Ebraheim, NA
   Jayasuriya, AC
AF Dreifke, Michael B.
   Ebraheim, Nabil A.
   Jayasuriya, Ambalangodage C.
TI Investigation of potential injectable polymeric biomaterials for bone
   regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE injectable; bone regeneration; biocompatibility; gel; polymer;
   microspheres; biodegradation; stem cells
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; HYBRID ORGANIC/INORGANIC
   MICROPARTICLES; TISSUE ENGINEERING SCAFFOLDS; HYALURONIC-ACID GEL;
   POLY(PROPYLENE FUMARATE); IN-VITRO; POLY(ETHYLENE GLYCOL); OSTEOGENIC
   DIFFERENTIATION; CHITOSAN MICROPARTICLES
AB This article reviews the potential injectable polymeric biomaterial scaffolds currently being investigated for application in bone tissue regeneration. Two types of injectable biomaterial scaffolds are focused in this review, including injectable microspheres and injectable gels. The injectable microspheres section covers several polymeric materials, including poly(L-lactide-co-glycolide)-PLGA, poly(propylene fumarate), and chitosan. The injectable gel section covers alginate gels, hyaluronan hydrogels, poly(ethylene-glycol)-PEG hydrogels, and PEG-PLGA copolymer hydrogels. This review focuses on the effect of cellular behavior in vitro and in vivo in terms of material properties of polymers, such as biodegradation, biocompatibility, porosity, microsphere size, and cross-linking nature. Injectable polymeric biomaterials offer a major advantage for orthopedic applications by allowing the ability to use noninvasive or minimally invasive treatment methods. Therefore, combining injectable polymeric biomaterial scaffolds with cells have a significant potential to treat orthopedic bone defects, including spine fusion, and craniofacial and periodontal defects. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Dreifke, Michael B.; Ebraheim, Nabil A.; Jayasuriya, Ambalangodage C.] Univ Toledo, Coll Med, Dept Orthopaed Surg, Toledo, OH 43614 USA.
RP Jayasuriya, AC (reprint author), Univ Toledo, Coll Med, Dept Orthopaed Surg, Toledo, OH 43614 USA.
EM a.jayasuriya@utoledo.edu
FU National Science Foundation [0652024]; National Institute of Health
   [DE019508]; University of Toledo
FX Contract grant sponsor: National Science Foundation; contract grant
   number: 0652024; Contract grant sponsor: National Institute of Health;
   contract grant number: DE019508; Contract grant sponsors: University of
   Toledo, Summer medical student research support
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z
   Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289
   Betz MW, 2010, BIOMACROMOLECULES, V11, P1160, DOI 10.1021/bm100061z
   Bhat A, 2010, J TISSUE ENG REGEN M, V4, P532, DOI 10.1002/term.270
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Briggs T, 2009, J BIOMED MATER RES A, V91A, P975, DOI 10.1002/jbm.a.32310
   Burguera EF, 2008, J BIOMED MATER RES B, V84B, P493, DOI 10.1002/jbm.b.30896
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   Chesnutt BM, 2009, TISSUE ENG PT A, V15, P2571, DOI 10.1089/ten.tea.2008.0054
   Chung YM, 2002, BIOMACROMOLECULES, V3, P511, DOI 10.1021/bm0156431
   Conway JD, 2010, ORTHOP CLIN N AM, V41, P75, DOI 10.1016/j.ocl.2009.07.006
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Docherty-Skogh AC, 2010, PLAST RECONSTR SURG, V125, P1383, DOI 10.1097/PRS.0b013e3181d629dc
   Doroski DM, 2010, TISSUE ENG PT A, V16, P3457, DOI 10.1089/ten.tea.2010.0233
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Eckardt H, 2005, INJURY, V36, P489, DOI 10.1016/j.injury.2004.10.019
   Erlandsson B, 2002, POLYM DEGRAD STABIL, V78, P571, DOI 10.1016/S0141-3910(02)00233-1
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19
   Fu SZ, 2012, BIOMATERIALS, V33, P4801, DOI 10.1016/j.biomaterials.2012.03.040
   Fu SZ, 2009, J PHYS CHEM B, V113, P16518, DOI 10.1021/jp907974d
   Gallet G, 2002, POLYMER, V43, P1081, DOI 10.1016/S0032-3861(01)00677-2
   Cruz DMG, 2008, J TISSUE ENG REGEN M, V2, P378, DOI 10.1002/term.106
   Grabowski P, 2009, ENDOCR DEV, V16, P32, DOI 10.1159/000223687
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Gyawali D, 2010, BIOMATERIALS, V31, P9092, DOI 10.1016/j.biomaterials.2010.08.022
   Hedberg EL, 2005, BIOMATERIALS, V26, P3215, DOI 10.1016/j.biomaterials.2004.09.012
   HOLLINGER J, 1993, BONE, V14, P575, DOI 10.1016/8756-3282(93)90196-H
   Hou J, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035002
   Hou T, 2009, OSTEOARTHR CARTILAGE, V17, P1377
   Huh KM, 2003, DRUG DEV DELIV, V3
   Jang CH, 2008, INT J PEDIATR OTORHI, V72, P1627, DOI 10.1016/j.ijporl.2008.07.017
   Jayasuriya AC, 2008, J TISSUE ENG REGEN M, V2, P43, DOI 10.1002/term.65
   Jayasuriya A Champa, 2011, J Biomed Sci Eng, V4, P383
   Jayasuriya AC, 2012, ADV MATER RES-SWITZ, V383-390, P4065, DOI 10.4028/www.scientific.net/AMR.383-390.4065
   Jayasuriya AC, 2010, J TISSUE ENG REGEN M, V4, P340, DOI 10.1002/term.244
   Jayasuriya AC, 2010, J BIOMED MATER RES A, V93A, P1280, DOI 10.1002/jbm.a.32623
   Jayasuriya AC, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055006
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Ji Y, 2010, ANN BIOMED ENG, V38, P632, DOI 10.1007/s10439-009-9888-6
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2009, J BIOMED MATER RES A, V90A, P863, DOI 10.1002/jbm.a.32149
   Kang SW, 2008, J BIOMED MATER RES A, V85A, P747, DOI 10.1002/jbm.a.31572
   Kempen DHR, 2006, J BIOMED MATER RES A, V77A, P103, DOI 10.1002/jbm.a.30336
   Kempen DHR, 2004, J BIOMED MATER RES A, V70A, P283, DOI 10.1002/jbm.a.30079
   Kempen DHR, 2009, TISSUE ENG PT A, V15, P587, DOI 10.1089/ten.tea.2007.0376
   Killion JA, 2011, J MECH BEHAV BIOMED, V4, P1219, DOI 10.1016/j.jmbbm.2011.04.004
   Kim CW, 2008, J BIOMED MATER RES A, V85A, P1114, DOI 10.1002/jbm.a.31633
   Kim D, 2010, CELL TISSUE RES, V341, P359, DOI 10.1007/s00441-010-1015-3
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim J, 2009, TISSUE ENG PT A, V15, P2299, DOI 10.1089/ten.tea.2008.0326
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Krebs MD, 2010, J BIOMED MATER RES A, V92A, P1131, DOI 10.1002/jbm.a.32441
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Lee PY, 2007, MOL THER, V15, P1189, DOI 10.1038/sj.mt.6300156
   Lieder R, 2012, J BIOMED MAT RES A, DOI 10.1002/jbm.a.34283
   Liu H, 2006, INT J NANOMED, V1, P541, DOI 10.2147/nano.2006.1.4.541
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Malaekeh-Nikouei B, 2008, DRUG DEV IND PHARM, V34, P492, DOI [10.1080/03639040701744004, 10.1080/03639040701744004 ]
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Martinez-Sanz E, 2011, J CONTROL RELEASE, V152, P232, DOI 10.1016/j.jconrel.2011.02.003
   Matsuno H, 2006, J ORTHOP SCI, V11, P497, DOI 10.1007/s00776-006-1059-0
   Mistry AS, 2010, J BIOMED MATER RES A, V92A, P451, DOI 10.1002/jbm.a.32371
   Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240
   Ni PY, 2012, J BIOMED MATER RES A, V100A, P171, DOI 10.1002/jbm.a.33262
   Nicodemus GD, 2007, J BIOMED MATER RES A, V83A, P323, DOI 10.1002/jbm.a.31251
   Nuss Katja M R, 2008, Open Orthop J, V2, P66, DOI 10.2174/1874325000802010066
   Patil S, 2010, J DRUG TARGET, V18, P321, DOI 10.3109/10611861003663523
   Peter SJ, 1997, J BIOMAT SCI-POLYM E, V8, P893, DOI 10.1163/156856297X00074
   Place ES, 2011, TISSUE ENG PT A, V17, P2713, DOI [10.1089/ten.TEA.2011.0059, 10.1089/ten.tea.2011.0059]
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   REDDI AH, 1995, CLIN ORTHOP RELAT R, P115
   Rees DC, 2003, HOSP MED, V64, P205, DOI 10.12968/hosp.2003.64.4.1777
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Ruhe PQ, 2005, J BIOMED MATER RES A, V74A, P533, DOI 10.1002/jbm.a.30341
   Shi XT, 2010, EUR J PHARM SCI, V39, P59, DOI 10.1016/j.ejps.2009.10.012
   Shi XT, 2009, PHARM RES-DORD, V26, P422, DOI 10.1007/s11095-008-9759-0
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Smith A, 2007, GEORGIA REV, V61, P119
   Steinmetz NJ, 2011, ACTA BIOMATER, V7, P3829, DOI 10.1016/j.actbio.2011.06.031
   Tan R, 2011, J TISSUE ENG REGEN M, DOI 10.1002/term.463
   Tarasevich BJ, 2009, J BIOMED MATER RES A, V89A, P248, DOI 10.1002/jbm.a.32025
   Tenorio DMH, 2011, J TISSUE ENG REGEN M, V5, P806, DOI 10.1002/term.381
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Varghese OP, 2010, MACROMOL RAPID COMM, V31, P1175, DOI 10.1002/marc.200900906
   Varghese OP, 2009, J AM CHEM SOC, V131, P8781, DOI 10.1021/ja902857b
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Vindigni V, 2009, INT J MOL SCI, V10, P2972, DOI 10.3390/ijms10072972
   Wang LY, 2005, J CONTROL RELEASE, V106, P62, DOI 10.1016/j.jconrel.2005.04.005
   Wang Y, 2008, J ORTHOP RES, V26, P539, DOI 10.1002/jor.20495
   Wang Z, 2006, TISSUE ENG, V12, P1753, DOI 10.1089/ten.2006.12.1753
   Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129
   Yu L, 2011, BIOMACROMOLECULES, V12, P1290, DOI 10.1021/bm101572j
   Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
NR 97
TC 54
Z9 57
U1 11
U2 223
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2013
VL 101
IS 8
BP 2436
EP 2447
DI 10.1002/jbm.a.34521
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169KD
UT WOS:000320778000031
PM 23401336
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Nijhuis, AWG
   van den Beucken, JJJP
   Boerman, OC
   Jansen, JA
   Leeuwenburgh, SCG
AF Nijhuis, Arnold W. G.
   van den Beucken, Jeroen J. J. P.
   Boerman, Otto C.
   Jansen, John A.
   Leeuwenburgh, Sander C. G.
TI 1-Step Versus 2-Step Immobilization of Alkaline Phosphatase and Bone
   Morphogenetic Protein-2 onto Implant Surfaces Using Polydopamine
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID GROWTH-FACTOR DELIVERY; IN-VITRO; COATINGS; TITANIUM; FUNCTIONALIZATION;
   ADSORPTION; DIFFERENTIATION; MONOLAYERS; ADHESION; CELLS
AB Immobilization of biomolecules onto implant surfaces is highly relevant in many areas of biomaterial research. Recently, a 2-step immobilization procedure was developed for the facile conjugation of biomolecules onto various surfaces using self-polymerization of dopamine into polydopamine. In the current study, a 1-step polydopamine-based approach was applied for alkaline phosphatase (ALP) and bone morphogenetic protein-2 (BMP-2) immobilization, and compared to the conventional 2-step polydopamine-based immobilization and plain adsorption. To this end, ALP and BMP-2 were immobilized onto titanium and polytetrafluoroethylene (PTFE) substrates. The absolute quantity and biological activity of immobilized ALP were assessed quantitatively to compare the three types of immobilization. Plain adsorption of both ALP and BMP-2 was inferior to both polydopamine-based immobilization approaches. ALP was successfully immobilized onto titanium and PTFE surfaces via the 1-step approach, and the immobilized ALP retained its enzymatic activity. Using the 1-step approach, the amount of immobilized ALP was increased twofold to threefold compared to the conventional 2-step immobilization process. In contrast, more BMP-2 was immobilized using the conventional 2-step immobilization approach. Retention of ALP and BMP-2 was measured over a period of 4 weeks and was found to be similar for the 1-step and 2-step methods and far superior to the retention of adsorbed biomolecules due to the formation of covalent linkages between catechol moieties and immobilized proteins. The biological behavior of ALP and BMP-2 coatings immobilized using polydopamine (1- and 2-step) as well as adsorption was assessed by culturing rat bone marrow cells, which revealed that the cell responses to the various experimental groups were not statistically different. In conclusion, the 1-step polydopamine-based immobilization method was shown to be more efficient for immobilization of ALP, whereas the conventional 2-step method was shown to be more efficient for attachment of BMP-2 onto implant surfaces.
C1 [Nijhuis, Arnold W. G.; van den Beucken, Jeroen J. J. P.; Jansen, John A.; Leeuwenburgh, Sander C. G.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6525 EX Nijmegen, Netherlands.
   [Boerman, Otto C.] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6525 EX Nijmegen, Netherlands.
RP Leeuwenburgh, SCG (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, Philips van Leijdenlaan 25,PB309, NL-6525 EX Nijmegen, Netherlands.
EM S.Leeuwenburgh@dent.umcn.nl
RI Boerman, Otto/A-8112-2014; van den beucken, jeroen/N-2910-2013;
   Leeuwenburgh, S.C.G./L-4483-2015; Jansen, John/H-8055-2014
OI Boerman, Otto/0000-0001-6832-101X; van den beucken,
   jeroen/0000-0002-0301-1966; Leeuwenburgh, S.C.G./0000-0003-1471-6133; 
FU Royal Netherlands Academy of Arts and Sciences (KNAW), Programme
   Strategic Scientific Alliances (PSA) [08-PSAM-02]
FX This study was supported by The Royal Netherlands Academy of Arts and
   Sciences (KNAW), Programme Strategic Scientific Alliances (PSA), grant
   no. 08-PSAM-02. Annemarie Eek, from the department of Nuclear Medicine,
   Radboud University, Nijmegen, is gratefully acknowledged for her help
   with the radiolabeling of biomolecules. C.C.M. Carcouet, from the
   Laboratory of Materials and Interface Chemistry, Eindhoven University of
   Technology, The Netherlands, is acknowledged for technical assistance
   with the contact-angle measurements.
CR Adden N, 2006, LANGMUIR, V22, P8197, DOI 10.1021/la060754c
   ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   de Jonge LT, 2009, ACTA BIOMATER, V5, P2773, DOI 10.1016/j.actbio.2009.03.019
   de Jonge LT, 2009, ADV FUNCT MATER, V19, P755, DOI 10.1002/adfm.200800819
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Ham HO, 2011, ANGEW CHEM INT EDIT, V50, P732, DOI 10.1002/anie.201005001
   Imamura K, 2008, J BIOSCI BIOENG, V106, P273, DOI 10.1263/jbb.106.273
   Jeong KJ, 2011, SOFT MATTER, V7, P8305, DOI 10.1039/c1sm05918a
   Jiang JH, 2011, LANGMUIR, V27, P14180, DOI 10.1021/la202877k
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   Lai M, 2011, BIOMACROMOLECULES, V12, P1097, DOI 10.1021/bm1014365
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee DW, 2012, BONE, V50, P974, DOI 10.1016/j.bone.2012.01.007
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lenghaus K, 2003, LANGMUIR, V19, P5971, DOI 10.1021/la034294o
   Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu YL, 2004, TISSUE ENG, V10, P101, DOI 10.1089/107632704322791745
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   Nijhuis AWG, 2010, MACROMOL BIOSCI, V10, P1316, DOI 10.1002/mabi.201000142
   Poh CK, 2011, J ORTHOP RES, V29, P1424, DOI 10.1002/jor.21409
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Pohl TLM, 2012, ACTA BIOMATER, V8, P772, DOI 10.1016/j.actbio.2011.10.019
   Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/015355b
   Shen H, 2009, BIOMATERIALS, V30, P3150, DOI 10.1016/j.biomaterials.2009.02.004
   Shin YM, 2011, MACROMOL RES, V19, P835, DOI 10.1007/s13233-011-0815-y
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yamachika E, 2009, J BIOMED MATER RES A, V88A, P599, DOI 10.1002/jbm.a.31833
   Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j
   Zhang HN, 2010, TISSUE ENG PT A, V16, P3441, DOI [10.1089/ten.tea.2010.0132, 10.1089/ten.TEA.2010.0132]
   Zhu LP, 2011, COLLOID SURFACE B, V86, P111, DOI 10.1016/j.colsurfb.2011.03.027
NR 37
TC 16
Z9 17
U1 2
U2 48
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD AUG
PY 2013
VL 19
IS 8
BP 610
EP 619
DI 10.1089/ten.tec.2012.0313
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 168LI
UT WOS:000320706900004
PM 23231507
OA Green Published
DA 2018-10-20
ER

PT J
AU Pace, LA
   Plate, JF
   Smith, TL
   Van Dyke, ME
AF Pace, Lauren A.
   Plate, Johannes F.
   Smith, Thomas L.
   Van Dyke, Mark E.
TI The effect of human hair keratin hydrogel on early cellular response to
   sciatic nerve injury in a rat model
SO BIOMATERIALS
LA English
DT Article
DE Keratin; Nerve; Conduit; Schwann cell; Hydrogel
ID IMMUNE-RESPONSE; CONDUITS; REPAIR; REGENERATION; RECONSTRUCTION;
   BIOMATERIALS; GUIDE
AB Peripheral nerve injuries requiring surgery can be repaired by autograft, the clinical "gold standard", allograft, or nerve conduits. Most published clinical studies show the effectiveness of nerve conduits in small size defects in sensory nerves. Many preclinical studies suggest that peripheral nerve regeneration through conduits can be enhanced and repair lengths increased with the use of a biomaterial filler in the conduit lumen. We have previously shown that a luminal hydrogel filler derived from human hair keratin (HHK) can improve electrophysiological and histological outcomes in mouse, rabbit, and non-human primate nerve injury models, but insight into potential mechanisms has been lacking. Based on the premise that a keratin biomaterial (KOS) hydrogel provides an instantaneous structural matrix within the lumen, the current study compares the cellular behavior elicited by KOS hydrogel to Matrigel (MAT) and saline (SAL) conduit fillers in a 1 cm rat sciatic nerve injury model at early stages of regeneration. While there was little difference in initial cellular influx, the KOS group showed earlier migration of dedifferentiated Schwann cells (SC) from the proximal nerve end compared to the other groups. The KOS group also showed faster SC dedifferentiation and myelin debris clearance, and decreased macrophage infiltration during Wallerian degeneration of the distal nerve tissue. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Pace, Lauren A.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Plate, Johannes F.; Smith, Thomas L.; Van Dyke, Mark E.] Wake Forest Sch Med, Dept Orthopaed Surg, Winston Salem, NC 27157 USA.
   [Pace, Lauren A.; Plate, Johannes F.] Wake Forest Sch Med, Program Neurosci, Winston Salem, NC 27157 USA.
RP Van Dyke, ME (reprint author), Virginia Polytech Inst & State Univ, Virginia Tech Wake Forest Sch Biomed Engn & Sci S, Blacksburg, VA 24061 USA.
EM mavandyk@wakehealth.edu
FU KeraNetics LLC; Errett Fisher Foundation; Armed Forces Institute for
   Regenerative Medicine (DOD) [W81XWH-08-2-0032]
FX The authors would like to gratefully acknowledge the Wake Forest
   Department of Orthopedic Surgery for their assistance with this study.
   Funding was provided by KeraNetics LLC, the Errett Fisher Foundation,
   and the Armed Forces Institute for Regenerative Medicine (DOD Contract
   #W81XWH-08-2-0032)
CR Alluin O, 2009, BIOMATERIALS, V30, P363, DOI 10.1016/j.biomaterials.2008.09.043
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781
   Brooks DN, 2011, MICROSURG, V32, P1
   Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   Dahlin LB, 2008, SCAND J SURG, V97, P310, DOI 10.1177/145749690809700407
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   de Guzman RC, 2010, J BIOMAT SCI-POLYM E, V21, P1081, DOI 10.1163/092050609X12457428936116
   Deal DN, 2012, J AM ACAD ORTHOP SUR, V20, P63, DOI 10.5435/JAAOS-20-02-063
   Gaudet AD, 2009, EXP NEUROL, V220, P320, DOI 10.1016/j.expneurol.2009.09.007
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   Ide C, 1996, NEUROSCI RES, V25, P101
   KALUZEWSKA M, 1991, INT BIODETERIOR, V27, P11, DOI 10.1016/0265-3036(91)90020-R
   Lee S K, 2000, J Am Acad Orthop Surg, V8, P243
   Lohmeyer JA, 2009, J RECONSTR MICROSURG, V25, P55, DOI 10.1055/s-0028-1103505
   Mackinnon SE, 2011, J HAND SURG-AM, V36A, P183, DOI 10.1016/j.jhsa.2010.10.013
   Meek MF, 2008, ANN PLAS SURG, V60, P466, DOI 10.1097/SAP.0b013e31804d441c
   Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Rotshenker S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-109
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Seddon HJ, 1943, BRAIN, V66, P237, DOI 10.1093/brain/66.4.237
   Shim S, 2009, EXP NEUROL, V223, P38
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Sunderland S, 1978, NERVES NERVE INJURIE
   Taras JS, 2011, J HAND SURG-AM, V36A, P1441, DOI 10.1016/j.jhsa.2011.06.009
   Waitayawinyu T, 2007, J HAND SURG-AM, V32A, P1521, DOI 10.1016/j.jhsa.2007.07.015
NR 29
TC 37
Z9 38
U1 4
U2 100
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2013
VL 34
IS 24
BP 5907
EP 5914
DI 10.1016/j.biomaterials.2013.04.024
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 164SS
UT WOS:000320430400004
PM 23680369
DA 2018-10-20
ER

PT J
AU Orlando, G
   Booth, C
   Wang, Z
   Totonelli, G
   Ross, CL
   Moran, E
   Salvatori, M
   Maghsoudlou, P
   Turmaine, M
   Delario, G
   Al-Shraideh, Y
   Farooq, U
   Farney, AC
   Rogers, J
   Iskandar, SS
   Burns, A
   Marini, FC
   De Coppi, P
   Stratta, RJ
   Soker, S
AF Orlando, Giuseppe
   Booth, Christopher
   Wang, Zhan
   Totonelli, Giorgia
   Ross, Christina L.
   Moran, Emma
   Salvatori, Marcus
   Maghsoudlou, Panagiotis
   Turmaine, Mark
   Delario, Ginger
   Al-Shraideh, Yousef
   Farooq, Umar
   Farney, Alan C.
   Rogers, Jeffrey
   Iskandar, Samy S.
   Burns, Alan
   Marini, Frank C.
   De Coppi, Paolo
   Stratta, Robert J.
   Soker, Shay
TI Discarded human kidneys as a source of ECM scaffold for kidney
   regeneration technologies
SO BIOMATERIALS
LA English
DT Article
DE Discarded kidneys; Renal transplantation; Organ bioengineering and
   regeneration; Scaffold; Decellularization; Biomaterial
ID GLOMERULAR-BASEMENT-MEMBRANE; EXTRACELLULAR-MATRIX; STEM-CELLS; TISSUE;
   LIVER; TRANSPLANTATION; EXPRESSION; REGRESSION; LUNG; DECELLULARIZATION
AB In the United States, more than 2600 kidneys are discarded annually, from the total number of kidneys procured for transplant. We hypothesized that this organ pool may be used as a platform for renal bioengineering and regeneration research. We previously showed that decellularization of porcine kidneys yields renal extracellular matrix (ECM) scaffolds that maintain their basic components, support cell growth and welfare in vitro and in vivo, and show an intact vasculature that, when such scaffolds are implanted in vivo, is able to sustain physiological blood pressure. The purpose of the current study was to test if the same strategy can be applied to discarded human kidneys in order to obtain human renal ECM scaffolds. The results show that the sodium dodecylsulfate-based decellularization protocol completely cleared the cellular compartment in these kidneys, while the innate ECM framework retained its architecture and biochemical properties. Samples of human renal ECM scaffolds stimulated angiogenesis in a chick chorioallantoic membrane assay. Importantly, the innate vascular network in the human renal ECM scaffolds retained its compliance. Collectively, these results indicate that discarded human kidneys are a suitable source of renal scaffolds and their use for tissue engineering applications may be more clinically applicable than kidneys derived from animals. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Orlando, Giuseppe; Al-Shraideh, Yousef; Farooq, Umar; Farney, Alan C.; Rogers, Jeffrey; Stratta, Robert J.] Wake Forest Sch Med, Dept Gen Surg, Sect Transplantat, Winston Salem, NC USA.
   [Orlando, Giuseppe; Booth, Christopher; Wang, Zhan; Ross, Christina L.; Moran, Emma; Salvatori, Marcus; Marini, Frank C.; Soker, Shay] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
   [Totonelli, Giorgia; Maghsoudlou, Panagiotis; De Coppi, Paolo] UCL, Inst Child Hlth, Surg Unit, London, England.
   [Totonelli, Giorgia; Maghsoudlou, Panagiotis; De Coppi, Paolo] UCL, Great Ormond St Hosp, London, England.
   [Turmaine, Mark] UCL, Div Biosci, London, England.
   [Delario, Ginger] Carolina Donor Serv, Durham, NC USA.
   [Iskandar, Samy S.] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA.
   [Burns, Alan] UCL, Neurodev Unit, London, England.
RP Orlando, G (reprint author), Wake Forest Sch Med, Dept Surg, Sect Transplantat, Winston Salem, NC USA.
EM gorlando@wakehealth.edu
RI Burns, Alan/C-4988-2008; Marini, Frank/L-8018-2016
OI De Coppi, Paolo/0000-0002-1659-0207
FU Medical Research Council [991877]
CR BACH FH, 1976, ANNU REV GENET, V10, P319, DOI 10.1146/annurev.ge.10.120176.001535
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Baiguera S, 2012, J BIOMED MATER RES B, V100B, P1425, DOI 10.1002/jbm.b.32653
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Barakat O, 2012, J SURG RES, V173, P11
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Groffen AJ, 1998, J HISTOCHEM CYTOCHEM, V46, P19, DOI 10.1177/002215549804600104
   Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604
   Hata T, 2013, ANN SURG, V257, P542, DOI 10.1097/SLA.0b013e31825c5349
   Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047
   Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005
   Lin S, 2010, J RENIN-ANGIO-ALDO S, V11, P149, DOI 10.1177/1470320310369603
   Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1
   Matas AJ, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/ajt.12019
   Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031
   Ng SLJ, 2011, BIOMATERIALS, V32, P7571, DOI 10.1016/j.biomaterials.2011.06.065
   Nichols JE, 2012, J CELL BIOCHEM, V113, P2185, DOI 10.1002/jcb.24112
   Orlando G, 2012, ANN SURG, V256, P363, DOI 10.1097/SLA.0b013e31825a02ab
   Orlando G, 2012, ANN SURG, V255, P867, DOI 10.1097/SLA.0b013e318243a4db
   Orlando G, 2011, TRANSPLANTATION, V91, P1310, DOI 10.1097/TP.0b013e318219ebb5
   Orlando Giuseppe, 2011, Transpl Int, V24, P223, DOI 10.1111/j.1432-2277.2010.01182.x
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022
   Remuzzi A, 2006, KIDNEY INT, V69, P1124, DOI 10.1038/sj.ki.5000060
   Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699
   Ross CL, 2013, EXPERT OPIN BIOL TH, V13, P103, DOI 10.1517/14712598.2013.732063
   Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196
   Shupe T, 2010, ORGANOGENESIS, V6, P134, DOI 10.4161/org.6.2.11546
   Song JJ, 2013, NAT MED, DOI DOI 10.1038/NM.3154.[EPUB
   Spenle C, 2012, CELL ADH MIGR, V7
   Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/j.annals.1334.015
   Wang YF, 2011, HEPATOLOGY, V53, P293, DOI 10.1002/hep.24012
   Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270
NR 40
TC 88
Z9 89
U1 1
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2013
VL 34
IS 24
BP 5915
EP 5925
DI 10.1016/j.biomaterials.2013.04.033
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 164SS
UT WOS:000320430400005
PM 23680364
DA 2018-10-20
ER

PT J
AU Traub, S
   Morgner, J
   Martino, MM
   Honing, S
   Swartz, MA
   Wickstrom, SA
   Hubbell, JA
   Eming, SA
AF Traub, Stephanie
   Morgner, Jessica
   Martino, Mikael M.
   Hoening, Stefan
   Swartz, Melody A.
   Wickstroem, Sara A.
   Hubbell, Jeffrey A.
   Eming, Sabine A.
TI The promotion of endothelial cell attachment and spreading using FNIII10
   fused to VEGF-A(165)
SO BIOMATERIALS
LA English
DT Article
DE Angiogenesis; VEGF; Fibronectin; Integrins; Adhesion; Cell spreading
ID VEGF GENE-TRANSFER; GROWTH-FACTOR; INTEGRIN ALPHA(V)BETA(3);
   EXTRACELLULAR-MATRIX; MICE LACKING; PHASE-II; ANGIOGENESIS; FIBRONECTIN;
   ACTIVATION; MIGRATION
AB Synergy in the downstream signaling pathways of the vascular endothelial growth factor receptor-2 (VEGFR-2) and the integrin alpha v beta 3 is critical for blood vessel formation. Thus, agents that activate both receptors could possess efficient pro-angiogenic potential. Here, we created a fibrin-binding bi-functional protein (FNIII10-VEGF) consisting of the 10th type III domain of fibronectin (FNIII10) fused to a plasmin-resistant VEGF-A(165) mutant (VEGF) that potentiated angiogenic processes when compared to the effect of the separate molecules. FNIII10-VEGF was able to bind both VEGFR-2 and integrin alpha v beta 3. Intriguingly, cell attachment and spreading to immobilized FNIII10-VEGF was significantly enhanced compared to individual FNIII10 or VEGF proteins. Delivery of immobilized FNIII10-VEGF by covalent linkage to a fibrin matrix significantly enhanced the angiogenic response in an in vivo wound healing assay compared to soluble VEGF. Unexpectedly, the angiogenic response to fibrin-immobilized FNIII10-VEGF was reduced in comparison to the pro-angiogenic effect of fibrin-immobilized VEGF. Collectively, findings of this study corroborate a critical role for a subtle balance of the integrin-VEGF interplay in angiogenesis and provide insight in how engineered growth factors in concert with biomaterial matrices may offer a potent molecular/material approach to harness these interactions for therapeutic angiogenesis. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Traub, Stephanie; Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany.
   [Morgner, Jessica; Wickstroem, Sara A.] Max Planck Inst Biol Ageing, Paul Gerson Unna Grp Skin Homeostasis & Ageing, Cologne, Germany.
   [Martino, Mikael M.; Swartz, Melody A.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland.
   [Hoening, Stefan] Univ Cologne, Fac Med, Ctr Biochem, D-50937 Cologne, Germany.
   [Hoening, Stefan; Eming, Sabine A.] Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany.
   [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland.
   [Eming, Sabine A.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany.
RP Eming, SA (reprint author), Univ Cologne, Dept Dermatol, Kerpenerstr 62, D-50937 Cologne, Germany.
EM sabine.eming@uni-koeln.de
RI Hubbell, Jeffrey/A-9266-2008; Traub, Stephanie/M-1709-2013; Martino,
   Mikael/N-9345-2013
OI Hubbell, Jeffrey/0000-0003-0276-5456; Martino,
   Mikael/0000-0002-5012-4605
FU EU [Angioscaff NMP-LA-2008-214402]; Bayer Innovation GmbH; Deutsche
   Forschungsgemeinschaft [SFB 829]
FX We thank Ann-Kathrin Becker and Raimund Wagener for performing the CD
   spectrum analysis, Eleonora Simeoni for her advice on the cloning
   strategy, Manuel Koch for help with the synthesis of recombinant
   proteins, and Martin Ehrbar for sharing his experiences on
   VEGF-functionalized fibrin gels. We are grateful to Mats Paulsson and
   Thomas Krieg for helpful discussions. Expert technical assistance by
   Michael Piekarek and Astrid Schauss (imaging) is gratefully
   acknowledged. We thank Kijawasch Shah-Hosseini and Martin Helmich for
   their advice on statistical analysis. This work was supported by grants
   from the EU (Angioscaff NMP-LA-2008-214402 to SAE, JAH, and MS), Bayer
   Innovation GmbH and the Deutsche Forschungsgemeinschaft (SFB 829 to
   SAE).
CR BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751
   BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8
   Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6
   Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379
   Carmeliet P, 2002, NAT MED, V8, P14, DOI 10.1038/nm0102-14
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001
   Eming SA, 2011, EXP DERMATOL, V20, P605, DOI 10.1111/j.1600-0625.2011.01309.x
   FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607
   Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Hall Heike, 2004, Angiogenesis, V7, P213, DOI 10.1007/s10456-004-1328-5
   Hanft JR, 2008, J WOUND CARE, V17, P4
   Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487
   Hoffmann DC, 2011, J BIOL CHEM, V286, P28889, DOI 10.1074/jbc.M111.249979
   Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje
   Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918
   Kirchner LM, 2003, WOUND REPAIR REGEN, V11, P127, DOI 10.1046/j.1524-475X.2003.11208.x
   Lauer G, 2002, FEBS LETT, V531, P309, DOI 10.1016/S0014-5793(02)03545-7
   Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709
   Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7
   Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234
   Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655
   Makinen K, 2002, MOL THER, V6, P127, DOI 10.1006/mthe.2002.0638
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Olea FD, 2009, GENE THER, V16, P716, DOI 10.1038/gt.2009.30
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200
   Papo N, 2011, P NATL ACAD SCI USA, V108, P14067, DOI 10.1073/pnas.1016635108
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766
   Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29
   Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27
   Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372
   Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Shen CJ, 2011, EXP CELL RES, V317, P1860, DOI 10.1016/j.yexcr.2011.05.006
   Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882
   Stupp R, 2007, J CLIN ONCOL, V25, P1637, DOI 10.1200/JCO.2006.09.8376
   Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478
   West XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031071
   Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 45
TC 22
Z9 22
U1 3
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2013
VL 34
IS 24
BP 5958
EP 5968
DI 10.1016/j.biomaterials.2013.04.050
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 164SS
UT WOS:000320430400009
PM 23683723
DA 2018-10-20
ER

PT J
AU Wu, ZK
   Li, N
   Jian, C
   Zhao, WQ
   Yan, JZ
AF Wu, Zhi-kai
   Li, Ning
   Jian, Chao
   Zhao, Wan-qian
   Yan, Jia-zhen
TI Low temperature degradation of Al2O3-doped 3Y-TZP sintered at various
   temperatures
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Sintering; Grain boundary; ZrO2; Low temperature degradation
ID MONOCLINIC PHASE-TRANSFORMATION; MOL-PERCENT YTTRIA; STABILIZED
   ZIRCONIA; MECHANICAL-PROPERTIES; ALUMINA; POLYCRYSTALS; CERAMICS;
   THERMODYNAMICS; BIOMATERIAL; ZRO2
AB The low temperature degradation of Al2O3;doped 3Y-TZP sintered at 1400-1600 degrees C was investigated by aging at 140 degrees C for various hours. X-ray diffraction and field emission scanning electron microscopy were used to study the microstructure of specimens. The results showed that the mean grain size of samples sintered at 1400-1600 degrees C was between 0.3 mu m and 0.9 mu m, addition of Al2O3 slightly promoted the coarsening of tetragonal grain during densification. Introduction of 0.5-5.0 wt% Al2O3 addition into 3Y-TZP effectively delayed the tetragonal-monoclinic phase transformation and the degradation of mechanical property during aging. Sintering temperature had a significant effect on the aging sensibility of 3Y-TZP. The aging resistance of 3Y-TZP decreased rapidly with the increase of sintering temperature, especially for the control group which is free of Al2O3 addition. This can be interpreted by the increase in grain size and the heterogeneous distribution of Y3+ ions within tetragonal grains. (C) 2013 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Wu, Zhi-kai; Li, Ning; Jian, Chao; Zhao, Wan-qian; Yan, Jia-zhen] Sichuan Univ, Coll Mfg Sci & Engn, Dept Mat Proc Engn, Chengdu 610065, Peoples R China.
RP Wu, ZK (reprint author), Sichuan Univ, Coll Mfg Sci & Engn, Dept Mat Proc Engn, Chengdu 610065, Peoples R China.
EM wuzhikai@163.com
CR Cattani-Lorente M, 2011, ACTA BIOMATER, V7, P858, DOI 10.1016/j.actbio.2010.09.020
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Elshazly ES, 2008, J MATER SCI TECHNOL, V24, P873
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Li JF, 1997, J MATER SCI, V32, P1149, DOI 10.1023/A:1018567414745
   Li JF, 1998, J AM CERAM SOC, V81, P2687
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Matsui K, 2006, J MATER RES, V21, P2278, DOI 10.1557/JMR.2006.0274
   Munoz-Saldana J, 2003, J MATER RES, V18, P2415, DOI 10.1557/JMR.2003.0337
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   Suresh A, 2003, J MATER RES, V18, P2912, DOI 10.1557/JMR.2003.0406
   TSUBAKINO H, 1991, J MATER SCI, V26, P5521, DOI 10.1007/BF00553654
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
   TSUKAMA K, 1985, J MATER SCI LETT, V4, P857, DOI 10.1007/BF00720523
NR 21
TC 7
Z9 8
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD AUG
PY 2013
VL 39
IS 6
BP 7199
EP 7204
DI 10.1016/j.ceramint.2013.02.065
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 162VY
UT WOS:000320295300150
DA 2018-10-20
ER

PT J
AU Zhao, DH
   Jiang, JH
   Xu, JI
   Yang, L
   Song, TY
   Zhang, P
AF Zhao, Dazhou
   Jiang, Jinhua
   Xu, Jianing
   Yang, Li
   Song, Tianyou
   Zhang, Ping
TI Synthesis of template-free hollow vaterite CaCO3 microspheres in the
   H2O/EG system
SO MATERIALS LETTERS
LA English
DT Article
DE Hollow CaCO3; H2O/EG; Microstructure; Vaterite; Polymeric composites
ID CALCIUM-CARBONATE PARTICLES; MIXED-SOLUTIONS; PRECIPITATION; POLYMORPHS;
   MORPHOLOGY; PHASE
AB We describe a simple and green method for synthesizing hollow calcium carbonate (CaCO3) microspheres composed of vaterite via the reaction of Ca(CH3COO)(2) with NaHCO3 in the solvent mixture of ethylene glycol (EG) and H2O, without any templates. We show that the reaction rapidly conducts to the formation of microspheres with an average diameter of 800 nm. XRD and FTIR analyses confirm that the hollow CaCO3 microspheres are the characteristic of the vaterite polymorph. SEM and TEM observations reveal that the microspheres have a hollow core of around 500 nm width and are composed of vaterite with an average diameter of 80 nm. A possible growth mechanism for the hollow structure has been proposed, which exhibits that the hollow CaCO3 microspheres are formed by an aggregation mechanism. This work may pave the way for the elaboration of a biomaterial with potential applications in therapy as well as drug delivery. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Zhao, Dazhou; Jiang, Jinhua; Xu, Jianing; Yang, Li; Song, Tianyou; Zhang, Ping] Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, Changchun 130012, Peoples R China.
RP Zhang, P (reprint author), Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, 2699 Qianjin St, Changchun 130012, Peoples R China.
EM dazhou550597667@l63.com; zhangping@jlu.edu.cn
FU National Nature Science Foundation of China [50573030, 21171065]
FX We acknowledge the financial support of the National Nature Science
   Foundation of China (Nos. 50573030 and 21171065).
CR Alivisatos AP, 2000, SCIENCE, V289, P736, DOI 10.1126/science.289.5480.736
   Beuvier T, 2011, J MATER CHEM, V21, P9757, DOI 10.1039/c1jm10770d
   Chen J, 2009, POWDER TECHNOL, V189, P64, DOI 10.1016/j.powtec.2008.06.004
   Dalas E, 1999, LANGMUIR, V15, P8322, DOI 10.1021/la981366g
   Deng SG, 2005, J PHYS CHEM B, V109, P11473, DOI 10.1021/jp050290b
   Hadiko G, 2005, MATER LETT, V59, P2519, DOI 10.1016/j.matlet.2005.03.036
   Han YS, 2006, J MATER SCI, V41, P4663, DOI 10.1007/s10853-006-0037-4
   Ji X, 2008, MATER LETT, V62, P751, DOI 10.1016/j.matlet.2007.06.063
   Kitamura M, 2001, J COLLOID INTERF SCI, V236, P318, DOI 10.1006/jcis.2000.7398
   Kontoyannis CG, 2000, ANALYST, V125, P251, DOI 10.1039/a908609i
   Liang P, 2004, J CRYST GROWTH, V261, P571, DOI 10.1016/j.jcrysgro.2003.03.001
   Manoli F, 2000, J CRYST GROWTH, V218, P359, DOI 10.1016/S0022-0248(00)00560-1
   Pan Y, 2007, MATER LETT, V61, P2810, DOI 10.1016/j.matlet.2006.10.034
   Peng CY, 2010, COLLOID SURFACE A, V353, P132, DOI 10.1016/j.colsurfa.2009.11.004
   Penn RL, 2001, J PHYS CHEM B, V105, P2177, DOI 10.1021/jp003570u
   Qi LM, 2002, ADV MATER, V14, P300
   WALSH D, 1995, NATURE, V377, P320, DOI 10.1038/377320a0
   Wang CY, 2006, MATER LETT, V60, P854, DOI 10.1016/j.matlet.2005.10.035
   Wang LF, 1999, J COLLOID INTERF SCI, V218, P545, DOI 10.1006/jcis.1999.6463
   Watanabe H, 2009, ADV POWDER TECHNOL, V20, P89, DOI 10.1016/j.apt.2008.10.004
   Wong EM, 1998, J PHYS CHEM B, V102, P7770, DOI 10.1021/jp982397n
   Yu JG, 2004, J SOLID STATE CHEM, V177, P681, DOI 10.1016/j.jssc.2003.08.017
   Yu SH, 2004, CRYST GROWTH DES, V4, P33, DOI 10.1021/cg0340906
NR 23
TC 16
Z9 18
U1 3
U2 104
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG 1
PY 2013
VL 104
BP 28
EP 30
DI 10.1016/j.matlet.2013.04.018
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 160TD
UT WOS:000320142500008
DA 2018-10-20
ER

PT J
AU Bahrami, R
   Omidvar, H
   Zangeneh, S
   Ketabchi, M
AF Bahrami, R.
   Omidvar, H.
   Zangeneh, Sh.
   Ketabchi, M.
TI Solid state diffusion bonding of Ti-6Al-4V and Co-28Cr-5Mo-0 center dot
   3C alloys
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Diffusion bonding; Co-28Cr-5Mo-0 center dot 3C; Ti-6Al-4V
ID NOZZLE
AB An attempt to investigate solid state diffusion bonding of Ti-6Al-4V and Co-28Cr-5Mo-0 center dot 3C alloys has been made. The results showed that the joint could not be successfully bonded at 800 degrees C, even though longer period of holding times (>1 h) was used. However, at 850 degrees C, successful joining was achieved at holding time of 1 h. It was found that increasing temperature up to 900 degrees C gave rise to intermetallic component formation, mainly Co3Ti, at the joining interface, which contributed to weak bonding strength. This technique provides a reliable method of bonding of Ti-6Al-4V to Co-28Cr-5Mo-0 center dot 3C alloys, which is very helpful in the development of biomaterial industry.
C1 [Bahrami, R.; Omidvar, H.; Zangeneh, Sh.; Ketabchi, M.] Amirkabir Univ Technol, Dept Min & Met Engn, Tehran, Iran.
RP Bahrami, R (reprint author), Amirkabir Univ Technol, Dept Min & Met Engn, Tehran, Iran.
EM R.bahrami@aut.ac.ir
CR Kemal A., 2012, MATER DESIGN, P356
   Lashgari HR, 2010, MAT SCI ENG A-STRUCT, V527, P4082, DOI 10.1016/j.msea.2010.03.018
   Li ZC, 1998, RARE METAL MAT ENG, V27, P59
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Saldivar-Garcia AJ, 2004, METALL MATER TRANS A, V35A, P2517, DOI 10.1007/s11661-006-0232-6
   Zangeneh S, 2012, MATER DESIGN, V37, P292, DOI 10.1016/j.matdes.2011.12.041
   Zangeneh S, 2010, MAT SCI ENG A-STRUCT, V527, P6494, DOI 10.1016/j.msea.2010.06.081
   Zangeneh S, 2010, J ALLOY COMPD, V497, P360, DOI 10.1016/j.jallcom.2010.03.070
   Zangeneh S, 2010, MATER DESIGN, V31, P3504, DOI 10.1016/j.matdes.2010.02.021
NR 9
TC 1
Z9 1
U1 0
U2 0
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD AUG
PY 2013
VL 29
IS 8
BP 908
EP 912
DI 10.1179/1743284713Y.0000000219
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 161YW
UT WOS:000320231600003
DA 2018-10-20
ER

PT J
AU Eckmann, DM
   Tsai, IY
   Tomczyk, N
   Weisel, JW
   Composto, RJ
AF Eckmann, David M.
   Tsai, Irene Y.
   Tomczyk, Nancy
   Weisel, John W.
   Composto, Russell J.
TI Hyaluronan and dextran modified tubes resist cellular activation with
   blood contact
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biocompatible surfaces; Dextran; Hyaluronate; Platelet aggregometry;
   Neutrophil activation; Flow cytometry
ID ENDOTHELIAL GLYCOCALYX; PROTEIN ADSORPTION; SURFACE MODIFICATION;
   POLYMER SURFACES; ADHESION; IMMOBILIZATION;
   POLY(ETHYLENE-TEREPHTHALATE); POLYSACCHARIDE; COAGULATION; BIOMATERIAL
AB This study was undertaken to evaluate the effects of thin film hyaluronic acid and dextran surface coatings to blunt cellular activation in a laboratory model of extracorporeal blood circulation. The inner lumen surface of polyurethane (PU) and poly(vinyl) chloride (PVC) tubing was grafted with hyaluronic acid and dextran. Surfaces were characterized for the presence of the grafted layer using ellipsometry, atomic force microscopy (AFM), and X-ray photoelectron spectroscopy (XPS). Persistence of the surface layer was maintained for up to 5 days of continuous exposure to shear flow using a Chandler loop apparatus. The Chandler loop method was used to study human whole blood activation activity. Whole blood aggregometry and flow cytometry measures of CD18, CD62L, CD62P, Annexin V and myeloperoxidase performed on blood samples exposed to the tubing for up to three hours were complemented by scanning electron microscopy (SEM) analysis of adherent cells and state of activation. In these studies commercial hospital products and uncoated PVC and PU tubes were used as controls. We found that hyaluranized PU and PVC conferred the greatest resistance to blood activation and that dextranization of the PU and PU tubing also provided significant diminution of the bioresponses measured. Based on our findings, we suggest that surface coating with hyaluronic acid or dextran acts as a potent shield from blood cellular activation during forms of extracorporeal circulation. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Eckmann, David M.; Tomczyk, Nancy] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Tsai, Irene Y.; Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Weisel, John W.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
RP Eckmann, DM (reprint author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
EM eckmanndm@uphs.upenn.edu
FU NIH [R01-HL060230, T32-GM007612]; NSF/NSEC [DMR08-32802]; NSF/Polymer
   Program [DMR09-07493]
FX This work was supported by NIH grants R01-HL060230 and T32-GM007612. RJC
   acknowledges partial support from NSF/NSEC (DMR08-32802) and NSF/Polymer
   Program (DMR09-07493). Use of University of Pennsylvania Nano/Bio
   Interface Center AFM/TIRF instrument is acknowledged. Thanks to Stephen
   R. Thom and Tatyana Milovanova for their assistance with the flow
   cytometry measurements and to Sekar Nagaswami for assistance with the
   SEM imaging. We appreciate Thomas P. Russell and Jack Hirsch (Materials
   Research Science and Engineering Center at University of Massachusetts)
   for XPS measurements.
CR Aksoy EA, 2008, J BIOACT COMPAT POL, V23, P505, DOI 10.1177/0883911508097422
   Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   Bech L, 2007, J POLYM SCI POL CHEM, V45, P2172, DOI 10.1002/pola.21983
   CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8
   Chacko BK, 2005, AM J PHYSIOL-HEART C, V289, pH908, DOI 10.1152/ajpheart.00781.2004
   CHANDLER AB, 1958, LAB INVEST, V7, P110
   Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Fadeev AY, 1998, LANGMUIR, V14, P5586, DOI 10.1021/la980512f
   Farrell M, 2010, COLLOID SURFACE B, V81, P468, DOI 10.1016/j.colsurfb.2010.07.059
   Ferrer MCC, 2010, LANGMUIR, V26, P14126, DOI 10.1021/la102315j
   Finley MJ, 2012, BIOMATERIALS, V33, P5803, DOI 10.1016/j.biomaterials.2012.04.051
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hanson S. R., 1998, HDB BIOMATERIAL PROP, P545
   HERRMANN K, 1994, J MATER SCI-MATER M, V5, P728, DOI 10.1007/BF00120365
   Holland NB, 1998, NATURE, V392, P799
   Jen M.Y., 1998, J MEMBRANE SCI, V138, P19
   Klinger A. L., 2011, INTEGRATIVE BIOL, DOI DOI 10.1039/CL1B00017A
   Kopp R, 2002, ASAIO J, V48, P598, DOI 10.1097/01.MAT.0000033639.23941.7E
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Martwiset S, 2006, LANGMUIR, V22, P8192, DOI 10.1021/la061064b
   McLean KM, 2000, COLLOID SURFACE B, V18, P221, DOI 10.1016/S0927-7765(99)00149-6
   Miksa D, 2006, BIOMACROMOLECULES, V7, P557, DOI 10.1021/bm050601o
   Miksa D., 2005, MAT RES SOC S PROC E, V826E
   Monchaux E, 2008, J BIOMED MATER RES A, V85A, P1052, DOI 10.1002/jbm.a.31580
   Mutch NJ, 2008, BRIT J PHARMACOL, V153, P124, DOI 10.1038/sj.bjp.0707543
   Ombelli M, 2005, MATER RES SOC SYMP P, V845, P163
   Ombelli M, 2005, J CHROMATOGR B, V826, P198, DOI 10.1016/j.jchromb.2005.09.002
   Ombelli M., 2003, MAT RES SOC S P, V734
   Ombelli M., 2003, MAT RES SOC S P, V774
   Ombelli M, 2011, BIOFOULING, V27, P505, DOI 10.1080/08927014.2011.585711
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   Sen Gupta A., 2006, BIOMATERIALS, V27, P3084
   Squire JM, 2001, J STRUCT BIOL, V136, P239, DOI 10.1006/jsbi.2002.4441
   Stachelek SJ, 2011, BIOMATERIALS, V32, P4317, DOI 10.1016/j.biomaterials.2011.02.053
   Stevens KN, 2009, ACS APPL MATER INTER, V1, P2049, DOI 10.1021/am900390h
   Stile RA, 2002, J BIOMED MATER RES, V61, P391, DOI 10.1002/jbm.10154
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Suh SW, 1996, INT J ARTIF ORGANS, V19, P712
   Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010
   Tsai I.Y., 2011, SOFT MATTER, V7, P3599
   Tsai IY, 2011, COLLOID SURFACE B, V84, P241, DOI 10.1016/j.colsurfb.2011.01.006
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   VROMAN L, 1974, SCIENCE, V184, P585, DOI 10.1126/science.184.4136.585
   WARD BJ, 1993, CARDIOVASC RES, V27, P384, DOI 10.1093/cvr/27.3.384
   Weinbaum S, 2003, P NATL ACAD SCI USA, V100, P7988, DOI 10.1073/pnas.1332808100
   Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959
   Zapanta CM, 2006, ASAIO J, V52, P17, DOI 10.1097/01.mat.0000189726.87077.ad
NR 48
TC 5
Z9 5
U1 5
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD AUG 1
PY 2013
VL 108
BP 44
EP 51
DI 10.1016/j.colsurfb.2013.02.013
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 152PQ
UT WOS:000319544000007
PM 23524078
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Vani, K
   Thomas, S
   Prabhawathi, V
   Boobalan, T
   Sawant, SN
   Doble, M
AF Vani, Kohila
   Thomas, Susha
   Prabhawathi, V.
   Boobalan, T.
   Sawant, Shilpa N.
   Doble, Mukesh
TI In vitro biocompatiblity of modified polycarbonate as a biomaterial
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Polycarbonate; L929 mouse fibroblast cells; Zeta potential; Biofilm;
   Cytotoxicity; Hydrophilicity
ID SURFACES; ADHESION; BACTERIAL; DERIVATIVES; FIBROBLASTS; BIOFILMS; OXIDE
AB Nitrated and aminated polycarbonates were prepared chemically, characterized and tested in vitro as a possible biomaterial. Adhesion of Staphylococcus aureus NCIM 5021, Escherichia coli NCIM 2931 and Proteus vulgaris NCIM 2813 and the presence of carbohydrate, protein, CPU and ATP on these surfaces were examined. Cytotoxicity of these surfaces was investigated by growing L929 mouse fibroblast cells. NO2-PC was more hydrophilic than un-PC and reduced adhesion of bacterial protein and carbohydrate. NH2-PC was the most hydrophilic surface biofilm prevention and increased proliferation of the fibroblast cells. The motility of all the three organisms decreased on aminated surface when compared to that on the other two. This study indicated that reducing the surface hydrophobicity alone was not sufficient to develop a biocompatible material, but providing favorable surface functional groups was also a necessary criterion. A strong correlation was observed between the hydrophobicity of the polymer surface and the zeta potential of the organism with bacterial attachment (CFU/ml). A multi-linear regression model with these two parameters was able to fit the observed bacterial attachment data well. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Vani, Kohila; Thomas, Susha; Prabhawathi, V.; Boobalan, T.; Doble, Mukesh] Indian Inst Technol Madras, Dept Biotechnol, Bioengn & Drug Design Lab, Chennai 600036, Tamil Nadu, India.
   [Sawant, Shilpa N.] Bhabha Atom Res Ctr, Div Chem, Mumbai 400085, Maharashtra, India.
RP Doble, M (reprint author), Indian Inst Technol Madras, Dept Biotechnol, Bioengn & Drug Design Lab, Chennai 600036, Tamil Nadu, India.
EM mukeshd@iitm.ac.in
OI Doble, Mukeshd/0000-0002-4335-0698
CR Arkatkar A, 2010, INT BIODETER BIODEGR, V64, P530, DOI 10.1016/j.ibiod.2010.06.002
   Bhole YS, 2007, EUR POLYM J, V43, P1450, DOI 10.1016/j.eurpolymj.2007.01.017
   Chen L., 2011, INT J ORAL SCI, V3, P73
   Conceicao TF, 2008, J BRAZIL CHEM SOC, V19, P111, DOI 10.1590/S0103-50532008000100016
   Eberl L, 1999, J BACTERIOL, V181, P1703
   Geesey GG, 2001, CURR OPIN MICROBIOL, V4, P296, DOI 10.1016/S1369-5274(00)00206-X
   Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0
   Hideharu S., 2004, TRENDS BIOMATER ARTI, V18, P1
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Khandwekar AP, 2009, J MATER SCI-MATER M, V20, P1115, DOI 10.1007/s10856-008-3655-3
   Lee JH, 1999, J BIOMAT SCI-POLYM E, V10, P283
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Lin D., 2003, BIOTECHNOL BIOENG, V82, P149
   Mascarenhas A. A. A., 2004, RADIAT MEAS, V44, P50
   Mascarenhas AAA, 2009, RADIAT MEAS, V44, P50, DOI 10.1016/j.radmeas.2008.10.011
   Mathur T., 2006, INDIAN J MED MICROBI, V24, P29
   Maya JD, 2003, BIOCHEM PHARMACOL, V65, P999, DOI 10.1016/S0006-2952(02)01663-5
   PAUL JH, 1985, APPL ENVIRON MICROB, V50, P431
   Pavithra D., 2008, BIOMED MATER, V3, P13
   Prabhakar PK, 2011, COLLOID SURFACE B, V86, P146, DOI 10.1016/j.colsurfb.2011.03.033
   Prabhawathi V, 2012, IND ENG CHEM RES, V51, P5230, DOI 10.1021/ie2029392
   Rather PN, 2005, ENVIRON MICROBIOL, V7, P1065, DOI 10.1111/j.1462-2920.2005.00806.x
   Siebert Werner E, 2008, J Long Term Eff Med Implants, V18, P69
   Sivakumar PM, 2010, COLLOID SURFACE B, V81, P439, DOI 10.1016/j.colsurfb.2010.07.037
   Sivakumar PM, 2012, CARBOHYD POLYM, V87, P353, DOI 10.1016/j.carbpol.2011.07.061
   Veluchamy P, 2011, J AGR FOOD CHEM, V59, P10869, DOI 10.1021/jf201124v
   Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6
   Von E. C., 2002, LANCET INFECT DIS, V2, P677
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Williams G. J., 2008, J MED MICROBIOL, V57, P1140
NR 30
TC 4
Z9 4
U1 0
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD AUG 1
PY 2013
VL 108
BP 191
EP 198
DI 10.1016/j.colsurfb.2013.01.067
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 152PQ
UT WOS:000319544000028
PM 23542052
DA 2018-10-20
ER

PT J
AU Zhang, K
   Li, JA
   Deng, K
   Liu, T
   Chen, JY
   Huang, N
AF Zhang, Kun
   Li, Jing-An
   Deng, Kun
   Liu, Tao
   Chen, Jun-Ying
   Huang, Nan
TI The endothelialization and hemocompatibility of the functional
   multilayer on titanium surface constructed with type IV collagen and
   heparin
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Functional multilayer; Type IV collagen; Heparin; Endothelialization;
   Blood compatibility; Mechanism
ID BASEMENT-MEMBRANE; BLOOD-COMPATIBILITY; ANTITHROMBIN-III; GRAFT
   INFECTION; PROLIFERATION; THROMBIN; FIBRONECTIN; MODULATION; IMPLANTS;
   ADHESION
AB The type IV collagen/heparin (IVCol/Hep) multilayer was developed on amino-silanized titanium (Ti) surface layer by layer self-assembly. Ti, TiOH, TiOHA and TiOHA(HC)(3)H were characterized by Fourier transform infrared spectroscopy (FTIR), water contact angle measurements and scanning electron microscopy (SEM), respectively. Alcian Blue 8GX staining and immunofluorescence staining were used to characterize the heparin (Hep) and type IV collagen (IVCol), respectively. The blood compatibilities of Ti and the treated Ti were evaluated by platelet adhesion test and clotting time using PRP. Blood compatibility tests reveal that the assembled functional multilayer displayed less platelets adhesion and prolonged APTTs time compared with the controlled Ti. Endothelial cells (ECs) culture results showed more attached and proliferated ECs on the TiOHA(HC)(3)H than that on Ti, especially compared with that on TiOH and TiOHA. Thus, the assembled Hep and IVCol multilayer can improve the cell compatibility and the blood compatibility. We anticipate that this IVCol/Hep functional multilayer will be beneficial to enhance the biocompatibility of the Ti-based biomaterial devices. (c) 2013 Published by Elsevier B.V.
C1 [Zhang, Kun; Li, Jing-An; Deng, Kun; Liu, Tao; Chen, Jun-Ying; Huang, Nan] Southwest Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Chen, JY (reprint author), Southwest Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM chenjy@263.net
FU Key Basic Research Program [2011CB606204]; National Natural Science
   Foundation of China [31170916]; Fundamental Research Funds for the
   Central Universities [SWJTU11ZT11]
FX The authors gratefully acknowledge the assistance from Dr Jialong Chen
   and Dr Guicai Li, and the financial support of Key Basic Research
   Program (2011CB606204), National Natural Science Foundation of China
   (No. 31170916#), and the Fundamental Research Funds for the Central
   Universities (No. SWJTU11ZT11).
CR Achneck HE, 2011, BIOMATERIALS, V32, P10, DOI 10.1016/j.biomaterials.2010.08.073
   Adali M.A., 2010, BIOTECHNOL ADV, V28, P119
   Agostoni P., 2010, INT J CARDIOL, V144, P19
   Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002
   Antonios VS, 2006, J INFECTION, V53, P49, DOI 10.1016/j.jinf.2005.10.004
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Bachinger H.P., 2010, COMPREHENSIVE NATURA, V115, P469
   Badylak S.F., 2009, ACTA BIOMATER, V5, P1
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   BALLEISEN L, 1980, THROMB RES, V18, P725, DOI 10.1016/0049-3848(80)90227-3
   BARNES MJ, 1980, THROMB RES, V18, P375, DOI 10.1016/0049-3848(80)90333-3
   BARROWCLIFFE TW, 1989, J PHARMACEUT BIOMED, V7, P217, DOI 10.1016/0731-7085(89)80086-X
   BORSODI A, 1979, BIOCHIM BIOPHYS ACTA, V566, P385, DOI 10.1016/0005-2744(79)90042-1
   Chen JL, 2009, APPL SURF SCI, V255, P6894, DOI 10.1016/j.apsusc.2009.03.011
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   DIXIT SN, 1983, COLLAGEN REL RES, V3, P263
   Garg S., 2010, J AM COLL CARDIOL, V56, P43
   Giglioli C, 2009, INT J CARDIOL, V131, P362, DOI 10.1016/j.ijcard.2007.10.032
   Giraux JL, 1998, EUR J CELL BIOL, V77, P352, DOI 10.1016/S0171-9335(98)80094-0
   GRIFFITH MJ, 1982, THROMB RES, V25, P245, DOI 10.1016/0049-3848(82)90244-4
   Hecht H.S., 2009, J AM COLL CARDIOL, V54, P1949
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Jamshidi P., 2008, INT J CARDIOL, V130, P111
   Karakurt O., 2011, INT J CARDIOL, V148, P51
   KAYTES PS, 1987, GENE, V54, P141, DOI 10.1016/0378-1119(87)90356-8
   Klaus Kuhn, 1995, MATRIX BIOL, V14, P439
   KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2
   Larosa C., 2010, INT J CARDIOL, V145, P60
   Laser A, 2011, J VASC SURG, V54, P58, DOI 10.1016/j.jvs.2010.11.111
   Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077
   Li A.Y., 2009, DIAGN HISTOPATHOL, V16, P17
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Li GC, 2010, COLLOID SURFACE B, V81, P255, DOI 10.1016/j.colsurfb.2010.07.016
   Lin QK, 2010, BIOMATERIALS, V31, P4017, DOI 10.1016/j.biomaterials.2010.01.092
   McGuigan AP, 2008, BIOMATERIALS, V29, P2453, DOI 10.1016/j.biomaterials.2008.02.010
   Monchaux Emmanuelle, 2010, Front Biosci (Schol Ed), V2, P239
   Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005
   Ofosu F.A., 1982, THROMB RES, V28, P487
   Pasco S, 2005, CANCER DETECT PREV, V29, P260, DOI 10.1016/j.cdp.2004.09.003
   Pineo G.F., 1998, HEAEMATOL, V11, P621
   Sanborn SL, 2002, BIOMATERIALS, V23, P1, DOI 10.1016/S0142-9612(01)00066-7
   Sarkees ML, 2009, CARDIOVASC REVASCULA, V10, P58, DOI 10.1016/j.carrev.2008.04.003
   Shireman PK, 2000, J VASC SURG, V31, P382, DOI 10.1016/S0741-5214(00)90168-X
   Suri C.R., 1996, BIOSENS BIOELECTRON, V11, P1199
   Tan GX, 2011, THIN SOLID FILMS, V519, P4997, DOI 10.1016/j.tsf.2011.01.068
   Visser MB, 2011, J COMP PATHOL, V145, P80, DOI 10.1016/j.jcpa.2010.11.009
   YAMANE T, 2004, INT C SER, V1262, P407
   Zittermann A, 2010, J PHOTOCH PHOTOBIO B, V101, P124, DOI 10.1016/j.jphotobiol.2010.01.006
NR 48
TC 19
Z9 20
U1 1
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD AUG 1
PY 2013
VL 108
BP 295
EP 304
DI 10.1016/j.colsurfb.2012.12.053
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 152PQ
UT WOS:000319544000042
PM 23563297
DA 2018-10-20
ER

PT J
AU Jahan, A
   Edwards, KL
AF Jahan, Ali
   Edwards, Kevin L.
TI Weighting of dependent and target-based criteria for optimal
   decision-making in materials selection process: Biomedical applications
SO MATERIALS & DESIGN
LA English
DT Article
DE Biomaterial selection; Target-based criteria; Multi-attribute
   decision-making; Continuous improvement in product development; Quality
   tools in engineering design; Dependent criteria in material selection
ID COMPREHENSIVE VIKOR; PRODUCT DESIGN; EXPERT-SYSTEM; NORMALIZATION;
   QUALITY
AB The selection of the most appropriate material, or combination of materials, is a demanding intellectual process that takes a lot of time and experience. There are a large number of established and newly developed materials, and their associated materials processes, necessitating the simultaneous consideration of many conflicting criteria. This has highlighted the importance of the developing field of multi-criteria decision-making (MCDM) to the material selection process which is especially useful for high technology market where product differentiation and competitive advantage are often achievable with just small gains in material performance. It is clear that decision-making techniques that address target criteria as well as cost and benefit criteria can help engineering designers make better informed choices of materials. Despite the progress has been made in the ranking of materials for target-based criteria, there is no formalized technique for calculating the weighting dependency when target criteria must be taken into account in material selection problems that usually deals with databases. Therefore, to overcome this shortcoming, the strategy of using dependent weightings is extended in this research. Also, an alternative method is proposed to incorporate the correlation, objective, and subjective weightings effectively when there is uncertainty in the importance of three types of weights. This issue is very important for inexperienced designers. The updated procedure is validated through biomedical applications. The first example demonstrates the importance of dependency weighting in amalgam tooth filling material selection and the second one is a hip joint prosthesis material selection problem, which includes target criteria. Furthermore, a model of continuous improvement in product development is outlined, and it is highlighted that the material selection/development is a permanent and endless task for sustainable and profitable growth. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Jahan, Ali] Islamic Azad Univ, Semnan Branch, Fac Engn, Semnan, Iran.
   [Edwards, Kevin L.] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England.
RP Jahan, A (reprint author), Islamic Azad Univ, Semnan Branch, Fac Engn, Semnan, Iran.
EM iranalijahan@yahoo.com
RI Jahan, Ali/B-2460-2010
OI Jahan, Ali/0000-0001-6347-1676; Edwards, Kevin/0000-0001-7619-9114
CR Ashby M., 2005, MAT SELECTION MECH D
   Ashby M. F., 2009, MAT ENG SCI PROCESSI
   Ashby MF, 2004, MATER DESIGN, V25, P51, DOI 10.1016/S0261-3069(03)00159-6
   Athawale VM, 2011, INT J ADV MANUF TECH, V57, P11, DOI 10.1007/s00170-011-3293-7
   Bahraminasab M, 2011, MATER DESIGN, V32, P4471, DOI 10.1016/j.matdes.2011.03.046
   Blanch R, 2011, INT J ADV MANUF TECH
   Chin KS, 2008, INT J ADV MANUF TECH, V36, P633, DOI 10.1007/s00170-006-0898-3
   Das Chakladar N, 2009, INT J ADV MANUF TECH, V43, P226, DOI 10.1007/s00170-008-1713-0
   Dehghan-Manshadi B, 2007, MATER DESIGN, V28, P8, DOI 10.1016/j.matdes.2005.06.023
   Deng YM, 2007, MATER DESIGN, V28, P131, DOI 10.1016/j.matdes.2005.05.003
   Edwards KL, 2008, MATER DESIGN, V29, P558, DOI 10.1016/j.matdes.2007.01.001
   Edwards KL, 2007, MATER DESIGN, V28, P1288, DOI 10.1016/j.matdes.2005.12.009
   Edwards KL, 2002, MATER DESIGN, V23, P255, DOI 10.1016/S0261-3069(01)00082-6
   Farag M. M, 1979, MAT PROCESS SELECTIO
   Farag M M, 2008, MAT PROCESS SELECTIO
   Farag Mahmoud M., 1997, MAT SELECTION ENG DE
   Farag MM, 2002, HDB MAT SELECTION
   Fathi MH, 2003, METALLIC BIOMATERIAL
   Huang H., 2010, INT J ADV MANUF TECH, V52, P421
   Jahan A, 2012, MATER DESIGN, V35, P647, DOI 10.1016/j.matdes.2011.09.005
   Jahan A, 2012, INT J ADV MANUF TECH, V58, P411, DOI 10.1007/s00170-011-3366-7
   Jahan A, 2011, MATER DESIGN, V32, P4918, DOI 10.1016/j.matdes.2011.05.050
   Jahan A, 2011, MATER DESIGN, V32, P1215, DOI 10.1016/j.matdes.2010.10.015
   Kazemzadeh RB, 2009, INT J ADV MANUF TECH, V41, P1019, DOI 10.1007/s00170-008-1533-2
   Mayyas A, 2011, MATER DESIGN, V32, P2771, DOI 10.1016/j.matdes.2011.01.001
   Michael P., 2009, DETAIL DESIGN TESTIN, P251
   Michael P., 2009, SELECTING MAT MAT EN, P51
   Milani AS, 2011, EXPRESS POLYM LETT, V5, P1062, DOI 10.3144/expresspolymlett.2011.104
   Rao RV, 2008, INT J ADV MANUF TECH, V35, P751, DOI 10.1007/s00170-006-0752-7
   Rao RV, 2010, MATER DESIGN, V31, P4738, DOI 10.1016/j.matdes.2010.05.014
   Ullah AMMS, 2008, ADV ENG INFORM, V22, P473, DOI 10.1016/j.aei.2008.05.006
   Zarandi MHF, 2011, INT J ADV MANUF TECH, V57, P885, DOI 10.1007/s00170-011-3362-y
NR 32
TC 16
Z9 17
U1 2
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
J9 MATER DESIGN
JI Mater. Des.
PD AUG
PY 2013
VL 49
BP 1000
EP 1008
DI 10.1016/j.matdes.2013.02.064
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 138YE
UT WOS:000318547000122
DA 2018-10-20
ER

PT J
AU Jia, L
   Prabhakaran, MP
   Qin, XH
   Kai, D
   Ramakrishna, S
AF Jia, Lin
   Prabhakaran, Molamma P.
   Qin, Xiaohong
   Kai, Dan
   Ramakrishna, Seeram
TI Biocompatibility evaluation of protein-incorporated electrospun
   polyurethane-based scaffolds with smooth muscle cells for vascular
   tissue engineering
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID NANOFIBROUS SCAFFOLDS; EXTRACELLULAR-MATRIX; MECHANICAL-BEHAVIOR;
   ALIGNED NANOFIBERS; GELATIN; FIBRIN; FIBERS; PROLIFERATION; FABRICATION;
   COLLAGEN
AB Nanotechnology has enabled the engineering of a variety of materials to meet the current challenges and needs in vascular tissue regeneration. In this study, four different kinds of native proteins namely collagen, gelatin, fibrinogen, and bovine serum albumin were incorporated with polyurethane (PU) and electropsun to obtain composite PU/protein nanofibers. SEM studies showed that the fiber diameters of PU/protein scaffolds ranged from 245 to 273 nm, mimicking the nanoscale dimensions of native ECM. Human aortic smooth muscle cells (SMCs) were cultured on the electrospun nanofibers, and the ability of the cells to proliferate on different scaffolds was evaluated via a cell proliferation assay. Cell proliferation on PU/Coll nanofibers was found the highest compared to other electrospun scaffolds and it was 42 % higher than the proliferation on PU/Fib nanofibers after 12 days of cell culture. The cell-biomaterial interaction studies by SEM confirmed that SMCs adhered to PU/Coll and PU/Gel nanofibers, with high cell substrate coverage, and both the scaffolds promoted cell alignment. The functionality of the cells was further demonstrated by immunocytochemical analysis, where the SMCs on PU/Coll and PU/Gel nanofibers expressed higher density of SMC proteins such as alpha smooth muscle actin and smooth muscle myosin heavy chain. Cells expressed biological markers of SMCs including aligned spindle-like morphology on both PU/Coll and PU/Gel with actin filament organizations, better than PU/Fib and PU/BSA scaffolds. Our studies demonstrate the potential of randomly oriented elastomeric composite scaffolds for engineering of vascular tissues causing cell alignment.
C1 [Jia, Lin; Qin, Xiaohong] Donghua Univ, Key Lab Text Sci & Technol, Minist Educ, Coll Text, Shanghai 201620, Peoples R China.
   [Jia, Lin; Prabhakaran, Molamma P.; Ramakrishna, Seeram] Natl Univ Singapore, Fac Engn, Ctr Nanofibers & Nanotechnol, Nanosci & Nanotechnol Initiat, Singapore 117576, Singapore.
   [Kai, Dan] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117576, Singapore.
RP Qin, XH (reprint author), Donghua Univ, Key Lab Text Sci & Technol, Minist Educ, Coll Text, 2999 North Renmin Rd, Shanghai 201620, Peoples R China.
EM nnimpp@nus.edu.sg; xhqin@dhu.edu.cn
RI Prabhakaran, Molamma/M-8630-2013
FU NRF-Technion grant [R-398-001-065-592]; Nanoscience and Nanotechnology
   Initiative, Faculty of Engineering, National University of Singapore,
   Singapore; National Natural Science Foundation of China [50973014,
   11172064]; Foundation for the Author of National Excellent Doctoral
   Dissertation of P.R. China [200961]; Shanghai Rising-Star Program in
   Chian [10QA1400100]; Fok Ying Tong Education Foundation [121071];
   Program for New Century Excellent Talents in University [NCET-10-0322];
   Fundamental Research Funds for the Central Universities; Shanghai
   Municipal Education Commission [11SG33]; Shanghai Education Development
   Foundation; China Scholarship Council
FX This research was supported by an NRF-Technion grant (R-398-001-065-592)
   and the Nanoscience and Nanotechnology Initiative, Faculty of
   Engineering, National University of Singapore, Singapore. This work was
   also partly supported by grants (50973014 and 11172064) from the
   National Natural Science Foundation of China and the Foundation for the
   Author of National Excellent Doctoral Dissertation of P.R.
   China(200961), as well as sponsored by the Shanghai Rising-Star Program
   in Chian(10QA1400100) and the Fok Ying Tong Education Foundation(121071)
   to Prof. Xiaohong Qin. It was also supported by the Program for New
   Century Excellent Talents in University (NCET-10-0322) and the
   Fundamental Research Funds for the Central Universities as well as the
   "Shu Guang'' (11SG33) project supported by Shanghai Municipal Education
   Commission and Shanghai Education Development Foundation. Furthermore,
   the first author would also like to acknowledge the China Scholarship
   Council for granting a scholarship that enables her to pursue this work
   at NUS, Singapore.
CR Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Blit PH, 2012, ACTA BIOMATER, V8, P2493, DOI 10.1016/j.actbio.2012.03.032
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chan-Park MB, 2009, J BIOMED MATER RES A, V88A, P1104, DOI 10.1002/jbm.a.32318
   Chen R, 2010, COLLOID SURFACE B, V79, P315, DOI 10.1016/j.colsurfb.2010.03.043
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Doan VHT, 2013, J MATER SCI, V48, P1640, DOI 10.1007/s10853-012-6921-1
   Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691
   Eichhorn SJ, 2005, J ROY SOC INTERFACE, V2, P309, DOI 10.1098/rsif.2005.0039
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Fong IW, 2000, CAN MED ASSOC J, V163, P49
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Goh YF, 2013, J MATER SCI, V48, P3027, DOI 10.1007/s10853-013-7145-8
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   He CL, 2011, J BIOMED MATER RES A, V97A, P339, DOI 10.1002/jbm.a.33067
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225
   Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862
   Kim HW, 2008, J BIOMED MATER RES A, V87A, P25, DOI 10.1002/jbm.a.31677
   Kitajima T, 2009, ACTA BIOMATER, V5, P2623, DOI 10.1016/j.actbio.2009.03.022
   Kolacna L, 2007, PHYSIOL RES, V56, pS51
   Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020
   Liang HF, 2010, MATER CHEM PHYS, V124, P964, DOI 10.1016/j.matchemphys.2010.07.073
   Lim TY, 2009, J MATER SCI-MATER M, V20, P1669, DOI 10.1007/s10856-009-3727-z
   Liu RJ, 2012, J ALLOY COMPD, V511, P163, DOI 10.1016/j.jallcom.2011.09.020
   Ma K, 2008, BIOMATERIALS, V29, P2096, DOI 10.1016/j.biomaterials.2008.01.024
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   McClendon MT, 2012, BIOMATERIALS, V33, P5713, DOI 10.1016/j.biomaterials.2012.04.040
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Mun CH, 2012, TISSUE ENG PT A, V18, P1608, DOI [10.1089/ten.tea.2011.0695, 10.1089/ten.TEA.2011.0695]
   Nivison-Smith L, 2012, J BIOMED MATER RES A, V100A, P155, DOI 10.1002/jbm.a.33255
   O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Pankajakshan D, 2008, J BIOMED MATER RES B, V87B, P570, DOI 10.1002/jbm.b.31146
   Parizek M, 2009, INT J MOL SCI, V10, P4352, DOI 10.3390/ijms10104352
   Pedicini A, 2003, POLYMER, V44, P6857, DOI 10.1016/j.polymer.2003.08.040
   Powell HM, 2008, J BIOMED MATER RES A, V84A, P1078, DOI 10.1002/jbm.a.31498
   Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822
   Sahni A, 2000, BLOOD, V96, P3772
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Tian LL, 2012, J MATER SCI, V47, P3272, DOI 10.1007/s10853-011-6166-4
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P984, DOI 10.1002/jbm.a.32504
   Zhang S, 2009, J BIOMED MATER RES A, V90A, P671, DOI 10.1002/jbm.a.32136
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhi J, 2006, SPECTROSC SPECT ANAL, V26, P624
   Zhu YB, 2010, J BIOMED MATER RES B, V92B, P508, DOI 10.1002/jbm.b.31544
   Zucchelli A, 2009, J MATER SCI, V44, P4969, DOI 10.1007/s10853-009-3759-2
NR 52
TC 19
Z9 23
U1 5
U2 117
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD AUG
PY 2013
VL 48
IS 15
BP 5113
EP 5124
DI 10.1007/s10853-013-7359-9
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 145GN
UT WOS:000319003300002
DA 2018-10-20
ER

PT J
AU Roy, N
   Dey, T
   Kundu, SC
   Bhowmick, AK
AF Roy, Nabarun
   Dey, Tuli
   Kundu, Subhas C.
   Bhowmick, Anil K.
TI Biocompatible composites of fibrous nanohydroxyapatite embedded in a
   polydimethylsiloxane
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; CARBON NANOTUBES; SILICONE-RUBBER; CELL
   STIFFNESS; NANOCOMPOSITES; SURFACE; CREEP; IRRADIATION; STABILITY;
   MECHANICS
AB Silicone elastomers have the potential to be a valuable biomaterial due to their mechanical and chemical properties, easy processing, and high gas permeability. Some inherent properties of the pure silicone implant such as high hydrophobicity and low load bearing capacity can be problematic for biomedical applications. The issues were addressed by fabricating hydroxyapatite nanofiber/polydimethylsiloxane nanocomposites. The morphology of nanocomposite structures was visualized by high resolution transmission electron microscopy and field emission scanning electron microscopy. Improved mechanical strength and compliance of the prepared nanocomposite structures were obtained by frequency sweep and creep measurements. Surface hydrophilicity of polydimethylsiloxane was enhanced by hydroxyapatite nanofiber incorporation into the polymer matrix. The cytotoxicity and biocompatibility of the structures were analyzed using breast epithelial cells (MDA MB 231 cell line). These studies showed that the nanocomposite scaffold did not leach any cytotoxic material and showed better cell adhesion and cell proliferation compared to the unfilled elastomer.
C1 [Roy, Nabarun; Bhowmick, Anil K.] Indian Inst Technol, Ctr Rubber Technol, Kharagpur 721302, W Bengal, India.
   [Dey, Tuli; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Bhowmick, Anil K.] Indian Inst Technol, Dept Chem, Patna 800013, Bihar, India.
RP Bhowmick, AK (reprint author), Indian Inst Technol, Ctr Rubber Technol, Kharagpur 721302, W Bengal, India.
EM director@iitp.ac.in; kundu@hijli.iitkgp.ernet.in;
   anilkb@rtc.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology and Department of Science and Technology,
   Govt. of India; Bridgestone Corporation, Japan; Council of Scientific
   and Industrial Research, Govt. of India
FX This study was supported by Department of Biotechnology and Department
   of Science and Technology, Govt. of India (S. C. Kundu), Bridgestone
   Corporation, Japan (A. K. Bhowmick), Council of Scientific and
   Industrial Research, Govt. of India (for Senior Research Fellowship to
   N. Roy). We are thankful to Ms. Deboki Naskar for taking part during the
   discussion on the cell culture experiment.
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Alauzun JG, 2010, BIOMATERIALS, V31, P3471, DOI 10.1016/j.biomaterials.2010.01.069
   Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051
   Bartalena G, 2012, SOFT MATTER, V8, P673, DOI 10.1039/c1sm06250f
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Bhattacharya S, 2007, APPL SURF SCI, V253, P4220, DOI 10.1016/j.apsusc.2006.09.028
   Bland DR, 1960, THEORY LINEAR VISCOE
   BRIDGES AJ, 1993, ANN INTERN MED, V118, P929, DOI 10.7326/0003-4819-118-12-199306150-00003
   Chlopek J, 2006, COMPOS SCI TECHNOL, V66, P1615, DOI 10.1016/j.compscitech.2005.11.016
   Colas A, 2004, BIOMATERIALS SCI INT
   Dupas-Bruzek C, 2009, APPL SURF SCI, V255, P8715, DOI 10.1016/j.apsusc.2009.06.025
   Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.202.8594
   Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z
   Hauser J, 2009, J MATER SCI-MATER M, V20, P2541, DOI 10.1007/s10856-009-3826-x
   Hong J, 2012, MACROMOL RES, V20, P465, DOI 10.1007/s13233-012-0066-6
   Hossain SGM, 2010, THESIS
   Ionescu M, 2012, NUCL INSTRUM METH B, V273, P161, DOI 10.1016/j.nimb.2011.07.065
   Kim BG, 2012, BREAST CANCER RES, V14, P88
   Kumar SK, 2010, ANNU REV CHEM BIOMOL, V1, P37, DOI 10.1146/annurev-chembioeng-073009-100856
   Kunzler JF, 1996, TRENDS POLYM SCI, V4, P52
   Lee HJ, 2006, CHEM MATER, V18, P5111, DOI 10.1021/cm061139x
   Lee JB, 2012, COMPOS SCI TECHNOL, V72, P1257, DOI 10.1016/j.compscitech.2012.04.012
   LEEPER HM, 1983, RUBBER CHEM TECHNOL, V56, P523, DOI 10.5254/1.3538140
   Liang XQ, 2009, PROTEOMICS, V9, P182, DOI 10.1002/pmic.200700957
   Liu CX, 2009, C P IEEE ENG MED BIO, P6391
   Matsuoka M, 2012, MAT SCI ENG C-MATER, V32, P574, DOI 10.1016/j.msec.2011.12.011
   Matsuoka M, 2009, BIO-MED MATER ENG, V19, P155, DOI 10.3233/BME-2009-0575
   Nanni G, 2012, MICROELECTRON ENG, V98, P607, DOI 10.1016/j.mee.2012.05.052
   Norkhairunnisa M, 2012, J COMPOS MATER, V46, P903, DOI 10.1177/0021998311412985
   OKADA T, 1991, MAKROMOL CHEM, V192, P1705
   ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x
   Ouyang G, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/7/074002
   Patlolla A, 2010, ETHNIC DIS, V20, P65
   PURKAYASTHA S, 1984, RHEOL ACTA, V23, P556, DOI 10.1007/BF01329288
   Purohit PJ, 2011, MACROMOLECULES, V44, P4342, DOI 10.1021/ma200323k
   Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c
   Roy N, 2012, J PHYS CHEM C, V116, P26551, DOI 10.1021/jp305373w
   Roy N, 2012, IND ENG CHEM RES, V51, P9571, DOI 10.1021/ie301027s
   Roy N, 2012, PROG POLYM SCI, V37, P781, DOI 10.1016/j.progpolymsci.2012.02.002
   Roy N, 2010, POLYMER, V51, P5172, DOI 10.1016/j.polymer.2010.08.064
   Sen Majumder P, 1998, RADIAT PHYS CHEM, V53
   Shirazi Y, 2012, J APPL POLYM SCI, V124, P2871, DOI 10.1002/app.35313
   STENOIEN MD, 1999, Patent No. 5866217
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Vasilakos SP, 2012, J BIOMED MATER RES B, V100B, P1899, DOI 10.1002/jbm.b.32757
   Villafiorita-Monteleone F, 2010, LANGMUIR, V26, P18557, DOI 10.1021/la1026398
   Wang ED, 2011, BIOMACROMOLECULES, V12, P672, DOI 10.1021/bm101322m
   ZOSEL A, 1985, COLLOID POLYM SCI, V263, P541, DOI 10.1007/BF01421887
NR 48
TC 6
Z9 7
U1 0
U2 53
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD AUG
PY 2013
VL 48
IS 15
BP 5132
EP 5139
DI 10.1007/s10853-013-7298-5
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 145GN
UT WOS:000319003300004
DA 2018-10-20
ER

PT J
AU Kokesch-Himmelreich, J
   Schumacher, M
   Rohnke, M
   Gelinsky, M
   Janek, J
AF Kokesch-Himmelreich, Julia
   Schumacher, Matthias
   Rohnke, Marcus
   Gelinsky, Michael
   Janek, Juergen
TI ToF-SIMS analysis of osteoblast-like cells and their mineralized
   extracellular matrix on strontium enriched bone cements
SO BIOINTERPHASES
LA English
DT Article
DE Strontium doped bone cements; Osteoblast-like cells; Mineralized
   extracellular matrix; ToF-SIMS; Strontium uptake in cells; Strontium
   incorporation in mineralized ECM
ID ION MASS-SPECTROMETRY; CALCIUM-PHOSPHATE; IN-VITRO; RANELATE TREATMENT;
   APATITE FORMATION; LASER-SNMS; OSTEOPOROSIS; DIFFERENTIATION;
   MECHANISMS; WOMEN
AB Commonly used implants for therapeutic approaches of non-systemically impaired bone do not sufficiently support the healing process of osteoporotic bone. Since strontium (II) has been proven as an effective anti-osteoporotic drug new types of strontium enriched calcium phosphate bone cements were developed. As osteoporosis is characterized by an imbalance of osteoblast and osteoclast activity the influence of this newly generated strontium enriched biomaterials on the cellular behavior of osteoblast-like cells was investigated by time of flight secondary ion mass spectrometry (ToF-SIMS). ToF-SIMS is used to analyze whether strontium is incorporated in the mineralized extracellular matrix (mECM) and whether there is strontium uptake by osteogenically differentiated human mesenchymal stem cells (hMSCs). Therefore hMSCs were cultured in osteogenic differentiation medium for 21 days on two different strontium enriched bone cements (S100 and A10) and for reference also on the pure calcium phosphate cement (CPC) and on a silicon wafer. The distribution of strontium in the osteoblast-like cells and within their mineralized extracellular matrix was analyzed. A higher intensity of the strontium signal could be detected in the region of the mECM, synthesized by cells cultivated on the Sr-substituted bone cement (S100) in comparison to the reference groups. The osteoblast-like cells used the released strontium from the biomaterial to synthesize their mECM. Apart from that a uniform strontium distribution was measured within all investigated cells. However, different amounts of strontium were found in cells cultured on different biomaterials and substrates. Compared to the negative controls the strontium content in the cells on the strontium enriched biomaterials was much higher. A higher concentration of strontium inside the cells means that more strontium can take part in signaling pathways. As strontium is known for its beneficial effects on osteoblasts by promoting osteoblastic cell replication and differentiation, and reducing apoptosis, the newly developed strontium enriched calcium phosphate cements are promising implant materials for osteoporotic bone.
C1 [Kokesch-Himmelreich, Julia; Rohnke, Marcus; Janek, Juergen] Univ Giessen, Inst Phys Chem, D-35392 Giessen, Germany.
   [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, D-01307 Dresden, Germany.
RP Rohnke, M (reprint author), Univ Giessen, Inst Phys Chem, Heinrich Buff Ring 58, D-35392 Giessen, Germany.
EM Marcus.Rohnke@phys.chemie.uni-giessen.de
RI Janek, Juergen/A-9482-2012; Rohnke, Marcus/I-2815-2013; Schumacher,
   Matthias/I-1530-2013
OI Schumacher, Matthias/0000-0001-7207-7355; Gelinsky,
   Michael/0000-0001-9075-5121; Janek, Jurgen/0000-0002-9221-4756
FU NIH [EB-002027]; Deutsche Forschungsgemeinschaft (DFG)
FX The authors thank Prof. Dr. Sabine Wenisch for helpful advice in writing
   the manuscript. The authors thank Dan Graham, Ph.D., for developing the
   NESAC/BIO Toolbox used in this study and NIH grant EB-002027 for
   supporting the toolbox development. This study was funded by the
   Deutsche Forschungsgemeinschaft (DFG) as part of the Collaborative
   Research Centre/Transregio 79 (SFB/TRR79 - subproject M5, in
   collaboration with M2).
CR Ammann P, 2004, J BONE MINER RES, V19, P2012, DOI 10.1359/JBMR.040906
   Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   BENNINGHOVEN A, 1994, SURF SCI, V299, P246, DOI 10.1016/0039-6028(94)90658-0
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bohner M., 1992, ORTHOP T, V16, P401
   Bohner M, 2007, J MATER CHEM, V17, P3980, DOI 10.1039/b706411j
   Boivin G, 1996, J BONE MINER RES, V11, P1302
   Bonnaire F, 2005, OSTEOPOROSIS INT, V16, pS93, DOI 10.1007/s00198-004-1746-7
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109
   Brison J, 2011, SURF INTERFACE ANAL, V43, P354, DOI 10.1002/sia.3415
   Brunelle A, 2005, J MASS SPECTROM, V40, P985, DOI 10.1002/jms.902
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Dambach S, 2004, SURF INTERFACE ANAL, V36, P711, DOI 10.1002/sia.1742
   De Souza RA, 2007, PHYS STATUS SOLIDI C, V4, P1785, DOI 10.1002/pssc.200675227
   Fartmann M, 2002, SURF INTERFACE ANAL, V34, P63, DOI 10.1002/sia.1253
   Fletcher JS, 2011, MASS SPECTROM REV, V30, P142, DOI 10.1002/mas.20275
   Fletcher JS, 2009, ANALYST, V134, P2204, DOI 10.1039/b913575h
   Fletcher JS, 2010, RAPID COMMUN MASS SP, V25, P925
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   LEEUWENKAMP OR, 1990, CALCIFIED TISSUE INT, V47, P136, DOI 10.1007/BF02555977
   Li CH, 2010, J BONE MINER RES, V25, P968, DOI 10.1359/jbmr.091038
   Li YF, 2012, CLIN ORAL IMPLAN RES, V23, P1038, DOI 10.1111/j.1600-0501.2011.02252.x
   Lieben Liesbet, 2012, Front Endocrinol (Lausanne), V3, P99, DOI 10.3389/fendo.2012.00099
   MA Robinson, 2012, ANAL CHEM, V84, P4880
   Malmberg P, 2008, APPL SURF SCI, V255, P1264
   Marie PJ, 2007, BONE, V40, pS5, DOI 10.1016/j.bone.2007.02.003
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Nygren H, 2007, MICROSC RES TECHNIQ, V70, P969, DOI 10.1002/jemt.20502
   Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5
   Roschger P, 2010, J BONE MINER RES, V25, P891, DOI 10.1359/jbmr.091028
   Saidak Z, 2012, PHARMACOL THERAPEUT, V136, P216, DOI 10.1016/j.pharmthera.2012.07.009
   Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014
   Takaoka S, 2010, HORM METAB RES, V42, P627, DOI 10.1055/s-0030-1255091
   Thormann U, 2013, BIOMATER IN PRESS
   Vickerman J. C., 2001, TOF SIMS SURFACE ANA
   Winograd N., 2005, ANAL CHEM, p143A, DOI DOI 10.1021/AC053355F
NR 39
TC 14
Z9 14
U1 1
U2 45
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1934-8630
J9 BIOINTERPHASES
JI Biointerphases
PD JUL 23
PY 2013
VL 8
AR 17
DI 10.1186/1559-4106-8-17
PG 12
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 193TE
UT WOS:000322583600001
PM 24706130
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Domingues, JFD
   van der Mei, HC
   Busscher, HJ
   van Kooten, TG
AF Domingues, Joana F. da Silva
   van der Mei, Henny C.
   Busscher, Henk J.
   van Kooten, Theo G.
TI Phagocytosis of Bacteria Adhering to a Biomaterial Surface in a Surface
   Thermodynamic Perspective
SO PLOS ONE
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS RP62A; HOST-DEFENSE; HUMAN NEUTROPHILS; HUMAN
   MACROPHAGES; BIOFILM FORMATION; OXIDATIVE-BURST; AUREUS; CELLS;
   INFLAMMATION; INFECTIONS
AB Bacterial biofilms can increase the pathogenicity of infection and constitute a major problem in modern health-care, especially on biomaterial implants and devices. Biofilms are difficult to eradicate by the host immune system, even with antibiotics, and have been the number one cause of biomaterial implant and device failure for decades. Therefore, it is important to understand how immune cells interact with adhering pathogens. This study firstly aims to develop a simple method to quantify phagocytosis of six different strains of staphylococci adhering on a surface with phase-contrast-microscopy. Phagocytosis of adhering staphylococci to a glass surface by phagocytes was quantified in a parallel plate flow chamber, and expressed as a phagocytosis rate, accounting for the number of adhering staphylococci initially present and for the duration of phagocytosis. Murine macrophages were more effective in clearing staphylococci from a surface than human phagocytes, which require differentiation from their monocyte or promyelocytic state during an experiment. Direct visualization of internalization of a GFP-modified S. aureus strain inside phagocytes confirmed the validity of the method proposed. As a second aim, the differences in phagocytosis rates observed were investigated on a surface thermodynamic basis using measured contact angles of liquids on macroscopic lawns of staphylococci and phagocytes, confirming that phagocytosis of adhering pathogens can be regarded as a surface phenomenon. In addition, surface thermodynamics revealed that phagocytosis of adhering pathogens is determined by an interplay of physical attraction between pathogens and phagocytes and the influence of chemo-attractants. For future studies, these results will help to place in vitro experiments and murine infection models in better perspective with respect to human ones.
C1 [van Kooten, Theo G.] Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.
RP van Kooten, TG (reprint author), Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
EM t.g.van.kooten@umcg.nl
CR Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Bien J, 2011, J PATHOG, DOI 10.4061/2011/601905
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930
   Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x
   GALLAGHER R, 1979, BLOOD, V54, P713
   Guenther F, 2009, INT J ARTIF ORGANS, V32, P565
   Gunther F, 2009, MOL IMMUNOL, V46, P1805, DOI 10.1016/j.molimm.2009.01.020
   Heilmann C., 2010, BACTERIAL SIGNALING, P7
   Heinzelmann M, 1997, CLIN DIAGN LAB IMMUN, V4, P705
   Herald MC, 2010, B MATH BIOL, V72, P765, DOI 10.1007/s11538-009-9468-9
   Hess KL, 1997, CYTOMETRY, V27, P145
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Mantovani A, 2009, BLOOD, V114, P3135, DOI 10.1182/blood-2009-07-231795
   Maye I, 1998, CELL BIOL TOXICOL, V14, P411, DOI 10.1023/A:1007547612154
   Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661
   Miller M, 2011, J PROTEOME RES, V10, P4018, DOI 10.1021/pr200224x
   Peltroche-Llacsahuanga H, 2000, FEMS MICROBIOL LETT, V191, P151, DOI 10.1016/S0378-1097(00)00384-0
   Robin S, 2011, RSC NANOSCI NANOTECH, P122, DOI 10.1039/9781849733366-00122
   Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104
   ROT A, 1987, P NATL ACAD SCI USA, V84, P7967, DOI 10.1073/pnas.84.22.7967
   Schommer NN, 2011, INFECT IMMUN, V79, P2267, DOI 10.1128/IAI.01142-10
   Skovbjerg S, 2010, J INTERF CYTOK RES, V30, P23, DOI 10.1089/jir.2009.0033
   Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005
   TABATA Y, 1989, J COLLOID INTERF SCI, V127, P132, DOI 10.1016/0021-9797(89)90013-1
   Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794
   VANOSS CJ, 1978, ANNU REV MICROBIOL, V32, P19, DOI 10.1146/annurev.mi.32.100178.000315
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xing S, 2002, J BIOMED MATER RES, V61, P619, DOI 10.1002/jbm.10078
NR 36
TC 5
Z9 5
U1 2
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 19
PY 2013
VL 8
IS 7
AR e70046
DI 10.1371/journal.pone.0070046
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 191CY
UT WOS:000322391400078
PM 23894585
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Xu, HP
   Cao, W
   Zhang, X
AF Xu, Huaping
   Cao, Wei
   Zhang, Xi
TI Selenium-Containing Polymers: Promising Biomaterials for Controlled
   Release and Enzyme Mimics
SO ACCOUNTS OF CHEMICAL RESEARCH
LA English
DT Review
ID SYNTHETIC ORGANOSELENIUM COMPOUNDS; BLOCK-COPOLYMER;
   GLUTATHIONE-PEROXIDASE; HYPERBRANCHED POLYMERS; EMERGING APPLICATIONS;
   BUILDING-BLOCKS; DRUG-DELIVERY; MICELLES; DISELENIDE; SUPERAMPHIPHILE
AB Although researchers have made great progress in the development of responsive polymeric materials for controlled drug release or diagnostics over the last 10 years, therapeutic results still lag behind expectations. The development of special materials that respond to physiological relevant concentrations, typically within the micromolar or nanomolar concentration regime, remains challenging. Therefore, researchers continue to pursue new biomaterials with unique properties and that respond to mild biochemical signals or biomarkers.
   Selenium is an essential element in human body with potential antioxidant properties. Because of selenium's electronegativity and atomic radius, selenium-containing compounds exhibit unique bond energy (C-Se bond 244 kJ mol(-1); Se-Se bond 172 kJ mol(-1)). These values give the C-Se or Se-Se covalent bonds dynamic character and make them responsive to mild stimuli. Therefore, selenium-containing polymers can disassemble in response to changes under physiological relevant conditions. This property makes them a promising biomaterial for controlled release of drugs or synthetic enzyme mimics.
   Until recently, few researchers have looked at selenium-containing polymers as novel biomaterials. In this Account, we summarize our recent research on selenium-containing polymers and show their potential application as mild-responsive drug delivery vehicles and artificial enzymes. We begin by reviewing the current state of the art In the synthesis of selenium-containing main chain block copolymers. We highlight the dual redox and gamma-irradiation behaviors of diselenide-containing block copolymers assemblies, discussing the possibility of their use in a combination of chemotherapy and actinotherapy. We also describe the coordination of platinum with monoselenide containing block copolymers. Such structures offer the possibility of fabricating multidrug systems for cooperative chemotherapy. In addition, we summarize the methods for the covalent and noncovalent preparation of selenium-containing polymers with side chains, which highlight the opportunity to reversibly tune the amphiphilicity of selenium-containing polymers. Finally, we present strategies for the design of highly efficient selenium-containing dendritic polymers that can mimic enzymes. This field is still in its infancy period, and further research can only be limited by our imagination.
C1 [Xu, Huaping; Cao, Wei; Zhang, Xi] Tsinghua Univ, Dept Chem, Key Lab Organ Optoelect & Mol Engn, Beijing 100084, Peoples R China.
RP Xu, HP (reprint author), Tsinghua Univ, Dept Chem, Key Lab Organ Optoelect & Mol Engn, Beijing 100084, Peoples R China.
EM xuhuaping@mail.tsinghua.edu.cn; xi@mail.tsinghua.edu.cn
RI Xu, Huaping/A-6367-2010; Zhang, Xi/C-8136-2011
OI Xu, Huaping/0000-0002-7530-7264; 
FU National Basic Research Program of China [2013CB834502]; National
   Natural Science Foundation of China [21074066]; Foundation for
   Innovative Research Groups of the National Natural Science Foundation of
   China [21121004]; NSFC-DFG [TRR 61]
FX This work was financially supported by the National Basic Research
   Program of China (2013CB834502), National Natural Science Foundation of
   China (21074066), the Foundation for Innovative Research Groups of the
   National Natural Science Foundation of China (21121004), and the
   NSFC-DFG joint grant (TRR 61).
CR Astruc D, 2001, CHEM REV, V101, P2991, DOI 10.1021/cr010323t
   Babin J, 2009, ANGEW CHEM INT EDIT, V48, P3329, DOI 10.1002/anie.200900255
   Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001
   BARKER MG, 1990, COORDIN CHEM REV, V103, P162, DOI 10.1016/0010-8545(90)80010-Q
   Boyd R, 2011, NAT CHEM, V3, P570, DOI 10.1038/nchem.1076
   Cabral H, 2011, ACCOUNTS CHEM RES, V44, P999, DOI 10.1021/ar200094a
   Cao W, 2012, CHEM SCI, V3, P3403, DOI 10.1039/c2sc21315j
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Deng C, 2012, NANO TODAY, V7, P467, DOI 10.1016/j.nantod.2012.08.005
   Fu Y, 2012, MACROMOL RAPID COMM, V33, P798, DOI 10.1002/marc.201100860
   Gao C, 2004, PROG POLYM SCI, V29, P183, DOI 10.1016/j.progpolymsci.2003.12.002
   Goodwin AP, 2005, J AM CHEM SOC, V127, P9952, DOI 10.1021/ja0523035
   Grayson SM, 2001, CHEM REV, V101, P3819, DOI 10.1021/cr990116h
   Han P, 2013, J MATER CHEM B, V1, P740, DOI 10.1039/c2tb00186a
   Han P, 2011, LANGMUIR, V27, P14108, DOI 10.1021/la203486q
   Han P, 2010, LANGMUIR, V26, P14414, DOI 10.1021/la102837a
   HARADA A, 1995, MACROMOLECULES, V28, P5294, DOI 10.1021/ma00119a019
   Hollinger J, 2010, J AM CHEM SOC, V132, P8546, DOI 10.1021/ja103191u
   Hu JM, 2012, CHEM SOC REV, V41, P5933, DOI 10.1039/c2cs35103j
   Huang X, 2011, CHEM SOC REV, V40, P1171, DOI 10.1039/c0cs00046a
   Kan J. T. W., 2005, J SULFUR CHEM, V26, P509
   KILDAHL NK, 1995, J CHEM EDUC, V72, P423, DOI 10.1021/ed072p423
   KISHORE K, 1995, ADV POLYM SCI, V121, P81
   Ma N, 2011, LANGMUIR, V27, P5874, DOI 10.1021/la2009682
   Ma N, 2010, POLYM CHEM-UK, V1, P1609, DOI 10.1039/c0py00144a
   Ma N, 2010, J AM CHEM SOC, V132, P442, DOI 10.1021/ja908124g
   Meng FX, 2012, CHEM RES CHINESE U, V28, P319
   Mugesh G, 2000, CHEM SOC REV, V29, P347, DOI 10.1039/a908114c
   Mugesh G, 2001, CHEM REV, V101, P2125, DOI 10.1021/cr000426w
   Patra A, 2008, J AM CHEM SOC, V130, P6734, DOI 10.1021/ja8018675
   Pelts P. M., 2012, ACS NANO, V6, P4157
   Ren HF, 2012, SOFT MATTER, V8, P1460, DOI 10.1039/c1sm06673k
   Schacher FH, 2012, ANGEW CHEM INT EDIT, V51, P7898, DOI 10.1002/anie.201200310
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tan XX, 2012, LANGMUIR, V28, P9601, DOI 10.1021/la301703t
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Wan PB, 2009, ADV MATER, V21, P4362, DOI 10.1002/adma.200901237
   Wang C, 2008, ANGEW CHEM INT EDIT, V47, P9049, DOI 10.1002/anie.200803361
   Wang C, 2012, ACCOUNTS CHEM RES, V45, P608, DOI 10.1021/ar200226d
   Wang C, 2010, ANGEW CHEM INT EDIT, V49, P8612, DOI 10.1002/anie.201004253
   Wang YP, 2010, LANGMUIR, V26, P709, DOI 10.1021/la9023844
   Wang Y, 2009, ADV MATER, V21, P2849, DOI 10.1002/adma.200803276
   Xu HP, 2006, CHEM COMMUN, P796, DOI 10.1039/b514701h
   Yi Y, 2012, CHEM COMMUN, V48, P7495, DOI 10.1039/c2cc33760f
   Zhang X, 2004, J AM CHEM SOC, V126, P10556, DOI 10.1021/ja048890w
   Zhang X, 2011, CHEM SOC REV, V40, P94, DOI 10.1039/b919678c
NR 46
TC 202
Z9 203
U1 32
U2 353
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0001-4842
EI 1520-4898
J9 ACCOUNTS CHEM RES
JI Accounts Chem. Res.
PD JUL 16
PY 2013
VL 46
IS 7
BP 1647
EP 1658
DI 10.1021/ar4000339
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA 187AC
UT WOS:000322086600028
PM 23581522
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Li, JA
   Yang, P
   Zhang, K
   Ren, HL
   Huang, N
AF Li, Jing-an
   Yang, Ping
   Zhang, Kun
   Ren, Hui-lan
   Huang, Nan
TI Preparation of SiO2/TiO2 and TiO2/TiO2 micropattern and their effects on
   platelet adhesion and endothelial cell regulation
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 18th International Conference on Ion Beam Modifications of Materials
   (IBMM)
CY SEP 02-07, 2012
CL Shandong Univ, Qingdao, PEOPLES R CHINA
SP Shanghai Inst Microsystem & Informat Technol, Tsinghua Univ, Natl Nat Sci Fdn China, Shandong Univ, Minist Educ, Key Lab Particle Phys & Particle Irradiat, Shandong Univ, State Key Lab Crystal Mat, High Voltage Engn Europa B V
HO Shandong Univ
DE TiO2 film; Unbalanced magnetron sputtering; Micropattern;
   Biocompatibility
ID SURFACES; TITANIUM
AB TiO2 films were applied on blood contact biomaterials for its excellent biocompatibility. The topological structure of the biomaterial surfaces have a significant impact on cell adhesion, spreading and proliferation. Thus, it is anticipated that the combination of TiO2 film deposition and surface micro-patterning will provide a potential application for cardiovascular implants materials. In this work, TiO2/TiO2 and SiO2/TiO2 micro-groove/ridge stripes on Si (100) were prepared by photolithography, wet etching and unbalanced magnetron sputtering (UBMS). Their surface morphology, chemical composition and wettability were investigated. The crystal structure of TiO2 films was characterised by X-ray diffraction (XRD). Platelet adhesion on the SiO2/TiO2 and TiO2/TiO2 surfaces was tested, and the morphology and behaviour of endothelial cells cultured on the micropatterned surfaces were observed. It was proved that the SiO2/TiO2 pattern could reduce platelet adhesion and aggregation compared with TiO2/TiO2 pattern, endothelial cells grew along the micro-stripes and their behaviour could be effectively regulated by micropatterned surface. So, it is suggested that the micropatterned SiO2/TiO2 surface can contribute more biocompatible function of regulating and coordinating the behaviour of endothelial cells and platelets. (C) 2013 Published by Elsevier B.V.
C1 [Li, Jing-an; Yang, Ping; Zhang, Kun; Ren, Hui-lan; Huang, Nan] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Yang, P (reprint author), Southwest Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM yangping8@263.net
CR Alfonso F, 2012, JACC-CARDIOVASC INTE, V5, P141, DOI 10.1016/j.jcin.2011.12.006
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Ito Y, 2000, J INORG BIOCHEM, V79, P77, DOI 10.1016/S0162-0134(99)00159-2
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073
   RADOMSKI MW, 1993, CARDIOVASC RES, V27, P1380, DOI 10.1093/cvr/27.7.1380
   Shao HH, 2010, APPL SURF SCI, V257, P1649, DOI 10.1016/j.apsusc.2010.08.116
   Spisni E, 2001, EXP CELL RES, V266, P31, DOI 10.1006/excr.2001.5198
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Vartanian KB, 2008, BIOCHEM BIOPH RES CO, V371, P787, DOI 10.1016/j.bbrc.2008.04.167
   Wang HJ, 2009, INT IMMUNOPHARMACOL, V9, P144, DOI 10.1016/j.intimp.2008.10.003
   Yazdanparast R, 2008, VASC PHARMACOL, V48, P32, DOI 10.1016/j.vph.2007.11.003
   Zhao YC, 2010, APPL SURF SCI, V257, P1596, DOI 10.1016/j.apsusc.2010.08.100
NR 13
TC 19
Z9 20
U1 2
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JUL 15
PY 2013
VL 307
BP 575
EP 579
DI 10.1016/j.nimb.2012.11.055
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 182DP
UT WOS:000321722200127
DA 2018-10-20
ER

PT J
AU Ameringer, T
   Ercole, F
   Tsang, KM
   Coad, BR
   Hou, XL
   Rodda, A
   Nisbet, DR
   Thissen, H
   Evans, RA
   Meagher, L
   Forsythe, JS
AF Ameringer, Thomas
   Ercole, Francesca
   Tsang, Kelly M.
   Coad, Bryan R.
   Hou, Xueliang
   Rodda, Andrew
   Nisbet, David R.
   Thissen, Helmut
   Evans, Richard A.
   Meagher, Laurence
   Forsythe, John S.
TI Surface grafting of electrospun fibers using ATRP and RAFT for the
   control of biointerfacial interactions
SO BIOINTERPHASES
LA English
DT Article
DE Electrospun fibers; Polymer brushes; Surface-initiated polymerisation;
   Surface fouling; Surface immobilisation
ID TRANSFER RADICAL POLYMERIZATION; NEURAL STEM-CELLS; PROTEIN ADSORPTION;
   NANOFIBERS; SCAFFOLDS; FUNCTIONALIZATION; REDUCTION; MEMBRANES
AB Background: The ability to present signalling molecules within a low fouling 3D environment that mimics the extracellular matrix is an important goal for a range of biomedical applications, both in vitro and in vivo. Cell responses can be triggered by non-specific protein interactions occurring on the surface of a biomaterial, which is an undesirable process when studying specific receptor-ligand interactions. It is therefore useful to present specific ligands of interest to cell surface receptors in a 3D environment that minimizes non-specific interactions with biomolecules, such as proteins.
   Method: In this study, surface-initiated atom transfer radical polymerization (SI-ATRP) of poly(ethylene glycol)-based monomers was carried out from the surface of electrospun fibers composed of a styrene/vinylbenzyl chloride copolymer. Surface initiated radical addition-fragmentation chain transfer (SI-RAFT) polymerisation was also carried out to generate bottle brush copolymer coatings consisting of poly(acrylic acid) and poly(acrylamide). These were grown from surface trithiocarbonate groups generated from the chloromethyl styrene moieties existing in the original synthesised polymer. XPS was used to characterise the surface composition of the fibers after grafting and after coupling with fluorine functional XPS labels.
   Results: Bottle brush type coatings were able to be produced by ATRP which consisted of poly(ethylene glycol) methacrylate and a terminal alkyne-functionalised monomer. The ATRP coatings showed reduced non-specific protein adsorption, as a result of effective PEG incorporation and pendant alkynes groups existing as part of the brushes allowed for further conjugation of via azide-alkyne Huisgen 1,3-dipolar cycloaddition. In the case of RAFT, carboxylic acid moieties were effectively coupled to an amine label via amide bond formation. In each case XPS analysis demonstrated that covalent immobilisation had effectively taken place.
   Conclusion: Overall, the studies presented an effective platform for the preparation of 3D scaffolds which contain effective conjugation sites for attachment of specific bioactive signals of interest, as well as actively reducing nonspecific protein interactions.
C1 [Ameringer, Thomas; Tsang, Kelly M.; Coad, Bryan R.; Rodda, Andrew; Thissen, Helmut; Evans, Richard A.; Meagher, Laurence] CSIRO, Mat Sci & Engn, Clayton, Vic 3168, Australia.
   [Ameringer, Thomas; Tsang, Kelly M.; Coad, Bryan R.; Rodda, Andrew; Thissen, Helmut; Evans, Richard A.; Meagher, Laurence] CRCP, Clayton, Vic, Australia.
   [Ercole, Francesca; Tsang, Kelly M.; Hou, Xueliang; Rodda, Andrew; Nisbet, David R.; Forsythe, John S.] Monash Univ, Dept Mat Engn, Clayton, Vic 3168, Australia.
RP Meagher, L (reprint author), CSIRO, Mat Sci & Engn, Clayton, Vic 3168, Australia.
EM laurence.meagher@csiro.au; john.forsythe@monash.edu
RI Thissen, Helmut/D-3835-2011; Coad, Bryan/B-4505-2009; Evans,
   Richard/C-6895-2009; Meagher, Laurence/G-1412-2012
OI Coad, Bryan/0000-0003-3297-3977; Evans, Richard/0000-0003-2960-3377;
   Meagher, Laurence/0000-0002-2055-6159; Forsythe,
   John/0000-0003-2849-229X; Nisbet, David/0000-0002-1343-0769; Rodda,
   Andrew/0000-0002-8716-4344
FU Cooperative Research Centre for Polymers (CRCP)
FX This research was supported by the Cooperative Research Centre for
   Polymers (CRCP). The authors are grateful to Suzanne Pereira who
   synthesized both the EGMAS-Alk monomer and the TFAB XPS label.
CR Ameringer T, 2012, J BIOMED MATER RES A, V100A, P370, DOI 10.1002/jbm.a.33194
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Boyer C, 2009, CHEM REV, V109, P5402, DOI 10.1021/cr9001403
   Brandl C, 2011, MACROMOL MATER ENG, V296, P858, DOI 10.1002/mame.201100031
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Coad BR, 2012, ACTA BIOMATER, V8, P608, DOI 10.1016/j.actbio.2011.10.006
   Doran MR, 2010, BIOMATERIALS, V31, P5137, DOI 10.1016/j.biomaterials.2010.03.015
   Fu GD, 2008, MACROMOLECULES, V41, P6854, DOI 10.1021/ma800499h
   Grafahrend D, 2011, NAT MATER, V10, P67, DOI [10.1038/nmat2904, 10.1038/NMAT2904]
   Gualandi C, 2013, MACROMOL RAPID COMM, V34, P51, DOI 10.1002/marc.201200648
   Hook AL, 2009, ACTA BIOMATER, V5, P2350, DOI 10.1016/j.actbio.2009.03.040
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Kochkodan VM, 2012, J ENVIRON SCI HEAL A, V47, P1713, DOI 10.1080/10934529.2012.689183
   Koegler P, 2012, ADV DRUG DELIVER REV, V64, P1820, DOI 10.1016/j.addr.2012.06.001
   Meagher L., 2008, Polymeric coatings and methods for forming them, Patent No. [WO2008019450-A1, 2008019450]
   Meyers SR, 2012, CHEM REV, V112, P1615, DOI 10.1021/cr2000916
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Polini A, 2010, SOFT MATTER, V6, P1668, DOI 10.1039/b921932c
   Rostovtsev W, 2002, ANGEW CHEM INT EDIT, V41, P2596
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Winblade ND, 2000, BIOMACROMOLECULES, V1, P523, DOI 10.1021/bm000040v
   Xu FJ, 2007, LANGMUIR, V23, P8585, DOI 10.1021/la7011342
   Yano T, 2011, POLYM J, V43, P838, DOI 10.1038/pj.2011.80
   Yao F, 2010, NANOSCALE, V2, P1348, DOI 10.1039/c0nr00016g
   Yoshikawa C, 2011, SCI TECHNOL ADV MAT, V12, P1
NR 29
TC 19
Z9 19
U1 5
U2 111
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUL 5
PY 2013
VL 8
AR 16
DI 10.1186/1559-4106-8-16
PG 11
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 193TA
UT WOS:000322583200002
PM 24706129
OA Other Gold
DA 2018-10-20
ER

PT J
AU Tien, LW
   Wu, F
   Tang-Schomer, MD
   Yoon, E
   Omenetto, FG
   Kaplan, DL
AF Tien, Lee W.
   Wu, Fan
   Tang-Schomer, Min D.
   Yoon, Euisik
   Omenetto, Fiorenzo G.
   Kaplan, David L.
TI Silk as a Multifunctional Biomaterial Substrate for Reduced Glial
   Scarring around Brain-Penetrating Electrodes
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE silk; gliosis; chondroitinase; brain; electrodes
ID SPINAL-CORD-INJURY; SILICON MICROELECTRODE ARRAYS; NEURAL PROBES;
   IN-VITRO; CHONDROITINASE ABC; CONTROLLED-RELEASE; MECHANICAL-PROPERTIES;
   SUSTAINED-RELEASE; NERVE CONDUITS; DRUG-DELIVERY
AB The reliability of chronic, brain-penetrating electrodes must be improved for these -neural recording technologies to be viable in widespread clinical applications. One approach to improving electrode reliability is to reduce the foreign body response at the probe-tissue interface. In this work, silk fibroin is investigated as a candidate material for fabricating mechanically dynamic neural probes with enhanced biocompatibility compared to traditional electrode materials. Silk coatings are applied to flexible cortical electrodes to produce devices that transition from stiff to flexible upon hydration. Theoretical modeling and in vitro testing show that the silk coatings impart mechanical properties sufficient for the electrodes to penetrate brain tissue. Further, it is demonstrated that silk coatings may reduce some markers of gliosis in an in vitro model and that silk can encapsulate and release the gliosis-modifying enzyme chondroitinase ABC. This work establishes a basis for future in vivo studies of silk-based brain-penetrating electrodes, as well as the use of silk materials for other applications in the central nervous system where gliosis must be controlled.
C1 [Tien, Lee W.; Tang-Schomer, Min D.; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Wu, Fan; Yoon, Euisik] Univ Michigan, Dept Elect Engn, Ann Arbor, MI 48109 USA.
RP Tien, LW (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH P41 Tissue Engineering Resource Center [EB002520]; AFOSR
FX This work was supported by the NIH P41 Tissue Engineering Resource
   Center (EB002520) and the AFOSR. The authors thank Gregory Frost, Dr.
   Yasuko Nakamura and the Steven J. Moss Lab in the Tufts University
   Neuroscience Department for providing the dissected rat cortices. The
   authors also thank Prof. Gary Leisk, Maria Arshanskiy, Tim Lo, and Ben
   Partlow for assistance with the laser cutter, electrode coating and
   mechanical characterization studies.
CR Achyuta AKH, 2010, MACROMOL BIOSCI, V10, P872, DOI 10.1002/mabi.200900451
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Andersen RA, 2010, ANNU REV PSYCHOL, V61, P169, DOI 10.1146/annurev.psych.093008.100503
   Azemi E, 2011, BIOMATERIALS, V32, P681, DOI 10.1016/j.biomaterials.2010.09.033
   Benfenati V, 2010, BIOMATERIALS, V31, P7883, DOI 10.1016/j.biomaterials.2010.07.013
   Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138
   Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002
   CHOROVER SL, 1972, PHYSIOL BEHAV, V9, P671, DOI 10.1016/0031-9384(72)90030-3
   Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070
   David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fayad G, 2009, NEW TECH SURG, V4, P133, DOI 10.1007/978-1-84882-283-2_8
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Frampton JP, 2007, J NEURAL ENG, V4, P399, DOI 10.1088/1741-2560/4/4/006
   Ghaznavi AM, 2011, ANN PLAS SURG, V66, P273, DOI 10.1097/SAP.0b013e3181e6cff7
   Griffith RW, 2006, NEUROSCI LETT, V406, P81, DOI 10.1016/j.neulet.2006.07.018
   Harris JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066011
   Harris JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046010
   Hess AE, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054009
   Hoffmann R., 2007, 29 ANN INT C IEEE EN, P4711
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Huang YC, 2011, CARBOHYD POLYM, V84, P788, DOI 10.1016/j.carbpol.2010.03.034
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Kato Y, 2006, 28 ANN INT C IEEE EN, P660
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021
   Kwon BK, 2011, J NEUROTRAUM, V28, P1589, DOI 10.1089/neu.2009.1150
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Lee H, 2005, J NEURAL ENG, V2, P81, DOI 10.1088/1741-2560/2/4/003
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Lewitus D, 2011, ACTA BIOMATER, V7, P2483, DOI 10.1016/j.actbio.2011.02.027
   Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346
   Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005
   Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271
   Liu X, 1999, IEEE Trans Rehabil Eng, V7, P315
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mercanzini Andre, 2007, Proceedings of the 29th Annual International Conference of the IEEE EMBS, P6612
   Mercanzini A, 2008, SENSOR ACTUAT A-PHYS, V143, P90, DOI 10.1016/j.sna.2007.07.027
   NAJAFI K, 1990, IEEE T BIO-MED ENG, V37, P474, DOI 10.1109/10.55638
   Nazari-Robati M, 2012, INT J BIOL MACROMOL, V50, P487, DOI 10.1016/j.ijbiomac.2012.01.009
   Polikov VS, 2006, BIOMATERIALS, V27, P5368, DOI 10.1016/j.biomaterials.2006.06.018
   Polikov VS, 2009, J NEUROSCI METH, V181, P170, DOI 10.1016/j.jneumeth.2009.05.002
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Porada I, 2000, J NEUROSCI METH, V95, P13, DOI 10.1016/S0165-0270(99)00139-9
   Pritchard EM, 2012, BIOPOLYMERS, V97, P479, DOI 10.1002/bip.22026
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Purcell EK, 2009, J NEUROSCI METH, V183, P149, DOI 10.1016/j.jneumeth.2009.06.026
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800
   Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024
   Sharp AA, 2009, IEEE T BIO-MED ENG, V56, P45, DOI 10.1109/TBME.2008.2003261
   Skousen JL, 2011, PROG BRAIN RES, V194, P167, DOI 10.1016/B978-0-444-53815-4.00009-1
   Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037
   Stice P, 2007, J NEURAL ENG, V4, P42, DOI 10.1088/1741-2560/4/2/005
   Subbaroyan J, 2005, J NEURAL ENG, V2, P103, DOI 10.1088/1741-2560/2/4/006
   Suzuki T, 2003, I IEEE EMBS C NEUR E, P154, DOI 10.1109/CNE.2003.1196780
   Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Takeuchi S, 2005, LAB CHIP, V5, P519, DOI 10.1039/b417497f
   Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199
   Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267
   Tien LW, 2012, MACROMOL BIOSCI, V12, P1671, DOI 10.1002/mabi.201200193
   Venkatraman S, 2009, IEEE T BIO-MED ENG, V56, P15, DOI 10.1109/TBME.2008.2005944
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wester BA, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/024002
   Wittmer CR, 2011, ADV FUNCT MATER, V21, P4232, DOI 10.1002/adfm.201100755
   Wu F., 2011, 16 INT SOL STAT SENS, P966
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]
   Zhang F., 2010, 4 INT C BIOINF BIOM, P1
   Zhong Y, 2005, I IEEE EMBS C NEUR E, P522
   Zhong YH, 2005, J CONTROL RELEASE, V106, P309, DOI 10.1016/j.jconrel.2005.05.012
   Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024
NR 78
TC 39
Z9 39
U1 7
U2 95
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JUL 5
PY 2013
VL 23
IS 25
BP 3185
EP 3193
DI 10.1002/adfm.201203716
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 190TG
UT WOS:000322362500006
DA 2018-10-20
ER

PT J
AU Fitzpatrick, AWP
   Park, ST
   Zewail, AH
AF Fitzpatrick, Anthony W. P.
   Park, Sang Tae
   Zewail, Ahmed H.
TI Exceptional rigidity and biomechanics of amyloid revealed by 4D electron
   microscopy
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE cross-beta structure; nanomechanics; microcantilever
ID SPIDER SILK; FIBRILS; VISUALIZATION; POLYPEPTIDE; CANTILEVERS; MEMBRANE;
   PROTEINS; COLLAGEN
AB Amyloid is an important class of proteinaceous material because of its close association with protein misfolding disorders such as Alzheimer's disease and type II diabetes. Although the degree of stiffness of amyloid is critical to the understanding of its pathological and biological functions, current estimates of the rigidity of these beta-sheet-rich protein aggregates range from soft (10(8) Pa) to hard (10(10) Pa) depending on the method used. Here, we use time-resolved 4D EM to directly and noninvasively measure the oscillatory dynamics of freestanding, self-supporting amyloid beams and their rigidity. The dynamics of a single structure, not an ensemble, were visualized in space and time by imaging in the microscope an amyloid-dye cocrystal that, upon excitation, converts light into mechanical work. From the oscillatory motion, together with tomographic reconstructions of three studied amyloid beams, we determined the Young modulus of these highly ordered, hydrogen-bonded beta-sheet structures. We find that amyloid materials are very stiff (10(9) Pa). The potential biological relevance of the deposition of such a highly rigid biomaterial in vivo are discussed.
C1 [Fitzpatrick, Anthony W. P.; Park, Sang Tae; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.
RP Zewail, AH (reprint author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.
EM zewail@caltech.edu
OI gaber, sarah/0000-0002-5995-7291
FU National Science Foundation [DMR-0964886]; Air Force Office of
   Scientific Research [FA9550-11-1-0055]
FX This manuscript was reviewed by three experts: D. Eisenberg, C.M. Dobson
   and T.P.J. Knowles. A.W.P.F. was previously a postdoctoral associate
   with C.M. Dobson who is a pioneer in the field of amyloid research. We
   are grateful to all reviewers for their helpful and penetrating
   comments. We thank H. B. Gristick for help with sample preparation and
   for useful discussions. This work was supported by National Science
   Foundation Grant DMR-0964886 and Air Force Office of Scientific Research
   Grant FA9550-11-1-0055 to the Gordon and Betty Moore Center for Physical
   Biology at the California Institute of Technology.
CR AARON BB, 1981, BIOPOLYMERS, V20, P1247, DOI 10.1002/bip.1981.360200611
   Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703
   Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   COWAN PM, 1955, NATURE, V176, P1062, DOI 10.1038/1761062a0
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022
   Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105
   Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002
   Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110
   Flannigan DJ, 2009, NANO LETT, V9, P875, DOI 10.1021/nl803770e
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106
   GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923
   Grellman W, 2001, DEFORMATION FRACTURE
   Guo SL, 2006, BIOMACROMOLECULES, V7, P1630, DOI 10.1021/bm0600724
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080
   Lorenz UJ, 2013, P NATL ACAD SCI USA, V110, P2822, DOI 10.1073/pnas.1300630110
   Lulevich V, 2010, P NATL ACAD SCI USA, V107, P13872, DOI 10.1073/pnas.1008341107
   Meirovich L, 1986, ELEMENTS VIBRATION A
   Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288
   Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109
   Mohanty P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.085416
   Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680
   PANTALONI D, 1985, P NATL ACAD SCI USA, V82, P7207, DOI 10.1073/pnas.82.21.7207
   Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Sachse C, 2010, ANGEW CHEM INT EDIT, V49, P1321, DOI 10.1002/anie.200904781
   Shen ZL, 2008, BIOPHYS J, V95, P3956, DOI 10.1529/biophysj.107.124602
   Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201
   Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Warner M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.134302
   Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786
   Zewail A. H., 2010, 4D ELECT MICROSCOPY
   Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135
NR 42
TC 41
Z9 41
U1 7
U2 86
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 2
PY 2013
VL 110
IS 27
BP 10976
EP 10981
DI 10.1073/pnas.1309690110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 185OF
UT WOS:000321978000035
PM 23784773
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Rohleder, NH
   Loeffelbein, DJ
   Feistl, W
   Eddicks, M
   Wolff, KD
   Gulati, A
   Steinstraesser, L
   Kesting, MR
AF Rohleder, Nils H.
   Loeffelbein, Denys J.
   Feistl, Wolfgang
   Eddicks, Matthias
   Wolff, Klaus-D
   Gulati, Aakshay
   Steinstraesser, Lars
   Kesting, Marco R.
TI Repair of Oronasal Fistulae by Interposition of Multilayered Amniotic
   Membrane Allograft
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID CLEFT-PALATE PATIENTS; FOREARM FLAP; DOG PALATE; CLOSURE; TISSUE;
   TRANSPLANTATION; SECONDARY; SPEECH; GRAFT; RATS
AB Background: Oronasal fistulas are a frequent complication after cleft palate surgery. Numerous repair methods have been described, but wound-healing problems occur often. The authors investigated, for the first time, the suitability of multilayered amniotic membrane allograft for fistula repair in a laboratory experiment (part A), a swine model (part B), and an initial patient series (part C).
   Methods: In part A, one-, two-, and four-layer porcine and human amniotic membranes (n = 20 each) were fixed in a digital towing device and the force needed for rupture was determined. In part B, iatrogenic oronasal fistulas in 18 piglets were repaired with amniotic membrane allograft, autofetal amniotic membrane, or small intestinal submucosa (n = 6 each). Healing was evaluated by probing and visual inflammation control (no/moderate/strong) on postoperative days 3, 7, 10, and 76. Histological analysis was performed to visualize tissue architecture. In part C, four patients (two women and two men, ages 21 to 51 years) were treated with multilayered amniotic membrane allograft.
   Results: In part A, forces needed for amniotic membrane rupture increased with additional layers (p < 0.001). Human amniotic membrane was stronger than porcine membrane (p < 0.001). In part B, fistula closure succeeded in all animals treated with amniotic membrane with less inflammation than in the small intestinal submucosa group. One fistula remained persistent in the small intestinal submucosa group. In part C, all fistulas healed completely without inflammation.
   Conclusions: Amniotic membrane is an easily available biomaterial and can be used successfully for oronasal fistula repair. The multilayer technique and protective plates should be utilized to prevent membrane ruptures.
C1 [Kesting, Marco R.] Tech Univ Munich, Dept Oral & Maxillofacial Surg, D-81675 Munich, Germany.
   Gen Hosp Linz, Dept Oral & Maxillofacial Surg, Linz, Austria.
   Univ Munich, Fac Vet Med, Clin Swine, Oberschleissheim, Germany.
   Southampton Univ Hosp NHS Fdn Trust, Dept Oral & Maxillofacial Surg, Southampton, Hants, England.
   Ruhr Univ Bochum, Dept Plast Surg, Burn Unit, BG Univ Hosp Bergmannsheil, Bochum, Germany.
RP Kesting, MR (reprint author), Tech Univ Munich, Dept Oral & Maxillofacial Surg, Ismaninger Str 22, D-81675 Munich, Germany.
EM kesting@mkg.med.tum.de
RI Eddicks, Matthias/K-7669-2014
OI Rohleder, Nils/0000-0002-7905-2924
FU German Research Foundation [WO 507-1]
FX This work was supported by the German Research Foundation (no. WO
   507-1). These data formed part of doctoral theses of Anne Nuber and
   Leopold Barthel.
CR Aldekhayel SA, 2012, PLAST RECONSTR SURG, V130, P177, DOI 10.1097/PRS.0b013e318254b2dc
   AMARATUNGA NAD, 1988, J ORAL MAXIL SURG, V46, P834, DOI 10.1016/0278-2391(88)90044-4
   Anani RA, 2012, J PLAST RECONSTR AES, V65, pE237, DOI 10.1016/j.bjps.2012.02.011
   Andersson EM, 2008, SCAND J PLAST RECONS, V42, P296, DOI 10.1080/02844310802299676
   Bureau S, 2001, J ORAL MAXIL SURG, V59, P1408, DOI 10.1053/joms.2001.28270
   Chaudhary Sachin V, 2011, J Assoc Physicians India, V59, P112
   CHEN HC, 1992, PLAST RECONSTR SURG, V90, P757, DOI 10.1097/00006534-199211000-00004
   Christiano JG, 2012, CLEFT PALATE-CRAN J, V49, P245, DOI 10.1597/11-008
   Clark J Madison, 2003, Arch Facial Plast Surg, V5, P40
   Clark JM, 2003, ARCH FACIAL PLAST S, V5, P45
   Cole P, 2006, J CRANIOFAC SURG, V17, P636, DOI 10.1097/00001665-200607000-00005
   Davis J, 1910, J HOPKINS HOSP REPOR, V15, P310
   Eberlinc A, 2012, CLEFT PALATE-CRAN J, V49, P643, DOI 10.1597/10-146
   Garner JM, 2006, AM J OTOLARYNG, V27, P268, DOI 10.1016/j.amjoto.2005.09.021
   Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a
   Honnebier MBOM, 2000, CLEFT PALATE-CRAN J, V37, P127, DOI 10.1597/1545-1569(2000)037<0127:COPFWA>2.3.CO;2
   Iijima K, 2007, TISSUE ENG, V13, P513, DOI 10.1089/ten.2006.0170
   KARLING J, 1993, SCAND J PLAST RECONS, V27, P193, DOI 10.3109/02844319309078111
   Kesting MR, 2008, J BURN CARE RES, V29, P907, DOI 10.1097/BCR.0b013e31818b9e40
   Kesting MR, 2008, ANN PLAS SURG, V60, P684, DOI 10.1097/SAP.0b013e31814fb9d2
   Kesting MR, 2010, BRIT J ORAL MAX SURG, V48, P131, DOI 10.1016/j.bjoms.2009.04.025
   Kirschner RE, 2006, PLAST RECONSTR SURG, V118, P1431, DOI 10.1097/01.prs.0000239612.25581.c3
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   Majid OW, 2008, BRIT J ORAL MAX SURG, V46, P50, DOI 10.1016/j.bjoms.2006.09.016
   Mermet I, 2007, WOUND REPAIR REGEN, V15, P459, DOI 10.1111/j.1524-475X.2007.00252.x
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Nord Gary A, 2012, N Y State Dent J, V78, P22
   Ophof R, 2008, EUR J ORTHODONT, V30, P1, DOI 10.1093/ejo/cjm082
   Ophof R, 2007, TISSUE ENG, V13, P2689, DOI 10.1089/ten.2006.0368
   Penna V, 2007, ANN PLAS SURG, V59, P679, DOI 10.1097/SAP.0b013e318033e88d
   Phua YS, 2008, CLEFT PALATE-CRAN J, V45, P172, DOI 10.1597/06-205.1
   POSNICK JC, 1987, J ORAL MAXIL SURG, V45, P907, DOI 10.1016/0278-2391(87)90438-1
   Richardson D, 1997, PLAST RECONSTR SURG, V99, P109, DOI 10.1097/00006534-199701000-00017
   Soukup JW, 2009, J VET DENT, V26, P86, DOI 10.1177/089875640902600203
   Taub PJ, 2001, J CRANIOFAC SURG, V12, P495, DOI 10.1097/00001665-200109000-00018
   THOMPSON SH, 1985, J ORAL MAXIL SURG, V43, P964, DOI 10.1016/0278-2391(85)90012-6
   Tuncbilek G, 2012, J CRANIOFAC SURG, V23, P780, DOI 10.1097/SCS.0b013e31824dbd68
   van de Wetering A, 2005, J VET DENT, V22, P243, DOI 10.1177/089875640502200404
   WALKER AB, 1977, J PEDIATR SURG, V12, P391, DOI 10.1016/0022-3468(77)90015-X
   ZEIDMAN A, 1988, J ORAL MAXIL SURG, V46, P412, DOI 10.1016/0278-2391(88)90228-5
NR 40
TC 9
Z9 9
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD JUL
PY 2013
VL 132
IS 1
BP 172
EP 181
DI 10.1097/PRS.0b013e3182910b50
PG 10
WC Surgery
SC Surgery
GA AB3YP
UT WOS:000331726400053
PM 23806920
OA Green Published
DA 2018-10-20
ER

PT J
AU Guedes, JC
   Park, JH
   Lakhkar, NJ
   Kim, HW
   Knowles, JC
   Wall, IB
AF Guedes, Joana C.
   Park, Jeong-Hui
   Lakhkar, Nilay J.
   Kim, Hae-Won
   Knowles, Jonathan C.
   Wall, Ivan B.
TI TiO2-doped phosphate glass microcarriers: A stable bioactive substrate
   for expansion of adherent mammalian cells
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Microcarriers; bioactive phosphate-based glass; cell expansion; titanium
ID GUIDED BONE REGENERATION; GENE-EXPRESSION; IN-VITRO; SURFACE
AB Scalable expansion of cells for regenerative cell therapy or to produce large quantities for high-throughput screening remains a challenge for bioprocess engineers. Laboratory scale cell expansion using t-flasks requires frequent passaging that exposes cells to many poorly defined bioprocess forces that can cause damage or alter their phenotype. Microcarriers offer a potential solution to scalable production, lending themselves to cell culture processes more akin to fermentation, removing the need for frequent passaging throughout the expansion period. One main problem with microcarrier expansion, however, is the difficulty in harvesting cells at the end of the process. Therefore, therapies that rely on cell delivery using biomaterial scaffolds could benefit from a microcarrier expansion system whereby the cells and microcarriers are transplanted together. In the current study, we used bioactive glass microcarriers doped with 5% TiO2 that display a controlled rate of degradation and conducted experiments to assess biocompatibility and growth of primary fibroblast cells as a model for cell therapy products. We found that the microcarriers are highly biocompatible and facilitate cell growth in a gradual controlled manner. Therefore, even without additional biofunctionalization methods, Ti-doped bioactive glass microcarriers offer potential as a cell expansion platform.
C1 [Guedes, Joana C.; Wall, Ivan B.] UCL, Dept Biochem Engn, London WC1E 7JE, England.
   [Guedes, Joana C.] Inst Super Tecn, Dept Bioengn, Lisbon, Portugal.
   [Park, Jeong-Hui; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea.
   [Park, Jeong-Hui; Kim, Hae-Won; Knowles, Jonathan C.; Wall, Ivan B.] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.
   [Park, Jeong-Hui; Kim, Hae-Won; Knowles, Jonathan C.; Wall, Ivan B.] Dankook Univ, WCU Res Ctr, Cheonan, South Korea.
   [Lakhkar, Nilay J.; Knowles, Jonathan C.] UCL, UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1E 7JE, England.
RP Wall, IB (reprint author), UCL, Dept Biochem Engn, Torrington Pl, London WC1E 7JE, England.
EM i.wall@ucl.ac.uk
OI Knowles, Jonathan Campbell/0000-0003-3917-3446
FU WCU Program through the National Research Foundation of Korea (NRF);
   Ministry of Education, Science and Technology [R31-10069]
FX This work was part supported by WCU Program through the National
   Research Foundation of Korea (NRF) funded by the Ministry of Education,
   Science and Technology (No. R31-10069).
CR Abou Neel EA, 2005, BIOMATERIALS, V26, P2247, DOI 10.1016/j.biomaterials.2004.07.024
   Abou Neel EA, 2007, BIOMATERIALS, V28, P2967, DOI 10.1016/j.biomaterials.2007.03.018
   Abou Neel EA, 2008, ACTA BIOMATER, V4, P523, DOI 10.1016/j.actbio.2007.11.007
   Ahmadi R, 2011, ACTA BIOMATER, V7, P1542, DOI 10.1016/j.actbio.2010.12.022
   Ahmed I, 2004, BIOMATERIALS, V25, P3223, DOI 10.1016/j.biomaterials.2003.10.013
   Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001
   Bitar M, 2004, BIOMATERIALS, V25, P2283, DOI 10.1016/j.biomaterials.2003.08.054
   Donos N, 2011, CLIN ORAL IMPLAN RES, V22, P390, DOI 10.1111/j.1600-0501.2010.02105.x
   dos Santos F, 2011, TISSUE ENG PART C-ME, V17, P1201, DOI 10.1089/ten.tec.2011.0255
   Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015
   Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12
   Ivanovski S, 2011, CLIN ORAL IMPLAN RES, V22, P382, DOI 10.1111/j.1600-0501.2010.02104.x
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   Lakhkar NJ, 2013, ADV DRUG DELIVER REV, V65, P405, DOI 10.1016/j.addr.2012.05.015
   Lakhkar NJ, 2012, ACTA BIOMATER, DOI DOI 10.1016/J.ACTBI0.2012.07.023
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P71, DOI 10.1111/j.1600-0501.2009.01805.x
   Senuma Y, 2000, BIOMATERIALS, V21, P1135, DOI 10.1016/S0142-9612(99)00276-8
   Wall IB, 2008, J INVEST DERMATOL, V128, P2526, DOI 10.1038/jid.2008.114
   Yun YR, 2012, REGEN MED, V7, P369, DOI [10.2217/rme.12.1, 10.2217/RME.12.1]
NR 23
TC 12
Z9 12
U1 0
U2 27
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2013
VL 28
IS 1
BP 3
EP 11
DI 10.1177/0885328212459093
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301JN
UT WOS:000330528700001
PM 22935537
OA Green Published
DA 2018-10-20
ER

PT J
AU Dawlee, S
   Jayabalan, M
AF Dawlee, S.
   Jayabalan, M.
TI Iodinated glycidyl methacrylate copolymer as a radiopaque material for
   biomedical applications
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Glycidyl methacrylate; iodinated copolymer; radiopacity;
   biocompatibility; tissue compatibility
ID ACRYLIC BONE-CEMENT; COMPRESSION FRACTURES; BIOCOMPATIBILITY;
   VERTEBROPLASTY; POLYMERIZATION; MICROSPHERES
AB Polymeric biomaterial was synthesized by copolymerizing 50:50 mol% of monomers, glycidyl methacrylate and methyl methacrylate. Iodine atoms were then grafted to the epoxide groups of glycidyl methacrylate units, rendering the copolymer radiopaque. The percentage weight of iodine in the present copolymer was found to be as high as 23%. The iodinated copolymer showed higher glass transition temperature and thermal stability in comparison with unmodified polymer. Radiographic analysis showed that the copolymer possessed excellent radiopacity. The iodinated copolymer was cytocompatible to L929 mouse fibroblast cells. The in vivo toxicological evaluation by intracutaneous reactivity test of the copolymer extracts has revealed that the material was nontoxic. Subcutaneous implantation of iodinated copolymer in rats has shown that the material was well tolerated. Upon explantation and histological examination, no hemorrhage, infection or necrosis was observed. The samples were found to be surrounded by a vascularized capsule consisting of connective tissue cells. The results indicate that the iodinated copolymer is biocompatible and may have suitable applications as implantable materials.
C1 [Dawlee, S.; Jayabalan, M.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Polymer Sci Div, Trivandrum 695012, Kerala, India.
RP Jayabalan, M (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Polymer Sci Div, Trivandrum 695012, Kerala, India.
EM muthujayabalan@rediffmail.com
FU Council for Scientific and Industrial Research, New Delhi
FX Thanks are due to Prof. K. Radhakrishnan, Director, SCTIMST and Dr G. S.
   Bhuvaneshwar, Head, BMT Wing, SCTIMST for providing the facilities to
   carry out this work. S. D. acknowledges the financial support from
   Council for Scientific and Industrial Research, New Delhi.
CR [Anonymous], 2009, 109935 ISO
   [Anonymous], 2002, ISO1099310
   Aviv H, 2009, BIOMATERIALS, V30, P5610, DOI 10.1016/j.biomaterials.2009.06.038
   Boelen EJH, 2008, J BIOMED MATER RES A, V86A, P76, DOI 10.1002/jbm.a.31601
   CABASSO I, 1989, J APPL POLYM SCI, V38, P1653, DOI 10.1002/app.1989.070380906
   Cotten A, 1998, RADIOGRAPHICS, V18, P311, DOI 10.1148/radiographics.18.2.9536480
   Dawlee S, 2009, J MATER SCI-MATER M, V20, P243, DOI 10.1007/s10856-008-3557-4
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   Ihova B, 1996, ADV DRUG DELIV REV, V21, P157
   ISO10993-6, 2007, ISO109936
   Jensen ME, 1997, AM J NEURORADIOL, V18, P1897
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   Lakshmi S, 2003, J APPL POLYM SCI, V88, P2580, DOI 10.1002/app.12187
   Lewis G, 2005, J BIOMED MATER RES B, V73B, P77, DOI 10.1002/jbm.b.30176
   Michel V, 2007, PROG POLYM SCI, V32, P755
   Molino LN, 1996, J BIOMED MATER RES, V31, P131, DOI 10.1002/(SICI)1097-4636(199605)31:1<131::AID-JBM14>3.0.CO;2-Q
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Navarro-Rodriguez D, 1998, EUR POLYM J, V34, P1039, DOI 10.1016/S0014-3057(97)00219-X
   Pereira IHL, 2010, ACTA BIOMATER, V6, P3056, DOI 10.1016/j.actbio.2010.02.036
   Rawls HR, 1996, J BIOMED MATER RES, V31, P339, DOI 10.1002/(SICI)1097-4636(199607)31:3<339::AID-JBM7>3.0.CO;2-N
   Safa KD, 2006, POLYM BULL, V57, P293, DOI 10.1007/s00289-006-0564-9
   Saralidze K, 2003, BIOMACROMOLECULES, V4, P793, DOI 10.1021/bm030002m
   Smid J, US Patent, Patent No. 5256334
   van Hooy-Corstjens CSJ, 2008, BIOMACROMOLECULES, V9, P84, DOI 10.1021/bm7008334
   van Hooy-Corstjens CSJ, 2004, BIOMATERIALS, V25, P2657, DOI 10.1016/j.biomaterials.2003.09.038
   Vasquez B, 1999, BIOMATERIALS, P2047
   Velayudhan S, 2005, ACTA BIOMATER, V1, P201, DOI 10.1016/j.actbio.2004.11.005
   Yang JM, 1997, BIOMATERIALS, V18, P1293, DOI 10.1016/S0142-9612(97)00060-4
   Zaharia C, 2007, J OPTOELECTRON ADV M, V9, P2143
   Zaharia C, 2008, ACTA BIOMATER, V4, P1762, DOI 10.1016/j.actbio.2008.06.009
   Zhao O H, 1992, J Biomed Mater Res, V26, P1019
NR 31
TC 6
Z9 6
U1 0
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2013
VL 28
IS 1
BP 28
EP 37
DI 10.1177/0885328211434090
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301JN
UT WOS:000330528700004
PM 22262573
DA 2018-10-20
ER

PT J
AU Kluppel, LE
   Antonini, F
   Olate, S
   Nascimento, FF
   Albergaria-Barbosa, JR
   Mazzonetto, R
AF Klueppel, Leandro Eduardo
   Antonini, Fernando
   Olate, Sergio
   Nascimento, Frederico Felipe
   Albergaria-Barbosa, Jose Ricardo
   Mazzonetto, Renato
TI Bone Repair is Influenced by Different Particle Sizes of Anorganic
   Bovine Bone Matrix: A Histologic and Radiographic Study In Vivo
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Bone healing; bone graft; dental implant
ID ALVEOLAR RIDGE AUGMENTATION; SINUS FLOOR AUGMENTATION; FREEZE-DRIED
   BONE; AUTOGENOUS BONE; GRAFT SUBSTITUTES; DEFECTS; REGENERATION;
   IMPLANTS; MARROW
AB Purpose: The aim of this study was to analyze histologically and radiographically the influence of particle size of anorganic bovine bone matrix (ABBM) on bone repair.
   Materials and Methods: Four calvarial defects of 8 mm each were prepared in 18 adult New Zealand rabbits. The defects were then filled with either particulate autogenous bone (control group) or ABBM of large, medium, and small size granules. The animals were sacrificed at 15, 30, and 60 days after surgery. The samples were radiographically examined before being submitted to histological processing.
   Results: Autogenous bone showed a slight radiopacity at the beginning, which was increased at the final period, being very similar to the adjacent bone tissue. The large and medium size ABBM particles maintained the same radiographic behavior, showing a radiolucent area in the central portion of the defect at 60 days. ABBM of small size granules showed a slight radiolucity at the initial period, which was increased at the subsequent periods. More intense bone formation occurred in the control group (autogenous bone). All 3 particle sizes of the biomaterial resulted in inflammatory infiltration at 15 and 30 days. ABBM of small size granules lead to a greater amount of osteoid tissue, and the particles were almost totally reabsorbed within 60 days of implantation.
   Conclusions: Autogenous bone graft lead to the best result in terms of bone defect repair; ABBM of large and medium size granules are not totally reabsorbed at the observed period; ABBM of small size granules was more intensively reabsorbed and led to a greater osteoid tissue formation when compared to the medium and large ABBM granules.
C1 [Klueppel, Leandro Eduardo; Olate, Sergio; Nascimento, Frederico Felipe; Mazzonetto, Renato] Univ Estadual Campinas, Piracicaba Sch Dent, Oral & Maxillofacial Surg Dept, Piracicaba, Brazil.
   [Klueppel, Leandro Eduardo] Univ Estadual Ponta Grossa, Dept Oral & Maxillofacial Surg, Ponta Grossa, Brazil.
   [Antonini, Fernando] Univ Fed Parana, Oral & Maxillofacial Surg Dept, BR-80045125 Curitiba, Parana, Brazil.
   [Olate, Sergio] Univ La Frontera, Sch Med, Dept Dent, Santiago, Chile.
   [Olate, Sergio] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, Brazil.
   [Nascimento, Frederico Felipe; Albergaria-Barbosa, Jose Ricardo] Hosp Base, Dept Oral & Maxillofacial Surg, Brasilia, DF, Brazil.
RP Antonini, F (reprint author), Univ Fed Parana, Oral & Maxillofacial Surg Dept, Hosp Cirurgia Bucomaxilofacial 15, Rua 15 Novembro,2223, BR-80045125 Curitiba, Parana, Brazil.
EM antonini_fernando@hotmail.com
OI Olate, Sergio/0000-0001-8153-0676
FU Campinas States University, Piracicaba School of Dentistry
FX The authors wish to thank Consulmat Company for kindly providing the
   biomaterial used for this research and the Campinas States University,
   Piracicaba School of Dentistry for supporting the study.
CR Alberius P, 1990, J CRANIOMAXILLOFAC S, V18, P179
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   CALLAN DP, 1993, J PERIODONTOL, V64, P575, DOI 10.1902/jop.1993.64.6.575
   DUPOIRIEUX L, 1994, INT J ORAL MAX SURG, V23, P395, DOI 10.1016/S0901-5027(05)80028-1
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Ferreira CEA, 2009, J PERIODONTOL, V80, P1920, DOI 10.1902/jop.2009.090263
   FUCINI SE, 1993, J PERIODONTOL, V64, P844, DOI 10.1902/jop.1993.64.9.844
   Galindo-Moreno P, 2011, CLIN ORAL IMPLAN RES, V22, P857, DOI 10.1111/j.1600-0501.2010.02073.x
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Misch CM, 1997, INT J ORAL MAX IMPL, V12, P767
   Silva FMSE, 2006, J ORAL MAXIL SURG, V64, P931, DOI 10.1016/j.joms.2006.02.026
   Pallesen L, 2002, INT J ORAL MAX IMPL, V17, P498
   Pecora G, 1997, ORAL SURG ORAL MED O, V84, P424, DOI 10.1016/S1079-2104(97)90043-3
   Pieri F, 2008, J PERIODONTOL, V79, P2093, DOI [10.1902/jop.2008.080061, 10.1902/jop.2008.080061 ]
   Pikos Michael A, 2005, Atlas Oral Maxillofac Surg Clin North Am, V13, P91, DOI 10.1016/j.cxom.2005.05.003
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Schwartz Z, 2008, CLIN ORAL IMPLAN RES, V19, P1233, DOI 10.1111/j.1600-0501.2008.01582.x
   SHAPOFF CA, 1980, J PERIODONTOL, V51, P625, DOI 10.1902/jop.1980.51.11.625
   Thorwarth M, 2006, ORAL SURG ORAL MED O, V101, P309, DOI 10.1016/j.tripleo.2005.04.024
   Tong L, 2000, J Craniomaxillofac Trauma, V6, P31
   Traini T, 2008, J PERIODONTOL, V79, P1232, DOI [10.1902/jop.2008.070504, 10.1902/jop.2008.070504 ]
   Waasdorp J, 2010, INT J ORAL MAX IMPL, V25, P525
   Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x
   ZANER DJ, 1984, J PERIODONTOL, V55, P406, DOI 10.1902/jop.1984.55.7.406
NR 27
TC 9
Z9 9
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUL
PY 2013
VL 24
IS 4
BP 1074
EP 1077
DI 10.1097/SCS.0b013e318286a0a3
PG 4
WC Surgery
SC Surgery
GA 295PW
UT WOS:000330129000057
PM 23851743
DA 2018-10-20
ER

PT J
AU Oliveira, MR
   Martins, ED
   Celio-Mariano, R
   Sonoda, CK
   Garcia, IR
   de Melo, WM
AF Oliveira, Marina Reis
   Martins, Elisa das Gracas
   Celio-Mariano, Ronaldo
   Sonoda, Celso Koogi
   Garcia, Idelmo Rangel, Jr.
   de Melo, Willian Morais
TI Tissue Engineering: Using Collagen Type I Matrix for Bone Healing of
   Bone Defects
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Collagen; biomaterial; benign tumors; jaw cyst; surgical management;
   tissue engineering
ID KERATOCYSTIC ODONTOGENIC-TUMOR; MANAGEMENT; LESIONS; REPAIR
AB Among the many tissues in the human body, bone has been considered as a powerful marker for regeneration and its formation serves as a prototype model for tissue engineering based on morphogenesis. Therefore, collagen type I is one of the most useful biomaterials used in tissue engineering as extracellular matrix components capable to promote bone healing. The literature reveals excellent biocompatibility and safety due to its biological characteristics, such as biodegradability and weak antigenicity, making collagen type I the primary resource in medical applications. Thus, it was also used for tissue engineering including skin replacement, bone substitutes, and artificial blood vessels and valves. The authors describe the treatment of an abscessed apical periodontal cyst and show good outcomes of bone healing, using tissue engineering, as collagen type I matrix.
C1 [Oliveira, Marina Reis; Martins, Elisa das Gracas; Celio-Mariano, Ronaldo] Fed Univ Alfenas UNIFAL, Alfenas Dent Sch, Clin & Surg Dept, Alfenas, MG, Brazil.
   [Sonoda, Celso Koogi; Garcia, Idelmo Rangel, Jr.] Univ Estadual Paulista Julio de Mesquita Filho UN, Aracatuba Dent Sch, Surg & Integrated Clin Dept, Sao Paulo, Brazil.
   Univ Estadual Paulista Julio de Mesquita Filho UN, Aracatuba Dent Sch, Dept Oral & Maxillofacial Surg, Sao Paulo, Brazil.
   Univ Estadual Paulista Julio de Mesquita Filho UN, Aracatuba Dent Sch, Integrated Clin, Sao Paulo, Brazil.
   [de Melo, Willian Morais] Antonio Dias Reg Hosp FHEMIG, Oral & Maxillofacial Dept, Patos De Minas, MG, Brazil.
RP de Melo, WM (reprint author), Ave Feijo 1309,Apto 03, BR-14801140 Sao Paulo, Brazil.
EM wmmelo@usp.br
RI Sonoda, Celso/C-3776-2012
OI MARIANO, RONALDO/0000-0001-7334-8276; Sonoda, Celso/0000-0001-8639-1767
CR Becconsall-Ryan K, 2010, INT ENDOD J, V43, P859, DOI 10.1111/j.1365-2591.2010.01751.x
   Caliskan MK, 2004, INT ENDOD J, V37, P408, DOI 10.1111/j.1365-2591.2004.00809.x
   Chimal-Monroy J, 1998, ANN NY ACAD SCI, V857, P232, DOI 10.1111/j.1749-6632.1998.tb10120.x
   de Melo WM, 2012, J CRANIOFAC SURG, V23, pE639, DOI 10.1097/SCS.0b013e31827101e9
   De Melo WM, 2012, J CRANIOFAC SURG, V23, pE499, DOI 10.1097/SCS.0b013e3182646b6a
   De Melo WM, 2012, J CRANIOFAC SURG, V23, pE398, DOI 10.1097/SCS.0b013e31825b353c
   de Melo WM, 2012, J CRANIOFAC SURG, V23, pE184, DOI 10.1097/SCS.0b013e31824de43f
   Dias GJ, 2007, INT J OSTEOARCHAEOL, V17, P619, DOI 10.1002/oa.902
   Holla VA, 2012, IMAGNG SCI DENT, V42, P105, DOI 10.5624/isd.2012.42.2.105
   Kim TG, 2009, J CLIN PERIODONTOL, V36, P589, DOI 10.1111/j.1600-051X.2009.01420.x
   Lindsey WH, 1996, ARCH OTOLARYNGOL, V122, P37
   Love RM, 2009, INT ENDOD J, V42, P198, DOI 10.1111/j.1365-2591.2008.01500.x
   Magro-Érnica Natasha, 2003, Braz. Dent. J., V14, P12, DOI 10.1590/S0103-64402003000100002
   Nakajima M, 1995, ARCH PATHOL LAB MED, V119, P1161
   Neville B., 2002, ORAL MAXILLOFACIAL P
   Saadeh PB, 2001, J CRANIOFAC SURG, V12, P573, DOI 10.1097/00001665-200111000-00015
   SWEENEY TM, 1995, J NEUROSURG, V83, P710, DOI 10.3171/jns.1995.83.4.0710
   Wang H L, 1998, Dent Clin North Am, V42, P505
NR 18
TC 0
Z9 1
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUL
PY 2013
VL 24
IS 4
BP E394
EP E396
DI 10.1097/SCS.0b013e3182802324
PG 4
WC Surgery
SC Surgery
GA 295PW
UT WOS:000330129000030
PM 23851732
DA 2018-10-20
ER

PT J
AU Versace, DL
   Ramier, J
   Grande, D
   Andaloussi, SA
   Dubot, P
   Hobeika, N
   Malval, JP
   Lalevee, J
   Renard, E
   Langlois, V
AF Versace, Davy-Louis
   Ramier, Julien
   Grande, Daniel
   Andaloussi, Samir Abbad
   Dubot, Pierre
   Hobeika, Nelly
   Malval, Jean-Pierre
   Lalevee, Jacques
   Renard, Estelle
   Langlois, Valerie
TI Versatile Photochemical Surface Modification of Biopolyester
   Microfibrous Scaffolds with Photogenerated Silver Nanoparticles for
   Antibacterial Activity
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE photochemistry; photogenerated silver nanoparticles;
   poly(3-hydroxybutyrate-co-3-hydroxyvalerate); electrospinning;
   biopolymers
ID ESR SPIN-TRAP; ANTIMICROBIAL PROPERTIES; QUATERNIZED CHITOSAN; BACTERIAL
   ADHESION; ZWITTERIONIC POLYSULFOBETAINE; RADICAL POLYMERIZATION;
   BIOLOGICAL-PROPERTIES; NANOFIBER COMPOSITES; POLY(VINYL ALCOHOL);
   NYLON-6 NANOFIBERS
AB A straightforward and versatile method for immobilizing macromolecules and silver nanoparticles on the surface of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBHV) electrospun fibers is developed with the objective of designing a new functional material having significant antibacterial activity. The approach relies on a two-step procedure: UV photografting of poly(methacrylic acid) (PMAA) on the surface of PHBHV fibers according to a grafting from method, and complexation of in situ photogenerated silver nanoparticles (Ag NPs) by carboxyl groups from tethered PMAA chains. The photografting process is conducted through a photoinduced free-radical process employing a ketone-based photoinitiator in aqueous medium. Under appropriate conditions, the photogenerated radicals abstract hydrogen atoms from the PHBHV backbone, thus initiating the UV-mediated photopolymerization of MAA from the PHBHV microfibrous surface. The photochemical mechanism of the ketone photolysis is entirely described by the electron spin resonance/spin-trapping technique, and the modified PHBHV microfibrous scaffold is extensively characterized by ATR-FTIR spectroscopy, water contact-angle measurements, and mercury intrusion porosimetry. In a second step, the in situ synthesis of Ag NPs within the microfibrous scaffold is implemented by photoreduction reaction in the presence of both a silver precursor and a photosensitizer. The photoinduced formation of Ag NPs is confirmed by UV spectrophotometry and XPS analysis. SEM and TEM experiments confirm the formation and dispersion of Ag NPs on the surface of the modified fibers. Finally, a primary investigation is conducted to support the antibacterial activity of the new functionalized biomaterial against Staphylococcus aureus and Escherichia coli.
C1 [Versace, Davy-Louis; Ramier, Julien; Grande, Daniel; Dubot, Pierre; Renard, Estelle; Langlois, Valerie] Univ Paris Est Creteil Val de Marne, CNRS, ICMPE, UMR 7182, F-94320 Thiais, France.
   [Andaloussi, Samir Abbad] Univ Paris Est Creteil Val de Marne, CNRS, Unite Bioemco Equipe IBIOS, UMR 7618, F-94320 Thiais, France.
   [Hobeika, Nelly; Malval, Jean-Pierre; Lalevee, Jacques] Univ Haute Alsace, CNRS, IS2M, LRC 7228, F-68057 Mulhouse, France.
RP Versace, DL (reprint author), Univ Paris Est Creteil Val de Marne, CNRS, ICMPE, UMR 7182, 2 Rue Henri Dunant, F-94320 Thiais, France.
EM versace@icmpe.cnrs.fr
RI Versace, Davy-Louis/D-8124-2016; LANGLOIS, Valerie/C-2584-2016
OI Grande, Daniel/0000-0002-9987-9961
CR Agarwal A, 2011, ADV FUNCT MATER, V21, P1863, DOI 10.1002/adfm.201002662
   Al-Muaikel NS, 2000, J APPL POLYM SCI, V77, P740, DOI 10.1002/(SICI)1097-4628(20000725)77:4<740::AID-APP4>3.0.CO;2-P
   Albert M, 2003, BIOMACROMOLECULES, V4, P1811, DOI 10.1021/bm0342180
   Amarjargal A., 2012, MAT CHEM PH IN PRESS
   Amna T, 2012, APPL MICROBIOL BIOT, V93, P743, DOI 10.1007/s00253-011-3459-0
   Babu R, 2006, BIOMATERIALS, V27, P4304, DOI 10.1016/j.biomaterials.2006.03.038
   Balan L, 2011, POLYMER, V52, P893, DOI 10.1016/j.polymer.2010.12.038
   Balan L, 2010, POLYMER, V51, P1363, DOI 10.1016/j.polymer.2009.05.003
   Balan L, 2008, MACROMOLECULES, V41, P9359, DOI 10.1021/ma8017926
   Baronavski AP, 2001, CHEM PHYS LETT, V333, P36, DOI 10.1016/S0009-2614(00)01350-6
   BARRIE A, 1976, PHYS REV B, V14, P2442, DOI 10.1103/PhysRevB.14.2442
   Borisov IM, 1999, REACT KINET CATAL L, V68, P271, DOI 10.1007/BF02475512
   Chae HH, 2011, SYNTHETIC MET, V161, P2124, DOI 10.1016/j.synthmet.2011.08.013
   Chang Y, 2008, LANGMUIR, V24, P5453, DOI 10.1021/la800228c
   Chang Y, 2010, BIOMACROMOLECULES, V11, P1101, DOI 10.1021/bm100093g
   Chen CP, 2012, ADV FUNCT MATER, V22, P780, DOI 10.1002/adfm.201102333
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Chung DW, 2003, INT J FOOD SCI TECH, V38, P165, DOI 10.1046/j.1365-2621.2003.00657.x
   Colucci G, 2011, MACROMOL MATER ENG, V296, P921, DOI 10.1002/mame.201100028
   Decraene V, 2006, APPL ENVIRON MICROB, V72, P4436, DOI 10.1128/AEM.02945-05
   El Habnouni S, 2011, ADV FUNCT MATER, V21, P3321, DOI 10.1002/adfm.201100412
   Elzatahry AA, 2012, INT J NANOMED, V7, P2829, DOI 10.2147/IJN.S31810
   Feiertag P, 2003, MACROMOL RAPID COMM, V24, P567, DOI 10.1002/marc.200390085
   Fouassier J.-P., 1993, RAD CURING POLYM SCI
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Haire L. D., 1988, J ORG CHEM, V53, P4535
   Hazer B., 2010, INT J POLYM SCI, V2010
   Hazer DB, 2012, MAT SCI ENG C-MATER, V32, P637, DOI 10.1016/j.msec.2012.01.021
   Herold BC, 2002, J VIROL, V76, P11236, DOI 10.1128/JVI.76.22.11236-11244.2002
   Ho CH, 2004, ADV MATER, V16, P957, DOI 10.1002/adma.200306253
   Hong KH, 2007, POLYM ENG SCI, V47, P43, DOI 10.1002/pen.20660
   Hong KH, 2006, J POLYM SCI POL PHYS, V44, P2468, DOI 10.1002/polb.20913
   Hu Q, 2012, EXPRESS POLYM LETT, V6, P258, DOI 10.3144/expresspolymlett.2012.29
   Iemma F, 2010, J APPL POLYM SCI, V115, P784, DOI 10.1002/app.31067
   Ignatova M, 2007, EUR POLYM J, V43, P1112, DOI 10.1016/j.eurpolymj.2007.01.012
   Ignatova M, 2006, CARBOHYD RES, V341, P2098, DOI 10.1016/j.carres.2006.05.006
   Ignatova M, 2012, MACROMOL BIOSCI, V12, P104, DOI 10.1002/mabi.201100178
   Ikeo N., 1991, HDB XRAY PHOTOELECTR
   JENSEN EJ, 1988, HUM TOXICOL, V7, P535, DOI 10.1177/096032718800700603
   Jeon HJ, 2008, APPL SURF SCI, V254, P5886, DOI 10.1016/j.apsusc.2008.03.141
   Jin EQ, 2011, J APPL POLYM SCI, V120, P701, DOI 10.1002/app.33232
   Jin WJ, 2005, MACROMOL RAPID COMM, V26, P1903, DOI 10.1002/marc.200500569
   Kamat PV, 2002, J PHYS CHEM B, V106, P7729, DOI 10.1021/jp0209289
   Kang SW, 2008, CHEM MATER, V20, P1308, DOI [10.1021/cm071516l, 10.1021/cm0715161]
   Kang YS, 2007, ADV MATER, V19, P475, DOI 10.1002/adma.200601009
   Kenawy ER, 2006, REACT FUNCT POLYM, V66, P419, DOI 10.1016/j.reactfunctpolym.2005.09.002
   Kenawy ER, 2003, MACROMOL BIOSCI, V3, P107, DOI 10.1002/mabi.200390016
   Kim J, 2008, COLLOID SURFACE A, V320, P189, DOI 10.1016/j.colsurfa.2008.01.046
   Kim SH, 2003, J MEMBRANE SCI, V211, P157, DOI 10.1016/S0376-7388(02)00418-0
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   KNOLL H, 1980, REACT KINET CATAL L, V15, P431
   Kometani N, 2002, PHYS CHEM CHEM PHYS, V4, P5142, DOI 10.1039/b205829d
   Kong H, 2008, BIOMACROMOLECULES, V9, P2677, DOI 10.1021/bm800574x
   Lao HK, 2011, J APPL POLYM SCI, V120, P184, DOI 10.1002/app.32967
   Lao HK, 2010, J APPL POLYM SCI, V116, P288, DOI 10.1002/app.31507
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Lim KS, 2012, POLYM INT, V61, P1519, DOI 10.1002/pi.4239
   Liu X, 2010, J BIOMED MATER RES A, V94A, P499, DOI 10.1002/jbm.a.32718
   LOUGNOT DJ, 1989, MACROMOLECULES, V22, P108, DOI 10.1021/ma00191a022
   Lu J, 2001, J APPL POLYM SCI, V82, P300, DOI 10.1002/app.1852.abs
   Luo Y.-R., 2003, HDB BOND DISSOCIATIO
   Malval JP, 2010, J PHYS CHEM C, V114, P10396, DOI 10.1021/jp102189u
   Mao JY, 2010, ADV FUNCT MATER, V20, P209, DOI 10.1002/adfm.200900782
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   Mekarbane PG, 1998, MAGN RESON CHEM, V36, P826, DOI 10.1002/(SICI)1097-458X(1998110)36:11<826::AID-OMR377>3.0.CO;2-1
   Mekarbane PG, 2000, MAGN RESON CHEM, V38, P183
   MERRITT MV, 1977, J AM CHEM SOC, V99, P3713, DOI 10.1021/ja00453a033
   MIGITA CT, 1991, CHEM LETT, P737
   Miyama T, 2004, J NANOPART RES, V6, P457, DOI 10.1007/s11051-004-1716-1
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Nguyen TH, 2010, MAT SCI ENG C-MATER, V30, P944, DOI 10.1016/j.msec.2010.04.012
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Pant B, 2012, COLLOID SURFACE A, V395, P94, DOI 10.1016/j.colsurfa.2011.12.011
   Pant HR, 2011, J HAZARD MATER, V189, P465, DOI 10.1016/j.jhazmat.2011.02.062
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Park SW, 2009, J APPL POLYM SCI, V112, P2320, DOI 10.1002/app.29520
   Parkin IP, 2005, J MATER CHEM, V15, P1689, DOI 10.1039/b412803f
   Penchev H, 2010, CARBOHYD RES, V345, P2374, DOI 10.1016/j.carres.2010.08.014
   Perni S, 2009, BIOMATERIALS, V30, P89, DOI 10.1016/j.biomaterials.2008.09.020
   Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+
   Ruckh TT, 2012, J MATER SCI-MATER M, V23, P1411, DOI 10.1007/s10856-012-4609-3
   Rupp B., 2010, GREEN CHEM, V12
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Sampedro MF, 2007, INFECT DIS CLIN N AM, V21, P785, DOI 10.1016/j.idc.2007.07.001
   Schmitt MA, 2004, J AM CHEM SOC, V126, P6848, DOI 10.1021/ja048546z
   Schmitt MA, 2007, J AM CHEM SOC, V129, P417, DOI 10.1021/ja0666553
   Selvakannan PR, 2004, LANGMUIR, V20, P7825, DOI 10.1021/la049258j
   Shi Q, 2011, EUR POLYM J, V47, P1402, DOI 10.1016/j.eurpolymj.2011.04.002
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Song AQ, 2011, J APPL POLYM SCI, V119, P629, DOI 10.1002/app.32683
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Sudeep PK, 2005, CHEM MATER, V17, P5404, DOI 10.1021/cm0512777
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Taylor PL, 2005, BIOMATERIALS, V26, P7221, DOI 10.1016/j.biomaterials.2005.05.040
   Tehfe MA, 2010, MACROMOLECULES, V43, P1364, DOI 10.1021/ma9025702
   Thomas S., 2008, NANOTECHNOLOGY, V18
   Wang S, 2012, COLLOID POLYM SCI, V290, P667, DOI 10.1007/s00396-011-2581-y
   WAYNER DDM, 1986, CHEM PHYS LETT, V131, P189, DOI 10.1016/0009-2614(86)80542-5
   White RJ, 2011, INT J MOL SCI, V12, P5782, DOI 10.3390/ijms12095782
   Wu J, 2009, BIOMACROMOLECULES, V10, P2686, DOI 10.1021/bm900620w
   Xing Z.-C., 2012, J NANOMATER, V2012
   Xing ZC, 2010, BIOMACROMOLECULES, V11, P1248, DOI 10.1021/bm1000372
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   YATES SF, 1984, J ORG CHEM, V49, P3349, DOI 10.1021/jo00192a019
   Yeo SY, 2003, J MATER SCI, V38, P2143, DOI 10.1023/A:1023767828656
   Zhao Q, 2007, APPL SURF SCI, V253, P7254, DOI 10.1016/j.apsusc.2007.03.011
NR 111
TC 17
Z9 17
U1 8
U2 82
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUL
PY 2013
VL 2
IS 7
BP 1008
EP 1018
DI 10.1002/adhm.201200269
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 267VX
UT WOS:000328127500012
PM 23299982
DA 2018-10-20
ER

PT J
AU Tran, PL
   Gamboa, JR
   McCracken, KE
   Riley, MR
   Slepian, MJ
   Yoon, JY
AF Tran, Phat L.
   Gamboa, Jessica R.
   McCracken, Katherine E.
   Riley, Mark R.
   Slepian, Marvin J.
   Yoon, Jeong-Yeol
TI Nanowell-Trapped Charged Ligand-Bearing Nanoparticle Surfaces: A Novel
   Method of Enhancing Flow-Resistant Cell Adhesion
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE cell adhesion; ensemble surface; detachment resistance; nanopatterning;
   nanotextured surface
ID MEDIATED ENDOTHELIAL MECHANOTRANSDUCTION; VASCULAR GRAFTS; SHEAR-STRESS;
   BIOMATERIALS; BEHAVIOR; PEPTIDE; NANOTOPOGRAPHY; POLYETHYLENE;
   MONOLAYERS; NANOARRAY
AB Assuring cell adhesion to an underlying biomaterial surface is vital in implant device design and tissue engineering, particularly under circumstances where cells are subjected to potential detachment from overriding fluid flow. Cell-substrate adhesion is a highly regulated process involving the interplay of mechanical properties, surface topographic features, electrostatic charge, and biochemical mechanisms. At the nanoscale level, the physical properties of the underlying substrate are of particular importance in cell adhesion. Conventionally, natural, pro-adhesive, and often thrombogenic, protein biomaterials are frequently utilized to facilitate adhesion. In the present study, nanofabrication techniques are utilized to enhance the biological functionality of a synthetic polymer surface, polymethymethacrylate, with respect to cell adhesion. Specifically we examine the effect on cell adhesion of combining: 1. optimized surface texturing, 2. electrostatic charge and 3. cell adhesive ligands, uniquely assembled on the substrata surface, as an ensemble of nanoparticles trapped in nanowells. Our results reveal that the ensemble strategy leads to enhanced, more than simply additive, endothelial cell adhesion under both static and flow conditions. This strategy may be of particular utility for enhancing flow-resistant endothelialization of blood-contacting surfaces of cardiovascular devices subjected to flow-mediated shear.
C1 [Tran, Phat L.; Gamboa, Jessica R.; Slepian, Marvin J.; Yoon, Jeong-Yeol] Univ Arizona, Biomed Engn Grad Interdisciplinary Program, Tucson, AZ 85721 USA.
   [Tran, Phat L.; Gamboa, Jessica R.; Slepian, Marvin J.; Yoon, Jeong-Yeol] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
   [McCracken, Katherine E.; Riley, Mark R.; Yoon, Jeong-Yeol] Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ 85721 USA.
   [Slepian, Marvin J.] Univ Arizona, Coll Med, Sarver Heart Ctr, Tucson, AZ 85721 USA.
   [Slepian, Marvin J.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85721 USA.
RP Slepian, MJ (reprint author), Univ Arizona, Biomed Engn Grad Interdisciplinary Program, Tucson, AZ 85721 USA.
EM chairman.syns@gmial.com; jyyoon@email.arizona.edu
OI Klug, Katherine/0000-0002-1728-4623
FU BIO5 Institute; NIH Cardiovascular Training Grant [T32HL007955]
FX The authors thank Dr. Brooke Beam and Paul Lee of the Keck's facility at
   the University of Arizona for their assistance in AFM, SEM, and confocal
   imaging. We also thank Dr. Felipe T. Lee-Montiel and Dr. David J. You
   for biochamber design. This work was supported by BIO5 Institute, as
   well as fellowship support for Phat L. Tran (NIH Cardiovascular Training
   Grant T32HL007955).
CR Carpenter J., 2008, NANOTECHNOLOGY, V19
   Carr HMH, 1996, ANN VASC SURG, V10, P469, DOI 10.1007/BF02000595
   Chen SF, 2003, LANGMUIR, V19, P2859, DOI 10.1021/la026498v
   Chin V, 2001, ADV MATER, V13, P1877, DOI 10.1002/1521-4095(200112)13:24<1877::AID-ADMA1877>3.0.CO;2-4
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   Davies PF, 1997, ANNU REV PHYSIOL, V59, P527, DOI 10.1146/annurev.physiol.59.1.527
   Feinberg AW, 2009, ACTA BIOMATER, V5, P2013, DOI 10.1016/j.actbio.2009.01.032
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Girard PP, 2007, SOFT MATTER, V3, P307, DOI 10.1039/b614008d
   Holland J., 1996, BIOMATERIALS, V22, P147
   Hoover DK, 2008, J AM CHEM SOC, V130, P3280, DOI 10.1021/ja711016m
   Junkin M, 2011, BIOMATERIALS, V32, P1848, DOI 10.1016/j.biomaterials.2010.11.009
   Kader KN, 2008, MAT SCI ENG C-BIO S, V28, P387, DOI 10.1016/j.msec.2007.04.027
   Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Li JH, 2008, J MATER SCI-MATER M, V19, P2595, DOI 10.1007/s10856-007-3354-5
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Malek AM, 1996, J CELL SCI, V109, P713
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Meyers SR, 2009, BIOMATERIALS, V30, P277, DOI 10.1016/j.biomaterials.2008.08.042
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   MOONEY DJ, 1992, MATER RES SOC SYMP P, V252, P199
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nerem RM, 1998, AM J MED SCI, V316, P169, DOI 10.1097/00000441-199809000-00004
   Nicosia R., 1991, AM J PATHOL, V38, P829
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   OTT MJ, 1995, SURGERY, V117, P334, DOI 10.1016/S0039-6060(05)80210-7
   Perlin L, 2008, SOFT MATTER, V4, P2331, DOI 10.1039/b801646a
   Pislaru SV, 2006, CIRCULATION, V114, pI314, DOI 10.1161/CIRCULATIONAHA.105.001446
   Reneman RS, 2006, J VASC RES, V43, P251, DOI 10.1159/000091648
   ROSENMAN JE, 1985, J VASC SURG, V2, P778, DOI 10.1067/mva.1985.avs0020778
   Rouslahti E., 1996, ANNU REV CELL DEV BI, V12, P697
   SEYFERT S, 1995, BIOMATERIALS, V16, P201, DOI 10.1016/0142-9612(95)92118-P
   Tajima S, 2008, J BIOMED MATER RES A, V84A, P828, DOI 10.1002/jbm.a.31539
   Tran PL, 2010, ANAL BIOANAL CHEM, V398, P759, DOI 10.1007/s00216-010-3990-3
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Zorlutuna P, 2009, ACTA BIOMATER, V5, P2451, DOI 10.1016/j.actbio.2009.03.027
NR 44
TC 2
Z9 2
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUL
PY 2013
VL 2
IS 7
BP 1019
EP 1027
DI 10.1002/adhm.201200250
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 267VX
UT WOS:000328127500013
PM 23225491
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lu, HD
   Soranno, DE
   Rodell, CB
   Kim, IL
   Burdick, JA
AF Lu, Hoang D.
   Soranno, Danielle E.
   Rodell, Christopher B.
   Kim, Iris L.
   Burdick, Jason A.
TI Secondary Photocrosslinking of Injectable Shear-Thinning Dock-and-Lock
   Hydrogels
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE hydrogel; shear-thinning; self-assembling; crosslinking; biomaterial
ID PROTEIN-KINASE-A; BIOMEDICAL APPLICATIONS; REVERSIBLE HYDROGELS;
   PEPTIDE; DELIVERY; RESPONSIVENESS; ENCAPSULATION; MEDICINE; MODULUS;
   SYSTEMS
AB Shear-thinning hydrogels are useful in numerous applications, including as injectable carriers that act as scaffolds to support cell and drug therapies. Here, we describe the engineering of a self-assembling Dock-and-Lock (DnL) system that forms injectable shear-thinning hydrogels using molecular recognition interactions that also possess photo-triggerable secondary crosslinks. These DnL hydrogels are fabricated from peptide-modified hyaluronic acid (HA) and polypeptide precursors, can self-heal immediately after shear induced flow, are cytocompatible, and can be stabilized through light-initiated radical polymerization of methacrylate functional groups to tune gel mechanics and erosion kinetics. Secondary crosslinked hydrogels retain self-adhesive properties and exhibit cooperative physical and chemical crosslinks with moduli as high as approximate to 10 times larger than moduli of gels based on physical crosslinking alone. The extent of reaction and change in properties are dependent on whether the methacrylate is incorporated either at the terminus of the peptide or directly to the HA backbone. Additionally, the gel erosion can be monitored through an incorporated fluorophore and physical-chemical gels remain intact in solution over months, whereas physical gels that are not covalently crosslinked erode completely within days. Mesenchymal stem cells exhibit increased viability when cultured in physical- chemical gels, compared with those cultured in gels based on physical crosslinks alone. The physical properties of these DnL gels may be additionally tuned by adjusting component compositions, which allows DnL gels with a wide range of physical properties to be constructed for use.
C1 [Lu, Hoang D.; Soranno, Danielle E.; Rodell, Christopher B.; Kim, Iris L.; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu
FU David and Lucile Packard Foundation; National Science Foundation through
   the Penn MRSEC [DMR-0520020]; Penn Institute for Regenerative Medicine
FX We are grateful for support from a Fellowship in Science and Engineering
   from the David and Lucile Packard Foundation (JAB), the National Science
   Foundation through the Penn MRSEC (DMR-0520020) and a Graduate Research
   Fellowship (HDL, ILK), and a Pilot Project grant from the Penn Institute
   for Regenerative Medicine (DES).
CR Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Chung HJ, 2009, NANO TODAY, V4, P429, DOI 10.1016/j.nantod.2009.08.008
   Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Foss KB, 1997, BBA-GENE STRUCT EXPR, V1350, P98, DOI 10.1016/S0167-4781(96)00152-2
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hamley IW, 2011, SOFT MATTER, V7, P4122, DOI 10.1039/c0sm01218a
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kiick KL, 2008, SOFT MATTER, V4, P29, DOI 10.1039/b711319f
   Lu HD, 2012, BIOMATERIALS, V33, P2145, DOI 10.1016/j.biomaterials.2011.11.076
   Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Newlon MG, 1999, NAT STRUCT BIOL, V6, P222
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Rajagopal K, 2009, BIOMACROMOLECULES, V10, P2619, DOI 10.1021/bm900544e
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rughani RV, 2009, BIOMACROMOLECULES, V10, P1295, DOI 10.1021/bm900113z
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Teles H, 2010, SOFT MATTER, V6, P4681, DOI 10.1039/c0sm00175a
   Tomatsu I, 2011, ADV DRUG DELIVER REV, V63, P1257, DOI 10.1016/j.addr.2011.06.009
   Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099
   Wheeldon IR, 2007, BIOMACROMOLECULES, V8, P2990, DOI 10.1021/bm700858p
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
NR 33
TC 43
Z9 45
U1 5
U2 97
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUL
PY 2013
VL 2
IS 7
BP 1028
EP 1036
DI 10.1002/adhm.201200343
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 267VX
UT WOS:000328127500014
PM 23299998
DA 2018-10-20
ER

PT J
AU Feigl, B
   Hutmacher, D
AF Feigl, Beatrix
   Hutmacher, Dietmar
TI Eyes on 3D-Current 3D Biomimetic Disease Concept Models and Potential
   Applications in Age-Related Macular Degeneration
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE Three-dimensional cell culture models; 3D disease concepts; age-related
   macular degeneration
ID ENDOTHELIAL GROWTH-FACTORS; CELL-CULTURE MODEL; IN-VITRO; 3-DIMENSIONAL
   COCULTURE; EXTRACELLULAR-MATRIX; COMPOSITE SCAFFOLDS; EPITHELIAL-CELLS;
   GENE-EXPRESSION; ANIMAL-MODELS; TISSUE
AB Three-dimensional cellular models that mimic disease are being increasingly investigated and have opened an exciting new research area into understanding pathomechanisms. The advantage of 3D in vitro disease models is that they allow systematic and in-depth studies of physiological and pathophysiological processes with less costs and ethical concerns that have arisen with animal models. The purpose of the 3D approach is to allow crosstalk between cells and microenvironment, and with cues from the microenvironment, cells can assemble their niche similar to in vivo conditions. The use of 3D models for mimicking disease processes such as cancer, osteoarthritis etc., is only emerging and allows multidisciplinary teams consisting of tissue engineers, biologist biomaterial scientists and clinicians to work closely together. While in vitro systems require rigorous testing before they can be considered as replicates of the in vivo model, major steps have been made, suggesting that they will become powerful tools for studying physiological and pathophysiological processes. This paper aims to summarize some of the existing 3D models and proposes a novel 3D model of the eye structures that are involved in the most common cause of blindness in the Western World, namely age-related macular degeneration (AMD).
C1 [Feigl, Beatrix; Hutmacher, Dietmar] Queensland Univ Technol QUT, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
   [Feigl, Beatrix; Hutmacher, Dietmar] QUT, Sch Biomed Sci, Brisbane, Qld 4059, Australia.
   [Feigl, Beatrix] Queensland Eye Inst, South Brisbane, Qld 4101, Australia.
RP Feigl, B (reprint author), Queensland Univ Technol QUT, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM b.feigl@qut.edu.au; dietmar.hutmacher@qut.edu.au
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134; Feigl,
   Beatrix/0000-0001-7198-7373
CR Ainscough SL, 2009, EXP EYE RES, V89, P629, DOI 10.1016/j.exer.2009.06.005
   Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5
   Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832
   BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X
   Birgersdotter A, 2007, LEUKEMIA LYMPHOMA, V48, P2042, DOI 10.1080/10428190701573190
   Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003
   Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655
   Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]
   Carlson Mark W, 2008, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1909s41
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Chekhonin V. P., 2012, CURR CANC DRUG TARGE, V2012
   Daud MFB, 2012, BIOMATERIALS, V33, P5901, DOI 10.1016/j.biomaterials.2012.05.008
   Domansky K, 2005, P ANN INT IEEE EMBS, P7490, DOI 10.1109/IEMBS.2005.1616244
   Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257
   Eming SA, 2011, EXP DERMATOL, V20, P605, DOI 10.1111/j.1600-0625.2011.01309.x
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Evans CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023434
   Evans HJ, 2003, AM J PHYSIOL-HEART C, V285, pH570, DOI 10.1152/ajpheart.01027.2002
   Feigl B, 2011, CURR MED RES OPIN, V27, P1745, DOI 10.1185/03007995.2011.603301
   Feigl B, 2009, PROG RETIN EYE RES, V28, P63, DOI 10.1016/j.preteyeres.2008.11.004
   Fletcher EL, 2011, PROG MOL BIOL TRANSL, V100, P211, DOI 10.1016/B978-0-12-384878-9.00006-6
   Fournier MV, 2006, J CELL PHYSIOL, V209, P625, DOI 10.1002/jcp.20787
   Gangatirkar P, 2007, NAT PROTOC, V2, P178, DOI 10.1038/nprot.2006.448
   Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI [10.1089/ten.tea.2010.0135, 10.1089/ten.TEA.2010.0135]
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Guillotin B, 2011, TRENDS BIOTECHNOL, V29, P183, DOI 10.1016/j.tibtech.2010.12.008
   Haberstroh K, 2010, J BIOMED MATER RES B, V93B, P520, DOI 10.1002/jbm.b.31611
   Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102
   Hamilton RD, 2007, J ANAT, V211, P707, DOI 10.1111/j.1469-7580.2007.00812.x
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431
   Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108
   Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417
   Khait L, 2008, J CARDIOVASC TRANSL, V1, P71, DOI 10.1007/s12265-007-9005-x
   Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557
   Koeneman KS, 1999, PROSTATE, V39, P246
   Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI [10.1016/S0076-6879(08)021105-3, 10.1016/S0076-6879(08)02005-3]
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Langer R, 1995, Tissue Eng, V1, P151, DOI 10.1089/ten.1995.1.151
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Leite SB, 2012, TOXICOL SCI, V130, P106, DOI 10.1093/toxsci/kfs232
   Leite SB, 2011, TOXICOL IN VITRO, V25, P825, DOI 10.1016/j.tiv.2011.02.002
   Leonard F, 2010, MOL PHARMACEUT, V7, P2103, DOI 10.1021/mp1000795
   Leor J, 2000, CIRCULATION, V102, P56
   Li L., 2011, JOVE-J VIS EXP, V54, P2937, DOI DOI 10.3791/2937
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   MacNeil S, 2011, METHODS MOL BIOL, V695, P129, DOI 10.1007/978-1-60761-984-0_9
   Mithieux SM, 2013, ADV DRUG DELIVER REV, V65, P421, DOI 10.1016/j.addr.2012.06.009
   Mullins RF, 2000, FASEB J, V14, P835
   Oortgiesen DAW, 2012, TISSUE ENG PART C-ME, V18, P81, DOI [10.1089/ten.tec.2011.0367, 10.1089/ten.TEC.2011.0367]
   PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064
   Peyton SR, 2011, BIOTECHNOL BIOENG, V108, P1181, DOI 10.1002/bit.23027
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   Powers MJ, 2002, TISSUE ENG, V8, P499, DOI 10.1089/107632702760184745
   Rethy A, 2010, J GASTROINTEST SURG, V14, P1969, DOI 10.1007/s11605-010-1283-y
   Rice J, 2012, NATURE, V484, pS9, DOI 10.1038/nature11102
   Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707
   SARKS JP, 1994, EYE, V8, P269, DOI 10.1038/eye.1994.57
   Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0
   Schmidt-Erfurth U, 2010, DEV OPHTHALMOL, V46, P21, DOI 10.1159/000320007
   Schumann Detlef, 2007, V140, P101
   Shadforth AMA, 2012, BIOMATERIALS, V33, P4110, DOI 10.1016/j.biomaterials.2012.02.040
   Singer MA, 2012, OPHTHALMOLOGY, V119, P1175, DOI 10.1016/j.ophtha.2011.12.016
   Strunnikova N, 2004, INVEST OPHTH VIS SCI, V45, P3767, DOI 10.1167/iovs.04-0311
   Subramanian B, 2012, BIOMATERIALS, V33, P8383, DOI 10.1016/j.biomaterials.2012.08.020
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Taylor DA, 2009, CURR OPIN BIOTECH, V20, P598, DOI 10.1016/j.copbio.2009.10.016
   Tremolada G, 2012, EXP DIABETES RES, DOI 10.1155/2012/728325
   Troutbeck R, 2012, CLIN EXP OPHTHALMOL, V40, P18, DOI 10.1111/j.1442-9071.2011.02581.x
   Vahidnezhad Hassan, 2009, Iranian Biomedical Journal, V13, P191
   Varley CL, 2011, METHODS MOL BIOL, V695, P197, DOI 10.1007/978-1-60761-984-0_13
   Wang RX, 2005, SEMIN CANCER BIOL, V15, P353, DOI 10.1016/j.semcancer.2005.05.005
   Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3
   Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5
   Wong C, 2012, JOVE-J VIS EXP, DOI 10.3791/4218
   Xu MG, 2010, BIOMATERIALS, V31, P3868, DOI 10.1016/j.biomaterials.2010.01.111
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yates C, 2007, ADV CANCER RES, V97, P225, DOI 10.1016/S0065-230X(06)97010-9
   Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003
   Zhau HE, 1997, IN VITRO CELL DEV-AN, V33, P375
   2012, NATURE, V483, P373
NR 88
TC 6
Z9 7
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUL
PY 2013
VL 2
IS 7
BP 1056
EP 1062
DI 10.1002/adhm.201200445
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 267VX
UT WOS:000328127500017
PM 24000403
DA 2018-10-20
ER

PT J
AU Kourtzelis, I
   Rafail, S
   DeAngelis, RA
   Foukas, PG
   Ricklin, D
   Lambris, JD
AF Kourtzelis, Ioannis
   Rafail, Stavros
   DeAngelis, Robert A.
   Foukas, Periklis G.
   Ricklin, Daniel
   Lambris, John D.
TI Inhibition of biomaterial-induced complement activation attenuates the
   inflammatory host response to implantation
SO FASEB JOURNAL
LA English
DT Article
DE C5a anaphylatoxin; immune cells; compstatin; C3; polypropylene
ID FOREIGN-BODY RESPONSE; C5A; HEMODIALYSIS; MEMBRANES; IMMUNE; MODEL;
   BIOCOMPATIBILITY; COMPSTATIN; NEUTROPHIL; PROTEINS
AB Although complement is a known contributor to biomaterial-induced complications, pathological implications and therapeutic options remain to be explored. Here we investigated the involvement of complement in the inflammatory response to polypropylene meshes commonly used for hernia repair. In vitro assays revealed deposition of complement activation fragments on the mesh after incubation in plasma. Moreover, significant mesh-induced complement and granulocyte activation was observed in plasma and leukocyte preparations, respectively. Pretreatment of plasma with the complement inhibitor compstatin reduced opsonization >2-fold, and compstatin and a C5a receptor antagonist (C5aRa) impaired granulocyte activation by 50 and 67%, respectively. We established a clinically relevant mouse model of implantation and could confirm deposition of C3 activation fragments on mesh implants in vivo using immunofluorescence. In meshes extracted after subcutaneous or peritoneal implantation, the amount of immune cell infiltrate in mice deficient in key complement components (C3, C5aR), or treated with C5aRa, was approximately half of that observed in wild-type littermates or mice treated with inactive C5aRa, respectively. Our data suggest that implantation of a widely used surgical mesh triggers the formation of an inflammatory cell microenvironment at the implant site through complement activation, and indicates a path for the therapeutic modulation of implant-related complications.Kourtzelis, I., Rafail, S., DeAngelis, R. A., Foukas, P. G., Ricklin, D., Lambris, J. D. Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation.
C1 [Kourtzelis, Ioannis; Rafail, Stavros; DeAngelis, Robert A.; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Foukas, Periklis G.] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Pathol 2, GR-11527 Athens, Greece.
RP Lambris, JD (reprint author), Univ Penn, Dept Pathol & Lab Med, 422 Curie Blvd, Philadelphia, PA 19104 USA.
EM lambris@upenn.edu
RI Kourtzelis, Ioannis/G-1767-2012
OI Kourtzelis, Ioannis/0000-0002-7292-5745; Lambris,
   John/0000-0002-9370-5776
FU U.S. National Institutes of Health [AI068730, AI030040, EY020633,
   GM097747, DE021685, AI097805]
FX This work was supported by grants from the U.S. National Institutes of
   Health: AI068730, AI030040, EY020633, GM097747, and DE021685 (J.D.L.)
   and AI097805 (D. R.). J.D.L. and D. R. are the inventors of patents
   describing compstatin analogs and their clinical use. J.D.L. is the
   founder of Amyndas Pharmaceuticals, which develops complement-targeted
   therapeutics. The authors thank Dr. Stergios Rafail (General Regional
   Hospital George Papanikolaou, Thessaloniki, Greece) for providing the
   mesh polypropylene biomaterials, Dr. Hongchang Qu (University of
   Pennsylvania, Philadelphia, PA, USA) for synthesis of complement
   inhibitors, and Dr. Deborah McClellan for her help in editing the
   manuscript. D. R. and J.D.L. shared the supervision of this work.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Asarias JR, 2011, J INVEST SURG, V24, P87, DOI 10.3109/08941939.2010.548904
   BOHLER J, 1991, AM J NEPHROL, V11, P479, DOI 10.1159/000168363
   Bray BL, 2003, NAT REV DRUG DISCOV, V2, P587, DOI 10.1038/nrd1133
   Cazander G, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/534291
   de Vroege R, 1997, PERFUSION-UK, V12, P369, DOI 10.1177/026765919701200605
   DeAngelis RA, 2012, IMMUNOBIOLOGY, V217, P1097, DOI 10.1016/j.imbio.2012.07.012
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Engberg AE, 2011, J BIOMED MATER RES A, V97A, P74, DOI 10.1002/jbm.a.33030
   Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594
   Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Hussain MA, 1998, J BIOMATER APPL, V12, P300, DOI 10.1177/088532829801200403
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051
   Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Mackenzie PJ, 2007, CAN J OPHTHALMOL, V42, P227, DOI 10.3129/canjophthalmol.i07-032
   Manthey HD, 2011, FASEB J, V25, P2447, DOI 10.1096/fj.10-174284
   Mares J, 2009, KIDNEY INT, V76, P404, DOI 10.1038/ki.2009.138
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   MCLEOD BC, 1983, TRANSFUSION, V23, P143, DOI 10.1046/j.1537-2995.1983.23283172853.x
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Nielsen EW, 2007, MOL IMMUNOL, V44, P1819, DOI 10.1016/j.molimm.2006.10.003
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Nilsson UR, 2001, MOL IMMUNOL, V38, P151, DOI 10.1016/S0161-5890(01)00039-6
   Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P381, DOI 10.1002/jbm.a.30907
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Qu HC, 2013, IMMUNOBIOLOGY, V218, P496, DOI 10.1016/j.imbio.2012.06.003
   Qu HC, 2011, MOL IMMUNOL, V48, P481, DOI 10.1016/j.molimm.2010.10.004
   Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20
   Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Rosch R, 2003, EUR SURG RES, V35, P161, DOI 10.1159/000070045
   Sahu A, 1996, J IMMUNOL, V157, P884
   Schachtrupp A, 2003, BRIT J SURG, V90, P114, DOI 10.1002/bjs.4023
   Schneider R L, 1987, Quintessence Dent Technol, V11, P93
   Sonmez K, 2009, B-ENT, V5, P149
   Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374
   Thomas SN, 2011, BIOMATERIALS, V32, P2194, DOI 10.1016/j.biomaterials.2010.11.037
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
NR 50
TC 19
Z9 20
U1 2
U2 20
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JUL
PY 2013
VL 27
IS 7
BP 2768
EP 2776
DI 10.1096/fj.12-225888
PG 9
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 277TA
UT WOS:000328841000025
PM 23558338
OA Green Published
DA 2018-10-20
ER

PT J
AU Saghiri, MA
   Garcia-Godoy, F
   Asatourian, A
   Lotfi, M
   Banava, S
   Khezri-Boukani, K
AF Saghiri, Mohammad-Ali
   Garcia-Godoy, Franklin
   Asatourian, Armen
   Lotfi, Mehrdad
   Banava, Sepideh
   Khezri-Boukani, Kaveh
TI Effect of pH on compressive strength of some modification of mineral
   trioxide aggregate
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Compressive strength; mineral trioxide aggregate; Nano
ID END FILLING MATERIAL; OUT BOND STRENGTH; PORTLAND-CEMENT; SETTING
   ACCELERATOR; SURFACE HARDNESS; ALKALINE PH; PROROOT MTA; MICROSTRUCTURE;
   BIOAGGREGATE
AB Objectives: Recently, it was shown that NanoMTA improved the setting time and promoted a better hydration process which prevents washout and the dislodgment of this novel biomaterial in comparison with WTMA. This study analyzed the compressive strength of ProRoot WMTA (Dentsply), a NanoWMTA (Kamal Asgar Research Center), and Bioaggregate (Innovative Bioceramix) after its exposure to a range of environmental pH conditions during hydration.
   Study Design: After mixing the cements under aseptic condition and based on the manufacturers' recommendations, the cements were condensed with moderate force using plugger into 9 x 6 mm split molds. Each type of cement was then randomly divided into three groups (n=10). Specimens were exposed to environments with pH values of 4.4, 7.4, or 10.4 for 3 days. Cement pellets were compressed by using an Instron testing machine. Values were recorded and compared. Data were analyzed by using one-way analysis of variance and a post hoc Tukey's test.
   Results: After 3 days, the samples were solid when probed with an explorer before removing them from the molds. The greatest mean compressive strength 133.19 +/- 11.14 MPa was observed after exposure to a pH value of 10.4 for NanoWMTA. The values decreased to 111.41 +/- 8.26 MPa after exposure to a pH value of 4.4. Increasing of pH had a significant effect on the compressive strength of the groups (p<0.001). The mean compressive strength for the NanoWMTA was statistically higher than for ProRoot WMTA and Bioaggregate (p<0.001). Moreover, increasing of pH values had a significant effect on compressive strength of the experimental groups (p<0.001).
   Conclusion: The compressive strength of NanoWMTA was significantly higher than WMTA and Bioaggregate; the more acidic the environmental pH, the lower was the compressive strength.
C1 [Saghiri, Mohammad-Ali] Azad Univ, Tehran Branch, Sch Dent, Dept Dent Mat, Tehran, Iran.
   [Garcia-Godoy, Franklin] Univ Tennessee, Ctr Hlth Sci, Coll Dent, Biosci Res Ctr, Memphis, TN 38163 USA.
   [Lotfi, Mehrdad] Tabriz Univ Med Sci, Fac Dent, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran.
   [Lotfi, Mehrdad] Tabriz Univ Med Sci, Fac Dent, Dept Endodont, Tabriz, Iran.
   [Banava, Sepideh] Islamic Azad Univ, Dept Dent Mat, Tehran Branch, Tehran, Iran.
   [Khezri-Boukani, Kaveh] Islamic Azad Univ, Tehran, Iran.
RP Banava, S (reprint author), Islamic Azad Univ, Dept Dent Mat, Tehran Branch, Tehran, Iran.
EM sbanava@gmail.com
RI Lotfi, Mehrdad/F-6687-2017
OI Lotfi, Mehrdad/0000-0002-4158-1417
CR Aminoshariae A, 2003, J ENDODONT, V29, P679, DOI 10.1097/00004770-200310000-00017
   Asgary S, 2010, ODONTOLOGY, V98, P126, DOI 10.1007/s10266-010-0127-2
   Ber BS, 2007, J ENDODONT, V33, P1231, DOI 10.1016/j.joen.2007.06.012
   Bortoluzzi EA, 2006, J ENDODONT, V32, P1194, DOI 10.1016/j.joen.2006.07.018
   Boutsioukis C, 2008, J ENDODONT, V34, P1239, DOI 10.1016/j.joen.2008.07.018
   Camilleri J, 2010, INT ENDOD J, V43, P231, DOI 10.1111/j.1365-2591.2009.01670.x
   Coomaraswamy KS, 2007, J ENDODONT, V33, P295, DOI 10.1016/j.joen.2006.11.018
   De-Deus G, 2009, J ENDODONT, V35, P1387, DOI 10.1016/j.joen.2009.06.022
   EFTIMIADI C, 1987, J INFECTION, V14, P43, DOI 10.1016/S0163-4453(87)90808-5
   Hashem AAR, 2012, J ENDODONT, V38, P245, DOI 10.1016/j.joen.2011.09.013
   Huang TH, 2008, J ENDODONT, V34, P590, DOI 10.1016/j.joen.2008.02.002
   *INTER ORGAN STAND, 2001, 6876 ISO BRIT STAND
   Kogan P, 2006, J ENDODONT, V32, P569, DOI 10.1016/j.joen.2005.08.006
   Komabayashi T, 2008, J ENDODONT, V34, P94, DOI 10.1016/j.joen.2007.10.013
   Leal F, 2011, INT ENDOD J, V44, P662, DOI 10.1111/j.1365-2591.2011.01871.x
   Lee YL, 2004, BIOMATERIALS, V25, P787, DOI 10.1016/S0142-9612(03)00591-X
   MALAMED S, 1990, HDB LOCAL ANESTHETIC, P1
   Namazikhah MS, 2008, INT ENDOD J, V41, P108
   Nandini S, 2010, J ENDODONT, V36, P135, DOI 10.1016/j.joen.2009.09.005
   Nekoofar MH, 2009, INT ENDOD J, V42, P534, DOI 10.1111/j.1365-2591.2009.01550.x
   Park JW, 2010, ORAL SURG ORAL MED O, V109, P155, DOI 10.1016/j.tripleo.2009.08.039
   Roberts HW, 2008, DENT MATER, V24, P149, DOI 10.1016/j.dental.2007.04.007
   Saghiri MA, 2012, INT ENDOD J, V45, P979, DOI 10.1111/j.1365-2591.2012.02056.x
   SAGHIRI MA, 2012, Patent No. 13211880
   SAGHIRI MA, 2012, DENT TRAUMATOL
   Saghiri MA, 2008, J ENDODONT, V34, P1226, DOI 10.1016/j.joen.2008.07.017
   Saghiri MA, 2012, ACTA ODONTOL SCAND, V70, P78, DOI 10.3109/00016357.2011.597777
   Saghiri MA, 2010, J ENDODONT, V36, P1856, DOI 10.1016/j.joen.2010.08.022
   Saghiri MA, 2009, J ENDODONT, V35, P706, DOI 10.1016/j.joen.2009.01.017
   Shie MY, 2009, J ENDODONT, V35, P98, DOI 10.1016/j.joen.2008.09.015
   Shokouhinejad N, 2010, J ENDODONT, V36, P871, DOI 10.1016/j.joen.2009.12.025
   Skibsted J, 2008, CEMENT CONCRETE RES, V38, P205, DOI 10.1016/j.cemconres.2007.09.010
   Tennis PD, 2000, CEMENT CONCRETE RES, V30, P855, DOI 10.1016/S0008-8846(00)00257-X
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010
   Tronstad L, 1981, J Endod, V7, P17, DOI 10.1016/S0099-2399(81)80262-2
   Watts JD, 2007, J ENDODONT, V33, P970, DOI 10.1016/j.joen.2007.01.024
   Zarrabi MH, 2010, J ENDODONT, V36, P1778, DOI 10.1016/j.joen.2010.08.024
   Zhang H, 2009, J ENDODONT, V35, P221, DOI 10.1016/j.joen.2008.11.001
NR 39
TC 14
Z9 15
U1 0
U2 5
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-6946
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD JUL
PY 2013
VL 18
IS 4
BP E714
EP E720
DI 10.4317/medoral.18922
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 264EF
UT WOS:000327859100024
PM 23722137
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Scotti, C
   Hirschmann, MT
   Antinolfi, P
   Martin, I
   Peretti, GM
AF Scotti, Celeste
   Hirschmann, Michael T.
   Antinolfi, Pierluigi
   Martin, Ivan
   Peretti, Giuseppe M.
TI MENISCUS REPAIR AND REGENERATION: REVIEW ON CURRENT METHODS AND RESEARCH
   POTENTIAL
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Meniscus; meniscal tear; tissue engineering; scaffold; bioreactor
ID MESENCHYMAL STEM-CELLS; KNEE-JOINT MENISCUS; HUMAN ARTICULAR
   CHONDROCYTES; TISSUE ENGINEERED MENISCUS; SMALL-INTESTINAL SUBMUCOSA;
   HUMAN SYNOVIAL-MEMBRANE; H ARTIFICIAL MENISCUS; SMOOTH-MUSCLE ACTIN;
   HUMAN BONE-MARROW; IN-VIVO
AB Meniscus regeneration is an unsolved clinical challenge. Despite the wide acceptance of the degenerative consequences of meniscectomy, no surgical procedure has succeeded to date in regenerating a functional and long-lasting meniscal fibrocartilage. Research proposed a number of experimental approaches encompassing all the typical strategies of regenerative medicine: cell-free scaffolds, gene therapy, intra-articular delivery of progenitor cells, biological glues for enhanced bonding of reparable tears, partial and total tissue engineered meniscus replacement. None of these approaches has been completely successful and can be considered suitable for all patients, as meniscal tears require specific and patient-related treatments depending on the size and type of lesion. Recent advances in cell biology, biomaterial science and bioengineering (e.g., bioreactors) have now the potential to drive meniscus regeneration into a series of clinically relevant strategies. In this tutorial paper, the clinical need for meniscus regeneration strategies will be explained, and past and current experimental studies on meniscus regeneration will be reported.
C1 [Scotti, Celeste; Peretti, Giuseppe M.] IRCCS, Ist Ortoped Galcazzi, Milan, Italy.
   [Hirschmann, Michael T.] Kantonsspital Bruderholz, Dept Orthopaed Surg & Traumatol, Bruderholz, Switzerland.
   [Antinolfi, Pierluigi] Univ Perugia, Osped S Maria Misericordia, I-06100 Perugia, Italy.
   [Martin, Ivan] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.
   [Martin, Ivan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Peretti, Giuseppe M.] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.
RP Martin, I (reprint author), Univ Basel Hosp, Inst Surg Res & Hosp Management, Hebelstr 20, CH-4031 Basel, Switzerland.
EM ivan.martin@usb.ch; gperetti@iol.it
RI Peretti, Giuseppe/K-6358-2016
OI Peretti, Giuseppe/0000-0001-9341-7187
CR Adams M. E., 1992, KNEE MENISCUS BASIC, P15
   AHMED AM, 1983, J BIOMECH ENG-T ASME, V105, P216, DOI 10.1115/1.3138409
   ALLEN PR, 1984, J BONE JOINT SURG BR, V66, P666
   Anderson DEJ, 2009, ARCH ORAL BIOL, V54, P138, DOI 10.1016/j.archoralbio.2008.09.018
   Angele P, 2008, J BIOMED MATER RES A, V85A, P445, DOI 10.1002/jbm.a.31480
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   APPEL H, 1970, ACTA ORTHOP SCAND, P1
   ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205
   ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305
   Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS244
   Arnoczky SP, 1988, INJURY REPAIR MUSCUL, P487
   Arnold MP, 2012, KNEE SURG SPORT TR A, V20, P195, DOI 10.1007/s00167-011-1733-4
   Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291
   Baker BM, 2009, OSTEOARTHR CARTILAGE, V17, P336, DOI 10.1016/j.joca.2008.08.001
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Baker BM, 2010, BIOMATERIALS, V31, P6190, DOI 10.1016/j.biomaterials.2010.04.036
   Balint E, 2012, J BIOMED MATER RES A, V100A, P195, DOI 10.1002/jbm.a.33260
   Ballyns JJ, 2008, TISSUE ENG PT A, V14, P1195, DOI 10.1089/ten.tea.2007.0186
   Ballyns JJ, 2010, BIOMATERIALS, V31, P6756, DOI 10.1016/j.biomaterials.2010.05.039
   BARBER FA, 1994, ARTHROSCOPY, V10, P206, DOI 10.1016/S0749-8063(05)80095-7
   BERJON JJ, 1991, J TRAUMA, V31, P342, DOI 10.1097/00005373-199103000-00006
   Bhargava MM, 1999, AM J SPORT MED, V27, P636, DOI 10.1177/03635465990270051601
   Bland Sutton J, 1987, LIGAMENTS THEIR NATU, P32
   Bodin A, 2007, J TISSUE ENG REGEN M, V1, P406, DOI 10.1002/term.51
   Bruns J, 1998, J BONE JOINT SURG BR, V80B, P918, DOI 10.1302/0301-620X.80B5.8023
   BUJIA J, 1994, ACTA OTO-LARYNGOL, V114, P75, DOI 10.3109/00016489409126020
   Bulgheroni P, 2010, KNEE, V17, P224, DOI 10.1016/j.knee.2009.08.011
   Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X
   Candrian C, 2008, ARTHRITIS RHEUM, V58, P197, DOI 10.1002/art.23155
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008
   Monllau JC, 2011, ARTHROSCOPY, V27, DOI 10.1016/j.arthro.2011.02.018
   Chevrier A, 2009, J ORTHOP RES, V27, P1197, DOI 10.1002/jor.20869
   Chiari C, 2006, OSTEOARTHR CARTILAGE, V14, P1056, DOI 10.1016/j.joca.2006.04.007
   CLARK CR, 1983, J BONE JOINT SURG AM, V65, P538, DOI 10.2106/00004623-198365040-00018
   Cole Brian J, 2003, Instr Course Lect, V52, P383
   COLLIER S, 1995, OSTEOARTHR CARTILAGE, V3, P127, DOI 10.1016/S1063-4584(05)80045-7
   Connelly JT, 2010, TISSUE ENG PT A, V16, P1913, DOI [10.1089/ten.tea.2009.0561, 10.1089/ten.TEA.2009.0561]
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   Cook JL, 2006, AM J SPORT MED, V34, P32, DOI 10.1177/0363546505278702
   COOPER DE, 1990, CLIN SPORT MED, V9, P589
   COOPER DE, 1991, CLIN SPORT MED, V10, P529
   Cucchiarini M, 2009, GENE THER, V16, P1363, DOI 10.1038/gt.2009.91
   Daniel R, 2008, HUM GENE THER, V19, P557, DOI 10.1089/hum.2007.148
   De Bari C, 2004, ARTHRITIS RHEUM-US, V50, P142, DOI 10.1002/art.11450
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   de Mulder ELW, 2013, J BIOMATER APPL, V27, P617, DOI 10.1177/0885328211417317
   DEHAVEN KE, 1985, CLIN SPORT MED, V4, P267
   DEHAVEN KE, 1990, CLIN ORTHOP RELAT R, P49
   Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099
   Deponti D, 2015, J TISSUE ENG REGEN M, V9, P512, DOI 10.1002/term.1760
   Dye SF, 1996, CLIN ORTHOP RELAT R, P10
   Efe T, 2012, KNEE SURG SPORT TR A, V20, P1822, DOI 10.1007/s00167-011-1779-3
   ElAttar M, 2011, KNEE SURG SPORT TR A, V19, P147, DOI 10.1007/s00167-010-1351-6
   Evans CH, 1999, CLIN ORTHOP RELAT R, pS410
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GHOSH P, 1987, CLIN ORTHOP RELAT R, P52
   GHOSH P, 1990, CLIN ORTHOP RELAT R, P101
   Goto H, 2000, OSTEOARTHR CARTILAGE, V8, P266, DOI 10.1053/joca.1999.0300
   Goto H, 1999, J BONE JOINT SURG AM, V81A, P918, DOI 10.2106/00004623-199907000-00003
   Gunja NJ, 2010, J BIOMED MATER RES A, V92A, P896, DOI 10.1002/jbm.a.32451
   Han SB, 2010, ARTHROSCOPY, V26, P1326, DOI 10.1016/j.arthro.2010.01.032
   Hannink G, 2011, KNEE SURG SPORT TR A, V19, P441, DOI 10.1007/s00167-010-1244-8
   Harston A, 2012, KNEE SURG SPORT TR A, V20, P135, DOI 10.1007/s00167-011-1579-9
   Heijkants RGJC, 2005, BIOMATERIALS, V26, P4219, DOI 10.1016/j.biomaterials.2004.11.005
   Heijkants RGJC, 2004, J MATER SCI-MATER M, V15, P423, DOI 10.1023/B:JMSM.0000021114.39595.1e
   Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664
   Hidaka C, 2002, TISSUE ENG, V8, P93, DOI 10.1089/107632702753503090
   Hirschmann MT, 2009, THE MENISCUS, P241
   Hoben GA, 2008, BIOTECHNOL BIOENG, V100, P587, DOI 10.1002/bit.21768
   Hoben GM, 2008, STEM CELLS, V26, P422, DOI 10.1634/stemcells.2007-0641
   HOCH D H, 1983, Journal of Orthopaedic Research, V1, P4, DOI 10.1002/jor.1100010102
   Hoffelner T, 2011, SKELETAL RADIOL, V40, P181, DOI 10.1007/s00256-010-0965-6
   Hommen JP, 2007, ARTHROSCOPY, V23, P388, DOI 10.1016/j.arthro.2006.11.032
   Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616
   Huckell J, 1965, CAN J SURG, V8, P254
   Huey DJ, 2011, BIOMATERIALS, V32, P2052, DOI 10.1016/j.biomaterials.2010.11.041
   Hyde G, 2008, J ANAT, V213, P531, DOI 10.1111/j.1469-7580.2008.00966.x
   JACKSON DW, 1993, AM J SPORT MED, V21, P540, DOI 10.1177/036354659302100411
   Jackson DW, 1992, ALLOGRAFTS ORTHOPAED, P197
   JACKSON JP, 1968, BRIT MED J, V2, P525, DOI 10.1136/bmj.2.5604.525
   Jacobi M, 2009, THE MENISCUS, P129
   Jiang D, 2012, ARTHROSCOPY, V28, P1147, DOI 10.1016/j.arthro.2012.01.001
   Johns DE, 2008, CELL TISSUE RES, V333, P439, DOI 10.1007/s00441-008-0652-2
   Johnson DL, 1999, CLIN SPORT MED, V18, P93, DOI 10.1016/S0278-5919(05)70132-0
   Johnson TS, 2004, TISSUE ENG, V10, P1308, DOI 10.1089/1076327042500445
   Kang SW, 2006, J BIOMED MATER RES A, V77A, P659, DOI 10.1002/jbm.a.30579
   Katabi M, 2009, THE MENISCUS, P191
   Kelly BT, 2007, AM J SPORT MED, V35, P43, DOI 10.1177/036354650629848
   Kim JM, 2012, AM J SPORT MED, V40, P1027, DOI 10.1177/0363546512437842
   King D, 1936, J BONE JOINT SURG, V18, P1069
   Klompmaker Jan, 1993, Clinical Materials, V14, P1, DOI 10.1016/0267-6605(93)90041-5
   Koay EJ, 2009, TISSUE ENG PT A, V15, P2249, DOI 10.1089/ten.tea.2008.0320
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kon E, 2008, TISSUE ENG PT A, V14, P1067, DOI 10.1089/ten.tea.2007.0193
   Kon E, 2012, TISSUE ENG PT A, V18, P1573, DOI [10.1089/ten.tea.2011.0572, 10.1089/ten.TEA.2011.0572]
   KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003
   Lebourg M, 2008, J MATER SCI-MATER M, V19, P2047, DOI 10.1007/s10856-007-3282-4
   Lee YHD, 2012, KNEE SURG SPORT TR A, V20, P904, DOI 10.1007/s00167-011-1647-1
   LEVY IM, 1989, J BONE JOINT SURG AM, V71A, P401, DOI 10.2106/00004623-198971030-00014
   Lietman SA, 2003, ORTHOPEDICS, V26, P799
   Longo U.G., 2012, STEM CELLS INT, V2012
   Lubowitz JH, 2007, KNEE SURG SPORT TR A, V15, P476, DOI 10.1007/s00167-006-0216-5
   LUTFI AM, 1975, J BONE JOINT SURG BR, V57, P525
   Madry H, 2004, AM J SPORT MED, V32, P1860, DOI 10.1177/0363546504265189
   Madry H, 2003, HUM GENE THER, V14, P393, DOI 10.1089/104303403321208998
   Majewski M, 2009, ACTA ORTHOP BELG, V75, P354
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Mandal BB, 2011, TISSUE ENG PT A, V17, P2749, DOI [10.1089/ten.tea.2011.0031, 10.1089/ten.TEA.2011.0031]
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Marsano A, 2007, OSTEOARTHR CARTILAGE, V15, P48, DOI 10.1016/j.joca.2006.06.009
   Marsano A, 2006, BIOMATERIALS, V27, P5927, DOI 10.1016/j.biomaterials.2006.08.020
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Martin I, 2009, TRENDS BIOTECHNOL, V27, P495, DOI 10.1016/j.tibtech.2009.06.002
   Martinek V, 2006, ARCH ORTHOP TRAUM SU, V126, P228, DOI 10.1007/s00402-005-0025-1
   Martinek V, 2002, TISSUE ENG, V8, P107, DOI 10.1089/107632702753503108
   Martinez H, 2012, J BIOMED MATER RES A, V100A, P948, DOI 10.1002/jbm.a.34035
   MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8
   McDevitt CA, 1992, KNEE MENISCUS BASIC, P29
   MCGINTY JB, 1977, J BONE JOINT SURG AM, V59, P763, DOI 10.2106/00004623-197759060-00008
   Mi Z, 2003, ARTHRITIS RES THER, V5, pR132, DOI 10.1186/ar745
   MILACHOWSKI KA, 1989, INT ORTHOP, V13, P1
   Mow VC, 1992, KNEE MENISCUS BASIC, P37
   Mueller SM, 1999, J BIOMED MATER RES, V45, P157, DOI 10.1002/(SICI)1097-4636(19990605)45:3<157::AID-JBM1>3.0.CO;2-B
   Muraglia A, 2000, J CELL SCI, V113, P1161
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Nakata K, 2001, CLIN ORTHOP RELAT R, pS208
   NOBLE J, 1986, CLIN ORTHOP RELAT R, P62
   NORTHMOREBALL MD, 1982, CLIN ORTHOP RELAT R, P34
   OCONNOR BL, 1978, AM J ANAT, V153, P431, DOI 10.1002/aja.1001530306
   OCONNOR BL, 1984, J ANAT, V138, P15
   Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023
   Pangborn CA, 2005, TISSUE ENG, V11, P1141, DOI 10.1089/ten.2005.11.1141
   Peretti GM, 1998, J ORTHOPAED RES, V16, P89, DOI 10.1002/jor.1100160115
   Peretti GM, 1999, TISSUE ENG, V5, P317, DOI 10.1089/ten.1999.5.317
   Peretti GM, 2004, AM J SPORT MED, V32, P146, DOI 10.1177/0095399703258790
   Peretti GM, 2001, J ORTHOPAED RES, V19, P278, DOI 10.1016/S0736-0266(00)90010-X
   Peretti GM, 2008, SPORT SCI HLTH, V3, P47
   Petri M, 2012, KNEE SURG SPORT TR A, V20, P223, DOI 10.1007/s00167-011-1600-3
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pitzalis C, 2007, STEM CELL REPAIR AND, V2, P107
   Pujol N, 2009, THE MENISCUS, P61
   RENSTROM P, 1990, CLIN SPORT MED, V9, P523
   Rodkey WG, 1999, CLIN ORTHOP RELAT R, pS281
   Rodkey WG, 2008, J BONE JOINT SURG AM, V90A, P1413, DOI 10.2106/JBJS.G.00656
   Rouwkema J, 2011, J TISSUE ENG REGEN M, V5, pE164, DOI 10.1002/term.414
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011
   Scordino LE, 2012, CLIN SPORT MED, V31, P91, DOI 10.1016/j.csm.2011.09.001
   Scotti C, 2009, KNEE SURG SPORT TR A, V17, P645, DOI 10.1007/s00167-009-0745-9
   Scotti C, 2012, TISSUE ENG PT A, V18, P362, DOI [10.1089/ten.tea.2011.0234, 10.1089/ten.TEA.2011.0234]
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   Seedhom B. B., 1979, Engineering in Medicine, V8, P220
   Setton LA, 1999, CLIN ORTHOP S, V367S, pS245
   Shaffer B, 2000, AM J SPORT MED, V28, P524, DOI 10.1177/03635465000280041301
   Shelbourne KD, 2003, AM J SPORT MED, V31, P718, DOI 10.1177/03635465030310051401
   Shrive N G, 1978, Clin Orthop Relat Res, P279
   SIEGEL MG, 1993, CLIN SPORT MED, V12, P59
   SOMMERLATH KG, 1991, INT ORTHOP, V15, P347
   Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233
   Steadman JR, 2005, ARTHROSCOPY, V21, P515, DOI 10.1016/j.arthro.2005.01.006
   Steenbrugge F, 2004, KNEE SURG SPORT TR A, V12, P43, DOI 10.1007/s00167-003-0446-8
   Steinert AF, 2007, TISSUE ENG, V13, P2227, DOI 10.1089/ten.2006.0270
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   Tan YB, 2010, TISSUE ENG PT A, V16, P67, DOI [10.1089/ten.tea.2008.0680, 10.1089/ten.TEA.2008.0680]
   Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572
   TOYONAGA T, 1983, CLIN ORTHOP RELAT R, P291
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   van Tienen TG, 2009, CLIN SPORT MED, V28, P143, DOI 10.1016/j.csm.2008.08.003
   Verdonk P, 2009, THE MENISCUS, P45
   Verdonk PCM, 2005, J BONE JOINT SURG AM, V87A, P715, DOI 10.2106/JBJS.C.01344
   Verdonk R, 2009, THE MENISCUS, P389
   Verdonk R, 2007, SPORTS MED ARTHROSC, V15, P121, DOI 10.1097/JSA.0b013e318140002c
   Verdonk R, 2011, AM J SPORT MED, V39, P774, DOI 10.1177/0363546511398040
   VOLOSHIN AS, 1983, J BIOMED ENG, V5, P157, DOI 10.1016/0141-5425(83)90036-5
   Walker P S, 1975, Clin Orthop Relat Res, P184, DOI 10.1097/00003086-197506000-00027
   Walsh CJ, 1999, TISSUE ENG, V5, P327, DOI 10.1089/ten.1999.5.327
   Weinand C, 2006, AM J SPORT MED, V34, P1779, DOI 10.1177/0363546506290666
   Weinand C, 2006, ARCH ORTHOP TRAUM SU, V126, P599, DOI 10.1007/s00402-005-0100-7
   Welsing RTC, 2008, AM J SPORT MED, V36, P1978, DOI 10.1177/0363546508319900
   Wendt D, 2009, ADV MATER, V21, P3352, DOI 10.1002/adma.200802748
   WILSON AS, 1969, ANAT REC, V165, P485, DOI 10.1002/ar.1091650404
   Wirth CJ, 2002, AM J SPORT MED, V30, P174, DOI 10.1177/03635465020300020501
   Wojtys Edward M, 2005, Instr Course Lect, V54, P323
   WOOD DJ, 1990, BIOMATERIALS, V11, P13, DOI 10.1016/0142-9612(90)90045-R
   Yoo JJ, 2011, J BIOMED MATER RES A, V99A, P102, DOI 10.1002/jbm.a.33168
   Zaffagnini S, 2007, KNEE SURG SPORT TR A, V15, P175, DOI 10.1007/s00167-006-0144-4
   Zaffagnini S, 2011, AM J SPORT MED, V39, P977, DOI 10.1177/0363546510391179
   Zaleskas JM, 2001, EXP CELL RES, V270, P21, DOI 10.1006/excr.2001.5325
   Zellner J, 2010, J BIOMED MATER RES A, V94A, P1150, DOI 10.1002/jbm.a.32796
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 200
TC 52
Z9 56
U1 1
U2 29
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2013
VL 26
BP 150
EP 170
DI 10.22203/eCM.v026a11
PG 21
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 232VY
UT WOS:000325523700008
PM 24057873
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Torres, FG
   Commeaux, S
   Troncoso, OP
AF Torres, Fernando G.
   Commeaux, Solene
   Troncoso, Omar P.
TI Starch-based biomaterials for wound-dressing applications
SO STARCH-STARKE
LA English
DT Review
DE Biomaterial; Starch; Wound dressings
ID DRUG-DELIVERY SYSTEMS; TISSUE ENGINEERING SCAFFOLDS; CHRONIC VENOUS
   ULCERS; CADEXOMER-IODINE; RANDOMIZED TRIAL; BIOCOMPOSITE FILMS; POROUS
   STRUCTURES; CHITOSAN; ALGINATE; HYDROGELS
AB Starch has been used as a biomaterial for several applications including tissue engineering scaffolds, substrates for cell seeding, drug delivery systems, bone replacement implants, wound dressings, among others. In this paper, we review the use of starch-based materials for the development of wound dressings. First, we shall cover the basic characteristics of wounds, including a brief discussion of the wound healing process and the different types of dressings available for the treatment of wounds. Then, the general properties of starch as a biomaterial are described with special emphasis on the properties of several modified starches. The different processing routes for the production of starch-based wound dressings are revised in some detail. Starch-based wound dressings under investigation and commercially available products are also reviewed in order to assess the performance of starch as a biomaterial in the healing processes.
C1 [Torres, Fernando G.; Commeaux, Solene; Troncoso, Omar P.] Catholic Univ Peru PUCP, Polymers & Composites Grp, Lima 32, Peru.
   [Commeaux, Solene] Univ Montpellier, Ecole Polytech Univ Montpellier, Montpellier, France.
RP Torres, FG (reprint author), Catholic Univ Peru PUCP, Polymers & Composites Grp, Lima 32, Peru.
EM fgtorres@pucp.edu.pe
RI Troncoso, Omar/G-6469-2013
OI Troncoso, Omar/0000-0001-9621-2435; Torres, Fernando
   G./0000-0002-3123-266X
CR Abdelrahman T, 2011, SURGERY OXFORD, V29, P491
   Adhirajan N, 2009, EUR J PHARM SCI, V36, P235, DOI 10.1016/j.ejps.2008.09.010
   Alves H R N, 2009, J Wound Care, V18, P27
   Arockianathan PM, 2012, CARBOHYD POLYM, V90, P717, DOI 10.1016/j.carbpol.2012.06.003
   Arockianathan PM, 2012, INT J BIOL MACROMOL, V50, P939, DOI 10.1016/j.ijbiomac.2012.02.022
   Aulton M. E., 2007, PHARM SCI DOSAGE FOR, P264
   Barlett R. H., 1981, J TRAUMA, V21, P731
   BeMiller J. N., 1984, STARCH CHEM TECHNOLO
   BeMiller JN, 1997, STARCH-STARKE, V49, P127, DOI 10.1002/star.19970490402
   Bhat SV, 2002, BIOMATERIALS
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Bolton L. L., 1990, DERMATOL NURS, V2, P146
   Bolton LL, 2000, OSTOMY WOUND MANAG, V46, P51
   Brachkova MI, 2011, J HOSP INFECT, V79, P375, DOI 10.1016/j.jhin.2011.09.003
   British Standards BS, 2002, 13761 BS EN
   Bursali EA, 2011, CARBOHYD POLYM, V83, P1377, DOI 10.1016/j.carbpol.2010.09.056
   Castro J, 2005, LAT TRADE, V13, P6
   Chikazu D., 2010, ASIAN J ORAL MAXILLO, V22, P61
   DONALD AM, 1994, REP PROG PHYS, V57, P1081, DOI 10.1088/0034-4885/57/11/001
   El-Hag AA, 2009, CARBOHYD POLYM, V78, P725
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Errede L. A., US Pat., Patent No. [4,373,519, 4373519]
   Falabella AF, 2006, DERMATOL THER, V19, P317, DOI 10.1111/j.1529-8019.2006.00090.x
   Fang Y., 2011, J FUNCT POLYM, V3, P280
   Fwu-Long M, 2001, BIOMATERIALS, V22, P165
   Gallandat Huet R. C. G., 2000, Canadian Journal of Anesthesia, V47, P1207
   GATTI AM, 1994, J MATER SCI-MATER M, V5, P190, DOI 10.1007/BF00121087
   Gustavsin B., 1983, CADEXOMER IODINE
   Hampton S, 1999, Nurs Times, V95, P58
   Hillstrom L, 1988, Acta Chir Scand Suppl, V544, P53
   HOLLOWAY GA, 1989, WESTERN J MED, V151, P35
   HUTCHINSON JJ, 1991, J HOSP INFECT, V17, P83, DOI 10.1016/0195-6701(91)90172-5
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Keller PJ, 2002, INTENS CARE MED, V28, P1379
   Kesler C. C., US Pat, Patent No. [2,516,633, 2516633]
   Kim JO, 2008, INT J PHARMACEUT, V359, P79, DOI 10.1016/j.ijpharm.2008.03.021
   Krasner D., 1993, OSTOMY WOUND MANAG, V39, P68
   Lamme EN, 1998, ARCH DERMATOL RES, V290, P18, DOI 10.1007/s004030050271
   LAUDANSKA H, 1988, J INT MED RES, V16, P428, DOI 10.1177/030006058801600604
   Lawal OS, 2005, INT J BIOL MACROMOL, V35, P71, DOI 10.1016/j.ijbiomac.2004.12.004
   Lin YK, 2009, J BIOACT COMPAT POL, V24, P424, DOI 10.1177/0883911509341161
   Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012
   Lu SY, 2008, BURNS, V34, P623, DOI 10.1016/j.burns.2007.08.020
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Martins A, 2009, J TISSUE ENG REGEN M, V3, P37, DOI 10.1002/term.132
   Meng X, 2010, J MATER SCI-MATER M, V21, P1751, DOI 10.1007/s10856-010-3996-6
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Mo X., 2012, J BIOMED MATER RES A, V94, P326
   MOBERG S, 1983, J AM GERIATR SOC, V31, P462, DOI 10.1111/j.1532-5415.1983.tb05117.x
   Moore Keith, 2006, Int Wound J, V3, P89, DOI 10.1111/j.1742-4801.2006.00212.x
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Nakamatsu J, 2006, BIOMACROMOLECULES, V7, P3345, DOI 10.1021/bm0605311
   ORMISTON MC, 1985, BRIT MED J, V291, P308, DOI 10.1136/bmj.291.6491.308
   Pal K, 2006, TRENDS BIOMATER ARTI, V20, P59, DOI DOI 10.4314/AJBR.V9I1.48769
   Pal K., 2006, AFR J BIOMED RES, V9, P23
   Pang S. C., 2001, CARBOHYD POLYM, V84, P424
   Percival NJ, 2002, SURGERY OXFORD, V20, P114, DOI [10.1383/surg.20.5.114.14626, DOI 10.1383/SURG.20.5.114.14626]
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Purnasai K, 2000, BURNS, V26, P54
   Queen Douglas, 2004, Int Wound J, V1, P59, DOI 10.1111/j.1742-4801.2004.0009.x
   Ramnath V., 2012, INT J PHARM PHARM SC, V4, P414
   Rastogi S, 2009, J ORAL MAXIL SURG, V67, P1600, DOI 10.1016/j.joms.2008.12.020
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Rodrigues A, 2012, CARBOHYD POLYM, V87, P987, DOI 10.1016/j.carbpol.2011.09.044
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Sangseethong K, 2009, STARCH-STARKE, V61, P92, DOI 10.1002/star.200800048
   Santander-Ortega MJ, 2010, J CONTROL RELEASE, V141, P85, DOI 10.1016/j.jconrel.2009.08.012
   Schultz G. S., 2000, ACUTE CHRONIC WOUNDS, P413
   SKOG E, 1983, BRIT J DERMATOL, V109, P77, DOI 10.1111/j.1365-2133.1983.tb03995.x
   Sundberg J, 1997, WOUNDS, V9, P68
   Suortti T, 1998, J CHROMATOGR A, V828, P515, DOI 10.1016/S0021-9673(98)00831-0
   Torres FG, 2011, INT J BIOL MACROMOL, V48, P603, DOI 10.1016/j.ijbiomac.2011.01.026
   Torres FG, 2007, J APPL POLYM SCI, V103, P1332, DOI 10.1002/app.25345
   Uppal R, 2011, J BIOMED MATER RES B, V97B, P20, DOI 10.1002/jbm.b.31776
   Waliszewski KN, 2003, CARBOHYD POLYM, V52, P237, DOI 10.1016/S0144-8617(02)00270-9
   Wang G, 2012, IND CROP PROD, V36, P299, DOI 10.1016/j.indcrop.2011.10.015
   Wang HL, 2011, IRAN POLYM J, V20, P551
   Wang YX, 2012, ACTA HISTOCHEM, V114, P311, DOI 10.1016/j.acthis.2011.06.012
   Wittaya-areekul S, 2006, INT J PHARM, V313, P123, DOI 10.1016/j.ijpharm.2006.01.027
   Woodworth BA, 2010, ORL J OTO-RHINO-LARY, V72, P101, DOI 10.1159/000276877
   Xu SS, 2009, POLYMER, V50, P3762, DOI 10.1016/j.polymer.2009.06.009
   Yuvarani I, 2012, J BIOMATER TISS ENG, V2, P54, DOI 10.1166/jbt.2012.1037
NR 82
TC 12
Z9 12
U1 2
U2 76
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0038-9056
EI 1521-379X
J9 STARCH-STARKE
JI Starch-Starke
PD JUL
PY 2013
VL 65
IS 7-8
SI SI
BP 543
EP 551
DI 10.1002/star.201200259
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA 237RJ
UT WOS:000325887900003
DA 2018-10-20
ER

PT J
AU Ronning, SB
   Pedersen, ME
   Andersen, PV
   Hollung, K
AF Ronning, Sissel Beate
   Pedersen, Mona Elisabeth
   Andersen, Petter Vejle
   Hollung, Kristin
TI The combination of glycosaminoglycans and fibrous proteins improves cell
   proliferation and early differentiation of bovine primary skeletal
   muscle cells
SO DIFFERENTIATION
LA English
DT Article
DE Extracellular matrix; Glycosaminoglycans; Bovine primary skeletal muscle
   cells; Proliferation; Differentiation; Myogenesis
ID EXTRACELLULAR-MATRIX; SATELLITE CELLS; IN-VITRO; SULFATE; LAMININ;
   GROWTH; MYOBLASTS; CULTURES; INSULIN; TISSUE
AB Primary muscle cell model systems from farm animals are widely used to acquire knowledge about muscle development, muscle pathologies, overweight issues and tissue regeneration. The morphological properties of a bovine primary muscle cell model system, in addition to cell proliferation and differentiation features, were characterized using immunocytochemistry, western blotting and real-time PCR. We observed a reorganization of the Golgi complex in differentiated cells. The Golgi complex transformed to a highly fragmented network of small stacks of cisternae positioned throughout the myotubes as well as around the nucleus. Different extracellular matrix (ECM) components were used as surface coatings in order to improve cell culture conditions. Our experiments demonstrated improved proliferation and early differentiation for cells grown on surface coatings containing a mixture of both glycosaminoglycans(GAGs) and fibrous proteins. We suggest that GAGs and fibrous proteins mixed together into a composite biomaterial can mimic a natural ECM, and this could improve myogenesis for in vitro cell cultures. (C) 2013 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.
C1 [Ronning, Sissel Beate; Pedersen, Mona Elisabeth; Andersen, Petter Vejle; Hollung, Kristin] Nofima AS, NO-1431 As, Norway.
RP Hollung, K (reprint author), Nofima AS, Pb 210, NO-1431 As, Norway.
EM kristin.hollung@nofima.no
OI Ronning, Sissel Beate/0000-0002-2255-0172
FU Fund for Research Levy on Agricultural Products in Norway; Norwegian
   Research Council [203697/O99]
FX We thank Grethe Enersen for technical support, Monica G. Tingbo for the
   GAGs preparations and Eva Veiseth-Kent for comments on the manuscript.
   This work was supported by grants from the Fund for Research Levy on
   Agricultural Products in Norway and the Norwegian Research Council
   (203697/O99).
CR Allen RE, 1997, METHOD CELL BIOL, V52, P155, DOI 10.1016/S0091-679X(08)60378-7
   ALLEN RE, 1991, J CELL PHYSIOL, V149, P525, DOI 10.1002/jcp.1041490323
   Boldrin L, 2010, J HISTOCHEM CYTOCHEM, V58, P941, DOI 10.1369/jhc.2010.956201
   Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009
   Capkovic KL, 2008, EXP CELL RES, V314, P1553, DOI 10.1016/j.yexcr.2008.01.021
   Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204
   Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Fthenou E, 2008, J CELL BIOCHEM, V103, P1866, DOI 10.1002/jcb.21570
   Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x
   Gaster M., 2001, ACTA PATHOLOGICA MIC, V109, P728
   Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094
   HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936
   KUHL U, 1986, DEV BIOL, V117, P628, DOI 10.1016/0012-1606(86)90331-3
   Langelaan MLP, 2011, J TISSUE ENG REGEN M, V5, P529, DOI 10.1002/term.345
   Lu ZM, 2001, MOL BIOL CELL, V12, P795, DOI 10.1091/mbc.12.4.795
   Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x
   Martelly I, 2010, MATRIX BIOL, V29, P317, DOI 10.1016/j.matbio.2010.02.002
   McIntyre EA, 2004, J CLIN ENDOCR METAB, V89, P3440, DOI 10.1210/jc.2003-031919
   Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001
   Parthasarathy N, 1998, J BIOL CHEM, V273, P21111, DOI 10.1074/jbc.273.33.21111
   Perruchot MH, 2012, DIFFERENTIATION, V84, P322, DOI 10.1016/j.diff.2012.08.001
   Schaefer D., 2010, CELL TISSUE RES, V339, P237
   Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193
   Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015
   Tingo MG, 2005, COMP BIOCHEM PHYS B, V140, P349, DOI 10.1016/j.cbpc.2004.09.032
   Velleman SG, 2000, COMP BIOCHEM PHYS A, V125, P503, DOI 10.1016/S1095-6433(00)00178-1
   Villena J, 2004, J CELL PHYSIOL, V198, P169, DOI 10.1002/jcp.10422
   Wilschut KJ, 2010, EXP CELL RES, V316, P341, DOI 10.1016/j.yexcr.2009.10.014
   Wu H., 2012, CELL BIOL INT
   Yablonka-Reuveni Z, 2011, STEM CELLS BIOL REG, P173, DOI 10.1007/978-1-61779-021-8_11
   YURCHENCO PD, 1990, J BIOL CHEM, V265, P3981
   Zaal KJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029057
   Zhu WH, 2010, MOL MED REP, V3, P463, DOI 10.3892/mmr_00000281
NR 34
TC 14
Z9 14
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4681
J9 DIFFERENTIATION
JI Differentiation
PD JUL-SEP
PY 2013
VL 86
IS 1-2
BP 13
EP 22
DI 10.1016/j.diff.2013.06.006
PG 10
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 222PY
UT WOS:000324744700002
PM 23933398
DA 2018-10-20
ER

PT J
AU Sun, KN
   Li, YP
   Lu, ZD
   Zhang, L
   Gao, ZH
   Jin, QH
AF Sun, Kening
   Li, Yaping
   Lu, Zhidong
   Zhang, Liang
   Gao, Zhihui
   Jin, Qunhua
TI Suppression of titanium particle-induced TNF-alpha expression and
   apoptosis in human U937 macrophages by siRNA silencing
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE SiRNA; TNF alpha; Titanium; Apoptosis; Aseptic joint loosening
ID WEAR PARTICLES; CHROMIUM IONS; IN-VITRO; PERITONEAL-MACROPHAGES;
   OSTEOLYSIS; COBALT; CELLS; INFLAMMATION; CASPASE-3; MODULATE
AB Aseptic loosening of joint prosthetics is one of the most frequent reasons for the failure of total joint replacement surgeries. A major cause of the aseptic loosening is osteolysis caused by a periprosthetic inflammatory response to wear particles released from implanted prosthetics. Tumor necrosis factor (TNF)-alpha is thought to play a dominant role in wear-induced inflammation. It was shown previously by our group, as well as by other researchers, that macrophages produce abundant TNF-alpha when exposed to particulate titanium (Ti), which is widely used as a biomaterial in arthroplastic surgery. In the present study, we have tested the feasibility of using siRNA as a therapeutic intervention against wear-induced TNF-alpha production. Our data show that transfection of U937 macrophage cells with TNF-alpha siRNA inhibits 77 particle-induced expression of TNF-alpha mRNA and protein by >65%. Moreover, U937 cells transfected with TNF-alpha siRNA were significantly more resistant to Ti particle-induced apoptosis (>60%, p<0.05) and caspase-3 activation (>50%, p<0.05) compared with normal U937 cells. Collectively, our data show that siRNA can be an effective way to inhibit 77 particle-induced TNF-alpha expression and the activation of downstream pathways such as apoptosis in macrophages. These data provide a foundation for future studies to investigate the use of siRNA targeting inflammatory cytokines as a therapeutic modality for the treatment of aseptic loosening of prosthetic materials used in arthroplastic surgery.
C1 [Sun, Kening; Li, Yaping; Lu, Zhidong; Zhang, Liang; Gao, Zhihui; Jin, Qunhua] Ningxia Med Univ, Gen Hosp, Dept Orthoped, Yinchuan, Peoples R China.
RP Jin, QH (reprint author), Ningxia Med Univ, Gen Hosp, Dept Orthoped, Yinchuan, Peoples R China.
EM qunhuajin@yahoo.com
FU Natural Science Foundation of Ningxia, China [NZ11264]
FX This study was supported by the Natural Science Foundation of Ningxia,
   China (NZ11264).
CR Al-Saffar N, 2000, J ORTHOP RES, V18, P800, DOI 10.1002/jor.1100180518
   Catelas I, 2003, BIOMATERIALS, V24, P383, DOI 10.1016/S0142-9612(02)00351-4
   Catelas I, 2001, J MATER SCI-MATER M, V12, P949, DOI 10.1023/A:1012800813662
   Dong L, 2008, J ORTHOP RES, V26, P1114, DOI 10.1002/jor.20607
   Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035
   Howard KA, 2009, MOL THER, V17, P162, DOI 10.1038/mt.2008.220
   Ingham E, 2000, BIOMATERIALS, V21, P1005, DOI 10.1016/S0142-9612(99)00261-6
   Kowalczewski Jacek B, 2006, Chir Narzadow Ruchu Ortop Pol, V71, P25
   Lee SS, 2012, BIOMATERIALS, V33, P4251, DOI 10.1016/j.biomaterials.2012.03.005
   MacQuarrie RA, 2004, J BIOMED MATER RES B, V69B, P104, DOI 10.1002/jbm.b.20031
   Marshall A, 2008, J AM ACAD ORTHOP SUR, V16, pS1, DOI 10.5435/00124635-200800001-00003
   Matthews JB, 2000, BIO-MED MATER ENG, V10, P229
   McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004
   Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10
   Petit A, 2004, BIOMATERIALS, V25, P2013, DOI 10.1016/j.biomaterials.2003.08.040
   Purdue P Edward, 2006, HSS J, V2, P102, DOI 10.1007/s11420-006-9003-6
   Qin CQ, 2011, ARTIF ORGANS, V35, P706, DOI 10.1111/j.1525-1594.2010.01175.x
   Rader CP, 1999, BIOMED TECH, V44, P135, DOI 10.1515/bmte.1999.44.5.135
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   Schwarz EM, 2003, J ORTHOPAED RES, V21, P1049, DOI 10.1016/S0736-0266(03)00093-7
   Taishi P, 2007, BRAIN RES, V1156, P125, DOI 10.1016/j.brainres.2007.04.072
   Tuan RS, 2008, J AM ACAD ORTHOP SUR, V16, pS42, DOI 10.5435/00124635-200800001-00010
   Valles G, 2008, J BIOMED MATER RES A, V84A, P324, DOI 10.1002/jbm.a.31315
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]
NR 25
TC 5
Z9 5
U1 0
U2 10
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2013
VL 36
IS 7
BP 522
EP 527
DI 10.5301/ijao.5000218
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 216KX
UT WOS:000324283400010
PM 23661556
DA 2018-10-20
ER

PT J
AU Sader, MS
   Lewis, K
   Soares, GA
   LeGeros, RZ
AF Sader, Marcia S.
   Lewis, Kanthi
   Soares, Gloria A.
   LeGeros, Racquel Z.
TI Simultaneous Incorporation of Magnesium and Carbonate in Apatite: Effect
   on Physico-chemical Properties
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE calcium-deficient apatite; ionic substitutions; crystallinity; bone
   graft
ID SUBSTITUTED HYDROXYAPATITE; BEHAVIOR
AB Synthetic apatites are widely used both in the dental and the orthopaedic fields due to their similarity in composition with the inorganic phase of hard tissues. Biologic apatites are not pure hydroxyapatite (HA), but are calcium-deficient apatites with magnesium and carbonate as minor but important substituents. The aim of the present study was to produce a more soluble biomaterial through the simultaneous substitution of magnesium and carbonate in the apatite structure to accelerate the degradation time in the body. The physico-chemical and dissolution properties of unsintered magnesium and carbonate-substituted apatite (MCAp) with similar Mg/Ca molar ratio (0.03) and varying C/P molar ratio were evaluated. The resultant powders were characterised using several techniques, such as FTIR, TGA, XRD, ICP and SEM, while the release of calcium ions in a pH 6 solution was monitored using a Ca-ion selective electrode. The results showed a decrease of crystallite size and an increase in the release of calcium to the medium as the carbonate content in the samples increased.
C1 [Sader, Marcia S.; Soares, Gloria A.] Univ Fed Rio de Janeiro, Program Met & Mat Engn PEMM, Alberto Luiz Coimbra Inst Grad Studies & Res Engn, Rio De Janeiro, RJ, Brazil.
   [Lewis, Kanthi; LeGeros, Racquel Z.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA.
RP Sader, MS (reprint author), Univ Fed Rio de Janeiro, Program Met & Mat Engn PEMM, Alberto Luiz Coimbra Inst Grad Studies & Res Engn, Rio De Janeiro, RJ, Brazil.
EM msader@metalmat.ufrj.br
FU NIAMS/NIH (LeGeros) [AR056208]; FAPERJ; CNPq; CAPES
FX This study was supported by research grant no. AR056208 from the
   NIAMS/NIH (LeGeros) and by FAPERJ, CNPq and CAPES (Dr. Soares). The
   authors are grateful for the professional collaboration of Dr. Dindo
   Mijares of NYU College of Dentistry.
CR Araujo JC, 2009, MATER CHEM PHYS, V118, P337, DOI 10.1016/j.matchemphys.2009.07.064
   BONEL G, 1972, ANN CHIM FRANCE, V7, P65
   Dorozhkin Sergey V, 2011, Biomatter, V1, P121, DOI 10.4161/biom.18790
   ELLIOTT JC, 1985, CALCIFIED TISSUE INT, V37, P372, DOI 10.1007/BF02553704
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Inoue M, 2004, J BIOMED MATER RES A, V70A, P585, DOI 10.1002/jbm.a.30116
   Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009
   Klug H. P., 1974, XRAY DIFFRACTION PRO
   Landi E, 2006, J EUR CERAM SOC, V26, P2593, DOI 10.1016/j.jeurceramsoc.2005.06.040
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   LeGeros R Z, 1996, Adv Dent Res, V10, P225
   LeGeros R Z, 1995, Connect Tissue Res, V33, P203, DOI 10.3109/03008209509017003
   Legeros R. Z., 1991, MONOGRAPHS ORAL SCI, V15, P37
   LeGeros RZ, 2009, ADV BIOMATERIALS FUN, DOI DOI 10.1002/9780470891315.CH2
   Liao S, 2007, MATER LETT, V61, P3624, DOI 10.1016/j.matlet.2006.12.007
   Okazaki M, 1992, Magnes Res, V5, P103
   Porter A, 2005, J MATER SCI-MATER M, V16, P899, DOI 10.1007/s10856-005-4424-1
   Ren F, 2010, ACTA BIOMATER, V6, P2787, DOI 10.1016/j.actbio.2009.12.044
   TONSUAADU K, 1995, THERMOCHIM ACTA, V256, P55, DOI 10.1016/0040-6031(94)02169-O
   Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008
   Yao F, 2009, ACTA BIOMATER, V5, P2169, DOI 10.1016/j.actbio.2009.02.007
   Zou C, 2011, J ALLOY COMPD, V509, P6852, DOI 10.1016/j.jallcom.2011.03.158
   Zyman ZZ, 2009, J MATER SCI-MATER M, V20, P1389, DOI 10.1007/s10856-009-3706-4
NR 23
TC 18
Z9 18
U1 1
U2 27
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD JUL-AUG
PY 2013
VL 16
IS 4
BP 779
EP 784
DI 10.1590/S1516-14392013005000046
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 195TX
UT WOS:000322727600012
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Lu, Y
   Hao, L
   Matsuzaka, K
   Pan, F
   Yoshida, H
AF Lu, Y.
   Hao, L.
   Matsuzaka, K.
   Pan, F.
   Yoshida, H.
TI Fabrication and characteristics of visible light active TiO2 films by
   reduction treatment in carbon powder
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Titanium dioxide; Composite films; Mechanical coating technique;
   Reduction reaction; Photocatalytic activity
ID MECHANICAL COATING TECHNIQUE; FERRITE COMPOSITE NANOPARTICLES;
   PHOTOCATALYTIC ACTIVITY; THIN-FILMS; BIOMATERIAL SYSTEM; MAGNETIC CORE;
   ALUMINA BALLS; DEGRADATION; SHELL
AB TiO2 film balls were fabricated by mechanical coating technique and the following high temperature oxidation, reduction reaction by carbon powder. The films were characterised by X-ray diffraction, SEM and electron probe microanalyser. X-ray diffraction revealed that rutile TiO2 films were formed during the oxidation and reserved in the following reduction reaction. Scanning electron microscopy results showed that the films had a composite microstructure of TiO2 and Ti films. After the reduction reaction, the films showed enhanced photocatalytic activity under ultraviolet (UV) or visible light irradiation. Absorption spectra analysis proved that the films' absorption spectra extended towards visible light. The balance of crystallinity and specific surface area is considered to be the main influencing factor of photocatalytic activity under UV light irradiation. The red shift of TiO2 films' absorption spectra due to the introduction of oxygen vacancy in the reduction reaction is believed to be the crucial reason of improving the visible light photocatalytic activity significantly.
C1 [Lu, Y.; Hao, L.; Matsuzaka, K.] Chiba Univ, Grad Sch, Inage Ku, Chiba 2638522, Japan.
   [Lu, Y.] Chiba Univ, Fac Engn, Inage Ku, Chiba 2638522, Japan.
   [Pan, F.] Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.
   [Yoshida, H.] Ind Technol Res Inst Chiba, Wakaba Ku, Chiba 2640017, Japan.
RP Lu, Y (reprint author), Chiba Univ, Grad Sch, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.
EM luyun@faculty.chiba-u.jp
RI Lu, Yun/A-5553-2017
OI Lu, Yun/0000-0001-6195-106X; Hao, Liang/0000-0003-2071-7044
CR Aman N, 2012, MATER RES BULL, V47, P179, DOI 10.1016/j.materresbull.2011.11.049
   Arabatzis IM, 2003, J CATAL, V220, P127, DOI 10.1016/S0021-9517(03)00241-0
   Chen CC, 2009, SUPERLATTICE MICROST, V46, P461, DOI 10.1016/j.spmi.2009.05.007
   Chen SF, 2005, POWDER TECHNOL, V160, P198, DOI 10.1016/j.powtec.2005.08.012
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   Hao L, 2012, POWDER TECHNOL, V228, P377, DOI 10.1016/j.powtec.2012.05.056
   Hao L, 2012, J MATER PROCESS TECH, V212, P1169, DOI 10.1016/j.jmatprotec.2012.01.001
   He J, 2011, MATER CHEM PHYS, V129, P242, DOI 10.1016/j.matchemphys.2011.04.011
   Hou XG, 2006, NUCL INSTRUM METH B, V251, P429, DOI 10.1016/j.nimb.2006.06.030
   Huo YN, 2011, APPL CATAL B-ENVIRON, V106, P69, DOI 10.1016/j.apcatb.2011.05.006
   Jiang D, 2008, J SOLID STATE CHEM, V181, P593, DOI 10.1016/j.jssc.2008.01.004
   Jitputti J, 2007, J SOLID STATE CHEM, V180, P1743, DOI 10.1016/j.jssc.2007.03.018
   Lu Y, 2006, MATER TRANS, V47, P1449, DOI 10.2320/matertrans.47.1449
   Lu Y, 2011, MATER SCI FORUM, V675-677, P1229, DOI 10.4028/www.scientific.net/MSF.675-677.1229
   Mills A, 2002, J PHOTOCH PHOTOBIO A, V151, P171, DOI 10.1016/S1010-6030(02)00190-9
   Miyauchi M, 2002, CHEM MATER, V14, P2812, DOI 10.1021/cm020076p
   Moon J, 2003, CATAL TODAY, V87, P77, DOI 10.1016/j.cattod.2003.10.009
   Nakamura I, 2000, J MOL CATAL A-CHEM, V161, P205, DOI 10.1016/S1381-1169(00)00362-9
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Subramanian V, 2004, J AM CHEM SOC, V126, P4943, DOI 10.1021/ja0315199
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Takeda S, 2001, THIN SOLID FILMS, V392, P338, DOI 10.1016/S0040-6090(01)01054-9
   Trapalis C, 2009, THIN SOLID FILMS, V517, P6243, DOI 10.1016/j.tsf.2009.02.070
   Wu YM, 2010, APPL CATAL B-ENVIRON, V97, P182, DOI 10.1016/j.apcatb.2010.03.038
   Yang ST, 2011, MATER RES BULL, V46, P531, DOI 10.1016/j.materresbull.2011.01.004
   Yoong LS, 2009, ENERGY, V34, P1652, DOI 10.1016/j.energy.2009.07.024
   Yoshida H, 2009, J ALLOY COMPD, V475, P383, DOI 10.1016/j.jallcom.2008.07.059
   Yu JG, 2007, APPL CATAL B-ENVIRON, V69, P171, DOI 10.1016/j.apcatb.2006.06.022
   Zhang ZZ, 2010, J CATAL, V276, P201, DOI 10.1016/j.jcat.2010.07.033
   Zhu JA, 2011, APPL CATAL B-ENVIRON, V102, P120, DOI 10.1016/j.apcatb.2010.11.032
NR 32
TC 5
Z9 5
U1 0
U2 8
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD JUL
PY 2013
VL 28
IS 4
BP 205
EP 213
DI 10.1179/106678512X13518574234731
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 213IW
UT WOS:000324050800006
DA 2018-10-20
ER

PT J
AU Singh, C
   Rai, RK
   Sinha, N
AF Singh, Chandan
   Rai, Ratan Kumar
   Sinha, Neeraj
TI Experimental aspect of solid-state nuclear magnetic resonance studies of
   biomaterials such as bones
SO SOLID STATE NUCLEAR MAGNETIC RESONANCE
LA English
DT Article
DE Solid-state nuclear magnetic resonance; Bone; Water; Preservation;
   Hetero-nuclear correlation
ID NMR-SPECTROSCOPY; MECHANICAL-PROPERTIES; CORTICAL BONE; HYDROXYAPATITE
   INTERFACE; MINERAL INTERFACE; CANCELLOUS BONE; TRABECULAR BONE; FRACTURE
   RISK; H-1 MAS; COLLAGEN
AB Solid-state nuclear magnetic resonance (SSNMR) spectroscopy is increasingly becoming a popular technique to probe micro-structural details of biomaterial such as bone with pico-meter resolution. Due to high-resolution structural details probed by SSNMR methods, handling of bone samples and experimental protocol are very crucial aspects of study. We present here first report of the effect of various experimental protocols and handling methods of bone samples on measured SSNMR parameters. Various popular SSNMR experiments were performed on intact cortical bone sample collected from fresh animal, immediately after removal from animal systems, and results were compared with bone samples preserved in different conditions. We find that the best experimental conditions for SSNMR parameters of bones correspond to preservation at -20 degrees C and in 70% ethanol solution. Various other SSNMR parameters were compared corresponding to different experimental conditions. Our study has helped in finding best experimental protocol for SSNMR studies of bone. This study will be of further help in the application of SSNMR studies on large bone disease related animal model systems for statistically significant results. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Singh, Chandan] Banaras Hindu Univ, Fac Sci, Sch Biotechnol, Varanasi 221005, Uttar Pradesh, India.
   [Rai, Ratan Kumar; Sinha, Neeraj] SGPGIMS Campus, Ctr Biomed Magnet Resonance, Lucknow 226014, Uttar Pradesh, India.
RP Sinha, N (reprint author), SGPGIMS Campus, Ctr Biomed Magnet Resonance, Lucknow 226014, Uttar Pradesh, India.
EM neeraj.sinha@cbmr.res.in
RI Rai, Ratan/N-6344-2018
OI Rai, Ratan/0000-0001-6015-5539; Singh, Chandan/0000-0001-8006-1329
FU Department of Biotechnology, India [BT/PR12700/BRB/10/719/2009]; Council
   of Scientific and Industrial Research, India
FX Financial support from the Department of Biotechnology, India (Grant
   number BT/PR12700/BRB/10/719/2009), is gratefully acknowledged. Chandan
   Singh and Ratan Kumar Rai gratefully acknowledge financial support from
   the Council of Scientific and Industrial Research, India.
CR Bailey AJ, 1999, CALCIFIED TISSUE INT, V65, P203, DOI 10.1007/s002239900683
   Banse X, 2002, J BONE MINER RES, V17, P1621, DOI 10.1359/jbmr.2002.17.9.1621
   Best SM, 2008, MAGN RESON CHEM, V46, P323, DOI 10.1002/mrc.2168
   Carden A, 2003, CALCIFIED TISSUE INT, V72, P166, DOI 10.1007/s00223-002-1039-0
   Cho GY, 2003, SCIENCE, V300, P1123, DOI 10.1126/science.1078470
   CHUNG H, 1993, P NATL ACAD SCI USA, V90, P10250, DOI 10.1073/pnas.90.21.10250
   CURREY JD, 1969, J BIOMECH, V2, P1, DOI 10.1016/0021-9290(69)90036-0
   Fernandez-Seara MA, 2002, BIOPHYS J, V82, P522, DOI 10.1016/S0006-3495(02)75417-9
   Harvey N, 2010, NAT REV RHEUMATOL, V6, P99, DOI 10.1038/nrrheum.2009.260
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001
   Huang TH, 2002, BONE, V30, P293, DOI 10.1016/S8756-3282(01)00659-7
   Jaeger C, 2005, CHEM MATER, V17, P3059, DOI 10.1021/cm050492k
   Jeffcott LB, 1998, VET J, V156, P177, DOI 10.1016/S1090-0233(98)80121-4
   Kaflak A., 2007, NUCL MAGN RESON, V31, P174
   Kaflak-Hachulska A, 2003, CALCIFIED TISSUE INT, V73, P476, DOI 10.1007/s00223-002-2111-5
   KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200
   Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5
   Khosla S, 2010, J CLIN ENDOCR METAB, V95, P3, DOI 10.1210/jc.2009-1740
   KLEMM WR, 1990, ALCOHOL, V7, P49, DOI 10.1016/0741-8329(90)90060-P
   Knott L, 1997, BIOCHEM J, V322, P535, DOI 10.1042/bj3220535
   Laurencin D, 2010, PHYS CHEM CHEM PHYS, V12, P1081, DOI 10.1039/b915708e
   LEVITT MH, 1993, SOLID STATE NUCL MAG, V2, P151, DOI 10.1016/0926-2040(93)90021-E
   LINDE F, 1993, J BIOMECH, V26, P1249, DOI 10.1016/0021-9290(93)90072-M
   Lips P., 1997, AM J MED, V103, pS3 S 11
   Lloyd SAJ, 2008, J APPL PHYSIOL, V104, P729, DOI 10.1152/japplphysiol.00632.2007
   MARCHANDISE X, 1992, MAGNET RESON MED, V28, P1, DOI 10.1002/mrm.1910280102
   McElderry JDP, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3574525
   Mukherjee S, 2008, J AM CHEM SOC, V130, P1264, DOI 10.1021/ja0759949
   Nikel O, 2012, J PHYS CHEM C, V116, P6320, DOI 10.1021/jp2125312
   Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049
   Particelli F, 2012, J MICROSC-OXFORD, V245, P302, DOI 10.1111/j.1365-2818.2011.03573.x
   PLESHKO NL, 1992, CALCIFIED TISSUE INT, V51, P72, DOI 10.1007/BF00296221
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Rack B, 2012, J PERINATOL, V32, P218, DOI 10.1038/jp.2011.82
   Rai RK, 2011, J PHYS CHEM C, V115, P14219, DOI 10.1021/jp2025768
   Ramamoorthy A., 2004, ANN REPORTS NMR SPEC, P1
   ROUFOSSE AH, 1984, BIOCHEMISTRY-US, V23, P6115, DOI 10.1021/bi00320a033
   Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006
   SANTOS RA, 1994, J MAGN RESON SER B, V105, P183, DOI 10.1006/jmrb.1994.1120
   Schulz J, 2007, CALCIFIED TISSUE INT, V80, P275, DOI 10.1007/s00223-007-9007-3
   Seifert AC, 2013, NMR BIOMED, V26, P1158, DOI 10.1002/nbm.2930
   Sroga G.E., MOL CELL PROTEOMICS, V10
   Sroga GE, 2011, J CHROMATOGR B, V879, P379, DOI 10.1016/j.jchromb.2010.12.024
   Stayton PS, 2003, CRIT REV ORAL BIOL M, V14, P370, DOI 10.1177/154411130301400507
   Takata Shinjiro, 2004, J Med Invest, V51, P133, DOI 10.2152/jmi.51.133
   Turunen MJ, 2011, APPL SPECTROSC, V65, P595, DOI 10.1366/10-06193
   Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9
   Viktoria P., 2010, PHYS MED BIOL, V55, P7363
   Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243
   Wu Y, 2003, CALCIFIED TISSUE INT, V72, P610, DOI 10.1007/s00223-002-1068-8
   Wu Y, 1998, CALCIFIED TISSUE INT, V62, P512
   Xu JD, 2010, J AM CHEM SOC, V132, P11504, DOI 10.1021/ja101961x
   YESINOWSKI JP, 1987, J AM CHEM SOC, V109, P6274, DOI 10.1021/ja00255a009
   Zhu PZ, 2009, J AM CHEM SOC, V131, P17064, DOI 10.1021/ja9081028
NR 55
TC 16
Z9 16
U1 0
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0926-2040
J9 SOLID STATE NUCL MAG
JI Solid State Nucl. Magn. Reson.
PD JUL-SEP
PY 2013
VL 54
BP 18
EP 25
DI 10.1016/j.ssnmr.2013.05.003
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical; Physics,
   Condensed Matter; Spectroscopy
SC Chemistry; Physics; Spectroscopy
GA 212MG
UT WOS:000323986900004
PM 23731548
DA 2018-10-20
ER

PT J
AU Pang, L
   Hao, W
   Jiang, M
   Huang, JG
   Yan, YNA
   Hu, YY
AF Pang, Long
   Hao, Wei
   Jiang, Ming
   Huang, Jianguo
   Yan, Yongnian
   Hu, Yunyu
TI Bony defect repair in rabbit using hybrid rapid prototyping
   polylactic-co-glycolic acid/beta-tricalciumphosphate collagen I/apatite
   scaffold and bone marrow mesenchymal stem cells
SO INDIAN JOURNAL OF ORTHOPAEDICS
LA English
DT Article
DE Apatite; bone tissue engineering; collagen I; hybrid scaffolds;
   segmental bone defect
ID SIMULATED BODY-FLUID; ALLOGRAFTS; DEPOSITION; MIGRATION; FUSION; GRAFT;
   STATE
AB Background: In bone tissue engineering, extracellular matrix exerts critical influence on cellular interaction with porous biomaterial and the apatite playing an important role in the bonding process of biomaterial to bone tissue. The aim of this study was to observe the therapeutic effects of hybrid rapid prototyping (RP) scaffolds comprising polylactic-co-glycolic acid (PLGA), beta-tricalciumphosphate (beta-TCP), collagen I and apatite (PLGA/beta-TCP-collagen I/apatite) on segmental bone defects in conjunction with combination with bone marrow mesenchymal stem cells (BMSCs).
   Materials and Methods: BMSCs were seeded into the hybrid RP scaffolds to repair 15 mm defect in the radius of rabbits. Radiograph, microcomputed tomography and histology were used to evaluate new bone formation.
   Results: Radiographic analysis done from 12 to 36 weeks postoperative period demonstrated that new bone formed at the radial defect site and continues to increase until the medullary cavity is recanalized and remodelling is complete. The bone defect remained unconnected in the original RP scaffolds (PLGA/beta-TCP) during the whole study. Histological observations conformed to the radiographic images. In hybrid RP scaffold group, woven bone united the radial defect at 12 weeks and consecutively remodeled into lamellar bone 24 weeks postoperation and finally matured into cortical bone with normal marrow cavity after another 12 weeks. No bone formation but connective tissue has been detected in RP scaffold at the same time.
   Conclusion: Collagen I/apatite sponge composite coating could improve new bone formation in vivo. The hybrid RP scaffold of PLGA/beta-TCP skeleton with collagen I/apatite sponge composite coating is a promising candidate for bone tissue engineering.
C1 [Pang, Long; Huang, Jianguo] Ningxia Med Univ, Affiliated Hosp, Dept Orthopaed 3, Ningxia, Peoples R China.
   [Hao, Wei] Qingdao Univ, Coll Med, Yantai Yu Huang Ding Hosp, Dept Orthopaed & Traumatol, Qingdao 266071, Peoples R China.
   [Jiang, Ming] 107 Hosp, Jinan Mil Area, Dept Stomatol, Yantai, Shandong, Peoples R China.
   [Yan, Yongnian] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.
   [Hu, Yunyu] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed & Traumatol, Xian 710032, Peoples R China.
RP Hu, YY (reprint author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed & Traumatol, Xian 710032, Peoples R China.
EM hjdabao@163.com
FU Yan'tai Technology Development Program [2011209]
FX Source of Support: Yan'tai Technology Development Program ( 2011209),
CR Alsaleh KAM, 2012, SPINE, V37, pE993, DOI 10.1097/BRS.0b013e3182518859
   Ayukawa Y, 1998, J BIOMED MATER RES, V41, P111
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Erbe EM, 2001, EUR SPINE J, V10, pS141, DOI 10.1007/s005860100287
   Grieb TA, 2005, BIOMATERIALS, V26, P2033, DOI 10.1016/j.biomaterials.2004.06.028
   Gunzer M, 2000, J LEUKOCYTE BIOL, V67, P622
   Hao W, 2010, J ORTHOP RES, V28, P252, DOI 10.1002/jor.20969
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Lamers E, 2012, EUR CELLS MATER, V23, P182, DOI 10.22203/eCM.v023a14
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Pang L, 2007, SURF COAT TECH, V201, P9549, DOI 10.1016/j.surfcoat.2007.04.035
   Pierres A, 2008, BIOPHYS J, V94, P4114, DOI 10.1529/biophysj.107.125278
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Valanezahad A, 2011, DENT MATER J, V30, P749, DOI 10.4012/dmj.2010-153
   Weszl M, 2012, J ORTHOP RES, V30, P489, DOI 10.1002/jor.21527
   Wheeler DL, 2005, CLIN ORTHOP RELAT R, P36, DOI 10.1097/01.blo.0000165850.58583.50
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
   Yu HS, 2011, J PERIODONTAL IMPLAN, V41, P293, DOI 10.5051/jpis.2011.41.6.293
NR 22
TC 11
Z9 16
U1 0
U2 28
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0019-5413
EI 1998-3727
J9 INDIAN J ORTHOP
JI Indian J. Orthop.
PD JUL-AUG
PY 2013
VL 47
IS 4
BP 388
EP 394
DI 10.4103/0019-5413.114927
PG 7
WC Orthopedics
SC Orthopedics
GA 207QV
UT WOS:000323619000011
PM 23960284
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Marcu, T
   Salantiu, AM
   Gligor, I
   Popa, C
AF Marcu, T.
   Salantiu, A. M.
   Gligor, I.
   Popa, C.
TI Microstructural characterization of PM Ti with dextrin addition for
   endosseous applications
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE CP Ti; dextrin; Powder Metallurgy; Biomaterial; Microstructure
ID POROUS TITANIUM
AB The aim of this research work was to study the microstructure of porous CP Ti with dextrin addition obtained by Powder Metallurgy, aimed for endosseous implants. Powder mixtures of CP Ti with 35 vol.% dextrin with different particle sizes were pressed with 400 MPa and sintered in two different conditions. The sintering behavior and microstructures were investigated by means of differential thermal calorimetry, optical microscopy and scanning electron microscopy. The results are helpful for the optimization of the processing cycle of Ti - dextrin powder mixtures.
C1 [Marcu, T.; Salantiu, A. M.; Gligor, I.; Popa, C.] Tech Univ Cluj Napoca, Fac Mat Sci & Engn, Dept Mat Sci & Technol, Cluj Napoca 400641, Romania.
RP Marcu, T (reprint author), Tech Univ Cluj Napoca, Fac Mat Sci & Engn, Dept Mat Sci & Technol, Muncii Ave 103-105, Cluj Napoca 400641, Romania.
EM Teodora.Marcu@stm.utcluj.ro
FU European Social Fund; Romanian National Council for the Higher Education
   Scientific Research;  [POSDRU/89/1.5/S157083]
FX Teodora Marcu wish to thank the project "Progress and development
   through post-doctoral research and innovation in engineering and applied
   sciences PRIDE Contract no. POSDRU/89/1.5/S157083", project co-funded
   from the European Social Fund through Sectorial Operational Program
   Human Resources 2007-2013.; The research was carried out within the
   BIOMAPIM project, financed by the Romanian National Council for the
   Higher Education Scientific Research.
CR [Anonymous], 1990, ASM METALS HDB, V3
   de Vasconcellos LM, 2010, MED ORAL PATOL ORAL, V15, P407
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gemelli E., 2007, REV MAT, V12, P525
   Gligor I., 2011, THESIS U CLUJ NAPOCA
   Niu WJ, 2009, MAT SCI ENG A-STRUCT, V506, P148, DOI 10.1016/j.msea.2008.11.022
   POPA C., 2008, STIINTA BIOMATERIALE
   Predoi D, 2007, DIG J NANOMATER BIOS, V2, P169
   Sobieszczyk S., 2010, ADV MAT SCI, V10
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   Wen CE, 2007, MATER SCI FORUM, V539-543, P720, DOI 10.4028/www.scientific.net/MSF.539-543.720
NR 11
TC 1
Z9 1
U1 0
U2 2
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD JUL-AUG
PY 2013
VL 15
IS 7-8
BP 847
EP 852
PG 6
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 204UX
UT WOS:000323397900042
DA 2018-10-20
ER

PT J
AU Garcia, JL
   Humpolicek, P
   Lehocky, M
   Junkar, I
   Mozetic, M
AF Garcia, Jorge Lopez
   Humpolicek, Petr
   Lehocky, Marian
   Junkar, Ita
   Mozetic, Miran
TI DIFFERENT SOURCE ATELOCOLLAGEN THIN FILMS: PREPARATION, PROCESS
   OPTIMISATION AND ITS INFLUENCE ON THE INTERACTION WITH EUKARYOTIC CELLS
SO MATERIALI IN TEHNOLOGIJE
LA English
DT Article
DE atelocollagen thin films; film optimisation; film quality; surface
   topography; eukaryotic cell response
ID RHEOLOGICAL BEHAVIOR; SURFACE-MORPHOLOGY; PLASMA TREATMENT;
   POLYMER-FILMS; COLLAGEN; DELIVERY; PROLIFERATION; BIOMATERIAL;
   SCAFFOLDS; CARTILAGE
AB Collagen thin films were prepared via bovine atelocollagen matrices. The film casting was carried out by using different culture dishes, concentrations, equipment, drying processes and periods of time. In order to optimise the repeatability and reproducibility, microscopic analyses were utilised to explore the film quality and topographical patterning. In addition, the human immortalised non-tumorigenic keratinocyte cell line (HaCaT) was seeded onto the obtained specimens, and the cell proliferation was determined by using the MTT assay. These results indicated how the substrate, its concentration and processing conditions influence the cellular response. The attempted technique shows itself to be an excellent procedure for continuous collagen film preparation with optimal cell-proliferation rates, which may potentially be used in tissue engineering or wound-healing applications.
C1 [Garcia, Jorge Lopez; Humpolicek, Petr; Lehocky, Marian] Tomas Bata Univ Zlin, Ctr Polymer Syst, Zlin 76001, Czech Republic.
   [Junkar, Ita; Mozetic, Miran] Jozef Stefan Inst, Dept Surface Engn, Plasma Lab, Ljubljana 1000, Slovenia.
RP Garcia, JL (reprint author), Tomas Bata Univ Zlin, Ctr Polymer Syst, Nam TG Masaryka 5555, Zlin 76001, Czech Republic.
EM lehocky@post.cz
RI Lopez Garcia, Jorge/H-6581-2012; Mozetic, Miran/K-8784-2014; Humpolicek,
   Petr/B-1785-2010; Lehocky, Marian/H-1981-2012
OI Humpolicek, Petr/0000-0002-6837-6878; Lehocky,
   Marian/0000-0002-5368-5029
FU Ministry of Education, Youth and Sport of the Czech Republic
   [CZ.1.05/2.1.00/03.0111]; Slovenia Ministry of Higher Education,
   Science, and Technology [P2-0082-2]; Ad Futura [L7-4009]
FX The authors would like to express their gratitude to the Ministry of
   Education, Youth and Sport of the Czech Republic
   (CZ.1.05/2.1.00/03.0111). The Slovenia Ministry of Higher Education,
   Science, and Technology (Program P2-0082-2) and Ad Futura L7-4009 are
   also gratefully acknowledged for the financial support of this research.
CR Avery NC, 1996, MEAT SCI, V42, P355, DOI 10.1016/0309-1740(95)00021-6
   Banerjee I, 2012, J BIOMAT SCI-POLYM E, V23, P355, DOI 10.1163/092050610X551943
   Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602
   Bernal A, 2013, POLYM BULL, V70, P431, DOI 10.1007/s00289-012-0802-2
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   EINBINDER J, 1951, J BIOL CHEM, V188, P335
   Fasl H., 2012, MACROMOLECULAR CHEM, V15, P1582
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Garcia JL, 2011, PROG COLL POL SCI S, V138, P89, DOI 10.1007/978-3-642-19038-4_16
   Garcia JL, 2010, MOLECULES, V15, P2845, DOI 10.3390/molecules15042845
   Harada O., 2000, J APPL POLYM SCI, V81, P2433
   Inaba S, 2012, MOL THER, V20, P356, DOI 10.1038/mt.2011.221
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Lai GL, 2008, INT J BIOL MACROMOL, V42, P285, DOI 10.1016/j.ijbiomac.2007.12.010
   Lehocky M, 2009, J MATER PROCESS TECH, V209, P2871, DOI 10.1016/j.jmatprotec.2008.06.042
   Machado AAS, 2002, J THERM ANAL CALORIM, V67, P491
   Matthew H.W.T., 2001, POLYM BIOMATERIALS, P167
   Muller-Buschbaum P, 2001, MACROMOLECULES, V34, P1369, DOI 10.1021/ma0009193
   Nambu N., 2009, ANN PLAS SURG, V62, P317
   Nomura Y, 2000, J AGR FOOD CHEM, V48, P2028, DOI 10.1021/jf990773a
   Okuyama K, 2008, CONNECT TISSUE RES, V49, P299, DOI 10.1080/03008200802325110
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   Roy N, 2012, INT J POLYM MATER, V61, P72, DOI 10.1080/00914037.2011.593058
   SAGE H, 1979, J BIOL CHEM, V254, P9893
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Silver F., 1997, HDB BIODEGRADABLE PO, P319
   Tabarestani H. S., 2012, International Food Research Journal, V19, P251
   Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102
   Tanaka Y, 2010, BIOMATERIALS, V31, P4506, DOI 10.1016/j.biomaterials.2010.02.028
   To T, 2004, THIN SOLID FILMS, V467, P59, DOI 10.1016/j.tsf.2004.03.004
   Vesel A, 2012, VACUUM, V86, P773, DOI 10.1016/j.vacuum.2011.07.019
   Vojdani F., 1996, METHODS TESTING PROT, P11
   Yamaoka H, 2010, J BIOMED MATER RES A, V93A, P123, DOI 10.1002/jbm.a.32509
   Zhang Z., 2005, J SOC LEATHER TECHNO, V90, P23
NR 37
TC 2
Z9 2
U1 1
U2 11
PU INST ZA KOVINSKE MATERIALE I IN TEHNOLOGIE
PI LJUBJANA
PA LEPI POT 11, LJUBJANA, 10000, SLOVENIA
SN 1580-2949
J9 MATER TEHNOL
JI Mater. Tehnol.
PD JUL-AUG
PY 2013
VL 47
IS 4
BP 473
EP 479
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 200QY
UT WOS:000323085200013
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhang, L
   Han, L
   Wang, YJ
   Zhao, TF
   Bao, XX
   Nakagaki, M
AF Zhang, Lei
   Han, Leng
   Wang, Yujun
   Zhao, Tianfu
   Bao, Xianxun
   Nakagaki, Masao
TI The Variability of Mechanical Properties and Molecular Conformation
   among Different Spider Dragline Fibers
SO FIBERS AND POLYMERS
LA English
DT Article
DE Spider dragline fiber; Mechanical properties; Molecular conformation;
   Variability
ID SAMIA-CYNTHIA-RICINI; SILK FIBERS; RAMAN SPECTROMICROSCOPY; SECONDARY
   STRUCTURE; ACTIVE CONTROL; MICROSPECTROSCOPY; SPECTROSCOPY; ORIENTATION;
   STRENGTH; PROTEINS
AB Spider dragline fiber is a high-performance biomaterial that has received much attention. To screen the outstanding spider dragline fibers, the mechanical properties and microstructures of dragline fibers collected from Nephia clavata, Nephia pilipes, Argiope bruennichi and Argiope amoena were investigated. It was found that the mechanical properties of spider dragline fiber were variable. Among the four different species, the larger spiders did not always extrude thicker dragline fibers and produce fibers with the maximum breaking force. The dragline fibers could sustain one to three times the body weight of the spider at a reeling speed of 20 mm/s. N. clavata dragline fiber showed a stronger breaking stress and initial modulus than that of N. pilipes, A. bruennichi and A. amoena. With an increasing reeling speed, the breaking strain decreased; the initial modulus increased in N clavata, N. pilipes and A. bruennichi, but the breaking stress exhibited a different tendency. The results also revealed that dragline fiber of N. clavata contained the most beta-sheet polypeptides and an excellent orientation of beta-sheet molecular chains.
C1 [Zhang, Lei; Han, Leng; Nakagaki, Masao] Shinshu Univ, Fac Text Sci & Technol, Div Appl Biol, Nagano 3868567, Japan.
   [Wang, Yujun; Zhao, Tianfu] Okamoto Corp, R&D Div, Nara 6358550, Japan.
RP Nakagaki, M (reprint author), Shinshu Univ, Fac Text Sci & Technol, Div Appl Biol, Nagano 3868567, Japan.
EM nakagak@shinshu-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   Anhui international science and technology cooperation project
   [12030603008]
FX The study was supported by a Grant-in-Aid for the Global COE program by
   the Ministry of Education, Culture, Sports, Science and Technology of
   Japan, as well as Anhui international science and technology cooperation
   project, No.12030603008. We are grateful to Ms. Keiko Kakegawa for her
   technical assistance in Raman measurements.
CR Augsten K, 2000, SCANNING, V22, P12
   Barghout JYJ, 1999, INT J BIOL MACROMOL, V24, P211, DOI 10.1016/S0141-8130(99)00007-0
   Creager MS, 2010, BIOMACROMOLECULES, V11, P2039, DOI 10.1021/bm100399x
   Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144
   Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f
   Garrido MA, 2002, POLYMER, V43, P1537, DOI 10.1016/S0032-3861(01)00713-3
   GILLESPIE DB, 1994, ACS SYM SER, V544, P155
   Glisovic A, 2007, APPL PHYS A-MATER, V87, P63, DOI 10.1007/s00339-006-3849-9
   GRIFFITHS JR, 1980, J MATER SCI, V15, P491, DOI 10.1007/BF00551703
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Kane DM, 2010, J APPL PHYS, V108, DOI 10.1063/1.3490220
   Lefevre T., 2011, BIOPOLYMERS, V97, P322
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Lefevre T, 2012, SOFT MATTER, V8, P6350, DOI 10.1039/c2sm25351h
   Ling SJ, 2011, BIOMACROMOLECULES, V12, P3344, DOI 10.1021/bm2006032
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Osaki S, 1996, NATURE, V384, P419, DOI 10.1038/384419a0
   Osaki S, 1999, INT J BIOL MACROMOL, V24, P283, DOI 10.1016/S0141-8130(98)00091-9
   Pan ZJ, 2009, FIBER POLYM, V10, P285, DOI 10.1007/s12221-009-0285-4
   Pan ZJ, 2004, J APPL POLYM SCI, V92, P901, DOI 10.1002/app.20055
   Papadopoulos P, 2007, EUR PHYS J E, V24, P193, DOI 10.1140/epje/i2007-10229-9
   Putthanarat S, 2000, POLYMER, V41, P7735, DOI 10.1016/S0032-3861(00)00036-7
   Romer L, 2008, PRION, V2, P154
   Rousseau ME, 2006, BIOMACROMOLECULES, V7, P2512, DOI 10.1021/bm060280w
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Shao Z, 1999, POLYMER, V40, P2493, DOI 10.1016/S0032-3861(98)00475-3
   Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3
   Shao ZZ, 1999, INT J BIOL MACROMOL, V24, P295, DOI 10.1016/S0141-8130(98)00093-2
   Sirichaisit J, 2000, POLYMER, V41, P1223, DOI 10.1016/S0032-3861(99)00293-1
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Vollrath F., 2000, REV MOL BIOTECHNOL, V74, P67, DOI DOI 10.1016/S1389-0352(00)00006-4)
   Yang MY, 2005, J BIOCHEM, V137, P721, DOI 10.1093/jb/mvi090
NR 37
TC 1
Z9 1
U1 3
U2 33
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
J9 FIBER POLYM
JI Fiber. Polym.
PD JUL
PY 2013
VL 14
IS 7
BP 1190
EP 1195
DI 10.1007/s12221-013-1190-4
PG 6
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 191LO
UT WOS:000322414700019
DA 2018-10-20
ER

PT J
AU Wang, F
   Li, YY
   Shen, YQ
   Wang, AM
   Wang, SL
   Xie, T
AF Wang, Fen
   Li, Yuanyuan
   Shen, Yingqiang
   Wang, Anming
   Wang, Shuling
   Xie, Tian
TI The Functions and Applications of RGD in Tumor Therapy and Tissue
   Engineering
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE RGD; tumor therapy; tissue engineering
ID TARGETED GENE DELIVERY; ALPHA-V INTEGRINS; IN-VIVO; CYCLIC-RGD;
   CELL-ADHESION; ENDOTHELIAL-CELLS; CONTAINING PEPTIDES; LIPOSOMES;
   CANCER; EXPRESSION
AB Arginine-Glycine-Aspartic (RGD), is the specific recognition site of integrins with theirs ligands, and regulates cell-cell and cell-extracellular matrix interactions. The RGD motif can be combined with integrins overexpressed on the tumor neovasculature and tumor cells with a certain affinity, becoming the new target for imaging agents, and drugs, and gene delivery for tumor treatment. Further, RGD as a biomimetic peptide can also promote cell adherence to the matrix, prevent cell apoptosis and accelerate new tissue regeneration. Functionalizing material surfaces with RGD can improve cell/biomaterial interactions, which facilitates the generation of tissue-engineered constructs. This paper reviews the main functions and advantages of RGD, describes the applications of RGD in imaging agents, drugs, gene delivery for tumor therapy, and highlights the role of RGD in promoting the development of tissue engineering (bone regeneration, cornea repair, artificial neovascularization) in recent years.
C1 [Wang, Fen; Li, Yuanyuan; Wang, Anming] Hangzhou Normal Univ, Coll Mat Chem & Chem Engn, Hangzhou 310036, Zhejiang, Peoples R China.
   [Wang, Fen; Shen, Yingqiang; Wang, Anming; Wang, Shuling; Xie, Tian] Hangzhou Normal Univ, Res Ctr Biomed & Hlth, Hangzhou 311121, Zhejiang, Peoples R China.
   [Shen, Yingqiang] Hangzhou Normal Univ, Coll Biol & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China.
RP Wang, AM (reprint author), Hangzhou Normal Univ, Coll Mat Chem & Chem Engn, Hangzhou 310036, Zhejiang, Peoples R China.
EM wangfen@126.com; liyuanyuan43@live.com; shenyq@126.com;
   waming@hznu.edu.cn; wsling222@163.com; tianxiehz@hotmail.com
FU National Natural Science Foundation of China [21076053, 20906016];
   Technological Research and Development Project of Hangzhou
   [20120232B13]; China Postdoctoral Science Foundation [2012M521198];
   Natural Science Foundation of Zhejiang Province [LY13B060008]; Program
   for Changjiang Scholars and Innovative Research Team in Chinese
   University [IRT1231]
FX This work was financially supported by the National Natural Science
   Foundation of China (21076053, 20906016), Technological Research and
   Development Project of Hangzhou (20120232B13), China Postdoctoral
   Science Foundation funded project (2012M521198), Natural Science
   Foundation of Zhejiang Province (LY13B060008), and the Program for
   Changjiang Scholars and Innovative Research Team in Chinese University
   (IRT1231).
CR Aguzzi MS, 2004, BLOOD, V103, P4180, DOI 10.1182/blood-2003-06-2144
   Anuradha CD, 2000, CELL BIOL TOXICOL, V16, P275, DOI 10.1023/A:1026758429238
   Bella J, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-4
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Chavakis E, 2002, DIABETOLOGIA, V45, P262, DOI 10.1007/s00125-001-0727-z
   Chen J, 2011, MAT SCI ENG C-MATER, V31, P826, DOI 10.1016/j.msec.2010.12.019
   Chen XM, 1997, BIOCHEM BIOPH RES CO, V234, P594, DOI 10.1006/bbrc.1997.6593
   Chen YX, 2001, CANCER RES, V61, P2434
   Choi N, 2011, BIOMATERIALS, V32, P7151, DOI 10.1016/j.biomaterials.2011.06.007
   Colombo M, 2010, MOLECULES, V15, P178, DOI 10.3390/molecules15010178
   Delouvrie B, 2012, BIOORG MED CHEM LETT, V22, P4117, DOI 10.1016/j.bmcl.2012.04.061
   Delouvrie B, 2012, BIOORG MED CHEM LETT, V22, P4111, DOI 10.1016/j.bmcl.2012.04.063
   Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869
   Enwerem I, 2012, COMPUT THEOR CHEM, V998, P141, DOI 10.1016/j.comptc.2012.07.013
   Frochot C, 2007, BIOORG CHEM, V35, P205, DOI 10.1016/j.bioorg.2006.11.005
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Haubner R, 2004, CURR PHARM DESIGN, V10, P1439, DOI 10.2174/1381612043384745
   Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014
   Hilgenbrink AR, 2005, J PHARM SCI-US, V94, P2135, DOI 10.1002/jps.20457
   Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Jiang JA, 2010, EUR J PHARM BIOPHARM, V76, P170, DOI 10.1016/j.ejpb.2010.06.011
   Jo DH, 2011, INT J MOL SCI, V12, P8288, DOI 10.3390/ijms12118288
   Kang IC, 2000, BIOCHEM BIOPH RES CO, V275, P169, DOI 10.1006/bbrc.2000.3130
   Katayama K, 2011, BIOMATERIALS, V32, P4185, DOI 10.1016/j.biomaterials.2011.02.038
   Kibria G, 2011, J CONTROL RELEASE, V153, P141, DOI 10.1016/j.jconrel.2011.03.012
   Kim J, 2011, BIOMATERIALS, V32, P5158, DOI 10.1016/j.biomaterials.2011.03.084
   Leng QX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1039/nar/gni040
   Li Z, 2009, MOL PHARM, V7, P94, DOI DOI 10.1021/MP9001415
   Liu S, 2006, MOL PHARMACEUT, V3, P472, DOI 10.1021/mp060049x
   Meyer A, 2006, CURR PHARM DESIGN, V12, P2723, DOI 10.2174/138161206777947740
   Mitjans F, 2000, INT J CANCER, V87, P716, DOI 10.1002/1097-0215(20000901)87:5<716::AID-IJC14>3.3.CO;2-I
   Naik S, 2012, NANOMED-NANOTECHNOL, V8, P951, DOI 10.1016/j.nano.2011.11.008
   Orsi S, 2012, ACTA BIOMATER, V8, P3228, DOI 10.1016/j.actbio.2012.05.010
   Park JA, 2008, CHEMBIOCHEM, V9, P2811, DOI 10.1002/cbic.200800529
   Patra C, 2012, BIOMATERIALS, V33, P4327, DOI 10.1016/j.biomaterials.2012.03.021
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Przystal JM, 2013, MOL ONCOL, V7, P55, DOI 10.1016/j.molonc.2012.08.001
   Ritchie CK, 2000, J CELL PHYSIOL, V184, P214, DOI 10.1002/1097-4652(200008)184:2<214::AID-JCP9>3.3.CO;2-Q
   Sakae M, 2008, BIOMED PHARMACOTHER, V62, P448, DOI 10.1016/j.biopha.2007.12.009
   Samanta S, 2010, BIOMATERIALS, V31, P1787, DOI 10.1016/j.biomaterials.2009.10.027
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Tanabe N, 2011, J BIOL CHEM, V286, P39871, DOI 10.1074/jbc.M111.295048
   Temming K, 2005, DRUG RESIST UPDATE, V8, P381, DOI 10.1016/j.drup.2005.10.002
   Tocce EJ, 2013, ACTA BIOMATER, V9, P5040, DOI 10.1016/j.actbio.2012.10.007
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   Vachutinsky Y, 2011, J CONTROL RELEASE, V149, P51, DOI 10.1016/j.jconrel.2010.02.002
   Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4
   Wang Z, 2012, NANOMED-NANOTECHNOL, V8, P194, DOI 10.1016/j.nano.2011.06.006
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   Wu Y, 2006, MOL IMAGING BIOL, V8, P226, DOI 10.1007/s11307-006-0041-8
   Xu Q, 2012, BIOMATERIALS, V33, P1627, DOI 10.1016/j.biomaterials.2011.11.012
   Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X
   Yan Jiang-Hua, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P409, DOI 10.1016/S1872-2075(07)60032-6
   Yonenaga N, 2012, J CONTROL RELEASE, V160, P177, DOI 10.1016/j.jconrel.2011.10.004
   Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398
   Zerda A., 2010, NANO LETT, V10, P2168, DOI DOI 10.1021/NL100890D
   Zhan CY, 2012, CHEM-ASIAN J, V7, P91, DOI 10.1002/asia.201100570
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhang LH, 2011, EUR J PHARM BIOPHARM, V79, P232, DOI 10.1016/j.ejpb.2011.03.025
   Zhang YF, 2010, EUR J PHARM BIOPHARM, V74, P467, DOI 10.1016/j.ejpb.2010.01.002
   Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047
   Zhu SJ, 2011, ADV MATER, V23, pH84, DOI 10.1002/adma.201003944
   Zitzmann S, 2002, CANCER RES, V62, P5139
NR 68
TC 45
Z9 48
U1 2
U2 135
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL
PY 2013
VL 14
IS 7
BP 13447
EP 13462
DI 10.3390/ijms140713447
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 188DH
UT WOS:000322171700032
PM 23807504
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Fathi, M
   Varshosaz, J
AF Fathi, Milad
   Varshosaz, Jaleh
TI Novel hesperetin loaded nanocarriers for food fortification: Production
   and characterization
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Hesperetin; Layer by layer coating; Nanostructure lipid carriers
ID CA-ALGINATE MICROPARTICLES; CONTROLLED-RELEASE; DELIVERY-SYSTEMS;
   CHITOSAN; PROTEIN; NANOPARTICLES; FLAVONOIDS; BIOMATERIAL; INHIBITION;
   NARINGENIN
AB The objective of this research was to encapsulate hesperetin as a natural antioxidant in order to enhance its functionality for food fortification. Hesperetin loaded nanostructure lipid carriers (NLC) were coated with different biopolymers (chitosan, alginate, and low methoxypectin) and some features of the developed nanocarriers, including size, zeta potential, morphology, release kinetics, stability, thermal behaviour, chemical structure, and sensory properties were studied. The developed nano size carries showed high zeta potential and excellent stability against aggregation. Thermal analysis indicated that hesperetin was well incorporated into nanoparticles. The Fourier transform infrared spectroscopy revealed no chemical reaction between encapsulating materials and hesperetin. Sensory analysis also showed that developed nanoparticles could be applied for milk fortification to mask bitterness, inhibit colour change and enhance its solubility. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Fathi, Milad] Isfahan Univ Technol, Fac Agr, Dept Food Sci & Technol, Esfahan 8415683111, Iran.
   [Varshosaz, Jaleh] Isfahan Univ Med Sci, Fac Pharm, Dept Pharmaceut, Esfahan, Iran.
RP Fathi, M (reprint author), Isfahan Univ Technol, Fac Agr, Dept Food Sci & Technol, Esfahan 8415683111, Iran.
EM mfathi@cc.iut.ac.ir
RI varshosaz, jaleh/V-6124-2017; Varshosaz, Jaleh/W-2290-2017
OI , Jaleh/0000-0001-9333-5798
CR Augustin MA, 2011, J FUNCT FOODS, V3, P25, DOI 10.1016/j.jff.2011.01.003
   Borradaile NM, 1999, LIPIDS, V34, P591, DOI 10.1007/s11745-999-0403-7
   Chakraborty M, 2011, J SOLID STATE CHEM, V184, P2439, DOI 10.1016/j.jssc.2011.07.015
   Crcarevska MS, 2008, EUR J PHARM BIOPHARM, V68, P565, DOI 10.1016/j.ejpb.2007.06.007
   de Souza JRR, 2009, FOOD HYDROCOLLOID, V23, P2278, DOI 10.1016/j.foodhyd.2009.06.004
   Erlund I, 2004, NUTR RES, V24, P851, DOI 10.1016/j.nutres.2004.07.005
   ESPEVIK T, 1993, EUR J IMMUNOL, V23, P255, DOI 10.1002/eji.1830230140
   Fathi M, 2013, FOOD BIOPROCESS TECH, V6, P1464, DOI 10.1007/s11947-012-0845-2
   Fathi M, 2012, TRENDS FOOD SCI TECH, V23, P13, DOI 10.1016/j.tifs.2011.08.003
   Frost MB, 2001, FOOD QUAL PREFER, V12, P327, DOI 10.1016/S0950-3293(01)00018-0
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Grant J, 2006, ACS SYM SER, V934, P201
   Horcajada M. N., 2004, HESPERIDIN CITRUS FL
   KIM CK, 1992, INT J PHARM, V79, P11, DOI 10.1016/0378-5173(92)90088-J
   Kopermsub P, 2011, FOOD RES INT, V44, P605, DOI 10.1016/j.foodres.2010.12.011
   Lee JS, 2009, COLLOID SURFACE B, V70, P213, DOI 10.1016/j.colsurfb.2008.12.028
   Li T, 2007, J BIOMED MATER RES A, V83A, P383, DOI 10.1002/jbm.a.31322
   Luo QH, 2011, INT J PHARMACEUT, V403, P185, DOI 10.1016/j.ijpharm.2010.10.013
   Madrigal-Carballo S, 2010, J FUNCT FOODS, V2, P99, DOI 10.1016/j.jff.2010.01.002
   Mimmo T, 2005, CARBOHYD RES, V340, P2510, DOI 10.1016/j.carres.2005.08.011
   Miyagi Y, 2000, NUTR CANCER, V36, P224, DOI 10.1207/S15327914NC3602_12
   Mladenovska K, 2007, INT J PHARM, V345, P59, DOI 10.1016/j.ijpharm.2007.05.059
   Mladenovska K, 2007, INT J PHARM, V342, P124, DOI 10.1016/j.ijpharm.2007.05.028
   NASH RA, 1966, J PHARM SCI-US, V55, P829, DOI 10.1002/jps.2600550816
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Sarmento B, 2006, CARBOHYD POLYM, V66, P1, DOI 10.1016/j.carbpol.2006.02.008
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   So FV, 1996, NUTR CANCER, V26, P167, DOI 10.1080/01635589609514473
   SUGAWARA S, 1994, PHARMACEUT RES, V11, P272, DOI 10.1023/A:1018963626248
   Tanaka T, 1997, CARCINOGENESIS, V18, P957, DOI 10.1093/carcin/18.5.957
   Sejersen MT, 2007, INT DAIRY J, V17, P302, DOI 10.1016/j.idairyj.2006.03.003
   Tomas-Barberen FA, 2000, J SCI FOOD AGR, V80, P1073, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1073::AID-JSFA568>3.0.CO;2-B, 10.1002/(SICI)1097-0010(20000515)80:7<1073::AID-JSFA568>3.3.CO;2-2]
   Tommasini S, 2005, J PHARMACEUT BIOMED, V39, P572, DOI 10.1016/j.jpba.2005.05.009
   Wise DL, 2000, HDB PHARM CONTROLLED
   Ying DY, 2013, J FUNCT FOODS, V5, P98, DOI 10.1016/j.jff.2012.08.009
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
NR 38
TC 33
Z9 35
U1 4
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUL
PY 2013
VL 5
IS 3
BP 1382
EP 1391
DI 10.1016/j.jff.2013.05.006
PG 10
WC Food Science & Technology
SC Food Science & Technology
GA 195GZ
UT WOS:000322691600040
DA 2018-10-20
ER

PT J
AU Kashiwazaki, H
   Harada, N
   Akazawa, T
   Kabir, MA
   Minamida, Y
   Murata, M
AF Kashiwazaki, Haruhiko
   Harada, Naoki
   Akazawa, Toshiyuki
   Kabir, Md. Arafat
   Minamida, Yasuhito
   Murata, Masaru
TI Bone Augmentation Using Novel Unidirectional Porous Hydroxyapatite with
   Bone Morphogenetic Protein-2 on Rat Skull
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE Unidirectional porous hydroxyapatite (UDPHAp); Onlay graft; Bone
   augmentation; Recombinant human bone morphogenetic protein-2 (rhBMP-2)
ID RECOMBINANT HUMAN BMP-2; IN-VIVO; OSTEOGENESIS; REGENERATION; CERAMICS;
   COLLAGEN
AB Unidirectional porous hydroxyapatite (UDPHAp) is a material whose microstructure consists of cross-sectional oval pores with a pore diameter in the range of 100-300 mu m that penetrate through the material. UDPHAp has proven suitable for osteogenesis and angiogenesis. The present study was designed to evaluate the osteogenic effect of a newly developed UDPHAp as a carrier of recombinant human bone morphogenetic protein-2 (rhBMP-2) in a rat onlay graft model. UDPHAp was implanted beneath the calvarial periosteum of rats to simulate alveolar bone augmentation in a clinical condition. At 2 weeks after implantation, UDPHAp with rhBMP-2 resulted in active bone formation, and the augmented bone was connected directly with the original bone, whereas commercialized porous hydroxyapatite (PHAp) with rhBMP-2 showed little bone formation. These results suggest that UDPHAp in this model is suitable for onlay graft and is an effective biomaterial for the rhBMP-2 delivery system.
C1 [Kashiwazaki, Haruhiko; Harada, Naoki] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Sapporo, Hokkaido 0608586, Japan.
   [Akazawa, Toshiyuki] Hokkaido Res Org, Ind Technol Res Dev, Ind Res Inst, Sapporo, Hokkaido, Japan.
   [Kabir, Md. Arafat; Minamida, Yasuhito; Murata, Masaru] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral & Maxillofacial Surg, Tobetszt, Japan.
RP Kashiwazaki, H (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Kita Ku, Kita 13 Nishi 7, Sapporo, Hokkaido 0608586, Japan.
EM kashi@den.hokudai.ac.jp
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   [21592489]
FX This work was supported in part by Grant-in-Aid for Scientific Research
   (C) from the Ministry of Education, Culture, Sports, Science, and
   Technology of Japan (No. 21592489).
CR Akazawa T, 2006, J BIOMED MATER RES A, V76A, P44, DOI 10.1002/jbm.a.30439
   Fujita R, 2003, J ORAL MAXIL SURG, V61, P1045, DOI 10.1016/S0278-2391(03)00317-3
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303
   Iwasashi M, 2009, KEY ENG MATER, V396-398, P11, DOI 10.4028/www.scientific.net/KEM.396-398.11
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kashiwazaki H, 2010, J HARD TISSUE BIOL, V19, P181, DOI 10.2485/jhtb.19.181
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   Murata M, 2000, CLIN ORAL IMPLAN RES, V11, P289, DOI 10.1034/j.1600-0501.2000.011004289.x
   Murata M, 2001, J HARD TISSUE BIOL, V10, P1
   ONO I, 1992, PLAST RECONSTR SURG, V90, P870, DOI 10.1097/00006534-199211000-00023
   Suetsugu Y, 2007, KEY ENG MATER, V330-332, P1003, DOI 10.4028/www.scientific.net/KEM.330-332.1003
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Watanabe Arata, 2010, [Biomaterials Research, 생체재료학회지], V14, P6
NR 17
TC 2
Z9 2
U1 0
U2 3
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD JUL
PY 2013
VL 22
IS 3
BP 337
EP 341
DI 10.2485/jhtb.22.337
PG 5
WC Engineering, Biomedical
SC Engineering
GA 185TF
UT WOS:000321992500008
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Velmurugan, P
   Rao, JR
   Nair, BU
AF Velmurugan, Punitha
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
TI Biochemical and biophysical characterization of EDC treated rattus type
   I collagen
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Biomatrix; Collagen stabilization; Collagenase; EDC; Sidechain
   modification
ID INTRAMOLECULAR ISOPEPTIDE BONDS; CROSS-LINKING; SIDE-CHAINS; PROTEIN;
   BINDING; ACID; STABILIZATION; BIOMATERIAL; STABILITY; PEPTIDES
AB 1-Ethyl-3[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) treatment changes the biophysical and biochemical properties of collagen. EDC is known to be able to form an isopeptide bond between carboxyl and amine reactive groups. Surprisingly EDC did not form significant number of isopeptide bonds between intra-collagen and inter-collagen. EDC treatment enhances the helicity of the polyproline II conformation and fibril assembly. The treatment increases the hydrothermal stability, enhances cell viability and inhibit breakdown by bacterial collagenases. EDC treatment is a simple method to manufacture durable biomatrix with desirable properties. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Velmurugan, Punitha; Rao, Jonnalagadda Raghava; Nair, Balachandran Unni] Cent Leather Res Inst, Council Sci & Ind Res, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Rao, JR (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Chem Lab, Madras 600020, Tamil Nadu, India.
EM jrrao@clri.res.in
FU CSIR, New Delhi
FX One of the authors (V.P.) wishes to thank the CSIR, New Delhi, for
   providing the Senior Research Fellowship.
CR Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Eckhard U, 2011, NAT STRUCT MOL BIOL, V18, P1109, DOI 10.1038/nsmb.2127
   Fathima NN, 2003, J INORG BIOCHEM, V95, P47, DOI 10.1016/S0162-0134(03)00071-0
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GAILL F, 1995, J MOL BIOL, V246, P284, DOI 10.1006/jmbi.1994.0084
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Gratzer PF, 2007, J BIOMED MATER RES B, V81B, P1, DOI 10.1002/jbm.b.30629
   HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   Hand D, 2000, MOL CELL BIOCHEM, V204, P65, DOI 10.1023/A:1007068017315
   Jones MER, 2007, BIOMATERIALS, V28, P5215, DOI 10.1016/j.biomaterials.2007.08.026
   Kadler KE, 1966, BIOCHEM J, V316, P1
   Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806
   Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007
   Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514
   Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200
   Laemmli U. K., 1973, NATURE, V227, P680, DOI DOI 10.1038/227680A0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Madhan B, 2007, INT J BIOL MACROMOL, V41, P16, DOI 10.1016/j.ijbiomac.2006.11.013
   MANDL I, 1953, J CLIN INVEST, V32, P1323, DOI 10.1172/JCI102861
   Menter JM, 2001, PHOTODERMATOL PHOTO, V17, P114, DOI 10.1034/j.1600-0781.2001.170302.x
   Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1
   Philominathan STL, 2012, PROTEIN SCI, V21, P1554, DOI 10.1002/pro.2145
   Philominathan STL, 2009, J BIOL CHEM, V284, P10868, DOI 10.1074/jbc.M807684200
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x
   Tang LX, 2003, BIOCHEMISTRY-US, V42, P14057, DOI 10.1021/bi034941a
   Usha R, 2012, COLLOID SURFACE B, V90, P83, DOI 10.1016/j.colsurfb.2011.10.002
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Zakeri B, 2010, J AM CHEM SOC, V132, P4526, DOI 10.1021/ja910795a
   Zhong WY, 2003, SPECTROCHIM ACTA A, V59, P1281, DOI 10.1016/S1386-1425(02)00301-3
NR 35
TC 5
Z9 5
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD JUL
PY 2013
VL 48
IS 7
BP 1059
EP 1064
DI 10.1016/j.procbio.2013.05.014
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA 198NC
UT WOS:000322928600010
DA 2018-10-20
ER

PT J
AU He, Y
   Wang, WR
   Ding, JD
AF He Yao
   Wang WeiRan
   Ding JianDong
TI Effects of L-lactic acid and D,L-lactic acid on viability and osteogenic
   differentiation of mesenchymal stem cells
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE biodegradable polymer; biomaterial; tissue engineering; lactic acid;
   cytotoxicity; biocompatibility; mesenchymal stem cells
ID IN-VITRO DEGRADATION; POROUS POLY(D,L-LACTIDE-CO-GLYCOLIDE) SCAFFOLDS;
   POLY(L-LACTIC ACID); TISSUE; BONE; FABRICATION; COMPOSITE; DRUG;
   CYTOTOXICITY; REGENERATION
AB Poly(lactic acid) (PLA) and other aliphatic polyesters containing the unit of lactic acid are very popular biodegradable materials. While the degradation products, lactic acids, have been worried to bring with negative influence on biocompatibility, the focused experimental studies are less reported. This study is aimed at an in vitro examination of cytotoxicity of both L-lactic acid and D,L-lactic acid. Mesenchymal stem cells (MSCs) derived from rat bone marrow are employed to test the cytotoxicity of the lactic acids. Considering that the addition of lactic acids not only introduces lactate groups but also alters medium pH and ion strength, these three candidate effects are examined in a decoupled way by setting different comparison groups. The results confirm that the change of medium pH is the predominant factor. It has also been found that D-lactate is more cytotoxic than L-lactate at high concentrations. Yet, either L- or D,L-lactic acids seem acceptable in most of medical applications, because the cytotoxicity is significant only when the concentrations are as high as 20 mmol/L for both of them.
C1 [He Yao; Wang WeiRan; Ding JianDong] Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Adv Mat Lab, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Adv Mat Lab, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
FU National Basic Research Program of China [2009CB930000, 2011CB606203];
   National Natural Science Foundation of China [21034002, 91127028,
   51273046]
FX This work was supported by the National Basic Research Program of China
   (2009CB930000, 2011CB606203), and the National Natural Science
   Foundation of China (21034002, 91127028, 51273046).
CR BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chen JW, 2005, CELL TISSUE RES, V319, P429, DOI 10.1007/s00441-004-1025-0
   Chen T, 2009, CELL BIOL TOXICOL, V25, P573, DOI 10.1007/s10565-008-9113-7
   Chen YM, 2009, J BIOACT COMPAT POL, V24, P137, DOI 10.1177/0883911509102710
   Disthabanchong S, 2007, KIDNEY INT, V71, P201, DOI 10.1038/sj.ki.5002035
   Ewaschuk JB, 2005, J NUTR, V135, P1619
   Ge ZG, 2009, J BIOMATER APPL, V23, P533, DOI 10.1177/0885328208094301
   Ge ZG, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/021001
   Hakkarainen M, 2007, J AM CHEM SOC, V129, P6308, DOI 10.1021/ja0702871
   Hild N, 2011, NANOSCALE, V3, P401, DOI 10.1039/c0nr00615g
   Hua N, 2008, J MATER SCI-MATER M, V19, P3243, DOI 10.1007/s10856-008-3460-z
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JH, 2010, MACROMOL BIOSCI, V10, P173, DOI 10.1002/mabi.200900169
   Li D, 2012, CHINESE SCI BULL, V57, P435, DOI 10.1007/s11434-011-4914-0
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Liu W, 2007, BIOMATERIALS, V28, P5078, DOI 10.1016/j.biomaterials.2007.07.028
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   McCullen SD, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035002
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Odelius K, 2011, BIOMACROMOLECULES, V12, P1250, DOI 10.1021/bm1015464
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Putnam D, 2008, NAT MATER, V7, P836, DOI 10.1038/nmat2309
   Qu ZH, 2013, J BIOMAT SCI-POLYM E, V24, P447, DOI 10.1080/09205063.2012.690285
   Qu ZH, 2012, CHINESE J CHEM, V30, P2292, DOI 10.1002/cjoc.201200841
   Sarasua JR, 2011, J MATER SCI-MATER M, V22, P2513, DOI 10.1007/s10856-011-4425-1
   Sarasua JR, 1998, MACROMOLECULES, V31, P3895, DOI 10.1021/ma971545p
   Schop D, 2009, TISSUE ENG PT A, V15, P1877, DOI 10.1089/ten.tea.2008.0345
   Smith LA, 2010, BIOMATERIALS, V31, P5526, DOI 10.1016/j.biomaterials.2010.03.065
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086
   Wang Z, 2009, CHINESE SCI BULL, V54, P2968, DOI 10.1007/s11434-009-0181-8
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487
   Wu LB, 2006, J BIOMED MATER RES A, V76A, P264, DOI 10.1002/jbm.a.30544
   Wu LB, 2005, TISSUE ENG, V11, P1105, DOI 10.1089/ten.2005.11.1105
   Wu LB, 2006, BIOMATERIALS, V27, P185, DOI 10.1016/j.biomaterials.2005.05.105
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Xie SJ, 2010, BIOMATERIALS, V31, P5100, DOI 10.1016/j.biomaterials.2010.03.004
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang JF, 2010, J BIOMED MATER RES A, V92A, P817, DOI 10.1002/jbm.a.32378
   Yang YF, 2011, CHINESE SCI BULL, V56, P982, DOI 10.1007/s11434-010-4132-1
   Yang YF, 2010, J BIOMAT SCI-POLYM E, V21, P53, DOI 10.1163/156856209X410229
   Zhang PB, 2011, BIOMACROMOLECULES, V12, P2667, DOI 10.1021/bm2004725
   Zhang YY, 2012, BIOMATERIALS, V33, P2926, DOI 10.1016/j.biomaterials.2012.01.006
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
NR 50
TC 14
Z9 15
U1 3
U2 57
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
EI 1861-9541
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD JUL
PY 2013
VL 58
IS 20
BP 2404
EP 2411
DI 10.1007/s11434-013-5798-y
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 186HF
UT WOS:000322032000002
OA Bronze
DA 2018-10-20
ER

PT J
AU Rahimi, A
   Mashak, A
AF Rahimi, A.
   Mashak, A.
TI Review on rubbers in medicine: natural, silicone and polyurethane
   rubbers
SO PLASTICS RUBBER AND COMPOSITES
LA English
DT Review
DE Natural rubber; Silicone rubber; Polyurethane; Biomaterial; Drug
   delivery systems; Biomedical devices
ID CONTROLLED DRUG-DELIVERY; ENZYME-INDUCED BIODEGRADATION; LYMPH-NODE
   ASSAY; IN-VITRO; CONTROLLED-RELEASE; MOLECULAR-WEIGHT;
   POLYCARBONATE-POLYURETHANES; BIOMEDICAL APPLICATIONS; POLY(ETHYLENE
   GLYCOL); MECHANICAL-PROPERTIES
AB Natural, silicone and polyurethane rubbers are considered as three important biomaterials which have found widespread applications in medical technology. Biocompatibility, biodurability, sterilisability, processibility, as well as mechanical properties, such as flexibility and resilience, are properties that make these kinds of rubbers appropriate candidates for medical applications. Medical devices based on natural rubber, silicone and polyurethane rubbers include cardiac pacemaker leads, mammary prostheses, artificial skin, catheters, denture liners, diaphragms, blood pressure cuff coil, tubes and seals. These types of rubbers are commonly used in controlled drug delivery systems as a carrier for pharmaceutical agents and in the fabrication of other medical devices. These polymers were evaluated for release of hormones (e. g. estradiol and progesterone), metronidazole, nonoxynol-9, etc. In this paper, some recent advances on the development of these polymers in the biomedical field and some reports on the modification and improvement of their properties such as drug release and mechanical properties are reviewed.
C1 [Rahimi, A.; Mashak, A.] Iran Polymer & Petrochem Inst, Dept Novel Drug Delivery Syst, Tehran, Iran.
RP Mashak, A (reprint author), Iran Polymer & Petrochem Inst, Dept Novel Drug Delivery Syst, POB 14965-115, Tehran, Iran.
EM a.mashak@ippi.ac.ir
FU Iran National Science Foundation [87041557]
FX Financial support from the Iran National Science Foundation (grant no.
   87041557) is gratefully acknowledged.
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Abraham EK, 2006, J APPL POLYM SCI, V102, P2055, DOI 10.1002/app.23449
   [Anonymous], 2000, NAT RUBB MED DEV
   [Anonymous], 2009, POLYM PEOPLE
   [Anonymous], 1999, SIL RUBB MED DEV APP
   [Anonymous], 2000, MEET POLYISOPRENE
   [Anonymous], 2005, Position paper, Patent No. 6951654
   Arcana IM, 2010, J POLYM ENVIRON, V18, P188, DOI 10.1007/s10924-010-0189-9
   Asplund B, 2008, J BIOMED MATER RES B, V86B, P45, DOI 10.1002/jbm.b.30986
   Asplund JOB, 2007, BIOMACROMOLECULES, V8, P905, DOI 10.1021/bm061058u
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   Bauman JT, 2008, FATIGUE STRESS STRAI
   Bich N. N., RINSING METHODS REMO
   Brannon-Peppas L., 1997, MED PLAST BIOMATER, V4, P34
   Cardarelli N. F., 1967, RUBBER WORLD, V157, P77
   Carrasquillo M., 2005, APPL ENG MECH MED
   Coelho JFJ, 2010, J APPL POLYM SCI, V116, P718, DOI 10.1002/app.31465
   Cohn D, 2002, J BIOMED MATER RES, V59, P273, DOI 10.1002/jbm.1242
   Colas A, 2001, SILICONES PHARM APPL
   CONDESALAZAR L, 1993, J AM ACAD DERMATOL, V29, P176, DOI 10.1016/0190-9622(93)70163-N
   Coran A. Y., 1978, VULCANISATION SCI TE, P291
   Cristina Bo M., 2006, MAKROMOL CHEM-M SYMP, V245-246, P668
   D'Souza J. I., SILICONES ITS PHARM
   Danielsson C, 2006, BIOMATERIALS, V27, P1410, DOI 10.1016/j.biomaterials.2005.08.026
   De Jong WH, 2002, TOXICOL SCI, V66, P226, DOI 10.1093/toxsci/66.2.226
   Eceiza A, 2008, POLYM ENG SCI, V48, P297, DOI 10.1002/pen.20905
   ESTLANDER T, 1986, CONTACT DERMATITIS, V14, P20, DOI 10.1111/j.1600-0536.1986.tb01147.x
   Fan LT, 1989, CONTROLLED RELEASE Q
   FAVERO RJ, 1995, J ANIM SCI, V73, P3230
   Frade M. A. C., 2001, INT J DERMATOL, V40, P237
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Furno F, 2004, J ANTIMICROB CHEMOTH, V54, P1019, DOI 10.1093/jac/dkh478
   Geier J, 2003, CONTACT DERMATITIS, V48, P39, DOI 10.1034/j.1600-0536.2003.480107.x
   Ghavi FF, 2010, J BIOMED MATER RES B, V94B, P388, DOI 10.1002/jbm.b.31666
   Gotz C, 2009, POLYMER, V50, P5499, DOI 10.1016/j.polymer.2009.09.051
   Gopakumar S, 2006, POLYM ENG SCI, V46, P1812, DOI 10.1002/pen.20635
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Hardee G.E., 1998, DEV FORMULATION VET
   Hasma H., 2003, J RUBBER RES, V6, P231
   Hayashida K, 2007, J THORAC CARDIOV SUR, V134, P152, DOI 10.1016/j.jtcvs.2007.01.087
   HEESE A, 1991, J AM ACAD DERMATOL, V25, P831, DOI 10.1016/S0190-9622(08)80977-2
   Hepburn C., 1992, IRAN J POLYM SCI TEC, V1, P84
   Herculano RD, 2006, MACROMOL SYMP, V245, P529, DOI 10.1002/masy.200651376
   Herculano RD, 2007, J APPL SCI, V7, P3801
   Herculano RD, 2011, MAT SCI ENG C-MATER, V31, P272, DOI 10.1016/j.msec.2010.09.007
   Herculano RD, 2010, MATER RES-IBERO-AM J, V13, P57, DOI 10.1590/S1516-14392010000100013
   Herculano RD, 2009, MATER RES-IBERO-AM J, V12, P253, DOI 10.1590/S1516-14392009000200023
   Herdman RC, 2001, CANCER INVEST, V19, P821, DOI 10.1081/CNV-100107744
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hill DJT, 2001, RADIAT PHYS CHEM, V62, P11, DOI 10.1016/S0969-806X(01)00416-9
   Honeycutt T., 2007, RUBBER WORLD, V237, P32
   Hong Y, 2010, BIOMATERIALS, V31, P4249, DOI 10.1016/j.biomaterials.2010.02.005
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Jedlinski Z., 2006, ACAD RES PROG BIOCH, V2, P36
   Jones Lyndon, 2004, SILCIONE HYDROGEN CO
   Kalman P. G., 1990, J BIOMED MATER RES, V25, P199
   Kandavilli S., 2002, PHARM TECHNOL, P62
   Kim C., 2000, CONTROLLED RELEASE D
   Kim J, 2010, J CONTROL RELEASE, V148, P110, DOI 10.1016/j.jconrel.2010.07.119
   KORHONEN A, 1983, TERATOGEN CARCIN MUT, V3, P163, DOI 10.1002/1520-6866(1990)3:2<163::AID-TCM1770030208>3.0.CO;2-K
   Kost J, 1996, POLYM MAT ENCY, P1509
   Krol P, 2003, POLYMER, V44, P5075, DOI 10.1016/S0032-3861(03)00431-2
   Lahiri D, 2010, ACTA BIOMATER, V6, P3524, DOI 10.1016/j.actbio.2010.02.044
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1987, POLYURETHANES MED
   Li B, 2009, BIOMATERIALS, V30, P3486, DOI 10.1016/j.biomaterials.2009.03.008
   Loh XJ, 2006, BIOMATERIALS, V27, P1841, DOI 10.1016/j.biomaterials.2005.10.038
   Lucas P, 2002, POLYM DEGRAD STABIL, V76, P449, DOI 10.1016/S0141-3910(02)00048-4
   Malcolm K., 2005, EMERGING POLYM DESIG, Patent No. 6,951,654
   Malcolm R.K., 2010, ANTIVIR RES S1, V88S, P30
   Malcolm RK, 2005, J ANTIMICROB CHEMOTH, V56, P954, DOI 10.1093/jac/dki326
   Marks JG, 2000, ARCH DERMATOL, V136, P272, DOI 10.1001/archderm.136.2.272
   Mashak A, 2006, RADIAT PHYS CHEM, V75, P229, DOI 10.1016/j.radphyschem.2005.08.013
   Mashak A., 2005, P 7 IR SEM POL SCI T, P256
   Mashak A, 2009, IRAN POLYM J, V18, P279
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   Mendonca RJ, 2009, PHYTOTHER RES, V24, P764
   Metherell C., 1992, DEV CROP SCI, V23, P426
   Misra GS, 1993, INTRO POLYM CHEM
   Morton M, 1987, RUBBER TECHNOLOGY, P375
   Mrue Fatima, 2004, Mat. Res., V7, P277, DOI 10.1590/S1516-14392004000200010
   NAKAMURA A, 1990, BIOMATERIALS, V11, P92
   Nettis E, 2002, CLIN EXP ALLERGY, V32, P441, DOI 10.1046/j.1365-2222.2002.01308.x
   Neves WFP, 2006, J APPL POLYM SCI, V100, P702, DOI 10.1002/app.23416
   Neves-Junior WFP, 2006, BRAZ J PHYS, V36, P586, DOI 10.1590/S0103-97332006000400021
   Nieponice A, 2010, TISSUE ENG PT A, V16, P1215, DOI 10.1089/ten.TEA.2009.0427
   Park J., 2007, BIOMATERIALS INTRO
   Paulo N. M., 2005, Acta Scientiae Veterinariae, V33, P79
   Pendle T. D., 1997, PLAST RUB COMPOS PRO, V26, P147
   Popovic N, 2006, INT J PHARM, V314, P120, DOI 10.1016/j.ijpharm.2005.09.040
   Pukanszky B, 2008, EUR POLYM J, V44, P2431, DOI 10.1016/j.eurpolymj.2008.06.008
   Rahimi A, 2004, IRAN POLYM J, V13, P149
   Rahimi A, 2001, INT J INORG MATER, V3, P843, DOI 10.1016/S1466-6049(01)00162-3
   Rahimi A., 2000, P 5 SEM POL SCI TECH, P32
   Rahimi A., 2003, P 6 IR INT SEM POL S, P75
   Robinson J., 2001, POLYM MED
   Rose K, 2005, APPL ENVIRON MICROB, V71, P2803, DOI 10.1128/AEM.71.6.2803-2812.2005
   Rossi S, 2004, J ANTIMICROB CHEMOTH, V54, P1013, DOI 10.1093/jac/dkh477
   Rowlands AS, 2007, BIOMATERIALS, V28, P2109, DOI 10.1016/j.biomaterials.2006.12.032
   Schierholz JM, 1997, BIOMATERIALS, V18, P839, DOI 10.1016/S0142-9612(96)00199-8
   SCHULTZ HA, 1969, MOSQ NEWS, V29, P38
   Schweitzer P., 1990, CORROSION RESISTANCE
   Schweitzer P.A., 2007, CORROSION ENG HDB
   Sin D, 2010, MAT SCI ENG C-MATER, V30, P78, DOI 10.1016/j.msec.2009.09.002
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Smith J. P., 2002, ADV POLYM MED APPL M
   Soulas DN, 2011, J APPL POLYM SCI, V120, P821, DOI 10.1002/app.33055
   Spaans CJ, 2000, BIOMATERIALS, V21, P2453, DOI 10.1016/S0142-9612(00)00113-7
   Spaans CJ, 1998, POLYM BULL, V41, P131, DOI 10.1007/s002890050343
   STEINER M, 1992, CONTRACEPTION, V46, P279, DOI 10.1016/0010-7824(92)90008-H
   STOREY RF, 1994, POLYMER, V35, P830, DOI 10.1016/0032-3861(94)90882-6
   SUBRAMANIAM A, 1995, IMMUNOL ALLERGY CLIN, V15, P1
   SWANSON JW, 1974, J BIOMED MATER RES, V8, P357, DOI 10.1002/jbm.820080603
   Swarbrick J, 2002, ENCY PHARM TECHNOLOG
   Szelest-Lewandowska A, 2007, J BIOMED MATER RES A, V82A, P509, DOI 10.1002/jbm.a.31357
   Taghizadeh S. M., 2003, P 6 IR SEM POL SCI T, P157
   Taghizadeh SM, 2003, IRAN POLYM J, V12, P407
   Tanaka Y., 2001, CHEM STRUCTURE OCCUR
   Tang Q, 2011, CURR APPL PHYS, V11, P945, DOI 10.1016/j.cap.2010.12.035
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Thomson KF, 1999, BRIT J DERMATOL, V141, P863, DOI 10.1046/j.1365-2133.1999.03160.x
   TOJO K, 1985, AICHE J, V31, P741, DOI 10.1002/aic.690310506
   Touitou E., 2006, ENHANCEMENT DRUG DEL, P449
   Uchegbu I. F., 2006, POLYM DRUG DELIVERY
   UENO N, 1982, J BIOMED MATER RES, V16, P669, DOI 10.1002/jbm.820160514
   van Och FMM, 2001, TOXICOLOGY, V167, P207, DOI 10.1016/S0300-483X(01)00425-5
   Varghese H, 2000, J THERM ANAL CALORIM, V63, P749, DOI 10.1023/A:1010144205297
   VONHINTZENSTERN J, 1991, CONTACT DERMATITIS, V24, P244, DOI 10.1111/j.1600-0536.1991.tb01717.x
   Wang L, 2010, J BIOMED MATER RES A, V93A, P1260, DOI 10.1002/jbm.a.32621
   Wells B. G., 2005, PHARMACOTHERAPY HDB
   Whang HS, 2007, J APPL POLYM SCI, V106, P4104, DOI 10.1002/app.26956
   Wise D. L., 2000, BIOMATERIAL BIOENGIN
   Woolfson AD, 2003, J CONTROL RELEASE, V91, P465, DOI 10.1016/S0168-3659(03)00277-3
   Woolfson D., 2003, J MATER CHEM, V13, P2465
   Yeganeh H, 2007, POLYM DEGRAD STABIL, V92, P480, DOI 10.1016/j.polymdegradstab.2006.10.011
   Zhou MH, 2001, J APPL POLYM SCI, V79, P2464, DOI 10.1002/1097-4628(20010328)79:13<2464::AID-APP1054>3.0.CO;2-N
   Zlatanic A, 2004, J POLYM SCI POL PHYS, V42, P809, DOI 10.1002/polb.10737
NR 140
TC 27
Z9 29
U1 12
U2 197
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1465-8011
J9 PLAST RUBBER COMPOS
JI Plast. Rubber Compos.
PD JUL
PY 2013
VL 42
IS 6
BP 223
EP 230
DI 10.1179/1743289811Y.0000000063
PG 8
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 182TV
UT WOS:000321768300001
DA 2018-10-20
ER

PT J
AU Santos, SG
   Lamghari, M
   Almeida, CR
   Oliveira, MI
   Neves, N
   Ribeiro, AC
   Barbosa, JN
   Barros, R
   Maciel, J
   Martins, MCL
   Goncalves, RM
   Barbosa, MA
AF Santos, S. G.
   Lamghari, M.
   Almeida, C. R.
   Oliveira, M. I.
   Neves, N.
   Ribeiro, A. C.
   Barbosa, J. N.
   Barros, R.
   Maciel, J.
   Martins, M. C. L.
   Goncalves, R. M.
   Barbosa, M. A.
TI Adsorbed fibrinogen leads to improved bone regeneration and correlates
   with differences in the systemic immune response
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone repair/regeneration; Fibrinogen; Immune response; In vivo test;
   Inflammation
ID SELF-ASSEMBLED MONOLAYERS; MESENCHYMAL STEM-CELLS; IN-VITRO;
   INFLAMMATORY RESPONSE; CHITOSAN; TISSUE; BIOMATERIALS; SCAFFOLDS;
   ADHESION; VIVO
AB Designing new biomaterials that can modulate the inflammatory response instead of attempting just to reduce it constitutes a paradigm change in regenerative medicine. This work aimed to investigate the capacity of an immunomodulatory biomaterial to enhance bone regeneration. For that purpose we incorporated a molecule with well-established pro-inflammatory and pro-healing roles, fibrinogen, in chitosan scaffolds. Two different incorporation strategies were tested, leading to concentrations of 0.54 +/- 0.10 mg fibrinogen g(-1) scaffold immediately upon adsorption (Fg-Sol), and 0.34 +/- 0.04 mg fibrinogen g(-1) scaffold after washing (Fg-Ads). These materials were implanted in a critical size bone defect in rats. At two months post-implantation the extent of bone regeneration was examined by histology and the systemic immune response triggered was evaluated by determining the percentages of myeloid cells, T and B lymphocytes in the draining lymph nodes. The results obtained indicate that the fibrinogen incorporation strategy conditioned the osteogenic capacity of biomaterials. Fg-Ads scaffolds led to more bone formation, and the presence of Fg stimulated angiogenesis. Furthermore, animals implanted with Fg-Ads scaffolds showed significant increases in the percentages of B lymphocytes and myeloid cells in the draining lymph nodes, while levels of T lymphocytes were not significantly different. Finally, a significant increase in TGF-beta was detected in the plasma of animals implanted with Fg-Ads. Taken together the results presented suggest a potential correlation between the elicited immune response and biomaterial osteogenic performance. (c) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Santos, S. G.; Lamghari, M.; Almeida, C. R.; Oliveira, M. I.; Neves, N.; Ribeiro, A. C.; Barbosa, J. N.; Barros, R.; Maciel, J.; Martins, M. C. L.; Goncalves, R. M.; Barbosa, M. A.] Univ Porto, Inst Biomed Engn, P-4150180 Oporto, Portugal.
   [Lamghari, M.; Barbosa, J. N.; Martins, M. C. L.; Barbosa, M. A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4050313 Oporto, Portugal.
   [Neves, N.] Hosp Sao Joao, Dept Orthoped, Spine Grp, P-4200319 Oporto, Portugal.
   [Neves, N.] Univ Porto, Fac Med, P-4200 Oporto, Portugal.
   [Barros, R.; Maciel, J.] Univ Porto, Fac Engn, P-4200465 Oporto, Portugal.
RP Santos, SG (reprint author), Univ Porto, Inst Biomed Engn, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM susana.santos@ineb.up.pt
RI Maciel, Joana/J-3956-2014; Lamghari, Meriem/K-2159-2013; Goncalves,
   Raquel/C-5940-2012; Martins, M. Cristina/J-8284-2013; Barbosa,
   Mario/F-5964-2011; Almeida, Catarina/A-7018-2012; Oliveira,
   Marta/M-9386-2013; Santos, Susana/L-9351-2013
OI Maciel, Joana/0000-0003-3546-3817; Lamghari, Meriem/0000-0002-2500-4548;
   Goncalves, Raquel/0000-0003-2841-0485; Martins, M.
   Cristina/0000-0002-6574-4794; Barbosa, Mario/0000-0003-3568-7482;
   Almeida, Catarina/0000-0001-6670-6004; Oliveira,
   Marta/0000-0002-0578-9202; Santos, Susana/0000-0002-8604-2978; Novais
   Barbosa, Judite/0000-0003-1852-2790; Neves, Nuno/0000-0002-5413-435X
FU FEDER funds through the Programa Operacional Factores de Competitividade
   - COMPETE; Portuguese funds through FCT - Fundacao para a Ciencia e a
   Tecnologia [PEst-C/SAU/LA0002/2011, PTDC/SAU-BEB/099954/2008]; FCT-POPH
   [SFRH/BPD/48533/2008, SFRH/BPD/37090/2007, SFRH/BD/37582/2007];
   FCT-POPH-FSE (Ciencia)
FX This work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade - COMPETE and by Portuguese funds through
   FCT - Fundacao para a Ciencia e a Tecnologia in the framework of the
   projects PEst-C/SAU/LA0002/2011 and PTDC/SAU-BEB/099954/2008. CRA and
   MIO are recipients of post-doctoral fellowships from FCT-POPH
   (SFRH/BPD/48533/2008, SFRH/BPD/37090/2007). JM is recipient of a Ph.D.
   fellowship from FCT-POPH (SFRH/BD/37582/2007). SGS has a research
   position funded by FCT-POPH-FSE (Ciencia 2007).
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Almeida CR, 2012, J R SOC INTERFACE, V9, P261, DOI 10.1098/rsif.2011.0357
   Amaral IF, 2006, J BIOMED MATER RES A, V76A, P335, DOI 10.1002/jbm.a.30522
   Amaral IF, 2005, J BIOMAT SCI-POLYM E, V16, P1575, DOI 10.1163/156856205774576736
   Amaral IF, 2009, BIOMATERIALS, V30, P5465, DOI 10.1016/j.biomaterials.2009.06.056
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Antunes JC, 2011, BIOMACROMOLECULES, V12, P4183, DOI 10.1021/bm2008235
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2005, MICROSC RES TECHNIQ, V66, P37, DOI 10.1002/jemt.20141
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Boccafoschi F, 2012, J BIOMED MATER RES A, V100A, P2373, DOI 10.1002/jbm.a.34180
   Bode U, 2007, INT IMMUNOL, V19, P81, DOI 10.1093/intimm/dxl124
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Choi YJ, 2013, J BIOMED MATER RES A, V101, P547, DOI 10.1002/jbm.a.34356
   Cunha-Reis C, 2007, J MATER SCI-MATER M, V18, P195, DOI 10.1007/s10856-006-0681-x
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691
   Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kim H, 2011, J BIOMED MATER RES A, V97A, P395, DOI 10.1002/jbm.a.33070
   Kuhns DB, 2007, INFLAMMATION, V30, P178, DOI 10.1007/s10753-007-9035-1
   Le Guehennec L, 2005, J BIOMED MATER RES B, V72B, P69, DOI 10.1002/jbm.b.30118
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c
   LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044
   McCullen SD, 2011, CURR OPIN BIOTECH, V22, P715, DOI 10.1016/j.copbio.2011.05.001
   MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077
   MORI S, 1988, J HISTOCHEM CYTOCHEM, V36, P111, DOI 10.1177/36.1.3275709
   Mountziaris PM, 2008, TISSUE ENG PT B-REV, V14, P179, DOI 10.1089/ten.teb.2008.0038
   Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.TEB.2011.0182, 10.1089/ten.teb.2011.0182]
   Nair A, 2011, ACTA BIOMATER, V7, P3887, DOI 10.1016/j.actbio.2011.06.050
   Nakagawa Y, 2003, J BIOMED MATER RES B, V66B, P347, DOI 10.1002/jbm.b.10020
   Ode A, 2010, J BIOMED MATER RES A, V95A, P1114, DOI 10.1002/jbm.a.32909
   Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10
   Pan WM, 2013, INJURY, V44, P550, DOI 10.1016/j.injury.2012.09.019
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Pelegri C, 2001, CLIN EXP IMMUNOL, V125, P470, DOI 10.1046/j.1365-2249.2001.01592.x
   Prabaharan M, 2009, INT J BIOL MACROMOL, V44, P320, DOI 10.1016/j.ijbiomac.2009.01.005
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822
   Schmidt-Bleek K, 2014, J TISSUE ENG REGEN M, V8, P120, DOI 10.1002/term.1505
   Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7
   Silva MM, 2011, AESTHET PLAST SURG, V35, P789, DOI 10.1007/s00266-011-9688-x
   Takayanagi H, 2010, ANN NY ACAD SCI, V1192, P117, DOI 10.1111/j.1749-6632.2009.05303.x
   Tamma Roberto, 2012, Inflammation & Allergy Drug Targets, V11, P196
   Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979
   Thacker RI, 2008, EXP MOL PATHOL, V84, P122, DOI 10.1016/j.yexmp.2008.01.001
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tunc S, 2005, COLLOID SURFACE B, V42, P219, DOI 10.1016/j.colsurfb.2005.03.004
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Wei S, 2008, PATHOL RES PRACT, V204, P695, DOI 10.1016/j.prp.2008.07.002
   Yu HJ, 2007, BIOMACROMOLECULES, V8, P1425, DOI 10.1021/bm060910u
   Yussof SJM, 2011, ISRN MAT SCI, V2011
   Zhou FH, 2006, J BONE MINER RES, V21, P1075, DOI 10.1359/JBMR.060410
NR 60
TC 19
Z9 21
U1 1
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2013
VL 9
IS 7
BP 7209
EP 7217
DI 10.1016/j.actbio.2013.04.008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 168VT
UT WOS:000320736700010
PM 23571000
DA 2018-10-20
ER

PT J
AU Ruan, QC
   Zhang, YZ
   Yang, XD
   Nutt, S
   Moradian-Oldak, J
AF Ruan, Qichao
   Zhang, Yuzheng
   Yang, Xiudong
   Nutt, Steven
   Moradian-Oldak, Janet
TI An amelogenin-chitosan matrix promotes assembly of an enamel-like layer
   with a dense interface
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Enamel; Amelogenin; Chitosan hydrogel; Apatite; Biomimetic
ID DEVELOPING DENTAL ENAMEL; TOOTH ENAMEL; IN-VITRO; STREPTOCOCCUS-MUTANS;
   HYDROXYAPATITE; APATITE; NANOPARTICLES; REPAIR; FLUORIDE; GROWTH
AB Biomimetic reconstruction of tooth enamel is a significant topic of study in materials science and dentistry as a novel approach to the prevention, restoration, and treatment of defective enamel. We have developed a new amelogenin-containing chitosan hydrogel for enamel reconstruction that works through amelogenin supramolecular assembly, stabilizing Ca-P clusters and guiding their arrangement into linear chains. These amelogenin Ca-P composite chains further fuse with enamel crystals and eventually evolve into enamel-like co-aligned crystals, anchored to the natural enamel substrate through a cluster growth process. A dense interface between the newly grown layer and natural enamel was formed and the enamel-like layer improved the hardness and elastic modulus compared with etched enamel. We anticipate that this chitosan hydrogel will provide effective protection against secondary caries because of its pH-responsive and antimicrobial properties. Our studies introduce an amelogenin-containing chitosan hydrogel as a promising biomaterial for enamel repair and demonstrate the potential of applying protein-directed assembly to biomimetic reconstruction of complex biomaterials. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ruan, Qichao; Yang, Xiudong; Moradian-Oldak, Janet] Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA.
   [Zhang, Yuzheng; Nutt, Steven] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.
RP Moradian-Oldak, J (reprint author), Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA.
EM joldak@usc.edu
FU NIH-NIDCR [DE-13414, DE-020099]
FX This research was supported by NIH-NIDCR grants DE-13414 and DE-020099
   to J.M.O. The authors would like to thank Dr Sisi Liu for assistance
   with the transmission electron microscopy, and the Center for Electron
   Microscopy and Microanalysis (CEMMA) at USC for electron microscopy.
CR Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101
   Busch S, 2004, ANGEW CHEM INT EDIT, V43, P1428, DOI 10.1002/anie.200352183
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Cheng ZJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015020
   Cui FZ, 2007, J TISSUE ENG REGEN M, V1, P185, DOI 10.1002/term.21
   Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   de Paz LEC, 2011, APPL ENVIRON MICROB, V77, P3892, DOI 10.1128/AEM.02941-10
   Decker EM, 2005, J PERIODONTAL RES, V40, P373, DOI 10.1111/j.1600-0765.2005.00817.x
   Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675
   EDGAR WM, 1976, CARIES RES, V10, P241, DOI 10.1159/000260206
   Eimar H, 2012, ACTA BIOMATER, V8, P3400, DOI 10.1016/j.actbio.2012.06.002
   Fan DM, 2011, CELLS TISSUES ORGANS, V194, P194, DOI 10.1159/000324208
   Fan DM, 2009, J STRUCT BIOL, V166, P88, DOI 10.1016/j.jsb.2009.01.003
   Fan YW, 2007, BIOMATERIALS, V28, P3034, DOI 10.1016/j.biomaterials.2007.02.016
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108
   Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130
   Fletcher J, 2011, CRYSTENGCOMM, V13, P3692, DOI 10.1039/c0ce00806k
   Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271
   Gorgieva S, 2012, J BIOMED MATER RES A, V100A, P1655, DOI 10.1002/jbm.a.34106
   Guentsch A, 2010, ADV ENG MATER, V12, pB571, DOI 10.1002/adem.201080008
   Henson BS, 2010, METHODS MOL BIOL, V666, P21, DOI 10.1007/978-1-60761-820-1_2
   Iijima M, 2006, EUR J ORAL SCI, V114, P304, DOI 10.1111/j.1600-0722.2006.00324.x
   Lakshminarayanan R, 2007, BIOPHYS J, V93, P3664, DOI 10.1529/biophysj.107.113936
   Lee HS, 2012, J COLLOID INTERF SCI, V385, P235, DOI 10.1016/j.jcis.2012.06.074
   Li BQ, 2011, J BIOMAT SCI-POLYM E, V22, P505, DOI 10.1163/092050610X487800
   Li L, 2008, J MATER CHEM, V18, P4079, DOI 10.1039/b806090h
   Li L, 2011, ADV MATER, V23, P4695, DOI 10.1002/adma.201102773
   lijima M, 2005, BIOMATERIALS, V26, P1595
   Lingstrom P, 2000, J DENT RES, V79, P770, DOI 10.1177/00220345000790021101
   Liu WG, 2005, BIOMATERIALS, V26, P2705, DOI 10.1016/j.biomaterials.2004.07.038
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Mehdawi I, 2009, ACTA BIOMATER, V5, P2525, DOI 10.1016/j.actbio.2009.03.030
   Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034
   Murugan R, 2005, J CRYST GROWTH, V274, P209, DOI 10.1016/j.jcrysgro.2004.09.069
   Neilands J, 2011, CARIES RES, V45, P501, DOI 10.1159/000331206
   Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c
   Onuma K, 2005, J CRYST GROWTH, V282, P199, DOI 10.1016/j.jcrysgro.2005.04.085
   Petta V, 2006, EUR J ORAL SCI, V114, P308, DOI 10.1111/j.1600-0722.2006.00325.x
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434
   Qia YP, 2012, ACTA BIOMATER, V8, P836, DOI 10.1016/j.actbio.2011.10.033
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Ruttermann S, 2011, ACTA BIOMATER, V7, P1160, DOI 10.1016/j.actbio.2010.10.002
   Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2
   Arnaud TMS, 2010, J DENT, V38, P848, DOI 10.1016/j.jdent.2010.06.004
   STEPHAN RM, 1947, J DENT RES, V26, P340
   Sun Z, 2010, J DENT RES, V89, P344, DOI 10.1177/0022034509360660
   Wang LJ, 2008, J PHYS CHEM C, V112, P5892, DOI 10.1021/jp077105+
   Xie RQ, 2011, CRYST GROWTH DES, V11, P5206, DOI 10.1021/cg101708y
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
   Yang XD, 2011, J STRUCT BIOL, V176, P220, DOI 10.1016/j.jsb.2011.07.016
   Yang XD, 2010, J PHYS CHEM B, V114, P2293, DOI 10.1021/jp910219s
   Yin YJ, 2009, CHEM COMMUN, P5892, DOI 10.1039/b911407f
NR 55
TC 32
Z9 35
U1 8
U2 79
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2013
VL 9
IS 7
BP 7289
EP 7297
DI 10.1016/j.actbio.2013.04.004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 168VT
UT WOS:000320736700017
PM 23571002
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wagner-Ecker, M
   Voltz, P
   Egermann, M
   Richter, W
AF Wagner-Ecker, Mechthild
   Voltz, Pia
   Egermann, Marcus
   Richter, Wiltrud
TI The collagen component of biological bone graft substitutes promotes
   ectopic bone formation by human mesenchymal stem cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biological bone graft substitute; MSC; Hydroxyapatite (HA); Collagen;
   beta-TCP
ID MARROW STROMAL CELLS; BETA-TRICALCIUM PHOSPHATE; EX-VIVO EXPANSION;
   IN-VIVO; POROUS HYDROXYAPATITE; PORE-SIZE; OSTEOGENIC DIFFERENTIATION;
   DONOR VARIATION; ASSAYED INVIVO; REPAIR
AB Synthetic bone substitutes are attractive materials for repairing a variety of bone defects. They are readily available in unlimited quantities, have a defined composition without batch variability and bear no risk of disease transmission. When combined with mesenchymal stem cells (MSCs), bone healing can be further enhanced due to the osteogenic potential of these cells. However, human MSCs showed considerable donor variability in ectopic bone formation assays on synthetic bone substitutes, which may limit clinical success. This study addresses whether bone formation variability of MSCs is cell-intrinsic or biomaterial-dependent and may be improved using biological bone substitutes with and without collagen. Ectopic bone formation of MSCs from nine donors was tested in immune-deficient mice on biological bone substitutes of bovine and equine origin, containing collagen (bHA-C; eHA-C) or not (bHA; eHA). Synthetic beta-TCP was used for comparison. Histology of 8-week explants demonstrated a significant influence of the bone graft substitute (BGS) on donor variability of ectopic bone formation with best results seen for eHA-C (15/17) and beta-TCP (16/18). Bone was of human origin in all groups according to species-specific in situ hybridization, but MSCs from one donor formed no bone with any bone substitute. According to histomorphometry, most neo-bone was formed on eHA-C with significant differences to bHA, eHA and beta-TCP (p < 0.001). Collagen-free biological BGSs were inferior to biological BGSs with collagen (p < 0.001), while species-origin was of little influence. In conclusion, BGS composition had a strong influence on ectopic bone formation ability of MSCs, and biological BGSs with a collagen component seem most promising to display the strong osteogenic potential of MSCs. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wagner-Ecker, Mechthild; Voltz, Pia; Egermann, Marcus; Richter, Wiltrud] Univ Heidelberg Hosp, Res Ctr Expt Orthopaed, Heidelberg, Germany.
RP Richter, W (reprint author), Univ Heidelberg Hosp, Res Ctr Expt Orthopaed, Heidelberg, Germany.
EM wiltrudsichter@med.uni-heidelberg.de
RI Richter, Wiltrud/V-3217-2017
OI Richter, Wiltrud/0000-0003-4694-2768
FU Orthopaedic University Hospital Heidelberg; Geistlich Pharma AG
FX The authors would like to thank Dr. h.c. Robert Mathys Stifung
   (Bettlach, Switzerland) for providing beta-TCP and Geistlich Pharma AG
   (Wolhusen, Switzerland) for providing bHA, eHA-C and eHA. We thank
   Sebastian Fuchs and Katja Martin for helpful discussions, Simone Gantz
   for statistical analysis and Birgit Frey for technical assistance. This
   work was supported by a grant of the Orthopaedic University Hospital
   Heidelberg. Part of the consumables was funded by Geistlich Pharma AG.
CR Brocher J, UNPUB
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Dexheimer V, 2012, STEM CELLS DEV, V21, P2160, DOI 10.1089/scd.2011.0670
   Dexheimer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022980
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   GOSHIMA J, 1991, BIOMATERIALS, V12, P253, DOI 10.1016/0142-9612(91)90209-S
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Iqbal Jameel, 2011, Curr Osteoporos Rep, V9, P258, DOI 10.1007/s11914-011-0080-1
   Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37
   Janicki P, 2010, ACTA BIOMATER, V6, P3292, DOI 10.1016/j.actbio.2010.01.037
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   Kasten P, 2006, CELLS TISSUES ORGANS, V183, P68, DOI 10.1159/000095511
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Kato E, 2012, CLIN IMPLANT DENT RE
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   Kubinova S, 2010, MINIM INVASIV THER, V19, P144, DOI 10.3109/13645706.2010.481398
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Kuznetsov SA, 2000, TRANSPLANTATION, V70, P1780, DOI 10.1097/00007890-200012270-00018
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li S. T., 1996, T ORTHOP RES SOC, V21, P647
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Matsushima A, 2009, ARTIF ORGANS, V33, P474, DOI 10.1111/j.1525-1594.2009.00749.x
   McLain RF, 2005, J BONE JOINT SURG AM, V87A, P2655, DOI 10.2106/JBJS.E.00230
   Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.3.CO;2-#
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312
   Schnurer SM, 2003, ORTHOPADE, V32, P2, DOI 10.1007/s00132-002-0407-9
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402
   Steck E, 2010, XENOTRANSPLANTATION, V17, P153, DOI 10.1111/j.1399-3089.2010.00577.x
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   Tasso R, 2012, BIOMATERIALS, V33, P2086, DOI 10.1016/j.biomaterials.2011.11.043
   Wang S, 2011, J MATER SCI-MATER M, V22, P1195, DOI 10.1007/s10856-011-4297-4
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Zou C, 2005, BIOMATERIALS, V26, P5276, DOI 10.1016/j.biomaterials.2005.01.064
NR 58
TC 13
Z9 13
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2013
VL 9
IS 7
BP 7298
EP 7307
DI 10.1016/j.actbio.2013.03.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 168VT
UT WOS:000320736700018
PM 23542556
DA 2018-10-20
ER

PT J
AU Strobel, LA
   Hild, N
   Mohn, D
   Stark, WJ
   Hoppe, A
   Gbureck, U
   Horch, RE
   Kneser, U
   Boccaccini, AR
AF Strobel, L. A.
   Hild, N.
   Mohn, D.
   Stark, W. J.
   Hoppe, A.
   Gbureck, U.
   Horch, R. E.
   Kneser, U.
   Boccaccini, A. R.
TI Novel strontium-doped bioactive glass nanoparticles enhance
   proliferation and osteogenic differentiation of human bone marrow
   stromal cells
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Bioactive glass; Human bone marrow stromal cells; Nanoparticles;
   Osteogenic differentiation; Strontium; Bone tissue engineering
ID MESENCHYMAL STEM-CELLS; IN-VITRO; HUMAN OSTEOBLASTS; IONIC PRODUCTS;
   GROWTH-FACTOR; 45S5; REGENERATION; BIOMATERIAL; DISSOLUTION; COMPOSITES
AB The present study investigates a new family of bioactive glass nanoparticles with and without Sr-doping focusing on the influence of the nanoparticles on human bonemarrow stromal cells (hBMSCs) in vitro. The bioactive glass nanoparticles were fabricated by flame spray synthesis and a particle diameter of 30-35 nm was achieved. Glass nanoparticles were undoped (BG13-93-0Sr) or doped with 5 wt% strontium (Sr) (BG13-93-5Sr) and used at concentrations of 10 and 100 mu g/cm(2) (particles per culture plate area), respectively. Cells were cultured for 14 days after which the samples were analysed regarding metabolic activity and expression of various bone-specific genes. Cell growth and morphology indicated the high cytocompatibility of the nanoparticulate bioactive glass. The presence of the nanoparticles enhanced cell growth compared to the plain polystyrene control group. At a concentration of 100 mu g/cm(2), Sr-doped particles led to significantly enhanced gene expression of osteocalcin, collagen type 1 and vascular endothelial growth factor. Thus, Sr-doped nanoparticles showing a dose-dependent increase of osteogenic differentiation in hBMSCs are a promising biomaterial for bone regeneration purposes.
C1 [Strobel, L. A.; Horch, R. E.; Kneser, U.] Univ Erlangen Nurnberg, Med Ctr, Dept Plast & Hand Surg, D-91054 Erlangen, Germany.
   [Strobel, L. A.; Kneser, U.] BG Trauma Ctr, Burn Ctr, Dept Hand Plast & Reconstruct Surg, Ludwigshafen, Germany.
   [Hild, N.; Mohn, D.; Stark, W. J.] ETH, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Zurich, Switzerland.
   [Mohn, D.] Univ Zurich, Ctr Dent Med, Dept Prevent Dent Periodontol & Cariol, Zurich, Switzerland.
   [Hoppe, A.; Boccaccini, A. R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
   [Gbureck, U.] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
RP Boccaccini, AR (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, Cauerstr 6, D-91058 Erlangen, Germany.
EM aldo.boccaccini@ww.uni-erlangen.de
RI Boccaccini, Aldo/C-7905-2013; Gbureck, Uwe/G-1430-2012; Stark,
   Wendelin/A-8680-2008
OI Horch, Raymund E./0000-0002-6561-2353
FU Emerging Fields Initiative (EFI) of the University of
   Erlangen-Nuremberg, Germany; Deutsche Forschungsgemeinschaft DFG [KN
   578/2-1]
FX This work was partially supported by the Emerging Fields Initiative
   (EFI) of the University of Erlangen-Nuremberg, Germany (project
   "TOPbiomat"), and a research grant from the Deutsche
   Forschungsgemeinschaft DFG (KN 578/2-1). The authors gratefully thank
   Marina Milde for expert technical assistance.
CR Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x
   Arora P, 2012, J CELL MOL MED, V16, P1991, DOI 10.1111/j.1582-4934.2012.01534.x
   AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Boyd D, 2009, J MATER SCI-MATER M, V20, P413, DOI 10.1007/s10856-008-3569-0
   Brunner TJ, 2006, CHEM COMMUN, P1384, DOI 10.1039/b517501a
   Curtis AR, 2010, ACTA BIOMATER, V6, P3740, DOI 10.1016/j.actbio.2010.02.045
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Gorustovich AA, 2010, J BIOMED MATER RES A, V92A, P232, DOI 10.1002/jbm.a.32355
   Hao YQ, 2012, J NANOSCI NANOTECHNO, V12, P207, DOI 10.1166/jnn.2012.5125
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Isaac J, 2011, EUR CELLS MATER, V21, P130, DOI 10.22203/eCM.v021a11
   Labbaf S, 2011, BIOMATERIALS, V32, P1010, DOI 10.1016/j.biomaterials.2010.08.082
   Lao J, 2008, CHEM MATER, V20, P4969, DOI 10.1021/cm800993s
   Lim JY, 2011, J ORTHOP RES, V29, P1627, DOI 10.1002/jor.21441
   Mackovic M, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0966-6
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Mohn D, 2010, INT ENDOD J, V43, P1037, DOI 10.1111/j.1365-2591.2010.01772.x
   Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105
   Sila-Asna Monnipha, 2007, Kobe J Med Sci, V53, P25
   Stark WJ, 2002, POWDER TECHNOL, V126, P103, DOI 10.1016/S0032-5910(02)00077-3
   Sun JY, 2007, J TISSUE ENG REGEN M, V1, P281, DOI 10.1002/term.34
   Teoh WY, 2010, NANOSCALE, V2, P1324, DOI 10.1039/c0nr00017e
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   Wu CT, 2012, ACTA BIOMATER, V8, P3805, DOI 10.1016/j.actbio.2012.06.023
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yang F, 2011, STEM CELLS, V29, P981, DOI 10.1002/stem.646
NR 32
TC 16
Z9 16
U1 0
U2 52
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD JUL
PY 2013
VL 15
IS 7
AR UNSP 1780
DI 10.1007/s11051-013-1780-5
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 188DZ
UT WOS:000322173600028
DA 2018-10-20
ER

PT J
AU Li, G
AF Li, G.
TI Wettability and hemocompatibility of parallel grating microstructure
   surface
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Biomaterials; Blood compatibility; Grating microstructure; Wettability;
   Hydrophobicity
ID AMORPHOUS-CARBON FILMS
AB The mechanism of biomaterial associated thrombosis has not been fully elucidated. It is believed that surface wettability of biomaterials is a key factor in influencing thrombogenicity. Parallel grating microstructure poly(dimethylsiloxane) (PDMS) surfaces were designed and fabricated using soft lithography. The surface morphology is observed using scanning electron microscopy. The average contact angles for water droplet on the flat PDMS surface and parallel grating surface were 114.7 and 161.8 degrees respectively, and the sliding angles were similar to 19 and <4 degrees respectively. The blood platelet adhesion test was carried out to study the blood compatibility of the surface. The experimental result of blood platelet adhesion demonstrated that the amount of adsorbed blood platelet on the parallel grating microstructure surface was fewer, and no distortion and no activation were found, as compared with the smooth surface. It may be that the suitable wettability could be a reason for the observed variation in hemocompatibility between the textured surface and the smooth surface.
C1 East China Jiaotong Univ, Sch Mech & Elect Engn, Nanchang 330013, Peoples R China.
RP Li, G (reprint author), East China Jiaotong Univ, Sch Mech & Elect Engn, Nanchang 330013, Peoples R China.
EM ligang0794@163.com
FU Natural Science Foundation of Jiangxi Province [2011ZBAB215035,
   20122BAB206029]; International Science and Technology Cooperation
   Project of Jiangxi Province [20121BDH80016]; Science Fund Project of
   Jiangxi Provincial Department of Education [GJJ13343]
FX This material is based on work supported by the Natural Science
   Foundation of Jiangxi Province (grant nos. 2011ZBAB215035 and
   20122BAB206029), the International Science and Technology Cooperation
   Project of Jiangxi Province (grant no. 20121BDH80016), and the Science
   Fund Project of Jiangxi Provincial Department of Education (grant no.
   GJJ13343). The authors are grateful for their support.
CR Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Li G, 2010, INORG MATER+, V46, P1072, DOI 10.1134/S0020168510100080
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   Ong SE, 2007, BIOMATERIALS, V28, P4033, DOI 10.1016/j.biomaterials.2007.05.031
   Saito T, 2005, DIAM RELAT MATER, V14, P1116, DOI 10.1016/j.diamond.2004.09.017
   Yang P, 2006, NUCL INSTRUM METH B, V242, P22, DOI 10.1016/j.nimb.2005.08.081
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Yu LJ, 2000, SURF COAT TECH, V128, P484, DOI 10.1016/S0257-8972(00)00626-5
   Zhang S, 2006, THIN SOLID FILMS, V515, P66, DOI 10.1016/j.tsf.2005.12.037
NR 11
TC 2
Z9 2
U1 1
U2 19
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
EI 1433-075X
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD JUL
PY 2013
VL 17
SU 1
BP S144
EP S147
DI 10.1179/1432891713Z.000000000205
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 181VX
UT WOS:000321698900032
DA 2018-10-20
ER

PT J
AU Michelini, E
   Cevenini, L
   Calabretta, MM
   Spinozzi, S
   Camborata, C
   Roda, A
AF Michelini, Elisa
   Cevenini, Luca
   Calabretta, Maria Maddalena
   Spinozzi, Silvia
   Camborata, Cecilia
   Roda, Aldo
TI Field-deployable whole-cell bioluminescent biosensors: so near and yet
   so far
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE Whole-cell biosensor; Bioluminescence; Nanomaterial; Cell encapsulation;
   Analytical device
ID POROUS SILICON; LIVING CELLS; SYSTEMS; DESIGN; ENCAPSULATION;
   PERSPECTIVES; BIOREPORTER; FABRICATION; BACTERIA; SPORES
AB The use of smart supports and bioinspired materials to confine living cells and use them for field-deployable biosensors has recently attracted much attention. In particular, bioluminescent whole-cell biosensors designed to respond to different analytes or classes of analyte have been successfully implemented in portable and cost-effective analytical devices. Significant advances in detection technology, biomaterial science, and genetic engineering of cells have recently been reported. Now the challenge is to move from benchtop traditional cell-based assays to portable biosensing devices. Improvement of the analytical performance of these biosensors depends on the availability of optimized bioluminescent reporters, and promising approaches that go beyond reporter gene technology are emerging. To enable handling of cells as ready-to-use reagents, nature-inspired strategies have been used, with the objective of keeping cells in a dormant state until use. Several issues must still be investigated, for example long-term viability of cells, the possibility of performing real-time analysis, and multiplexing capability.
C1 [Michelini, Elisa; Spinozzi, Silvia; Camborata, Cecilia; Roda, Aldo] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Michelini, Elisa; Cevenini, Luca; Calabretta, Maria Maddalena; Roda, Aldo] INBB, I-00136 Rome, Italy.
RP Michelini, E (reprint author), Univ Bologna, Dept Chem G Ciamician, Via Selmi 2, I-40126 Bologna, Italy.
EM elisa.michelini8@unibo.it
OI CALABRETTA, Maria Maddalena/0000-0002-5673-3073; Roda,
   Aldo/0000-0001-7649-4797; CEVENINI, Luca/0000-0003-2506-8792; Michelini,
   Elisa/0000-0002-8651-0575
CR Affi M, 2009, SENSOR ACTUAT B-CHEM, V138, P310, DOI 10.1016/j.snb.2009.02.001
   Alloush HM, 2010, CLIN CHEM, V56, P1862, DOI 10.1373/clinchem.2010.145581
   Ataei F, 2013, BIOSENS BIOELECTRON, V41, P642, DOI 10.1016/j.bios.2012.09.037
   Ben-Yoav H, 2011, CRIT REV BIOTECHNOL, V31, P337, DOI 10.3109/07388551.2010.532767
   Blondeau M, 2012, J MATER CHEM, V22, P22335, DOI 10.1039/c2jm33647b
   Bolton EK, 2002, SENSOR ACTUAT B-CHEM, V85, P179, DOI 10.1016/S0925-4005(02)00106-5
   Branchini BR, 2005, ANAL BIOCHEM, V345, P140, DOI 10.1016/j.ab.2005.07.015
   Cevenini L, 2013, ANAL BIOANAL CHEM, V405, P1035, DOI 10.1007/s00216-012-6416-6
   Charrier T, 2011, ANAL BIOANAL CHEM, V400, P1061, DOI 10.1007/s00216-010-4354-8
   Checa SK, 2012, CURR OPIN BIOTECH, V23, P766, DOI 10.1016/j.copbio.2012.05.003
   Cheli F, 2012, J AGR FOOD CHEM, V60, P9529, DOI 10.1021/jf302555b
   Cheng KCC, 2012, NAT METHODS, V9, P937, DOI 10.1038/nmeth.2170
   Christensen Douglas A., 2009, V503, P239, DOI 10.1007/978-1-60327-567-5_13
   Close DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012441
   Date A, 2010, ANAL BIOANAL CHEM, V398, P349, DOI 10.1007/s00216-010-3930-2
   Date A, 2010, ADV BIOCHEM ENG BIOT, V117, P57, DOI 10.1007/10_2009_22
   Date A, 2007, ANAL CHEM, V79, P9391, DOI 10.1021/ac701606g
   Dhanekar S, 2013, BIOSENS BIOELECTRON, V41, P54, DOI 10.1016/j.bios.2012.09.045
   Elad T, 2012, BIOENGINEERED, V3, P124, DOI 10.4161/bbug.18879
   Esquembre R, 2012, SOFT MATTER, V8, P408, DOI 10.1039/c1sm06264f
   Flavel BS, 2011, ACS APPL MATER INTER, V3, P2463, DOI 10.1021/am2003526
   French C. E., 2011, SCI APPL SYNTH SYST
   Funes-Huacca M, 2012, LAB CHIP, V12, P4269, DOI 10.1039/c2lc40391a
   Harper JC, 2010, ACS NANO, V4, P5539, DOI 10.1021/nn101793u
   Jouanneau S, 2012, ENVIRON SCI TECHNOL, V46, P11979, DOI 10.1021/es3024918
   Lagarde F, 2011, ANAL BIOANAL CHEM, V400, P947, DOI 10.1007/s00216-011-4816-7
   Lam MHY, 2012, PROTEOMICS, V12, P1519, DOI 10.1002/pmic.201100471
   Li HQ, 2012, BIOSENS BIOELECTRON, V33, P299, DOI 10.1016/j.bios.2012.01.008
   Melamed S, 2012, CURR OPIN BIOTECH, V23, P2, DOI 10.1016/j.copbio.2011.11.024
   Michelini E, 2008, PHOTOCH PHOTOBIO SCI, V7, P212, DOI 10.1039/b714251j
   Michelini E, 2012, ANAL BIOANAL CHEM, V402, P1785, DOI 10.1007/s00216-011-5364-x
   Michelini E, 2009, METHODS MOL BIOL, V574, P1, DOI 10.1007/978-1-60327-321-3_1
   Raut N, 2012, ANAL BIOANAL CHEM, V402, P3147, DOI 10.1007/s00216-012-5756-6
   Rebois RV, 2008, METHODS, V45, P214, DOI 10.1016/j.ymeth.2008.06.006
   Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920
   Ripp S, 2008, ANAL BIOANAL CHEM, V391, P507, DOI 10.1007/s00216-007-1812-z
   Roda A, 2004, TRENDS BIOTECHNOL, V22, P295
   Roda A, 2011, BIOSENS BIOELECTRON, V26, P3647, DOI 10.1016/j.bios.2011.02.022
   Roda A, 2009, ANAL BIOANAL CHEM, V393, P109, DOI 10.1007/s00216-008-2435-8
   Scott D, 2011, ANNU REV ANAL CHEM, V4, P297, DOI 10.1146/annurev-anchem-061010-113855
   Scott D, 2011, BIOCONJUGATE CHEM, V22, P475, DOI 10.1021/bc100486b
   Yan SC, 2012, J NANOSCI NANOTECHNO, V12, P6873, DOI 10.1166/jnn.2012.6489
   Yang SH, 2013, SMALL, V9, P178, DOI 10.1002/smll.201202174
   Yang SH, 2009, ANGEW CHEM INT EDIT, V48, P9160, DOI 10.1002/anie.200903010
   Yoo SK, 2007, BIOSENS BIOELECTRON, V22, P1586, DOI 10.1016/j.bios.2006.07.014
   Zhang DY, 2012, MICROB BIOTECHNOL, V5, P87, DOI 10.1111/j.1751-7915.2011.00301.x
   Zhou M, 2011, ACCOUNTS CHEM RES, V44, P1232, DOI 10.1021/ar200096g
NR 47
TC 36
Z9 38
U1 2
U2 55
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD JUL
PY 2013
VL 405
IS 19
BP 6155
EP 6163
DI 10.1007/s00216-013-7043-6
PG 9
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 177OM
UT WOS:000321384700003
PM 23739749
DA 2018-10-20
ER

PT J
AU Tunali, M
   Ozdemir, H
   Kucukodaci, Z
   Akman, S
   Firatli, E
AF Tunali, Mustafa
   Ozdemir, Hakan
   Kucukodaci, Zafer
   Akman, Serhan
   Firatli, Erhan
TI In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a
   new platelet concentrate
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Article
DE Tissue engineering; Biomaterial(s); Scanning electron microscopy (EM);
   In vivo; Biocompatibility; Regenerative medicine
ID PLASMA PRP; SINUS-LIFT; VITRO; OSTEOBLASTS; MEMBRANE; TRIAL
AB We have developed a new, titanium-prepared, platelet-rich fibrin (T-PRF) together with the protocol for forming it, which is based on the hypothesis that titanium tubes may be more effective at activating platelets than the glass tubes used by Chouckroun in his platelet-rich fibrin (PRF) method. The aim of this study was to find a suitable animal model in which to evaluate the method and to investigate the efficacy of T-PRF for wound healing. Blood samples from 6 rabbits were used to confirm the protocol for formation of T-PRF. We evaluated T-PRF or T-PRF-like clots morphologically using scanning electron microscopy (EM). Blood samples from 5 rabbits were used to develop an experiment in which to evaluate the effects of T-PRF on wound healing. The mucoperiosteal flaps were filled with autologous T-PRF membranes from the vestibule in the anterior mandibular regions. Samples collected from the surgical sites were stained with haematoxylin and eosin. We found a mature fibrin network in T-PRF clots that had been centrifuged for 15 min at 3500 rpm and, 15 days after placement of the membrane, we found newly-forming connective tissue and islets of bony tissue in the T-PRF membrane. These results show that T-PRF could induce the formation of new bone with new connective tissue in a rabbit model of wound healing within 30 days of treatment. Published by Elsevier Ltd. on behalf of The British Association of Oral and Maxillofacial Surgeons.
C1 [Tunali, Mustafa; Kucukodaci, Zafer] Gulhane Mil Med Acad, Istanbul, Turkey.
   [Ozdemir, Hakan] Cumhuriyet Univ, Sch Dent, Sivas, Turkey.
   [Akman, Serhan] Selcuk Univ, Sch Dent, Konya, Turkey.
   [Firatli, Erhan] Istanbul Univ, Sch Dent, Istanbul, Turkey.
RP Tunali, M (reprint author), Gulhane Mil Med Acad, Dept Periodontol, Haydarpasa Training Hosp, Istanbul, Turkey.
EM mustafatunali@hotmail.com
OI FIRATLI, Erhan/0000-0002-4154-6929; Tunali, Mustafa/0000-0002-1251-3431
FU Scientific Research Project Coordination Center of the Gulhane Military
   Medical Academy
FX This study was supported by the Scientific Research Project Coordination
   Center of the Gulhane Military Medical Academy.
CR Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010
   Baeyens W, 2010, Rev Med Brux, V31, P521
   Braccini F, 2009, Rev Laryngol Otol Rhinol (Bord), V130, P175
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J, 2001, IMPLANTODONTIE, V42, P55
   Del Corso M, 2009, J PERIODONTOL, V80, P1694, DOI 10.1902/jop.2009.090253
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Ehrenfest DMD, 2010, ORAL SURG ORAL MED O, V110, P409, DOI 10.1016/j.tripleo.2010.05.056
   Ehrenfest DMD, 2009, ORAL SURG ORAL MED O, V108, P341, DOI 10.1016/j.tripleo.2009.04.020
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Gurbuzer B, 2010, J ORAL MAXIL SURG, V68, P980, DOI 10.1016/j.joms.2009.09.092
   He L, 2009, ORAL SURG ORAL MED O, V108, P707, DOI 10.1016/j.tripleo.2009.06.044
   Huang FM, 2010, J ENDODONT, V36, P1628, DOI 10.1016/j.joen.2010.07.004
   Inchingolo F, 2010, EUR REV MED PHARMACO, V14, P1075
   KINLOUGHRATHBONE RL, 1993, BLOOD, V82, P103
   Lee EH, 2010, ORAL SURG ORAL MED O, V109, pE33, DOI 10.1016/j.tripleo.2009.12.043
   O'Connell SM, 2008, WOUND REPAIR REGEN, V16, P749, DOI 10.1111/j.1524-475X.2008.00426.x
   O'Connell SM, 2007, ORAL SURG ORAL MED O, V103, P587, DOI 10.1016/j.tripleo.2007.03.017
   Sharma A, 2011, J PERIODONTOL, V82, P1396, DOI 10.1902/jop.2011.100731
   Simonpieri A, 2011, IMPLANT DENT, V20, P2, DOI 10.1097/ID.0b013e3181faa8af
   Toffler M, 2010, IMPLANT DENT, V19, P447, DOI 10.1097/ID.0b013e3181f57288
NR 22
TC 14
Z9 14
U1 3
U2 24
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
EI 1532-1940
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD JUL
PY 2013
VL 51
IS 5
BP 438
EP 443
DI 10.1016/j.bjoms.2012.08.003
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 178WY
UT WOS:000321479300013
PM 22951383
DA 2018-10-20
ER

PT J
AU Zhang, ZC
   Giordano, R
   Shen, G
   Chou, LL
   Qian, YF
AF Zhang, Zhe-chen
   Giordano, Russell
   Shen, Gang
   Chou, L. Lee
   Qian, Yu-fen
TI Shear bond strength of an experimental composite bracket
SO JOURNAL OF OROFACIAL ORTHOPEDICS-FORTSCHRITTE DER KIEFERORTHOPADIE
LA English
DT Article
DE Composite bracket; Orthodontic adhesive; Silane coupling agent;
   Sandblasting; Shear bond strength
ID IN-VITRO; PLASTIC BRACKETS; CERAMIC BRACKETS; DEFORMATION
   CHARACTERISTICS; POLYCARBONATE BRACKETS; ORTHODONTIC BRACKETS; METAL
   BRACKETS; ENAMEL; PORCELAIN; ADHESION
AB The in vitro shear bond strength of MZ100 brackets (an experimental composite bracket developed by the Dental Biomaterial Laboratory at Boston University) and the effect of different treatment methods on these brackets were evaluated.
   As the bonding substrates, 80 VitablocsA (R) Mark II (Vident, Brea, CA, USA) were chosen. Three treatment methods were employed on 60 MZ100 bracket bases (20 brackets per treatment): silane coupling agent (Porcelain Primer; Ormco, Orange, CA, USA), sandblasting (Basic Professional Model Sandblaster; Renfert GmbH, Germany), and non-treatment. Two different orthodontic adhesives were also used: Blugloo (TM) (Ormco, Orange, CA, USA) and Enlight (TM) (Ormco, Orange, CA, USA). Twenty metal brackets were used as controls. Shear bond strength tests were performed after sample preparation and bracket bonding.
   The mean shear bond strength of non-treated MZ100 brackets bonded with Enlight (TM) had the lowest value (7.9 MPa), while that of sandblasted MZ100 brackets bonded with Blugloo (TM) showed the highest value (17.9 MPa). The mean shear bond strength of non-treated MZ100 brackets was significantly lower than that of the other groups (p < 0.05). The mean shear bond strength of sandblasted MZ100 brackets bonded with Blugloo (TM) was significantly higher than that of those bonded with Enlight (TM) (p < 0.05). With the exception of the silane-Blugloo (TM) group, the treated MZ100 brackets demonstrated shear bond strengths that did not significantly differ from metal brackets.
   The use of sandblasting and silane coupling agent significantly increases the shear bond strength of the MZ100 brackets to values resembling those of metal brackets.
C1 [Zhang, Zhe-chen; Shen, Gang; Qian, Yu-fen] Jiao Tong Univ, Dept Orthodont, Sch Med, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200030, Peoples R China.
   [Giordano, Russell; Chou, L. Lee] Boston Univ, Dept Biomat, Boston, MA 02215 USA.
RP Qian, YF (reprint author), Shanghai Jiao Tong Univ, Dept Orthodont, Sch Med, Shanghai Key Lab Stomatol,Peoples Hosp 9, Room 213,Bldg 1,639 Zhi Zao Ju Rd, Shanghai 200030, Peoples R China.
EM yufen62004@yahoo.com.cn
FU Research Award Fund for Outstanding Young Teachers in Higher Education
   Institutions, China [jdy10046]
FX The authors wish to thank Mr. Ron L'Herault for technical help and Dr.
   Quan Yu for his statistical advice. This project was supported by the
   Research Award Fund for Outstanding Young Teachers in Higher Education
   Institutions, China (Grant No. jdy10046).
CR Addiego D, 2006, COMP MECH PROPERTIES, P1
   Aird J C, 1987, Br J Orthod, V14, P191
   AkinNergiz N, 1996, EUR J ORTHODONT, V18, P295
   Artun J, 1997, EUR J ORTHODONT, V19, P219, DOI 10.1093/ejo/19.2.219
   Bishara SE, 2008, ANGLE ORTHOD, V78, P1078, DOI 10.2319/112007-540.1
   Chang JC, 2003, J PROSTHET DENT, V90, P18, DOI 10.1016/S0022-3913(03)00217-8
   DOBRIN RJ, 1975, AM J ORTHOD DENTOFAC, V67, P24, DOI 10.1016/0002-9416(75)90126-8
   DOUGLASS JB, 1989, AM J ORTHOD DENTOFAC, V95, P96, DOI 10.1016/0889-5406(89)90387-9
   Faltermeier A, 2007, EUR J ORTHODONT, V29, P304, DOI 10.1093/ejo/cjm025
   FELDNER JC, 1994, AM J ORTHOD DENTOFAC, V106, P265, DOI 10.1016/S0889-5406(94)70046-X
   Forsberg C M, 1992, Br J Orthod, V19, P183
   Guan GQ, 2000, AM J ORTHOD DENTOFAC, V117, P438, DOI 10.1016/S0889-5406(00)70163-6
   Guan GQ, 2001, EUR J ORTHODONT, V23, P425, DOI 10.1093/ejo/23.4.425
   Harzer W, 2004, EUR J ORTHODONT, V26, P435, DOI 10.1093/ejo/26.4.435
   Imthiaz N, 2008, AUST ORTHOD J, V24, P15
   International Organisation for Standardization Office, 2003, 11405 ISOTS
   Krejci I, 1994, Quintessence Int, V25, P199
   Kunzelmann K, 2001, J DENT RES, V80
   Lai P Y, 1999, Aust Orthod J, V15, P235
   Liu JK, 2004, EUR J ORTHODONT, V26, P531, DOI 10.1093/ejo/26.5.531
   Liu JK, 2002, ANGLE ORTHOD, V72, P141
   Miller S, 1996, J Clin Orthod, V30, P217
   NAKAMICHI I, 1983, J DENT RES, V62, P1076, DOI 10.1177/00220345830620101501
   NEWBURG R, 1978, J AM DENT ASSOC, V96, P288, DOI 10.14219/jada.archive.1978.0071
   NEWMAN GV, 1969, AMER J ORTHODONTICS, V56, P573, DOI 10.1016/0002-9416(69)90193-6
   Powers JM, 2006, RESTORATIVE DENT MAT
   Reimann S, 2012, J OROFAC ORTHOP, V73, P184, DOI 10.1007/s00056-012-0074-3
   Reynolds I R, 1976, Br J Orthod, V3, P143
   Sadat-Khonsari Reza, 2004, J Orofac Orthop, V65, P26, DOI 10.1007/s00056-004-0205-6
   SCOTT GE, 1988, ANGLE ORTHOD, V58, P5
   Stanford S K, 1997, Semin Orthod, V3, P206, DOI 10.1016/S1073-8746(97)80071-0
   Summers A, 2004, AM J ORTHOD DENTOFAC, V126, P200, DOI 10.1016/j.ojodo.2003.06.013
   Swartz M L, 1988, J Clin Orthod, V22, P82
   THURMOND JW, 1994, J PROSTHET DENT, V72, P355, DOI 10.1016/0022-3913(94)90553-3
   Urabe H, 1999, ANGLE ORTHOD, V69, P267
   VIAZIS AD, 1990, AM J ORTHOD DENTOFAC, V98, P103, DOI 10.1016/0889-5406(90)70003-U
   Willems G, 1997, J DENT, V25, P271, DOI 10.1016/S0300-5712(96)00007-3
   Wood DP, 1996, ANGLE ORTHOD, V66, P207
   Zachrisson YO, 1996, AM J ORTHOD DENTOFAC, V109, P420, DOI 10.1016/S0889-5406(96)70124-5
NR 39
TC 1
Z9 2
U1 1
U2 9
PU URBAN & VOGEL
PI MUNICH
PA NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY
SN 1434-5293
J9 J OROFAC ORTHOP
JI J. Orofac. Orthop.
PD JUL
PY 2013
VL 74
IS 4
BP 319
EP 331
DI 10.1007/s00056-013-0154-z
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 180BK
UT WOS:000321567600007
PM 23807258
DA 2018-10-20
ER

PT J
AU Simcock, JW
   Than, M
   Ward, BR
   May, BCH
AF Simcock, J. W.
   Than, M.
   Ward, B. R.
   May, B. C. H.
TI Treatment of ulcerated necrobiosis lipoidica with ovine forestomach
   matrix
SO JOURNAL OF WOUND CARE
LA English
DT Article
DE ovine forestomach matrix; necrobiosis lipoidica; wound healing; chronic
   ulcer; extracellular matrix
ID EXTRACELLULAR-MATRIX; BIOMATERIAL
AB Necrobiosis lipoidica (NL) results from degradation of the collagen extracellular matrix; these recurring ulcerated lesions are an especially challenging condition to treat. Ovine forestomach matrix (OFM) is a decellularised extracellular matrix and was used to successfully close a pretibial ulcer resulting from NL. Complete closure of the wound was achieved in 22 weeks, after four applications of OFM. This suggests OFM may be considered for the treatment of these challenging wounds.
C1 [Simcock, J. W.] Univ Otago, Christchurch, New Zealand.
   [Than, M.] Christchurch Hosp, Christchurch, New Zealand.
   [Ward, B. R.; May, B. C. H.] Mesynthes Ltd, Lower Hutt, New Zealand.
RP Simcock, JW (reprint author), Univ Otago, Christchurch, New Zealand.
EM barnaby.may@mesynthes.com
FU Mesynthes Ltd.
FX This study was funded by Mesynthes Ltd., which manufactures Endoform.
   BRW and BCHM are shareholders of Mesynthes.
CR Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Brauns B, 2011, EUR J DERMATOL, V21, P791, DOI 10.1684/ejd.2011.1445
   Calne S, 2010, INT CONSENSUS ACELLU
   Hammami Houda, 2008, Dermatol Online J, V14, P11
   Irvine SM, 2011, BIOMATERIALS, V32, P6351, DOI 10.1016/j.biomaterials.2011.05.040
   Kosaka S., 2011, J DERMATOL, V39, P497
   Liden BA, 2013, ADV SKIN WOUND CARE, V26, P164, DOI 10.1097/01.ASW.0000428862.34294.d4
   Lun S, 2010, BIOMATERIALS, V31, P4517, DOI 10.1016/j.biomaterials.2010.02.025
   OIKARINEN A, 1987, J INVEST DERMATOL, V88, P227, DOI 10.1111/1523-1747.ep12525395
   Patsatsi A, 2011, CASE REP DERMATOL, V3, P89, DOI 10.1159/000327936
   Peyri J, 2007, SEMIN CUTAN MED SURG, V26, P87, DOI 10.1016/j.sder.2007.02.004
   Stewart E, 2006, J Wound Care, V15, P74
   Tidman MJ, 2005, BR J DIABETES VASC D, V5, P37, DOI DOI 10.1177/14746514050050010701
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
NR 14
TC 3
Z9 3
U1 0
U2 0
PU MA HEALTHCARE LTD
PI LONDON
PA ST JUDES CHURCH, DULWICH ROAD, LONDON SE24 0PB, ENGLAND
SN 0969-0700
J9 J WOUND CARE
JI J. Wound Care
PD JUL
PY 2013
VL 22
IS 7
BP 383
EP 384
DI 10.12968/jowc.2013.22.7.383
PG 2
WC Dermatology
SC Dermatology
GA 179UY
UT WOS:000321548100008
PM 24159661
DA 2018-10-20
ER

PT J
AU Hwang, YS
   Chiang, PR
   Hong, WH
   Chiao, CC
   Chu, IM
   Hsiue, GH
   Shen, CR
AF Hwang, Yih-Shiou
   Chiang, Ping-Ray
   Hong, Wei-Hsin
   Chiao, Chuan-Chin
   Chu, I-Ming
   Hsiue, Ging-Ho
   Shen, Chia-Rui
TI Study In Vivo Intraocular Biocompatibility of In Situ Gelation
   Hydrogels: Poly(2-Ethyl
   Oxazoline)-Block-Poly(epsilon-Caprolactone)-Block-Poly(2-Ethyl
   Oxazoline) Copolymer, Matrigel and Pluronic F127
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; POLY(ETHYLENE GLYCOL);
   DIBLOCK COPOLYMER; DRUG-DELIVERY; RELEASE; NEOVASCULARIZATION; VITRO;
   CYTOTOXICITY; RANIBIZUMAB
AB The long term in vivo biocompatibility is an essential feature for the design and development of sustained drug release carriers. In the recent intraocular drug delivery studies, hydrogels were suggested as sustained release carriers. The biocompatibility test for these hydrogels, however, was commonly performed only through in vitro cell culture examination, which is insufficient before the clinical applications. We compared three thermosensitive hydrogels that have been suggested as the carriers for drugs by their gel-solution phase-change properties. A new block terpolymer (PEOz-PCL-PEOz, ECE) and two commercial products (Matrigel (R) and Pluronic F127) were studied. The results demonstrated that the ocular media remained translucent for ECE and Pluronic F127 in the first 2 weeks, but cataract formation for Matrigel occurred in 2 weeks and for Pluronic F127 in 1 month, while turbid media was observed for both Matrigel and Pluronic F127 in 2 months. The electrophysiology examinations showed significant neuroretinal toxicity of Matrigel and Pluronic F127 but good biocompatibility of ECE. The neuroretinal toxicity of Matrigel and Pluronic F127 and superior biocompatibility of ECE hydrogel suggests ECE as more appropriate biomaterial for use in research and potentially in intraocular application.
C1 [Hwang, Yih-Shiou] Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan.
   [Hwang, Yih-Shiou] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan.
   [Chiang, Ping-Ray; Chu, I-Ming; Hsiue, Ging-Ho] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.
   [Hong, Wei-Hsin; Shen, Chia-Rui] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan.
   [Chiao, Chuan-Chin] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan.
   [Hsiue, Ging-Ho] Chung Yuan Christian Univ, Dept Chem Engn, R&D Ctr Membrane Technol, Chungli, Taiwan.
RP Shen, CR (reprint author), Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan.
EM crshen@mail.cgu.edu.tw
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
FU National Science Council of the Republic of China, Taiwan [NSC
   98-2622-E-033-011-CC1, NSC 99-2622-E-033-005-CC1,
   101-2320-B-182-027-MY3]; Chang Gung Memorial Hospital funds [CMRPG
   390311, CMRPG 380181, CMRPD180403, BMRP440]
FX This work was supported by the funding from the National Science Council
   of the Republic of China, Taiwan (NSC 98-2622-E-033-011-CC1, NSC
   99-2622-E-033-005-CC1 and 101-2320-B-182-027-MY3), and the Chang Gung
   Memorial Hospital funds (CMRPG 390311, CMRPG 380181, CMRPD180403 and
   BMRP440). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   DAVIDORF FH, 1990, RETINA-J RET VIT DIS, V10, P297, DOI 10.1097/00006982-199010000-00013
   Deng JJ, 2011, SOFT MATTER, V7, P5944, DOI 10.1039/c1sm05259d
   FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640
   Gong J, 2008, EXP EYE RES, V86, P957, DOI 10.1016/j.exer.2008.03.014
   Gu ZY, 2004, MACROMOLECULES, V37, P912, DOI 10.1021/ma0206218
   Hsiue GH, 2006, INT J PHARM, V317, P69, DOI 10.1016/j.ijpharm.2006.03.002
   Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060771u
   Kang Derwent Jennifer J, 2008, Trans Am Ophthalmol Soc, V106, P206
   Khattak SF, 2005, TISSUE ENG, V11, P974, DOI 10.1089/ten.2005.11.974
   Kibbey MC, 1994, METHODS CELL SCI, V16, P227
   Kitahara S, 2010, MED MOL MORPHOL, V43, P26, DOI 10.1007/s00795-009-0481-8
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Kwon JW, 2005, J CATARACT REFR SURG, V31, P607, DOI 10.1016/j.jcrs.2004.05.051
   Lee SC, 1999, MACROMOLECULES, V32, P1847, DOI 10.1021/ma981664k
   Luxenhofer R, 2011, J CONTROL RELEASE, V153, P73, DOI 10.1016/j.jconrel.2011.04.010
   Marashi SM, 2011, J ALLERGY CLIN IMMUN, V127
   Matthew JE, 2002, BIOMATERIALS, V23, P4615, DOI 10.1016/S0142-9612(02)00208-9
   Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K
   Misra GP, 2009, BIOMATERIALS, V30, P6541, DOI 10.1016/j.biomaterials.2009.08.025
   Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036
   Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099
   Peng K, 2010, SOFT MATTER, V6, P85, DOI 10.1039/b914166a
   Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001
   Qiu G, 2006, EXP EYE RES, V83, P141, DOI 10.1016/j.exer.2005.11.014
   Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004
   Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481
   Schlaad H, 2010, MACROMOL RAPID COMM, V31, P511, DOI 10.1002/marc.200900683
   Shen DF, 2006, OPHTHAL RES, V38, P71, DOI 10.1159/000090266
   Shen WY, 2000, GRAEF ARCH CLIN EXP, V238, P273, DOI 10.1007/s004170050353
   Shishido SM, 2003, BIOMATERIALS, V24, P3543, DOI 10.1016/S0142-9612(03)00153-4
   Sonoda A, 2010, CARDIOVASC INTER RAD, V33, P135, DOI 10.1007/s00270-009-9741-1
   Sun L, 2010, J POLYM SCI POL CHEM, V48, P4583, DOI 10.1002/pola.24255
   Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Turturro SB, 2011, BIOMATERIALS, V32, P3620, DOI 10.1016/j.biomaterials.2011.01.058
   Wang CH, 2012, BIOMACROMOLECULES, V13, P40, DOI 10.1021/bm2009558
   Wolinsky JB, 2007, MACROMOLECULES, V40, P7065, DOI 10.1021/ma071276v
   Zhong X, 2011, J MATER SCI-MATER M, P1
NR 45
TC 12
Z9 17
U1 8
U2 44
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 1
PY 2013
VL 8
IS 7
AR e67495
DI 10.1371/journal.pone.0067495
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 175ZH
UT WOS:000321271900012
PM 23840873
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Szarek, D
   Marycz, K
   Laska, J
   Bednarz, P
   Jarmundowicz, W
AF Szarek, Dariusz
   Marycz, Krzysztof
   Laska, Jadwiga
   Bednarz, Paulina
   Jarmundowicz, Wlodzimierz
TI Assessment of In vivo behavior of polymer tube nerve grafts
   simultaneously with the peripheral nerve regeneration process using
   scanning electron microscopy technique
SO SCANNING
LA English
DT Article
DE scanning electron microscopy; nerve fiber; neuroregeneration; tube nerve
   grafts; autograft; rat; sciatic nerve
ID FIBERS; DEGENERATION; AUTOGRAFTS; CONDUITS; POROSITY; SHEATHS; REPAIR;
   GAPS; RAT
AB In this study, scanning electron microscopy (SEM) has been applied for instantaneous assessment of processes occurring at the site of regenerating nerve. The technique proved to be especially useful when an artificial implant should have been observed but have not yet been extensively investigated before for assessment of nerve tissue. For in vivo studies, evaluation of implant's morphology and its neuroregenerative properties is of great importance when new prototype is developed. However, the usually applied histological techniques require separate and differently prepared samples, and therefore, the results are never a 100% comparable. In our research, we found SEM as a technique providing detailed data both on an implant behavior and the nerve regeneration process inside the implant. Observations were carried out during 12-week period on rat sciatic nerve injury model reconstructed with nerve autografts and different tube nerve grafts. Samples were analyzed with haematoxylin-eosin (HE), immunocytochemical staining for neurofillament and S-100 protein, SEM, TEM, and the results were compared. SEM studies enabled to obtain characteristic pictures of the regeneration process similarly to TEM and histological studies. Schwann cell transformation and communication as well as axonal outgrowth were identified, newly created and matured axons could be recognized. Concurrent analysis of biomaterial changes in the implant (degradation, collapsing of the tube wall, migration of alginate gel) was possible. This study provides the groundwork for further use of the described technique in the nerve regeneration studies. SCANNING 35: 232-245, 2013. (c) 2012 Wiley Periodicals, Inc.
C1 [Szarek, Dariusz] Wroclaw Univ Hosp, Dept Neurosurg, PL-55056 Wroclaw, Poland.
   [Marycz, Krzysztof] Univ Environm & Life Sci, Fac Biol & Anim Sci, Lab Electron Microscopy Studies, Wroclaw, Poland.
   [Laska, Jadwiga; Bednarz, Paulina] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biomat, Krakow, Poland.
   [Jarmundowicz, Wlodzimierz] Wroclaw Med Univ, Fac Postgrad Med Training, Dept Neurosurg, Wroclaw, Poland.
RP Szarek, D (reprint author), Wroclaw Univ Hosp, Dept Neurosurg, Borowska 213, PL-55056 Wroclaw, Poland.
EM szarekdariusz@gmail.com
RI Marycz, Krzysztof/A-2249-2017
OI Bednarz, Paulina/0000-0002-8286-9556
FU Polish Ministry of Science and Higher Education [2011/01/B/ST8/07795]
FX Contract grant sponsor: Polish Ministry of Science and Higher Education;
   Contract grant number: 2011/01/B/ST8/07795.
CR Blacher S, 2003, BIOMATERIALS, V24, P1033, DOI 10.1016/S0142-9612(02)00423-4
   Colonna M, 1996, J RECONSTR MICROSURG, V12, P205, DOI 10.1055/s-2007-1006477
   Dahlin L, 2004, OPER TECHN ORTHOP, V14, P138
   DENDUNNEN WFA, 1993, J MATER SCI-MATER M, V4, P521, DOI 10.1007/BF00120133
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   HAFTEK J, 1968, J ANAT, V103, P233
   Hall S, 2001, J HAND SURG-BRIT EUR, V26, P129, DOI 10.1054/jhsb.2000.0497
   Katayama Y, 2006, BIOMATERIALS, V27, P505, DOI 10.1016/j.biomaterials.2005.07.016
   Kline DG, 2000, NEUROSURGERY, V46, P1285, DOI 10.1097/00006123-200006000-00001
   Lee DY, 2006, J CRANIO MAXILL SURG, V34, P50, DOI 10.1016/jcm.2005.07.011
   Li C, 2009, ANAT REC, V292, P1648, DOI 10.1002/ar.20959
   Martinel R, 2008, GLIA, V56, P1506
   MATHUR A, 1983, SCAN ELECTRON MICROS, P975
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Matsuyama T, 2000, NEUROL MED-CHIR, V40, P187, DOI 10.2176/nmc.40.187
   Meek M, 2011, BIOMATERIALS, V22, P1177
   Meek MF, 2009, MICROSURG, V29, P473, DOI 10.1002/micr.20642
   Navarro X, 2011, NEUROL SCI, V22, P7
   OHMI S, 1962, Z ZELLFORSCH MIK ANA, V56, P625, DOI 10.1007/BF00540586
   Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031
   Rodriguez FJ, 1999, BIOMATERIALS, V20, P1489, DOI 10.1016/S0142-9612(99)00055-1
   Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   SHARMA AK, 1975, J NEUROL SCI, V24, P417, DOI 10.1016/0022-510X(75)90167-7
   Soldani G, 1998, BIOMATERIALS, V19, P1919, DOI 10.1016/S0142-9612(98)00085-4
   Szarek D, 2006, ENG BIOMATER, V56-57, P40
   Szarek D, 2012, J BIOMATERIALS NANOB, V3, P20, DOI DOI 10.4236/JBNB.2012.31004
   THOMAS PK, 1980, ACTA NEUROPATHOL, V52, P1, DOI 10.1007/BF00687222
   THOMAS PK, 1964, J ANAT, V98, P175
   Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833
   Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168
   Vleggeert-Lankamp CLAM, 2008, J NEUROSURG, V109, P294, DOI 10.3171/JNS/2008/109/8/0294
   Yoshimoto M, 2008, INT J ORAL MAX IMPL, V23, P457
   Yucel D, 2010, BIOMATERIALS, V31, P1596, DOI 10.1016/j.biomaterials.2009.11.013
NR 35
TC 5
Z9 5
U1 1
U2 17
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 0161-0457
EI 1932-8745
J9 SCANNING
JI Scanning
PD JUL
PY 2013
VL 35
IS 4
BP 232
EP 245
DI 10.1002/sca.21056
PG 14
WC Instruments & Instrumentation; Microscopy
SC Instruments & Instrumentation; Microscopy
GA 183NK
UT WOS:000321822600004
PM 23037803
DA 2018-10-20
ER

PT J
AU Balakrishnan, M
   Narayanan, R
AF Balakrishnan, M.
   Narayanan, R.
TI Synthesis of anodic titania nanotubes in Na2SO4/NaF electrolyte: A
   comparison between anodization time and specimens with biomaterial based
   approaches
SO THIN SOLID FILMS
LA English
DT Article
DE Titanium; Anodization; Nanotubes; Hydroxyapatite; Polarization
ID CORROSION-RESISTANCE; OXIDE-FILMS; OXIDATION; ALLOY; HYDROXYAPATITE;
   FABRICATION; TIO2
AB Surface modification of commercially pure titanium (cp-Ti) has been carried out by electrochemical anodic oxidation at constant voltage for different time periods (0.5, 1, 2 and 4.5 h). Currents developed during the anodization indicate that the nanotubes are formed due to the competition of titania formation and dissolution under the assistance of electric field. Topologies of the anodized titanium change remarkably with time of oxidation. The morphology of the as-prepared nanotubes was characterized by scanning electron microscopy and atomic force microscopy while the chemistry and crystallinity were characterized by energy-dispersive X-ray spectroscopy and X-ray diffraction respectively. The as-anodized oxide was of amorphous but transformed to anatase and/or rutile crystal structure upon annealing for 3 h at 600 degrees C. The anatase structure showed excellent apatite-forming ability and produced a compact apatite layer covering the surface completely upon treatment in simulated body fluid (SBF) solution for 30 h. Corrosion of anodized titanium samples was studied in a SBF solution using open circuit potential, polarization and electrochemical impedance measurements and compared with that of non-oxidized titanium. Among these samples, titanium anodized for 4.5 h exhibited superior corrosion properties. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Balakrishnan, M.] PSG Coll Technol, Dept Met Engn, Coimbatore 641004, Tamil Nadu, India.
   [Balakrishnan, M.] Indian Inst Technol Madras, Dept Met & Mat Engn, Chennai 600036, Tamil Nadu, India.
   [Narayanan, R.] Saveetha Sch Engn, Dept Mech Engn, Chennai 602105, Tamil Nadu, India.
RP Balakrishnan, M (reprint author), Indian Inst Technol Madras, Dept Met & Mat Engn, Chennai 600036, Tamil Nadu, India.
EM blkrish88@gmail.com
OI Munirathinam, Balakrishnan/0000-0002-7499-6424
FU University Grants Commission (UGC)
FX The authors kindly acknowledge the financial support provided by the
   University Grants Commission (UGC) to carry out this research work. We
   would like to express sincere thanks to Dr. Lakshman Neelakantan and D.
   Arvinda Babu for their useful advice, technical support and providing
   beam time. Thanks are also due to the staff members of PSG college of
   Technology, Indian Institute of Technology Madras for their help during
   the synthesis and characterization of the samples.
CR Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   Eliaz N, 2005, SURF ENG, V21, P238, DOI 10.1179/174329405X50091
   Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Jakubowicz J, 2008, ELECTROCHEM COMMUN, V10, P735, DOI 10.1016/j.elecom.2008.02.027
   Jianling Zhao X, 2005, SOLID STATE COMMUN, V13, P705
   Krupa D, 2003, J MATER PROCESS TECH, V143, P158, DOI 10.1016/S0924-0136(03)00398-4
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   Lakshmi BB, 1997, CHEM MATER, V9, P2544, DOI 10.1021/cm970268y
   Leach J.S.L., 1988, CORROS SCI, P2843
   Macak J.M., 2008, THESIS U ERLANGEN NU
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   Mor GK, 2003, J MATER RES, V18, P2588, DOI 10.1557/JMR.2003.0362
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Raja KS, 2005, ELECTROCHIM ACTA, V51, P154, DOI 10.1016/j.electacta.2005.04.011
   Saji VS, 2009, ACTA BIOMATER, V5, P2303, DOI 10.1016/j.actbio.2009.02.017
   Shukla AK, 2005, INTERMETALLICS, V13, P631, DOI 10.1016/j.intermet.2004.10.001
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Xiao P, 2007, ELECTROCHEM COMMUN, V9, P2441, DOI 10.1016/j.elecom.2007.07.020
   Xuanyong Liua, 2004, MAT SCI ENG R, V47, P49
   Yu XF, 2008, SENSOR ACTUAT B-CHEM, V130, P25, DOI 10.1016/j.snb.2007.07.076
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
NR 26
TC 14
Z9 15
U1 0
U2 33
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD JUL 1
PY 2013
VL 540
BP 23
EP 30
DI 10.1016/j.tsf.2013.05.122
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 178HN
UT WOS:000321437400004
DA 2018-10-20
ER

PT J
AU Franco, GR
   Laraia, IO
   Maciel, AAW
   Miguel, NM
   dos Santos, GR
   Fabrega-Carvalho, CA
   Pinto, CAL
   Pettian, MS
   Cunha, MR
AF Franco, G. R.
   Laraia, I. O.
   Maciel, A. A. W.
   Miguel, N. M.
   dos Santos, G. R.
   Fabrega-Carvalho, C. A.
   Pinto, C. A. L.
   Pettian, M. S.
   Cunha, M. R.
TI Effects of chronic passive smoking on the regeneration of rat femoral
   defects filled with hydroxyapatite and stimulated by laser therapy
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Osseointegration; Hydroxyapatite; Laser therapy; Tobacco; Osteoporosis
ID GENE-EXPRESSION; BONE SUBSTITUTE; SYNTHETIC HYDROXYAPATITE; NICOTINE;
   RECONSTRUCTION; SUBPERIOSTEAL; IMPLANTS; DENSITY; CELLS; TIBIA
AB Defects associated with bone mass loss are frequently treated by autogenous bone grafting. However, synthetic biomaterials such as calcium phosphate ceramics can substitute autologous grafts as long as they are biocompatible with bone tissue. In addition, low-level laser therapy (LLLT) is used to enhance bone regeneration by stimulating the local microcirculation and increasing the synthesis of collagen by bone cells. However, bone health is fundamental for osseointegration of the graft and bone repair. In this respect, excessive tobacco consumption can compromise expected outcomes because of its deleterious effects on bone metabolism that predispose to the development of osteoporosis. The objective of this study was to evaluate the regeneration of bone defects implanted with biomaterial and stimulated by LLLT in rats submitted to passive cigarette smoking. Porous hydroxyapatite granules were implanted into critical-size defects induced experimentally in the distal epiphysis of the right femur of 20 female Wistar rats submitted to passive smoking for 8 months in a smoking box. The defect site was irradiated with a gallium-arsenide laser at an intensity of 5.0 J/cm(2). The animals were divided into four groups: control (non-smoking) rates submitted (G2) or not (G1) to laser irradiation, and smoking rats submitted (G4) or not (G3) to laser irradiation. The animals were sacrificed 8 weeks after biomaterial implantation. The right femurs were removed for photodocumentation, radiographed, and processed for routine histology. The results showed good radiopacity of the implant site and of the hydroxyapatite granules. Histologically, formation of new trabecular bone was observed adjacent to the hydroxyapatite granules in G1 and G2. In G3 and G4, the granules were surrounded mainly by connective tissue. In conclusion, passive smoking compromised bone neoformation in the defects and the LLLT protocol was not adequate to stimulate local osteogenesis. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Franco, G. R.; Laraia, I. O.; Maciel, A. A. W.; Miguel, N. M.; dos Santos, G. R.; Fabrega-Carvalho, C. A.; Pinto, C. A. L.; Pettian, M. S.; Cunha, M. R.] Fac Med Jundiai, Dept Morphol & Pathol, BR-13202550 Sao Paulo, Brazil.
RP Cunha, MR (reprint author), Fac Med Jundiai, Dept Morphol & Pathol, Rua Francisco Telles 250,Cx Postal 1295, BR-13202550 Sao Paulo, Brazil.
EM cunhamr@hotmail.com
RI Pinto, Clovis/P-5629-2014
OI Pinto, Clovis/0000-0003-1711-0081
FU Nucleus of Support to Research and Teaching (NAPED), Faculty of Medicine
   of Jundiai and Research Foundation of the State of Sao Paulo (FAPESP)
   [2010/05769-2]
FX This work was supported by the Nucleus of Support to Research and
   Teaching (NAPED), Faculty of Medicine of Jundiai and Research Foundation
   of the State of Sao Paulo (FAPESP) (grant number: 2010/05769-2).
CR Akmal M, 2004, SPINE, V29, P568, DOI 10.1097/01.BRS.0000101422.36419.D8
   Alemdaroglu KB, 2009, INJURY, V40, P1151, DOI 10.1016/j.injury.2008.12.011
   Borges APB, 2000, ARQ BRAS MED VET ZOO, V52, P616, DOI 10.1590/S0102-09352000000600011
   Burstein FD, 1997, PLAST RECONSTR SURG, V100, P869, DOI 10.1097/00006534-199709001-00007
   Camilli JA, 2004, ARCH ORAL BIOL, V49, P747, DOI 10.1016/j.archoralbio.2004.02.009
   Cesar-Neto JB, 2005, IMPLANTOL BRAZ ORAL, V19, P47
   Franco KL, 2001, ARQ BRAS MED VET ZOO, V53, P431, DOI 10.1590/S0102-09352001000400007
   FRAYSSINET P, 1992, BIOMATERIALS, V13, P668, DOI 10.1016/0142-9612(92)90126-9
   Gao SG, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-131
   Gondim ALMF, 2007, THESIS CATHOLIC U PO
   GORDJESTANI M, 1994, INT J ORAL MAX SURG, V23, P54, DOI 10.1016/S0901-5027(05)80329-7
   Gullihorn L, 2005, J ORTHOP TRAUMA, V19, P17, DOI 10.1097/00005131-200501000-00004
   Hapidin H, 2010, CALCIFIED TISSUE INT, V88, P41
   Hollinger JO, 1999, J BIOMED MATER RES, V45, P294
   HONIG JF, 1993, AESTHET PLAST SURG, V17, P93, DOI 10.1007/BF02274727
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Lirani Ana Paula R., 2005, Arq Bras Endocrinol Metab, V49, P891, DOI 10.1590/S0004-27302005000600006
   Ma L, 2010, J ORAL MAXIL SURG, V68, P777, DOI 10.1016/j.joms.2009.07.102
   Mandarim de Lacerda CA, 1999, BRAZ J MORPHOL, V16, P131
   Merli LAD, 2005, PHOTOMED LASER SURG, V23, P212, DOI 10.1089/pho.2005.23.212
   Nandi SK, 2008, J VET SCI, V9, P183, DOI 10.4142/jvs.2008.9.2.183
   Okazaki A, 2000, BIOMATERIALS, V21, P483, DOI 10.1016/S0142-9612(99)00198-2
   ONO I, 1993, PLAST RECONSTR SURG, V92, P819, DOI 10.1097/00006534-199392050-00007
   Ono I, 2000, BIOMATERIALS, V21, P143, DOI 10.1016/S0142-9612(99)00141-6
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Pinheiro Thiago Cerizza, 2008, Rev. bras. ortop., V43, P433, DOI 10.1590/S0102-36162008001000003
   Rezende CMF, 1998, ARQ BRAS MED VET ZOO, V50, P537
   Rothem DE, 2011, BONE, V48, P903, DOI 10.1016/j.bone.2010.12.007
   SANZANA S EDGARDO, 2006, Rev Chil Cir, V58, P431, DOI 10.4067/S0718-40262006000600007
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   Shen V, 2000, J BONE MINER RES, V15, P740, DOI 10.1359/jbmr.2000.15.4.740
   Shirane Henrique Yassuhiro, 2010, Rev. bras. ortop., V45, P478, DOI [10.1590/S0102-36162010000500017, 10.1016/S2255-4971(15)30439-0]
   Silva R. V., 2006, J CRANIOFAC SURG, V17, P297
   Tanaka H, 2005, LIFE SCI, V77, P2273, DOI 10.1016/j.lfs.2005.02.022
   Theiss SM, 2000, SPINE, V25, P2588, DOI 10.1097/00007632-200010150-00008
   Thomsnom RC, 1998, BIOMATERIALS, V9, P935
   Vidigal Jr GM, 1997, REV BRAS ODONTOL, V54, P218
   Vieira Daniel Ferreira Fernandes, 2011, Rev. bras. ortop., V46, P718, DOI [10.1590/S0102-36162011000600015, 10.1016/S2255-4971(15)30331-1]
   Vital CC, 2006, ARQ BRAS MED VET ZOO, V58, P175, DOI 10.1590/S0102-09352006000200005
   Walker LM, 2001, BONE, V28, P603, DOI 10.1016/S8756-3282(01)00427-6
   Yamano S, 2010, CLIN ORAL IMPLAN RES, V21, P1353, DOI 10.1111/j.1600-0501.2010.01955.x
   Zheng LW, 2008, BONE, V43, P355, DOI 10.1016/j.bone.2008.04.002
NR 42
TC 9
Z9 11
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
J9 INJURY
JI Injury-Int. J. Care Inj.
PD JUL
PY 2013
VL 44
IS 7
BP 908
EP 913
DI 10.1016/j.injury.2012.12.022
PG 6
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 166XF
UT WOS:000320592500006
PM 23340234
DA 2018-10-20
ER

PT J
AU Xiao, W
   Hu, XY
   Zeng, W
   Huang, JH
   Zhang, YG
   Luo, ZJ
AF Xiao, Wei
   Hu, X. Y.
   Zeng, Wen
   Huang, J. H.
   Zhang, Y. G.
   Luo, Z. J.
TI Rapid sciatic nerve regeneration of rats by a surface modified
   collagen-chitosan scaffold
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Peripheral nerve injury; Nerve regeneration; Tissue engineering; Surface
   modification; Collagen; Chitosan; Peptide; Sciatic nerve; Scaffold;
   Biomaterial
ID CELL-ADHESION; RGD; POLYMERS; PEPTIDE; GRAFTS
AB In the previous study, we attempted to use a collagen-chitosan (CCH) scaffold to mimic the biofunctional peripheral nerve and to bridge sciatic nerve defects in rats. The results demonstrated that it could support and guide the nerve regeneration after three months. In the current study, a type of peptide which carried RGD sequences was connected to the CCH surface by a chemical method. After this process, the microtubule structure of the scaffold was not changed. Then the coated scaffolds were used to repair a 15 mm sciatic nerve defect in rats. Four weeks after implantation, linear growth of axons in the longitudinal structure was observed, and the number of regenerated axons remarkably increased. Two months later, the scaffold was partly absorbed and replaced by large quantity of regenerated axons. Importantly, the functional examinations also support the morphological results. Compared with the CCH group, all of the achievements revealed the superior function of RGD-CCH in the rapid regeneration of injured sciatic nerve. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Xiao, Wei; Hu, X. Y.; Zeng, Wen; Huang, J. H.; Zhang, Y. G.; Luo, Z. J.] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China.
RP Luo, ZJ (reprint author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China.
EM magicdoc@yahoo.cn
FU National Foundation Grant (NSFC) [81101352]; Forth Military Medical
   University
FX This work was supported by a National Foundation Grant (NSFC, no.
   81101352), and a grant for young scientists of Forth Military Medical
   University.
CR [Anonymous], 1984, SOLID PHASE PEPTIDE, P114
   Boyd JG, 2003, EXP NEUROL, V183, P610, DOI 10.1016/S0014-4886(03)00183-3
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   Fechine GJM, 2004, POLYMER, V45, P2303, DOI 10.1016/j.polymer.2004.02.003
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hu XY, 2009, TISSUE ENG PART A, V11, P3297
   Huang JH, 2009, J NEUROTRAUM, V26, P1805, DOI [10.1089/neu.2008.0732, 10.1089/neu.2008-0732]
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Lateef SS, 2002, BIOMATERIALS, V23, P3159, DOI 10.1016/S0142-9612(02)00062-5
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rafiuddin Ahmed M, 2003, BRAIN RES, P208
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
NR 16
TC 20
Z9 22
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
J9 INJURY
JI Injury-Int. J. Care Inj.
PD JUL
PY 2013
VL 44
IS 7
BP 941
EP 946
DI 10.1016/j.injury.2013.03.029
PG 6
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 166XF
UT WOS:000320592500011
PM 23642627
DA 2018-10-20
ER

PT J
AU Zhuang, Z
   Yoshimura, H
   Aizawa, M
AF Zhuang, Zhi
   Yoshimura, Hideyuki
   Aizawa, Mamoru
TI Synthesis and ultrastructure of plate-like apatite single crystals as a
   model for tooth enamel
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydroxyapatite single crystal; Morphology control; Ultrastructure; Tooth
   enamel
ID OCTACALCIUM PHOSPHATE; HYDROXYAPATITE; BONE; PROLIFERATION;
   BIOMATERIALS; REPLACEMENT; BIOCERAMICS; OSTEOBLASTS; MACROPORES;
   AIR/WATER
AB Hydroxyapatite (HAp) is an inorganic constituent compound of human bones and teeth, with superior biocompatibility and bioactivity characteristics. Its crystal structure is hexagonal, characterized by a(b)- and c-planes. In vertebrate long bones, HAp crystals have a c-axis orientation, while in tooth enamel, they have an a(b)-axis orientation. Many methods can be used to synthesize c-axis oriented HAp single crystals; however, to the best of our knowledge, there have been no reports on a synthesis method for a(b)-axis oriented HAp single crystals. In this study, we successfully synthesized plate-like HAp crystals at the air-liquid interface of a starting solution via an enzyme reaction of urea with urease. Crystal phase analysis and ultrastructure observations were carried out, and the results indicated that the particles were single crystals, with almost the same a(b)-axis orientation as tooth enamel. It is hoped that by utilizing their unique surface charge and atomic arrangement, the resulting particles can be used as a high-performance biomaterial, capable of adsorbing bio-related substances and a model for tooth enamel. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Zhuang, Zhi; Aizawa, Mamoru] Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan.
   [Yoshimura, Hideyuki] Meiji Univ, Sch Sci & Technol, Dept Phys, Kawasaki, Kanagawa 2148571, Japan.
RP Aizawa, M (reprint author), Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.
EM zhuang@meiji.ac.jp; hyoshi@isc.meiji.ac.jp; mamorua@isc.meiji.ac.jp
CR Aizawa M, 2006, J EUR CERAM SOC, V26, P501, DOI 10.1016/j.jeurceramsoc.2005.07.007
   Aizawa M, 2005, BIOMATERIALS, V26, P3427, DOI 10.1016/j.biomaterials.2004.09.044
   Aoki H, 1989, SURF SCI, V10, P96
   Bagambisa BF, 1993, J BIOMED MATER RES, V27, P1047
   BIGI A, 1990, J INORG BIOCHEM, V40, P293, DOI 10.1016/0162-0134(90)80063-4
   CARLSTROM D, 1954, BIOCHIM BIOPHYS ACTA, V13, P183, DOI 10.1016/0006-3002(54)90302-9
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Chen KC, 2011, COLLOID SURFACE A, V373, P124, DOI 10.1016/j.colsurfa.2010.10.035
   DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Honda M, 2010, J BIOMED MATER RES A, V94A, P937, DOI 10.1002/jbm.a.32779
   IIJIMA M, 1992, J CRYST GROWTH, V116, P319, DOI 10.1016/0022-0248(92)90639-Z
   Ioku K, 2006, J MATER SCI, V41, P1341, DOI 10.1007/s10853-006-7338-5
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   KAWASAKI T, 1990, J CHROMATOGR, V515, P125, DOI 10.1016/S0021-9673(01)89307-9
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   KEREBEL B, 1976, J ULTRA MOL STRUCT R, V57, P266, DOI 10.1016/S0022-5320(76)80116-5
   LeGeros Z.R., 1981, PROG CRYSTAL GROWTH, V4, P1
   Mahmud K, 2010, CERAM INT, V36, P1893, DOI 10.1016/j.ceramint.2010.03.027
   Morisue H, 2009, J BIOMED MATER RES A, V90A, P811, DOI 10.1002/jbm.a.32147
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Okuda T, 2008, BIOMATERIALS, V29, P2719, DOI 10.1016/j.biomaterials.2008.03.028
   RASPANTI M, 1994, BIOMATERIALS, V15, P433, DOI 10.1016/0142-9612(94)90222-4
   Shrestha LK, 2013, J AM CHEM SOC, V135, P586, DOI 10.1021/ja3108752
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Wang CW, 2009, COLLOID SURFACE A, V340, P93, DOI 10.1016/j.colsurfa.2009.03.003
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
   Zhang HQ, 2010, ACTA BIOMATER, V6, P3216, DOI 10.1016/j.actbio.2010.02.011
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhuang Z, 2012, PHOSPHORUS RES B, V26, P81
   Zhuang Z, 2012, POWDER TECHNOL, V222, P193, DOI 10.1016/j.powtec.2012.02.046
NR 34
TC 15
Z9 15
U1 1
U2 73
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2013
VL 33
IS 5
BP 2534
EP 2540
DI 10.1016/j.msec.2013.02.035
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 153VH
UT WOS:000319630100009
PM 23623065
DA 2018-10-20
ER

PT J
AU Sadat-Shojai, M
   Khorasani, MT
   Jamshidi, A
   Irani, S
AF Sadat-Shojai, Mehdi
   Khorasani, Mohammad-Taghi
   Jamshidi, Ahmad
   Irani, Shiva
TI Nano-hydroxyapatite reinforced polyhydroxybutyrate composites: A
   comprehensive study on the structural and in vitro biological properties
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Polyhydroxybutyrate; Hydroxyapatite; Biocompatibility; Bone repair;
   Nanocomposite; Osteoblast
ID DYNAMIC-MECHANICAL PROPERTIES; BONE TISSUE; NANOCOMPOSITE SCAFFOLDS;
   ALKALINE-PHOSPHATASE; CELL-PROLIFERATION; HUMAN-FIBROBLASTS; CALCIUM;
   DIFFERENTIATION; POLY(3-HYDROXYBUTYRATE); NANOPARTICLES
AB Nanocomposites based on polyhydroxybutyrate (PHB) and hydroxyapatite (HAp) have recently been proposed for application in bone repair and regeneration, but very limited studies have investigated the effect of HAp on the rheological and thermal behavior of PHB. More important, the efficiency of a biomaterial depends greatly on its ability to interact with cells, but little is known about this interaction for this kind of nanocomposite. Hence, this paper dealt with some of the characteristics of solution-casted PHB/HAp nanocomposite films, and tried to explore the effect of HAp nanoparticles on cellular responses. The results showed that both theological and thermal properties can be tailored by incorporating appropriate amounts of nanoparticles. In vitro studies showed a significant increase in proliferation and differentiation of MC3T3-E1 on nanocomposites compared to the neat polymer. Surface examination indicated that topography and chemistry of surface are important factors influencing cellular processes; while no cell differentiation was found on the neat polymer, nanocomposite with 15 wt.% filler content exhibited a pronounced differentiation resulting from high surface roughness and large amount of exposed HAp. These results suggest that HAp particles play a much more important role in determining the biological performance of PHB than has previously been supposed. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Sadat-Shojai, Mehdi; Khorasani, Mohammad-Taghi] Iran Polymer & Petrochem Inst, Dept Biomat, Tehran, Iran.
   [Jamshidi, Ahmad] Iran Polymer & Petrochem Inst, Dept Novel Drug Delivery Syst, Tehran, Iran.
   [Irani, Shiva] Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran.
RP Sadat-Shojai, M (reprint author), Iran Polymer & Petrochem Inst, Dept Biomat, POB 14965-115, Tehran, Iran.
EM MSadatShojai@gmail.com
OI Irani, Shiva/0000-0002-4202-9931
CR Adams CS, 2001, J BIOL CHEM, V276, P20316, DOI 10.1074/jbc.M006492200
   Ben-David D, 2010, J TISSUE ENG REGEN M, V4, P30, DOI 10.1002/term.213
   Bergmann A, 2003, POLYM INT, V52, P1145, DOI 10.1002/pi.1206
   Cai L, 2011, ACTA BIOMATER, V7, P2185, DOI 10.1016/j.actbio.2011.01.034
   Capanna R, 2007, ORTHOP CLIN N AM, V38, P51, DOI 10.1016/j.ocl.2006.10.008
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chen DZ, 2007, COMPOS SCI TECHNOL, V67, P1617, DOI 10.1016/j.compscitech.2006.07.034
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cheng S, 2006, BIOMATERIALS, V27, P3758, DOI 10.1016/j.biomaterials.2006.02.046
   Cheng S, 2005, BIOMACROMOLECULES, V6, P593, DOI 10.1021/bm049465y
   Daly PA, 2005, J APPL POLYM SCI, V98, P66, DOI 10.1002/app.21986
   Damadzadeh B, 2010, J MATER SCI-MATER M, V21, P2523, DOI 10.1007/s10856-010-4110-9
   Diao HX, 2012, MAT SCI ENG C-MATER, V32, P1796, DOI 10.1016/j.msec.2012.04.065
   Dorigato A., 2012, J POLYM RES, V19, P1
   Drosos GI, 2012, INJURY, V43, P266, DOI 10.1016/j.injury.2011.02.004
   Duan B, 2011, FRONT MATER SCI, V5, P57, DOI 10.1007/s11706-011-0101-0
   Duan B, 2010, J R SOC INTERFACE, V7, pS615, DOI 10.1098/rsif.2010.0127.focus
   FUKADA E, 1986, INT J BIOL MACROMOL, V8, P361, DOI 10.1016/0141-8130(86)90056-5
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Hayati AN, 2012, MAT SCI ENG C-MATER, V32, P416, DOI 10.1016/j.msec.2011.11.013
   Hayati AN, 2011, MATER LETT, V65, P736, DOI 10.1016/j.matlet.2010.11.004
   Hong D, 2010, EXP CELL RES, V316, P2291, DOI 10.1016/j.yexcr.2010.05.011
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Hou CH, 2009, BIOMATERIALS, V30, P3956, DOI 10.1016/j.biomaterials.2009.04.020
   K-hasuwan PR, 2011, LANGMUIR, V27, P10938, DOI [10.1021/la20255w, 10.1021/la202255w]
   Khasim HRI, 2010, MACROMOL SYMP, V294-I, P144, DOI 10.1002/masy.201050813
   Kim HJ, 2005, J ELECTROANAL CHEM, V577, P243, DOI 10.1016/j.jelechem.2004.11.035
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee YK, 2004, J BIOMED MATER RES A, V69A, P188, DOI 10.1002/jbm.a.20137
   Li J, 2008, APPL SURF SCI, V255, P494, DOI 10.1016/j.apsusc.2008.06.067
   Li SD, 2001, J APPL POLYM SCI, V80, P2237, DOI 10.1002/app.1327
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Malmberg P, 2008, PROTEOMICS, V8, P3755, DOI 10.1002/pmic.200800198
   Marchi J, 2010, INT J APPL CERAM TEC, V7, P139, DOI 10.1111/j.1744-7402.2009.02388.x
   McGarvey WC, 1996, ORTHOPEDICS, V19, P389
   Medvecky L, 2012, MATER LETT, V68, P157, DOI 10.1016/j.matlet.2011.10.044
   Misra SK, 2007, BIOMACROMOLECULES, V8, P2112, DOI 10.1021/bm0701954
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   ORLY I, 1989, J BIOMED MATER RES, V23, P1433, DOI 10.1002/jbm.820231206
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Radmehr M, 2010, IFMBE PROC, V31, P833, DOI 10.1007/978-3-642-14515-5_212
   Ribeiro N, 2010, J COLLOID INTERF SCI, V351, P398, DOI 10.1016/j.jcis.2010.08.013
   Sadat-Shojai M., 2010, HYDROXYAPATITE INORG
   Sadat-Shojai M, 2012, J CRYST GROWTH, V361, P73, DOI 10.1016/j.jcrysgro.2012.09.010
   Sadat-Shojai M, 2011, J BRAZIL CHEM SOC, V22, P571, DOI 10.1590/S0103-50532011000300023
   Sadat-Shojai M, 2010, DENT MATER, V26, P471, DOI 10.1016/j.dental.2010.01.005
   Tang CY, 2006, J APPL POLYM SCI, V102, P5388, DOI 10.1002/app.25016
   Tong HW, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054111
   Velayudhan S, 2005, MATER CHEM PHYS, V89, P454, DOI 10.1016/j.matchemphys.2004.10.004
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Zhao Y, 2007, BIOMATERIALS, V28, P3063, DOI 10.1016/j.biomaterials.2007.03.003
NR 52
TC 27
Z9 29
U1 0
U2 51
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2013
VL 33
IS 5
BP 2776
EP 2787
DI 10.1016/j.msec.2013.02.041
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA 153VH
UT WOS:000319630100040
PM 23623096
DA 2018-10-20
ER

PT J
AU Stylianou, A
   Yova, D
AF Stylianou, Andreas
   Yova, Dido
TI Surface nanoscale imaging of collagen thin films by Atomic Force
   Microscopy
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Atomic Force Microscopy; Collagen films; Nanobiomaterials;
   Nanocharacterization; Pre-determined characteristics; Orientation
ID ADSORBED COLLAGEN; NATIVE COLLAGEN; I COLLAGEN; FIBRILS; CELLS; AFM;
   ADHESION; MATRICES; LAYERS; BIOMATERIALS
AB Collagen, the most abundant protein in mammals, due to its unique properties is widely used as biomaterial, scaffold and culture substrate for cell and tissue regeneration studies.
   Since the majority of biological reactions occur on surfaces and structures at the nanoscale level it is of great importance to image the nanostructural surface of collagen based materials. The aim of this paper was to characterize, with Atomic Force Microscopy (AFM), collagen thin films formed on different substrates (glass, mica, polystyrene latex particle surfaces) and correlate their morphology with the used substrates, formation methodologies (spin coating, hydrodynamic flow) and original collagen solution. The results demonstrated that, by altering a number of parameters, it was possible to control the formation of collagen nanostructured films consisting of naturally occurring fibrils. The spin coating procedure enabled the formation of films with random oriented fibrils, while substrates influenced the fibril packing and surface roughness. The hydrodynamic flow was used for guiding fibril major orientation, while adsorption time, rinsing with buffer and solution concentration influenced the fibril orientation. The clarification of the contribution that different parameters had on thin film formation will enable the design and control of collagen nanobiomaterials with pre-determined characteristics. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Stylianou, Andreas; Yova, Dido] Natl Tech Univ Athens, Sch Elect & Comp Engn, Div Electromagnet Electroopt & Elect Mat, Biomed Opt & Appl Biophys Lab, Athens 15780, Greece.
RP Stylianou, A (reprint author), Natl Tech Univ Athens, Sch Elect & Comp Engn, Div Electromagnet Electroopt & Elect Mat, 9 Iroon Polytechniou, Athens 15780, Greece.
EM styliand@mail.ntua.gr
RI Stylianou, Andreas/B-9466-2014
OI Stylianou, Andreas/0000-0002-1641-1854
FU European Union (European Social Fund-ESF); Greek national funds through
   the Operational Program through the European Social Fund
FX This research has been co-financed by the European Union (European
   Social Fund-ESF) and Greek national funds through the Operational
   Program "Education and Lifelong Learning" of the National Strategic
   Reference Framework (NSRF)-Research Funding Program: Heracleitus II.
   Investigating in knowledge society through the European Social Fund.
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Allison DP, 2010, WIRES NANOMED NANOBI, V2, P618, DOI 10.1002/wnan.104
   ARAGNO I, 1995, EXPERIENTIA, V51, P1063, DOI 10.1007/BF01946917
   Au AY, 2012, J BIOMED MATER RES A, V100A, P342, DOI 10.1002/jbm.a.33277
   BASELT DR, 1993, BIOPHYS J, V65, P2644, DOI 10.1016/S0006-3495(93)81329-8
   Brouwer KM, 2011, J TISSUE ENG REGEN M, V5, P501, DOI 10.1002/term.397
   Casuso I, 2011, J MOL RECOGNIT, V24, P406, DOI 10.1002/jmr.1081
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   CHAPMAN J A, 1972, Connective Tissue Research, V1, P31, DOI 10.3109/03008207209152053
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   CHERNOFF EAG, 1992, J VAC SCI TECHNOL A, V10, P596, DOI 10.1116/1.577736
   Cisneros DA, 2007, SMALL, V3, P956, DOI 10.1002/smll.200600598
   Covani U, 2007, J BIOMED MATER RES A, V82A, P723, DOI 10.1002/jbm.a.31055
   Dupont-Gillain CC, 2004, PROG COLL POL SCI S, V128, P98
   Dupont-Gillain CC, 2003, SURF SCI, V539, P145, DOI 10.1016/S0039-6028(03)00779-9
   Dupont-Gillain CC, 2004, J MATER SCI-MATER M, V15, P347, DOI 10.1023/B:JMSM.0000021100.71256.29
   Elliott JT, 2005, MATRIX BIOL, V24, P489, DOI 10.1016/j.matbio.2005.07.005
   Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091
   Fortunel NO, 2011, EUR J DERMATOL, V21, P12, DOI 10.1684/ejd.2011.1268
   Fratzl P., 2008, COLLAGEN STRUCTURE M
   Grant CA, 2012, J MECH BEHAV BIOMED, V5, P165, DOI 10.1016/j.jmbbm.2011.08.020
   Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010
   Gutsmann T, 2003, BIOPHYS J, V84, P2593, DOI 10.1016/S0006-3495(03)75064-4
   Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1
   Horcas I., 2007, REV SCI INSTRUM, V78
   Hsu YM, 2009, J BIOMED MATER RES B, V91B, P737, DOI 10.1002/jbm.b.31450
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   HULMES DJS, 1979, NATURE, V282, P878, DOI 10.1038/282878a0
   Jiang FZ, 2004, J STRUCT BIOL, V148, P268, DOI 10.1016/j.jsb.2004.07.001
   Jiang FZ, 2004, MICROSC RES TECHNIQ, V64, P435, DOI 10.1002/jemt.20101
   Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453
   KADLER KE, 1987, J BIOL CHEM, V262, P15696
   KAJIKAWA K, 1980, LAB INVEST, V43, P410
   Katsura N, 1998, EXTRACELLULAR MATRIX-CELL INTERACTION, P185
   Keresztes Z, 2006, J BIOMED MATER RES A, V76A, P223, DOI 10.1002/jbm.a.30472
   Lee GJ, 2011, J NANOSCI NANOTECHNO, V11, P773, DOI 10.1166/jnn.2011.3275
   Leow WW, 2011, LANGMUIR, V27, P10907, DOI 10.1021/la2018055
   Liu D, 2010, SOFT MATTER, V6, P5408, DOI 10.1039/c0sm00201a
   Loo RW, 2008, LANGMUIR, V24, P13276, DOI 10.1021/la803041v
   Mandal A., 2010, BIOL ENG, V2, P63
   Mertig M, 1997, SURF INTERFACE ANAL, V25, P514
   Morris V. J., 2008, ATOMIC FORCE MICROSC
   Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055
   Nagao E, 1999, BIOPHYS J, V76, P3289, DOI 10.1016/S0006-3495(99)77481-3
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Paige MF, 1998, BIOPHYS J, V74, P3211, DOI 10.1016/S0006-3495(98)78027-0
   Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012
   PARK P, 1985, TISSUE CELL, V17, P699, DOI 10.1016/0040-8166(85)90005-9
   PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871
   Phong HQ, 2010, MATER SCI ENG B-ADV, V169, P94, DOI 10.1016/j.mseb.2010.01.009
   Plant A.L., 2009, CELL RES, V793, P839
   Poole K, 2005, J MOL BIOL, V349, P380, DOI 10.1016/j.jmb.2005.03.064
   Popescu R, 2010, MOL CRYST LIQ CRYST, V522, P529, DOI 10.1080/15421401003722757
   Raspanti M, 1997, J STRUCT BIOL, V119, P118, DOI 10.1006/jsbi.1997.3865
   REVENKO I, 1994, BIOL CELL, V80, P67, DOI 10.1016/0248-4900(94)90019-1
   Rezakhaniha R, 2011, BIOMECH MODEL MECHAN, P1
   Riehle MO, 2003, MAT SCI ENG C-BIO S, V23, P337, DOI 10.1016/S0928-4931(02)00282-5
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   SMITH JW, 1968, NATURE, V219, P157, DOI 10.1038/219157a0
   Strasser S, 2007, BIOCHEM BIOPH RES CO, V354, P27, DOI 10.1016/j.bbrc.2006.12.114
   Stylianou A, 2011, BIOMED SIGNAL PROCES, V6, P307, DOI 10.1016/j.bspc.2011.02.006
   Stylianou A., 2011, IFMBE P, V37, P1058
   Stylianou A, 2010, IFMBE P, V29, P612, DOI [10.1007/978-3-642-13039-7_154, DOI 10.1007/978-3-642-13039-7_154]
   Stylianou A., 2009, INT C INF TECHN APPL, DOI DOI 10.1109/ITAB2009.5394311
   Sun M, 2008, LANGMUIR, V24, P5418, DOI 10.1021/la703292h
   Tay CY, 2011, SMALL, V7, P1361, DOI 10.1002/smll.201100046
   Tenboll A, 2010, LANGMUIR, V26, P12165, DOI 10.1021/la1018136
   Theodossiou T, 2002, LASER MED SCI, V17, P34, DOI 10.1007/s10103-002-8264-7
   Thery M, 2009, COLD SPRING HARB PRO, V4
   Tong WD, 2002, J BIOMED MATER RES, V61, P346, DOI 10.1002/jbm.10165
   TRUS BL, 1980, NATURE, V286, P300, DOI 10.1038/286300a0
   Tsai SW, 2010, J TAIWAN INST CHEM E, V41, P247, DOI 10.1016/j.jtice.2009.10.002
   van der Smissen A, 2011, BIOMATERIALS, V32, P8938, DOI 10.1016/j.biomaterials.2011.08.025
   Venturoni M, 2003, BIOCHEM BIOPH RES CO, V303, P508, DOI 10.1016/S0006-291X(03)00390-5
   Wallace JM, 2011, J STRUCT BIOL, V173, P146, DOI 10.1016/j.jsb.2010.08.003
   Wirth C, 2008, MAT SCI ENG C-BIO S, V28, P990, DOI 10.1016/j.msec.2007.10.085
   Yamamoto S, 2002, JPN J OPHTHALMOL, V46, P496, DOI 10.1016/S0021-5155(02)00558-0
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   Zhang XY, 2006, ACTA POLYM SIN, P959
NR 79
TC 20
Z9 21
U1 3
U2 90
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2013
VL 33
IS 5
BP 2947
EP 2957
DI 10.1016/j.msec.2013.03.029
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA 153VH
UT WOS:000319630100062
PM 23623118
DA 2018-10-20
ER

PT J
AU Chandanshive, BB
   Rai, P
   Rossi, AL
   Ersen, O
   Khushalani, D
AF Chandanshive, Balasaheb B.
   Rai, Priyanka
   Rossi, Andre L.
   Ersen, Ovidiu
   Khushalani, Deepa
TI Synthesis of hydroxyapatite nanotubes for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydroxyapatite; Nanotubes; Alumina; Biomaterial
ID SPRAY-DRYING METHOD; HOLLOW MICROSPHERES; BONE; NANOSTRUCTURE;
   ADSORPTION; PHOSPHATE; DELIVERY
AB Single phase, stoichiometrically pure, hollow nanotubes of hydroxyapatite have been synthesized and single-particle analysis has been performed to successfully prove the sole formation of Ca-10(PO4)(6)(OH)(2) phase. The facile synthesis involves a sol-gel process under neutral conditions in the presence of a sacrifical anodic alumina template. The structures formed are hollow nanotubes that have been characterized by XRD, SEM, TEM, SAED, EELS, EDS and BET measurements. The diameter of the resulting tubes is in the range of 140-350 nm, length is on the order of a few microns and the wall thickness of the tubes was found to be ca. 30 nm. Moreover these tubes had a large BET surface area of 115 m(2)/g and were found to be biocompatible. They displayed inertness in the presence of NIH 3T3 mouse fibroblast cells as dictated by an MTT assay. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Chandanshive, Balasaheb B.; Khushalani, Deepa] Tata Inst Fundamental Res, Dept Chem Sci, Mat Chem Grp, Bombay 400005, Maharashtra, India.
   [Rai, Priyanka] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India.
   [Rossi, Andre L.; Ersen, Ovidiu] IPCMS DSI, F-67034 Strasbourg 2, France.
RP Khushalani, D (reprint author), Tata Inst Fundamental Res, Dept Chem Sci, Mat Chem Grp, Dr Homi Bhabha Rd, Bombay 400005, Maharashtra, India.
EM khushalani@tifr.res.in
RI Rossi, Andre/E-8149-2013; Ersen, Ovidiu/I-1983-2016
OI Rossi, Andre/0000-0002-9920-4411; ERSEN, Ovidiu/0000-0002-1553-0915;
   Khushalani, Deepa/0000-0002-6838-1394
CR Chandanshive B, 2010, J MATER CHEM, V20, P6923, DOI 10.1039/c0jm00145g
   Curry JD, 2002, BONES STRUCTURE MECH
   Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002
   Dorozhkin Sergey V, 2011, Biomatter, V1, P121, DOI 10.4161/biom.18790
   Fujii S, 2007, J COLLOID INTERF SCI, V315, P287, DOI 10.1016/j.jcis.2007.06.071
   Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228
   Jiang DL, 2009, CURR APPL PHYS, V9, pS252, DOI 10.1016/j.cap.2009.01.029
   Jiang SD, 2012, J PHYS CHEM C, V116, P4484, DOI 10.1021/jp211648x
   Jiao Y, 2012, POWDER TECHNOL, V217, P581, DOI 10.1016/j.powtec.2011.11.025
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Luo P, 1995, MAT SCI ENG C-BIOMIM, V3, P75, DOI 10.1016/0928-4931(95)00089-5
   LYZNICKI EP, 1974, CAN J CHEM, V52, P1066, DOI 10.1139/v74-170
   Ma MG, 2009, EUR J INORG CHEM, P5522, DOI 10.1002/ejic.200900839
   Mateus Y. Pataquiva, 2007, J KEY ENG MAT, V330, P243
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   POPE MI, 1970, POWDER TECHNOL, V3, P367, DOI 10.1016/0032-5910(69)80110-5
   Porter S., 2007, WOUNDS UK, V3, P33
   Qi C, 2012, J MATER CHEM, V22, P22642, DOI 10.1039/c2jm35280j
   ROBINSON RA, 1952, J BONE JOINT SURG AM, V34-A, P389, DOI 10.2106/00004623-195234020-00013
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6
   Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002
   Sun RX, 2009, MAT SCI ENG C-BIO S, V29, P1088, DOI 10.1016/j.msec.2008.08.010
   WALSH WR, 1994, J MATER SCI-MATER M, V5, P72, DOI 10.1007/BF00121694
   Wang KW, 2011, MATER LETT, V65, P2361, DOI 10.1016/j.matlet.2011.04.104
   Wang KW, 2010, CHEM-ASIAN J, V5, P2477, DOI 10.1002/asia.201000463
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   [朱伟民 Zhu WM], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P9781
NR 30
TC 14
Z9 15
U1 2
U2 75
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2013
VL 33
IS 5
BP 2981
EP 2986
DI 10.1016/j.msec.2013.03.022
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 153VH
UT WOS:000319630100066
PM 23623122
DA 2018-10-20
ER

PT J
AU Mukherjee, K
   Saha, R
   Ghosh, A
   Saha, B
AF Mukherjee, Kakali
   Saha, Rumpa
   Ghosh, Aniruddha
   Saha, Bidyut
TI Chromium removal technologies
SO RESEARCH ON CHEMICAL INTERMEDIATES
LA English
DT Review
DE Chromium; Toxicity; Biosorption
ID MICELLAR-ENHANCED ULTRAFILTRATION; TEXTILE WASTE-WATER; DEAD FUNGAL
   BIOMASS; LOW-COST ADSORBENTS; NEEM LEAF POWDER; HEXAVALENT-CHROMIUM;
   AQUEOUS-SOLUTIONS; ACTIVATED CARBON; CHROMATE REDUCTION; AGRICULTURAL
   WASTE
AB Chromium can exist in different oxidation states (e.g. 0, III, VI). Chromium can be both beneficial and toxic to animals and humans depending on its oxidation state and concentration. At low concentration, Cr(III) is essential for animal and human health. Chromium(VI) compounds are highly soluble, mobile and bioavailable compared to trivalent chromium. Chromium(VI) is dangerous for humans due to its toxicity and carcinogenic properties. The presence of hexavalent chromium in waste water is a potential hazard to aquatic animals and humans. Various methods are adopted for the removal of hexavalent chromium from industrial effluents. Among these different techniques, biosorption is the most promising one. In this process, the various components present in biomaterial reduce the toxic hexavalent chromium to non-toxic trivalent chromium. Algae, fungi and bacteria have biosorption properties, and cell walls are responsible for biosorption of dead biomaterial. But this process removes chromium from waste water very slowly. So for chemical modification of biosorbents, optimization of biosorption parameters is required to increase the effectiveness of this process.
C1 [Mukherjee, Kakali; Saha, Rumpa; Ghosh, Aniruddha; Saha, Bidyut] Univ Burdwan, Dept Chem, Bioremediat Lab, Burdwan 713104, W Bengal, India.
RP Saha, B (reprint author), Univ Burdwan, Dept Chem, Bioremediat Lab, Burdwan 713104, W Bengal, India.
EM b_saha31@rediffmail.com
OI Saha, Bidyut/0000-0001-6711-0763
FU UGC, New Delhi; CSIR, New Delhi
FX Thanks to UGC, New Delhi and CSIR, New Delhi for providing financial
   help in the form of a project and fellowship.
CR Ackerley DF, 2004, ENVIRON MICROBIOL, V6, P851, DOI 10.1111/j.1462-2920.2004.00639.x
   Ackerley DF, 2004, APPL ENVIRON MICROB, V70, P873, DOI 10.1128/AEM.70.2.873-882.2004
   Aggarwal D, 1999, CARBON, V37, P1989, DOI 10.1016/S0008-6223(99)00072-X
   Aksu Z, 1996, ENVIRON TECHNOL, V17, P215, DOI 10.1080/09593331708616379
   AOKI T, 1982, WATER RES, V16, P793, DOI 10.1016/0043-1354(82)90006-9
   Aroua MK, 2007, J HAZARD MATER, V147, P752, DOI 10.1016/j.jhazmat.2007.01.120
   Arulmozhi M., 2010, CHEM ENG COMMUN, V198, P69
   Bansal M, 2009, J HAZARD MATER, V171, P83, DOI 10.1016/j.jhazmat.2009.05.124
   Beng S., 2004, WATER RES, V38, P2424
   Bertini L., 2002, P NATL ACAD SCI USA, V99, P9750
   Bhattacharya AK, 2008, CHEM ENG J, V137, P529, DOI 10.1016/j.cej.2007.05.021
   Bhattacharyya KG, 2004, J HAZARD MATER, V113, P97, DOI 10.1016/j.jhazmat.2004.05.034
   Biswas N., 1991, INT J ENVIRON STUD, V38, P65
   Brant L.L., 1989, SURFACTANT BASED SEP, P323
   CAMPOS J, 1995, ANTON LEEUW INT J G, V68, P203, DOI 10.1007/BF00871816
   CENKIN VE, 1985, EFFLUENT WATER TREAT, V25, P243
   CHAKRAVARTI AK, 1995, COLLOID SURFACE A, V103, P59, DOI 10.1016/0927-7757(95)03201-N
   Chang KL, 2012, SEP SCI TECHNOL, V47, P1514, DOI 10.1080/01496395.2011.647212
   Chen XM, 2000, SEP PURIF TECHNOL, V19, P65, DOI 10.1016/S1383-5866(99)00072-6
   CHRISTIAN SD, 1989, SURFACTANT BASED SEP, pCH1
   CIESLAKGOLONKA M, 1992, POLYHEDRON, V11, P2549
   Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8
   Convington A.D., 1997, CHEM SOC REV, V72, P111
   Cotton F. A., 1980, ADV INORG CHEM, P686
   Dabrowski A. A., 1999, ADSORPTION ITS APPL
   Daneshvar N, 2002, J HAZARD MATER, V94, P49, DOI 10.1016/S0304-3894(02)00054-7
   Davis CM, 1997, J BIOL INORG CHEM, V2, P675, DOI 10.1007/s007750050183
   Debnath S, 2008, J CHEM THERMODYN, V40, P67, DOI 10.1016/j.jct.2007.05.014
   Demiral H., 2008, CHEM ENG J, V141, P188
   Dermatas D, 2003, ENG GEOL, V70, P377, DOI 10.1016/S0013-7952(03)00105-4
   DO JS, 1994, J APPL ELECTROCHEM, V24, P785, DOI 10.1007/BF00578095
   Dubey SP, 2007, J HAZARD MATER, V145, P465, DOI 10.1016/j.jhazmat.2006.11.041
   Dubey SP, 2009, J HAZARD MATER, V164, P968, DOI 10.1016/j.jhazmat.2008.08.111
   Dunpont L., 2003, ENVIRON SCI TECHNOL, V37, P4235
   Elangovan R, 2008, J HAZARD MATER, V152, P100, DOI 10.1016/j.jhazmat.2007.06.067
   Escudero C, 2008, INT J ENVIRON POLLUT, V34, P215, DOI 10.1504/IJEP.2008.020793
   Fan YX, 2012, J TRACE ELEM MED BIO, V26, P188, DOI 10.1016/j.jtemb.2012.04.009
   Fien J.B., 2001, GEOMICROBIOL J, V19, P369
   Fiol N, 2003, ENVIRON CHEM LETT, V1, P135, DOI 10.1007/s10311-003-0027-6
   Flores A, 1999, TOXICOL APPL PHARM, V161, P75, DOI 10.1006/taap.1999.8779
   Fluid L., 1994, APPL ENVIRON MICROB, V60, P1525
   Gonmez G., 2002, PROCESS BIOCHEM, V38, P751
   Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200
   Goodale BC, 2008, AQUAT TOXICOL, V87, P60, DOI 10.1016/j.aquatox.2008.01.014
   Greenwood N. N, 2005, CHEM ELEMENTS, P1008
   Guo YP, 2003, MATER CHEM PHYS, V78, P132, DOI 10.1016/S0254-0584(02)00302-4
   Gutsche C. D., 1998, CALIXARENES REVISITE
   Gutsche C. D., 1989, CALIXARENES
   Gzara L, 2001, DESALINATION, V137, P241, DOI 10.1016/S0011-9164(01)00225-9
   HAMADA F, 1991, J INCLUS PHENOM MOL, V10, P57, DOI 10.1007/BF01041639
   Hamadi NK, 2001, CHEM ENG J, V84, P95, DOI 10.1016/S1385-8947(01)00194-2
   Hasan A A., 2010, ENVIRON SCI TECHNOL, V44, P400
   Hasan SH, 2008, J HAZARD MATER, V152, P356, DOI 10.1016/j.jhazmat.2007.07.006
   HO YS, 1995, WATER RES, V29, P1327, DOI 10.1016/0043-1354(94)00236-Z
   Hong HL, 2008, APPL CLAY SCI, V42, P292, DOI 10.1016/j.clay.2008.01.015
   Hosseini S. H., 2005, IRAN POLYM J, V4, P333
   Hsu NH, 2009, J HAZARD MATER, V171, P1066, DOI 10.1016/j.jhazmat.2009.06.112
   HUANG CP, 1975, J WATER POLLUT CON F, V47, P2437
   HUANG SD, 1982, J COLLOID INTERF SCI, V89, P504, DOI 10.1016/0021-9797(82)90201-6
   Icopini GA, 2002, ENVIRON SCI TECHNOL, V36, P2994, DOI 10.1021/es015655u
   Iki N., 1998, TETRAHEDRON LETT, V397, P559
   JABALPURWALA KE, 1964, J INORG NUCL CHEM, V26, P1027, DOI 10.1016/0022-1902(64)80264-5
   Jain S.K., 2012, MOL NUTR FOOD RES, V56, P1033
   Jiao C., 2009, ENV CHEM ENG, V13, P263
   Khambaty Y., 2009, J MICROBIOL BIOTECHN, V25, P1413
   Kongsricharoern N, 1996, WATER SCI TECHNOL, V34, P109, DOI 10.1016/S0273-1223(96)00793-7
   Kulkarni PS, 2000, J CHEM TECHNOL BIOT, V75, P553, DOI 10.1002/1097-4660(200007)75:7<553::AID-JCTB252>3.0.CO;2-I
   Kumar KK, 2006, INDIAN J MAR SCI, V35, P263
   Kuykendall JR, 2006, AQUAT TOXICOL, V78, P27, DOI 10.1016/j.aquatox.2006.01.019
   Lakshmanraj L, 2009, J HAZARD MATER, V169, P1141, DOI 10.1016/j.jhazmat.2009.03.022
   LEE SE, 1989, WATER RES, V23, P67
   LIN CF, 1992, WATER SCI TECHNOL, V26, P2301
   LIN SH, 1994, WATER RES, V28, P277, DOI 10.1016/0043-1354(94)90264-X
   Lin SH, 1997, WATER RES, V31, P868, DOI 10.1016/S0043-1354(96)00318-1
   Liu MH, 2001, WATER ENVIRON RES, V73, P322, DOI 10.2175/106143001X139344
   Ludwig R, 1997, CHEM COMMUN, P1985, DOI 10.1039/a704868h
   Ludwig R., 1995, JAERI REV, P95
   Ludwig R., 1999, P 2 NUCEF INT S IB J, P99
   Malkoc E, 2007, SEP PURIF TECHNOL, V54, P291, DOI 10.1016/j.seppur.2006.09.017
   Malkoc E, 2006, J HAZARD MATER, V138, P142, DOI 10.1016/j.jhazmat.2006.05.051
   Malysa K, 2005, ADV COLLOID INTERFAC, V114, P205, DOI 10.1016/j.cis.2004.08.004
   Martinez M, 2006, J HAZARD MATER, V133, P203, DOI 10.1016/j.jhazmat.2005.10.030
   Mattagajasingh SN, 1996, J BIOL CHEM, V271, P33550, DOI 10.1074/jbc.271.52.33550
   Mattuck R, 1996, J CONTAM HYDROL, V23, P213, DOI 10.1016/0169-7722(95)00097-6
   Mazoch J., 2004, J BIOL CHEM, V271, P553
   McLean J, 2001, APPL ENVIRON MICROB, V67, P1076, DOI 10.1128/AEM.67.3.1076-1084.2001
   Middleton SS, 2003, BIOTECHNOL BIOENG, V83, P627, DOI 10.1002/bit.10725
   Miretzky P, 2006, CHEMOSPHERE, V62, P247, DOI 10.1016/j.chemosphere.2005.05.010
   Mohanty K, 2005, CHEM ENG SCI, V60, P3049, DOI 10.1016/j.ces.2004.12.049
   Morales J. M. V., 2012, OPEN J INORG NONMET, V2, P19
   Morokutti A, 2005, BIOCHEMISTRY-US, V44, P13724, DOI 10.1021/bi0510835
   Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015
   Nataraj SK, 2007, DESALINATION, V217, P181, DOI 10.1016/j.desal.2007.02.012
   NGUYEN TKD, 1999, NEW J CHEM, V23, P603
   NGUYEN TKD, 1999, B CHEM SOC JPN, V72, P1005
   OGUTVEREN UB, 1994, INT J ENVIRON STUD, V45, P81
   Oguz E, 2005, COLLOID SURFACE A, V252, P121, DOI 10.1016/j.colsurfa.2004.10.004
   Olad A, 2007, J HAZARD MATER, V147, P845, DOI 10.1016/j.jhazmat.2007.01.083
   Onyancha D, 2008, J HAZARD MATER, V158, P605, DOI 10.1016/j.jhazmat.2008.02.043
   OSBORNELEE IW, 1983, J COLLOID INTERF SCI, V94, P179, DOI 10.1016/0021-9797(83)90248-5
   Pagilla KR, 1999, J ENVIRON ENG-ASCE, V125, P243, DOI 10.1061/(ASCE)0733-9372(1999)125:3(243)
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Park D., 2005, CHEMOSPHERE, V60, P1536
   Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   Pehlivan E, 2012, FOOD CHEM, V133, P1478, DOI 10.1016/j.foodchem.2012.02.037
   Persin F., 1989, TRIBUNE EAU, V42, P45
   Poljsak B, 2011, CELLULAR EFFECTS OF HEAVY METALS, P59, DOI 10.1007/978-94-007-0428-2_3
   POUET MF, 1995, WATER SCI TECHNOL, V31, P275, DOI 10.1016/0273-1223(95)00230-K
   Puzon GJ, 2005, ENVIRON SCI TECHNOL, V39, P2811, DOI 10.1021/es048967g
   Puzon GJ, 2002, BIOCHEM BIOPH RES CO, V294, P76, DOI 10.1016/S0006-291X(02)00438-2
   Rajeshwar K, 1997, ENV ELECTROCHEMISTRY
   Romero-Gonzalez J, 2005, J CHEM THERMODYN, V37, P343, DOI 10.1016/j.jct.2004.09.013
   Sadaoui Z, 1997, J CHEM ENG JPN, V30, P799, DOI 10.1252/jcej.30.799
   Saha B, 2010, COORDIN CHEM REV, V254, P2959, DOI 10.1016/j.ccr.2010.06.005
   Saha R, 2013, CAN J CHEM ENG, V91, P814, DOI 10.1002/cjce.21703
   Saha R, 2011, J COORD CHEM, V64, P1782, DOI 10.1080/00958972.2011.583646
   Samani M. R., 2011, IRAN J CHEM CHEM ENG, V30, P97
   Sawalha MF, 2006, J COLLOID INTERF SCI, V300, P100, DOI 10.1016/j.jcis.2006.03.029
   Scamehorn J.F., 1988, SURFACTANTS CHEM PRO
   Seader J. D., 1998, SEPARATION PROCESS P, P778
   Seaman JC, 1999, ENVIRON SCI TECHNOL, V33, P938, DOI 10.1021/es980546+
   Selvaraj K, 2003, BIORESOURCE TECHNOL, V89, P207, DOI 10.1016/S0960-8524(03)00062-2
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V49, P31, DOI 10.1016/0960-8524(94)90170-8
   SHEN H, 1993, APPL ENVIRON MICROB, V59, P3771
   Smith WL, 2000, J APPL MICROBIOL, V88, P983, DOI 10.1046/j.1365-2672.2000.01066.x
   Altundogan HS, 2007, J HAZARD MATER, V144, P255, DOI 10.1016/j.hazmat.2006.10.018
   SRIVASTAVA HCP, 1986, ENVIRON TECHNOL LETT, V7, P55, DOI 10.1080/09593338609384391
   STEARNS DM, 1995, BIOCHEMISTRY-US, V34, P910, DOI 10.1021/bi00003a025
   TAN WT, 1993, ENVIRON TECHNOL, V14, P277, DOI 10.1080/09593339309385290
   Tiravanti G, 1997, WATER SCI TECHNOL, V36, P197, DOI 10.1016/S0273-1223(97)00388-0
   Tong C. C., 1989, COMMUNICATION
   Ungaro R., 1984, J INCLUSION PHENOM, V2, P199, DOI DOI 10.1007/BF00663257
   Venkateswaran P, 2004, SEP PURIF TECHNOL, V40, P279, DOI 10.1016/j.seppur.2004.03.005
   Venkateswarlu P, 2007, INT J PHYS SCI, V2, P188
   Vicens J., 1990, CALIXARENES VERSATIL
   VIK EA, 1984, WATER RES, V18, P1355, DOI 10.1016/0043-1354(84)90003-4
   Villaescusa I, 2004, WATER RES, V38, P992, DOI 10.1016/j.watres.2003.10.040
   Voitkun V, 1998, NUCLEIC ACIDS RES, V26, P2024, DOI 10.1093/nar/26.8.2024
   Wang JL, 2006, BIOTECHNOL ADV, V24, P427, DOI 10.1016/j.biotechadv.2006.03.001
   Wang S., 2000, AM J PHYSIOL-CELL PH, V279, P868
   Wang SW, 2001, CARCINOGENESIS, V22, P757, DOI 10.1093/carcin/22.5.757
   Weng CH, 2008, J HAZARD MATER, V155, P65, DOI 10.1016/j.jhazmat.2007.11.029
   Xing GX, 2006, CARBOHYD POLYM, V66, P246, DOI 10.1016/j.carbpol.2006.03.005
   Xu J, 1996, CARCINOGENESIS, V17, P1511, DOI 10.1093/carcin/17.7.1511
   Ye J., 1999, J BIOL CHEM, V49, P34974
   Ying L., 2005, COLLOID SURFACE B, V65, P25
   Yokel RA, 2006, J TOXICOL ENV HEAL B, V9, P63, DOI 10.1080/15287390500196230
NR 150
TC 31
Z9 32
U1 3
U2 140
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0922-6168
EI 1568-5675
J9 RES CHEM INTERMEDIAT
JI Res. Chem. Intermed.
PD JUL
PY 2013
VL 39
IS 6
BP 2267
EP 2286
DI 10.1007/s11164-012-0779-3
PG 20
WC Chemistry, Multidisciplinary
SC Chemistry
GA 166MO
UT WOS:000320559100001
DA 2018-10-20
ER

PT J
AU Yu, ZJ
   Chen, YQ
   Yang, XD
AF Yu Zhan-Jiang
   Chen Yong-Qiang
   Yang Xiao-Da
TI Effective Adsorption of Functional Biological Macromolecules on
   Stainless Steel Surface with Micro/Nanoporous Texture
SO ACTA PHYSICO-CHIMICA SINICA
LA English
DT Article
DE Micro/nano texture; Stainless steel; Antibody; Horse radish peroxidase;
   Surface adsorption
ID BETA-LACTOGLOBULIN; PROTEIN ADSORPTION; RE-ENDOTHELIALIZATION;
   SERUM-ALBUMIN; BIOCOMPATIBILITY; IMMOBILIZATION; IMPLANTS; BEHAVIOR;
   STENTS; NANOPARTICLES
AB Stainless steel (AISI 316L) is commonly used as a material in medical devices. Modification of the metal surface with bioactive molecules and/or nanoparticles to develop next-generation smart biomaterial, e. g., cardiovascular stents, has recently attracted great attention. The present work investigated adsorption of antibodies and enzymes on micro/nanoporous 316L stainless steel compared with that on smooth and gold-coated stainless steel surfaces. The experimental results showed that the micro/nanoporous stainless steel surface produced by electrochemical erosion can adsorb a large amount of proteins (antibodies or horse radish peroxidase (HRP)), with comparable or better results than the sputtered-gold surface. Washes with surfactants (e.g., 10% bull serum albumin (BSA) or 0.2% Tween 20 solution) did not remove the enzymes/antibodies. In contrast, pretreatment of the metal plates with 5% Tween 20 halved antibody adsorption but did not affect adsorption of HRP. The wettability of the porous metal surface coated with proteins depended on the protein species and amount of protein adsorbed. The protein-coated porous surface was hydrophilic (water contact angle<50 degrees), which should make it biocompatible. The proteins on the micro/nanoporous stainless steel surface retained their high biological activity; in particular, micro/nanoporous stainless steel stents modified with an anti-CD34 antibody using the present method can effectively and selectively capture KG-1 cells. Our work provides a basis for developing novel polymer-free, smart, economic biomaterials with stainless steel for biomedical applications.
C1 [Yu Zhan-Jiang; Yang Xiao-Da] Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
   [Chen Yong-Qiang] Lepu Med Technol Beijing Co Ltd, Beijing 100022, Peoples R China.
RP Yang, XD (reprint author), Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
EM xyang@bjmu.edu.cn
FU National Natural Science Foundation of China [30770581, 20971008];
   Research Fund for the Doctoral Program of Higher Education, China
   [20090001110068]
FX The project was supported by the National Natural Science Foundation of
   China (30770581, 20971008) and Research Fund for the Doctoral Program of
   Higher Education, China (20090001110068).
CR Abdel-Fattah TM, 2011, J BIOMED NANOTECHNOL, V7, P794, DOI 10.1166/jbn.2011.1346
   Bee JS, 2010, BIOTECHNOL BIOENG, V105, P121, DOI 10.1002/bit.22525
   Bee JS, 2009, J PHARM SCI-US, V98, P3218, DOI 10.1002/jps.21768
   Berry JL, 2000, ANN BIOMED ENG, V28, P386, DOI 10.1114/1.276
   Buhagiar J, 2011, J MATER SCI-MATER M, V22, P1269, DOI 10.1007/s10856-011-4298-3
   Caro A, 2009, J PHYS CHEM B, V113, P2101, DOI 10.1021/jp805284s
   Ceylan H, 2011, BIOMATERIALS, V32, P8797, DOI 10.1016/j.biomaterials.2011.08.018
   Davis EM, 2011, BIOMATERIALS, V32, P5311, DOI 10.1016/j.biomaterials.2011.04.027
   Desroches MJ, 2008, PHYS CHEM CHEM PHYS, V10, P2502, DOI 10.1039/b719371h
   Falentin-Daudre C, 2012, LANGMUIR, V28, P7233, DOI 10.1021/la3003965
   FUKUZAKI S, 1995, J FERMENT BIOENG, V80, P6, DOI 10.1016/0922-338X(95)98168-K
   Granada JF, 2010, CIRC-CARDIOVASC INTE, V3, P257, DOI 10.1161/CIRCINTERVENTIONS.109.919936
   Hagiwara T, 2009, LANGMUIR, V25, P226, DOI 10.1021/la8024149
   Hao L, 2006, P I MECH ENG H, V220, P47, DOI 10.1243/095441105X68999
   Harvey J, 2012, BIOTECHNOL LETT, V34, P1159, DOI 10.1007/s10529-012-0885-8
   Hayes JS, 2010, EXPERT REV MED DEVIC, V7, P843, DOI [10.1586/erd.10.53, 10.1586/ERD.10.53]
   He CX, 2012, ACTA PHYS-CHIM SIN, V28, P2721, DOI 10.3866/PKU.WHXB201207191
   Hedberg YS, 2012, LANGMUIR, V28, P16306, DOI 10.1021/la3039279
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Hori N, 2010, DENT MATER, V26, P275, DOI 10.1016/j.dental.2009.11.077
   Ignatova M, 2009, LANGMUIR, V25, P891, DOI 10.1021/la802472e
   Imamura K, 2003, J COLLOID INTERF SCI, V267, P294, DOI 10.1016/S0021-9797(03)00700-8
   Joung YK, 2012, COLLOID SURFACE B, V99, P102, DOI 10.1016/j.colsurfb.2011.10.047
   Kang CK, 2007, J MATER SCI-MATER M, V18, P1389, DOI 10.1007/s10856-006-0079-9
   Kang CK, 2013, COLLOID SURFACE B, V102, P744, DOI 10.1016/j.colsurfb.2012.09.008
   Le Guehennec L, 2008, NANOMEDICINE-UK, V3, P61, DOI 10.2217/17435889.3.1.61
   Lionetto S, 2013, J BIOMED MATER RES A, V101, P991, DOI 10.1002/jbm.a.34402
   Liu P, 2010, ACTA PHYS-CHIM SIN, V26, P1113, DOI 10.3866/PKU.WHXB20100448
   Matsumura H, 2006, COLLOID SURFACE B, V47, P146, DOI 10.1016/j.colsurfb.2005.12.004
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Mikulewicz M, 2011, BIOL TRACE ELEM RES, V142, P865, DOI 10.1007/s12011-010-8798-7
   Mourtas S, 2011, COLLOID SURFACE B, V84, P214, DOI 10.1016/j.colsurfb.2011.01.002
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   Nagarajan S, 2012, ACS APPL MATER INTER, V4, P5134, DOI 10.1021/am301559r
   Nayak BK, 2010, OPT LASER ENG, V48, P940, DOI 10.1016/j.optlaseng.2010.04.010
   Omanovic S, 2000, J COLLOID INTERF SCI, V227, P452, DOI 10.1006/jcis.2000.6913
   Pan HA, 2013, BIOMATERIALS, V34, P841, DOI 10.1016/j.biomaterials.2012.09.078
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Rossi ML, 2010, INT J CARDIOL, V141, pE20, DOI 10.1016/j.ijcard.2008.11.134
   Sakiyama T, 2006, J BIOSCI BIOENG, V101, P434, DOI 10.1263/jbb.101.434
   Secker TJ, 2012, BIOFOULING, V28, P563, DOI 10.1080/08927014.2012.698387
   Slaney AM, 2011, ACS APPL MATER INTER, V3, P1601, DOI 10.1021/am200158y
   Subramanian B, 2012, J MATER SCI-MATER M, V23, P329, DOI 10.1007/s10856-011-4500-7
   Subramanian B, 2012, J BIOMATER APPL, V26, P687, DOI 10.1177/0885328210377534
   Valanezahad A, 2011, DENT MATER J, V30, P749, DOI 10.4012/dmj.2010-153
   Weckbach S, 2012, UNFALLCHIRURG, V115, P75, DOI 10.1007/s00113-011-2145-0
   Wendel HP, 2010, INT J CARDIOL, V145, P115, DOI 10.1016/j.ijcard.2009.06.020
   Yang ZL, 2012, ADV HEALTHC MATER, V1, P548, DOI 10.1002/adhm.201200073
   [张峰 ZHANG Feng], 2011, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V31, P862
NR 49
TC 2
Z9 2
U1 3
U2 43
PU PEKING UNIV PRESS
PI BEIJING
PA PEKING UNIV, CHEMISTRY BUILDING, BEIJING 100871, PEOPLES R CHINA
SN 1000-6818
J9 ACTA PHYS-CHIM SIN
JI Acta Phys.-Chim. Sin.
PD JUL
PY 2013
VL 29
IS 7
BP 1595
EP 1602
DI 10.3866/PKU.WHXB201305082
PG 8
WC Chemistry, Physical
SC Chemistry
GA 164VR
UT WOS:000320439300029
DA 2018-10-20
ER

PT J
AU Yang, DY
   Lu, XY
   Hong, Y
   Xi, TF
   Zhang, DY
AF Yang, Dayun
   Lu, Xiaoying
   Hong, Ying
   Xi, Tingfei
   Zhang, Deyuan
TI The molecular mechanism of mediation of adsorbed serum proteins to
   endothelial cells adhesion and growth on biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial surface; Protein adsorption and cell adhesion; Molecular
   mechanism; Proteomics and bioinformatics; Verification experiment
ID SURFACE MODIFICATION; INTEGRIN ACTIVATION; SIGNALING PATHWAYS;
   ADSORPTION; PLASMA; EXPRESSION; TITANIUM; CHITOSAN; ANGIOGENESIS;
   FIBRONECTIN
AB To explore molecular mechanism of mediation of adsorbed proteins to cell adhesion and growth on biomaterials, this study examined endothelial cell adhesion, morphology and viability on bare and titanium nitride (TiN) coated nickel titanium (NiTi) alloys and chitosan film firstly, and then identified the type and amount of serum proteins adsorbed on the three surfaces by proteomic technology. Subsequently, the mediation role of the identified proteins to cell adhesion and growth was investigated with bioinformatics analyses, and further confirmed by a series of cellular and molecular biological experiments. Results showed that the type and amount of adsorbed serum proteins associated with cell adhesion and growth was obviously higher on the alloys than on the chitosan film, and these proteins mediated endothelial cell adhesion and growth on the alloys via four ways. First, proteins such as adiponectin in the adsorbed protein layer bound with cell surface receptors to generate signal transduction, which activated cell surface integrins through increasing intracellular calcium level. Another way, thrombospondin 1 in the adsorbed protein layer promoted TGF-13 signaling pathway activation and enhanced integrins expression. The third, RGD sequence containing proteins such as fibronectin 1, vitronectin and thrombospondin 1 in the adsorbed protein layer bound with activated integrins to activate focal adhesion pathway, increased focal adhesion formation and actin cytoskeleton organization and mediated cell adhesion and spreading. In addition, the activated focal adhesion pathway promoted the expression of cell growth related genes and resulted in cell proliferation. The fourth route, coagulation factor II (F2) and fibronectin 1 in the adsorbed protein layer bound with cell surface F2 receptor and integrin, activated regulation of actin cytoskeleton pathway and regulated actin cytoskeleton organization. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Yang, Dayun; Lu, Xiaoying] Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China.
   [Hong, Ying] Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.
   [Xi, Tingfei] Peking Univ, Shenzhen Res Inst, Shenzhen 518055, Peoples R China.
   [Zhang, Deyuan] R&D Ctr Lifetech Sci Shenzhen Co Ltd, Shenzhen 518057, Peoples R China.
RP Lu, XY (reprint author), Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China.
EM luxy@seu.edu.cn
FU 973 Project [2009CB930000]; National Natural Science Foundation of China
   [31271012, 31170910]; Specialized Research Fund for the Doctoral Program
   of Higher Education of China [20100092110027]
FX This paper was supported by 973 Project (No. 2009CB930000), the National
   Natural Science Foundation of China (Nos. 31271012, 31170910), and the
   Specialized Research Fund for the Doctoral Program of Higher Education
   of China (No. 20100092110027).
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200
   Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002
   Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353
   Buechler C, 2010, FEBS LETT, V584, P4280, DOI 10.1016/j.febslet.2010.09.035
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen XY, 2012, CELL MOL BIOENG, V5, P307, DOI 10.1007/s12195-012-0237-8
   Chen YH, 2012, BIOMATERIALS, V33, P1336, DOI 10.1016/j.biomaterials.2011.10.048
   Clarke B, 2007, ACTA BIOMATER, V3, P103, DOI 10.1016/j.actbio.2006.07.006
   Danmark S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035011
   de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004
   Derhami K, 2001, J BIOMED MATER RES, V56, P234, DOI 10.1002/1097-4636(200108)56:2<234::AID-JBM1090>3.3.CO;2-R
   Huang L, 2011, ACTA BIOMATER, V7, P395, DOI 10.1016/j.actbio.2010.08.002
   Huang Y, 2010, ACTA BIOMATER, V6, P2083, DOI 10.1016/j.actbio.2009.12.035
   Hung HS, 2009, BIOMATERIALS, V30, P1502, DOI 10.1016/j.biomaterials.2008.12.003
   Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001
   Kaneko H, 2011, ANAL BIOCHEM, V418, P276, DOI 10.1016/j.ab.2011.07.022
   Koh LB, 2010, PHYS CHEM CHEM PHYS, V12, P10301, DOI 10.1039/c001747g
   Ku Y, 2005, BIOMATERIALS, V26, P5153, DOI 10.1016/j.biomaterials.2005.01.060
   Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200
   Lai YX, 2010, BIOMATERIALS, V31, P4809, DOI 10.1016/j.biomaterials.2010.02.064
   Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029
   Lord MS, 2011, BIOMATERIALS, V32, P6655, DOI 10.1016/j.biomaterials.2011.05.062
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Lu XY, 2007, SURF COAT TECH, V201, P6843, DOI 10.1016/j.surfcoat.2006.09.019
   Lu XY, 2003, J BIOMED MATER RES A, V66A, P722, DOI 10.1002/jbm.a.10014
   Lu XY, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044103
   Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011
   Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015
   Nikitovic D, 2011, INT J BIOCHEM CELL B, V43, P928, DOI 10.1016/j.biocel.2011.03.008
   Sask KN, 2010, ACTA BIOMATER, V6, P2911, DOI 10.1016/j.actbio.2010.02.043
   Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Silva SS, 2008, MACROMOL BIOSCI, V8, P568, DOI 10.1002/mabi.200700264
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Steyn FJ, 2009, J NEUROENDOCRINOL, V21, P698, DOI 10.1111/j.1365-2826.2009.01887.x
   VROMAN L, 1980, BLOOD, V55, P156
   Warstat K, 2010, STEM CELLS DEV, V19, P645, DOI 10.1089/scd.2009.0208
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Ruiz-Loredo AY, 2011, J CELL PHYSIOL, V226, P414, DOI 10.1002/jcp.22347
   Zhao LF, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025012
NR 47
TC 53
Z9 56
U1 3
U2 129
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2013
VL 34
IS 23
BP 5747
EP 5758
DI 10.1016/j.biomaterials.2013.04.028
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 161UW
UT WOS:000320219800002
PM 23660250
DA 2018-10-20
ER

PT J
AU Sami, H
   Kumar, A
AF Sami, Haider
   Kumar, Ashok
TI Tunable hybrid cryogels functionalized with microparticles as
   supermacroporous multifunctional biomaterial scaffolds
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE cellmaterial interaction; cryogel-micoparticle composites; drug delivery
   systems; multifunctional biomaterials; tissue engineering
ID POLYMERIC CRYOGELS; CONTROLLED-RELEASE; GELATIN CRYOGELS; DELIVERY;
   FUMARATE); MICROSPHERES; HYDROGELS
AB This study aims at incorporating microparticles (MPs) into polymeric network of cryogels to fabricate a multifunctional biomaterial scaffold (cryogel-microparticle [C-MP] composite) which has microstructured biocompatible pore surface, supermacroporous interconnected pore distribution and capability to simultaneously deliver bioactive molecules. Three types of MPs (i.e. poly(D,L-lactide-co-glycolide), chitosan, and silica MPs) were separately incorporated in three different cryogels (i.e. chitosanagarose, chitosanagarosegelatin, and chitosangelatin), demonstrating the generality of the approach. Factors affecting distribution of MPs within the cryogel were investigated to achieve uniform distribution of MPs within the pore wall of cryogel as well as the whole cryogel monolith to create microstructured pore surface of C-MP composites, which was characterized by scanning electron microscopy, fluorescence microscopy, infrared spectral analysis (FTIR), and water uptake properties. Further, mouse embryonic fibroblasts (NIH 3T3), mouse myoblasts (C2C12), and human lung cancer cells (NCI-H460) were grown on microstructured C-MP composites and nonstructured cryogels to check adherence and growth of cells, and investigate their biocompatibility. To test the potential of C-MP composites for delivery of bioactive/drug molecules to cells growing in three-dimensional (3D) conditions, doxorubicin-loaded silica MP-chitosangelatin C-MP composites were fabricated and anti-proliferative effect of doxorubicin was observed on growing human cervical cancer cells (HeLa).
C1 [Sami, Haider; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
RP Kumar, A (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
EM ashokkum@iitk.ac.in
RI Kumar, Ashok/G-8515-2015
FU Department of Biotechnology (DBT); Department of Science and Technology
   (DST), Ministry of Science and Technology, Govt. of India; DBT; IIT
   Kanpur
FX The authors would like to acknowledge Department of Biotechnology (DBT)
   and Department of Science and Technology (DST), Ministry of Science and
   Technology, Govt. of India for the financial support. HS would like to
   thank DBT and IIT Kanpur for providing the fellowship during the study
   program.
CR Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Dubey Rajesh R, 2004, AAPS PharmSciTech, V5, pE5, DOI 10.1208/pt050105
   Hedberg EL, 2002, J CONTROL RELEASE, V84, P137, DOI 10.1016/S0168-3659(02)00261-4
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Kempen DHR, 2006, J BIOMED MATER RES A, V77A, P103, DOI 10.1002/jbm.a.30336
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kumar A, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70202-9
   Kumar A, 2010, NAT PROTOC, V5, P1737, DOI 10.1038/nprot.2010.135
   Liu Tsang V, 2004, ADV DRUG DELIVERY RE, V56, P1635
   Lozinsky VI, 2003, TRENDS BIOTECHNOL, V21, P445, DOI 10.1016/j.tibtech.2003.08.002
   Lozinsky VI, 2001, BIOSEPARATION, V10, P163, DOI 10.1023/A:1016386902611
   Lozinsky VI, 2002, RUSS CHEM REV, V71, P489, DOI DOI 10.1070/RC2002V071N06ABEH000720
   Mishra R, 2011, J BIOMAT SCI-POLYM E, V22, P2107, DOI 10.1163/092050610X534230
   Mooney DJ, 1996, BIOTECHNOL BIOENG, V50, P422, DOI 10.1002/(SICI)1097-0290(19960520)50:4<422::AID-BIT9>3.0.CO;2-N
   Plieva FM, 2005, SOFT MATTER, V1, P303, DOI 10.1039/b510010k
   Shi M, 2003, J CONTROL RELEASE, V89, P167, DOI 10.1016/S0168-3659(02)00493-5
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057
   Srivastava A, 2009, J BIOMAT SCI-POLYM E, V20, P1393, DOI 10.1163/092050609X12457418891946
   Tim M, 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4.PMID:6606682
   Tripathi A, 2011, MACROMOL BIOSCI, V11, P22, DOI 10.1002/mabi.201000286
   Tripathi A, 2010, ENZYME MICROB TECH, V47, P44, DOI 10.1016/j.enzmictec.2010.03.009
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Xue ZX, 2007, J APPL POLYM SCI, V103, P2759, DOI 10.1002/app.25335
NR 31
TC 4
Z9 4
U1 2
U2 47
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUL 1
PY 2013
VL 24
IS 10
BP 1165
EP 1184
DI 10.1080/09205063.2012.743062
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 151YN
UT WOS:000319496400001
PM 23713421
DA 2018-10-20
ER

PT J
AU Wang, XH
   Li, S
   Liang, L
   Xu, XD
   Zhang, XZ
   Jiang, FG
AF Wang, Xing-Hua
   Li, Shuang
   Liang, Liang
   Xu, Xiao-Ding
   Zhang, Xian-Zheng
   Jiang, Fa-Gang
TI Evaluation of RGD peptide hydrogel in the posterior segment of the
   rabbit eye
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE peptide hydrogel; biocompatibility; vitreous cavity; suprachoroidal
   space; rabbit eye
ID DRUG-DELIVERY; MACULAR DEGENERATION; SUPRACHOROIDAL SPACE; AGE;
   BIOCOMPATIBILITY; PERMEABILITY; BEVACIZUMAB; RELEASE
AB The aim of this study was to evaluate the biocompatibility and biodegradability of RGD peptide hydrogel in the posterior segment of the eye as a biomaterial potentially useful for sustained drug delivery systems. RGD peptide hydrogel was injected into the vitreous cavity and suprachoroidal space of rabbit eyes. Clinical follow-up and histological observation were performed up to fourweeks. The biodegradability was also evaluated by the lifetime of the hydrogel which was defined by ophthalmoscopic observation or ultrasonography. The results showed that RGD peptide hydrogel was well tolerated in the vitreous cavity and suprachoroidal space, and disappeared from the injection sites progressively. As for suprachoroidal injection, the hydrogel was clearly identified by ultrasound echography and was confirmed innoxious to the retinal vessels by fluorescein angiography. Histological observations showed that the structures of retina, choroid and other tissues around the injection site remained normal after the injection. The lifetime of the hydrogel was 25.7 +/- 2.65days and 14.3 +/- 3.3days in the vitreous cavity and suprachoroidal space, respectively. The results obtained demonstrated that RGD peptide hydrogel, which showed excellent biocompatibility and favorable biodegradability in the posterior segment of rabbit eyes, appears to be a promising biomaterial to deliver drugs focally to the choroid and the retina.
C1 [Wang, Xing-Hua; Jiang, Fa-Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ophthalmol, Wuhan 430022, Peoples R China.
   [Li, Shuang] Cent Hosp Wuhan, Dept Ophthalmol, Wuhan 430014, Peoples R China.
   [Liang, Liang] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Ophthalmol, Yichang 443003, Peoples R China.
   [Xu, Xiao-Ding; Zhang, Xian-Zheng] Wuhan Univ, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
   [Xu, Xiao-Ding; Zhang, Xian-Zheng] Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
RP Liang, L (reprint author), China Three Gorges Univ, Coll Clin Med Sci 1, Dept Ophthalmol, Yichang 443003, Peoples R China.
EM liangliang419519@163.com; fgjiang@hotmail.com
CR Altunbas A, 2011, BIOMATERIALS, V32, P5906, DOI 10.1016/j.biomaterials.2011.04.069
   Bourges JL, 2006, ADV DRUG DELIVER REV, V58, P1182, DOI 10.1016/j.addr.2006.07.026
   Brandl F, 2010, J CONTROL RELEASE, V142, P221, DOI 10.1016/j.jconrel.2009.10.030
   Chen MC, 2009, BIOMATERIALS, V30, P2102, DOI 10.1016/j.biomaterials.2008.12.047
   Colthurst MJ, 2000, BIOMATERIALS, V21, P649, DOI 10.1016/S0142-9612(99)00220-3
   Einmahl S, 2002, INVEST OPHTH VIS SCI, V43, P1533
   Einmahl S, 2003, J BIOMED MATER RES A, V67A, P44, DOI 10.1002/jbm.a.10597
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   Fung AE, 2006, BRIT J OPHTHALMOL, V90, P1344, DOI 10.1136/bjo.2006.099598
   Geroski DH, 2000, INVEST OPHTH VIS SCI, V41, P961
   Kleinberg TT, 2011, SURV OPHTHALMOL, V56, P300, DOI 10.1016/j.survophthal.2010.09.001
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Li ZQ, 2011, EXPERT OPIN DRUG DEL, V8, P991, DOI 10.1517/17425247.2011.581656
   Liang LA, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045008
   Liang L, 2010, J BIOMED MATER RES B, V93B, P324, DOI 10.1002/jbm.b.31562
   Loftsson T, 2008, PHARMAZIE, V63, P171, DOI 10.1691/ph.2008.7322
   Lutolf MP, 2009, NAT MATER, V8, P451, DOI 10.1038/nmat2458
   Myung D, 2008, BIOTECHNOL PROGR, V24, P735, DOI 10.1021/bp070476n
   Olsen TW, 2006, AM J OPHTHALMOL, V142, P777, DOI 10.1016/j.ajo.2006.05.045
   Olsen TW, 2011, INVEST OPHTH VIS SCI, V52, P4749, DOI 10.1167/iovs.10-6291
   OLSEN TW, 1995, INVEST OPHTH VIS SCI, V36, P1893
   Perale G, 2011, J BIOMED NANOTECHNOL, V7, P476, DOI 10.1166/jbn.2011.1302
   Pitkanen L, 2005, INVEST OPHTH VIS SCI, V46, P641, DOI 10.1167/iovs.04-1051
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481
   Xu XD, 2010, ACS APPL MATER INTER, V2, P2663, DOI 10.1021/am100484c
NR 26
TC 6
Z9 6
U1 3
U2 26
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUL 1
PY 2013
VL 24
IS 10
BP 1185
EP 1197
DI 10.1080/09205063.2012.745714
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 151YN
UT WOS:000319496400002
PM 23713422
DA 2018-10-20
ER

PT J
AU Pan, YS
   Shen, QQ
   Pan, CL
   Wang, J
AF Pan Yusong
   Shen Qianqian
   Pan Chengling
   Wang Jing
TI Prediction of mechanical properties of multilayer gradient
   hydroxyapatite reinforced poly(vinyl alcohol) gel biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE multilayer gradient HA; PVA gel composites; compressive strength;
   mechanical model
ID ARTICULAR-CARTILAGE; POLYVINYL-ALCOHOL; COMPOSITES; HYDROGELS
AB Functional graded materials provided us one new concept for artificial articular cartilage design with graded component and graded structure. In this article, a novel functional material design was proposed by functionalizing hydroxyapatite (HA) particles in poly(vinyl alcohol) (PVA) hydrogel. The goal of the present study was to fabricate a multilayer gradient HA/PVA gel biocomposites through layer-by-layer casting method combining with freeze/thaw cycle technology and establish a mechanical model to predict the compressive mechanical properties of multilayer gradient gel biocomposites. The results showed that the compressive strength of the multilayer gradient gel biocomposites increased with the rise of HA content, but it presented decreasing trend with the rise of interlayer gradient concentration of HA particles. Furthermore, the compressive strength of multilayer gradient biocomposites would be approximately predicted by the established mechanical model. The maximum error between theoretical compressive strength predicted by the model and the experimental strength is less than 7%. On the other hand, the compressive mechanical properties of multilayer gradient composites could be designed and controlled by the mechanical model as established in this study. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [Pan Yusong; Shen Qianqian; Pan Chengling; Wang Jing] An Hui Univ Sci & Technol, Sch Mat Sci & Engn, Huai Nan 232001, Peoples R China.
RP Pan, YS (reprint author), An Hui Univ Sci & Technol, Sch Mat Sci & Engn, Huai Nan 232001, Peoples R China.
EM yusongpan@163.com
FU National Natural Science Foundation of China [51175004]; Natural Science
   Research of key projects of Anhui Provincial Universities [KJ2010A099]
FX Contract grant sponsor: National Natural Science Foundation of China;
   contract grant number: Project No. 51175004.; Contract grant sponsor:
   Natural Science Research of key projects of Anhui Provincial
   Universities; contract grant number: Project No.KJ2010A099
CR ALEXANDROS EB, 2005, INJURY, V365, ps14
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Jin R, 2009, BIOMATERIALS, V30, P2544, DOI 10.1016/j.biomaterials.2009.01.020
   Kubarev O. L., 2010, Inorganic Materials: Applied Research, V1, P182, DOI 10.1134/S2075113310030020
   PAN YS, 2008, J TRIBOL, V130, P256
   Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4
   Pan YS, 2012, MICRO NANO LETT, V7, P880, DOI 10.1049/mnl.2012.0467
   Pan YS, 2010, J MATER SCI, V45, P5495, DOI 10.1007/s10853-010-4607-0
   Pan YS, 2010, J WUHAN UNIV TECHNOL, V25, P474, DOI 10.1007/s11595-010-0026-y
   Pan YS, 2009, J MATER SCI-MATER M, V20, P1291, DOI 10.1007/s10856-008-3679-8
   Poursamar S A, 2010, International Journal of Nanomanufacturing, V5, P330
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Spiller KL, 2009, J BIOMED MATER RES B, V90B, P752, DOI 10.1002/jbm.b.31344
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Sureshbabu S, 2012, J AM CERAM SOC, V95, P915, DOI 10.1111/j.1551-2916.2011.04987.x
   Wang MB, 2008, J BIOMED MATER RES A, V85A, P418, DOI 10.1002/jbm.a.31585
   Wong KL, 2009, BIOMATERIALS, V30, P3810, DOI 10.1016/j.biomaterials.2009.04.016
   Zeng S, 2011, J BIOMED NANOTECHNOL, V7, P549, DOI 10.1166/jbn.2011.1316
NR 18
TC 15
Z9 16
U1 3
U2 48
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2013
VL 101B
IS 5
BP 729
EP 735
DI 10.1002/jbm.b.32875
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 160PL
UT WOS:000320131500006
PM 23359553
DA 2018-10-20
ER

PT J
AU Lim, J
   Chong, MSK
   Teo, EY
   Chen, GQ
   Chan, JKY
   Teoh, SH
AF Lim, Jing
   Chong, Mark Seow Khoon
   Teo, Erin Yiling
   Chen, Guo-Qiang
   Chan, Jerry K. Y.
   Teoh, Swee-Hin
TI Biocompatibility studies and characterization of
   poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)/polycaprolactone blends
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE poly(3-hydroxybutyrate-co-3-hydroxyhexanoate); medical-grade
   polycaprolactone; degradation; polymer; tissue engineering
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS;
   MECHANICAL-PROPERTIES; IN-VITRO; DEGRADATION; BONE; SCAFFOLDS; VIVO;
   POLY(EPSILON-CAPROLACTONE); POLY(L-LACTIDE)
AB Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) is a biocompatible and bioresorbable copolymer that has generated research interest as a bone scaffold material. However, its brittleness and degradation characteristics can be improved upon. We hypothesized that blending with medical-grade polycaprolactone (PCL) can improve degradation and mechanical characteristics. Here, we report the development of solvent-blended PHBHHx/PCL for application as a potential biomaterial for tissue engineering. Enhanced yield strength, yield strain and Young's modulus occurred at 30/70 blend when compared with PHBHHx and PCL. Polarized light microscopy demonstrated PHBHHx and PCL to exist as morphologically and optically distinct phases and, together with thermal analyses, revealed immiscibility. Hydrophilicity improved with the addition of PCL. Accelerated hydrolytic studies suggested predictable behavior of PHBHHx/PCL. Notably, 30/70 blend exhibited similar degradation behavior to PCL in terms of changes in crystallinity, molecular weight, morphology, and mass loss. Finally, human fetal mesenchymal stem cells (hfMSCs) were evaluated on PHBHHx/PCL using live/dead assay and results suggested encouraging hfMSC adhesion and proliferative capacity, with near-confluence occurring in PHBHHx and 30/70 blend after 5 days. Taken together, these are encouraging results for the further development of PHBHHx/PCL as a potential biomaterial for tissue engineering. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [Lim, Jing; Teo, Erin Yiling; Teoh, Swee-Hin] Natl Univ Singapore, Dept Mech Engn, Fac Engn, Ctr Biomed Mat & Technol BIOMAT, Singapore 117576, Singapore.
   [Lim, Jing; Chong, Mark Seow Khoon; Teoh, Swee-Hin] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 637459, Singapore.
   [Chong, Mark Seow Khoon; Chan, Jerry K. Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore 119074, Singapore.
   [Chong, Mark Seow Khoon; Chan, Jerry K. Y.] Natl Univ Hosp Syst, Singapore 119074, Singapore.
   [Teo, Erin Yiling; Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore.
   [Chen, Guo-Qiang] Tsinghua Univ, Sch Life Sci, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
   [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Singapore 169857, Singapore.
RP Teoh, SH (reprint author), Natl Univ Singapore, Dept Mech Engn, Fac Engn, Ctr Biomed Mat & Technol BIOMAT, Singapore 117576, Singapore.
EM teohsh@ntu.edu.sg
RI Wang, Zuyong/J-6140-2017; Chong, Mark/D-2678-2013
OI Wang, Zuyong/0000-0003-0136-6402; Chong, Mark/0000-0002-9586-6303
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   BARLOW JW, 1981, POLYM ENG SCI, V21, P985, DOI 10.1002/pen.760211502
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bian YZ, 2009, BIOMATERIALS, V30, P217, DOI 10.1016/j.biomaterials.2008.09.036
   CAM D, 1995, BIOMATERIALS, V16, P833, DOI 10.1016/0142-9612(95)94144-A
   Chan J, 2005, STEM CELLS, V23, P93, DOI 10.1634/stemcells.2004-0138
   Cheng ML, 2011, POLYMER, V52, P1391, DOI 10.1016/j.polymer.2011.01.039
   Chong MSK, 2010, METHODS MOL BIOL, V614, P135, DOI 10.1007/978-1-60761-533-0_9
   Chong MSK, 2009, BIOMATERIALS, V30, P2241, DOI 10.1016/j.biomaterials.2008.12.056
   Chong MSK, 2010, TISSUE ENG PT A, V16, P2485, DOI [10.1089/ten.tea.2009.0680, 10.1089/ten.TEA.2009.0680]
   Chong MSK, 2012, HUMAN FETAL MESENCHY, V3, P289
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   Coury AJ, 2004, BIOMATERIALS SCI
   Donoghue K, 2006, CURR STEM CELL RES T, V1, P371
   HRABAK O, 1992, FEMS MICROBIOL LETT, V103, P251, DOI 10.1111/j.1574-6968.1992.tb05845.x
   Ibim SEM, 1997, BIOMATERIALS, V18, P1565, DOI 10.1016/S0142-9612(97)00099-9
   Katsumata K, 2011, POLYM J, V43, P484, DOI 10.1038/pj.2011.12
   KUMAGAI Y, 1992, POLYM DEGRAD STABIL, V36, P241, DOI 10.1016/0141-3910(92)90062-A
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   LAM CXF, 2008, BIOMED MAT, V3
   Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93
   Lei Y, 2007, MAT SCI ENG C-BIO S, V27, P293, DOI 10.1016/j.msec.2006.05.006
   MACHELL JS, 1990, MACROMOLECULES, V23, P186, DOI 10.1021/ma00203a033
   POLKINGHORNE J, 1989, CM762
   Qiu YZ, 2005, BIOTECHNOL LETT, V27, P1381, DOI 10.1007/s10529-005-3685-6
   Rai B, 2004, BIOMATERIALS, V25, P5499, DOI 10.1016/j.biomaterials.2004.01.007
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P765
   REUSCH RN, 1995, CAN J MICROBIOL, V41, P50, DOI 10.1139/m95-167
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Shen F, 2009, COLLOID SURFACE B, V73, P302, DOI 10.1016/j.colsurfb.2009.05.032
   Teo EY, 2011, BIOMATERIALS, V32, P279, DOI 10.1016/j.biomaterials.2010.08.089
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Wang YW, 2004, POLYM DEGRAD STABIL, V85, P815, DOI 10.1016/j.polymdegradstab.2004.02.010
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yeo A, 2010, J BIOMED MATER RES A, V92A, P311, DOI 10.1002/jbm.a.32366
   Zhang ZY, 2010, BIOMATERIALS, V31, P8684, DOI 10.1016/j.biomaterials.2010.07.097
   Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
   Zhao Q, 2012, J BIOMED MATER RES B, V100B, P23, DOI 10.1002/jbm.b.31915
NR 41
TC 13
Z9 16
U1 1
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2013
VL 101B
IS 5
BP 752
EP 761
DI 10.1002/jbm.b.32878
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 160PL
UT WOS:000320131500009
PM 23359588
DA 2018-10-20
ER

PT J
AU Pelaez-Vargas, A
   Gallego-Perez, D
   Carvalho, A
   Fernandes, MH
   Hansford, DJ
   Monteiro, FJ
AF Pelaez-Vargas, Alejandro
   Gallego-Perez, Daniel
   Carvalho, Angela
   Fernandes, Maria H.
   Hansford, Derek J.
   Monteiro, Fernando J.
TI Effects of density of anisotropic microstamped silica thin films on
   guided bone tissue regenerationIn vitro study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell-material interactions; bone; cell proliferation
ID NANO-STRUCTURED SURFACES; OSTEOBLAST-LIKE CELLS; TITANIUM IMPLANTS;
   SOL-GEL; IN-VIVO; BEHAVIOR; BIOMATERIAL; INTEGRATION; RESPONSES;
   COATINGS
AB The growing demand for better implant aesthetics has led to increased research on the development of all-ceramic dental implants. The use of microtextured coatings with enhanced properties has been presented as a viable way to improve tissue integrability of all-ceramic implants. The aim of this study was to evaluate the effects of different densities of anisotropic microtextured silica thin films, which served as a model coating, on the behavior of human osteoblast-like cells. The differential responses of human osteoblast-like cells to anisotropic silica microtextures with varying densities, produced via a combination of sol-gel and soft lithography processing, were evaluated in terms of alignment, elongation (using fluorescence microscopy), overall cellular activity, and the expression/activity levels of alkaline phosphatase (ALP). Statistical analysis was conducted using one-way ANOVA/Tukey HSD post hoc test. The thin films were thoroughly characterized via scanning electron microscopy/energy dispersive spectroscopy, Fourier transform infrared, and contact angle measurements. Thin film characterization revealed increased nanoscale roughness and reduced wettability on the micropatterned surfaces. Cell culture experiments indicated that the microtextures induced cell alignment, elongation, and guided colonization on the surface. Cells cultured on denser micropatterns exhibited increased metabolic activity (t = 14-21 days). The early expression/activity levels of ALP released into the medium were found to be significantly higher only on the least dense micropattern. These results suggest the possibility that microstructured silica thin films could be used to guide and enhance peri-implant cell/tissue responses, potentially improving tissue integration for metallic and all-ceramic dental implants. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [Pelaez-Vargas, Alejandro; Carvalho, Angela; Monteiro, Fernando J.] Univ Porto, INEB Inst Engn Biomed, P-4100 Oporto, Portugal.
   [Pelaez-Vargas, Alejandro; Carvalho, Angela; Monteiro, Fernando J.] Univ Porto, Dept Engn Met & Mat, FEUP Fac Engn, P-4100 Oporto, Portugal.
   [Pelaez-Vargas, Alejandro] Univ Cooperat Colombia, Fac Dent, Medellin, Colombia.
   [Gallego-Perez, Daniel; Hansford, Derek J.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.
   [Fernandes, Maria H.] Univ Porto, Fac Med Dent, Lab Farmacol & Biocompatibilidade Celular, P-4100 Oporto, Portugal.
RP Pelaez-Vargas, A (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
EM alejopv@ineb.up.pt
RI Fernandes, Maria Helena/K-6917-2014; Carvalho, Angela/L-3224-2014;
   Hansford, Derek/B-5306-2012; Gallego-Perez, Daniel/F-6605-2016
OI Carvalho, Angela/0000-0002-4837-6539; Gallego Perez,
   Daniel/0000-0002-6263-3191; Fernandes, Maria Helena/0000-0001-9391-9574;
   Monteiro, Fernando/0000-0002-1361-4605; Pelaez-Vargas,
   Alejandro/0000-0001-7582-2760
FU Portuguese Science and Technology Foundation [FCT/SFRH/BD/36220/2007,
   FCT/PTDC/CTM/100120/2008]; NSF Nanoscale Science and Engineering Center
   fellowship (NSF) [EEC-0425626]
FX Contract grant sponsor: Portuguese Science and Technology Foundation
   (Scholarship FCT/SFRH/BD/36220/2007); contract grant number:
   FCT/PTDC/CTM/100120/2008 "Bonamidi"; Contract grant sponsor: NSF
   Nanoscale Science and Engineering Center fellowship (NSF); contract
   grant number: EEC-0425626
CR Abron A, 2001, J PROSTHET DENT, V85, P40, DOI 10.1067/mpr.2001.112415
   ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Ahmad I, 2010, J EUR CERAM SOC, V30, P865, DOI 10.1016/j.jeurceramsoc.2009.09.032
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   ALBREKTSSON T, 1988, J PERIODONTOL, V59, P287, DOI 10.1902/jop.1988.59.5.287
   Ali NN, 1996, J BONE MINER RES, V11, P512
   Binon PP, 2000, INT J ORAL MAX IMPL, V15, P76
   Body SC, 1996, J CARDIOVASC PHARM, V27, pS13
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Charest JL, 2004, BIOMATERIALS, V25, P4767, DOI 10.1016/j.biomaterials.2003.12.011
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   Chehroudi B, 2002, BIOMATERIALS, V23, P229, DOI 10.1016/S0142-9612(01)00100-4
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Davies John E, 2003, J Dent Educ, V67, P932
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gallardo J, 2000, J SOL-GEL SCI TECHN, V19, P107, DOI 10.1023/A:1008726608539
   Garcia C, 2004, J NON-CRYST SOLIDS, V348, P218, DOI 10.1016/j.jnoncrysol.2004.08.172
   GOTFREDSEN K, 1990, International Journal of Prosthodontics, V3, P463
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Hallgren C, 2001, Clin Implant Dent Relat Res, V3, P194, DOI 10.1111/j.1708-8208.2001.tb00141.x
   Hallgren C, 2001, J BIOMED MATER RES, V57, P485, DOI 10.1002/1097-4636(20011215)57:4<485::AID-JBM1194>3.0.CO;2-1
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Ivanoff CJ, 2001, CLIN ORAL IMPLAN RES, V12, P128, DOI 10.1034/j.1600-0501.2001.012002128.x
   Jung YC, 2006, NANOTECHNOLOGY, V17, P4970, DOI 10.1088/0957-4484/17/19/033
   Kim EJ, 2010, ACTA BIOMATER, V6, P160, DOI 10.1016/j.actbio.2009.06.016
   Klinge Bjorn, 2005, Dent Clin North Am, V49, P661, DOI 10.1016/j.cden.2005.03.007
   Klinger A, 2011, CLIN IMPLANT DENT R, V13, P64, DOI 10.1111/j.1708-8208.2009.00177.x
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   Leong P, 2004, J PROSTHET DENT, V91, P215, DOI 10.1016/j.prosdent.2003.12.024
   LiuTsang V., 2004, ADV DRUG DELIVERY RE, V56, P1635
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   MCQUILLAN DJ, 1995, BONE, V16, P415
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Ogawa T, 2006, J DENT RES, V85, P566, DOI 10.1177/154405910608500617
   Pacifico J, 2006, LANGMUIR, V22, P11072, DOI 10.1021/la060925d
   Palmquist A, 2011, CLIN IMPLANT DENT RE, DOI 10.1111/j.1708-8208.2011.00361.x
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Pelaez-Vargas A, 2011, BONE, V48, pS105, DOI 10.1016/j.bone.2011.03.166
   Pelaez-Vargas A, 2010, DENT MATER, V27, P581
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Ribeiro N, 2010, J COLLOID INTERF SCI, V351, P398, DOI 10.1016/j.jcis.2010.08.013
   Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P290, DOI 10.1111/j.1600.051X.2006.00906.x
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Schwartz Zvi, 2005, Alpha Omegan, V98, P9
   Shibli JA, 2009, J BIOMED MATER RES A, V93, P607
   Tadanaga K, 2004, CERAM INT, V30, P1815, DOI 10.1016/j.ceramint.2003.12.069
   Trisi P, 2003, J PERIODONTOL, V74, P945, DOI 10.1902/jop.2003.74.7.945
   Wang CC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/33/335709
   Wang LP, 2006, BIOMATERIALS, V27, P3716, DOI 10.1016/j.biomaterials.2006.02.022
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
NR 55
TC 11
Z9 12
U1 2
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2013
VL 101B
IS 5
BP 762
EP 769
DI 10.1002/jbm.b.32879
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 160PL
UT WOS:000320131500010
PM 23359600
DA 2018-10-20
ER

PT J
AU Gumel, AM
   Annuar, SM
   Heidelberg, T
AF Gumel, Ahmad M.
   Annuar, Suffian M.
   Heidelberg, Thorsten
TI Single-step lipase-catalyzed functionalization of medium-chain-length
   polyhydroxyalkanoates
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE biopolymer; Candida antarctica; lipase; polyhydroxyalkanoates;
   sugar-ester; sucrose
ID CANDIDA-ANTARCTICA; WATER ACTIVITY; CHEMOENZYMATIC SYNTHESIS;
   ORGANIC-SOLVENTS; ESTER SYNTHESIS; FATTY-ACID; SUGAR; POLYMER;
   POLYESTERS; COSOLVENT
AB Background Functionalization of aliphatic biopolymers such as bacterial polyhydroxyalkanoates (PHA) using biologically active hydrophilic moieties like sugars helps to improve the hydrophilicity and biodegradability of the biomaterial. Results The effects of reaction variables reaction time, temperature, enzyme concentration and substrate ratio on reaction rate and yield in the synthesis of poly(1'-O-3-hydroxyacyl-sucrose) using Candida antarctica lipase B (EC 3.1.1.3) were studied. Using H2O2 as micro-initiator, enzyme-mediated synthesis yielded reaction rate, vapp of 0.076 x 10-5 mol L-1 s-1. The biodegradability of the functionalized polymer was observed to increase by 1.5 fold compared with the non-functionalized material apart from showing better compostability. Increasing the reaction temperature (>50 degrees C), enzyme concentration (>15 g L-1) and reactant ratio (w/w) of sucrose:PHA (>2) did not increase further the rate or yield. The sucrose-functionalized mcl-PHA was characterized with respect to the non-functionalized material. Conclusions Novozym (R) 435 can be used effectively to synthesize poly(1'-O-3-hydroxyacyl sucrose) in micro-aqueous medium bypassing the need for chemo-synthetic steps. The synthesized biomaterials have potential applications in biomedical and industrial niches.(c) 2012 Society of Chemical Industry
C1 [Gumel, Ahmad M.; Annuar, Suffian M.] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
   [Heidelberg, Thorsten] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia.
RP Annuar, SM (reprint author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
EM suffian_annuar@um.edu.my
RI HEIDELBERG, THORSTEN/B-9963-2010; MOHAMAD ANNUAR, MOHAMAD
   SUFFIAN/B-9031-2010; GUMEL, AHMAD MOHAMMED/E-9906-2011
OI HEIDELBERG, THORSTEN/0000-0003-4428-2233; MOHAMAD ANNUAR, MOHAMAD
   SUFFIAN/0000-0003-3387-0160; GUMEL, AHMAD MOHAMMED/0000-0002-2998-4088
FU University of Malaya [PV036/2012A, RG165/11AFR, RP024-2012A]
FX The authors thank the University of Malaya for research grants
   PV036/2012A, RG165/11AFR and RP024-2012A.
CR Antczak T, 2004, J MOL CATAL B-ENZYM, V29, P155, DOI 10.1016/j.molcatb.2004.02.009
   Barros MT, 2010, EUR POLYM J, V46, P1151, DOI 10.1016/j.eurpolymj.2010.02.002
   Chamouleau F, 2001, J MOL CATAL B-ENZYM, V11, P949, DOI 10.1016/S1381-1177(00)00166-1
   Cheng YC, 2003, ENZYME MICROB TECH, V32, P362, DOI 10.1016/S0141-0229(02)00318-6
   Cordova A, 2001, BIOMACROMOLECULES, V2, P1347, DOI 10.1021/bm0101015
   Gross RA, 2005, Patent No. [6972315 B2, 6972315]
   Gumel AM, 2012, POLYM DEGRAD STABIL, V97, P1224, DOI 10.1016/j.polymdegradstab.2012.05.041
   Gumel AM, 2012, ULTRASON SONOCHEM, V19, P659, DOI 10.1016/j.ultsonch.2011.10.016
   Gumel AM, 2011, PROCESS BIOCHEM, V46, P2079, DOI 10.1016/j.procbio.2011.07.021
   Gumel AM, 2011, BIORESOURCE TECHNOL, V102, P8727, DOI 10.1016/j.biortech.2011.07.024
   Gumel AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045214
   Ha SH, 2010, BIOPROC BIOSYST ENG, V33, P63, DOI 10.1007/s00449-009-0363-4
   Hatanaka K, 1997, J CARBOHYD CHEM, V16, P667, DOI 10.1080/07328309708007344
   Kitagawa M, 1999, BIOTECHNOL LETT, V21, P355, DOI 10.1023/A:1005451009804
   Kitagawa M, 1998, BIOTECHNOL LETT, V20, P627, DOI 10.1023/A:1005334926926
   Kobayashi K, 1997, MACROMOLECULES, V30, P2016, DOI 10.1021/ma961681e
   Li C, 2010, J BIOL CHEM, V285, P28434, DOI 10.1074/jbc.M110.136200
   Li J, 1999, MACROMOLECULES, V32, P2789, DOI 10.1021/ma981816b
   Lozano P, 2004, J SUPERCRIT FLUID, V29, P121, DOI 10.1016/S0896-8446(03)00050-0
   Lu DS, 2002, CHINESE J POLYM SCI, V20, P579
   MARTIN BD, 1992, MACROMOLECULES, V25, P7081, DOI 10.1021/ma00052a001
   Massardier-Nageotte V, 2006, POLYM DEGRAD STABIL, V91, P620, DOI 10.1016/j.polymdegradstab.2005.02.029
   Ottosson J, 2001, ENTHALPY ENTROPY ENZ
   Radzi SM, 2005, ELECTRON J BIOTECHN, V8, DOI 10.2225/vol8-issue3-fulltext-4
   Rai R, 2011, BIOMACROMOLECULES, V12, P2126, DOI 10.1021/bm2001999
   ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
   Seyednejad H, 2011, J CONTROL RELEASE, V152, P168, DOI 10.1016/j.jconrel.2010.12.016
   Shi YG, 2011, J CHEM TECHNOL BIOT, V86, P1457, DOI 10.1002/jctb.2711
   Teng Y, 2007, ANAL BIOCHEM, V363, P297, DOI 10.1016/j.ab.2007.01.026
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tokiwa Y, 2000, MACROMOLECULES, V33, P1636, DOI 10.1021/ma981451v
   Tokiwa Y, 2000, CLEAN PRODUCTS PROCE, V2, P108, DOI [10.1021/ma981451v, DOI 10.1021/MA981451V]
   UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9
   UYAMA H, 1993, P JPN ACAD B-PHYS, V69, P203, DOI 10.2183/pjab.69.203
   Varma AJ, 2004, CARBOHYD POLYM, V56, P429, DOI 10.1016/j.carbpol.2004.03.007
   Veld M.J., 2011, ENZYMATIC POLYM, P55
   Wang X, 2005, CARBOHYD POLYM, V60, P357, DOI 10.1016/j.carbpol.2005.01.007
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Wei DZ, 2004, J IND MICROBIOL BIOT, V31, P133, DOI 10.1007/s10295-004-0126-9
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yeniad B, 2011, LIPASES POLYM CHEM B, P69
NR 41
TC 7
Z9 7
U1 0
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD JUL
PY 2013
VL 88
IS 7
BP 1328
EP 1335
DI 10.1002/jctb.3980
PG 8
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 159II
UT WOS:000320038700018
DA 2018-10-20
ER

PT J
AU Brouwer, KM
   Daamen, WF
   Reijnen, D
   Verstegen, RH
   Lammers, G
   Hafmans, TG
   Wismans, RG
   van Kuppevelt, TH
   Wijnen, RM
AF Brouwer, Katrien M.
   Daamen, Willeke F.
   Reijnen, Daphne
   Verstegen, Ruud H.
   Lammers, Gerwen
   Hafmans, Theo G.
   Wismans, Ronnie G.
   van Kuppevelt, Toin H.
   Wijnen, Rene M.
TI Repair of surgically created diaphragmatic defect in rat with use of a
   crosslinked porous collagen scaffold
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterial; collagen; diaphragmatic hernia; rat model; regenerative
   medicine; scaffold; surgical repair; tissue engineering
ID SMALL-INTESTINE SUBMUCOSA; NEURAL-TUBE DEFECT; HERNIA REPAIR;
   ABDOMINAL-WALL; SHEEP MODEL; HISTOLOGICAL-EVALUATION; MESOTHELIAL CELLS;
   PROSTHETIC PATCH; FETAL SHEEP; RECONSTRUCTION
AB Large defects in congenital diaphragmatic hernia are closed by patch repair, which is associated with a high complication risk and reherniation rate. New treatment modalities are warranted. We evaluated the feasibility of using an acellular biodegradable collagen bioscaffold for a regenerative medicine approach to close a surgically created diaphragmatic defect in a rat model. Scaffold degradation, cellular ingrowth and regeneration of the diaphragm were studied. In 25 rats, a subcostal incision was made and one third of the right hemidiaphragm was resected. Crosslinked porous type I collagen scaffolds (O similar to 14mm) were sutured into the lesion. Rats were sacrificed at 2, 4, 8, 12 or 24weeks after scaffold implantation. Implants were evaluated macroscopically and (immuno)histologically. Survival after surgery was 88% with no evidence of reherniation. Histological examination showed that the collagen scaffold degraded slowly and new collagen, elastin and mesothelium were deposited. Blood vessels were observed primarily at the outer borders of the scaffold; their number gradually increased in time. Muscle fibres were found on the scaffold covering up to 10% of the defect. Macroscopically, adhesion of the scaffold to the liver was observed. Use of a collagen scaffold to close a surgically created diaphragmatic defect is feasible, with evidence of new tissue formation. The use of crosslinked collagen scaffolds allows targeted modification; e.g. addition of growth factors to further stimulate growth of muscle cells. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Brouwer, Katrien M.; Daamen, Willeke F.; Lammers, Gerwen; Hafmans, Theo G.; Wismans, Ronnie G.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 280, NL-6500 HB Nijmegen, Netherlands.
   [Reijnen, Daphne] Radboud Univ Nijmegen, Med Ctr, Cent Anim Facil 231, NL-6525 EZ Nijmegen, Netherlands.
   [Verstegen, Ruud H.; Wijnen, Rene M.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6500 HB Nijmegen, Netherlands.
RP Brouwer, KM (reprint author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 280, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM K.Brouwer@ncmls.ru.nl
RI Kuppevelt, A.H.M.S.M./L-4463-2015; Verstegen, Ruud/R-8613-2018; Wijnen,
   R.M.H./L-4758-2015; Daamen, Willeke/D-5854-2015; Brouwer,
   Katrien/K-6168-2012
OI Verstegen, Ruud/0000-0001-6638-8405; Daamen,
   Willeke/0000-0003-3155-3030; Brouwer, Katrien/0000-0002-6768-3358
FU EU-FP6 project EuroSTEC [LSHB-CT-2006-037409]; Dutch Program for Tissue
   Engineering [DPTE 6735]
FX Ko Hagoort is kindly acknowledged for his critical revision of the
   manuscript. Paul Jap is gratefully acknowledged for his histological
   expertise. The Microscopical Imaging Centre (NCMLS, RUNMC) is
   acknowledged for facilitating electron microscopical services. This work
   was financially supported by EU-FP6 project EuroSTEC (soft tissue
   engineering for congenital birth defects in children: contract:
   LSHB-CT-2006-037409) and by the Dutch Program for Tissue Engineering
   (grant DPTE 6735).
CR ATKINSON JB, 1992, J PEDIATR SURG, V27, P754, DOI 10.1016/S0022-3468(05)80109-5
   Bancroft J, 1996, THEORY PRACTICE HIST
   Clark RH, 1998, J PEDIATR SURG, V33, P1004, DOI 10.1016/S0022-3468(98)90522-X
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   DALTON ML, 1966, AM J SURG, V111, P668, DOI 10.1016/0002-9610(66)90038-9
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Eggink AJ, 2006, FETAL DIAGN THER, V21, P210, DOI 10.1159/000089305
   Eggink AJ, 2005, FETAL DIAGN THER, V20, P335, DOI 10.1159/000086808
   Faraj KA, 2007, TISSUE ENG, V13, P2387, DOI 10.1089/ten.2006.0320
   Fuchs JR, 2004, J PEDIATR SURG, V39, P834, DOI 10.1016/j.jpedsurg.2004.02.014
   Gamba PG, 2002, PEDIATR SURG INT, V18, P327, DOI 10.1007/s00383-002-0849-5
   GILBERT DL, 1990, J BIOMED MATER RES, V24, P1221, DOI 10.1002/jbm.820240907
   Grethel EJ, 2006, J PEDIATR SURG, V41, P29, DOI 10.1016/j.jpedsurg.2005.10.005
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Hosper NA, 2010, BIOMATERIALS, V31, P3910, DOI 10.1016/j.biomaterials.2010.01.129
   Jancelewicz T, 2010, J PEDIATR SURG, V45, P155, DOI 10.1016/j.jpedsurg.2009.10.028
   Kimber CP, 2000, J PEDIATR SURG, V35, P120, DOI 10.1016/S0022-3468(00)80027-5
   Kunisaki SM, 2006, J PEDIATR SURG, V41, P34, DOI 10.1016/j.jpedsurg.2005.10.011
   Laituri CA, 2010, EUR J PEDIATR SURG, V20, P363, DOI 10.1055/s-0030-1261939
   LALLY KP, 1992, ANN SURG, V216, P569, DOI 10.1097/00000658-199211000-00008
   LALLY KP, 1993, J PEDIATR SURG, V28, P45, DOI 10.1016/S0022-3468(05)80352-5
   LAROCCA PJ, 1984, CANCER RES, V44, P2991
   Lee SL, 2002, J PEDIATR SURG, V37, P367, DOI 10.1053/jpsu.2002.30837
   MACKAY AM, 1990, J CELL SCI, V95, P97
   Mitchell IC, 2008, J PEDIATR SURG, V43, P2161, DOI 10.1016/j.jpedsurg.2008.08.040
   Moss RL, 2001, J PEDIATR SURG, V36, P152
   Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2
   OCONNOR WN, 1982, STAIN TECHNOL, V57, P207, DOI 10.3109/10520298209066710
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Poulose BK, 2005, J SURG RES, V123, P262, DOI 10.1016/j.jss.2004.08.011
   RODGERS BM, 1981, ANN SURG, V193, P606, DOI 10.1097/00000658-198105000-00010
   Roelofs LAJ, 2008, FETAL DIAGN THER, V24, P7, DOI 10.1159/000132399
   Roelofs LAJ, 2008, TISSUE ENG PT A, V14, P2033, DOI 10.1089/ten.tea.2007.0191
   Sandoval JA, 2006, J PEDIATR SURG, V41, P518, DOI 10.1016/j.jpedsurg.2005.11.068
   St Peter SD, 2007, J SURG RES, V140, P234, DOI 10.1016/j.jss.2007.03.018
   Tingstedt B, 2007, EUR SURG RES, V39, P259, DOI 10.1159/000102591
   Urita Y, 2008, PEDIATR SURG INT, V24, P1041, DOI 10.1007/s00383-008-2212-y
NR 39
TC 7
Z9 7
U1 2
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUL
PY 2013
VL 7
IS 7
BP 552
EP 561
DI 10.1002/term.549
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 168TJ
UT WOS:000320728400005
PM 22589175
DA 2018-10-20
ER

PT J
AU Yang, BC
   Wang, FX
   Zhang, SQ
   Song, N
   Li, JX
   Yang, ZQ
   Wen, YJ
   Wu, H
AF Yang, Bo-Chao
   Wang, Feng-Xue
   Zhang, Shu-Qin
   Song, Ni
   Li, Jian-Xi
   Yang, Zhi-Qiang
   Wen, Yong-Jun
   Wu, Hua
TI Comparative evaluation of conventional polymerase chain reaction (PCR),
   with loop-mediated isothermal amplification and SYBR green I-based
   real-time PCR for the quantitation of porcine circovirus-1 DNA in
   contaminated samples destined for vaccine production
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Porcine circovirus type1; Polymerase chain reaction; Real-time
   polymerase chain reaction; Loop-mediated isothermal amplification; SYBR
   green I-mediated polymerase chain reaction
ID RAPID DETECTION; CELL-LINES; TYPE-2; QUANTIFICATION; MICROBIOLOGY;
   VIRUS; ASSAY; PIGS
AB Porcine circovirus type1 (PCV1), described initially as a contaminant of a porcine kidney cell line, is ubiquitous within the swine population The presence of PCV1 in porcine cell lines can lead to contamination during both human and porcine vaccine production. Therefore, a rapid, specific, sensitive and practical method is needed for the detection of PCV1 in bio-products. The aim of this study was to compare three assays in their ability to accurately quantify PCV1 virus in biological samples, namely loop-mediated isothermal amplification (LAMP), SYBR green I-based real-time polymerase chain reaction (PCR) and conventional PCR. All assays yielded successful quantitation of PCV1 DNA and differentiated between PCV1-free and-contaminated cells. In addition, the results were specific for PCV1, since amplification of samples containing closely-related PCV2 or other pathogenic swine viruses yielded negative results. The lowest detection threshold of 10(2) copies was displayed by the SYBR green I-based real-time PCR assay. In addition, this assay was the most effective in detecting PCV1 contamination in a set of commercially available porcine vaccines. Therefore we conclude that SYBR green I-based real-time PCR is specific and sensitive for detecting PCV1 in biological samples and maybe used for quality control of vaccine and biomaterial production. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Yang, Bo-Chao; Wang, Feng-Xue; Zhang, Shu-Qin; Song, Ni; Wen, Yong-Jun] Chinese Acad Agr Sci CAAS, Inst Special Econ Anim & Plant Sci, State Key Lab Mol Biol Special Econ Anim, Chuangchun 130112, Peoples R China.
   [Yang, Bo-Chao; Li, Jian-Xi; Yang, Zhi-Qiang] Chinese Acad Agr Sci, Lanzhou Inst Anim & Vet Pharmaceut, Lanzhou 730050, Peoples R China.
   [Wu, Hua] Sinovet Beijing Biotechnol Co Ltd, Beijing, Peoples R China.
RP Wen, YJ (reprint author), Chinese Acad Agr Sci, Inst Special Econ Anim & Plant Sci, 4899 Juye St, Jilin 130112, Peoples R China.
EM yongjunwen@126.com; wuhua@sinovetah.com
FU National High Technology Research and Development Program of China (863
   Program) [2011AA10A21]; innovation team for special economic animal
   diseases prevention and control research in Jilin province, standard of
   epidemic diseases in wild animals and tracking study (OIE) [20121823]
FX The Authors wish to thank all the personnel that collected the samples,
   as well as the companies that allowed the use of their vaccine samples
   for research studies. This study was supported by the National High
   Technology Research and Development Program of China (863 Program) (no.
   2011AA10A21), and innovation team for special economic animal diseases
   prevention and control research in Jilin province (20121823), standard
   of epidemic diseases in wild animals and tracking study (OIE 2012).
CR Allan G, 1998, VET REC, V142, P467
   Allan G. M., 1994, Journal of Veterinary Medicine Series B, V41, P17
   ALLAN GM, 1995, VET MICROBIOL, V44, P49, DOI 10.1016/0378-1135(94)00136-K
   Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102
   Chen HT, 2008, J VIROL METHODS, V149, P264, DOI 10.1016/j.jviromet.2008.01.023
   Dezen D, 2010, RES VET SCI, V88, P436, DOI 10.1016/j.rvsc.2009.10.006
   DULAC GC, 1989, CAN J VET RES, V53, P431
   Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006
   HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026
   HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276
   Jiang YH, 2010, RES VET SCI, V89, P133, DOI 10.1016/j.rvsc.2010.01.009
   Katayama S, 1998, J VET MED SCI, V60, P23, DOI 10.1292/jvms.60.23
   Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007
   Larochelle R, 1999, VET REC, V145, P140, DOI 10.1136/vr.145.5.140
   Ma HL, 2011, VACCINE, V29, P8429, DOI 10.1016/j.vaccine.2011.07.123
   Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x
   Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292
   McClenahan SD, 2011, VACCINE, V29, P4745, DOI 10.1016/j.vaccine.2011.04.087
   Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921
   Nagamine K, 2001, CLIN CHEM, V47, P1742
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Olvera A, 2007, VIROLOGY, V357, P175, DOI 10.1016/j.virol.2006.07.047
   Park JS, 2009, J COMP PATHOL, V140, P208, DOI 10.1016/j.jcpa.2008.11.004
   Pastoret PP, 2010, BIOLOGICALS, V38, P332, DOI 10.1016/j.biologicals.2010.02.015
   Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18
   Roic B, 2006, J VET MED B, V53, P17, DOI 10.1111/j.1439-0450.2006.00907.x
   TISCHER I, 1986, ARCH VIROL, V91, P271, DOI 10.1007/BF01314286
   TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153
   TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0
   Todd D, 2005, VIRUS TAXONOMY, P327
   Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09
   Vlasakova M, 2012, J VIROL METHODS, V179, P311, DOI 10.1016/j.jviromet.2011.11.014
   Welch J, 2006, TRANSFUSION, V46, P1951, DOI 10.1111/j.1537-2995.2006.01003.x
   Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0
   Yue FX, 2009, VIRUS GENES, V38, P392, DOI 10.1007/s11262-009-0333-6
   Zhao K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-126
NR 36
TC 5
Z9 8
U1 0
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
J9 J VIROL METHODS
JI J. Virol. Methods
PD JUL
PY 2013
VL 191
IS 1
BP 1
EP 8
DI 10.1016/j.jviromet.2013.03.014
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 161TV
UT WOS:000320217100001
PM 23538038
DA 2018-10-20
ER

PT J
AU Maachou, H
   Genet, MJ
   Aliouche, D
   Dupont-Gillain, CC
   Rouxhet, PG
AF Maachou, Hamida
   Genet, Michel J.
   Aliouche, Djamel
   Dupont-Gillain, Christine C.
   Rouxhet, Paul G.
TI XPS analysis of chitosan-hydroxyapatite biomaterials: from elements to
   compounds
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE XPS; chitosan; hydroxyapatite; biomaterials; calcium carbonate; SBF
ID PHOSPHORYLATED CHITOSAN; COMPOSITE SCAFFOLDS; POLYELECTROLYTE COMPLEX;
   STAINLESS-STEEL; BONE-GRAFT; IN-VITRO; SURFACE; FILM; BIOMINERALIZATION;
   NANOCOMPOSITES
AB Chitosan (Cs) and hydroxyapatite (Ha) were analysed by X-ray photoelectron spectroscopy (XPS). Phosphorylated Cs microparticles and hybrid Cs/Ha microparticles were prepared and analysed by XPS before and after immersion in a solution 1.5 times more concentrated than a simulated body fluid (SBF). The accuracy of spectrum recording, peak decomposition and peak component assignment was insured by a post-control of charge stabilization, and by the examination of correlations between spectral data guided by stoichiometry and charge balance. The concentration of organic oxygen was determined from the concentrations of the oxidized forms of carbon, allowing a sharper insight into speciation and O 1s peak shape. This indicated that the hydroxide ion of Ha, and hydrogenophosphate if present, give a contribution near 532.4 eV, which overlaps with organic oxygen. As a result of immersion in the 1.5*SBF solution, the formation of CaCO3 and of Ha material occurred. A quantification could be made for the constituents of biomaterial interest, contaminating salts and paraffin oil residues from the microparticle manufacturing process. The uncertainties regarding the nature of the model calcium phosphate used and the best marker for calcium carbonate were addressed by comparing the possible effect on the output, which was facilitated by using ternary composition diagrams. Whatever their formulation, the native microparticles were found to be coated by a thick layer of paraffin oil. The induction of calcium carbonate and phosphate precipitation or the retention of precipitates by the microparticles was favored by the presence of phosphate in the initial formulation either by phosphorylation or by incorporation of Ha. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Maachou, Hamida] Univ Yahia Fares, Fac Sci & Technol, Dept Genie Procedes & Environm, Medea 26000, Algeria.
   [Genet, Michel J.; Dupont-Gillain, Christine C.; Rouxhet, Paul G.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci Bio & Soft Matter, B-1348 Louvain, Belgium.
   [Aliouche, Djamel] Univ MHamed Bougara, Lab Traitement & Mise Forme Polymeres Fibreux, Fac Sci Ingenieur, Boumerdes 35000, Algeria.
RP Rouxhet, PG (reprint author), Catholic Univ Louvain, Inst Condensed Matter & Nanosci Bio & Soft Matter, Croix Sud 1 L7-04-01, B-1348 Louvain, Belgium.
EM paul.rouxhet@uclouvain.be
FU Belgian National Foundation for Scientific Research (FNRS)
FX The authors express their deep gratitude to late Prof. K.E. Bal, who
   initiated this research. They thank the Laboratory of Molecular and
   Macromolecular Physical Chemistry, Faculty of Sciences, University of
   Blida, Algeria. The support of the Belgian National Foundation for
   Scientific Research (FNRS) is gratefully acknowledged.
CR Aizenberg J, 2000, J CRYST GROWTH, V211, P143, DOI 10.1016/S0022-0248(99)00814-3
   AMRAHBOUALI S, 1994, BIOMATERIALS, V15, P269, DOI 10.1016/0142-9612(94)90050-7
   Andronico N. C., 2008, J CHIL CHEM SOC, V53
   [Anonymous], NIST XRAY PHOT SPECT
   Bloemers FW, 2003, J BIOMED MATER RES B, V66B, P526, DOI 10.1002/jbm.b.10045
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Chen ZQ, 2005, KEY ENG MAT, V288-289, P429, DOI 10.4028/www.scientific.net/KEM.288-289.429
   Chesnutt BM, 2009, J BIOMED MATER RES A, V88A, P491, DOI 10.1002/jbm.a.31878
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Genet Michel J., 2008, P177, DOI 10.1007/978-0-387-76921-9_5
   GERIN PA, 1995, J CHIM PHYS PCB, V92, P1043, DOI 10.1051/jcp/1995921043
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Gouveia DS, 2006, MATER SCI FORUM, V530-531, P593, DOI 10.4028/www.scientific.net/MSF.530-531.593
   Graham DJ, 2000, EARTH SURF PROC LAND, V25, P1473, DOI 10.1002/1096-9837(200012)25:13<1473::AID-ESP158>3.0.CO;2-C
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Landoulsi J, 2008, J COLLOID INTERF SCI, V320, P508, DOI 10.1016/j.jcis.2008.01.038
   Landoulsi J, 2008, J COLLOID INTERF SCI, V318, P278, DOI 10.1016/j.jcis.2007.09.087
   Li QL, 2005, KEY ENG MAT, V288-289, P75, DOI 10.4028/www.scientific.net/KEM.288-289.75
   Li QL, 2006, MATER LETT, V60, P3533, DOI 10.1016/j.matlet.2006.03.046
   Lowenstam HA, 1989, BIOMINERALIZATION
   Maachou H, 2012, APPL BIOCHEM BIOTECH, V168, P1459, DOI 10.1007/s12010-012-9870-x
   Madhumathi K, 2009, INT J BIOL MACROMOL, V44, P1, DOI 10.1016/j.ijbiomac.2008.09.013
   Malafaya PB, 2003, KEY ENG MAT, V240-2, P39, DOI 10.4028/www.scientific.net/KEM.240-242.39
   MANN S, 1989, BIOMINERALIZATION
   Mann S, 2001, BIOMINERALIZATION PR
   Mladenovic Z, 2010, SURF INTERFACE ANAL, V42, P452, DOI 10.1002/sia.3337
   Rajesh R. D., 2004, AAPS PHARMSCITECH, V5, P20
   Robert G. A. F., 1997, CHITIN CHEM
   Rouxhet PG, 2008, SURF INTERFACE ANAL, V40, P718, DOI 10.1002/sia.2779
   Rouxhet PG, 2011, SURF INTERFACE ANAL, V43, P1453, DOI 10.1002/sia.3831
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   VEREECKE G, 1990, J CRYST GROWTH, V104, P820, DOI 10.1016/0022-0248(90)90108-W
   WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Yamaguchi T, 2006, NUCL INSTRUM METH B, V249, P723, DOI 10.1016/j.nimb.2006.03.126
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 46
TC 25
Z9 25
U1 7
U2 98
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUL
PY 2013
VL 45
IS 7
BP 1088
EP 1097
DI 10.1002/sia.5229
PG 10
WC Chemistry, Physical
SC Chemistry
GA 163JO
UT WOS:000320332300003
DA 2018-10-20
ER

PT J
AU Groen, N
   van de Peppel, J
   Yuan, HP
   van Leeuwen, JPTM
   van Blitterswijk, CA
   de Boer, J
AF Groen, Nathalie y
   van de Peppel, Jeroen
   Yuan, Huipin
   van Leeuwen, Johannes P. T. M.
   van Blitterswijk, Clemens A.
   de Boer, Jan
TI Bioinformatics-based selection of a model cell type for in vitro
   biomaterial testing
SO BIOMATERIALS
LA English
DT Article
DE Biomaterials; Bioactivity; Bone regeneration; In vitro testing; Cell
   type comparison; Whole genome expression profiling
ID MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE CERAMICS; BONE-FORMATION;
   STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; DONOR VARIATION; EXPRESSION;
   SCAFFOLDS; LIBRARY; GROWTH
AB Biomaterial properties can be tailored for specific applications via systematic and high-throughput screening of biomaterial cell interactions. However, progress in material development is often hampered by the lack of adequate in vitro testing methods, frequently due to incomplete understanding of involved in vivo mechanisms. In line with drug discovery in pharmacology, a crucial step in assay development for biomaterial screening is the identification of a target to direct the screen against. Herein, the cell type to be used for screening is of essential importance and has to be carefully chosen. So far, few attention has been put on selecting a cell type specifically suitable for in vitro testing of materials for predefined applications. In this manuscript, we describe an approach to define a suitable cell type for screening assays, for which biomaterials for bone regeneration served as example. Using a bioinformatics methodology, different cell lines are compared on three well-characterized model materials. The transcriptional profiles of MG63, iMSC, SV-HFO, hPPCT, hBPCT and SW480 cells are assessed on 3 calcium phosphate-based materials to evaluate their potential application in a screening assay. We show that MG63 is the most suitable cell line to evaluate biomaterials for bone regeneration applications, evidenced by their robust gene expression differences between the 3 model materials. The gene expression differences between the cell lines were assessed based on the overall gene expression profiles and specific subsets of genes and pathways related to osteogenesis and bone homeostasis in response to the 3 materials tested. In the next phase, this cell line will be used to identify a target correlating with in vivo biomaterial performance and henceforth to develop an in vitro screening system. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Groen, Nathalie y; Yuan, Huipin; van Blitterswijk, Clemens A.; de Boer, Jan] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [van de Peppel, Jeroen; van Leeuwen, Johannes P. T. M.] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands.
RP de Boer, J (reprint author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, Drienerlolaan 5, NL-7500 AE Enschede, Netherlands.
EM j.deboer@utwente.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615; van Leeuwen,
   Johannes/0000-0002-2282-4006
FU Dutch Ministry of Economic Affairs, Agriculture and Innovation; STW
FX This research forms part of the Project BONE-IP of the research program
   of the BioMedical Materials Institute, co-funded by the Dutch Ministry
   of Economic Affairs, Agriculture and Innovation. The authors acknowledge
   STW for funding JdB. We wish to acknowledge Takashi Kanda for kindly
   providing us with the two pericyte cell lines, H. Chiba (Department of
   Basic Pathology, Fukushima Medical University, Japan) for the SV-HFO
   cell line, Hans Clevers for the SW480 cell line and Ola Myklebost for
   the iMSC cell line.
CR Alves H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042908
   Alves H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026678
   Barbieri D, 2010, EUR CELLS MATER, V19, P252, DOI 10.22203/eCM.v019a24
   Bari CD, 2008, ARTHRITIS RHEUM, V58, P240
   Barradas AMC, 2012, BIOMATERIALS, V33, P5696, DOI 10.1016/j.biomaterials.2012.04.021
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Brey DM, 2011, BIOTECHNOL BIOENG, V108, P163, DOI 10.1002/bit.22925
   Brown SA, 1983, ASTM SPECIAL TECHNIC, P810
   Chan BP, 2007, TISSUE ENG, V13, P73, DOI 10.1089/ten.2006.004
   Chatterjee K, 2011, BIOMATERIALS, V32, P1361, DOI 10.1016/j.biomaterials.2010.10.043
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   CHIBA H, 1993, JPN J CANCER RES, V84, P290, DOI 10.1111/j.1349-7006.1993.tb02869.x
   Corum LE, 2010, BIOMATERIALS, V31, P3148, DOI 10.1016/j.biomaterials.2010.01.025
   de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016
   De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753
   Doorn J, 2011, BIOMATERIALS, V32, P6089, DOI 10.1016/j.biomaterials.2011.05.010
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108
   Fernandes H, 2009, TISSUE ENG PT A, V15, P3857, DOI 10.1089/ten.tea.2009.0011
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382
   Habibovic P, 2006, ADV EXP MED BIOL, V585, P327
   Kaltz N, 2010, EXP CELL RES, V316, P2609, DOI 10.1016/j.yexcr.2010.06.002
   Kobel S, 2010, BIOTECHNIQUES, V48
   Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122
   Menicanin D, 2010, STEM CELLS DEV, V19, P1501, DOI 10.1089/scd.2009.0492
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Olivares-Navarrete R, 2012, J BONE MINER RES, V27, P1773, DOI 10.1002/jbmr.1628
   Olivares-Navarrete R, 2012, SPINE J, V12, P265, DOI 10.1016/j.spinee.2012.02.002
   Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.3.CO;2-#
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Shikinami Y, 2006, J R SOC INTERFACE, V3, P805, DOI 10.1098/rsif.2006.0144
   Shimizu F, 2011, J CELL PHYSIOL, V226, P255, DOI 10.1002/jcp.22337
   Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105
   Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402
   Smyth GK, 2005, STAT BIOL HEALTH, P397
   Svensen N, 2011, CHEM BIOL, V18, P1284, DOI 10.1016/j.chembiol.2011.07.017
   Takagishi Y, 2006, TISSUE ENG, V12, P927, DOI 10.1089/ten.2006.12.927
   Tenstad E, 2010, LAB CHIP, V10, P1401, DOI 10.1039/b926738g
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   van Driel M, 2006, FASEB J, V20, P2417, DOI 10.1096/fj.06-6374fje
   Vohra S, 2008, J MATER SCI-MATER M, V19, P3567, DOI 10.1007/s10856-008-3525-z
   Yuan H, 2011, NAT REV RHEUMATOL, V7, pc2
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
   Yuan Huipin, 2011, Nat Rev Rheumatol, V7, pc2
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 51
TC 6
Z9 6
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2013
VL 34
IS 22
BP 5552
EP 5561
DI 10.1016/j.biomaterials.2013.04.001
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 156WW
UT WOS:000319855600011
PM 23632322
DA 2018-10-20
ER

PT J
AU Murali, S
   Rai, B
   Dombrowski, C
   Lee, JLJ
   Lim, ZXH
   Bramono, DS
   Ling, L
   Bell, T
   Hinkley, S
   Nathan, SS
   Hui, JH
   Wong, HK
   Nurcombe, V
   Cool, SM
AF Murali, S.
   Rai, B.
   Dombrowski, C.
   Lee, J. L. J.
   Lim, Z. X. H.
   Bramono, D. S.
   Ling, L.
   Bell, T.
   Hinkley, S.
   Nathan, S. S.
   Hui, J. H.
   Wong, H. K.
   Nurcombe, V.
   Cool, S. M.
TI Affinity-selected heparan sulfate for bone repair
SO BIOMATERIALS
LA English
DT Article
DE Glycosaminoglycans; Heparan sulfate; Bone morphogenetic protein; Bone
   repair
ID MORPHOGENETIC PROTEIN-2; REGENERATIVE MEDICINE; CONTROLLED-RELEASE;
   GROWTH-FACTORS; STEM-CELLS; EXPRESSION; PROTEOGLYCANS; DIFFERENTIATION;
   MODEL; BMP-2
AB Bone morphogenetic protein (BMP)-2 is a potent bone healing compound produced at sites of bone trauma. Here we present a therapeutic strategy to harness the activity of endogenously produced BMP-2 by delivery of an affinity-matched heparan sulfate (HS) glycos aminoglycan biomaterial that increases the bioavailability, bioactivity and half-life of this growth factor. We have developed a robust, cost effective, peptide-based affinity platform to isolate a unique BMP-2 binding HS variant from commercially available preparations of HS, so removing the manufacturing bottleneck for their translation into the clinic. This affinity-matched HS enhanced BMP-2-induced osteogenesis through improved BMP-2 kinetics and receptor modulation, prolonged pSMAD signaling and reduced interactions with its antagonist noggin. When co-delivered with a collagen implant, the HS was as potent as exogenous BMP-2 for the healing of critical-sized bone defects in rabbits. This affinity platform can be readily tuned to isolate HS variants targeted ata range of clinically-relevant growth and adhesive factors. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Murali, S.; Rai, B.; Dombrowski, C.; Lee, J. L. J.; Lim, Z. X. H.; Bramono, D. S.; Ling, L.; Nurcombe, V.; Cool, S. M.] ASTAR, Inst Med Biol, Glycotherapeut Grp, Singapore 138648, Singapore.
   [Bell, T.; Hinkley, S.] Ind Res Ltd, Lower Hutt 5040, New Zealand.
   [Nathan, S. S.; Hui, J. H.; Wong, H. K.; Cool, S. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 119074, Singapore.
RP Cool, SM (reprint author), ASTAR, Inst Med Biol, Glycotherapeut Grp, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.
EM simon.cool@imb.a-star.edu.sg
OI Hinkley, Simon F.R./0000-0002-1831-8389
FU Biomedical Research Council, Agency for Science, Technology and Research
   (A*STAR), Singapore; Institute of Medical Biology (IMB), A*STAR,
   Singapore
FX We acknowledge the grant support from the Biomedical Research Council,
   Agency for Science, Technology and Research (A*STAR), Singapore and the
   Institute of Medical Biology (IMB), A*STAR, Singapore. We wish to thank
   Dr Lucy Robinson of Insight Editing London for critical reading of the
   manuscript and assistance in its preparation.
CR Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030
   Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8
   Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Carragee EJ, 2011, SPINE J, V11, P463, DOI 10.1016/j.spinee.2011.06.001
   DANIELSSON A, 1986, J BIOL CHEM, V261, P5467
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766
   Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459
   Guo J, 2012, CYTOKINE GROWTH F R, V23, P61, DOI 10.1016/j.cytogfr.2012.02.001
   Jackson RA, 2007, J CELL PHYSIOL, V210, P38, DOI 10.1002/jcp.20813
   Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200
   Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Ling L, 2006, J CELL PHYSIOL, V209, P811, DOI 10.1002/jcp.20760
   Ling L, 2010, J CELL BIOCHEM, V109, P1222, DOI 10.1002/jcb.22506
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Luong-Van E, 2007, BIOMATERIALS, V28, P2127, DOI 10.1016/j.biomaterials.2007.01.002
   Lyon M, 1998, MATRIX BIOL, V17, P485, DOI 10.1016/S0945-053X(98)90096-8
   Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267
   Manton KJ, 2006, J CELL PHYSIOL, V209, P219, DOI 10.1002/jcp.20727
   Mazziotti G, 2010, AM J MED, V123, P877, DOI 10.1016/j.amjmed.2010.02.028
   McKay B, 2002, SPINE, V27, pS66, DOI 10.1097/01.BRS.0000020738.16636.B3
   Murali S, 2011, J BIOL CHEM, V286, P17755, DOI 10.1074/jbc.M110.148874
   Murali S, 2009, J CELL BIOCHEM, V108, P1132, DOI 10.1002/jcb.22340
   Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200
   Nauth A, 2009, INJURY, V40, P27
   NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010
   Nurcombe V, 2007, J MOL HISTOL, V38, P469, DOI 10.1007/s10735-007-9123-4
   Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200
   Park SH, 2002, J ORTHOPAED RES, V20, P1197, DOI 10.1016/S0736-0266(02)00072-4
   Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   PRAEMER A, 1999, MUSCULOSKELETAL COND
   Rai B, 2011, CRIT REV EUKAR GENE, V21, P1
   Ramel MC, 2012, FEBS LETT, V586, P1929, DOI 10.1016/j.febslet.2012.02.035
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   SANDERSON RD, 1994, J BIOL CHEM, V269, P13100
   Sipe JB, 2004, BONE, V35, P1316, DOI 10.1016/j.bone.2004.08.020
   Song SJ, 2006, GENE, V379, P92, DOI 10.1016/j.gene.2006.04.029
   Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200
   Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3
   Woo EJ, 2012, SPINE J, V12, P894, DOI 10.1016/j.spinee.2012.09.052
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
   Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200
   Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191
NR 55
TC 30
Z9 34
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2013
VL 34
IS 22
BP 5594
EP 5605
DI 10.1016/j.biomaterials.2013.04.017
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 156WW
UT WOS:000319855600016
PM 23632323
DA 2018-10-20
ER

PT J
AU Grech, L
   Mallia, B
   Camilleri, J
AF Grech, L.
   Mallia, B.
   Camilleri, J.
TI Characterization of set Intermediate Restorative Material, Biodentine,
   Bioaggregate and a prototype calcium silicate cement for use as root-end
   filling materials
SO INTERNATIONAL ENDODONTIC JOURNAL
LA English
DT Article
DE Bioaggregate; Biodentine; characterization; hydration; leaching;
   tricalcium silicate cement
ID MINERAL TRIOXIDE AGGREGATE; COMPOSITE BONE-CEMENT; TRICALCIUM SILICATE;
   PHYSICAL-PROPERTIES; DENTAL BIOMATERIAL; CURING CONDITIONS;
   PORTLAND-CEMENT
AB Aim To investigate the composition of materials and leachate of a hydrated prototype cement composed of tricalcium silicate and radiopacifier and compare this to other tricalcium silicate-based cements (Biodentine and Bioaggregate) to assess whether the additives in the proprietary brand cements affect the hydration of the materials, using Intermediate Restorative Material (IRM), a standard root-end filling material as a control. Methodology The materials investigated included a prototype-radiopacified tricalcium silicate cement, Biodentine, Bioaggregate and Intermediate Restorative Material (IRM). The pH and calcium ion concentration of the leachate were investigated. The hydrated cements were characterized using scanning electron microscopy (SEM) and X-ray energy dispersive analysis (EDX), X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FT-IR). Results All the cements tested were alkaline. The tricalcium silicate-based cements leached calcium in solution. Scanning electron microscopy of the prototype-radiopacified tricalcium silicate cement, Biodentine and Bioaggregate displayed hydrating cement grains, surrounded by a matrix composed of calcium silicate hydrate and calcium hydroxide. The presence of calcium hydroxide was evident from the XRD plots. FT-IR indicated the occurrence of a poorly crystalline calcium silicate hydrate. Biodentine displayed the presence of calcium carbonate. Bioaggregate incorporated a phosphate-containing phase. IRM consisted of zinc oxide interspersed in an organic matrix. Conclusions The hydration of prototype-radiopacified tricalcium silicate cement, Biodentine and Bioaggregate resulted in the formation of calcium silicate hydrate and calcium hydroxide, which was leached in solution. The hydrated materials were composed of a cementitous phase that was rich in calcium and silicon and a radiopacifying material. Biodentine included calcium carbonate, and Bioaggregate included silica and calcium phosphate in the powders. IRM was composed of zinc oxide interspersed in a matrix of organic material.
C1 [Grech, L.; Mallia, B.] Univ Malta, Dept Met & Mat Engn, Fac Engn, Msida 2090, Msd, Malta.
   [Camilleri, J.] Univ Malta, Dept Restorat Dent, Fac Dent Surg, Msida 2090, Msd, Malta.
RP Camilleri, J (reprint author), Univ Malta, Dept Restorat Dent, Sch Med, Fac Dent Surg,Mater Dei Hosp, Msida 2090, Msd, Malta.
EM josette.camilleri@um.edu.mt
RI Camilleri, Josette/N-9409-2015
OI Camilleri, Josette/0000-0003-3556-6365; Mallia,
   Bertram/0000-0002-4719-0855
FU Faculty of Dental Surgery; Research Grant Committee, University of
   Malta; ERDF (Malta) [012, 011, 018]
FX The Faculty of Dental Surgery and the Research Grant Committee,
   University of Malta for funding; Mineral Research Processing, Septodont
   and Verio Dental Co. Ltd for the materials; Ing. J Camilleri of the
   Department of Metallurgy and Materials Engineering, Faculty of
   Engineering, and Mr J Spiteri of the Department of Chemistry, Faculty of
   Science, University of Malta for their technical expertise; ERDF (Malta)
   for the financing of the testing equipment through the project:
   'Developing an Interdisciplinary Material Testing and Rapid Prototyping
   R&D Facility (Ref. no. 012)', 'Furnishing and Equipping of the Chemistry
   and Biology Extensions (Ref. no. 011)', and 'Strengthening of Analytical
   Chemistry, Biomedical Engineering and Electromagnetics RTDI Facilities
   (Ref. no. 018)'.
CR Biodentine Scientific File, 2010, ACT BIOS TECHN SEPT
   Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x
   Camilleri J, 2012, INT ENDOD J, V45, P737, DOI 10.1111/j.1365-2591.2012.02027.x
   Camilleri J, 2011, DENT MATER, V27, P836, DOI 10.1016/j.dental.2011.04.010
   Camilleri J, 2011, DENT MATER, V27, P845, DOI 10.1016/j.dental.2011.04.011
   Chen CC, 2009, J ENDODONT, V35, P1288, DOI 10.1016/j.joen.2009.05.036
   Chong BS, 2003, INT ENDOD J, V36, P520, DOI 10.1046/j.1365-2591.2003.00682.x
   Cutajar A, 2011, DENT MATER, V27, P879, DOI 10.1016/j.dental.2011.04.012
   Formosa LM, 2012, DENT MATER, V28, P584, DOI 10.1016/j.dental.2012.02.006
   Formosa LM, 2012, INT ENDOD J, V45, P326, DOI 10.1111/j.1365-2591.2011.01980.x
   Han LL, 2010, DENT MATER J, V29, P512, DOI 10.4012/dmj.2009-133
   Huan ZG, 2008, J MATER SCI-MATER M, V19, P2913, DOI 10.1007/s10856-008-3423-4
   Huan ZG, 2007, J BIOMED MATER RES B, V82B, P352, DOI 10.1002/jbm.b.30740
   Li SQ, 1988, J MATER RES, V30, P380
   Park JW, 2010, ORAL SURG ORAL MED O, V109, P155, DOI 10.1016/j.tripleo.2009.08.039
   Pointeau I, 2001, J COLLOID INTERF SCI, V236, P252, DOI 10.1006/jcis.2000.7411
   Sorrentino F, 2008, CEM WAPNO BETON, V13, P177
   Taddei P, 2009, J RAMAN SPECTROSC, V40, P1858, DOI 10.1002/jrs.2333
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   Wang XH, 2008, DENT MATER, V24, P74, DOI 10.1016/j.dental.2007.02.006
NR 20
TC 52
Z9 53
U1 2
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0143-2885
J9 INT ENDOD J
JI Int. Endod. J.
PD JUL
PY 2013
VL 46
IS 7
BP 632
EP 641
DI 10.1111/iej.12039
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 160PS
UT WOS:000320132200003
PM 23289940
DA 2018-10-20
ER

PT J
AU Yu, N
   Oortgiesen, DAW
   Bronckers, ALJJ
   Yang, F
   Walboomers, XF
   Jansen, JA
AF Yu, Na
   Oortgiesen, Daniel A. W.
   Bronckers, Antonius L. J. J.
   Yang, Fang
   Walboomers, X. Frank
   Jansen, John A.
TI Enhanced periodontal tissue regeneration by periodontal cell
   implantation
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE gelatin; GFP; intrabony defect; Periodontal cell; tissue engineering
ID FIBROBLAST-LIKE CELLS; STEM-CELLS; LIGAMENT CELLS; 3-DIMENSIONAL
   SCAFFOLD; FENESTRATION DEFECTS; FURCATION DEFECTS; BONE; MODEL; SHEETS;
   DOG
AB Aim Due to a lack of regenerative potential, current treatments for periodontal defects do not always provide satisfactory clinical results. Previously, the implantation of a biomaterial scaffold-cell construct has been suggested as a clinically achievable approach. In this study, it was aimed to investigate the contribution of implanted periodontal ligament (PDL) cells to periodontal tissue regeneration. Materials & Methods Gelatin sponges were seeded with green fluorescent protein (GFP) transfected PDL or gingival fibroblasts (GF) cells, and implanted into a surgically created rat intrabony periodontal defect model. After six weeks, decalcified maxillae were used for histomorphometrical and immunohistochemical analyses. Results After six weeks, animals that had received the PDL cells exhibited significantly more functional bone and ligament. Furthermore, there were remarkable differences in the distribution of the transplanted cells. Periodontal ligament cells were always located directly lining the newly regenerated areas. In contrast, GF cells dispersed over the whole defect area, and did not provide a favourable effect on the regeneration of the periodontal tissues. Conclusion We concluded that PDL cells transplanted into a periodontal defect survive and favour regeneration of periodontium, possibly in a paracrine manner.
C1 [Yu, Na; Oortgiesen, Daniel A. W.; Yang, Fang; Walboomers, X. Frank; Jansen, John A.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   [Bronckers, Antonius L. J. J.] Univ Amsterdam, MOVE Res Inst, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands.
   [Bronckers, Antonius L. J. J.] Vrije Univ Amsterdam, Amsterdam, Netherlands.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, 309 PB,POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Jansen, John/H-8055-2014; Walboomers, X.Frank/B-3692-2013; Yang,
   Fang/E-1937-2011
OI Yang, Fang/0000-0002-4022-7643
FU Dutch Technology Foundation STW [NKG.6099]; Royal Netherlands Academy of
   Arts and Sciences (PSA) [08-PSA-M-02]; China Scholarship Council
   [2008627114]
FX The authors declare that there are no conflicts of interest in this
   study. This study was financially supported by Dutch Technology
   Foundation STW (grant number NKG.6099), Royal Netherlands Academy of
   Arts and Sciences (PSA) (grant number 08-PSA-M-02) and China Scholarship
   Council (No. 2008627114)
CR Aichelmann-Reidy ME, 2008, J PERIODONTOL, V79, P387, DOI [10.1902/jop.2008.060521, 10.1902/jop.2008.060521 ]
   Alpaslan C, 1997, BRIT J ORAL MAX SURG, V35, P129, DOI 10.1016/S0266-4356(97)90689-6
   Anders JO, 2009, J BONE JOINT SURG BR, V91B, P409, DOI 10.1302/0301-620X.91B3.20869
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x
   Berkovitz Barry K, 2004, Dent Update, V31, P46
   Bongio M, 2011, Eur Cell Mater, V22, P359
   BOYKO GA, 1981, J PERIODONTAL RES, V16, P73, DOI 10.1111/j.1600-0765.1981.tb00951.x
   Bronckers A. L., 2012, J TISSUE ENG REGENER, DOI 10.1002/term.1514
   Bruckmann C, 2005, BIOMATERIALS, V26, P339, DOI 10.1016/j.biomaterials.2004.02.031
   BRUNETTE DM, 1976, ARCH ORAL BIOL, V21, P393, DOI 10.1016/0003-9969(76)90001-7
   Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]
   Dogan A, 2003, TISSUE ENG, V9, P1189, DOI 10.1089/10763270360728099
   Dogan A, 2002, TISSUE ENG, V8, P273, DOI 10.1089/107632702753725030
   Flores MG, 2008, J CLIN PERIODONTOL, V35, P1066, DOI 10.1111/j.1600-051X.2008.01326.x
   Hasegawa M, 2005, TISSUE ENG, V11, P469, DOI 10.1089/ten.2005.11.469
   Hasegawa N, 2006, J PERIODONTOL, V77, P1003, DOI 10.1902/jop.2006.050341
   Isaka J, 2001, J PERIODONTOL, V72, P314, DOI 10.1902/jop.2001.72.3.314
   Ishikawa I, 2004, PERIODONTOL 2000, V36, P9, DOI 10.1111/j.1600-0757.2004.03670.x
   Ito T, 2001, EXP NEPHROL, V9, P444
   Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032
   Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005
   King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801
   Kunze M, 2009, J DENT, V37, P502, DOI 10.1016/j.jdent.2009.03.001
   Lekic P, 2001, J PERIODONTAL RES, V36, P71, DOI 10.1034/j.1600-0765.2001.360202.x
   Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734
   MCCULLOCH CAG, 1991, J PERIODONTAL RES, V26, P144, DOI 10.1111/j.1600-0765.1991.tb01638.x
   MELCHER AH, 1976, J PERIODONTOL, V47, P256, DOI 10.1902/jop.1976.47.5.256
   Nakahara T, 2004, TISSUE ENG, V10, P537, DOI 10.1089/107632704323061898
   Nemcovsky CE, 2006, J PERIODONTOL, V77, P996, DOI 10.1902/jop.2006.050317
   Oortgiesen DAW, 2012, TISSUE ENG PART C-ME, V18, P81, DOI [10.1089/ten.tec.2011.0367, 10.1089/ten.TEC.2011.0367]
   Oortgiesen DAW, 2012, J CLIN PERIODONTOL, V39, P546, DOI 10.1111/j.1600-051X.2012.01877.x
   Paganelli C, 2006, J ORAL REHABIL, V33, P625, DOI 10.1111/j.1365-2842.2005.01594.x
   Park CH, 2012, BIOMATERIALS, V33, P137, DOI 10.1016/j.biomaterials.2011.09.057
   Pellegrini G, 2009, J DENT RES, V88, P1065, DOI 10.1177/0022034509349748
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Trubiani O, 2008, J BIOMED MATER RES A, V87A, P986, DOI 10.1002/jbm.a.31837
   Tsumanuma Y, 2011, BIOMATERIALS, V32, P5819, DOI 10.1016/j.biomaterials.2011.04.071
   Yang JR, 2013, J CLIN PERIODONTOL, V40, P364, DOI 10.1111/jcpe.12069
   Yang Y, 2010, BIOMATERIALS, V31, P8574, DOI 10.1016/j.biomaterials.2010.06.026
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
   Zhao M, 2004, J PERIODONTOL, V75, P154, DOI 10.1902/jop.2004.75.1.154
NR 43
TC 27
Z9 27
U1 2
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JUL
PY 2013
VL 40
IS 7
BP 698
EP 706
DI 10.1111/jcpe.12113
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 157MN
UT WOS:000319900500006
PM 23675871
DA 2018-10-20
ER

PT J
AU Tamuly, C
   Hazarika, M
   Bordoloi, M
   Das, MR
AF Tamuly, Chandan
   Hazarika, Moushumi
   Bordoloi, Manobjyoti
   Das, Manash R.
TI Photocatalytic activity of Ag nanoparticles synthesized by using Piper
   pedicellatum C.DC fruits
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Piper pedicellatum C.DC; Nanoparticles; Photocatalytic
   degradation
ID SILVER NANOPARTICLES; BIOSYNTHESIS; EXTRACT; AU
AB Synthesis of Ag nanoparticles by using Piper pedicellatum C.DC fruits extract in aqueous medium is reported. Transmission electron microscopy (TEM) analysis shows that the Ag nanoparticles predominantly formed spherical in shape. The X-ray diffraction (XRD) analysis shows face center cubic lattice plane for Ag nanoparticles. Photocatalytic activity of the Ag nanoparticles was investigated by degradation of Methyl red (MR) dye under UV light. The rate constant of photocatalytic degradation of MR was investigated. The results show that Ag nanoparticles have suitable photocatalytic activity for the degradation of MR dye. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Bordoloi, Manobjyoti; Das, Manash R.] CSIR, North East Inst Sci & Technol, Jorhat 785006, Assam, India.
EM c.tamuly@gmail.com
OI Das, Dr Manash R./0000-0002-6317-7933
FU SEED Division, DST, New Delhi
FX The authors thank Director, CSIR-North East Institute of Science &
   Technology, Jorhat, Assam for providing facilities, valuable advice and
   SEED Division, DST, New Delhi for financial support.
CR An CH, 2010, ADV MATER, V22, P2570, DOI 10.1002/adma.200904116
   Aromal SA, 2012, SPECTROCHIM ACTA A, V97, P1, DOI 10.1016/j.saa.2012.05.083
   Balazs N, 2008, APPL CATAL B-ENVIRON, V84, P356, DOI 10.1016/j.apcatb.2008.04.018
   Jacob SJP, 2012, COLLOID SURFACE B, V91, P212, DOI 10.1016/j.colsurfb.2011.11.001
   KAMAT PV, 1993, CHEM REV, V93, P267, DOI 10.1021/cr00017a013
   Kamat PV, 2002, J PHYS CHEM B, V106, P7729, DOI 10.1021/jp0209289
   Kaviya S, 2012, MATER LETT, V67, P64, DOI 10.1016/j.matlet.2011.09.023
   Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008
   Mahmouda MA, 2009, S AFR J SCI, P299
   Philip D, 2009, SPECTROCHIM ACTA A, V73, P374, DOI 10.1016/j.saa.2009.02.037
   Sheny DS, 2012, SPECTROCHIM ACTA A, V97, P306, DOI 10.1016/j.saa.2012.06.009
   Shukla VK, 2010, J ALLOY COMPD, V507, pL13, DOI 10.1016/j.jallcom.2010.07.156
   Tamuly C, 2013, COLLOID SURFACE B, V102, P627, DOI 10.1016/j.colsurfb.2012.09.007
   Zheng YH, 2008, J PHYS CHEM C, V112, P10773, DOI 10.1021/jp8027275
NR 14
TC 12
Z9 12
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL
PY 2013
VL 102
BP 1
EP 4
DI 10.1016/j.matlet.2013.03.090
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 160VP
UT WOS:000320148900001
DA 2018-10-20
ER

PT J
AU Aydin, RST
   Hazer, B
   Acar, M
   Gumusderelioglu, M
AF Aydin, R. Seda Tigli
   Hazer, Baki
   Acar, Merve
   Gumusderelioglu, Menemse
TI Osteogenic activities of polymeric soybean oil-g-polystyrene membranes
SO POLYMER BULLETIN
LA English
DT Article
DE Soybean oil; Styrene; Cell-biomaterial interaction; Bone tissue
   engineering
ID GUIDED BONE REGENERATION; RAT MANDIBULAR DEFECTS; METHYL-METHACRYLATE;
   BARRIER MEMBRANES; CHITOSAN SCAFFOLDS; PTFE MEMBRANES; MC3T3-E1 CELLS;
   VEGETABLE-OIL; COPOLYMERIZATION; PROLIFERATION
AB A novel biocompatible copolymer membrane was synthesized and characterized for use in guided bone regeneration using polymeric soybean oil-g-polystyrene (PSO-g-PS) graft copolymer which was successfully obtained by free radical polymerization of styrene initiated by PSO peroxide as a macroinitiator at 80 A degrees C. Osteoblastic cellular activities of MC3T3-E1 cells on PSO-g-PS membranes with different soybean oil composition (PSO-g-PS1, PSO-g-PS2, and PSO-g-PS3) were evaluated. Nuclear magnetic resonance (H-1 NMR) spectra showed that PSO inclusion (mol%) was found to be 27, 69, and 51 % for PSO-g-PS1, PSO-g-PS2, and PSO-g-PS3 membranes, respectively. Superior biocompatibility of the PSO-g-PS membranes was determined compared to polystyrene tissue culture plates (TCPS) as positive control. Cell proliferation was enhanced on PSO-g-PS2 and PSO-g-PS3 membranes compared to PSO-g-PS1 membranes (p < 0.001), and a statistically significant higher ALP value of MC3T3-E1 cells on PSO-g-PS2 membranes (p < 0.05) suggested that proliferation and differentiation of preosteoblastic on PSO-g-PS membranes were enhanced with regard to soybean oil content within the membranes. Thus, the present study suggests that PSO-g-PS2 membranes, which showed a favorable biological environment for the preosteoblastic cells, can be well suited for bone tissue engineering applications.
C1 [Aydin, R. Seda Tigli] Bulent Ecevit Univ, Dept Biomed Engn, TR-67100 Zonguldak, Turkey.
   [Hazer, Baki; Acar, Merve] Bulent Ecevit Univ, Dept Chem, TR-67100 Zonguldak, Turkey.
   [Gumusderelioglu, Menemse] Hacettepe Univ, Dept Chem Engn, TR-06530 Beytepe, Turkey.
RP Aydin, RST (reprint author), Bulent Ecevit Univ, Dept Biomed Engn, TR-67100 Zonguldak, Turkey.
EM rseda.tigli@gmail.com; bhazer2@yahoo.com; merwe802@hotmail.com;
   menemse@hacettepe.edu.tr
FU TUBITAK [211T016]; Bulent Ecevit University [2011-10-3-02]
FX The Authors thank to TUBITAK (Grant No. 211T016) and Bulent Ecevit
   University (Grant# 2011-10-3-02) for financial support.
CR Acar M, 2013, J MACROMOL SCI A, V50, P287, DOI 10.1080/10601325.2013.755443
   Ajiro H, 2010, BIOMACROMOLECULES, V11, P2840, DOI 10.1021/bm100926p
   Akman AC, 2010, J BIOMED MATER RES A, V92A, P953, DOI 10.1002/jbm.a.32428
   Akman AC, 2010, ARTIF ORGANS, V34, P65, DOI 10.1111/j.1525-1594.2009.00798.x
   Alli A, 2008, EUR POLYM J, V44, P1701, DOI 10.1016/j.eurpolymj.2008.04.004
   Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P2
   Cakmakli B, 2005, BIOMACROMOLECULES, V6, P1750, DOI 10.1021/bm050063f
   Cakmakli B, 2004, MACROMOL BIOSCI, V4, P649, DOI 10.1002/mabi.200300117
   Can E, 2006, J APPL POLYM SCI, V102, P2433, DOI 10.1002/app.24548
   de Macedo NL, 2008, MED ORAL PATOL ORAL, V13, pE375
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Gielkens PFM, 2008, CLIN ORAL IMPLAN RES, V19, P516, DOI 10.1111/j.1600-0501.2007.01511.x
   Gumusderelioglu M, 2011, J BIOACT COMPAT POL, V26, P257, DOI 10.1177/0883911511406329
   Guner FS, 2000, J COATING TECHNOL, V72, P107, DOI 10.1007/BF02698030
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hammerle CH, 2003, PERIODONTOLOGY, V2000, P36
   HAZER B, 1995, MACROMOL CHEM PHYSIC, V196, P1945, DOI 10.1002/macp.1995.021960614
   Hazer DB, 2012, MAT SCI ENG C-MATER, V32, P637, DOI 10.1016/j.msec.2012.01.021
   Hazer DB, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035011
   Huang JQ, 2002, J ORAL MAXIL SURG, V60, P1449, DOI 10.1053/joms.2002.36108
   Ilter S, 2001, MACROMOL CHEM PHYSIC, V202, P2281, DOI 10.1002/1521-3935(20010701)202:11<2281::AID-MACP2281>3.0.CO;2-9
   Jung RE, 2006, CLIN ORAL IMPLAN RES, V17, P426, DOI 10.1111/j.1600-0501.2005.01228.x
   Keles E, 2008, MACROMOL SYMP, V269, P154, DOI 10.1002/masy.200850919
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Li J, 2006, BIOMACROMOLECULES, V7, P1112, DOI 10.1021/bm050913r
   ligadas GL, 2010, BIOMACROMOLECULES, V11, P2825
   Liu ZX, 2012, SOFT MATTER, V8, P5888, DOI 10.1039/c2sm25115a
   Lukyanova L, 2010, COLLOID SURFACE B, V79, P105, DOI 10.1016/j.colsurfb.2010.03.044
   Machtei EE, 2001, J PERIODONTOL, V72, P512, DOI 10.1902/jop.2001.72.4.512
   Miao SD, 2012, EUR J LIPID SCI TECH, V114, P1165, DOI [10.1002/ejlt.201200050, 10.1002/ejlt.201290028]
   Monteiro ASF, 2010, MED ORAL PATOL ORAL, V15, pE401, DOI 10.4317/medoral.15.e401
   Narine SS, 2007, J AM OIL CHEM SOC, V84, P65, DOI 10.1007/s11746-006-1008-2
   Piattelli A, 1996, BIOMATERIALS, V17, P791, DOI 10.1016/0142-9612(96)81416-5
   Piattelli A, 1996, BIOMATERIALS, V17, P1725, DOI 10.1016/0142-9612(96)87653-8
   Soucek MD, 2012, PROG ORG COAT, V73, P435, DOI 10.1016/j.porgcoat.2011.08.021
   Stavropoulos F, 2004, CLIN ORAL IMPLAN RES, V15, P435, DOI 10.1111/j.1600-0501.2004.01029.x
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tan SG, 2011, EXPRESS POLYM LETT, V5, P480, DOI 10.3144/expresspolymlett.2011.47
   Tigli RS, 2011, J BIOMAT SCI-POLYM E, V22, P207, DOI 10.1163/092050609X12591500475424
   Tigli RS, 2009, BIOTECHNOL BIOENG, V104, P601, DOI 10.1002/bit.22426
   van Leeuwen AC, 2012, ACTA BIOMATER, V8, P1422, DOI 10.1016/j.actbio.2011.12.004
   Vinu R, 2010, J POLYM ENG, V30, P57, DOI 10.1515/POLYENG.2010.30.1.57
   Wang Z, 2012, MACROMOLECULES, V45, P9010, DOI 10.1021/ma301938a
   Wu B, 1999, MACROMOLECULES, V32, P6856, DOI 10.1021/ma990166o
   Xia Y, 2010, GREEN CHEM, V12, P1893, DOI 10.1039/c0gc00264j
NR 45
TC 7
Z9 7
U1 3
U2 43
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
EI 1436-2449
J9 POLYM BULL
JI Polym. Bull.
PD JUL
PY 2013
VL 70
IS 7
BP 2065
EP 2082
DI 10.1007/s00289-013-0976-2
PG 18
WC Polymer Science
SC Polymer Science
GA 157GO
UT WOS:000319884300008
DA 2018-10-20
ER

PT J
AU Volpato, FZ
   Fuhrmann, T
   Migliaresi, C
   Hutmacher, DW
   Dalton, PD
AF Volpato, Fabio Zomer
   Fuehrmann, Tobias
   Migliaresi, Claudio
   Hutmacher, Dietmar W.
   Dalton, Paul D.
TI Using extracellular matrix for regenerative medicine in the spinal cord
SO BIOMATERIALS
LA English
DT Review
DE Spinal cord injury; Tissue engineering; Extracellular matrix;
   Decellularization
ID CENTRAL-NERVOUS-SYSTEM; CHONDROITIN SULFATE PROTEOGLYCAN;
   OLFACTORY-ENSHEATHING GLIA; MESENCHYMAL STEM-CELLS; MYELIN-ASSOCIATED
   GLYCOPROTEIN; TISSUE ENGINEERING SCAFFOLDS; SMALL-INTESTINAL SUBMUCOSA;
   ADULT-RAT; AXONAL REGENERATION; SCHWANN-CELLS
AB Regeneration within the mammalian central nervous system (CNS) is limited, and traumatic injury often leads to permanent functional motor and sensory loss. The lack of regeneration following spinal cord injury (SCI) is mainly caused by the presence of glial scarring, cystic cavitation and a hostile environment to axonal growth at the lesion site. The more prominent experimental treatment strategies focus mainly on drug and cell therapies, however recent interest in biomaterial-based strategies are increasing in number and breadth. Outside the spinal cord, approaches that utilize the extracellular matrix (ECM) to promote tissue repair show tremendous potential for various application including vascular, skin, bone, cartilage, liver, lung, heart and peripheral nerve tissue engineering (TE). Experimentally, it is unknown if these approaches can be successfully translated to the CNS, either alone or in combination with synthetic biomaterial scaffolds. In this review we outline the first attempts to apply the potential of ECM-based biomaterials and combining cell-derived ECM with synthetic scaffolds. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Volpato, Fabio Zomer; Fuehrmann, Tobias; Hutmacher, Dietmar W.; Dalton, Paul D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove 4059, Australia.
   [Volpato, Fabio Zomer; Migliaresi, Claudio] Univ Trento, BIOtech Res Ctr, I-38123 Trento, Italy.
RP Dalton, PD (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove 4059, Australia.
EM paul.dalton@qut.edu.au
RI Fuhrmann, Tobias/D-3880-2014
OI Fuhrmann, Tobias/0000-0003-1857-4806; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134
FU European Union [PCOFUND-GA-2008-226070]; US Army [MS090180P1]
FX We appreciate the financial support from the European Union, Seventh
   Framework Programme [FP7/2007-2013] under grant agreement [Marie Curie
   FP7 - PCOFUND-GA-2008-226070, acronym "progetto Trentino"] and the US
   Army Grant MS090180P1.
CR Adachi E, 1997, INT REV CYTOL, V173, P73
   Afshari FT, 2010, GLIA, V58, P857, DOI 10.1002/glia.20970
   Anderson Aileen J, 2002, J Spinal Cord Med, V25, P70
   Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005
   BALENTINE JD, 1978, LAB INVEST, V39, P236
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Bauchet L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P330, DOI 10.1016/j.annrmp.2008.10.004
   Baumann N, 2001, PHYSIOL REV, V81, P871
   Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119
   Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   BERRY M, 1988, BRAIN RES BULL, V20, P223, DOI 10.1016/0361-9230(88)90182-7
   BERRY M, 1988, J NEUROCYTOL, V17, P727, DOI 10.1007/BF01216702
   Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5
   Bunge MB, 2003, J REHABIL RES DEV, V40, P55, DOI 10.1682/JRRD.2003.08.0055
   BUNGE RP, 1993, ADV NEUROL, V59, P75
   Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110
   Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822
   Chan Carmen C M, 2008, Recent Pat CNS Drug Discov, V3, P189, DOI 10.2174/157488908786242434
   Chan CCM, 2005, EXP NEUROL, V196, P352, DOI 10.1016/j.expneurol.2005.08.011
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Condic ML, 2002, NEUROREPORT, V13, pA37, DOI 10.1097/00001756-200203040-00002
   Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Costantino PD, 2000, HEAD NECK-J SCI SPEC, V22, P765, DOI 10.1002/1097-0347(200012)22:8<765::AID-HED4>3.0.CO;2-7
   Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Dalton PD, 2009, FRONT BIOSCI, V14, P769, DOI 10.2741/3277
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   DEZAWA M, 1993, J NEUROCYTOL, V22, P1103, DOI 10.1007/BF01235752
   Dityatev A, 2010, TRENDS NEUROSCI, V33, P503, DOI 10.1016/j.tins.2010.08.003
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   FERGUSON TA, 2011, J TISSUE ENG, V2, P1
   Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Fitch MT, 1999, J NEUROSCI, V19, P8182
   Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092
   Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005
   Fournier AE, 2003, J NEUROSCI, V23, P1416
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338
   Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F
   Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934
   Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621
   FUEHRMANN T, 2011, CENTRAL NERVOUS SYST, P221
   Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110
   Gelain F, 2012, NANOSCALE, V4, P2946, DOI 10.1039/c2nr30220a
   Gerardo-Nava J, 2009, NANOMEDICINE-UK, V4, P11, DOI 10.2217/17435889.4.1.11
   Ghirnikar RS, 2000, J NEUROSCI RES, V59, P63, DOI 10.1002/(SICI)1097-4547(20000101)59:1<63::AID-JNR8>3.0.CO;2-W
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Giannetti S, 2001, NEUROL RES, V23, P405, DOI 10.1179/016164101101198622
   Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Golding JP, 1999, GLIA, V26, P309, DOI 10.1002/(SICI)1098-1136(199906)26:4<309::AID-GLIA5>3.0.CO;2-0
   Gotz B, 1996, J CELL BIOL, V132, P681, DOI 10.1083/jcb.132.4.681
   Gouk SS, 2008, J BIOMED MATER RES B, V84B, P205, DOI 10.1002/jbm.b.30862
   Gratzer PF, 2001, J BIOMED MATER RES, V58, P172, DOI 10.1002/1097-4636(2001)58:2<172::AID-JBM1004>3.0.CO;2-9
   Grimpe B, 2002, PROG BRAIN RES, V137, P333
   Guo SZ, 2010, SPINAL CORD, V48, P576, DOI 10.1038/sc.2009.170
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   HALL S, 1989, J NEUROCYTOL, V18, P171, DOI 10.1007/BF01206660
   Hara M, 2000, J NEUROSURG, V93, P94, DOI 10.3171/spi.2000.93.1.0094
   Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000
   Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Hoganson DM, 2010, BIOMATERIALS, V31, P6934, DOI 10.1016/j.biomaterials.2010.05.026
   Hoganson DM, 2010, BIOMATERIALS, V31, P6730, DOI 10.1016/j.biomaterials.2010.05.019
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Huang X, 2009, J NEUROL SCI, V277, P87, DOI 10.1016/j.jns.2008.10.022
   Huang YC, 2005, J BIOMED MATER RES B, V74B, P659, DOI 10.1002/jbm.b.30267
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Jones LL, 2003, J NEUROSCI, V23, P9276
   Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088
   Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Kang KN, 2012, BIOMATERIALS, V33, P4828, DOI 10.1016/j.biomaterials.2012.03.043
   Kang KN, 2011, TISSUE ENG PT A, V17, P2143, DOI [10.1089/ten.tea.2011.0122, 10.1089/ten.TEA.2011.0122]
   Karabekmez Furkan E, 2009, Hand (N Y), V4, P245, DOI 10.1007/s11552-009-9195-6
   Kassar-Duchossoy L, 2001, BRAIN RES, V908, P25, DOI 10.1016/S0006-8993(01)02554-9
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082
   Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002
   Kohama I, 2001, J NEUROSCI, V21, P944
   Koppe G, 1997, HISTOCHEM J, V29, P11, DOI 10.1023/A:1026408716522
   Korossis SA, 2002, J HEART VALVE DIS, V11, P463
   Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974
   Lee SJ, 2004, J BIOMAT SCI-POLYM E, V15, P1003, DOI 10.1163/1568562041526487
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   Liao JH, 2010, BIOMATERIALS, V31, P8911, DOI 10.1016/j.biomaterials.2010.07.110
   Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891
   Liu S, 2001, NEUROSURGERY, V49, P143, DOI 10.1097/00006123-200107000-00022
   Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]
   Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091
   Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   McKeon RJ, 1999, J NEUROSCI, V19, P10778
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   Minor KH, 2011, BRAIN, V134, P1140, DOI 10.1093/brain/awq304
   Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0
   Montgomery CT, 1996, EXP NEUROL, V137, P277, DOI 10.1006/exnr.1996.0026
   Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615
   Morgenstern DA, 2002, PROG BRAIN RES, V137, P313
   MOTHE AJ, 2013, BIOMATERIALS
   Munirah S, 2008, EUR CELLS MATER, V15, P41, DOI 10.22203/eCM.v015a04
   Nakayama M, 2005, GENES CELLS, V10, P107, DOI 10.1111/j.1365-2443.2005.00823.x
   Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055
   Niederost B, 2002, J NEUROSCI, V22, P10368
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Nisbet DR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0002-x
   Nishimura S, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-3
   NOBLE M, 1985, NATURE, V316, P725, DOI 10.1038/316725a0
   Noble M, 2011, NEUROTHERAPEUTICS, V8, P677, DOI 10.1007/s13311-011-0071-z
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/NEU.0000219859.35349.EF
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221
   Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]
   Rahman S, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-8
   Raisman G, 1997, REV NEUROL, V153, P521
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   Ramon-Cueto A, 1998, BRAIN RES BULL, V46, P175, DOI 10.1016/S0361-9230(97)00463-2
   RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099
   Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814
   Ratcliffe A, 2011, BIOMATERIALS, V32, P4215, DOI 10.1016/j.biomaterials.2011.02.028
   Rauch U, 2007, BIOCHEM SOC T, V35, P656, DOI 10.1042/BST0350656
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Reier Paul J, 2004, NeuroRx, V1, P424, DOI 10.1007/BF03206629
   Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6
   Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Ruff CA, 2012, EXP NEUROL, V235, P78, DOI 10.1016/j.expneurol.2011.02.010
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   Schwartz M, 2001, PROG NEUROBIOL, V65, P489, DOI 10.1016/S0301-0082(01)00009-0
   SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341
   Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310
   Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/i.tins.2007.11.001
   Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727
   Shoichet MS, 2007, PROG BRAIN RES, V161, P385, DOI 10.1016/S0079-6123(06)61027-3
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   SMITH GM, 1990, DEV BIOL, V138, P377, DOI 10.1016/0012-1606(90)90204-V
   SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103
   SMITH GV, 1988, EXP BRAIN RES, V69, P299
   Sobel RA, 1998, J NEUROPATH EXP NEUR, V57, P205, DOI 10.1097/00005072-199803000-00001
   SOSALE A, 1988, EXP NEUROL, V102, P14, DOI 10.1016/0014-4886(88)90074-X
   Sung JK, 2003, BRAIN RES, V959, P29, DOI 10.1016/S0006-8993(02)03717-4
   Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9212(03)00497-6
   Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219
   Taoka Y, 1998, J NEUROSCI, V18, P1393
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Vavrek R, 2007, J NEUROTRAUM, V24, P1667, DOI 10.1089/neu.2007.0290
   Wamil AW, 1998, P NATL ACAD SCI USA, V95, P13188, DOI 10.1073/pnas.95.22.13188
   Wang YF, 2009, J CONTROL RELEASE, V140, P218, DOI 10.1016/j.jconrel.2009.05.025
   WATABE K, 1995, J NEUROSCI RES, V41, P279, DOI 10.1002/jnr.490410215
   White RE, 2008, RESTOR NEUROL NEUROS, V26, P197
   Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309
   Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhang XY, 2012, J BIOMED MATER RES A, V100A, P578, DOI 10.1002/jbm.a.33237
   Zhang YW, 2006, STEM CELLS DEV, V15, P943, DOI 10.1089/scd.2006.15.943
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   Zuidema JM, 2011, ACTA BIOMATER, V7, P1634, DOI 10.1016/j.actbio.2010.11.039
   Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951
   2010, J NEUROCHEM, V114, P1447
NR 211
TC 42
Z9 44
U1 2
U2 164
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2013
VL 34
IS 21
BP 4945
EP 4955
DI 10.1016/j.biomaterials.2013.03.057
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 153VG
UT WOS:000319630000006
PM 23597407
DA 2018-10-20
ER

PT J
AU Lim, JJ
   Temenoff, JS
AF Lim, Jeremy J.
   Temenoff, Johnna S.
TI The effect of desulfation of chondroitin sulfate on interactions with
   positively charged growth factors and upregulation of cartilaginous
   markers in encapsulated MSCs
SO BIOMATERIALS
LA English
DT Article
DE Chondroitin sulfate; Glycosaminoglycan; Growth factors; Mesenchymal stem
   cell; Cartilage tissue engineering
ID MESENCHYMAL STEM-CELLS; IN-VITRO; TGF-BETA; HYALURONAN; HYDROGELS;
   BINDING; GLYCOSAMINOGLYCANS; DIFFERENTIATION; PROTEOGLYCANS; RELEASE
AB Sulfated glycosaminoglycans (GAGs) are known to interact electrostatically with positively charged growth factors to modulate signaling. Therefore, regulating the degree of sulfation of GAGs may be a promising approach to tailor biomaterial carriers for controlled growth factor delivery and release. For this study, chondroitin sulfate (CS) was first desulfated to form chondroitin, and resulting crosslinked CS and chondroitin hydrogels were examined in vitro for release of positively charged model protein (histone) and for their effect on cartilaginous differentiation of encapsulated human mesenchymal stem cells (MSCs). Desulfation significantly increased the release of histone from chondroitin hydrogels (30.6 +/- 23 mu g released over 8 days, compared to natively sulfated CS with 20.2 +/- 0.8 mu g), suggesting that sulfation alone plays a significant role in modulating protein interactions with GAG hydrogels. MSCs in chondroitin hydrogels significantly upregulated gene expression of collagen II and aggrecan by day 21 in chondrogenic medium (115 +/- 100 and 23.1 +/- 7.9 fold upregulation of collagen II and aggrecan, respectively), compared to CS hydrogels and PEG-based swelling controls, indicating that desulfation may actually enhance the response of MSCs to soluble chondrogenic cues, such as TGF-beta 1. Thus, desulfated chondroitin materials present a promising biomaterial tool to further investigate electrostatic GAG/growth factor interactions, especially for repair of cartilaginous tissues. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Lim, Jeremy J.; Temenoff, Johnna S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Lim, Jeremy J.; Temenoff, Johnna S.] Emory Univ, Atlanta, GA 30332 USA.
   [Temenoff, Johnna S.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Temenoff, JS (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM johnna.temenoff@bme.gatech.edu
FU NCRR of the NIH [P40RR017447]; NSF; NSF CAREER Award; NIH [1R01AR062006]
FX The authors would like to thank Seth L. Young and Dr. Vladimir V.
   Tsukruk (GT Materials Science and Engineering) for assistance and use of
   the Fourier transform infrared spectroscopy equipment, Dr. Sharon K.
   Hamilton (GT Chemical and Biomolecular Engineering) for acquisition of
   the <SUP>1</SUP>H NMR spectra, Rachel H. Van Stelle (GT Biomedical
   Engineering) for assistance with degradation studies, Thomas W.
   Bongiorno and Dr. Todd A. Sulchek (GT Mechanical Engineering) for
   acquisition of the atomic force microscopy data, and the Complex
   Carbohydrate Research Center at University of Georgia for the SAX-HPLC
   and SEC-HPLC analyses. The human MSCs employed in these studies were
   provided by the Texas A&M Health Science Center College of Medicine
   Institute for Regenerative Medicine at Scott & White through a grant
   from NCRR of the NIH, Grant #P40RR017447. This work was also supported
   by an NSF Graduate Research Fellowship to J. J. Lim, the NSF CAREER
   Award, and NIH 1R01AR062006.
CR Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623
   Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817
   Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200
   BOX GEP, 1964, J ROY STAT SOC B, V26, P211
   Brink KS, 2009, ACTA BIOMATER, V5, P570, DOI 10.1016/j.actbio.2008.09.015
   CANAL T, 1989, J BIOMED MATER RES, V23, P1183, DOI 10.1002/jbm.820231007
   Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002
   Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Farndale R.W., 1986, BIOCHIM BIOPHYS ACTA, V883, P173
   French MM, 1999, J CELL BIOL, V145, P1103, DOI 10.1083/jcb.145.5.1103
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   HARDINGHAM TE, 1992, FASEB J, V6, P861
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Ichinose S, 2005, CLIN EXP PHARMACOL P, V32, P561, DOI 10.1111/j.1440-1681.2005.04231.x
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   KNUDSON CB, 1993, FASEB J, V7, P1233
   LAMBERG SI, 1974, J INVEST DERMATOL, V63, P433, DOI 10.1111/1523-1747.ep12680346
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522
   LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125
   NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648
   NAGASAWA K, 1986, CARBOHYD RES, V158, P183, DOI 10.1016/0008-6215(86)84016-2
   Navarro DA, 2007, CARBOHYD POLYM, V69, P742, DOI 10.1016/j.carbpol.2007.02.009
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Qiu YZ, 2011, ACTA BIOMATER, V7, P959, DOI 10.1016/j.actbio.2010.11.002
   Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458
   Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   SCHUBERT MAXWELL, 1965, METHOD CARBOHYD CHEM, V5, P109
   Shibata S, 2003, J ANAT, V203, P425, DOI 10.1046/j.1469-7580.2003.00226.x
   Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107
   Steinmetz NJ, 2012, BIOTECHNOL BIOENG, V109, P2671, DOI 10.1002/bit.24519
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Villanueva I, 2009, TISSUE ENG PT A, V15, P3037, DOI [10.1089/ten.tea.2009.0001, 10.1089/ten.TEA.2009.0001]
   Villanueva I, 2010, MATRIX BIOL, V29, P51, DOI 10.1016/j.matbio.2009.08.004
   YAMAGATA T, 1968, J BIOL CHEM, V243, P1523
   Zafiropoulos A, 2008, CONNECT TISSUE RES, V49, P153, DOI 10.1080/03008200802148702
NR 45
TC 26
Z9 26
U1 1
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2013
VL 34
IS 21
BP 5007
EP 5018
DI 10.1016/j.biomaterials.2013.03.037
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 153VG
UT WOS:000319630000011
PM 23570717
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wu, D
   Yang, JJ
   Li, JY
   Chen, L
   Tang, B
   Chen, XY
   Wu, W
   Li, JS
AF Wu, Duo
   Yang, Jiaojiao
   Li, Jiyao
   Chen, Liang
   Tang, Bei
   Chen, Xingyu
   Wu, Wei
   Li, Jianshu
TI Hydroxyapatite-anchored dendrimer for in situ remineralization of human
   tooth enamel
SO BIOMATERIALS
LA English
DT Article
DE Dendrimer; Specific adsorption; Hydroxyapatite; In situ
   biomineralization; Dental restorative material
ID TARGETED DRUG-DELIVERY; STARBURST DENDRIMERS; HYDROTHERMAL METHOD; BONE;
   CRYSTALLIZATION; AMELOGENIN; NANOPARTICLES; REGENERATION; CRYSTALS;
   NANORODS
AB In situ remineralization of hydroxyapatite (HA) on human tooth enamel surface induced by organic matrices is of great interest in the fields of material science and stomatology. In order to mimic the organic matrices induced biomineralization process in developing enamel and enhance the binding strength at the remineralization interface, carboxyl-terminated poly(amido amine) (PAMAM COOH) alendronate (ALN) conjugate (ALN PAMAM COOH) was synthesized and characterized. PAMAM COOH has a highly ordered architecture and is capable of promoting the HA crystallization process. ALN is conjugated on PAMAM COOH due to its specific adsorption on HA (the main component of tooth enamel), resulting in increased binding strength which is tight enough to resist phosphate buffered saline (PBS) rinsing as compared with that of PAMAM COOH alone. While incubated in artificial saliva, ALN PAMAM COOH could induce in situ remineralization of HA on acid-etched enamel, and the regenerated HA has the nanorod-like crystal structure similar to that of human tooth enamel. The hardness of acid-etched enamel samples treated by ALN PAMAM COOH can recover up to 95.5% of the original value with strong adhesion force. In vivo experiment also demonstrates that ALN PAMAM COOH is effective in repairing acid-etched enamel in the oral cavity. Overall, these results suggest that ALN PAMAM COOH is highly promising as a restorative biomaterial for in situ remineralization of human tooth enamel. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Wu, Duo; Yang, Jiaojiao; Chen, Xingyu; Wu, Wei; Li, Jianshu] Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
   [Li, Jiyao; Chen, Liang; Tang, Bei] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610065, Peoples R China.
   [Li, Jiyao; Chen, Liang; Tang, Bei] Sichuan Univ, West China Sch Stomatol, Chengdu 610065, Peoples R China.
RP Li, JS (reprint author), Sichuan Univ, Coll Polymer Sci & Engn, Yi Huan Rd,South Sect 1,24, Chengdu 610065, Peoples R China.
EM jianshu_li@scu.edu.cn
OI Li, Jianshu/0000-0002-1522-7326
FU National Natural Science Foundation of China [51073102, 81170958]; Fok
   Ying Tung Education Foundation [122034]; Program for New Century
   Excellent Talents in University [NCET-10-0592]; Program for Changjiang
   Scholars and Innovative Research Team in University [IRT1163];
   Foundations of Sichuan Province [2012JQ0009, 2011SZ0130]; Fundamental
   Research Funds for the Central Universities [2010SCU22001,
   2011SCU04A04]; Natural Science Foundation of Jiangsu Province
   [BK2010248, BK2011340]
FX Financial support from the National Natural Science Foundation of China
   (51073102, 81170958), Fok Ying Tung Education Foundation (122034),
   Program for New Century Excellent Talents in University (NCET-10-0592),
   Program for Changjiang Scholars and Innovative Research Team in
   University (IRT1163), Foundations of Sichuan Province (2012JQ0009,
   2011SZ0130), Fundamental Research Funds for the Central Universities
   (2010SCU22001, 2011SCU04A04) and Natural Science Foundation of Jiangsu
   Province (BK2010248, BK2011340) are gratefully acknowledged.
CR Ashok M, 2007, J MATER SCI-MATER M, V18, P895, DOI 10.1007/s10856-006-0070-5
   Busch S, 2004, ANGEW CHEM INT EDIT, V43, P1428, DOI 10.1002/anie.200352183
   Chen F, 2010, PHARM RES-DORDR, V27, P2356, DOI 10.1007/s11095-010-0119-5
   Chen F, 2009, ANTIMICROB AGENTS CH, V53, P4898, DOI 10.1128/AAC.00387-09
   Chen H, 2003, J DENT RES, V82, P443, DOI 10.1177/154405910308200608
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Chen HF, 2005, J COLLOID INTERF SCI, V288, P97, DOI 10.1016/j.jcis.2005.02.064
   Choi SW, 2007, J CONTROL RELEASE, V122, P24, DOI 10.1016/j.jconrel.2007.06.003
   Dong ZH, 2010, APPL SURF SCI, V256, P2388, DOI 10.1016/j.apsusc.2009.10.072
   Donners JJJM, 2003, ADV MATER, V15, P313, DOI 10.1002/adma.200390076
   Fan YW, 2007, BIOMATERIALS, V28, P3034, DOI 10.1016/j.biomaterials.2007.02.016
   Fan YW, 2011, ACTA BIOMATER, V7, P2293, DOI 10.1016/j.actbio.2011.01.028
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Fowler CE, 2005, J MATER CHEM, V15, P3317, DOI 10.1039/b503312h
   Huang Z, 2010, BIOMATERIALS, V31, P9202, DOI 10.1016/j.biomaterials.2010.08.013
   Khopade AJ, 2002, INT J PHARM, V241, P145, DOI 10.1016/S0378-5173(02)00235-1
   Kirkham J, 2007, J DENT RES, V86, P426, DOI 10.1177/154405910708600507
   Li L, 2011, ADV MATER, V23, P4695, DOI 10.1002/adma.201102773
   Liu XM, 2008, BIOMATERIALS, V29, P1686, DOI 10.1016/j.biomaterials.2007.12.023
   Milhem OM, 2000, INT J PHARM, V197, P239, DOI 10.1016/S0378-5173(99)00463-9
   Mukherjee S, 2009, J AM CHEM SOC, V131, P8374, DOI 10.1021/ja902895p
   Naka K, 2002, LANGMUIR, V18, P3655, DOI 10.1021/la011345d
   Palazzo B, 2007, ADV FUNCT MATER, V17, P2180, DOI 10.1002/adfm.200600361
   Perumal OP, 2008, BIOMATERIALS, V29, P3469, DOI 10.1016/j.biomaterials.2008.04.038
   Pignatello R, 2009, NANOMEDICINE-UK, V4, P161, DOI 10.2217/17435889.4.2.161
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   TENCATE JM, 1982, CARIES RES, V16, P201, DOI 10.1159/000260599
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   Tsiourvas D, 2011, J AM CERAM SOC, V94, P2023, DOI 10.1111/j.1551-2916.2010.04342.x
   Wang D, 2003, BIOCONJUGATE CHEM, V14, P853, DOI 10.1021/bc034090j
   Wang LL, 2008, POLYMER, V49, P1199, DOI 10.1016/j.polymer.2008.01.023
   Wang ZJ, 2011, J DENT, V39, P746, DOI 10.1016/j.jdent.2011.08.006
   Xie LB, 2011, POLYM BULL, V66, P119, DOI 10.1007/s00289-010-0350-6
   Xie RQ, 2011, CRYST GROWTH DES, V11, P5206, DOI 10.1021/cg101708y
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
   Yan SJ, 2006, MATER CHEM PHYS, V99, P164, DOI 10.1016/j.matchemphys.2005.10.009
   Yang S, 2011, CHEM COMMUN, V47, P10100, DOI 10.1039/c1cc13661e
   Zhan JH, 2005, ADV FUNCT MATER, V15, P2005, DOI 10.1002/adfm.200500274
   Zhang JL, 2010, LANGMUIR, V26, P2989, DOI 10.1021/la9043649
NR 40
TC 61
Z9 65
U1 6
U2 165
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2013
VL 34
IS 21
BP 5036
EP 5047
DI 10.1016/j.biomaterials.2013.03.053
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 153VG
UT WOS:000319630000014
PM 23578556
DA 2018-10-20
ER

PT J
AU Frescaline, G
   Bouderlique, T
   Mansoor, L
   Carpentier, G
   Baroukh, B
   Sineriz, F
   Trouillas, M
   Saffar, JL
   Courty, J
   Lataillade, JJ
   Papy-Garcia, D
   Albanese, P
AF Frescaline, Guilhem
   Bouderlique, Thibault
   Mansoor, Leyya
   Carpentier, Gilles
   Baroukh, Brigitte
   Sineriz, Fernando
   Trouillas, Marina
   Saffar, Jean-Louis
   Courty, Jose
   Lataillade, Jean-Jacques
   Papy-Garcia, Dulce
   Albanese, Patricia
TI Glycosaminoglycan Mimetic Associated to Human Mesenchymal Stem
   Cell-Based Scaffolds Inhibit Ectopic Bone Formation, but Induce
   Angiogenesis In Vivo
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID RAT CRANIOTOMY DEFECTS; SMOOTH-MUSCLE-CELLS; HEPARAN-SULFATE;
   GROWTH-FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; FRACTURE REPAIR;
   MATRIX THERAPY; TISSUE; DIFFERENTIATION; OSTEOCLASTS
AB Tissue engineering approaches to stimulate bone formation currently combine bioactive scaffolds with osteo-competent human mesenchymal stem cells (hMSC). Moreover, osteogenic and angiogenic factors are required to promote differentiation and survival of hMSC through improved vascularization through the damaged extracellular matrix (ECM). Glycosaminoglycans (GAGs) are ECM compounds acting as modulators of heparin-binding protein activities during bone development and regenerative processes. GAG mimetics have been proposed as ECM stabilizers and were previously described for their positive effects on bone formation and angiogenesis after local treatment. Here, we developed a strategy associating the GAG mimetic [OTR4120] with bone substitutes to optimize stem cell-based therapeutic products. We showed that [OTR4120] was able to potentiate proliferation, migration, and osteogenic differentiation of hMSC in vitro. Its link to tricalcium phosphate/hydroxyapatite scaffolds improved their colonization by hMSC. Surprisingly, when these combinations were tested in an ectopic model of bone formation in immunodeficient mice, the GAG mimetics inhibit bone formation induced by hMSC and promoted an osteoclastic activity. Moreover, the inflammatory response was modulated, and the peri-implant vascularization stimulated. All together, these findings further support the ability of GAG mimetics to organize the local ECM to coordinate the host response toward the implanted biomaterial, and to inhibit the abnormal bone formation process on a subcutaneous ectopic site.
C1 [Frescaline, Guilhem; Bouderlique, Thibault; Mansoor, Leyya; Carpentier, Gilles; Courty, Jose; Papy-Garcia, Dulce; Albanese, Patricia] Univ Paris Est Creteil, Fac Sci & Technol, F-94010 Creteil, France.
   [Frescaline, Guilhem; Bouderlique, Thibault; Mansoor, Leyya; Carpentier, Gilles; Courty, Jose; Papy-Garcia, Dulce; Albanese, Patricia] Univ Paris Est Creteil, CNRS, EAC 7149, Lab CRRET, F-94010 Creteil, France.
   [Baroukh, Brigitte; Saffar, Jean-Louis] Univ Paris 05, EA2496, Lab Pathol & Biotherapies Organe Dent, Montrouge, France.
   [Sineriz, Fernando] OTR3 SAS, Paris, France.
   [Trouillas, Marina; Lataillade, Jean-Jacques] Hop Instruct Armees Percy, Ctr Therapie Brulures Graves, Clamart, France.
RP Albanese, P (reprint author), Univ Paris Est Creteil, CNRS, EAC 7149, Lab CRRET, F-94010 Creteil, France.
EM albanese@u-pec.fr
RI Bouderlique, Thibault/E-6780-2017; Courty, Jose/Q-3702-2018
OI Bouderlique, Thibault/0000-0002-3926-990X; Saffar,
   Jean-Louis/0000-0001-6288-9325
FU Region Ile de France; Delegation Generale pour l'Armement [07coV02]
FX The G.F. doctoral fellowship was financed by Region Ile de France. This
   work has been supported by the Delegation Generale pour l'Armement
   (grant PEA No. 07coV02). We thank A. LLorens for helpful technical
   support. The authors are grateful to A. Destainville from Ceraver
   companies, which kindly provided TCP/HA ceramics.
CR Albanese P, 2009, EXP HEMATOL, V37, P1072, DOI 10.1016/j.exphem.2009.06.005
   Alexakis C, 2004, FASEB J, V18, P1147, DOI 10.1096/fj.03-1126fje
   Ariyoshi W, 2008, J CELL BIOCHEM, V103, P1707, DOI 10.1002/jcb.21559
   Barbier-Chassefiere V, 2009, J BIOMED MATER RES A, V90A, P641, DOI 10.1002/jbm.a.32124
   Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082
   Baroukh B, 2000, BONE, V27, P627, DOI 10.1016/S8756-3282(00)00372-0
   Baud'huin M, 2011, EUR J CELL BIOL, V90, P49, DOI 10.1016/j.ejcb.2010.08.001
   Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007
   Blanquaert F, 1999, J BIOMED MATER RES, V44, P63, DOI 10.1002/(SICI)1097-4636(199901)44:1<63::AID-JBM7>3.0.CO;2-S
   Carpentier G., 2007, CUSTOM TAB STAT RESU
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Chebbi CK, 2008, J FR OPHTALMOL, V31, P465
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Chen PR, 2005, BIOMATERIALS, V26, P6579, DOI 10.1016/j.biomaterials.2005.03.037
   Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043
   Colombier ML, 1999, CELLS TISSUES ORGANS, V164, P131, DOI 10.1159/000016651
   Cool SM, 2006, J CELL BIOCHEM, V99, P1040, DOI 10.1002/jcb.20936
   COURTY J, 1991, BIOCHEM BIOPH RES CO, V180, P145, DOI 10.1016/S0006-291X(05)81267-7
   Desgranges P, 1999, FASEB J, V13, P761
   Desgranges P., 1997, International Journal of Artificial Organs, V20, P589
   Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   Escartin Q, 2003, FASEB J, V17, P644, DOI 10.1096/fj.02-0708com
   Folwarczna J, 2005, PHARMACOL REP, V57, P635
   Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001
   Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747
   Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667
   Ikeda Y, 2011, BIOMATERIALS, V32, P769, DOI 10.1016/j.biomaterials.2010.09.043
   Irie A, 2007, BONE, V41, P165, DOI 10.1016/j.bone.2007.04.190
   Ito K, 2005, J BIOMED MATER RES A, V73A, P63, DOI 10.1002/jbm.a.30248
   Jackson RA, 2006, J ORTHOP RES, V24, P636, DOI 10.1002/jor.20103
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Lafont J, 1998, GROWTH FACTORS, V16, P23, DOI 10.3109/08977199809017489
   Lafont J, 2004, CALCIFIED TISSUE INT, V75, P517, DOI 10.1007/s00223-004-0012-5
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Ling L., J CELL BIOCH, V109, P1222
   Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054
   Luong-Van E, 2007, J MOL HISTOL, V38, P459, DOI 10.1007/s10735-007-9129-y
   Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065
   Martelly I, 2010, MATRIX BIOL, V29, P317, DOI 10.1016/j.matbio.2010.02.002
   Mestries P, 2001, MATRIX BIOL, V20, P171, DOI 10.1016/S0945-053X(01)00131-7
   Nicoletti A, 2007, EPILEPSIA, V48, P894, DOI 10.1111/j.1528-1167.2007.01104.x
   Niemeyer Philipp, 2006, Curr Stem Cell Res Ther, V1, P21, DOI 10.2174/157488806775269151
   Papy-Garcia D, 2005, MACROMOLECULES, V38, P4647, DOI 10.1021/ma048485p
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P423, DOI 10.1016/j.jcms.2010.01.003
   Rouet V, 2005, J BIOL CHEM, V280, P32792, DOI 10.1074/jbc.M5044922200
   SAFFAR JL, 1990, J PERIODONTOL, V61, P209, DOI 10.1902/jop.1990.61.4.209
   TSAI WH, 1985, COMPUT VISION GRAPH, V29, P377, DOI 10.1016/0734-189X(85)90133-1
   Turnbull JE, 2010, METHOD ENZYMOL, V480, P65, DOI 10.1016/S0076-6879(10)80004-7
   Yamauchi H, 2000, FASEB J, V14, P2133
NR 52
TC 13
Z9 13
U1 0
U2 17
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL
PY 2013
VL 19
IS 13-14
BP 1641
EP 1653
DI 10.1089/ten.tea.2012.0377
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 152WU
UT WOS:000319563200020
PM 23521005
OA Green Published
DA 2018-10-20
ER

PT J
AU Zhang, YX
   Nypelo, T
   Salas, C
   Arboleda, J
   Hoeger, IC
   Rojas, OJ
AF Zhang, Yanxia
   Nypelo, Tiina
   Salas, Carlos
   Arboleda, Julio
   Hoeger, Ingrid C.
   Rojas, Orlando J.
TI Cellulose Nanofibrils: From Strong Materials to Bioactive Surfaces
SO JOURNAL OF RENEWABLE MATERIALS
LA English
DT Article
DE Cellulose nanofibrils; CNF; nanofibrillar cellulose; NFC; cellulose
   materials; aerogels; hydrogels; composites; bioactive surfaces;
   inorganic/organic hybrids
AB Cellulose nanofibrils (CNF), also known as nanofibrillar cellulose (NFC), are an advanced biomaterial made mainly from renewable forest and agricultural resources that have demonstrated exceptional performance in composites. In addition, they have been utilized in barrier coatings, food, transparent flexible films and other applications. Research on CNF has advanced rapidly over the last decade and several of the fundamental questions about production and characterization of CNF have been addressed. An interesting shift in focus in the recent reported literature indicates increased efforts aimed at taking advantage of the unique properties of CNF. This includes its nanoscale dimensions, high surface area, unique morphology, low density and mechanical strength. In addition, CNF can be easily (chemically) modified and is readily available, renewable, and biodegradable. These facts are expected to materialize in a more widespread use of CNF. However, there is no clear indication of the most promising avenues for CNF deployment in commercial products. This review attempts to illustrate some exciting opportunities for CNF, specifically, in the development of aerogels, composites, bioactive materials and inorganic/organic hybrid materials.
C1 [Zhang, Yanxia; Nypelo, Tiina; Salas, Carlos; Arboleda, Julio; Hoeger, Ingrid C.; Rojas, Orlando J.] N Carolina State Univ, Dept Forest Biomat, Raleigh, NC 27695 USA.
   [Zhang, Yanxia; Nypelo, Tiina; Salas, Carlos; Arboleda, Julio; Hoeger, Ingrid C.; Rojas, Orlando J.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
   [Rojas, Orlando J.] Aalto Univ, Dept Forest Prod Technol, Sch Chem Technol, FI-00076 Espoo, Finland.
RP Nypelo, T (reprint author), N Carolina State Univ, Dept Forest Biomat, Raleigh, NC 27695 USA.
EM tenypelo@ncsu.edu; ichoeger@ncsu.edu; ojrojas@ncsu.edu
RI Rojas, Orlando/O-2890-2014; zhang, Yanxia/F-5199-2011
OI Rojas, Orlando/0000-0003-4036-4020; zhang, Yanxia/0000-0002-1920-6709
CR Ahola S, 2008, CELLULOSE, V15, P303, DOI 10.1007/s10570-007-9167-3
   Andresen M, 2007, BIOMACROMOLECULES, V8, P2149, DOI 10.1021/bm070304e
   Ashori A, 2008, BIORESOURCE TECHNOL, V99, P4661, DOI 10.1016/j.biortech.2007.09.043
   Aulin C, 2010, SOFT MATTER, V6, P3298, DOI 10.1039/c001939a
   Aulin C, 2010, CELLULOSE, V17, P559, DOI 10.1007/s10570-009-9393-y
   Aulin C, 2009, LANGMUIR, V25, P7675, DOI 10.1021/la900323n
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Barud HS, 2008, J SOL-GEL SCI TECHN, V46, P363, DOI 10.1007/s10971-007-1669-9
   BATAILLE P, 1989, POLYM COMPOSITE, V10, P103, DOI 10.1002/pc.750100207
   Belbekhouche S, 2011, CARBOHYD POLYM, V83, P1740, DOI 10.1016/j.carbpol.2010.10.036
   Berglund LA, 2010, MRS BULL, V35, P201, DOI 10.1557/mrs2010.652
   Berndt S, 2013, CELLULOSE, V20, P771, DOI 10.1007/s10570-013-9870-1
   Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039
   Bitinis N, 2011, ADV MATER, V23, P5229, DOI 10.1002/adma.201101948
   Bledzki AK, 1996, J APPL POLYM SCI, V59, P1329, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1329::AID-APP17>3.3.CO;2-5
   Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5
   Brodin FW, 2012, CELLULOSE, V19, P1413, DOI 10.1007/s10570-012-9706-4
   Cai ZJ, 2012, CARBOHYD POLYM, V87, P1073, DOI 10.1016/j.carbpol.2011.08.037
   Cervin NT, 2012, CELLULOSE, V19, P401, DOI 10.1007/s10570-011-9629-5
   Chinga-Carrasco G, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1280-z
   Choudalakis G, 2009, EUR POLYM J, V45, P967, DOI 10.1016/j.eurpolymj.2009.01.027
   Cunha AM, 2006, PLAST RUBBER COMPOS, V35, P233, DOI 10.1179/174328906X146487
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Dahman Y, 2012, J APPL POLYM SCI, V126, pE187, DOI 10.1002/app.36756
   Dankovich TA, 2011, ENVIRON SCI TECHNOL, V45, P1992, DOI 10.1021/es103302t
   Diez I, 2011, MACROMOL BIOSCI, V11, P1185, DOI 10.1002/mabi.201100099
   Dufresne A, 2008, MONOMERS, POLYMERS AND COMPOSITES FROM RENEWABLE RESOURCES, P401, DOI 10.1016/B978-0-08-045316-3.00019-3
   Duncan TV, 2011, J COLLOID INTERF SCI, V363, P1, DOI 10.1016/j.jcis.2011.07.017
   Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0
   Eriksson M, 2006, IND ENG CHEM RES, V45, P5279, DOI 10.1021/ie060226w
   Faruk O, 2012, PROG POLYM SCI, V37, P1552, DOI 10.1016/j.progpolymsci.2012.04.003
   FELIX JM, 1991, J APPL POLYM SCI, V42, P609, DOI 10.1002/app.1991.070420307
   Ferrer A, 2012, CELLULOSE, V19, P2179, DOI 10.1007/s10570-012-9788-z
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u
   Gandini A, 2011, GREEN CHEM, V13, P1061, DOI 10.1039/c0gc00789g
   Gao C, 2011, CELLULOSE, V18, P1555, DOI 10.1007/s10570-011-9571-6
   Gao JH, 2009, ACCOUNTS CHEM RES, V42, P1097, DOI 10.1021/ar9000026
   Gardner DJ, 2008, J ADHES SCI TECHNOL, V22, P545, DOI 10.1163/156856108X295509
   George J, 2001, POLYM ENG SCI, V41, P1471, DOI 10.1002/pen.10846
   Gohel MC, 2005, J PHARM PHARM SCI, V8, P76
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Guimond R, 2010, J PULP PAP SCI, V36, P55
   Gutierrez J, 2012, CHEMSUSCHEM, V5, P2323, DOI 10.1002/cssc.201200516
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n
   Herrick F, 1982, J APPL POLYM SCI APP, V37, P797
   Ho MP, 2012, COMPOS PART B-ENG, V43, P3549, DOI 10.1016/j.compositesb.2011.10.001
   Holbery J, 2006, JOM-US, V58, P80, DOI 10.1007/s11837-006-0234-2
   Hu WL, 2009, MAT SCI ENG C-BIO S, V29, P1216, DOI 10.1016/j.msec.2008.09.017
   Hubbe MA, 2008, BIORESOURCES, V3, P929
   Husing N, 1998, ANGEW CHEM INT EDIT, V37, P23, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<22::AID-ANIE22>3.0.CO;2-I
   Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e
   Iwamoto S, 2005, APPL PHYS A-MATER, V81, pCP8, DOI 10.1007/s00339-005-3316-z
   Jin H, 2011, LANGMUIR, V27, P1930, DOI 10.1021/la103877r
   Jung R, 2009, J BIOMAT SCI-POLYM E, V20, P311, DOI 10.1163/156856209X412182
   Jung R, 2008, J POLYM SCI POL PHYS, V46, P1235, DOI 10.1002/polb.21457
   Kalia S, 2008, FIBER POLYM, V9, P416, DOI 10.1007/s12221-008-0067-4
   Kettunen M, 2011, ADV FUNCT MATER, V21, P510, DOI 10.1002/adfm.201001431
   Kistler SS, 1931, NATURE, V127, P741, DOI 10.1038/127741a0
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Koga H, 2012, J MATER CHEM, V22, P5538, DOI 10.1039/c2jm15661j
   Kolakovic R, 2011, AAPS PHARMSCITECH, V12, P1366, DOI 10.1208/s12249-011-9705-z
   Korhonen JT, 2011, ACS APPL MATER INTER, V3, P1813, DOI 10.1021/am200475b
   Koronis G, 2013, COMPOS PART B-ENG, V44, P120, DOI 10.1016/j.compositesb.2012.07.004
   Kulachenko A, 2012, CELLULOSE, V19, P793, DOI 10.1007/s10570-012-9685-5
   Lavoine N, 2012, CARBOHYD POLYM, V90, P735, DOI 10.1016/j.carbpol.2012.05.026
   Li WL, 2012, INT MATER REV, V57, P37, DOI 10.1179/1743280411Y.0000000011
   Lingstrom R, 2006, J COLLOID INTERF SCI, V296, P396, DOI 10.1016/j.jcis.2005.09.017
   Liu AD, 2011, BIOMACROMOLECULES, V12, P633, DOI 10.1021/bm101296z
   Liu WX, 2004, J COLLOID INTERF SCI, V275, P584, DOI 10.1016/j.jcis.2004.02.008
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Martins NCT, 2012, CELLULOSE, V19, P1425, DOI 10.1007/s10570-012-9713-5
   Minelli M, 2010, J MEMBRANE SCI, V358, P67, DOI 10.1016/j.memsci.2010.04.030
   Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W
   Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b
   Morseburg K, 2009, CELLULOSE, V16, P795, DOI 10.1007/s10570-009-9290-4
   Nakagaito A.N., 2006, ACS SYM SER, P151, DOI [10.1021/bk-2006-0938.ch011, DOI 10.1021/BK-2006-0938.CH011]
   Nakagaito AN, 2005, APPL PHYS A-MATER, V80, P155, DOI 10.1007/s00339-003-2225-2
   Nakagaito AN, 2010, MRS BULL, V35, P214, DOI 10.1557/mrs2010.654
   Nogi M, 2009, ADV MATER, V21, P1595, DOI 10.1002/adma.200803174
   Nypelo T, 2012, CELLULOSE, V19, P779, DOI 10.1007/s10570-012-9656-x
   Okahisa Y, 2009, COMPOS SCI TECHNOL, V69, P1958, DOI 10.1016/j.compscitech.2009.04.017
   Oksman K, 2009, PLAST RUBBER COMPOS, V38, P396, DOI 10.1179/146580109X12540995045723
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Orelma H, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0061-7
   Orelma H, 2012, BIOMACROMOLECULES, V13, P2802, DOI 10.1021/bm300781k
   Paakko M, 2007, BIOMACROMOLECULES, V8, P1934, DOI 10.1021/bm061215p
   Paakko M, 2008, SOFT MATTER, V4, P2492, DOI 10.1039/b810371b
   Pelton R, 2009, TRAC-TREND ANAL CHEM, V28, P925, DOI 10.1016/j.trac.2009.05.005
   Pertile R, 2012, BIOTECHNOL PROGR, V28, P526, DOI 10.1002/btpr.1501
   Pierre AC, 2002, CHEM REV, V102, P4243, DOI 10.1021/cr0101306
   Reddy LH, 2012, CHEM REV, V112, P5818, DOI 10.1021/cr300068p
   Riedel U, 2001, MATERIALWISS WERKST, V32, P493, DOI 10.1002/1521-4052(200105)32:5<493::AID-MAWE493>3.3.CO;2-3
   Rodionova G, 2011, CELLULOSE, V18, P127, DOI 10.1007/s10570-010-9474-y
   Saheb DN, 1999, ADV POLYM TECH, V18, P351, DOI 10.1002/(SICI)1098-2329(199924)18:4<351::AID-ADV6>3.0.CO;2-X
   Sain M., 2006, ACS SYM SER, P2
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Sehaqui H, 2012, ACS APPL MATER INTER, V4, P1043, DOI 10.1021/am2016766
   Sehaqui H, 2011, BIOMACROMOLECULES, V12, P3638, DOI 10.1021/bm2008907
   Sehaqui H, 2011, SOFT MATTER, V7, P7342, DOI 10.1039/c1sm05325f
   Shalwan A, 2013, MATER DESIGN, V48, P14, DOI 10.1016/j.matdes.2012.07.014
   Siqueira G, 2010, POLYMERS-BASEL, V2, P728, DOI 10.3390/polym2040728
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Spence KL, 2011, BIORESOURCES, V6, P4370
   Spence KL, 2011, CELLULOSE, V18, P1097, DOI 10.1007/s10570-011-9533-z
   Sun QH, 2007, COMPOS SCI TECHNOL, V67, P1823, DOI 10.1016/j.compscitech.2006.10.022
   Sureshkumar M, 2010, J MATER CHEM, V20, P6948, DOI 10.1039/c0jm00565g
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Syverud K, 2009, CELLULOSE, V16, P75, DOI 10.1007/s10570-008-9244-2
   Taipale T, 2010, CELLULOSE, V17, P1005, DOI 10.1007/s10570-010-9431-9
   Tan CB, 2001, ADV MATER, V13, P644, DOI 10.1002/1521-4095(200105)13:9<644::AID-ADMA644>3.0.CO;2-#
   Tingaut P, 2012, J MATER CHEM, V22, P20105, DOI 10.1039/c2jm32956e
   Trovatti E, 2012, INT J PHARMACEUT, V435, P83, DOI 10.1016/j.ijpharm.2012.01.002
   Trovatti E, 2011, BIOMACROMOLECULES, V12, P4162, DOI 10.1021/bm201303r
   Valo H, 2011, J CONTROL RELEASE, V156, P390, DOI 10.1016/j.jconrel.2011.07.016
   Vitta S, 2010, J APPL PHYS, V108, DOI 10.1063/1.3476058
   Wagberg L, 2002, J PULP PAP SCI, V28, P222
   Wagberg L, 2008, LANGMUIR, V24, P784, DOI 10.1021/la702481v
   Wallenberger F. T., 2004, NATURAL FIBERS PLAST
   Wang J, 2012, IET NANOBIOTECHNOL, V6, P52, DOI 10.1049/iet-nbt.2011.0038
   Wu CN, 2012, BIOMACROMOLECULES, V13, P1927, DOI 10.1021/bm300465d
   Xie YJ, 2010, COMPOS PART A-APPL S, V41, P806, DOI 10.1016/j.compositesa.2010.03.005
   Yang H, 2005, J PEPT RES, V66, P120, DOI 10.1111/j.1747-0285.2006.00342.x
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Yano H, 2004, J MATER SCI, V39, P1635, DOI 10.1023/B:JMSC.0000016162.43897.0a
   Yousefi H, 2013, IND CROP PROD, V43, P732, DOI 10.1016/j.indcrop.2012.08.030
   Yu QA, 2011, ACTA BIOMATER, V7, P1550, DOI 10.1016/j.actbio.2010.12.021
   ZADORECKI P, 1989, POLYM COMPOSITE, V10, P69, DOI 10.1002/pc.750100202
   Zhang TJ, 2010, ADV FUNCT MATER, V20, P1152, DOI 10.1002/adfm.200902104
   Zhang W, 2012, J MATER CHEM, V22, P11642, DOI 10.1039/c2jm30688c
NR 133
TC 66
Z9 66
U1 5
U2 31
PU SCRIVENER PUBLISHING LLC
PI BEVERLY
PA 100 CUMMINGS CENTER, SUITE 541J, BEVERLY, MA 01915-6106 USA
SN 2164-6325
EI 2164-6341
J9 J RENEW MATER
JI J. Renew. Mater.
PD JUL
PY 2013
VL 1
IS 3
BP 195
EP 211
DI 10.7569/JRM.2013.634115
PG 17
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Materials Science, Composites;
   Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA V41HD
UT WOS:000209536400003
DA 2018-10-20
ER

PT J
AU Wu, Y
   Wang, QC
   Libera, M
AF Wu, Yong
   Wang, Qichen
   Libera, Matthew
TI PEG-Based Microgels to Modify Biomaterials Surfaces
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT Polymer Networks Conference (PNG)
CY AUG 12-16, 2012
CL WY
DE biomaterials; drug delivery; infection; microgels; poly(ethylene glycol)
ID DRUG-DELIVERY; NANOPARTICLES; RELEASE; ANTIBIOTICS; CATHETERS;
   INFECTION; HYDROGELS; BIOFILMS; ADHESION; SYSTEMS
AB Microgels are hydrogel particles similar to 0.1-10 microns in size which have been increasingly explored for biomaterials applications. They can be designed to sequester drugs based on both hydrophobic and electrostatic interactions, and different strategies exist to trigger drug release from them. Microgels based on poly (ethylene glycol) are particularly attractive because of their intrinsic antifouling properties, the flexibility they bring to microgel design and synthesis, and the regulatory precedents set by PEG's use in a number of FDA-approved applications. This paper briefly reviews progress in the field of PEG-based microgels. We give examples illustrating their electrostatic deposition onto biomaterial surfaces and their ability to sequester antimicrobials for applications involving biomaterials-associated infection.
C1 [Wu, Yong; Wang, Qichen; Libera, Matthew] Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
RP Libera, M (reprint author), Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
EM mlibera@stevens.edu
CR Cormio L, 2001, EUR UROL, V40, P354, DOI 10.1159/000049799
   Cormio L., 2001, EUR UROL, V40, P359
   Fernandez-Nieves A., 2011, MICROGEL SUSPENSIONS
   Fisher OZ, 2009, MACROMOLECULES, V42, P3391, DOI 10.1021/ma801966r
   Gong CY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215103
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Gutowska A, 1997, J CONTROL RELEASE, V48, P141, DOI 10.1016/S0168-3659(97)00041-2
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Ketonis C, 2009, CLIN ORTHOP RELAT R, V467, P1678, DOI 10.1007/s11999-009-0828-4
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Li YP, 2011, BIOMATERIALS, V32, P6633, DOI 10.1016/j.biomaterials.2011.05.050
   OLIVEBERG M, 1995, BIOCHEMISTRY-US, V34, P9424, DOI 10.1021/bi00029a018
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Pai MP, 2001, ANN PHARMACOTHER, V35, P1255, DOI 10.1345/aph.10416
   Rosin D., 1933, J INST FUEL, V7, P29
   Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007
   Speziale P, 2008, CURR MED CHEM, V15, P3185, DOI 10.2174/092986708786848442
   Steinhilber D, 2011, BIOMATERIALS, V32, P1311, DOI 10.1016/j.biomaterials.2010.10.010
   Tan GX, 2012, J APPL POLYM SCI, V125, P3509, DOI 10.1002/app.36683
   Wang QC, 2012, ACS APPL MATER INTER, V4, P2498, DOI 10.1021/am300197m
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Zhang L, 2010, CURR MED CHEM, V17, P585, DOI 10.2174/092986710790416290
NR 27
TC 3
Z9 3
U1 1
U2 24
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2013
VL 329
IS 1
BP 35
EP 40
DI 10.1002/masy.201200106
PG 6
WC Polymer Science
SC Polymer Science
GA AG5BR
UT WOS:000335434600005
DA 2018-10-20
ER

PT J
AU Tzeng, SY
   Higgins, LJ
   Pomper, MG
   Green, JJ
AF Tzeng, Stephany Y.
   Higgins, Luke J.
   Pomper, Martin G.
   Green, Jordan J.
TI Student award winner in the Ph.D. category for the 2013 society for
   biomaterials annual meeting and exposition, april 1013, 2013, Boston,
   Massachusetts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE non-viral gene therapy; nanoparticles; drug delivery; liver cancer; DNA
ID NONVIRAL GENE DELIVERY; HUMAN HEPATOCELLULAR-CARCINOMA; POLY(BETA-AMINO
   ESTERS); CANCER-CELLS; THERAPY; EXPRESSION; POLYMERS; PROMOTER; DESIGN;
   VECTOR
AB Liver cancer is a leading cause of cancer death. Most patients are treated by arterial injection of chemoembolizing agents, providing a convenient avenue for local treatment by novel therapies, including gene therapy. Poly(beta-amino ester)s (PBAEs) were synthesized and used to form nanoparticles for non-viral transfection of buffalo rat hepatoma (MCA-RH7777) and hepatocyte (BRL-3A) lines with eGFP and luciferase DNA. Hepatoma cells were transfected with up to (98 +/- 0.4)% efficacy with no measurable cytotoxicity. Hepatocytes were transfected with as high as (73 +/- 0.4)% efficacy with (10 +/- 4)% non-specific cytotoxicity. In contrast, positive controls (branched polyethylenimine, Lipofectamine 2000, and X-tremeGENE (R) DNA HP) caused 3090% toxicity in BRL-3A cells at doses required for >50% transfection. Of the 21 optimized PBAE-DNA formulations tested, 12 showed significant specificity for hepatoma cells over hepatocytes in monoculture (p < 0.05 for both percentage transfected and eGFP expression intensity). Top polymers from eGFP studies also delivered luciferase DNA with 220 +/- 30-fold and 470 +/- 30-fold greater specificity for hepatoma cells than hepatocytes. Transfections of co-cultures of hepatoma and hepatocytes with eGFP DNA also showed high specificity (1.9 +/- 0.1- to 5.8 +/- 1.4-fold more transfected hepatoma cells than hepatocytes, measured by percentage transfected and flow cytometry). By eGFP intensity, up to 530 +/- 60-fold higher average expression per cell was measured in hepatoma cells. One top formulation caused (95 +/- 0.2)% transfection in hepatoma cells and (27 +/- 0.2)% in hepatocytes [(96 +/- 9)% relative hepatocyte viability]. PBAE-based nanoparticles are a viable strategy for liver cancer treatment, delivering genes to nearly 100% of cancer cells while maintaining high biomaterial-mediated specificity to prevent toxic side-effects on healthy hepatocytes. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Tzeng, Stephany Y.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.
   [Tzeng, Stephany Y.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD USA.
   [Tzeng, Stephany Y.; Higgins, Luke J.; Pomper, Martin G.; Green, Jordan J.] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA.
   [Higgins, Luke J.; Pomper, Martin G.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.
EM green@jhu.edu
FU NIH [R21CA152473]; CCNE [U54 CA151838]; National Science Foundation
FX Contract grant sponsor: NIH; contract grant number: R21CA152473;
   Contract grant sponsor: CCNE; contract grant number: U54 CA151838;
   Contract grant sponsor: National Science Foundation
CR Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
   Bhang HEC, 2011, NAT MED, V17, P123, DOI 10.1038/nm.2269
   Bhise NS, 2010, BIOMATERIALS, V31, P8088, DOI 10.1016/j.biomaterials.2010.07.023
   CHOU FI, 1995, NUCL MED BIOL, V22, P379, DOI 10.1016/0969-8051(94)00112-W
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Green JJ, 2007, ADV MATER, V19, P2836, DOI 10.1002/adma.200700371
   Green JJ, 2012, ANN BIOMED ENG, V40, P1408, DOI 10.1007/s10439-012-0550-3
   Hanazaki K, 2000, J AM COLL SURGEONS, V191, P381, DOI 10.1016/S1072-7515(00)00700-6
   Higgins LJ, 2011, J VASC INTERV RADIOL, V22, P1457, DOI 10.1016/j.jvir.2011.06.025
   Huppert P, 2011, ABDOM IMAGING, V36, P677, DOI 10.1007/s00261-011-9755-4
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Kim YI, 2012, J VASC INTERV RADIOL, V23, P704, DOI 10.1016/j.jvir.2012.01.053
   Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3
   Mohr L, 2004, GASTROENTEROLOGY, V127, pS225, DOI 10.1053/j.gastro.2004.09.037
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006
   Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102
   Sunshine J, 2009, ADV MATER, V21, P4947, DOI 10.1002/adma.200901718
   Sunshine JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037543
   Sunshine JC, 2011, THER DELIV, V2, P493, DOI 10.4155/TDE.11.14
   Tzeng SY, 2012, BIOMATERIALS, V33, P8142, DOI 10.1016/j.biomaterials.2012.07.036
   Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016
   Tzeng SY, 2012, ADV HEALTHCARE MAT, DOI 10.1002/adhm.201200257
   Viola JR, 2010, EXPERT OPIN DRUG DEL, V7, P721, DOI 10.1517/17425241003716810
   Wolschek MF, 2002, HEPATOLOGY, V36, P1106, DOI 10.1053/jhep.2002.36372
NR 27
TC 18
Z9 18
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2013
VL 101
IS 7
BP 1837
EP 1845
DI 10.1002/jbm.a.34616
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 150XE
UT WOS:000319424100001
PM 23559534
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Peng, QM
   Li, K
   Han, ZS
   Wang, ED
   Xu, ZG
   Liu, RP
   Tian, YJ
AF Peng, Qiuming
   Li, Kun
   Han, Zengsheng
   Wang, Erde
   Xu, Zhigang
   Liu, Riping
   Tian, Yongjun
TI Degradable magnesium-based implant materials with anti-inflammatory
   activity
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE metallic implant; mechanical properties; degradation properties;
   anti-inflammatory activity
ID OSTEOBLAST-LIKE CELLS; ALLOYS; BIOMATERIALS; CORROSION; SILVER; BONE;
   HYDROXYAPATITE
AB The objective of this study was to prepare a new biodegradable Mg-based biomaterial, which provides good mechanical integrity in combination with anti-inflammatory function during the degradation process. The silver element was used, because it improved the mechanical properties as an effective grain refiner and it is also treated as a potential anti-inflammatory core. The new degradable Mg-Zn-Ag biomaterial was prepared by zone solidification technology and extrusion. The mechanical properties were mostly enhanced by fine grain strengthening. In addition, the alloys exhibited good cytocompatibility. The anti-inflammatory function of degradation products was identified by both interleukin-1 and nitric oxide modes. The anti-inflammatory impact was significantly associated with the concentration of silver ion. It was demonstrated that Mg-Zn-Ag system was a potential metallic stent with anti-inflammatory function, which can reduce the long-term dependence of anti-inflammatory drug after coronary stent implantation. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Peng, Qiuming; Li, Kun; Han, Zengsheng; Liu, Riping; Tian, Yongjun] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.
   [Wang, Erde] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Peng, QM (reprint author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.
EM pengqiuming@gmail.com
RI Tian, Yongjun/A-1693-2010; Han, Zengsheng/A-4378-2009
OI Tian, Yongjun/0000-0002-4594-4879; Han, Zengsheng/0000-0001-8304-8832
FU National Natural Science Foundation of China [51101142, 50821001];
   Postdoctoral Science Foundation [2012M510766]; Science Foundation for
   the Excellent Youth Scholars of Hebei Province [Y2012019]
FX Contract grant sponsor: National Natural Science Foundation of China;
   contract grant number: 51101142 and 50821001; Contract grant sponsor:
   Postdoctoral Science Foundation; contract grant number: 2012M510766;
   Contract grant sponsor: Science Foundation for the Excellent Youth
   Scholars of Hebei Province; contract grant number: Y2012019
CR Acharya G, 2006, ADV DRUG DELIVER REV, V58, P387, DOI 10.1016/j.addr.2006.01.016
   American Society for Testing and Materials, 1999, ASTMG10289
   [Anonymous], 2004, ASTMG3172
   Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   Avedesian M, 1999, HDB MAGNESIUM MAGNES
   Balagna C, 2011, J BIOMATER APPL, V6, P596
   Bhol KC, 2004, CLIN EXP DERMATOL, V29, P282, DOI 10.1111/j.1365-2230.2004.01515.x
   Declerq HA, 2005, BIOMATERIALS, V26, P4964, DOI 10.1016/j.biomaterials.2005.01.025
   Ferreira ME, 2003, J TRACE ELEM MED BIO, V17, P45, DOI 10.1016/S0946-672X(03)80045-7
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Gibson LJ, 1988, CELLULAR SOLIDS STRU
   GRANCHI D, 1995, BIOMATERIALS, V16, P1187, DOI 10.1016/0142-9612(95)93585-2
   Hanzi AC, 2009, PHIL MAG LETT, V89, P377, DOI 10.1080/09500830902960125
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Maria CC, 2004, BIOL TRACE ELEM RES, V100, P151
   Milazzo G., 1978, TABLES STANDARD ELEC
   Na YG, 2005, MATER SCI FORUM, V488-489, P839, DOI 10.4028/www.scientific.net/MSF.488-489.839
   Pelkonen KHO, 2003, TOXICOLOGY, V186, P151, DOI 10.1016/S0300-483X(02)00743-6
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Rollett A., 2004, RECRYSTALLIZATION RE
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Shaw CA, 2009, J INORG BIOCHEM, V103, P1555, DOI 10.1016/j.jinorgbio.2009.05.019
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tang HQ, 2007, NUCL INSTRUM METH B, V255, P304, DOI 10.1016/j.nimb.2006.10.083
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Yilma A, 2011, NANOTECHNOLOGY, V3, P447
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhao MC, 2008, CORROS SCI, V50, P3168, DOI 10.1016/j.corsci.2008.08.023
NR 36
TC 12
Z9 13
U1 8
U2 82
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2013
VL 101
IS 7
BP 1898
EP 1906
DI 10.1002/jbm.a.34494
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 150XE
UT WOS:000319424100007
PM 23203562
DA 2018-10-20
ER

PT J
AU Coates, EE
   Riggin, CN
   Fisher, JP
AF Coates, Emily E.
   Riggin, Corinne N.
   Fisher, John P.
TI Photocrosslinked alginate with hyaluronic acid hydrogels as vehicles for
   mesenchymal stem cell encapsulation and chondrogenesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE photocrosslink; alginate; hyaluronic acid; mesenchymal stem cell;
   chondrogenesis
ID MARROW STROMAL CELLS; CARTILAGE; CHONDROCYTES; EXPRESSION; GENOTOXICITY;
   CYTOTOXICITY; METHACRYLATE; PHENOTYPE; NETWORKS; MONOMERS
AB Ionic crosslinking of alginate via divalent cations allows for high viability of an encapsulated cell population, and is an effective biomaterial for supporting a spherical chondrocyte morphology. However, such crosslinking chemistry does not allow for injectable and stable hydrogels which are more appropriate for clinical applications. In this study, the addition of methacrylate groups to the alginate polymer chains was utilized so as to allow the free radical polymerization initiated by a photoinitiator during UV light exposure. This approach establishes covalent crosslinks between methacrylate groups instead of the ionic crosslinks formed by the calcium in unmodified alginate. Although this approach has been well described in the literature, there are currently no reports of stem cell differentiation and subsequent chondrocyte gene expression profiles in photocrosslinked alginate. In this study, we demonstrate the utility of photocrosslinked alginate hydrogels containing interpenetrating hyaluronic acid chains to support stem cell chondrogenesis. We report high cell viability and no statistical difference in metabolic activity between mesenchymal stem cells cultured in calcium crosslinked alginate and photocrosslinked alginate for up to 10 days of culture. Furthermore, chondrogenic gene markers are expressed throughout the study, and indicate robust differentiation up to the day 14 time point. At early time points, days 1 and 7, the addition of hyaluronic acid to the photocrosslinked scaffolds upregulates gene markers for both the chondrocyte and the superficial zone chondrocyte phenotype. Taken together, we show that photocrosslinked, injectable alginate shows significant potential as a delivery mechanism for cell-based cartilage repair therapies. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Coates, Emily E.; Riggin, Corinne N.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
FU National Science Foundation [0448684]; Arthritis Foundation
FX Contract grant sponsor: The National Science Foundation; contract grant
   number: #0448684.; Contract grant sponsor: The Arthritis Foundation
CR Aydelotte MB, 1998, IN VITRO CELL DEV-AN, V34, P123
   Blasiak J, 2011, J PINEAL RES, V51, P157, DOI 10.1111/j.1600-079X.2011.00877.x
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2003, BIOMACROMOLECULES, V4, P149, DOI 10.1021/bm025677o
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Chou AI, 2009, J BIOMED MATER RES A, V91A, P187, DOI 10.1002/jbm.a.32191
   Coates E, 2012, J TISSUE ENG REGEN M, V6, P179, DOI 10.1002/term.411
   Coates EE, 2012, J ORTHOP RES, V30, P1886, DOI 10.1002/jor.22166
   Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Jung YJ, 2009, AM J DENT, V22, P295
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   Kim K, 2009, BIOMACROMOLECULES, V10, P1810, DOI 10.1021/bm900240k
   Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI [10.1089/ten.teb.2008.0563, 10.1089/ten.TEB.2008.0563]
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336
   Magne D, 2005, TRENDS MOL MED, V11, P519, DOI 10.1016/j.molmed.2005.09.002
   Pawlowska E, 2010, MUTAT RES-GEN TOX EN, V696, P122, DOI 10.1016/j.mrgentox.2009.12.019
   Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Poplawski T, 2010, TOXICOL IN VITRO, V24, P854, DOI 10.1016/j.tiv.2009.12.004
   Poplawski T, 2009, CHEM-BIOL INTERACT, V180, P69, DOI 10.1016/j.cbi.2009.02.001
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]
   Rouillard AD, 2011, TISSUE ENG PART C-ME, V17, P173, DOI [10.1089/ten.tec.2009.0582, 10.1089/ten.TEC.2009.0582]
   Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Ulrich-Vinther Michael, 2003, J Am Acad Orthop Surg, V11, P421
   Vasudeva Gaurav, 2009, J Calif Dent Assoc, V37, P389
   Yoon DM, 2008, TISSUE ENG PT A, V14, P1263, DOI 10.1089/ten.tea.2007.0172
   Yoon DM, 2006, ADV EXP MED BIOL, V585, P67
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
   Yoon DM, 2009, TISSUE ENG PT A, V15, P3449, DOI [10.1089/ten.tea.2009.0069, 10.1089/ten.TEA.2009.0069]
NR 36
TC 18
Z9 20
U1 4
U2 81
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2013
VL 101
IS 7
BP 1962
EP 1970
DI 10.1002/jbm.a.34499
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 150XE
UT WOS:000319424100014
PM 23225791
DA 2018-10-20
ER

PT J
AU Arruda, T
   Sukekava, F
   de Souza, AB
   Rasmusson, L
   Araujo, MG
AF Arruda, Thiago
   Sukekava, Flavia
   de Souza, Andre B.
   Rasmusson, Lars
   Araujo, Mauricio G.
TI Early healing in alveolar sockets grafted with titanium granules. An
   experimental study in a dog model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium granules; grafting; bone formation; extraction socket;
   biomaterial
ID MAXILLARY SINUS AUGMENTATION; EXTRACTION SOCKETS; TOOTH EXTRACTION;
   BONE-GRAFTS; FLOOR AUGMENTATION; AUTOGENOUS BONE; BIOACTIVE GLASS;
   DENTAL IMPLANTS; FEMORAL STEM; BOVINE BONE
AB The aim of the present study was to evaluate the effect of the placement of titanium granules in fresh extraction sockets on early bone formation. The mesial roots of the third maxillary premolars of five adult beagle dogs were removed. On one side of the maxilla (Test group) the fresh extraction socket was grafted with titanium granules, while the contra-lateral socket was left non-grafted (Control group). After 1 month of healing, the dogs were euthanized and biopsies were obtained. The healing tissues were described, and histometric measurements were performed to obtain the percentage area occupied by connective tissue, new mineralized bone, bone marrow, and biomaterial particles. After 1 month of healing the findings from the histological examination revealed the titanium graft to be well incorporated into the provisional connective tissue or newly formed woven bone. The histometric measurements showed, however, that less mineralized bone was formed in the Test group than in the Control group. The present study suggests that the use of titanium granules in fresh extraction sockets was conducive to new bone formation. The graft of titanium granules seems, however, to delay the early phase of the healing process. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Arruda, Thiago; de Souza, Andre B.; Araujo, Mauricio G.] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [Sukekava, Flavia] Univ Sao Paulo, Div Periodont, Sch Dent, Sao Paulo, Brazil.
   [Rasmusson, Lars] Univ Gothenburg, Dept Oral & Maxillofacial Surg, Sahlgrenska Acad, Gothenburg, Sweden.
RP Araujo, MG (reprint author), Rua Silva Jardim 49-03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
RI Sukekava, Flavia/F-9134-2018
OI Sukekava, Flavia/0000-0003-1331-5821
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Alffram PA, 2007, UPSALA J MED SCI, V112, P183, DOI 10.3109/2000-1967-192
   AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P9, DOI 10.1111/j.1600-0501.2010.01937.x
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Bashara H, 2012, CLIN ORAL IMPLAN RES, V23, P911, DOI 10.1111/j.1600-0501.2011.02240.x
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Bystedt H, 2009, CLIN IMPLANT DENT R, V11, P101, DOI 10.1111/j.1708-8208.2008.00100.x
   Camargo PM, 2000, ORAL SURG ORAL MED O, V90, P581, DOI 10.1067/moe.2000.110035
   Cardaropoli G, 2005, J CLIN PERIODONTOL, V32, P435, DOI 10.1111/j.1600-051X.2005.00692.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Donath K, 1993, PREPARATION HISTOLOG
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Hirota M, 2011, INT J ORAL MAX IMPL, V26, P245
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Holmberg L, 2008, UPSALA J MED SCI, V113, P217, DOI 10.3109/2000-1967-224
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Kahnberg KE, 1989, INT J ORAL MAXILLOF, V4, P297
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23
   Masago Hiroshi, 2007, Kobe J Med Sci, V53, P257
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Nkenke E, 2004, INT J ORAL MAX SURG, V33, P157, DOI 10.1054/ijom.2003.0465
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   Norton MR, 2002, INT J ORAL MAX IMPL, V17, P249
   Nystrom E, 1993, Int J Oral Maxillofac Implants, V8, P45
   NYSTROM E, 1995, INT J ORAL MAX SURG, V24, P20, DOI 10.1016/S0901-5027(05)80851-3
   Proussaefs Periklis, 2006, J Oral Implantol, V32, P237, DOI 10.1563/1548-1336(2006)32[237:UOTMFS]2.0.CO;2
   Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009
   SCHROEDER HE, 1973, ARCH ORAL BIOL, V18, P899, DOI 10.1016/0003-9969(73)90060-5
   Shin SI, 2012, J PERIODONTOL, DOI 10.1902/jop.2012.110241
   Simion M, 1998, Int J Periodontics Restorative Dent, V18, P8
   Steveling H, 2011, ZAHNARZT PRAXIS, V14, P6
   Strandkvist T, 1998, J CRANIOMAXILLOFACIA, V26, P183
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x
   Turner TM, 2007, UPSALA J MED SCI, V112, P191, DOI 10.3109/2000-1967-193
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vignoletti F, 2009, J CLIN PERIODONTOL, V36, P265, DOI 10.1111/j.1600-051X.2008.01363.x
   Widmark G, 1997, INT J ORAL MAX SURG, V26, P106, DOI 10.1016/S0901-5027(05)80827-6
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   Wohlfahrt CJ, 2010, CLIN ORAL IMPLAN RES, V21, P165
   Wohlfahrt JC, 2012, J PERIODONTOL, V83, P211, DOI 10.1902/jop.2011.110128
   Wohlfahrt Johan Caspar, 2011, Int J Oral Maxillofac Implants, V26, pe9
NR 51
TC 2
Z9 2
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2013
VL 101
IS 7
BP 1971
EP 1976
DI 10.1002/jbm.a.34501
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 150XE
UT WOS:000319424100015
PM 23225833
DA 2018-10-20
ER

PT J
AU Xie, DC
   Cai, KY
   Hu, Y
   Luo, Z
AF Xie, Daichao
   Cai, Kaiyong
   Hu, Yan
   Luo, Zhong
TI Surface engineering of titanium substrates with chitosan-atorvastatin
   conjugate for reduced inflammation responses and improved
   cytocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium; chitosan-atorvastatin conjugate; inflammatory response;
   macrophage; cytocompatibility
ID MESENCHYMAL STEM-CELLS; NITRIC-OXIDE; IN-VITRO; DIFFERENTIATION;
   BIOMATERIAL; COATINGS; MACROPHAGES; CYTOKINES; IMPLANTS; ALLOYS
AB In this study, chitosan-atorvastatin (Chi-AT) conjugate was immobilized onto the surfaces of titanium substrates to reduce inflammation responses and improve cytocompatibility. Polydopamine film was initially formed onto the titanium surfaces as the intermediate layer for the successful immobilization of Chi-AT, which was confirmed by scanning electron microscopy, X-ray photoelectron spectroscopy, and contact angle measurements, respectively. Endothelial cells grown onto Chi-AT immobilized titanium substrates displayed significantly higher (p < 0.01) cell viability and statistically lower (p < 0.01) lactate dehydrogenase production than those of native titanium substrates (control) after culture for 4 days and 7 days, respectively. Furthermore, macrophages cells cultured onto Chi-AT immobilized titanium substrates demonstrated significantly lower (p < 0.01) production levels of nitric oxide, acid phosphatase, reactive oxygen species, pro-inflammatory cytokines of tumor necrosis factor , and interleukin-1 than those of controls. All results indicated that the immobilization of Chi-AT conjugate onto titanium substrates was beneficial for improving their cytocompatibility and inhibiting pro-inflammatory responses. The study thus presents an alternative to fabricate bio-functionalized titanium-based implants for further clinical application. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Xie, Daichao; Cai, Kaiyong; Hu, Yan; Luo, Zhong] Chongqing Univ, Joint Coll Biomed Engn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.
RP Cai, KY (reprint author), Chongqing Univ, Joint Coll Biomed Engn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.
EM kaiyong_cai@cqu.edu.cn
RI 蔡, 开勇/G-1233-2011
FU China Ministry of Science and Technology [2009CB930000]; Natural Science
   Foundation of Chongqing Municipal Government [CSTC, 2011JJJQ10004,
   2010AB5116]; Natural Science Foundation of China [11032012, 51173216];
   National Key Technology R&D Program of the Ministry of Science and
   Technology [2012BAI18B04]; Fok Ying Tung Education Foundation [121035];
   Chongqing University Innovative Talent Training Project of "211 Project'
   [S-09104]
FX Contract grant sponsor: China Ministry of Science and Technology;
   contract grant number: 973 Project No. 2009CB930000; Contract grant
   sponsor: Natural Science Foundation of Chongqing Municipal Government;
   contract grant numbers: CSTC, 2011JJJQ10004, 2010AB5116; Contract grant
   sponsor: Natural Science Foundation of China; contract grant numbers:
   11032012, 51173216; Contract grant sponsor: National Key Technology R&D
   Program of the Ministry of Science and Technology; contract grant
   number: 2012BAI18B04; Contract grant sponsor: Fok Ying Tung Education
   Foundation; contract grant number: 121035; Contract grant sponsor:
   Chongqing University Innovative Talent Training Project of the Third
   Stage of "211 Project''; contract grant number: S-09104
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDERSON JM, 1988, ASAIO, V11, P101
   Anwar M, 2011, EUR J PHARM SCI, V44, P241, DOI 10.1016/j.ejps.2011.08.001
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Ariganello MB, 2009, J HEART VALVE DIS, V18, P187
   Cai KY, 2008, J MATER SCI-MATER M, V19, P499, DOI 10.1007/s10856-007-3184-5
   Cai KY, 2009, COLLOID SURFACE B, V72, P230, DOI 10.1016/j.colsurfb.2009.04.008
   Cai KY, 2005, APPL SURF SCI, V250, P252, DOI 10.1016/j.apsusc.2005.01.013
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Feng D, 2011, INFLAMM RES, V60, P817, DOI 10.1007/s00011-011-0337-2
   Gao Y, 2009, BIOMATERIALS, V30, P1790, DOI 10.1016/j.biomaterials.2008.12.025
   Grubl A, 2007, J BIOMED MATER RES B, V83B, P127, DOI 10.1002/jbm.b.30775
   Hirvonen MR, 1997, TOXICOLOGY, V124, P105, DOI 10.1016/S0300-483X(97)00141-8
   Hu Y, 2010, ADV ENG MATER, V12, pB18, DOI 10.1002/adem.200980006
   Hu Y, 2009, BIOMATERIALS, V30, P3626, DOI 10.1016/j.biomaterials.2009.03.037
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kang S, 2011, BIOMATERIALS, V32, P3487, DOI 10.1016/j.biomaterials.2011.01.046
   Kim HJ, 2006, FREE RADICAL BIO MED, V40, P1483, DOI 10.1016/j.freeradbiomed.2005.10.066
   Lai M, 2011, BIOMACROMOLECULES, V12, P1097, DOI 10.1021/bm1014365
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Li XL, 2011, CELL IMMUNOL, V271, P455, DOI 10.1016/j.cellimm.2011.08.015
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MARCINKIEWICZ J, 1995, EUR J IMMUNOL, V25, P947, DOI 10.1002/eji.1830250414
   Martin HJ, 2008, THIN SOLID FILMS, V516, P6277, DOI 10.1016/j.tsf.2007.12.001
   Pavithra D., 2008, BIOMED MATER, V3, P1
   Peng CW, 2011, BIOMATERIALS, V32, P2907, DOI 10.1016/j.biomaterials.2010.12.053
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Qian ZJ, 2012, J PHYCOL, V48, P475, DOI 10.1111/j.1529-8817.2012.01117.x
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Sodhi RNS, 1996, J ELECTRON SPECTROSC, V81, P269, DOI 10.1016/0368-2048(95)02665-7
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Van den Beucken JJJ, 2006, J BIOMED MATER RES A, V79, P612
   Wang G, 2012, TOXICOLOGY, V299, P99, DOI 10.1016/j.tox.2012.05.012
   Wu X, 2010, EUR J PHARMACOL, V636, P114, DOI 10.1016/j.ejphar.2010.03.028
   Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003
   Yamaguchi K, 2003, BONE, V33, P144, DOI 10.1016/S8756-3282(03)00085-1
NR 39
TC 6
Z9 6
U1 2
U2 57
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2013
VL 101
IS 7
BP 2005
EP 2014
DI 10.1002/jbm.a.34508
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 150XE
UT WOS:000319424100019
PM 23239618
DA 2018-10-20
ER

PT J
AU Hsu, SH
   Huang, GS
AF Hsu, Shan-hui
   Huang, Guo-shiang
TI Substrate-dependent Wnt signaling in MSC differentiation within
   biomaterial-derived 3D spheroids
SO BIOMATERIALS
LA English
DT Article
DE Mesenchymal stem cells (MSCs); Spheroids; Wnt signaling; Chitosan;
   Hyaluronan
ID MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; CYTOSKELETAL
   TENSION; CHITOSAN SCAFFOLDS; STROMAL CELLS; SELF-RENEWAL; CANCER CELLS;
   N-CADHERIN; CHONDROGENESIS; CULTURE
AB A unique biomaterial-based system was developed to generate dynamic three-dimensional (3D) multicellular spheroids of mesenchymal stem cells (MSCs). MSCs were cultured on transparent membranes made of chitosan or those further grafted with hyaluronan (HA) in different densities. MSCs vigorously migrated and were self-assembled into highly mobile 3D spheroids with substrate-dependent upregulation of adhesion molecule N-cadherin. MSC spheroids showed increased expression of Wnt genes/proteins and substrate-dependent cell fate. The correlation of differentiation capacities with Wnt signaling and crosstalk with other pathways such as ERK1/2 or Smad2/3 were observed for MSC spheroids but not for the conventional 2D cultured cells. Wnt3a-mediated canonical Wnt signaling was more active for MSC spheroids derived on chitosan, which were prone to osteogenesis. Wnt5a-mediated non-canonical Wnt signaling was more active for MSC spheroids derived on HA-grafted chitosan, which were prone to chondrogenesis. In particular, the relative importance of Wnt5a-mediated non-canonical vs. Wnt3a-mediated canonical Wnt signals in determining the cell fate was controlled by the grafting density of HA on chitosan. Treatment with the inhibitor of canonical Wnt-associated signaling molecules suppressed the osteogenesis of MSC spheroids on chitosan. This study demonstrates that Wnt signaling of MSCs is distinct in 3D environment and is substrate-dependent. The convenient 3D platform may be used to examine the role of Wnt signaling in controlling MSC fate under different extracellular environments, and potentially applied to study stem cell behavior in regenerative medicine, normal development, and cancer. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Hsu, Shan-hui; Huang, Guo-shiang] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
   [Hsu, Shan-hui; Huang, Guo-shiang] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10617, Taiwan.
RP Hsu, SH (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, 1,Sec 4 Roosevelt Rd, Taipei 10617, Taiwan.
EM shhsu@ntu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
FU Program for Stem Cell and Regenerative Medicine Frontier Research
   [NSC100-2321-B-002-077]; National Science Council, Taiwan, R.O.C.
FX This research was supported by the Program for Stem Cell and
   Regenerative Medicine Frontier Research (NSC100-2321-B-002-077)
   sponsored by the National Science Council, Taiwan, R.O.C.
CR Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002
   Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035
   Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049
   Correia CR, 2011, TISSUE ENG PART C-ME, V17, P717, DOI 10.1089/ten.tec.2010.0467
   Dakeng S, 2012, J CELL BIOCHEM, V113, P49, DOI 10.1002/jcb.23326
   Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109
   Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Haga T, 2008, APOPTOSIS, V13, P97, DOI 10.1007/s10495-007-0132-2
   Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08
   Hsu SH, 2012, TISSUE ENG PT A, V18, P67, DOI [10.1089/ten.tea.2011.0157, 10.1089/ten.TEA.2011.0157]
   Hsu SH, 2012, BIOMATERIALS, V33, P2642, DOI 10.1016/j.biomaterials.2011.12.032
   Huang GS, 2011, BIOMATERIALS, V32, P6929, DOI 10.1016/j.biomaterials.2011.05.092
   Ishida-Takagishi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1861
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Li BQ, 2011, J BIOMAT SCI-POLYM E, V22, P505, DOI 10.1163/092050610X487800
   Liao HT, 2011, TISSUE ENG PART C-ME, V17, P1139, DOI 10.1089/ten.tec.2011.0140
   Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Miyagawa Y, 2011, TISSUE ENG PT A, V17, P513, DOI 10.1089/ten.TEA.2009.0810
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Pittet P, 2008, J CELL SCI, V121, P877, DOI 10.1242/jcs.024877
   Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329
   Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014
   Sonoda T, 2003, CANCER LETT, V196, P229, DOI 10.1016/S0304-3835(03)00216-7
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030
   Zhou Y, 2010, BRIT J PHARMACOL, V161, P1542, DOI 10.1111/j.1476-5381.2010.00998.x
NR 34
TC 35
Z9 36
U1 2
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2013
VL 34
IS 20
BP 4725
EP 4738
DI 10.1016/j.biomaterials.2013.03.031
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 137UR
UT WOS:000318464200003
PM 23562051
DA 2018-10-20
ER

PT J
AU Seth, A
   Chung, YG
   Gil, ES
   Tu, D
   Franck, D
   Di Vizio, D
   Adam, RM
   Kaplan, DL
   Estrada, CR
   Mauneya, JR
AF Seth, Abhishek
   Chung, Yeun Goo
   Gil, Eun Seok
   Tu, Duong
   Franck, Debra
   Di Vizio, Dolores
   Adam, Rosalyn M.
   Kaplan, David L.
   Estrada, Carlos R., Jr.
   Mauneya, Joshua R.
TI The performance of silk scaffolds in a rat model of augmentation
   cystoplasty
SO BIOMATERIALS
LA English
DT Article
DE Silk; Bladder tissue engineering; Bladder; Wound healing
ID SMALL-INTESTINAL SUBMUCOSA; BLADDER AUGMENTATION; URINARY-BLADDER;
   MURINE MODEL; STEM-CELLS; IN-VIVO; BIOMATERIALS; REGENERATION;
   DEGRADATION; EXPRESSION
AB The diverse processing plasticity of silk-based biomaterials offers a versatile platform for understanding the impact of structural and mechanical matrix properties on bladder regenerative processes. Three distinct groups of 3-D matrices were fabricated from aqueous solutions of Bombyx mori silk fibroin either by a gel spinning technique (GS1 and GS2 groups) or a solvent-casting/salt-leaching method in combination with silk film casting (FF group). SEM analyses revealed that GS1 matrices consisted of smooth, compact multi-laminates of parallel-oriented silk fibers while GS2 scaffolds were composed of porous (pore size range, 5-50 mu m) lamellar-like sheets buttressed by a dense outer layer. Bi-layer FF scaffolds were comprised of porous foams (pore size, similar to 400 mu m) fused on their external face with a homogenous, nonporous silk film. Silk groups and small intestinal submucosa (SIS) matrices were evaluated in a rat model of augmentation cystoplasty for 10 weeks of implantation and compared to cystotomy controls. Gross tissue evaluations revealed the presence of intra-luminal stones in all experimental groups. The incidence and size of urinary calculi was the highest in animals implanted with gel spun silk matrices and SIS with frequencies >= 57% and stone diameters of 3-4 mm. In contrast, rats augmented with FF scaffolds displayed substantially lower rates (20%) and stone size (2 mm), similar to the levels observed in controls (13%, 2 mm). Histological (hematoxylin and eosin, Masson's trichrome) and immunohistochemical (IHC) analyses showed comparable extents of smooth muscle regeneration and contractile protein (alpha-smooth muscle actin and SM22 alpha) expression within defect sites supported by all matrix groups similar to controls. Parallel evaluations demonstrated the formation of a transitional, multilayered urothelium with prominent uroplakin and p63 protein expression in all experimental groups. De novo innervation and vascularization processes were evident in all regenerated tissues indicated by Fox3-positive neuronal cells and vessels lined with CD31 expressing endothelial cells. In comparison to other biomaterial groups, cystometric analyses at 10 weeks post-op revealed that animals implanted with the FF matrix configuration displayed superior urodynamic characteristics including compliance, functional capacity, as well as spontaneous non voiding contractions consistent with control levels. Our data demonstrate that variations in scaffold processing techniques can influence the in vivo functional performance of silk matrices in bladder reconstructive procedures. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Seth, Abhishek; Chung, Yeun Goo; Tu, Duong; Franck, Debra; Adam, Rosalyn M.; Estrada, Carlos R., Jr.; Mauneya, Joshua R.] Boston Childrens Hosp, Dept Urol, Urol Dis Res Ctr, Boston, MA 02115 USA.
   [Adam, Rosalyn M.; Estrada, Carlos R., Jr.; Mauneya, Joshua R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.
   [Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Di Vizio, Dolores] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
RP Mauneya, JR (reprint author), Boston Childrens Hosp, Dept Urol, John F Enders Res Labs, 300 Longwood Ave,Rm 1009, Boston, MA 02115 USA.
EM joshua.mauney@childrens.harvard.edu
RI Estrada, Carlos/H-2199-2015
OI Estrada, Carlos/0000-0003-0586-9832
FU Tissue Engineering Resource Center; NIH/NIBIB [P41 EB002520]; NIH/NIDDK
   [P50 DK065298-06, T32-DK60442, R00 DK083616-01A2]
FX The authors wish to thank Dr. Lin Huang for her help with statistical
   analyses. Suzanne White and staff at the Histology Core Facility at Beth
   Israel Deaconess Medical Center are acknowledged for technical
   assistance with tissue processing for histological analyses. This
   research was supported by the Tissue Engineering Resource Center,
   NIH/NIBIB P41 EB002520 (KAPLAN); NIH/NIDDK P50 DK065298-06 (ADAM);
   NIH/NIDDK T32-DK60442 (FREEMAN); NIH/NIDDK R00 DK083616-01A2 (MAUNEY).
CR Abrams P, 2003, UROLOGY, V62, P28, DOI 10.1016/j.urology.2003.09.050
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Biers SM, 2012, BJU INT, V109, P1280, DOI 10.1111/j.1464-410X.2011.10650.x
   Blaivas JG, 2009, J UROLOGY, V182, P2814, DOI 10.1016/j.juro.2009.08.039
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301
   Chang SJ, 2009, J UROLOGY, V182, P1933, DOI 10.1016/j.juro.2009.02.086
   DEBOER WI, 1994, AM J PATHOL, V145, P1199
   Franck D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056237
   Gomez P, 2011, BIOMATERIALS, V32, P7562, DOI 10.1016/j.biomaterials.2011.06.067
   Guys JM, 2011, SCAND J SURG, V100, P256, DOI 10.1177/145749691110000405
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Husmann D A, 2008, J Pediatr Urol, V4, P381, DOI 10.1016/j.jpurol.2008.06.003
   Iijima K, 2007, TISSUE ENG, V13, P513, DOI 10.1089/ten.2006.0170
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Scales CD, 2008, J UROLOGY, V180, P2323, DOI 10.1016/j.juro.2008.08.050
   Tu DD, 2012, J VIS EXP, V66, pe3981
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhu WD, 2011, UROLOGE, V50, P1420, DOI 10.1007/s00120-011-2627-2
NR 31
TC 33
Z9 33
U1 6
U2 99
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2013
VL 34
IS 20
BP 4758
EP 4765
DI 10.1016/j.biomaterials.2013.03.038
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 137UR
UT WOS:000318464200006
PM 23545287
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Riaz, B
   Ansari, TM
   Hanif, MA
   Riaz, S
   Khan, MA
   Riaz, M
   Jilani, MI
AF Riaz, Beenish
   Ansari, Tariq Mahmood
   Hanif, Muhammad Asif
   Riaz, Sana
   Khan, Muhammad Aslam
   Riaz, Muhammad
   Jilani, Muhammad Idrees
TI Utilization of Extensively Available Environmental Waste Mentha spicata
   for Uptake of Pb(II) from Aqueous Solutions
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Pb(II); Mentha spicata; Biosorption; Waste biomass; Kinetics
ID HEAVY-METALS; BIOSORPTION; REMOVAL; BIOMASS; LEAD(II); SLUDGE;
   EQUILIBRIUM; CADMIUM(II); SORPTION; COPPER
AB The present study was focused on extensively available Mentha spicata distillation waste biomass for Pb(II) uptake from aqueous solutions. The biomass was entrapped in alginate bead after adopting a specially carried out process. The effect of various experimental parameters on adsorption of Pb(II) was investigated under laboratory conditions. The results clearly indicated the importance of various experimental parameters such as pH, biosorbent dose, biosorbent particle size, initial metal concentration and contact time for removal of Pb(II) from aqueous solutions. The uptake of Pb(II) by immobilized Mentha spicata distillation waste biomass increased with increase in pH reaching a maximum at 5. The equilibrium sorption data agrees well with Freundlich sorption isotherm with high correlation coefficients. The kinetics of the sorption process was found to follow pseudo-second order kinetic model in batch mode and pseudo-first order in continuous mode of adsorption. High Pb(II) uptake capacity of immobilized Mentha spicata distillation waste biomass suggested that it could be used as a potential biomaterial to remove Pb(II) ions from aqueous solutions.
C1 [Riaz, Beenish; Ansari, Tariq Mahmood] Govt Coll Univ, Dept Environm Sci, Faisalabad 38000, Pakistan.
   [Hanif, Muhammad Asif; Jilani, Muhammad Idrees] Univ Agr Faisalabad, Dept Chem & Biochem, Faisalabad 38040, Pakistan.
   [Riaz, Sana] Govt Coll Univ, Dept Bot, Faisalabad 38000, Pakistan.
   [Khan, Muhammad Aslam] Univ Agr Faisalabad, Inst Hort Sci, Faisalabad 38040, Pakistan.
   [Riaz, Muhammad] Govt Coll Univ, Dept Chem, Faisalabad 38000, Pakistan.
   [Ansari, Tariq Mahmood] Bahauddin Zakariya Univ, Inst Chem Sci, Multan, Pakistan.
RP Ansari, TM (reprint author), Govt Coll Univ, Dept Environm Sci, Faisalabad 38000, Pakistan.
EM drtariq2000@gmail.com; riaz_453@yahoo.com
RI Hanif, Muhammad Asif/G-7242-2015; Ansari, Tariq Mahmood/J-2845-2015
OI Ansari, Prof Dr Tariq Mahmood/0000-0002-8074-3941
CR Ahalya N., 2004, RES J CHEM ENVIRON, V7, P71
   Atkinson BW, 1998, WATER SA, V24, P129
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   Bhattacharyya KG, 2004, J HAZARD MATER, V113, P97, DOI 10.1016/j.jhazmat.2004.05.034
   BRIERLEY JA, 1985, Patent No. 85112810
   Chang JS, 1997, WATER RES, V31, P1651, DOI 10.1016/S0043-1354(97)00008-0
   CHENG MH, 1975, J WATER POLLUT CON F, V47, P362
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   Gadd G. M., 1998, BIOTECHNOLOGY SPECIA, P401
   Han RP, 2006, J HAZARD MATER, V133, P262, DOI 10.1016/j.jhazmat.2005.10.019
   Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040
   Ho YS, 2006, J HAZARD MATER, V129, P137, DOI 10.1016/j.jhazmat.2005.08.020
   Kim HS, 2005, HUM IMMUNOL, V66, P1074, DOI 10.1016/j.humimm.2005.08.242
   Kong IC, 1998, B ENVIRON CONTAM TOX, V61, P505, DOI 10.1007/s001289900791
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Lee SM, 2001, WATER RES, V35, P534, DOI 10.1016/S0043-1354(00)00284-0
   Malakootian M, 2009, INT J ENVIRON SCI TE, V6, P183
   Martinez M, 2006, J HAZARD MATER, V133, P203, DOI 10.1016/j.jhazmat.2005.10.030
   Matheickal JT, 1999, WATER RES, V33, P335, DOI 10.1016/S0043-1354(98)00237-1
   MCKAY G, 1980, WATER RES, V14, P15, DOI 10.1016/0043-1354(80)90037-8
   Muraleedharan, 1990, BIOTECHNOL BIOENG, V35, P320
   Nadeem R, 2008, J HAZARD MATER, V156, P64, DOI 10.1016/j.jhazmat.2007.11.124
   Nasir MH, 2007, J HAZARD MATER, V147, P1006, DOI 10.1016/j.jhazmat.2007.01.131
   Quek SY, 1998, WATER SA, V24, P251
   SAG Y, 1995, PROCESS BIOCHEM, V30, P169, DOI 10.1016/0032-9592(95)95716-V
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Weber Jr WJ, 1985, SLEJKO ADSORPTION TH, P1
   Zubair A, 2008, WATER AIR SOIL POLL, V191, P305, DOI 10.1007/s11270-008-9626-y
NR 28
TC 0
Z9 0
U1 0
U2 5
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
J9 ASIAN J CHEM
JI Asian J. Chem.
PD JUL
PY 2013
VL 25
IS 8
BP 4551
EP 4555
PN B
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 121LN
UT WOS:000317246400100
DA 2018-10-20
ER

PT J
AU Harjanto, D
   Lee, J
   Kim, JM
   Jaworski, J
AF Harjanto, Dewi
   Lee, Joosub
   Kim, Jong-Man
   Jaworski, Justyn
TI Controlling and Assessing the Surface Display of Cell-Binding Domains on
   Magnetite Conjugated Fluorescent Liposomes
SO LANGMUIR
LA English
DT Article
ID COLORIMETRIC DETECTION; ADHESION ASSAYS; RGD; POLYDIACETYLENE;
   NANOPARTICLES
AB Biological systems provide us with a diverse source of peptide-based ligands for cellular adhesion. Controlling and assessing the ligand surface density as well as tailoring the surface chemistry to have specific cellular adhesion properties are important in biomaterials design. In the following work, we provide a means for displaying peptide-based ligands on magnetic liposomes in which the surface density and chemistry may be controlled. Simultaneously, the conjugated vesicles provide a fluorescent signal for examining steric hindrance among surface ligands. In addition, the inherent magnetic and fluorescence features of this system revealed potential for magnet-based cell isolation and fluorescent labeling of adhered cells, respectively. Adhered cells were found to remain viable and proliferative, thereby allowing them to be used for subsequent evaluation. In a specific demonstration, we control the density of fibronectin-mimetic ligands on the polydiacetylene liposome surfaces. We find that steric limitation occurring at over 20% surface density result in decreased cell adhesion, in accord with related techniques. The magnetic-liposome system offers the means for not only separating cells adhered to the biomaterial, but also providing the ability to control and assess the biomaterial surface. This may prove particularly useful for examining combinations of peptide-based ligands or for evaluating the molecular-level ligand accessibility and its effect on cell attachment to a biomaterial surface.
C1 [Harjanto, Dewi] Rockefeller Univ, New York, NY 10021 USA.
   [Lee, Joosub; Kim, Jong-Man; Jaworski, Justyn] Hanyang Univ, Seoul 133791, South Korea.
   [Kim, Jong-Man; Jaworski, Justyn] Inst Nano Sci & Technol, Seoul, South Korea.
RP Jaworski, J (reprint author), Hanyang Univ, 222 Wangsimni Ro, Seoul 133791, South Korea.
EM justynj@hanyang.ac.kr
FU Priority Research Centers Program through the National Research
   Foundation of Korea (NRF); Ministry of Education, Science and Technology
   [2012R1A6A1029029]; Hanyang University [HY-2011-N]; NSF EAPSI grant
FX This work was supported by the Priority Research Centers Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (2012R1A6A1029029), by the research
   fund of Hanyang University (HY-2011-N), and by the NSF EAPSI grant.
CR ALBELDA SM, 1990, FASEB J, V4, P2868
   [Anonymous], 2001, BD BIOSCIENCES, p[60, 60]
   Aparicio CL, 1997, BIOTECHNIQUES, V23, P1056, DOI 10.2144/97236st01
   BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066
   Biesalski M, 2005, LANGMUIR, V21, P5663, DOI 10.1021/la0504558
   Biesalski MA, 2006, BIOMATERIALS, V27, P1259, DOI 10.1016/j.biomaterials.2005.08.002
   Charych D, 1996, CHEM BIOL, V3, P113, DOI 10.1016/S1074-5521(96)90287-2
   Chen X, 2010, ANGEW CHEM INT EDIT, V49, P1422, DOI 10.1002/anie.200905041
   Chen XL, 2011, ANGEW CHEM INT EDIT, V50, P5486, DOI 10.1002/anie.201100064
   Corr SA, 2006, CHEM COMMUN, P4474, DOI 10.1039/b610746j
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Dino A. K, 2001, BIOMATERIALS, V22, p[1493, 1493]
   Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054
   Fortin-Ripoche JP, 2006, RADIOLOGY, V239, P415, DOI 10.1148/radiol.2392042110
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hsu L, 2008, J AM CHEM SOC, V130, P3892, DOI 10.1021/ja076553s
   Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14
   Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57
   Ito A, 2005, BIOMATERIALS, V26, P6185, DOI 10.1016/j.biomaterials.2005.03.039
   Jain S, 2003, INT J PHARM, V261, P43, DOI 10.1016/S0378-5173(03)00269-2
   Jaworski J, 2011, LANGMUIR, V27, P3180, DOI 10.1021/la104476p
   Jun YW, 2008, ACCOUNTS CHEM RES, V41, P179, DOI 10.1021/ar700121f
   Jung YK, 2006, BIOSENS BIOELECTRON, V21, P1536, DOI 10.1016/j.bios.2005.07.010
   Kim D, 2008, J AM CHEM SOC, V130, P16454, DOI 10.1021/ja805201v
   Kim JM, 2005, MACROMOL RES, V13, P253, DOI 10.1007/BF03219060
   Kwon IK, 2012, SMALL, V8, P209, DOI 10.1002/smll.201101322
   Lee J, 2012, MACROMOL CHEM PHYS, V213, P893, DOI 10.1002/macp.201200049
   Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Reppy MA, 2007, CHEM COMMUN, P4317, DOI 10.1039/b703691d
   Safarik I, 1999, J CHROMATOGR B, V722, P33, DOI 10.1016/S0378-4347(98)00338-7
   Scindia Y, 2007, LANGMUIR, V23, P4682, DOI 10.1021/la0636208
   Son H, 2012, ANALYST, V137, P3914, DOI 10.1039/c2an35704f
   Sun XM, 2010, CHEM SOC REV, V39, P4244, DOI 10.1039/c001151g
   Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308
   Yarimaga O, 2012, CHEM COMMUN, V48, P2469, DOI 10.1039/c2cc17441c
NR 36
TC 7
Z9 7
U1 1
U2 40
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 25
PY 2013
VL 29
IS 25
BP 7949
EP 7956
DI 10.1021/la4005714
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 173QN
UT WOS:000321094100043
PM 23672731
DA 2018-10-20
ER

PT J
AU Stylianou, A
   Yova, D
   Alexandratou, E
AF Stylianou, Andreas
   Yova, Dido
   Alexandratou, Eleni
TI Nanotopography of collagen thin films in correlation with fibroblast
   response
SO JOURNAL OF NANOPHOTONICS
LA English
DT Article
DE atomic force microscopy; collagen; nanostructured films; biomaterials;
   orientation; fibroblasts
ID ATOMIC-FORCE MICROSCOPY; BIOMEDICAL APPLICATIONS; CELL MORPHOLOGY; I
   COLLAGEN; NANOSCALE; AFM; ADHESION; MATRICES; ALIGNMENT; SURFACES
AB Collagen thin films consisting of randomly oriented and oriented collagen fibrils/fibers are fabricated by hydrodynamic flow and spin coating, and then they are characterized by atomic force microscopy (AFM). Fibroblasts are cultured on these films in order to correlate their morphology and alignment, which are assessed with fluorescence and AFM imaging with different film characteristics. The results showed that the formed films could be used as substrates for culturing cells. Furthermore, cells reacted to film nanocharacteristics and especially to the orientation of fibrils/fibers. The investigation of the influence that the substrate nanotopography has on cells will help to elucidate the mechanisms of cell-biomaterial interactions, and will enable the design of intelligent coatings for implants and tissue engineering purposes. (c) 2013 Society of Photo-Optical Instrumentation Engineers (SPIE)
C1 [Stylianou, Andreas; Yova, Dido; Alexandratou, Eleni] Natl Tech Univ Athens, Sch Elect & Comp Engn, Biomed Opt & Appl Biophys Lab, Athens 15780, Greece.
RP Stylianou, A (reprint author), Natl Tech Univ Athens, Sch Elect & Comp Engn, Biomed Opt & Appl Biophys Lab, Iroon Polytechiou 9, Athens 15780, Greece.
EM styliand@mail.ntua.gr
RI Stylianou, Andreas/B-9466-2014
OI Stylianou, Andreas/0000-0002-1641-1854
FU European Union (European Social Fund-ESF); Greek national funds through
   the Operational Program "Education and Lifelong Learning" of the
   National Strategic Reference Framework (NSRF)-Research Funding Program:
   Heracleitus II
FX The authors are grateful to Dr. D. Kletsas from the Laboratory of Cell
   Proliferation and Ageing, National Centre for Scientific Research
   "Demokritos," for kindly providing the human fibroblast primary cell
   line. This research has been co-financed by the European Union (European
   Social Fund-ESF) and Greek national funds through the Operational
   Program "Education and Lifelong Learning" of the National Strategic
   Reference Framework (NSRF)-Research Funding Program: Heracleitus II.
   Investigating in knowledge society through the European Social Fund.
CR Alexandratou E, 2002, PHOTOCH PHOTOBIO SCI, V1, P547, DOI 10.1039/b110213n
   Allison DP, 2010, WIRES NANOMED NANOBI, V2, P618, DOI 10.1002/wnan.104
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Biino GG, 1998, PHYS CHEM MINER, V25, P168, DOI 10.1007/s002690050100
   Brouwer KM, 2011, J TISSUE ENG REGEN M, V5, P501, DOI 10.1002/term.397
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   Cisneros DA, 2007, SMALL, V3, P956, DOI 10.1002/smll.200600598
   Dupont-Gillain CC, 2001, LANGMUIR, V17, P7261, DOI 10.1021/la010042g
   Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091
   Fratzl P., 2008, COLLAGEN STRUCTURE M, P506
   Gagner JE, 2012, J PHYS CHEM LETT, V3, P3149, DOI 10.1021/jz301253s
   Grant CA, 2012, J MECH BEHAV BIOMED, V5, P165, DOI 10.1016/j.jmbbm.2011.08.020
   Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Hou S, 2009, ANAL BIOANAL CHEM, V394, P2111, DOI 10.1007/s00216-009-2892-8
   Hsu YM, 2009, J BIOMED MATER RES B, V91B, P737, DOI 10.1002/jbm.b.31450
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Jiang FZ, 2004, J STRUCT BIOL, V148, P268, DOI 10.1016/j.jsb.2004.07.001
   Jiang FZ, 2004, MICROSC RES TECHNIQ, V64, P435, DOI 10.1002/jemt.20101
   Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453
   KADLER KE, 1987, J BIOL CHEM, V262, P15696
   Keresztes Z, 2006, J BIOMED MATER RES A, V76A, P223, DOI 10.1002/jbm.a.30472
   Klocek J, 2012, THIN SOLID FILMS, V520, P2498, DOI 10.1016/j.tsf.2011.10.026
   Kontomaris S. V., 2012, P 2012 IEEE 12 INT C, P608
   Koutsopoulos S, 2012, ADV DRUG DELIVER REV, V64, P1459, DOI 10.1016/j.addr.2012.08.002
   Lee GJ, 2011, J NANOSCI NANOTECHNO, V11, P773, DOI 10.1166/jnn.2011.3275
   Liang ZH, 2010, SCANNING, V32, P104, DOI 10.1002/sca.20189
   Livingston FE, 2009, PROC SPIE, V7321, DOI 10.1117/12.818170
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Mandal A., 2010, BIOL ENG, V2, P63
   Morris V. J., 2008, ATOMIC FORCE MICROSC, P332
   Mulley S, 1996, J MATER CHEM, V6, P661, DOI 10.1039/jm9960600661
   Phong HQ, 2010, MATER SCI ENG B-ADV, V169, P94, DOI 10.1016/j.mseb.2010.01.009
   Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012
   Poole K, 2005, J MOL BIOL, V349, P380, DOI 10.1016/j.jmb.2005.03.064
   Popescu LM, 2011, MATER LETT, V65, P2032, DOI 10.1016/j.matlet.2011.04.028
   Popescu R, 2010, MOL CRYST LIQ CRYST, V522, P529, DOI 10.1080/15421401003722757
   Rainey JK, 2002, PROTEIN SCI, V11, P2748, DOI 10.1110/ps.0218502
   Reungpatthanaphong P, 2003, J BIOCHEM BIOPH METH, V57, P1, DOI 10.1016/S0165-022X(03)00032-0
   Rezakhaniha R., 2011, BIOMECH MODEL MECHAN, V11, P1
   Sawhney RK, 2002, J CELL BIOL, V157, P1083, DOI 10.1083/jcb.200203069
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Silver FH, 2009, J ENG FIBER FABR, V4, P9
   Stylianou A, 2012, EMERGING TECHNOLOGIES IN NON-DESTRUCTIVE TESTING V, P415
   Stylianou A, 2013, PROC SPIE, V8594, DOI 10.1117/12.2002460
   Stylianou A, 2011, BIOMED SIGNAL PROCES, V6, P307, DOI 10.1016/j.bspc.2011.02.006
   Stylianou A., 2012, P 2010 IEEE 12 INT C, P602, DOI DOI 10.1109/BIBE.2012.6399741
   Stylianou A., 2011, IFMBE P, V37, P1058
   Stylianou A, 2010, IFMBE P, V29, P612, DOI [10.1007/978-3-642-13039-7_154, DOI 10.1007/978-3-642-13039-7_154]
   Stylianou A, 2013, MAT SCI ENG C-MATER, V33, P2947, DOI 10.1016/j.msec.2013.03.029
   Su HW, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4726119
   Sun M, 2008, LANGMUIR, V24, P5418, DOI 10.1021/la703292h
   Sun YJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/11/115604
   Sun YJ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2832322
   Tay CY, 2011, SMALL, V7, P1361, DOI 10.1002/smll.201100046
   Tenboll A, 2010, LANGMUIR, V26, P12165, DOI 10.1021/la1018136
   Tsai SW, 2010, J TAIWAN INST CHEM E, V41, P247, DOI 10.1016/j.jtice.2009.10.002
   Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z
   Wallace JM, 2011, J STRUCT BIOL, V173, P146, DOI 10.1016/j.jsb.2010.08.003
   Yang H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001325
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
NR 66
TC 11
Z9 11
U1 2
U2 32
PU SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1934-2608
J9 J NANOPHOTONICS
JI J. Nanophotonics
PD JUN 25
PY 2013
VL 7
AR 073590
DI 10.1117/1.JNP.7.073590
PG 16
WC Nanoscience & Nanotechnology; Optics
SC Science & Technology - Other Topics; Optics
GA 170IO
UT WOS:000320843800001
DA 2018-10-20
ER

PT J
AU Kim, MJ
   Lim, HJ
   Lee, BG
   Kim, JH
   Choi, J
   Kang, HG
AF Kim, Mi-Ju
   Lim, Hee-Joung
   Lee, Byung Gun
   Kim, Jong-Hoon
   Choi, Jinsub
   Kang, Hee-Gyoo
TI Establishment of Validation Methods to Test the Biocompatibility of
   Titanium Dioxide
SO BULLETIN OF THE KOREAN CHEMICAL SOCIETY
LA English
DT Article
DE Biomaterials; Titanium dioxide; Biocompatibility; Validation;
   Conditioned media
ID FIBROBLAST-GROWTH-FACTOR; MARROW STROMAL CELLS; SOLAR-CELLS; OSTEOBLAST
   DIFFERENTIATION; COLONY FORMATION; NANOTUBE ARRAYS; TIO2; BONE;
   SURFACES; REPLACEMENT
AB Most of biomaterials come in direct contact with the body, making standardized methods of evaluation and validation of biocompatibility an important aspect to biomaterial development. However, biomaterial validation guidelines have not been fully established, until now. This study was to compare the in vitro behavior of osteoblasts cultured on nanomaterial TiO2 surfaces to osteoblast behavior on culture plates. Comparisons were also made to cells grown in conditioned media (CM) that creates an environment similar to the in vivo environment. Comparisons were made between the different growth conditions for osteoblast adhesion, proliferation, differentiation, and functionality. We found that the in vivo-like system of growing cells in concentrated CM provided a good validation method for biomaterial development and in vivo implant therapy. The TiO2 materials were biocompatible, showing similar behavior to that observed in vivo. This study provided valuable information that would aid in the creation of guidelines into standardization and evaluation of biocompatibility in TiO2 biomaterials.
C1 [Kim, Mi-Ju; Kang, Hee-Gyoo] Eulji Univ, Coll Hlth Sci, Dept Biomed Lab Sci, Songnam 461713, South Korea.
   [Lim, Hee-Joung; Kim, Jong-Hoon] Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Lab Stem Cell & Tissue Regenerat, Seoul, South Korea.
   [Lee, Byung Gun; Choi, Jinsub] Inha Univ, Dept Chem Engn & Biotechnol, Inchon 402751, South Korea.
RP Choi, J (reprint author), Inha Univ, Dept Chem Engn & Biotechnol, Inchon 402751, South Korea.
EM jinsub@inha.ac.kr; kanghg@eulji.ac.kr
RI Choi, Jinsub/D-7131-2012; Kim, Jong-Hoon/H-1476-2015
FU Bio-Medtech Regional Innovation Center at Eulji University under the
   Regional Innovation Center Program of Ministry of Commerce, Industry and
   Energy
FX This work was supported by the Bio-Medtech Regional Innovation Center at
   Eulji University, under the Regional Innovation Center Program of
   Ministry of Commerce, Industry and Energy.
CR Akemichi U., 2001, MATRIX BIOL, V20, P347
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Albu SP, 2007, NANO LETT, V7, P1286, DOI 10.1021/nl070264k
   Barbara B. D., 2001, ANN REV MATER RES, V31, P357
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Bruijin J. D., 1992, J BIOMED MATER RES, V26, P1365
   Davies John E, 2003, J Dent Educ, V67, P932
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Gary S., 1993, ENDOCRINE, V14, P424
   Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032
   HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562
   Jia YY, 2007, J NANOSCI NANOTECHNO, V7, P458, DOI 10.1166/jnn.2007.132
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774
   Kim JH, 2010, J NANOSCI NANOTECHNO, V10, P3581, DOI 10.1166/jnn.2010.2235
   Kislyuk VV, 2008, J NANOSCI NANOTECHNO, V8, P131, DOI 10.1166/jnn.2008.N16
   Laintinen M., 1999, LIFE SCI, V64, P847
   Lee D, 2009, BONE, V44, pS276, DOI 10.1016/j.bone.2009.03.488
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Liu SQ, 2005, LANGMUIR, V21, P8409, DOI 10.1021/la050875x
   Mahmoudifar N, 2005, BIOMATERIALS, V26, P7012, DOI 10.1016/j.biomaterials.2005.04.062
   MCGEERUSSELL SM, 1958, J HISTOCHEM CYTOCHEM, V6, P22, DOI 10.1177/6.1.22
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Paul J., 2001, CURR PHARM DESIGN, V7, P613
   Paulose M, 2006, J PHYS CHEM B, V110, P16179, DOI 10.1021/jp064020k
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Saral A., 1993, J BONE MINER RES, V8, P157
   Scutt A, 1999, CALCIFIED TISSUE INT, V64, P69, DOI 10.1007/s002239900581
   Seunghan Oh., 2006, J BIOMED MATER RES A, V78, P97
   Shankar K, 2007, LANGMUIR, V23, P12445, DOI 10.1021/la7020403
   Spector JA, 2002, PLAST RECONSTR SURG, V109, P631, DOI 10.1097/00006534-200202000-00033
   Su HL, 2008, BIOMACROMOLECULES, V9, P499, DOI 10.1021/bm700993m
   Szebenyi G, 1999, INT REV CYTOL, V185, P45
   Varghese OK, 2003, J NANOSCI NANOTECHNO, V3, P277, DOI 10.1166/jnn.2003.158
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Wei-qiang Y., 2010, J BIOMED MATER RES, V4, P1012
   Zhang X, 2002, BIOCHEM BIOPH RES CO, V290, P526, DOI 10.1006/bbrc.2001.6217
   Zhu K, 2007, NANO LETT, V7, P69, DOI 10.1021/nl062000o
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 45
TC 4
Z9 4
U1 0
U2 25
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1229-5949
J9 B KOREAN CHEM SOC
JI Bull. Korean Chem. Soc.
PD JUN 20
PY 2013
VL 34
IS 6
BP 1857
EP 1863
DI 10.5012/bkcs.2013.34.6.1857
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 175MH
UT WOS:000321234300044
OA Bronze
DA 2018-10-20
ER

PT J
AU Trescher, K
   Roch, T
   Cui, J
   Kratz, K
   Lendlein, A
   Jung, F
AF Trescher, Karoline
   Roch, Toralf
   Cui, Jing
   Kratz, Karl
   Lendlein, Andreas
   Jung, Friedrich
TI Test system for evaluating the influence of polymer properties on
   primary human keratinocytes and fibroblasts in mono- and coculture
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Keratinocytes; Fibroblasts; Coculture; Poly(n-butyl acrylate) networks;
   Biomaterial characterization
ID POLY(N-BUTYL ACRYLATE) NETWORKS; HUMAN EPIDERMAL-KERATINOCYTES;
   SUBSTRATE STIFFNESS; HUMAN ARTERIES; CELLS; CYTOKINES; SKIN;
   DIFFERENTIATION; PROLIFERATION; INTERLEUKIN-6
AB Interactions of cells with polymer-based biomaterials are influenced by properties of the substrate. Polymers, which are able to induce cell specific effects, gain increasing importance for biotechnology and regenerative therapies. A test system was developed, which allows studying primary human keratinocytes and fibroblasts in mono-and cocultures to analyze and operate the effect of polymer properties. This system offers to identify polymers for keratinocyte cultivation or wound dressings, since adherence, viability and functionality can be analyzed. Especially the coculture system enables the characterization of potential cell specific effects of polymer-based biomaterials. To establish a coculture test system, it is challenging to find a suitable culture medium, to identify initial seeding densities for comparable cell growth and to develop methods to distinguish and characterize both cell types.
   Poly(n-butyl acrylate) networks (cPnBAs) as model biomaterials were used to demonstrate the applicability of our newly developed coculture screening system for differential cell growth. The apparent Young's modulus of the cPnBAs differentially regulated fibroblasts and keratinocytes. Particularly, cPnBA73 with an apparent Young's modulus of 930 +/- 140 kPa measured in phosphate buffered saline (PBS) solution at ambient temperature seemed to have favoring properties for keratinocyte adhesion, while fibroblast adhesion was not affected. For keratinocytes the concentration of some pro-inflammatory cytokines was lower on cPnBA73 and a decreased deposition of collagen, elastin and fibronectin was observed in the coculture. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Trescher, Karoline; Roch, Toralf; Cui, Jing; Kratz, Karl; Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Trescher, Karoline; Roch, Toralf; Cui, Jing; Kratz, Karl; Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Roch, Toralf; Kratz, Karl; Lendlein, Andreas; Jung, Friedrich] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Roch, Toralf/K-9531-2013; Jung, Friedrich/L-1301-2013; Kratz,
   Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Kratz, Karl/0000-0002-9229-4266;
   Lendlein, Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU Bundesministerium fur Bildung und Forschung [0313910, 0315696A];
   Berlin-Brandenburg School for Regenerative Therapies DFG-GSC [203]
FX The authors thank the Bundesministerium fur Bildung und Forschung for
   financial support through grant no. 0313910 (Berlin Brandenburg Center
   for Regenerative Therapies) and grant no. 0315696A (Poly4BioBB). K. T.
   is grateful to the Berlin-Brandenburg School for Regenerative Therapies
   DFG-GSC 203 for a fellowship.
CR Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241
   Apte RN, 1995, FOLIA MICROBIOL, V40, P392, DOI 10.1007/BF02814747
   Braune S, 2011, CLIN HEMORHEOL MICRO, V49, P375, DOI 10.3233/CH-2011-1487
   Corsini E, 1998, TOXICOL LETT, V103, P277, DOI 10.1016/S0378-4274(98)00323-3
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Grone A, 2002, VET IMMUNOL IMMUNOP, V88, P1, DOI 10.1016/S0165-2427(02)00136-8
   GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Jiang YZ, 2011, J TISSUE ENG REGEN M, V5, P402, DOI 10.1002/term.332
   Jubin K, 2011, CYTOTECHNOLOGY, V63, P655, DOI 10.1007/s10616-011-9382-5
   Kanitakis J, 2002, EUR J DERMATOL, V12, P390
   Kubo K, 2005, ARTIF ORGANS, V29, P845, DOI 10.1111/j.1525-1594.2005.00138.x
   Lammers G, 2009, BIOMATERIALS, V30, P6213, DOI 10.1016/j.biomaterials.2009.07.050
   Mayer A, 2012, ARTIF ORGANS, V36, pE28, DOI 10.1111/j.1525-1594.2011.01410.x
   MCKENZIE RC, 1990, J INVEST DERMATOL, V95, pS105, DOI 10.1111/1523-1747.ep12874955
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0
   Roch T, 2012, CLIN HEMORHEOL MICRO, V50, P131, DOI 10.3233/CH-2010-1449
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Shirakata Y, 2010, J DERMATOL SCI, V59, P73, DOI 10.1016/j.jdermsci.2010.05.002
   Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x
   Stoppato M, 2013, J TISSUE ENG REGEN M, V7, P161, DOI 10.1002/term.516
   Trescher K, 2012, EXP DERMATOL, V21, pe8
   Trescher K, 2012, CLIN HEMORHEOL MICRO, V52, P391, DOI 10.3233/CH-2012-1613
   WAELTI ER, 1992, J INVEST DERMATOL, V98, P805, DOI 10.1111/1523-1747.ep12499961
   Wang Y, 2012, BURNS, V38, P414, DOI 10.1016/j.burns.2011.09.002
   Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786
   WILMER JL, 1994, J INVEST DERMATOL, V102, P915, DOI 10.1111/1523-1747.ep12383512
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yoshikawa HY, 2012, J PHYS CHEM B, V116, P8024, DOI 10.1021/jp212385p
NR 34
TC 5
Z9 5
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD JUN 20
PY 2013
VL 166
IS 1-2
BP 58
EP 64
DI 10.1016/j.jbiotec.2013.04.012
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 167RO
UT WOS:000320651500009
PM 23643480
DA 2018-10-20
ER

PT J
AU Wang, XT
   Li, L
   Zhu, YB
   Du, YS
   Song, XR
   Chen, YX
   Huang, RL
   Que, HY
   Fang, XD
   Zhang, GF
AF Wang, Xiaotong
   Li, Li
   Zhu, Yabing
   Du, Yishuai
   Song, Xiaorui
   Chen, Yuanxin
   Huang, Ronglian
   Que, Huayong
   Fang, Xiaodong
   Zhang, Guofan
TI Oyster Shell Proteins Originate from Multiple Organs and Their Probable
   Transport Pathway to the Shell Formation Front
SO PLOS ONE
LA English
DT Article
ID EASTERN OYSTER; MINERALIZATION; INTERFACE; MOLLUSK; MATRIX; NACRE
AB Mollusk shell is one kind of potential biomaterial, but its vague mineralization mechanism hinders its further application. Mollusk shell matrix proteins are important functional components that are embedded in the shell, which play important roles in shell formation. The proteome of the oyster shell had been determined based on the oyster genome sequence by our group and gives the chance for further deep study in this area. The classical model of shell formation posits that the shell proteins are mantle-secreted. But, in this study, we further analyzed the shell proteome data in combination with organ transcriptome data and we found that the shell proteins may be produced by multiple organs though the mantle is still the most important organ for shell formation. To identify the transport pathways of these shell proteins not in classical model of shell formation, we conducted a shell damage experiment and we determined the shell-related gene set to identify the possible transport pathways from multiple organs to the shell formation front. We also found that there may exist a remodeling mechanism in the process of shell formation. Based on these results along with some published results, we proposed a new immature model, which will help us think about the mechanism of shell formation in a different way.
C1 [Wang, Xiaotong; Li, Li; Du, Yishuai; Song, Xiaorui; Huang, Ronglian; Que, Huayong; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.
   [Zhu, Yabing; Chen, Yuanxin; Fang, Xiaodong] BGI Shenzhen, Shenzhen, Peoples R China.
RP Zhang, GF (reprint author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.
EM gfzhang@qdio.ac.cn
RI FANG, xiaodong/K-6743-2018
OI FANG, xiaodong/0000-0001-7061-3337
FU National Basic Research Program of China (973 Program) [2010CB126401];
   National Natural Science Foundation of China [40730845]; National High
   Technology Research and Development Program (863 program)
   [2012AA10A405]; Mollusc Research and Development Center; CARS [CARS-48];
   Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar
   Program of Shandong
FX This research was supported by National Basic Research Program of China
   (973 Program, No. 2010CB126401), the National Natural Science Foundation
   of China (no. 40730845), National High Technology Research and
   Development Program (863 program, 2012AA10A405), Mollusc Research and
   Development Center, CARS (CARS-48), Taishan Scholars Climbing Program of
   Shandong and Oversea Taishan Scholar Program of Shandong. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019
   Chen SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008613
   CRENSHAW MA, 1969, AM ZOOL, V9, P881
   Duplat D, 2007, BIOMATERIALS, V28, P4769, DOI 10.1016/j.biomaterials.2007.07.036
   Ficai M, 2010, REV ROM MATER, V40, P359
   Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011
   Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198
   Geist J, 2008, J MOLLUS STUD, V74, P337, DOI 10.1093/mollus/eyn025
   GORDON J, 1978, SCIENCE, V202, P519, DOI 10.1126/science.202.4367.519
   Johnstone MB, 2008, J EXP ZOOL PART B, V310B, P227, DOI 10.1002/jez.b.21206
   Lao YX, 2007, COMP BIOCHEM PHYS B, V148, P201, DOI 10.1016/j.cbpb.2007.05.010
   Liu HL, 2007, BIOCHEMISTRY-US, V46, P844, DOI 10.1021/bi061881a
   Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8
   Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6
   Mount A, 2009, J ENVIRON MANAGE, V91, P168, DOI 10.1016/j.jenvman.2009.08.002
   Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506
   Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   Wang X SX, 2012, ISRAELI J AQUACULTUR
   Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413
NR 20
TC 17
Z9 18
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 19
PY 2013
VL 8
IS 6
AR e66522
DI 10.1371/journal.pone.0066522
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 190ST
UT WOS:000322361200091
PM 23840499
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sakata, T
   Fukuda, R
AF Sakata, Toshiya
   Fukuda, Ryushi
TI Simultaneous Biosensing with Quartz Crystal Microbalance with a
   Dissipation Coupled-Gate Semiconductor Device
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID FIELD-EFFECT TRANSISTOR; CELL; ADSORPTION; ELECTRODE
AB In this study, we proposed and demonstrated a novel simultaneous analysis system of biosensing by combining a semiconductor-based field effect transistor (FET) with quartz crystal microbalance with a dissipation (QCM-D) monitoring system. Using the combined system, the changes of not only mass and viscoelasticity but also electrical charge for interaction of charged dextran molecules with substrate, recognition of glucose with low molecular weight, and programmed cell death, apoptosis, were simultaneously and quantitatively monitored in a label-free and real-time manner. The combined system will give more detailed information of biomolecule/substrate interface for development of new biomaterial.
C1 [Sakata, Toshiya] Univ Tokyo, Dept Mat Engn, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Fukuda, Ryushi] Meiwafosis Co Ltd, Shinjuku Ku, Tokyo 1600022, Japan.
RP Sakata, T (reprint author), Univ Tokyo, Dept Mat Engn, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM sakata@biofet.t.u-tokyo.ac.jp
RI Sakata, Toshiya/I-2804-2016
FU Core Research for Evolutional Science and Technology (CREST) of Japan
   Science and Technology (JST)
FX The authors wish to thank Drs. Michael Rodal, Peter Svensson, Fredrik
   Pettersson and Jennie Wikstrom of Biolin Scientific in Sweden for their
   help and useful discussions. A part of this study was supported by Core
   Research for Evolutional Science and Technology (CREST) of Japan Science
   and Technology (JST).
CR BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688
   COVEY TR, 1985, ANAL CHEM, V57, P474, DOI 10.1021/ac50001a036
   Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873
   Fatisson J, 2011, BIOSENS BIOELECTRON, V26, P3207, DOI 10.1016/j.bios.2010.12.027
   FROMHERZ P, 1991, SCIENCE, V252, P1290, DOI 10.1126/science.1925540
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   Jain KK, 2001, SCIENCE, V294, P621, DOI 10.1126/science.294.5542.621
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Matsumoto A, 2009, J SOLID STATE ELECTR, V13, P165, DOI 10.1007/s10008-008-0610-7
   Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x
   Reimhult E, 2002, J CHEM PHYS, V117, P7401, DOI 10.1063/1.1515320
   Rezek B, 2010, BIOSENS BIOELECTRON, V26, P1307, DOI 10.1016/j.bios.2010.07.027
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Sakata T, 2006, ANGEW CHEM INT EDIT, V45, P2225, DOI 10.1002/anie.200503154
   Sakata T, 2005, JPN J APPL PHYS 1, V44, P2854, DOI 10.1143/JJAP.44.2854
   Sakata T, 2005, JPN J APPL PHYS 1, V44, P2860, DOI 10.1143/JJAP.44.2860
   Sakata T, 2008, ANAL CHEM, V80, P1493, DOI 10.1021/ac701977e
   Sakata T, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.017001
   Sakata T, 2009, ANAL CHEM, V81, P7532, DOI 10.1021/ac900457m
   Straub B, 2001, NAT BIOTECHNOL, V19, P121, DOI 10.1038/84369
   UPDIKE SJ, 1967, NATURE, V214, P986, DOI 10.1038/214986a0
NR 21
TC 10
Z9 10
U1 0
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD JUN 18
PY 2013
VL 85
IS 12
BP 5796
EP 5800
DI 10.1021/ac400468m
PG 5
WC Chemistry, Analytical
SC Chemistry
GA 169AL
UT WOS:000320749200028
PM 23662927
DA 2018-10-20
ER

PT J
AU Howorka, S
AF Howorka, Stefan
TI DNA Nanoarchitectonics: Assembled DNA at Interfaces
SO LANGMUIR
LA English
DT Article
ID NUCLEIC-ACID NANOSTRUCTURES; INDIUM TIN OXIDE; PROTEIN-PROTEIN
   INTERACTIONS; DIP-PEN NANOLITHOGRAPHY; GOLD NANOPARTICLES; BIOLOGICAL
   APPLICATIONS; POLY(ETHYLENE GLYCOL); NANOMETER-SCALE; NANOCOMPONENT
   ARRAYS; SURFACE INTERACTIONS
AB DNA is a powerful biomaterial for creating rationally designed and functionally enhanced nanostructures. DNA nanoarchitectures positioned at substrate interfaces can offer unique advantages leading to improved surface properties relevant to biosensing, nanotechnology, materials science, and cell biology. This Perspective highlights the benefits and challenges of using assembled DNA as a nanoscale building block for interfacial layers and surveys their applications in three areas: homogeneous dense surface coatings, bottom-up nanopatterning, and 3D nanoparticle lattices. Possible future research developments are discussed at the end of the Perspective.
C1 Univ London Univ Coll, Inst Struct Mol Biol, Dept Chem, London WC1H 0AJ, England.
RP Howorka, S (reprint author), Univ London Univ Coll, Inst Struct Mol Biol, Dept Chem, Torrington Pl, London WC1H 0AJ, England.
EM s.howorka@ucl.ac.uk
OI Howorka, Stefan/0000-0002-6527-2846
FU Leverhulme Trust [RPG-170]
FX This project was supported by the Leverhulme Trust (project RPG-170).
CR Agheli H, 2006, NANO LETT, V6, P1165, DOI 10.1021/nl060403i
   Aldaye FA, 2008, SCIENCE, V321, P1795, DOI 10.1126/science.1154533
   Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971
   Anikin K, 2005, J PHYS CHEM B, V109, P5418, DOI 10.1021/jp0506282
   Appleyard SFJ, 2000, J MATER CHEM, V10, P169, DOI 10.1039/a903708j
   Ariga K, 2010, ADV COLLOID INTERFAC, V154, P20, DOI 10.1016/j.cis.2010.01.005
   Baker LA, 2008, NAT NANOTECHNOL, V3, P73, DOI 10.1038/nnano.2008.13
   Bald I, 2011, SMALL, V7, P939, DOI 10.1002/smll.201002033
   Banwell EF, 2009, NAT MATER, V8, P596, DOI [10.1038/nmat2479, 10.1038/NMAT2479]
   Bellini T, 2012, TOP CURR CHEM, V318, P225, DOI 10.1007/128_2011_230
   Bermudez VM, 2006, LANGMUIR, V22, P11113, DOI 10.1021/la061578a
   Biswas A, 2012, ADV COLLOID INTERFAC, V170, P2, DOI 10.1016/j.cis.2011.11.001
   Borjesson K, 2011, ANGEW CHEM INT EDIT, V50, P8312, DOI 10.1002/anie.201103338
   Browne KP, 2011, LANGMUIR, V27, P1246, DOI 10.1021/la103960q
   Brubaker CE, 2012, LANGMUIR, V28, P2200, DOI 10.1021/la300044v
   Bruckbauer A, 2002, J AM CHEM SOC, V124, P8810, DOI 10.1021/ja026816c
   Carneiro KMM, 2010, J AM CHEM SOC, V132, P679, DOI 10.1021/ja907735m
   Caro A, 2009, J PHYS CHEM B, V113, P2101, DOI 10.1021/jp805284s
   Castronovo M, 2008, NANO LETT, V8, P4140, DOI 10.1021/nl802370g
   Chhabra R, 2007, J AM CHEM SOC, V129, P10304, DOI 10.1021/ja072410u
   Chhabra R, 2010, ADV DRUG DELIVER REV, V62, P617, DOI 10.1016/j.addr.2010.03.005
   Christman KL, 2006, SOFT MATTER, V2, P928, DOI 10.1039/b611000b
   Cigler P, 2010, NAT MATER, V9, P918, DOI [10.1038/NMAT2877, 10.1038/nmat2877]
   Cui L, 2008, ACS NANO, V2, P921, DOI 10.1021/nn800177v
   Cutler JI, 2011, J AM CHEM SOC, V133, P9254, DOI 10.1021/ja203375n
   Delamarche E, 2003, LANGMUIR, V19, P8749, DOI 10.1021/la034370n
   Ding BQ, 2010, NANO LETT, V10, P5065, DOI 10.1021/nl1033073
   Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436
   Endo M, 2010, CHEM-EUR J, V16, P5362, DOI 10.1002/chem.200903057
   Fan JA, 2011, NANO LETT, V11, P4859, DOI 10.1021/nl203194m
   Fu JL, 2012, ACCOUNTS CHEM RES, V45, P1215, DOI 10.1021/ar200295q
   Fujibayashi K, 2008, NANO LETT, V8, P1791, DOI 10.1021/nl0722830
   Ge BX, 2010, ANGEW CHEM INT EDIT, V49, P9965, DOI 10.1002/anie.201004946
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Gietl A., 2012, NUCLEIC ACIDS RES, V40, pe110
   Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608
   Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367
   Goodman RP, 2004, CHEM COMMUN, P1372, DOI 10.1039/b402293a
   Goodman RP, 2008, NAT NANOTECHNOL, V3, P93, DOI 10.1038/nnano.2008.3
   Grainger DW, 2009, NAT NANOTECHNOL, V4, P543, DOI 10.1038/nnano.2009.249
   Gu HZ, 2009, NAT NANOTECHNOL, V4, P245, DOI [10.1038/NNANO.2009.5, 10.1038/nnano.2009.5]
   Hazen RM, 2003, NAT MATER, V2, P367, DOI 10.1038/nmat879
   He Y, 2006, J AM CHEM SOC, V128, P12664, DOI 10.1021/ja065467+
   Helmig S, 2010, ACS NANO, V4, P7475, DOI 10.1021/nn102701f
   Hill HD, 2009, NANO LETT, V9, P1283, DOI 10.1021/nl900320p
   Howorka S, 2011, CURR OPIN BIOTECH, V22, P485, DOI 10.1016/j.copbio.2011.05.003
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Hung AM, 2010, NANOSCALE, V2, P2530, DOI 10.1039/c0nr00430h
   Hung AM, 2010, NAT NANOTECHNOL, V5, P121, DOI [10.1038/nnano.2009.450, 10.1038/NNANO.2009.450]
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kaiser W, 2010, J AM CHEM SOC, V132, P7935, DOI 10.1021/ja908727d
   Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082
   Kelley SO, 1998, LANGMUIR, V14, P6781, DOI 10.1021/la980874n
   Kershner RJ, 2009, NAT NANOTECHNOL, V4, P557, DOI [10.1038/NNANO.2009.220, 10.1038/nnano.2009.220]
   Kim AJ, 2009, NAT MATER, V8, P52, DOI 10.1038/NMAT2338
   Kim HJ, 2010, LANGMUIR, V26, P18315, DOI 10.1021/la101086h
   Kira A, 2009, LANGMUIR, V25, P1285, DOI 10.1021/la803385x
   Koyfman AY, 2009, J AM CHEM SOC, V131, P14237, DOI 10.1021/ja9015638
   Kufer SK, 2008, SCIENCE, V319, P594, DOI 10.1126/science.1151424
   Lalander CH, 2010, ACS NANO, V4, P6153, DOI 10.1021/nn101431k
   Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c
   Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   Leitner M, 2011, ACS NANO, V5, P7048, DOI 10.1021/nn201705p
   Li HW, 2003, LANGMUIR, V19, P1963, DOI 10.1021/la0269098
   Lin C., 2009, NAT NANOTECHNOL, V4, P249
   LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018
   Liu M, 2010, NAT NANOTECHNOL, V5, P570, DOI [10.1038/nnano.2010.128, 10.1038/NNANO.2010.128]
   Liu MZ, 2005, LANGMUIR, V21, P1972, DOI 10.1021/la047586d
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Lu N, 2012, J AM CHEM SOC, V134, P13148, DOI 10.1021/ja302447r
   Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012
   Luo C., 2004, NUCL ACIDS RES, V32, pe144
   Ma N, 2009, NAT NANOTECHNOL, V4, P121, DOI [10.1038/nnano.2008.373, 10.1038/NNANO.2008.373]
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   Mei QA, 2011, NANO LETT, V11, P1477, DOI 10.1021/nl1040836
   Mendes PM, 2007, NANOSCALE RES LETT, V2, P373, DOI 10.1007/s11671-007-9083-3
   Michel R, 2002, LANGMUIR, V18, P8580, DOI 10.1021/la0258244
   Mirkin C., 2007, NANOBIOTECHNOLOGY
   Mirmomtaz E, 2008, NANO LETT, V8, P4134, DOI 10.1021/nl802722k
   Mitchell N, 2009, ANGEW CHEM INT EDIT, V48, P525, DOI 10.1002/anie.200804264
   Moyano DF, 2011, LANGMUIR, V27, P10376, DOI 10.1021/la2004535
   Nandivadaa H., 2009, PROG POLYM SCI, V35, P141
   Nangreave J, 2010, CURR OPIN CHEM BIOL, V14, P608, DOI 10.1016/j.cbpa.2010.06.182
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Niemeyer C.M., 2004, NANOBIOTECHNOLOGY CO
   Noh H, 2011, SMALL, V7, P3021, DOI 10.1002/smll.201101212
   Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560
   Onses MS, 2011, ACS NANO, V5, P7899, DOI 10.1021/nn2021277
   Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998
   Pammer P, 2005, CHEMPHYSCHEM, V6, P900, DOI 10.1002/cphc.200400526
   Papapostolou D, 2009, MOL BIOSYST, V5, P723, DOI 10.1039/b902440a
   Papra A, 2001, LANGMUIR, V17, P4090, DOI 10.1021/la0016930
   Park SH, 2006, ANGEW CHEM INT EDIT, V45, P735, DOI 10.1002/anie.200503797
   Park SH, 2005, NANO LETT, V5, P729, DOI 10.1021/nl050175c
   Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508
   Pearson AC, 2011, NANO LETT, V11, P1981, DOI 10.1021/nl200306w
   Pei H, 2011, CHEM COMMUN, V47, P6254, DOI 10.1039/c1cc11660f
   Peterson AW, 2002, J AM CHEM SOC, V124, P14601, DOI 10.1021/ja0279996
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Pinto YY, 2005, NANO LETT, V5, P2399, DOI 10.1021/nl0515495
   Prigodich AE, 2010, J AM CHEM SOC, V132, P16296, DOI 10.1021/ja1087419
   Pu SY, 2011, LANGMUIR, V27, P5009, DOI 10.1021/la104984x
   Qamhieh K, 2009, BIOMACROMOLECULES, V10, P1720, DOI 10.1021/bm9000662
   Qing GY, 2010, J AM CHEM SOC, V132, P15228, DOI 10.1021/ja105246b
   Rakickas T, 2008, NANO LETT, V8, P3369, DOI 10.1021/nl801892m
   Reynolds NP, 2009, J AM CHEM SOC, V131, P896, DOI 10.1021/ja8079252
   Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Rundqvist J, 2006, LANGMUIR, V22, P5100, DOI 10.1021/la052306v
   Sacca B, 2012, ANGEW CHEM INT EDIT, V51, P58, DOI 10.1002/anie.201105846
   Sacca B, 2010, ANGEW CHEM INT EDIT, V49, P9378, DOI 10.1002/anie.201005931
   Sakakibara K, 2011, SMALL, V7, P1288, DOI 10.1002/smll.201002350
   Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197
   Schlapak R, 2006, LANGMUIR, V22, P277, DOI 10.1021/la0521793
   Schlapak R, 2007, LANGMUIR, V23, P10244, DOI 10.1021/la7011414
   Schlapak R, 2012, NANO LETT, V12, P1983, DOI 10.1021/nl2045414
   Schlapak R, 2012, SMALL, V8, P89, DOI 10.1002/smll.201101576
   Schlapak R, 2009, SOFT MATTER, V5, P4104, DOI 10.1039/b913836f
   Schlapak R, 2009, SOFT MATTER, V5, P613, DOI 10.1039/b815065f
   Schmid H, 2000, MACROMOLECULES, V33, P3042, DOI 10.1021/ma982034l
   Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244
   Sekula S, 2008, SMALL, V4, P1785, DOI 10.1002/smll.200800949
   Sharma J, 2008, ANGEW CHEM INT EDIT, V47, P5157, DOI 10.1002/anie.200801485
   Sharma J, 2008, J AM CHEM SOC, V130, P7820, DOI 10.1021/ja802853r
   Shen WQ, 2009, J AM CHEM SOC, V131, P6660, DOI 10.1021/ja901407j
   Spatz JP, 1999, ADV MATER, V11, P149, DOI 10.1002/(SICI)1521-4095(199902)11:2<149::AID-ADMA149>3.0.CO;2-W
   Stephanopoulos N, 2010, NANO LETT, V10, P2714, DOI 10.1021/nl1018468
   Suzuki K, 2009, J AM CHEM SOC, V131, P7518, DOI 10.1021/ja9011386
   Taylor ZR, 2009, LANGMUIR, V25, P10932, DOI 10.1021/la901512z
   Teller C, 2010, CURR OPIN BIOTECH, V21, P376, DOI 10.1016/j.copbio.2010.06.001
   Tinazli A, 2007, NAT NANOTECHNOL, V2, P220, DOI 10.1038/nnano.2007.63
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   Tong WJ, 2012, CHEM SOC REV, V41, P6103, DOI 10.1039/c2cs35088b
   Torring T., 2011, CHEM SOC REV, V40, P5636
   Truskett VN, 2006, TRENDS BIOTECHNOL, V24, P312, DOI 10.1016/j.tibtech.2006.05.005
   Vainrub A, 2011, J PHYS CHEM B, V115, P13300, DOI 10.1021/jp208141g
   Wen YL, 2011, ANAL CHEM, V83, P7418, DOI 10.1021/ac201491p
   Wickham SFJ, 2012, NAT NANOTECHNOL, V7, P169, DOI [10.1038/nnano.2011.253, 10.1038/NNANO.2011.253]
   Wickham SFJ, 2011, NAT NANOTECHNOL, V6, P166, DOI [10.1038/nnano.2010.284, 10.1038/NNANO.2010.284]
   Williams BAR, 2007, ANGEW CHEM INT EDIT, V46, P3051, DOI 10.1002/anie.200603919
   Xu W, 2010, ANGEW CHEM INT EDIT, V49, P9373, DOI 10.1002/anie.201003390
   Yan C, 2000, LANGMUIR, V16, P6208, DOI 10.1021/la000128a
   Yang XH, 2006, LANGMUIR, V22, P5654, DOI 10.1021/la052907m
   Yang Y, 2010, NANO LETT, V10, P1393, DOI 10.1021/nl100169p
   Yun JM, 2012, ANGEW CHEM INT EDIT, V51, P912, DOI 10.1002/anie.201106198
   Zhang C, 2012, J AM CHEM SOC, V134, P11998, DOI 10.1021/ja305969c
   Zhang JP, 2006, NANO LETT, V6, P248, DOI 10.1021/nl052210l
   Zhao Z, 2011, NANO LETT, V11, P2997, DOI 10.1021/nl201603a
   Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c
NR 151
TC 35
Z9 35
U1 3
U2 105
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 18
PY 2013
VL 29
IS 24
BP 7344
EP 7353
DI 10.1021/la3045785
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 169AB
UT WOS:000320748200022
PM 23373872
DA 2018-10-20
ER

PT J
AU Castilho, S
   Kiennemann, A
   Pereira, MFC
   Dias, APS
AF Castilho, Sara
   Kiennemann, Alain
   Costa Pereira, Manuel Francisco
   Soares Dias, Ana Paula
TI Sorbents for CO2 capture from biogenesis calcium wastes
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Carbon capture; CaO looping cycle; Carbon dioxide; Alimentary wastes;
   Natural sorbents
ID CARBON CAPTURE; OYSTER SHELLS; CYCLES; OXIDE
AB Egg shells, shellfish shells and cuttlefish bones, high calcium content alimentary wastes, were used to prepare CaO sorbents for CO2 capture. The materials were prepared by a simple procedure including two steps: crushing and calcination at 900 degrees C. Fine powders displaying chalky-white to pale grey-green shades were obtained depending on the starting material. All the prepared sorbents were microcrystalline limes containing various trace elements.
   The CO2 sorption ability of the obtained lime materials was assessed using cycle carbonation/calcination tests by thermogravimetry. The CO2 sorption profiles showed two regions: an initial region controlled by chemical reaction and a second region with diffusional control. The rate of chemical reaction of carbonation was almost invariant with the nature of the biomaterial used to produces the sorbent. The decarbonation (calcination step) was much faster than the carbonation for all the examined sorbents and also almost invariant with the sample. The diffusion rate depends on the calcite film thickness formed during chemical reaction controlled region.
   Results showed that alimentary wastes with high calcium content can be used to produces CO2 sorbents thus contributing to mitigate the anthropogenic carbon and the environment contamination with alimentary wastes. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Castilho, Sara; Soares Dias, Ana Paula] Univ Lisbon, ICEMS, Dept Chem Engn, Inst Super Tecn, P-1049001 Lisbon, Portugal.
   [Kiennemann, Alain] Univ Strasbourg, LMSPC, UMR 7515, F-67087 Strasbourg 2, France.
   [Costa Pereira, Manuel Francisco] Univ Lisbon, CEPGIST, Dept Civil Engn, Inst Super Tecn, P-1049001 Lisbon, Portugal.
RP Dias, APS (reprint author), Univ Lisbon, ICEMS, Dept Chem Engn, Inst Super Tecn, Av Rovisco Pais S-N, P-1049001 Lisbon, Portugal.
EM spncist@gmail.com; kiennemann@unistra.fr; mfcp@ist.utl.pt;
   apsoares@ist.utl.pt
RI Soares Dias, Ana Paula/J-6392-2012; Pereira, Manuel/H-7288-2012
OI Soares Dias, Ana Paula/0000-0002-4585-470X; Pereira,
   Manuel/0000-0002-7932-8062
CR [Anonymous], 2010, Patent No. [US 7,678,351 B2, 7678351, US7678351]
   [Anonymous], 2009, TECHN ROADM CARB CAP
   Broda M, 2012, ENVIRON SCI TECHNOL, V46, P10849, DOI 10.1021/es302757e
   Broda M, 2012, CHEMSUSCHEM, V5, P411, DOI 10.1002/cssc.201100468
   Carre M, 2006, GEOCHIM COSMOCHIM AC, V70, P4906, DOI 10.1016/j.gca.2006.07.019
   Chen C, 2012, MATER LETT, V75, P140, DOI 10.1016/j.matlet.2012.02.015
   Cousins A, 2011, INT J GREENH GAS CON, V5, P605, DOI 10.1016/j.ijggc.2011.01.002
   Cousins A, 2011, CHEM ENG RES DES, V89, P1237, DOI 10.1016/j.cherd.2011.02.008
   Ghommem M, 2012, ECOL MODEL, V235, P1, DOI 10.1016/j.ecolmodel.2012.04.005
   Herzog H., 2009, ADV POSTCOMBUSTION C
   Karami D, 2012, IND ENG CHEM RES, V51, P4567, DOI 10.1021/ie2024257
   Kotyczka-Moranska M, 2012, PHYSICOCHEM PROBL MI, V48, P77
   Kwon HB, 2004, RESOUR CONSERV RECY, V41, P75, DOI 10.1016/j.resconrec.2003.08.005
   Lee ZH, 2012, RENEW SUST ENERG REV, V16, P2599, DOI 10.1016/j.rser.2012.01.077
   Li YJ, 2009, CHEM ENG TECHNOL, V32, P1176, DOI 10.1002/ceat.200900008
   Lilliestam J, 2012, ENERG POLICY, V47, P447, DOI 10.1016/j.enpol.2012.05.020
   Liu WQ, 2012, ENERG FUEL, V26, P2751, DOI 10.1021/ef300220x
   Liu WQ, 2010, ENVIRON SCI TECHNOL, V44, P3093, DOI 10.1021/es903436v
   Lu H, 2009, ENERG FUEL, V23, P1093, DOI 10.1021/ef8007882
   Luo C, 2012, CHEM ENG TECHNOL, V35, P547, DOI 10.1002/ceat.201000299
   Ma KW, 2010, J AM CERAM SOC, V93, P221, DOI 10.1111/j.1551-2916.2009.03379.x
   Markusson N., 2012, TECHNOL FORECAST SOC, DOI DOI 10.1016/J.TECHF0RE.2011.12.010
   Mohamed M, 2012, J ENG SCI TECHNOL, V7, P1
   Rashidi NA, 2011, WASET, V60, P818
   Santos ET, 2012, FUEL, V94, P624, DOI 10.1016/j.fuel.2011.10.011
   SING KSW, 1982, PURE APPL CHEM, V54, P2201, DOI 10.1351/pac198254112201
   van Alphen K, 2010, RENEW SUST ENERG REV, V14, P971, DOI 10.1016/j.rser.2009.10.028
   Vieille L, 2012, POWDER TECHNOL, V228, P319, DOI 10.1016/j.powtec.2012.05.042
   Visakh PM, 2012, EXPRESS POLYM LETT, V6, P396, DOI 10.3144/expresspolymlett.2012.42
   YanqingZhu Y., 2011, CHEM CHEM ENG ENG J, V175, P512
   Yu FC, 2012, IND ENG CHEM RES, V51, P2133, DOI 10.1021/ie200802y
   Zhang L., 2012, PHYS CHEM CHEM PHYS
NR 32
TC 15
Z9 16
U1 3
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD JUN 15
PY 2013
VL 226
BP 146
EP 153
DI 10.1016/j.cej.2013.04.017
PG 8
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 177YR
UT WOS:000321411800020
DA 2018-10-20
ER

PT J
AU Krishnamoorthy, G
   Selvakumar, R
   Sastry, TP
   Mandal, AB
   Doble, M
AF Krishnamoorthy, Ganesan
   Selvakumar, Rajendran
   Sastry, Thotapalli Parvathaleswara
   Mandal, Asit Baran
   Doble, Mukesh
TI Effect of D-amino acids on collagen fibrillar assembly and stability:
   Experimental and modelling studies
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Collagen; Collagenase; Collagen like peptide; D-Amino acids
ID ACETATE BUFFER; CROSS-LINKING; DOCKING; PEPTIDES; PROTEOLYSIS;
   HYDRATION; CULTURE; LEATHER; MATRIX; DOMAIN
AB The effect of selected D-amino acids (D-AAs) on collagen with 1-ethyl-3-(3-dimethylamino propyl)carbodiimide (EDC)/N-hydroxysuccinimide (NHS) initiated crosslinking is evaluated by using experimental and modelling tools. The experimental results suggest that D-Lysine (D-Lys) plays a pivotal role in the self-assembly and conformation of collagen fibrils than D-Alanine (D-Ala) and D-Glutamic acid (D-Glu). The SDS-PAGE, absorption spectrum and viscosity measurements indicate significant differences in the D-Lys crosslinked collagen when compared to other systems. The CD spectra show an increase in the peak intensity at 220 nm in the presence of D-Lys, which could be due to increase in propensity of the structure to form a triple helix. Modelling studies indicated that D-Lys bind with collagen-like peptide (CLP) through multiple H-bonding and hydrophobic interactions. D-Lys has the lowest binding energy (-4.2 kcal/mol, indicating strongest interactions) when compared to D-Ala and D-Glu (-3.6 and -3.7 kcal/mol, respectively). Orientational changes in the collagenase on CLP-D-Lys are observed which may decrease its accessibility to degradation and stabilise CLP against the action of the former. D-Lys has the lowest binding energy and improved fibrillar-assembly and staggered alignment without the undesired structural stiffness and aggregations. The information derived from the present study could help in designing heterochiral collagen-based biomaterial. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Krishnamoorthy, Ganesan; Sastry, Thotapalli Parvathaleswara; Mandal, Asit Baran] Cent Leather Res Inst, CSIR, Bioproducts Lab, Madras 600020, Tamil Nadu, India.
   [Selvakumar, Rajendran; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Bioengn & Drug Design Lab, Madras 600036, Tamil Nadu, India.
RP Mandal, AB (reprint author), Cent Leather Res Inst, CSIR, Bioproducts Lab, Madras 600020, Tamil Nadu, India.
EM abmandal@hotmail.com
RI Mandal, Asit Baran/B-9977-2009
OI Doble, Mukeshd/0000-0002-4335-0698
FU Council of Scientific & Industrial Research (CSIR), New Delhi,
   Government of India
FX One of the authors (GK) acknowledges the Council of Scientific &
   Industrial Research (CSIR), New Delhi, Government of India, for CSIR-SRF
   fellowship.
CR Anil B, 2004, J AM CHEM SOC, V126, P13194, DOI 10.1021/ja047119i
   Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318
   Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185
   Everaerts F, 2008, J BIOMED MATER RES A, V85A, P547, DOI 10.1002/jbm.a.31524
   Friedman M, 2010, CHEM BIODIVERS, V7, P1491, DOI 10.1002/cbdv.200900225
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gurry T, 2010, BIOPHYS J, V98, P2634, DOI 10.1016/j.bpj.2010.01.065
   Hamamoto K, 2002, MICROBIOL IMMUNOL, V46, P741, DOI 10.1111/j.1348-0421.2002.tb02759.x
   Jarman-Smith M, 2004, BIOCHEM ENG J, V20, P217, DOI 10.1016/j.bej.2003.09.016
   Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200
   Khoshfetrat AB, 2009, BIOCHEM ENG J, V45, P60, DOI 10.1016/j.bej.2009.02.007
   Krishnamoorthy G, 2012, J HAZARD MATER, V215, P173, DOI 10.1016/j.jhazmat.2012.02.046
   Krishnamoorthy G, 2011, APPL BIOCHEM BIOTECH, V165, P1075
   Krishnamoorthy G, 2013, J CLEAN PROD, V42, P277, DOI 10.1016/j.jclepro.2012.11.004
   Krishnamoorthy G, 2013, J BIOMAT SCI-POLYM E, V24, P344, DOI 10.1080/09205063.2012.690280
   Krishnamoorthy G, 2013, J BIOMED MATER RES A, V101, P1173, DOI 10.1002/jbm.a.34411
   Latacz G, 2006, ACTA POL PHARM, V62, P430
   Liang GL, 2009, LANGMUIR, V25, P8419, DOI 10.1021/la804271d
   Luca G, 2010, CURR PHARM DESIGN, V16, P3185
   MANDAL AB, 1987, EUR J BIOCHEM, V169, P617, DOI 10.1111/j.1432-1033.1987.tb13653.x
   Mashiach E, 2010, PROTEINS, V78, P3197, DOI 10.1002/prot.22790
   Mogilner IG, 2002, J MOL GRAPH MODEL, V21, P209, DOI 10.1016/S1093-3263(02)00145-6
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Oh JE, 1999, BIOORGAN MED CHEM, V7, P2985, DOI 10.1016/S0968-0896(99)00247-3
   Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   ROSE C, 1988, BIOCHEM J, V249, P127, DOI 10.1042/bj2490127
   Rose C, 1996, INT J BIOL MACROMOL, V18, P41, DOI 10.1016/0141-8130(95)01054-8
   Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481
   Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397
   Shah NK, 1999, BIOPOLYMERS, V49, P297
   Shukla SC, 2012, BIOCHEM ENG J, V65, P70, DOI 10.1016/j.bej.2012.04.001
   Vaidyanathan J, 2001, BIOMATERIALS, V22, P2911, DOI 10.1016/S0142-9612(01)00038-2
   Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 37
TC 4
Z9 4
U1 1
U2 30
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1369-703X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD JUN 15
PY 2013
VL 75
BP 92
EP 100
DI 10.1016/j.bej.2013.04.002
PG 9
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 167IR
UT WOS:000320626200012
DA 2018-10-20
ER

PT J
AU Parameshwaran, R
   Kalaiselvam, S
   Jayavel, R
AF Parameshwaran, R.
   Kalaiselvam, S.
   Jayavel, R.
TI Green synthesis of silver nanoparticles using Beta vulgaris: Role of
   process conditions on size distribution and surface structure
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; Crystal structure; Nucleation; Nanostructures
ID GOLD NANOPARTICLES; LEAF EXTRACT; EXTRACELLULAR BIOSYNTHESIS; AQUEOUS
   EXTRACT; PARTICLE-SIZE; CITRUS-LIMON; REDUCTION; DISPERSIONS;
   DEGRADATION; EXTINCTION
AB The present work reports the green synthesis of silver nanoparticles, using Beta vulgaris peel extract with a subsequent investigation on the size distribution and surface structure of nanoparticles formed under various process conditions. The green-chemical reduction mechanism of silver ions to nanoparticles by the active organic functional groups present in the extract was characterized, using the respective spectroscopic techniques. The effects of various process parameters, including induced intraparticle ripening, were attributed to the controlled formation of anisotropic silver nanoparticles within the supporting matrix of the extract. The plasmon absorption and resonance scattering properties were expected to be favourable for small and larger size nanoparticles (below 25 nm and above 75 nm) respectively, which was considered to be an indicative aspect for synthesizing nanoparticles of narrow size distribution. The zeta potential and dynamic light scattering (DLS) results suggest the good stability and mono-dispersed size distribution of the silver nanoparticles. The transmission electron microscope, selective area electron diffraction (SAED) and X-ray diffraction studies infer that the nanoparticles formed were spherical/quasi-spherical in shape, which primarily exhibited a face centred cubic crystal (FCC) structure. The green-chemical reduction of organic phases in the extract (especially amine (NH2) groups) as reflected through shifts observed in the Fourier-transform infra red (FTIR) peaks, reveal the possible interaction of the organic molecules with the silver ions in the effective formation, surface modification and stabilization of the silver nanoparticles. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Parameshwaran, R.] Anna Univ, Dept Mech Engn, Madras 600025, Tamil Nadu, India.
   [Parameshwaran, R.; Kalaiselvam, S.; Jayavel, R.] Anna Univ, Ctr Nanosci & Technol, Madras 600025, Tamil Nadu, India.
   [Kalaiselvam, S.] Anna Univ, Dept Appl Sci & Technol, Madras 600025, Tamil Nadu, India.
RP Kalaiselvam, S (reprint author), Anna Univ, Ctr Nanosci & Technol, Madras 600025, Tamil Nadu, India.
EM parameshviews@gmail.com; kalai@annauniv.edu; rjvel@annauniv.edu
RI Ramasamy, Jayavel/R-8016-2018; Rajagopalan, Parameshwaran/E-9320-2014
OI Ramasamy, Jayavel/0000-0001-6270-1484; Rajagopalan,
   Parameshwaran/0000-0003-3906-1081
FU DST, New Delhi [SR/FTP/ETA-07/2009]
FX The authors are grateful to the DST, New Delhi, for providing financial
   support to carry out this research work under the PURSE scheme and SERC
   Fast Track Proposals for Young Scientists scheme (DST Sanction order No.
   SR/FTP/ETA-07/2009). One of the authors, Mr. R. Parameshwaran is
   thankful to the DST, New Delhi, for the award of the DST-PURSE
   fellowship. The authors thankfully acknowledge the support of Dr. S.
   Balakumar, NCNSNT, University of Madras, Chennai, for the nanomaterials
   characterization using the HRTEM facility. The authors are also grateful
   to Dr. Parvathi for her valuable comments and suggestions on the
   language used in the manuscript. The authors express their sincere
   thanks to the Editor and Reviewers for their positive criticism and
   constructive advice.
CR Ahamed M, 2011, PHYSICA E, V43, P1266, DOI 10.1016/j.physe.2011.02.014
   Arunachalam R, 2012, COLLOID SURFACE B, V94, P226, DOI 10.1016/j.colsurfb.2012.01.040
   Azeredo HMC, 2009, INT J FOOD SCI TECH, V44, P2365, DOI 10.1111/j.1365-2621.2007.01668.x
   Bankar A, 2010, COLLOID SURFACE A, V368, P58, DOI 10.1016/j.colsurfa.2010.07.024
   Bar H, 2009, COLLOID SURFACE A, V348, P212, DOI 10.1016/j.colsurfa.2009.07.021
   Castro L, 2011, PROCESS BIOCHEM, V46, P1076, DOI 10.1016/j.procbio.2011.01.025
   Castro L, 2010, CHEM ENG J, V164, P92, DOI 10.1016/j.cej.2010.08.034
   Chen J, 2008, MATER CHEM PHYS, V108, P421, DOI 10.1016/j.matchemphys.2007.10.019
   Dadosh T, 2009, MATER LETT, V63, P2236, DOI 10.1016/j.matlet.2009.07.042
   Darroudi M, 2011, INT J NANOMED, V6, P569, DOI 10.2147/IJN.S16867
   Dubey SP, 2010, COLLOID SURFACE A, V364, P34, DOI 10.1016/j.colsurfa.2010.04.023
   Dubey SP, 2010, PROCESS BIOCHEM, V45, P1065, DOI 10.1016/j.procbio.2010.03.024
   Dwivedi AD, 2010, COLLOID SURFACE A, V369, P27, DOI 10.1016/j.colsurfa.2010.07.020
   Edison TJI, 2012, PROCESS BIOCHEM, V47, P1351, DOI 10.1016/j.procbio.2012.04.025
   Evanoff DD, 2004, J PHYS CHEM B, V108, P13957, DOI 10.1021/jp0475640
   Filippo E, 2013, SENSOR ACTUAT B-CHEM, V178, P1, DOI 10.1016/j.snb.2012.12.061
   Filippo E, 2010, J NON-CRYST SOLIDS, V356, P344, DOI 10.1016/j.jnoncrysol.2009.11.021
   Filippo E, 2009, COLLOID SURFACE A, V348, P205, DOI 10.1016/j.colsurfa.2009.07.023
   Gan PP, 2012, BIORESOURCE TECHNOL, V113, P132, DOI 10.1016/j.biortech.2012.01.015
   Ghoreishi SM, 2011, PHYSICA E, V44, P97, DOI 10.1016/j.physe.2011.07.008
   Guidelli EJ, 2011, SPECTROCHIM ACTA A, V82, P140, DOI 10.1016/j.saa.2011.07.024
   Guzman M. G, 2008, P WORLD ACAD SCI ENG, V33, P367
   Halim E.S.A., 2011, CARBOHYD POLYM, V86, P1615
   Henglein A, 1999, J PHYS CHEM B, V103, P9533, DOI 10.1021/jp9925334
   Herbach KM, 2006, J FOOD SCI, V71, pR41, DOI 10.1111/j.1750-3841.2006.00022.x
   Herbach KM, 2004, J FOOD SCI, V69, pC491
   Huang NM, 2010, COLLOID SURFACE A, V353, P69, DOI 10.1016/j.colsurfa.2009.10.023
   Ji XH, 2007, J AM CHEM SOC, V129, P13939, DOI 10.1021/ja074447k
   KOTOV NA, 1993, LANGMUIR, V9, P3710, DOI 10.1021/la00036a057
   Kouvaris P, 2012, MATER LETT, V76, P18, DOI 10.1016/j.matlet.2012.02.025
   Kreibig U., 1995, SPRINGER SERIES MAT, V25, P24
   Kumar CG, 2012, PROCESS BIOCHEM, V47, P1488, DOI 10.1016/j.procbio.2012.05.023
   Lu YC, 2008, J CHIN INST CHEM ENG, V39, P673, DOI 10.1016/j.jcice.2008.06.005
   Muraviev D. N., 2005, CONTRIB SCI, V3, P19
   Narayanan KB, 2011, ADV COLLOID INTERFAC, V169, P59, DOI 10.1016/j.cis.2011.08.004
   Oluwafemi OS, 2013, COLLOID SURFACE B, V102, P718, DOI 10.1016/j.colsurfb.2012.09.001
   Paulraj P, 2011, COLLOID SURFACE A, V377, P28, DOI 10.1016/j.colsurfa.2010.12.001
   Peng X., 2005, SEMICONDUCTOR NANOCR, P79
   Philip D, 2011, PHYSICA E, V43, P1318, DOI 10.1016/j.physe.2010.10.006
   Philip D, 2011, SPECTROCHIM ACTA A, V78, P327, DOI 10.1016/j.saa.2010.10.015
   Philip D, 2010, PHYSICA E, V42, P1417, DOI 10.1016/j.physe.2009.11.081
   Philip D, 2010, SPECTROCHIM ACTA A, V75, P1078, DOI 10.1016/j.saa.2009.12.058
   Prathna TC, 2011, COLLOID SURFACE B, V82, P152, DOI 10.1016/j.colsurfb.2010.08.036
   Radziuk D, 2007, MACROMOL RAPID COMM, V28, P848, DOI 10.1002/marc.200600895
   Rastogi L, 2011, MATER CHEM PHYS, V129, P558, DOI 10.1016/j.matchemphys.2011.04.068
   Saito Y, 2003, LANGMUIR, V19, P6857, DOI 10.1021/la0301240
   Santos J.P., 1999, LANGMUIR, V15, P948
   Selvi JA, 2009, PORT ELECTROCHIM ACT, V27, P1, DOI 10.4152/pea.200901001
   Shirtcliffe N, 1999, J COLLOID INTERF SCI, V211, P122, DOI 10.1006/jcis.1998.5980
   Sujitha MV, 2013, SPECTROCHIM ACTA A, V102, P15, DOI 10.1016/j.saa.2012.09.042
   Vijayakumar R, 2011, PHYSICA E, V44, P665, DOI 10.1016/j.physe.2011.11.002
   Roldan MV, 2008, MATER CHEM PHYS, V112, P984, DOI 10.1016/j.matchemphys.2008.06.057
   Wang HS, 2005, COLLOID SURFACE A, V256, P111, DOI 10.1016/j.colsurfa.2004.12.058
   Xia NX, 2011, CARBOHYD POLYM, V86, P956, DOI 10.1016/j.carbpol.2011.05.053
   Yilmaz M, 2011, MATER CHEM PHYS, V130, P1195, DOI 10.1016/j.matchemphys.2011.08.068
   Yin YD, 2002, J MATER CHEM, V12, P522, DOI 10.1039/b107469e
   Zhang WZ, 2008, MATER CHEM PHYS, V109, P411, DOI 10.1016/j.matchemphys.2007.12.009
   Zhao LL, 2009, J PHYS CHEM C, V113, P16645, DOI 10.1021/jp9058406
NR 58
TC 15
Z9 15
U1 0
U2 31
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD JUN 15
PY 2013
VL 140
IS 1
BP 135
EP 147
DI 10.1016/j.matchemphys.2013.03.012
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA 155ZM
UT WOS:000319789500022
DA 2018-10-20
ER

PT J
AU Pal, S
   Yadav, AR
   Lifson, MA
   Baker, JE
   Fauchet, PM
   Miller, BL
AF Pal, Sudeshna
   Yadav, Amrita R.
   Lifson, Mark A.
   Baker, James E.
   Fauchet, Philippe M.
   Miller, Benjamin L.
TI Selective virus detection in complex sample matrices with photonic
   crystal optical cavities
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Biosensor; Photonic crystal; Virus
ID HUMAN-PAPILLOMAVIRUS; L1 PROTEIN; PARTICLES; BIOSENSORS
AB Rapid, sensitive, and selective detection of viruses is critical for applications in medical diagnostics, biosecurity, and environmental safety. In this article, we report the application of a point-defect-coupled W1 photonic crystal (PhC) waveguide biosensor to label-free optical detection of viruses. Fabricated on a silicon-on-insulator (SOI) substrate using electron-beam (e-beam) lithography and reactive-ion-etching, the PhC sensing platform allows optical detection based on resonant mode shifts in response to ambient refractive index changes produced by infiltration of target biomaterial within the holes of the PhC structure. Finite difference time domain (FDTD) calculations were performed to assist with design of the sensor, and to serve as a theoretical benchmark against which experimental results could be compared. Using Human Papillomavirus virus-like particles (VLPs) spiked in 10% fetal bovine serum as a model system, we observed a limit of detection of 1.5 nM in simple (buffer only) or complex (10% serum) sample matrices. The use of anti-VLP antibodies specific for intact VLPs with the PhC sensors provided highly selective VLP detection. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Pal, Sudeshna; Fauchet, Philippe M.] Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA.
   [Yadav, Amrita R.; Baker, James E.; Fauchet, Philippe M.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA.
   [Miller, Benjamin L.] Univ Rochester, Dept Dermatol, Rochester, NY 14627 USA.
   [Lifson, Mark A.; Miller, Benjamin L.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.
RP Miller, BL (reprint author), Univ Rochester, Dept Dermatol, Rochester, NY 14627 USA.
EM Benjamin_miller@urmc.rochester.edu
OI Miller, Benjamin/0000-0003-1647-0122
FU National Institute of Health [1 R01A108077-01]; National Science
   Foundation [ECS 03-35765]
FX This work was supported by the National Institute of Health (1
   R01A108077-01). Device fabrication was performed in part at the Cornell
   NanoScale Facility, a member of the National Nanotechnology
   Infrastructure Network, which is supported by the National Science
   Foundation (Grant ECS 03-35765). We thank Dr. Elisa Guillermain for
   acquiring the SEM image shown in Fig. 1, and Professor Robert Rose for
   generous donation of materials. We also thank the Center for Integrated
   Research Computing at the University of Rochester for providing the
   computing resources used in this research.
CR Baker J. E., 2011, P SOC PHOTO-OPT INS, V7888
   Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200
   Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9
   Dorfner D, 2009, BIOSENS BIOELECTRON, V24, P3688, DOI 10.1016/j.bios.2009.05.014
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   Garland SM, 2010, DRUGS, V70, P1079, DOI 10.2165/10898580-000000000-00000
   GUILD E., 2009, COMMUNICATIONS, P1
   Harvey AH, 1998, J PHYS CHEM REF DATA, V27, P761, DOI 10.1063/1.556029
   Heiniger A. T., 2011, P SOC PHOTO-OPT INS, V7888
   Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1
   Lee M, 2007, OPT EXPRESS, V15, P4530, DOI 10.1364/OE.15.004530
   Liu K, 2009, OPT COMMUN, V282, P4445, DOI 10.1016/j.optcom.2009.08.001
   Mace C.R., 2009, P SOC PHOTO-OPT INS, V7553
   Mandal S, 2009, LAB CHIP, V9, P2924, DOI 10.1039/b907826f
   Olivier S., 2001, PHYS REV B, V63, P1
   Oskooi AF, 2010, COMPUT PHYS COMMUN, V181, P687, DOI 10.1016/j.cpc.2009.11.008
   Painter O, 1999, J OPT SOC AM B, V16, P275, DOI 10.1364/JOSAB.16.000275
   Pal S., 2010, P SOC PHOTO-OPT INS, V7553
   Pal S, 2012, ANAL CHEM, V84, P8900, DOI 10.1021/ac3012945
   Pal S, 2011, BIOSENS BIOELECTRON, V26, P4024, DOI 10.1016/j.bios.2011.03.024
   Prather D. W., 2009, PHOTONIC CRYSTALS TH
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   ROSE RC, 1993, J VIROL, V67, P1936
   Sheehan PE, 2005, NANO LETT, V5, P803, DOI 10.1021/nl050298x
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
   Yuan Y, 1998, J CHROMATOGR A, V816, P21, DOI 10.1016/S0021-9673(98)00065-X
   Zlatanovic S, 2009, SENSOR ACTUAT B-CHEM, V141, P13, DOI 10.1016/j.snb.2009.06.007
NR 27
TC 35
Z9 35
U1 2
U2 158
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JUN 15
PY 2013
VL 44
BP 229
EP 234
DI 10.1016/j.bios.2013.01.004
PG 6
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 120DJ
UT WOS:000317150700038
PM 23434758
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Swartjes, JJTM
   Das, T
   Sharifi, S
   Subbiahdoss, G
   Sharma, PK
   Krom, BP
   Busscher, HJ
   van der Mei, HC
AF Swartjes, Jan J. T. M.
   Das, Theerthankar
   Sharifi, Shahriar
   Subbiahdoss, Guruprakash
   Sharma, Prashant K.
   Krom, Bastiaan P.
   Busscher, Henk J.
   van der Mei, Henny C.
TI A Functional DNase I Coating to Prevent Adhesion of Bacteria and the
   Formation of Biofilm
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE extracellular DNA; biofilm; DNase; dopamine; bacterial adhesion
ID EXTRACELLULAR DNA; STAPHYLOCOCCUS-EPIDERMIDIS; DEOXYRIBONUCLEASE-I;
   CELL-ADHESION; RELEASE; SURFACE; MATRIX; AUREUS
AB Biofilms are detrimental in many industrial and biomedical applications and prevention of biofilm formation has been a prime challenge for decades. Biofilms consist of communities of adhering bacteria, supported and protected by extracellular-polymeric-substances (EPS), the so-called house of biofilm organisms. EPS consists of water, proteins, polysaccharides and extracellular-DNA (eDNA). eDNA, being the longest molecule in EPS, connects the different EPS components and therewith holds an adhering biofilm together. eDNA is associated with bacterial cell surfaces by specific and non-specific mechanisms, mediating binding of other biopolymers in EPS. eDNA therewith assists in facilitating adhesion, aggregation and maintenance of biofilm structure. Here, a new method is described to prevent biofilm formation on surfaces by applying a DNase I enzyme coating to polymethylmethacrylate, using dopamine as an intermediate. The intermediate coupling layer and final DNase I coating are characterized by water-contact-angle measurements and X-ray photoelectron-spectroscopy. The DNase I coating strongly reduces adhesion of Staphylococcus aureus (95%) and Pseudomonas aeruginosa (99%) and prevents biofilm formation up to 14 h, without affecting mammalian cell adhesion and proliferation. Also agarose-gel-electrophoresis indicates loss of enzyme activity between 8 and 24 h. This duration however, is similar to many local antibiotic-delivery devices, which makes it an ideal coating for biomaterial implants and devices, known to fail due to biofilm formation with disastrous consequences for patients and high costs to the healthcare system. With threatening increases in antibiotic resistance, the DNase I coating may provide a timely, potent new approach to biofilm prevention on biomaterial implants and devices.
C1 [Swartjes, Jan J. T. M.; Das, Theerthankar; Sharifi, Shahriar; Subbiahdoss, Guruprakash; Sharma, Prashant K.; Krom, Bastiaan P.; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, NL-9713 AV Groningen, Netherlands.
   [Swartjes, Jan J. T. M.; Das, Theerthankar; Sharifi, Shahriar; Subbiahdoss, Guruprakash; Sharma, Prashant K.; Krom, Bastiaan P.; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
RP Swartjes, JJTM (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@umcg.nl
OI Sharifi, shahriar/0000-0002-3853-5428
CR Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   Bakker E M, 2007, Expert Rev Respir Med, V1, P317, DOI 10.1586/17476348.1.3.317
   Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x
   Cabanillas PF, 2000, INT J PHARM, V209, P15
   Conover M. S., 2011, PLOS ONE, V6
   Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h
   Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09
   Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003
   Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27
   Grande R, 2011, J APPL MICROBIOL, V110, P490, DOI 10.1111/j.1365-2672.2010.04911.x
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hancock REW, 2001, NAT GENET, V29, P360, DOI 10.1038/ng1201-360
   Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09
   Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Kirkpatrick CL, 2010, MOL MICROBIOL, V77, P801, DOI 10.1111/j.1365-2958.2010.07268.x
   Ku SH, 2010, LANGMUIR, V26, P15104, DOI 10.1021/la102825p
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Leem H., 2007, SCIENCE, V318, P426
   Lium H.-H., 2008, CURR MICROBIOL, V57, P139
   Mann EE, 2009, PLOS ONE, V4, pe5822, DOI DOI 10.1371/J0URNAL.P0NE.0005822
   Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x
   Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x
   NADANO D, 1993, CLIN CHEM, V39, P448
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720
   Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Schooling SR, 2009, J BACTERIOL, V191, P4097, DOI 10.1128/JB.00717-08
   Steinberger R. E., 2005, APPL ENVIRON MICROB, P71
   Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08
   Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08
   Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9
   Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08
   Walker JT, 2004, INT BIODETER BIODEGR, V54, P87, DOI 10.1016/j.ibiod.2004.03.012
   Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   Zijlstra GS, 2009, PHARM DEV TECHNOL, V14, P358, DOI 10.1080/10837450802662820
NR 44
TC 55
Z9 58
U1 12
U2 121
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JUN 13
PY 2013
VL 23
IS 22
BP 2843
EP 2849
DI 10.1002/adfm.201202927
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 158XG
UT WOS:000320006700008
DA 2018-10-20
ER

PT J
AU Zhao, HC
   Zhu, B
   Luo, SC
   Lin, HA
   Nakao, A
   Yamashita, Y
   Yu, HH
AF Zhao, Haichao
   Zhu, Bo
   Luo, Shyh-Chyang
   Lin, Hsing-An
   Nakao, Aiko
   Yamashita, Yoshiro
   Yu, Hsiao-hua
TI Controlled Protein Absorption and Cell Adhesion on Polymer-Brush-Grafted
   Poly(3,4-ethylenedioxythiophene) Films
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE electropolymerization; biomaterial; enzyme resistance; cell adhesion;
   conducting polymer; polymer brush
ID TRANSFER RADICAL POLYMERIZATION; SURFACE-INITIATED POLYMERIZATION;
   FIBRINOGEN ADSORPTION; FUNCTIONAL-GROUPS; NANO-NETWORKS; COATINGS;
   DESIGN; METAL; OXIDE; ACID)
AB Tailoring the surface of biometallic implants with protein-resistant polymer brushes represents an efficient approach to improve the biocompability and mechanical compliance with soft human tissues. A general approach utilizing electropolymerization to form initiating group (-Br) containing poly(3,4-ethylenedioxythiophen)s (poly(EDOT)s) is described. After the conducting polymer is deposited, neutral poly((oligo(ethylene glycol) methacrylate), poly(OEGMA), and zwitterionic poly([2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide), poly(SBMA), brushes are grafted by surface-initiated atom transfer radical polymerization. Quartz crystal microbalance (QCM) experiments confirm protein resistance of poly(OEGMA) and poly(SBMA)-grafted poly(EDOT)s. The protein binding properties of the surface are modulated by the density of polymer brushes, which is controlled by the feed content of initiator-containing monomer (EDOT-Br) in the monomer mixture solution for electropolymerization. Furthermore these polymer-grafted poly(EDOT)s also prevent cells to adhere on the surface.
C1 [Zhao, Haichao; Zhu, Bo; Luo, Shyh-Chyang; Lin, Hsing-An; Yu, Hsiao-hua] RIKEN, Adv Sci Inst, Yu Initiat Res Unit, Wako, Saitama 3510198, Japan.
   [Lin, Hsing-An; Yamashita, Yoshiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Wako, Saitama 3510198, Japan.
   [Nakao, Aiko] RIKEN, RNC Ind Cooperat Team, Wako, Saitama 3510198, Japan.
RP Zhao, HC (reprint author), RIKEN, Adv Sci Inst, Yu Initiat Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM haichaozhao@riken.jp; bruceyu@riken.jp
RI Yu, Hsiao-hua/B-5565-2013; Zhao, Haichao/K-4067-2016; Nakao,
   Aiko/B-3441-2018; Zhu, Bo/H-2304-2011
OI Yu, Hsiao-hua/0000-0002-3603-6932; Zhao, Haichao/0000-0002-3558-1306;
   Nakao, Aiko/0000-0001-7323-624X; Zhu, Bo/0000-0002-6526-5937; LUO,
   SHYH-CHYANG/0000-0003-3972-1086
FU RIKEN Advanced Science Institute; JSPS/MEXT, Japan [22681016, 23700565];
   RIKEN
FX This work was supported by RIKEN Advanced Science Institute and
   Grant-in-Aid for Young Scientist (22681016 and 23700565) from JSPS/MEXT,
   Japan. B.Z. thanks RIKEN for a Special Postdoctoral Researcher
   Fellowship.
CR Abidian MR, 2008, BIOMATERIALS, V29, P1273, DOI 10.1016/j.biomaterials.2007.11.022
   Bajpai AK, 2008, J MATER SCI-MATER M, V19, P343, DOI 10.1007/s10856-006-0024-y
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Brown AA, 2005, EUR POLYM J, V41, P1757, DOI 10.1016/j.eurpolymj.2005.02.026
   Butson CR, 2006, CLIN NEUROPHYSIOL, V117, P447, DOI 10.1016/j.clinph.2005.10.007
   Chang Y, 2008, LANGMUIR, V24, P5453, DOI 10.1021/la800228c
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   Eshet I, 2011, BIOMACROMOLECULES, V12, P2681, DOI 10.1021/bm200476g
   Fan XW, 2006, BIOMACROMOLECULES, V7, P2443, DOI 10.1021/bm060276k
   Gillich T, 2011, J AM CHEM SOC, V133, P10940, DOI 10.1021/ja202760x
   Grande CD, 2011, MACROMOLECULES, V44, P966, DOI 10.1021/ma102065u
   Horbett T. A., BIOL BIOCH MED BIO 2, P133
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   Jiang GQ, 2010, MACROMOLECULES, V43, P10262, DOI 10.1021/ma101746e
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Kim TG, 2009, BIOMACROMOLECULES, V10, P1532, DOI 10.1021/bm900116r
   Kobayashi M, 2012, LANGMUIR, V28, P7212, DOI 10.1021/la301033h
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Kuo WH, 2011, BIOMACROMOLECULES, V12, P4348, DOI 10.1021/bm2013185
   Li Y, 2012, LANGMUIR, V28, P12509, DOI 10.1021/la3022563
   Lu Y, 2009, BIOMATERIALS, V30, P4143, DOI 10.1016/j.biomaterials.2009.04.030
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   Luo SC, 2012, CHEM COMMUN, V48, P6942, DOI 10.1039/c2cc31789c
   Luo SC, 2012, ACS NANO, V6, P3018, DOI 10.1021/nn300737e
   Luo SC, 2011, ADV ENG MATER, V13, pB423, DOI 10.1002/adem.201080109
   Ma HW, 2010, ACS APPL MATER INTER, V2, P3223, DOI 10.1021/am1006832
   Ma HW, 2006, LANGMUIR, V22, P3751, DOI 10.1021/la052796r
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Malisova B, 2010, LANGMUIR, V26, P4018, DOI 10.1021/la903486z
   Martin D. C., 2010, MICROSC MICROANAL, V<IT>16</IT>, P1022
   Meyers SR, 2012, CHEM REV, V112, P1615, DOI 10.1021/cr2000916
   Monge S, 2011, BIOMACROMOLECULES, V12, P1973, DOI 10.1021/bm2004803
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Nishizawa K, 2008, BIOMACROMOLECULES, V9, P403, DOI 10.1021/bm7010246
   Pei YW, 2012, LANGMUIR, V28, P8072, DOI 10.1021/la301031b
   Pernites RB, 2011, ADV MATER, V23, P1287, DOI 10.1002/adma.201004003
   Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b
   Sekine J, 2011, ADV MATER, V23, P4788, DOI 10.1002/adma.201102151
   Shingo T., 2012, PLOS ONE, V<IT>7</IT>
   Tria MCR, 2010, BIOMACROMOLECULES, V11, P3422, DOI 10.1021/bm1009365
   Tsarevsky NV, 2007, CHEM REV, V107, P2270, DOI 10.1021/cr050947p
   Tugulu S, 2008, BIOMACROMOLECULES, V9, P906, DOI 10.1021/bm7012939
   Wallace GG, 2009, SCIENCE, V324, P185, DOI 10.1126/science.1168346
   Xu Y, 2009, BIOMACROMOLECULES, V10, P267, DOI 10.1021/bm801279y
   Yang W, 2009, LANGMUIR, V25, P11911, DOI 10.1021/la9015788
   Yoshimoto K, 2009, MACROMOL RAPID COMM, V30, P2136, DOI 10.1002/marc.200900484
   Zhang Z, 2006, J PHYS CHEM B, V110, P10799, DOI 10.1021/jp057266i
   Zhang Z, 2006, BIOMACROMOLECULES, V7, P3311, DOI 10.1021/bm060750m
   Zhao HC, 2012, ACS APPL MATER INTER, V4, P680, DOI 10.1021/am2012905
   Zhong YH, 2001, J REHABIL RES DEV, V38, P627
NR 51
TC 31
Z9 31
U1 6
U2 121
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 12
PY 2013
VL 5
IS 11
BP 4536
EP 4543
DI 10.1021/am400135c
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 165KY
UT WOS:000320484000008
PM 23573953
DA 2018-10-20
ER

PT J
AU Tang, Z
   Xie, YT
   Yang, F
   Huang, Y
   Wang, CD
   Dai, KR
   Zheng, XB
   Zhang, XL
AF Tang, Ze
   Xie, Youtao
   Yang, Fei
   Huang, Yan
   Wang, Chuandong
   Dai, Kerong
   Zheng, Xuebin
   Zhang, Xiaoling
TI Porous Tantalum Coatings Prepared by Vacuum Plasma Spraying Enhance
   BMSCs Osteogenic Differentiation and Bone Regeneration In Vitro and In
   Vivo
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; GEOMETRIC CONTROL; IMPLANTS; SHAPE; BIOMATERIAL;
   PERFORMANCE; ADHESION; MATRIX; GROWTH; METAL
AB Tantalum, as a potential metallic implant biomaterial, is attracting more and more attention because of its excellent anticorrosion and biocompatibility. However, its significantly high elastic modulus and large mechanical incompatibility with bone tissue make it unsuitable for load-bearing implants. In this study, porous tantalum coatings were first successfully fabricated on titanium substrates by vacuum plasma spraying (VPS), which would exert the excellent biocompatibility of tantalum and alleviate the elastic modulus of tantalum for bone tissue. We evaluated cytocompatibility and osteogenesis activity of the porous tantalum coatings using human bone marrow stromal cells (hBMSCs) and its ability to repair rabbit femur bone defects. The morphology and actin cytoskeletons of hBMSCs were observed via electron microscopy and confocal, and the cell viability, proliferation and osteogenic differentiation potential of hBMSCs were examined quantitatively by PrestoBlue assay, Ki67 immunofluorescence assay, real-time PCR technology and ALP staining. For in vivo detection, the repaired femur were evaluated by histomorphology and double fluorescence labeling 3 months postoperation. Porous tantalum coating surfaces promoted hBMSCs adhesion, proliferation, osteogenesis activity and had better osseointegration and faster new bone formation rate than titanium coating control. Our observation suggested that the porous tantalum coatings had good biocompatibility and could enhance osseoinductivity in vitro and promote new bone formation in vivo. The porous tantalum coatings prepared by VPS is a promising strategy for bone regeneration.
C1 [Tang, Ze; Huang, Yan; Wang, Chuandong; Dai, Kerong; Zhang, Xiaoling] Chinese Acad Sci, SIBS, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.
   [Tang, Ze; Huang, Yan; Wang, Chuandong; Dai, Kerong; Zhang, Xiaoling] SJTUSM, Shanghai, Peoples R China.
   [Tang, Ze; Yang, Fei; Dai, Kerong; Zhang, Xiaoling] SJTUSM, Shanghai Key Lab Orthopaed Implant, Dept Orthopaed Surg, Shanghai Peoples Hosp 9, Shanghai, Peoples R China.
   [Xie, Youtao; Zheng, Xuebin] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Xie, YT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
EM xieyoutao@mail.sic.ac.cn; xlzhang@sibs.ac.cn
FU Ministry of Science and Technology of China [2011DFA30790,
   2010CB945600]; National Natural Science Foundation of China [81190133,
   31101056]; Chinese Academy of Sciences [XDA01030404, KSCX2-EW-Q-1-07];
   Science and Technology Commission of Shanghai Municipality
   [11QH1401600]; Shanghai Municipal Education Commission [J50206, 10SG22]
FX This work was supported by grants from: The Ministry of Science and
   Technology of China (No.2011DFA30790, 2010CB945600), www.most.gov.cn;
   National Natural Science Foundation of China (No.81190133, 31101056),
   http://www.nsfc.gov.cn; Chinese Academy of Sciences (No.XDA01030404,
   KSCX2-EW-Q-1-07), http://www.cas.cn/; Science and Technology Commission
   of Shanghai Municipality (No.11QH1401600), www.stcsm.gov.cn; and
   Shanghai Municipal Education Commission (No.J50206, 10SG22),
   www.shmec.gov.cn/. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akiyama S K, 1996, Hum Cell, V9, P181
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x
   de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Holt GE, 2009, J ARTHROPLASTY, V24, P1079, DOI 10.1016/j.arth.2008.08.010
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Kaiser JP, 2004, J MATER SCI-MATER M, V15, P429, DOI 10.1023/B:JMSM.0000021115.55254.a8
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Long WJ, 2009, J ARTHROPLASTY, V24, P1086, DOI 10.1016/j.arth.2008.08.011
   Lyons A Bruce, 2004, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0911s27
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Nadeau Melissa, 2007, Mcgill J Med, V10, P4
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Rojewski MT, 2008, TRANSFUS MED HEMOTH, V35, P168, DOI 10.1159/000129013
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   Sidhu KS, SPINE J, V1, P331
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Smith PJ, 2000, CYTOMETRY, V40, P280, DOI 10.1002/1097-0320(20000801)40:4<280::AID-CYTO4>3.0.CO;2-7
   Urbani S, 2006, CYTOTHERAPY, V8, P243, DOI 10.1080/14653240600735834
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 40
TC 27
Z9 32
U1 3
U2 49
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 11
PY 2013
VL 8
IS 6
AR e66263
DI 10.1371/journal.pone.0066263
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 169CU
UT WOS:000320755400130
PM 23776648
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wang, HM
   Chou, YT
   Wen, ZH
   Wang, ZR
   Chen, CH
   Ho, ML
AF Wang, Hui-Min
   Chou, Yi-Ting
   Wen, Zhi-Hong
   Wang, Zhao-Ren
   Chen, Chun-Hong
   Ho, Mei-Ling
TI Novel Biodegradable Porous Scaffold Applied to Skin Regeneration
SO PLOS ONE
LA English
DT Article
ID CROSS-LINKING; ARTIFICIAL SKIN; HYALURONIC-ACID; GROWTH-FACTOR;
   COLLAGEN; KERATINOCYTES; MATRIX; CELLS; BIOMATERIAL; SUBSTITUTES
AB Skin wound healing is an important lifesaving issue for massive lesions. A novel porous scaffold with collagen, hyaluronic acid and gelatin was developed for skin wound repair. The swelling ratio of this developed scaffold was assayed by water absorption capacity and showed a value of over 20 g water/g dried scaffold. The scaffold was then degraded in time- and dose-dependent manners by three enzymes: lysozyme, hyaluronidase and collagenase I. The average pore diameter of the scaffold was 132.5 +/- 8.4 mu m measured from SEM images. With human skin cells growing for 7 days, the SEM images showed surface fractures on the scaffold due to enzymatic digestion, indicating the biodegradable properties of this scaffold. To simulate skin distribution, the human epidermal keratinocytes, melanocytes and dermal fibroblasts were seeded on the porous scaffold and the cross-section immunofluorescent staining demonstrated normal human skin layer distributions. The collagen amount was also quantified after skin cells seeding and presented an amount 50% higher than those seeded on culture wells. The in vivo histological results showed that the scaffold ameliorated wound healing, including decreasing neutrophil infiltrates and thickening newly generated skin compared to the group without treatments.
C1 [Wang, Hui-Min; Chou, Yi-Ting] Kaohsiung Med Univ, Dept Fragrance & Cosmet Sci, Kaohsiung, Taiwan.
   [Wang, Hui-Min] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan.
   [Chou, Yi-Ting; Wang, Zhao-Ren; Ho, Mei-Ling] Kaohsiung Med Univ, Coll Med, Dept Physiol, Kaohsiung, Taiwan.
   [Wen, Zhi-Hong; Chen, Chun-Hong] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan.
   [Wang, Zhao-Ren; Ho, Mei-Ling] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan.
RP Ho, ML (reprint author), Kaohsiung Med Univ, Coll Med, Dept Physiol, Kaohsiung, Taiwan.
EM homelin@cc.kmu.edu.tw
OI Chen, Chun-Hong/0000-0002-5166-9017
FU National Science Council of the Republic of China
   [NSC-99-2221-E-037-006-MY3]; Economics Department [97-EC-17-A-17-S1-041]
FX This work was financially supported by the National Science Council of
   the Republic of China under Grant No.: NSC-99-2221-E-037-006-MY3;
   Economics Department: 97-EC-17-A-17-S1-041. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117
   Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614
   Bayat M, 2005, J PHOTOCH PHOTOBIO B, V78, P171, DOI 10.1016/j.jphotobiol.2004.08.012
   Boyce ST, 2001, BURNS, V27, P523, DOI 10.1016/S0305-4179(01)00019-5
   Cardinali G, 2008, J INVEST DERMATOL, V128, P558, DOI 10.1038/sj.jid.5701063
   Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Corin KA, 2010, BIOMATERIALS, V31, P4835, DOI 10.1016/j.biomaterials.2010.01.149
   Dainiak MB, 2010, BIOMATERIALS, V31, P67, DOI 10.1016/j.biomaterials.2009.09.029
   Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720
   Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406
   Duan X, 2005, J BIOMED MATER RES A, V75A, P510, DOI 10.1002/jbm.a.30475
   Eves PC, 2005, BIOMATERIALS, V26, P7068, DOI 10.1016/j.biomaterials.2005.05.015
   Fioretti F, 2008, WOUND REPAIR REGEN, V16, P87, DOI 10.1111/j.1524-475X.2007.00304.x
   Flasza M, 2007, REGEN MED, V2, P903, DOI 10.2217/17460751.2.6.903
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gauglitz GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029942
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347
   Huang KD, 2008, ELECTROPHORESIS, V29, P4862, DOI 10.1002/elps.200800392
   Huang MH, 2008, INT J PHARM, V346, P38, DOI 10.1016/j.ijpharm.2007.06.021
   Hunt Nicola C., 2009, Biotechnology Journal, V4, P730, DOI 10.1002/biot.200800292
   Ishibuchi H, 2010, EXP DERMATOL, V19, pE111, DOI 10.1111/j.1600-0625.2009.00999.x
   Joshi PG, 2007, PIGM CELL RES, V20, P380, DOI 10.1111/j.1600-0749.2007.00397.x
   Kremer M, 2000, BRIT J PLAST SURG, V53, P459, DOI 10.1054/bjps.2000.3368
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   Li CQ, 2010, J MATER SCI-MATER M, V21, P741, DOI 10.1007/s10856-009-3871-5
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x
   Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8
   Mathew P, 2010, J CLIN ONCOL, V28, pE197, DOI 10.1200/JCO.2009.27.1098
   Nam K, 2010, ACTA BIOMATER, V6, P409, DOI 10.1016/j.actbio.2009.06.022
   Nam K, 2010, ACTA BIOMATER, V6, P403, DOI 10.1016/j.actbio.2009.06.021
   Navsaria HA, 2004, PLAST RECONSTR SURG, V113, P978, DOI 10.1097/01.PRS.0000105632.86651.EF
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pomahac B, 1998, CRIT REV ORAL BIOL M, V9, P333, DOI 10.1177/10454411980090030601
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Saito A, 2012, ACTA BIOMATER, V8, P2932, DOI 10.1016/j.actbio.2012.04.019
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Schulz JT, 2000, ANNU REV MED, V51, P231, DOI 10.1146/annurev.med.51.1.231
   Seet WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040978
   Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910
   Souto Luís Ricardo Martinhão, 2006, Sao Paulo Med. J., V124, P71, DOI 10.1590/S1516-31802006000200005
   Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373
   Stiernberg J, 2000, WOUND REPAIR REGEN, V8, P204, DOI 10.1046/j.1524-475x.2000.00204.x
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tripathi Mukesh, 2009, Indian J Med Sci, V63, P392, DOI 10.4103/0019-5359.56110
   Wang HM, 2012, J APPL POLY IN PRESS
   Wang HM, 2011, EXP DERMATOL, V20, P242, DOI 10.1111/j.1600-0625.2010.01161.x
   Wang HM, 2010, BIOORGAN MED CHEM, V18, P5241, DOI 10.1016/j.bmc.2010.05.045
   WEISS SJ, 1989, NEW ENGL J MED, V320, P365
   Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089
NR 55
TC 45
Z9 47
U1 1
U2 48
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 10
PY 2013
VL 8
IS 6
AR e56330
DI 10.1371/journal.pone.0056330
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 164VY
UT WOS:000320440500001
PM 23762223
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Schlie-Wolter, S
   Ngezahayo, A
   Chichkov, BN
AF Schlie-Wolter, Sabrina
   Ngezahayo, Anaclet
   Chichkov, Boris N.
TI The selective role of ECM components on cell adhesion, morphology,
   proliferation and communication in vitro
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE Extracellular matrix; Cell adhesion; Cell-cell and cell-matrix
   interaction; Selective cell control
ID EXTRACELLULAR-MATRIX; FOCAL ADHESIONS; ACTIVATION; INTEGRINS; COLLAGEN;
   LAMININ; DIFFERENTIATION; BIOMATERIALS; CHONDROCYTES; ORGANIZATION
AB Cell binding to the extracellular matrix (ECM) is essential for cell and tissue functions. In this context, each tissue consists of a unique ECM composition, which may be responsible for tissue-specific cell responses. Due to the complexity of ECM-cell interactions which depend on the interplay of inside-out and outside-in signaling cascades, cell and tissue specificity of ECM-guidance is poorly understood. In this paper, we investigate the role of different ECM components like laminin, fibronectin, and collagen type I with respect to the essential cell behaviour patterns: attachment dynamics such as adhesion kinetic and force, formation of focal adhesion complexes, morphology, proliferation, and intercellular communication. A detailed in vitro comparison of fibroblasts, endothelial cells, osteoblasts, smooth muscle cells, and chondrocytes reveals significant differences in their cell responses to the ECM: cell behaviour follows a cell specific ligand priority ranking, which was independent of the cell type origin. Fibroblasts responded best to fibronectin, chondrocytes best to collagen I, the other cell types best to laminin. This knowledge is essential for optimization of tissue-biomaterial interfaces in all tissue engineering applications and gives insight into tissue-specific cell guidance. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Schlie-Wolter, Sabrina; Chichkov, Boris N.] Laser Zentrum Hannover eV, D-30419 Hannover, Germany.
   [Ngezahayo, Anaclet] Leibniz Univ Hannover, Inst Biophys, D-30419 Hannover, Germany.
RP Schlie-Wolter, S (reprint author), Laser Zentrum Hannover eV, Hollerithallee 8, D-30419 Hannover, Germany.
EM s.schlie@lzh.de; ngezahayo@biophysik.uni-hannover.de; b.chichkov@lzh.de
RI Chichkov, Boris/M-4112-2015
OI Chichkov, Boris/0000-0002-8129-7373; Ngezahayo,
   Anaclet/0000-0002-3686-923X
FU Cluster of Excellence Rebirth "From Regenerative Biology to
   Reconstructive Therapy"; BMBF-project REMEDIS
FX This work was partly supported by Cluster of Excellence Rebirth "From
   Regenerative Biology to Reconstructive Therapy" and BMBF-project
   REMEDIS. The authors thank A. Deiwick from the Laser Zentrum Hannover
   e.V. (Germany) for preparing chondrocytes.
CR Adams JC, 2001, CELL MOL LIFE SCI, V58, P371, DOI 10.1007/PL00000864
   Altankov G, 1997, J BIOMAT SCI-POLYM E, V8, P721, DOI 10.1163/156856297X00524
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002
   Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Begandt D, 2010, J BIOENERG BIOMEMBR, V42, P79, DOI 10.1007/s10863-009-9262-2
   Cai WJ, 2009, MOL CELL BIOCHEM, V322, P161, DOI 10.1007/s11010-008-9953-8
   Clark EA, 1996, J BIOL CHEM, V271, P14814, DOI 10.1074/jbc.271.25.14814
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Durr J, 1996, EXP CELL RES, V222, P225, DOI 10.1006/excr.1996.0028
   El-Sabban ME, 2003, J CELL SCI, V116, P3531, DOI 10.1242/jcs.00656
   Frantz C, 2011, J CELL SCI, V123, P4195, DOI [10.1242/jcs.023820, DOI 10.1242/JCS.023820)]
   Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021
   Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359
   Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040
   Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2
   Letourneau P C, 1992, Curr Opin Genet Dev, V2, P625, DOI 10.1016/S0959-437X(05)80183-2
   Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029
   Loeser RF, 2000, OSTEOARTHR CARTILAGE, V8, P96, DOI 10.1053/joca.1999.0277
   Mineur P, 2005, BBA-MOL CELL RES, V1746, P28, DOI 10.1016/j.bbamcr.2005.07.004
   Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114
   Pattaramalai S, 1996, EXP CELL RES, V222, P281, DOI 10.1006/excr.1996.0036
   Plante I, 2006, CARCINOGENESIS, V27, P1923, DOI 10.1093/carcin/bgl059
   Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X
   Rutgers M, 2013, TISSUE ENG PT A, V19, P59, DOI [10.1089/ten.tea.2011.0416, 10.1089/ten.TEA.2011.0416]
   Schlie S, 2012, TISSUE ENG PART C-ME, V18, P688, DOI [10.1089/ten.tec.2011.0635, 10.1089/ten.TEC.2011.0635]
   Schlie S, 2010, J BIOMATER APPL, V25, P217, DOI 10.1177/0885328209345553
   Schwartz MA, 2001, J CELL SCI, V114, P2553
   Shanker A.J., 2009, CIRC RES, V96, P559
   Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979
   SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145
   Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004
   Sun Z, 2008, AM J PHYSIOL-CELL PH, V295, pC268, DOI 10.1152/ajpcell.00516.2007
   Tagaki J., 2007, CURR OPIN CELL BIOL, V19, P557
   Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
NR 43
TC 34
Z9 35
U1 1
U2 44
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD JUN 10
PY 2013
VL 319
IS 10
BP 1553
EP 1561
DI 10.1016/j.yexcr.2013.03.016
PG 9
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 155ZQ
UT WOS:000319789900019
PM 23588204
DA 2018-10-20
ER

PT J
AU Reid, AJ
   de Luca, AC
   Faroni, A
   Downes, S
   Sun, MZ
   Terenghi, G
   Kingham, PJ
AF Reid, Adam J.
   de Luca, Alba C.
   Faroni, Alessandro
   Downes, Sandra
   Sun, Mingzhu
   Terenghi, Giorgio
   Kingham, Paul J.
TI Long term peripheral nerve regeneration using a novel PCL nerve conduit
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE Nerve regeneration; Biomaterial; Nerve conduit; Peripheral nerve; Poly
   epsilon-caprolactone
ID REPAIR; GAPS
AB The gold standard in surgical management of a peripheral nerve gap is currently autologous nerve grafting. This confers patient morbidity and increases surgical time therefore innovative experimental strategies towards engineering a synthetic nerve conduit are welcome. We have developed a novel synthetic conduit made of poly epsilon-caprolactone (PCL) that has demonstrated promising peripheral nerve regeneration in short-term studies. This material has been engineered to permit translation into clinical practice and here we demonstrate that histological outcomes in a long-term in vivo experiment are comparable with that of autologous nerve grafting. A 1 cm nerve gap in a rat sciatic nerve injury model was repaired with a PCL nerve conduit or an autologous nerve graft. At 18 weeks post surgical repair, there was a similar volume of regenerating axons within the nerve autograft and PCL conduit repair groups, and similar numbers of myelinated axons in the distal stump of both groups. Furthermore, there was evidence of comparable re-innervation of end organ muscle and skin with the only significant difference the lower wet weight of the muscle from the PCL conduit nerve repair group. This study stimulates further work on the potential use of this synthetic biodegradable PCL nerve conduit in a clinical setting. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Reid, Adam J.; de Luca, Alba C.; Faroni, Alessandro; Terenghi, Giorgio] Univ Manchester, Blond McIndoe Res Labs, Manchester M13 9PT, Lancs, England.
   [Reid, Adam J.; Kingham, Paul J.] Umea Univ, Dept Integrat Med Biol, Sect Anat, S-90187 Umea, Sweden.
   [de Luca, Alba C.; Downes, Sandra; Sun, Mingzhu] Univ Manchester, Dept Engn & Phys Sci, Manchester M13 9PT, Lancs, England.
RP Reid, AJ (reprint author), Univ Manchester, Blond McIndoe Res Labs, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM adam.reid@manchester.ac.uk
RI Faroni, Alessandro/P-6590-2014; Reid, Adam/G-4460-2014
OI Faroni, Alessandro/0000-0003-4435-6423; Reid, Adam/0000-0003-1752-3302;
   Kingham, Paul/0000-0003-2596-5936
FU National Institute for Health Research, Academy of Medical Sciences;
   British Society for Surgery of the Hand; Swedish Research Council; Newby
   Trust; Academy of Medical Sciences (AMS) [AMS-SGCL7-Reid]; National
   Institute for Health Research [1679, II-AR-0209-10050]
FX A.R. is supported by the National Institute for Health Research, Academy
   of Medical Sciences and the British Society for Surgery of the Hand. We
   also acknowledge support from the Swedish Research Council and the Newby
   Trust.
CR Birch R, 1998, SURG DISORDERS PERIP, P240
   Carlstedt T, 2011, J HAND SURG-EUR VOL, V36E, P726, DOI 10.1177/1753193411422329
   Dahlin LB, 2004, J AM SOC SURG HAND, V4, P143, DOI DOI 10.1016/J.JASSH.2004.06.006
   de Luca AC, 2014, J TISSUE ENG REGEN M, V8, P153, DOI 10.1002/term.1509
   Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M
   Hart AM, 2004, AIDS, V18, P1549, DOI 10.1097/01.aids.0000131354.14408.fb
   Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165
   Meek MF, 2008, ANN PLAS SURG, V60, P466, DOI 10.1097/SAP.0b013e31804d441c
   Millesi H, 2007, ACTA NEUROCHIR SUPPL, V100, P37
   Pettersson J, 2011, NEUROSCI LETT, V500, P41, DOI 10.1016/j.neulet.2011.06.002
   Pettersson J, 2010, J PLAST RECONSTR AES, V63, P1893, DOI 10.1016/j.bjps.2009.11.024
   Reid AJ, 2011, NEUROSCIENCE, V199, P515, DOI 10.1016/j.neuroscience.2011.09.064
   Rolfe B., 2011, GREENS OPERATIVE HAN, P1035
   Rosberg HE, 2005, J HAND SURG-BRIT EUR, V30B, P35, DOI 10.1016/j.jhsb.2004.09.003
   Sun M, 2010, J BIOMED MATER RES A, V93A, P1470, DOI 10.1002/jbm.a.32681
   Sun MZ, 2010, J MATER SCI-MATER M, V21, P2765, DOI 10.1007/s10856-010-4120-7
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Waitayawinyu T, 2007, J HAND SURG-AM, V32A, P1521, DOI 10.1016/j.jhsa.2007.07.015
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   Wiberg Mikael, 2003, Surg Technol Int, V11, P303
NR 20
TC 21
Z9 22
U1 1
U2 35
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD JUN 7
PY 2013
VL 544
BP 125
EP 130
DI 10.1016/j.neulet.2013.04.001
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA 167LA
UT WOS:000320632300025
PM 23583695
OA Other Gold
DA 2018-10-20
ER

PT J
AU Miyoshi, NSB
   Pinheiro, DG
   Silva, WA
   Felipe, JC
AF Brandao Miyoshi, Newton Shydeo
   Pinheiro, Daniel Guariz
   Silva, Wilson Araujo, Jr.
   Felipe, Joaquim Cezar
TI Computational framework to support integration of biomolecular and
   clinical data within a translational approach
SO BMC BIOINFORMATICS
LA English
DT Article
ID GENOME; SYSTEM; RESOURCE; INFORMATION
AB Background: The use of the knowledge produced by sciences to promote human health is the main goal of translational medicine. To make it feasible we need computational methods to handle the large amount of information that arises from bench to bedside and to deal with its heterogeneity. A computational challenge that must be faced is to promote the integration of clinical, socio-demographic and biological data. In this effort, ontologies play an essential role as a powerful artifact for knowledge representation. Chado is a modular ontology-oriented database model that gained popularity due to its robustness and flexibility as a generic platform to store biological data; however it lacks supporting representation of clinical and socio-demographic information.
   Results: We have implemented an extension of Chado - the Clinical Module - to allow the representation of this kind of information. Our approach consists of a framework for data integration through the use of a common reference ontology. The design of this framework has four levels: data level, to store the data; semantic level, to integrate and standardize the data by the use of ontologies; application level, to manage clinical databases, ontologies and data integration process; and web interface level, to allow interaction between the user and the system. The clinical module was built based on the Entity-Attribute-Value (EAV) model. We also proposed a methodology to migrate data from legacy clinical databases to the integrative framework. A Chado instance was initialized using a relational database management system. The Clinical Module was implemented and the framework was loaded using data from a factual clinical research database. Clinical and demographic data as well as biomaterial data were obtained from patients with tumors of head and neck. We implemented the IPTrans tool that is a complete environment for data migration, which comprises: the construction of a model to describe the legacy clinical data, based on an ontology; the Extraction, Transformation and Load (ETL) process to extract the data from the source clinical database and load it in the Clinical Module of Chado; the development of a web tool and a Bridge Layer to adapt the web tool to Chado, as well as other applications.
   Conclusions: Open-source computational solutions currently available for translational science does not have a model to represent biomolecular information and also are not integrated with the existing bioinformatics tools. On the other hand, existing genomic data models do not represent clinical patient data. A framework was developed to support translational research by integrating biomolecular information coming from different "omics" technologies with patient's clinical and socio-demographic data. This framework should present some features: flexibility, compression and robustness. The experiments accomplished from a use case demonstrated that the proposed system meets requirements of flexibility and robustness, leading to the desired integration. The Clinical Module can be accessed in http://dcm.ffclrp.usp.br/caib/pg=iptrans.
C1 [Brandao Miyoshi, Newton Shydeo; Felipe, Joaquim Cezar] Univ Sao Paulo, Fac Philosophy Sci & Languages Ribeirao Preto, Dept Comp & Math, Sao Paulo, Brazil.
   [Pinheiro, Daniel Guariz] Univ Sao Paulo, Fac Philosophy Sci & Languages Ribeirao Preto, Dept Biol, Sao Paulo, Brazil.
   [Silva, Wilson Araujo, Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil.
RP Felipe, JC (reprint author), Univ Sao Paulo, Fac Philosophy Sci & Languages Ribeirao Preto, Dept Comp & Math, Sao Paulo, Brazil.
EM jfelipe@ffclrp.usp.br
RI CTC USP, CEPID 13 18/J-8951-2014; CEPID, CTC USP/J-5104-2015; Miyoshi,
   Newton/A-7566-2010; Silva Jr, Wilson Araujo/E-9487-2011
OI CTC USP, CEPID 13 18/0000-0002-7123-9524; Silva Jr, Wilson
   Araujo/0000-0001-9364-2886; Guariz Pinheiro, Daniel/0000-0001-7062-5936
FU CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior);
   FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo,
   Brazil) [2012/02757-9]
FX The authors thank CAPES (Coordenadoria de Aperfeicoamento de Pessoal de
   Nivel Superior) and FAPESP (Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo, Sao Paulo, Brazil, 2012/02757-9) for the financial support.
CR Arnaiz O, 2011, NUCLEIC ACIDS RES, V39, pD632, DOI 10.1093/nar/gkq918
   Borlawsky Tara B, 2011, J Biomed Inform, V44 Suppl 1, pS56, DOI 10.1016/j.jbi.2011.07.006
   Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826
   Brochhausen M, 2011, J BIOMED INFORM, V44, P8, DOI 10.1016/j.jbi.2010.04.008
   Chisham B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-98
   Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112
   Dinu V, 2007, INT J MED INFORM, V76, P769, DOI 10.1016/j.ijmedinf.2006.09.023
   Hitzler P., 2012, OWL 2 WEB ONTOLOGY L
   Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38
   John AS, 2009, CATALYST 5 8 PERL MV, P244
   JUNG SJ, 2011, DATABASE-OXFORD, V29, DOI DOI 10.1116/1.3626795
   Kasprzyk A, 2004, GENOME RES, V14, P160
   Legeai F, 2010, INSECT MOL BIOL, V19, P5, DOI 10.1111/j.1365-2583.2009.00930.x
   Lewis SE, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0082
   Lowe HJ, 2009, AMIA S, V1, P391
   Luciano Joanne S, 2011, J Biomed Semantics, V2 Suppl 2, pS1, DOI 10.1186/2041-1480-2-S2-S1
   Merelli I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S5
   Mungall CJ, 2007, BIOINFORMATICS, V23, pI337, DOI 10.1093/bioinformatics/btm189
   MURPHY SN, 2007, AMIA ANN S P, V1, P548
   MySQL, WORLDS MOST POP OP S
   Payne Philip R O, 2008, Summit Transl Bioinform, V2008, P85
   Rubin DL, 2008, BRIEF BIOINFORM, V9, P75, DOI 10.1093/bib/bbm059
   Seligman Len, 2010, P 2010 ACM SIGMOD IN, P1057
   Shah SP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-34
   Smith R, 1996, BRIT MED J, V313, P1062
   Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602
   Stein LD, 1999, COMPUT SCI ENG, V1, P44, DOI 10.1109/5992.764215
   Viangteeravat T, 2009, CTS-CLIN TRANSL SCI, V2, P238, DOI 10.1111/j.1752-8062.2009.00109.x
   Wang LJ, 2007, NUCLEIC ACIDS RES, V35, pD476, DOI 10.1093/nar/gkl776
   Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219
   Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26
   Zhang F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S7
NR 32
TC 9
Z9 9
U1 0
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD JUN 6
PY 2013
VL 14
AR 180
DI 10.1186/1471-2105-14-180
PG 12
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 167SF
UT WOS:000320653800001
PM 23742129
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jin, J
   Jiang, W
   Yin, JH
   Ji, XL
   Stagnaro, P
AF Jin, Jing
   Jiang, Wei
   Yin, Jinghua
   Ji, Xiangling
   Stagnaro, Paola
TI Plasma Proteins Adsorption Mechanism on Polyethylene-Grafted
   Poly(ethylene glycol) Surface by Quartz Crystal Microbalance with
   Dissipation
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; CO-ACRYLIC ACID; PLATELET-ADHESION;
   BLOOD-COMPATIBILITY; POLYMER SURFACES; KINETICS; BRUSHES; OXIDE;
   IMMOBILIZATION; PHOSPHOLIPIDS
AB Protein adsorption has a vital role in biomaterial surface science because it is directly related to the hemocompatibility of blood-contacting materials. In this study, monomethoxy poly(ethylene glycol) (mPEG) with two different molecular weights was grafted on polyethylene as a model to elucidate the adsorption mechanisms of plasma protein through quartz crystal microbalance with dissipation (QCM-D). Combined with data from platelet adhesion, whole blood clotting time, and hemolysis rate, the blood compatibility of PE-g-mPEG film was found to have significantly improved. Two adsorption schemes were developed for real-time monitoring of protein adsorption. Results showed that the preadsorbed bovine serum albumin (BSA) on the surfaces of PE-g-mPEG films could effectively inhibit subsequent adsorption of fibrinogen (Fib). Nonspecific protein adsorption of BSA was determined by surface coverage, not by the chain length of PEG. Dense PEG brush could release more trapped water molecules to resist BSA adsorption. Moreover, the preadsorbed Fib could be gradually displaced by high-concentration BSA. However, the adsorption and displacement of Fib was determined by surface hydrophilicity.
C1 [Jin, Jing; Jiang, Wei; Yin, Jinghua; Ji, Xiangling] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   [Stagnaro, Paola] CNR, Ist Studio Macromol, I-16149 Genoa, Italy.
RP Jiang, W (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
EM wjiang@ciac.jl.cn; yinjh@ciac.jl.cn
RI Jiang, Wei/O-8445-2018; Jin, Jing/G-2953-2011
OI Jiang, Wei/0000-0003-4316-880X; Jin, Jing/0000-0002-2710-4243; Stagnaro,
   Paola/0000-0003-3437-1435
FU National Natural Science Foundation of China [51273199, 50920105302,
   21274150]
FX We acknowledge the financial support of the National Natural Science
   Foundation of China (Projects 51273199, 50920105302, and 21274150). The
   work was carried out in accordance with the framework of the Research
   Cooperation Agreement between the Chinese Academy of Sciences and the
   National Research Council of Italy.
CR Alibeik S, 2010, COLLOID SURFACE B, V81, P389, DOI 10.1016/j.colsurfb.2010.07.024
   Andrade J. D., 1996, INTERFACIAL PHENOMEN, P19
   BAEKMARK TR, 1995, LANGMUIR, V11, P3975, DOI 10.1021/la00010a058
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Chong KT, 2002, LANGMUIR, V18, P9932, DOI 10.1021/la020507i
   Deutsch S, 2006, ANNU REV FLUID MECH, V38, P65, DOI 10.1146/annurev.fluid.38.050304.092022
   Guthold M, 2007, CELL BIOCHEM BIOPHYS, V49, P165, DOI 10.1007/s12013-007-9001-4
   Guzman E, 2011, LANGMUIR, V27, P6836, DOI 10.1021/la200522r
   Guzman E, 2009, SOFT MATTER, V5, P2130, DOI 10.1039/b901193e
   Halperin A, 2009, LANGMUIR, V25, P11621, DOI 10.1021/la9008569
   HASEGAWA M, 1992, LANGMUIR, V8, P1582, DOI 10.1021/la00042a015
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   IMAI Y, 1972, KOBUNSHI, V21, P569
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jin J, 2012, APPL SURF SCI, V258, P5841, DOI 10.1016/j.apsusc.2012.02.113
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Kulmashiro Y, 2008, J PHYS CHEM B, V112, P8291, DOI 10.1021/jp7104506
   Larsson A, 2007, BIOMACROMOLECULES, V8, P287, DOI 10.1021/bm060685g
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   Li GC, 2011, BIOMACROMOLECULES, V12, P1155, DOI 10.1021/bm101468v
   Ma HW, 2006, LANGMUIR, V22, P3751, DOI 10.1021/la052796r
   MACRITCHIE F, 1987, ACS SYM SER, V343, P165
   Miwa Y, 2011, KOBUNSHI RONBUNSHU, V68, P133, DOI 10.1295/koron.68.133
   Muller C., 2009, LANGMUIR, V26, P4136
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   Renner L, 2005, LANGMUIR, V21, P4571, DOI 10.1021/la046801n
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006
   Sask KN, 2011, ACTA BIOMATER, V7, P2029, DOI 10.1016/j.actbio.2011.01.031
   Sauerbrey G., 1959, J PHYS, V155, p206~222
   Seo JH, 2008, BIOMATERIALS, V29, P1367, DOI 10.1016/j.biomaterials.2007.11.039
   Slavin S, 2012, SOFT MATTER, V8, P118, DOI 10.1039/c1sm06410j
   Su XD, 2005, J COLLOID INTERF SCI, V287, P35, DOI 10.1016/j.jcis.2005.01.089
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wu JD, 2012, BIOMATERIALS, V33, P810, DOI 10.1016/j.biomaterials.2011.10.022
   Xu FJ, 2005, BIOMACROMOLECULES, V6, P1759, DOI 10.1021/bm050071w
   Xu KR, 2013, BIOMATERIALS, V34, P1461, DOI 10.1016/j.biomaterials.2012.10.078
   Yang ZH, 1999, LANGMUIR, V15, P8405, DOI 10.1021/la990260y
   Zhang C, 2006, LANGMUIR, V22, P6851, DOI 10.1021/la0532712
   Zhang GZ, 2009, MACROMOL RAPID COMM, V30, P328, DOI 10.1002/marc.200800611
   Zhao CS, 2003, BIOMATERIALS, V24, P3747, DOI 10.1016/S0142-9612(03)00250-3
   Zhao J., 2010, J MEMBRANE SCI, V369, P5
   Zhou CR, 1999, BIOMATERIALS, V20, P2093, DOI 10.1016/S0142-9612(99)00080-0
   Zwang TJ, 2012, LANGMUIR, V28, P9616, DOI 10.1021/la301718m
NR 51
TC 35
Z9 36
U1 7
U2 129
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 4
PY 2013
VL 29
IS 22
BP 6624
EP 6633
DI 10.1021/la4017239
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 160DK
UT WOS:000320097000014
PM 23659226
DA 2018-10-20
ER

PT J
AU Alexander, JC
   Browne, S
   Pandit, A
   Rochev, Y
AF Alexander, Jennifer C.
   Browne, Shane
   Pandit, Abhay
   Rochev, Yury
TI Biomaterial Constructs for Delivery of Multiple Therapeutic Genes: A
   Spatiotemporal Evaluation of Efficacy Using Molecular Beacons
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; NITRIC-OXIDE SYNTHASE; MESSENGER-RNA; LIVING
   CELLS; INTERLEUKIN-10; EXPRESSION; HYBRIDIZATION; PREDICTION; DISEASE;
   GROWTH
AB Gene therapy is emerging as a potential therapeutic approach for cardiovascular pathogenesis. An appropriate therapy may require multiple genes to enhance therapeutic outcome by modulating inflammatory response and angiogenesis in a controlled and time-dependent manner. Thus, the aim of this research was to assess the spatiotemporal efficacy of a dualgene therapy model based on 3D collagen scaffolds loaded with the therapeutic genes interleukin 10 (IL-10), a potent anti-inflammatory cytokine, and endothelial nitric oxide synthase (eNOS), a promoter of angiogenesis. A collagen-based scaffold loaded with plasmid IL-10 polyplexes and plasmid eNOS polyplexes encapsulated into microspheres was used to transfect HUVECs and HMSCs cells. The therapeutic efficacy of the system was monitored at 2, 7 and 14 days for eNOS and IL-10 mRNA expression using RT-PCR and live cell imaging molecular beacon technology. The dual gene releasing collagen-based scaffold provided both sustained and delayed release of functional polyplexes in vitro over a 14 day period which was corroborated with variation in expression levels seen using RT-PCR and MB imaging. Maximum fold increases in IL-10 mRNA and eNOS mRNA expression levels occurred at day 7 in HMSCs and HUVECs. However, IL-10 mRNA expression levels seemed dependent on frequency of media changes and/or ease of transfection of the cell type. It was demonstrated that molecular beacons are able to monitor changes in mRNA levels at various time points, in the presence of a 3D scaffolding gene carrier system and the results complemented those of RT-PCR.
C1 [Alexander, Jennifer C.; Browne, Shane; Pandit, Abhay; Rochev, Yury] Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Rochev, Yury] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland.
RP Rochev, Y (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.
EM yury.rochev@nuigalway.ie
RI Pandit, Abhay/B-6187-2008; Rochev, Yury/M-9077-2014
OI Pandit, Abhay/0000-0002-6292-4933; Rochev, Yury/0000-0003-4213-9476
FU Science Foundation Ireland; European Research Development Fund
   [07/SRC/B1163]
FX This material is based upon works supported by the Science Foundation
   Ireland and the European Research Development Fund [Grant no.
   07/SRC/B1163]. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Alexander JC, 2011, LAB CHIP, V11, P3908, DOI 10.1039/c1lc20447e
   [Anonymous], 2012, EURO SURVEILL, V17
   Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4
   Bratu Diana P., 2006, V319, P1
   Browne S, 2012, MOL PHARM
   Cannon RO, 1998, CLIN CHEM, V44, P1809
   Cattaruzza M, 2003, J BIOL CHEM, V278, P37874, DOI 10.1074/jbc.M301670200
   Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32
   Curtis MW, 2009, J CARDIOVASC NURS, V24, P87, DOI 10.1097/01.JCN.0000343562.06614.49
   Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017
   Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002
   Helary C, 2012, ACTA BIOMATER
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4269, DOI 10.1016/j.biomaterials.2006.02.033
   Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174
   Mooney E, 2008, NANO LETT, V8, P2137, DOI 10.1021/nl073300o
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Murphy JM, 2002, ARTHRITIS RHEUM, V46, P704, DOI 10.1002/art.10118
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129
   Rhee WJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn039
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584-46059.E3
   Rissanen TT, 2007, MOL THER, V15, P1233, DOI 10.1038/sj.mt.6300175
   Santangelo PJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh062
   Sase K, 1997, TRENDS CARDIOVAS MED, V7, P28, DOI 10.1016/S1050-1738(96)00121-1
   Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Tsutsui M, 2009, CIRC J, V73, P986, DOI 10.1253/circj.CJ-09-0208
   Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303
   Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 36
TC 4
Z9 4
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 3
PY 2013
VL 8
IS 6
AR e65749
DI 10.1371/journal.pone.0065749
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 157CD
UT WOS:000319872300095
PM 23755278
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Liu, TX
   Wang, Z
AF Liu, Tai-Xiang
   Wang, Zheng
TI Collagen crosslinking of porcine sclera using genipin
SO ACTA OPHTHALMOLOGICA
LA English
DT Article
DE genipin; myopia; Young's modulus; sclera; Stress-Strain; collagen
   cross-linking
ID REFRACTIVE ERROR; UNITED-STATES; TREE SHREW; IN-VITRO; MYOPIA;
   RIBOFLAVIN; TISSUE; CELLS; UVA; PREVALENCE
AB Abstract.
   Purpose: To evaluate the effect of collagen cross-linking induced by genipin in porcine sclera.
   Methods: Porcine cadaver eyes were treated with genipin at concentrations (by w/v) of 0.01%, 0.03%, 0.1%, 0.3%, 1.0% for 15 and 30 min. Riboflavin/ultraviolet A(UVA)-treated and untreated samples were used as controls. After treatment, scleral strips of 4.0 x 10.0 mm were cut. Twenty-four hours later, the stress-strain parameters of the strips were measured using a biomaterial microtester. The stress and Young's modulus at 8% strain were evaluated.
   Results: Compared with untreated groups, after treatment with genipin for 15 min, the stress was increased by 66-246%, depending on the concentration of genipin. As for the 30-min groups, the stress was 171-444% higher than that of the control. The difference of the Young's modulus between genipin 15-min groups, except the 0.01% groups (p = 0.095), also had statistical significance (p < 0.05). The Young's modulus had significant difference between the untreated group and the genipin 30-min groups (all p < 0.05). Of 0.3% genipin for 15 min or 0.01% genipin for 30 min had a similar stress-strain curve with those of eyes treated with the riboflavin/UVA group. The sclera exhibited a bluish colour which became deeper with increase concentration and cross-linking time.
   Conclusions: Collagen cross-linking induced by genipin could increase the biomechanical strength in porcine sclera. The effect depends on the concentration and treatment time of genipin.
C1 [Liu, Tai-Xiang; Wang, Zheng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.
RP Wang, Z (reprint author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, 54th Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China.
EM wangzhengykzx@163.com
CR Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8
   Avila MY, 2012, MOL VIS, V18, P1068
   Avila MY, 2010, J CATARACT REFR SURG, V36, P659, DOI 10.1016/j.jcrs.2009.11.003
   BAILEY AJ, 1987, EYE-T OPHTH SOC UK, V1, P175, DOI 10.1038/eye.1987.34
   Chen MJ, 2009, J CHIN MED ASSOC, V72, P133, DOI 10.1016/S1726-4901(09)70038-3
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   CURTIN B J, 1958, Trans Am Acad Ophthalmol Otolaryngol, V62, P777
   Curtin B J, 1969, Trans Am Ophthalmol Soc, V67, P417
   FUJIKAWA S, 1987, J FERMENT BIOENG, V65, P419, DOI 10.1016/0385-6380(87)90138-5
   FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314
   GOSS DA, 1983, AM J OPTOM PHYS OPT, V60, P651
   GROSVENOR T, 1993, OPTOMETRY VISION SCI, V70, P677, DOI 10.1097/00006324-199308000-00017
   Jin Xunjie, 2008, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V25, P150
   Kitano A, 2006, OPHTHAL RES, V38, P355, DOI 10.1159/000096231
   Kitano A, 2006, J CATARACT REFR SURG, V32, P1727, DOI 10.1016/j.jcrs.2006.05.015
   Kosmala JD, 2000, BIOMATERIALS, V21, P2019, DOI 10.1016/S0142-9612(00)00057-0
   Kymionis George D, 2011, Open Ophthalmol J, V5, P11, DOI 10.2174/1874364101105010011
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lam CSY, 2004, OPTOMETRY VISION SCI, V81, P317, DOI 10.1097/01.opx.0000134905.98403.18
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133
   McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0
   Moffat KL, 2004, J BIOMED MATER RES B, V71B, P181, DOI 10.1002/jbm.b.30070
   ONEAL MR, 1987, AM J OPTOM PHYS OPT, V64, P344
   Paik DC, 2008, EXP EYE RES, V87, P279, DOI 10.1016/j.exer.2008.06.008
   Paik DC, 2010, INVEST OPHTH VIS SCI, V51, P836, DOI 10.1167/iovs.09-3937
   Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028
   Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009
   Sergienko NM, 2012, GRAEF ARCH CLIN EXP, V250, P1009, DOI 10.1007/s00417-012-1973-0
   Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182
   Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Wollensak G, 2008, J CATARACT REFR SURG, V34, P651, DOI [10.1016/j.jcrs.2007.12.030, 10.1016/i.jcrs.2007.12.030]
   Wollensak G, 2009, ACTA OPHTHALMOL, V87, P193, DOI 10.1111/j.1755-3768.2008.01229.x
   Woo W W, 2004, Singapore Med J, V45, P470
   YAMANO T, 1990, FOOD CHEM TOXICOL, V28, P515, DOI 10.1016/0278-6915(90)90122-4
   Yamazaki M, 2001, J NEUROCHEM, V79, P45, DOI 10.1046/j.1471-4159.2001.00533.x
   Young TL, 2007, ARCH OPHTHALMOL-CHIC, V125, P38, DOI 10.1001/archopht.125.1.38
   Zadnik K, 1997, OPTOMETRY VISION SCI, V74, P603, DOI 10.1097/00006324-199708000-00021
NR 45
TC 17
Z9 22
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-375X
EI 1755-3768
J9 ACTA OPHTHALMOL
JI Acta Ophthalmol.
PD JUN
PY 2013
VL 91
IS 4
BP E253
EP E257
DI 10.1111/aos.12172
PG 5
WC Ophthalmology
SC Ophthalmology
GA AF0FE
UT WOS:000334387500001
PM 23710671
OA Bronze
DA 2018-10-20
ER

PT J
AU Mardani, M
   Hashemibeni, B
   Ansar, MM
   Esfahani, SHZ
   Kazemi, M
   Goharian, V
   Esmaeili, N
   Esfandiary, E
AF Mardani, Mohmmad
   Hashemibeni, Batool
   Ansar, Malek Masoud
   Esfahani, Sayeed Hamid Zarkesh
   Kazemi, Mohmmad
   Goharian, Vahid
   Esmaeili, Nafiseh
   Esfandiary, Ebrahim
TI Comparison between Chondrogenic Markers of Differentiated Chondrocytes
   from Adipose Derived Stem Cells and Articular Chondrocytes In Vitro
SO IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES
LA English
DT Article
DE Alginate; Stem cell; Chondrocyte; TGFbeta
ID TISSUE-ENGINEERED CARTILAGE; GROWTH-FACTOR-BETA; BONE-MARROW; PELLET
   CULTURE; STROMAL CELLS; EXTRACELLULAR-MATRIX; PROGENITOR CELLS;
   GENE-EXPRESSION; AGAROSE CULTURE; TGF-BETA
AB Objective(s): Osteoarthritis is one of the most common diseases in middle-aged population in the world. Cartilage tissue engineering (TE) has been presented as an effort to introduce the best combination of cells, biomaterial scaffolds and stimulating growth factors to produce a cartilage tissue similar to the natural articular cartilage. In this study, the chondrogenic potential of adipose derived stem cells (ADSCs) was compared with natural articular chondrocytes cultured in alginate scaffold.
   Materials and Methods: Human ADSCs were obtained from subcutaneous adipose tissue and human articular chondrocytes from non-weight bearing areas of knee joints. Cells were seeded in 1.5% alginate and cultured in chondrogenic media for three weeks with and without TGF beta 3. The genes expression of types II and X collagens was assessed by Real Time PCR and the amount of aggrecan (AGC) and type I collagen measured by ELISA and the content of glycosaminoglycan evaluated by GAG assay.
   Results: Our findings showed that type II collagen, GAG and AGC were expressed, in differentiated ADSCs. Meanwhile, they produced a lesser amount of types II and X collagens but more AGC, GAG and type I collagen in comparison with natural chondrocytes (NCs).
   Conclusion: Further attempt should be carried out to optimize achieving type II collagen in DCs, as much as, natural articular chondrocytes and decline of the production of type I collagen in order to provide efficient hyaline cartilage after chondrogenic induction, prior to the usage of harvested tissues in clinical trials.
C1 [Mardani, Mohmmad; Hashemibeni, Batool; Ansar, Malek Masoud; Kazemi, Mohmmad; Esfandiary, Ebrahim] Esfahan Univ Med Sci, Sch Med, Dept Anat Sci & Mol Biol, Esfahan, Iran.
   [Esfahani, Sayeed Hamid Zarkesh] Esfahan Univ Med Sci, Sch Med, Dept Immunol, Esfahan, Iran.
   [Goharian, Vahid] Esfahan Univ Med Sci, Sch Med, Amin Hosp, Esfahan, Iran.
   [Esmaeili, Nafiseh] Esfahan Univ Med Sci, Sch Med, Dept Immunol, Esfahan, Iran.
RP Esfandiary, E (reprint author), Univ Med Sci, Sch Med, Dept Anat Sci & Mol Biol, HezarJerib St, Esfahan, Iran.
EM esfandiari@med.mui.ac.ir
RI Hashemibeni, batool/V-6848-2017; mardani, mohammad/V-6843-2017; Ansar,
   Malek Masoud/G-4394-2017
OI Ansar, Malek Masoud/0000-0003-4291-4241; Kazemi,
   Mohammad/0000-0002-6794-6891; mardani, mohammad/0000-0001-8464-1734;
   Ansar, Malek Masoud/0000-0001-8207-852X; Esfandiari,
   Ebrahim/0000-0001-6436-5672
FU IRAN National Science Fund [90000737]
FX Special thanks go to IRAN National Science Fund for financial supporting
   of the project No. 90000737. We also appreciate Mr. Rhman haghiri and Dr
   Malek Moien Ansar for their sincere help that without their
   contributions this study could not be performed.
CR Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950
   Aguiar DJ, 1999, EXP CELL RES, V252, P292, DOI 10.1006/excr.1999.4641
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Becker JC, 2005, GASTROINTEST ENDOSC, V61, P560, DOI 10.1016/S0016-5107(05)00291-9
   Bernstein P, 2009, BIOTECHNOL PROGR, V25, P1146, DOI 10.1002/btpr.186
   Browne J E, 2000, J Am Acad Orthop Surg, V8, P180
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Gleghorn JP, 2005, T ORTHOP RES SOC
   Grimaud E, 2002, CYTOKINE GROWTH F R, V13, P241, DOI 10.1016/S1359-6101(02)00004-7
   GUILAK F, 2001, CLIN ORTHOP S, V391, P295
   Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9
   Hashemi Beni B, 2008, IRAN J BASIC MED SCI, V11, P10
   Hashemi beni B, 2009, JIMS, V27, P613
   Hilfiker A, 2011, LANGENBECK ARCH SURG, V396, P489, DOI 10.1007/s00423-011-0762-2
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Jakobsen RB, 2010, KNEE SURG SPORT TR A, V18, P1407, DOI 10.1007/s00167-009-1017-4
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Karlsson C, 2007, J ORTHOP RES, V25, P152, DOI 10.1002/jor.20287
   Keeney M, 2011, CURR OPIN BIOTECH, V22, P734, DOI 10.1016/j.copbio.2011.04.003
   Kim HJ, 2009, J ORTHOP RES, V27, P612, DOI 10.1002/jor.20766
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leddy HA, 2004, J BIOMED MATER RES B, V70B, P397, DOI 10.1002/jbm.b.30053
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Mahmoudifar N, 2010, BIOTECHNOL BIOENG, V107, P393, DOI 10.1002/bit.22798
   Majumdar MK, 2000, J CELL PHYSIOL, V185, P98
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mwale F, 2006, J ORTHOP RES, V24, P1791, DOI 10.1002/jor.20200
   Naughton GK, 2002, ANN NY ACAD SCI, V961, P372, DOI 10.1111/j.1749-6632.2002.tb03127.x
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Pelttari K, 2008, INJURY, V39, P58
   REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruettger Anke, 2010, BMC Res Notes, V3, P7, DOI 10.1186/1756-0500-3-7
   Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898
   Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x
   SKANTZE KA, 1985, CANCER RES, V45, P4416
   Song L, 2004, CYTOTHERAPY, V6, P596, DOI 10.1080/14653240410005276
   Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Yang IH, 2004, YONSEI MED J, V45, P891
   Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026
   Zhang ZJ, 2004, J ANAT, V205, P229, DOI 10.1111/j.0021-8782.2004.00327.x
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 59
TC 14
Z9 14
U1 0
U2 3
PU MASHHAD UNIV MED SCIENCES
PI MASHHAD
PA VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 -
   445, MASHHAD, 00000, IRAN
SN 2008-3866
EI 2008-3874
J9 IRAN J BASIC MED SCI
JI Iran. J. Basic Med. Sci.
PD JUN
PY 2013
VL 16
IS 6
BP 763
EP 771
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 298KM
UT WOS:000330322800005
PM 23997902
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Nakai, M
   Niinomi, M
   Hieda, J
   Yilmazer, H
   Todaka, Y
AF Nakai, M.
   Niinomi, M.
   Hieda, J.
   Yilmazer, H.
   Todaka, Y.
TI Heterogeneous grain refinement of biomedical Ti-29Nb-13Ta-4.6Zr alloy
   through high-pressure torsion
SO SCIENTIA IRANICA
LA English
DT Article
DE Biomaterial; beta-type titanium alloy; Severe plastic deformation; Grain
   refinement
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; YOUNGS MODULUS; ZR
AB The biomedical beta-type titanium alloy Ti-29Nb-13Ta-4.6Zr (TNTZ) exhibits non-toxicity and a low Young's modulus that is similar to that of bone. This alloy has a low Young's modulus because it contains a metastable beta phase. Strengthening due to grain refinement tends to provide high mechanical strength, while keeping the Young's modulus low, because it maintains the original beta phase. In this case, severe plastic deformation, such as High-Pressure Torsion (HPT), is a potential treatment for obtaining these properties simultaneously. Thus, in this study, the effect of HPT on the microstructure and hardness of TNTZ was systematically investigated. On the cross sections of TNTZ subjected to HPT, heterogeneous microstructures, consisting of a matrix and an unetched band not corroded by an etching solution, were observed. Both the matrix and the unetched band were comprised of a single beta phase with submicron-sized grains, but their grain geometries differed: equiaxed grains and elongated grains are observed in the matrix and the unetched band, respectively. The hardness distribution in the cross section of TNTZ subjected to HPT is also heterogeneous; the hardness is higher in the matrix than in the unetched band, when the number of HPT rotations is small. (C) 2013 Sharif University of Technology. Production and hosting by Elsevier B.V. All rights reserved.
C1 [Nakai, M.; Niinomi, M.; Hieda, J.; Yilmazer, H.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Todaka, Y.] Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
EM nakai@imr.tohoku.ac.jp
RI Niinomi, Mitsuo/B-5965-2011; Todaka, Yoshikazu/D-3809-2015; Nakai,
   Masaaki/C-1919-2009; Yilmazer, Hakan/C-2911-2011
OI Yilmazer, Hakan/0000-0001-5602-4966
FU Global CUE Program "Materials Integration (International Center of
   Education and Research), Tohoku University"; Ministry of Education,
   Culture, Sports, Science and Technology (MEXT), Japan; Inter-University
   Cooperative Research Program; MEXT, Japan; Japan Society for the
   Promotion of Science (JSPS), Japan; Research Seeds Quest Program; Japan
   Science and Technology Agency (JST), Japan; Cooperative Research Program
   of the Institute for Materials Research, Tohoku University, Japan;
   Cooperative Research Program of the Advanced Research Center of Metallic
   Glasses, Institute for Materials Research, Tohoku University, Japan
FX This work was supported in part by the Global CUE Program "Materials
   Integration (International Center of Education and Research), Tohoku
   University", the Ministry of Education, Culture, Sports, Science and
   Technology (MEXT), Japan, the Inter-University Cooperative Research
   Program "Highly-Functional Interface Science: Innovation of Biomaterials
   with Highly Functional Interface to Host and Parasite, Tohoku University
   and Kyushu University", MEXT, Japan, Grants-in-Aid for Young Scientists
   (B), the Japan Society for the Promotion of Science (JSPS), Japan,
   Research Seeds Quest Program, Japan Science and Technology Agency (JST),
   Japan, the Cooperative Research Program of the Institute for Materials
   Research, Tohoku University, Japan, and the Cooperative Research Program
   of the Advanced Research Center of Metallic Glasses, Institute for
   Materials Research, Tohoku University, Japan.
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Geng F, 2011, MAT SCI ENG A-STRUCT, V528, P5435, DOI 10.1016/j.msea.2011.03.064
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Nakai M, 2012, METALL MATER TRANS A, V43A, P294, DOI 10.1007/s11661-011-0860-3
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   Narita K, 2011, J JPN I MET, V75, P198, DOI 10.2320/jinstmet.75.198
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Song X, 2011, MAT SCI ENG A-STRUCT, V528, P5600, DOI 10.1016/j.msea.2011.03.108
   Stolyarov VV, 2003, MAT SCI ENG A-STRUCT, V343, P43, DOI 10.1016/S0921-5093(02)00366-0
   Tsuji N, 1999, SCRIPTA MATER, V40, P795, DOI 10.1016/S1359-6462(99)00015-9
   Yilmazer H, 2010, 15 INT MET MAT C IMM, P570
   Zhilyaev AP, 2008, PROG MATER SCI, V53, P893, DOI 10.1016/j.pmatsci.2008.03.002
NR 15
TC 6
Z9 6
U1 4
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1026-3098
J9 SCI IRAN
JI Sci. Iran.
PD JUN
PY 2013
VL 20
IS 3
BP 1067
EP 1070
DI 10.1016/j.scient.2013.01.004
PG 4
WC Engineering, Multidisciplinary
SC Engineering
GA 224OC
UT WOS:000324896800074
DA 2018-10-20
ER

PT J
AU Reys, LL
   Silva, SS
   Oliveira, JM
   Caridade, SG
   Mano, JF
   Silva, TH
   Reis, RL
AF Reys, L. L.
   Silva, S. S.
   Oliveira, J. M.
   Caridade, S. G.
   Mano, J. F.
   Silva, T. H.
   Reis, R. L.
TI Revealing the potential of squid chitosan-based structures for
   biomedical applications
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID TISSUE-ENGINEERING APPLICATIONS; CHITIN; POLYMERS; DEACETYLATION;
   ACETYLATION; DERIVATIVES; SCAFFOLDS; SYSTEMS; ORIGIN; CELLS
AB In recent years, much attention has been given to different marine organisms, namely as potential sources of valuable materials with a vast range of properties and characteristics. In this work, beta-chitin was isolated from the endoskeleton of the giant squid Dosidicus gigas and further deacetylated to produce chitosan. Then, the squid chitosan was processed into membranes and scaffolds using solvent casting and freeze-drying, respectively, to assess their potential biomedical application. The developed membranes have shown to be stiffer and less hydrophobic than those obtained with commercial chitosan. On the other hand, the morphological characterization of the developed scaffolds, by SEM and micro-computed tomography, revealed that the matrices were formed with a lamellar structure. The findings also indicated that the treatment with ethanol prior to neutralization with sodium hydroxide caused the formation of larger pores and loss of some lamellar features. The in vitro cell culture study has shown that all chitosan scaffolds exhibited a non-cytotoxic effect over the mouse fibroblast-like cell line, L929 cells. Thus, chitosan produced from the endoskeletons of the giant squid Dosidicus gigas has proven to be a valuable alternative to existing commercial materials when considering its use as biomaterial.
C1 [Reys, L. L.; Silva, S. S.; Oliveira, J. M.; Caridade, S. G.; Mano, J. F.; Silva, T. H.; Reis, R. L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Reys, L. L.; Silva, S. S.; Oliveira, J. M.; Caridade, S. G.; Mano, J. F.; Silva, T. H.; Reis, R. L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
RP Reys, LL (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePark, P-4806909 Taipas, Guimaraes, Portugal.
EM lara.reys@dep.uminho.pt
RI Caridade, Sofia/P-1925-2015; Oliveira, Joaquim Miguel/H-8636-2012; Reis,
   Rui L./A-8938-2008; Silva, Tiago/A-2048-2008; Group, 3Bs/E-4374-2012;
   Silva, Simone/F-9757-2011; Mano, Joao/A-4418-2009; Reys,
   Lara/J-2880-2013
OI Caridade, Sofia/0000-0002-0448-1871; Oliveira, Joaquim
   Miguel/0000-0001-7052-8837; Reis, Rui L./0000-0002-4295-6129; Silva,
   Tiago/0000-0001-8520-603X; Group, 3Bs/0000-0002-5195-3456; Silva,
   Simone/0000-0003-4268-9419; Mano, Joao/0000-0002-2342-3765; Reys,
   Lara/0000-0001-5379-7277
FU FEDER through INTERREG III A Project Proteus; POCTEP Project IBEROMARE;
   Portuguese Foundation for Science and Technology
FX This work was partially funded by FEDER through INTERREG III A Project
   Proteus and POCTEP Project IBEROMARE. The Portuguese Foundation for
   Science and Technology is gratefully acknowledged for post-doctoral
   grants of THS, JMO and SSS. The authors would also like to acknowledge
   to Dr Julio Maroto from the Fundacion CETMAR and Roi Vilela from
   PESCANOVA S.A, Spain, for the kind offer of squid pens and to Dr Ramon
   Novoa, Professor Ricardo Riguera and Professor Mariana Landin from the
   University of Santiago of Compostela for the SEC-MALLS measurements.
CR Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   [Anonymous], 2009, 109935 ISO
   BENDER M, 1952, J CHEM EDUC, V29, P15
   Bras AR, 2007, J THERM ANAL CALORIM, V88, P425, DOI 10.1007/s10973-006-8038-8
   Charcosset C, 2006, BIOTECHNOL ADV, V24, P482, DOI 10.1016/j.biotechadv.2006.03.002
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chaussard G, 2004, BIOMACROMOLECULES, V5, P559, DOI 10.1021/bm.034401t
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   Jiankang H., 2007, POLYMER, V48, P4578, DOI DOI 10.1016/J.POLYMER.2007.05.048
   Khor E, 2001, CHITIN FULFILLING BI, P65
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Luz GM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/054104
   Madihally V M, 1999, BIOMATERIALS, V20, P1133
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mano J F, 2008, MACROMOL BIOSCI, V8, P67
   Mano J F, 2005, BIODEGRADABLE SYSTEM, P152
   Mano JF, 2002, NATO SCI SER II MATH, V86, P139
   Martins AM, 2009, ACTA BIOMATER, V5, P3328, DOI 10.1016/j.actbio.2009.05.027
   Methacanon P, 2003, CARBOHYD POLYM, V52, P119, DOI 10.1016/S0144-8617(02)00300-4
   Nguyen S, 2009, CARBOHYD POLYM, V75, P636, DOI 10.1016/j.carbpol.2008.09.002
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Rhazi M, 2000, POLYM INT, V49, P337, DOI 10.1002/(SICI)1097-0126(200004)49:4<337::AID-PI375>3.0.CO;2-B
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sagheer FAA, 2009, CARBOHYD POLYM, V77, P410, DOI DOI 10.1016/J.CARBP0L.2009.01.032
   Shimojoh M, 1998, CARBOHYD POLYM, V35, P223, DOI 10.1016/S0144-8617(97)00244-0
   Signini R, 2001, POLIMEROS, V11, P58, DOI [10.1590/S0104-14282001000200007, DOI 10.1590/S0104-14282001000200007]
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Silva TH, 2012, INT MATER REV, V57, P276, DOI 10.1179/1743280412Y.0000000002
   Tolaimate A, 2003, POLYMER, V44, P7939, DOI 10.1016/j.polymer.2003.10.025
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
NR 36
TC 14
Z9 14
U1 3
U2 25
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2013
VL 8
IS 4
AR 045002
DI 10.1088/1748-6041/8/4/045002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 188BX
UT WOS:000322167700005
PM 23715133
DA 2018-10-20
ER

PT J
AU Donaldson, L
AF Donaldson, Laurie
TI New biomaterial for diabetes treatment
SO MATERIALS TODAY
LA English
DT News Item
CR PHELPS, 2013, BIOMATERIALS, DOI DOI 10.1016/J.BIOMATERIALS.2013.03.012
NR 1
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
J9 MATER TODAY
JI Mater. Today
PD JUN
PY 2013
VL 16
IS 6
BP 206
EP 207
DI 10.1016/j.mattod.2013.06.014
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 211RG
UT WOS:000323926800004
OA Other Gold
DA 2018-10-20
ER

PT J
AU Pramanik, S
   Pingguan-Murphy, B
   Abu Osman, NA
AF Pramanik, Sumit
   Pingguan-Murphy, Belinda
   Abu Osman, Noor Azuan
TI Developments of Immobilized Surface Modified Piezoelectric Crystal
   Biosensors for Advanced Applications
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Review
DE piezoelectric quartz crystal; immobilization; surface modification;
   nanotechnology; nanomaterial; biomaterial
ID RESONANCE ENERGY-TRANSFER; LOW-TEMPERATURE SYNTHESIS; PULSED-LASER
   DEPOSITION; BOVINE SERUM-ALBUMIN; SOL-GEL METHOD; ELECTROCHEMICAL
   SENSORS; CARBON NANOTUBES; THIN-FILMS; AMPEROMETRIC DETERMINATION;
   FLUORESCENT PROTEINS
AB The development of biosensors has seen recent growth owing to their wide range of potential applications from the defending of bioterrorism to the detection of various diseases. Recent investigations in highly sensitive nanomaterials containing nanotechnology suggest the possibility of its advanced applications as biosensors in different biomedical fields. Besides highlighting the characteristic features of different classes of advanced biosensor across different fields of potential application, this article gives a clear overview of some specific investigations related to the surface immobilizations of piezoelectric biosensors employing effective materials and advanced technologies. Further, the current development of piezoelectric biosensors in the detection of potential biomolecules for advanced biomedical applications is critically reviewed. The qualitative and quantitative sensitivity of piezoelectric biosensors, various expressions of resonant frequency shift with changes in mass, thickness, density, and stress for piezoelectric materials are distinctly explored. The importance of several novel nanomaterials for the detection of various diseased biomolecules is clearly illustrated. This study concludes that proper selection of materials is potential to bring improvement in quality as well as reduction in cost of advanced biosensor devices.
C1 [Pramanik, Sumit; Pingguan-Murphy, Belinda; Abu Osman, Noor Azuan] Univ Malaya, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
RP Pramanik, S (reprint author), Univ Malaya, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
EM prsumit@gmail.com
RI Pingguan-Murphy, Belinda/B-8332-2010; ABU OSMAN, NOOR AZUAN/B-9265-2010
OI Pingguan-Murphy, Belinda/0000-0001-5567-1141; ABU OSMAN, NOOR
   AZUAN/0000-0002-2853-4421
FU UM/MOHE/HIR [D000010-16001]
FX This study was supported by UM/MOHE/HIR grant (Project number:
   D000010-16001).
CR Ailertz P., 1961, P IRE, V49, P1161
   Angeli A., 1916, GAZZ CHIM ITAL, V46
   Arwin H, 2001, SENSOR ACTUAT A-PHYS, V92, P43, DOI 10.1016/S0924-4247(01)00538-6
   Babacan S, 2000, BIOSENS BIOELECTRON, V15, P615, DOI 10.1016/S0956-5663(00)00115-9
   Bardea A, 1999, ANAL CHIM ACTA, V385, P33, DOI 10.1016/S0003-2670(98)00666-7
   BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688
   BIRKHOLZ M, 1995, Z PHYS B CON MAT, V96, P333, DOI 10.1007/BF01313055
   Bohunicky B, 2011, NANOTECHNOL SCI APPL, V4, P1, DOI 10.2147/NSA.S13465
   Calame F, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2472529
   CASS AEG, 1984, ANAL CHEM, V56, P667, DOI 10.1021/ac00268a018
   Chen L, 2007, SENSOR ACTUAT B-CHEM, V121, P423, DOI 10.1016/j.snb.2006.04.067
   Chen SH, 2008, J MICROBIOL METH, V73, P7, DOI 10.1016/j.mimet.2008.01.004
   Chinnayelka S, 2005, ANAL CHEM, V77, P5501, DOI 10.1021/ac050755u
   CLARK LC, 1953, J APPL PHYSIOL, V6, P189
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0
   Coon DR, 1997, ANAL CHEM, V69, P4120, DOI 10.1021/ac970171v
   Cosnier S, 1997, ELECTROANAL, V9, P894, DOI 10.1002/elan.1140091206
   Cui DX, 2007, J NANOSCI NANOTECHNO, V7, P1639, DOI 10.1166/jnn.2007.348
   Das N, 2007, MATER LETT, V61, P2100, DOI 10.1016/j.matlet.2006.08.026
   Ding YJ, 2007, BIOMATERIALS, V28, P2147, DOI 10.1016/j.biomaterials.2006.12.025
   Dubois MA, 1999, SENSOR ACTUAT A-PHYS, V77, P106, DOI 10.1016/S0924-4247(99)00070-9
   Egusa S, 2010, NAT MATER, V9, P643, DOI [10.1038/nmat2792, 10.1038/NMAT2792]
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   Farrar D, 2008, SCRIPTA MATER, V59, P1051, DOI 10.1016/j.scriptamat.2008.07.022
   Frense D, 1998, SENSOR ACTUAT B-CHEM, V51, P256, DOI 10.1016/S0925-4005(98)00203-2
   Garipcan B., 2010, NEW PERSPECT BIO, p[9, 197]
   Ghosh S, 2005, MATER RES BULL, V40, P2073, DOI 10.1016/j.materresbull.2005.07.017
   Ghoshal S., 2010, SENSORS TRANSDUCERS, V113, P1
   Gopidas KR, 2003, NANO LETT, V3, P1757, DOI 10.1021/nl0348490
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   GUILBAULT GG, 1973, ANAL CHIM ACTA, V64, P439, DOI 10.1016/S0003-2670(01)82476-4
   Gupta R, 2007, BIOSENS BIOELECTRON, V22, P2387, DOI 10.1016/j.bios.2006.12.025
   Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x
   He FJ, 2002, ANAL SCI, V18, P397, DOI 10.2116/analsci.18.397
   HENNIG EM, 1982, J BIOMED ENG, V4, P213, DOI 10.1016/0141-5425(82)90005-X
   Huang MH, 2005, LANGMUIR, V21, P323, DOI 10.1021/la048337s
   Hughes WS, 1922, J AM CHEM SOC, V44, P2860, DOI 10.1021/ja01433a021
   Ivnitski D, 1999, BIOSENS BIOELECTRON, V14, P599, DOI 10.1016/S0956-5663(99)00039-1
   Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767
   Jia X, 2008, SENSOR ACTUAT B-CHEM, V134, P273, DOI 10.1016/j.snb.2008.04.043
   Justino CIL, 2010, TRAC-TREND ANAL CHEM, V29, P1172, DOI 10.1016/j.trac.2010.07.008
   KANAZAWA KK, 1985, ANAL CHIM ACTA, V175, P99
   Kar KK, 2012, US Patent, Patent No. [20120107612 A1, 20120107612]
   KING WH, 1964, ANAL CHEM, V36, P1735, DOI 10.1021/ac60215a012
   Kingon AI, 2005, NAT MATER, V4, P233, DOI 10.1038/nmat1334
   Ko HJ, 2005, BIOSENS BIOELECTRON, V20, P1327, DOI 10.1016/j.bios.2004.05.002
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Krame D. A., 2003, US GEOLOGICAL SURVEY, V2003, P281
   Kumar MA, 2011, SENSORS-BASEL, V11, P5087, DOI 10.3390/s110505087
   Kumar MM, 2000, APPL PHYS LETT, V76, P2764, DOI 10.1063/1.126468
   LE D, 1995, J MICROBIOL METH, V23, P229, DOI 10.1016/0167-7012(95)00018-G
   Lec RM, 2001, P IEEE INT FREQ CONT, P419, DOI 10.1109/FREQ.2001.956265
   Li IT, 2006, BIOTECHNOL LETT, V28, P1971, DOI 10.1007/s10529-006-9193-5
   Li YY, 2010, GOLD BULL, V43, P29, DOI 10.1007/BF03214964
   LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7
   Ligler FS, 2006, NATO SCI SER II-MATH, V224, P437
   Lu X, 2011, CURR APPL PHYS, V11, pS285, DOI 10.1016/j.cap.2011.03.006
   Lubk A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104110
   Luginbuhl P, 1996, SENSOR ACTUAT A-PHYS, V54, P530, DOI 10.1016/S0924-4247(95)01196-X
   Luo XL, 2006, ELECTROANAL, V18, P319, DOI 10.1002/elan.200503415
   Ma RN, 2009, SCI CHINA SER B, V52, P2013, DOI 10.1007/s11426-009-0248-z
   Mach KE, 2011, TRENDS PHARMACOL SCI, V32, P330, DOI 10.1016/j.tips.2011.03.001
   Manbachi A, 2011, ULTRASOUND, V19, P187, DOI 10.1258/ult.2011.011027
   Mao XL, 2006, BIOSENS BIOELECTRON, V21, P1178, DOI 10.1016/j.bios.2005.04.021
   Martin-Palma RJ, 2009, SENSORS-BASEL, V9, P5149, DOI 10.3390/s90705149
   Martinez M, 2007, J BIOCHEM BIOPH METH, V70, P455, DOI 10.1016/j.jbbm.2006.11.001
   MATTHEWS DR, 1987, LANCET, V1, P778
   May EL, 2003, J THERM BIOL, V28, P469, DOI 10.1016/S0306-4565(03)00047-0
   Mohanty SP, 2006, IEEE POTENTIALS, V25, P35, DOI 10.1109/MP.2006.1649009
   Mok W, 2008, SENSORS-BASEL, V8, P7050, DOI 10.3390/s8117050
   Monk DJ, 2004, ANAL BIOANAL CHEM, V379, P931, DOI 10.1007/s00216-004-2650-x
   Mulchandani A, 2001, BIOSENS BIOELECTRON, V16, P225, DOI 10.1016/S0956-5663(01)00126-9
   Muralt P, 2008, J AM CERAM SOC, V91, P1385, DOI 10.1111/j.1551-2916.2008.02421.x
   MURAMATSU H, 1987, ANAL CHEM, V59, P2760, DOI 10.1021/ac00150a007
   Nanduri V, 2007, BIOSENS BIOELECTRON, V22, P986, DOI 10.1016/j.bios.2006.03.025
   NGEHNGWAINBI J, 1990, BIOSENS BIOELECTRON, V5, P13, DOI 10.1016/0956-5663(90)80023-7
   Nishikawa H., 2006, 2006APSMARV16011N
   Niu SY, 2008, CHINESE J CHEM, V26, P134, DOI 10.1002/cjoc.200890007
   Noheda B, 1999, APPL PHYS LETT, V74, P2059, DOI 10.1063/1.123756
   OPITZ N, 1975, PFLUG ARCH EUR J PHY, V355, pR120
   Ottova A, 1997, SUPRAMOL SCI, V4, P101, DOI 10.1016/S0968-5677(96)00054-5
   Pan BF, 2007, CANCER RES, V67, P8156, DOI 10.1158/0008-5472.CAN-06-4762
   Pan BF, 2007, COLLOID SURFACE A, V295, P217, DOI 10.1016/j.colsurfa.2006.09.002
   Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983
   Patel I, 2010, SENSOR ACTUAT A-PHYS, V159, P213, DOI 10.1016/j.sna.2010.03.022
   Patolsky F, 2000, J AM CHEM SOC, V122, P418, DOI 10.1021/ja992834r
   PETERSON JI, 1980, ANAL CHEM, V52, P864, DOI 10.1021/ac50056a022
   Pierce GW, 1923, P AM ACAD ARTS SCI, V59, P81, DOI 10.2307/20026061
   Pohanka M, 2008, J APPL BIOMED, V6, P57
   Pramanik S, 2011, THESIS KANPUR, P392
   Pramanik S, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/4/043002
   Pramanik S, 2012, J APPL POLYM SCI, V123, P1100, DOI 10.1002/app.34582
   Qi Y, 2010, ENERG ENVIRON SCI, V3, P1275, DOI 10.1039/c0ee00137f
   Qi Y, 2010, NANO LETT, V10, P524, DOI 10.1021/nl903377u
   Qiu ZC, 2009, B MATER SCI, V32, P193, DOI 10.1007/s12034-009-0030-z
   Reshetilov AN, 2010, INTELLIGENT AND BIOSENSORS, P289
   Reyes PI, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3582555
   Rodriguez-Mozaz S, 2004, PURE APPL CHEM, V76, P723, DOI 10.1351/pac200476040723
   Saghi-Szabo G, 1999, PHYS REV B, V59, P12771, DOI 10.1103/PhysRevB.59.12771
   Sagmeister BP, 2009, BIOSENS BIOELECTRON, V24, P2643, DOI 10.1016/j.bios.2009.01.023
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847
   Schultz J S, 1986, ASAIO Trans, V32, P705
   SCHULTZ JS, 1982, DIABETES CARE, V5, P245, DOI 10.2337/diacare.5.3.245
   Severinghaus J W, 1986, J Clin Monit, V2, P60, DOI 10.1007/BF01619178
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Shanthy S, 2008, INTEGR FERROELECTR, V99, P77, DOI 10.1080/10584580802107726
   Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571
   Shen GY, 2011, ELECTROCHIM ACTA, V56, P8272, DOI 10.1016/j.electacta.2011.06.090
   Shen GY, 2005, TALANTA, V67, P217, DOI 10.1016/j.talanta.2005.02.020
   Shetty S, 2002, PRAMANA-J PHYS, V58, P1027, DOI 10.1007/s12043-002-0211-4
   Smith AM, 2006, EXPERT REV MOL DIAGN, V6, P231, DOI 10.1586/14737159.6.2.231
   Song GR, 2009, MEASUREMENT, V42, P1214, DOI 10.1016/j.measurement.2009.04.008
   SRIYUDTHSAK M, 1988, THIN SOLID FILMS, V160, P463, DOI 10.1016/0040-6090(88)90092-2
   Stolen S, 2006, PHYS CHEM CHEM PHYS, V8, P429, DOI 10.1039/b512271f
   Tan CZ, 2003, OPT LETT, V28, P1466, DOI 10.1364/OL.28.001466
   Taratula O, 2010, CURR OPIN CHEM BIOL, V14, P97, DOI 10.1016/j.cbpa.2009.10.009
   Tatsuma T, 1997, ANAL CHEM, V69, P887, DOI 10.1021/ac960750k
   Tavakolpour AR, 2010, SIMUL MODEL PRACT TH, V18, P516, DOI 10.1016/j.simpat.2009.12.007
   Thust M, 1999, J MOL CATAL B-ENZYM, V7, P77, DOI 10.1016/S1381-1177(99)00023-5
   Tombelli S, 2000, BIOSENS BIOELECTRON, V15, P363, DOI 10.1016/S0956-5663(00)00092-0
   Tombelli S, 2002, BIOSENS BIOELECTRON, V17, P929, DOI 10.1016/S0956-5663(02)00084-2
   Ujimoto K, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3692579
   Verardi P, 1999, SENSOR ACTUAT A-PHYS, V74, P41, DOI 10.1016/S0924-4247(98)00342-2
   Verissimo MIS, 2009, CERAM INT, V35, P617, DOI 10.1016/j.ceramint.2008.01.016
   Vittayakorn N., 2006, NU SCI J, V2, P157
   Vo-Dinh T, 2000, FRESEN J ANAL CHEM, V366, P540, DOI 10.1007/s002160051549
   WALKER AC, 1953, J AM CERAM SOC, V36, P250, DOI 10.1111/j.1151-2916.1953.tb12877.x
   Wang B, 2009, BIOSENS BIOELECTRON, V24, P1141, DOI 10.1016/j.bios.2008.06.053
   Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113
   Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615
   Wang J, 2001, ELECTROANAL, V13, P13, DOI 10.1002/1521-4109(200101)13:1<13::AID-ELAN13>3.0.CO;2-F
   Xiong S, 2008, THIN SOLID FILMS, V516, P5309, DOI 10.1016/j.tsf.2007.07.085
   Xu JH, 2009, J ALLOY COMPD, V472, P473, DOI 10.1016/j.jallcom.2008.04.090
   Yang JY, 2011, INT J ELECTROCHEM SC, V6, P2223
   Yin J, 2007, ANAL BIOCHEM, V360, P99, DOI 10.1016/j.ab.2006.10.007
   Yogeswaran U, 2008, SENSORS-BASEL, V8, P290, DOI 10.3390/s8010290
   Yoo EH, 2010, SENSORS-BASEL, V10, P4558, DOI 10.3390/s100504558
   You XG, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/3/035701
   Zachariasz R, 2007, MATER SCI-POLAND, V25, P781
   Zhang DD, 2010, BIOSENS BIOELECTRON, V25, P1088, DOI 10.1016/j.bios.2009.09.032
   Zhang XY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3062857
   Zhang XQ, 2009, SENSORS-BASEL, V9, P1033, DOI 10.3390/s90201033
   Zhao J, 2001, J CRYST GROWTH, V225, P173, DOI 10.1016/S0022-0248(01)00865-X
   Zhou XC, 2001, BIOSENS BIOELECTRON, V16, P85, DOI 10.1016/S0956-5663(00)00136-6
NR 147
TC 16
Z9 16
U1 2
U2 62
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD JUN
PY 2013
VL 8
IS 6
BP 8863
EP 8892
PG 30
WC Electrochemistry
SC Electrochemistry
GA 206TP
UT WOS:000323546100114
DA 2018-10-20
ER

PT J
AU Girard, J
   Brunetto, PS
   Braissant, O
   Rajacic, Z
   Khanna, N
   Landmann, R
   Daniels, AU
   Fromm, KM
AF Girard, Jerome
   Brunetto, Priscilla S.
   Braissant, Olivier
   Rajacic, Zarko
   Khanna, Nina
   Landmann, Regine
   Daniels, Alma U.
   Fromm, Katharina M.
TI Development of a polystyrene sulfonate/silver nanocomposite with
   self-healing properties for biomaterial applications
SO COMPTES RENDUS CHIMIE
LA English
DT Article
DE Nanocomposite; Silver; Antibacterial; Self-healing; Biomaterial;
   Polymers
ID SILVER NANOPARTICLES; POLYMER NANOCOMPOSITES; PARTICLE-SIZE; SURFACES;
   CELLS; BIOCOMPATIBILITY; AGGREGATION; SULFONATION; COMPOSITES;
   DISPERSION
AB A silver polystyrene sulfonate polyelectrolyte was synthesized, showing a spontaneous reduction of silver ions to silver nanoparticles over a period of approximately 1 month. A follow-up of the nanoparticle formation via scanning electron microscopy (SEM) reveals migration of the nanoparticles towards the cracks of the polymer over time, leading to a self-healing process of the nanocomposite. Antibacterial tests show excellent antibacterial activity of our compound, which allows us to use this compound e.g. for external medical applications. (C) 2013 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.
C1 [Girard, Jerome; Brunetto, Priscilla S.; Fromm, Katharina M.] Univ Fribourg, Dept Chem, CH-1700 Fribourg, Switzerland.
   [Braissant, Olivier; Daniels, Alma U.] Univ Basel, Biomech & Calorimetry Ctr Basel, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Rajacic, Zarko; Khanna, Nina; Landmann, Regine] Univ Basel Hosp, Dept Biomed, CH-4056 Basel, Switzerland.
RP Fromm, KM (reprint author), Univ Fribourg, Dept Chem, 9 Chemin Musee, CH-1700 Fribourg, Switzerland.
EM katharina.fromm@unifr.ch
RI Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X
CR Asthana H, 1997, J ADHES SCI TECHNOL, V11, P1269, DOI 10.1163/156856197X00138
   Atlas R. M., 2004, HDB MICROBIOLOGICAL
   Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557
   Beek WJE, 2004, ADV MATER, V16, P1009, DOI 10.1002/adma.200306659
   Belser K, 2009, ANGEW CHEM INT EDIT, V48, P3661, DOI 10.1002/anie.200806265
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Brunetto PS, 2008, CHIMIA, V62, P249, DOI 10.2533/chimia.2008.249
   Brunetto PS, 2011, MATERIALS, V4, P355, DOI 10.3390/ma4020355
   Chatterjee U, 2009, POLYM COMPOSITE, V30, P827, DOI 10.1002/pc.20655
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dutta S, 2011, LANGMUIR, V27, P5000, DOI 10.1021/la104903z
   Fromm KM, 2011, NAT CHEM, V3, P178, DOI 10.1038/nchem.970
   Fromm KM, 2010, MACROMOL SYMP, V291-292, P75, DOI 10.1002/masy.201050509
   GIBSON HW, 1980, MACROMOLECULES, V13, P34, DOI 10.1021/ma60073a007
   Goldstein J., 1981, SCANNING ELECT MICRO
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   Gupta S, 2006, NAT MATER, V5, P229, DOI 10.1038/nmat1582
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Huang HH, 1996, LANGMUIR, V12, P909, DOI 10.1021/la950435d
   Kallay N, 2002, J COLLOID INTERF SCI, V253, P70, DOI 10.1006/jcis.2002.8476
   Ktari N, 2011, J PHYS CHEM C, V115, P17891, DOI 10.1021/jp205343r
   Lee JY, 2006, MACROMOLECULES, V39, P7392, DOI 10.1021/ma061210k
   Lee JY, 2004, J CHEM PHYS, V121, P5531, DOI 10.1063/1.1784432
   Lienkamp K, 2006, MACROMOL CHEM PHYSIC, V207, P2066, DOI 10.1002/macp.200600322
   Liu J, 2011, LANGMUIR, V27, P7926, DOI 10.1021/la201073m
   Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745
   Madigan M. T., 2006, BROCK BIOL MICROORGA
   Mannan MA, 2007, POLYM J, V39, P500
   Meyer I., 1993, NEPHROL NURS J, V20, P93
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MURRAY PR, 2003, MANUAL CLIN MICROBIO
   Nam KT, 2008, ACS NANO, V2, P1480, DOI 10.1021/nn800018n
   Nic M., 2009, POLYELECTROLYTE
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Scherrer P., 1918, GOTTINGER NACHRICHTE, V2, P98
   Sun YG, 2003, ANALYST, V128, P686, DOI 10.1039/b212437h
   Tyagi S, 2004, MACROMOLECULES, V37, P9160, DOI 10.1021/ma0487731
   Watson M, 2010, CLIN J AM SOC NEPHRO, V5, P1723, DOI 10.2215/CJN.03700410
   Wu DY, 2008, PROG POLYM SCI, V33, P479, DOI 10.1016/j.progpolymsci.2008.02.001
NR 39
TC 13
Z9 13
U1 1
U2 45
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1631-0748
J9 CR CHIM
JI C. R. Chim.
PD JUN
PY 2013
VL 16
IS 6
BP 550
EP 556
DI 10.1016/j.crci.2013.04.010
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 198MK
UT WOS:000322926800007
DA 2018-10-20
ER

PT J
AU Deepa, R
   Paul, W
   Anilkumar, TV
   Sharma, CP
AF Deepa, R.
   Paul, Willi
   Anilkumar, T. V.
   Sharma, Chandra P.
TI Differential Healing of Full Thickness Rabbit Skin Wound by Fibroblast
   Loaded Chitosan Sponge
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Wound Healing; Chitosan Skin Graft; Histomorphometry;
   Re-Epithelialisation; Cell-Proliferation
ID EPIDERMAL-GROWTH-FACTOR; DERMAL FIBROBLASTS; CELLS; SCAFFOLDS;
   RECONSTRUCTION; FORMULATION; INSIGHTS; MODEL; BFGF; GEL
AB For fabricating skin grafts with differential healing properties, enrichment with biomolecules/cells may be desirable. Earlier, we have developed a biomaterial-quality chitosan for biomedical application. Here we evaluated the wound healing potential of the chitosan-preparation and its variant, prepared by loading homologus fibroblast. Dermal fibroblasts isolated from rabbit skin were seeded on chitosan sponge to fabricate a homologous fibroblast loaded chitosan graft (HFLC). Full thickness excision wounds created on the rabbit dorsum were grafted with these two types of the chitosan sponges; naked or non cellular chitosan graft (NCC) and the homologous fibroblast loaded chitosan graft (HFLC). Post-graft skin-wound samples were examined histomorphologically at 7th, 14th and 21st day for evaluating the nature of the tissue reaction induced by the grafts. The wound healing parameters considered were the extent of re-epithelialisation, collagen deposition and angiogenesis, the thickness of epidermis, number of proliferating cells, vimentin positive cells and alpha smooth muscle actin cells. The results suggested that both the grafts aided wound healing but the HFLC induced a differential pattern of healing at 7 and 14 days featured by enhanced angiogenesis, desmoplasia and a hyperkeratotic dermis. Under therapeutic conditions, the HFLC may be useful for regulating the extent of collagen deposition in the early phases of a healing wound.
C1 [Deepa, R.; Anilkumar, T. V.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Lab Expt Pathol, Trivandrum 695012, Kerala, India.
   [Paul, Willi; Sharma, Chandra P.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Biosurface Technol Div, Trivandrum 695012, Kerala, India.
RP Anilkumar, TV (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Lab Expt Pathol, Trivandrum 695012, Kerala, India.
FU CSIR; Department of Science and Technology, Government of India [8013]
FX Ms. Deepa Ravi acknowledges CSIR for the fellowship. This work was
   supported by Department of Science and Technology, Government of India
   through project "Facility for nano/microparticle based
   biomaterials-advanced drug delivery systems" # 8013, under Drugs and
   Pharmaceuticals Research Programme.
CR Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015
   Alemdaroglu C, 2008, J BIOMED MATER RES A, V85A, P271, DOI 10.1002/jbm.a.31588
   Anilkumar TV, 2011, BIOLOGICALS, V39, P81, DOI 10.1016/j.biologicals.2011.01.003
   Bancroft J. D., 2007, THEORY PRACTICE HIST
   Barie P. S., 2008, WOUNDS BIOL PATHOLOG, P191
   Barisic-Dujmovic T, 2010, J CELL PHYSIOL, V222, P703, DOI 10.1002/jcp.21997
   Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Choi JS, 2010, J BIOMED MATER RES A, V95A, P564, DOI 10.1002/jbm.a.32848
   CLARK RAF, 1993, AM J MED SCI, V306, P42, DOI 10.1097/00000441-199307000-00011
   Cui FY, 2011, DRUG DELIV, V18, P173, DOI 10.3109/10717544.2010.509363
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   de la Puente P, 2011, J BIOMED MATER RES A, V99A, P648, DOI 10.1002/jbm.a.33231
   Eckes B, 2000, J CELL SCI, V113, P2455
   Ejaz S, 2009, BIOMED ENVIRON SCI, V22, P278, DOI 10.1016/S0895-3988(09)60057-X
   Francesko A, 2011, ADV BIOCHEM ENG BIOT, V125, P1, DOI [10.1007/10_2010_93, 10.10007/10_2010_93]
   Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153
   Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013
   Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730
   Hsieh WC, 2007, COLLOID SURFACE B, V57, P250, DOI 10.1016/j.colsurfb.2007.02.004
   Kanazawa S., 2010, PLOS ONE, V5
   Lauder CIW, 2011, J SURG RES, V171, P877, DOI 10.1016/j.jss.2010.06.028
   Lee WR, 2009, WOUND REPAIR REGEN, V17, P505, DOI 10.1111/j.1524-475X.2009.00496.x
   MIGNATTI P, 1991, P NATL ACAD SCI USA, V88, P11007, DOI 10.1073/pnas.88.24.11007
   Minagawa T, 2007, CARBOHYD POLYM, V67, P640, DOI 10.1016/j.carbpol.2006.07.007
   Mujaj S, 2010, TISSUE ENG PT A, V16, P1407, DOI 10.1089/ten.TEA.2009.0251
   Nakagawa H, 2005, BRIT J DERMATOL, V153, P29, DOI 10.1111/j.1365-2133.2005.06554.x
   Parnigotto Pier Paolo, 1994, Italian Journal of Anatomy and Embryology, V99, P17
   Paul W., 2012, TRENDS BIOMATERIALS, V26, P3
   Pearson AS, 2000, PRIMARY CARE, V27, P475, DOI 10.1016/S0095-4543(05)70208-6
   Qin YM, 2004, J APPL POLYM SCI, V91, P953, DOI 10.1002/app.13291
   RIECK P, 1992, CURR EYE RES, V11, P1161, DOI 10.3109/02713689208999541
   Sandulache VC, 2003, ARCH OTOLARYNGOL, V129, P345, DOI 10.1001/archotol.129.3.345
   Schreml S, 2010, J AM ACAD DERMATOL, V63, P866, DOI 10.1016/j.jaad.2009.10.048
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   TUAN TL, 1994, J CELL SCI, V107, P2285
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Woodroof EA, 2010, EPLASTY, V10, pe60
   Yannas IV, 2005, ADV BIOCHEM ENG BIOT, V93, P1, DOI 10.1007/b99965
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
NR 42
TC 9
Z9 9
U1 1
U2 12
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD JUN
PY 2013
VL 3
IS 3
BP 261
EP 272
DI 10.1166/jbt.2013.1094
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 194AY
UT WOS:000322604600002
DA 2018-10-20
ER

PT J
AU Chen, B
   Yin, DG
   Chen, X
   Yuan, Q
   Zhang, ZL
AF Chen, Bin
   Yin, Dagang
   Chen, Xi
   Yuan, Quan
   Zhang, Zhiling
TI Nanostructural Mechanism of Toughness of Crab Carapace
SO JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE
LA English
DT Article
DE Crab Carapace; Calcite Crystal Sheet; Nanostructure; Pullout Energy;
   Fracture Toughness
ID DENTIN
AB Crab carapace is a kind of biomaterial in nature with high fracture strength and fracture toughness. The excellent mechanical property of the carapace is closely related to its fine nanostructures. The observation of scanning electron microscope (SEM) on the carapace of a Cyclodorippoidea crab shows that the carapace is a kind of natural bioceramic composite which consists of calcite crystal layers and collagen protein matrix. It is also found that the calcite crystal layers consist further of long and thin calcite crystal sheets. The thickness of the calcite crystal sheets is within nanometer scale. The nanometer calcite crystal sheets are arranged in a kind of parallel distribution. The maximum pullout energy of the nanometer calcite crystal sheets, which is closely related to the fracture toughness of the carapace, is investigated based on the representative model of the parallel distribution of the nanometer calcite crystal sheets. It shows that the long and thin shape as well as the parallel distribution of the nanometer calcite crystal sheets bring their larger pullout energy and endow the carapace with the high fracture toughness.
C1 [Chen, Bin; Yin, Dagang; Yuan, Quan; Zhang, Zhiling] Chongqing Univ, Dept Engn Mech, Coll Resources & Environm Sci, Chongqing 400044, Peoples R China.
   [Chen, Bin] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 400044, Peoples R China.
   [Chen, Xi] Columbia Univ, Dept Earth & Environm Engn, New York, NY 10027 USA.
RP Chen, B (reprint author), Chongqing Univ, Dept Engn Mech, Coll Resources & Environm Sci, Chongqing 400044, Peoples R China.
RI Chen, Xi/B-1539-2008
OI Chen, Xi/0000-0002-1263-1024
FU Natural Science Foundations of China [11272367, 50921063]
FX The authors gratefully acknowledge the financial supports to this work
   from the Natural Science Foundations of China (Grant nos. 11272367 and
   50921063).
CR Bobelmann F, 2007, THERMOCHIM ACTA, V463, P65, DOI 10.1016/j.tca.2007.07.018
   Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010
   CHONG KP, 1999, MECH AAM, V28, P1
   Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2
   JERONIMIDIS G, 1980, PROC R SOC SER B-BIO, V208, P447, DOI 10.1098/rspb.1980.0062
   Katti D R, 2001, COMP THEO POLY SCI, V11, P396
   Koester KJ, 2008, BIOMATERIALS, V29, P1318, DOI 10.1016/j.biomaterials.2007.12.008
   Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6
   Sarikaya M., 1989, P AM COMP, V7, P176
   Yang Q.S., 2000, MICROSTRUCTURAL MECH
   Zhou F, 2010, J MECH BEHAV BIOMED, V3, P454, DOI 10.1016/j.jmbbm.2010.05.001
NR 11
TC 0
Z9 0
U1 2
U2 14
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1546-1955
J9 J COMPUT THEOR NANOS
JI J. Comput. Theor. Nanosci.
PD JUN
PY 2013
VL 10
IS 6
BP 1436
EP 1440
DI 10.1166/jctn.2013.2867
PG 5
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 180NA
UT WOS:000321600700022
DA 2018-10-20
ER

PT J
AU Kim, BS
   Park, KE
   Park, WH
   Lee, J
AF Kim, Beom-Su
   Park, Ko Eun
   Park, Won Ho
   Lee, Jun
TI Fabrication of nanofibrous scaffold using a PLA and hagfish thread
   keratin composite; its effect on cell adherence, growth, and osteoblast
   differentiation
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID GLAND THREAD; EPTATRETUS-STOUTI; POLY(LACTIC ACID); DRUG-DELIVERY;
   ELECTROSPUN; SLIME; FIBER; CULTIVATION; BIOPOLYMER; COMPONENTS
AB Electrospinning is a useful method for the production of nanofibrous scaffolds in the field of tissue engineering. Keratin has been used as a biomaterial for electrospinning and can be used in a variety of biomedical applications because it is a natural protein, giving it the ability to improve cell affinity of scaffolds. In this study, keratin was extracted from hagfish slime thread (H-keratin) and blended with polylactic acid (PLA) polymer solution to construct a nanofibrous scaffold. Wool keratin (W-keratin) was used as a control for the comparison of morphological, physical, and biological properties. The results of Fourier transform infrared spectroscopy showed the presence of both W-keratin and H-keratin in the electrospun PLA/keratin. Observations with a scanning electron microscope revealed that PLA, PLA/W-keratin, and PLA/H-keratin had similar average diameters (similar to 800 nm). Cell attachment experiments showed that MG-63 cells adhered more rapidly and spread better onto PLA/H-keratin than onto the pure PLA or PLA/W-keratin. Cell proliferation assay, DNA content, live/dead, and alkaline phosphatase activity assays showed that PLA/H-keratin scaffolds could accelerate the viability, proliferation, and osteogenesis of MG-63 cells relative to pure PLA or PLA/W-keratin nanofibrous scaffolds. These findings suggest that H-keratin can improve cellular attraction and has great potential to be used as a biomaterial in bone tissue engineering.
C1 [Kim, Beom-Su; Lee, Jun] Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan 570749, South Korea.
   [Kim, Beom-Su] Bonecell Biotech Inc, Taejon 302830, South Korea.
   [Park, Ko Eun; Park, Won Ho] Chungnam Natl Univ, Dept Adv Organ Mat & Textile Engn Syst, Taejon 305764, South Korea.
RP Lee, J (reprint author), Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan 570749, South Korea.
EM omslee@wku.ac.kr
OI Park, Won Ho/0000-0003-1768-830X
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science and Technology [2012-040526]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Science and Technology (2012-040526).
CR Aluigi A, 2008, EUR POLYM J, V44, P2465, DOI 10.1016/j.eurpolymj.2008.06.004
   Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   FEUGHELMANN M, 1985, ENCY POLYM SCI ENG, P566
   Fudge DS, 2005, J EXP BIOL, V208, P4613, DOI 10.1242/jeb.01963
   Fudge DS, 2004, P ROY SOC B-BIOL SCI, V271, P291, DOI 10.1098/rspb.2003.2591
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Gui-Bo Y, 2010, J BIOMED MATER RES A, V93A, P158, DOI 10.1002/jbm.a.32496
   Hadjiargyrou M, 2008, EXPERT OPIN DRUG DEL, V5, P1093, DOI [10.1517/17425247.5.10.1093 , 10.1517/17425240802399695]
   Jannesari Marziyeh, 2011, Int J Nanomedicine, V6, P993, DOI 10.2147/IJN.S17595
   Kirsner RS, 2012, ADV SKIN WOUND CARE, V25, P400, DOI 10.1097/01.ASW.0000419404.44947.de
   KOCH EA, 1991, CELL TISSUE RES, V264, P79, DOI 10.1007/BF00305724
   KOCH EA, 1994, J CELL SCI, V107, P3133
   KOCH EA, 1995, INT J BIOL MACROMOL, V17, P283, DOI 10.1016/0141-8130(95)98156-S
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P933, DOI 10.1002/pol.1981.180190603
   Li MY, 2005, P ANN INT IEEE EMBS, P5858
   Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6
   Liu HC, 2004, BIOMATERIALS, V25, P4047, DOI 10.1016/j.biomaterials.2003.10.098
   Lv R, 2008, J FIBER BIOENG INFOR, V1, P29
   Meyer DC, 2006, CLIN ORTHOP RELAT R, P143, DOI 10.1097/01.blo.0000185033.32220.57
   Qiao Dong-Fang, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P902
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   SPITZER RH, 1984, J CELL BIOL, V98, P670, DOI 10.1083/jcb.98.2.670
   SPITZER RH, 1988, CELL MOTIL CYTOSKEL, V11, P31, DOI 10.1002/cm.970110105
   Subramanian A, 2005, J BIOMAT SCI-POLYM E, V16, P861, DOI 10.1163/1568562054255682
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
NR 30
TC 9
Z9 9
U1 3
U2 64
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2013
VL 8
IS 4
AR 045006
DI 10.1088/1748-6041/8/4/045006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 188BX
UT WOS:000322167700009
PM 23735650
DA 2018-10-20
ER

PT J
AU Nakada, A
   Shigeno, K
   Sato, T
   Kobayashi, T
   Wakatsuki, M
   Uji, M
   Nakamura, T
AF Nakada, A.
   Shigeno, K.
   Sato, T.
   Kobayashi, T.
   Wakatsuki, M.
   Uji, M.
   Nakamura, T.
TI Manufacture of a weakly denatured collagen fiber scaffold with excellent
   biocompatibility and space maintenance ability
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID POLYGLYCOLIC ACID; POROUS SCAFFOLDS; CROSS-LINKING; NERVE REPAIR; BONE;
   SKIN; REGENERATION; BIOMATERIAL; NANOFIBERS; MODEL
AB Although collagen scaffolds have been used for regenerative medicine, they have insufficient mechanical strength. We made a weakly denatured collagen fiber scaffold from a collagen fiber suspension (physiological pH 7.4) through a process of freeze drying and denaturation with heat under low pressure (1 x 10(-1) Pa). Heat treatment formed cross-links between the collagen fibers, providing the scaffold with sufficient mechanical strength to maintain the space for tissue regeneration in vivo. The scaffold was embedded under the back skin of a rat, and biocompatibility and space maintenance ability were examined after 2 weeks. These were evaluated by using the ratio of foreign body giant cells and thickness of the residual scaffold. A weakly denatured collagen fiber scaffold with moderate biocompatibility and space maintenance ability was made by freezing at -10 degrees C, followed by denaturation at 140 degrees C for 6 h. In addition, the direction of the collagen fibers in the scaffold was adjusted by cooling the suspension only from the bottom of the container. This process increased the ratio of cells that infiltrated into the scaffold. A weakly denatured collagen fiber scaffold thus made can be used for tissue regeneration or delivery of cells or proteins to a target site.
C1 [Nakada, A.; Shigeno, K.; Kobayashi, T.; Wakatsuki, M.; Uji, M.; Nakamura, T.] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto 6068501, Japan.
   [Sato, T.] Kyoto Univ, Dept Thorac Surg, Kyoto 6068501, Japan.
RP Nakamura, T (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto 6068501, Japan.
EM nakada@frontier.kyoto-u.ac.jp
CR Akita S, 2010, STEM CELLS INT, V2010
   Bushnell BD, 2008, J HAND SURG-AM, V33A, P1081, DOI 10.1016/j.jhsa.2008.03.015
   Choi JS, 2010, TISSUE ENG PART C-ME, V16, P387, DOI [10.1089/ten.tec.2009.0276, 10.1089/ten.TEC.2009.0276]
   DREXLER JW, 2010, TISSUE ENG, V17, P9
   Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   Guan JJ, 2006, CELL TRANSPLANT, V15, pS17, DOI 10.3727/000000006783982412
   Hamada H, 2010, BIOL PHARM BULL, V33, P1228, DOI 10.1248/bpb.33.1228
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11
   Kato Y, 2009, EUR J CARDIO-THORAC, V35, P37, DOI 10.1016/j.ejcts.2008.07.067
   Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   King G, 1996, PROTEIN ENG, V9, P43, DOI 10.1093/protein/9.1.43
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Lee H, 2011, J BIOMED MATER RES B, V97B, P263, DOI 10.1002/jbm.b.31809
   Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   MOELLER HD, 1995, J ANAT, V187, P161
   Nakamura T, 2010, SURG TODAY, V40, P734, DOI 10.1007/s00595-009-4131-5
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473
   Seo K, 2008, J ORAL MAXIL SURG, V66, P1481, DOI 10.1016/j.joms.2007.08.029
   Sobol E, 2000, BIOTECHNOL GENET ENG, V17, P553, DOI 10.1080/02648725.2000.10648005
   SUGANUMA J, 1993, J APPL BIOMATER, V4, P13, DOI 10.1002/jab.770040103
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Torres-Giner S, 2009, ACS APPL MATER INTER, V1, P218, DOI 10.1021/am800063x
   Ueda H, 2003, J CONTROL RELEASE, V88, P55, DOI 10.1016/S0168-3659(02)00481-9
   Ueda K, 2010, J THORAC CARDIOV SUR, V139, P600, DOI 10.1016/j.jtcvs.2009.06.021
   Waitayawinyu T, 2007, J HAND SURG-AM, V32A, P1521, DOI 10.1016/j.jhsa.2007.07.015
   WANG MC, 1994, BIOMATERIALS, V15, P507
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
NR 33
TC 5
Z9 5
U1 0
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2013
VL 8
IS 4
AR 045010
DI 10.1088/1748-6041/8/4/045010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 188BX
UT WOS:000322167700013
PM 23804650
DA 2018-10-20
ER

PT J
AU O'Donnell, MJ
   George, MN
   Carrington, E
AF O'Donnell, Michael J.
   George, Matthew N.
   Carrington, Emily
TI Mussel byssus attachment weakened by ocean acidification
SO NATURE CLIMATE CHANGE
LA English
DT Article
ID MYTILUS-CALIFORNIANUS; SEASONAL-VARIATION; MECHANICAL DESIGN; BLUE
   MUSSELS; STRENGTH; ECOMECHANICS; DISTURBANCE; ADHESION; IMPACTS; EDULIS
AB Biomaterials connect organisms to their environments. Their function depends on biological, chemical and environmental factors, both at the time of creation and throughout the life of the material. Shifts in the chemistry of the oceans driven by anthropogenic CO2 (termed ocean acidification) have profound implications for the function of critical materials formed under these altered conditions. Most ocean acidification studies have focused on one biomaterial (secreted calcium carbonate), frequently using a single assay (net rate of calcification) to quantify whether reductions in environmental pH alter how organisms create biomaterials(1). Here, we examine biological structures critical for the success of ecologically and economically important bivalve molluscs. One non-calcified material, the proteinaceous byssal threads that anchor mytilid mussels to hard substrates, exhibited. reduced mechanical performance when secreted under elevated p(CO2) conditions, whereas shell and tissue growth were unaffected. Threads made under high p(CO2) (>1,200 mu atm) were weaker and less extensible owing to compromised attachment to the substratum. According to a mathematical model, this reduced byssal fibre performance, decreasing individual tenacity by 40%. In the face of ocean acidification, weakened attachment presents a potential challenge for suspension-culture mussel farms and for intertidal communities anchored by mussel beds.
C1 [O'Donnell, Michael J.; George, Matthew N.; Carrington, Emily] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA.
   [George, Matthew N.; Carrington, Emily] Univ Washington, Dept Biol, Seattle, WA 98195 USA.
RP O'Donnell, MJ (reprint author), Univ Washington, Friday Harbor Labs, 620 Univ Rd, Friday Harbor, WA 98250 USA.
EM mooseo@uw.edu
RI George, Matthew/M-8748-2018
OI George, Matthew/0000-0003-1264-8667
FU NSF [DBI0829486, EF104113]
FX Thanks to M. Herko and L. Newcomb for assistance with water chemistry
   and animal care, and L. Miller for help with figures. This work was
   supported by NSF award #DBI0829486 to K. Sebens, T. Klinger and J.
   Murray, and by NSF award #EF104113 to E. Carrington.
CR [Anonymous], 2009, FAO YB FISH AQ STAT
   Bell EC, 1996, J EXP BIOL, V199, P1005
   Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037
   Carrington E, 2002, LIMNOL OCEANOGR, V47, P1723, DOI 10.4319/lo.2002.47.6.1723
   Carrington E, 2004, AM MALACOL BULL, V18, P135
   Carrington E, 2009, LIMNOL OCEANOGR, V54, P978, DOI 10.4319/lo.2009.54.3.0978
   Denny M, 2009, INTEGR COMP BIOL, V49, P197, DOI 10.1093/icb/icp070
   Denny MW, 2010, ANNU REV MAR SCI, V2, P89, DOI 10.1146/annurev-marine-120308-081011
   Dickson AG, 2007, PICES SPEC PUBL, V3
   Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676
   Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939
   Harrington MJ, 2007, J EXP BIOL, V210, P4307, DOI 10.1242/jeb.009753
   Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509
   Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x
   Lachance AA, 2008, AQUAT BIOL, V2, P119, DOI 10.3354/ab00041
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223
   Moeser GM, 2006, J EXP BIOL, V209, P1996, DOI 10.1242/jeb.02234
   Nicklisch SCT, 2012, BIOFOULING, V28, P865, DOI 10.1080/08927014.2012.719023
   O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346
   PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Robbins LL, 2010, 20101280 USGS
   *ROY SOC, 2005, OC AC DUE INCR ATM C
   Waite JH, 2012, J EXP BIOL, V215, P873, DOI 10.1242/jeb.058925
   Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105
   Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200
NR 27
TC 42
Z9 44
U1 6
U2 149
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1758-678X
EI 1758-6798
J9 NAT CLIM CHANGE
JI Nat. Clim. Chang.
PD JUN
PY 2013
VL 3
IS 6
BP 587
EP 590
DI 10.1038/NCLIMATE1846
PG 4
WC Environmental Sciences; Environmental Studies; Meteorology & Atmospheric
   Sciences
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences
GA 174OX
UT WOS:000321166400020
DA 2018-10-20
ER

PT J
AU Totea, G
   Branzoi, IV
   Ionita, D
AF Totea, Georgeta
   Branzoi, Ioan Viorel
   Ionita, Daniela
TI Lactic Acid Influence on the Electrochemical Behaviour of Stainless
   Steel and CoCrMo Alloy in Human Serum
SO REVISTA DE CHIMIE
LA English
DT Article
DE biomaterial; electrochemical behaviour; lactic acid; EIS
ID PHYSIOLOGICAL SOLUTION; TITANIUM; ENVIRONMENT; STABILITY; IMPLANTS
AB The aim of this study is to evaluate the influence of lactic acid on the electrochemical behavior of three alloys used as prosthetic joints, in simulated physiological conditions. The used alloys were: SS316 and SS316L and CoCrMo. We used open circuit potential (OCP), electrochemical impedance spectroscopy (EIS) and potentiodynamic polarization, as electrolyte being chosen the human serum with different concentrations of lactic acid The inhibitor efficiency of lactic acid has been established being greater for CoCrMo alloy and for greater lactic acid concentration.
C1 [Totea, Georgeta; Branzoi, Ioan Viorel] Univ Politehn Bucuresti, Dept Inorgan Chem Phys Chem & Electrochem, Bucharest 011061, Romania.
   [Ionita, Daniela] Univ Politehn Bucuresti, Dept Gen Chem, Bucharest 011061, Romania.
RP Ionita, D (reprint author), Univ Politehn Bucuresti, Dept Gen Chem, 1-3 Gh Polizu Str, Bucharest 011061, Romania.
EM md_ionita@yahoo.com
CR [Anonymous], 2006, J ELECTROCHEM SOC, V153, P260
   Ballarre J, 2010, ACTA BIOMATER, V6, P1601, DOI 10.1016/j.actbio.2009.10.015
   Bommersbach P, 2005, ELECTROCHIM ACTA, V51, P1076, DOI 10.1016/j.electacta.2005.06.001
   Camara OR, 2010, ELECTROCHIM ACTA, V55, P4519, DOI 10.1016/j.electacta.2010.03.003
   Contu F, 2004, CORROS SCI, V46, P2241, DOI 10.1016/j.corsci.2004.01.005
   FITTS R. H., 2003, BIOCHEMISTRY-US, V3, P279
   Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701
   HANAVA T., 2011, J MATER SCI-MATER M, V22, P437
   HANSEN D. C., 2008, ELECTROCHEM SOC INTE, V2, P31
   Henriques B, 2012, J MECH BEHAV BIOMED, V12, P83, DOI 10.1016/j.jmbbm.2012.03.015
   Lewis AC, 2005, J BIOMED MATER RES A, V73A, P456, DOI 10.1002/jbm.a.30368
   Man I, 2008, REV CHIM-BUCHAREST, V59, P615
   MANSFELD E, 1973, J ELECTROCHEM SOC, V120, P515
   MARECI D., 2009, REV CHIM-BUCHAREST, V60, P787
   Milosev I, 2003, ELECTROCHIM ACTA, V48, P2767, DOI 10.1016/S0013-4686(03)00396-7
   Milosev I, 2000, J BIOMED MATER RES, V52, P404, DOI 10.1002/1097-4636(200011)52:2<404::AID-JBM22>3.0.CO;2-Z
   Milosev I, 2012, ELECTROCHIM ACTA, V78, P259, DOI 10.1016/j.electacta.2012.05.146
   Minovic A., 2003, J MATER SCI-MATER M, V14, P69
   Munoz A. I., 2007, J ELECTROCHEM SOC, V154, P562
   NELSON D. L., 2005, LEHNINGER PRINCIPLES, V4, P543
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   POPESCU R., 2005, REV CHIM-BUCHAREST, V56, P12
   Sovar MM, 2008, KEY ENG MATER, V361-363, P737, DOI 10.4028/www.scientific.net/KEM.361-363.737
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   YAZICI H., 2013, ACTA BIOMATER, V9, P5341
NR 25
TC 6
Z9 6
U1 0
U2 1
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD JUN
PY 2013
VL 64
IS 6
BP 625
EP 629
PG 5
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 172SK
UT WOS:000321025000013
DA 2018-10-20
ER

PT J
AU Stiehler, C
   Bunger, C
   Overall, RW
   Royer, L
   Schroeder, M
   Foss, M
   Besenbacher, F
   Kruhoffer, M
   Kassem, M
   Gunther, KP
   Stiehler, M
AF Stiehler, Claudia
   Bunger, Cody
   Overall, Rupert W.
   Royer, Loic
   Schroeder, Michael
   Foss, Morten
   Besenbacher, Flemming
   Kruhoffer, Mogens
   Kassem, Moustapha
   Guenther, Klaus-Peter
   Stiehler, Maik
TI Whole-Genome Expression Analysis of Human Mesenchymal Stromal Cells
   Exposed to Ultrasmooth Tantalum vs. Titanium Oxide Surfaces
SO CELLULAR AND MOLECULAR BIOENGINEERING
LA English
DT Article
DE Cell culture; Gene expression; Mesenchymal stem cell; Osteoblast;
   Tantalum; Titanium; Biocompatibility; Cell differentiation; Pathway
   analysis; Cell proliferation; Oxidative stress; NRF2; EGR1; IRF-1;
   IRF-8; NF-Y; p53
ID POROUS TANTALUM; OXIDATIVE STRESS; RHO-GTPASES; STEM-CELLS; BONE;
   PROTEIN; ROUGHNESS; IMPLANTS; BINDING; DIFFERENTIATION
AB Durable osseointegration of metallic bone implants requires that progenitor cells attach, proliferate and differentiate on the implant surface. Previously, we demonstrated superior biocompatibility of human mesenchymal stromal cells (MSCs) cultivated on ultrasmooth tantalum (Ta) as compared to titanium (Ti) surface. The aim of this study was to extend the previous investigation of biocompatibility by monitoring temporal gene expression of MSCs on topographically comparable smooth Ta and Ti surfaces using whole-genome gene expression analysis. Total RNA samples from telomerase-immortalized human MSCs cultivated on plain sputter-coated surfaces of Ta or Ti for 1, 2, 4, and 8 days were hybridized to n = 16 U133 Plus 2.0 arrays (Affymetrix(A (R))). Functional annotation, cluster and pathway analyses were performed. The vast majority of genes were differentially regulated after 4 days of cultivation and genes upregulated by MSCs exposed to Ta and Ti were predominantly related to the processes of differentiation and transcription, respectively. Functional annotation analysis of the 1,000 temporally most significantly regulated genes suggests earlier cellular differentiation on Ta compared to Ti surface. Key genes related to osteogenesis and cell adhesion were upregulated by MSCs exposed to Ta. We further identified differentially regulated candidate transcription factors, e.g., NRF2, EGR1, IRF-1, IRF-8, NF-Y, and p53 as well as relevant signaling pathways, e.g., p53 and mTOR, indicating e.g., differences in the Ta- and Ti-induced oxidative stress reactions at the cell/biomaterial interface. These findings suggest that Ta is a promising material for bone implants.
C1 [Stiehler, Claudia; Guenther, Klaus-Peter; Stiehler, Maik] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Orthopaed, D-01062 Dresden, Germany.
   [Stiehler, Claudia; Guenther, Klaus-Peter; Stiehler, Maik] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Translat Bone Joint & Soft Tissue Res, D-01062 Dresden, Germany.
   [Stiehler, Claudia; Overall, Rupert W.; Guenther, Klaus-Peter; Stiehler, Maik] Tech Univ Dresden, CRTD Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany.
   [Bunger, Cody] Aarhus Univ Hosp, Orthopaed Res Lab, DK-8000 Aarhus, Denmark.
   [Bunger, Cody; Foss, Morten; Besenbacher, Flemming] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark.
   [Royer, Loic; Schroeder, Michael] Tech Univ Dresden, BIOTEC, D-01062 Dresden, Germany.
   [Besenbacher, Flemming] Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark.
   [Kruhoffer, Mogens] AROS Appl Biotechnol AS, Aarhus, Denmark.
   [Kassem, Moustapha] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark.
   [Kassem, Moustapha] King Saud Univ, Coll Med, Stem Cell Unit, Riyadh 11461, Saudi Arabia.
RP Stiehler, M (reprint author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Orthopaed, D-01062 Dresden, Germany.
EM maik.stiehler@uniklinikum-dresden.de
RI Overall, Rupert/P-3102-2016; Schroeder, Michael/A-3040-2010; Kassem,
   Moustapha/J-7688-2013
OI Overall, Rupert/0000-0002-3882-6073; Kassem,
   Moustapha/0000-0003-1557-0869; Royer, Loic/0000-0002-9991-9724
FU Interdisciplinary Research Group "Nanoscience and Biocompatibility''
   [2052-01-0049]; Interdisciplinary Nanoscience Center (iNANO), University
   of Aarhus, Denmark; DFG Center for Regenerative Therapies Dresden
   (CRTD); German Academic Exchange Service/German Federal Ministry of
   Education and Research [D/09/04774]
FX Prof. Martin Lind, M. D., Ph.D. is thanked for initiation of this study.
   We are grateful to Anette Baatrup for her excellent technical assistance
   during cell culture work and to Juliane Rauh, Ph.D. for help with
   establishing candidate gene lists. Financial support was kindly provided
   by the Interdisciplinary Research Group "Nanoscience and
   Biocompatibility'' (grant no. 2052-01-0049, Danish Research Agency), by
   the Interdisciplinary Nanoscience Center (iNANO), University of Aarhus,
   Denmark, by a seed grant of the DFG Center for Regenerative Therapies
   Dresden (CRTD), and by the German Academic Exchange Service/German
   Federal Ministry of Education and Research (Grant No. D/09/04774).
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Barbosa M. A., 1998, HDB BIOMATERIAL PROP, P425
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   CARDONNE SM, 1995, INT J REFRACT MET H, V13, P187, DOI 10.1016/0263-4368(95)94023-R
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   Dennis G. J., 2003, GENOME BIOL, V4, pP3, DOI DOI 10.1186/GB-2003-4-5-P3
   Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004
   Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2
   Frisbie C. D., 2002, ENCY PHYS SCI TECHNO
   FUKUMOTO Y, 1990, ONCOGENE, V5, P1321
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Harris WH, 2001, CLIN ORTHOP RELAT R, P66
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   JOHNSON PF, 1977, J BIOMED MATER RES, V11, P637, DOI 10.1002/jbm.820110502
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59
   LAAKMAN RW, 1985, RADIOLOGY, V157, P711, DOI 10.1148/radiology.157.3.4059558
   Lee NK, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.050901
   LEONARD D, 1992, J BIOL CHEM, V267, P22860
   Li HS, 2007, J BIOMED MATER RES B, V81B, P194, DOI 10.1002/jbm.b.30653
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143
   Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4
   Park JB, 1984, BIOMATERIALS SCI ENG
   Patil N, 2009, J BIOMED MATER RES B, V89B, P242, DOI 10.1002/jbm.b.31198
   Pypen CMJM, 1997, J MATER SCI-MATER M, V8, P781, DOI 10.1023/A:1018568830442
   Rechendorff K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2011790
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592
   SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Su LF, 2001, J BIOL CHEM, V276, P3231, DOI 10.1074/jbc.M005547200
   Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178
   Vater C., 2010, ACTA BIOMATER, V7, P466
   Wang JC, 1998, SPINE, V23, P1684, DOI 10.1097/00007632-199808010-00014
   Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
NR 49
TC 2
Z9 2
U1 1
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1865-5025
J9 CELL MOL BIOENG
JI Cell. Mol. Bioeng.
PD JUN
PY 2013
VL 6
IS 2
BP 199
EP 209
DI 10.1007/s12195-012-0255-6
PG 11
WC Cell & Tissue Engineering; Biophysics; Cell Biology
SC Cell Biology; Biophysics
GA 174UV
UT WOS:000321182000011
DA 2018-10-20
ER

PT J
AU Siegismund, D
   Schroeter, A
   Schuster, S
   Rettenmayr, M
AF Siegismund, Daniel
   Schroeter, Anja
   Schuster, Stefan
   Rettenmayr, Markus
TI Quantitative Modeling of Fibrinogen Adsorption on Different Biomaterials
SO CELLULAR AND MOLECULAR BIOENGINEERING
LA English
DT Article
DE Adsorption; Biomaterials; Computer simulation; Fibrinogen; Kinetics
ID PROTEIN ADSORPTION; SURFACE WETTABILITY; ADSORBED PROTEINS;
   ANTIBODY-BINDING; STAINLESS-STEEL; KINETICS; SIMULATION; DIFFUSION;
   THERMODYNAMICS; PARTICLES
AB Adsorption processes of biological macromolecules on solid surfaces, e.g. on implant materials, are of scientific, medical and technological interest. The adsorption process of the blood plasma protein fibrinogen from aqueous solutions on biomaterial surfaces is simulated by solving the diffusion equation in one dimension in combination with a two dimensional cellular automaton model. The adsorption/desorption kinetics of fibrinogen on different metallic biomaterials is tracked until a dynamic equilibrium is reached. In addition to mass transfer towards the surface, adsorption of fibrinogen molecules and surface diffusion of single fibrinogen molecules and clusters the algorithm also accounts for the desorption of single molecules. By varying the desorption behavior in the simulation calculation, the equilibrium surface coverage changes in the range of 0.2-0.85, implying more flexible and higher surface coverage than previous models. The influences of surface properties of the biomaterials and of the initial concentration of fibrinogen on the adsorption process are quantified. Experimental results from the literature on fibrinogen adsorption kinetics are compared with our simulation results and illustrate good quantitative agreement that is only achievable using desorption as essential model component.
C1 [Siegismund, Daniel; Rettenmayr, Markus] Univ Jena, Dept Metall Mat, Inst Mat Sci & Technol IMT, D-07743 Jena, Germany.
   [Siegismund, Daniel; Schroeter, Anja; Schuster, Stefan] Univ Jena, Dept Bioinformat, D-07743 Jena, Germany.
RP Siegismund, D (reprint author), Univ Jena, Dept Metall Mat, Inst Mat Sci & Technol IMT, Lobdergraben 32, D-07743 Jena, Germany.
EM daniel.siegismund@uni-jena.de
FU Jena School for Microbial Communication (JSMC) within MikroInter
FX This work was supported by the Jena School for Microbial Communication
   (JSMC) within MikroInter.
CR Adamczyk Z, 2000, J COLLOID INTERF SCI, V229, P477, DOI 10.1006/jcis.2000.6993
   Adamczyk Z, 2011, LANGMUIR, V27, P6868, DOI 10.1021/la200798d
   Adamczyk Z, 2010, LANGMUIR, V26, P11934, DOI 10.1021/la101261f
   Bai ZJ, 2009, SURF SCI, V603, P839, DOI 10.1016/j.susc.2009.01.040
   Bellion M, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/40/404226
   Brash J. L., 1995, ACS SYM SER, P1
   CHINN JA, 1991, J BIOMED MATER RES, V25, P535, DOI 10.1002/jbm.820250410
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Desroches MJ, 2008, PHYS CHEM CHEM PHYS, V10, P2502, DOI 10.1039/b719371h
   Dolatshahi-Pirouz A, 2011, J PHYS CHEM C, V115, P13617, DOI 10.1021/jp202815h
   Feng L, 1995, ACS SYM SER, V602, P66
   Gettens RTT, 2008, J BIOMED MATER RES A, V85A, P176, DOI 10.1002/jbm.a.31530
   Gettens RTT, 2005, J BIOMED MATER RES A, V72A, P246, DOI 10.1002/jbm.a.30218
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gugutkov D, 2011, J BIOACT COMPAT POL, V26, P375, DOI 10.1177/0883911511409020
   Hoefling M, 2010, LANGMUIR, V26, P8347, DOI 10.1021/la904765u
   Huang Y, 2010, ACTA BIOMATER, V6, P2083, DOI 10.1016/j.actbio.2009.12.035
   Johnson MA, 2008, ANN BIOMED ENG, V36, P349, DOI 10.1007/s10439-007-9434-3
   Kastantin M, 2011, J AM CHEM SOC, V133, P4975, DOI 10.1021/ja110663u
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   Koo J, 2010, J THROMB HAEMOST, V8, P2727, DOI 10.1111/j.1538-7836.2010.04072.x
   Latour RA, 2008, BIOINTERPHASES, V3, pFC2, DOI 10.1116/1.2965132
   NYGREN H, 1994, BIOPHYS CHEM, V49, P263, DOI 10.1016/0301-4622(93)E0090-R
   NYGREN H, 1992, J BIOMED MATER RES, V26, P77, DOI 10.1002/jbm.820260108
   Oberholzer MR, 1997, J CHEM PHYS, V107, P9157, DOI 10.1063/1.475207
   PALMER GR, 1979, BIOPOLYMERS, V18, P1647, DOI 10.1002/bip.1979.360180705
   Rabe M, 2010, J PHYS CHEM B, V114, P5862, DOI 10.1021/jp909601m
   Raffaini G, 2004, J PHYS CHEM B, V108, P13850, DOI 10.1021/jp0477452
   Raffaini G, 2007, MACROMOL BIOSCI, V7, P552, DOI 10.1002/mabi.200600278
   Senger B, 2000, COLLOID SURFACE A, V165, P255, DOI 10.1016/S0927-7757(99)00413-6
   Shahryari A, 2010, ACTA BIOMATER, V6, P695, DOI 10.1016/j.actbio.2009.07.007
   Siegismund D, 2010, MACROMOL BIOSCI, V10, P1216, DOI 10.1002/mabi.201000120
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   Vieira EP, 2009, LANGMUIR, V25, P9879, DOI 10.1021/la9009948
   VROMAN L, 1962, NATURE, V196, P476, DOI 10.1038/196476a0
   Zhdanov VP, 1998, PROTEINS, V30, P177, DOI 10.1002/(SICI)1097-0134(19980201)30:2<177::AID-PROT7>3.3.CO;2-Y
NR 39
TC 2
Z9 2
U1 0
U2 35
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1865-5025
J9 CELL MOL BIOENG
JI Cell. Mol. Bioeng.
PD JUN
PY 2013
VL 6
IS 2
BP 210
EP 219
DI 10.1007/s12195-012-0266-3
PG 10
WC Cell & Tissue Engineering; Biophysics; Cell Biology
SC Cell Biology; Biophysics
GA 174UV
UT WOS:000321182000012
DA 2018-10-20
ER

PT J
AU Lee, AJ
   Lee, SH
   Chung, WH
   Kim, DH
   Chung, DJ
   Do, SH
   Kim, HY
AF Lee, A-Jin
   Lee, Sung-Ho
   Chung, Wook-Hun
   Kim, Dae-Hyun
   Chung, Dai-Jung
   Do, Sun Hee
   Kim, Hwi-Yool
TI Evaluation of a canine small intestinal submucosal xenograft and
   polypropylene mesh as bioscaffolds in an abdominal full-thickness
   resection model of growing rats
SO JOURNAL OF VETERINARY SCIENCE
LA English
DT Article
DE biological scaffold; canine small intestinal submucosa (canine SIS);
   inflammatory response; polypropylene mesh; tensile load test
ID WALL RECONSTRUCTION; MAST-CELLS; DOG-MODEL; REPAIR; BIOMATERIAL;
   IMMUNITY
AB We evaluated the biological scaffold properties of canine small intestinal submucosa (SIS) compared to a those of polypropylene mesh in growing rats with full-thickness abdominal defects. SIS is used to repair musculoskeletal tissue while promoting cell migration and supporting tissue regeneration. Polypropylene mesh is a non-resorbable synthetic material that can endure mechanical tension. Canine SIS was obtained from donor German shepherds, and its porous collagen fiber structure was identified using scanning electron microscopy (SEM). A 2.50-cm(2) section of canine SIS (SIS group) or mesh (mesh group) was implanted in Sprague-Dawley rats. At 1, 2, 4, 12, and 24 weeks after surgery, the implants were histopathologically examined and tensile load was tested. One month after surgery, CD68+ macrophage numbers in the SIS group were increased, but the number of CD8+ T cells in this group declined more rapidly than that in rats treated with the mesh. In the SIS group, few adhesions and well-developed autologous abdominal muscle infiltration into the SIS collagen fibers were observed. No significant differences in the tensile load test results were found between the SIS and mesh groups at 24 weeks. Canine SIS may therefore be a suitable replacement for artificial biological scaffolds in small animals.
C1 [Lee, A-Jin; Lee, Sung-Ho; Chung, Wook-Hun; Kim, Dae-Hyun; Kim, Hwi-Yool] Konkuk Univ, Dept Vet Surg, Coll Vet Med, Seoul 143701, South Korea.
   [Do, Sun Hee] Konkuk Univ, Dept Vet Clin Pathol, Coll Vet Med, Seoul 143701, South Korea.
   [Chung, Dai-Jung] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA.
RP Kim, HY (reprint author), Konkuk Univ, Dept Vet Surg, Coll Vet Med, Seoul 143701, South Korea.
EM hykim@konkuk.ac.kr
FU Konkuk University (Korea)
FX The authors would like to thank members of the National Veterinary
   Research and Quarantine Service (Korea) for their technical support with
   SEM for this project. And this paper was supported by Konkuk University
   (Korea) in 2012.
CR Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0
   Allman AJ, 2002, TISSUE ENG, V8, P53, DOI 10.1089/107632702753503054
   Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Liang R, 2006, J ORTHOP RES, V24, P811, DOI 10.1002/jor.20080
   Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010
   Mathes SJ, 2000, ANN SURG, V232, P586, DOI 10.1097/00000658-200010000-00014
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Pu LLQ, 2005, PLAST RECONSTR SURG, V115, P2127, DOI 10.1097/01.PRS.0000168883.65715.2F
   Sandoval JA, 2006, J PEDIATR SURG, V41, P518, DOI 10.1016/j.jpedsurg.2005.11.068
   Smith MJ, 2004, PEDIATR SURG INT, V20, P859, DOI 10.1007/s00383-004-1298-0
   SMITH RS, 1971, SURG CLIN N AM, V51, P1387
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 27
TC 4
Z9 4
U1 2
U2 13
PU KOREAN SOC VETERINARY SCIENCE
PI SEOUL
PA SEOUL NATL UNIV,  COLLEGE VETERINARY MEDICINE,, SEOUL, 151-742, SOUTH
   KOREA
SN 1229-845X
J9 J VET SCI
JI J. Vet. Sci.
PD JUN
PY 2013
VL 14
IS 2
BP 175
EP 184
DI 10.4142/jvs.2013.14.2.175
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA 172SM
UT WOS:000321025200009
PM 23628657
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Leung, KM
   Wanger, G
   El-Naggar, MY
   Gorby, Y
   Southam, G
   Lau, WM
   Yang, J
AF Leung, Kar Man
   Wanger, Greg
   El-Naggar, Mohamed Y.
   Gorby, Yuri
   Southam, Gordon
   Lau, Woon Ming
   Yang, Jun
TI Shewanella oneidensis MR-1 Bacterial Nanowires Exhibit p-Type, Tunable
   Electronic Behavior
SO NANO LETTERS
LA English
DT Article
DE Bacterial nanowire; S. oneidensis; electron transport; semiconductor;
   bioelectronics; microbial fuel cell
ID ELECTRICAL-CONDUCTIVITY; MICROBIAL NANOWIRES; CHARGE-TRANSPORT;
   PROTEINS; BIOFILMS
AB The study of electrical transport in biomolecular materials is critical to our fundamental understanding of physiology and to the development of practical bioelectronics applications. In this study, we investigated the electronic transport characteristics of Shewanella oneidensis MR-1 nanowires by conducting-probe atomic force microscopy (CP-AFM) and by constructing field-effect transistors (FETs) based on individual S. oneidensis nanowires. Here we show that S. oneidensis nanowires exhibit p-type, tunable electronic behavior with a field-effect mobility on the order of 10(-1) cm(2)/(V s), comparable to devices based on synthetic organic semiconductors. This study opens up opportunities to use such bacterial nanowires as a new semiconducting biomaterial for making bioelectronics and to enhance the power output of microbial fuel cells through engineering the interfaces between metallic electrodes and bacterial nanowires.
C1 [Leung, Kar Man; Yang, Jun] Univ Western Ontario, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada.
   [Wanger, Greg] J Craig Venter Inst, San Diego, CA 92121 USA.
   [El-Naggar, Mohamed Y.] Univ So Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA.
   [Gorby, Yuri] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.
   [Southam, Gordon] Univ Western Ontario, Dept Earth Sci, London, ON N6A 3K7, Canada.
   [Lau, Woon Ming] Univ Western Ontario, Surface Sci Western, London, ON N6A 5B7, Canada.
   [Lau, Woon Ming] Chengdu Green Energy & Green Mfg Technol R&D Ctr, Chengdu 610207, Sichuan, Peoples R China.
   [Yang, Jun] Univ Western Ontario, Biomed Engn Program, London, ON N6A 5B9, Canada.
RP Lau, WM (reprint author), Univ Western Ontario, Surface Sci Western, London, ON N6A 5B7, Canada.
EM llau22@uwo.ca; jyang@eng.uwo.ca
RI Southam, Gordon/D-1983-2013; Lau, Leo/B-9187-2014
OI Southam, Gordon/0000-0002-8941-1249; 
FU Canadian Natural Science and Engineering Research Council;
   Interdisciplinary Development Initiatives Program; Canada Foundation for
   Innovation; Ministry of Research and Innovation; Air Force Office of
   Scientific Research YIP [FA9550-10-1-0144]
FX This work was supported by the Canadian Natural Science and Engineering
   Research Council, Interdisciplinary Development Initiatives Program,
   Canada Foundation for Innovation, and The Ministry of Research and
   Innovation. M.E.-N. acknowledges support from the Air Force Office of
   Scientific Research YIP FA9550-10-1-0144.
CR Clarke TA, 2011, P NATL ACAD SCI USA, V108, P9384, DOI 10.1073/pnas.1017200108
   Cordes M, 2009, CHEM SOC REV, V38, P892, DOI 10.1039/b805743p
   El-Naggar MY, 2008, BIOPHYS J, V95, pL10, DOI 10.1529/biophysj.108.134411
   El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107
   EVANS MG, 1949, BIOCHIM BIOPHYS ACTA, V3, P188, DOI 10.1016/0006-3002(49)90091-8
   Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103
   Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541
   Grozema FC, 2008, INT REV PHYS CHEM, V27, P87, DOI 10.1080/01442350701782776
   Howard EC, 2011, J MICROBIOL METH, V87, P320, DOI 10.1016/j.mimet.2011.09.008
   Leung KM, 2011, SOFT MATTER, V7, P6617, DOI 10.1039/c1sm05611e
   Liu M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/12/125302
   Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]
   OTTO P, 1986, CHEM PHYS, V108, P223, DOI 10.1016/0301-0104(86)85044-3
   Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586
   Pirbadian S, 2012, PHYS CHEM CHEM PHYS, V14, P13802, DOI 10.1039/c2cp41185g
   Polizzi NF, 2012, FARADAY DISCUSS, V155, P43, DOI 10.1039/c1fd00098e
   Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661
   Reguera G., 2009, MICROBE, P506
   ROSENBERG B, 1962, NATURE, V193, P364, DOI 10.1038/193364a0
   Snider RM, 2012, P NATL ACAD SCI USA, V109, P15467, DOI 10.1073/pnas.1209829109
   Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e
   Szent-Gyorgyi A, 1941, SCIENCE, V93, P609, DOI 10.1126/science.93.2426.609
   Veazey JP, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.060901
   Yamauchi Y., 2009, SCI TECHNOL ADV MAT, V10, P9
   Zhang ZY, 2007, ADV FUNCT MATER, V17, P2478, DOI 10.1002/adfm.200600475
NR 25
TC 53
Z9 54
U1 6
U2 129
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD JUN
PY 2013
VL 13
IS 6
BP 2407
EP 2411
DI 10.1021/nl400237p
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 165LJ
UT WOS:000320485100015
PM 23701405
DA 2018-10-20
ER

PT J
AU Irion, VH
   Flanigan, DC
AF Irion, Val H.
   Flanigan, David C.
TI New and Emerging Techniques in Cartilage Repair: Other Scaffold-Based
   Cartilage Treatment Options
SO OPERATIVE TECHNIQUES IN SPORTS MEDICINE
LA English
DT Article
DE cartilage restoration; scaffolds; tissue engineering
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE MULTILAYERED BIOMATERIAL;
   FIBRIN-HYALURONAN MATRIX; ARTICULAR-CARTILAGE; OSTEOCHONDRAL
   REGENERATION; CHONDRAL DEFECTS; FOLLOW-UP; CLINICAL-TRIAL; TISSUE
   IMPLANT; KNEE
AB The field of cartilage repair and restoration continues to expand in interest and research, bridging the gap for individuals between palliation and reconstruction for chondral defects. Tissue engineering, specifically scaffold technology, has recently received a lot of attention in the search for an ideal cartilage procedure that is cost-effective, time efficient, and simple. Various biomaterials are being explored for an optimal scaffold design that is biocompatible, stable, reproducible, noncytotoxic, and permeable to allow ingrowth of new tissue. Early clinical and histologic results have proved to be promising, but it remains to be seen if currently available scaffolds will maintain results over time. Additionally, new developments and improvements in the technology continue to be investigated. These therapies are both cell based and non cell based. Non cell-based therapy holds a particular interest in this field as it favors 1-step surgery without the morbidity, necessity, or cost of a preliminary chondral biopsy prior to definitive treatment. We explore some of these new and emerging techniques in scaffold-based cartilage treatment options. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Irion, Val H.; Flanigan, David C.] Ohio State Univ, Ctr Sports Med, Columbus, OH 43221 USA.
RP Flanigan, DC (reprint author), Ohio State Univ, Ctr Sports Med, 2050 Kenny Rd,Suite 3100, Columbus, OH 43221 USA.
EM David.Flanigan@osumc.edu
CR BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Cole BJ, 2003, ARTHROSCOPY, V19, P1, DOI 10.1016/j.arthro.2003.09.025
   Crawford DC, 2012, INT CART REP SOC ICR
   Crawford DC, 2012, J BONE JOINT SURG AM, V94A, P979, DOI 10.2106/JBJS.K.00533
   Crawford DC, 2009, AM J SPORT MED, V37, P1334, DOI 10.1177/0363546509333011
   Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9
   Davidson PA, 2007, 26 ANN M ARTHR ASS N
   Dhollander AAM, 2012, J KNEE SURG, V25, P179, DOI 10.1055/s-0032-1322596
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Efe T, 2012, KNEE SURG SPORT TR A, V20, P1911, DOI 10.1007/s00167-011-1777-5
   Erggelet C, 2010, ARCH ORTHOP TRAUM SU, V130, P957, DOI 10.1007/s00402-009-0957-y
   Erggelet C, 2009, J ORTHOP RES, V27, P1353, DOI 10.1002/jor.20879
   Eshed I, 2012, EUR J RADIOL, V81, P1216, DOI 10.1016/j.ejrad.2011.03.031
   Flanigan DC, 2010, MED SCI SPORT EXER, V42, P1795, DOI 10.1249/MSS.0b013e3181d9eea0
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Gavenis K, 2012, KNEE SURG SPORT TR A, V20, P2307, DOI 10.1007/s00167-011-1847-8
   Gavenis K, 2010, ARTIF ORGANS, V34, P79, DOI 10.1111/j.1525-1594.2009.00776.x
   Gobbi A, 2006, AM J SPORT MED, V34, P1763, DOI 10.1177/0363546506288853
   Harris JD, 2010, ARTHROSCOPY, V26, P841, DOI 10.1016/j.arthro.2009.12.030
   Hegewald AA, 2004, TISSUE CELL, V36, P431, DOI 10.1016/j.tice.2004.07.003
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Iwasa J, 2003, ARTIF ORGANS, V27, P249, DOI 10.1046/j.1525-1594.2003.07073.x
   Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256
   Kreuz PC, 2009, AM J SPORTS MED, V11, pR33
   Kreuz PC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2638
   LaPorta TF, 2012, ORTHOP CLIN N AM, V43, P245, DOI 10.1016/j.ocl.2012.02.002
   Lim HC, 2012, CLIN ORTHOP RELAT R, V470, P2261, DOI 10.1007/s11999-012-2304-9
   Manfredini M, 2007, ACTA ORTHOP BELG, V73, P207
   MCNICKLE AG, 2008, SPORTS MED ARTHROSC, V16, P196, DOI DOI 10.1097/JSA.0B013E31818CDB82
   Minas T, 1998, Am J Orthop (Belle Mead NJ), V27, P739
   Mithoefer K, 2006, AM J SPORT MED, V34, P1413, DOI 10.1177/0363546506288240
   Morales TI, 2007, OSTEOARTHR CARTILAGE, V15, P861, DOI 10.1016/j.joca.2007.02.022
   Nehrer S, 2008, CLIN ORTHOP RELAT R, V466, P1849, DOI 10.1007/s11999-008-0322-4
   Nehrer S, 2009, AM J SPORT MED, V37, p81S, DOI 10.1177/0363546509350704
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Patrascu JM, 2010, J BONE JOINT SURG BR, V92B, P1160, DOI 10.1302/0301-620X.92B8.24341
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Ruano-Ravina A, 2006, OSTEOARTHR CARTILAGE, V14, P47, DOI 10.1016/j.joca.2005.07.017
   Safmn MR, 2008, ARTHROSCOPY, V16, P306
   Safran MR, 2008, J AM ACAD ORTHOP SUR, V16, P306, DOI 10.5435/00124635-200806000-00002
   Saithna AA, 2008, BRIT ORTH ASS C LIV
   Schneider U, 2011, KNEE SURG SPORT TR A, V19, P2145, DOI 10.1007/s00167-011-1460-x
   SELIKTAR D, 2007, INT CART REP SOC WAR
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Shive MS, 2006, OPER TECH ORTHOP, V16, P271, DOI 10.1053/j.oto.2006.08.001
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   Steinwachs MR, 2008, INJURY, V39, pS26, DOI 10.1016/j.injury.2008.01.042
   Van Assche D, 2010, KNEE SURG SPORT TR A, V18, P486, DOI 10.1007/s00167-009-0955-1
   Vanlauwe JJE, 2012, AM J SPORT MED, V40, P1799, DOI 10.1177/0363546512452712
   Vasiliadis HS, 2010, KNEE SURG SPORT TR A, V18, P1645, DOI 10.1007/s00167-010-1050-3
   Williams Riley J, 2008, Instr Course Lect, V57, P563
   Yayon A, 2006, J BONE JOINT SURG BR, V88B, P344
   Zantop T, 2009, ARTHROSCOPY, V25, P1354, DOI 10.1016/j.arthro.2009.04.077
NR 59
TC 7
Z9 7
U1 1
U2 26
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1060-1872
J9 OPER TECHN SPORT MED
JI Oper. Tech. Sports Med.
PD JUN
PY 2013
VL 21
IS 2
BP 125
EP 137
DI 10.1053/j.otsm.2013.03.001
PG 13
WC Sport Sciences; Surgery
SC Sport Sciences; Surgery
GA 180PE
UT WOS:000321606300009
DA 2018-10-20
ER

PT J
AU Carvalho, I
   Henriques, M
   Oliveira, JC
   Alves, CFA
   Piedade, AP
   Carvalho, S
AF Carvalho, Isabel
   Henriques, Mariana
   Oliveira, Joao Carlos
   Almeida Alves, Cristiana Filipa
   Piedade, Ana Paula
   Carvalho, Sandra
TI Influence of surface features on the adhesion of Staphylococcus
   epidermidis to Ag-TiCN thin films
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Article
DE sputtering; microorganism adhesion; biofilm; hydrophobicity; biomaterial
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOMEDICAL APPLICATIONS; NANOCOMPOSITE
   COATINGS; SILVER NANOPARTICLES; BIOFILM FORMATION; TIN; HYDROPHOBICITY;
   INFECTIONS; BEHAVIOR
AB Staphylococcus epidermidis has emerged as one of the major nosocomial pathogens associated with infections of implanted medical devices. The initial adhesion of these organisms to the surface of biomaterials is assumed to be an important stage in their colonization. The main objective of this work is to assess the influence of surface features on the adhesion of S. epidermidis to Ag-TiCN coatings deposited by dc reactive magnetron sputtering. The structural results obtained by x-ray diffraction show that the coatings crystallize in a B1-NaCl crystal structure typical of TiC0.3N0.7. The increase of Ag content promoted the formation of Ag crystalline phases. According to the results obtained with atomic force microscopy, a decrease on the surface roughness of the films from 39 to 7 nm is observed as the Ag content increases from 0 to 15 at.%. Surface energy results show that the increase of Ag promotes an increase in hydrophobicity. Bacterial adhesion and biofilm formation on coatings were assessed by the enumeration of the number of viable cells. The results showed that the surface with lower roughness and higher hydrophobicity leads to greater bacterial adhesion and biofilm formation, highlighting that surface morphology and hydrophobicity rule the colonization of materials.
C1 [Carvalho, Isabel; Almeida Alves, Cristiana Filipa; Carvalho, Sandra] Univ Minho, GRF CFUM, Campus Azurem, P-4800058 Guimaraes, Portugal.
   [Carvalho, Isabel; Henriques, Mariana] Univ Minho, Ctr Biol Engn, IBB Inst Biotechnol & Bioengn, P-4700057 Minho, Portugal.
   [Oliveira, Joao Carlos; Piedade, Ana Paula; Carvalho, Sandra] Univ Coimbra, Dept Mech Engn, CEMUC, P-3030788 Coimbra, Portugal.
RP Carvalho, I (reprint author), Univ Minho, GRF CFUM, Campus Azurem, P-4800058 Guimaraes, Portugal.
EM isascarvalho@hotmail.com
RI Carvalho, Sandra/F-3530-2013; Oliveira, Joao/J-3669-2013; Henriques,
   Mariana/A-2117-2013; Piedade, Ana/K-8637-2012
OI Carvalho, Sandra/0000-0002-3643-4973; Henriques,
   Mariana/0000-0003-0317-4877; Almeida Alves, Cristiana
   F./0000-0001-7898-5047; Oliveira, Joao Carlos/0000-0002-6218-3098;
   Piedade, Ana/0000-0002-1588-0640; Carvalho, Isabel/0000-0002-7569-2019
FU FCT-Fundacao para a Ciencia e a Tecnologia [SFRH / BD / 67022 / 2009];
   FEDER funds through the program COMPETE-Programa Operacional Factores de
   Competitividade; national funds through FCT-Fundacao para a Ciencia e a
   Tecnologia [PEST-C/FIS/UI607/2011, PEST-C/EME/UI0285/2011,
   PTDC/CTM/102853/2008]
FX IC acknowledges the financial support of FCT-Fundacao para a Ciencia e a
   Tecnologia through grant SFRH / BD / 67022 / 2009. The authors are
   grateful to Dr Tomas Polcar, Czech Technical University in Prague, Czech
   Republic, for his assistance in carrying out the Raman spectroscopic
   analysis. This research was sponsored by FEDER funds through the program
   COMPETE-Programa Operacional Factores de Competitividade-and by national
   funds through FCT-Fundacao para a Ciencia e a Tecnologia-in the
   framework of the Strategic Projects PEST-C/FIS/UI607/2011 and
   PEST-C/EME/UI0285/2011, and under the project PTDC/CTM/102853/2008.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   [Anonymous], 2000, ANT PROD TEST ANT AC
   Bahl R, 1999, APPL PHYS A-MATER, V69, pS643, DOI 10.1007/s003390051495
   Boswald M, 1999, INFECTION, V27, pS38, DOI 10.1007/BF02561616
   Carvalho S, 2009, VACUUM, V83, P1206, DOI 10.1016/j.vacuum.2009.03.009
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chiang WC, 2010, MATER CHEM PHYS, V119, P123, DOI 10.1016/j.matchemphys.2009.08.035
   Constable CP, 1999, SURF COAT TECH, V116, P155, DOI 10.1016/S0257-8972(99)00072-9
   Do Nascimento R, 2003, CERAMICA, V49, P178, DOI DOI 10.1590/S0366-69132003000400002
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Doyle RJ, 2000, MICROBES INFECT, V2, P391, DOI 10.1016/S1286-4579(00)00328-2
   Dreiling I, 2009, SURF COAT TECH, V204, P1008, DOI 10.1016/j.surfcoat.2009.05.029
   Endrino JL, 2010, IOP CONF SER-MAT SCI, V12, DOI 10.1088/1757-899X/12/1/012012
   Escobar-Alarcon L, 2011, APPL SURF SCI, V257, P9033, DOI 10.1016/j.apsusc.2011.05.094
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Fitzpatrick F, 2002, J HOSP INFECT, V52, P212, DOI 10.1053/jhin.2002.1309
   Hsieh JH, 2008, SURF COAT TECH, V202, P5586, DOI 10.1016/j.surfcoat.2008.06.107
   JANCZUK B, 1993, J COLLOID INTERF SCI, V159, P421, DOI 10.1006/jcis.1993.1342
   KAPOOR RR, 1989, METALL TRANS B, V20, P919, DOI 10.1007/BF02670197
   Kelly PJ, 2010, SURF COAT TECH, V205, P1606, DOI 10.1016/j.surfcoat.2010.07.029
   Kelly PJ, 2009, SURF COAT TECH, V204, P1137, DOI 10.1016/j.surfcoat.2009.05.012
   Lu Y H, 2011, J MATER RES, V22, P2460
   Manninen NK, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/37/375501
   Martinez-Martinez D, 2005, THIN SOLID FILMS, V472, P64, DOI 10.1016/j.tsf.2004.06.140
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Oliveira C, 2010, THIN SOLID FILMS, V518, P5694, DOI 10.1016/j.tsf.2010.05.050
   Oliveira C, 2008, SURF COAT TECH, V203, P490, DOI 10.1016/j.surfcoat.2008.06.121
   Oliveira R, 2003, IMPORTANCE PHYSICOCH, P211
   Oliveira R, 2001, BIOFILM COMMUNITY IN, P11
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Sanchez-Lopez JC, 2012, SURF COAT TECH, V206, P2192, DOI 10.1016/j.surfcoat.2011.09.059
   Serro AP, 2009, SURF COAT TECH, V203, P3701, DOI 10.1016/j.surfcoat.2009.06.010
   Silva E, 2010, SURF COAT TECH, V205, P2134, DOI 10.1016/j.surfcoat.2010.08.126
   Simon J G, 1994, ASM HDB, V5
   Sousa C, 2009, INT J BIOMATER, DOI 10.1155/2009/718017
   Sousa C, 2009, J BASIC MICROB, V49, P363, DOI 10.1002/jobm.200800196
   SPENGLER W, 1978, PHYS REV B, V17, P1095, DOI 10.1103/PhysRevB.17.1095
   Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   THORNTON JA, 1977, ANNU REV MATER SCI, V7, P239, DOI 10.1146/annurev.ms.07.080177.001323
   VANOSS CJ, 1995, CLAY CLAY MINER, V43, P474, DOI 10.1346/CCMN.1995.0430411
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   ZHANG SY, 1993, MAT SCI ENG A-STRUCT, V163, P141, DOI 10.1016/0921-5093(93)90588-6
NR 45
TC 11
Z9 11
U1 3
U2 37
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1468-6996
EI 1878-5514
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PD JUN
PY 2013
VL 14
IS 3
AR 035009
DI 10.1088/1468-6996/14/3/035009
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 180DH
UT WOS:000321572700010
PM 27877582
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Glew, D
   Stringer, LC
   McQueen-Mason, S
AF Glew, David
   Stringer, Lindsay C.
   McQueen-Mason, Simon
TI Achieving sustainable biomaterials by maximising waste recovery
SO WASTE MANAGEMENT
LA English
DT Article
DE Interviews; Expert focus group; Waste; Biomaterial; Policy; Legislation
ID TECHNOLOGIES; ENERGY; PREFERENCES; INTEGRATION
AB The waste hierarchy of 'reduce, reuse, recycle, recover' can be followed to improve the sustainability of a product, yet it is not applied in any meaningful way in the biomaterials industry which focuses more on sustainable sourcing of inputs. This paper presents the results of industry interviews and a focus group with experts to understand how waste recovery of biomaterials could become more widespread. Interview findings were used to develop three scenarios: (1) do nothing; (2) develop legislation; and (3) develop certification standards. These scenarios formed the basis for discussions at an expert focus group. Experts considered that action was required, rejecting the first scenario. No preference was apparent for scenarios (2) and (3). Experts agreed that there should be collaboration on collection logistics, promotion of demand through choice editing, product 'purity' could be championed though certification and there should be significant investment and research into recovery technologies. These considerations were incorporated into the development of a model for policy makers and industry to help increase biomaterial waste recovery. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Glew, David; McQueen-Mason, Simon] Univ York, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.
   [Stringer, Lindsay C.] Univ Leeds, Sustainabil Res Inst, Leeds LS2 9JT, W Yorkshire, England.
RP Glew, D (reprint author), Univ York, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.
EM dwg501@york.ac.uk
OI Stringer, Lindsay/0000-0003-0017-1654
FU White Rose Consortium of Universities; Biotechnology and Biological
   Sciences Research Council [BB/G016178/1]
FX The research is funded by the White Rose Consortium of Universities and
   the authors are indebted to those company representatives and experts
   that contributed to the interviews and focus group.
CR Billson J.M., 2006, 27 WED EC SOC RES CU
   Black M.J., 2011, IND CROP PROD, V45, P12
   Brenner M., 1985, INTERVIEWING REPRESE
   de Boer J., 2003, BUSINESS STRATEGY EN, V12, P254, DOI DOI 10.1002/BSE.362
   De Lange WJ, 2012, J ENVIRON MANAGE, V99, P76, DOI 10.1016/j.jenvman.2012.01.014
   European Commission, 2011, BUYING GREEN GREEN P
   [European Commission Studies I.F.P.T.], 2009, STUD SEL WAST STREAM
   Flowerdew R., 2005, METHODS HUMAN GEOGRA
   Gallagher E., 2008, RENEWABLE FUELS AGEN, V42, P21
   Gillham B., 2005, RES INTERVIEWING RAN
   Glew D, 2012, J CLEAN PROD, V29-30, P122, DOI 10.1016/j.jclepro.2012.02.005
   Golden J.S., 2010, ECOLOGY SOC, V15
   Hocking JS, 2006, J CLIN EPIDEMIOL, V59, P521, DOI 10.1016/j.jclinepi.2005.10.009
   Holsti ORMN, 1969, CONTENT ANAL SOCIAL
   Lieten I., 2010, KNOWL BAS BIOEC 2020
   Luiten E, 2006, TECHNOVATION, V26, P1029, DOI 10.1016/j.technovation.2005.10.004
   Lynes JK, 2008, J INT MANAG, V14, P377, DOI 10.1016/j.intman.2007.09.004
   Morgan-Davies C, 2010, LAND USE POLICY, V27, P387, DOI 10.1016/j.landusepol.2009.05.002
   Nemoto J, 2004, INT J IND ORGAN, V22, P67, DOI 10.1016/S0167-7187(03)00091-2
   Neuman L., 2004, BASICS SOCIAL RES QU
   Nicolli F, 2012, ENVIRON ECON POLICY, V14, P261, DOI 10.1007/s10018-012-0031-9
   NNFCC, 2012, MARK REV BIOB PROD
   *OECD, 2001, APPL BIOT IND SUST
   [Office of Fair Trading Copyright C], 2009, GOVT MARKETS WHY COM
   Pagell M, 2004, J OPER MANAG, V22, P459, DOI 10.1016/j.jom.2004.05.008
   Regula-Herzog A., 1988, J GERONTOLOGY SOCIAL, V43, P200
   Ross S, 2003, J CLEAN PROD, V11, P561, DOI 10.1016/S0959-6526(02)00089-6
   Sacramento-Rivero JC, 2012, BIOFUEL BIOPROD BIOR, V6, P32, DOI 10.1002/bbb.335
   Schmitt E, 2012, BIORESOURCE TECHNOL, V104, P400, DOI 10.1016/j.biortech.2011.10.094
   Searchinger TD, 2010, SCIENCE, V327, P781, DOI 10.1126/science.327.5967.781-a
   Shen L, 2010, RESOUR CONSERV RECY, V55, P34, DOI 10.1016/j.resconrec.2010.06.014
   Tang KC, 1995, FAM PRACT, V12, P474, DOI 10.1093/fampra/12.4.474
   Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970
   Tompkins EL, 2008, J ENVIRON MANAGE, V88, P1580, DOI 10.1016/j.jenvman.2007.07.025
   Vandermeulen V, 2012, BIOFUEL BIOPROD BIOR, V6, P453, DOI 10.1002/bbb.1333
NR 35
TC 7
Z9 7
U1 1
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0956-053X
J9 WASTE MANAGE
JI Waste Manage.
PD JUN
PY 2013
VL 33
IS 6
BP 1499
EP 1508
DI 10.1016/j.wasman.2013.03.005
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 177VK
UT WOS:000321403300023
PM 23562447
OA Green Published
DA 2018-10-20
ER

PT J
AU Chen, Y
   Wang, ML
   Fang, L
AF Chen, Yang
   Wang, Manli
   Fang, Liang
TI Biomaterials as novel penetration enhancers for transdermal and dermal
   drug delivery systems
SO DRUG DELIVERY
LA English
DT Review
DE Biomaterial; dermal; mechanism; penetration enhancer; transdermal
ID N-TRIMETHYL CHITOSAN; POTENTIAL ABSORPTION ENHANCER; PROTEIN
   TRANSDUCTION DOMAINS; HAIRLESS MOUSE SKIN; IN-VITRO EVALUATION; CATIONIC
   END-GROUP; THERAPEUTIC SYSTEM; POLY(AMIDOAMINE) DENDRIMERS; CYCLODEXTRIN
   COMPLEXATION; POLYAMIDOAMINE DENDRIMER
AB The highly organized structure of the stratum corneum provides an effective barrier to the drug delivery into or across the skin. To overcome this barrier function, penetration enhancers are always used in the transdermal and dermal drug delivery systems. However, the conventional chemical enhancers are often limited by their inability to delivery large and hydrophilic molecules, and few to date have been routinely incorporated into the transdermal formulations due to their incompatibility and local irritation issues. Therefore, there has been a search for the compounds that exhibit broad enhancing activity for more drugs without producing much irritation. More recently, the use of biomaterials has emerged as a novel method to increase the skin permeability. In this paper, we present an overview of the investigations on the feasibility and application of biomaterials as penetration enhancers for transdermal or dermal drug delivery systems.
C1 [Chen, Yang; Wang, Manli; Fang, Liang] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Zambia, Peoples R China.
RP Fang, L (reprint author), Shenyang Pharmaceut Univ, Sch Pharm, 103 Wenhua Rd, Shenyang 110016, Zambia, Peoples R China.
EM fangliang2003@yahoo.com
FU National Natural Science Foundation of China [30973654, 81173007]
FX This work was supported by the National Natural Science Foundation of
   China (No: 30973654 and No: 81173007).
CR Akimoto T, 1997, J CONTROL RELEASE, V49, P229, DOI 10.1016/S0168-3659(97)00092-8
   Akimoto T, 2003, J CONTROL RELEASE, V88, P243, DOI 10.1016/S0168-3659(03)00006-3
   Akimoto T, 2001, J CONTROL RELEASE, V77, P49, DOI 10.1016/S0168-3659(01)00455-2
   Akimoto T, 2000, MACROMOL CHEM PHYSIC, V201, P2729, DOI 10.1002/1521-3935(20001201)201:18<2729::AID-MACP2729>3.0.CO;2-U
   AOYAGI T, 1990, J CONTROL RELEASE, V13, P63, DOI 10.1016/0168-3659(90)90075-5
   AOYAGI T, 1991, POLYMER, V32, P2106, DOI 10.1016/0032-3861(91)90179-M
   AOYAGI T, 1992, MAKROMOL CHEM, V193, P2821
   Aoyagi T, 1996, MACROMOL CHEM PHYSIC, V197, P677, DOI 10.1002/macp.1996.021970222
   AOYAGI T, 1992, POLYMER, V33, P2203, DOI 10.1016/0032-3861(92)90889-5
   AOYAGI T, 1992, POLYM J, V24, P375, DOI 10.1295/polymj.24.375
   AOYAGI T, 1992, POLYM J, V24, P545, DOI 10.1295/polymj.24.545
   Arima H, 1996, CHEM PHARM BULL, V44, P582
   Babita K, 2005, AAPS PHARMSCITECH, V6
   Babita Kumar, 2004, Current Drug Delivery, V1, P397, DOI 10.2174/1567201043334579
   Babita K, 2005, MOL PHARMACEUT, V2, P57, DOI 10.1021/mp049926u
   BASON MM, 1991, INT J DERMATOL, V30, P623, DOI 10.1111/j.1365-4362.1991.tb03485.x
   BERARDESCA E, 1994, CONTACT DERMATITIS, V31, P281, DOI 10.1111/j.1600-0536.1994.tb02019.x
   Borowska K, 2012, INT J PHARMACEUT, V426, P280, DOI 10.1016/j.ijpharm.2012.01.041
   Borowska K, 2010, INT J PHARMACEUT, V398, P185, DOI 10.1016/j.ijpharm.2010.07.019
   Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x
   Brown MB, 2006, DRUG DELIV, V13, P175, DOI 10.1080/10717540500455975
   Carmichael NME, 2010, PAIN, V149, P316, DOI 10.1016/j.pain.2010.02.024
   Chauhan AS, 2003, J CONTROL RELEASE, V90, P335, DOI 10.1016/S0168-3659(03)00200-1
   Chen YP, 2006, NAT BIOTECHNOL, V24, P455, DOI 10.1038/nbt1193
   Cheng YY, 2007, J PHARM SCI-US, V96, P595, DOI 10.1002/jps.20745
   Davaran S, 2006, J BIOMED MATER RES A, V78A, P590, DOI 10.1002/jbm.a.30850
   de Jager MW, 2004, BBA-BIOMEMBRANES, V1664, P132, DOI 10.1016/j.bbamem.2004.05.001
   Di Colo G, 2004, J PHARM SCI-US, V93, P2851, DOI 10.1002/jps.20197
   Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019
   Elias PM, 2002, J INVEST DERM SYMP P, V7, P79, DOI 10.1046/j.1523-1747.2002.19632.x
   FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664
   Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200
   Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200
   Filipowicz A, 2011, INT J PHARMACEUT, V408, P152, DOI 10.1016/j.ijpharm.2011.01.033
   Finnin BC, 1999, J PHARM SCI, V88, P955, DOI 10.1021/js990154g
   Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i
   Guillard EC, 2009, EUR J PHARM SCI, V36, P192, DOI 10.1016/j.ejps.2008.10.010
   Gupta Babita S, 2002, Int J Pharm, V238, P43, DOI 10.1016/S0378-5173(02)00063-7
   Gupta M, 2004, PHARMAZIE, V59, P212
   Hadgraft J, 2004, EUR J PHARM BIOPHARM, V58, P291, DOI 10.1016/j.ejpb.2004.03.002
   He W, 2008, INT J PHARM, V356, P82, DOI 10.1016/j.ijphann.2007.12.050
   He W, 2009, INT J PHARMACEUT, V382, P234, DOI 10.1016/j.ijpharm.2009.07.038
   Ho A, 2001, CANCER RES, V61, P474
   Hou YW, 2007, EXP DERMATOL, V16, P999, DOI 10.1111/j.1600-0625.2007.00622.x
   Hsu T, 2011, P NATL ACAD SCI USA, V108, P15816, DOI 10.1073/pnas.1016152108
   Jonker C, 2002, INT J PHARM, V238, P205, DOI 10.1016/S0378-5173(02)00068-6
   Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102
   Karande P, 2009, BBA-BIOMEMBRANES, V1788, P2362, DOI 10.1016/j.bbamem.2009.08.015
   Kaushik S, 2001, PHARMACEUT RES, V18, P894, DOI 10.1023/A:1011013218494
   Kim YC, 2007, J CONTROL RELEASE, V122, P375, DOI 10.1016/j.jconrel.2007.05.031
   Kim YC, 2008, INT J PHARM, V362, P20, DOI 10.1016/j.ijpharm.2008.05.042
   Kotze AF, 1997, PHARMACEUT RES, V14, P1197, DOI 10.1023/A:1012106907708
   Kuchler S, 2009, EUR J PHARM BIOPHARM, V71, P243, DOI 10.1016/j.ejpb.2008.08.019
   Kumar S, 2012, MOL PHARMACEUT, V9, P1320, DOI 10.1021/mp200594z
   Legendre JY, 1995, EUR J PHARM SCI, V3, P311, DOI 10.1016/0928-0987(95)00020-0
   Li YZ, 2008, BIOL PHARM BULL, V31, P1574, DOI 10.1248/bpb.31.1574
   Li Y, 2009, J PHARM PHARMACOL, V61, P1005, DOI 10.1211/jpp/61.08.0003
   Lim Jun Man, 2003, J Cosmet Sci, V54, P483
   Loftsson T, 2001, INT J PHARMACEUT, V225, P15, DOI 10.1016/S0378-5173(01)00761-X
   Loftsson T, 1998, INT J DERMATOL, V37, P241, DOI 10.1046/j.1365-4362.1998.00369.x
   LOFTSSON T, 1995, INT J PHARM, V115, P255, DOI 10.1016/0378-5173(94)00302-L
   Loftsson T, 1997, P 8 INT S CYCL, P403
   Lopes LB, 2005, PHARM RES, V22, P750, DOI 10.1007/s11095-005-2591-x
   Lopez RFV, 2000, INT J PHARM, V200, P127, DOI 10.1016/S0378-5173(00)00365-3
   Lv HX, 2011, MOLECULES, V16, P6778, DOI 10.3390/molecules16086778
   Matsuda H, 1999, ADV DRUG DELIVER REV, V36, P81, DOI 10.1016/S0169-409X(98)00056-8
   Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P2104, DOI 10.1021/bi961870p
   MENON GK, 1992, BRIT J DERMATOL, V126, P337, DOI 10.1111/j.1365-2133.1992.tb00675.x
   Menon GK, 2002, ADV DRUG DELIVER REV, V54, pS3, DOI 10.1016/S0169-409X(02)00121-7
   Mignani S, 2013, ADV DRUG DELIVER REV, V65, P1316, DOI 10.1016/j.addr.2013.01.001
   NAGASE Y, 1992, MAKROMOL CHEM-RAPID, V13, P441
   Naik A, 2000, PHARM SCI TECHNOL TO, V3, P318, DOI DOI 10.1016/S1461-5347(00)00295-9
   Nanjwade BK, 2009, EUR J PHARM SCI, V38, P185, DOI 10.1016/j.ejps.2009.07.008
   Nasrollahi SA, 2012, CHEM BIOL DRUG DES, V80, P639, DOI 10.1111/cbdd.12008
   Ohtake K, 2003, PHARMACEUT RES, V20, P153, DOI 10.1023/A:1022485816755
   ORIENTI I, 1991, ARCH PHARM, V324, P943
   Pathan IB, 2009, TROP J PHARM RES, V8, P173
   Patil S, 1996, J PHARM SCI, V85, P249, DOI 10.1021/js950220o
   Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504
   Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359
   Sakuma S, 2010, J CONTROL RELEASE, V148, P187, DOI 10.1016/j.jconrel.2010.08.022
   Sandri G, 2005, INT J PHARM, V297, P146, DOI 10.1016/j.ijpharm.2005.03.017
   Sapra B, 2008, DRUG DELIV, V15, P443, DOI [10.1080/10717540802327047, 10.1080/10717540802327047 ]
   Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7
   Shaker DS, 2003, INT J PHARM, V253, P1, DOI 10.1016/S0378-5173(02)00625-7
   Sinha VR, 2000, DRUG DEV IND PHARM, V26, P1131, DOI 10.1081/DDC-100100984
   Sinico C, 2006, EXPERT OPIN DRUG DEL, V6, P813
   Sun MJ, 2012, SOFT MATTER, V8, P4301, DOI 10.1039/c2sm07280g
   Tanner T, 2008, SKIN RES TECHNOL, V14, P249, DOI 10.1111/j.1600-0846.2008.00316.x
   Taveira SF, 2009, J CONTROL RELEASE, V134, P35, DOI 10.1016/j.jconrel.2008.11.002
   Thanou M, 2001, ADV DRUG DELIVER REV, V50, pS91, DOI 10.1016/S0169-409X(01)00180-6
   Thanou MM, 2000, J CONTROL RELEASE, V64, P15, DOI 10.1016/S0168-3659(99)00131-5
   Thomas BJ, 2004, DRUG DISCOV TODAY, V9, P697, DOI 10.1016/S1359-6446(04)03180-0
   Tsai JC, 1996, J PHARM SCI, V85, P643, DOI 10.1021/js950219p
   Uchida T, 2011, CHEM PHARM BULL, V59, P196, DOI 10.1248/cpb.59.196
   Umemura M, 1990, Drug Des Deliv, V6, P297
   Ventura CA, 2006, INT J PHARM, V314, P37, DOI 10.1016/j.ijpharm.2006.02.006
   Venuganti VV, 2011, PHARM RES-DORDR, V28, P2246, DOI 10.1007/s11095-011-0455-0
   Venuganti VVK, 2008, INT J PHARM, V361, P230, DOI 10.1016/j.ijpharm.2008.05.034
   Venuganti VVK, 2009, J PHARM SCI-US, V98, P2345, DOI 10.1002/jps.21603
   Vives E, 2003, J MOL RECOGNIT, V16, P265, DOI 10.1002/jmr.636
   Walker RB, 1996, ADV DRUG DELIVER REV, V18, P295, DOI 10.1016/0169-409X(95)00078-L
   Wang ZX, 2003, J BIOSCI BIOENG, V96, P537, DOI 10.1016/S1389-1723(04)70146-2
   Wang ZX, 2003, J BIOSCI BIOENG, V95, P541, DOI 10.1016/S1389-1723(03)80059-2
   Welss T, 2004, TOXICOL IN VITRO, V18, P231, DOI 10.1016/j.tiv.2003.09.009
   Wertz PW, 1998, CHEM PHYS LIPIDS, V91, P85, DOI 10.1016/S0009-3084(97)00108-4
   Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025
   Yang Y, 2012, BIOMACROMOLECULES, V13, P2154, DOI 10.1021/bm300545b
   Zaro JL, 2003, BIOCHEM BIOPH RES CO, V307, P241, DOI 10.1016/S006-291X(03)01167-7
   ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449
   Zesch A, 1983, Derm Beruf Umwelt, V31, P74
   Zhou XQ, 2010, J PHARM SCI-US, V99, P2991, DOI 10.1002/jps.22063
   Zi P, 2008, INT J PHARM, V358, P151, DOI 10.1016/j.ijpharm.2008.03.001
NR 113
TC 16
Z9 16
U1 1
U2 86
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-7544
EI 1521-0464
J9 DRUG DELIV
JI Drug Deliv.
PD JUN-JUL
PY 2013
VL 20
IS 5
BP 199
EP 209
DI 10.3109/10717544.2013.801533
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 171MN
UT WOS:000320933600001
PM 23763451
OA Bronze
DA 2018-10-20
ER

PT J
AU Kim, AR
   Hwang, JH
   Kim, HM
   Kim, HN
   Song, JE
   Yang, YI
   Yoon, KH
   Lee, D
   Khang, G
AF Kim, A. Ram
   Hwang, Ji Hye
   Kim, Hye Min
   Kim, Ha Neul
   Song, Jeong Eun
   Yang, Young Il
   Yoon, Kun Ho
   Lee, Dongwon
   Khang, Gilson
TI Reduction of inflammatory reaction in the use of purified alginate
   microcapsules
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE alginate; purification; microcapsule; inflammatory reaction;
   biocompatibility
ID HUMAN POLYMORPHONUCLEAR LEUKOCYTES; NECROSIS-FACTOR-ALPHA; CELL
   ENCAPSULATION; MICROENCAPSULATED ISLETS; POLYMERIC BIOMATERIALS;
   ACTIVATED-CHARCOAL; DRUG-RELEASE; IN-VITRO; TISSUE; HYDROGEL
AB Alginate, a polysaccharide extracted from brown seaweed, remains the most widely used biomaterial for immobilizing cells to be transplanted, because of the good viability of the encapsulated cells and the relatively ease of processing for cell encapsulation. However, the main drawback is the immune reaction in vivo. To overcome this problem, we have demonstrated a modified Korbutt method for alginate purification. After alginate microcapsules were manufactured, NIH/3T3 fibroblast cells were seeded in purified and non-purified alginate microcapsules, and the cell proliferation was analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide assay. Reverse transcriptase-polymerase chain reaction was performed to assess the mRNA expression of RAW 264.7 macrophage cells for inflammation cytokines such as TNF-. Purified and non-purified alginate microcapsules were implanted into Wister rats, and subsequently extracted after 1-2weeks. Tissues surrounding the implants were harvested and underwent histological evaluation through H&E staining and immunohistochemical evaluation through ED-1 staining. In this result, contaminated materials in the purified alginate were eliminated by purification process. Thereby, density of inflammatory cell decreased about 30% more than non-purified alginate and thickness of fibrotic wall decreased about three times. In concluding, the purified alginate is anticipated to be highly potent for numerous biomaterial applications.
C1 [Kim, A. Ram; Hwang, Ji Hye; Kim, Hye Min; Kim, Ha Neul; Song, Jeong Eun; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Dept BIN Fus Technol Polymer Nano Sci & Technol, Deokjin 561756, Jeonju, South Korea.
   [Kim, A. Ram; Hwang, Ji Hye; Kim, Hye Min; Kim, Ha Neul; Song, Jeong Eun; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Polymer Fus Res Ctr, Deokjin 561756, Jeonju, South Korea.
   [Yang, Young Il] Inje Univ, Paik Hosp, Coll Med, Dept Pathol, Pusan 614735, South Korea.
   [Yoon, Kun Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seochogu Seoul 137701, South Korea.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept BIN Fus Technol Polymer Nano Sci & Technol, 567 Beackje Daero, Deokjin 561756, Jeonju, South Korea.
EM gskhang@chonbuk.ac.kr
RI song, jeong eun/P-9106-2015; Khang, Gilson/B-2109-2013
OI song, jeong eun/0000-0001-6879-7616; 
FU WCU [R31-20, 029]; XRC [A040004]; MBC [0405-B001-0204-0006]
FX This research was supported by WCU (R31-20,029), XRC (A040004), and MBC
   (0405-B001-0204-0006).
CR Aaron GM, 2009, TISSUE ENG PART A, V15, P1301
   ARIMORI K, 1989, J PHARM PHARMACOL, V41, P445, DOI 10.1111/j.2042-7158.1989.tb06498.x
   Azad N, 2008, J TOXICOL ENV HEAL B, V11, P1, DOI 10.1080/10937400701436460
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   DAWSON RM, 1987, BIOMATERIALS, V8, P360, DOI 10.1016/0142-9612(87)90006-8
   ESPEVIK T, 1993, EUR J IMMUNOL, V23, P255, DOI 10.1002/eji.1830230140
   Gaserod O, 1999, BIOMATERIALS, V20, P773, DOI 10.1016/S0142-9612(98)00230-0
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   GOODE HF, 1994, CLIN SCI, V86, P411, DOI 10.1042/cs0860411
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Iwamoto Y, 2001, BIOSCI BIOTECH BIOCH, V65, P133, DOI 10.1271/bbb.65.133
   IWATA H, 1989, DIABETES, V38, P224, DOI 10.2337/diab.38.1.S224
   Jacobs AT, 2001, J BIOL CHEM, V276, P47950, DOI 10.1074/jbc.M106639200
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jork A, 2000, APPL MICROBIOL BIOT, V53, P224, DOI 10.1007/s002530050012
   KESSLER L, 1991, HORM METAB RES, V23, P312, DOI 10.1055/s-2007-1003685
   Khattak SF, 2006, BIOTECHNOL LETT, V28, P1361, DOI 10.1007/s10529-006-9104-9
   Kim O. Y., 2011, INT J TISSUE REG, V2, P13
   Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407
   Kim TH, 2011, INT J TISSUE REGEN, V2, P1
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   Koarai A, 2002, EUR RESPIR J, V20, P609, DOI 10.1183/09031936.02.00274902
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Lee HJ, 2010, BIOCHEM BIOPH RES CO, V391, P1400, DOI 10.1016/j.bbrc.2009.12.073
   Lee JH, 2010, INT J TISSUE REGEN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0015394
   Liew CV, 2006, INT J PHARM, V309, P25, DOI 10.1016/ijpharm.2005.10.040
   Lim EJ, 2007, J PHARM PHARMACOL, V59, P1235, DOI 10.1211/jpp.59.9.0007
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lirk Philipp, 2002, Current Drug Targets - Inflammation and Allergy, V1, P89, DOI 10.2174/1568010023344913
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   NOLAN JP, 1975, P SOC EXP BIOL MED, V149, P766
   Numata M, 1998, J IMMUNOL, V160, P3031
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   OTTERLEI M, 1993, INFECT IMMUN, V61, P1917
   OTTERLEI M, 1991, EUR J IMMUNOL, V10, P286
   Park H, 2010, BIOMACROMOLECULES, V11, P2103, DOI 10.1021/bm100474w
   PEGUES AS, 1979, INT J ARTIF ORGANS, V2, P153
   Pitarresi G, 2007, INT J PHARMACEUT, V335, P130, DOI 10.1016/j.ijpharm.2006.11.012
   Prokop A, 1997, ANN NY ACAD SCI, V831, P223
   Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shilpa A, 2003, J MACROMOL SCI-POL R, VC43, P187, DOI 10.1081/MC-120020160
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1991, TRANSPLANT P, V23, P758
   Takeichi O, 1998, IMMUNOLOGY, V93, P275
   Tam SK, 2006, BIOMATERIALS, V27, P1296, DOI 10.1016/j.biomaterials.2005.08.027
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vacanti JP, 1999, LANCET S1, V354, pSi32
   Wandrey C, 2001, ANN NY ACAD SCI, V944, P187
   Wang B, 2006, REACT FUNCT POLYM, V66, P509, DOI 10.1016/j.reactfunctpolym.2005.10.003
   YAN L, 1994, J IMMUNOL, V153, P1825
   Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 58
TC 13
Z9 13
U1 0
U2 28
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUN 1
PY 2013
VL 24
IS 9
BP 1084
EP 1098
DI 10.1080/09205063.2012.735100
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 159YU
UT WOS:000320084000005
PM 23683040
DA 2018-10-20
ER

PT J
AU Jung, MH
   Shon, WJ
   Park, YS
   Chung, SH
AF Jung, Min-Ho
   Shon, Won-Jun
   Park, Young-Seok
   Chung, Shin-Hye
TI Effects of silanation time on shear bond strength between a gold alloy
   surface and metal bracket
SO KOREAN JOURNAL OF ORTHODONTICS
LA English
DT Article
DE Bonding; Biomaterial science
ID PORCELAIN SURFACES; COMPOSITE; ADULTS
AB Objective: We aimed to investigate the effects of silanation time on the shear bond strength (SBS) of metal brackets on gold alloy in a silicoating procedure and compare the SBS of metal brackets on gold alloy and enamel. Methods: Type 111 gold alloy plates were sandblasted with 30-mu m silicon dioxide. Excess particles were removed with gentle air after silica coating, and silane was applied. Maxillary central-incisor metal brackets were bonded to each conditioned alloy surface with a light curing resin adhesive for 1 s, 30 s, 60 s, or 120 s after applying silane. The brackets were also bonded to 36 upper central incisors with the same adhesive. All samples were cured for 40 s with a light emitting diode curing light. The SBS was tested after 1 h and after 24 h. The adhesive remnant index (ARI) of the samples was also compared. Results: The 60-s and 120-s silanation time groups showed a higher SBS than the other groups (p < 0.05). Samples tested after 24 h showed a significantly higher SBS than did the samples tested after 1 h (p < 0.05). The 1-s group showed higher ARI scores. The one-way analysis of variance and Student-Newman-Keuls test showed that the SBS values of the 60-s and 120-s silanation time groups were not significantly different from the SBS values of enamel. Conclusions: Adequate silanation time is required to produce sufficient bond strength during silicoating.
C1 [Jung, Min-Ho] Seoul Natl Univ, Dept Orthodont, Sch Dent, Seoul 137909, South Korea.
   [Jung, Min-Ho; Shon, Won-Jun; Park, Young-Seok; Chung, Shin-Hye] Seoul Natl Univ, Dent Res Inst, Seoul 137909, South Korea.
   [Shon, Won-Jun; Chung, Shin-Hye] Seoul Natl Univ, Dept Conservat Dent, Sch Dent, Seoul 137909, South Korea.
   [Park, Young-Seok] Seoul Natl Univ, Dept Oral Anat, Sch Dent, Seoul 137909, South Korea.
RP Jung, MH (reprint author), Seoul Natl Univ, SNU HONORS Orthodont Clin, Sch Dent, Dept Orthodont, 3rd Fl,Taenam Bldg,72-3 Chamwon Dong, Seoul 137909, South Korea.
EM fortit@chol.com
CR [Anonymous], 2012, INSTR US
   [Anonymous], 2012, INSTR US
   Bishara SE, 1999, AM J ORTHOD DENTOFAC, V116, P616, DOI 10.1016/S0889-5406(99)70195-2
   BOYD RL, 1992, ANGLE ORTHOD, V62, P117
   BUYUKYILMAZ T, 1995, AM J ORTHOD DENTOFAC, V108, P510, DOI 10.1016/S0889-5406(95)70051-X
   Jost-Brinkmann P G, 1999, J Adhes Dent, V1, P243
   Jung M., 2005, J KOREAN FDN GNATHOO, V7, P61
   Jung MH, 2012, KOREAN J ORTHOD, V42, P80, DOI 10.4041/kjod.2012.42.2.80
   Jung MH, 2010, KOREAN J ORTHOD, V40, P27, DOI 10.4041/kjod.2010.40.1.27
   McLain J B, 1985, J Dent Educ, V49, P386
   Nebbe B, 1996, AM J ORTHOD DENTOFAC, V109, P431, DOI 10.1016/S0889-5406(96)70125-7
   Nergiz I, 2004, AM J ORTHOD DENTOFAC, V125, P42, DOI 10.1016/S0889-5406(03)00507-9
   Ozcan M, 2002, INT J PROSTHODONT, V15, P299
   PEUTZFELDT A, 1988, SCAND J DENT RES, V96, P171
   PROFFIT WR, 1983, J DENT RES, V62, P566, DOI 10.1177/00220345830620051201
   Reynolds I. R., 1975, BRIT J ORTHODONT, V2, P171, DOI DOI 10.1080/0301228X.1975.11743666
   SCHNEIDER W, 1992, DENT MATER, V8, P211, DOI 10.1016/0109-5641(92)90086-R
   Shon WJ, 2012, EUR J ORTHODONT, V34, P72, DOI 10.1093/ejo/cjq163
   Toroglu MS, 2008, AM J ORTHOD DENTOFAC, V134, P181, DOI 10.1016/j.ajodo.2008.05.012
   Trakyali G, 2009, EUR J ORTHODONT, V31, P402, DOI 10.1093/ejo/cjn118
   Watanabe I, 1999, J PROSTHET DENT, V82, P462, DOI 10.1016/S0022-3913(99)70035-1
   Zachrisson BU, 2000, AM J ORTHOD DENTOFAC, V117, P592, DOI 10.1016/S0889-5406(00)70211-3
NR 22
TC 4
Z9 4
U1 0
U2 2
PU KOREAN ASSOC ORTHODONTISTS
PI SEOUL
PA 603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH
   KOREA
SN 2234-7518
J9 KOREAN J ORTHOD
JI Korean J. Orthod.
PD JUN
PY 2013
VL 43
IS 3
BP 127
EP 133
DI 10.4041/kjod.2013.43.3.127
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 171FH
UT WOS:000320910000004
PM 23814707
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Dilea, M
   Mazare, A
   Ionita, D
   Demetrescu, I
AF Dilea, M.
   Mazare, A.
   Ionita, D.
   Demetrescu, I.
TI Comparison between corrosion behaviour of implant alloys Ti6Al7Nb and
   Ti6Al4Zr in artificial saliva
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
DE artificial saliva; corrosion behaviour; EIS; titanium alloys
ID IN-VITRO; ELECTROCHEMICAL-BEHAVIOR; TITANIUM-ALLOYS; BIOCOMPATIBILITY;
   SURFACE; PERFORMANCE; REPLACEMENT; ZIRCONIUM
AB The present paper investigates two different titanium alloys: Ti6Al7Nb - a well-established implant biomaterial and Ti6Al4Zr - a relatively new titanium alloy. Roughness is evaluated with atomic force microscopy (AFM) and the hydrophilic/hydrophobic balance by contact angle measurements. Furthermore, an extensive characterization was done in order to evaluate and compare the electrochemical behaviour for both titanium alloys in artificial Fusayama and Afnor saliva, at different immersion times, and consisted of Tafel plots, cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). Also, metals ions release was measured using inductively coupled plasma mass spectrometry (ICP-MS). In both studied artificial saliva, Ti6Al4Zr alloy presents a better electrochemical behaviour according to corrosion rates from both electrochemical techniques and ICP-MS.
C1 [Dilea, M.; Mazare, A.; Ionita, D.; Demetrescu, I.] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
RP Ionita, D (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Polizu 1-7, Bucharest 011061, Romania.
EM md_ionita@yahoo.com
OI Mazare, Anca/0000-0002-4836-946X
FU Romanian National CNCSIS Grant IDEI PCCE [248/2010]; Romanian Ministry
   of Labour, Family and Social Protection [POS-DRU/88/1.5/S/60203]
FX The authors gratefully acknowledge the financial support of the Romanian
   National CNCSIS Grant IDEI PCCE No. 248/2010. M. Dilea and A. Mazare
   wish to thank the Sectoral Operational Programme Human Resources
   Development 2007-2013 of the Romanian Ministry of Labour, Family and
   Social Protection through the Financial Agreement
   POS-DRU/88/1.5/S/60203.
CR [Anonymous], 1994, STANDARD SPECIFICATI, V1295-92, P687
   [Anonymous], 1994, STANDARD SPECIFICATI, V136-82, P19
   Asti A, 2010, BIOINORG CHEM APPL, DOI 10.1155/2010/831031
   Bartakova S., 2009, SCR MED, V82, P76
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Demetrescu I, 2010, BIOELECTROCHEMISTRY, V79, P122, DOI 10.1016/j.bioelechem.2010.02.001
   Demetrescu I., 2008, MOL CRYST LIQ CRYST, V486, P110
   Donachie Jr M. J, 1988, TITANIUM TECHNICAL G
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Elias C. N., 2008, J MECH BEHAV BIOMED, V1, P242
   Gabriel S. B., 2011, J ALLOYS COMPD
   Ionita D, 2011, MATER CORROS, V62, P1111, DOI 10.1002/maco.201005661
   Ionita D, 2011, APPL SURF SCI, V257, P9164, DOI 10.1016/j.apsusc.2011.05.125
   Karthega M, 2007, ACTA BIOMATER, V3, P1019, DOI 10.1016/j.actbio.2007.02.009
   Leung VWH, 1997, J DENT, V25, P475, DOI 10.1016/S0300-5712(96)00068-1
   Magdy I., 2002, J SOLID STATE ELECTR, V6, P341
   Mareci D, 2007, MATER CORROS, V58, P848, DOI 10.1002/maco.200704065
   Mareci D, 2008, ENVIRON ENG MANAG J, V7, P701, DOI 10.30638/eemj.2008.093
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Mindroiu M, 2010, ELECTROCHIM ACTA, V56, P193, DOI 10.1016/j.electacta.2010.08.100
   Narayanan R, 2008, CORROS SCI, V50, P1521, DOI 10.1016/j.corsci.2008.02.023
   Pirvu C, 2011, MATER CORROS, V62, P948, DOI 10.1002/maco.201006041
   Popa MV, 2007, MATER CORROS, V58, P667, DOI 10.1002/maco.200704053
   RAE T, 1981, J BONE JOINT SURG BR, V63, P435
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   SEMLITSCH M, 1987, CLIN MATER, V2, P1, DOI DOI 10.1016/0267-6605(87)90015-1
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   Souto B. M., 1997, J MATER SCI-MATER M, V7, P337
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   Vasilescu E, 2009, CORROS SCI, V51, P2885, DOI 10.1016/j.corsci.2009.08.014
   Verrier S, 2011, BIOMATERIALS, V32, P672, DOI 10.1016/j.biomaterials.2010.09.028
   Wang BL, 2009, MATER CORROS, V60, P788, DOI 10.1002/maco.200805173
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Zhang BB, 2011, MATER CORROS, V62, P766, DOI 10.1002/maco.200905561
NR 34
TC 20
Z9 20
U1 1
U2 16
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-5117
J9 MATER CORROS
JI Mater. Corros.
PD JUN
PY 2013
VL 64
IS 6
BP 493
EP 499
DI 10.1002/maco.201206526
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 166LD
UT WOS:000320555200007
DA 2018-10-20
ER

PT J
AU Yang, YJ
   Choi, YS
   Jung, D
   Park, BR
   Hwang, WB
   Kim, HW
   Cha, HJ
AF Yang, Yun Jung
   Choi, Yoo Seong
   Jung, Dooyup
   Park, Byung Rak
   Hwang, Woon Bong
   Kim, Hyun Woo
   Cha, Hyung Joon
TI Production of a novel silk-like protein from sea anemone and fabrication
   of wet-spun and electrospun marine-derived silk fibers
SO NPG ASIA MATERIALS
LA English
DT Article
DE electrospun nanofiber; marine silk fibers; recombinant silk proteins;
   sea anemone; wet-spun fiber
ID SPIDER SILK; NEMATOSTELLA-VECTENSIS; MECHANICAL-PROPERTIES;
   ESCHERICHIA-COLI; POLYMER; BIOMATERIALS; PURIFICATION; STRENGTH
AB Silk-based biomaterials, which for centuries were primarily used as the raw materials for textile fabrics, are now being used in the medical, food and industrial fields because of their extraordinary properties. Their advantageous characteristics include high strength, extensibility, biocompatibility, biodegradability and minimal production of inflammatory reactions. To date, only silkworm silk has been applied in mass-produced technological applications, but spider silk proteins have been extensively studied because of their superior mechanical stability. Here we report the discovery of a novel silk-like protein (named aneroin) from the sea anemone Nematostella vectensis and the successful fabrication of wet-spun and electrospun silk fibers from purified recombinant aneroins. Aneroin fibers have promising mechanical properties, similar to those of recombinant spider silks with molecular weights of similar to 100 kDa and those of natural mammalian tendon collagen. The results of this study demonstrate that aneroin, a new repertoire of silk-like protein found in sea anemones, has potential for use as a novel fibrous biomaterial. Its use would expand the applications of silk in the development of multifunctional and bio-inspired materials.
C1 [Yang, Yun Jung; Jung, Dooyup; Cha, Hyung Joon] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
   [Choi, Yoo Seong] Chungnam Natl Univ, Dept Chem Engn, Taejon, South Korea.
   [Park, Byung Rak; Hwang, Woon Bong] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang 790784, South Korea.
   [Kim, Hyun Woo] Pukyong Natl Univ, Dept Marine Biol, Pusan, South Korea.
RP Cha, HJ (reprint author), Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
EM hjcha@postech.ac.kr
FU Marine Biotechnology Program; Ministry of Land, Transport and Maritime
   Affairs of Korea; Rising Star Program; POSTECH
FX This work was supported by the Marine Biotechnology Program, funded by
   the Ministry of Land, Transport and Maritime Affairs of Korea and the
   Rising Star Program funded by POSTECH. We thank Dr F Rentzsch (Sars
   Centre, Norway) for providing us with Nematostella vectensis, Drs H-S
   Lee (KORDI, Korea) and K-S Choi (JNU, Korea) for their useful advice on
   sea anemone, and Y-H Park (SNU, Korea) and K H Lee (SNU, Korea) for
   their useful advice on wet-spinning.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x
   Bandmann N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1171
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   Chen X, 2006, SOFT MATTER, V2, P448, DOI 10.1039/b601286h
   Committee on Disability Determination for Mental Retardation, 2002, MAR BIOT 21 CENT PRO, P1
   Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181
   David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001
   Ehrlich H, 2010, BIOL INSPIR SYST, V1, P3, DOI 10.1007/978-90-481-9130-7_1
   Fournier E, 2001, CURRENT PROTOCOLS FO
   Goldberg HA, 1997, ANAL BIOCHEM, V251, P227, DOI 10.1006/abio.1997.2252
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341
   HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Izard J, 2003, J MICROBIOL METH, V55, P411, DOI 10.1016/S0167-7012(03)00193-3
   Kaplan D, 1994, SILK POLYM MAT SCI B, P2
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015
   Mello CM, 2004, BIOMACROMOLECULES, V5, P1849, DOI 10.1021/bm049815g
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Northolt MG, 2005, ADV POLYM SCI, V178, P1, DOI 10.1007/b104207
   Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   POLLOCK M, 1994, AM J PHYSIOL, V266, pR1016
   Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Teule F, 2007, J MATER SCI, V42, P8974, DOI 10.1007/s10853-007-1642-6
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Trevino M, 2011, DEV DYNAM, V240, P2673, DOI 10.1002/dvdy.22774
   Um IC, 2004, INT J BIOL MACROMOL, V34, P89, DOI 10.1016/j.ijbiomac.2004.03.007
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
NR 34
TC 11
Z9 11
U1 2
U2 50
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1884-4049
EI 1884-4057
J9 NPG ASIA MATER
JI NPG Asia Mater.
PD JUN
PY 2013
VL 5
AR e50
DI 10.1038/am.2013.19
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 173VB
UT WOS:000321108400001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Tasli, PN
   Dogan, A
   Demirci, S
   Sahin, F
AF Tasli, Pakize Neslihan
   Dogan, Aysegul
   Demirci, Selami
   Sahin, Fikrettin
TI Boron Enhances Odontogenic and Osteogenic Differentiation of Human Tooth
   Germ Stem Cells (hTGSCs) In Vitro
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article
DE Sodium pentaborate pentahydrate; hTGSCs; Odontogenic differentiation;
   Osteogenic differentiation; Boron
ID MARROW STROMAL CELLS; DENTAL-PULP CELLS; BONE-MARROW; TISSUE;
   EXPRESSION; VIVO; REGENERATION; BIOMATERIAL; CULTURES; SCAFFOLD
AB Stem cell technology has been a great hope for the treatment of many common problems such as Parkinson's disease, Alzheimer's disease, diabetes, cancer, and tissue regeneration. Therefore, the main challenge in hard tissue engineering is to make a successful combination of stem cells and efficient inductors in the concept of stem cell differentiation into odontogenic and osteogenic cell types. Although some boron derivatives have been reported to promote bone and teeth growth in vivo, the molecular mechanism of bone formation has not been elucidated yet. Different concentrations of sodium pentaborate pentahydrate (NaB) were prepared for the analysis of cell toxicity and differentiation evaluations. The odontogenic, osteogenic differentiation and biomineralization of human tooth germ stem cells (hTGSCs) were evaluated by analyzing the mRNA expression levels, odontogenic and osteogenic protein expressions, alkaline phosphatase (ALP) activity, mineralization, and calcium deposits. The NaB-treated group displayed the highest ALP activity and expression of osteo- and odontogenic-related genes and proteins compared to the other groups and baseline. In the current study, increased in vitro odontogenic and osteogenic differentiation capacity of hTGSCs by NaB application has been shown for the first time. The study offers considerable promise for the development of new scaffold systems combined with NaB in both functional bone and tooth tissue engineering.
C1 [Tasli, Pakize Neslihan; Dogan, Aysegul; Demirci, Selami; Sahin, Fikrettin] Yeditepe Univ, Fac Engn & Architecture, Dept Genet & Bioengn, TR-34755 Istanbul, Turkey.
RP Sahin, F (reprint author), Yeditepe Univ, Fac Engn & Architecture, Dept Genet & Bioengn, 26 Agustos Campus,Kayisdagi Cad, TR-34755 Istanbul, Turkey.
EM fsahin@yeditepe.edu.tr
OI Tasli, Pakize Neslihan/0000-0002-0455-9894
CR Alliot-Licht B, 2005, CELL TISSUE RES, V321, P391, DOI 10.1007/s00441-005-1115-7
   Bakopoulou A, 2011, ARCH ORAL BIOL, V56, P709, DOI 10.1016/j.archoralbio.2010.12.008
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cavalcanti BN, 2013, DENT MATER, V29, P97, DOI 10.1016/j.dental.2012.08.002
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Demirer S, 2012, ARCH ORAL BIOL, V57, P60, DOI 10.1016/j.archoralbio.2011.07.012
   Devirian TA, 2003, CRIT REV FOOD SCI, V43, P219, DOI 10.1080/10408690390826491
   Dogan A, 2012, INT J NANOMED, V7, P4849, DOI 10.2147/IJN.S31949
   Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077
   GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hakki SS, 2013, J TRACE ELEM MED BIO, V27, P148, DOI 10.1016/j.jtemb.2012.07.001
   He HX, 2008, CELL BIOL INT, V32, P827, DOI 10.1016/j.cellbi.2008.03.013
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Kitagawa M, 2007, ARCH ORAL BIOL, V52, P727, DOI 10.1016/j.archoralbio.2007.02.006
   Lee JH, 2011, BIOMATERIALS, V32, P9696, DOI 10.1016/j.biomaterials.2011.09.007
   Lin CY, 2011, J ENDODONT, V37, P211, DOI 10.1016/j.joen.2010.11.009
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   Mareschi K, 2001, HAEMATOLOGICA, V86, P1099
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nielsen FH, 2008, BIOFACTORS, V3, P161
   Okamoto Y, 2009, J ENDODONT, V35, P367, DOI 10.1016/j.joen.2008.11.024
   Pan HB, 2010, J R SOC INTERFACE, V7, P1025, DOI 10.1098/rsif.2009.0504
   Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.3.CO;2-#
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Ryu JS, 2009, BIOCHEM BIOPH RES CO, V387, P266, DOI 10.1016/j.bbrc.2009.07.005
   Serigano K, 2010, J ORTHOP RES, V28, P1267, DOI 10.1002/jor.21147
   Stucki U, 2001, CLIN ORAL IMPLAN RES, V12, P121, DOI 10.1034/j.1600-0501.2001.012002121.x
   Tasli PN, 2013, J ENDODONT, V39, P31, DOI 10.1016/j.joen.2012.09.024
   Terasawa M, 2004, J BONE MINER METAB, V22, P430, DOI 10.1007/s00774-004-0504-4
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Yalvac ME, 2010, PHARMACOGENOMICS J, V10, P105, DOI 10.1038/tpj.2009.40
   Yalvac ME, 2011, NEUROCHEM RES, V36, P2227, DOI 10.1007/s11064-011-0546-7
   Yamada Y, 2006, BIOMATERIALS, V27, P3766, DOI 10.1016/j.biomaterials.2006.02.009
   Yang X, 2007, TISSUE ENG, V13, P2803, DOI 10.1089/ten.2006.0439
   Ying XZ, 2011, BIOL TRACE ELEM RES, V144, P306, DOI 10.1007/s12011-011-9094-x
   Young HE, 2001, ANAT REC, V264, P51, DOI 10.1002/ar.1128
   Yu JH, 2007, BIOL CELL, V99, P465, DOI 10.1042/BC20070013
   Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357
   Zhang YM, 2002, CIRCULATION, V106, P1294, DOI 10.1161/01.CIR.0000027585.05868.67
   Zou LJ, 2008, J ORTHOP RES, V26, P56, DOI 10.1002/jor.20467
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 44
TC 24
Z9 24
U1 0
U2 29
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
EI 1559-0720
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD JUN
PY 2013
VL 153
IS 1-3
BP 419
EP 427
DI 10.1007/s12011-013-9657-0
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 155KF
UT WOS:000319745900053
PM 23575901
DA 2018-10-20
ER

PT J
AU Resende, RFB
   Fernandes, GVO
   Santos, SRA
   Rossi, AM
   Lima, I
   Granjeiro, JM
   Calasans-Maia, MD
AF Resende, Rodrigo F. B.
   Fernandes, Gustavo V. O.
   Santos, Silvia R. A.
   Rossi, Alexandre M.
   Lima, Inaya
   Granjeiro, Jose M.
   Calasans-Maia, Monica D.
TI Long-term biocompatibility evaluation of 0.5 % zinc containing
   hydroxyapatite in rabbits
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; PROMOTING BONE-FORMATION; IN-VITRO;
   SUBSTITUTED HYDROXYAPATITE; REPAIR; HYDROXYLAPATITE; MICROSPHERES;
   BIOCERAMICS; DIVALENT; MATRICES
AB This study investigates the long-term biocompatibility of 0.5 % zinc-containing hydroxyapatite compared with hydroxyapatite. Spheres (425 < a... < 550) of both materials were produced by extrusion of ceramic slurry in calcium chloride and characterized by FTIR, XRD, XRF and SEM. Fifteen White New Zealand rabbits were submitted to general anesthesia, and an perforation (2 mm), was made in each tibia, one for zinc-containing hydroxyapatite sphere implantation and one for hydroxyapatite sphere implantation. After 26, 52 and 78 weeks, the animals were euthanized, and the fragment containing the biomaterial was harvested. A 30-50 mu m section was obtained for histological analysis in bright field and polarized light. SEM images revealed similar morphologies between the tested biomaterials. Histological analysis showed that there was no difference between the test groups. The morphometric analysis, however, indicates that there was a greater absorption. The materials are biocompatible, promote osteogenesis and that the zinc-containing hydroxyapatite microspheres were absorbed more quickly.
C1 [Resende, Rodrigo F. B.; Fernandes, Gustavo V. O.; Granjeiro, Jose M.] Univ Fed Fluminense, Cell & Mol Biol Dept, Inst Biol, Rio De Janeiro, Brazil.
   [Resende, Rodrigo F. B.; Calasans-Maia, Monica D.] Univ Fed Fluminense, Dept Oral Surg, Sch Dent, Rio De Janeiro, Brazil.
   [Santos, Silvia R. A.; Rossi, Alexandre M.] Brazilian Phys Ctr Researches, Biomat Lab LABIOMAT, Rio De Janeiro, Brazil.
   [Lima, Inaya] COPPE UFRJ, Nucl Engn Program, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
   [Granjeiro, Jose M.] Natl Inst Metrol Qual & Technol, Dept Bioengn, Rio De Janeiro, Brazil.
   [Granjeiro, Jose M.] Univ Fed Fluminense, Clin Res Unit, Rio De Janeiro, Brazil.
RP Resende, RFB (reprint author), Univ Fed Fluminense, Cell & Mol Biol Dept, Inst Biol, Rio De Janeiro, Brazil.
EM resende.r@hotmail.com; monicacalasansmaia@gmail.com
RI Granjeiro, Jose/D-8289-2012; Calasans-Maia, Monica/G-6203-2013
OI Granjeiro, Jose/0000-0002-8027-8293; Fernandes,
   Gustavo/0000-0003-3022-4390
FU FAPERJ; FINEP; DECIT-MS; CNPq; LNLS; COPPE; INMETRO; CBPF
FX The authors acknowledge the financial support of FAPERJ, FINEP, DECIT-MS
   and CNPq. In addition to the research partners LNLS, COPPE, INMETRO and
   CBPF.
CR Accorsi-Mendonça Thais, 2008, Braz. oral res., V22, P5, DOI 10.1590/S1806-83242008000100002
   Barrere F, 2006, INT J NANOMED, V1, P317
   Bazin D, 2008, J SYNCHROTRON RADIAT, V15, P506, DOI 10.1107/S0909049508014556
   Calasans-Maia M, 2008, KEY ENG MATER, V361-363, P1269, DOI 10.4028/www.scientific.net/KEM.361-363.1269
   Cestari TM, 2009, CLIN ORAL IMPLAN RES, V20, P340, DOI 10.1111/j.1600-0501.2008.01659.x
   Conz MB, 2011, J APPL ORAL SCI, V19, P337, DOI 10.1590/S1678-77572011005000007
   Costa AM, 2004, KEY ENG MAT, V254-2, P119, DOI 10.4028/www.scientific.net/KEM.254-256.119
   de Lima IR, 2011, J BIOMED MATER RES A, V98A, P351, DOI 10.1002/jbm.a.33126
   Fernandes GVO, 2009, KEY ENG MATER, V396-398, P15, DOI 10.4028/www.scientific.net/KEM.396-398.15
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Ito A, 2005, CURR APPL PHYS, V5, P402, DOI 10.1016/j.cap.2004.10.006
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Kawachi EY, 2000, QUIM NOVA, V23, P518, DOI 10.1590/S0100-40422000000400015
   Kawamura H, 2003, J BIOMED MATER RES A, V65A, P468, DOI 10.1002/jbm.a.10524
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Li X, 2009, MAT SCI ENG C-BIO S, V29, P969, DOI 10.1016/j.msec.2008.08.021
   Matsunaga K, 2009, ACTA BIOMATER, V6, P2289
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   Pradeesh TS, 2005, B MATER SCI, V28, P383, DOI 10.1007/BF02711223
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Riminucci M, 2003, BRAZ J MED BIOL RES, V36, P1027, DOI 10.1590/S0100-879X2003000800008
   Salgueiro MJ, 2000, BIOL TRACE ELEM RES, V76, P193, DOI 10.1385/BTER:76:3:193
   de Souza CAS, 2011, COLLOID SURFACE B, V87, P310, DOI 10.1016/j.colsurfb.2011.05.035
   Storrie H, 2005, BIOMATERIALS, V26, P5492, DOI 10.1016/j.biomaterials.2005.01.043
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Torrent-Burgues J, 2001, CRYST RES TECHNOL, V36, P1075, DOI 10.1002/1521-4079(200110)36:8/10<1075::AID-CRAT1075>3.0.CO;2-E
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
NR 29
TC 5
Z9 7
U1 0
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2013
VL 24
IS 6
BP 1455
EP 1463
DI 10.1007/s10856-013-4865-x
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 158VX
UT WOS:000320003000011
PM 23606217
DA 2018-10-20
ER

PT J
AU Niu, HX
   Mu, JS
   Zhang, JQ
   Hu, P
   Bo, P
   Wang, Y
AF Niu, Hongxing
   Mu, Junsheng
   Zhang, Jianqun
   Hu, Ping
   Bo, Ping
   Wang, Yan
TI Comparative study of three types of polymer materials co-cultured with
   bone marrow mesenchymal stem cells for use as a myocardial patch in
   cardiomyocyte regeneration
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; INFARCTED MYOCARDIUM; HEART; MODEL
AB The purpose of this study was to investigate the most suitable polymer material for supporting stem cell growth as a myocardial patch. After cell isolation and expansion of mouse bone marrow mesenchymal stem cells (BMSC), the cells were induced to differentiate into cardiomyocytes with 5-azacytidine to determine their differentiation potential. BMSCs were also seeded onto three types of polymer material film, including polyurethane (PU), 3-hydroxybutyrate-co-4-hydroxybutyrate [P(3HB-co-4HB)], and polypropylene carbonate (PPC). The results revealed that cell numbers were more abundant on both the PU and P(3HB-co-4HB) material surfaces. Conversely, the surface of PPC was smooth with only cell lysate debris observed. The average cell counts were as follows: 143.78 +/- A 38.38 (PU group), 159.50 +/- A 33.07 [P(3HB-co-4HB) group], and 1.40 +/- A 0.70 (PPC group). There was no statistically significant difference in cell numbers between the PU and P(3HB-co-4HB) groups. A statistically significant difference was identified between the PPC group and both the PU (P1) and P(3HB-co-4HB) groups (P2). Polymer biomaterial patches composed of PU and P(3HB-co-4HB) permit good stem cell growth. P(3HB-co-4HB) has the potential for development as a clinical alternative to current treatment methods for the regeneration of cardiomyocytes in patients with myocardial infarction.
C1 [Niu, Hongxing; Mu, Junsheng; Zhang, Jianqun; Bo, Ping] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China.
   [Hu, Ping; Wang, Yan] Tsinghua Univ, Dept Chem, High Polymer Inst Lab, Beijing 100084, Peoples R China.
RP Mu, JS (reprint author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China.
EM wesleymu@hotmail.com
CR Al Kindi AH, 2011, EUR J CARDIO-THORAC, V39, P241, DOI 10.1016/j.ejcts.2010.03.066
   Antonitsis P, 2008, THORAC CARDIOV SURG, V56, P77, DOI 10.1055/s-2007-989328
   Antonitsis Polychronis, 2007, Interact Cardiovasc Thorac Surg, V6, P593, DOI 10.1510/icvts.2007.157875
   DARBY RT, 1968, APPL MICROBIOL, V16, P900
   HUI J, 2010, J CARDIOVASC PULM DI, V29, P43
   Jain M, 2005, CORONARY ARTERY DIS, V16, P93, DOI 10.1097/00019501-200503000-00003
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   LIOYD DR, 1991, J MEMBRANE SCI, V64, P13
   MacDonald DJ, 2005, J THORAC CARDIOV SUR, V130, P1114, DOI 10.1016/j.jtcvs.2005.04.033
   Martens Timothy P, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS18, DOI 10.1038/ncpcardio0404
   Park BW, 2012, DIFFERENTIATION, V83, P249, DOI 10.1016/j.diff.2012.02.008
   SAEED H, 2011, STEM CELL REV, V7, P161
   Saito T, 2003, J THORAC CARDIOV SUR, V126, P114, DOI 10.1016/S0022-5223(03)00118-1
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Valarmathi MT, 2010, BIOMATERIALS, V31, P3185, DOI 10.1016/j.biomaterials.2010.01.041
   Zhang SH, 2006, J CELL BIOCHEM, V99, P1132, DOI 10.1002/jcb.20949
   Zhou Q, 2010, J THORAC CARDIOV SUR, V140, P1388, DOI 10.1016/j.jtcvs.2010.02.036
NR 19
TC 6
Z9 6
U1 1
U2 26
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2013
VL 24
IS 6
BP 1535
EP 1542
DI 10.1007/s10856-012-4842-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 158VX
UT WOS:000320003000019
PM 23620011
DA 2018-10-20
ER

PT J
AU Emohare, O
   Rushton, N
AF Emohare, Osa
   Rushton, Neil
TI Immobilized MWCNT support osteogenic cell culture
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID WALL CARBON NANOTUBES; IN-VITRO; BIOCOMPATIBILITY; CYTOTOXICITY;
   OSTEOLYSIS; TOXICITY; BIOLOGY
AB The broad use of versatile, strong, lightweight multi-walled carbon nanotubes (MWCNT) for use in biomaterial applications is tempered by ongoing debate about their safety. Recent reports suggest that factors such as their diameter and surface coating affect their function and cytotoxicity. The cell culture surfaces used in the current study were made of MWCNT immobilized in a high-density polyethylene substrate, differentiating it from most studies of MWCNT cytotoxicity. The purity, chemical functionalization, and immobilization of MWCNT were evaluated to elucidate their effect on MWCNT behavior relative to controls. While purity was found not to be significant in determining the behavior of cells on MWCNT relative to standard controls, the presence of carboxyl functional groups was generally associated with reduced cell metabolic activity, proliferation, and differentiation as measured using the MTS assay, nucleic acid incorporation, and alkaline phosphatase expression, respectively. This study demonstrates that the culture of osteogenic cells on surfaces made of nonfunctionalized and immobilized MWCNT is associated with a level of cell growth and differentiation comparable to those of standard tissue culture controls.
C1 [Emohare, Osa; Rushton, Neil] Univ Cambridge, Orthopaed Res Unit, Dept Surg, Cambridge CB2 2QQ, England.
RP Emohare, O (reprint author), Univ Cambridge, Orthopaed Res Unit, Dept Surg, Hills Rd, Cambridge CB2 2QQ, England.
EM oemohare@umn.edu
FU Orthopaedic Research UK (ORUK)
FX This study was funded by Orthopaedic Research UK (ORUK).
CR Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Ajayan PM, 2007, NATURE, V447, P1066, DOI 10.1038/4471066a
   Bhumbra RPS, 2000, CLIN ORTHOP RELAT R, P192
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   Chlopek J, 2006, CARBON, V44, P1106, DOI 10.1016/j.carbon.2005.11.022
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108
   Greenfield EM, 2002, J ORTHOPAED RES, V20, P1, DOI 10.1016/S0736-0266(01)00070-5
   Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147
   JUKKOLA A, 1993, J BONE MINER RES, V8, P651
   Lobo AO, 2010, CARBON, V48, P245, DOI 10.1016/j.carbon.2009.09.012
   Magrez A, 2006, NANO LETT, V6, P1121, DOI 10.1021/nl060162e
   Monteiro-Riviere NA, 2006, CARBON, V44, P1070, DOI 10.1016/j.carbon.2005.11.004
   Nagai H, 2011, P NATL ACAD SCI USA, V108, pE1330, DOI 10.1073/pnas.1110013108
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   Reis J, 2010, BRAZ J MED BIOL RES, V43, P476, DOI 10.1590/S0100-879X2010007500038
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
NR 20
TC 2
Z9 2
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2013
VL 24
IS 6
BP 1543
EP 1550
DI 10.1007/s10856-013-4904-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 158VX
UT WOS:000320003000020
PM 23471503
DA 2018-10-20
ER

PT J
AU Skop, NB
   Calderon, F
   Levison, SW
   Gandhi, CD
   Cho, CH
AF Skop, Nolan B.
   Calderon, Frances
   Levison, Steven W.
   Gandhi, Chirag D.
   Cho, Cheul H.
TI Heparin crosslinked chitosan microspheres for the delivery of neural
   stem cells and growth factors for central nervous system repair
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nerve tissue regeneration; Regenerative medicine; Multifunctional
   scaffold; Fibroblast growth factor-2; Cell transplantation
ID TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; SPINAL-CORD; IN-VIVO;
   CONTROLLED-RELEASE; COLLAGEN MATRICES; NEURITE EXTENSION; GEL STIFFNESS;
   GLIAL-CELLS; RAT-BRAIN
AB An effective paradigm for transplanting large numbers of neural stem cells after central nervous system (CNS) injury has yet to be established. Biomaterial scaffolds have shown promise in cell transplantation and in regenerative medicine, but improved scaffolds are needed. In this study we designed and optimized multifunctional and biocompatible chitosan-based films and microspheres for the delivery of neural stem cells and growth factors for CNS injuries. The chitosan microspheres were fabricated by coaxial airflow techniques, with the sphere size controlled by varying the syringe needle gauge and the airflow rate. When applying a coaxial airflow at 30 standard cubic feet per hour, similar to 300 mu m diameter spheres were reproducibly generated that were physically stable yet susceptible to enzymatic degradation. Heparin was covalently crosslinked to the chitosan scaffolds using genipin, which bound fibroblast growth factor-2 (FGF-2) with high affinity while retaining its biological activity. At 1 mu g ml(-1) approximately 80% of the FGF-2 bound to the scaffold. A neural stem cell line, GFP + RG3.6 derived from embryonic rat cortex, was used to evaluate cytocompatibility, attachment and survival on the crosslinked chitosan-heparin complex surfaces. The MTT assay and microscopic analysis revealed that the scaffold containing tethered FGF-2 was superior in sustaining survival and growth of neural stem cells compared to standard culture conditions. Altogether, our results demonstrate that this multifunctional scaffold possesses good cytocompatibility and can be used as a growth factor delivery vehicle while supporting neural stem cell attachment and survival. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Skop, Nolan B.; Calderon, Frances; Levison, Steven W.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07102 USA.
   [Gandhi, Chirag D.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07102 USA.
   [Skop, Nolan B.; Cho, Cheul H.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.
RP Cho, CH (reprint author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.
EM cho@njit.edu
OI Levison, Steven/0000-0002-1264-7309
FU New Jersey Commission on Brain Injury Research [08.001.BIR2,
   CBIR12FEL025]; Wallace H. Coulter Foundation
FX This study was partially supported by the New Jersey Commission on Brain
   Injury Research grant number 08.001.BIR2 awarded to C.D.G. and S.W.L.,
   fellowship grant number CBIR12FEL025 awarded to N.P.S. and the Wallace
   H. Coulter Foundation.
CR Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Barbucci R, 2009, HYDROGELS BIOL PROPE, VXII, P200
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040
   Cervera A, 2004, J NEUROSCI RES, V77, P565, DOI 10.1002/jnr.20186
   Chandy T, 2000, J MICROENCAPSUL, V17, P625
   Cho CH, 2008, J BIOMED MATER RES A, V86A, P98, DOI 10.1002/jbm.a.31614
   Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Crompton KE, 2006, J MATER SCI-MATER M, V17, P633, DOI 10.1007/s10856-006-9226-6
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eroglu H, 2010, CHEM PHARM BULL, V58, P1161, DOI 10.1248/cpb.58.1161
   FOLKMAN J, 1983, CIBA F SYMP, V100, P132
   Francesko A, 2011, ADV BIOCHEM ENG BIOT, V125, P1, DOI [10.1007/10_2010_93, 10.10007/10_2010_93]
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Guo XD, 2012, CELL TRANSPLANT, V21, P1177, DOI 10.3727/096368911X612503
   Guo XL, 2003, J BIOMAT SCI-POLYM E, V14, P551, DOI 10.1163/15685620360674245
   Harris R, 2010, MAR DRUGS, V8, P1750, DOI 10.3390/md8061750
   Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037
   Hassan EE, 1993, J DRUG TARGET, V1, P7, DOI 10.3109/10611869308998759
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   Hussain A, 2013, BIOTECHNOL BIOENG, V110, P637, DOI 10.1002/bit.24727
   Jumaa M, 2002, EUR J PHARM BIOPHARM, V53, P115, DOI 10.1016/S0939-6411(01)00191-6
   Kai D, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095705
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kim S, 2009, BIOMATERIALS, V30, P4743, DOI 10.1016/j.biomaterials.2009.05.010
   Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011
   Koriyama Y, 2011, J NEUROCHEM, V119, P1232, DOI 10.1111/j.1471-4159.2011.07533.x
   Kou JH, 1997, J CONTROL RELEASE, V43, P123, DOI 10.1016/S0168-3659(96)01477-0
   LAMOUREUX P, 1989, Nature (London), V340, P159, DOI 10.1038/340159a0
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Li HD, 2004, DEV BIOL, V271, P225, DOI 10.1016/j.ydbio.2004.02.028
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Maysinger D, 1996, EXP NEUROL, V141, P47, DOI 10.1006/exnr.1996.0138
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078
   Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180
   Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nam KN, 2010, INT IMMUNOPHARMACOL, V10, P493, DOI 10.1016/j.intimp.2010.01.011
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   RIBATTI D, 1987, ACTA ANAT, V130, P257
   Seo MC, 2008, J NEUROSCI RES, V86, P1087, DOI 10.1002/jnr.21552
   Shen H, 2011, BIOMATERIALS, V32, P3404, DOI 10.1016/j.biomaterials.2011.01.037
   Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129
   Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057
   Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Thakur G, 2011, J MATER SCI-MATER M, V22, P115, DOI 10.1007/s10856-010-4185-3
   Tolaimate A, 2000, POLYMER, V41, P2463, DOI 10.1016/S0032-3861(99)00400-0
   Turkoglu OF, 2005, SURG NEUROL, V64, P11, DOI 10.1016/j.surneu.2005.07.041
   Turkoglu OF, 2010, BRIT J NEUROSURG, V24, P578, DOI 10.3109/02688697.2010.487126
   Vasavada VA, 2012, AM J OPHTHALMOL, V154, pe4
   Vergano-Vera E, 2009, NEUROSCIENCE, V162, P39, DOI 10.1016/j.neuroscience.2009.03.033
   Volpato FZ, 2012, ACTA BIOMATER, V8, P1551, DOI 10.1016/j.actbio.2011.12.023
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wu JM, 2011, J MATER SCI-MATER M, V22, P107, DOI 10.1007/s10856-010-4176-4
   Yamazaki M, 2004, EUR J PHARMACOL, V488, P35, DOI 10.1016/j.ejphar.2004.02.009
   Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618
   Yuan Y, 2007, CARBOHYD POLYM, V68, P561, DOI 10.1016/j.carbpol.2006.10.023
   Zeng Y, 2011, MED HYPOTHESES, V77, P680, DOI 10.1016/j.mehy.2011.07.015
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 79
TC 42
Z9 44
U1 2
U2 88
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2013
VL 9
IS 6
BP 6834
EP 6843
DI 10.1016/j.actbio.2013.02.043
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 158EF
UT WOS:000319951500009
PM 23467042
DA 2018-10-20
ER

PT J
AU Bettahalli, NMS
   Arkesteijn, ITM
   Wessling, M
   Poot, AA
   Stamatialis, D
AF Bettahalli, N. M. S.
   Arkesteijn, I. T. M.
   Wessling, M.
   Poot, A. A.
   Stamatialis, D.
TI Corrugated round fibers to improve cell adhesion and proliferation in
   tissue engineering scaffolds
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Corrugated fibers; Scaffolds; Cell adhesion and proliferation; Tissue
   engineering
ID DYNAMIC-MECHANICAL PROPERTIES; POROUS SCAFFOLDS; IMMERSION
   PRECIPITATION; POLYMER SCAFFOLDS; PORE-SIZE; FABRICATION; CULTURE;
   DESIGN; MEMBRANES; ORGANIZATION
AB Optimal cell interaction with biomaterial scaffolds is one of the important requirements for the development of successful in vitro tissue-engineered tissues. Fast, efficient and spatially uniform cell adhesion can improve the clinical potential of engineered tissue. Three-dimensional (3-D) solid free form fabrication is one widely used scaffold fabrication technique today. By means of deposition of polymer fibers, scaffolds with various porosity, 3-D architecture and mechanical properties can be prepared. These scaffolds consist mostly of solid round fibers. In this study, it was hypothesized that a corrugated fiber morphology enhances cell adhesion and proliferation and therefore leads to the development of successful in vitro tissue-engineered constructs. Corrugated round fibers were prepared and characterized by extruding poly(ethylene oxide terephthalate)-co-poly(butylene terephthalate) (300PEOT55PBT45) block co-polymer through specially designed silicon wafer inserts. Corrugated round fibers with 6 and 10 grooves on the fiber surface were compared with solid round fibers of various diameters. The culture of mouse pre-myoblast (C2C12) cells on all fibers was studied under static and dynamic conditions by means of scanning electron microscopy, cell staining and DNA quantification. After 7 days of culturing under static conditions, the DNA content on the corrugated round fibers was approximately twice as high as that on the solid round fibers. Moreover, under dynamic culture conditions, the cells on the corrugated round fibers seemed to experience lower mechanical forces and therefore adhered better than on the solid round fibers. The results of this study show that the surface architecture of fibers in a tissue engineering scaffold can be used as a tool to improve the performance of the scaffold in terms of cell adhesion and proliferation. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bettahalli, N. M. S.; Arkesteijn, I. T. M.; Wessling, M.] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Membrane Technol Grp, NL-7500 AE Enschede, Netherlands.
   [Poot, A. A.; Stamatialis, D.] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
RP Stamatialis, D (reprint author), Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.
EM d.stamatialis@utwente.nl
RI Wessling, Matthias/K-4797-2012; bettahalli, srivatsa/E-8564-2017
OI Wessling, Matthias/0000-0002-7874-5315; bettahalli,
   srivatsa/0000-0001-8605-0241
FU Technology Foundation STW [TKG. 6716]
FX The authors acknowledge the financial support from Technology Foundation
   STW (Project number TKG. 6716) and Prof. C. van Blitterswijk, Tissue
   Regeneration (TR) group, University of Twente, The Netherlands, for the
   use of the bioplotter and performing cell culture experiments in his
   lab.
CR Culfaz P. Z., 2009, J MEMBRANE SCI, V347, P32
   Curtis A S G, 2005, Eur Cell Mater, V9, P50
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Dunn JCY, 2006, TISSUE ENG, V12, P705, DOI 10.1089/ten.2006.12.705
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Khabiry M, 2009, SMALL, V5, P1186, DOI 10.1002/smll.200801644
   Kim SY, 2004, J APPL POLYM SCI, V92, P2082, DOI 10.1002/app.20144
   Kim TK, 2006, BIOMATERIALS, V27, P152, DOI 10.1016/j.biomaterials.2005.05.081
   Korin N, 2009, BIOTECHNOL BIOENG, V102, P1222, DOI 10.1002/bit.22153
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Mitchel JA, 2011, PLOS ONE, P6
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   Nijdam W, 2005, J MEMBRANE SCI, V256, P209, DOI 10.1016/j.memsci.2005.02.022
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Papadaki M, 2001, J BIOMED MATER RES, V54, P47, DOI 10.1002/1097-4636(200101)54:1<47::AID-JBM6>3.0.CO;2-3
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   Saltzman W, 2004, TISSUE ENG PRINCIPLE
   Sawalha H, 2007, J APPL POLYM SCI, V104, P959, DOI 10.1002/app.25808
   Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008
   Wang XX, 2006, BIOMATERIALS, V27, P1924, DOI 10.1016/j.biomaterials.2005.09.029
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zoppi RA, 1999, POLYMER, V40, P3275, DOI 10.1016/S0032-3861(98)00562-X
NR 36
TC 14
Z9 15
U1 1
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2013
VL 9
IS 6
BP 6928
EP 6935
DI 10.1016/j.actbio.2013.02.029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 158EF
UT WOS:000319951500019
PM 23485858
DA 2018-10-20
ER

PT J
AU Liu, Y
   Wang, YM
   Pang, HF
   Zhao, Q
   Liu, L
AF Liu, Yan
   Wang, Yi-Mei
   Pang, Hui-Fang
   Zhao, Qiu
   Liu, Lin
TI A Ni-free ZrCuFeAlAg bulk metallic glass with potential for biomedical
   applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Zr-based metallic glass; Toughness; Fatigue; Biocorrosion resistance;
   Metal ion release
ID ZR65AL7.5NI10CU17.5 AMORPHOUS ALLOY; PHOSPHATE-BUFFERED SOLUTION;
   FRACTURE-TOUGHNESS; MECHANICAL-PROPERTIES; POLARIZATION BEHAVIOR; CU-BE;
   SURFACE MODIFICATION; CORROSION BEHAVIOR; TITANIUM-ALLOYS; IN-VITRO
AB The mechanical properties and biocompatibility of an Ni-free Zr-based bulk metallic glass (BMG) Zr60.14Cu22.31Fe4.85Al9.7Ag3 were investigated in detail to evaluate its potential as a biomaterial. The BMG was found to have a low Young's modulus of 82 +/- 1.9 GPa, a high strength of 1720 +/- 28 MPa and a high fracture toughness of 94 +/- 19 MPa m(1/2), as well as good fatigue strength over 400 MPa. The corrosion behavior of the alloy was investigated in simulated body fluid (SBF) by electrochemical measurements, which indicates that the Zr-based BMG has a better corrosion resistance than pure Zr and Ti6Al4V. X-ray photoelectron spectroscopy analysis revealed that the passive film formed on the BMG surface is enriched in Al- and Zr-oxides, which could account for the good corrosion resistance of the BMG. On the other hand, metal ion release of the BMG in SBF was determined by inductively coupled plasma mass spectrometry after the BMG was immersed in SBF at 37 degrees C for 30 days, showing a ppb (ng ml(-1)) level of metal ion release. The in vitro test via cell culture indicates that the BMG exhibits a cytotoxicity of Grade 0-1, which is as good as Ti6Al4V alloy. Cell adhesion morphological analysis shows that the cells were flattened and well spread out on the surfaces of the BMG, showing that the BMG had good biocompatibility. The combination of good mechanical properties and biocompatibility demonstrates that the Ni-free Zr-based BMG studied in this work is a good candidate for a new type of load-bearing biomedical material. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Liu, Yan; Wang, Yi-Mei; Liu, Lin] Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, Wuhan 430074, Peoples R China.
   [Pang, Hui-Fang; Zhao, Qiu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China.
RP Liu, L (reprint author), Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, Wuhan 430074, Peoples R China.
EM lliu2000@mail.hust.edu.cn
RI BAI, JIE/D-7448-2016
FU National Nature Science Foundation of China [51071072, 51271081]
FX This work was financially supported by the National Nature Science
   Foundation of China (Grant Nos. 51071072 and 51271081). The authors are
   grateful to the Analytical and Testing Center, Huazhong University of
   Science and Technology for technical assistance.
CR American Society for Testing Materials, 2004, ANN BOOK ASTM STAND
   [Anonymous], 1999, ISO10993E5 ANSIAAMI
   Arola D, 2010, INT J FATIGUE, V32, P1400, DOI 10.1016/j.ijfatigue.2009.08.007
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   ASTM, 1999, ANN BOOK ASTM STAND
   Brown Jr WF, 2001, CINDAS USAF CRDA HDB
   Buzzi S, 2006, INTERMETALLICS, V14, P729, DOI 10.1016/j.intermet.2005.11.003
   CHARNLEY J, 1973, CLIN ORTHOP RELAT R, P9
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   Chen Q, 2011, PHILOS MAG, V91, P3705, DOI 10.1080/14786435.2011.589867
   Colic M, 2009, ACTA BIOMATER, V6, P308
   Colic M, 2010, J BIOMATER APPL, V25, P269, DOI 10.1177/0885328209354613
   Cortizo MC, 2004, BIOL TRACE ELEM RES, V102, P129, DOI 10.1385/BTER:102:1-3:129
   Demetriou MD, 2011, NAT MATER, V10, P123, DOI [10.1038/nmat2930, 10.1038/NMAT2930]
   Demetriou MD, 2010, JOM-US, V62, P83, DOI 10.1007/s11837-010-0038-2
   El-Shabasy AB, 2010, SCRIPTA MATER, V62, P481, DOI 10.1016/j.scriptamat.2009.12.016
   Freels M, 2007, J MATER RES, V22, P374, DOI 10.1557/JMR.2007.0052
   GEORGETTE FS, 1986, J BIOMED MATER RES, V20, P1229, DOI 10.1002/jbm.820200812
   Gilbert CJ, 1998, SCRIPTA MATER, V38, P537, DOI 10.1016/S1359-6462(97)00522-8
   Gua XJ, 2010, ACTA MAT, V58, P1708
   HARTY M, 1982, ORTHOP CLIN N AM, V13, P667
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   Hiromoto S, 2000, CORROS SCI, V42, P2193, DOI 10.1016/S0010-938X(00)00056-1
   Hiromoto S, 2000, CORROS SCI, V42, P2167, DOI 10.1016/S0010-938X(00)00043-3
   Horton JA, 2002, MAT RES SOC S P
   Huang L, 2009, INTERMETALLICS, V17, P195, DOI 10.1016/j.intermet.2008.07.020
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Jia P, 2009, SCRIPTA MATER, V61, P137, DOI 10.1016/j.scriptamat.2009.03.024
   Jin K, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1948513
   Johnson WL, 1999, MRS BULL, V24, P42, DOI 10.1557/S0883769400053252
   Kawashima A, 2005, MATER TRANS, V46, P1725, DOI 10.2320/matertrans.46.1725
   Kim CP, 2009, SCRIPTA MATER, V60, P80, DOI 10.1016/j.scriptamat.2008.09.001
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Launey ME, 2008, ACTA MATER, V56, P500, DOI 10.1016/j.actamat.2007.10.007
   Lewandowski JJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2890489
   Lewandowski JJ, 2001, MATER TRANS, V42, P633, DOI 10.2320/matertrans.42.633
   Liu CT, 1998, METALL MATER TRANS A, V29, P1811, DOI 10.1007/s11661-998-0004-6
   Liu L, 2008, J BIOMED MATER RES A, V86A, P160, DOI 10.1002/jbm.a.31425
   Liu L, 2008, SCRIPTA MATER, V58, P231, DOI 10.1016/j.scriptamat.2007.09.040
   Liu L, 2010, INTERMETALLICS, V18, P1978, DOI 10.1016/j.intermet.2010.02.039
   Liu L, 2009, INTERMETALLICS, V17, P235, DOI 10.1016/j.intermet.2008.07.022
   Liu Z, 2009, J ALLOY COMPD, V487, P152, DOI 10.1016/j.jallcom.2009.08.030
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lowhaphandu P, 2000, INTERMETALLICS, V8, P487, DOI 10.1016/S0966-9795(99)00137-5
   Lowhaphandu P, 1998, SCRIPTA MATER, V38, P1811, DOI 10.1016/S1359-6462(98)00102-X
   MALCHAU H, 1998, 65 ANN M AM AC ORTH, P19
   Maruyama N, 2005, J JPN I MET, V69, P481, DOI 10.2320/jinstmet.69.481
   McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3
   Morrison ML, 2007, MAT SCI ENG A-STRUCT, V467, P190, DOI 10.1016/j.msea.2007.05.066
   NEUMANN P, 1969, ACTA METALL MATER, V17, P1219, DOI 10.1016/0001-6160(69)90099-6
   Newman Jr JC, 1983, 85793 NASA, P85793
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   PRENDERGAST PJ, 1990, J BIOMED ENG, V12, P379, DOI 10.1016/0141-5425(90)90020-N
   Qiao DC, 2006, INTERMETALLICS, V14, P1043, DOI 10.1016/j.intermet.2006.01.044
   Qiu CL, 2006, SCRIPTA MATER, V55, P605, DOI 10.1016/j.scriptamat.2006.06.018
   Qiu CL, 2005, J BIOMED MATER RES A, V75A, P950, DOI 10.1002/jbm.a.30502
   ROGERS SD, 1993, J ORTHOPAED RES, V11, P856, DOI 10.1002/jor.1100110612
   Schroers J, 2009, JOM-US, V61, P21, DOI 10.1007/s11837-009-0128-1
   Scully JR, 2007, J MATER RES, V22, P302, DOI 10.1557/JMR.2007.0051
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Tada H., 1973, STRESS ANAL CRACKS H
   Wang GY, 2009, J ALLOY COMPD, V483, P143, DOI 10.1016/j.jallcom.2008.07.228
   Wang WH, 2004, MAT SCI ENG R, V44, P45, DOI 10.1016/j.mser.2004.03.001
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Wataha JC, 2000, J BIOMED MATER RES, V52, P360, DOI 10.1002/1097-4636(200011)52:2<360::AID-JBM16>3.0.CO;2-B
   Wessels V, 2012, ADV ENG MATER, V14, pB357, DOI 10.1002/adem.201180200
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yuan SJ, 2007, CORROS SCI, V49, P1276, DOI 10.1016/j.corsci.2006.07.003
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhai QW, 2000, J CELL PHYSIOL, V184, P161, DOI 10.1002/1097-4652(200008)184:2<161::AID-JCP3>3.3.CO;2-E
NR 74
TC 37
Z9 38
U1 7
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2013
VL 9
IS 6
BP 7043
EP 7053
DI 10.1016/j.actbio.2013.02.019
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 158EF
UT WOS:000319951500031
PM 23429233
DA 2018-10-20
ER

PT J
AU Cohen, HC
   Joyce, EJ
   Kao, WJ
AF Cohen, Hannah C.
   Joyce, Evan J.
   Kao, W. John
TI Biomaterials Selectively Modulate Interactions between Human
   Blood-Derived Polymorphonuclear Leukocytes and Monocytes
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID FOREIGN-BODY REACTION; CYTOKINE PRODUCTION; GRANULE PROTEINS;
   NEUTROPHILS; CELLS; INFLAMMATION; MACROPHAGES; MIP-1-ALPHA; MIP-1-BETA;
   DEFENSINS
AB Implantation of a biomaterial into the body elicits a host foreign body response, during which polymorphonuclear leukocytes (PMNs) and then monocytes (MCs) are recruited to the site of implantation. MCs and MC-derived macrophages are central players in this response because they secrete proinflammatory and/or pro wound-healing cytokines and growth factors that influence subsequent healing events. Although mechanisms of MC response to biomaterials are often studied in in vitro monoculture models, few studies have investigated how biomaterials modulate PMN-MC paracrine and juxtacrine interactions. To address this, we cultured human blood-derived MCs alone or in the presence of autologous PMN-conditioned medium (PCM) on poly(ethylene glycol) hydrogels, poly(dimethyl siloxane), and tissue culture polystyrene. We also directly co-cultured autologous PMNs and MCs on these biomaterials. PCM increased MC adhesion/viability and expression of IL-1 beta and tumor necrosis factor-alpha in a biomaterial- and time-dependent manner when compared with MCs that were not cultured in PCM. There were also biomaterial- and time-dependent differences in cell adhesion/viability, apoptosis, and expression of IL-6 and IL-8 in the PMN-MC direct co-cultures when compared with the sums of these activities in PMN and MC monocultures. In conclusion, these data suggest that biomaterials selectively modulate PMN-MC paracrine and juxtacrine interactions to influence MC and/or PMN adhesion/viability, apoptosis, and cytokine expression.
C1 [Cohen, Hannah C.; Kao, W. John] Univ Wisconsin, Sch Med & Publ Hlth, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA.
   [Joyce, Evan J.; Kao, W. John] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomed Engn, Madison, WI 53705 USA.
   [Kao, W. John] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@wisc.edu
FU NIH [EB6613]; Department of Defense
FX Supported by NIH grant EB6613 and the Department of Defense through a
   National Defense Science and Engineering Graduate fellowship (H.C.C.).
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968
   Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257
   Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739
   Eken C, 2010, J BIOL CHEM, V285, P39914, DOI 10.1074/jbc.M110.126748
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   GANZ T, 1987, INFECT IMMUN, V55, P568
   GANZ T, 1990, EUR J HAEMATOL, V44, P1
   Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361
   Heinzelmann M, 1998, J IMMUNOL, V160, P5530
   Janardhan KS, 2006, FRONT BIOSCI-LANDMRK, V11, P1569, DOI 10.2741/1904
   Kirk JT, 2010, J BIOMED MATER RES A, V94A, P683, DOI 10.1002/jbm.a.32682
   Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001
   Mikolajczyk TP, 2009, IMMUNOLOGY, V128, P103, DOI 10.1111/j.1365-2567.2009.03087.x
   Mutch DM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-17
   Nares S, 2005, MEASURING IMMUNITY: BASIC BIOLOGY AND CLINICAL ASSESSMENT, P299, DOI 10.1016/B978-012455900-4/50287-7
   PANYUTICH AV, 1995, AM J RESP CELL MOL, V12, P351, DOI 10.1165/ajrcmb.12.3.7873202
   Rasmussen PB, 1996, FEBS LETT, V390, P109, DOI 10.1016/0014-5793(96)00639-4
   SCHALL TJ, 1993, J EXP MED, V177, P1821, DOI 10.1084/jem.177.6.1821
   Schmidt D, 2011, ACTA BIOMATER, V7, P515, DOI 10.1016/j.actbio.2010.08.022
   Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276
   Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536
   Soehnlein O, 2008, CLIN EXP IMMUNOL, V151, P139, DOI 10.1111/j.1365-2249.2007.03532.x
   Soehnlein O, 2005, J IMMUNOL, V174, P6399, DOI 10.4049/jimmunol.174.10.6399
   Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740
   Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634
   Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779
   Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630
   Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006
   Soehnlein O, 2009, THROMB HAEMOSTASIS, V102, P198, DOI 10.1160/TH08-11-0720
   Soehnlein O, 2009, J LEUKOCYTE BIOL, V85, P344, DOI 10.1189/jlb.0808495
   TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337
   TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394
   UGUCCIONI M, 1995, EUR J IMMUNOL, V25, P64, DOI 10.1002/eji.1830250113
   Waldeck H, 2012, BIOMATERIALS, V33, P29, DOI 10.1016/j.biomaterials.2011.09.044
   Xu KD, 2012, ACTA BIOMATER, V8, P2504, DOI 10.1016/j.actbio.2012.03.049
NR 38
TC 14
Z9 14
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD JUN
PY 2013
VL 182
IS 6
BP 2180
EP 2190
DI 10.1016/j.ajpath.2013.02.022
PG 11
WC Pathology
SC Pathology
GA 155WT
UT WOS:000319781800023
PM 23708212
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Wright, B
AF Wright, Bernice
TI Forging a modern generation of polyphenol-based therapeutics
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE polyphenols; resveratrol; drug therapy; systems; network pharmacology;
   cardiovascular disease therapy; drug delivery; biomaterial delivery
   systems
ID CLINICAL-TRIAL; RESVERATROL; CELLS; QUERCETIN; APOPTOSIS; PATHWAY; ACID;
   BIOAVAILABILITY; INHIBITION; ADHESION
AB The long-standing debate that polyphenol secondary metabolites from dietary plants are important nutritional components continues due to compelling evidence for their abilities to ameliorate degenerative conditions including, cancer, neurological disorders and cardiovascular disease. The clinical use of polyphenols is not, however, mainstream as issues regarding poor selectivity, dosage, toxicity and delivery methods are unresolved. The paper by Rieder etal. suggests that the lack of selectivity, at least for the stilbene, resveratrol, may not be a major limiting factor. The present commentary is a critique of this significant finding that is focused on deciding how the use of resveratrol as clinical medicine could be advanced, and how this new information integrates with current knowledge of polyphenol physiological effects. This commentary suggests that the multi-target nature of polyphenols may be translated into reliable therapy using the current systems/network pharmacology approach concerned with developing viable therapeutic agents that achieve specific effects through interactions with a wide array of targets. Linked Article This article is a commentary on Rieder etal., pp. 12441258 of BJP 167:6. To view this paper visit http://dx.doi.org/10.1111/j.1476-5381.2012.02063.x
C1 Univ Reading, Sch Pharm, Reading RG6 6UB, Berks, England.
RP Wright, B (reprint author), Univ Reading, Sch Pharm, Reading RG6 6UB, Berks, England.
EM b.wright@reading.ac.uk
CR Cadena PG, 2013, BBA-BIOMEMBRANES, V1828, P309, DOI 10.1016/j.bbamem.2012.10.022
   Chiva-Blanch G, 2012, AM J CLIN NUTR, V95, P326, DOI 10.3945/ajcn.111.022889
   Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437
   Dhandayuthapani S, 2013, J MED FOOD, V16, P139, DOI 10.1089/jmf.2012.0141
   GALI HU, 1991, CANCER RES, V51, P2820
   Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51
   Huang H, 2009, EUR J MED CHEM, V44, P1982, DOI 10.1016/j.ejmech.2008.09.051
   Iyengar R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003563
   Jacobson KA, 2002, ADV EXP MED BIOL, V505, P163
   Kim HJ, 2012, INT J ONCOL, V41, P1628, DOI 10.3892/ijo.2012.1615
   Li Y, 2011, ACTA BIOMATER, V7, P751, DOI 10.1016/j.actbio.2010.09.008
   Lin YL, 2010, J NUTR, V140, P2187, DOI 10.3945/jn.110.123505
   Liu L, 2013, EUR REV MED PHARMACO, V17, P88
   Manach C, 2005, AM J CLIN NUTR, V81, p230S
   Mennen LI, 2005, AM J CLIN NUTR, V81, p326S, DOI 10.1093/ajcn/81.1.326S
   Navarro-Nunez L, 2008, J AGR FOOD CHEM, V56, P2970, DOI 10.1021/jf0723209
   Pawlikowska-Pawlega B, 2007, BBA-BIOMEMBRANES, V1768, P2195, DOI 10.1016/j.bbamem.2007.05.027
   Pignatelli P, 2006, ATHEROSCLEROSIS, V188, P77, DOI 10.1016/j.atherosclerosis.2005.10.025
   Rieder SA, 2012, BRIT J PHARMACOL, V167, P1244, DOI 10.1111/j.1476-5381.2012.02063.x
   SCALBERT A, 1993, POLYPHENOLIC PHENOME
   Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x
   Tome-Carneiro J, 2013, CARDIOVASC DRUG THER, V27, P37, DOI 10.1007/s10557-012-6427-8
   Trung LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055183
   Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x
   Wright B, 2012, REGEN MED, V7, P295, DOI [10.2217/RME.12.7, 10.2217/rme.12.7]
   Wright B, 2010, BRIT J PHARMACOL, V159, P1312, DOI 10.1111/j.1476-5381.2009.00632.x
NR 26
TC 6
Z9 6
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD JUN
PY 2013
VL 169
IS 4
BP 844
EP 847
DI 10.1111/bph.12195
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 151RF
UT WOS:000319477200011
PM 23530697
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Gabrielli, L
   Russo, L
   Poveda, A
   Jones, JR
   Nicotra, F
   Jimenez-Barbero, J
   Cipolla, L
AF Gabrielli, Luca
   Russo, Laura
   Poveda, Ana
   Jones, Julian R.
   Nicotra, Francesco
   Jimenez-Barbero, Jesus
   Cipolla, Laura
TI Epoxide Opening versus Silica Condensation during Sol-Gel Hybrid
   Biomaterial Synthesis
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE hybrid materials; mass spectrometry; NMR spectroscopy; silanes; sol-gel
   processes
ID ORGANIC-INORGANIC MATERIALS; SELF-ORGANIZATION; COATINGS; POLYMERS;
   (3-GLYCIDOXYPROPYL)TRIMETHOXYSILANE; 3-GLYCIDOXYPROPYLTRIMETHOXYSILANE;
   CRYSTALLIZATION
AB Hybrid organic-inorganic solids represent an important class of engineering materials, usually prepared by sol-gel processes by cross-reaction between organic and inorganic precursors. The choice of the two components and control of the reaction conditions (especially pHvalue) allow the synthesis of hybrid materials with novel properties and functionalities. 3-Glycidoxypropyltrimethoxysilane (GPTMS) is one of the most commonly used organic silanes for hybrid-material fabrication. Herein, the reactivity of GPTMS in water at different pHvalues (pH2-11) was deeply investigated for the first time by solution-state multinuclear NMR spectroscopic and mass spectrometric analysis. The extent of the different and competing reactions that take place as a function of the pHvalue was elucidated. The NMR spectroscopic and mass spectrometric data clearly indicate that the pHvalue determines the kinetics of epoxide hydrolysis versus silicon condensation. Under slighly acidic conditions, the epoxy-ring hydrolysis is kinetically more favourable than the formation of the silica network. In contrast, under basic conditions, silicon condensation is the main reaction that takes place. Full characterisation of the formed intermediates was carried out by using NMR spectroscopic and mass spectrometric analysis. These results indicate that strict control of the pHvalues allows tuning of the reactivity of the organic and inorganic moities, thus laying the foundations for the design and synthesis of sol-gel hybrid biomaterials with tuneable properties.
C1 [Gabrielli, Luca; Russo, Laura; Nicotra, Francesco; Cipolla, Laura] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy.
   [Poveda, Ana] Univ Autonoma Madrid, Serv Interdept Invest, E-28049 Madrid, Spain.
   [Jones, Julian R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Jimenez-Barbero, Jesus] CSIC, Ctr Invest Biol, Madrid 28040, Spain.
RP Jimenez-Barbero, J (reprint author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.
EM jjbarbero@cib.csic.es; laura.cipolla@unimib.it
RI Poveda, Ana/A-9534-2015; Jones, Julian/B-1007-2012; JESUS,
   JIMENEZ-BARBERO/D-4431-2014; Russo, Laura/I-3237-2014
OI Poveda, Ana/0000-0001-5060-2307; Jones, Julian/0000-0002-2647-8024;
   JESUS, JIMENEZ-BARBERO/0000-0001-5421-8513; Russo,
   Laura/0000-0002-5914-766X; Cipolla, Laura/0000-0003-2678-8329
FU Fondazione Cariplo [2008-3175]; Engineering and Physical Sciences
   Research Council [EP/I020861/1]
FX This work was funded by Fondazione Cariplo, grant no. 2008-3175. J.R.J.
   acknowledges the EPSRC Challenging Engineering Scheme (EP/I02086).
CR Alonso B, 2005, CHEM MATER, V17, P3172, DOI 10.1021/cm047765g
   Dave BC, 2004, J SOL-GEL SCI TECHN, V32, P143, DOI 10.1007/s10971-004-5779-3
   Davis SR, 2003, J NON-CRYST SOLIDS, V315, P197, DOI 10.1016/S0022-3093(02)01431-X
   Dubois G., 2007, DIELECTRIC FILMS ADV
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Hoebbel D, 2001, J SOL-GEL SCI TECHN, V21, P177, DOI 10.1023/A:1011274301896
   Innocenzi P, 1999, CHEM MATER, V11, P1672, DOI 10.1021/cm980734z
   Innocenzi P, 2001, CHEM MATER, V13, P3635, DOI 10.1021/cm011034o
   Innocenzi P, 2000, CHEM MATER, V12, P3726, DOI 10.1021/cm001139b
   Innocenzi P, 2011, J CERAM SOC JPN, V119, P387, DOI 10.2109/jcersj2.119.387
   Innocenzi P, 2009, DALTON T, P9146, DOI 10.1039/b905830c
   Kasten LS, 2003, PROG ORG COAT, V47, P214, DOI 10.1016/j.porgcoat.2003.08.010
   Liu J, 2006, J ADHES SCI TECHNOL, V20, P277, DOI 10.1163/156856106776381811
   Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838
   Maly M, 2008, MOL SIMULAT, V34, P1215, DOI 10.1080/08927020802235706
   Mammeri F, 2005, J MATER CHEM, V15, P3787, DOI 10.1039/b507309j
   Menaa B, 2007, CHEM MATER, V19, P1946, DOI 10.1021/cm062660u
   Oliver MS, 2010, J SOL-GEL SCI TECHN, V55, P360, DOI 10.1007/s10971-010-2262-1
   Que W, 2001, APPL PHYS A-MATER, V73, P171, DOI 10.1007/s003390000612
   Ren L, 2001, J SOL-GEL SCI TECHN, V21, P115, DOI 10.1023/A:1011226104173
   Schottner G, 2001, CHEM MATER, V13, P3422, DOI 10.1021/cm011060m
   Snodgrass JM, 2002, ACTA MATER, V50, P2395, DOI 10.1016/S1359-6454(02)00072-1
   Templin M, 1997, ADV MATER, V9, P814, DOI 10.1002/adma.19970091011
   Valliant EM, 2011, SOFT MATTER, V7, P5083, DOI 10.1039/c0sm01348j
   Wang QG, 2003, MACROMOLECULES, V36, P5760, DOI 10.1021/ma0345246
   Wu KH, 2006, J POLYM SCI POL CHEM, V44, P335, DOI 10.1002/pola.21094
   Zhang JL, 2008, J ELECTRON MATER, V37, P135, DOI 10.1007/s11664-007-0324-0
   Zheludkevich ML, 2006, SURF COAT TECH, V200, P3084, DOI 10.1016/j.surfcoat.2004.09.007
NR 28
TC 33
Z9 34
U1 2
U2 51
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD JUN
PY 2013
VL 19
IS 24
BP 7856
EP 7864
DI 10.1002/chem.201204326
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 156ME
UT WOS:000319825500026
PM 23576425
DA 2018-10-20
ER

PT J
AU Lambert, F
   Lecloux, G
   Leonard, A
   Sourice, S
   Layrolle, P
   Rompen, E
AF Lambert, France
   Lecloux, Geoffrey
   Leonard, Angelique
   Sourice, Sophie
   Layrolle, Pierre
   Rompen, Eric
TI Bone Regeneration Using Porous Titanium Particles versus Bovine
   Hydroxyapatite: A Sinus Lift Study in Rabbits
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE bone regeneration; histomorphometry; hydroxyapatite; osteoconduction;
   titanium
ID X-RAY MICROTOMOGRAPHY; EPITHELIAL-CELL ATTACHMENT; MAXILLARY SINUS;
   FLOOR ELEVATION; DENTAL IMPLANTS; IMAGE-ANALYSIS; IN-VITRO;
   AUGMENTATION; TETRACYCLINES; GINGIVAL
AB Aim: The first objective of this study was to qualitatively and quantitatively assess the bone formation process, particularly the long-term behavior and three-dimensional volume stability of subsinusal bone regeneration, using titanium (Ti) or bovine hydroxyapatite (BHA) granules, in a rabbit model. The second objective was to evaluate the effect of the hydration of the BHA particles with a therapeutic concentration of doxycycline solution on the osteogenesis and biomaterial resorption. Materials and Methods: Rabbits underwent a double sinus lift procedure using one of three materials: grade 1 porous Ti particles, BHA, or BHA hydrated with doxycycline solution (0.1mg/ml) (BHATTC). Animals were sacrificed after 1 week, 5 weeks, or 6 months. Samples were analyzed using mu CT and nondecalcified histology. Results: The materials used in each of the three groups allowed an optimal bone formation; bone quantities and densities were not statistically different between the three groups. At 6 months, more stable three-dimensional volume stability was found with Ti and BHATTC (p=.0033). At 5weeks and 6 months, bone to material contact corroborating osteoconduction was significantly higher with BHA and BHATTC than with Ti (p<.0001). Conclusions and Clinical Implications: Even though the studied biomaterials displayed different architectures, they are relevant candidates for sinus lift bone augmentation prior to dental implants because they allow adequate three-dimensional stability and osteogenesis. However, to recommend the clinical use of Ti, both an observation on the drilling effects of Ti particles and clinical trials are needed.
C1 [Lambert, France; Lecloux, Geoffrey; Rompen, Eric] Univ Liege, Fac Med, Dept Periodontol & Oral Surg, B-4000 Liege, Belgium.
   [Leonard, Angelique] Univ Liege, Dept Appl Chem, B-4000 Liege, Belgium.
   [Sourice, Sophie] Univ Nantes, INSERM, U791, Lab Osteoarticular & Dent Tissue Engn, F-44035 Nantes, France.
   [Layrolle, Pierre] Univ Nantes, INSERM, U957, Lab Physiopathol Bone Resorpt,Fac Med, F-44035 Nantes, France.
RP Lambert, F (reprint author), Serv Med Dent, Domaine Sart Tilman Bat B35, B-4000 Liege, Belgium.
EM france.lambert@chu.ulg.ac.be
RI Layrolle, Pierre/K-9257-2015
OI Layrolle, Pierre/0000-0001-9800-5210
CR Alffram PA, 2007, UPSALA J MED SCI, V112, P183, DOI 10.3109/2000-1967-192
   Almazin SM, 2009, J PERIODONTOL, V80, P999, DOI 10.1902/jop.2009.080574
   Asai S, 2002, CLIN ORAL IMPLAN RES, V13, P405, DOI 10.1034/j.1600-0501.2002.130409.x
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Blacher S, 2004, COLLOID SURFACE A, V241, P201, DOI 10.1016/j.colsurfa.2004.04.006
   Blacher S, 2002, STUD SURF SCI CATAL, V144, P331
   Bystedt H, 2009, CLIN IMPLANT DENT R, V11, P101, DOI 10.1111/j.1708-8208.2008.00100.x
   Chiapasco M, 2009, CLIN ORAL IMPLAN RES, V20, P113, DOI 10.1111/j.1600-0501.2009.01781.x
   Esposito M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003607.pub2
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Gomes PS, 2008, ACTA BIOMATER, V4, P630, DOI 10.1016/j.actbio.2007.12.006
   GREVSTAD HJ, 1995, EUR J ORAL SCI, V103, P156, DOI 10.1111/j.1600-0722.1995.tb00017.x
   Hatano N, 2004, CLIN ORAL IMPLAN RES, V15, P339, DOI 10.1111/j.1600-0501.2004.00996.x
   Holmes SG, 2004, BONE, V35, P471, DOI 10.1016/j.bone.2004.02.028
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Le Guehennec L, 2008, CLIN ORAL IMPLAN RES, V19, P1103, DOI 10.1111/j.1600-0501.2008.01547.x
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Leonard A, 2007, J MICROSC-OXFORD, V225, P258, DOI 10.1111/j.1365-2818.2007.01740.x
   Leonard A, 2005, J MICROSC-OXFORD, V218, P247, DOI 10.1111/j.1365-2818.2005.01485.x
   Leonard A, 2008, J POROUS MAT, V15, P397, DOI 10.1007/s10934-006-9094-y
   Leonard A, 2008, J FOOD ENG, V85, P154, DOI 10.1016/j.jfoodeng.2007.07.017
   Luginbuehl V, 2010, J BIOMED MATER RES B, V92B, P341, DOI 10.1002/jbm.b.31520
   Newman Takei, 2006, CARRANZAS CLIN PERIO
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   RIFKIN BR, 1994, ANN NY ACAD SCI, V732, P165, DOI 10.1111/j.1749-6632.1994.tb24733.x
   ROMPEN EH, 1993, J DENT RES, V72, P607, DOI 10.1177/00220345930720030901
   Sbordone L, 2009, INT J ORAL MAX SURG, V38, P1059, DOI 10.1016/j.ijom.2009.06.024
   Sun XJ, 2008, CLIN ORAL IMPLAN RES, V19, P804, DOI 10.1111/j.1600-0501.2008.01577.x
   Tondi G, 2009, MICROSC MICROANAL, V15, P384, DOI 10.1017/S1431927609990444
   Vanheusden A, 1998, J PERIODONTAL RES, V33, P377, DOI 10.1111/j.1600-0765.1998.tb02213.x
   Vanheusden AJ, 1999, J PERIODONTOL, V70, P594, DOI 10.1902/jop.1999.70.6.594
   Wohlfahrt JC, 2010, CLIN ORAL IMPLAN RES, V21, P165, DOI 10.1111/j.1600-0501.2009.01813.x
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P493, DOI 10.1016/j.bjoms.2005.02.001
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P40, DOI 10.1016/j.bjoms.2004.10.004
   Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x
   Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x
NR 37
TC 11
Z9 11
U1 2
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD JUN
PY 2013
VL 15
IS 3
BP 412
EP 426
DI 10.1111/j.1708-8208.2011.00374.x
PG 15
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 158SZ
UT WOS:000319994700011
PM 21815992
DA 2018-10-20
ER

PT J
AU Davis, NF
   Kheradmand, F
   Creagh, T
AF Davis, Niall F.
   Kheradmand, F.
   Creagh, T.
TI Injectable biomaterials for the treatment of stress urinary
   incontinence: their potential and pitfalls as urethral bulking agents
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Review
DE Stress urinary incontinence; Urethral bulking agent; Urethral
   biomaterials
ID COLLAGEN INJECTION THERAPY; FEMALE STRESS; FOLLOW-UP; POLYACRYLAMIDE
   HYDROGEL; CONTROLLED-TRIAL; ELDERLY-WOMEN; MULTICENTER; BLIND;
   MACROPLASTIQUE; COMPLICATIONS
AB Injectable urethral bulking agents composed of synthetic and biological biomaterials are minimally invasive treatment options for stress urinary incontinence (SUI). The development of an ideal urethral bulking agent remains challenging because of clinical concerns over biocompatibility and durability. Herein, the mechanical and biological features of injectable urethral biomaterials are investigated, with particular emphasis on their future potential as primary and secondary treatment options for SUI. A literature search for English language publications using the two online databases was performed. Keywords included "stress urinary incontinence", "urethral bulking agent" and "injectable biomaterial". A total of 98 articles were analysed, of which 45 were suitable for review based on clinical relevance and importance of content. Injectable biomaterials are associated with a lower cure rate and fewer postoperative complications than open surgery for SUI. They are frequently reserved as secondary treatment options for patients unwilling or medically unfit to undergo surgery. Glutaraldehyde cross-linked bovine collagen remains the most commonly injected biomaterial and has a cure rate of up to 53 %. Important clinical features of an injectable biomaterial are durability, biocompatibility and ease of administration, but achieving these requirements is challenging. In carefully selected patients, injectable biomaterials are feasible alternatives to open surgical procedures as primary and secondary treatment options for SUI. In future, higher cure rates may be feasible as researchers investigate alternative biomaterials and more targeted injection techniques for treating SUI.
C1 [Davis, Niall F.; Kheradmand, F.; Creagh, T.] Beaumont Hosp, Dept Urol, Dublin, Ireland.
RP Davis, NF (reprint author), Beaumont Hosp, Dept Urol, Dublin, Ireland.
EM nialldavis2001@yahoo.com
CR Andersen Roger C, 2002, J Low Genit Tract Dis, V6, P239, DOI 10.1097/00128360-200210000-00009
   Bano F, 2005, INT UROGYNECOL J, V16, P147, DOI 10.1007/s00192-004-1216-y
   Bedir S, 2004, J UROLOGY, V172, P247, DOI 10.1097/01.ju.0000129006.16287.06
   Cardozo L, 2005, J Obstet Gynaecol, V25, P539, DOI 10.1080/01443610500227961
   Carr LK, 2008, INT UROGYNECOL J, V19, P881, DOI 10.1007/s00192-007-0553-z
   Corcos J, 2005, UROLOGY, V65, P898, DOI 10.1016/j.urology.2004.11.054
   Delancey JOL, 2004, GASTROENTEROLOGY, V126, pS23, DOI 10.1053/j.gastro.2003.10.080
   Dmochowski R, 2004, J UROLOGY, V172, P8, DOI 10.1097/01.ju.0000129053.03180.f0
   Dmochowski Roger, 2003, Curr Urol Rep, V4, P350, DOI 10.1007/s11934-003-0005-3
   Dmochowski RR, 2000, UROLOGY, V56, P32, DOI 10.1016/S0090-4295(00)01019-0
   Faerber G J, 1998, Tech Urol, V4, P124
   Faerber GJ, 1996, J UROLOGY, V155, P512, DOI 10.1016/S0022-5347(01)66436-X
   Falconer C, 1997, EUR J OBSTET GYN R B, V72, P195, DOI 10.1016/S0301-2115(96)02685-1
   GARIBAY SG, 1989, J UROLOGIE, V95, P363
   Ghoniem G, 2009, J UROLOGY, V181, P204, DOI 10.1016/j.juro.2008.09.032
   Ghoniem GM, 2013, INT UROGYNECOL J, V24, P27, DOI 10.1007/s00192-012-1825-9
   HENLY DR, 1995, J UROLOGY, V153, P2039, DOI 10.1016/S0022-5347(01)67398-1
   HERSCHORN S, 1992, J UROLOGY, V148, P1797, DOI 10.1016/S0022-5347(17)37032-5
   Hurtado E, 2007, INT UROGYNECOL J, V18, P869, DOI 10.1007/s00192-006-0251-2
   Hurtado EA, 2009, INT UROGYNECOL J, V20, P127, DOI 10.1007/s00192-008-0674-z
   Isom-Batz G, 2009, J UROLOGY, V181, P701, DOI 10.1016/j.juro.2008.10.027
   Keegan PE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003881.pub2
   Kerr Lindsey A, 2005, Rev Urol, V7 Suppl 1, pS3
   Kershen RT, 2002, UROL CLIN N AM, V29, P559, DOI 10.1016/S0094-0143(02)00066-6
   Kirchin V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003881.pub3
   Klarskov N, 2008, NEUROUROL URODYNAM, V27, P789, DOI 10.1002/nau.20602
   Kulseng-Hanssen S, 2008, INT UROGYNECOL J, V19, P391, DOI 10.1007/s00192-007-0449-y
   Kushner L, 2004, NEUROUROL URODYNAM, V23, P198, DOI 10.1002/nau.10174
   Leach GE, 1997, J UROLOGY, V158, P875, DOI 10.1016/S0022-5347(01)64346-5
   Lee PE, 2001, J UROLOGY, V165, P153, DOI 10.1097/00005392-200101000-00037
   Lightner D, 2001, UROLOGY, V58, P12, DOI 10.1016/S0090-4295(01)01148-7
   Lightner D, 2009, UROLOGY, V74, P771, DOI 10.1016/j.urology.2009.05.034
   Lightner Deborah J, 2002, Curr Opin Urol, V12, P333, DOI 10.1097/00042307-200207000-00012
   Lose G, 2006, BJU INT, V98, P100, DOI 10.1111/j.1464-410X.2006.06205.x
   Maher CF, 2005, BJOG-INT J OBSTET GY, V112, P797, DOI 10.1111/j.1471-0528.2005.00547.x
   Mayer RD, 2007, UROLOGY, V69, P876, DOI 10.1016/j.urology.2007.01.050
   Murless BC, 1938, J OBSTET GYN BR COMM, V45, P521
   Petros PEP, 2008, INT UROGYNECOL J, V19, P35, DOI 10.1007/s00192-007-0475-9
   Pickard R, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003881
   SACHSE H, 1963, Urol Int, V15, P225
   Schulz JA, 2004, INT UROGYNECOL J, V15, P261, DOI 10.1007/s00192-004-1148-6
   Meulen PH, 2009, INT UROGYNECOL J, V20, P177, DOI 10.1007/s00192-008-0741-5
   Toozs-Hobson P, 2012, INT UROGYNECOL J, V23, P1373, DOI 10.1007/s00192-012-1761-8
   Winters JC, 2000, UROLOGY, V55, P856, DOI 10.1016/S0090-4295(00)00514-8
NR 44
TC 33
Z9 33
U1 0
U2 16
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD JUN
PY 2013
VL 24
IS 6
BP 913
EP 919
DI 10.1007/s00192-012-2011-9
PG 7
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA 157HR
UT WOS:000319887600003
PM 23224022
DA 2018-10-20
ER

PT J
AU Hanzlik, JA
   Day, JS
AF Hanzlik, Josa A.
   Day, Judd S.
CA Acknowledged Contributors Ingrowth
TI Bone Ingrowth in Well-Fixed Retrieved Porous Tantalum Implants
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE aseptic loosening; bone ingrowth; porous tantalum components
ID TOTAL KNEE ARTHROPLASTY; COATED ACETABULAR COMPONENTS; RADIOLOGICAL
   EVALUATION; POSTMORTEM RETRIEVAL; TIBIAL COMPONENTS; INTERFACE;
   REPLACEMENT; BIOMATERIAL; METALS
AB While first generation porous coatings have had clinical success, aseptic loosening remains a leading cause of revision. The purpose of this study was to investigate the reasons for revision and to assess the amount of bone ingrowth in retrieved porous tantalum components. In a prospective multicenter retrieval program, 76 porous tantalum acetabular shells, 5 femoral stems, 7 patellas and 36 tibial trays were collected from revision surgeries. A subset of the implants was analyzed for bone ingrowth. The main reason for revision was infection for acetabular shells (1.4 yeah implantation time) and instability for tibial trays (1.8 years implantation time). Two of the thirty primary surgery acetabular shells and one of the thirty-six primary surgery tibial trays were revised for implant loosening. We observed full depth penetration of bone into the porous tantalum layer for the acetabular shells and femoral stems. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Hanzlik, Josa A.; Day, Judd S.] Drexel Univ, Implant Res Ctr, Philadelphia, PA 19104 USA.
   [Day, Judd S.] Exponent Inc, Philadelphia, PA USA.
RP Hanzlik, JA (reprint author), Drexel Univ, Implant Res Ctr, Sch Biomed Engn Sci & Hlth Syst, 3401 Market St,Suite 345, Philadelphia, PA 19104 USA.
FU National Institutes of Health (NIAMS) [R01 AR47904]; Stryker
   Orthopaedics, Inc.; Zimmer, Inc.; Stelkast, Inc.; Wilbert J. Austin
   Professor of Engineering Chair (CMR)
FX Institutional funding has been received from the National Institutes of
   Health (NIAMS) R01 AR47904; Stryker Orthopaedics, Inc.; Zimmer, Inc.;
   Stelkast, Inc.; and through the Wilbert J. Austin Professor of
   Engineering Chair (CMR).
CR [Anonymous], 2011, ANN REPORT
   Berger RA, 2001, CLIN ORTHOP RELAT R, P196
   Bloebaum RD, 1997, J ARTHROPLASTY, V12, P920, DOI 10.1016/S0883-5403(97)90162-5
   Bloebaum RD, 1997, J BONE JOINT SURG AM, V79A, P1013, DOI 10.2106/00004623-199707000-00007
   Bloebaum RD, 1998, J BONE JOINT SURG AM, V80A, P518, DOI 10.2106/00004623-199804000-00008
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   - Cystic Fibrosis Foundation, 2010, ANN REPORT
   Dunbar MJ, 2009, J BONE JOINT SURG AM, V91A, P1578, DOI 10.2106/JBJS.H.00282
   ENGH CA, 1993, J BONE JOINT SURG AM, V75A, P814, DOI 10.2106/00004623-199306000-00003
   Fehring TK, 2001, CLIN ORTHOP RELAT R, P315
   FERNANDEZFAIREN M, 2012, J APPL BIOMATER BIOM
   Helm AT, 2009, J ARTHROPLASTY, V24, P941, DOI 10.1016/j.arth.2008.06.018
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6
   Levine BR, 2010, MATERIALWISS WERKST, V41, P1002, DOI 10.1002/mawe.201000701
   Levine B, 2008, ADV ENG MATER, V10, P788, DOI 10.1002/adem.200800215
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Minoda Y, 2010, J BONE JOINT SURG AM, V92A, P700, DOI 10.2106/JBJS.H.01349
   MORAN CG, 1991, J BONE JOINT SURG AM, V73A, P848, DOI 10.2106/00004623-199173060-00007
   SAMBAZIOTIS C, 2012, J ARTHROPLASTY, V27, P1413
   SAMBAZIOTIS C, 2011, J ARTHROPLASTY
   Simon JP, 2009, ACTA ORTHOP BELG, V75, P623
   Sinclair SK, 2012, SPINE, V37, pE571, DOI 10.1097/BRS.0b013e318240f981
   SUMNER DR, 1993, ACTA ORTHOP SCAND, V64, P619, DOI 10.3109/17453679308994584
   SUMNER DR, 1995, J ARTHROPLASTY, V10, P157, DOI 10.1016/S0883-5403(05)80122-6
   Tanzer M, 2008, J BONE JOINT SURG AM, V90A, P1282, DOI 10.2106/JBJS.F.00847
   Tigani D, 2009, Chir Organi Mov, V93, P187, DOI 10.1007/s12306-009-0047-x
   VIGORITA VJ, 1993, CLIN ORTHOP RELAT R, P211
   Wilson DAJ, 2010, J ARTHROPLASTY, V25, P893, DOI 10.1016/j.arth.2009.06.015
   Xenakis TA, 2009, INT ORTHOP, V33, P911, DOI 10.1007/s00264-008-0581-4
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 35
TC 28
Z9 32
U1 0
U2 20
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD JUN
PY 2013
VL 28
IS 6
BP 922
EP 927
DI 10.1016/j.arth.2013.01.035
PG 6
WC Orthopedics
SC Orthopedics
GA 156TI
UT WOS:000319846400010
PM 23518432
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Tan, LL
   Yu, XM
   Wan, P
   Yang, K
AF Tan, Lili
   Yu, Xiaoming
   Wan, Peng
   Yang, Ke
TI Biodegradable Materials for Bone Repairs: A Review
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE Biomaterial; Biodegradable; Polymer; Magnesium; Ceramic; Bone repair
ID IN-VITRO CORROSION; POLY(ETHYLENE OXIDE) BLENDS; FRONTAL-SINUS
   OBLITERATION; CALCIUM-PHOSPHATE CERAMICS; ORBITAL FLOOR FRACTURES;
   BIOACTIVE GLASS S53P4; MARROW STROMAL CELLS; X-RAY-SCATTERING; Y-ZN
   ALLOYS; MAGNESIUM ALLOYS
AB With attractive research and development of biomaterials, more and more opportunities have been brought to the treatments of human tissue repairs. The implant is usually no need to exist in the body accompanied with the recovery or regeneration of the tissue lesions, and the long-term effect of exotic substance to human body should be reduced as lower as possible. For this purpose, biodegradable materials, including polymers, magnesium alloys and ceramics, have attracted much attention for medical applications due to their biodegradable characters in body environment. This paper in turn introduces these three different types of widely studied biodegradable materials as well as their advantages as implants in applications for bone repairs. Relevant history and research progresses are summarized.
C1 [Tan, Lili; Yu, Xiaoming; Wan, Peng; Yang, Ke] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Yang, K (reprint author), Chinese Acad Sci, Inst Met Res, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
EM kyang@imr.ac.cn
FU National Basic Research Program of China (973 Program) [2012CB619101]
FX The authors would like to thank the financial support of the National
   Basic Research Program of China (973 Program, No.2012CB619101).
CR Aghion E, 2010, J MATER SCI, V45, P3096, DOI 10.1007/s10853-010-4317-7
   Aitasalo K, 2001, J ORAL MAXIL SURG, V59, P1390, DOI 10.1053/joms.2001.27524
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Asano S, 1994, Eur Spine J, V3, P39, DOI 10.1007/BF02428315
   Ashammakhi N, 1997, BIOMATERIALS, V18, P3, DOI 10.1016/S0142-9612(96)00107-X
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Athanasiou KA, 1998, TISSUE ENG, V4, P53, DOI 10.1089/ten.1998.4.53
   AVELLA M, 1993, POLYMER, V34, P3234, DOI 10.1016/0032-3861(93)90396-R
   AVELLA M, 1991, POLYMER, V32, P1647, DOI 10.1016/0032-3861(91)90401-4
   AZUMA Y, 1992, POLYMER, V33, P4763, DOI 10.1016/0032-3861(92)90690-X
   Bai W, 2009, J POLYM RES, V16, P471, DOI 10.1007/s10965-008-9250-y
   Bai W, 2009, J BIOMED MATER RES B, V90B, P945, DOI 10.1002/jbm.b.31367
   Balcik C, 2007, ACTA BIOMATER, V3, P985, DOI 10.1016/j.actbio.2007.04.004
   BENICEWICZ BC, 1991, J BIOACT COMPAT POL, V6, P64, DOI 10.1177/088391159100600106
   Black J., 1988, ORTHOPEDIC BIOMATERI, P191
   Boehlert CJ, 2006, MAT SCI ENG A-STRUCT, V417, P315, DOI 10.1016/j.msea.2005.11.006
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   BOHNER M, 2001, EUR SPINE J, V10, P114
   Bolland BJRF, 2008, BIOMATERIALS, V29, P3221, DOI 10.1016/j.biomaterials.2008.04.017
   Brandt J, 2010, J MATER SCI-MATER M, V21, P283, DOI 10.1007/s10856-009-3859-1
   Brosnahan R., 2000, US Patent, Patent No. 6149688
   CAMERON HU, 1977, J BIOMED MATER RES, V11, P179, DOI 10.1002/jbm.820110204
   CANETTI M, 1994, POLYMER, V35, P2884, DOI 10.1016/0032-3861(94)90324-7
   Casey DJ, 1989, US Patent, Patent No. 4857602
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   COOK SD, 1988, CLIN ORTHOP RELAT R, P303
   Cutright D E, 1972, Oral Surg Oral Med Oral Pathol, V33, P850, DOI 10.1016/0030-4220(72)90457-4
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Dai HL, 2011, J MATER SCI TECHNOL, V27, P431, DOI 10.1016/S1005-0302(11)60087-X
   Daniels A., 2004, J APPL BIOMATER, V1, P57
   Datta R, 2006, J CHEM TECHNOL BIOT, V81, P1119, DOI 10.1002/jctb.1486
   De G.K., 1988, BIOCERAMICS MAT CHAR, P227
   DEKONING GJM, 1993, POLYMER, V34, P4089, DOI 10.1016/0032-3861(93)90671-V
   Disegi J A, 2000, Injury, V31 Suppl 4, P2
   Dominique G., 2004, BIOMECHANICS BIOMATE, P22
   Dorea HC, 2005, VET COMP ORTHOPAED, V18, P157
   Dubok VA, 2000, POWDER METALL MET C+, V39, P381, DOI 10.1023/A:1026617607548
   Duskova M, 2002, AESTHET PLAST SURG, V26, P274, DOI 10.1007/s00266-002-1032-z
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P116, DOI 10.1097/00001665-199703000-00010
   Erbe E., 2001, ANN M ORTH RES SOC S
   ERBE EM, 2001, EUR SPINE J, V10, P141
   Fambri L, 1997, POLYMER, V38, P79, DOI 10.1016/S0032-3861(96)00486-7
   Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034
   Fiz D., 1999, US Patent, Patent No. 5951558
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Geng F, 2009, J MATER SCI-MATER M, V20, P1149, DOI 10.1007/s10856-008-3669-x
   Gertzman A., 1986, US Patent, Patent No. 4620541
   Ghosh SK, 2008, J BIOMED MATER RES B, V86B, P217, DOI 10.1002/jbm.b.31009
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1988, CRIT REV BIOCOMPAT, V4, P155
   Gu XN, 2011, ACTA BIOMATER, V7, P1880, DOI 10.1016/j.actbio.2010.11.034
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Hanzi AC, 2009, INT J MATER RES, V100, P1127, DOI 10.3139/146.110157
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   Heikkila JT, 1995, BIOCERAMICS, P35
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hench LL, 2004, J BIOMED MATER RES, V5, P117
   HENCH LL, 1993, INTRO CERAMICS
   Heymann D, 1999, HISTOL HISTOPATHOL, V14, P871, DOI 10.14670/HH-14.871
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Hulbert S. F., 1987, HIGH TECH CERAMICS, P189
   Ibrahim DM, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-74
   Ido K, 2000, SPINAL CORD, V38, P315, DOI 10.1038/sj.sc.3100992
   Irigaray J.L., 1999, WORLD CER C FOR NEW, V28, P399
   Jelinek M, 2010, APPL PHYS A-MATER, V101, P615, DOI 10.1007/s00339-010-5911-x
   Jimenez G, 1997, J APPL POLYM SCI, V64, P2211, DOI 10.1002/(SICI)1097-4628(19970613)64:11<2211::AID-APP17>3.0.CO;2-6
   Katsuyuki F., 2005, JIKEIKAI MED J, V52, P47
   Kinnunen I, 2000, J CRANIO MAXILL SURG, V28, P229, DOI 10.1054/jcms.2000.0140
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Larsson S, 2002, CLIN ORTHOP RELAT R, P23
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Leonetti J A, 2000, Implant Dent, V9, P177, DOI 10.1097/00008505-200009020-00012
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lin X., 2012, ACTA BIOMATER, DOI DOI 10.1016/J.ACTBI0.2012.12.016
   Lou CW, 2008, TEXT RES J, V78, P958, DOI 10.1177/0040517507087856
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Lu YJ, 2012, J MATER SCI TECHNOL, V28, P636, DOI 10.1016/S1005-0302(12)60109-1
   Ma E, 2009, NAT MATER, V8, P855, DOI 10.1038/nmat2550
   MANKIN HJ, 1976, NEW ENGL J MED, V294, P1247, DOI 10.1056/NEJM197606032942301
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Mardziah C.M., 2009, TRENDS BIOMATER ARTI, V23, P105
   Mattei F. V., 1984, US Patent, Patent No. 4443430
   Matthew H. W. T., 2000, BIOMATERIALS, V21, P2589
   Maurus PB, 2004, OPER TECHN SPORT MED, V12, P158, DOI 10.1053/j.otsm.2004.07.015
   MCVICAR I, 1995, BRIT J ORAL MAX SURG, V33, P220, DOI 10.1016/0266-4356(95)90003-9
   Mehta R, 2005, J MACROMOL SCI-POL R, VC45, P325, DOI 10.1080/15321790500304148
   MESSERSMITH PB, 1995, J POLYM SCI POL CHEM, V33, P1047, DOI 10.1002/pola.1995.080330707
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Nakamura Y, 1997, FUND APPL TOXICOL, V37, P106, DOI 10.1006/faat.1997.2322
   Nandi SK, 2008, SMALL RUMINANT RES, V75, P144, DOI 10.1016/j.smallrumres.2007.09.006
   Nandi SK, 2009, RES VET SCI, V86, P162, DOI 10.1016/j.rvsc.2008.04.008
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   PEARCE R, 1992, POLYMER, V33, P4647, DOI 10.1016/0032-3861(92)90428-Y
   PEARCE R, 1994, POLYMER, V35, P3984, DOI 10.1016/0032-3861(94)90284-4
   Peltola M, 2000, ACTA OTO-LARYNGOL, P167
   Peltola MJ, 2000, J BIOMED MATER RES, V53, P161, DOI 10.1002/(SICI)1097-4636(2000)53:2<161::AID-JBM5>3.0.CO;2-3
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Pezzin APT, 2003, J APPL POLYM SCI, V88, P2744, DOI 10.1002/app.11984
   Pezzin APT, 2002, POLYM DEGRAD STABIL, V78, P405, DOI 10.1016/S0141-3910(02)00174-X
   Pietrzak WS, 1997, J CRANIOFAC SURG, V8, P87, DOI 10.1097/00001665-199703000-00004
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   RADIN SR, 1994, J BIOMED MATER RES, V28, P1303, DOI 10.1002/jbm.820281108
   RECK R, 1983, LARYNGOSCOPE, V93, P196
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Ryu HS, 2004, BIOMATERIALS, V25, P393, DOI 10.1016/S0142-9612(03)00538-6
   Sachlos E, 2003, EUR CELLS MATER, V5, P39
   SADOCCO P, 1993, POLYMER, V34, P3368, DOI 10.1016/0032-3861(93)90462-J
   Santos MH, 2007, BIOMED MATER, V2, P135, DOI 10.1088/1748-6041/2/2/012
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sinn H. J. F., 1993, US Patent, Patent No. 5249671
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song Y, 2010, ACTA BIOMATER, V6, P1736, DOI 10.1016/j.actbio.2009.12.020
   Sousa RA, 2003, COMPOS SCI TECHNOL, V63, P389, DOI 10.1016/S0266-3538(02)00213-0
   SPIESSL B, 1976, NEW CONCEPTS MAXILLO
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Suominen E, 1996, SCAND J PLAST RECONS, V30, P281, DOI 10.3109/02844319609056406
   Suonpaa J, 1997, ACTA OTO-LARYNGOL, P181
   SUURONEN R, 1992, J MATER SCI-MATER M, V3, P288, DOI 10.1007/BF00705295
   Tachdjian MO, 1990, PEDIAT ORTHOPEDICS
   Thian ES, 2006, J BIOMED MATER RES B, V76B, P326, DOI 10.1002/jbm.b.30368
   Thordarson DB, 2002, FOOT ANKLE INT, V23, P1003, DOI 10.1177/107110070202301106
   Truumees E, 1999, U PENN ORTHOP J, V12, P77
   Villaça José Henrique, 2005, Braz. Dent. J., V16, P67, DOI 10.1590/S0103-64402005000100012
   Vink ETH, 2003, POLYM DEGRAD STABIL, V80, P403, DOI 10.1016/S0141-3910(02)00372-5
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   Wang Q, 2011, MATER SCI ENG B-ADV, V176, P1718, DOI 10.1016/j.mseb.2011.06.005
   Weiler A, 1998, AM J SPORT MED, V26, P119, DOI 10.1177/03635465980260010401
   Wen CL, 2009, APPL SURF SCI, V255, P6433, DOI 10.1016/j.apsusc.2008.09.078
   Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Xing PX, 1997, MACROMOLECULES, V30, P2726, DOI 10.1021/ma960615+
   Xu LP, 2009, J MATER SCI-MATER M, V20, P859, DOI 10.1007/s10856-008-3648-2
   Xu X.H., 2011, J MAT SCI MAT M, V22, P1735
   Xue DC, 2011, MAT SCI ENG C-MATER, V31, P215, DOI 10.1016/j.msec.2010.08.019
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   YAMAMUTO T, 1990, BIOACTIVE GLASSES GL, V1
   Yan TT, 2010, MAT SCI ENG C-MATER, V30, P740, DOI 10.1016/j.msec.2010.03.007
   Yang KK, 2002, J MACROMOL SCI-POL R, VC42, P373, DOI 10.1081/MC-120006453
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
   YOKOUCHI M, 1973, POLYMER, V14, P267, DOI 10.1016/0032-3861(73)90087-6
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zhang H, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045007
   Zhang MY, 2010, J PLAST RECONSTR AES, V63, P227, DOI 10.1016/j.bjps.2008.11.017
   Zhang XN, 2009, MAT SCI ENG C, V29, P1907
   Zhang XN, 2010, ACTA BIOMATER, V6, P626
   Zheng YF, 2011, JOM-US, V63, P105, DOI 10.1007/s11837-011-0049-7
   Zignani M, 2000, BIOMATERIALS, V21, P1773, DOI 10.1016/S0142-9612(00)00065-X
NR 167
TC 111
Z9 119
U1 9
U2 164
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD JUN
PY 2013
VL 29
IS 6
BP 503
EP 513
DI 10.1016/j.jmst.2013.03.002
PG 11
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 158EM
UT WOS:000319952200002
DA 2018-10-20
ER

PT J
AU Pan, YS
   Shen, QQ
   Pan, CL
   Wang, J
AF Pan, Yusong
   Shen, Qianqian
   Pan, Chengling
   Wang, Jing
TI Compressive Mechanical Characteristics of Multi-layered Gradient
   Hydroxyapatite Reinforced Poly (Vinyl Alcohol) Gel Biomaterial
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE Multi-layered gradient HA/PVA gel biocomposites; Freeze/thaw cycle
   times; Strength; Modulus
ID ARTICULAR-CARTILAGE; COMPOSITE; HYDROGEL; BIOCOMPOSITES; REGENERATION;
   SCAFFOLDS; BEHAVIOR; REPAIR
AB Functional gradient materials provided us a new concept for artificial articular cartilage design with gradient component and gradient structure where one side of the material is high free water content thereby providing excellent lubrication function and the opposite side of the material is high hydroxyapatite content, thereby improving the bioactivity of the material and stimulating cell growth. The goal of the present study was to develop a multi-layered gradient HA/PVA gel biocomposites through layer-by-layer casting method combing with freeze/thaw cycle technology. The various influence factors on the compressive strength and modulus of the multi-layered gradient biocomposites were investigated. The results showed that the compressive mechanical characteristics of the biocomposites were similar to that of natural articular cartilage. Both the compressive strength and modulus of the multi-layered gradient HA/PVA gel biocomposites increased exponentially with the rise of compressive strain ratio. Both the compressive strength and average compressive modulus of the biocomposites improved with the rise of freeze/thaw cycle times and total concentration of HA particles in the biocomposites, but they showed decreasing tendency with the rise of HA concentration difference between adjacent layers.
C1 [Pan, Yusong; Shen, Qianqian; Pan, Chengling; Wang, Jing] Anhui Univ Sci & Technol, Sch Mat Sci & Engn, Huainan 232001, Peoples R China.
RP Pan, YS (reprint author), Anhui Univ Sci & Technol, Sch Mat Sci & Engn, Huainan 232001, Peoples R China.
EM yusongpan@163.com
FU National Natural Science Foundation of China [51175004]; Natural Science
   Research of Key Projects of Anhui Provincial Universities [KJ2010A099]
FX The authors gratefully acknowledge the financial support from the
   National Natural Science Foundation of China (No. 51175004) and the
   Natural Science Research of Key Projects of Anhui Provincial
   Universities (No. KJ2010A099).
CR Asran AS, 2010, POLYMER, V51, P868, DOI 10.1016/j.polymer.2009.12.046
   Bonakdar S, 2010, MAT SCI ENG C-MATER, V30, P636, DOI 10.1016/j.msec.2010.02.017
   Chang Q, 2011, J MATER SCI TECHNOL, V27, P546, DOI 10.1016/S1005-0302(11)60106-0
   Dong CX, 2011, J MATER SCI TECHNOL, V27, P659, DOI 10.1016/S1005-0302(11)60122-9
   Ebrahimian-Hosseinabadi M, 2011, J MATER SCI TECHNOL, V27, P1105, DOI 10.1016/S1005-0302(12)60004-8
   Hesse E, 2010, J BIOMED MATER RES A, V94A, P442, DOI 10.1002/jbm.a.32696
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Lv XY, 2011, ADV MATER RES-SWITZ, V181-182, P99, DOI 10.4028/www.scientific.net/AMR.181-182.99
   Nourbakhsh A, 2010, J THERMOPLAST COMPOS, V23, P169, DOI 10.1177/0892705709340962
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Pan YS, 2008, J MATER SCI-MATER M, V19, P1963, DOI 10.1007/s10856-007-3280-6
   Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4
   Pan YS, 2012, MICRO NANO LETT, V7, P880, DOI 10.1049/mnl.2012.0467
   Pan YS, 2010, J WUHAN UNIV TECHNOL, V25, P474, DOI 10.1007/s11595-010-0026-y
   Pan YS, 2009, J MATER SCI-MATER M, V20, P1291, DOI 10.1007/s10856-008-3679-8
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Rosa R., 2004, MACROMOLECULES, V37, P1921
   Rosa R., 2004, MACROMOLECULES, V37, P9510
   Sinha A, 2007, MAT SCI ENG C-BIO S, V27, P70, DOI 10.1016/j.msec.2006.02.008
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Wu G, 2008, MATER CHEM PHYS, V107, P364, DOI 10.1016/j.matchemphys.2007.07.028
   Zheng YD, 2007, KEY ENG MATER, V330-332, P475, DOI 10.4028/www.scientific.net/KEM.330-332.475
NR 22
TC 6
Z9 7
U1 5
U2 53
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD JUN
PY 2013
VL 29
IS 6
BP 551
EP 556
DI 10.1016/j.jmst.2013.03.011
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 158EM
UT WOS:000319952200008
DA 2018-10-20
ER

PT J
AU Zhu, L
   Zhou, HM
   Sun, ZX
   Lou, WJ
   Lang, JH
AF Zhu, Lan
   Zhou, Huimei
   Sun, Zhixing
   Lou, Wenjia
   Lang, Jinghe
TI Anatomic and Sexual Outcomes after Vaginoplasty Using Tissue-Engineered
   Biomaterial Graft in Patients with Mayer-Rokitansky-Kuster-Hauser
   Syndrome: A New Minimally Invasive and Effective Surgery
SO JOURNAL OF SEXUAL MEDICINE
LA English
DT Article
DE Mayer-Rokitansky-Kuster-Hauser Syndrome; Vaginal Reconstruction;
   Vaginoplasty; Tissue-Engineered Biomaterial Graft; Anatomic Outcome;
   Sexual Outcome
ID RECTOSIGMOID VAGINOPLASTY; INDEX
AB Introduction Recent years have seen continuous reports about the successful reconstruction of numerous organs with the application of tissue-engineering techniques. Thus, we assess the outcomes for vagina reconstruction using tissue-engineered biological material, which we suggested previously as an ideal graft for vaginoplasty. Aim To evaluate the anatomic and sexual outcomes in patients undergoing vaginoplasty using tissue-engineered biomaterial mesh. Methods This prospective study included 53 patients with Mayer-Rokitansky-Kuster-Hauser syndrome admitted to our hospital. Patients underwent vaginoplasty with tissue-engineered biological material (acellular dermal matrix). Postoperatively, a silicone vaginal dilator (length: 10cm, diameter: 3.5cm) was advised to be used for the first 3-6 months to prevent contraction of the neovagina. Follow-up was performed at 4 weeks, 12 weeks, 12 months, and then annually. Twenty-four age-matched women who underwent health examinations during the same time period were selected as a health control group and answered Female Sexual Function Index (FSFI) questionnaires for the purpose of comparing sexuality. Main Outcome Measures Anatomic success was defined by a vaginal length 8cm and a width allowing the easy introduction of two fingers. Sexual outcomes were assessed at the 12-month follow-up according to body image perception and FSFI questionnaires validated for the Chinese-speaking population. Results No severe intra-operative complications occurred. No graft-related infection, rejection, or detachment was recorded. The cost for tissue-engineered biomaterial graft was $1,900 (yen12,000) per person. Postoperatively, granulomatous polyps occurred in 6/53 patients (11.3%) at the vaginal vault and were removed in an outpatient clinic. During a mean follow-up of 21.1 months, the anatomic success rate was 100%, and all of the patients were satisfied with their body image. Postoperatively, 42 patients were followed up for more than 1 year, and 32 of them were sexually active. Among the 24/32 patients (75%) who answered the FSFI questionnaire, the mean total FSFI score was 26.7 +/- 3.5, which was similar to that of the control group (25.6 +/- 7.4, P=0.46). The similarity was also observed in six separate domains of the functional aspect of female sexuality. Conclusions Vaginoplasty with tissue-engineered biomaterial graft is a safe, effective, minimally invasive cosmetic procedure that provides near normal sexual function for patients with vaginal aplasia.
C1 [Zhu, Lan; Zhou, Huimei; Sun, Zhixing; Lou, Wenjia; Lang, Jinghe] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynaecol, Beijing 100730, Peoples R China.
RP Zhu, L (reprint author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynaecol, Beijing 100730, Peoples R China.
EM zhu_julie@sina.com
CR Bao-Yan L, 2011, MATERN CHILD HLTH CA, V26, P1712
   Callens N, 2012, J SEX MED, V9, P1842, DOI 10.1111/j.1743-6109.2012.02747.x
   Djordjevic ML, 2011, J SEX MED, V8, P3487, DOI 10.1111/j.1743-6109.2011.02494.x
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   Fotopoulou C, 2010, FERTIL STERIL, V94, P317, DOI 10.1016/j.fertnstert.2009.01.154
   Ghezzi Fabio, 2003, Archives of Gynecology and Obstetrics, V268, P41
   GOLDWYN RM, 1977, PLAST RECONSTR SURG, V59, P319, DOI 10.1097/00006534-197703000-00002
   Kim SK, 2003, PLAST RECONSTR SURG, V112, P143, DOI 10.1097/01.PRS.0000066169.78208.D4
   Lattari Vincent, 1997, Journal of Burn Care and Rehabilitation, V18, P147, DOI 10.1097/00004630-199703000-00010
   Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597
   Seccia A, 2002, ANN PLAS SURG, V49, P379, DOI 10.1097/01.SAP.0000017981.07692.CF
   Selvaggi G, 2003, FERTIL STERIL, V80, P607, DOI 10.1016/S0015-0282(03)00977-4
   Sinha Uttam K, 2003, Arch Facial Plast Surg, V5, P109
   Sun XG, 2011, J SEX MED, V8, P1101, DOI 10.1111/j.1743-6109.2010.02171.x
   Tian L, 2007, J PRACT OBSTET GYNEC, V23, P164
   Zhou Hui-Mei, 2009, Zhonghua Fu Chan Ke Za Zhi, V44, P846
   Zhou JH, 2010, FERTIL STERIL, V94, P2281, DOI 10.1016/j.fertnstert.2010.02.010
   朱兰, 2006, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V22, P953
NR 18
TC 17
Z9 23
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1743-6095
EI 1743-6109
J9 J SEX MED
JI J. Sex. Med.
PD JUN
PY 2013
VL 10
IS 6
BP 1652
EP 1658
DI 10.1111/jsm.12143
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 157DZ
UT WOS:000319877400023
PM 23510210
DA 2018-10-20
ER

PT J
AU Turp, V
   Sen, D
   Tuncelli, B
   Goller, G
   Ozcan, M
AF Turp, V.
   Sen, D.
   Tuncelli, B.
   Goller, G.
   Oezcan, M.
TI Evaluation of air-particle abrasion of Y-TZP with different particles
   using microstructural analysis
SO AUSTRALIAN DENTAL JOURNAL
LA English
DT Article
DE Air-particle abrasion; Y-TZP; surface roughness; XRD analysis;
   profilometry
ID FLEXURAL STRENGTH; DENTAL CERAMICS; BOND STRENGTH; RESIN CEMENT;
   ZIRCONIA; SURFACE; RELIABILITY; BIOMATERIAL; METAL
AB Background This study evaluated the effect of air-particle abrasion with different particle sizes on the surface roughness and phase transformation of yttria-stabilized tetragonal zirconia ceramics (Y-TZP). Methods Eighty-four Y-TZP discs of 15mm diameter and 1.0mm thickness were fabricated. The samples were divided into four groups (n=21): (1) air-particle abrasion with 30m CoJet sand blast coating agent (CoJet, 3M ESPE); (2) 50m Al2O3 particles; (3) 110m Al2O3 particles; and (4) 250m Al2O3 particles. Each group was further divided into three subgroups each (n=7) and treated for 5seconds, 15seconds and 30seconds. Mean surface roughness was determined using a profilometer. The surfaces were analysed with a scanning electron microscope. XRD analysis was employed and the relative amount of the monoclinic phase was calculated. The results were statistically analysed by two-way analysis of variance (ANOVA, p<0.05). Results Air-particle abrasion with 250m Al2O3 particles for 30seconds had the highest surface roughness (p<0.001) and a significantly higher amount of monoclinic phase compared to air-particle abrasion with 30m, 50m and 110m particles (p<0.001). Conclusions Duration and particle size of air-particle abrasion affects the roughness and phase transformation of Y-TZP. Longer treatment times with larger particles may result in degradation of material.
C1 [Turp, V.; Sen, D.; Tuncelli, B.] Istanbul Univ, Fac Dent, Dept Prosthodont, TR-34098 Istanbul, Turkey.
   [Goller, G.] Istanbul Tech Univ, Dept Met Mat & Engn, TR-80626 Istanbul, Turkey.
   [Oezcan, M.] Univ Zurich, Dent Mat Unit, Ctr Dent & Oral Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Zurich, Switzerland.
RP Turp, V (reprint author), Istanbul Univ, Fac Dent, Dept Prosthodont, TR-34098 Istanbul, Turkey.
EM vturp@istanbul.edu.tr
RI Turp, Volkan/H-4611-2013
OI Tuncelli, Betul/0000-0001-5412-9297; Goller,
   Gultekin/0000-0003-4680-3936
CR Aboushelib MN, 2010, J PROSTHODONT, V19, P340, DOI 10.1111/j.1532-849X.2010.00575.x
   Amaral R, 2006, DENT MATER, V22, P283, DOI 10.1016/j.dental.2005.04.021
   Bachhav VC, 2011, QUINTESSENCE INT, V42, P173
   Blatz MB, 2003, J PROSTHET DENT, V89, P268, DOI 10.1067/mpr.2003.50
   Cavalcanti AN, 2009, OPER DENT, V34, P344, DOI 10.2341/08-79
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Denry IL, 2006, J BIOMED MATER RES B, V76B, P440, DOI 10.1002/jbm.b.30382
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Edelhoff D, 2007, CLIN ORAL IMPLAN RES, V18, P193, DOI 10.1111/j.1600-0501.2007.01442.x
   Filser F, 2001, Int J Comput Dent, V4, P89
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   ISO, 2008, 13356 ISO
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   Koutayas O, 2009, EUR J ESTHET DENT, V4, P348
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   MIYAZAKI T, 2007, DENTISTRY JAPAN, V43, P189
   Mizrahi B, 2008, BRIT DENT J, V205, P251, DOI 10.1038/sj.bdj.2008.735
   Ozcan M, 2003, DENT MATER, V19, P725, DOI 10.1016/S0109-5641(03)00019-8
   Ozcan M, 2003, J ORAL REHABIL, V30, P194, DOI 10.1046/j.1365-2842.2003.01037.x
   Ozcan M, 1998, QUINTESSENCE INT, V29, P713
   Ozcan M, 2008, CLIN ORAL INVEST, V12, P279, DOI 10.1007/s00784-007-0151-y
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sato H, 2008, DENT MATER J, V27, P408, DOI 10.4012/dmj.27.408
   Toraya H., 1984, J AM CERAM SOC, V67, P119
   Wang H, 2008, DENT MATER, V24, P633, DOI 10.1016/j.dental.2007.06.030
NR 27
TC 15
Z9 16
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0045-0421
J9 AUST DENT J
JI Aust. Dent. J.
PD JUN
PY 2013
VL 58
IS 2
BP 183
EP 191
DI 10.1111/adj.12065
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 154IF
UT WOS:000319667100009
PM 23713638
OA Bronze
DA 2018-10-20
ER

PT J
AU Muthulakshmi, S
   Saravanan, R
AF Muthulakshmi, Shanmugam
   Saravanan, Ramalingam
TI Efficacy of azelaic acid on hepatic key enzymes of carbohydrate
   metabolism in high fat diet induced type 2 diabetic mice
SO BIOCHIMIE
LA English
DT Article
DE Azelaic acid; High fat diet; C57BL/6J mice; Type 2 diabetes; Fatty acid
   induced insulin resistance
ID WHOLE-GRAIN; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; RATS; MELLITUS;
   OBESITY; PHOSPHORYLATION; LIPOTOXICITY; PATHOGENESIS; HEXOKINASE
AB Azelaic acid (AzA), a C9 linear alpha,omega-dicarboxylic acid, is found in whole grains namely wheat, rye, barley, oat seeds and sorghum. The study was performed to investigate whether AzA exerts beneficial effect on hepatic key enzymes of carbohydrate metabolism in high fat diet (HFD) induced type 2 diabetic C57BL/6J mice. C57BL/6J mice were fed high fat diet for 10 weeks and subjected to intragastric administration of various doses (20 mg, 40 mg and 80 mg/kg BW) of AzA daily for the subsequent 5 weeks. Rosiglitazone (RSG) was used as reference drug. Body weight, food intake, plasma glucose, plasma insulin, blood haemoglobin (Hb), blood glycosylated haemoglobin (HbA1c), liver glycolytic enzyme (hexokinase), hepatic shunt enzyme (glucose-6-phosphate dehydrogenase), gluconeogenic enzymes(glucose-6-phosphatase and fructose-1,6-bisphosphatase), liver glycogen, plasma and liver triglycerides were examined in mice fed with normal standard diet (NC), high fat diet (HFD), HFD with AzA (HFD + AzA) and HFD with rosiglitazone (HFD + RSG). Among the three doses, 80 mg/kg BW of AzA was able to positively regulate plasma glucose, insulin, blood HbA1c and haemoglobin levels by significantly increasing the activity of hexokinase and glucose-6-phosphate dehydrogenase and significantly decreasing the activity of glucose-6-phosphatase and fructose-1,6-bisphosphatase thereby increasing the glycogen content in the liver. From this study, we put forward that AzA could significantly restore the levels of plasma glucose, insulin, HbA1c, Hb, liver glycogen and carbohydrate metabolic key enzymes to near normal in diabetic mice and hence, AzA may be useful as a biomaterial in the development of therapeutic agents against high fat diet induced T2DM. (C) 2013 Elsevier Masson SAS. All rights reserved.
C1 [Muthulakshmi, Shanmugam; Saravanan, Ramalingam] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Chidambaram 608002, Tamil Nadu, India.
RP Saravanan, R (reprint author), Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Chidambaram 608002, Tamil Nadu, India.
EM jayamsaranbio@gmail.com
FU Indian Council of Medical Research, India
FX The author(s) sincerely thank Indian Council of Medical Research, India
   for providing financial support for this research project, in the form
   of Senior Research Fellowship (ICMR-SRF), to Mrs. Shanmugam
   Muthulakshmi.
CR ABDELRAHIM EA, 1992, NAHRUNG, V36, P8
   ALBERTI KGM, 1982, COMPLICATIONS DIABET, P231
   Anderson JW, 2000, J AM COLL NUTR, V19, p291S, DOI 10.1080/07315724.2000.10718963
   Andrikopoulos S, 2010, MOL CELL ENDOCRINOL, V316, P140, DOI 10.1016/j.mce.2009.09.031
   Baquer N Z, 1998, Indian J Clin Biochem, V13, P63, DOI 10.1007/BF02867866
   Bergmeyer H. U., 1984, GLUCOSE 6 PHOSPHATE, P222
   BRANDSTRUP N, 1957, J GERONTOL, V12, P166, DOI 10.1093/geronj/12.2.166
   Breathnach AS, 1999, MED HYPOTHESES, V52, P221, DOI 10.1054/mehy.1997.0647
   Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909
   BURGI W, 1988, CLIN BIOCHEM, V21, P311, DOI 10.1016/S0009-9120(88)80087-0
   Chamock C., 2004, EUR J PHARM SCI, V21, P589
   Corsetti JP, 2000, ATHEROSCLEROSIS, V148, P231, DOI 10.1016/S0021-9150(99)00265-8
   Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008
   Gallou-Kabani A., 2007, OBESITY, V15, P1996
   GANCEDO JM, 1971, ARCH MIKROBIOL, V76, P132, DOI 10.1007/BF00411787
   Ghibaudi L, 2002, OBES RES, V10, P956, DOI 10.1038/oby.2002.130
   Han BG, 2008, AM J PHYSIOL-ENDOC M, V295, pE981, DOI 10.1152/ajpendo.90283.2008
   Holland K, 1989, J DERMATOL TREAT, V1, P17
   Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7
   Kelley DE, 1996, J CLIN INVEST, V97, P2705, DOI 10.1172/JCI118724
   Kim MR, 2002, NUTR RES, V22, P715, DOI 10.1016/S0271-5317(02)00372-X
   Koeing R.J., 1976, NEW ENGL J MED, V295, P417
   LAAKSO M, 1995, DIABETES, V44, P330, DOI 10.2337/diabetes.44.3.330
   LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878
   Levin B.E., 1997, AM J PHYSIOL, V273, P725
   Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3
   Liukkonen KH, 2003, P NUTR SOC, V62, P117, DOI 10.1079/PNS2002218
   Lockheart MSK, 2007, BRIT J NUTR, V98, P380, DOI 10.1017/S0007114507701654
   MARSDEN JR, 1983, BRIT J DERMATOL, V109, P723, DOI 10.1111/j.1365-2133.1983.tb00560.x
   MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V
   Mastrofrancesco A, 2010, EXP DERMATOL, V19, P813, DOI 10.1111/j.1600-0625.2010.01107.x
   McAnuff MA, 2005, W INDIAN MED J, V54, P97
   Mehmood S, 2008, FOOD CHEM, V109, P855, DOI 10.1016/j.foodchem.2008.01.014
   Mei, 2010, BMC ENDOCR DISORD, V10, P17
   Montonen J, 2003, AM J CLIN NUTR, V77, P622
   MUNTER JSL, 2007, PLOS MED, V4, pE261, DOI DOI 10.1371/JOURNALS.PMED.0040261
   NGUYEN QH, 1995, INT J DERMATOL, V34, P75, DOI 10.1111/j.1365-4362.1995.tb03583.x
   PASSI S, 1991, FREE RADICAL RES COM, V11, P329, DOI 10.3109/10715769109088931
   Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958
   ROTHMAN DL, 1995, P NATL ACAD SCI USA, V92, P983, DOI 10.1073/pnas.92.4.983
   Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583
   Sudhakar N.S., 1981, CLIN CHIM ACTA, V109, P267, DOI DOI 10.1016/0009-8981(81)90312-0
   Surwit R.S., 1995, METABOLISM, V44, P645
   Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z
   Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118
   Veerapur VP, 2010, INDIAN J EXP BIOL, V48, P800
   Wang HQ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1352, DOI 10.1152/ajpendo.00230.2001
NR 47
TC 16
Z9 16
U1 1
U2 24
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
J9 BIOCHIMIE
JI Biochimie
PD JUN
PY 2013
VL 95
IS 6
BP 1239
EP 1244
DI 10.1016/j.biochi.2013.01.018
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 152QO
UT WOS:000319546400018
PM 23402910
DA 2018-10-20
ER

PT J
AU Han, SE
   Lim, SY
   Pyon, JK
   Mun, GH
   Bang, SI
   Oh, KS
AF Han, So-Eun
   Lim, So Young
   Pyon, Jai-Kyung
   Mun, Goo-Hyun
   Bang, Sa-Ik
   Oh, Kap Sung
TI Aesthetic Refinement of Secondary Cranioplasty Using Methyl Methacrylate
   Bone Cements
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article; Proceedings Paper
CT 5th Congress of the European Association of Societies of Aesthetic
   Plastic Surgery (EASAPS)
CY JUN, 2012
CL Istanbul, TURKEY
DE Depressed skull; Methyl Methacrylate; Skull fracture
ID HYDROXYAPATITE CEMENT; GRAFT INFECTION; TECHNICAL NOTE; SKULL DEFECTS;
   RECONSTRUCTION; METHYLMETHACRYLATE; EXPERIENCE
AB Background Cranioplasty using alternate alloplastic bone substitutes instead of autologous bone grafting is inevitable in the clinical field. The authors present their experiences with cranial reshaping using methyl methacrylate (MMA) and describe technical tips that are keys to a successful procedure.
   Methods A retrospective chart review of patients who underwent cranioplasty with MMA between April 2007 and July 2010 was performed. For 20 patients, MMA was used for cranioplasty after craniofacial trauma (n = 16), tumor resection (n = 2), and a vascular procedure (n = 2). The patients were divided into two groups. In group 1, MMA was used in full-thickness inlay fashion (n = 3), and in group 2, MMA was applied in partial-thickness onlay fashion (n = 17). The locations of reconstruction included the frontotemporal region (n = 5), the frontoparietotemporal region (n = 5), the frontal region (n = 9), and the vertex region (n = 1). The size of cranioplasty varied from 30 to 144 cm(2).
   Results The amount of MMA used ranged from 20 to 70 g. This biomaterial was applied without difficulty, and no intraoperative complications were linked to the applied material. The patients were followed for 6 months to 4 years (mean, 2 years) after MMA implantation. None of the patients showed any evidence of implant infection, exposure, or extrusion. Moreover, the construct appeared to be structurally stable over time in all the patients.
   Conclusions Methyl methacrylate is a useful adjunct for treating deficiencies of the cranial skeleton. It provides rapid and reliable correction of bony defects and contour deformities. Although MMA is alloplastic, appropriate surgical procedures can avoid problems such as infection and extrusion. An acceptable overlying soft tissue envelope should be maintained together with minimal contamination of the operative site.
   Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
C1 [Han, So-Eun; Lim, So Young; Pyon, Jai-Kyung; Mun, Goo-Hyun; Bang, Sa-Ik; Oh, Kap Sung] Sungkyunkwan Univ, Dept Plast Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea.
RP Lim, SY (reprint author), Sungkyunkwan Univ, Dept Plast Surg, Samsung Med Ctr, Sch Med, 50 Irwon Dong, Seoul 135710, South Korea.
EM sy00.lim@samsung.com
CR Afifi AM, 2010, J CRANIOFAC SURG, V21, P1205, DOI 10.1097/SCS.0b013e3181e17c1e
   Badie B, 1996, SURG NEUROL, V45, P383, DOI 10.1016/0090-3019(95)00452-1
   Belmahi A, 2002, Ann Chir Plast Esthet, V47, P298, DOI 10.1016/S0294-1260(02)00121-8
   BENZEL EC, 1990, NEURORADIOLOGY, V32, P151, DOI 10.1007/BF00588566
   Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091
   Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   DAVIES JP, 1995, J APPL BIOMATER, V6, P209, DOI 10.1002/jab.770060311
   Ducic J, 2002, J ORAL MAXIL SURG, V60, P272, DOI 10.1053/joms.2002.30575
   Elshahat A, 2004, J CRANIOFAC SURG, V15, P483, DOI 10.1097/00001665-200405000-00029
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   Fujishiro Y, 2001, J BIOMED MATER RES, V54, P525, DOI 10.1002/1097-4636(20010315)54:4<525::AID-JBM80>3.0.CO;2-#
   Gasparini G, 2009, J CRANIOFAC SURG, V20, P184, DOI 10.1097/SCS.0b013e318191ced4
   HAMMON WM, 1971, ACTA NEUROCHIR, V25, P69, DOI 10.1007/BF01808863
   JACKSON IJ, 1956, J NEUROSURG, V13, P116, DOI 10.3171/jns.1956.13.1.0116
   Li CH, 2010, CHILD NERV SYST, V26, P1807, DOI 10.1007/s00381-010-1228-5
   Magee WP, 2004, PLAST RECONSTR SURG, V114, P289, DOI 10.1097/01.PRS.0000131868.67896.83
   MANSON PN, 1986, PLAST RECONSTR SURG, V77, P888, DOI 10.1097/00006534-198606000-00003
   Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055
   Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012
   Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6
   Miyake H, 2000, NEUROSURGERY, V46, P414, DOI 10.1097/00006123-200002000-00028
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   ROBINSON AC, 1989, J OTOLARYNGOL, V18, P241
   Sahoo N, 2010, J CRANIOFAC SURG, V21, P79, DOI 10.1097/SCS.0b013e3181c3ba58
   SHAPIRO SA, 1991, NEUROSURGERY, V28, P789, DOI 10.1227/00006123-199106000-00001
   Tadros M, 2008, FACIAL PLAST SURG, V24, P135, DOI 10.1055/s-2008-1037455
   Verheggen R, 2001, ACTA NEUROCHIR, V143, P919, DOI 10.1007/s007010170022
   YANAI A, 1991, J NEUROSURG, V75, P328, DOI 10.3171/jns.1991.75.2.0328
NR 29
TC 4
Z9 5
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-216X
EI 1432-5241
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD JUN
PY 2013
VL 37
IS 3
BP 592
EP 600
DI 10.1007/s00266-013-0110-8
PG 9
WC Surgery
SC Surgery
GA 148XP
UT WOS:000319282500017
PM 23584430
DA 2018-10-20
ER

PT J
AU Kavitha, K
   Prabhu, M
   Rajendran, V
   Manivasankan, P
   Prabu, P
   Jayakumar, T
AF Kavitha, K.
   Prabhu, M.
   Rajendran, V.
   Manivasankan, P.
   Prabu, P.
   Jayakumar, T.
TI Optimization of Nano-Titania and Titania-Chitosan Nanocomposite to
   Enhance Biocompatibility
SO CURRENT NANOSCIENCE
LA English
DT Article
DE Titania; titania-chitosan; cytotoxicity; biocompatibility; antibacterial
   activity; in vitro bioactivity
ID DIOXIDE TIO2 NANOPARTICLES; STAPHYLOCOCCUS-AUREUS; HYDROXYAPATITE; BONE;
   SIZE; CYTOTOXICITY; FABRICATION; STABILITY; NANOTUBES; SCAFFOLDS
AB Nano-structured titania (TiO2) has received considerable attention in the field of biomedical research because of its numerous advantages and few health concerns. To produce good biocompatible biomaterial, we synthesized different structural nano-TiO2 and TiO2-chitosan (CH) nanocomposite by precipitation, hydrothermal, and in situ sol-gel methods. The prepared samples were characterized comprehensively. Nano-TiO2 prepared by precipitation and hydrothermal methods (sintered at 673 K) showed an anatase phase with spherical morphology, whereas precipitation at 393 K confirmed amorphous phase. In situ synthesized composites were amorphous and had irregular morphology. The samples were further analyzed for in vitro bioactivity, antibacterial activity, and cytotoxicity. The characterization after bioactivity study confirmed formation of stoichiometric ratio of hydroxyapatite on TiO2-CH nanocomposite compared with other TiO2 samples. No significant cytotoxic effect of all the samples on gastric adenocarcinoma (AGS) human cell line was observed. This study shows that method of synthesis has no significant effect on the bioactivity and antibacterial activity, whereas it influences cytotoxicity. However, TiO2-CH nanocomposite has an important function in conferring better biocompatibility. Thus, TiO2-based polymer composites prepared with appropriate synthesis methods are recommended for implant and tissue engineering applications.
C1 [Kavitha, K.; Prabhu, M.; Rajendran, V.; Manivasankan, P.; Prabu, P.] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
   [Jayakumar, T.] Indira Gandhi Ctr Atom Res, Met & Mat Grp, Kalpakkam 603102, Tamil Nadu, India.
RP Rajendran, V (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
EM veerajendran@gmail.com
RI VENKATACHALAM, RAJENDRAN/H-5099-2012
OI VENKATACHALAM, RAJENDRAN/0000-0001-9471-5311
FU UGC-DAE Consortium for Scientific Research, Kalpakkam Node
   [CSR/Acctts/2010-11/1136]; Department of Atomic Energy (DAE)-MKU
   research project on "Cancer Drug Discovery Assay Development"
FX The authors acknowledge the financial support from the UGC-DAE
   Consortium for Scientific Research, Kalpakkam Node, to carry out this
   research project (CSR/Acctts/2010-11/1136 dt. 06.01.2011) and thank G.
   Amarendra, Head, Metal Physics Section, Indira Gandhi Centre for Atomic
   Research, Kalpakkam, for his valuable suggestions. The authors also
   thank G. Kumaresan and P. Jayaprakash of the Department of Genetics,
   School of Biological Sciences, Madurai Kamaraj University (MKU) for
   their help in the cell line study with the support of the Department of
   Atomic Energy (DAE)-MKU research project on "Cancer Drug Discovery Assay
   Development."
CR Al-Sagheer FA, 2011, CARBOHYD POLYM, V85, P356, DOI 10.1016/j.carbpol.2011.02.032
   Asahara T, 2009, JPN J INFECT DIS, V62, P378
   Choi D, 2006, J AM CERAM SOC, V89, P444, DOI 10.1111/j.1551-2916.2005.00738.x
   Choi HC, 2004, APPL SPECTROSC, V58, P598, DOI 10.1366/000370204774103435
   Chung YC, 2004, ACTA PHARMACOL SIN, V25, P932
   Dai SX, 2010, NANOSCALE RES LETT, V5, P1829, DOI 10.1007/s11671-010-9720-0
   Eichenseer C, 2010, J MATER SCI-MATER M, V21, P131, DOI 10.1007/s10856-009-3857-3
   Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5
   Ghosh M, 2010, CHEMOSPHERE, V81, P1253, DOI 10.1016/j.chemosphere.2010.09.022
   Guoa W., 2003, MICROELECTRON ENG, V66, P95
   He G, 2008, APPL SURF SCI, V255, P442, DOI 10.1016/j.apsusc.2008.06.088
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Hua D., 2007, T NONFERR METAL SOC, V17, P700
   Lopez-Leon T, 2005, J COLLOID INTERF SCI, V283, P344, DOI 10.1016/j.jcis.2004.08.186
   Luo YB, 2009, APPL SURF SCI, V255, P6795, DOI 10.1016/j.apsusc.2009.02.074
   Manivasakan P, 2010, J AM CERAM SOC, V93, P2236, DOI 10.1111/j.1551-2916.2010.03727.x
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   Murugan R, 2005, J CRYST GROWTH, V274, P209, DOI 10.1016/j.jcrysgro.2004.09.069
   Nakayama N., 2007, POLYM DEGRADATION ST, V2, P1255
   Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014
   Ou HH, 2007, SEP PURIF TECHNOL, V58, P179, DOI 10.1016/j.seppur.2007.07.017
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Rajkumar M, 2011, DIG J NANOMATER BIOS, V6, P169
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Rani VVD, 2011, CARBOHYD POLYM, V83, P858, DOI 10.1016/j.carbpol.2010.08.065
   Roy ME, 2001, J MATER SCI-MATER M, V12, P699, DOI 10.1023/A:1011268525937
   Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011
   Shiraishi K, 2009, SURF INTERFACE ANAL, V41, P17, DOI 10.1002/sia.2965
   Shivaraju HP, 2010, B CATAL SOC INDIA, V9, P37
   Siriphannon P, 2002, J EUR CERAM SOC, V22, P511, DOI 10.1016/S0955-2219(01)00301-6
   Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22
   Teoh LG, 2010, CURR NANOSCI, V6, P77, DOI 10.2174/157341310790226298
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Vlachou M, 2001, J BIOMATER APPL, V16, P125, DOI 10.1106/RJ4E-95LE-46BT-PUK0
   Wang CC, 1999, CHEM MATER, V11, P3113, DOI 10.1021/cm990180f
   Wilson RM, 2005, BIOMATERIALS, V26, P1317, DOI 10.1016/j.biomaterials.2004.04.038
   Xu W., 2006, T NONFERR METAL SOC, V16, P209
   Yan L, 2001, INT J INORG MATER, V3, P633, DOI 10.1016/S1466-6049(01)00164-7
   Yang D, 2009, CHEM ENG SCI, V64, P3130, DOI 10.1016/j.ces.2009.03.042
   Yanqinm L., 2010, CURR NANOSCI, V6, P256
NR 40
TC 12
Z9 12
U1 3
U2 43
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4137
J9 CURR NANOSCI
JI Curr. Nanosci.
PD JUN
PY 2013
VL 9
IS 3
BP 308
EP 317
DI 10.2174/1573413711309030003
PG 10
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA 149PN
UT WOS:000319333400002
DA 2018-10-20
ER

PT J
AU Biela, E
   Galas, J
   Lee, B
   Johnson, GL
   Darzynkiewicz, Z
   Dobrucki, JW
AF Biela, Ewa
   Galas, Jerzy
   Lee, Brian
   Johnson, Gary L.
   Darzynkiewicz, Zbigniew
   Dobrucki, Jurek W.
TI Col-F, a fluorescent probe for ex vivo confocal imaging of collagen and
   elastin in animal tissues
SO CYTOMETRY PART A
LA English
DT Article
DE extracellular matrix; collagen; elastin; fluorescence microscopy; live
   cell imaging; confocal microscopy
ID EXTRACELLULAR-MATRIX; LAMELLAR UNIT; BLOOD-VESSELS; IN-VITRO;
   MICROSCOPY; GENERATION; CARTILAGE; FIBRILS; CELLS
AB A new low-molecular-weight fluorescent probe, Col-F, that exhibits affinity to collagen and elastin, was used successfully in imaging of extracellular matrix in freshly excised animal tissues. Col-F readily penetrates between live cells into tissues and binds to fibers of collagen and elastin by a noncovalent mechanism. Fibers of collagen and elastin have been stained in a variety of tissues, including tendon, skeletal muscle, connective tissue, and arteries. Cells migrating in a Col-F-stained collagenous biomaterial were also imaged. No phototoxic effects were detected when live keratocytes were imaged in the in vitro culture in the presence of Col-F. In conclusion, Col-F provides a simple and convenient tool for fluorescence three-dimensional imaging of intricate collagenous and elastic structures in live and fixed animal tissues, as well as in collagen-containing biomaterials. (c) 2013 International Society for Advancement of Cytometry
C1 [Biela, Ewa; Dobrucki, Jurek W.] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Div Cell Biophys, PL-30387 Krakow, Poland.
   [Galas, Jerzy] Jagiellonian Univ, Fac Biol & Earth Sci, Inst Zool, PL-30387 Krakow, Poland.
   [Lee, Brian; Johnson, Gary L.] Immunochem Technol LLC, Bloomington, MN 55431 USA.
   [Darzynkiewicz, Zbigniew] New York Med Coll, Dept Pathol, Brander Canc Res Inst, Valhalla, NY 10595 USA.
RP Dobrucki, JW (reprint author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Div Cell Biophys, PL-30387 Krakow, Poland.
EM jerzy.dobrucki@uj.edu.pl
OI Darzynkiewicz, Zbigniew/0000-0002-2040-7081
FU MNSW [2067/PO1/2007/32]; EU [POIG.02.01.00-12-064/08]; NCI [CA 28704];
   Robert A. Welke Foundation for Cancer Research
FX Grant sponsor: MNSW; Grant number: 2067/PO1/2007/32 (EB, JG, JWD) and EU
   structural funds grant BMZ no. POIG.02.01.00-12-064/08; NCI; CA 28704
   and Robert A. Welke Foundation for Cancer Research (ZD).
CR AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4
   Baxter BT, 2005, CARDIOVASC PATHOL, V14, P185, DOI 10.1016/j.carpath.2005.04.003
   Brightman AO, 2000, BIOPOLYMERS, V54, P222
   Burrage PS, 2006, FRONT BIOSCI, V11, P529, DOI 10.2741/1817
   Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894
   FINE S, 1971, APPL OPTICS, V10, P2350, DOI 10.1364/AO.10.002350
   Fritze O, 2010, TISSUE ENG PART C-ME, V16, P705, DOI 10.1089/ten.TEC.2009.0309
   Huang X, 2005, CELL CYCLE, V4, P140, DOI 10.4161/cc.4.1.1322
   HWANG WS, 1990, HISTOCHEM J, V22, P487, DOI 10.1007/BF01007233
   Kadler Karl, 2004, Birth Defects Res C Embryo Today, V72, P1, DOI 10.1002/bdrc.20002
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013
   Liu MY, 2005, BIO-MED MATER ENG, V15, P413
   Mansfield J, 2009, J ANAT, V215, P682, DOI 10.1111/j.1469-7580.2009.01149.x
   O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Petroll WM, 2006, SCANNING, V28, P305
   PUCHTLER H, 1979, HISTOCHEMISTRY, V64, P119, DOI 10.1007/BF00490093
   Rajwa B, 2002, THESIS JAGIELLONIAN
   Ricard C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821421
   SWEAT F, 1964, ARCH PATHOL, V78, P69
   Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520
   Trembecka DO, 2010, CYTOM PART A, V77A, P366, DOI 10.1002/cyto.a.20866
   Voytik-Harbin SL, 2001, METHOD CELL BIOL, V63, P583
   Weigert C., 1898, Z ALLG PATHOL, V9, P289
   Wess TJ, 2005, ADV PROTEIN CHEM, V70, P341, DOI 10.1016/S0065-3233(05)70010-3
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Wolf K, 2005, BIOCHIMIE, V87, P315, DOI 10.1016/j.biochi.2004.10.016
   WOLINSKY H, 1964, CIRC RES, V14, P400, DOI 10.1161/01.RES.14.5.400
   WOLINSKY H, 1967, CIRC RES, V20, P99, DOI 10.1161/01.RES.20.1.99
NR 30
TC 7
Z9 7
U1 2
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4922
J9 CYTOM PART A
JI Cytom. Part A
PD JUN
PY 2013
VL 83A
IS 6
BP 533
EP 539
DI 10.1002/cyto.a.22264
PG 7
WC Biochemical Research Methods; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 149VG
UT WOS:000319348900006
PM 23404939
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Liang, K
   Gong, Y
   Fu, JL
   Yan, S
   Tan, YY
   Du, R
   Xing, XQ
   Mo, G
   Chen, ZJ
   Cai, Q
   Sun, DB
   Wu, ZH
AF Liang, Ku
   Gong, Yu
   Fu, Jianlong
   Yan, Shi
   Tan, Yuanyuan
   Du, Rong
   Xing, Xueqing
   Mo, Guang
   Chen, Zhongjun
   Cai, Quan
   Sun, Dongbai
   Wu, Zhonghua
TI Microstructural change of degummed Bombyx mori silk: An in situ
   stretching wide-angle X-ray-scattering study
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Bombyx mori silk fiber; Wide angle X-ray scattering; Crystallite size;
   Crystallinity; Orientation
ID CRYSTAL-STRUCTURE; FIBROIN; FIBERS; BIOMATERIAL; MORPHOLOGY; BEHAVIOR
AB The microstructural change of degummed Bombyx mod silk was examined by in situ wide-angle X-ray-scattering (WAXS) with applied stretching force. WAXS patterns confirmed that the crystalline and amorphous regions coexist in the silk fibers. The crystallites with beta-sheet structure have an orthorhombic unit cell with lattice parameters: a = 9.10 angstrom, b = 9.71 angstrom and c = 6.80 angstrom. The crystallite size, crystallite orientation and crystallinity were also estimated based on the WAXS patterns. The results demonstrate that the crystallite size is almost unchanged with the stretching strain. The crystallinity is approximately linearly increasing with the applied stretching force. However, the change of the unit-cell orientation degree with c-axis along the fiber axis behaves as a fast stage and an approximately unchanged stage during the in situ stretching process. All these experimental phenomena confirm that the microstructure of the degummed silk fibers can be well explained by the model of oriented beta-sheet structure with a banded feature. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Liang, Ku; Fu, Jianlong; Yan, Shi; Tan, Yuanyuan; Sun, Dongbai] Univ Sci & Technol Beijing, Natl Ctr Mat Serv Safety, Beijing 100083, Peoples R China.
   [Gong, Yu; Du, Rong; Xing, Xueqing; Mo, Guang; Chen, Zhongjun; Cai, Quan; Wu, Zhonghua] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China.
   [Gong, Yu; Du, Rong; Xing, Xueqing; Mo, Guang; Chen, Zhongjun; Cai, Quan; Wu, Zhonghua] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China.
RP Wu, ZH (reprint author), Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China.
EM wuzh@ihep.ac.cn
FU National Natural Scientific Foundation of China [10385008]; Knowledge
   Innovation Program of Chinese Academy of Sciences [kjcx3.syw.n8];
   Momentous Equipment Program of Chinese Academy of Sciences [YZ200829]
FX This work is supported by National Natural Scientific Foundation (No.
   10385008) of China and the Knowledge Innovation Program of Chinese
   Academy of Sciences (Grant No. kjcx3.syw.n8), and the Momentous
   Equipment Program of Chinese Academy of Sciences (Grant No. YZ200829).
CR Anderson JP, 1998, BIOPOLYMERS, V45, P307
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Drummy LF, 2005, BIOMACROMOLECULES, V6, P3328, DOI 10.1021/bm0503524
   He JX, 2010, J APPL POLYM SCI, V118, P3260, DOI 10.1002/app.32631
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Kawahara Y, 1999, J APPL POLYM SCI, V73, P363, DOI 10.1002/(SICI)1097-4628(19990718)73:3<363::AID-APP7>3.0.CO;2-R
   Kawahara Y, 1997, J MACROMOL SCI PHYS, V36, P503, DOI 10.1080/00222349708220438
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KRATKY O, 1950, NATURE, V165, P319, DOI 10.1038/165319a0
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Martel A, 2007, BIOMACROMOLECULES, V8, P3548, DOI 10.1021/bm700935w
   Okuyama K, 2001, BIOPOLYMERS, V59, P310, DOI 10.1002/1097-0282(20011015)59:5<310::AID-BIP1028>3.0.CO;2-5
   Sangappa S.S. Mahesh, 2005, J BIOSCIENCE, V30, P259
   Shen Y, 1998, MACROMOLECULES, V31, P8857, DOI 10.1021/ma980281j
   Takahashi Y, 1999, INT J BIOL MACROMOL, V24, P127, DOI 10.1016/S0141-8130(98)00080-4
   Tao YZ, 2012, POLYM INT, V61, P760, DOI 10.1002/pi.4136
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wei Qiao Na, 2012, J APPL POLYM SCI, V125, P477
   Zhao CH, 2003, BIOPOLYMERS, V69, P253, DOI 10.1002/bip.10350
   Zheng Z.S., 2002, NATURE, V418, P741
NR 21
TC 6
Z9 6
U1 0
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN
PY 2013
VL 57
BP 99
EP 104
DI 10.1016/j.ijbiomac.2013.02.018
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 146NX
UT WOS:000319098900016
PM 23466498
DA 2018-10-20
ER

PT J
AU Jeong, HS
   Venkatesan, J
   Kim, SK
AF Jeong, Hee-Seok
   Venkatesan, Jayachandran
   Kim, Se-Kwon
TI Hydroxyapatite-fucoidan nanocomposites for bone tissue engineering
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Nano hydroxyapatite; Fucoidan; Nano composites; Tissue engineering
ID COMPOSITE SCAFFOLDS
AB Hydroxyapatite (HAp) is the promising biomaterials to construct the article bone from the last two decades. In the present study, we have developed hydroxyapatite-fucoidan (HApF) nanocomposite for bone tissue engineering and subsequently characterized by different analytical techniques for bone graft substitute. The chemical characterization suggested that the prepared nanocomposite HApF have amorphous nature, crystal size between 41 and 153 nm was observed. The biochemical characterization inferred that the prepared nanocomposite were non-toxic and mineralization effect of HApF was observed two times higher then HAp. Hence, HApF is the promising biomaterial and could be used for bone tissue construct. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Jeong, Hee-Seok; Venkatesan, Jayachandran; Kim, Se-Kwon] Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea.
   [Venkatesan, Jayachandran; Kim, Se-Kwon] Pukyong Natl Univ, Marine Bioproc Res Ctr, Pusan 608737, South Korea.
RP Kim, SK (reprint author), Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea.
EM venkatjchem@pknu.ac.kr; sknkim@pknu.ac.kr
OI Kim, Se-Kwon/0000-0001-6507-9539
FU Marine Bioprocess Research Centre of the Marine Bio 21 Center; Ministry
   of Land, Transport and Maritime, Republic of Korea
FX This work was supported by a grant from Marine Bioprocess Research
   Centre of the Marine Bio 21 Center funded by the Ministry of Land,
   Transport and Maritime, Republic of Korea.
CR Bongio M, 2010, J MATER CHEM, V20, P8747, DOI 10.1039/c0jm00795a
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Cho YS, 2009, FOOD CHEM, V116, P990, DOI 10.1016/j.foodchem.2009.03.051
   Jin G, 2011, J MATER CHEM, V21, P17710, DOI 10.1039/c1jm12915e
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JS, 2012, CARBOHYD POLYM, V90, P181, DOI 10.1016/j.carbpol.2012.05.012
   Nejati E, 2008, COMPOS PART A-APPL S, V39, P1589, DOI 10.1016/j.compositesa.2008.05.018
   Park S, 2011, J FUNCT PROGRAM, V21, P21, DOI 10.1017/S0956796810000249
   Sezer AD, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802039
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
NR 14
TC 19
Z9 20
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN
PY 2013
VL 57
BP 138
EP 141
DI 10.1016/j.ijbiomac.2013.03.011
PG 4
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 146NX
UT WOS:000319098900022
PM 23500439
DA 2018-10-20
ER

PT J
AU Li, JY
   He, FP
   Ye, JD
AF Li, Jiyan
   He, Fupo
   Ye, Jiandong
TI Effect of the surface topographic modification on cytocompatibility of
   hardened calcium phosphate cement
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Calcium phosphate cement; Topography; Cell response
ID HYDROXYAPATITE; DIFFERENTIATION; OSTEOBLAST; ROUGHNESS; SYSTEM
AB As cells are inherently sensitive to local nanoscale patterns of topography, the aim of this study was to determine the effect of the topographic modification of hardened calcium phosphate cement on cell response which was conducted with MC3T3-E1 cells. The results exhibited that the samples with regular blade-like crystalline structure had better cell response (cell attachment, viability, proliferation and differentiation) compared to those with irregular blade-like crystalline structure. The method of topographic modification is promising for developing a novel biomaterial of hardened calcium phosphate cement for bone repair. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Li, Jiyan; He, Fupo; Ye, Jiandong] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
   [Ye, Jiandong] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.
RP Ye, JD (reprint author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
EM jdye@scut.edu.cn
FU National Natural Science Foundation of China (NSFC) [51172074]; National
   Basic Research Program of China [2012CB619100]; Program for Changjiang
   Scholars and Innovative Research Team in University [IRT0919]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) under Grant No. 51172074 and the National Basic Research
   Program of China under Grant No. 2012CB619100 as well as the Program for
   Changjiang Scholars and Innovative Research Team in University under
   Grant No. IRT0919.
CR Bigi A, 2004, BIOMATERIALS, V25, P2893, DOI 10.1016/j.biomaterials.2003.09.059
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Fulmer MT, 1998, J MATER SCI-MATER M, V9, P197, DOI 10.1023/A:1008832006277
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   HORIKOSHI K, 1990, J MOL STRUCT, V239, P33, DOI 10.1016/0022-2860(90)80200-4
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Tas AC, 2008, J MATER SCI-MATER M, V19, P2231, DOI 10.1007/s10856-007-3326-9
   Van den Vreken NMF, 2010, ACTA BIOMATER, V6, P617, DOI 10.1016/j.actbio.2009.07.038
   Wang XP, 2007, ACTA BIOMATER, V3, P757, DOI 10.1016/j.actbio.2007.01.004
   Wang XP, 2007, J BIOMED MATER RES A, V81A, P781, DOI 10.1002/jbm.a.31059
   Wang XP, 2008, J MATER SCI-MATER M, V19, P813, DOI 10.1007/s10856-006-0029-6
   Yang YZ, 2005, INT J ORAL MAX IMPL, V20, P187
NR 14
TC 5
Z9 5
U1 0
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUN 1
PY 2013
VL 274
BP 237
EP 240
DI 10.1016/j.apsusc.2013.03.023
PG 4
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 139QK
UT WOS:000318598600038
DA 2018-10-20
ER

PT J
AU Forni
   Cristovam, PC
AF Forni
   Cristovam, Priscila Cardoso
TI Comparison Between Different Biomaterial Scaffolds for Limbal Derived
   Stem Cells Growth and Enrichment (vol 38, pg 27, 2013)
SO CURRENT EYE RESEARCH
LA English
DT Correction
CR Forni MF, 2013, CURR EYE RES, V38, P27, DOI 10.3109/02713683.2012.733053
NR 1
TC 0
Z9 0
U1 0
U2 2
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0271-3683
J9 CURR EYE RES
JI Curr. Eye Res.
PD JUN
PY 2013
VL 38
IS 6
BP 707
EP 707
DI 10.3109/02713683.2013.791789
PG 1
WC Ophthalmology
SC Ophthalmology
GA 140IB
UT WOS:000318646600013
OA Bronze
DA 2018-10-20
ER

PT J
AU Chan, RTH
   Marcal, H
   Ahmed, T
   Russell, RA
   Holden, PJ
   Foster, LJR
AF Chan, Rodman T. H.
   Marcal, Helder
   Ahmed, Tania
   Russell, Robert A.
   Holden, Peter J.
   Foster, L. John R.
TI Poly(ethylene glycol)-modulated cellular biocompatibility of
   polyhydroxyalkanoate films
SO POLYMER INTERNATIONAL
LA English
DT Article
DE polyhydroxyalkanoates; poly(ethylene glycol); olfactory ensheathing
   cells; biomaterial; crystallinity; degradation
ID OLFACTORY ENSHEATHING CELLS; IN-VITRO; PHB/PEG BLENDS; SCHWANN-CELLS;
   GLYCOL) BLEND; DEGRADATION; BIODEGRADATION; COPOLYMERS; SCAFFOLDS;
   MORPHOLOGY
AB Polyhydroxybutyrate (PHB) and its copolymer with hydroxyvalerate, P(HB-co-HV), are widely used biomaterials. In this study, improvements of their biological properties of degradability and compatibility were achieved by blending with low-molecular-weight poly(ethylene glycol) (PEG106) approved for medical use. Surface morphology and chemistry are known to support cell attachment. Attachment and proliferation of neural olfactory ensheathing cells increased by 17.0 and 32.2% for PHB and P(HB-co-HV) composite films. Cell attachment was facilitated by increases in surface hydrophilicity, water contact angles decreased by 26 +/- 2 degrees and water uptake increased by 23.3% depending upon biopolymer and PEG loading. Cells maintained high viability (>95%) on the composite films with no evidence of cytotoxic effects. Assays of mitochondrial function and cell leakage showed improved cell health as a consequence of PEG loading. The PEG component was readily solubilised from composite films, allowing control of degradation profiles in the cell growth medium. Promotion of biopolymer compatibility and degradability was not at the expense of material properties, with the extension to break of the composites increasing by 5.83 +/- 1.06%. Similarly, crystallinity decreased by 36%. The results show that blending of common polyhydroxyalkanoate biomaterials with low-molecular-weight PEG can be used to promote biocompatibility and manipulate physiochemical and material properties as well as degradation.(c) 2013 Society of Chemical Industry
C1 [Chan, Rodman T. H.; Marcal, Helder; Ahmed, Tania; Russell, Robert A.; Foster, L. John R.] Univ New S Wales, Bio Polymer Res Grp, Ctr Adv Macromol Design, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Russell, Robert A.; Holden, Peter J.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, Bio Polymer Res Grp, Ctr Adv Macromol Design, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
EM J.Foster@unsw.edu.au
OI Russell, Robert/0000-0002-6819-8194
CR Ahmed T, 2010, BIOMACROMOLECULES, V11, P2707, DOI 10.1021/bm1007579
   Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160
   Barnett SC, 2000, BRAIN, V123, P1581, DOI 10.1093/brain/123.8.1581
   BUCHANAN CM, 1992, MACROMOLECULES, V25, P7373, DOI 10.1021/ma00052a046
   Calvao PS, 2010, POLYM INT, V59, P851, DOI 10.1002/pi.2799
   Cheng GX, 2003, J MATER SCI-MATER M, V14, P1073, DOI 10.1023/B:JMSM.0000004004.37103.f4
   Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y
   Doi Y., 2002, BIOPOLYMERS A, V3a
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Foster L. J. R., 2010, BIOPOLYMERS, P243
   Foster LJR, 2007, APPL MICROBIOL BIOT, V75, P1241, DOI 10.1007/s00253-007-0976-y
   Foster LJR, 2010, BIOMACROMOLECULES, V11, P3563, DOI 10.1021/bm101028g
   Foster LJR, 2009, POLYM INT, V58, P1442, DOI 10.1002/pi.2682
   Foster LJR, 1995, BIOMATERIALS, V16, P314
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Hady EEA, 2006, J PHYS C SER, V262, P1
   Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Huang W, 2010, BIOMATERIALS, V31, P4278, DOI 10.1016/j.biomaterials.2010.01.059
   Kapritchkoff FM, 2006, J BIOTECHNOL, V122, P453, DOI 10.1016/j.jbiotec.2005.09.009
   Kumarasuriyar A, 2005, TISSUE ENG, V11, P1281, DOI 10.1089/ten.2005.11.1281
   Li HY, 2005, POLYM DEGRAD STABIL, V87, P301, DOI 10.1016/j.polymdegradstab.2004.09.001
   Li X, 2006, BIOMACROMOLECULES, V7, P3112, DOI 10.1021/bm060675f
   Li X, 2009, ACTA BIOMATER, V5, P2002, DOI 10.1016/j.actbio.2009.01.035
   Liu JO, 2010, J BIOMED MATER RES A, V94A, P603, DOI 10.1002/jbm.a.32730
   Liu KL, 2010, J PHYS CHEM B, V114, P7489, DOI 10.1021/jp1018247
   Marcal H, 2008, BIOMACROMOLECULES, V9, P2719, DOI 10.1021/bm800418e
   Meng W, 2007, J BIOMAT SCI-POLYM E, V18, P81, DOI 10.1163/156856207779146114
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   O'Toole SA, 2003, CANCER DETECT PREV, V27, P47, DOI 10.1016/S0361-090X(02)00171-X
   Parra DF, 2006, POLYM DEGRAD STABIL, V91, P1954, DOI 10.1016/j.polymdegradstab.2006.02.008
   Ravenelle F, 2002, BIOMACROMOLECULES, V3, P1057, DOI 10.1021/bm025553b
   Renard E, 2004, POLYM DEGRAD STABIL, V85, P779, DOI 10.1016/j.pllymdegradstab.2003.11.019
   Rodrigues JAFR, 2005, J THERM ANAL CALORIM, V79, P379, DOI 10.1007/s10973-005-0069-z
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Saad B, 1996, J MATER SCI-MATER M, V7, P56, DOI 10.1007/BF00121191
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Shen YX, 2010, CELL TRANSPLANT, V19, P147, DOI 10.3727/096368910X492616
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P915, DOI 10.1023/B:JMSM.0000036280.98763.c1
   STOLLE LB, 2005, TOXICOL SCI, V88, P412
   Tabesh H, 2009, NEUROCHEM INT, V54, P73, DOI 10.1016/j.neuint.2008.11.002
   Townsend KJ, 2005, BIOTECHNOL PROGR, V21, P959, DOI 10.1021/bp050044h
   Wang SA, 2008, POLYM DEGRAD STABIL, V93, P1364, DOI 10.1016/j.polymdegradstab.2008.03.026
   Woolnough CA, 2008, POLYM INT, V57, P1042, DOI 10.1002/pi.2444
   Woolnough CA, 2010, POLYM INT, V59, P658, DOI 10.1002/pi.2746
   Xia CY, 2005, NEUROPEPTIDES, V39, P453, DOI 10.1016/j.npep.2005.07.004
   Zanzig J, 2003, J BIOACT COMPAT POL, V18, P339, DOI 10.1177/088391103038229
   Zhang QQ, 1998, J MATER SCI TECHNOL, V14, P95
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhao K, 2003, BIOCHEM ENG J, V16, P115, DOI 10.1016/S1369-703X(03)00029-9
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 52
TC 14
Z9 15
U1 0
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JUN
PY 2013
VL 62
IS 6
BP 884
EP 892
DI 10.1002/pi.4451
PG 9
WC Polymer Science
SC Polymer Science
GA 142HT
UT WOS:000318788700006
DA 2018-10-20
ER

PT J
AU Wang, XS
   Li, Y
   Gao, YF
   Chen, X
   Yao, J
   Lin, WW
   Chen, Y
   Liu, J
   Yang, YM
   Wang, X
AF Wang, Xuesong
   Li, Yi
   Gao, Yinfeng
   Chen, Xue
   Yao, Jian
   Lin, Weiwei
   Chen, Ying
   Liu, Jie
   Yang, Yumin
   Wang, Xiaodong
TI Combined use of spinal cord-mimicking partition type scaffold
   architecture and neurotrophin-3 for surgical repair of completely
   transected spinal cord in rats
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE chitosan; spinal cord-mimicking; partition-type architecture;
   neurotrophin-3; spinal cord injury; regeneration
ID NEURAL STEM-CELLS; AXONAL REGENERATION; FUNCTIONAL RECOVERY;
   SCHWANN-CELLS; CHITOSAN TUBE; NERVE GRAFTS; INJURY; IMPLANTATION;
   STRATEGIES; ACID
AB A body of evidence has suggested that tissue-engineered nerve grafts hold promise for the surgical repair of spinal cord injuries. In this study, a novel nerve graft was prepared to be implantated into a 5mm gap which was caused by a complete transection of the rat spinal cord. The graft was featured by incorporation of neurotrophin-3 into a chitosan-based tube scaffold with a spinal cord-mimicking, partition-type architecture, which was prepared based on the morphometric insights of normal spinal cord anatomy. A set of behavioral, functional, and histological examinations were carried out to evaluate the repair. Results from Basso, Beattie, and Bresnahan tests, motor evoked potential measurements, anterograde tracing, and histological analyses suggested that the combined application of chitosan as the scaffold biomaterial, a spinal cord-mimicking partition-type as the scaffold architecture, and neurotrophin-3 (NT-3) as the bioactive component might probably create synergetic promotion on spinal cord regeneration. This composite nerve graft yielded significantly better results in axonal regeneration and function restoration as compared to its scaffold alone or other types of hollow tube scaffold alone.
C1 [Li, Yi; Gao, Yinfeng; Chen, Xue; Yao, Jian; Lin, Weiwei; Chen, Ying; Wang, Xiaodong] Nantong Univ, Dept Histol & Embryol, Coll Med, Nantong 226001, Jiangsu, Peoples R China.
   [Wang, Xuesong] Nantong Univ, Dept Osteol, Affiliated Hosp 3, Wuxi 214045, Jiangsu, Peoples R China.
   [Liu, Jie; Yang, Yumin; Wang, Xiaodong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
   [Wang, Xiaodong] Nantong Univ, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.
RP Wang, X (reprint author), Nantong Univ, Dept Histol & Embryol, Coll Med, Nantong 226001, Jiangsu, Peoples R China.
EM wxdzw@ntu.edu.cn
FU Natural Science Foundation of China [30870643]; Natural Science Fund for
   Colleges and Universities in Jiangsu Province [11KJB310007]; Priority
   Academic Program Development of Jiangsu Higher Education Institutions
FX This research was supported by grant from Natural Science Foundation of
   China, No. 30870643, Natural Science Fund for Colleges and Universities
   in Jiangsu Province, No. 11KJB310007 and a Project Funded by the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions.
CR Bani-Yaghoub M, 2008, BIOCHEM CELL BIOL, V86, P361, DOI [10.1139/O08-116, 10.1139/o08-116]
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Cheng MY, 2003, J BIOMAT SCI-POLYM E, V14, P1155, DOI 10.1163/156856203769231628
   Fan JA, 2010, J NEUROTRAUM, V27, P1671, DOI 10.1089/neu.2010.1281
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x
   Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Khodagholi F, 2010, MOL CELL BIOCHEM, V337, P39, DOI 10.1007/s11010-009-0284-1
   Kim BG, 2010, CYTOTHERAPY, V12, P841, DOI 10.3109/14653249.2010.501784
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X
   Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Yang YM, 2009, CELL BIOL INT, V33, P352, DOI 10.1016/j.cellbi.2009.01.005
   Yang ZY, 2010, BIOMATERIALS, V31, P4846, DOI 10.1016/j.biomaterials.2010.02.015
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072
NR 32
TC 10
Z9 10
U1 0
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUN 1
PY 2013
VL 24
IS 8
BP 927
EP 939
DI 10.1080/09205063.2012.727267
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 137YP
UT WOS:000318474800003
PM 23647249
DA 2018-10-20
ER

PT J
AU Kim, MK
   Lee, JH
   Lee, JY
   Koh, AY
   Kim, YH
   Wee, WR
   Jeon, S
AF Kim, Mee Kum
   Lee, Joo Hee
   Lee, Ja Young
   Koh, Ah Young
   Kim, Yun Hee
   Wee, Won Ryang
   Jeon, Saewha
TI Characterization of Biomaterial free Cell Sheets Cultured from Human
   Oral Mucosal Epithelial Cells
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 721 stem cells
C1 [Kim, Mee Kum; Lee, Ja Young; Wee, Won Ryang] Seoul Natl Univ Hosp, Ophthalmol, Seoul, South Korea.
   [Kim, Mee Kum; Lee, Ja Young; Koh, Ah Young; Wee, Won Ryang] Seoul Artificial Eye Ctr, Laboraory Corneal Regenerat Med & Ocular Immunol, Seoul, South Korea.
   [Lee, Joo Hee; Kim, Yun Hee; Jeon, Saewha] Tego Sci Inc, Cutigen Res Inst, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2013
VL 54
IS 15
MA 991
PG 2
WC Ophthalmology
SC Ophthalmology
GA VD1WC
UT WOS:000436232702224
DA 2018-10-20
ER

PT J
AU Postic, I
   Sheardown, H
AF Postic, Ivana
   Sheardown, Heather
TI Evaluating & Predicting Drug Release from an Implantable Biomaterial
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 688 retina
C1 [Postic, Ivana; Sheardown, Heather] McMaster Univ, Chem Engn, Hamilton, ON, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2013
VL 54
IS 15
MA 5074
PG 2
WC Ophthalmology
SC Ophthalmology
GA VD1WD
UT WOS:000436232902164
DA 2018-10-20
ER

PT J
AU Annich, G
   Adachi, I
AF Annich, Gail
   Adachi, Iki
TI Anticoagulation for Pediatric Mechanical Circulatory Support
SO PEDIATRIC CRITICAL CARE MEDICINE
LA English
DT Article
DE activated clotting time; extracorporeal membrane oxygenation; heparin;
   ventricular assist device
ID EXTRACORPOREAL MEMBRANE-OXYGENATION; HEPARIN-INDUCED THROMBOCYTOPENIA;
   VENTRICULAR ASSIST DEVICE; ACTIVATED CLOTTING TIME; CARDIOPULMONARY
   BYPASS; UNFRACTIONATED HEPARIN; CARDIAC-SURGERY; FACTOR-XA; CHILDREN;
   ANTITHROMBIN
AB Extracorporeal life support applications have evolved considerably in recent years. However, the blood-biomaterial interface remains incompletely understood, and management of the acute inflammatory response and coagulation pathways continues to be challenging. At present, the gold standard for anticoagulation is unfractionated heparin. Since the inception of extracorporeal life support, the mainstay for anticoagulation monitoring has been activated clotting time. However, alongside the technological evolution in extracorporeal life support, the methods for monitoring heparin have also become more sophisticated, adding additional layers of complexity to creating an ideal safe protocol for anticoagulation during extracorporeal life support. To address this, the Extracorporeal Life Support Organization has formed an Anticoagulation Task Force to help direct both a consensus statement and potential guidelines within which the multiple monitoring methods can be customized for extracorporeal life support. One key question that remains in the use of these monitoring methods is whether the objective during extracorporeal life support is to anticoagulate the circuit to prevent thrombus formation within the extracorporeal device or whether it is to systemically anticoagulate the patient. This review details all current monitoring methods and highlights how they can be used during pediatric mechanical circulatory support.
C1 [Annich, Gail] Univ Michigan Hosp, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA.
   [Adachi, Iki] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Adachi, Iki] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.
RP Annich, G (reprint author), Univ Michigan Hosp, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA.
EM gannich@med.umich.edu
CR Alexander DC, 2010, THROMB RES, V125, P387, DOI 10.1016/j.thromres.2009.07.001
   Almond CS, 2011, AM HEART J, V162, P425, DOI 10.1016/j.ahj.2011.05.026
   ANDREW M, 1994, PEDIATR RES, V35, P78, DOI 10.1203/00006450-199401000-00016
   Arnold P, 2001, INTENS CARE MED, V27, P1395, DOI 10.1007/s001340100991
   Balasubramanian SK, 2005, ASAIO J, V5, P477
   Bates S M, 2000, J Invasive Cardiol, V12 Suppl F, p27F
   Beiderlinden M, 2007, ARTIF ORGANS, V31, P461, DOI 10.1111/j.1525-1594.2007.00388.x
   BRILLEDWARDS P, 1993, ANN INTERN MED, V119, P104, DOI 10.7326/0003-4819-119-2-199307150-00002
   Chan AKC, 2002, THROMB HAEMOSTASIS, V87, P606
   Chan AKC, 2008, THROMB RES, V122, P135, DOI 10.1016/j.thromres.2007.09.007
   DANIELSSON A, 1986, J BIOL CHEM, V261, P5467
   Fleming GM, 2007, ASAIO J, V53, P556, DOI 10.1097/MAT.0b013e31810082f
   Fraser CD, 2012, NEW ENGL J MED, V367, P532, DOI 10.1056/NEJMoa1014164
   GREEN TP, 1990, CLIN PHARMACOL THER, V48, P148, DOI 10.1038/clpt.1990.129
   Gruenwald C, 2000, PERFUSION-UK, V15, P203, DOI 10.1177/026765910001500304
   Guzzetta NA, 2010, ANESTH ANALG, V111, P173, DOI 10.1213/ANE.0b013e3181e13470
   Hetzer R, 2011, J THORAC CARDIOV SUR, V141, P616, DOI 10.1016/j.jtcvs.2010.06.066
   Hetzer Roland, 2006, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P99
   Hirsh J, 2004, CHEST, V126, P188
   HUANG ZF, 1993, J BIOL CHEM, V268, P26950
   Kelton J., 2005, CHEST, V127, P9
   Koster A, 2007, ANN THORAC SURG, V83, P1865, DOI 10.1016/j.athoracsur.2006.11.051
   Kuhle S, 2007, HAEMATOL-HEMATOL J, V92, P554, DOI 10.3324/haematol.10696
   Lequier LL, 2012, ECMO EXTRACORPOREAL, P157
   Male C, 1999, CLIN LAB MED, V19, P39
   Martindale SJ, 1996, J CARDIOTHOR VASC AN, V10, P458, DOI 10.1016/S1053-0770(05)80004-7
   Miller BE, 1997, ANESTH ANALG, V84, P745, DOI 10.1097/00000539-199704000-00008
   Monagle P, 2004, HEART, V90, P808, DOI 10.1136/hrt.2003.024299
   Monagle P, 2008, CHEST, V133, P887
   Nankervis CA, 2007, ASAIO J, V53, P111, DOI 10.1097/01.mat.0000247777.65764.b3
   Olson JD, 1998, ARCH PATHOL LAB MED, V122, P782
   Peek GJ, 1999, ASAIO J, V45, P250, DOI 10.1097/00002480-199907000-00003
   POLLOCK ME, 1995, THROMB HAEMOSTASIS, V73, P936
   PRATT CW, 1991, SEMIN HEMATOL, V28, P3
   Raymond PD, 2003, PERFUSION-UK, V18, P277, DOI 10.1191/0267659103pf673oa
   SCHMIDT B, 1989, PEDIATR RES, V25, P405, DOI 10.1203/00006450-198904000-00020
   SCHMIDT B, 1995, PEDIATRICS, V96, P939
   Scott LK, 2006, PEDIATR CRIT CARE ME, V7, P473, DOI 10.1097/01.PCC.0000231946.88688.07
   Shapiro A, 1995, SEMIN HEMATOL, V32, P33
   Thureen PJ, 1990, 2 ANN M ELSO
   Urlesberger B, 1996, J PEDIATR-US, V129, P264, DOI 10.1016/S0022-3476(96)70252-4
   Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676
   Warkentin TE, 2005, J LAB CLIN MED, V146, P341, DOI 10.1016/j.lab.2005.08.003
   WU YI, 1994, BLOOD COAGUL FIBRIN, V5, P83, DOI 10.1097/00001721-199402000-00012
   Yeh T, 2005, PROG PEDIATR CARDIOL, V21, P87
   Young G, 2004, PERFUSION-UK, V19, P283, DOI 10.1191/0267659104pf759oa
   Young G, 2008, HEMATOL-AM SOC HEMAT, V208, P245
   Young G, 2007, BLOOD COAGUL FIBRIN, V18, P547, DOI 10.1097/MBC.0b013e328201c9a9
NR 48
TC 20
Z9 20
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1529-7535
EI 1947-3893
J9 PEDIATR CRIT CARE ME
JI Pediatr. Crit. Care Med.
PD JUN
PY 2013
VL 14
IS 5
SU S
BP S37
EP S42
DI 10.1097/PCC.0b013e318292dfa7
PG 6
WC Critical Care Medicine; Pediatrics
SC General & Internal Medicine; Pediatrics
GA AI0EP
UT WOS:000336519300007
PM 23735984
DA 2018-10-20
ER

PT J
AU Thakkar, S
   Ghebes, CA
   Ahmed, M
   Kelder, C
   van Blitterswijk, CA
   Saris, D
   Fernandes, HAM
   Moroni, L
AF Thakkar, Shraddha
   Ghebes, Corina A.
   Ahmed, Maqsood
   Kelder, Cindy
   van Blitterswijk, Clemens A.
   Saris, Daniel
   Fernandes, Hugo A. M.
   Moroni, Lorenzo
TI Mesenchymal stromal cell-derived extracellular matrix influences gene
   expression of chondrocytes
SO BIOFABRICATION
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; STEM-CELLS; IN-VITRO;
   ARTICULAR-CARTILAGE; HEART-VALVES; ADIPOSE-TISSUE; II COLLAGEN;
   DIFFERENTIATION; OSTEOARTHRITIS; SCAFFOLDS
AB Decellularized extracellular matrix (ECM) has recently gained a lot of interest as an instructive biomaterial for regenerative medicine applications. In this study, the ability of adult human mesenchymal stem cell (hMSC)-derived ECM to rescue the phenotype of osteoarthritic (OA) chondrocytes and to further stimulate the differentiation of healthy (HL) chondrocytes was evaluated. ECMs were prepared by decellularizing hMSCs cultured in basic medium (BM) and chondrogenic medium (CM). The obtained ECM was then combined with a polymeric solution of Poly (e-caprolactone) (PCL) dissolved in 1, 1, 1, 3, 3, 3-hexafluoro-2-propanol (HFIP) and electrospun meshes were fabricated. Electrospun ECM scaffolds were characterized using scanning electron microscopy (SEM) and picrosirius red staining was used to confirm the presence of collagen. OA and HL chondrocytes were cultured on scaffolds containing hMSC ECM in BM or CM and compared to PCL electrospun scaffolds without ECM. Metabolic activity and chondrogenic gene expression were assessed by Alamar blue assay and quantitative PCR (qPCR) analysis, respectively. The ECM presence resulted in a significant difference in chondrocyte metabolic activity compared to PCL scaffolds alone. HL chondrocytes cultured for 21 days in chondrogenic medium on electrospun scaffolds containing hMSC ECM from BM showed a significant increase in collagen II and aggrecan expression compared to hMSC ECM from CM and PCL scaffolds without ECM incorporation. No significant influence of hMSC ECM presence on the chondrogenic signature of OA chondrocytes was found. The influence of decellularized hMSC ECM on HL chondrocytes suggests that hMSC-derived ECM scaffolds are promising candidates for cartilage tissue engineering applications.
C1 [Thakkar, Shraddha; Ghebes, Corina A.; Ahmed, Maqsood; Kelder, Cindy; van Blitterswijk, Clemens A.; Saris, Daniel; Fernandes, Hugo A. M.; Moroni, Lorenzo] Univ Twente, Tissue Regenerat Dept, NL-7522 NB Enschede, Netherlands.
RP Thakkar, S (reprint author), Univ Twente, Tissue Regenerat Dept, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.
EM l.moroni@utwente.nl
RI Fernandes, Hugo/H-6192-2014; Moroni, Lorenzo/D-2826-2014
OI Fernandes, Hugo/0000-0002-4574-7648; Moroni,
   Lorenzo/0000-0003-1298-6025; van Blitterswijk,
   Clemens/0000-0003-2371-4615
CR Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011
   Arenas-Herrera JE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014106
   ARSENAULT AL, 1987, J MICROSC-OXFORD, V145, P357
   Badylak S, 2008, TISSUE ENG
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/1076327042500427
   Bertipaglia B, 2003, ANN THORAC SURG, V75, P1274, DOI 10.1016/S0003-4975(02)04706-9
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bhati RS, 2001, J BIOMED MATER RES, V56, P74, DOI 10.1002/1097-4636(200107)56:1<74::AID-JBM1070>3.0.CO;2-M
   Bi WM, 1999, NAT GENET, V22, P85
   Bissell M J, 1995, DEV BIOL, V6, P149
   Blair-Levy JM, 2008, ARTHRITIS RHEUM, V58, P1096, DOI 10.1002/art.23277
   Both SK, 2007, TISSUE ENG, V13, P3, DOI 10.1089/ten.2005.0513
   Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chang C-H, 2005, BIOMED ENG-APP BAS C, V17, P1, DOI DOI 10.4015/S101623720500010X
   Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725
   Cheng HW, 2009, TISSUE ENG PART C-ME, V15, P697, DOI [10.1089/ten.tec.2008.0635, 10.1089/ten.TEC.2008.0635]
   Choi JS, 2012, TISSUE ENG PT A, V18, P80, DOI 10.1089/ten.tea.2011.0103
   Choi KH, 2010, BIOMATERIALS, V31, P5355, DOI 10.1016/j.biomaterials.2010.03.053
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Danisovic L., 2007, J APPL BIOMED, V5, P139
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   DODGE GR, 1989, J CLIN INVEST, V83, P647, DOI 10.1172/JCI113929
   Eslaminejad MB, 2010, IRAN J BASIC MED SCI, V13, P187
   Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073
   Galois L, 2005, PATHOL BIOL, V53, P590, DOI 10.1016/j.patbio.2004.12.019
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Havlas V, 2011, ACTA CHIR ORTHOP TR, V78, P138
   HIPPESANWALD S, 1993, MICROSC RES TECHNIQ, V24, P400, DOI 10.1002/jemt.1070240506
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Hong Y, 2011, BIOMATERIALS, V32, P3387, DOI 10.1016/j.biomaterials.2011.01.025
   Hoshiba T, 2007, BIOCHEM BIOPH RES CO, V359, P151, DOI 10.1016/j.bbrc.2007.05.079
   Hoshiba T, 2011, BIOTECHNOL PROGR, V27, P788, DOI 10.1002/btpr.592
   Huang K, 2008, J INT MED RES, V36, P1149, DOI 10.1177/147323000803600601
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Kasimir MT, 2005, THROMB HAEMOSTASIS, V94, P562, DOI 10.1160/TH05-01-0025
   Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243
   Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Lichtenberg A, 2006, BIOMATERIALS, V27, P4221, DOI 10.1016/j.biomaterials.2006.03.047
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lorenz H, 2006, PROG HISTOCHEM CYTO, V40, P135, DOI 10.1016/j.proghi.2006.02.003
   Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091
   Martinez-Alvernia E A, 2008, HEAD NECK SURG, V138, P435
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McFetridge PS, 2004, J BIOMED MATER RES A, V70A, P224, DOI 10.1002/jbm.a.30060
   Moroni L, 2007, TISSUE ENG, V13, P361, DOI 10.1089/ten.2006.0127
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Mullen P, 2004, METH MOLEC MED, V88, P287
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007
   Pelttari K, 2009, SWISS MED WKLY, V139, P602, DOI smw-12742
   Postovit LM, 2006, STEM CELLS, V24, P501, DOI 10.1634/stemcells.2005-0459
   Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014
   Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97
   ROJKIND M, 1980, J CELL BIOL, V87, P255, DOI 10.1083/jcb.87.1.255
   Roy I, 2004, BIOTECHNOL APPL BIOC, V39, P165, DOI 10.1042/BA20030133
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Sekiya I, 2001, J ENDOCRINOL, V169, P573, DOI 10.1677/joe.0.1690573
   Shores Jaimie T, 2007, Adv Skin Wound Care, V20, P493, DOI 10.1097/01.ASW.0000288217.83128.f3
   Sodek KL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-223
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Tedder ME, 2011, TISSUE ENG PT A, V17, P25, DOI [10.1089/ten.tea.2010.0138, 10.1089/ten.TEA.2010.0138]
   Tortelli F, 2009, EUR CELLS MATER, V17, P1
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wainwright David, 1996, Journal of Burn Care and Rehabilitation, V17, P124, DOI 10.1097/00004630-199603000-00006
   Wan Y, 2008, POLYM DEGRAD STABIL, V93, P1736, DOI 10.1016/j.polymdegradstab.2008.08.001
   Xu B, 2011, INT J BIOMATER, DOI 10.1155/2011/172389
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
NR 86
TC 10
Z9 10
U1 2
U2 35
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2013
VL 5
IS 2
AR 025003
DI 10.1088/1758-5082/5/2/025003
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 133PA
UT WOS:000318149900004
PM 23443652
DA 2018-10-20
ER

PT J
AU Phelps, EA
   Headen, DM
   Taylor, WR
   Thule, PM
   Garcia, AJ
AF Phelps, Edward A.
   Headen, Devon M.
   Taylor, W. Robert
   Thule, Peter M.
   Garcia, Andres J.
TI Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet
   engraftment and function in type 1 diabetes
SO BIOMATERIALS
LA English
DT Article
DE Polyethylene glycol; Islet; Hydrogel; Transplantation; Angiogenesis;
   VEGF
ID GROWTH-FACTOR PRODUCTION; FACTOR GENE DELIVERY; CELL TRANSPLANTATION;
   POLY(ETHYLENE GLYCOL); INSULIN-SECRETION; BLOOD PERFUSION; GRAFT
   FUNCTION; RAT ISLETS; REVASCULARIZATION; VASCULARIZATION
AB Type 1 diabetes (T1DM) affects one in every 400 children and adolescents in the US. Due to the limitations of exogenous insulin therapy and whole pancreas transplantation, pancreatic islet transplantation has emerged as a promising therapy for T1DM. However, this therapy is severely limited by donor islet availability and poor islet engraftment and function. We engineered an injectable bio-synthetic, polyethylene glycol-maleimide hydrogel to enhance vascularization and engraftment of transplanted pancreatic islets in a mouse model of T1DM. Controlled presentation of VEGF-A and cell-adhesive peptides within this engineered material significantly improved the vascularization and function of islets delivered to the small bowel mesentery, a metabolically relevant site for insulin release. Diabetic mice receiving islets transplanted in proteolytically degradable hydrogels incorporating VEGF-A exhibited complete reversal of diabetic hyperglycemia with a 40% reduction in the number of islets required. Furthermore, hydrogel-delivered islets significantly improved weight gain, regulation of a glucose challenge, and intra-islet vascularization and engraftment compared to the clinical standard of islet infusion through the hepatic portal vein. This study establishes a simple biomaterial strategy for islet transplantation to promote enhanced islet engraftment and function. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Phelps, Edward A.; Headen, Devon M.; Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Phelps, Edward A.; Headen, Devon M.; Taylor, W. Robert; Thule, Peter M.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Taylor, W. Robert] Emory Univ, Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.
   [Taylor, W. Robert] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA.
   [Taylor, W. Robert] Atlanta Vet Affairs Med Ctr, Div Cardiol, Decatur, GA 30033 USA.
   [Thule, Peter M.] Emory Univ, Sch Med, Div Endocrinol & Metab, Atlanta, GA 30322 USA.
   [Thule, Peter M.] Atlanta Vet Affairs Med Ctr, Div Endocrinol Metab & Lipids, Decatur, GA 30033 USA.
RP Garcia, AJ (reprint author), 2310 IBB Bldg,315 Ferst Dr, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Phelps, Edward/Q-1302-2016
OI Phelps, Edward/0000-0001-8666-805X
FU Georgia Tech/Emory Center for the Engineering of Living Tissues; Atlanta
   Clinical and Translational Science Institute under PHS Grant from the
   Clinical and Translational Science Award Program [UL RR025008]; Center
   for Pediatric Healthcare Technology Innovation at Georgia Tech and
   Children's Hospital of Atlanta; VA Merit Review; NIH NIDDK [R01
   DK076801-01]; JDRF
FX This work was funded by the Georgia Tech/Emory Center for the
   Engineering of Living Tissues and the Atlanta Clinical and Translational
   Science Institute under PHS Grant UL RR025008 from the Clinical and
   Translational Science Award Program; the Center for Pediatric Healthcare
   Technology Innovation at Georgia Tech and Children's Hospital of
   Atlanta; a VA Merit Review; NIH NIDDK R01 DK076801-01; JDRF.
CR Azzi J, 2010, EXPERT REV CLIN IMMU, V6, P111, DOI 10.1586/ECI.09.67
   Ballian N, 2007, WORLD J SURG, V31, P705, DOI 10.1007/s00268-006-0719-8
   Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063
   Brissova M, 2008, DIABETES, V57, P2269, DOI 10.2337/db08-0814
   Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690
   Cantarelli E, 2011, CURR DIABETES REP, V11, P364, DOI 10.1007/s11892-011-0216-9
   Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0
   Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Cheng K, 2004, GENE THER, V11, P1105, DOI 10.1038/sj.gt.3302267
   Cheng Y, 2007, WORLD J GASTROENTERO, V13, P2862
   Chow LW, 2010, BIOMATERIALS, V31, P6154, DOI 10.1016/j.biomaterials.2010.04.002
   Cizza G, 2012, J ENDOCRINOL INVEST, V35, P541, DOI 10.3275/8411
   Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716
   Figliuzzi M, 2009, TRANSPL P, V41, P1797, DOI 10.1016/j.transproceed.2008.11.015
   Gibly RF, 2011, DIABETOLOGIA, V54, P2494, DOI 10.1007/s00125-011-2243-0
   Gibly RF, 2011, BIOMATERIALS, V32, P9677, DOI 10.1016/j.biomaterials.2011.08.084
   Giraldo Jaime A, 2010, J Diabetes Sci Technol, V4, P1238
   Gupta R, 2011, TISSUE ENG PT A, V17, P2005, DOI [10.1089/ten.tea.2010.0542, 10.1089/ten.TEA.2010.0542]
   Henriksnas J, 2012, DIABETES, V61, P665, DOI 10.2337/db10-0895
   Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4
   Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198
   Kaufman-Francis K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040741
   Lakey JRT, 2006, METH MOL B, V333, P47
   Lau J, 2012, DIABETOLOGIA, V55, P1390, DOI 10.1007/s00125-012-2476-6
   Lee DY, 2007, BIOMATERIALS, V28, P1957, DOI 10.1016/j.biomaterials.2006.12.015
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Narang AS, 2004, PHARM RES, V21, P15, DOI 10.1023/B:PHAM.0000012147.52900.b8
   Olerud J, 2008, DIABETES, V57, P1870, DOI 10.2337/db07-0724
   Olsson R, 2006, INT J BIOCHEM CELL B, V38, P492, DOI 10.1016/j.biocel.2005.06.021
   Patterson J, 2011, BIOMATERIALS, V32, P1301, DOI 10.1016/j.biomaterials.2010.10.016
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Rickels MR, 2005, DIABETES, V54, P3205, DOI 10.2337/diabetes.54.11.3205
   Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425
   Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Shapiro AMJ, 2011, CURR OPIN ORGAN TRAN, V16, P627, DOI 10.1097/MOT.0b013e32834cfb84
   Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8
   Sigrist S, 2003, CELL TRANSPLANT, V12, P627, DOI 10.3727/000000003108747109
   Stendahl JC, 2008, TRANSPLANTATION, V86, P478, DOI 10.1097/TP.0b013e3181806d9d
   Su DM, 2007, DIABETES, V56, P2274, DOI 10.2337/db07-0371
   Vaithilingam V, 2008, CURR OPIN ORGAN TRAN, V13, P633, DOI 10.1097/MOT.0b013e328317a48b
   Weber LM, 2007, CELL TRANSPLANT, V16, P1049, DOI 10.3727/000000007783472336
   Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001
   Webster R, 2007, DRUG METAB DISPOS, V35, P9, DOI 10.1124/dmd.106.012419
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432
   Yin N, 2011, TRANSPLANTATION, V92, P25, DOI 10.1097/TP.0b013e31821d2661
   Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 50
TC 68
Z9 71
U1 5
U2 80
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2013
VL 34
IS 19
BP 4602
EP 4611
DI 10.1016/j.biomaterials.2013.03.012
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135CE
UT WOS:000318262800006
PM 23541111
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Das, B
   Mandal, M
   Upadhyay, A
   Chattopadhyay, P
   Karak, N
AF Das, Beauty
   Mandal, Manabendra
   Upadhyay, Aadesh
   Chattopadhyay, Pronobesh
   Karak, Niranjan
TI Bio-based hyperbranched polyurethane/Fe3O4 nanocomposites: smart
   antibacterial biomaterials for biomedical devices and implants
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; SEED OIL; STAPHYLOCOCCUS-AUREUS; POLYMERS;
   RESINS
AB The fabrication of a smart magnetically controllable bio-based polymeric nanocomposite (NC) has immense potential in the biomedical domain. In this context, magneto-thermoresponsive sunflower oil modified hyperbranched polyurethane (HBPU)/Fe3O4 NCs with different wt.% of magnetic nanoparticles (Fe3O4) were prepared by an in situ polymerization technique. Fourier-transform infrared, x-ray diffraction, vibrating sample magnetometer, scanning electron microscope, transmission electron microscope, thermal analysis and differential scanning calorimetric were used to analyze various physico-chemical structural attributes of the prepared NC. The results showed good interfacial interactions between HBPU and well-dispersed superparamagnetic Fe3O4, with an average diameter of 7.65 nm. The incorporation of Fe3O4 in HBPU significantly improved the thermo-mechanical properties along with the shape-memory behavior, antibacterial activity, biocompatibility as well as biodegradability in comparison to the pristine system. The cytocompatibility of the degraded products of the NC was also verified by in vitro hemolytic activity and MTT assay. In addition, the in vivo biocompatibility and non-immunological behavior, as tested in Wistar rats after subcutaneous implantation, show promising signs for the NC to be used as antibacterial biomaterial for biomedical device and implant applications.
C1 [Das, Beauty; Karak, Niranjan] Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
   [Mandal, Manabendra] Tezpur Univ, Tezpur 784028, Assam, India.
   [Upadhyay, Aadesh; Chattopadhyay, Pronobesh] Def Res Lab, Tezpur 784001, Assam, India.
RP Karak, N (reprint author), Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
EM karakniranjan@yahoo.com
RI Karak, Niranjan/A-1030-2014
OI Karak, Niranjan/0000-0002-3402-9536
FU UGC [F16-1884(SC)/2010(SA-III)]; SAP (UGC), Indian [F.3-30/2009(SAP-II)]
FX The authors express their gratitude to UGC for providing financial
   assistance through RGNF via, sanction no F16-1884(SC)/2010(SA-III) dated
   18/7/2011 and SAP (UGC), Indian through grant no. F.3-30/2009(SAP-II).
   The authors also acknowledge DRL, Tezpur, Assam and CIF, IIT, Guwahati
   for extending their help with instruments.
CR Adhikari R, 2008, BIOMATERIALS, V29, P3762, DOI 10.1016/j.biomaterials.2008.06.021
   Ajili SH, 2009, ACTA BIOMATER, V5, P1519, DOI 10.1016/j.actbio.2008.12.014
   Anzai Y, 2003, RADIOLOGY, V228, P777, DOI 10.1148/radiol.2283020892
   Arya A, 2008, PACE, V31, P597, DOI 10.1111/j.1540-8159.2008.01047.x
   Ashjari M, 2010, J INORG ORGANOMET P, V20, P213, DOI 10.1007/s10904-010-9337-x
   Bumb A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/33/335601
   Cai Y, 2013, J APPL POLYM SCI, V127, P49, DOI 10.1002/app.36849
   Das B., 2012, MACROMOL BIOSCI, V13, P126
   Deka G, 2009, J MACROMOL SCI A, V46, P1128, DOI 10.1080/10601320903245474
   Deka H, 2010, CARBON, V48, P2013, DOI 10.1016/j.carbon.2010.02.009
   Deka H, 2010, J APPL POLYM SCI, V116, P106, DOI 10.1002/app.31516
   Dutta N, 2004, PROG ORG COAT, V49, P146, DOI 10.1016/j.porgcoat.2003.09.005
   Dutta S, 2006, POLYM INT, V55, P49, DOI 10.1002/pi.1914
   Guo Z., 2007, J APPL PHYS, V101
   Guo ZH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/33/335704
   Guo ZH, 2008, COMPOS SCI TECHNOL, V68, P1513, DOI 10.1016/j.compscitech.2007.10.018
   Hafeman AE, 2008, PHARM RES-DORDR, V25, P2387, DOI 10.1007/s11095-008-9618-z
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Hassan MS, 2012, J BIOMED NANOTECHNOL, V8, P394, DOI 10.1166/jbn.2012.1393
   Jin SH, 2007, COMPOS SCI TECHNOL, V67, P3434, DOI 10.1016/j.compscitech.2007.03.013
   Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j
   Kim DK, 2001, SCRIPTA MATER, V44, P1713, DOI 10.1016/S1359-6462(01)00870-3
   Konwarh R, 2010, COLLOID SURFACE B, V81, P578, DOI 10.1016/j.colsurfb.2010.07.062
   LAMBA NMK, 1998, POLYURETHANES BIOMED, P5
   Lastbom L, 2003, SCAND J WORK ENV HEA, V29, P152, DOI 10.5271/sjweh.717
   Li Z, 2013, BIOMED MATER, V8
   Meenach SA, 2009, J BIOMED MATER RES A, V91A, P903, DOI 10.1002/jbm.a.32322
   Mihaiescu DE, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015007
   Mitry RR, 2003, CELL TRANSPLANT, V12, P69, DOI 10.3727/000000003783985197
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   Nair DG, 2007, BIOCHEM J, V402, P93, DOI 10.1042/BJ20060318
   Santos CM, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/39/395101
   Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358
   Sun J, 2007, J BIOMED MATER RES A, V80A, P333, DOI 10.1002/jbm.a.30909
   Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518
   Tran N, 2010, INT J NANOMED, V5, P277
   Turkoglu A, 2007, FOOD CHEM, V101, P267, DOI 10.1016/j.foodchem.2006.01.025
   Welham NJ, 2000, J MATER RES, V15, P2400, DOI 10.1557/JMR.2000.0345
   Zeng XB, 2012, INT J NANOMED, V7, P3365, DOI 10.2147/IJN.S32264
   Zhang DJ, 1998, PHYS REV B, V58, P14167, DOI 10.1103/PhysRevB.58.14167
   Zhou YF, 2010, ADV MATER, V22, P4567, DOI 10.1002/adma.201000369
NR 41
TC 41
Z9 41
U1 4
U2 131
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2013
VL 8
IS 3
AR 035003
DI 10.1088/1748-6041/8/3/035003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134LV
UT WOS:000318212600004
PM 23532037
DA 2018-10-20
ER

PT J
AU Li, JF
   Zheng, QX
   Guo, XD
   Zou, ZW
   Liu, YD
   Lan, SH
   Chen, LB
   Deng, Y
AF Li, Jingfeng
   Zheng, Qixin
   Guo, Xiaodong
   Zou, Zhenwei
   Liu, Yudong
   Lan, Shenghui
   Chen, Liaobin
   Deng, Yu
TI Bone induction by surface-double-modified true bone ceramics in vitro
   and in vivo
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID SIMULATED BODY-FLUID; APATITE FORMATION; MORPHOGENETIC PROTEIN-2; BOVINE
   HYDROXYAPATITE; BMP-2-RELATED PEPTIDE; TRICALCIUM PHOSPHATE; BIOMIMETIC
   PROCESS; ORGANIC POLYMERS; SILANOL GROUPS; STEM-CELLS
AB True bone ceramic (TBC), obtained by twice sintering fresh bovine cancellous bone at high temperatures, is an osteoconductive and bioactive bone substitute material that exhibits excellent biocompatibility with hard tissue. The authors have previously synthesized a novel BMP-2-related peptide, P24, and found that it could enhance the osteoblastic differentiation of cells. The objective of the present study was to construct a double-modified TBC via mineralization into simulated body fluid and P24 incorporation for enhanced bone formation. In vitro experiments revealed that surface mineralization-modified (SMM) TBC scaffolds demonstrated efficiency for sustained release of P24. The P24/SMM-TBC composite exhibited increased osteogenic activity by cell adhesion rate determination, MTT assay, alkaline phosphatase staining, and calcium nodule staining with alizarin red compared with SMM-TBC and TBC. In vivo studies showed that the P24/SMM-TBC composite scaffold promoted significant bone defect repair, in marked contrast to stand-alone SMM-TBC and TBC, based on the results of radiographic evaluation and histological examination. These findings indicate that SMM-TBC is a good scaffold for the controlled release of P24 and that the P24/SMM-TBC composite could improve the adhesion, proliferation and differentiation of cells and repair bone defects. The double-modified P24/SMM-TBC composite biomaterial shows potential for clinical application in bone tissue engineering.
C1 [Li, Jingfeng; Chen, Liaobin; Deng, Yu] Wuhan Univ, Dept Orthoped, Zhongnan Hosp, Wuhan 430071, Peoples R China.
   [Zheng, Qixin; Guo, Xiaodong; Zou, Zhenwei; Liu, Yudong; Lan, Shenghui] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Orthoped, Union Hosp, Wuhan 430074, Peoples R China.
RP Li, JF (reprint author), Wuhan Univ, Dept Orthoped, Zhongnan Hosp, Wuhan 430071, Peoples R China.
EM hbjfeng@163.com
RI guo, xiaodong/K-2600-2013
FU '863' Key Project of the National High Technology Research and
   Development Program of China [2006AA02A124]; Program for New Century
   Excellent Talents in University from the Ministry of Education of China
   [NCET-05-0647]; National Natural Sciences Foundation of China [30973027,
   81171159]
FX This work was financially supported by the '863' Key Project of the
   National High Technology Research and Development Program of China
   (grant no 2006AA02A124), the Program for New Century Excellent Talents
   in University from the Ministry of Education of China (NCET-05-0647),
   the National Natural Sciences Foundation of China (nos 30973027,
   81171159).
CR Arvidsson A, 2009, J MATER SCI-MATER M, V20, P1869, DOI 10.1007/s10856-009-3755-8
   Bodde EWH, 2008, J BIOMED MATER RES A, V85A, P206, DOI 10.1002/jbm.a.31549
   Cestari TM, 2009, CLIN ORAL IMPLAN RES, V20, P340, DOI 10.1111/j.1600-0501.2008.01659.x
   Chang MC, 2002, BIOMATERIALS, V23, P3879, DOI 10.1016/S0142-9612(02)00133-3
   Culpepper BK, 2010, BIOMATERIALS, V31, P9586, DOI 10.1016/j.biomaterials.2010.08.020
   Duan ZX, 2008, J HUAZHONG U SCI-MED, V28, P426, DOI 10.1007/s11596-008-0411-3
   Garreta E, 2007, BIOMOL ENG, V24, P75, DOI 10.1016/j.bioeng.2006.05.017
   Hao W, 2010, INT ORTHOP, V34, P1341, DOI 10.1007/s00264-009-0946-3
   HEIPLE KG, 1963, J BONE JOINT SURG AM, V45, P1593, DOI 10.2106/00004623-196345080-00003
   Herliansyah MK, 2009, MAT SCI ENG C-BIO S, V29, P1674, DOI 10.1016/j.msec.2009.01.007
   Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936
   Kawai T, 2007, J MATER SCI-MATER M, V18, P1037, DOI 10.1007/s10856-006-0081-2
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kim SJ, 2007, CYTOTECHNOLOGY, V54, P115, DOI 10.1007/s10616-007-9084-1
   Kokubo T, 2005, MAT SCI ENG C-BIO S, V25, P97, DOI 10.1016/j.msec.2005.01.002
   Kokubo T, 1999, MATER SCI FORUM, V293, P65, DOI 10.4028/www.scientific.net/MSF.293.65
   Lee HU, 2011, J NANOSCI NANOTECHNO, V11, P7100, DOI 10.1166/jnn.2011.4867
   Li Jingfeng, 2012, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V29, P474
   Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439
   Li JF, 2010, MAT SCI ENG C-MATER, V30, P1272, DOI 10.1016/j.msec.2010.07.011
   Li R, 2009, J ORTHOP RES, V27, P8, DOI 10.1002/jor.20658
   Lin FH, 1999, BIOMATERIALS, V20, P475, DOI 10.1016/S0142-9612(98)00193-8
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Lozano D, 2009, ENDOCRINOLOGY, V150, P2027, DOI 10.1210/en.2008-1108
   Minamide A, 2004, J ORTHOP SCI, V9, P142, DOI 10.1007/s00776-003-0749-0
   Moutzouri AG, 2011, ANN BIOMED ENG, V39, P730, DOI 10.1007/s10439-010-0188-y
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Oyane A, 1999, J BIOMED MATER RES, V47, P367, DOI 10.1002/(SICI)1097-4636(19991205)47:3<367::AID-JBM11>3.0.CO;2-A
   Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Rahimzadeh R, 2012, ACTA CIR BRAS, V27, P148, DOI 10.1590/S0102-86502012000200009
   Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1, DOI 10.2106/00004623-200100001-00001
   Rouhi AM, 1999, CHEM ENG NEWS, V77, P51, DOI 10.1021/cen-v077n003.p051
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Schliephake H, 2002, INT J ORAL MAX SURG, V31, P469, DOI 10.1054/ijom.2002.0244
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   TANAHASHI M, 1994, J APPL BIOMATER, V5, P339, DOI 10.1002/jab.770050409
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   Tsai WC, 2010, J ORTHOP SCI, V15, P223, DOI 10.1007/s00776-009-1441-9
   Lluch AV, 2009, COLLOID SURFACE B, V70, P218, DOI 10.1016/j.colsurfb.2008.12.027
   Villavicencio AT, 2005, J NEUROSURG-SPINE, V3, P436, DOI 10.3171/spi.2005.3.6.0436
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   YANG CY, 1994, CLIN ORTHOP RELAT R, P286
   Zhang YY, 2012, BIOMATERIALS, V33, P2926, DOI 10.1016/j.biomaterials.2012.01.006
   Zhou DS, 2006, J BIOACT COMPAT POL, V21, P373, DOI 10.1177/0883911506068554
NR 51
TC 10
Z9 10
U1 2
U2 34
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2013
VL 8
IS 3
AR 035005
DI 10.1088/1748-6041/8/3/035005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134LV
UT WOS:000318212600006
PM 23532088
DA 2018-10-20
ER

PT J
AU Brown, PT
   Handorf, AM
   Jeon, WB
   Li, WJ
AF Brown, Patrick T.
   Handorf, Andrew M.
   Jeon, Won Bae
   Li, Wan-Ju
TI Stem Cell-based Tissue Engineering Approaches for Musculoskeletal
   Regeneration
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Tissue engineering; musculoskeletal tissues; biomaterial scaffolds; stem
   cell regulation; oxygen; growth factors; extracellular matrix
ID HUMAN EMBRYONIC STEM; HUMAN BONE-MARROW; MESENCHYMAL STROMAL CELLS;
   EX-VIVO EXPANSION; BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; CANONICAL
   WNT/BETA-CATENIN; MATRIX-MEDIATED RETENTION; FIBROBLAST-GROWTH-FACTOR;
   REDUCED OXYGEN-TENSION; MAINTAINS SELF-RENEWAL
AB The field of regenerative medicine and tissue engineering is an ever evolving field that holds promise in treating numerous musculoskeletal diseases and injuries. An important impetus in the development of the field was the discovery and implementation of stem cells. The utilization of mesenchymal stem cells, and later embryonic and induced pluripotent stem cells, opens new arenas for tissue engineering and presents the potential of developing stem cell-based therapies for disease treatment. Multipotent and pluripotent stem cells can produce various lineage tissues, and allow for derivation of a tissue that may be comprised of multiple cell types. As the field grows, the combination of biomaterial scaffolds and bioreactors provides methods to create an environment for stem cells that better represent their microenvironment for new tissue formation. As technologies for the fabrication of biomaterial scaffolds advance, the ability of scaffolds to modulate stem cell behavior advances as well. The composition of scaffolds could be of natural or synthetic materials and could be tailored to enhance cell self-renewal and/or direct cell fates. In addition to biomaterial scaffolds, studies of tissue development and cellular microenvironments have determined other factors, such as growth factors and oxygen tension, that are crucial to the regulation of stem cell activity. The overarching goal of stem cell-based tissue engineering research is to precisely control differentiation of stem cells in culture. In this article, we review current developments in tissue engineering, focusing on several stem cell sources, induction factors including growth factors, oxygen tension, biomaterials, and mechanical stimulation, and the internal and external regulatory mechanisms that govern proliferation and differentiation.
C1 [Brown, Patrick T.; Handorf, Andrew M.; Li, Wan-Ju] Univ Wisconsin, Lab Musculoskeletal Biol & Regenerat Med, Dept Orthoped & Rehabil, Sch Med & Publ Hlth, Madison, WI USA.
   [Brown, Patrick T.] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI USA.
   [Handorf, Andrew M.; Li, Wan-Ju] Univ Wisconsin, Dept Biomed Engn, Sch Engn, Madison, WI USA.
   [Jeon, Won Bae] Daegu Gyeongbuk Inst Sci & Technol, Lab Biochem & Cellular Engn, Div NanoBio Technol, Taegu 711873, South Korea.
RP Li, WJ (reprint author), Wisconsin Inst Med Res, 1111 Highland Ave,Room 5051, Madison, WI 53705 USA.
EM wbjeon@dgist.ac.kr; li@ortho.wisc.edu
OI Li, Wan-Ju/0000-0002-6579-8063
FU Ministry of Education, Science and Technology of the Republic of Korea
   [11-BD-02]
FX This work was supported in part by the Biodefense Fund (Project No.
   11-BD-02) to WBJ from the Ministry of Education, Science and Technology
   of the Republic of Korea.
CR Adesida AB, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt100
   Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002
   Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293
   Baer PC, 2012, STEM CELLS INT, DOI 10.1155/2012/812693
   Bai XW, 2004, BIOCHEM BIOPH RES CO, V325, P453, DOI 10.1016/j.bbrc.2004.10.055
   Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21907
   Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533
   Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0
   Barber JG, 2011, TISSUE ENG A
   Barhanpurkar AP, 2012, BIOCHEM BIOPH RES CO, V418, P669, DOI 10.1016/j.bbrc.2012.01.074
   Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740
   BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0
   Bernardo ME, 2012, ANN NY ACAD SCI, V1266, P107, DOI 10.1111/j.1749-6632.2012.06667.x
   Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1
   Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284
   Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679
   Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x
   Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351
   Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020
   Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533
   Brown SE, 2009, CELLS TISSUES ORGANS, V189, P256, DOI 10.1159/000151746
   Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503
   Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chang CH, 2008, ARTIF ORGANS, V32, P561, DOI 10.1111/j.1525-1594.2008.00575.x
   Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200
   Charwat S, 2008, EXP HEMATOL, V36, P672, DOI 10.1016/j.exphem.2008.01.005
   Chen HF, 2010, TISSUE ENG PT A, V16, P2901, DOI 10.1089/ten.tea.2009.0722
   Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133
   Chen TS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-47
   Chen WC, 2012, J TISSUE ENG REGEN M
   Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021
   Cheng XJ, 2012, CELLS TISSUES ORGANS, V196, P56, DOI 10.1159/000330791
   Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008
   CIPOLLESCHI MG, 1993, BLOOD, V82, P2031
   Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938
   Coluet J, 2009, DRUG DISCOV TODAY, V14, P913, DOI 10.1016/j.drudis.2009.07.012
   Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   D'Alimonte I, 2011, J BIOL REG HOMEOS AG, V25, P57
   D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Das B, 2012, STEM CELLS, V30, P1685, DOI 10.1002/stem.1142
   Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109
   Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538
   Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214
   Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dupree MA, 2006, BIOPHYS J, V91, P3097, DOI 10.1529/biophysj.106.087098
   Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128
   Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908
   Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172
   Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102
   Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x
   Ferreira MSV, 2012, BIOMATERIALS, V33, P6987, DOI 10.1016/j.biomaterials.2012.06.029
   Folkman J, 2000, NAT REV MOL CELL BIO, V1, P76, DOI 10.1038/35036100
   Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300
   Furth ME, 2008, PRINCIPLES REGENERAT, P2
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Gomez DE, 2012, INT J ONCOL
   Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054
   Gu ZF, 2012, CELL SIGNAL, V24, P2307, DOI 10.1016/j.cellsig.2012.07.012
   Handorf AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022887
   Handschel Jorg, 2008, Head Face Med, V4, P10, DOI 10.1186/1746-160X-4-10
   Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977
   Ho JH, 2011, CELL TRANSPLANT, V20, P1209, DOI [10.3727/0963689109X546562, 10.3727/096368910X546562]
   Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11
   Hsia HC, 2011, PLAST RECONSTR SURG, V127, P2312, DOI 10.1097/PRS.0b013e3182139fa4
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Hu JA, 2010, TISSUE ENG PT A, V16, P3507, DOI [10.1089/ten.tea.2010.0097, 10.1089/ten.TEA.2010.0097]
   Huang CH, 2009, J CELL BIOCHEM, V108, P1263, DOI 10.1002/jcb.22356
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Hung SP, 2012, J ORTHOP RES, V30, P260, DOI 10.1002/jor.21517
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Iglesias-Bartolome R, 2010, CELL STEM CELL, V7, P143, DOI 10.1016/j.stem.2010.07.008
   Im GI, 2011, BIOMATERIALS, V32, P4385, DOI 10.1016/j.biomaterials.2011.02.054
   Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di
   Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067
   James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706
   Janjanin S, 2008, J SURG RES, V149, P47, DOI 10.1016/j.jss.2007.12.788
   Jeon BG, 2011, CELL TISSUE RES, V345, P149, DOI 10.1007/s00441-011-1191-9
   Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Jin YH, 2010, BIOCHEM BIOPH RES CO, V391, P1471, DOI 10.1016/j.bbrc.2009.12.096
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jukes JM, 2010, J TISSUE ENG REGEN M, V4, P165, DOI 10.1002/term.234
   Jullien N, 2012, J CELL BIOCHEM, V113, P2047, DOI 10.1002/jcb.24076
   Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130
   Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446
   Karlsson C, 2009, STEM CELL RES, V3, P39, DOI 10.1016/j.scr.2009.05.002
   Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019
   Kawazoe N, 2010, BIOTECHNOL PROGR, V26, P819, DOI 10.1002/btpr.375
   Kearney EM, 2010, ANN BIOMED ENG, V38, P1767, DOI 10.1007/s10439-010-9979-4
   Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605
   Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173
   Khan WS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2211
   Khan WS, 2010, J ORTHOP RES, V28, P834, DOI 10.1002/jor.21043
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342
   Kim MJ, 2011, STEM CELLS DEV, V20, P1349, DOI 10.1089/scd.2010.0311
   Kim YJ, 2008, BIOCHEM BIOPH RES CO, V373, P104, DOI 10.1016/j.bbrc.2008.05.183
   Koay EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1450, DOI 10.1016/j.joca.2008.04.007
   Kollmer M, 2012, BIOMACROMOLECULES, V13, P963, DOI 10.1021/bm300332w
   Kopher RA, 2010, BONE, V47, P718, DOI 10.1016/j.bone.2010.06.020
   Koyama N, 2011, LIFE SCI, V89, P741, DOI 10.1016/j.lfs.2011.09.005
   Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393
   Kropf J, 1997, CLIN CHEM, V43, P1965
   Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107
   Kvist AJ, 2008, MATRIX BIOL, V27, P22, DOI 10.1016/j.matbio.2007.07.007
   Lane JG, 2004, AM J SPORT MED, V32, P1440, DOI 10.1177/0363546504263945
   Lee JM, 2012, BIOCHEM BIOPH RES CO, V421, P819, DOI 10.1016/j.bbrc.2012.04.096
   Lee JH, 2012, CELL TISSUE RES, V348, P475, DOI 10.1007/s00441-012-1392-x
   Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247
   Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Liao JH, 2010, BIOMATERIALS, V31, P8911, DOI 10.1016/j.biomaterials.2010.07.110
   Lim HJ, 2011, MOL CELLS, V31, P123, DOI 10.1007/s10059-011-0016-8
   Liu LY, 2012, BIOMECH MODEL MECHAN, V11, P391, DOI 10.1007/s10237-011-0319-x
   Liu LY, 2010, BIOMECH MODEL MECHAN, V9, P659, DOI 10.1007/s10237-010-0206-x
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213
   Lutz M, 2002, CELL SIGNAL, V14, P977, DOI 10.1016/S0898-6568(02)00058-X
   Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005
   Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560
   Marolt D, 2012, P NATL ACAD SCI USA, V109, P8705, DOI 10.1073/pnas.1201830109
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253
   Mastrogiacomo M, 2001, OSTEOARTHR CARTILAGE, V9, pS36, DOI 10.1053/joca.2001.0442
   Mauney JR, 2005, BIOMATERIALS, V26, P6167, DOI 10.1016/j.biomaterials.2005.03.024
   Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mimura S, 2011, INT J DEV BIOL, V55, P181, DOI 10.1387/ijdb.103232sm
   MITCHELL JA, 1968, ENDOCRINOLOGY, V83, P701, DOI 10.1210/endo-83-4-701
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Motaln H, 2010, CANCER-AM CANCER SOC, V116, P2519, DOI 10.1002/cncr.25056
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Nadzir MM, 2011, J BIOSCI BIOENG, V112, P395, DOI 10.1016/j.jbiosc.2011.06.005
   Nakanishi M, 2009, FASEB J, V23, P114, DOI 10.1096/fj.08-111203
   Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Nur-E-Kamal A, 2005, BIOCHEM BIOPH RES CO, V331, P428, DOI 10.1016/j.bbrc.2005.03.195
   Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170
   Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019
   Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032
   Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496
   Pei M, 2008, DIFFERENTIATION, V76, P1044, DOI 10.1111/j.1432-0436.2008.00299.x
   Peura T, 2011, CURR PROTOC STEM CEL
   Peura TT, 2007, THERIOGENOLOGY, V67, P32, DOI 10.1016/j.theriogenology.2006.09.031
   Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/nmeth.1699, 10.1038/NMETH.1699]
   Phinney DG, 2012, J CELL BIOCHEM, V113, P2806, DOI 10.1002/jcb.24166
   Prasad SM, 2009, CELL PROLIFERAT, V42, P63, DOI 10.1111/j.1365-2184.2008.00571.x
   Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061
   Quarto N, 2010, TISSUE ENG PT A, V16, P3185, DOI 10.1089/ten.tea.2010.0133
   Santos A, 2010, CYTOTHERAPY, V12, P924, DOI 10.3109/14653241003774011
   Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297
   Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x
   Schuh E, 2012, J BIOMED MATER RES A, V100A, P38, DOI 10.1002/jbm.a.33226
   Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   Sefcik LS, 2008, J TISSUE ENG REGEN M, V2, P210, DOI 10.1002/term.85
   Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551
   Sengupta S, 2010, TISSUE ENG PT A, V16, P3623, DOI [10.1089/ten.tea.2010.0302, 10.1089/ten.TEA.2010.0302]
   Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278
   Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312
   Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319
   Silvan U, 2009, DIFFERENTIATION, V78, P159, DOI 10.1016/j.diff.2009.06.002
   Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354
   Sng J, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/521343
   Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238
   Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910
   Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064
   Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121
   Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176
   Tamama K, 2011, J CELL BIOCHEM, V112, P804, DOI 10.1002/jcb.22961
   Tan GK, 2011, BIOMATERIALS, V32, P5600, DOI 10.1016/j.biomaterials.2011.04.033
   Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x
   Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228
   Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972
   Thilagavathi J, 2012, ANDROLOGIA
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tigli RS, 2011, J BIOMED MATER RES A, V96A, P21, DOI 10.1002/jbm.a.32949
   Toh WS, 2012, BIOMATERIALS, V33, P3835, DOI 10.1016/j.biomaterials.2012.01.065
   Toubai T, 2009, CURR STEM CELL RES T, V4, P252, DOI 10.2174/157488809789649269
   Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007
   Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020
   Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508
   Tsai KS, 2010, J BIOMED MATER RES A, V94A, P673, DOI 10.1002/jbm.a.32693
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   Tyndall A, 2010, ANN RHEUM DIS, V69, P1413, DOI 10.1136/ard.2010.132639
   Uda Y, 2011, BIOCHEM BIOPH RES CO, V415, P396, DOI 10.1016/j.bbrc.2011.10.080
   Vacanti CA, 2006, J CELL MOL MED, V10, P569, DOI 10.2755/jcmm010.003.20
   Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092
   van der Sanden B, 2010, J CELL BIOCHEM, V111, P801, DOI 10.1002/jcb.22847
   Vishnubalaji R, 2012, CELL TISSUE RES, V347, P419, DOI 10.1007/s00441-011-1306-3
   Volkmer E, 2010, TISSUE ENG PT A, V16, P153, DOI 10.1089/ten.TEA.2009.0021
   Wagner W., 2009, PLOS ONE, V9, pe5846
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299
   Wang F, 2010, ADV DRUG DELIVER REV, V62, P784, DOI 10.1016/j.addr.2010.03.001
   Wang HB, 2012, J CELL MOL MED, V16, P1310, DOI 10.1111/j.1582-4934.2011.01409.x
   Wang LM, 2009, J ORTHOP RES, V27, P1109, DOI 10.1002/jor.20848
   Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293
   Wang YT, 2012, MOL CELL BIOCHEM, V362, P25, DOI 10.1007/s11010-011-1124-7
   Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013
   Wild L, 2010, CARCINOGENESIS, V31, P1854, DOI 10.1093/carcin/bgq080
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299
   Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016
   Xu DL, 2006, GROWTH FACTORS, V24, P268, DOI 10.1080/08977190601075865
   Yamashita A, 2005, CLONING STEM CELLS, V7, P232, DOI 10.1089/clo.2005.7.232
   Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023965
   Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894
   Yang Z, 2012, TISSUE ENG PT A, V18, P242, DOI [10.1089/ten.tea.2011.0315, 10.1089/ten.TEA.2011.0315]
   Yang Z, 2009, STEM CELLS DEV, V18, P929, DOI 10.1089/scd.2008.0219
   Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001
   Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032
   Yourek G, 2010, REGEN MED, V5, P713, DOI [10.2217/rme.10.60, 10.2217/RME.10.60]
   Yu HB, 2007, TRANSPL P, V39, P3030, DOI 10.1016/j.transproceed.2007.03.108
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
   Zachar V, 2010, IN VITRO CELL DEV-AN, V46, P276, DOI 10.1007/s11626-010-9305-3
   ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115
   Zhou JA, 2011, ACTA BIOMATER, V7, P3999, DOI 10.1016/j.actbio.2011.06.040
   Zoumaro-Djayoon AD, 2011, PROTEOMICS, V11, P3962, DOI 10.1002/pmic.201100048
NR 238
TC 23
Z9 24
U1 0
U2 47
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD JUN
PY 2013
VL 19
IS 19
BP 3429
EP 3445
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 133RN
UT WOS:000318157300009
PM 23432679
DA 2018-10-20
ER

PT J
AU Ozdemir, T
   Higgins, AM
   Brown, JL
AF Ozdemir, Tugba
   Higgins, Andrew M.
   Brown, Justin L.
TI Osteoinductive Biomaterial Geometries for Bone Regenerative Engineering
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Osteoinduction; biomaterials; substrate surface geometries
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VIVO; FOCAL ADHESION;
   NANOSCALE TOPOGRAPHY; FIBROBLAST RESPONSE; GRAFT SUBSTITUTES; TITANIUM;
   MATRIX; NANOFIBER
AB Worldwide, more than 2.2 million patients undergo bone graft procedures annually. In each of these procedures an interface is formed between the host tissue and the graft material. Synthetic implants exhibit an interface with the host tissue and the formation of a homogenous interface consisting of bone and void of intervening soft tissue is desired (osseointegration); recent developments have highlighted the benefit of incorporating nanostructures at that interface. Autograft and allograft bone are frequently used for bone loss, nonunion fractures, and spinal fusions; however, both are plagued with complications either due to supply or inadequate graft properties. In contrast to bone tissue engineering, which uses a top-down approach to repair bone defects, bone regenerative engineering uses a bottom-up approach focused on strategies incorporating stem cells, biomaterials, and growth factors alone or in combination to generate or regenerate bone tissue. Early constructs developed for bone regenerative engineering utilized polymeric microstructures, presenting surface features with characteristic dimensions similar to that of a cell (1 mu m - 1000 mu m). These microstructures were typically biodegradable and demonstrated an excellent ability to match the mechanics of native bone tissue. They were also osteoconductive-capable of promoting osteoblast growth. On the other hand, the osteoinductive abilities of these microstructures were lacking. Osteoinduction, or the ability to promote the progression of a preosteoblastic cell to a mature osteoblast, historically was achieved in two ways: via the addition of nanoscale ceramics to the microstructures or via an external stimulus such as the addition of bone morphogenetic proteins (BMPs). More recent developments in bone regenerative engineering have utilized polymeric nanostructures (less than 1 mu m) with characteristic dimensions an order of magnitude or more less than that of a cell to stimulate and drive an osteoinductive response in the absence of growth factors. Despite strong literature evidence supporting the nanostructures' ability to be both osteoconductive and osteoinductive, there is still disparity regarding how nanostructures regulate the progression towards an osteoblastic phenotype. This review will explore unique micro- and nano-architectures, how they initiate osteoinductive signals through pathways similar to BMPs, and how these unique geometries can be translated to the clinic.
C1 [Ozdemir, Tugba; Higgins, Andrew M.; Brown, Justin L.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA.
RP Brown, JL (reprint author), Penn State Univ, Dept Bioengn, Hallowell Bldg, University Pk, PA 16802 USA.
EM jlbbio@engr.psu.edu
RI Brown, Justin/N-4775-2015
OI Brown, Justin/0000-0001-9401-6094
CR Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   BIRK DE, 1989, DEVELOPMENT, V107, P437
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Braccini A, 2005, STEM CELLS, V23, P1066, DOI 10.1634/stemcells.2005-0002
   Brandi ML, 2009, RHEUMATOLOGY OXFO S4, V48, P3
   Brown JL, 2010, J BIOMED MATER RES A, V95A, P1150, DOI 10.1002/jbm.a.32934
   Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071
   Chavez VL, 2010, ACTA BIOMATER, V6, P3035, DOI 10.1016/j.actbio.2010.02.005
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chuenjitkuntaworn B, 2010, J BIOMED MATER RES A, V94A, P241, DOI 10.1002/jbm.a.32657
   Coathup MJ, 2012, J BIOMED MATER RES A, V100A, P1550, DOI 10.1002/jbm.a.34094
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Deng M, 2012, IEEE T NANOBIOSCI, V11, P3, DOI 10.1109/TNB.2011.2179554
   Deng M, 2011, ADV FUNCT MATER, V21, P2641, DOI 10.1002/adfm.201100275
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Heinzel K, 2007, P NATL ACAD SCI USA, V104, P8421, DOI 10.1073/pnas.0608274104
   Helvering LM, 2000, GENE, V256, P123, DOI 10.1016/S0378-1119(00)00364-4
   Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ingber D E, 1997, Gravit Space Biol Bull, V10, P49
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Jahangir A. A., 2008, BONE GRAFT SUBSTITUT
   Jaiswal D, 2012, J BIOMED MAT RES A
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P698, DOI 10.1002/jbm.a.30848
   Krishnan V, 2001, ENDOCRINOLOGY, V142, P940, DOI 10.1210/en.142.2.940
   Lamers E, 2010, EUR CELLS MATER, V20, P329
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McNamara LE, 2010, J TISSUE ENG, V2010
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Milner KR, 2007, INT J NANOMED, V2, P201
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   MORONI A, 1994, BIOMATERIALS, V15, P926, DOI 10.1016/0142-9612(94)90119-8
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nukavarapu SP, 2008, BIOMACROMOLECULES, V9, P1818, DOI 10.1021/bm800031t
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ripamonti U, 1999, SADJ, V54, P257
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Seib FP, 2009, EUR J CELL BIOL, V88, P257, DOI 10.1016/j.ejcb.2009.01.003
   Sheu TJ, 2003, J BIOL CHEM, V278, P438, DOI 10.1074/jbc.M208292200
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   URIST M R, 1965, J Bone Joint Surg Br, V47, P304
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   URIST MR, 1952, J BONE JOINT SURG AM, V34-A, P443, DOI 10.2106/00004623-195234020-00015
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   WEISS P, 1952, P NATL ACAD SCI USA, V38, P264, DOI 10.1073/pnas.38.3.264
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060
NR 82
TC 21
Z9 21
U1 1
U2 54
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD JUN
PY 2013
VL 19
IS 19
BP 3446
EP 3455
DI 10.2174/1381612811319190010
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 133RN
UT WOS:000318157300010
PM 23432675
DA 2018-10-20
ER

PT J
AU Jeon, O
   Alsberg, E
AF Jeon, Oju
   Alsberg, Eben
TI Photofunctionalization of Alginate Hydrogels to Promote Adhesion and
   Proliferation of Human Mesenchymal Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID OSTEOGENIC DIFFERENTIATION; STROMAL CELLS; RGD; PEPTIDES; GROWTH;
   ANGIOGENESIS; MICROARRAY; DELIVERY; BEHAVIOR
AB Photocrosslinkable biomaterials are promising for biomedical applications, as they can be injected in a minimally invasive manner, crosslinked in situ to form hydrogels with cells and/or bioactive factors, and engineered to provide instructive signals to transplanted and host cells. Our group has previously reported on biodegradable, photocrosslinkable alginate (ALG) hydrogels with controlled cell adhesivity for tissue engineering. The polymer backbone of this methacrylated ALG was covalently modified with cell adhesion ligands containing the RGD sequence to enhance the proliferation and differentiation response of encapsulated cells. However, this approach permits limited control over the spatial presentation of these ligands within the three-dimensional hydrogel structure. Here we present a system that easily allows for spatial control of cell adhesion ligands within photocrosslinked ALG hydrogels. A cell adhesive peptide composed of the specific amino acid sequence Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) was covalently modified with acrylate moieties. The acrylated peptide was then covalently incorporated into bulk hydrogels by adding it to methacrylated ALG solutions with a photoinitiator, and then photocrosslinking under long-wave ultraviolet light. The hydrogels were characterized with respect to their swelling and degradation profiles, and the effects of the acrylated peptide on human mesenchymal stem cell (hMSC) viability, adhesion, spreading, and proliferation were examined in vitro. hMSC adhesion and spreading on and proliferation in this biomaterial system could be regulated by varying the concentration of cell adhesion ligand. This new biomaterial system may be a useful platform for tissue engineering, drug delivery, and stem cell transplantation with spatial control of cell adhesivity.
C1 [Jeon, Oju; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
RI Jeon, Oju/K-7227-2018
OI Jeon, Oju/0000-0003-3972-9272; Alsberg, Eben/0000-0002-3487-4625
FU National Institutes of Health [AR063194, DE022376, AR061265]; Department
   of Defense [OR110196]; AO Foundation; Ellison Medical Foundation
FX The authors thank Caitlin Powell for research assistance, and Dr. Arnold
   Caplan's Skeletal Research Center Mesenchymal Stem Cell facility,
   especially Dr. Donald Lennon and Ms. Margie Harris, for providing the
   hMSCs. The authors gratefully acknowledge funding from the National
   Institutes of Health (AR063194, DE022376, AR061265), the Department of
   Defense Congressionally Directed Medical Research Programs (OR110196),
   the AO Foundation, and a New Scholar in Aging grant from the Ellison
   Medical Foundation.
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cavalcanti-Adam EA, 2008, HFSP J, V2, P276, DOI 10.2976/1.2976662
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gallego-Perez D, 2010, LAB CHIP, V10, P775, DOI 10.1039/b919475d
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Jeon O, 2012, BIOMATERIALS, V33, P3503, DOI 10.1016/j.biomaterials.2012.01.041
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Kang SW, 2011, MACROMOL BIOSCI, V11, P673, DOI 10.1002/mabi.201000479
   KISHIDA A, 1992, BIOMATERIALS, V13, P924, DOI 10.1016/0142-9612(92)90115-5
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   Liu B, 2009, BIOMACROMOLECULES, V10, P3182, DOI 10.1021/bm900908g
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Onuki Y, 2008, INT J PHARM, V349, P47, DOI 10.1016/j.ijpham.2007.07.021
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pillay V, 1999, J CONTROL RELEASE, V59, P243, DOI 10.1016/S0168-3659(98)00197-7
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Rydholm AE, 2008, J BIOMED MATER RES A, V86A, P23, DOI 10.1002/jbm.a.31526
   Seidlits SK, 2011, ACTA BIOMATER, V7, P2401, DOI 10.1016/j.actbio.2011.03.024
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Suri S, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P297, DOI 10.1007/978-0-387-98161-1_15
   Yang F, 2009, COMB CHEM HIGH T SCR, V12, P554, DOI 10.2174/138620709788681916
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
NR 38
TC 31
Z9 31
U1 2
U2 49
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUN
PY 2013
VL 19
IS 11-12
BP 1424
EP 1432
DI 10.1089/ten.tea.2012.0581
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 133XI
UT WOS:000318173800016
PM 23327676
OA Green Published
DA 2018-10-20
ER

PT J
AU Schubert, T
   Lafont, S
   Beaurin, G
   Grisay, G
   Behets, C
   Gianello, P
   Dufrane, D
AF Schubert, Thomas
   Lafont, Sebastien
   Beaurin, Gwen
   Grisay, Guillaume
   Behets, Catherine
   Gianello, Pierre
   Dufrane, Denis
TI Critical size bone defect reconstruction by an autologous 3D
   osteogenic-like tissue derived from differentiated adipose MSCs
SO BIOMATERIALS
LA English
DT Article
DE Bone; Critical-size defect; Pre-clinical; Adipose mesenchymal stem cell;
   Three-dimensional; Pigs
ID MESENCHYMAL STEM-CELLS; LUMBAR INTERBODY FUSION; RETRIEVED HUMAN
   ALLOGRAFTS; PROTEIN EXTRACT; STROMAL CELLS; FLOW PERFUSION; AUTOGRAFT;
   IRRADIATION; SCAFFOLDS; RHBMP-2
AB For critical size bone defects and bone non-unions, bone tissue engineering using osteoblastic differentiated adipose mesenchymal stem cells (AMSCs) is limited by the need for a biomaterial to support cell transplantation. An osteoblastic three-dimensional autologous graft made of AMSCs (3D AMSC) was developed to solve this issue. This autograft was obtained by supplementing the osteoblastic differentiation medium with demineralized bone matrix. Two surgical models were developed to assess the potential of this 3D osteogenic AMSC autograft. A four-level spinal fusion using polyetheretherketone cages was designed in six pigs to assess the early phase of ossification (8-12 weeks postimplantation). In each pig, four groups were compared: cancellous bone autograft, freeze-dried irradiated cancellous pig bone, 3D AMSC, and an empty cage. A critical size femoral defect (n = 4, bone non-union confirmed 6 months postoperatively) was used to assess the 3D AMSCs' ability to achieve bone fusion. Pigs were followed by CT scan and explanted specimens were analyzed for bone tissue remodeling by micro-CT scan, micro-radiography, and histology/histomorphometry. In the spine fusion model, bone formation with the 3D AMSC was demonstrated by a significant increase in bone content. In the critical-size femoral defect model, the 3D AMSC achieved new bone formation and fusion in a poorly vascularized fibrotic environment. This custom-made 3D osteogenic AMSC autograft is a therapeutic solution for bone non-unions and for critical-size defects. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Schubert, Thomas; Dufrane, Denis] Catholic Univ Louvain, Clin Univ St Luc, Ctr Tissue & Cell Therapy, Endocrine Cell Therapy Unit, B-1200 Brussels, Belgium.
   [Schubert, Thomas; Lafont, Sebastien; Beaurin, Gwen; Grisay, Guillaume; Behets, Catherine; Gianello, Pierre; Dufrane, Denis] Catholic Univ Louvain, Sect Sci Sante, Inst Rech Expt & Clin, B-1200 Brussels, Belgium.
RP Dufrane, D (reprint author), Catholic Univ Louvain, Sect Sci Sante, UCL SSS IREC CHEX, Inst Rech Expt & Clin, Ave Hippocrate 55,B1-55-04, B-1200 Brussels, Belgium.
EM denis.dufrane@uclouvain.be
OI Schubert, Thomas/0000-0001-6670-886X; Gianello,
   Pierre/0000-0002-5326-0864
FU Salus Sanguinis Foundation; Saint-Luc Foundation; DepuySynthes
FX This work was supported by grants of the Salus Sanguinis and Saint-Luc
   Foundations. The authors thank DepuySynthes for their support and the
   Department of Radiology of the University Clinical Hospital of
   Saint-Luc, Brussels, for authorizing the CT scan access.
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Arlet V, 2006, EUR SPINE J, V15, P1352, DOI 10.1007/s00586-006-0100-5
   Arrigoni E, 2009, CELL TISSUE RES, V338, P401, DOI 10.1007/s00441-009-0883-x
   Cornu O, 2000, J ORTHOPAED RES, V18, P426, DOI 10.1002/jor.1100180314
   Cornu O, 2009, J BIOMECH, V42, P2238, DOI 10.1016/j.jbiomech.2009.06.045
   Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042
   Dath R, 2007, CLIN BIOMECH, V22, P607, DOI 10.1016/j.clinbiomech.2007.01.014
   de Girolamo L, 2011, J ORTHOP RES, V29, P100, DOI 10.1002/jor.21184
   Delloye C, 2003, Acta Orthop Belg, V69, P104
   Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039
   Dimitriou R, 2005, INJURY, V36, P28, DOI 10.1016/j.injury.2005.07.031
   Donati D, 2008, INJURY, V39, pS65, DOI 10.1016/S0020-1383(08)70017-2
   Dufrane D, 2010, Patent, Patent No. [PCT/EP2010/057847, 2010027847]
   DZIEDZICGOCLAWSKA A, 1991, CLIN ORTHOP RELAT R, P30
   Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001
   ENNEKING WF, 1991, J BONE JOINT SURG AM, V73A, P1123, DOI 10.2106/00004623-199173080-00002
   Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215
   Fawzi-Grancher S, 2009, J MATER SCI-MATER M, V20, P1709, DOI 10.1007/s10856-009-3726-0
   Foldager C, 2009, BONE, V45, P267, DOI 10.1016/j.bone.2009.04.240
   Foldager C, 2008, SPINE, V33, P2683, DOI 10.1097/BRS.0b013e31817fce91
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Janssen FW, 2010, J TISSUE ENG REGEN M, V4, P12, DOI 10.1002/term.197
   Kuhbier JW, 2010, ADV BIOCHEM ENG BIOT, V123, P55, DOI 10.1007/10_2009_24
   Lee JA, 2003, ANN PLAS SURG, V50, P610, DOI 10.1097/01.SAP.0000069069.23266.35
   Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177
   Li HW, 2007, BIOCHEM BIOPH RES CO, V356, P836, DOI 10.1016/j.bbrc.2007.02.165
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Munting E, 2001, EUR SPINE J, V10, pS153, DOI 10.1007/s005860100272
   Nather A, 2004, CLIN BIOMECH, V19, P526, DOI 10.1016/j.clinbiomech.2004.01.010
   Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085
   Panagiotis M, 2005, INJURY, V36, pS30, DOI 10.1016/j.injury.2005.10.008
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120
   Post S, 2008, BONE, V43, P32, DOI 10.1016/j.bone.2008.03.011
   Qu CQ, 2007, IN VITRO CELL DEV-AN, V43, P95, DOI 10.1007/s11626-006-9008-y
   Raschke M, 2001, BONE, V29, P368, DOI 10.1016/S8756-3282(01)00587-7
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Schubert T, 2011, BIOMATERIALS, V32, P8880, DOI 10.1016/j.biomaterials.2011.08.009
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Sorensen JR, 2012, EUR SPINE J, V21, P1740, DOI 10.1007/s00586-012-2421-x
   Steffen T, 2000, EUR SPINE J, V9, pS114, DOI 10.1007/PL00008316
   Supronowicz P, 2011, TISSUE ENG PT A, V17, P789, DOI 10.1089/ten.TEA.2010.0357
   Tzioupis C, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(07)80003-9
   Urist M, 2009, CLIN ORTHOP RELAT R, V462, P3051
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Wang L, 2009, J BIOMED MATER RES A, V91A, P102, DOI 10.1002/jbm.a.32189
   WIENTROUB S, 1988, CALCIFIED TISSUE INT, V42, P255, DOI 10.1007/BF02553752
   Yeatts AB, 2012, BIOTECHNOL BIOENG, V109, P2381, DOI 10.1002/bit.24497
   Zerbo IR, 2003, CLIN ORAL IMPLAN RES, V14, P759, DOI 10.1046/j.0905-7161.2003.00967.x
   Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488
   Zou XN, 2009, BIOMATERIALS, V30, P991, DOI 10.1016/j.biomaterials.2008.10.061
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589
NR 60
TC 37
Z9 42
U1 1
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2013
VL 34
IS 18
BP 4428
EP 4438
DI 10.1016/j.biomaterials.2013.02.053
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 130AJ
UT WOS:000317884800004
PM 23507085
OA Green Published
DA 2018-10-20
ER

PT J
AU Yeul, VS
   Rayalu, SS
AF Yeul, Vijay S.
   Rayalu, Sadhana S.
TI Unprecedented Chitin and Chitosan: A Chemical Overview
SO JOURNAL OF POLYMERS AND THE ENVIRONMENT
LA English
DT Review
DE Chitin; Chitosan; Polysaccharide; Glucosamine
ID X-RAY-DIFFRACTION; PHYSICOCHEMICAL CHARACTERISTICS; ALPHA-CHITIN;
   FUNCTIONAL-PROPERTIES; CRYSTAL-STRUCTURE; PRODUCTS; POLYSACCHARIDES;
   SHELL
AB Chitin and Chitosan are polysaccharide polymers. Polysaccharide is a carbohydrate whose molecules consist of a number of sugar molecules bonded together. It contains more than 5,000 acetylglucosamine and glucosamine (sugar) units, respectively and their molecular weights are over one million Daltons. Most of the naturally occurring polysaccharides are neutral or acidic in nature, whereas Chitin and Chitosan are examples of highly basic polysaccharides. Chitin is isolated from crab and shrimp waste and is a renewable resource. It is widely accepted that this biopolymer is an important biomaterial in many aspects. This review explores the various aspects of Chitin research.
C1 [Yeul, Vijay S.; Rayalu, Sadhana S.] Natl Environm Engn Res Inst, Nagpur 440020, Maharashtra, India.
RP Rayalu, SS (reprint author), Natl Environm Engn Res Inst, Nagpur 440020, Maharashtra, India.
EM s_rayalu@neeri.res.in
RI Lohiya, Rajesh/F-7644-2013
CR ATKINS E, 1985, J BIOSCIENCE, V8, P375, DOI 10.1007/BF02703990
   Attwood NA, 1967, COMP BIOCH PHYSL, V20, P993
   Austine DR, 1981, SCIENCE, V212, P749
   BLAIR HS, 1987, J APPL POLYM SCI, V33, P641, DOI 10.1002/app.1987.070330226
   BLUMENTHAL HJ, 1957, J BACTERIOL, V74, P222
   Bough WA, 1978, P 1 INT C CHIT CHIT, P218
   BRINE CJ, 1981, COMP BIOCHEM PHYS B, V69, P283, DOI 10.1016/0305-0491(81)90242-X
   Cho YI, 1998, J AGR FOOD CHEM, V46, P3839, DOI 10.1021/jf971047f
   Clark GL, 1936, J PHYS CHEM-US, V40, P863, DOI 10.1021/j150376a001
   Cuero RG, 1999, EXS, V87, P315
   Desphpande MV, 1986, J SCI IND RES INDIA, V45, P273
   Domard A., 1996, P 2 AS PAC S CHIT CH, P1
   El GA, 1992, HORTIC SCI, V27, P1016
   El-heian E. A., 2011, AUST J BASIC APPL SC, V5, P670
   FOX DL, 1973, COMP BIOCHEM PHYSIOL, V44, P953, DOI 10.1016/0305-0491(73)90247-2
   Green JH, 1979, FOOD PROCESSING WAST, P202
   HERRING PJ, 1979, PURE APPL CHEM, V51, P1901, DOI 10.1351/pac197951091901
   HIRANO S, 1989, AGR BIOL CHEM TOKYO, V53, P3065, DOI 10.1080/00021369.1989.10869777
   Johnson EL, 1982, UTILIZATION SHELL WA
   Khan WM, 2002, PHOTOSYNTHETICA, V40, P621, DOI 10.1023/A:1024320606812
   KNORR D, 1982, J FOOD SCI, V47, P593, DOI 10.1111/j.1365-2621.1982.tb10131.x
   Knorr D, 1984, FOOD TECHNOL, V38, P58
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Kurita K, 1998, POLYM DEGRAD STABIL, V59, P117, DOI 10.1016/S0141-3910(97)00160-2
   Lavall RL, 2007, BIORESOURCE TECHNOL, V98, P2465, DOI 10.1016/j.biortech.2006.09.002
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Lusena C.V., 1953, J FISH RES BOARD CAN, V10, P521
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   MATHUR NK, 1990, J CHEM EDUC, V67, P938, DOI 10.1021/ed067p938
   MAZEAU K, 1994, MACROMOLECULES, V27, P7606, DOI 10.1021/ma00104a015
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   MOORE GK, 1980, INT J BIOL MACROMOL, V2, P115, DOI 10.1016/0141-8130(80)90040-9
   Moorjani M. N., 1975, J FOOD SCI TECHNOL, V12, P187
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   MUZZARELLI RAA, 1977, CHITIN
   No H. K., 1995, Journal of Aquatic Food Product Technology, V4, P27, DOI 10.1300/J030v04n02_03
   NO HK, 1989, J AGR FOOD CHEM, V37, P575, DOI 10.1021/jf00087a001
   No HK, 2000, J FOOD SCI, V65, P1134, DOI 10.1111/j.1365-2621.2000.tb10252.x
   No HK, 1998, J AGR FOOD CHEM, V46, P3844, DOI 10.1021/jf9802676
   Peniston QP, 1980, CHITIN CHEM, P54
   Rigby GW, 1936, U.S. Patent No, Patent No. [2,040,879, 4195175]
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Robert H, 1992, CHITIN CHEM
   ROBERTS GAF, 1982, INT J BIOL MACROMOL, V4, P374, DOI 10.1016/0141-8130(82)90074-5
   Rout SK, 2001, THESIS LOUSIANA STAT
   Rudall KM, 1973, BIOL REV
   Schiffman JD, 2009, MAT SCI ENG C-BIO S, V29, P1370, DOI 10.1016/j.msec.2008.11.006
   SHAHIDI F, 1991, J AGR FOOD CHEM, V39, P1527, DOI 10.1021/jf00008a032
   Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e
   Struszczyk M. H., 2006, POLISH CHITIN SOC MO, VXI, P95
   Tian F, 2004, CARBOHYD POLYM, V57, P31, DOI 10.1016/j.carbpol.2004.03.016
   Tolaimate A, 2000, POLYMER, V41, P2463, DOI 10.1016/S0032-3861(99)00400-0
   Tsai CJ, 1999, BIOL PHARM BULL, V22, P397
   WAGNER GP, 1993, EXPERIENTIA, V49, P317, DOI 10.1007/BF01923410
   Wu A. C. M., 1978, P 1 INT C CHIT CHIT, P88
NR 56
TC 26
Z9 26
U1 1
U2 192
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1566-2543
J9 J POLYM ENVIRON
JI J. Polym. Environ.
PD JUN
PY 2013
VL 21
IS 2
BP 606
EP 614
DI 10.1007/s10924-012-0458-x
PG 9
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA 129MK
UT WOS:000317844200034
DA 2018-10-20
ER

PT J
AU Solorio, LD
   Vieregge, EL
   Dhami, CD
   Alsberg, E
AF Solorio, Loran D.
   Vieregge, Eran L.
   Dhami, Chirag D.
   Alsberg, Eben
TI High-Density Cell Systems Incorporating Polymer Microspheres as
   Microenvironmental Regulators in Engineered Cartilage Tissues
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; IN-VITRO CHONDROGENESIS; HUMAN ARTICULAR
   CHONDROCYTES; GROWTH-FACTOR DELIVERY; GELATIN MICROSPHERES;
   CULTURE-SYSTEM; TRANSFORMING GROWTH-FACTOR-BETA-1; HYDROGEL COMPOSITES;
   INJECTABLE SCAFFOLD; ACID) MICROSPHERES
AB To address the significant clinical need for tissue-engineered therapies for the repair and regeneration of articular cartilage, many systems have recently been developed using bioactive polymer microspheres as regulators of the chondrogenic microenvironment within high-density cell cultures. In this review, we highlight various densely cellular systems utilizing polymer microspheres as three-dimensional (3D) structural elements within developing engineered cartilage tissue, carriers for cell expansion and delivery, vehicles for spatiotemporally controlled growth factor delivery, and directors of cell behavior via regulation of cell-biomaterial interactions. The diverse systems described herein represent a shift from the more traditional tissue engineering approach of combining cells and growth factors within a biomaterial scaffold, to the design of modular systems that rely on the assembly of cells and bioactive polymer microspheres as building blocks to guide the creation of articular cartilage. Cell-based assembly of 3D microsphere-incorporated structures represents a promising avenue for the future of tissue engineering.
C1 [Solorio, Loran D.; Dhami, Chirag D.; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Vieregge, Eran L.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Deparment Orthopaed Surg, Cleveland, OH 44106 USA.
   [Alsberg, Eben] AO Fdn, Collaborat Res Ctr, Davos, Switzerland.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Wickenden Bldg,Rm 204 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
OI Alsberg, Eben/0000-0002-3487-4625
FU National Institutes of Health [AR007505, AR063194, DE022376, AR061265];
   Department of Defense [OR110196]; AO Foundation; Ohio Department of
   Development [09-071]; Ellison Medical Foundation
FX The authors acknowledge funding from the National Institutes of Health
   (AR007505, AR063194, DE022376, and AR061265), the Department of Defense
   Congressionally Directed Medical Research Programs (OR110196), the AO
   Foundation, a Biomedical Research and Technology Transfer Grant 09-071
   from the Ohio Department of Development, and a New Scholar in Aging
   grant from the Ellison Medical Foundation.
CR Argoff CE, 2011, CURR MED RES OPIN, V27, P1315, DOI 10.1185/03007995.2011.568058
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Berkland C, 2001, J CONTROL RELEASE, V73, P59, DOI 10.1016/S0168-3659(01)00289-9
   Bouffi C, 2010, BIOMATERIALS, V31, P6485, DOI 10.1016/j.biomaterials.2010.05.013
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007
   Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Choong PFM, 2011, INT J RHEUM DIS, V14, P167, DOI 10.1111/j.1756-185X.2011.01617.x
   Chun KW, 2004, BIOTECHNOL PROGR, V20, P1797, DOI 10.1021/bp0496981
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Chung HJ, 2008, TISSUE ENG PT A, V14, P607, DOI 10.1089/tea.2007.0263
   Dang P.N., 2012, TISSUE E A UNPUB SEP
   Darling EM, 2003, ANN BIOMED ENG, V31, P1114, DOI 10.1114/1.1603752
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Elbert DL, 2011, CURR OPIN BIOTECH, V22, P674, DOI 10.1016/j.copbio.2011.04.001
   Elder SH, 2009, TISSUE ENG PT A, V15, P3025, DOI [10.1089/ten.tea.2008.0617, 10.1089/ten.TEA.2008.0617]
   Fan HB, 2008, BIOMACROMOLECULES, V9, P927, DOI 10.1021/bm7013203
   Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31
   Feeley BT, 2010, J AM ACAD ORTHOP SUR, V18, P406, DOI 10.5435/00124635-201007000-00003
   Fishman JA, 2012, CLIN INFECT DIS, V55, P720, DOI 10.1093/cid/cis519
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Han YS, 2010, JOINT BONE SPINE, V77, P27, DOI 10.1016/j.jbspin.2009.05.013
   Han YS, 2009, GERONTOLOGY, V55, P592, DOI 10.1159/000235547
   Hangody L, 2010, AM J SPORT MED, V38, P1125, DOI 10.1177/0363546509360405
   Harris JD, 2010, J BONE JOINT SURG AM, V92A, P2220, DOI 10.2106/JBJS.J.00049
   Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013
   Henderson JH, 2007, TISSUE ENG, V13, P843, DOI 10.1089/ten.2006.0256
   HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Jin CZ, 2011, TISSUE ENG PT A, V17, P3057, DOI [10.1089/ten.tea.2010.0605, 10.1089/ten.TEA.2010.0605]
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kang SW, 2009, J BIOMAT SCI-POLYM E, V20, P399, DOI 10.1163/156856209X412236
   Kang SW, 2005, TISSUE ENG, V11, P438, DOI 10.1089/ten.2005.11.438
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Lao LH, 2008, COLLOID SURFACE B, V66, P218, DOI 10.1016/j.colsurfb.2008.06.014
   Lee CR, 2000, J ORTHOPAED RES, V18, P790, DOI 10.1002/jor.1100180517
   Lee J I, 2011, Eur Cell Mater, V22, P275
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   MANNING WK, 1967, ARTHRITIS RHEUM-US, V10, P235, DOI 10.1002/art.1780100309
   Marlovits S, 2003, INT J ARTIF ORGANS, V26, P319
   Matthews GL, 2011, EXPERT OPIN EMERG DR, V16, P479, DOI 10.1517/14728214.2011.576670
   Mayer-Wagner S, 2010, TISSUE ENG PT A, V16, P513, DOI [10.1089/ten.tea.2009.0326, 10.1089/ten.TEA.2009.0326]
   Mei Y, 2010, J BIOTECHNOL, V150, P438, DOI 10.1016/j.jbiotec.2010.09.953
   Melero-Martin JM, 2006, BIOMATERIALS, V27, P2970, DOI 10.1016/j.biomaterials.2006.01.023
   Mercier NR, 2005, BIOMATERIALS, V26, P1945, DOI 10.1016/j.biomaterials.2004.06.030
   Mercier NR, 2004, ANN BIOMED ENG, V32, P418, DOI 10.1023/B:ABME.0000017547.84146.fd
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Naumann A, 2004, TISSUE ENG, V10, P1695, DOI 10.1089/ten.2004.10.1695
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Ogawa T, 2010, J BIOMAT SCI-POLYM E, V21, P609, DOI 10.1163/156856209X434638
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   Park JS, 2011, BIOMATERIALS, V32, P28, DOI 10.1016/j.biomaterials.2010.08.088
   Park JS, 2009, BIOMATERIALS, V30, P4796, DOI 10.1016/j.biomaterials.2009.05.054
   Park JS, 2008, BIOMACROMOLECULES, V9, P2162, DOI 10.1021/bm800251x
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038
   Penick KJ, 2005, BIOTECHNIQUES, V39, P687, DOI 10.2144/000112009
   Pettersson S, 2009, J TISSUE ENG REGEN M, V3, P450, DOI 10.1002/term.179
   Pilgaard L, 2009, REGEN MED, V4, P539, DOI 10.2217/RME.09.28
   Ravindran S, 2011, BIOMATERIALS, V32, P8436, DOI 10.1016/j.biomaterials.2011.07.056
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Robert H, 2011, ORTHOP TRAUMATOL-SUR, V97, P418, DOI 10.1016/j.otsr.2011.04.001
   Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007.0300
   Shainer R, 2010, REGEN MED, V5, P255, DOI 10.2217/RME.09.90
   Singh M, 2010, ACTA BIOMATER, V6, P137, DOI 10.1016/j.actbio.2009.07.042
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
   Solorio LD, 2012, STEM CELL TRANSL MED, V1, P632, DOI 10.5966/sctm.2012-0039
   Solorio LD, 2012, J CONTROL RELEASE, V158, P224, DOI 10.1016/j.jconrel.2011.11.003
   Solorio LD, 2010, J BIOMED MATER RES A, V92A, P1139, DOI 10.1002/jbm.a.32440
   Thissen H, 2006, J BIOMED MATER RES A, V77A, P590, DOI 10.1002/jbm.a.30612
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Wang HA, 2012, TISSUE ENG PART B-RE, V18, P24, DOI [10.1089/ten.teb.2011.0184, 10.1089/ten.TEB.2011.0184]
   Whittlesey KJ, 2004, EXP NEUROL, V190, P1, DOI 10.1016/j.expneurol.2004.06.020
   Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646
   Wu YN, 2007, BIOMATERIALS, V28, P4056, DOI 10.1016/j.biomaterials.2007.05.039
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zangi L, 2006, TISSUE ENG, V12, P2343, DOI 10.1089/ten.2006.12.2343
   Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x
NR 86
TC 21
Z9 21
U1 2
U2 62
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD JUN
PY 2013
VL 19
IS 3
BP 209
EP 220
DI 10.1089/ten.teb.2012.0252
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 125VY
UT WOS:000317571000003
PM 23126333
OA Green Published
DA 2018-10-20
ER

PT J
AU Hendriks, JAA
   Moroni, L
   Riesle, J
   de Wijn, JR
   van Blitterswijk, CA
AF Hendriks, J. A. A.
   Moroni, L.
   Riesle, J.
   de Wijn, J. R.
   van Blitterswijk, C. A.
TI The effect of scaffold-cell entrapment capacity and physico-chemical
   properties on cartilage regeneration
SO BIOMATERIALS
LA English
DT Article
DE Rapid prototyping; Pore volume; Physico-chemical properties; Dynamic
   stiffness; Cartilage
ID DYNAMIC-MECHANICAL PROPERTIES; CHONDROCYTES IN-VITRO; ARTICULAR
   CHONDROCYTES; PASSAGED CHONDROCYTES; EXTRACELLULAR-MATRIX; COPOLYMER
   SCAFFOLDS; SIGNAL-TRANSDUCTION; POLYMER SCAFFOLDS; TISSUE FORMATION;
   ARCHITECTURE
AB An important tenet in designing scaffolds for regenerative medicine consists in mimicking the dynamic mechanical properties of the tissues to be replaced to facilitate patient rehabilitation and restore daily activities. In addition, it is important to determine the contribution of the forming tissue to the mechanical properties of the scaffold during culture to optimize the pore network architecture. Depending on the biomaterial and scaffold fabrication technology, matching the scaffolds mechanical properties to articular cartilage can compromise the porosity, which hampers tissue formation. Here, we show that scaffolds with controlled and interconnected pore volume and matching articular cartilage dynamic mechanical properties, are indeed effective to support tissue regeneration by co-cultured primary and expanded chondrocyte (1:4). Cells were cultured on scaffolds in vitro for 4 weeks. A higher amount of cartilage specific matrix (ECM) was formed on mechanically matching (M) scaffolds after 28 days. A less protein adhesive composition supported chondrocytes rounded morphology, which contributed to cartilaginous differentiation. Interestingly, the dynamic stiffness of matching constructs remained approximately at the same value after culture, suggesting a comparable kinetics of tissue formation and scaffold degradation. Cartilage regeneration in matching scaffolds was confirmed subcutaneously in vivo. These results imply that mechanically matching scaffolds with appropriate physico-chemical properties support chondrocyte differentiation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Hendriks, J. A. A.; Moroni, L.; Riesle, J.; de Wijn, J. R.; van Blitterswijk, C. A.] Univ Twente, Inst BioMed Technol MIRA, NL-7500 AE Enschede, Netherlands.
   [Hendriks, J. A. A.; Riesle, J.] CellcoTec NV, NL-3723 MB Bilthoven, Netherlands.
RP Moroni, L (reprint author), Univ Twente, Dept Tissue Regenerat, Inst Biomed Technol, Drienerlolaan 5,Zuidhorst 147, NL-7522 NB Enschede, Netherlands.
EM Jeanine.Hendriks@cellcotec.com; l.moroni@utwente.nl
RI Moroni, Lorenzo/D-2826-2014
OI Moroni, Lorenzo/0000-0003-1298-6025; van Blitterswijk,
   Clemens/0000-0003-2371-4615
CR Ahmed N, 2009, TISSUE ENG PT A, V15, P665, DOI 10.1089/ten.tea.2008.0004
   Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4
   Bhadriraju K, 2002, EXP CELL RES, V278, P92, DOI 10.1006/excr.2002.5557
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   Gan L, 2007, TISSUE ENG, V13, P831, DOI 10.1089/ten.2006.0231
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Hendriks JAA, 2006, ORS T 51 ANN M
   Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jeschke B, 2002, BIOMATERIALS, V23, P3455, DOI 10.1016/S0142-9612(02)00052-2
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahmood TA, 2005, TISSUE ENG, V11, P1244, DOI 10.1089/ten.2005.11.1244
   Mahmood TA, 2004, EXP CELL RES, V301, P179, DOI 10.1016/j.yexcr.2004.07.027
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Malda J, 2004, BIOMATERIALS, V25, P5773, DOI 10.1016/j.biomaterials.2004.01.028
   Malda J, 2004, OSTEOARTHR CARTILAGE, V12, P306, DOI 10.1016/j/joca.2003.12.001
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Mofrad MRK, 2005, ACTA BIOMATER, V1, P281, DOI 10.1016/j.actbio.2005.02.008
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Moroni L, 2006, J BIOMED MATER RES A, V78A, P605, DOI 10.1002/jbm.a.30716
   Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Orner BP, 2004, J AM CHEM SOC, V126, P10808, DOI 10.1021/ja0474291
   Reuss A., 1929, PMM-J APPL MATH MEC, V9, P49
   Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528
   Sohier J, 2003, J CONTROL RELEASE, V87, P57, DOI 10.1016/S0168-3659(02)00350-4
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stewart MC, 2000, J BONE MINER RES, V15, P166, DOI 10.1359/jbmr.2000.15.1.166
   Takai E, 2005, ANN BIOMED ENG, V33, P963, DOI 10.1007/s10439-005-3555-3
   Taylor DW, 2010, TISSUE ENG PT A, V16, P643, DOI 10.1089/ten.TEA.2009.0236
   Treppo S, 2000, J ORTHOP RES, V18, P739, DOI 10.1002/jor.1100180510
   van Dijkhuizen-Radersma R, 2002, BIOMATERIALS, V23, P1527, DOI 10.1016/S0142-9612(01)00286-1
   Voigt W, 1910, LEHRBUCH KRYSTALLPHS
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Woesz A, 2004, ADV ENG MATER, V6, P134, DOI 10.1002/adem.200300529
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
NR 45
TC 22
Z9 22
U1 2
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2013
VL 34
IS 17
BP 4259
EP 4265
DI 10.1016/j.biomaterials.2013.02.060
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 127LL
UT WOS:000317700400007
PM 23489921
DA 2018-10-20
ER

PT J
AU Yuan, SJ
   Yin, J
   Jiang, W
   Liang, B
   Pehkonen, SO
   Choong, C
AF Yuan, Shaojun
   Yin, Jia
   Jiang, Wei
   Liang, Bin
   Pehkonen, S. O.
   Choong, Cleo
TI Enhancing antibacterial activity of surface-grafted chitosan with
   immobilized lysozyme on bioinspired stainless steel substrates
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Stainless steel; Chitosan; Lysozyme; Bacterial adhesion; Covalent
   immobilization
ID ANTIMICROBIAL ACTIVITY; QUATERNIZED CHITOSAN; SILVER NANOPARTICLES;
   COATINGS; BACTERIA; DERIVATIVES; FABRICATION; MULTILAYER; CHITIN; FILMS
AB Bacterial infections have been widely recognized as a major cause of the failure of medical implants and devices. One promising strategy to reduce the incidence of infections is to impart the material surfaces with bactericidal function for inhibiting bacterial adhesion and biofilm formation. In this study, stainless steel (SS) surface was first activated by a biomimetic dopamine anchor to provide active amino groups, followed by covalently immobilizing chitosan (CS) with glutaraldehyde (GA) as a bifunctional linker. Hen egg white lysozyme, a natural defensive enzyme, was finally conjugated to the grafted chitosan to enhance biocidal functionality. The antibacterial assay results demonstrated substantial enhancement in bactericidal efficiency against Staphylococcus aureus (S. aureus) on the lysozyme-immobilized SS substrates under the neutral pH conditions as compared to the chitosan-grafted SS substrates. With the inherent advantages of robust anchoring ability of dopamine and specific functionality of lysozyme, the metallic substrates can be readily tailored with antibacterial property to combat biomaterial-centered infection for potential biomedical applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Yuan, Shaojun; Yin, Jia; Jiang, Wei; Liang, Bin] Sichuan Univ, Coll Chem Engn, Multiphases Mass Transfer & React Engn Lab, Chengdu 610065, Peoples R China.
   [Pehkonen, S. O.] Masdar Inst Sci & Technol, Chem Engn Program, Abu Dhabi, U Arab Emirates.
   [Choong, Cleo] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
RP Yuan, SJ (reprint author), Sichuan Univ, Coll Chem Engn, Multiphases Mass Transfer & React Engn Lab, Chengdu 610065, Peoples R China.
EM yuanshaojun@gmail.com; cleochoong@ntu.edu.sg
RI Yuan, Shaojun/B-2145-2012; Choong, Cleo/A-2240-2011
OI Yuan, Shaojun/0000-0002-3580-7977; Pehkonen, Simo/0000-0002-0362-9176
FU Sichuan University [208-220-413-4022]; National Natural Science
   Foundation of China [21176157]
FX The authors would like to acknowledge Sichuan University for the
   financial support of this study under the Research Starting Fund
   208-220-413-4022 and the financial assistance of National Natural
   Science Foundation of China project NO. 21176157.
CR Ali SW, 2011, CARBOHYD POLYM, V83, P438, DOI 10.1016/j.carbpol.2010.08.004
   An J, 2011, J APPL POLYM SCI, V120, P3180, DOI 10.1002/app.33532
   Appendini P., 1997, Packaging Technology & Science, V10, P271, DOI 10.1002/(SICI)1099-1522(199709/10)10:5<271::AID-PTS412>3.3.CO;2-I
   Bratskaya D. M. S., 2007, BIOMACROMOLECULES, V8, P2960
   Busscher H J, 1997, Adv Dent Res, V11, P24
   Busscher HJ, 2008, EUR J ORAL SCI, V116, P493, DOI 10.1111/j.1600-0722.2008.00568.x
   Busscher HJ, 2010, CURR OPIN COLLOID IN, V15, P510, DOI 10.1016/j.cocis.2010.05.014
   Caro A, 2010, J COLLOID INTERF SCI, V349, P13, DOI 10.1016/j.jcis.2009.12.001
   Chung YC, 2008, BIORESOURCE TECHNOL, V99, P2806, DOI 10.1016/j.biortech.2007.06.044
   CRAPISI A, 1993, PROCESS BIOCHEM, V28, P17, DOI 10.1016/0032-9592(94)80031-6
   CROWLEY SC, 1986, J CHROMATOGR, V359, P359, DOI 10.1016/0021-9673(86)80090-5
   Devlieghere F, 2004, FOOD MICROBIOL, V21, P703, DOI 10.1016/j.fm.2004.02.008
   Duan J, 2007, J FOOD SCI, V72, pM355, DOI 10.1111/j.1750-3841.2007.00556.x
   Elsabee MZ, 2008, CARBOHYD POLYM, V71, P187, DOI 10.1016/j.carbpol.2007.05.022
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   FARBER IY, 2010, J NANOPART RES, V12, P591
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   HADWIGER L.A., 1986, CHITIN NATURE TECHNO, P209, DOI DOI 10.1007/978-1-4613-2167-5
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   HUGHEY VL, 1987, APPL ENVIRON MICROB, V53, P2165
   IACONO VJ, 1980, INFECT IMMUN, V29, P623
   Karamdoust S, 2012, J MATER CHEM, V22, P4881, DOI 10.1039/c2jm15814k
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013
   Lim SH, 2003, J MACROMOL SCI-POL R, VC43, P223, DOI 10.1081/MC-120020161
   Lin CH, 2005, J APPL POLYM SCI, V97, P893, DOI 10.1002/app.21844
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Marini M, 2007, EUR POLYM J, V43, P3621, DOI 10.1016/j.eurpolymj.2007.06.002
   Martin HJ, 2007, LANGMUIR, V23, P6645, DOI 10.1021/la063284v
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   NOA HK, 2002, INT J FOOD MICROBIOL, V74, P65
   PAPINEAU AM, 1991, FOOD BIOTECHNOL, V5, P45, DOI 10.1080/08905439109549790
   PELLEGRINI A, 1992, J APPL BACTERIOL, V72, P180, DOI 10.1111/j.1365-2672.1992.tb01821.x
   Peng Z. X., 2010, ANTIMICROB AGENTS CH, V55, P860
   Ploux L., 2012, J NANOMATER, V2012, P1, DOI DOI 10.1155/2012/674145HINDAWI
   Potara M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/13/135101
   Poulter N., 2009, CHEM COMMUN, V47, P7312
   Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Ravindra S, 2010, COLLOID SURFACE A, V367, P31, DOI 10.1016/j.colsurfa.2010.06.013
   Sajomsang W, 2012, INT J BIOL MACROMOL, V50, P263, DOI 10.1016/j.ijbiomac.2011.11.004
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   SUDARSHAN NR, 1992, FOOD BIOTECHNOL, V6, P257, DOI 10.1080/08905439209549838
   Sun W. H., 1999, J FOOD PROTECT, V62, P239
   Swanson TE, 2011, J BIOMED MATER RES A, V97A, P167, DOI 10.1002/jbm.a.33043
   Thomas V., 2010, J IND TEXT, V40, P229
   Tin S, 2009, INT J BIOL SCI, V5, P153
   Vallapa N, 2011, CARBOHYD POLYM, V83, P868, DOI 10.1016/j.carbpol.2010.08.075
   Vreuls C, 2010, BIOFOULING, V26, P645, DOI 10.1080/08927014.2010.506678
   Wang Q, 2009, BIOPROC BIOSYST ENG, V32, P633, DOI 10.1007/s00449-008-0286-5
   Wang Y, 2012, SURF COAT TECH, V210, P71, DOI 10.1016/j.surfcoat.2012.08.066
   Wiarachai O, 2012, COLLOID SURFACE B, V92, P121, DOI 10.1016/j.colsurfb.2011.11.034
   Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j
   Yuan SJ, 2007, J ELECTROCHEM SOC, V154, pC645, DOI 10.1149/1.2777013
   Yuan SJ, 2011, LANGMUIR, V27, P2761, DOI 10.1021/la104442f
   Yudovin Farber I, 2008, BIOMACROMOLECULES, V9, P3044
NR 59
TC 25
Z9 29
U1 8
U2 202
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUN 1
PY 2013
VL 106
BP 11
EP 21
DI 10.1016/j.colsurfb.2012.12.048
PG 11
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 124CQ
UT WOS:000317441800002
PM 23434686
DA 2018-10-20
ER

PT J
AU Ramirez-Fernandez, MP
   Calvo-Guirado, JL
   Delgado-Ruiz, RA
   del Val, JEMS
   Negri, B
   Diago, MP
AF Piedad Ramirez-Fernandez, Maria
   Luis Calvo-Guirado, Jose
   Arcesio Delgado-Ruiz, Rafael
   Eduardo Mate-Sanchez del Val, Jose
   Negri, Bruno
   Penarrocha Diago, Maria
TI Ultrastructural study by backscattered electron imaging and elemental
   microanalysis of biomaterial-to-bone interface and mineral degradation
   of bovine xenografts in maxillary sinus floor elevation
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE back-scattered electron imaging; bovine bone xenograft; graft material;
   maxillary sinus lift
ID POROUS HYDROXYAPATITE; AUGMENTATION TECHNIQUES; CALCIUM-PHOSPHATE;
   IMPLANTS; SUBSTITUTE; GRAYLEVELS; MICROSCOPY; EFFICACY; INGROWTH;
   ENDOBON
AB Objectives The aim of this study was to perform an ultrastructural study of the bone-to-biomaterial interface and biomaterial mineral degradation in retrieved bone biopsies following maxillary sinus augmentation using bovine xenografts (Endobon (R)) in 15 clinical cases. Materials and methods Nine months after sinus lifting, bone cores were harvested from the maxillary sinus. The specimens were processed for observation under a scanning electron microscope with backscattered electron imaging (SEM-BSE). In addition, chemical analysis and elemental mapping of the mineral composition were generated using a microanalytical system based on energy-dispersive X-ray spectrometry (EDX). Results No clinical complications occurred during surgery. Scanning electron microscopy revealed that newly formed bone was closely attached to the xenograft. Elemental analysis showed a significantly high Ca/P ratio in the residual biomaterials (3.031 +/- 0.104) compared with the interface (2.908 +/- 0.115) and new bone (2.889 +/- 0.113), which suggests that there may be a gradual diffusion of Ca ions from the biomaterial into the newly forming bone at the interface as part of the biomaterial's resorption process. EDX analysis of the residual bovine biomaterial showed particle categories with different mean Ca/P ratios according to size, pointing to different stages of the resorption process. Conclusions The biomaterial proved to be biocompatible and osteoconductive when used as a bone substitute for maxillary sinus elevation. The grafting material used is not a completely resorbable material over the time period covered by this study.
C1 [Piedad Ramirez-Fernandez, Maria; Luis Calvo-Guirado, Jose; Negri, Bruno] Univ Murcia, Fac Med & Dent, Dept Implant Dent, Murcia 30007, Spain.
   [Arcesio Delgado-Ruiz, Rafael; Eduardo Mate-Sanchez del Val, Jose] Univ Murcia, Fac Med & Dent, Dept Restorat Dent, Murcia 30007, Spain.
   [Penarrocha Diago, Maria] Univ Valencia, Fac Med & Dent, Dept Oral Surg, Murcia, Spain.
RP Ramirez-Fernandez, MP (reprint author), Univ Murcia, Fac Med & Dent, Hosp Morales Meseguer, 2 Planta Clin Odontol Calle Marques de los Velez, Murcia 30007, Spain.
EM mpramirezfern@hotmail.com
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; calvo guirado,
   jose luis/0000-0002-4067-2253; Delgado-Ruiz, Rafael/0000-0003-1721-0509;
   RAMIREZ FERNANDEZ, MARIA PIEDAD/0000-0003-1913-9902; Penarrocha-Diago,
   Maria/0000-0001-6657-6959
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Arcuri C, 2005, Minerva Stomatol, V54, P351
   Baer W, 2002, J HAND SURG-BRIT EUR, V27B, P101, DOI 10.1054/jhsb.2001.0686
   Bareille R, 2000, BIOMATERIALS, V21, P1345, DOI 10.1016/S0142-9612(00)00015-6
   Bloebaum R D, 1990, J Biomater Appl, V5, P56
   Briem D, 2002, UNFALLCHIRURG, V105, P128, DOI 10.1007/s001130100303
   Calvo-Guirado JL, 2012, CLIN ORAL IMPLAN RES, V23, P667, DOI 10.1111/j.1600-0501.2011.02193.x
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Dellavia C., 2009, CLIN IMPLANT DENT R, V11, P59
   Franch J, 1998, VET COMP ORTHOPAED, V11, P105
   Gholami GA, 2012, CLIN ORAL IMPLAN RES, V23, P1198, DOI 10.1111/j.1600-0501.2011.02288.x
   Gierse H, 1999, ARCH ORTHOP TRAUM SU, V119, P349, DOI 10.1007/s004020050426
   Grimm J, 2001, ARCH ORTHOP TRAUM SU, V121, P158, DOI 10.1007/s004020000194
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   Hising P, 2001, INT J ORAL MAX IMPL, V16, P90
   JASTY M, 1989, SCANNING MICROSCOPY, V3, P1051
   Kehr P, 2000, EUR J ORTHOP SURG TR, V10, P217
   Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002
   Liebendorfer, 1997, UNFALLCHIRURGIE, V23, P60
   Lindgren C, 2010, CLIN ORAL IMPLAN RES, V21, P924, DOI 10.1111/j.1600-0501.2010.01933.x
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Nevins M, 2011, INT J PERIODONT REST, V31, P227
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Ottani V, 2002, MICRON, V33, P121, DOI 10.1016/S0968-4328(01)00008-7
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Pikdoken L, 2011, J ORAL MAXIL SURG, V69, P160, DOI 10.1016/j.joms.2010.07.036
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P47, DOI 10.1002/jbm.820270107
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P57, DOI 10.1002/jbm.820270108
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   Traini T, 2008, J PERIODONTOL, V79, P1232, DOI [10.1902/jop.2008.070504, 10.1902/jop.2008.070504 ]
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   van Steenberghe D, 2000, CLIN ORAL IMPLAN RES, V11, P210, DOI 10.1034/j.1600-0501.2000.011003210.x
   Werber KD, 2000, J HAND SURG-AM, V25A, P833, DOI 10.1053/jhsu.2000.16354
   Wierzchos J, 2008, MICRON, V39, P1363, DOI 10.1016/j.micron.2008.01.022
   Wiltfang J, 1996, J CRANIO MAXILL SURG, V24, P300, DOI 10.1016/S1010-5182(96)80063-1
   Worth A, 2005, CLIN ORAL IMPLAN RES, V16, P379, DOI 10.1111/j.1600-0501.2005.01113.x
NR 41
TC 11
Z9 11
U1 0
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2013
VL 24
IS 6
BP 645
EP 651
DI 10.1111/j.1600-0501.2012.02439.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 122EW
UT WOS:000317301700008
PM 22420524
DA 2018-10-20
ER

PT J
AU Manfrini, M
   Di Bona, C
   Canella, A
   Lucarelli, E
   Pellati, A
   D'Agostino, A
   Barbanti-Brodano, G
   Tognon, M
AF Manfrini, M.
   Di Bona, C.
   Canella, A.
   Lucarelli, E.
   Pellati, A.
   D'Agostino, A.
   Barbanti-Brodano, G.
   Tognon, M.
TI Mesenchymal stem cells from patients to assay bone graft substitutes
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID IN-VITRO; STROMAL CELLS; MARROW; BIOCOMPATIBILITY; HYDROXYAPATITES;
   DIFFERENTIATION; PROLIFERATION; BIOMATERIAL; SCAFFOLDS; BEHAVIOR
AB Bio-engineered scaffolds used in orthopedic clinical applications induce different tissue responses after implantation. In this study, non-stoichiometric Mg2+ ions and stoichiometric apatites, which are used in orthopedic surgery as bone substitutes, have been assayed in vitro with human adult mesenchymal stem cells (hMSC) to evaluate cytocompatibility and osteoconductivity. hMSCs from the bone marrow aspirates of orthopedic patients were isolated and analyzed by flow cytometry for the surface markers Stro1, CD29, CD44, CD71, CD73, CD90, CD105 (positive) and CD45, CD235 (negative). The hMSC were analyzed for self-renewal capacity and for differentiation potential. The hMSC, which were grown on different biomaterials, were analyzed for (i) cytotoxicity by AlamarBlue metabolic assay, (ii) osteoconductivity by ELISA for activated focal adhesion kinase, (iii) cytoskeleton organization by fluorescence microscopy, and (iv) cell morphology which was investigated by scan electron microscopy (SEM). Results indicate that isolated cell populations agree with minimal criteria for defining hMSC cultures. Non-stoichiometric Mg2+ and stoichiometric apatites, in granular form, represent a more favorable environment for mesenchymal stem cell adhesion and growth compared to the non-stoichiometric Mg2+ apatite, in nano-structured paste form. This study indicates that different forms of biomaterials modulate osteoconductivity and cellular growth by differential activation focal adhesion kinase. J. Cell. Physiol. 228: 12291237, 2013. (c) 2012 Wiley Periodicals, Inc.
C1 [Manfrini, M.; Di Bona, C.; Tognon, M.] Univ Ferrara, Sect Cell Biol & Mol Genet, Dept Morphol Surg & Expt Med, Sch Med & Surg, I-44121 Ferrara, Italy.
   [Canella, A.] Univ Ferrara, Dept Biochem & Mol Biol, I-44121 Ferrara, Italy.
   [Lucarelli, E.] Ist Ortoped Rizzoli, Lab Bone Regenerat, Bologna, Italy.
   [Pellati, A.] Univ Ferrara, Sect Histol & Embryol, Dept Morphol Surg & Expt Med, Sch Med & Surg, I-44121 Ferrara, Italy.
   [D'Agostino, A.] Univ Verona, Sch Med, Dept Odontostomatol & Maxillofacial Surg, I-37100 Verona, Italy.
   [D'Agostino, A.] Univ Verona, Sch Dent, I-37100 Verona, Italy.
   [Barbanti-Brodano, G.] Ist Ortoped Rizzoli, Bologna, Italy.
RP Tognon, M (reprint author), Univ Ferrara, Sect Cell Biol & Mol Genet, Dept Morphol Surg & Expt Medicne, Sch Med & Surg, V Fossato Mortara 64-B, I-44121 Ferrara, Italy.
EM tgm@unife.it
RI Lucarelli, Enrico/G-3588-2015
OI Lucarelli, Enrico/0000-0002-6681-6374
FU Fondazione Cassa di Risparmio di Bologna, Bologna, Italy; Fondazione
   Cassa di Risparmio di Cento, Cento, Italy; Regione Emilia-Romagna,
   project "Medicina rigenerativa''; AOSpine International, Dubendorf,
   Switzerland, project "Gene therapy for bone regeneration"; University of
   Verona, Verona. Italy; University of Ferrara, Ferrara. Italy; Fondazione
   Cassa di Risparmio di Bologna, Bologna; Fondazione Cassa di Risparmio di
   Cento, Cento; University of Verona, Verona
FX Contract grant sponsor: Fondazione Cassa di Risparmio di Bologna,
   Bologna, Italy.; Contract grant sponsor: Fondazione Cassa di Risparmio
   di Cento, Cento, Italy.; Contract grant sponsor: Regione Emilia-Romagna,
   project "Medicina rigenerativa''.; Contract grant sponsor: AOSpine
   International, Dubendorf, Switzerland, project "Gene therapy for bone
   regeneration''.; Contract grant sponsor: University of Verona, Verona.
   Italy.; Contract grant sponsor: University of Ferrara, Ferrara. Italy.;
   Dr. Rita Bovolenta's technical assistance is gratefully acknowledged for
   her SEM analysis performed at the Center of Electron Microscopy,
   University of Ferrara, Ferrara, Italy. This study was supported, in
   part, by grants from Fondazione Cassa di Risparmio di Bologna, Bologna;
   Fondazione Cassa di Risparmio di Cento, Cento; Regione Emilia Romagna,
   project "Medicina rigenerativa''; AOSpine International, Dubendorf,
   Switzerland, project "Gene therapy for bone regeneration''; University
   of Verona, Verona and University of Ferrara, Ferrara. Italy.
CR Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Barrere F, 2006, INT J NANOMED, V1, P317
   Bigi A, 1998, BIOMATERIALS, V19, P2335, DOI 10.1016/S0142-9612(98)00149-5
   Buhring HJ, 2007, ANN NY ACAD SCI, V1106, P262, DOI 10.1196/annals.1392.000
   Campioni K., 2010, J BIOMATER NANOBIOTE, V1, P1
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gregory CA, 2007, CULTURE HUMAN STEM C
   Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807
   Jenis L. G., 2006, US MUSCULOSKELETAL R, V2, P48
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Landi E, 2006, J EUR CERAM SOC, V26, P2593, DOI 10.1016/j.jeurceramsoc.2005.06.040
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Martinetti R, 2004, KEY ENG MAT, V254-2, P1095, DOI 10.4028/www.scientific.net/KEM.254-256.1095
   Morelli C, 2007, J BIOMED MATER RES A, V83A, P178, DOI 10.1002/jbm.a.31262
   Padilla S, 2006, ACTA BIOMATER, V2, P331, DOI 10.1016/j.actbio.2006.01.006
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   SIMMONS PJ, 1991, BLOOD, V78, P55
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   Tampieri A, 2005, ANAL BIOANAL CHEM, V381, P568, DOI 10.1007/s00216-004-2943-0
   Tognon M, 2008, TOPICS TISSUE ENG, P11
   Vidal MA, 2006, VET SURG, V35, P601, DOI 10.1111/j.1532-950X.2006.00197.x
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
NR 33
TC 14
Z9 14
U1 0
U2 111
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD JUN
PY 2013
VL 228
IS 6
BP 1229
EP 1237
DI 10.1002/jcp.24276
PG 9
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 096OL
UT WOS:000315414000012
PM 23129455
DA 2018-10-20
ER

PT J
AU Mori, H
   Kondo, E
   Kawaguchi, Y
   Kitamura, N
   Nagai, N
   Iida, H
   Yasuda, K
AF Mori, Hiroyuki
   Kondo, Eiji
   Kawaguchi, Yasuyuki
   Kitamura, Nobuto
   Nagai, Nobuhiro
   Iida, Hirokazu
   Yasuda, Kazunori
TI Development of a salmon-derived crosslinked atelocollagen sponge disc
   containing osteogenic protein-1 for articular cartilage regeneration: in
   vivo evaluations with rabbits
SO BMC MUSCULOSKELETAL DISORDERS
LA English
DT Article
DE Salmon-Derived Atelocollagen Sponge; Crosslinked Collagen; Cartilage
   Regeneration; Scaffold; Biomaterial
ID BONE MORPHOGENETIC PROTEIN-7; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   COLLAGEN GEL; CELLS; OP-1; LIGAMENT; DEFECTS; GROWTH;
   INSULIN-LIKE-GROWTH-FACTOR-1; PROTEOGLYCAN
AB Background: We have developed crosslinked salmon-derived atelocollagen sponge, which has a denaturation temperature of 47 degrees Celsius. The purpose of this study is to evaluate the fundamental in vivo efficacy of the osteogenic protein (OP) -1 containing salmon-derived collagen sponge disc (SCS) on cartilage regeneration, using a rabbit model.
   Methods: A total of 24 rabbits were used in this study. In each animal, a full-thickness osteochondral defect was created in each femoral trochlea. Then, each 12 rabbits were randomly divided into the two groups. In Group I, an OP1-SCS disc was implanted into the defect in the right knee. In Group II, a SCS disc without OP-1 was implanted into the defect in the right knee. A control group of 12 rabbits was assembled from randomly-selected left knees from among the first two groups. In Group-III, we applied no treatment for a defect in the left knee to obtain the untreated control. All rabbits were sacrificed at 12 weeks after surgery. In each group, 10 animals were used for histological and immunohistological evaluations, and the remaining 2 were used for real-time polymerase chain reaction (PCR) analyses.
   Results: In Group I, a regenerated cartilage tissue rich in proteoglycan and type-2 collagen was found at 12 weeks, although the width was thicker than that of Group II. In Group II, the defect was filled with thick inhomogeneous tissues, including cartilage, fibrous, and bone tissues at 12 weeks. Concerning the gross observation and histological scores at 12 weeks, the ANOVA showed significant differences (p < 0.0001, and p < 0.0001, respectively). The post-hoc test indicated that the gross observation and histological scores of Group I was significantly greater than those of Groups II (p = 0.035, and p = 0.0104, respectively) and III (p < 0.0001, and p < 0.0001, respectively), while Group II was significantly greater than Group III (p = 0.0069, and p = 0.005, respectively). The real time PCR analysis showed that gene expression of type-2 collagen and aggrecan of Group I was greater than that of Group II.
   Conclusions: The present study clearly demonstrated that the implantation of the OP1-SCS disc without any cultured cells may induce spontaneous hyaline-like cartilage regeneration to greater degrees than implantation of only the salmon-derived collagen sponge disc.
C1 [Mori, Hiroyuki; Kondo, Eiji; Kawaguchi, Yasuyuki; Kitamura, Nobuto; Yasuda, Kazunori] Hokkaido Univ, Grad Sch Med, Dept Sports Med & Joint Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Mori, Hiroyuki; Iida, Hirokazu] Kansai Med Univ, Dept Orthopaed Surg, Osaka, Japan.
   [Nagai, Nobuhiro] Tohoku Univ, Sch Med, Dept Translat Res, Sendai, Miyagi 980, Japan.
RP Kondo, E (reprint author), Hokkaido Univ, Grad Sch Med, Dept Sports Med & Joint Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.
EM eijik@med.hokudai.ac.jp
RI Kondo, Eiji/G-2004-2012; Yasuda, Kazunori/C-9998-2009
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [21500400]
FX This study was supported financially in part by the Grants-in-Aid for
   Scientific Research (21500400) from the Ministry of Education, Culture,
   Sports, Science and Technology, Japan.
CR BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BURJANADZE TV, 1992, BIOPOLYMERS, V32, P941, DOI 10.1002/bip.360320805
   Chubinskaya S, 2007, OSTEOARTHR CARTILAGE, V15, P421, DOI 10.1016/j.joca.2006.10.004
   Chubinskaya S, 2002, BBA-MOL BASIS DIS, V1588, P126, DOI 10.1016/S0925-4439(02)00158-8
   Chubinskaya S, 2000, J HISTOCHEM CYTOCHEM, V48, P239, DOI 10.1177/002215540004800209
   Chubinskaya S, 2007, J ORTHOP RES, V25, P517, DOI 10.1002/jor.20339
   Cook SD, 1999, ORTHOPEDICS, V22, P669
   Fan Z, 2004, CLIN EXP RHEUMATOL, V22, P103
   Flechtenmacher J, 1996, ARTHRITIS RHEUM-US, V39, P1896, DOI 10.1002/art.1780391117
   Friedlaender GE, 2001, J BONE JOINT SURG S1, V83, P151
   Hayashi M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2521
   Hayashi R, 2008, J BONE JOINT SURG BR, V90B, P1392, DOI 10.1302/0301-620X.90B10.20924
   Huch K, 1997, ARTHRITIS RHEUM, V40, P2157, DOI 10.1002/art.1780401209
   Im HJ, 2003, J BIOL CHEM, V278, P25386, DOI 10.1074/jbc.M302048200
   Jelic M, 2001, GROWTH FACTORS, V19, P101, DOI 10.3109/08977190109001079
   Kanayama M, 2006, SPINE, V31, P1067, DOI 10.1097/01.brs.0000216444.01888.21
   Kawaguchi Y, 2011, J MATER SCI-MATER M, V22, P397, DOI 10.1007/s10856-010-4215-1
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Koepp HE, 1999, INFLAMM RES, V47, P1
   Kuzuya M, 1998, DIABETOLOGIA, V41, P491, DOI 10.1007/s001250050937
   Lietman SA, 1997, J BONE JOINT SURG AM, V79A, P1132, DOI 10.2106/00004623-199708000-00003
   Loeser RF, 2005, ARTHRITIS RHEUM, V52, P3910, DOI 10.1002/art.21472
   Loeser RF, 2003, ARTHRITIS RHEUM, V48, P2188, DOI 10.1002/art.11209
   Louwerse RT, 2000, J BIOMED MATER RES, V49, P506, DOI 10.1002/(SICI)1097-4636(20000315)49:4<506::AID-JBM9>3.0.CO;2-A
   Nagai N, 2004, J BIOSCI BIOENG, V97, P389, DOI 10.1263/jbb.97.389
   Nagai N, 2008, J BIOMATER APPL, V23, P275, DOI 10.1177/0885328208092109
   Nagai N, 2007, J BIOMED MATER RES A, V82A, P395, DOI 10.1002/jbm.a.31110
   Nishida Y, 2000, ARTHRITIS RHEUM, V43, P206, DOI 10.1002/1529-0131(200001)43:1<206::AID-ANR25>3.0.CO;2-1
   NISHIKAWA A, 1987, EXP CELL RES, V171, P164, DOI 10.1016/0014-4827(87)90259-X
   Ochi M, 2004, ARTIF ORGANS, V28, P28, DOI 10.1111/j.1525-1594.2004.07317.x
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
NR 37
TC 2
Z9 2
U1 1
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2474
J9 BMC MUSCULOSKEL DIS
JI BMC Musculoskelet. Disord.
PD MAY 30
PY 2013
VL 14
AR 174
DI 10.1186/1471-2474-14-174
PG 10
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 176LF
UT WOS:000321305200001
PM 23721417
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Herbers, CR
   Li, CL
   van der Vegt, NFA
AF Herbers, Claudia R.
   Li, Chunli
   van der Vegt, Nico F. A.
TI Grand challenges in quantum-classical modeling of molecule-surface
   interactions
SO JOURNAL OF COMPUTATIONAL CHEMISTRY
LA English
DT Review
DE surface interactions; quantum-classical modeling; force field
   development
ID DENSITY-FUNCTIONAL THEORY; GENERALIZED GRADIENT APPROXIMATION;
   FORCE-FIELD; DYNAMICS APPROACH; METAL-SURFACES; ORGANIC-MOLECULES;
   AU(111) SURFACES; AQUEOUS-SOLUTION; WATER INTERFACE; AB-INITIO
AB A detailed understanding of the adsorption of small molecules or macromolecules to a materials surface is of importance, for example, in the context of material and biomaterial research. Classical atomistic simulations in principle provide microscopic insight in the complex entropic and enthalpic interplay at the interface. However, an application of classical atomistic simulation techniques to such interface systems is a nontrivial problem, mostly because commonly used force fields cannot be straightforwardly applied, as they are usually developed to reproduce bulk properties of either solids or liquids but not the interfacial region between two phases. Therefore, a dual-scale modeling approach has often been the method of choice in the past, in which the classical force field is parameterized such that quantum chemical information on near-surface conformations and adsorption energies is reproduced by the classical force field. We will discuss in this review the current state-of-the-art of quantum-classical modeling of moleculesurface interactions and outline the major challenges in this field. In this context, we will, among other things, lay emphasis on discussing ways to obtain representable force fields and propose systematic and system-independent strategies to optimize the quantum-classical fitting procedure. (c) 2013 Wiley Periodicals, Inc.
C1 [Herbers, Claudia R.; Li, Chunli; van der Vegt, Nico F. A.] Tech Univ Darmstadt, Ctr Smart Interfaces, Petersenstr 17, D-64287 Darmstadt, Germany.
RP Herbers, CR (reprint author), Tech Univ Darmstadt, Ctr Smart Interfaces, Petersenstr 17, D-64287 Darmstadt, Germany.
EM vandervegt@csi.tu-darmstadt.de
RI van der Vegt, Nico/B-3441-2010
OI van der Vegt, Nico/0000-0003-2880-6383
FU German Research Foundation (DFG) within the Cluster of Excellence 259
   "Smart Interfaces - Understanding and Designing Fluid Boundaries"
FX Contract/grant sponsor: German Research Foundation (DFG) within the
   Cluster of Excellence 259 "Smart Interfaces - Understanding and
   Designing Fluid Boundaries."
CR Abrams CF, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021807
   Alexiadis O, 2007, J PHYS CHEM C, V111, P6380, DOI 10.1021/jp067347u
   Alimohammadi M, 2011, J PHYS CHEM C, V115, P24206, DOI 10.1021/jp207272e
   Bandura AV, 2003, J PHYS CHEM B, V107, P11072, DOI 10.1021/jp034093t
   BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098
   Borodin O, 2003, MACROMOLECULES, V36, P7873, DOI 10.1021/ma0346005
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Brown WM, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3294562
   Butenuth A, 2012, PHYS STATUS SOLIDI B, V249, P292, DOI 10.1002/pssb.201100786
   Carravetta V, 2006, J PHYS CHEM B, V110, P6160, DOI 10.1021/jp056760j
   Cohavi O, 2010, J MOL RECOGNIT, V23, P259, DOI 10.1002/jmr.993
   Cole DJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799196
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   de Leeuw NH, 2001, PHYS CHEM CHEM PHYS, V3, P3217, DOI 10.1039/b102928m
   de Leeuw NH, 1998, PHYS REV B, V58, P13901, DOI 10.1103/PhysRevB.58.13901
   Delle Site L, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.115401
   Delle Site L, 2004, J AM CHEM SOC, V126, P2944, DOI 10.1021/ja0387406
   Delle Site L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.156103
   Di Felice R, 2011, J PHYS CHEM LETT, V2, P1510, DOI 10.1021/jz200297k
   Freeman CL, 2007, J PHYS CHEM C, V111, P11943, DOI 10.1021/jp071887p
   Freeman CL, 2009, J PHYS CHEM C, V113, P3666, DOI 10.1021/jp807051u
   Ghiringhelli LM, 2008, J AM CHEM SOC, V130, P13460, DOI 10.1021/ja804350v
   Goldberg D. E, 1989, GENETIC ALGORITHMS S
   Grimme S., 2011, COMPUT MOL SCI, V1, P211, DOI DOI 10.1002/WCMS.30
   Harding JH, 2006, J MATER CHEM, V16, P1105, DOI 10.1039/b511650c
   Harding JH, 2008, CHEM REV, V108, P4823, DOI 10.1021/cr078278y
   Heinz H, 2008, J PHYS CHEM C, V112, P17281, DOI 10.1021/jp801931d
   Heinz H, 2009, J AM CHEM SOC, V131, P9704, DOI 10.1021/ja900531f
   Herbers CR, 2011, PHYS CHEM CHEM PHYS, V13, P10577, DOI 10.1039/c0cp02889d
   HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807
   Horinek D, 2008, P NATL ACAD SCI USA, V105, P2842, DOI 10.1073/pnas.0707879105
   Iori F, 2009, J COMPUT CHEM, V30, P1465, DOI 10.1002/jcc.21165
   Johnston K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.121404
   Johnston K, 2012, J PHYS CHEM C, V116, P19781, DOI 10.1021/jp3044187
   Johnston K, 2012, SOFT MATTER, V8, P6320, DOI 10.1039/c2sm25567g
   Johnston K, 2011, J PHYS CHEM C, V115, P14707, DOI 10.1021/jp2003485
   Johnston K, 2011, SOFT MATTER, V7, P6457, DOI 10.1039/c1sm05410d
   Johnston K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235428
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   Kim HJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.041403
   Langreth DC, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/8/084203
   Latour RA, 2008, BIOINTERPHASES, V3, pFC2, DOI 10.1116/1.2965132
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Li G, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.121409
   Lopes PEM, 2006, J PHYS CHEM B, V110, P2782, DOI 10.1021/jp055341j
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017
   McCarthy MI, 1996, J PHYS CHEM-US, V100, P16989, DOI 10.1021/jp961373i
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090
   Pavese A, 1996, PHYS CHEM MINER, V23, P89, DOI 10.1007/BF00202303
   PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D
   Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533
   Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Perdew JP, 1998, J CHEM PHYS, V108, P1522, DOI 10.1063/1.475524
   Perdew P., 1988, PHYS REV LETT, V80, P891
   Qian J, 1997, LANGMUIR, V13, P7092, DOI 10.1021/la9707484
   Raiteri P, 2010, J PHYS CHEM C, V114, P5997, DOI 10.1021/jp910977a
   Riley KE, 2010, CHEM REV, V110, P5023, DOI 10.1021/cr1000173
   Schneider J, 2011, J CHEM THEORY COMPUT, V7, P473, DOI 10.1021/ct1004388
   Schravendijk P, 2005, CHEMPHYSCHEM, V6, P1866, DOI 10.1002/cphc.200400591
   Schravendijk P, 2007, J PHYS CHEM C, V111, P2631, DOI 10.1021/jp065568u
   Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078
   Skelton AA, 2011, LANGMUIR, V27, P8700, DOI 10.1021/la2005826
   Skelton AA, 2011, J PHYS CHEM C, V115, P2076, DOI 10.1021/jp109446d
   Smith JS, 2007, J POLYM SCI POL PHYS, V45, P1599, DOI 10.1002/polb.21119
   Sushko ML, 2006, J PHYS CHEM B, V110, P4853, DOI 10.1021/jp055486q
   Tarmyshov KB, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2472357
   Tkatchenko A, 2010, MRS BULL, V35, P435, DOI 10.1557/mrs2010.581
   Tonigold K, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3439691
   WEINER PK, 1981, J COMPUT CHEM, V2, P287, DOI 10.1002/jcc.540020311
   Wellendorff J, 2010, TOP CATAL, V53, P378, DOI 10.1007/s11244-010-9443-6
   Wilson M, 2000, J CHEM PHYS, V113, P9180, DOI 10.1063/1.1320056
   Wright LB, 2012, J PHYS CHEM C, V116, P2933, DOI 10.1021/jp209554g
   Youngs TGA, 2009, J PHYS CHEM C, V113, P21342, DOI 10.1021/jp906677c
   Zhang YK, 1998, PHYS REV LETT, V80, P890, DOI 10.1103/PhysRevLett.80.890
NR 78
TC 0
Z9 0
U1 3
U2 60
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0192-8651
EI 1096-987X
J9 J COMPUT CHEM
JI J. Comput. Chem.
PD MAY 30
PY 2013
VL 34
IS 14
BP 1177
EP 1188
DI 10.1002/jcc.23247
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA 132CB
UT WOS:000318044300001
PM 23420673
DA 2018-10-20
ER

PT J
AU Youngstrom, DW
   Barrett, JG
   Jose, RR
   Kaplan, DL
AF Youngstrom, Daniel W.
   Barrett, Jennifer G.
   Jose, Rod R.
   Kaplan, David L.
TI Functional Characterization of Detergent-Decellularized Equine Tendon
   Extracellular Matrix for Tissue Engineering Applications
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; DIGITAL FLEXOR TENDON; HEART-VALVES; EXTRACTION
   TECHNIQUES; STROMAL CELLS; IN-VIVO; SCAFFOLD; REPAIR; REGENERATION;
   SLICES
AB Natural extracellular matrix provides a number of distinct advantages for engineering replacement orthopedic tissue due to its intrinsic functional properties. The goal of this study was to optimize a biologically derived scaffold for tendon tissue engineering using equine flexor digitorum superficialis tendons. We investigated changes in scaffold composition and ultrastructure in response to several mechanical, detergent and enzymatic decellularization protocols using microscopic techniques and a panel of biochemical assays to evaluate total protein, collagen, glycosaminoglycan, and deoxyribonucleic acid content. Biocompatibility was also assessed with static mesenchymal stem cell (MSC) culture. Implementation of a combination of freeze/thaw cycles, incubation in 2% sodium dodecyl sulfate (SDS), trypsinization, treatment with DNase-I, and ethanol sterilization produced a non-cytotoxic biomaterial free of appreciable residual cellular debris with no significant modification of biomechanical properties. These decellularized tendon scaffolds (DTS) are suitable for complex tissue engineering applications, as they provide a clean slate for cell culture while maintaining native three-dimensional architecture.
C1 [Youngstrom, Daniel W.] Virginia Tech, Dept Biomed & Vet Sci, Virginia Maryland Reg Coll Vet Med, Leesburg, VA USA.
   [Barrett, Jennifer G.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Marion duPont Scott Equine Med Ctr, Dept Large Anim Clin Sci, Leesburg, VA USA.
   [Jose, Rod R.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Tissue Engn Resource Ctr, Medford, MA USA.
RP Barrett, JG (reprint author), Virginia Tech, Virginia Maryland Reg Coll Vet Med, Marion duPont Scott Equine Med Ctr, Dept Large Anim Clin Sci, Leesburg, VA USA.
EM jgbarrett@vt.edu
OI Barrett, Jennifer/0000-0002-5550-4412; Youngstrom,
   Daniel/0000-0002-1193-8868
FU Virginia Tech Institute for Critical Technology and Applied Science
   (ICTAS); Morris Animal Foundation; Tissue Engineering Resource Center
   (TERC) at Tufts University [NIH P41 EB002520]
FX The authors would like to acknowledge partial funding by the Virginia
   Tech Institute for Critical Technology and Applied Science (ICTAS), the
   Morris Animal Foundation, and the Tissue Engineering Resource Center
   (TERC) at Tufts University [NIH P41 EB002520]. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ABRAHAMSSON SO, 1989, SCAND J PLAST RECONS, V23, P191, DOI 10.3109/02844318909075117
   Ahmad Z, 2012, ARTHROSCOPY, V28, P1018, DOI 10.1016/j.arthro.2011.12.009
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630
   Birch HL, 1997, J EXP BIOL, V200, P1703
   Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x
   Blevins FT, 1997, ORTHOP CLIN N AM, V28, P1, DOI 10.1016/S0030-5898(05)70260-1
   Butcher MT, 2009, COMP BIOCHEM PHYS A, V152, P100, DOI 10.1016/j.cbpa.2008.09.007
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.3.CO;2-4
   Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x
   Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Deeken CR, 2011, J BIOMED MATER RES B, V96B, P199, DOI 10.1002/jbm.b.31753
   Dowling BA, 2005, VET J, V170, P184, DOI 10.1016/j.tvjl.2004.03.021
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Goodship AE, 2002, EQUINE VET J S, V34, P288, DOI DOI 10.1111/J.2042-3306.2002.TB05435.X
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   KRAUSHANSEN AE, 1992, EQUINE VET J, V24, P46, DOI 10.1111/j.2042-3306.1992.tb02778.x
   LOPPNOW H, 1989, IMMUNOBIOLOGY, V179, P283, DOI 10.1016/S0171-2985(89)80023-3
   Lui PPY, 2012, J CELL MOL MED, V20, P1
   MCINTOSH JK, 1989, J IMMUNOL, V143, P162
   Ning LJ, 2012, J BIOMED MATER RES A, V100A, P1448, DOI 10.1002/jbm.a.34083
   Omae H, 2009, J ORTHOP RES, V27, P937, DOI 10.1002/jor.20823
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park KM, 2012, TRANSPL P, V44, P1151, DOI 10.1016/j.transproceed.2012.03.017
   Patterson-Kane JC, 2012, J COMP PATHOL, V147, P227, DOI 10.1016/j.jcpa.2012.05.010
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pridgen BC, 2011, TISSUE ENG PART C-ME, V17, P819, DOI 10.1089/ten.tec.2010.0457
   Qin TW, 2012, J BIOMED MATER RES B, V100B, P752, DOI 10.1002/jbm.b.32508
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Santiago JA, 2009, TISSUE ENG PT A, V15, P3911, DOI 10.1089/ten.tea.2008.0603
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schulze-Tanzil Gundula, 2012, Cells, V1, P1010, DOI 10.3390/cells1041010
   Stewart AA, 2009, AM J VET RES, V70, P750, DOI 10.2460/ajvr.70.6.750
   Thornton GM, 2011, J MUSCULOSKEL NEURON, V11, P94
   Thorpe CT, 2010, EQUINE VET J, V42, P174, DOI 10.2746/042516409X480395
   Tran RT, 2010, MATERIALS, V3, P1375, DOI 10.3390/ma3021375
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Weber B, 2011, SEMIN IMMUNOPATHOL, V33, P307, DOI 10.1007/s00281-011-0258-8
   Whitlock PW, 2007, BIOMATERIALS, V28, P4321, DOI 10.1016/j.biomaterials.2007.05.029
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Xu Q, 2012, ADV HEALTHC MAT 1212
   Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843
   Zhang JY, 2011, BIOMATERIALS, V32, P6972, DOI 10.1016/j.biomaterials.2011.05.088
NR 57
TC 36
Z9 37
U1 1
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 27
PY 2013
VL 8
IS 5
AR e64151
DI 10.1371/journal.pone.0064151
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 155HH
UT WOS:000319738100019
PM 23724028
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Acheampong, MA
   Pakshirajan, K
   Annachhatre, AP
   Lens, PNL
AF Acheampong, Mike A.
   Pakshirajan, Kannan
   Annachhatre, Ajit P.
   Lens, Piet N. L.
TI Removal of Cu(II) by biosorption onto coconut shell in fixed-bed column
   systems
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE Adsorption; Biosorption; Breakthrough curve; Copper; Fixed-bed column;
   Wastewater
ID AQUEOUS-SOLUTION; NATURAL ZEOLITE; PACKED-COLUMN; BREAKTHROUGH CURVES;
   ACTIVATED CARBON; HEAVY-METALS; WASTE-WATER; IONS; ADSORPTION; BATCH
AB Biosorption of Cu(II) onto coconut shell, an agricultural biomaterial, was studied in a fixed-bed column. The Cu(II) biosorption column had the best performance at 10 mg L-1 inlet Cu(II) concentration, 10 mL min(-1) flow rate and 20 cm bed depth. The equilibrium uptake of Cu(II) amounted to 7.25 mg g(-1). The simulation of the breakthrough curve was successful with the BDST and Yoon-Nelson models, but the entire breakthrough curve was best predicted by the Clark model. The design of a fixed bed column for Cu(II) removal from wastewater by biosorption onto coconut shell can be done based on these models. (C). 2012 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [Acheampong, Mike A.; Pakshirajan, Kannan; Lens, Piet N. L.] UNESCO IHE, Inst Water Educ, Dept Environm Engn & Water Technol, Pollut Prevent & Resource Recovery Core, NL-2611 AX Delft, Netherlands.
   [Acheampong, Mike A.] Kumasi Polytech, Dept Chem Engn, Kumasi, Ghana.
   [Pakshirajan, Kannan] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati 781039, Assam, India.
   [Annachhatre, Ajit P.] Asian Inst Technol, Sch Environm Resources & Dev, Dept Environm Engn & Management, Khlong Luang, Thailand.
RP Acheampong, MA (reprint author), UNESCO IHE, Inst Water Educ, Dept Environm Engn & Water Technol, Pollut Prevent & Resource Recovery Core, Westvest 7, NL-2611 AX Delft, Netherlands.
EM m.acheampong@unesco-ihe.org
RI Lens, Piet Nicolaas Luc/B-7245-2018
OI Lens, Piet Nicolaas Luc/0000-0002-5825-878X
FU Netherlands Government under the Netherlands Fellowship Programme (NFP),
   NUFFIC award [32022513]; Staff Development and Postgraduate Scholarship
   Scheme (Kumasi Polytechnic, Ghana); UNESCO-IHE Partner Research Fund,
   UPaRF III research project PRBRAMD [101014]
FX The authors acknowledge funding from the Netherlands Government under
   the Netherlands Fellowship Programme (NFP), NUFFIC award (2009-2013),
   project number: 32022513. We also acknowledge funding from the Staff
   Development and Postgraduate Scholarship Scheme (Kumasi Polytechnic,
   Ghana) and the UNESCO-IHE Partner Research Fund, UPaRF III research
   project PRBRAMD (no. 101014).
CR Acheampong M.A., SEPARATION SCI UNPUB
   Acheampong MA, 2011, J CHEM TECHNOL BIOT, V86, P1184, DOI 10.1002/jctb.2630
   Ahmad AA, 2010, J HAZARD MATER, V175, P298, DOI 10.1016/j.jhazmat.2009.10.003
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aksu Z, 2004, PROCESS BIOCHEM, V39, P599, DOI 10.1016/S0032-9592(03)00132-8
   Al-Degs YS, 2009, J HAZARD MATER, V165, P944, DOI 10.1016/j.jhazmat.2008.10.081
   Amarasinghe BMWPK, 2007, CHEM ENG J, V132, P299, DOI 10.1016/j.cej.2007.01.016
   Apiratikul R, 2008, BIORESOURCE TECHNOL, V99, P2766, DOI 10.1016/j.biortech.2007.06.036
   Baral SS, 2009, J HAZARD MATER, V161, P1427, DOI 10.1016/j.jhazmat.2008.04.127
   Batzias FA, 2004, J HAZARD MATER, V114, P167, DOI 10.1016/j.jhazmat.2004.08.014
   Bohart GS, 1920, J AM CHEM SOC, V42, P523, DOI 10.1021/ja01448a018
   Chen CY, 2011, J ENVIRON MANAGE, V92, P796, DOI 10.1016/j.jenvman.2010.10.029
   Chen SH, 2012, BIORESOURCE TECHNOL, V113, P114, DOI 10.1016/j.biortech.2011.11.110
   CLARK RM, 1987, ENVIRON SCI TECHNOL, V21, P573, DOI 10.1021/es00160a008
   Fagundes-Klen MR, 2010, WATER AIR SOIL POLL, V213, P15, DOI 10.1007/s11270-010-0363-7
   Ghribi A., 2011, ASIAN J TEXTILE, P161, DOI DOI 10.3923/AJT.2011.161.171
   Han RP, 2006, J HAZARD MATER, V133, P262, DOI 10.1016/j.jhazmat.2005.10.019
   Han RP, 2009, CHEM ENG J, V149, P123, DOI 10.1016/j.cej.2008.10.015
   Ko DCK, 2000, CHEM ENG SCI, V55, P5819, DOI 10.1016/S0009-2509(00)00416-4
   Lu XW, 2009, J HAZARD MATER, V161, P1058, DOI 10.1016/j.jhazmat.2008.04.052
   Luo XG, 2011, CARBOHYD POLYM, V86, P753, DOI 10.1016/j.carbpol.2011.05.020
   Luo XG, 2011, J HAZARD MATER, V187, P182, DOI 10.1016/j.jhazmat.2011.01.019
   Malkoc E, 2006, CHEM ENG SCI, V61, P4363, DOI 10.1016/j.ces.2006.02.005
   Martin-Lara MA, 2012, J IND ENG CHEM, V18, P1006, DOI 10.1016/j.jiec.2011.11.150
   Medvidovic NV, 2008, SEP SCI TECHNOL, V43, P944, DOI 10.1080/01496390701870622
   Mohan S, 2008, J HAZARD MATER, V153, P75, DOI 10.1016/j.jhazmat.2007.08.021
   Mondal MK, 2009, J ENVIRON MANAGE, V90, P3266, DOI 10.1016/j.jenvman.2009.05.025
   Futalan CM, 2011, CARBOHYD POLYM, V83, P697, DOI 10.1016/j.carbpol.2010.08.043
   Naja G, 2006, COLLOID SURFACE A, V281, P194, DOI 10.1016/j.colsurfa.2006.02.040
   Nayek S, 2010, J HAZARD MATER, V178, P588, DOI 10.1016/j.jhazmat.2010.01.126
   Oguz E, 2010, CHEM ENG J, V164, P56, DOI 10.1016/j.cej.2010.08.016
   Oliveira RC, 2012, BIOTECHNOL PROGR, V28, P715, DOI 10.1002/btpr.1525
   Pakshirajan K, 2006, SOIL SEDIMENT CONTAM, V15, P187, DOI 10.1080/15320380500506347
   Qaiser S, 2009, J HAZARD MATER, V166, P998, DOI 10.1016/j.jhazmat.2008.12.003
   Sag Y, 2001, PROCESS BIOCHEM, V36, P1187, DOI 10.1016/S0032-9592(01)00150-9
   Sekhar KC, 2003, INT J MINER PROCESS, V68, P37
   Shi WY, 2009, J HAZARD MATER, V170, P1, DOI 10.1016/j.jhazmat.2009.04.097
   Singh S, 2009, COLLOID SURFACE A, V332, P50, DOI 10.1016/j.colsurfa.2008.08.025
   Singh TS, 2006, SEP PURIF TECHNOL, V48, P288, DOI 10.1016/j.seppur.2005.07.035
   Sousa FW, 2010, J ENVIRON MANAGE, V91, P1634, DOI 10.1016/j.jenvman.2010.02.011
   Stylianou MA, 2007, DESALINATION, V215, P133, DOI 10.1016/j.desal.2006.10.031
   Taty-Costodes VC, 2005, J HAZARD MATER, V123, P135, DOI 10.1016/j.jhazmat.2005.03.032
   Thomas HC, 1944, J AM CHEM SOC, V66, P1664, DOI 10.1021/ja01238a017
   Tung CC, 2002, WASTE MANAGE, V22, P695, DOI 10.1016/S0956-053X(02)00049-1
   Vijayaraghavan K, 2008, CHEM ENG J, V145, P44, DOI 10.1016/j.cej.2008.03.001
   Vijayaraghavan K, 2006, J HAZARD MATER, V137, P558, DOI 10.1016/j.jhazmat.2006.02.030
   Vijayaraghavan K, 2004, J HAZARD MATER, V113, P223, DOI 10.1016/j.jhazmat.2004.06.014
   Vilar VJP, 2008, J HAZARD MATER, V154, P1173, DOI 10.1016/j.jhazmat.2007.11.060
   Wu G, 2010, J HAZARD MATER, V174, P1, DOI 10.1016/j.jhazmat.2009.09.113
   Yahaya N. K. E. M, 2011, INT J ENG TECHNOL, V11, P248
   YOON YH, 1984, AM IND HYG ASSOC J, V45, P509, DOI 10.1080/15298668491400197
   Zhao XM, 2009, J HAZARD MATER, V170, P570, DOI 10.1016/j.jhazmat.2009.05.026
NR 52
TC 44
Z9 44
U1 2
U2 59
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD MAY 25
PY 2013
VL 19
IS 3
BP 841
EP 848
DI 10.1016/j.jiec.2012.10.029
PG 8
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 128XI
UT WOS:000317802600021
DA 2018-10-20
ER

PT J
AU Pelto, JM
   Haimi, SP
   Siljander, AS
   Miettinen, SS
   Tappura, KM
   Higgins, MJ
   Wallace, GG
AF Pelto, Jani M.
   Haimi, Suvi P.
   Siljander, Aliisa S.
   Miettinen, Susanna S.
   Tappura, Kirsi M.
   Higgins, Michael J.
   Wallace, Gordon G.
TI Surface Properties and Interaction Forces of Biopolymer-Doped Conductive
   Polypyrrole Surfaces by Atomic Force Microscopy
SO LANGMUIR
LA English
DT Article
ID ADIPOSE STEM-CELLS; HYALURONIC-ACID; OSTEOGENIC DIFFERENTIATION;
   POLYMERS; BIOMATERIALS; SUBSTRATE; GLASS
AB Surface properties and electrical charges are critical factors elucidating cell interactions on biomaterial surfaces. The surface potential distribution and the nanoscopic and microscopic surface elasticity of organic polypyrrole-hyaluronic acid (PPy-HA) were studied by atomic force microscopy (AFM) in a fluid environment in order to explain the observed enhancement in the attachment of human adipose stem cells on positively charged PPy-HA films. The electrostatic force between the AFM tip and a charged PPy-HA surface, the tip-sample adhesion force, and elastic moduli were estimated from the AFM force curves, and the data were fitted to electrostatic double-layer and elastic contact models. The surface potential of the charged and dried PPy-HA films was assessed with Kelvin probe force microscopy (KPFM), and the KPFM data were correlated to the fluid AFM data. The surface charge distribution and elasticity were both found to correlate well with the nodular morphology of PPy-HA and to be sensitive to the electrochemical charging conditions. Furthermore, a significant change in the adhesion was detected when the surface was electrochemically charged positive. The results highlight the potential of positively charged PPy-HA as a coating material to enhance the stem cell response in tissue-engineering scaffolds.
C1 [Pelto, Jani M.; Siljander, Aliisa S.; Tappura, Kirsi M.] VTT Tech Res Ctr Finland, Tampere 33101, Finland.
   [Haimi, Suvi P.] Univ Twente, Dept Biomat Sci & Technol, NL-7500 AE Enschede, Netherlands.
   [Haimi, Suvi P.; Siljander, Aliisa S.; Miettinen, Susanna S.] Univ Tampere, Inst Biomed Technol, FI-33014 Tampere, Finland.
   [Higgins, Michael J.; Wallace, Gordon G.] Univ Wollongong, ARC Ctr Excellence Electromat Sci ACES, IPRI, Australian Inst Innovat Mat AIIM Facil, Wollongong, NSW 2522, Australia.
RP Pelto, JM (reprint author), VTT Tech Res Ctr Finland, Sinitaival 6,POB 1300, Tampere 33101, Finland.
EM Jani.Pelto@vtt.fi
RI Wallace, Gordon/H-1123-2011; Haimi, Suvi/D-4966-2014
OI Wallace, Gordon/0000-0002-0381-7273; Haimi, Suvi/0000-0001-8467-0252;
   Miettinen, Susanna/0000-0002-0647-9556; Tappura,
   Kirsi/0000-0002-8032-9652
FU Finnish Funding Agency for Technology and Innovation (TEKES); Australian
   Research Council under the Australian Research Fellowship [DP110104359];
   ARC Federation Fellowship
FX The support of this work by The Finnish Funding Agency for Technology
   and Innovation (TEKES) is gratefully acknowledged. This work has been
   supported by the Australian Research Council under the Australian
   Research Fellowship and DP110104359 (M.J.H.) and ARC Federation
   Fellowship (G.G.W.). We also greatly acknowledge the Australian National
   Fabrication Facility (ANFF) for providing atomic force microscopy
   instrumentation. We thank Miss Anne Rajala and Miss Leena Jaatinen for
   the preparation of the samples.
CR Barisci JN, 2000, ELECTROCHIM ACTA, V46, P519, DOI 10.1016/S0013-4686(00)00627-7
   Bay L, 2001, J PHYS CHEM B, V105, P8492, DOI 10.1021/jp003872w
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   De Santis G, 2011, EUR CELLS MATER, V22, P202, DOI 10.22203/eCM.v022a16
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dubiel EA, 2011, CHEM REV, V111, P2900, DOI 10.1021/cr9002598
   Gelmi A, 2012, J PHYS CHEM B, V116, P13498, DOI 10.1021/jp302944n
   Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Haimi S, 2009, J BIOMED MATER RES A, V91A, P540, DOI 10.1002/jbm.a.32233
   Haimi S, 2009, TISSUE ENG PT A, V15, P1473, DOI 10.1089/ten.tea.2008.0241
   Higgins MJ, 2012, CHEM MATER, V24, P828, DOI 10.1021/cm203138j
   HULL M, 1969, T FARADAY SOC, V65, P3093, DOI 10.1039/tf9696503093
   Lee JY, 2010, ACTA BIOMATER, V6, P4396, DOI 10.1016/j.actbio.2010.06.011
   Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081
   Lubarsky GV, 2005, COLLOID SURFACE B, V44, P56, DOI 10.1016/j.colsurfb.2005.05.010
   O'Neil KD, 2007, J PHYS CHEM B, V111, P9253, DOI 10.1021/jp071564t
   Ohshima H, 1998, J COLLOID INTERF SCI, V198, P42, DOI 10.1006/jcis.1997.5240
   PEI QB, 1992, J PHYS CHEM-US, V96, P10507, DOI 10.1021/j100204a071
   Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021
   Serra Moreno J., 2009, J BIOMED MATER RES A, V88A, P832, DOI DOI 10.1002/JBM.A.32230
   Vuorinen T., 2010, J BIOMED MATER RES A, V93, P1056
   Wang J, 2001, J PHYS CHEM B, V105, P5217, DOI 10.1021/jp003687i
   Zhang X, 2003, LANGMUIR, V19, P10703, DOI 10.1021/la034893v
NR 26
TC 13
Z9 13
U1 1
U2 78
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 21
PY 2013
VL 29
IS 20
BP 6099
EP 6108
DI 10.1021/la4009366
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 154WW
UT WOS:000319708400020
PM 23621360
DA 2018-10-20
ER

PT J
AU Samaranayake, YH
   Cheung, BPK
   Yau, JYY
   Yeung, SKW
   Samaranayake, LP
AF Samaranayake, Yuthika Hemamala
   Cheung, Becky P. K.
   Yau, Joyce Y. Y.
   Yeung, Shadow K. W.
   Samaranayake, Lakshman P.
TI Human Serum Promotes Candida albicans Biofilm Growth and Virulence Gene
   Expression on Silicone Biomaterial
SO PLOS ONE
LA English
DT Article
ID SECRETED ASPARTYL PROTEINASES; IMMUNODEFICIENCY-VIRUS-INFECTION; HUMAN
   ORAL EPITHELIUM; ACRYLIC SURFACES; IN-VITRO; TISSUE-DAMAGE; WILD-TYPE;
   FAMILY; MODEL; ADHERENCE
AB Objectives: Systemic candidal infections are a common problem in hospitalized patients due to central venous catheters fabricated using silicone biomaterial (SB). We therefore evaluated the effect of human serum on C. albicans biofilm morphology, growth, and the expression of virulence-related genes on SB in vitro.
   Methods: We cultivated C. albicans SC5314 (wild-type strain, WT) and its derivative HLC54 (hyphal mutant, HM) for 48 h in various conditions, including the presence or absence of SB discs, and human serum. The growth of planktonic and biofilm cells of both strains was monitored at three time points by a tetrazolium salt reduction assay and by scanning electron microscopy. We also analyzed by RT-PCR its expression of the virulence-related genes ALS3, HWP1, EAP1, ECE1, SAP1 - SAP10, PLB1, PLB2, PLC and PLD.
   Results: At each time point, planktonic cells of WT strain cultured in yeast nitrogen base displayed a much higher expression of EAP1 and HWP1, and a moderately higher ALS3 expression, than HM cells. In planktonic cells, expression of the ten SAP genes was higher in the WT strain initially, but were highly expressed in the HM strain by 48 h. Biofilm growth of both strains on SB was promoted in the presence of human serum than in its absence. Significant upregulation of ALS3, HWP1, EAP1, ECE1, SAP1, SAP4, SAP6 - SAP10, PLB1, PLB2 and PLC was observed for WT biofilms grown on serum-treated SB discs for at least one time point, compared with biofilms on serum-free SB discs.
   Conclusions: Human serum stimulates C. albicans biofilm growth on SB discs and upregulates the expression of virulence genes, particularly adhesion genes ALS3 and HWP1, and hydrolase-encoding genes SAP, PLB1 and PLB2. This response is likely to promote the colonization of this versatile pathogen within the human host.
C1 [Samaranayake, Yuthika Hemamala; Cheung, Becky P. K.; Yau, Joyce Y. Y.; Yeung, Shadow K. W.; Samaranayake, Lakshman P.] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.
RP Samaranayake, LP (reprint author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.
EM lakshman@hkucc.hku.hk
FU Research Grants Council of the University of Hong Kong (HKU)
   [201109176041]
FX This study was funded by the Research Grants Council of the University
   of Hong Kong (HKU, Project code: 201109176041). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0
   Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200
   Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004
   Aoki W, 2011, J BIOCHEM, V150, P431, DOI 10.1093/jb/mvr073
   BIRSE CE, 1993, INFECT IMMUN, V61, P3648
   Borg-von Zepelin M, 1999, J INVEST DERMATOL, V113, P747, DOI 10.1046/j.1523-1747.1999.00747.x
   Cao YY, 2005, ANTIMICROB AGENTS CH, V49, P584, DOI 10.1128/AAC.49.2.584-589.2005
   Cauda R, 2009, DRUGS, V69, P33, DOI 10.2165/11315520-000000000-00000
   Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101
   Chen YC, 2002, MICROBIOL-SGM, V148, P3743, DOI 10.1099/00221287-148-11-3743
   Coleman DA, 2009, J MICROBIOL METH, V78, P71, DOI 10.1016/j.mimet.2009.05.002
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Dolan JW, 2004, MED MYCOL, V42, P439, DOI 10.1080/13693780410001657162
   Felk A, 2002, INFECT IMMUN, V70, P3689, DOI 10.1128/IAI.70.7.3689-3700.2002
   Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475
   Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112
   Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x
   Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004
   Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7
   Green CB, 2005, MICROBIOL-SGM, V151, P1051, DOI 10.1099/mic.0.27696-0
   Hilmioglu S, 2007, MYCOSES, V50, P282, DOI 10.1111/j.1439-0507.2007.01359.x
   Hoyer LL, 1998, CURR GENET, V33, P451, DOI 10.1007/s002940050359
   Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9
   HUBE B, 1994, MOL MICROBIOL, V14, P87, DOI 10.1111/j.1365-2958.1994.tb01269.x
   Hube B, 2001, MICROBIOL-SGM, V147, P1997, DOI 10.1099/00221287-147-8-1997
   Ibrahim AS, 1998, INFECT IMMUN, V66, P3003
   Jayatilake JAMS, 2006, J ORAL PATHOL MED, V35, P484, DOI 10.1111/j.1600-0714.2006.00435.x
   Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002
   Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.00616.x
   Kunze D, 2005, MICROBIOL-SGM, V151, P3381, DOI 10.1099/mic.0.28353-0
   Kvaal C, 1999, INFECT IMMUN, V67, P6652
   Lachke SA, 2000, INFECT IMMUN, V68, P884, DOI 10.1128/IAI.68.2.884-895.2000
   Li F, 2003, EUKARYOT CELL, V2, P1266, DOI 10.1128/EC.2.6.1266-1273.2003
   Li F, 2007, EUKARYOT CELL, V6, P931, DOI 10.1128/EC.00049-07
   Liu HP, 2002, INT J MED MICROBIOL, V292, P299, DOI 10.1078/1438-4221-00215
   Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10
   Marchais V, 2005, FEMS MICROBIOL LETT, V245, P25, DOI 10.1016/j.femsle.2005.02.014
   Mendes A, 2007, BIOL PHARM BULL, V30, P1813, DOI 10.1248/bpb.30.1813
   Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003
   Nailis H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-114
   Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838
   Nikawa H, 2000, MYCOSES, V43, P139, DOI 10.1046/j.1439-0507.2000.00564.x
   Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06
   O'Connor L, 2005, MOL CELL PROBE, V19, P153, DOI 10.1016/j.mcp.2004.10.007
   Odds F. C., 1994, ASM News (Washington), V60, P313
   Raad Issam, 1993, Journal of Infectious Diseases, V168, P400
   Ramage G, 2001, Am Clin Lab, V20, P42
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   SAMARANAYAKE LP, 1980, ARCH ORAL BIOL, V25, P611, DOI 10.1016/0003-9969(80)90076-X
   Samaranayake YH, 2006, APMIS, V114, P857, DOI 10.1111/j.1600-0463.2006.apm_479.x
   Samaranayake YH, 2005, J MED MICROBIOL, V54, P583, DOI 10.1099/jmm.0.45762-0
   Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x
   Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x
   Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003
   Sharkey LL, 1999, J BACTERIOL, V181, P5273
   SHEPHERD MG, 1980, CAN J MICROBIOL, V26, P21, DOI 10.1139/m80-004
   SNIDE JL, 2006, 8 ASM C CAND CAND DE
   Sohn K, 2003, MOL MICROBIOL, V47, P89, DOI 10.1046/j.1365-2958.2003.03300.x
   Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535
   Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982
   Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x
   Taniguchi L, 2009, J MICROBIOL METH, V78, P171, DOI 10.1016/j.mimet.2009.05.012
   Taylor BN, 2005, INFECT IMMUN, V73, P7061, DOI 10.1128/IAI.73.10.7061-7063.2005
   Thein ZM, 2007, ARCH ORAL BIOL, V52, P1200, DOI 10.1016/j.archoralbio.2007.06.007
   Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435
   White TC, 1995, J BACTERIOL, V177, P5214
   Yeater KM, 2007, MICROBIOL-SGM, V153, P2373, DOI 10.1099/mic.0.2007/006163-0
   Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07
   Zhao X, 2005, MICROBIOL-SGM, V151, P1619, DOI 10.1099/mic.0.27763-0
   Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0
NR 72
TC 25
Z9 30
U1 1
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2013
VL 8
IS 5
AR e62902
DI 10.1371/journal.pone.0062902
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 149OK
UT WOS:000319330200013
PM 23704884
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Cazon, JP
   Viera, M
   Donati, E
AF Plaza Cazon, Josefina
   Viera, Marisa
   Donati, Edgardo
TI Dynamic Cr(III) uptake by Macrocystis pyrifera and Undaria pinnatifida
   biomasses
SO ELECTRONIC JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE biosorption; brown algae; chromium; heavy metals
ID HEAVY-METAL BIOSORPTION; BROWN SEAWEED BIOMASS; AQUEOUS-SOLUTION;
   REMOVAL; WASTE; MECHANISM; CHROMIUM; KINETICS; GREEN; IONS
AB Background: The increased industrial activity has resulted in the discharge of large amount of pollutants including non-degradable metals into the environment. Chromium is produced in several industrial processes and it can be found in the environment in two stable oxidation states, Cr(VI) and Cr(III). Cr(VI) is more hazardous due to its carcinogenic and mutagenic effects on living organisms. Although much less toxic, Cr(III) can also exert genotoxic effects under prolonged or severe exposure. It can be separated from the solution by precipitation but biosorption using brown algae seems to be an effective and sustainable treatment technique owing to its cost-effectiveness and environmental friendly characteristics. Macrocystis pyrifera and Undaria pinnatifida are two marine brown macroalgae with high capability of removing heavy metals including Cr(III) in batch mode of operation. In this work packed bed biosorption of Cr(III) by M. pyrifera and U. pinnatifida biomasses was evaluated.
   Results: The shapes of the breakthrough curves were rather different for each biomaterial. Parameters like the breakthrough time (t(b)) andzone mass transfer (MTZ) showed that U. pinnatifida has greater affinity for Cr(III). The maximum adsorption capacity at the exhaustion operating time (t(e)) demonstrated that M. pyrifera has higher retention capacity of Cr(III). The experimental data were fitted to Thomas, Yoon-Nelson and Dose-Response models. The best correlation coefficient (0.94 or 0.96) was obtained with Dose-Response that accurately describes the uptake behaviour of Cr(III) on the seaweed biomasses under different experimental conditions. The FT-IR spectra evidenced that Cr(III) adsorption occurred mainly by interaction between metal and carboxylate groups present on both the seaweed surfaces.
   Conclusions: M. pyrifera and U. pinnatifida biomasses are efficient biosorbents for Cr(III) adsorption under a continuous mode of operation although differences between uptake capacities suggest different mechanisms involved in the biosorption.
C1 [Plaza Cazon, Josefina; Viera, Marisa; Donati, Edgardo] Univ Nacl La Plata, Fac Ciencias Exactas, Ctr Invest & Desarrollo Fermentac Ind, La Plata, Buenos Aires, Argentina.
RP Donati, E (reprint author), Univ Nacl La Plata, Fac Ciencias Exactas, Ctr Invest & Desarrollo Fermentac Ind, La Plata, Buenos Aires, Argentina.
EM donati@quimica.unlp.edu.ar
RI Donati, Edgardo/I-8241-2017
OI Donati, Edgardo/0000-0002-3534-2938
FU ANPCyT [PICT 339]; CONICET [PIP 0368]; UNLP [X631]
FX This research work was supported by ANPCyT (PICT 339), CONICET (PIP
   0368) and UNLP (X631).
CR Amuda OS, 2007, BIOCHEM ENG J, V36, P174, DOI 10.1016/j.bej.2007.02.013
   Arica MY, 2005, PROCESS BIOCHEM, V40, P2351, DOI 10.1016/j.procbio.2004.09.008
   Garcia-Reyes RB, 2009, J HAZARD MATER, V170, P845, DOI 10.1016/j.jhazmat.2009.05.046
   Boraso A., 2012, ATLAS SENSIBILIDAD A
   Bueno BYM, 2008, MINER ENG, V21, P65, DOI 10.1016/j.mineng.2007.08.013
   Calero M, 2009, J HAZARD MATER, V171, P886, DOI 10.1016/j.jhazmat.2009.06.082
   Cazon JPH, 2012, ENG LIFE SCI, V12, P95, DOI 10.1002/elsc.201100098
   Chojnacka K, 2005, CHEMOSPHERE, V59, P75, DOI 10.1016/j.chemosphere.2004.10.005
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   DELLATORRE F.G., 2012, ALGA EXOTICA UNDARIA
   Eastmond DA, 2012, MUTAT RES-REV MUTAT, V751, P49, DOI 10.1016/j.mrrev.2012.04.001
   Ferraz AI, 2004, CHEM ENG J, V105, P11, DOI 10.1016/j.cej.2004.07.009
   Gupta VK, 2004, SEP PURIF TECHNOL, V40, P87, DOI 10.1016/j.seppur.2004.01.008
   Han X, 2006, J COLLOID INTERF SCI, V303, P365, DOI 10.1016/jjcis.2006.08.028
   Kleinubing SJ, 2011, BIORESOURCE TECHNOL, V102, P4610, DOI 10.1016/j.biortech.2010.12.049
   Lee SW, 2008, J IND ENG CHEM, V14, P10, DOI 10.1016/j.jiec.2007.08.001
   Martin JP, 2006, BIOL INVASIONS, V8, P1399, DOI 10.1007/s10530-006-0004-7
   Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015
   Marin ABP, 2009, CHEM ENG J, V155, P199, DOI 10.1016/j.cej.2009.07.034
   Plaza Cazon J, 2012, BIORESOURCE TECHNOL, V116, P195, DOI 10.1016/j.biortech.2012.04.014
   Plaza J, 2011, J ENVIRON SCI-CHINA, V23, P1778, DOI 10.1016/S1001-0742(10)60650-X
   Sari A, 2007, BIOCHEM ENG J, V37, P151, DOI 10.1016/j.bej.2007.04.007
   Sawalha MF, 2007, CHEMOSPHERE, V66, P1424, DOI 10.1016/j.chemosphere.2006.09.028
   Senthilkumar R, 2006, J HAZARD MATER, V136, P791, DOI 10.1016/j.jhazmat.2006.01.014
   Singh A, 2012, WATER RES, V46, P779, DOI 10.1016/j.watres.2011.11.050
   Uluozlu OD, 2008, BIORESOURCE TECHNOL, V99, P2972, DOI 10.1016/j.biortech.2007.06.052
   Wilson D, 2012, TALANTA, V93, P285, DOI 10.1016/j.talanta.2012.02.035
   Yahya SK, 2012, COLLOID SURFACE B, V94, P362, DOI 10.1016/j.colsurfb.2012.02.016
   Yun YS, 2001, ENVIRON SCI TECHNOL, V35, P4353, DOI 10.1021/es010866k
   Zhang Y, 2006, WATER RES, V40, P788, DOI 10.1016/j.watres.2005.12.011
NR 30
TC 0
Z9 0
U1 0
U2 14
PU UNIV CATOLICA DE VALPARAISO
PI VALPARAISO
PA AV BRASIL 2950, PO BOX 4059, VALPARAISO, CHILE
SN 0717-3458
J9 ELECTRON J BIOTECHN
JI Electron. J. Biotechnol.
PD MAY 15
PY 2013
VL 16
IS 3
SI SI
AR 8
DI 10.2225/vol16-issue3-fulltext-8
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 270SJ
UT WOS:000328338700013
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Toskas, G
   Cherif, C
   Hund, RD
   Laourine, E
   Mahltig, B
   Fahmi, A
   Heinemann, C
   Hanke, T
AF Toskas, Georgios
   Cherif, Chokri
   Hund, Rolf-Dieter
   Laourine, Ezzeddine
   Mahltig, Boris
   Fahmi, Amir
   Heinemann, Christiane
   Hanke, Thomas
TI Chitosan(PEO)/silica hybrid nanofibers as a potential biomaterial for
   bone regeneration
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan(PEO)/silica nanofibers; Sol-gel; Electrospinning;
   Cytocompatibility; Bioactivity
ID SOL-GEL PROCESS; CHITOSAN; SILICA; COMPOSITE; BIOACTIVITY; MEMBRANES;
   ABILITY; CELLS
AB New hybrid nanofibers prepared with chitosan (CTS), containing a total amount of polyethylene oxide (PEO) down to 3.6 wt.%, and silica precursors were produced by electrospinning. The solution of modified sol-gel particles contained tetraethoxysilane (TEOS) and the organosilane 3-glycidyloxypropyltriethoxysilane (GPTEOS). This is rending stable solution toward gelation and contributing in covalent bonding with chitosan. The fibers encompass advantages of biocompatible polymer template silicate components to form self-assembled core-shell structure of the polymer CTS/PEO encapsulated by the silica. Potential applicability of this hybrid material to bone tissue engineering was studied examining its cellular compatibility and bioactivity. The nanofiber matrices were proved cytocompatible when seeded with bone-forming 7F2-cells, promoting attachment and proliferation over 7 days. These found to enhance a fast apatite formation by incorporation of Ca2+ ions and subsequent immersion in modified simulated body fluid (m-SBF). The tunable properties of these hybrid nanofibers can find applications as active biomaterials in bone repair and regeneration. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Toskas, Georgios; Cherif, Chokri; Hund, Rolf-Dieter; Laourine, Ezzeddine] Tech Univ Dresden, Inst Text Machinery & High Performance Mat Techno, D-01069 Dresden, Germany.
   [Mahltig, Boris] Univ Appl Sci, Fac Text & Clothing Technol, D-41065 Monchengladbach, Germany.
   [Fahmi, Amir] Rhine Waal Univ Appl Sci, Fac Technol & Bion, D-47533 Kleve, Germany.
   [Heinemann, Christiane; Hanke, Thomas] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Heinemann, Christiane; Hanke, Thomas] Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
RP Toskas, G (reprint author), Technol Educ Inst Piraeus, Sch Engn, Dept Text, 250 Thivon & P Ralli, Egaleo 12244, Greece.
EM georg.toskas@gmx.de
RI Cherif, Chokri/R-8818-2016
OI Cherif, Chokri/0000-0003-3835-0420
CR Agboh OC, 1997, POLYM ADVAN TECHNOL, V8, P355, DOI 10.1002/(SICI)1099-1581(199706)8:6<355::AID-PAT651>3.0.CO;2-T
   Allo BA, 2010, LANGMUIR, V26, P18340, DOI 10.1021/la102845k
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Cherif C., 2009, INT C LAT ADV HIGH T
   Cho SB, 1996, J BIOMED MATER RES, V32, P375
   Choi SS, 2003, J MATER SCI LETT, V22, P891, DOI 10.1023/A:1024475022937
   Chronakis IS, 2002, BIOMACROMOLECULES, V3, P793, DOI 10.1021/bm020015k
   Coradin T, 2002, LANGMUIR, V18, P2331, DOI 10.1021/la011106q
   Coradin T, 2007, ACCOUNTS CHEM RES, V40, P819, DOI 10.1021/ar068129m
   Gaharwar AK, 2010, ACS APPL MATER INTER, V2, P3119, DOI 10.1021/am100609t
   Heinemann S., 2011, COMPOS SCI TECHNOL, V71, P873
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Jun SH, 2010, ACTA BIOMATER, V6, P302, DOI 10.1016/j.actbio.2009.06.024
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kim YJ, 2010, EUR POLYM J, V46, P1957, DOI 10.1016/j.eurpolymj.2010.08.009
   Klossner RR, 2008, BIOMACROMOLECULES, V9, P2947, DOI 10.1021/bm800738u
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee JS, 2010, J MATER CHEM, V20, P8894, DOI 10.1039/c0jm01389g
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Liu Y, 2008, J NANOSCI NANOTECHNO, V8, P1528, DOI 10.1166/jnn.2008.043
   Liu YL, 2004, POLYMER, V45, P6831, DOI 10.1016/j.polymer.2004.08.006
   Mahltig B, 2010, J SOL-GEL SCI TECHN, V55, P269, DOI 10.1007/s10971-010-2245-2
   Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838
   MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Poologasundarampillai G, 2010, J MATER CHEM, V20, P8952, DOI 10.1039/c0jm00930j
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   Seol YJ, 2010, J BIOMED MATER RES A, V94A, P649, DOI 10.1002/jbm.a.32738
   Shao CL, 2003, MATER LETT, V57, P1579, DOI 10.1016/S0167-577X(02)01036-4
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   Shirosaki Y, 2009, J NANOSCI NANOTECHNO, V9, P3714, DOI 10.1166/jnn.2009.NS56
   Shirosaki Y, 2009, ACTA BIOMATER, V5, P346, DOI 10.1016/j.actbio.2008.07.022
   Spirk S., 2012, CARBOHYDRATE POLYM
   Sridhar R., 2012, J BIOMATERIALS SCI P, P1
   Suzuki T, 1997, J FERMENT BIOENG, V84, P128, DOI 10.1016/S0922-338X(97)82541-X
   Tian D, 1997, CHEM MATER, V9, P871, DOI 10.1021/cm960514q
   Toskas G, 2012, TEXTILES TYPES USES, P203
   Toskas G, 2011, ACS APPL MATER INTER, V3, P3673, DOI 10.1021/am200858s
   Toskas G, 2011, CARBOHYD POLYM, V84, P1093, DOI 10.1016/j.carbpol.2010.12.075
   Wei M, 2005, MACROMOL RAPID COMM, V26, P1127, DOI 10.1002/marc.200500212
   Zhang JF, 2009, MACROMOLECULES, V42, P5278, DOI 10.1021/ma900657y
NR 45
TC 68
Z9 74
U1 6
U2 225
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAY 15
PY 2013
VL 94
IS 2
BP 713
EP 722
DI 10.1016/j.carbpol.2013.01.068
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 130US
UT WOS:000317946200001
PM 23544625
DA 2018-10-20
ER

PT J
AU Sott, K
   Geback, T
   Pihl, M
   Loren, N
   Hermansson, AM
   Heintz, A
   Rasmuson, A
AF Sott, Kristin
   Geback, Tobias
   Pihl, Maria
   Loren, Niklas
   Hermansson, Anne-Marie
   Heintz, Alexei
   Rasmuson, Anders
TI mu PIV methodology using model systems for flow studies in heterogeneous
   biopolymer gel microstructures
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Biomaterial; Microstructure; Micro-PIV; Microfluidics; Model material;
   Mass transport; Flow simulation
ID PARTICLE IMAGE VELOCIMETRY; MICROFLUIDIC SYSTEMS; MICRO-PIV;
   POLY(DIMETHYLSILOXANE); DIFFUSION; VELOCITY; SCALES
AB A methodology for studying flow in heterogeneous soft microstructures has been developed. The methodology includes: (I) model fractal or random heterogeneous microstructures fabricated in PDMS and characterised using CLSM; (2) mu PIV measurements; (3) Lattice-Boltzmann simulations of flow. It has been found that the flow behaviour in these model materials is highly dependent on pore size as well as on the connectivity and occurrence of dead ends. The experimental flow results show good agreement with predictions from the Lattice-Boltzmann modelling. These simulations were performed in geometries constructed from 3D CLSM images of the actual PDMS structures. Given these results, mass transport behaviour may be predicted for even more complex structures, like gels or composite material in, e.g., food or biomaterials. This is a step in the direction towards predictive science with regards to tailoring soft biomaterials for specific mass transport properties. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Sott, Kristin; Loren, Niklas; Hermansson, Anne-Marie] SIK Swedish Inst Food & Biotechnol, SE-40229 Gothenburg, Sweden.
   [Sott, Kristin; Geback, Tobias; Pihl, Maria; Hermansson, Anne-Marie; Heintz, Alexei; Rasmuson, Anders] Chalmers, SE-41296 Gothenburg, Sweden.
RP Sott, K (reprint author), SIK Swedish Inst Food & Biotechnol, Box 5401, SE-40229 Gothenburg, Sweden.
EM kristin.sott@sik.se; tobias.geback@chalmers.se; maria.pihl@chalmers.se;
   niklas.loren@sik.se; anne-marie.hermansson@chalmers.se;
   heintz@chalmers.se; rasmuson@chalmers.se
FU VINN Excellence Centre SuMo Biomaterials
FX This work is part of the VINN Excellence Centre SuMo Biomaterials, which
   is gratefully acknowledged for financial support. The authors would also
   like to thank Professor Erich Windhab, Dr. Elisabeth Rondeau and, Dr.
   Manuela Duxenneuner for valuable discussions and instructions on mu PIV
   technique. Dr. Camilla Ohgren is acknowledged for her kind help with
   providing confocal images of beta-lactoglobulin.
CR Berne B. J., 2000, DYNAMIC LIGHT SCATTE
   Bernin D, 2011, SOFT MATTER, V7, P5711, DOI 10.1039/c1sm05070b
   Boek ES, 2010, COMPUT MATH APPL, V59, P2305, DOI 10.1016/j.camwa.2009.08.063
   Bourdon CJ, 2006, J FLUID ENG-T ASME, V128, P883, DOI 10.1115/1.2201649
   Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329
   Devasenathipathy S, 2003, EXP FLUIDS, V34, P504, DOI [10.1007/S00348-003-0588-y, 10.1007/S00348-003-0588-Y]
   Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Fridjonsson E.O., 2011, EUR PHYS J E, V34
   Ginzburg I, 2008, COMMUN COMPUT PHYS, V3, P427
   Gunda NSK, 2011, LAB CHIP, V11, P3785, DOI 10.1039/c1lc20556k
   Hagman J, 2012, FOOD HYDROCOLLOID, V29, P106, DOI 10.1016/j.foodhyd.2012.02.010
   HERMANSSON A. M., 1986, FUNCTIONAL PROPERTIE
   Hermansson AM, 2006, FOOD PRESERV TECHNOL, V9, P79
   Hoffmann M, 2006, CHEM ENG SCI, V61, P2968, DOI 10.1016/j.ces.2005.11.029
   Junk M, 2005, J COMPUT PHYS, V210, P676, DOI 10.1016/j.jcp.2005.05.003
   Karadimitriou NK, 2012, LAB CHIP, V12, P3413, DOI 10.1039/c2lc40530j
   Kinoshita H, 2007, LAB CHIP, V7, P338, DOI 10.1039/b617391h
   Lindken R, 2009, LAB CHIP, V9, P2551, DOI 10.1039/b906558j
   Loren N, 2009, ADV COLLOID INTERFAC, V150, P5, DOI 10.1016/j.cis.2009.05.004
   Mandelbrot B.B, 1983, FRACTAL GEOMETRY NAT
   Mazaheri AR, 2005, ADV WATER RESOUR, V28, P1267, DOI 10.1016/j.advwatres.2004.10.016
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Meinhart CD, 2000, J FLUID ENG-T ASME, V122, P285, DOI 10.1115/1.483256
   Olsen MG, 2000, EXP FLUIDS, V29, pS166, DOI 10.1007/s003480070018
   Olsson C, 2002, FOOD HYDROCOLLOID, V16, P111, DOI 10.1016/S0268-005X(01)00069-8
   Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0
   Rodd LE, 2007, J NON-NEWTON FLUID, V143, P170, DOI 10.1016/j.jnnfm.2007.02.006
   Santiago JG, 1998, EXP FLUIDS, V25, P316, DOI 10.1007/s003480050235
   Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9
   Sott K, 2009, LAB CHIP TECHNOLOGY, P151
   Valiei A, 2012, LAB CHIP, V12, P5133, DOI 10.1039/c2lc40815e
   Vennemann P, 2006, J BIOMECH, V39, P1191, DOI 10.1016/j.jbiomech.2005.03.015
   White FM, 2006, VISCOUS FLUID FLOW
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Zerai B, 2005, TRANSPORT POROUS MED, V60, P159, DOI 10.1007/s11242-004-4796-6
NR 37
TC 5
Z9 5
U1 0
U2 41
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAY 15
PY 2013
VL 398
BP 262
EP 269
DI 10.1016/j.jcis.2013.02.022
PG 8
WC Chemistry, Physical
SC Chemistry
GA 125LB
UT WOS:000317540200033
PM 23489610
DA 2018-10-20
ER

PT J
AU Liu, XM
   Mou, YA
   Wu, SL
   Man, HC
AF Liu, Xiangmei
   Mou, Yanan
   Wu, Shuilin
   Man, H. C.
TI Synthesis of silver-incorporated hydroxyapatite nanocomposites for
   antimicrobial implant coatings
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Hydroxyapatite; Nanocomposite; Silver; Antibacterial; Implant
ID ELECTROPHORETIC DEPOSITION; LOCAL APPLICATION; ANTIBACTERIAL;
   NANOPARTICLES; PROPHYLAXIS; COMPOSITES; MODEL
AB Because of excellent osteoconductivity and resorbability, hydroxyapatite (HA) is commonly used as a bone substitute material or implant coating. Both ionic and metallic silver are considered to have a broad spectrum of antimicrobial properties especially associated with biomaterial-related infections. The present work proposes a facile chemical reduction method to synthesize an Ag incorporated HA nanocomposite. Ammoniacal silver solution was firstly prepared and then added into the HA solution, followed by hydrazine hydrate (N2H4 center dot H2O) being used to reduce the silver ions to metallic silver. The formed Ag nanoparticles had diameters of 20-30 nm and were firmly attached on the HA particle surfaces. This approach can also keep the integrity of the HA chemical structure and the morphology. The strain Escherichia coli was used to evaluate the antibacterial effect of the nanocomposite. An In vitro bacterial adhesion study indicated a significant enhancement in the antibacterial property of silver containing HA. (c) 2013 Published by Elsevier B.V.
C1 [Liu, Xiangmei; Man, H. C.] Hong Kong Polytech Univ, Dept Ind & Syst Engn, Kowloon, Hong Kong, Peoples R China.
   [Liu, Xiangmei; Mou, Yanan; Wu, Shuilin] Hubei Univ, Minist Of Educ, Key Lab Green Preparat & Applicat Funct Mat, Sch Mat Sci & Engn, Wuhan 430062, Peoples R China.
RP Man, HC (reprint author), Hong Kong Polytech Univ, Dept Ind & Syst Engn, Kowloon, Hong Kong, Peoples R China.
EM mfhcman@polyu.edu.hk
FU Hong Kong Polytechnic University Postdoctoral Fellowship Scheme
   (G-YX4Z), National Natural Science Foundation of China [50901032,
   51101053, 81271715]
FX This work was jointly supported by The Hong Kong Polytechnic University
   Postdoctoral Fellowship Scheme (G-YX4Z), National Natural Science
   Foundation of China Nos. 50901032, 51101053, 81271715.
CR Arumugam SK, 2007, J BIOMED MATER RES A, V80A, P391, DOI 10.1002/jbm.a.30895
   Babu R, 2006, BIOMATERIALS, V27, P4304, DOI 10.1016/j.biomaterials.2006.03.038
   Bai Y, 2011, APPL SURF SCI, V257, P7010, DOI 10.1016/j.apsusc.2011.03.058
   Chen KF, 2010, NANOSCALE RES LETT, V5, P1449, DOI 10.1007/s11671-010-9660-8
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Ciobanu CS, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-613
   Claessens RAMJ, 2000, LANGMUIR, V16, P1360, DOI 10.1021/la9812166
   Diaz M, 2009, J NANOMATER, DOI 10.1155/2009/498505
   Diefenbeck M, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2006.04.015
   Fielding GA, 2012, ACTA BIOMATER, V8, P3144, DOI 10.1016/j.actbio.2012.04.004
   Han IH, 2007, BIOMED MATER, V2, pS91, DOI 10.1088/1748-6041/2/3/S01
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   Isobe T, 2002, J PHYS CHEM B, V106, P5169, DOI 10.1021/jp0138936
   Kwok CT, 2009, APPL SURF SCI, V255, P6736, DOI 10.1016/j.apsusc.2009.02.086
   Liu JK, 2008, POWDER TECHNOL, V184, P21, DOI 10.1016/j.powtec.2007.07.034
   Lucke M, 2005, BONE, V36, P770, DOI 10.1016/j.bone.2005.01.008
   McConnell WP, 2000, J PHYS CHEM B, V104, P8925, DOI 10.1021/jp000926t
   Park EJ, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-223
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Shen ZJ, 2001, ADV MATER, V13, P214, DOI 10.1002/1521-4095(200102)13:3<214::AID-ADMA214>3.0.CO;2-5
   Sun YG, 2002, NANO LETT, V2, P165, DOI 10.1021/nl010093y
   Surmenev RA, 2012, SURF COAT TECH, V206, P2035, DOI 10.1016/j.surfcoat.2011.11.002
   Sygnatowicz M, 2010, JOM-US, V62, P65, DOI 10.1007/s11837-010-0111-x
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Torres N, 2010, ACTA BIOMATER, V6, P3242, DOI 10.1016/j.actbio.2010.02.032
   Vukomanovic M, 2011, CRYST GROWTH DES, V11, P3802, DOI 10.1021/cg2003436
   Wong MH, 2007, APPL SURF SCI, V253, P7527, DOI 10.1016/j.apsusc.2007.03.055
   Yang S, 2009, APPL SURF SCI, V255, P9889, DOI 10.1016/j.apsusc.2009.04.113
NR 31
TC 36
Z9 36
U1 3
U2 91
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 15
PY 2013
VL 273
BP 748
EP 757
DI 10.1016/j.apsusc.2013.02.130
PG 10
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 125ZU
UT WOS:000317581700108
DA 2018-10-20
ER

PT J
AU Wacey, D
   McLoughlin, N
   Kilburn, MR
   Saunders, M
   Cliff, JB
   Kong, C
   Barley, ME
   Brasier, MD
AF Wacey, David
   McLoughlin, Nicola
   Kilburn, Matt R.
   Saunders, Martin
   Cliff, John B.
   Kong, Charlie
   Barley, Mark E.
   Brasier, Martin D.
TI Nanoscale analysis of pyritized microfossils reveals differential
   heterotrophic consumption in the similar to 1.9-Ga Gunflint chert
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biogeochemistry; taphonomy; paleontology
ID BILLION YEARS AGO; IRON-FORMATION; OCEAN; MICROORGANISMS; FOSSILS;
   MICROBIOTA; ONTARIO; SULFUR
AB The 1.88-Ga Gunflint biota is one of the most famous Precambrian microfossil lagerstatten and provides a key record of the biosphere at a time of changing oceanic redox structure and chemistry. Here, we report on pyritized replicas of the iconic autotrophic Gunflintia-Huroniospora microfossil assemblage from the Schreiber Locality, Canada, that help capture a view through multiple trophic levels in a Paleoproterozoic ecosystem. Nanoscale analysis of pyritic Gunflintia (sheaths) and Huroniospora (cysts) reveals differing relic carbon and nitrogen distributions caused by contrasting spectra of decay and pyritization between taxa, reflecting in part their primary organic compositions. In situ sulfur isotope measurements from individual microfossils (delta S-34(V-CDT) + 6.7 parts per thousand to + 21.5 parts per thousand) show that pyritization was mediated by sulfate-reducing microbes within sediment pore waters whose sulfate ion concentrations rapidly became depleted, owing to occlusion of pore space by coeval silicification. Three-dimensional nanotomography reveals additional pyritized biomaterial, including hollow, cellular epibionts and extracellular polymeric substances, showing a preference for attachment to Gunflintia over Huroniospora and interpreted as components of a saprophytic heterotrophic, decomposing community. This work also extends the record of remarkable biological preservation in pyrite back to the Paleoproterozoic and provides criteria to assess the authenticity of even older pyritized microstructures that may represent some of the earliest evidence for life on our planet.
C1 [Wacey, David; McLoughlin, Nicola] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway.
   [Wacey, David; McLoughlin, Nicola] Univ Bergen, Ctr Geobiol, N-5007 Bergen, Norway.
   [Wacey, David; Kilburn, Matt R.; Cliff, John B.] Univ Western Australia, Australian Res Council, Ctr Excellence Core Crust Fluid Syst, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia.
   [Wacey, David; Kilburn, Matt R.; Cliff, John B.] Univ Western Australia, Ctr Explorat Targeting, Crawley, WA 6009, Australia.
   [Saunders, Martin] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia.
   [Barley, Mark E.] Univ Western Australia, Australian Res Council, Ctr Excellence Core Crust Fluid Syst, Crawley, WA 6009, Australia.
   [Barley, Mark E.] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia.
   [Kong, Charlie] Univ New S Wales, Electron Microscopy Unit, Kingsford, NSW 2052, Australia.
   [Brasier, Martin D.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England.
RP Wacey, D (reprint author), Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway.
EM David.Wacey@geo.uib.no
RI Wacey, David/D-4080-2011; Saunders, Martin/B-3082-2011; Kilburn,
   Matthew/C-4515-2011; Cliff, John/C-7696-2011
OI Wacey, David/0000-0002-7124-0701; Saunders, Martin/0000-0001-6873-7816;
   Kilburn, Matthew/0000-0002-1858-8485; Cliff, John/0000-0002-7395-5604;
   McLoughlin, Nicola/0000-0003-0410-5160
FU Australian Research Council Centre of Excellence for Core to Crust Fluid
   Systems; Bergen Research Foundation; University of Bergen; Oxford
   University; UWA Research Collaboration award
FX The authors thank Russell Garwood for advice regarding SPIERS software
   and Owen Green and Jeremy Hyde for thin section preparation. We
   acknowledge the facilities and scientific and technical assistance of
   the Australian Microscopy and Microanalysis Research Facility (AMMRF) at
   both CMCA [The University of Western Australia (UWA)] and EMU
   (University of New South Wales), which are funded by the Universities,
   State, and Commonwealth Governments. We also acknowledge funding from
   the Australian Research Council Centre of Excellence for Core to Crust
   Fluid Systems (M. E. B. and D. W.), the Bergen Research Foundation and
   University of Bergen (N.M. and D. W.), field funds from Oxford
   University (to M. D. B.), and a UWA Research Collaboration award (to D.
   W. and M.D.B.).
CR Allison PA, 1991, TAPHONOMY RELEASING, P25
   AWRAMIK SM, 1977, PRECAMBRIAN RES, V5, P121, DOI 10.1016/0301-9268(77)90025-0
   BARGHOORN ES, 1965, SCIENCE, V147, P563, DOI 10.1126/science.147.3658.563
   Briggs DEG, 1996, AM J SCI, V296, P633, DOI 10.2475/ajs.296.6.633
   BRIGGS DEG, 1991, GEOLOGY, V19, P1221, DOI 10.1130/0091-7613(1991)019<1221:POSBFB>2.3.CO;2
   Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697
   Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839
   CLOUD PE, 1965, SCIENCE, V148, P27, DOI 10.1126/science.148.3666.27
   DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73
   FERRIS FG, 1988, GEOLOGY, V16, P149, DOI 10.1130/0091-7613(1988)016<0149:MIBBBS>2.3.CO;2
   Gehling JG, 1999, PALAIOS, V14, P40, DOI 10.2307/3515360
   KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195
   KNOLL AH, 1978, J PALEONTOL, V52, P976
   Laflamme M, 2011, LETHAIA, V44, P203, DOI 10.1111/j.1502-3931.2010.00235.x
   Lamb DM, 2009, PRECAMBRIAN RES, V173, P93, DOI 10.1016/j.precamres.2009.05.005
   LICARI GR, 1968, P NATL ACAD SCI USA, V59, P1053, DOI 10.1073/pnas.59.4.1053
   Mojzsis SJ, 2007, DEV PREC G, V15, P923, DOI 10.1016/S0166-2635(07)15075-1
   Oehler JH, 1977, ALCHERINGA, V1, P315, DOI 10.1080/03115517708527768
   Planavsky N, 2009, EARTH PLANET SC LETT, V286, P230, DOI 10.1016/j.epsl.2009.06.033
   Planavsky NJ, 2011, NATURE, V477, P448, DOI 10.1038/nature10327
   Poulton SW, 2010, NAT GEOSCI, V3, P486, DOI 10.1038/NGEO889
   Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912
   Rasmussen B, 2000, NATURE, V405, P676, DOI 10.1038/35015063
   Rickard D, 2007, CHEM GEOL, V236, P228, DOI 10.1016/j.chemgeo.2006.09.011
   Schelble RT, 2004, ADV SPACE RES, V33, P1268, DOI 10.1016/j.asr.2003.10.036
   Stevenson BS, 2006, BIOL BULL-US, V210, P73, DOI 10.2307/4134596
   STROTHER PK, 1987, PRECAMBRIAN RES, V36, P323, DOI 10.1016/0301-9268(87)90029-5
   Sutton MD, 2012, PALAEONTOL ELECTRON, V15
   TYLER SA, 1954, SCIENCE, V119, P606, DOI 10.1126/science.119.3096.606
   Wacey D., 2009, EARLY LIFE EARTH PRA
   Wacey D, 2012, PRECAMBRIAN RES, V220, P234, DOI 10.1016/j.precamres.2012.08.005
   Williford KH, 2013, GEOCHIM COSMOCHIM AC, V104, P165, DOI 10.1016/j.gca.2012.11.005
   Xiao SH, 2010, EARTH PLANET SC LETT, V297, P481, DOI 10.1016/j.epsl.2010.07.001
NR 33
TC 37
Z9 37
U1 1
U2 50
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 14
PY 2013
VL 110
IS 20
BP 8020
EP 8024
DI 10.1073/pnas.1221965110
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 156EH
UT WOS:000319803500020
PM 23630257
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Rodriguez-Fuentes, N
   Rodriguez-Hernandez, AG
   Enriquez-Jimenez, J
   Alcantara-Quintana, LE
   Fuentes-Mera, L
   Pina-Barba, MC
   Zepeda-Rodriguez, A
   Ambrosio, JR
AF Rodriguez-Fuentes, Nayeli
   Rodriguez-Hernandez, Ana G.
   Enriquez-Jimenez, Juana
   Alcantara-Quintana, Luz E.
   Fuentes-Mera, Lizeth
   Pina-Barba, Maria C.
   Zepeda-Rodriguez, Armando
   Ambrosio, Javier R.
TI Nukbone (R) promotes proliferation and osteoblastic differentiation of
   mesenchymal stem cells from human amniotic membrane
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Nukbone; Human mesenchymal stem cells; Xenoimplant; Osteoblastic
   differentiation
ID IN-VIVO; SUBSTITUTES
AB Bovine bone matrix Nukbone (R) (NKB) is an osseous tissue-engineering biomaterial that retains its mineral and organic phases and its natural bone topography and has been used as a xenoimplant for bone regeneration in clinics. There are not studies regarding its influence of the NKB in the behavior of cells during the repairing processes. The aim of this research is to demonstrate that NKB has an osteoinductive effect in human mesenchymal stem cells from amniotic membrane (AM-hMSCs). Results indicated that NKB favors the AM-hMSCs adhesion and proliferation up to 7 days in culture as shown by the scanning electron microscopy and proliferation measures using an alamarBlue assay. Furthermore, as demonstrated by reverse transcriptase polymerase chain reaction, it was detected that two gene expression markers of osteoblastic differentiation: the core binding factor and osteocalcin were higher for AM-hMSCs co-cultured with NKB in comparison with cultivated cells in absence of the biomaterial. As the results indicate, NKB possess the capability for inducing successfully the osteoblastic differentiation of AM-hMSC, so that, NKB is an excellent xenoimplant option for repairing bone tissue defects. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Rodriguez-Fuentes, Nayeli; Rodriguez-Hernandez, Ana G.; Ambrosio, Javier R.] Univ Nacl Autonoma Mexico, Depto Microbiol & Parasitol, Fac Med, Mexico City 04510, DF, Mexico.
   [Enriquez-Jimenez, Juana] INCMNSZ, Depto Biol Reprod, Mexico City 14000, DF, Mexico.
   [Alcantara-Quintana, Luz E.] Secretaria Salud Mexico, Ctr Nacl Transfus Sanguinea, Subd Invest, Mexico City 07370, DF, Mexico.
   [Fuentes-Mera, Lizeth] Hosp Gen Dr Manuel Gea Gonzalez, Depto Biol Mol & Histocompatibilidad, Mexico City 4800, DF, Mexico.
   [Pina-Barba, Maria C.] Univ Nacl Autonoma Mexico, Depto Mat Met & Ceram, Inst Invest Mat, Mexico City 04510, DF, Mexico.
   [Zepeda-Rodriguez, Armando] Univ Nacl Autonoma Mexico, Fac Med, Depto Biol Celular & Tisular, Mexico City 04510, DF, Mexico.
RP Ambrosio, JR (reprint author), Univ Nacl Autonoma Mexico, Depto Microbiol & Parasitol, Fac Med, Circuito Escolar S-N CU, Mexico City 04510, DF, Mexico.
EM jrah@unam.mx
RI Rodriguez-Hernandez, Ana/E-8729-2011
OI Rodriguez-Hernandez, Ana/0000-0001-7094-1912; Ambrosio,
   Javier/0000-0001-7441-0609
FU Consejo Nacional de Ciencia y Tecnologia (CONACyT) [49887]; DGAPA
   [IN201510]; DGAPA IXTLI [IX200610]; DGAPA-UNAM
FX The authors thank for their invaluable technical assistance to M.C.
   Margarita Leyva L., Dr. Felipe Badillo O., M.C. Marisol Castillo C., Dr.
   Abraham Landa P., Tec. Francisco Pasos N., Q.F.B. Damaris Cabrero P.,
   and Biol. Olivia Reynoso D. The authors also thank sincerely to staff of
   Immunology and Rheumatology Lab, INCMNSZ especially to Dr. Carlos Nunez
   A., and Q.F.B. Jose L. Garcia H., for technical support during the
   study. This paper constitutes a partial fulfillment of the Graduate
   Program in Biological Sciences of the UNAM. Rodriguez N acknowledges the
   scholarship and financial support provided by the Consejo Nacional de
   Ciencia y Tecnologia (CONACyT No.49887), DGAPA IN201510 and DGAPA IXTLI
   IX200610. Rodriguez A received a posdoctoral grant from DGAPA-UNAM.
CR Ball M, 2008, J BIOMED MATER RES A, V86A, P637, DOI 10.1002/jbm.a.31652
   Cornell CN, 1999, ORTHOP CLIN N AM, V30, P591, DOI 10.1016/S0030-5898(05)70112-7
   Fassina L, 2010, BIOINORG CHEM APPL, DOI 10.1155/2010/456240
   Feng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049955
   Castillo JFCD, 2009, CIR CIR, V77, P267
   Hao YQ, 2012, J NANOSCI NANOTECHNO, V12, P207, DOI 10.1166/jnn.2012.5125
   Kang SW, 2008, J MICROBIOL BIOTECHN, V18, P975
   Leyva-Leyva M, 2013, STEM CELLS DEV, V22, P1275, DOI 10.1089/scd.2012.0359
   Lu LX, 2013, ACS APPL MATER INTER, V5, P319, DOI 10.1021/am302146w
   Mauck R.L., 2013, BIOMATERIALS, V5, P1
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Milan JL, 2013, EUR CELLS MATER, V25, P97, DOI 10.22203/eCM.v025a07
   Penk F.Y., 2012, OSTEOPOROSIS INT
   Pietrucha K, 2005, INT J BIOL MACROMOL, V36, P299, DOI 10.1016/j.ijbiomac.2005.07.004
   Pina M. C., 2012, MAT RES SOC S, V1487
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Reichert Christoph, 2009, Head Face Med, V5, P23, DOI 10.1186/1746-160X-5-23
   Rivera N, 2013, PARASITOL RES, V112, P1021, DOI 10.1007/s00436-012-3224-z
   Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017
   Villajosa C.L.M.-O.d., 2006, REV ORTOP TRAUMATOL, V50, P224
   Wang Jiwen, 2009, Biomaterials, V30, P6565, DOI 10.1016/j.biomaterials.2009.08.048
   Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
NR 23
TC 6
Z9 7
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 10
PY 2013
VL 434
IS 3
BP 676
EP 680
DI 10.1016/j.bbrc.2013.04.007
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 151SW
UT WOS:000319481500046
PM 23598057
DA 2018-10-20
ER

PT J
AU Vilaeti, AD
   Dimos, K
   Lampri, ES
   Mantzouratou, P
   Tsitou, N
   Mourouzis, I
   Oikonomidis, DL
   Papalois, A
   Pantos, C
   Malamou-Mitsi, V
   Agathopoulos, S
   Kolettis, TM
AF Vilaeti, Agapi D.
   Dimos, Konstantinos
   Lampri, Evangeli S.
   Mantzouratou, Polyxeni
   Tsitou, Natalia
   Mourouzis, Iordanis
   Oikonomidis, Dimitrios L.
   Papalois, Apostolos
   Pantos, Constantinos
   Malamou-Mitsi, Vassiliki
   Agathopoulos, Simeon
   Kolettis, Theofilos M.
TI Short-term ventricular restraint attenuates post-infarction remodeling
   in rats
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Article
DE Myocardial infarction; Ventricular remodeling; Biomaterial scaffold;
   Hydrogel; Inflammatory response; Restraint
ID ACUTE MYOCARDIAL-INFARCTION; FOREIGN-BODY REACTION; POSTMYOCARDIAL
   INFARCTION; HEART-FAILURE; HYDROGELS; DYNAMICS; SURGERY; MODEL
AB Background/objectives: Left ventricular restraint attenuates post-infarction remodeling, but may be associated with unfavorable long-term histological response. We hypothesized that beneficial effects can be obtained with short-term restraint during the early post-infarction period; for this purpose, we evaluated a biodegradable scaffold in the in vivo rat model and compared it with epicardial hydrogel application.
   Methods: A total of 230 Wistar rats (358+/-7 g) were studied. Implantation was performed with and without prior myocardial infarction, induced by permanent coronary artery ligation. Diastolic filling was evaluated by left ventricular pressure recordings after scaffold implantation. Degradation rates and inflammatory/foreign body response were studied at 3, 7 and 15 days post-ligation. Remodeling indices were evaluated by echocardiography 15 days post-ligation.
   Results: No differences were found in diastolic pressure. Biodegradability was similar to 50% by 7 days and 100% by 15 days for both materials. Likewise, inflammatory/foreign body response peaked at 3 days post-implant, with subsequent remission, but fibroblastic reaction was more pronounced after scaffold than after hydrogel implantation. Post-ligation, ejection fraction was higher in the scaffold (40.0+/-1.5%) or hydrogel groups (37.0+/-1.3%), compared to controls (30.6+/-1.9%). Wall tension index was lower with either biomaterial, but left ventricular end-diastolic diameter was shorter (p=0.044) and sphericity was attenuated (p=0.029) after scaffold, compared to hydrogel implantation.
   Conclusions: Both biomaterials showed a favorable histological response and attenuated remodeling, but epicardial restraint produced better results compared to hydrogel alone. The latter approach merits further investigation due to the ease of implantation. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Vilaeti, Agapi D.; Tsitou, Natalia; Oikonomidis, Dimitrios L.; Kolettis, Theofilos M.] Univ Ioannina, Sch Med, Dept Cardiol, GR-45110 Ioannina, Greece.
   [Dimos, Konstantinos; Agathopoulos, Simeon] Univ Ioannina, Dept Mat Sci & Engn, Ceram & Composites Lab, GR-45110 Ioannina, Greece.
   [Dimos, Konstantinos; Papalois, Apostolos; Kolettis, Theofilos M.] Cardiovasc Res Inst, Ioannina, Greece.
   [Dimos, Konstantinos; Papalois, Apostolos; Kolettis, Theofilos M.] Cardiovasc Res Inst, Athens, Greece.
   [Lampri, Evangeli S.; Malamou-Mitsi, Vassiliki] Univ Ioannina, Dept Pathol, Sch Med, GR-45110 Ioannina, Greece.
   [Mantzouratou, Polyxeni; Mourouzis, Iordanis; Pantos, Constantinos] Univ Athens, Sch Med, Dept Pharmacol, GR-10679 Athens, Greece.
   [Papalois, Apostolos] ELPEN Res Lab, Athens, Greece.
RP Kolettis, TM (reprint author), Univ Ioannina, 1 Stavrou Niarxou Ave, GR-45110 Ioannina, Greece.
EM thkolet@cc.uoi.gr
RI Dimos, Konstantinos/G-4809-2014
OI Dimos, Konstantinos/0000-0001-7390-1289; Kolettis,
   Theofilos/0000-0002-6680-9131
FU Cardiovascular Research Institute, Greece
FX This work was supported by the Cardiovascular Research Institute,
   Greece.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Anversa P, 2006, J AM COLL CARDIOL, V47, P1769, DOI 10.1016/j.jacc.2006.02,003
   Baltogiannis GG, 2005, CARDIOVASC RES, V67, P647, DOI 10.1016/j.cardiores.2005.04.020
   Bowen FW, 2001, ANN THORAC SURG, V72, P1950, DOI 10.1016/S0003-4975(01)03282-9
   CLEUTJENS JPM, 1995, AM J PATHOL, V147, P325
   CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kim JK, 2008, BIOMACROMOLECULES, V9, P149, DOI 10.1021/bm700924n
   Kolettis TM, 2011, MINI-REV MED CHEM, V11, P263
   Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mitsi AC, 2006, GROWTH HORM IGF RES, V16, P93, DOI 10.1016/j.ghir.2006.02.001
   Moainie SL, 2002, ANN THORAC SURG, V74, P444, DOI 10.1016/S0003-4975(02)03747-5
   OLIVETTI G, 1990, CIRC RES, V67, P23, DOI 10.1161/01.RES.67.1.23
   Olsson A, 2005, EUR J CARDIO-THORAC, V28, P448, DOI 10.1016/j.ejcts.2005.05.027
   Pantos C, 2007, EUR J CARDIO-THORAC, V32, P333, DOI 10.1016/j.ejcts.2007.05.004
   Pilla JJ, 2005, ANN THORAC SURG, V80, P2257, DOI 10.1016/j.athoracsur.2005.05.089
   Pilla JJ, 2003, J THORAC CARDIOV SUR, V126, P1467, DOI 10.1016/S0022-5223(03)00739-6
   Qiu YZ, 2011, ACTA BIOMATER, V7, P959, DOI 10.1016/j.actbio.2010.11.002
   Saavedra WF, 2002, J AM COLL CARDIOL, V39, P2069, DOI 10.1016/S0735-1097(02)01890-9
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   WARREN SE, 1988, J AM COLL CARDIOL, V11, P12, DOI 10.1016/0735-1097(88)90159-3
   Xu LJ, 2008, INT J PHARM, V355, P249, DOI 10.1016/j.ijpharm.2007.12.019d
NR 30
TC 7
Z9 7
U1 0
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD MAY 10
PY 2013
VL 165
IS 2
BP 278
EP 284
DI 10.1016/j.ijcard.2011.08.036
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 128CX
UT WOS:000317747600022
PM 21917336
DA 2018-10-20
ER

PT J
AU Fan, X
   Guo, L
   Liu, TX
AF Fan, Xin
   Guo, Li'ang
   Liu, Tianxi
TI Preparation and Mechanical Properties of PLGA/beta-TCP Composites
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE -TCP; Characterization; Composite; PLGA; Preparation
ID TRICALCIUM PHOSPHATE; BONE; ACID
AB Poly(lactide-co-glycolide)/-Tricalcium Phosphate (PLGA/-TCP) composites were successfully prepared via solution dispersion method. Laser particle size analyzer (LPSA), X-ray diffraction (XRD) and SEM were used to characterize -TCP powder. The mechanical properties of composites were carried out by the three-point-bending test, and the morphologies of cross-section of composites were observed using SEM. The results indicate that both the bending strength and modulus of composites increased with -TCP amount of up to 10wt%, then decreased gradually, indicating the change of fracture mode with the variation of -TCP content. PLGA/-TCP would be an ideal and promising biomaterial for internal fixation devices.
C1 [Fan, Xin; Guo, Li'ang; Liu, Tianxi] Guilin Univ Technol, Coll Mat Sci & Engn, Minist Educ, Key Lab New Proc Technol Nonferrous Met & Mat, Guilin 541004, Peoples R China.
   [Fan, Xin] Zhejiang Univ, Minist Educ, Key Lab Biomass Chem Engn, Hangzhou 310003, Zhejiang, Peoples R China.
   [Liu, Tianxi] Fudan Univ, Dept Macromol Sci, Minist Educ, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
RP Fan, X (reprint author), Guilin Univ Technol, Coll Mat Sci & Engn, Minist Educ, Key Lab New Proc Technol Nonferrous Met & Mat, Guilin 541004, Peoples R China.
EM glfanxinql@glite.edu.cn
RI Liu, Tianxi/E-6628-2011
OI Liu, Tianxi/0000-0002-5592-7386
FU Scientific Research Foundation from Guilin University of Technology;
   Innovation Team of Guangxi Universities' Talent Highland; Foundation of
   Key Laboratory of Biomass Chemical Engineering of Ministry of Education,
   Zhejiang University, China
FX The authors acknowledge the financial support of the Scientific Research
   Foundation for Ph.D. from Guilin University of Technology, and the
   Innovation Team of Guangxi Universities' Talent Highland, and the
   Foundation of Key Laboratory of Biomass Chemical Engineering of Ministry
   of Education, Zhejiang University, China.
CR Bandyopadhyay-Ghosh S, 2008, TRENDS BIOMATER ARTI, V22, P112
   Chen JA, 2010, POLYM-PLAST TECHNOL, V49, P1155, DOI 10.1080/03602551003664610
   DEBRUIJN JD, 1994, BIOMATERIALS, V15, P543, DOI 10.1016/0142-9612(94)90021-3
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Fan X, 2010, POLYM-PLAST TECHNOL, V49, P309, DOI 10.1080/03602550903284255
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Koc N, 2004, CERAM INT, V30, P205, DOI 10.1016/S0272-8842(03)00090-7
   Lu DD, 2012, INT J POLYM MATER, V61, P384, DOI 10.1080/00914037.2011.610069
   McDonald PF, 2010, POLYM-PLAST TECHNOL, V49, P678, DOI 10.1080/03602551003681846
   Nie HM, 2008, J CONTROL RELEASE, V129, P207, DOI 10.1016/j.jconrel.2008.04.018
   Pamula E, 2008, J MATER SCI-MATER M, V19, P2063, DOI 10.1007/s10856-007-3292-2
   Roudet F, 2002, INT J FATIGUE, V24, P327, DOI 10.1016/S0142-1123(01)00088-3
   Sharon JL, 2008, BIOMATERIALS, V29, P3137, DOI 10.1016/j.biomaterials.2008.04.019
   Xin F, 2009, POLYM-PLAST TECHNOL, V48, P658, DOI 10.1080/03602550902824523
   Xiong LZ, 2011, POLYM-PLAST TECHNOL, V50, P136, DOI 10.1080/03602559.2010.531419
   Zhou ZH, 2012, INT J POLYM MATER, V61, P643, DOI 10.1080/00914037.2011.610064
NR 17
TC 6
Z9 6
U1 1
U2 27
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0360-2559
EI 1525-6111
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PD MAY 3
PY 2013
VL 52
IS 6
BP 621
EP 625
DI 10.1080/03602559.2012.762661
PG 5
WC Polymer Science
SC Polymer Science
GA 135KG
UT WOS:000318286400015
DA 2018-10-20
ER

PT J
AU Tete, S
   Zizzari, VL
   D'Aloja, E
   Vinci, R
   Zara, S
   Di Tore, U
   Cataldi, A
   Mortellaro, C
   Gherlone, E
AF Tete, Stefano
   Zizzari, Vincenzo Luca
   D'Aloja, Ernesto
   Vinci, Raffaele
   Zara, Susi
   Di Tore, Umberto
   Cataldi, Amelia
   Mortellaro, Carmen
   Gherlone, Enrico
TI Histological Evaluation of Fresh Frozen Bone Integration at Different
   Experimental Times
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Fresh frozen bone; bone regeneration; socket preservation; maxillary
   sinus augmentation; scaffold; osteoblasts
ID ENDOTHELIAL GROWTH-FACTOR; NITRIC OXIDE SYNTHASE; MAXILLARY SINUS; ILIAC
   CREST; ALLOGRAFTS; GRAFT; AUGMENTATION; IMPLANTS; REGENERATION;
   CALVARIAL
AB The aim of this work was to investigate, through histological evaluation, the in vivo behavior of fresh frozen bone (FFB) used as particulate bone substitute in intraoral regenerative procedures. A total of 10 patients (group 1) received particulate FFB graft for bone regeneration in postextractive sockets, and 10 (group 2) underwent maxillary sinus augmentation by using the same bone substitute as filling. Fresh frozen bone was supplied from the Tissue Bank of the Veneto Region, Treviso Section.
   Healing was uneventful for all the patients and was monitored by periodical radiographs. Patients were scheduled for implant insertion according to the radiographic aspect. However, the mean healing time for group 1 was 45 days, whereas for group 2 patients, it was 100 days. At the moment of implant insertion, bone specimens were collected at the site of implant placement, from both groups and processed for histological analysis.
   Histological analysis after hematoxylin-eosin staining obtained from group 1 patients showed the presence of newly formed bone tissue, still well distinguishable from the grafted bone substitute. In samples from group 2 patients, a better integration could be recognized associated with active bone remodeling phenomena.
   These results showed a good integration of the considered FFB graft within the host tissue both at 45 and 100 days after grafting, displaying this biomaterial as suitable for preimplant regenerative procedures.
C1 [Tete, Stefano; Di Tore, Umberto] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
   [Zizzari, Vincenzo Luca; Zara, Susi; Cataldi, Amelia] Univ G DAnnunzio, Dept Pharm, Chieti, Italy.
   [Vinci, Raffaele; Gherlone, Enrico] Univ Ateneo Vita Salute S Raffaele, Dept Dent, Milan, Italy.
   [Mortellaro, Carmen] Univ Piemonte Orientale, Dept Med Sci, Fac Med, Novara, Italy.
   [Mortellaro, Carmen] Regina Margherita Pediat Hosp, Oral Surg Unit, Turin, Italy.
RP Tete, S (reprint author), Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Via Vestini 31, Chieti, Italy.
EM tete@unich.it
RI d'Aloja, Ernesto/P-4539-2017; Gherlone, Enrico/M-7376-2016
OI d'Aloja, Ernesto/0000-0003-4456-6252
CR Agarwal Garima, 2012, Compend Contin Educ Dent, V33, P320
   Aguirre Zorzano Luis Antonio, 2007, Med Oral Patol Oral Cir Bucal, V12, pE532
   Bastos MF, 2010, J PERIODONTOL, V81, P1075, DOI 10.1902/jop.2010.090705
   Bedini R, 2009, PROPOSTA VALUTAZIONE
   Bormann N, 2010, ARCH ORTHOP TRAUM SU, V130, P143, DOI 10.1007/s00402-009-0908-7
   BUSER D, 1995, INT J PERIODONT REST, V15, P11
   Cardaropoli D, 2012, INT J PERIODONT REST, V32, P421
   Carinci F, 2009, QUINTESSENCE INT, V40, P413
   Chiapasco M, 2003, RIABILITAZIONE IMPLA
   Chiapasco M, 2009, J ORAL MAXIL SURG, V67, P867, DOI 10.1016/j.joms.2008.11.023
   Crespi R, 2007, INT J ORAL MAX IMPL, V22, P527
   D'Aloja C, 2011, BLOOD TRANSFUS-ITALY, V9, P41, DOI 10.2450/2010.0130-09
   De Leonardis D, 1999, INT J ORAL MAX IMPL, V14, P869
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Egli RJ, 2003, BONE, V33, P352, DOI 10.1016/S8756-3282(03)00192-3
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51
   Holzmann P, 2010, ALTEX-ALTERN ANIM EX, V27, P97
   Lambert F, 2011, CLIN ORAL IMPLAN RES, V22, P538, DOI 10.1111/j.1600-0501.2010.02069.x
   Mangano Carlo, 2006, J Oral Implantol, V32, P122, DOI 10.1563/796.1
   Morjaria KR, 2012, CLIN IMPLANT DENT RE
   Ozan O, 2013, J PROSTHODONT, V22, P42, DOI 10.1111/j.1532-849X.2012.00877.x
   Peleg M, 2004, J ORAL MAXIL SURG, V62, P1535, DOI 10.1016/j.joms.2004.06.048
   Pelegrine AA, 2011, CELL TISSUE BANK, V12, P171, DOI 10.1007/s10561-010-9178-4
   Penarrocha M, 2004, INT J ORAL MAX IMPL, V19, P861
   Piattelli A, 1996, BIOMATERIALS, V17, P1127, DOI 10.1016/0142-9612(96)85915-1
   Pollock R, 2008, EUR SPINE J, V17, P845, DOI 10.1007/s00586-008-0648-3
   RUMMELHART JM, 1989, J PERIODONTOL, V60, P655, DOI 10.1902/jop.1989.60.12.655
   Schwartz Z, 1998, J PERIODONTOL, V69, P470, DOI 10.1902/jop.1998.69.4.470
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P496
   Sloff TJ, 1996, CLIN ORTHOP RELAT R, V324, P108
   Spin-Neto R, 2012, CLIN ORAL IMPLANTS R
   Stacchi C, 2008, J PERIODONTOL, V79, P1789, DOI [10.1902/jop.2008.070649, 10.1902/jop.2008.070649 ]
   Tallgren A, 2003, J PROSTHET DENT, V89, P427, DOI 10.1016/S0022-3913(03)00158-6
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   Tete S, 2009, INT J IMMUNOPATH PH, V22, P1105, DOI 10.1177/039463200902200427
   Tete S, 2012, CLIN ORAL IMPLAN RES, V23, P1254, DOI 10.1111/j.1600-0501.2011.02300.x
   Tete S, 2010, J CRANIOFAC SURG, V21, P1147, DOI 10.1097/SCS.0b013e3181e484a7
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   Viscioni A, 2010, J Ir Dent Assoc, V56, P186
   Yao F, 2007, AM J TRANSPLANT, V7, P2723, DOI 10.1111/j.1600-6143.2007.02012.x
   Yukna RA, 2005, J PERIODONTOL, V76, P57, DOI 10.1902/jop.2005.76.1.57
NR 42
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAY
PY 2013
VL 24
IS 3
BP 836
EP 840
DI 10.1097/SCS.0b013e31827c9de4
PG 5
WC Surgery
SC Surgery
GA 294WI
UT WOS:000330078200081
PM 23714892
DA 2018-10-20
ER

PT J
AU Fan, W
   Wu, CT
   Miao, XG
   Liu, G
   Saifzadeh, S
   Sugiyama, S
   Afara, I
   Crawford, R
   Xiao, Y
AF Fan, Wei
   Wu, Chengtie
   Miao, Xigeng
   Liu, Gang
   Saifzadeh, Siamak
   Sugiyama, Sadahiro
   Afara, Isaac
   Crawford, Ross
   Xiao, Yin
TI Biomaterial scaffolds in cartilage-subchondral bone defects influencing
   the repair of autologous articular cartilage transplants
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE HA-TCP; PLGA; cartilage; bone defect; scaffolds
ID MECHANICAL ENVIRONMENT; OSTEOARTHRITIC CARTILAGE; SURFACE MODIFICATION;
   TISSUE; CHONDROCYTES; COMPOSITE; CULTURE; ACID); GLASS; DIFFERENTIATION
AB The repair of articular cartilage typically involves the repair of cartilage-subchondral bone tissue defects. Although various bioactive materials have been used to repair bone defects, how these bioactive materials in subchondral bone defects influence the repair of autologous cartilage transplant remains unclear. The aim of this study was to investigate the effects of different subchondral biomaterial scaffolds on the repair of autologous cartilage transplant in a sheep model. Cylindrical cartilage-subchondral bone defects were created in the right femoral knee joint of each sheep. The subchondral bone defects were implanted with hydroxyapatite-beta-tricalcium phosphate (HA-TCP), poly lactic-glycolic acid (PLGA)-HA-TCP dual-layered composite scaffolds (PLGA/HA-TCP scaffolds), or autologous bone chips. The autologous cartilage layer was placed on top of the subchondral materials. After 3 months, the effect of different subchondral scaffolds on the repair of autologous cartilage transplant was systematically studied by investigating the mechanical strength, structural integration, and histological responses. The results showed that the transplanted cartilage layer supported by HA-TCP scaffolds had better structural integration and higher mechanical strength than that supported by PLGA/HA-TCP scaffolds. Furthermore, HA-TCP-supported cartilage showed higher expression of acid mucosubstances and glycol-amino-glycan contents than that supported by PLGA/HA-TCP scaffolds. Our results suggested that the physicochemical properties, including the inherent mechanical strength and material chemistry of the scaffolds, play important roles in influencing the repair of autologous cartilage transplants. The study may provide useful information for the design and selection of proper subchondral biomaterials to support the repair of both subchondral bone and cartilage defects.
C1 [Fan, Wei; Wu, Chengtie; Miao, Xigeng; Liu, Gang; Saifzadeh, Siamak; Sugiyama, Sadahiro; Afara, Isaac; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
   [Fan, Wei] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430079, Peoples R China.
RP Wu, CT (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM chengtie.wu@qut.edu.au
RI Saifzadeh, Siamak/J-1240-2012
OI Saifzadeh, Siamak/0000-0002-0295-7477; Crawford,
   Ross/0000-0001-6079-1316; Xiao, Yin/0000-0003-1785-3491; Afara,
   Isaac/0000-0001-7114-0439
FU Australian Research Council [DP0881045]; Australian Orthopaedic
   Association (AOA) [2006005657]
FX This project is financially supported by Australian Research Council
   (DP0881045) and Australian Orthopaedic Association (AOA 2006005657).
CR Adams MA, 2006, BIORHEOLOGY, V43, P537
   Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]
   Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Bachrach NM, 1995, J BIOMECH, V28, P1561, DOI 10.1016/0021-9290(95)00103-4
   Bandyopadhyay-Ghosh S, 2007, J BIOMED MATER RES A, V80A, P175, DOI 10.1002/jbm.a.30878
   Beutner R, 2010, J R SOC INTERFACE, V7, pS93, DOI 10.1098/rsif.2009.0418.focus
   Castillo M, 2001, Biomed Sci Instrum, V37, P469
   Durrant LA, 1999, J ANAT, V194, P343, DOI 10.1046/j.1469-7580.1999.19430343.x
   El-Ayoubi R, 2011, J BIOMATER APPL, V25, P429, DOI 10.1177/0885328209355332
   Erggelet C, 2009, J ORTHOP RES, V27, P1353, DOI 10.1002/jor.20879
   Fang W, 2010, J ORAL PATHOL MED, V39, P356, DOI 10.1111/j.1600-0714.2009.00831.x
   Gao Y, 2009, J BIOMATER APPL, V24, P119, DOI 10.1177/0885328208094265
   Gavenis K, 2010, J BIOMATER IN PRESS
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Gooch KJ, 2001, BIOCHEM BIOPH RES CO, V286, P909, DOI 10.1006/bbrc.2001.5486
   Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6
   Guldberg R. E., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P333
   Ho D, 2011, NANOSCALE, V3, P907, DOI 10.1039/c0nr00666a
   Lin YY, 2009, ANN BIOMED ENG, V37, P1358, DOI 10.1007/s10439-009-9696-z
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   MIAO X, 2004, MAT P PROP PERF, V3, P319
   Miao XG, 2008, ACTA BIOMATER, V4, P638, DOI 10.1016/j.actbio.2007.10.006
   Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023
   Palmquist A, 2010, J R SOC INTERFACE, V7, pS515, DOI 10.1098/rsif.2010.0118.focus
   Perron JK, 2009, J BIOMED MATER RES B, V91B, P876, DOI 10.1002/jbm.b.31470
   Prasadam I, 2010, BONE, V46, P226, DOI 10.1016/j.bone.2009.10.014
   Pufe T, 2004, AM J PATHOL, V164, P185, DOI 10.1016/S0002-9440(10)63109-4
   Pufe T, 2001, ARTHRITIS RHEUM, V44, P1082, DOI 10.1002/1529-0131(200105)44:5<1082::AID-ANR188>3.0.CO;2-X
   Spiller KL, 2008, ACTA BIOMATER, V4, P17, DOI 10.1016/j.actbio.2007.09.001
   Stenhamre H, 2011, J TISSUE ENG REGEN M, V5, P578, DOI 10.1002/term.350
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   Toyokawa N, 2010, ARTHROSCOPY, V26, P375, DOI 10.1016/j.arthro.2009.08.006
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Wei JD, 2011, J BIOMATER IN PRESS
   Wu CT, 2008, J BIOMED MATER RES B, V87B, P346, DOI 10.1002/jbm.b.31109
   Wu CT, 2007, J BIOMATER APPL, V21, P251, DOI 10.1177/0885328206062360
   Wu CT, 2006, J BIOMATER APPL, V21, P119, DOI 10.1177/0885328206057953
   Wu CT, 2011, ACTA BIOMATER, V7, P2229, DOI 10.1016/j.actbio.2010.12.019
   Wu CT, 2010, J BIOMED MATER RES B, V94B, P32, DOI 10.1002/jbm.b.31621
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu C, 2009, BIOMATERIALS, V30, P2199, DOI 10.1016/j.biomaterials.2009.01.029
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
NR 43
TC 7
Z9 10
U1 2
U2 34
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2013
VL 27
IS 8
BP 979
EP 989
DI 10.1177/0885328211431310
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 298LB
UT WOS:000330324300006
PM 22684516
DA 2018-10-20
ER

PT J
AU Shah, PN
   Yun, YH
AF Shah, Parth N.
   Yun, Yang H.
TI Cellular interactions with biodegradable polyurethanes formulated from
   L-tyrosine
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE L-tyrosine; polyurethanes; cytotoxicity; cell adhesion; biocompatibility
ID PROTEIN ADSORPTION; BIOMATERIAL APPLICATIONS; PLATELET-ADHESION;
   IN-VITRO; BIOMEDICAL APPLICATIONS; LYSINE DIISOCYANATE; TRIBLOCK
   COPOLYMERS; ENDOTHELIAL-CELLS; POLYMER SURFACES; ANTIBODY-BINDING
AB L-Tyrosine polyurethanes (LTUs) have been synthesized by structural modification of the poly (amino acid) backbone to circumvent the problems associated with the processing of poly (amino acids) arising from their high crystallinity, insolubility in common organic solvents, and high glass-transition and melting temperatures. Additionally, problems such as unpredictable swelling characteristics, change in conformation, and uncontrolled enzymatic degradation have severely restricted the use of poly (amino acids). In contrast, LTUs are designed to retain their superior physico-chemical properties, while incorporating biodegradability through enzymatic, hydrolytic, and oxidative pathways. The aim of this study is to evaluate initially the biocompatibility of LTUs and their degradation products. Studies involving primary dermal human fibroblasts cultured in contact with LTU films or degradation products suggest a lack of toxicity (cell viabilities >93% with p< 0.05 compared to the control for all studies). The diversity of LTU polymer chemistry and the ability of LTUs to phase separate seem to present a heterogeneous surface with variable wettability. This phenomenon influences the adhesion and proliferation of human fibroblasts on polymeric surfaces, wherein fibroblast adhesion on polycaprolactone diol (PCL) based LTUs is characterized by higher cell counts (81,250 +/- 18,390 for PCL-C-DTH (desaminotyrosine- tyrosyl hexyl, DTH), 58,360 +/- 7370 for PCL-L-DTH, 38,480 +/- 12,680 for PEG-C-DTH (polyethylene glycol, PEG), and 46,430 +/- 16,000 for PEG-L-DTH at 120 h with p< 0.001 for comparison between PCL-C-DTH and all other LTUs), more rapid cellular proliferation (doubling time of 37-49 h for PCL-based LTUs compared to 68-90 h for PEG-based LTUs), and a uniform cell distribution compared to PEG-based LTUs. However, immunofluorescence assay for F-actin suggests that the cells are well attached. Thus, the lack of cytotoxicity and the ability to control cellular adhesion through polymer chemistry make LTUs attractive candidates for tissue-engineering applications that require elastomeric, biodegradable, and biocompatible polymers.
C1 [Shah, Parth N.] Univ Akron, Dept Biomol & Chem Engn, Akron, OH 44325 USA.
   [Shah, Parth N.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.
   [Yun, Yang H.] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
RP Yun, YH (reprint author), Univ Akron, Dept Biomed Engn, 302 Buchtel Common, Akron, OH 44325 USA.
EM yy@uakron.edu
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Blais P., 1990, J APPL BIOMATER, V1, P197
   BRUIN P, 1990, BIOMATERIALS, V11, P291, DOI 10.1016/0142-9612(90)90013-G
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   Chen M, 2003, J BIOMAT SCI-POLYM E, V14, P917, DOI 10.1163/156856203322381410
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Coury A, 2004, BIOMATERIALS SCI INT
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   DEVRINGER T, 1986, COLLOID POLYM SCI, V264, P623, DOI 10.1007/BF01412602
   El Sayegh TY, 2002, J BIOMED MATER RES, V61, P482, DOI 10.1002/jbm.10217
   Glenn HL, 2003, CELL MOTIL CYTOSKEL, V55, P265, DOI 10.1002/cm.10128
   GOGOLEWSKI S, 1983, MAKROMOL CHEM-RAPID, V4, P675
   GOGOLEWSKI S, 1987, COLLOID POLYM SCI, V265, P971, DOI 10.1007/BF01412399
   GOGOLEWSKI S, 1987, COLLOID POLYM SCI, V265, P774, DOI 10.1007/BF01418452
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   GOGOLEWSKI S, 2001, P 27 SOC BIOM ANN M, V24, P573
   Gogolewski S, 2002, P 48 ANN M ORTH RES, P10
   GOGOLEWSKI S, 1997, DESK REFERENCE FUNCT
   Gorna K, 2006, J BIOMED MATER RES A, V79A, P128, DOI 10.1002/jbm.a.30708
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Gupta AS, 2003, SYNTHESIS CHARACTERI
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   Hatakeyama H, 1998, MACROMOL SYMP, V130, P127, DOI 10.1002/masy.19981300112
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Hsu SH, 2004, J BIOMATER APPL, V19, P135, DOI 10.1177/0885328204044160
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Khang G, 1997, BIO-MED MATER ENG, V7, P357
   Kylma J, 1997, MACROMOLECULES, V30, P2876, DOI 10.1021/ma961569g
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lannutti J, 2007, MAT SCI ENG C-BIO S, V27, P504, DOI 10.1016/j.msec.2006.05.019
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Lelah M. D., 1986, POLYURETHANES MED
   Marcos-Fernandez A, 2006, POLYMER, V47, P785, DOI 10.1016/j.polymer.2005.12.007
   Nahum A. M, 2002, ACCIDENTAL INJURY BI
   Nakao A, 1996, SURF INTERFACE ANAL, V24, P252, DOI 10.1002/(SICI)1096-9918(199604)24:4<252::AID-SIA113>3.0.CO;2-R
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6
   Ozdemir Y, 2002, J MATER SCI-MATER M, V13, P1147, DOI 10.1023/A:1021185803716
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Sarkar D, 2007, EXPRESS POLYM LETT, V1, P724, DOI 10.3144/expresspolymlett.2007.100
   Sarkar D., 2007, DEV CHARACTERIZATION
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Shah PN, 2009, J APPL POLYM SCI, V114, P3235, DOI 10.1002/app.30509
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   STOREY RF, 1994, J POLYM SCI POL CHEM, V32, P2345, DOI 10.1002/pola.1994.080321216
   Szycher M, 1991, J Biomater Appl, V5, P256, DOI 10.1177/088532829100500402
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tsai IY, 2004, J BIOMED MATER RES A, V71A, P462, DOI 10.1002/jbm.a.30183
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   YAMADA H, 1970, STRENGTH BIOL MAT
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   Zhu BS, 2004, J BIOMED MATER RES B, V70B, P43, DOI 10.1002/jbm.b.30011
NR 65
TC 4
Z9 4
U1 1
U2 20
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2013
VL 27
IS 8
BP 1017
EP 1031
DI 10.1177/0885328211432325
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 298LB
UT WOS:000330324300009
PM 22207610
DA 2018-10-20
ER

PT J
AU Lim, DI
   Park, HS
   Park, JH
   Knowles, JC
   Gong, MS
AF Lim, Dong-In
   Park, Hyung-Seok
   Park, Jeong-Hui
   Knowles, Jonathan C.
   Gong, Myoung-Seon
TI Application of high-strength biodegradable polyurethanes containing
   different ratios of biobased isomannide and poly (E-caprolactone) diol
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Biodegradable; biobased monomer; polyurethane; biocompatible; isomannide
ID EPSILON-CAPROLACTONE; SCAFFOLDS; POLY(EPSILON-CAPROLACTONE);
   BIOCOMPATIBILITY; REGENERATION; BIOMATERIAL; DERIVATIVES; SEGMENT
AB Biodegradable-biocompatible polyurethanes were prepared with fixed hexamethylene diisocyanate and varying ratios of isomannide and poly(E-caprolactone) diol using a simple one-step polymerization without a catalyst. The polyurethane structures were confirmed by H-1-nuclear magnetic resonance, Fourier transform infrared spectroscopy, and gel permeation chromatography. The glass transition temperatures were determined by thermal analysis to be between 25 degrees C and 30 degrees C. Degradation tests performed at 37 degrees C in phosphate buffer produced mass losses of 5%-10% after 8 weeks. After 5 days of culture, using osteoblastic cells, the relative cell number on all the polyurethane films was only slightly lower than that of an optimized tissue culture plastic. These polymers offer significant promise with a simplistic synthesis and controlled degradation.
C1 [Lim, Dong-In; Park, Hyung-Seok; Park, Jeong-Hui; Knowles, Jonathan C.; Gong, Myoung-Seon] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Lim, Dong-In; Park, Hyung-Seok; Park, Jeong-Hui; Knowles, Jonathan C.; Gong, Myoung-Seon] Dankook Univ, Grad Sch, WCU Res Ctr, Cheonan 330714, South Korea.
   [Knowles, Jonathan C.] UCL Eastman Dent Inst, Dept Biomat & Tissue Engn, London, England.
RP Gong, MS (reprint author), Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
EM msgong@dankook.ac.kr
RI Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446
FU Priority Research Centers Program [2009-0093829]; World Class University
   (WCU) Program through the National Research Foundation of Korea
   [R31-10069]; Ministry of Education, Science, and Technology
FX This study was supported by Priority Research Centers Program (no.
   2009-0093829) and the World Class University (WCU) Program through the
   National Research Foundation of Korea (no. R31-10069) and funded by the
   Ministry of Education, Science, and Technology.
CR Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019
   Danmark S, 2010, J BIOACT COMPAT POL, V25, P207, DOI 10.1177/0883911509358812
   Geoghegan M, 2003, PROG POLYM SCI, V28, P261, DOI 10.1016/S0079-6700(02)00080-1
   GOGOLEWSKI S, 1987, COLLOID POLYM SCI, V265, P971, DOI 10.1007/BF01412399
   Gorna K, 2006, J BIOMED MATER RES A, V79A, P128, DOI 10.1002/jbm.a.30708
   Gualandi C, 2012, J BIOACT COMPAT POL, V27, P244, DOI 10.1177/0883911512440536
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   Habeych DI, 2011, J MOL CATAL B-ENZYM, V71, P1, DOI 10.1016/j.molcatb.2011.02.015
   Hassan N, 2007, J BIOACT COMPAT POLY, V22, P77
   Heijkants RGJC, 2005, BIOMATERIALS, V26, P4219, DOI 10.1016/j.biomaterials.2004.11.005
   Holzapfel GA, 2000, BIOMECH PREPRINT SER
   Izhar U, 2001, J SURG RES, V95, P152, DOI 10.1006/jsre.2000.6042
   Katarzyna G, 2002, J BIOMED MATER RES, V60, P592
   Kawase T, 2012, J BIOACT COMPAT POL, V27, P107, DOI 10.1177/0883911512438306
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Koh T, 2012, BMC COMPLEM ALTERN M, V78, P1
   Lelah M. D., 1986, POLYURETHANES MED
   Lisa T, 2007, BIOMATERIALS, V28, P5407
   Luo N, 1997, MACROMOLECULES, V30, P4405
   Marcos-Fernandez A, 2006, POLYMER, V47, P785, DOI 10.1016/j.polymer.2005.12.007
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rivera-Armenta JL, 2004, EUR POLYM J, V40, P2803, DOI 10.1016/j.eurpolymj.2004.07.015
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Sharma B, 2005, POLYMER, V46, P1775, DOI 10.1016/j.polymer.2004.11.024
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Tomas E, 2010, J BIOACT COMPAT POLY, V25, P5
   Zhang CH, 2007, J BIOMED MATER RES A, V82A, P637, DOI 10.1002/jbm.a.30992
NR 27
TC 12
Z9 12
U1 2
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2013
VL 28
IS 3
BP 274
EP 288
DI 10.1177/0883911513484572
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 208HC
UT WOS:000323667500007
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Aberg, KA
   Xie, LY
   Nerella, S
   Copeland, WE
   Costello, EJ
   van den Oord, EJCG
AF Aberg, Karolina A.
   Xie, Lin Y.
   Nerella, Srilaxmi
   Copeland, William E.
   Costello, E. Jane
   van den Oord, Edwin J. C. G.
TI High quality methylome-wide investigations through next-generation
   sequencing of DNA from a single archived dry blood spot
SO EPIGENETICS
LA English
DT Article
DE archived blood spots; methylation; next-generation sequencing; DNA
   extraction; MBD-seq
ID METHYLATION ANALYSIS; COMPLEX TRAITS; HUMAN-DISEASE; GENOME;
   EPIGENETICS; SAMPLES; ASSOCIATION; DEMETHYLATION; PRINCIPLE; ADULT
AB The potential importance of DNA methylation in the etiology of complex diseases has led to interest in the development of methylome-wide association studies (MWAS) aimed at interrogating all methylation sites in the human genome. When using blood as biomaterial for a MWAS the DNA is typically extracted directly from fresh or frozen whole blood that was collected via venous puncture. However, DNA extracted from dry blood spots may also be an alternative starting material. In the present study, we apply a methyl-CpG binding domain (MBD) protein enrichment-based technique in combination with next generation sequencing (MBD-seq) to assess the methylation status of the similar to 27 million CpGs in the human autosomal reference genome. We investigate eight methylomes using DNA from blood spots. This data are compared with 1,500 methylomes previously assayed with the same MBD-seq approach using DNA from whole blood. When investigating the sequence quality and the enrichment profile across biological features, we find that DNA extracted from blood spots gives comparable results with DNA extracted from whole blood. Only if the amount of starting material is <= 0.5 mu g DNA we observe a slight decrease in the assay performance. In conclusion, we show that high quality methylome-wide investigations using MBD-seq can be conducted in DNA extracted from archived dry blood spots without sacrificing quality and without bias in enrichment profile as long as the amount of starting material is sufficient. In general, the amount of DNA extracted from a single blood spot is sufficient for methylome-wide investigations with the MBD-seq approach.
C1 [Aberg, Karolina A.; Xie, Lin Y.; Nerella, Srilaxmi; van den Oord, Edwin J. C. G.] Virginia Commonwealth Univ, Sch Pharm, Ctr Biomarker Res & Personalized Med, Richmond, VA 23284 USA.
   [Copeland, William E.; Costello, E. Jane] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, Durham, NC USA.
RP Aberg, KA (reprint author), Virginia Commonwealth Univ, Sch Pharm, Ctr Biomarker Res & Personalized Med, Richmond, VA 23284 USA.
EM kaaberg@vcu.edu
RI copeland, william/N-5413-2014; Aberg, Karolina/A-6772-2010
OI Aberg, Karolina/0000-0001-6103-5168
FU National Institute of Mental Health [RC2 MH089996]
FX This work was supported by the National Institute of Mental Health
   (Grant RC2 MH089996). This paper is subject to the NIH Public Access
   Policy.
CR Aberg KA, 2012, EPIGENOMICS-UK, V4, P605, DOI [10.2217/EPI.12.59, 10.2217/epi.12.59]
   Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409
   Beyan H, 2012, GENOME RES, V22, P2138, DOI 10.1101/gr.134304.111
   Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14
   Boks MP, 2012, EPIGENETICS-US, V7, P20, DOI 10.4161/epi.7.1.18688
   COONEY CA, 1993, GROWTH DEVELOP AGING, V57, P261
   Costello EJ, 1996, ARCH GEN PSYCHIAT, V53, P1129
   COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0
   Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919
   Fowler Katie E, 2012, BMC Res Notes, V5, P503, DOI 10.1186/1756-0500-5-503
   Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554
   Fuks F, 2000, NAT GENET, V24, P88
   Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682
   Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005
   Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779
   Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111
   Hollegaard MV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-58
   Hollegaard MV, 2013, MOL GENET METAB, V108, P225, DOI 10.1016/j.ymgme.2013.01.016
   Hollegaard MV, 2009, ELECTROPHORESIS, V30, P2532, DOI 10.1002/elps.200800655
   JOST JP, 1991, NUCLEIC ACIDS RES, V19, P5771, DOI 10.1093/nar/19.20.5771
   Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557
   Kwok JBJ, 2010, EPIGENOMICS-UK, V2, P671, DOI 10.2217/EPI.10.43
   Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732
   Lan X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022226
   Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009
   Mei JV, 2001, J NUTR, V131, p1631S
   Melas PA, 2012, FASEB J, V26, P2712, DOI 10.1096/fj.11-202069
   Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008
   Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313
   Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104
   Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]
   Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230
   Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000
   Sarkies P, 2012, TRENDS GENET, V28, P118, DOI 10.1016/j.tig.2011.11.005
   Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992
   Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x
   van den Oord EJCG, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-50
   Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011
   Winkel BG, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-22
   Worthman CM, 1997, AM J PHYS ANTHROPOL, V104, P1
   Xu HM, 2012, FORENSIC SCI INT-GEN, V6, P306, DOI 10.1016/j.fsigen.2011.06.007
   YOKOMORI N, 1995, P NATL ACAD SCI USA, V92, P1302, DOI 10.1073/pnas.92.5.1302
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 43
TC 11
Z9 11
U1 0
U2 14
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1559-2294
EI 1559-2308
J9 EPIGENETICS-US
JI Epigenetics
PD MAY 1
PY 2013
VL 8
IS 5
BP 542
EP 547
DI 10.4161/epi.24508
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 205VU
UT WOS:000323473700011
PM 23644822
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Oliveira, LD
   Giovanini, AF
   Abuabara, A
   Klug, LG
   Gonzaga, CC
   Zielak, JC
   Urban, CD
   Deliberador, TM
AF Oliveira, Lidiane-da Costa
   Giovanini, Allan-Fernando
   Abuabara, Allan
   Klug, Luiz-Gustavo
   Gonzaga, Carla-Castiglia
   Zielak, Joao-Cezar
   Urban, Cicero-de Andrade
   Deliberador, Tatiana-Miranda
TI Fragmented adipose tissue graft for bone healing: Histological and
   histometric study in rabbits' calvaria
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Adipose tissue; bone regeneration; rabbits; critical defects
ID CRITICAL-SIZE DEFECTS; PLATELET-RICH PLASMA; STEM-CELLS; STROMAL CELLS;
   FAT; SCAFFOLD; PROTEIN; REPAIR; MODEL
AB Objective The adipose tissue represents an important reservoir of stem cells. There are few studies in the literature with which to histologically evaluate whether or not the adipose tissue graft is really a safe option to achieve bone repair. This study histologically analyzed the effect of fragmented autogenous adipose tissue grafts on bone healing in surgically created, critical-size defects (CSD) in a rabbit's calvaria.
   Study design Forty-two New Zealand rabbits were used in this study. CSD that were 15 mm in diameter were created in the calvarium of each animal. The defects were randomly divided into two groups: in Group C (control), the defect was filled only by a blood clot and, in Group FAT (i.e., fragmented adipose tissue), the defect was filled with fragmented autogenous adipose tissue grafts. The groups were divided into subgroups (n = 7) for euthanasia at 7, 15, and 40 days after the procedure had been conducted. Histologic and histometric analyses were performed. Data were statistically analysed with ANOVA and Tukey's tests (p < 0.05).
   Results The amount of bone formation did not show statistically significant differences seven days after the operation, which indicates that the groups had similar amounts of mineral deposition in the earlier period of the repair. Conversely, a significant of amount of bone matrix deposition was identified in the FAT group at 15 and 40 days following the operation, both on the border and in the body of the defect. Such an outcome was not found in the control group.
   Conclusion In this study, an autologous adipose tissue graft may be considered as likely biomaterial for bone regeneration, since it positively affected the amount of bone formation in surgically created CSD in the rabbits' calvaria 40 days after the procedure had been performed. Further investigations with a longer time evaluation are warranted to determine the effectiveness of autologous adipose tissue graft in the bone healing.
C1 [Oliveira, Lidiane-da Costa; Giovanini, Allan-Fernando; Klug, Luiz-Gustavo; Gonzaga, Carla-Castiglia; Zielak, Joao-Cezar; Urban, Cicero-de Andrade; Deliberador, Tatiana-Miranda] Posit Univ, Curitiba, Parana, Brazil.
   [Abuabara, Allan] Joinville Municipal Author, Joinville, SC, Brazil.
RP Deliberador, TM (reprint author), Rua Prof Pedro Viriato Parigot de Sousa,5300 Camp, BR-81280330 Curitiba, Parana, Brazil.
EM tdeliberador@gmail.com
RI Deliberador, Tatiana/C-3022-2016; Gonzaga, Carla/K-2997-2012; Giovanini,
   Allan/K-5215-2012
OI Deliberador, Tatiana/0000-0003-4076-4905; Gonzaga,
   Carla/0000-0001-6374-1605; Giovanini, Allan/0000-0002-1637-2955
CR Barone CM, 1997, J CRANIOFAC SURG, V8, P43, DOI 10.1097/00001665-199701000-00015
   Bohnenblust ME, 2009, J CRANIOFAC SURG, V20, P340, DOI 10.1097/SCS.0b013e3181992316
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042
   Dudas JR, 2006, ANN PLAS SURG, V56, P543, DOI 10.1097/01.sap.0000210629.17727.bd
   Follmar KE, 2007, ANN PLAS SURG, V58, P561, DOI 10.1097/01.sap.0000245119.74126.09
   GOODRICH JT, 1992, PEDIATR NEUROSURG, V18, P195, DOI 10.1159/000120662
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Hattori H, 2006, J BIOMED MATER RES B, V76B, P230, DOI 10.1002/jbm.b.30357
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Inoue Akira, 1995, Neurologia Medico-Chirurgica, V35, P804
   Judas F, 2005, TRANSPLANT P, V37, P2799, DOI 10.1016/j.transproceed.2005.05.004
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JA, 2003, ANN PLAS SURG, V50, P610, DOI 10.1097/01.SAP.0000069069.23266.35
   Lee JH, 2006, BIOCHEM BIOPH RES CO, V341, P882, DOI 10.1016/j.bbrc.2006.01.038
   Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002
   Messora MR, 2008, J PERIODONTAL RES, V43, P217, DOI 10.1111/j.1600-0765.2007.01017.x
   Nagata MJH, 2009, J CLIN PERIODONTOL, V36, P775, DOI 10.1111/j.1600-051X.2009.01450.x
   Qu CQ, 2007, IN VITRO CELL DEV-AN, V43, P95, DOI 10.1007/s11626-006-9008-y
   Scherberich A, 2010, J CELL PHYSIOL, V225, P348, DOI 10.1002/jcp.22313
   Shen Chia-Ning, 2004, Organogenesis, V1, P36
   Song L, 2004, TISSUE ENG, V18, P980
   Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003
   Torres FC, 2007, AESTHET PLAST SURG, V31, P574, DOI 10.1007/s00266-007-0001-y
   Wang Q, 2009, J CRANIOFAC SURG, V20, P2193, DOI 10.1097/SCS.0b013e3181bf04af
   Zielak JC, 2011, J ORAL IMPLANTOL
   Zou J, 2011, J SURG RES, V168, P76, DOI 10.1016/j.jss.2009.07.021
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 29
TC 3
Z9 4
U1 0
U2 3
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-6946
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD MAY
PY 2013
VL 18
IS 3
BP E510
EP E515
DI 10.4317/medoral.18407
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 193NH
UT WOS:000322566000022
PM 23524416
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Li, YH
   Llu, H
   Zhang, J
   Sun, ZQ
   Deng, ZY
AF Li, Yong-Hua
   Llu, Hong
   Zhang, Jing
   Sun, Zhen-Qian
   Deng, Zi-Yu
TI Powder sintering of porous TiNi alloy using pore forming agent of
   NH4HCO3
SO OPTOELECTRONICS AND ADVANCED MATERIALS-RAPID COMMUNICATIONS
LA English
DT Article
DE Porous shape memory alloy; Biomaterial; Powder sintering; Pore
   characteristics; Mechanical property
ID SHAPE-MEMORY ALLOY; ELEMENTAL POWDERS; NITI ALLOY; FABRICATION;
   CORROSION; BEHAVIOR; SURFACE; BONE
AB Porous TiNi shape memory alloy (SMA) was fabricated by powder sintering using powders of TiH2, Ni and pore forming agent of NH4HCO3. The research results reveal that phase compositions of the sintered porous TiNi SMA are independent of addition of pore forming agent. Microstructures and mechanical properties are dependent strongly on the adding amount of pore forming agent. Average pore size and porosity increase while compressive strength and elastic modulus decrease with the amount of pore forming agent. The appropriate pore structure and mechanical properties meet the demands of cancellous bone, suggesting porous TiNi SMA is fit for orthopedic application.
C1 [Li, Yong-Hua; Zhang, Jing; Sun, Zhen-Qian; Deng, Zi-Yu] Shenyang Ligong Univ, Sch Mat Sci & Engn, Shenyang 110159, Peoples R China.
   [Llu, Hong] Shenyang Ligong Univ, Inst Higher Educ Res, Shenyang 110159, Peoples R China.
RP Li, YH (reprint author), Shenyang Ligong Univ, Inst Higher Educ Res, Shenyang 110159, Peoples R China.
EM yhlicn@163.com
OI Li, Yong-Hua/0000-0003-0005-3789
FU office of Education in Liaoning Province [2008S198]; Science Public
   Welfare Research Funds of Liaoning Province in China [2012002008]
FX The authors are grateful for the financial supports from the office of
   Education in Liaoning Province (Grant No.2008S198) and the Science
   Public Welfare Research Funds of Liaoning Province in China under Grant
   No.2012002008.
CR Bansiddhi A, 2008, ACTA BIOMATER, V4, P773, DOI 10.1016/j.actbio.2008.02.009
   Bansiddhi A, 2007, INTERMETALLICS, V15, P1612, DOI 10.1016/j.intermet.2007.06.013
   Chu CL, 2005, J MATER PROCESS TECH, V169, P103, DOI 10.1016/j.jmatprotec.2005.03.002
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Ismail MH, 2012, MATER LETT, V70, P142, DOI 10.1016/j.matlet.2011.12.008
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Jiang HC, 2006, SURF COAT TECH, V201, P1017, DOI 10.1016/j.surfcoat.2006.01.015
   Li YH, 2002, MATER LETT, V57, P448, DOI 10.1016/S0167-577X(02)00809-1
   Man HC, 2005, MAT SCI ENG A-STRUCT, V404, P173, DOI 10.1016/j.msea.2005.05.020
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Tang CY, 2011, MAT SCI ENG A-STRUCT, V528, P6006, DOI 10.1016/j.msea.2011.04.040
   Yuan B, 2004, MAT SCI ENG A-STRUCT, V382, P181, DOI 10.1016/j.msea.2004.04.068
   Zhu SL, 2004, MATER LETT, V58, P2369, DOI 10.1016/j.matlet.2004.02.017
NR 15
TC 1
Z9 1
U1 0
U2 11
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1842-6573
J9 OPTOELECTRON ADV MAT
JI Optoelectron. Adv. Mater.-Rapid Commun.
PD MAY-JUN
PY 2013
VL 7
IS 5-6
BP 414
EP 416
PG 3
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 189SE
UT WOS:000322287800019
DA 2018-10-20
ER

PT J
AU Guo, ZH
   Zhou, L
   Rong, MD
   Ding, JW
   Zhu, AD
   Li, SB
   Lu, HB
AF Guo, Zehong
   Zhou, Lei
   Rong, Mingdeng
   Ding, Jingwen
   Zhu, Andi
   Li, Shaobing
   Lu, Haibin
TI Bone Augmentation in a Titanium Cap with a Porous Surface Modified by
   Microarc Oxidation
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone augmentation; microarc oxidation; surface modification; titanium
   cap
ID CONTROLLED CLINICAL-TRIAL; RABBIT CALVARIUM; DENTAL IMPLANTS; IN-VIVO;
   REGENERATION; MEMBRANE
AB Purpose: To compare bone augmentation on pure titanium-machined surfaces and surfaces that have been modified by microarc oxidation (MAO) using titanium caps. Materials and Methods: Twenty caps were manufactured from rods of commercially pure titanium. The control group (CG) consisted of 10 titanium caps with machined inner walls. The test group (TG) consisted of 10 titanium caps that were modified by MAO in an electrolyte solution containing calcium phosphate ions. The two types of titanium caps were fixed on the calvaria of 10 New Zealand rabbits. Each rabbit received two different caps. Although each cap was unfilled, the marrow and blood from the wound of the rabbit skulls could penetrate into the caps. After 4 weeks, the rabbits were sacrificed, and the skulls were removed for observation. The zenith of new bone was measured directly after the caps were removed from the skulls; subsequently, the bone volume was calculated by microcomputed tomography. Results: Little bone augmentation could be observed in the CG caps, and the new bone height of the CG group was inconspicuous. In contrast, the new bone extended along the inner walls of the TG caps. The mean height of new bone of the TG group was 2.3 +/- 0.28 mm. The mean volume of new bone in the TG group was 18.63 +/- 3.80 mm(3). Conclusions: New bone formation in a titanium cap surface modified by MAO was greater than that of a nonmodified cap. A titanium cap allowed new bone formation on the MAO surface to be observed and is a promising device for bone augmentation. Additionally, this finding suggests that observation through a titanium cap is a feasible method for biomaterial testing in hard tissue.
C1 [Guo, Zehong; Zhou, Lei; Rong, Mingdeng; Ding, Jingwen; Zhu, Andi; Li, Shaobing; Lu, Haibin] Southern Med Univ, Affiliated Stomatol Hosp, Guangdong Prov Stomatol Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510280, Guangdong, Peoples R China.
RP Zhou, L (reprint author), Southern Med Univ, Affiliated Stomatol Hosp, Guangdong Prov Stomatol Hosp, 366 South Jiang Nan Rd, Guangzhou 510280, Guangdong, Peoples R China.
EM Zho668@263.net
FU National Natural Science Foundation of China [81170998]; Medical Science
   Research Fund of Guangdong Province [B2011033]
FX This work was supported by the National Natural Science Foundation of
   China (grant number: 81170998) and the Medical Science Research Fund of
   Guangdong Province (grant number: B2011033). The authors reported no
   conflicts of interest related to this study.
CR Busenlechner D, 2008, BIOMATERIALS, V29, P3195, DOI 10.1016/j.biomaterials.2008.04.021
   Guo ZH, 2010, INT J ORAL MAX IMPL, V25, P130
   Han Y, 2002, MATER LETT, V56, P744, DOI 10.1016/S0167-577X(02)00606-7
   Hasegawa Y, 2008, J PERIODONTOL, V79, P348, DOI [10.1902/jop.2008.070305, 10.1902/jop.2008.070305 ]
   Hermann J S, 1996, Curr Opin Periodontol, V3, P168
   Jung RE, 2009, CLIN ORAL IMPLAN RES, V20, P162, DOI 10.1111/j.1600-0501.2008.01634.x
   Kim BK, 2010, ORAL SURG ORAL MED O, V110, pE8, DOI 10.1016/j.tripleo.2010.03.031
   Kim HR, 2010, CLIN ORAL IMPLAN RES, V21, P346, DOI 10.1111/j.1600-0501.2009.01855.x
   Louis PJ, 2008, J ORAL MAXIL SURG, V66, P235, DOI 10.1016/j.joms.2007.08.022
   Mardas N, 2010, CLIN ORAL IMPLAN RES, V21, P688, DOI 10.1111/j.1600-0501.2010.01918.x
   Mariano R, 2010, ORAL SURG ORAL MED O, V109, P72, DOI 10.1016/j.tripleo.2009.08.003
   Nagata MJH, 2009, J CLIN PERIODONTOL, V36, P775, DOI 10.1111/j.1600-051X.2009.01450.x
   Nasatzky E, 2003, Refuat Hapeh Vehashinayim (1993), V20, P8
   Nishida T, 2006, J PERIODONTOL, V77, P983, DOI 10.1902/jop.2006.050170
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sul YT, 2001, J MATER SCI-MATER M, V12, P1025, DOI 10.1023/A:1012837905910
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x
   Yamada Y, 2008, CLIN ORAL IMPLAN RES, V19, P1003, DOI 10.1111/j.1600-0501.2008.01554.x
   Zhu L, 2006, J BIOMED MATER RES A, V78A, P515, DOI 10.1002/jbm.e.30745
NR 21
TC 2
Z9 2
U1 0
U2 7
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAY-JUN
PY 2013
VL 28
IS 3
BP 767
EP 773
DI 10.11607/jomi.2208
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 186XE
UT WOS:000322078500021
PM 23748307
OA Bronze
DA 2018-10-20
ER

PT J
AU Satoh, K
   Komata, M
   Mizuhira, M
   Wagatsuma, K
   Ohtsu, N
AF Satoh, Kozue
   Komata, Masashi
   Mizuhira, Manabu
   Wagatsuma, Kazuaki
   Ohtsu, Naofumi
TI Direct and Rapid Quantification of Calcium Phosphate Precipitate on
   Titanium by X-Ray Fluorescence Analysis Using Fundamental Parameter
   Method
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE X-ray fluorescence analysis; fundamental parameter method; thin film;
   calcium phosphate; titanium; metallic biomaterial; bioactivity
ID SIMULATED BODY-FLUID; BONELIKE APATITE FORMATION; TI METAL; CHEMICAL
   TREATMENTS; HYDROGEN-PEROXIDE; FORMING ABILITY; HEAT-TREATMENT;
   HYDROXYAPATITE; SURFACE; ALLOYS
AB In the present study, we propose a characterization technique to determine the amount of calcium phosphate (CP) precipitate formed on a titanium (Ti) substrate. The quantitative analysis of the CP precipitate on a metallic substrate is significant for researchers of metallic biomaterials because CP that spontaneously precipitates in a simulated-body fluid gives information on the bioactivity of the metallic biomaterials. We focused on X-ray fluorescence (XRF) analysis and adopted the thin-film fundamental parameter method (thin-film FP method) because it allows direct (non-pretreatment) and rapid quantitative analysis without any reference materials. We show that XRF analysis using the thin-film FP method can be adequately applied to the quantitative analysis of the CP precipitate in the simulated-body fluid immersion test. We also show that the density of the CP-precipitate layer can be estimated by combining the XRF results with images of cross-sectional scanning electron microscopy (SEM).
   Consequently, XRF analysis combined with the thin-film FP method can provide a convenient means to evaluate the CP precipitate on a Ti substrate, which improves the accuracy and accessibility of the simulated-body fluid immersion test.
C1 [Satoh, Kozue; Ohtsu, Naofumi] Kitami Inst Technol, Instrumental Anal Ctr, Kitami, Hokkaido 0908507, Japan.
   [Komata, Masashi] Kitami Inst Technol, Dept Biotechnol & Environm Chem, Kitami, Hokkaido 0908507, Japan.
   [Mizuhira, Manabu] Bruker AXS KK, Yokohama, Kanagawa 2210022, Japan.
   [Wagatsuma, Kazuaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Satoh, K (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
EM kozue.satoh@imr.tohoku.ac.jp
RI Wagatsuma, Kazuaki/B-3079-2012; Ohtsu, Naofumi/L-6021-2018
OI Ohtsu, Naofumi/0000-0001-7935-3949
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [20791460]
FX The authors gratefully acknowledge Mr. Yamane and Mr. Tokuda of Kitami
   Institute of Technology, and Ms. Abe of Tohoku University for technical
   supports of experiments. Part of this work was supported by a
   Grant-in-aid for Young Scientist (B) (20791460) from the Ministry of
   Education, Culture, Sports, Science and Technology of Japan.
CR Abe C, 2009, MATER TRANS, V50, P2297, DOI 10.2320/matertrans.M2009158
   Bekkers MHJ, 1997, X-RAY SPECTROM, V26, P122, DOI 10.1002/(SICI)1097-4539(199705)26:3<122::AID-XRS220>3.3.CO;2-M
   Gupta A, 2006, TRENDS BIOMATER ARTI, V20, P84
   Ha JY, 2011, SURF COAT TECH, V205, P4948, DOI 10.1016/j.surfcoat.2011.04.079
   Han XY, 2006, J QUANT SPECTROSC RA, V97, P68, DOI 10.1016/j.jqsrt.2004.12.018
   Hiromoto S, 2010, MATER TRANS, V51, P2080, DOI 10.2320/matertrans.M2010192
   Hiromoto S, 2009, ELECTROCHIM ACTA, V54, P7085, DOI 10.1016/j.electacta.2009.07.033
   Johnson Anthony, 2011, J Oral Sci, V53, P387
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   Kim HM, 2000, J MATER SCI-MATER M, V11, P421, DOI 10.1023/A:1008935924847
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kim HM, 2003, J BIOMED MATER RES A, V67A, P1305, DOI 10.1002/jbm.a.20039
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Klenk M, 1999, SOL ENERG MAT SOL C, V58, P299, DOI 10.1016/S0927-0248(99)00014-8
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2010, MATERIALS, V3, P48, DOI 10.3390/ma3010048
   Liu XY, 2002, BIOMATERIALS, V23, P4065, DOI 10.1016/S0142-9612(02)00143-6
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Ohtsu N, 2007, J BIOMED MATER RES A, V82A, P304, DOI 10.1002/jbm.a.31136
   Ohtsu N, 2007, J MATER SCI-MATER M, V18, P1009, DOI 10.1007/s10856-006-0114-x
   Ohtsu N, 2012, SURF COAT TECH, V206, P2616, DOI 10.1016/j.surfcoat.2011.11.022
   Ohtsu N, 2011, SURF COAT TECH, V205, P3785, DOI 10.1016/j.surfcoat.2011.01.035
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   Sitko R, 2009, SPECTROCHIM ACTA B, V64, P1161, DOI 10.1016/j.sab.2009.09.005
   Steflik DE, 1998, J BIOMED MATER RES, V39, P611, DOI 10.1002/(SICI)1097-4636(19980315)39:4<611::AID-JBM16>3.0.CO;2-9
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Sugiyama K., 1993, B I ADV MAT PROCESS, V48, P140
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Vrielink JAM, 2012, THIN SOLID FILMS, V520, P1740, DOI 10.1016/j.tsf.2011.08.049
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
   Yamaguchi S, 2009, J CERAM SOC JPN, V117, P1126, DOI 10.2109/jcersj2.117.1126
NR 40
TC 1
Z9 1
U1 1
U2 13
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAY
PY 2013
VL 54
IS 5
BP 817
EP 824
DI 10.2320/matertrans.M2013020
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 179SD
UT WOS:000321540700031
OA Bronze
DA 2018-10-20
ER

PT J
AU Stetiu, AA
   Oleksik, M
   Oleksik, V
   Petruse, R
   Stetiu, M
AF Stetiu, Andreea Angela
   Oleksik, Mihaela
   Oleksik, Valentin
   Petruse, Radu
   Stetiu, Mircea
TI THE MINIMAL BURR DIMENSIONING OF TEETH PREPARATIONS TO BE RESTORED WITH
   BIOMATERIALS
SO ROMANIAN BIOTECHNOLOGICAL LETTERS
LA English
DT Article
DE Black class I preparation; burr diameter; dental materials; composites
AB In the work we determine the minimal diameter of the burr for a Black class I preparation to be filled in with different biomaterials. We used a model of a 46 molar to be cured with photopolymerisable composite materials, metallic or ceramic inlays. The scanned model of a 46 real tooth is processed in CATIA software. It is generated a model of class I preparation and filling shape. In order to obtain a reliable restoration with minimum tooth sacrificed substance the minimum burr diameter to be used for the shape and bottom of the preparation was determined. A 400 N constriction force was considered as a maximum clenching force in mastication. A finite element analyze is made in Ansys software. Shapes of tensions, deformations and safety factor of the modelled tooth are presented, pointing the dangerous areas and sections. The results show an increasing of the safety factor when the section of the shape becomes greater than the proposed value for minimum preparation for a specific biomaterial.
C1 [Stetiu, Andreea Angela] Lucian Blaga Univ, Fac Med, Sibiu, Romania.
   [Oleksik, Mihaela; Oleksik, Valentin; Petruse, Radu; Stetiu, Mircea] Lucian Blaga Univ, Fac Engn, Sibiu, Romania.
RP Stetiu, M (reprint author), Str Xenopol Alexandru 13, RO-550159 Sibiu, Romania.
EM stetium@yahoo.com
RI Mircea, Stetiu/U-2920-2017
OI Mircea, Stetiu/0000-0002-0896-8345; Oleksik,
   Valentin/0000-0002-0582-1647
FU Social European Fund through the Sectorial Operational Program for Human
   Resources Development;  [POSDRU/88/1.5/S/60370]
FX Research done within the project POSDRU/88/1.5/S/60370, co-financed
   through the Social European Fund through the Sectorial Operational
   Program for Human Resources Development 2007-2013.
CR BLASER P.K., 1993, OPER DENT
   BURNS N., 1998, J CANADIAN DENTAL AS, V19, P43
   DUYGU K, 2010, EUROPEAN J DENT, V4, P223
   Fratila A, 2012, ROM BIOTECH LETT, V17, P7474
   Jones D W, 1990, J Can Dent Assoc, V56, P851
   Merdji A, 2013, MAT SCI ENG C-MATER, V33, P691, DOI 10.1016/j.msec.2012.10.020
   Ortug G, 2002, ANN ANAT, V184, P393, DOI 10.1016/S0940-9602(02)80063-2
   STETIU M., 2009, P 4 INT C MAN SCI ED, VI, p[287, 287]
   WALTIMO A, 1993, SCAND J DENT RES, V101, P171
NR 9
TC 4
Z9 4
U1 0
U2 8
PU ARS DOCENDI
PI BUCHAREST
PA SOS PANDURI 90, SECT 5, BUCHAREST, RO-050663, ROMANIA
SN 1224-5984
J9 ROM BIOTECH LETT
JI Rom. Biotech. Lett.
PD MAY-JUN
PY 2013
VL 18
IS 3
BP 8381
EP 8390
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 174WS
UT WOS:000321188400018
DA 2018-10-20
ER

PT J
AU Lionzo, MIZ
   Muniz, EC
   da Silveira, NP
AF Lionzo, Maria I. Z.
   Muniz, Edvani C.
   da Silveira, Nadya P.
TI The influence of chondroitin sulfate on composite multilamellar
   liposomes containing chitosan
SO COLLOID AND POLYMER SCIENCE
LA English
DT Article
DE Multilamellar liposomes; Chitosan; Chondroitin; Polysaccharide-liposome
   complex; SAXS; Membrane rigidity
ID MEMBRANES; VESICLES; MECHANISM; BEHAVIOR; BINDING
AB A composite multilamellar liposome containing chitosan attached to the inside and outside of the membrane as well as an opposite charged polyelectrolyte, chondroitin, adsorbed at the surface was developed. Not only the chitosan/chondroitin ratio but also the concentration of them were varied. The structure and superficial properties of the liposomes were studied through a combination of light scattering, zeta potential, and small-angle X-rays scattering techniques. While the chitosan/chondroitin ratio affected the superficial charge distributions, the concentration of polyelectrolytes affected the structural properties of the liposomes, as the rigidity of the phospholipid layers. The superficial charge of the resultant composite liposome was influenced by the type and concentration of the polyelectrolyte. Information about the charge density could be obtained by the treatment of zeta potential data, and it was used to estimate the amount of chondroitin adsorbed to the liposome surface. Applying the modified Caille theory to the X-rays scattering curves, information about the internal structure of the liposomes was accessed. The ability to control the properties of composite multilamellar liposomes is an important issue when they have to be applied as a biomaterial device component.
C1 [Lionzo, Maria I. Z.] Univ Fed Ciencias Saude Porto Alegre, BR-90050170 Porto Alegre, RS, Brazil.
   [Lionzo, Maria I. Z.; da Silveira, Nadya P.] Univ Fed Rio Grande do Sul, Inst Quim, Programa Posgrad Ciencias Mat, BR-91501970 Porto Alegre, RS, Brazil.
   [Muniz, Edvani C.] Univ Fed Maringa, Dept Quim, BR-87020970 Maringa, Parana, Brazil.
RP Lionzo, MIZ (reprint author), Univ Fed Rio Grande do Sul, Inst Quim, Programa Posgrad Ciencias Mat, Ave Bento Goncalves,9500,CP 15003, BR-91501970 Porto Alegre, RS, Brazil.
EM mlionzo@ufcspa.edu.br
RI Inomat, Inct/H-9989-2013; silveira, nadya/G-9970-2016
OI silveira, nadya/0000-0002-1556-7304; Muniz, Edvani/0000-0001-6685-1519
FU Rede de Nanocosmeticos/MCT; CNPq
FX The authors thank LNLS for SAXS measurements and Rede de
   Nanocosmeticos/MCT and CNPq for financial support. The author would like
   to thank Prof. R. Itri for her valuable helpful comments.
CR Adrhammar M, 2002, PNAS, V99, P15313
   BATES FS, 1982, MACROMOLECULES, V15, P589, DOI 10.1021/ma00230a073
   Betz G, 2005, INT J PHARM, V296, P44, DOI 10.1016/j.ijpharm.2005.02.032
   Bhattarai NN, 2009, ADV DRUG DELIV REV, V62, P83
   Ceppi P, 2005, P NATL ACAD SCI USA, V102, P16269, DOI 10.1073/pnas.0508157102
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Denuziere A, 1996, CARBOHYD POLYM, V29, P317, DOI 10.1016/S0144-8617(96)00035-5
   Dowson D, 2004, TRIBOLOGY INTERFACE, V48
   Guo J, 2003, INT J PHARM, V260, P167, DOI 10.1016/S0378-5173(03)00254-0
   Hammersley A. P., 1997, 97HA02T ESRF
   HENRIKSEN I, 1994, INT J PHARMACEUT, V101, P227, DOI 10.1016/0378-5173(94)90218-6
   LARSSON B, 1981, BIOCHEM PHARMACOL, V30, P2963, DOI 10.1016/0006-2952(81)90260-4
   LASIC DD, 1988, BIOCHEM J, V256, P1
   Lasic DD, 1998, TIBTECH, V16, P207
   Lee JH, 2005, LANGMUIR, V21, P26, DOI 10.1021/la048194+
   Ma MM, 2011, LANGMUIR, V27, P1480, DOI 10.1021/la104405r
   Matos C, 2004, LANGMUIR, V20, P369, DOI 10.1021/la034780b
   Mertins O, 2006, J NANOSCI NANOTECHNO, V6, P2425, DOI 10.1166/jnn.2006.521
   Mertins O, 2011, LANGMUIR, V27, P5506, DOI 10.1021/la200553t
   Mertins O, 2009, MAT SCI ENG C-BIO S, V29, P463, DOI 10.1016/j.msec.2008.08.038
   Mertins O, 2009, BIOPHYS J, V96, P2719, DOI 10.1016/j.bpj.2008.12.3928
   Mertins O, 2008, QUIM NOVA, V31, P1856, DOI 10.1590/S0100-40422008000700043
   Musale DA, 1999, J MEMBRANE SCI, V154, P163, DOI 10.1016/S0376-7388(98)00265-8
   Notin L, 2006, ACTA BIOMATER, V2, P387, DOI 10.1016/j.actbio.2006.03.003
   Pabst G, 2003, J APPL CRYSTALLOGR, V36, P1378, DOI 10.1107/S0021889803017527
   Pabst Georg, 2006, Biophysical Reviews and Letters, V1, P57, DOI 10.1142/S1793048006000069
   Quemeneur F, 2010, SOFT MATTER, V6, P4471, DOI 10.1039/c0sm00154f
   Rinaudo M, 2009, MACROMOL SYMP, V278, P67, DOI 10.1002/masy.200950409
   SAFINYA CR, 1986, PHYS REV LETT, V57, P2718, DOI 10.1103/PhysRevLett.57.2718
   Sawant RR, 2010, EUR J PHARM BIOPHARM, V75, P321, DOI 10.1016/j.ejpb.2010.04.010
   SEELIG J, 1987, BIOCHEMISTRY-US, V26, P7535, DOI 10.1021/bi00398a001
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   TAYLOR KMG, 1995, THERMOCHIM ACTA, V248, P289, DOI 10.1016/0040-6031(94)01884-J
   ZHANG RT, 1995, PHYS REV LETT, V74, P2832, DOI 10.1103/PhysRevLett.74.2832
NR 34
TC 0
Z9 0
U1 1
U2 39
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0303-402X
EI 1435-1536
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD MAY
PY 2013
VL 291
IS 5
BP 1057
EP 1064
DI 10.1007/s00396-012-2828-2
PG 8
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 155PY
UT WOS:000319761600002
DA 2018-10-20
ER

PT J
AU Pereira, OCM
   Rahal, SC
   Lima-Neto, JF
   Landim-Alvarenga, FD
   Monteiro, FOB
AF Marques Pereira-Junior, Oduvaldo Camara
   Rahal, Sheila Canevese
   Lima-Neto, Joao Ferreira
   Landim-Alvarenga, Fernanda da Cruz
   Barros Monteiro, Frederico Ozanan
TI In vitro evaluation of three different biomaterials as scaffolds for
   canine mesenchymal stem cells
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Hydroxyapatites; Bone Matrix; Castor Oil; Polyurethanes; Stem Cells
ID BONE-GRAFT SUBSTITUTES; CLINICAL-APPLICATIONS; TRICALCIUM PHOSPHATE;
   MARROW; HYDROXYAPATITE; BIOCERAMICS; CHALLENGES; SURGERY; REPAIR; DEFECT
AB PURPOSE: To evaluate in vitro ability the of three different biomaterials - purified hydroxyapatite, demineralized bone matrix and castor oil-based polyurethane - as biocompatible 3D scaffolds for canine bone marrow mesenchymal stem cell (MSC) intending bone tissue engineering.
   METHODS: MSCs were isolated from canine bone marrow, characterized and cultivated for seven days with the biomaterials. Cell proliferation and adhesion to the biomaterial surface were evaluated by scanning electron microscopy while differentiation into osteogenic lineage was evaluated by Alizarin Red staining and Sp7/Osterix surface antibody marker.
   RESULTS: The biomaterials allowed cellular growth, attachment and proliferation. Osteogenic differentiation occurred in the presence of hydroxyapatite, and matrix deposition commenced in the presence of the castor oil-based polyurethane.
   CONCLUSION: All the tested biomaterials may be used as mesenchymal stem cell scaffolds in cell-based orthopedic reconstructive therapy.
C1 [Marques Pereira-Junior, Oduvaldo Camara] UNESP, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, Postgrad Program Vet Med, BR-18618970 Botucatu, SP, Brazil.
   [Rahal, Sheila Canevese] UNESP, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, BR-18618970 Botucatu, SP, Brazil.
   [Lima-Neto, Joao Ferreira; Landim-Alvarenga, Fernanda da Cruz] UNESP, Sch Vet Med & Anim, Dept Anim Reprod & Vet Radiol, BR-18618970 Botucatu, SP, Brazil.
   [Landim-Alvarenga, Fernanda da Cruz] Fed Rural Univ Amazon, Inst Anim Hlth & Prod, Belem Do Para, PA, Brazil.
   Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, Botucatu, SP, Brazil.
RP Rahal, SC (reprint author), UNESP, Fac Med Vet & Ciencia Anim, Dept Cirurg Vet & Anestesiol, Dist Rubiao Jr S-N, BR-18618970 Botucatu, SP, Brazil.
EM odujunior@yahoo.com.br; sheilacr@fmvz.unesp.br
RI Monteiro, Frederico/J-1967-2012
OI Monteiro, Frederico/0000-0002-1406-9979; Rahal,
   Sheila/0000-0002-9211-4093
FU National Council of Technological and Scientific Development (CNPQ);
   Coordination of Improvement for Higher Academic Staff (CAPES); PROCAD
FX National Council of Technological and Scientific Development (CNPQ),
   Coordination of Improvement for Higher Academic Staff (CAPES) and PROCAD
CR Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180
   Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552
   Alison MR, 2009, J PATHOL, V217, P144, DOI 10.1002/path.2498
   Beloti MM, 2003, J BIOMED MATER RES A, V64A, P171, DOI 10.1002/jbm.a.10435
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Fibbe WE, 2002, ANN RHEUM DIS, V61, P29
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   GEBHART M, 1991, Acta Orthopaedica Belgica, V57, P130
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, V225, P7
   Ignacio H., 1999, THESIS SAO PAULO U B
   Itoh T, 1998, J VET MED SCI, V60, P451, DOI 10.1292/jvms.60.451
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kassem M, 2004, CLONING STEM CELLS, V6, P369, DOI 10.1089/clo.2004.6.369
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Khan SN, 2000, ORTHOP CLIN N AM, V31, P389, DOI 10.1016/S0030-5898(05)70158-9
   Koc ON, 2001, BONE MARROW TRANSPL, V27, P235, DOI 10.1038/sj.bmt.1702791
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Pereira-Junior OCM, 2007, J BIOMATER APPL, V21, P283, DOI 10.1177/0885328206063526
   Minguell JJ, 2001, EXP BIOL MED, V226, P507
   Niemeyer P, 2004, CELLS TISSUES ORGANS, V177, P68, DOI 10.1159/000079182
   Silva TSN, 2011, ACTA CIR BRAS, V26, P7, DOI 10.1590/S0102-86502011000100003
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Preston SL, 2003, J CLIN PATHOL-MOL PA, V56, P86
   Short B, 2003, ARCH MED RES, V34, P565, DOI 10.1016/j.arcmed.2003.09.007
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Vats A, 2002, CLIN OTOLARYNGOL, V27, P227, DOI 10.1046/j.1365-2273.2002.00579.x
   Warren SM, 2004, J CRANIOFAC SURG, V15, P34, DOI 10.1097/00001665-200401000-00012
NR 38
TC 7
Z9 7
U1 1
U2 13
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
EI 1678-2674
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD MAY
PY 2013
VL 28
IS 5
BP 353
EP 360
DI 10.1590/S0102-86502013000500006
PG 8
WC Surgery
SC Surgery
GA 158SV
UT WOS:000319994200006
PM 23702937
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Chang, J
   DeLillo, N
   Khan, M
   Nacinovich, MR
AF Chang, Jennifer
   DeLillo, Nicholas, Jr.
   Khan, Mark
   Nacinovich, Mario R., Jr.
TI Review of Small Intestine Submucosa Extracellular Matrix Technology in
   Multiple Difficult-To-Treat Wound Types
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Review
DE extracellular matrix; wound healing; small intestine submucosa
ID CHRONIC VENOUS ULCERS; RANDOMIZED CLINICAL-TRIAL; CHRONIC LEG ULCERS;
   IN-VITRO; SKIN FIBROBLASTS; VASCULAR GRAFT; GROWTH-FACTOR; FIBRONECTIN;
   CELLS; MANAGEMENT
AB The extracellular matrix (ECM) of the dermis is a critical structural component required for normal wound healing. The ECM, along with its key signaling components, provides the support structure necessary for fibroblasts, immune cells, and keratinocytes. When ECM activity is dysfunctional, the normal wound healing process is compromised, leading to slow, irregular repair, which may result in the development of chronic wounds. To replace dysfunctional ECM, several strategies have been developed to promote the development of a proper ECM or to replace the ECM entirely. One such method is the use of small intestine submucosa (SIS) to replace the nonfunctional ECM. Small intestine submucosa closely mimics the normal ECM of the human dermis despite being of porcine derivation. Small intestine submucosa wound matrix is an example of an available ECM-based biomaterial that has demonstrated improvements in wound management in the clinical setting.
C1 [Chang, Jennifer; DeLillo, Nicholas, Jr.; Khan, Mark; Nacinovich, Mario R., Jr.] AXON Commun, Rye Brook, NY 10573 USA.
RP DeLillo, N (reprint author), AXON Commun, 800 Westchester Ave,Suite S-540, Rye Brook, NY 10573 USA.
EM ndelillo@axon-com.com
CR ADAIR HM, 1977, BRIT J SURG, V64, P800, DOI 10.1002/bjs.1800641113
   Akiyama S K, 1996, Hum Cell, V9, P181
   Angle N, 1997, BRIT MED J, V314, P1019, DOI 10.1136/bmj.314.7086.1019
   [Anonymous], 2011, OASIS ULTR MATR
   [Anonymous], 2011, OASIS WOUND MATR
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Brown-Etris M, 2002, WOUNDS, V14, P150
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Cook H, 2000, J INVEST DERMATOL, V115, P225, DOI 10.1046/j.1523-1747.2000.00044.x
   Cutting KF, 2011, J WOUND CARE, V20, P424, DOI 10.12968/jowc.2011.20.9.424
   de la Torre J, CHRONIC WOUNDS
   DOILLON CJ, 1988, BIOMATERIALS, V9, P91, DOI 10.1016/0142-9612(88)90077-4
   Ehrenreich Michael, 2006, Acta Dermatovenerol Croat, V14, P172
   Eisenbud D, 2004, WOUNDS, V16
   FALANGA V, 1993, J DERMATOL SURG ONC, V19, P764, DOI 10.1111/j.1524-4725.1993.tb00422.x
   Falanga V, 1999, WOUND REPAIR REGEN, V7, P201, DOI 10.1046/j.1524-475X.1999.00201.x
   FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   Frenkel JS, 2014, INT WOUND J, V11, P159, DOI 10.1111/j.1742-481X.2012.01057.x
   Garrone R, 1997, MICROSC RES TECHNIQ, V38, P407, DOI 10.1002/(SICI)1097-0029(19970815)38:4<407::AID-JEMT8>3.0.CO;2-F
   Ghauri ASK, 2000, BRIT J SURG, V87, P1048, DOI 10.1046/j.1365-2168.2000.01491.x
   Ghauri ASK, 1998, EUR J VASC ENDOVASC, V16, P350, DOI 10.1016/S1078-5884(98)80056-7
   GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   HAUKIPURO K, 1991, ANN SURG, V213, P75, DOI 10.1097/00000658-199101000-00013
   HERRICK SE, 1992, AM J PATHOL, V141, P1085
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   Hodde J P, 2005, J Wound Care, V14, P23
   Hodde JP, 2007, AM J CLIN DERMATOL, V8, P61, DOI 10.2165/00128071-200708020-00001
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Holbrook KA, 2003, CONNECTIVE TISSUE IT, P19
   Kantor J, 2000, WOUNDS, V12, P155
   Kim BC, 2003, J CELL PHYSIOL, V195, P331, DOI 10.1002/jcp.10301
   Ko R, 2006, J SURG RES, V135, P9, DOI 10.1016/j.jss.2006.02.007
   Landsman A, 2008, WOUNDS, V20, P111
   LAZARUS GS, 1994, ARCH DERMATOL, V130, P489, DOI 10.1001/archderm.130.4.489
   Markova A, 2012, DERMATOL CLIN, V30, P107, DOI 10.1016/j.det.2011.08.005
   Marston WA, 2004, EXPERT REV MED DEVIC, V1, P21, DOI 10.1586/17434440.1.1.21
   McDaniel HB, 2002, J VASC SURG, V35, P723, DOI 10.1067/mva.2002.121128
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   MONK BE, 1982, CLIN EXP DERMATOL, V7, P397, DOI 10.1111/j.1365-2230.1982.tb02447.x
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   O'Brien JF, 2003, BRIT J SURG, V90, P794, DOI 10.1002/bjs.4167
   Ongenae KC, 2000, DERMATOL SURG, V26, P447, DOI 10.1046/j.1524-4725.2000.99281.x
   Papanas N, 2012, CURR DIABETES REV, V8, P209, DOI 10.2174/157339912800563963
   Peel SAF, 1998, TISSUE ENG, V4, P143, DOI 10.1089/ten.1998.4.143
   Pham C, 2007, BURNS, V33, P946, DOI 10.1016/j.burns.2007.03.020
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Rando T, 2009, J Wound Care, V18, P70
   Robson MC, 2001, WOUND REPAIR REGEN, V9, P347, DOI 10.1046/j.1524-475x.2001.00347.x
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Romanelli Marco, 2007, Int Wound J, V4, P3, DOI 10.1111/j.1742-481X.2007.00300.x
   Romanelli M, 2010, ADV SKIN WOUND CARE, V23, P34, DOI 10.1097/01.ASW.0000363485.17224.26
   SCHUBERT V, 1994, CLIN PHYSIOL, V14, P1, DOI 10.1111/j.1475-097X.1994.tb00484.x
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048
   Takehara K, 2000, J DERMATOL SCI, V24, pS70, DOI 10.1016/S0923-1811(00)00144-4
   Tang AM, 1996, J DERMATOL SCI, V11, P41, DOI 10.1016/0923-1811(95)00418-1
   Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x
   Truong Anh-Tuan N, 2005, J Burns Wounds, V4, pe4
   Vande Berg JS, 2003, SURG CLIN N AM, V83, P509, DOI 10.1016/S0039-6109(02)00195-0
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590
   Xue ML, 2006, EXPERT OPIN THER TAR, V10, P143, DOI 10.1517/14728222.10.1.143
NR 70
TC 9
Z9 9
U1 1
U2 10
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD MAY
PY 2013
VL 25
IS 5
BP 113
EP 120
PG 8
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 154CL
UT WOS:000319649000003
PM 25866891
DA 2018-10-20
ER

PT J
AU Krishna, V
   Konakondla, S
   Nicholas, J
   Varma, A
   Kindy, M
   Wen, XJ
AF Krishna, Vibhor
   Konakondla, Sanjay
   Nicholas, Joyce
   Varma, Abhay
   Kindy, Mark
   Wen, Xuejun
TI Biomaterial-based interventions for neuronal regeneration and functional
   recovery in rodent model of spinal cord injury: A systematic review
SO JOURNAL OF SPINAL CORD MEDICINE
LA English
DT Review
DE Spinal cord injuries; Axonal regeneration; Neuronal bridge;
   Biomaterials; Functional recovery; Translational research
ID NEURAL STEM-CELLS; TEMPLATED AGAROSE SCAFFOLDS; AXONAL REGENERATION;
   ADULT-RAT; NEUROTROPHIC FACTOR; SCHWANN-CELLS; GROWTH-FACTOR; TRAUMATIC
   PARAPLEGIA; COMPLETE TRANSECTION; LOCOMOTOR RECOVERY
AB Context: There is considerable interest in translating laboratory advances in neuronal regeneration following spinal cord injury (SCI). A multimodality approach has been advocated for successful functional neuronal regeneration. With this goal in mind several biomaterials have been employed as neuronal bridges either to support cellular transplants, to release neurotrophic factors, or to do both. A systematic review of this literature is lacking. Such a review may provide insight to strategies with a high potential for further investigation and potential clinical application.
   Objective: To systematically review the design strategies and outcomes after biomaterial-based multimodal interventions for neuronal regeneration in rodent SCI model. To analyse functional outcomes after implantation of biomaterial- based multimodal interventions and to identify predictors of functional outcomes.
   Methods: A broad PubMed, CINHAL, and a manual search of relevant literature databases yielded data from 24 publications; 14 of these articles included functional outcome information. Studies reporting behavioral data in rat model of SCI and employing biodegradable polymer-based multimodal intervention were included. For behavioral recovery, studies using severe injury models (transection or severe clip compression (>16.9 g) or contusion (50 g/cm)) were categorized separately from those investigating partial injury models (hemisection or moderate-to-severe clip compression or contusion).
   Results: The cumulative mean improvements in Basso, Beattie, and Bresnahan scores after biomaterial- based interventions are 5.93 (95% CI = 2.41 - 9.45) and 4.44 (95% CI = 2.65 - 6.24) for transection and hemisection models, respectively. Factors associated with improved outcomes include the type of polymer used and a follow- up period greater than 6 weeks.
   Conclusion: The functional improvement after implantation of biopolymer- based multimodal implants is modest. The relationship with neuronal regeneration and functional outcome, the effects of inflammation at the site of injury, the prolonged survival of supporting cells, the differentiation of stem cells, the effective delivery of neurotrophic factors, and longer follow- up periods are all topics for future elucidation. Future investigations should strive to further define specific factors associated with improved functional outcomes in clinically relevant models.
C1 [Krishna, Vibhor; Nicholas, Joyce; Varma, Abhay; Kindy, Mark; Wen, Xuejun] Med Univ S Carolina, Charleston, SC USA.
   [Konakondla, Sanjay] St Georges Univ, Sch Med, St Georges, Grenada.
   [Wen, Xuejun] Clemson Univ, Dept Bioengn, Clemson, SC 29631 USA.
RP Krishna, V (reprint author), Med Univ S Carolina, Dept Neurosci, Div Neurosurg, 96 Jonathan Lucas St, Charleston, SC 29407 USA.
EM Krishna@musc.edu
CR Assina R, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E3
   Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098
   Bouhy D, 2006, FASEB J, V20, P1239, DOI 10.1096/fj.05-4382fje
   Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Di Giovanni S, 2006, EXPERT OPIN THER TAR, V10, P363, DOI 10.1517/14728222.10.3.363
   Egger M, 2001, SYSTEMATIC REV HLTH
   Fan JA, 2010, J NEUROTRAUM, V27, P1671, DOI 10.1089/neu.2010.1281
   Fehlings MG, 2011, J NEUROTRAUM, V28, P1329, DOI 10.1089/neu.2011.1955
   Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005
   Friedman Jonathan A, 2004, Clin Neurosurg, V51, P314
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Guest J, 2011, BRAIN RES BULL, V84, P267, DOI 10.1016/j.brainresbull.2010.11.007
   Guo JS, 2007, SPINAL CORD, V45, P15, DOI 10.1038/sj.sc.3101943
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Harvey LA, 2009, SPINAL CORD, V47, P184, DOI 10.1038/sc.2008.100
   Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802
   He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255
   Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008
   HOULE JD, 1994, J NEURAL TRANSP PLAS, V5, P115, DOI 10.1155/NP.1994.115
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068
   Kwon BK, 2011, J NEUROTRAUM, V28, P1525, DOI 10.1089/neu.2010.1296
   Kwon BK, 2011, J NEUROTRAUM, V28, P1589, DOI 10.1089/neu.2009.1150
   Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Meijs MFL, 2004, J NEUROTRAUM, V21, P1415, DOI 10.1089/neu.2004.21.1415
   Metz GAS, 2000, BRAIN RES, V883, P165, DOI 10.1016/S0006-8993(00)02778-5
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Pan HC, 2008, J CLIN NEUROSCI, V15, P656, DOI 10.1016/j.jocn.2007.03.020
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Qian LM, 2009, CHINESE MED J-PEKING, V122, P2032, DOI 10.3760/cma.j.issn.0366-6999.2009.17.014
   Rochkind S, 2006, EUR SPINE J, V15, P234, DOI 10.1007/s00586-005-0981-8
   Rochkind S, 2002, NEUROL RES, V24, P355, DOI 10.1179/016164102101200131
   Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007
   Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Yarygin V N, 2006, Neurosci Behav Physiol, V36, P483, DOI 10.1007/s11055-006-0044-6
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhang XB, 2007, J NEUROTRAUM, V24, P1863, DOI 10.1089/neu.2007.0334
NR 67
TC 17
Z9 20
U1 0
U2 31
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1079-0268
EI 2045-7723
J9 J SPINAL CORD MED
JI J. Spinal Cord. Med.
PD MAY
PY 2013
VL 36
IS 3
BP 174
EP 190
DI 10.1179/2045772313Y.0000000095
PG 17
WC Clinical Neurology
SC Neurosciences & Neurology
GA 151ZY
UT WOS:000319500100002
PM 23809587
OA Green Published
DA 2018-10-20
ER

PT J
AU Ma, YH
   Woo, KD
   Kang, DS
   Kim, SM
AF Ma, Yanhua
   Woo, Kee-Do
   Kang, Dong Soo
   Kim, Sang-Mi
TI Microstructure and Biocompatibility of Porous Ti-Nb-Zr-CPP Composite
   Fabricated by Spark Plasma Sintering and Leaching Process
SO KOREAN JOURNAL OF METALS AND MATERIALS
LA English
DT Article
DE biomaterials; sintering; microstructure; SEM; calcium pyrophosphate
   (CPP)
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; MARTENSITE; ALPHA''
AB Metallic biomaterials such as titanium and its alloys have been widely used as permanent implant materials due to their excellent corrosion resistance, fatigue property, and strength. Calcium pyrophosphate (CPP) is an attractive bioceramic for human tissue implantation due to its good biocompatibility and similar composition to human bone. High energy mechanical milling and spark plasma sintering (SPS) can be used to fabricate a sound composite of the Ti-Nb-Zr-CPP. In a biomaterial such as the Ti-6Al-4V ELI alloy, the coating property between the bioceramic and Ti-based alloy is very important. By addition of CPP to the Ti-Nb-Zr alloy, the Ti-Nb-Zr alloy can improve the wetability between the Ti alloy and bioceramic as a coating material. Also the porous surface of the biomaterials can improve the symphyseal ability With osteoblast. In this study, a porous surface can be made by using several different leaching solutions such as aqueous diluted H3PO4. Ti-Nb-Zr-CPP composite was fabricated by spark plasma sintering (SPS) at 1000 degrees C under 70 MPa using high energy mechanical milled powder. A porous surface was successfully fabricated by using a 40 vol%H3PO4+ 60 vol.%H2O leaching solution at room temperature for 24 h.
C1 [Ma, Yanhua] Henan Univ Sci & Technol, Sch Mat Sci & Engn, Luoyang, Henan, Peoples R China.
   [Woo, Kee-Do; Kang, Dong Soo; Kim, Sang-Mi] Chonbuk Natl Univ, Res Ctr Adv Mat Technol, Div Adv Mat Engn, Chonju, South Korea.
RP Woo, KD (reprint author), Chonbuk Natl Univ, Res Ctr Adv Mat Technol, Div Adv Mat Engn, Chonju, South Korea.
EM kdwoo@chonbuk.ac.kr
FU Korea Research Foundation [2012-0004936]
FX This work was supported by a grant from the Korea Research Foundation
   (No. 2012-0004936). The authors also thank Dr. Ik-Hyun Oh at KITECH who
   permitted the use of SPS.
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   Cimenoglu H, 2011, MET MATER INT, V17, P765, DOI 10.1007/s12540-011-1011-5
   EISENBARTH E, 2001, BIOMATERIALIEN, V2, P4
   Kang D. S., 2011, THESIS CHONBUK NATL
   Karimi S, 2011, CORROS SCI, V53, P3262, DOI 10.1016/j.corsci.2011.06.009
   Kim HS, 2006, SCRIPTA MATER, V54, P887, DOI 10.1016/j.scriptamat.2005.11.001
   Kim T. Y., 2002, J KOREAN RES SOC DEN, V29, P253
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Mantani Y, 2006, MAT SCI ENG A-STRUCT, V438, P315, DOI 10.1016/j.msea.2006.02.180
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M., 1998, MAT JAPAN, V37, P843
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Park S. H., 2012, THESIS CHONBUK NATL
   Park SH, 2012, KOREAN J MET MATER, V50, P469, DOI 10.3365/KJMM.2012.50.6.469
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   Woo KD, 2010, KOREAN J MET MATER, V48, P369, DOI 10.3365/KJMM.2010.48.04.369
   Woo Kee-Do, 2010, J KOR POWDER METALL, V17, P443
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
NR 18
TC 2
Z9 2
U1 1
U2 22
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA POSCO CENTER, 4TH FL (EAST WING), 892 DAECHI-4-DONG, KANGNAM-KU, SEOUL
   135-777, SOUTH KOREA
SN 1738-8228
J9 KOREAN J MET MATER
JI Korean J. Met. Mater.
PD MAY
PY 2013
VL 51
IS 5
BP 377
EP 383
DI 10.3365/KJMM.2013.51.5.377
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 153ZM
UT WOS:000319641300008
DA 2018-10-20
ER

PT J
AU Li, HL
   Zhang, H
   Huang, H
   Liu, ZQ
   Li, YB
   Yu, H
   An, YH
AF Li, Hai-Long
   Zhang, Han
   Huang, Hua
   Liu, Zhen-Qiang
   Li, Yan-Bing
   Yu, Hao
   An, Yi-Hua
TI The effect of amino density on the attachment, migration, and
   differentiation of rat neural stem cells In Vitro
SO MOLECULES AND CELLS
LA English
DT Article
DE biocompatible; cell adhesion molecular; cell migration assays; coated
   materials; neural stem cells
ID SURFACE MODIFICATION; FUNCTIONAL-GROUPS; GROWTH-FACTOR; BEHAVIOR;
   PROLIFERATION; SCAFFOLDS; ADHESION; CHITOSAN; MODEL; REGENERATION
AB Artificial extracellular matrices play important roles in the regulation of stem cell behavior. To generate materials for tissue engineering, active functional groups, such as amino, carboxyl, and hydroxyl, are often introduced to change the properties of the biomaterial surface. In this study, we chemically modified coverslips to create surfaces with different amino densities and investigated the adhesion, migration, and differentiation of neural stem cells (NSCs) under serum-free culture conditions. We observed that a higher amino density significantly promoted NSCs attachment, enhanced neuronal differentiation and promoted excitatory synapse formation in vitro. These results indicate that the amino density significantly affected the biological behavior of NSCs. Thus, the density and impact of functional groups in extracellular matrices should be considered in the research and development of materials for tissue engineering.
C1 [Li, Hai-Long; Zhang, Han; Huang, Hua; Liu, Zhen-Qiang; Li, Yan-Bing; Yu, Hao; An, Yi-Hua] Capital Med Univ, Beijing Neurosurg Inst, Beijing Tiantan Hosp, Beijing 100050, Peoples R China.
RP An, YH (reprint author), Capital Med Univ, Beijing Neurosurg Inst, Beijing Tiantan Hosp, Beijing 100050, Peoples R China.
EM sjwkyjs@gmail.com
CR Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104
   BADOYANNIS HC, 1991, MOL BRAIN RES, V11, P79, DOI 10.1016/0169-328X(91)90024-R
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207
   Cai L, 2012, BIOMACROMOLECULES, V13, P1663, DOI 10.1021/bm300381d
   Cook AD, 1997, BIOMATERIALS, V18, P1417, DOI 10.1016/S0142-9612(97)00075-6
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Han S, 2012, LAB CHIP, V12, P2305, DOI 10.1039/c2lc21285d
   Ho M, 2006, BIOMATERIALS, V27, P4333, DOI 10.1016/j.biomaterials.2006.03.037
   Horwitz JA, 2010, J BIOMED MATER RES A, V95A, P371, DOI 10.1002/jbm.a.32858
   Hu SG, 2002, J APPL POLYM SCI, V86, P2977, DOI 10.1002/app.11261
   Hung CH, 2006, BIOMATERIALS, V27, P4461, DOI 10.1016/j.biomaterials.2006.04.021
   Hwang DH, 2011, CELL TRANSPLANT, V20, P1361, DOI 10.3727/096368910X557155
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lee S, 2011, BIOMATERIALS, V32, P8816, DOI 10.1016/j.biomaterials.2011.07.058
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Li B, 2005, BIOMATERIALS, V26, P4956, DOI 10.1016/j.biomaterials.2005.01.018
   Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Rampichova M, 2013, CELL PROLIFERAT, V46, P23, DOI 10.1111/cpr.12001
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Soman P, 2012, BIOMED MICRODEVICES, V14, P829, DOI 10.1007/s10544-012-9662-7
   Symons JR, 2002, BIOCHEM J, V365, P513, DOI 10.1042/BJ20020381
   Teng XR, 2007, J BIOMED MATER RES B, V81B, P185, DOI 10.1002/jbm.b.30652
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Wang JH, 2006, BIOMATERIALS, V27, P3441, DOI 10.1016/j.biomaterials.2006.02.002
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zhang H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-67
NR 34
TC 8
Z9 8
U1 0
U2 29
PU KOREAN SOC MOLECULAR & CELLULAR  BIOLOGY
PI SEOUL
PA 635-4, YUCKSAM-DONG, GANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 1016-8478
J9 MOL CELLS
JI Mol. Cells
PD MAY
PY 2013
VL 35
IS 5
BP 436
EP 443
DI 10.1007/s10059-013-0046-5
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 151PX
UT WOS:000319473800009
PM 23639969
OA Green Published
DA 2018-10-20
ER

PT J
AU Han, YJ
   Chen, HZ
AF Han, Yejun
   Chen, Hongzhang
TI Enhancement of nanofiber elasticity by using wheat glutenin as an
   addition
SO POLYMER SCIENCE SERIES A
LA English
DT Article
ID POLY(VINYL ALCOHOL); POLYMER NANOFIBERS; PROTEIN; BREADMAKING; MEMBRANE;
   BLENDS
AB The properties of glutenin allow it to be a potential substrate for biomaterial production. In the present study, composite nanofiber was fabricated from polyvinyl alcohol (PVA) and glutenin based on the synergy of them. In the composite nanofiber, glutenin and PVA act as elasticizer and skeleton polymer, respectively. The property of composite nanofiber is markedly superior to that of PVA. For example, the homogeneity and average diameter of nanofiber from PVA/glutenin were increased, while the number and diameter of beads were decreased. Compared to nanofiber from PVA, the elongation and water absorbance of nanofiber from PVA/glutenin were increased by 121 and 150%, respectively. The proposed mechanism of composite nanofiber formation might be non-covalent networks such as hydrogen bond and SS bond that were built up during electrospinning. It is illustrated that the combination of elasticity of glutenin and crosslinking of PVA/glutenin lead to higher water absorbance, looser texture and better mechanical strength.
C1 [Han, Yejun; Chen, Hongzhang] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
RP Han, YJ (reprint author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
EM hzchen@home.ipe.ac.cn
FU National Basic Research Program of China (973 Project) [2011CB707401];
   National High Technology Research and Development Program of China (863
   Program) [SS2012AA022502]; National Key Project of Scientific and
   Technical Supporting Program of China [2011BAD22B02]
FX The authors would like to thank the National Basic Research Program of
   China (973 Project, no. 2011CB707401), the National High Technology
   Research and Development Program of China (863 Program, SS2012AA022502),
   and the National Key Project of Scientific and Technical Supporting
   Program of China (no. 2011BAD22B02) for financially supporting of this
   research.
CR Arfvidsson C, 2004, J CEREAL SCI, V39, P1, DOI 10.1016/S0733-5210(03)00038-9
   BRADSTREET RB, 1954, ANAL CHEM, V26, P185, DOI 10.1021/ac60085a028
   Chronakis T. S., 2005, J MATER PROCESS TECH, V167, P283
   Dong J, 2008, BIOMACROMOLECULES, V9, P568, DOI 10.1021/bm7011136
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Han YJ, 2007, ENZYME MICROB TECH, V41, P638, DOI 10.1016/j.enzmictec.2007.05.012
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jerez A, 2007, RHEOL ACTA, V46, P711, DOI 10.1007/s00397-007-0165-z
   Kubo S, 2003, BIOMACROMOLECULES, V4, P561, DOI 10.1021/bm025727p
   Lagrain B, 2010, BIOMACROMOLECULES, V11, P533, DOI 10.1021/bm100008p
   Maeda T, 2007, CARBOHYD POLYM, V68, P658, DOI 10.1016/j.carbpol.2006.07.034
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Peresin MS, 2010, BIOMACROMOLECULES, V11, P2471, DOI 10.1021/bm1006689
   Reddy N, 2007, BIOMACROMOLECULES, V8, P638, DOI 10.1021/bm0608840
   Salmanowicz BP, 2004, J CHROMATOGR A, V1032, P313, DOI 10.1016/j.chroma.2003.12.031
   Sedlarik V, 2009, POLYM COMPOSITE, V30, P1158, DOI 10.1002/pc.20672
   Shewry PR, 1997, J CEREAL SCI, V25, P207, DOI 10.1006/jcrs.1996.0100
   Veraverbeke WS, 2002, CRIT REV FOOD SCI, V42, P179, DOI 10.1080/10408690290825510
   Woerdeman DL, 2004, BIOMACROMOLECULES, V5, P1262, DOI 10.1021/bm034530+
   Zhou YS, 2008, BIOMACROMOLECULES, V9, P349, DOI 10.1021/bm7009015
NR 20
TC 2
Z9 2
U1 1
U2 17
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0965-545X
J9 POLYM SCI SER A+
JI Polym. Sci. Ser. A
PD MAY
PY 2013
VL 55
IS 5
BP 320
EP 326
DI 10.1134/S0965545X13050076
PG 7
WC Polymer Science
SC Polymer Science
GA 150XB
UT WOS:000319423800005
DA 2018-10-20
ER

PT J
AU Pan, YS
   Xiong, DS
AF Pan, Yusong
   Xiong, Dangsheng
TI Stress-relaxation models of nano-HA/PVA gel biocomposites
SO MECHANICS OF TIME-DEPENDENT MATERIALS
LA English
DT Article
DE Nano-HA/PVA gel composites; Stress-relaxation mechanism;
   Stress-relaxation model
ID POLY(VINYL ALCOHOL) GEL; ARTIFICIAL KNEE-JOINT; ARTICULAR-CARTILAGE;
   MECHANICAL-PROPERTIES; PVA HYDROGEL; BONE REPAIR; HYDROXYAPATITE;
   COMPRESSION; LUBRICATION; COMPOSITES
AB Nanohydroxyapatite reinforced poly (vinyl alcohol) (nano-HA/PVA) gel composites have been proposed as a promising biomaterial to replace diseased or damaged articular cartilage. In this paper, the logarithmic model and multimode Maxwell model were used to describe the stress-relaxation process of nano-HA/PVA gel bio-composites, respectively. The results showed that both models can precisely describe the stress-relaxation behavior of nano-HA/PVA gel composites and their maximum absolute errors are not in excess of 6 %. However, the logarithmic model is only an empirical model and lacks definite physical meaning. It is very difficult to distinguish each relaxation stage of the composites such as the rapid and slow relaxation stage for the logarithmic model. To the contrary, every element in the multimode Maxwell model possesses definite physical meaning and it is corresponding to a certain stress-relaxation mechanism. It cannot only accurately depict the stress-relaxation properties of nanohydroxyapatite reinforced poly (vinyl alcohol) gel composites but also can reveal the relaxation mechanism of the composites. The investigation on the mechanism showed that the stress-relaxation mechanism of the composites was mainly predominated by the synergistic effect of two mechanisms which were the stress-relaxation characteristics of nature articular cartilage and that of the polymer.
C1 [Pan, Yusong] An Hui Univ Sci & Technol, Dept Mat Sci & Engn, Huai Nan 232001, Peoples R China.
   [Xiong, Dangsheng] Nan Jing Univ Sci & Technol, Dept Mat Sci & Engn, Nan Jing 210094, Peoples R China.
RP Pan, YS (reprint author), An Hui Univ Sci & Technol, Dept Mat Sci & Engn, Huai Nan 232001, Peoples R China.
EM yusongpan@163.com
RI xiong, dangsheng/B-1823-2015
OI xiong, dangsheng/0000-0003-3210-3728
FU Natural Science Research of key projects of Anhui Provincial
   Universities [KJ2010A099]
FX Research reported in the paper was funded by the Natural Science
   Research of key projects of Anhui Provincial Universities (Project No.
   KJ2010A099).
CR Auger D D, 1995, Proc Inst Mech Eng H, V209, P73, DOI 10.1243/PIME_PROC_1995_209_323_02
   Brandt J, 2008, KEY ENG MATER, V361-363, P35, DOI 10.4028/www.scientific.net/KEM.361-363.35
   Dai M., 1998, CHIN J ORTHOP, V18, P484
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Grant C, 2006, BIOTECHNOL PROGR, V22, P1400, DOI 10.1021/bp060181u
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Machida Y, 2000, J MOL STRUCT, V554, P81, DOI 10.1016/S0022-2860(00)00561-5
   [孟广伟 Meng Guangwei], 2003, [医用生物力学, Journal of medical biomechanics], V18, P239
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Murakami T, 1998, P I MECH ENG H, V212, P23, DOI 10.1243/0954411981533791
   Nebahat D., 2006, COLLOID SURFACE B, V48, P42
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Pan YS, 2008, J MATER SCI-MATER M, V19, P1963, DOI 10.1007/s10856-007-3280-6
   Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4
   Pan YS, 2009, J MATER SCI-MATER M, V20, P1291, DOI 10.1007/s10856-008-3679-8
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Rebeccah J. C., 2003, WEAR, V255, P1064
   Rosa R., 2004, MACROMOLECULES, V37, P1921
   Roy TD, 2003, J BIOMED MATER RES A, V67A, P1228, DOI 10.1002/jbm.a.20034
   Song J, 2009, J BIOMED MATER RES A, V89A, P1098, DOI 10.1002/jbm.a.32110
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P209, DOI 10.1299/jsmec.47.209
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Wang CCB, 2001, J BIOMECH, V34, P75, DOI 10.1016/S0021-9290(00)00137-8
   Wang K.Y., 1995, J APPL BIOMECH, V10, P224
   WAYNE JS, 1992, ADV BIOENG, V22, P585
   Weng X.S., 1999, ACTA ACAD MED SINICA, V21, P53
   Zhang X.L., 2000, J BONE JOINT INJURY, V15, P30
   Zheng QG, 1998, BIOMED MAT ENG, V8, P75
NR 29
TC 5
Z9 5
U1 2
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1385-2000
J9 MECH TIME-DEPEND MAT
JI Mech. Time-Depend. Mater.
PD MAY
PY 2013
VL 17
IS 2
BP 195
EP 204
DI 10.1007/s11043-012-9186-9
PG 10
WC Mechanics; Materials Science, Characterization & Testing
SC Mechanics; Materials Science
GA 149ZF
UT WOS:000319359300003
DA 2018-10-20
ER

PT J
AU Lim, GT
   Valente, SA
   Hart-Spicer, CR
   Evancho-Chapman, MM
   Puskas, JE
   Horne, WI
   Schmidt, SP
AF Lim, Goy Teck
   Valente, Stephanie A.
   Hart-Spicer, Cherie R.
   Evancho-Chapman, Mary M.
   Puskas, Judit E.
   Horne, Walter I.
   Schmidt, Steven P.
TI New biomaterial as a promising alternative to silicone breast implants
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Breast implants; Biopolymers; SIBS; Mechanical properties; In vivo
   biocompatibility; Histological study
ID POLYISOBUTYLENE-BASED BIOMATERIALS; BLOCK-COPOLYMERS; THERMOPLASTIC
   ELASTOMERS; ARBORESCENT; POLYSTYRENE; PROSTHESES; RUPTURE; WOMEN
AB One in eight American women develops breast cancer. Of the many patients requiring mastectomy yearly as a consequence, most elect some form of breast reconstruction. Since 2006, only silicone breast implants have been approved by the FDA for the public use. Unfortunately, over one-third of women with these implants experience complications as a result of tissue-material biocompatibility issues, which may include capsular contracture, calcification, hematoma, necrosis and implant rupture. Our group has been working on developing alternatives to silicone. Linear triblock poly(styrene-b-isobutylene-b-styrene) (SIBS) polymers are self-assembling nanostructured thermoplastic rubbers, already in clinical practice as drug eluting stent coatings. New generations with a branched (arborescent or dendritic) polyisobutylene core show promising potential as a biomaterial alternative to silicone rubber. The purpose of this pre-clinical research was to evaluate the material-tissue interactions of a new arborescent block copolymer (TPE1) in a rabbit implantation model compared to a linear SIBS (SIBSTAR 103T) and silicone rubber. This study is the first to compare the molecular weight and molecular weight distribution, tensile properties and histological evaluation of arborescent SIBS-type materials with silicone rubber before implantation and after explantation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Lim, Goy Teck; Puskas, Judit E.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Valente, Stephanie A.] Akron City Hosp, Summa Hlth Syst, Dept Surg, Akron, OH 44304 USA.
   [Hart-Spicer, Cherie R.] Akron City Hosp, Summa Hlth Syst, Dept Pathol & Lab Med, Akron, OH 44304 USA.
   [Evancho-Chapman, Mary M.; Schmidt, Steven P.] Akron City Hosp, Summa Hlth Syst, Dept Surg, Div Surg Educ & Res, Akron, OH 44304 USA.
   [Puskas, Judit E.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
   [Horne, Walter I.] Northeast Ohio Med Univ, NE Ohio Univ, Colleges Med & Pharm, Comparat Med Unit, Rootstown, OH 44272 USA.
RP Schmidt, SP (reprint author), Akron City Hosp, Summa Hlth Syst, Dept Surg, Div Surg Educ & Res, 525 East Market St, Akron, OH 44304 USA.
EM schmidts@summahealth.org
CR American Cancer Society, 2009, BREAST CANC FACTS FI
   American Society of Plastic Surgeons, 2011, REP 2010 PLAST SURG
   ASTM International, 2006, D41206A ASTM INT
   Beekman WH, 1997, PLAST RECONSTR SURG, V100, P1723, DOI 10.1097/00006534-199712000-00012
   Brandon HJ, 2003, PLAST RECONSTR SURG, V111, P2295, DOI 10.1097/01.PRS.0000060795.16982.1C
   Brandon HJ, 2003, ANN PLAS SURG, V51, P335
   Cadieux P, 2003, COLLOID SURFACE B, V28, P95, DOI 10.1016/S0927-7765(02)00147-9
   El Fray M, 2006, BIOMACROMOLECULES, V7, P844, DOI 10.1021/bm050971c
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P879, DOI 10.1097/00006534-199105000-00012
   Flassbeck D, 2003, ANAL BIOANAL CHEM, V375, P356, DOI 10.1007/s00216-002-1694-z
   Flory P. J., 1953, PRINCIPLES POLYM CHE, P485
   Foreman E. A., 2008, ACS POLY PREPRINTS, V49, P822
   Foreman EA, 2007, J POLYM SCI POL CHEM, V45, P5847, DOI 10.1002/pola.22335
   Fruhstorfer BH, 2004, ANN PLAS SURG, V53, P536, DOI 10.1097/01.sap.0000134508.43550.6f
   Gherardini G, 2004, PLAST RECONSTR SURG, V113, P1024, DOI 10.1097/01.PRS.0000105650.09456.86
   Gotz C, 2012, J MECH BEHAV BIOMED, V10, P206, DOI 10.1016/j.jmbbm.2012.02.016
   GREENSMITH HW, 1963, CHEM PHYSICS RUBBER, P249
   Harkness J. E., 1995, BIOL MED RABBITS ROD, P28
   Ikeda DM, 1999, PLAST RECONSTR SURG, V104, P2054, DOI 10.1097/00006534-199912000-00016
   Kaszas G., 1993, POLYM MAT SCI ENG, V68, P325
   Kennedy J.P., 1990, U.S. Patent, Patent No. [4,946,899, 4946899]
   KENNEDY JP, 2004, THERMOPLASTIC ELASTO, P285
   Lim GT, 2009, RUBBER CHEM TECHNOL, V82, P461, DOI 10.5254/1.3548258
   Marotta JS, 2002, ANN PLAS SURG, V49, P227, DOI 10.1097/00000637-200209000-00001
   Munoz-Robledo L. G., 2009, ACS POLYM PEPRINTS, V50, P533
   National Research Center for Women & Families, 2006, DEC DARK FDA BREAST
   Peters V, 1999, ANN PLAS SURG, V43, P324, DOI 10.1097/00000637-199909000-00020
   Pinchuk L, 2008, BIOMATERIALS, V29, P448, DOI 10.1016/j.biomaterials.2007.09.041
   Piza-Katzer H, 2002, PLAST RECONSTR SURG, V110, P1455, DOI 10.1097/01.PRS.0000029359.02532.FF
   Puskas J.E., 2004, U.S. Patent, Patent No. [6,747,098, 6747098]
   Puskas J. E., 2007, RUBBER CHEM TECHNOL, V80, P671
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k
   Puskas JE, 2005, J POLYM SCI POL CHEM, V43, P1811, DOI 10.1002/pola.20638
   Puskas JE, 2004, J POLYM SCI POL CHEM, V42, P3091, DOI 10.1002/pola.20114
   Puskas JE, 2001, MACROMOL MATER ENG, V286, P565, DOI 10.1002/1439-2054(20011001)286:10<565::AID-MAME565>3.0.CO;2-E
   Puskas JE, 2006, POLYM ADVAN TECHNOL, V17, P615, DOI 10.1002/pat.770
   Puskas JE, 2006, J POLYM SCI POL CHEM, V44, P6494, DOI [10.1002/pola.21693, 10.1021/pola.21693]
   Puskas JE, 2012, WIRES NANOMED NANOBI, V4, P153, DOI 10.1002/wnan.164
   Puskas JE, 2010, BIOMATERIALS, V31, P2477, DOI 10.1016/j.biomaterials.2009.12.003
   Puskas JE, 2009, J POLYM SCI POL CHEM, V47, P1148, DOI 10.1002/pola.23218
   Puskas JE, 2009, POLYMER, V50, P591, DOI 10.1016/j.polymer.2008.10.061
   Puskas JE, 2009, POLYMER, V50, P245, DOI 10.1016/j.polymer.2008.10.030
   Ranade SV, 2005, ACTA BIOMATER, V1, P137, DOI 10.1016/j.actbio.2004.09.004
   Tomkins M. R., 2006, THESIS QUEENS U KING
   US FDA, 2006, GUID SAL SIL GEL ALT
   US FDA, 2004, SUMM SAF EFF DAT TAX
   XU P, 1995, POLYM GELS NETW, V3, P255, DOI 10.1016/0966-7822(95)00006-7
NR 47
TC 16
Z9 16
U1 3
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAY
PY 2013
VL 21
BP 47
EP 56
DI 10.1016/j.jmbbm.2013.01.025
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 143AA
UT WOS:000318837500006
DA 2018-10-20
ER

PT J
AU Liu, KC
   Yeo, Y
AF Liu, Karen C.
   Yeo, Yoon
TI Zwitterionic Chitosan-Polyamidoamine Dendrimer Complex Nanoparticles as
   a pH-Sensitive Drug Carrier
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE polyamidoamine dendrimer; nanoparticulate drug carrier; pH-sensitive;
   surface protection; zwitterionic chitosan
ID NONVIRAL GENE DELIVERY; TUMOR-BEARING MICE; PAMAM DENDRIMERS;
   CANCER-THERAPY; IN-VITRO; CELL-DEATH; DOXORUBICIN; RELEASE; RATS;
   BIODISTRIBUTION
AB Polyamidoamine (PAMAM) dendrimers have been widely explored as carriers of therapeutics and imaging agents. However, amine-terminated PAMAM dendrimers are rarely utilized in systemic applications due to their cytotoxicity and risk of opsonization, caused by their cationic charges. Such undesirable effects may be mitigated by shielding the PAMAM dendrimer surface with polymers that reduce the charges. However, this shielding may also interfere with the PAMAM dendrimers' ability to interact with target cells, thus reducing the cellular uptake and overall efficacy of the delivery system. Therefore, we propose to use zwitterionic chitosan (ZWC), a new chitosan derivative, which has a unique pH-sensitive charge profile, as an alternative biomaterial to modify the cationic surface of PAMAM dendrimers. A stable electrostatic complex of ZWC and PAMAM dendrimers was formed at pH 7.4, where the PAMAM dendrimer surface was covered with ZWC, as demonstrated by fluorescence spectroscopy and transmission electron microscopy. The presence of ZWC coating protected red blood cells and fibroblast cells from hemolytic and cytotoxic activities of PAMAM dendrimers, respectively. Confocal microscopy showed that the protective effect of ZWC disappeared at low pH as the complex dissociated due to the charge conversion of ZWC, allowing PAMAM dendrimers to enter cells. These results demonstrate that ZWC is able to provide a surface coverage of PAMAM dendrimers in a pH-dependent manner and, thus, enhance the utility of PAMAM dendrimers as a drug carrier to solid tumors with acidifying microenvironments.
C1 [Liu, Karen C.; Yeo, Yoon] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Yeo, Yoon] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
RP Yeo, Y (reprint author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
EM yyeo@purdue.edu
FU NSF [DMR-1056997]; NIH [R21 CA135130]; Lilly Endowment, Inc.;
   NIH/NCRR-Indiana Clinical and Translational Sciences Institute
   Predoctoral Fellowship [TL1 RR025759]
FX We thank Johann H. Weidle III for technical assistance with ZWC
   synthesis and characterization and Ms. Debra Sherman for the help with
   TEM. We also thank BioActs (DKC Corporation, Korea) for the generous
   donation of Flamma FPR dyes. This work was supported by NSF DMR-1056997,
   NIH R21 CA135130, and a grant from the Lilly Endowment, Inc. to College
   of Pharmacy. This study was also partly supported by the
   NIH/NCRR-Indiana Clinical and Translational Sciences Institute
   Predoctoral Fellowship (TL1 RR025759, PI: A. Shekhar) to K.L.
CR [Anonymous], 2006, SURF MIC CHAR US DYN, P1
   Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001
   Beezer AE, 2003, TETRAHEDRON, V59, P3873, DOI 10.1016/S0040-4020(03)00437-X
   BROWN JM, 1990, J NATL CANCER I, V82, P338, DOI 10.1093/jnci/82.5.338
   Brown JM, 1998, CANCER RES, V58, P1408
   Chandrasekar D, 2007, BIOMATERIALS, V28, P504, DOI 10.1016/j.biomaterials.2006.07.046
   Co CC, 2001, MACROMOLECULES, V34, P3245, DOI 10.1021/ma001248b
   Crampton HL, 2007, POLYM INT, V56, P489, DOI 10.1002/pi.2230
   Domanski DM, 2004, BIOELECTROCHEMISTRY, V63, P189, DOI 10.1016/j.bioelechem.2003.09.023
   Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019
   ENGIN K, 1995, INT J HYPERTHER, V11, P211, DOI 10.3109/02656739509022457
   Gerweck LE, 1996, CANCER RES, V56, P1194
   Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704
   Hayat M. A., 2000, URANYL PREPARATIONS
   He H, 2011, BIOMATERIALS, V32, P478, DOI 10.1016/j.biomaterials.2010.09.002
   Henry SM, 2006, BIOMACROMOLECULES, V7, P2407, DOI 10.1021/bm060143z
   Hong RL, 1999, CLIN CANCER RES, V5, P3645
   Ito T, 2004, LANGMUIR, V20, P6940, DOI 10.1021/la049524t
   JAHDE E, 1982, CANCER RES, V42, P1498
   Jasmine MJ, 2009, J LUMIN, V129, P506, DOI 10.1016/j.jlumin.2008.12.005
   Jeong JH, 2001, BIOCONJUGATE CHEM, V12, P917, DOI 10.1021/bc010052t
   Jones CF, 2012, MOL PHARMACEUT, V9, P1599, DOI 10.1021/mp2006054
   Khandare J, 2005, BIOCONJUGATE CHEM, V16, P330, DOI 10.1021/bc0498018
   Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501
   KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H
   Kolhe P, 2003, INT J PHARM, V259, P143, DOI 10.1016/S0378-5173(03)00225-4
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   Kuo JHS, 2005, J PHARM PHARMACOL, V57, P489, DOI 10.1211/0022357055803
   Lai PS, 2007, J CONTROL RELEASE, V122, P39, DOI 10.1016/j.jconrel.2007.06.012
   Li CG, 2009, J MOL CELL BIOL, V1, P37, DOI 10.1093/jmcb/mjp002
   Liu XX, 2011, BIOCONJUGATE CHEM, V22, P2461, DOI 10.1021/bc200275g
   Lopez AI, 2009, MOL BIOSYST, V5, P1148, DOI 10.1039/b904746h
   Luo D, 2002, MACROMOLECULES, V35, P3456, DOI 10.1021/ma0106346
   Majoros IJ, 2006, BIOMACROMOLECULES, V7, P572, DOI 10.1021/bm0506142
   Mintzer MA, 2011, CHEM SOC REV, V40, P173, DOI 10.1039/b901839p
   Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363
   Naha PC, 2010, TOXICOL APPL PHARM, V246, P91, DOI 10.1016/j.taap.2010.04.014
   OBERHAMMER FA, 1994, J CELL BIOL, V126, P827, DOI 10.1083/jcb.126.4.827
   Ouyang D, 2011, BIOPHYS CHEM, V158, P126, DOI 10.1016/j.bpc.2011.06.003
   Patri AK, 2005, ADV DRUG DELIVER REV, V57, P2203, DOI 10.1016/j.addr.2005.09.014
   Pierri E, 2005, J BIOMED MATER RES A, V75A, P639, DOI 10.1002/jbm.a.30490
   Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7
   Shao NM, 2011, INT J NANOMED, V6, P3361, DOI 10.2147/IJN.S27028
   Singh P, 2008, BIOCONJUGATE CHEM, V19, P2239, DOI 10.1021/bc800125u
   Tomalia DA, 2007, BIOCHEM SOC T, V35, P61, DOI 10.1042/BST0350061
   Wang W., J BIOMED MAT RES B, V93B, P59
   Xu PS, 2010, BIOMACROMOLECULES, V11, P2352, DOI 10.1021/bm100481r
   Xu XY, 2007, COLLOID SURFACE B, V55, P222, DOI 10.1016/j.colsurfb.2006.12.006
   Yang H, 2008, J MATER SCI-MATER M, V19, P1991, DOI 10.1007/s10856-007-3278-0
   Yoo HS, 2001, J CONTROL RELEASE, V70, P63, DOI 10.1016/S0168-3659(00)00340-0
   Zhang JX, 2007, PHARM RES, V24, P1944, DOI 10.1007/s11095-007-9322-4
   Zhang LH, 2011, EUR J PHARM BIOPHARM, V79, P232, DOI 10.1016/j.ejpb.2011.03.025
   Zhang XQ, 2007, BIOCONJUGATE CHEM, V18, P2068, DOI 10.1021/bc070116l
   Zhang YQ, 2010, J MED CHEM, V53, P3262, DOI 10.1021/jm901910j
   Zhu SJ, 2010, BIOMATERIALS, V31, P1360, DOI 10.1016/j.biomaterials.2009.10.044
NR 55
TC 29
Z9 29
U1 7
U2 111
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD MAY
PY 2013
VL 10
IS 5
BP 1695
EP 1704
DI 10.1021/mp300522p
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 140QI
UT WOS:000318669600019
PM 23510114
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ditto, AJ
   Reho, JJ
   Shah, KN
   Smolen, JA
   Holda, JH
   Ramirez, RJ
   Yun, YH
AF Ditto, Andrew J.
   Reho, John J.
   Shah, Kush N.
   Smolen, Justin A.
   Holda, James H.
   Ramirez, Rolando J.
   Yun, Yang H.
TI In Vivo Gene Delivery with L-Tyrosine Polyphosphate Nanoparticles
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE nanoparticles; L-tyrosine; gene therapy; nonviral; immune response
ID POTENTIAL BIOMATERIAL APPLICATIONS; IMMUNE-RESPONSE; THERAPY;
   TRANSFECTION; RELEASE; CELLS; MICROSPHERES; ENDOMETRIUM; EFFICIENCY;
   POLYPLEXES
AB The concept of gene therapy is promising; however, the perceived risks and side effects associated with this technology have severely dampened the researchers' enthusiasm.(1-3) Thus, the development of a nonviral gene vector without immunological effects and with high transfection efficiency is necessary. Currently, most nonviral vectors have failed to achieve the in vivo transfection efficiencies of viral vectors due to their toxicity,(4) rapid clearance,(5,6) and/or inappropriate release rates.(7) Although our previous studies have successfully demonstrated the controlled-release of plasmid DNA (pDNA) polyplexes encapsulated into nanoparticles formulated with L-tyrosine polyphosphate (LTP-pDNA nanopartides),(8,9) the in vivo transfection capabilities and immunogenicity of this delivery system have yet to be examined. Thus, we evaluate LTP-pDNA nanopartides in an in vivo setting via injection into rodent uterine tissue. Our results demonstrate. through X-gal staining and immunohistochemistry of uterine tissue that transfection has successfully occurred after a nine-day incubation. In contrast, the results for the control nanoparticles show results similar to those of shams. Furthermore, reverse transcriptase polymerase chain reaction (RT-PCR) from the injected tissues confirms the transfection in vivo. To examine the immunogenicity, the L-tyrosine polyphosphate (LTP) nanoparticles have been evaluated in a mouse model. No significant differences in the activation of the innate immune system are observed These data provide the first report for the potential use of controlled-release nanoparticles formulated from an amino acid based polymer as an in vivo nonviral vector for gene therapy.
C1 [Ditto, Andrew J.; Shah, Kush N.; Smolen, Justin A.; Yun, Yang H.] Univ Akron, Dept Biomed Engn, Olson Res Ctr, Akron, OH 44325 USA.
   [Ditto, Andrew J.] Univ Toledo, Dept Biochem & Canc Biol, Toledo, OH 43614 USA.
   [Reho, John J.; Shah, Kush N.] Univ Akron, Dept Integrated Biosci, Auburn Sci & Engn Ctr, Akron, OH 44325 USA.
   [Reho, John J.; Holda, James H.; Ramirez, Rolando J.] Univ Akron, Auburn Sci & Engn Ctr, Dept Biol, Akron, OH 44325 USA.
   [Smolen, Justin A.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.
RP Yun, YH (reprint author), Univ Akron, Dept Biomed Engn, 302 Buchtel Common, Akron, OH 44325 USA.
EM yy@uakron.edu
OI Shah, Kush/0000-0003-1652-2105; Reho, John/0000-0003-0981-3027
FU National Institute of General Medical Sciences [1R01 GM086895]; National
   Science Foundation [CBET-0954360]; University of Akron
FX We are grateful for the funding of this research, which was made
   possible in part through the National Institute of General Medical
   Sciences (1R01 GM086895), the National Science Foundation (CAREER Award
   to Y.H.Y., CBET-0954360), and the University of Akron (Firestone
   Fellowship to Y.H.Y. and Integrated Biosciences Research Grant to
   J.J.R.). We also thank Dr. Ronald Salisbury, Associate Professor in the
   Department of Biology at the University of Akron, for his histological
   expertise.
CR Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   Anderson WF, 1998, NATURE, V392, P25
   Angella GJ, 2000, INVEST OPHTH VIS SCI, V41, P4158
   Angulo Inigo, 1995, Journal of Immunology, V155, P15
   AVERY M, 1992, RADIAT RES, V132, P50, DOI 10.2307/3578332
   BERTALANFFY FD, 1963, ACTA ANAT, V54, P39
   CharnockJones DS, 1997, HUM REPROD, V12, P17, DOI 10.1093/humrep/12.1.17
   Christ M, 1997, IMMUNOL LETT, V57, P19, DOI 10.1016/S0165-2478(97)00049-7
   Csaba N, 2006, J CONTROL RELEASE, V113, P164, DOI 10.1016/j.jconrel.2006.03.017
   Dash PR, 1999, GENE THER, V6, P643, DOI 10.1038/sj.gt.3300843
   de Bruin KG, 2008, J CONTROL RELEASE, V130, P175, DOI 10.1016/j.jconrel.2008.06.001
   Ditto AJ, 2009, EXPERT OPIN DRUG DEL, V6, P1149, DOI 10.1517/17425240903241796
   Ditto AJ, 2009, MOL PHARMACEUT, V6, P986, DOI 10.1021/mp9000316
   Ditto AJ, 2009, INT J PHARM, V368, P199, DOI 10.1016/j.ijpharm.2008.10.019
   Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038
   Giger EV, 2011, J CONTROL RELEASE, V150, P87, DOI 10.1016/j.jconrel.2010.11.012
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Grigsby CL, 2010, J R SOC INTERFACE, V7, pS67, DOI 10.1098/rsif.2009.0260
   Gwak S. J., 2011, J BIOMATER IN PRESS
   Haskins KA, 2003, INT IMMUNOPHARMACOL, V3, P169, DOI 10.1016/S1567-5769(02)00143-1
   Hollon T, 2000, NAT MED, V6, P6, DOI 10.1038/71545
   Hollon T, 2000, AM J OPHTHALMOL, V129, P701
   Hsieh YY, 2002, J ASSIST REPROD GEN, V19, P79, DOI 10.1023/A:1014495614792
   Itaka K., 2004, J GENE MED, V6, P76
   Jiang XA, 2010, ADV MATER, V22, P2556, DOI 10.1002/adma.200903933
   Jovcic G, 2004, CELL PROLIFERAT, V37, P401, DOI 10.1111/j.1365-2184.2004.00322.x
   Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971
   Krstic A, 2009, GROWTH FACTORS, V27, P79, DOI 10.1080/08977190902757153
   Lecocq M, 2000, BIOCHEM BIOPH RES CO, V278, P414, DOI 10.1006/bbrc.2000.3809
   Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884
   Li S, 1999, AM J PHYSIOL-LUNG C, V276, pL796, DOI 10.1152/ajplung.1999.276.5.L796
   Mavilio F, 2010, EMBO REP, V11, P75, DOI 10.1038/embor.2009.284
   Mayo AS, 2010, INT J PHARMACEUT, V387, P278, DOI 10.1016/j.ijpharm.2009.12.024
   Park EK, 2005, J CONTROL RELEASE, V109, P158, DOI 10.1016/j.jconrel.2005.09.039
   Pathak Atul, 2009, Biotechnology Journal, V4, P1559, DOI 10.1002/biot.200900161
   Porteus MH, 2006, PLOS GENET, V2, P1285, DOI 10.1371/journal.pgen.0020133
   Relloso M, 1998, FERTIL STERIL, V70, P366, DOI 10.1016/S0015-0282(98)00144-7
   Rogers M. L., 2011, J CONTROL RELEASE, V157, P183
   Schluep T, 2009, P NATL ACAD SCI USA, V106, P11394, DOI 10.1073/pnas.0905487106
   Sen Gupta A, 2005, POLYMER, V46, P2133, DOI 10.1016/j.polymer.2005.01.023
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Tang CK, 2009, BIOMATERIALS, V30, P1389, DOI 10.1016/j.biomaterials.2008.11.010
   Tuschl H, 2002, TOXICOLOGY, V172, P35, DOI 10.1016/S0300-483X(01)00583-2
   Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016
   Uduehi AN, 2001, EUR J CARDIO-THORAC, V20, P159, DOI 10.1016/S1010-7940(01)00714-X
   Wells DJ, 2010, CELL BIOL TOXICOL, V26, P21, DOI 10.1007/s10565-009-9144-8
   Xu QG, 2013, J CONTROL RELEASE, V167, P76, DOI 10.1016/j.jconrel.2013.01.018
   You JO, 2005, J GENE MED, V7, P398, DOI 10.1002/jgm.695
   Yun Y. H., 2005, J BIOMAT SCI-POLYM E, V16, P1359
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zaric V, 2004, J GENE MED, V6, P176, DOI 10.1002/jgm.484
   Zuckerman JE, 2012, P NATL ACAD SCI USA, V109, P3137, DOI 10.1073/pnas.1200718109
NR 52
TC 6
Z9 6
U1 0
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD MAY
PY 2013
VL 10
IS 5
BP 1836
EP 1844
DI 10.1021/mp300623a
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 140QI
UT WOS:000318669600032
PM 23510151
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Leung, ACW
   Lam, E
   Chong, J
   Hrapovic, S
   Luong, JHT
AF Leung, Alfred C. W.
   Lam, Edmond
   Chong, Jonathan
   Hrapovic, Sabahudin
   Luong, John H. T.
TI Reinforced plastics and aerogels by nanocrystalline cellulose
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Review
DE Nanocrystalline cellulose; Nanofiller; Nanocomposite; Nanomaterials;
   Nanoparticles; Renewable biomass; Cellulose
ID FILLED POLYMER NANOCOMPOSITES; RING-OPENING POLYMERIZATION; CHIRAL
   NEMATIC PHASE; X-RAY-DIFFRACTION; NATIVE CELLULOSE;
   MECHANICAL-PROPERTIES; RADICAL POLYMERIZATION; POLY(LACTIC ACID);
   ELASTIC-MODULUS; MICROCRYSTALLINE CELLULOSE
AB Nanocrystalline cellulose (NCC), a rigid rod-like nanoscale material, can be produced from cellulosic biomass in powder, liquid, or gel forms by acid and chemical hydrolysis. Owing to its unique and exceptional physicochemical properties, the incorporation of a small amount of NCC into plastic enhances the mechanical strength of the latter by several orders of magnitudes. Carbohydrate-based NCC poses no serious environmental concerns, providing further impetus for the development and applications of this green and renewable biomaterial to fabricate lightweight and biodegradable composites and aerogels. Surface functionalization of NCC remains the main focus of NCC research to tailor its properties for dispersion in hydrophilic or hydrophobic media. It is of uttermost importance to develop tools and protocols for imaging of NCC in a complex matrix and quantify its reinforcement effect.
C1 [Leung, Alfred C. W.; Lam, Edmond; Chong, Jonathan; Hrapovic, Sabahudin; Luong, John H. T.] Natl Res Council Canada, Montreal, PQ H4P 2R2, Canada.
RP Luong, JHT (reprint author), Natl Res Council Canada, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.
EM john.luong@cnrc-nrc.gc.ca
OI Luong, John/0000-0002-1709-1223
CR Akerholm M, 2004, CARBOHYD RES, V339, P569, DOI 10.1016/j.carres.2003.11.012
   Araki J, 2001, LANGMUIR, V17, P21, DOI 10.1021/la001070m
   Atalla RH, 1999, SOLID STATE NUCL MAG, V15, P1, DOI 10.1016/S0926-2040(99)00042-9
   Auad ML, 2008, POLYM INT, V57, P651, DOI 10.1002/pi.2394
   Auad ML, 2011, POLYM INT, V60, P743, DOI 10.1002/pi.3004
   Auad ML, 2010, J APPL POLYM SCI, V115, P1215, DOI 10.1002/app.31218
   Azouz AB, 2012, ACS MACRO LETT, V1, P236
   Azzam F, 2010, BIOMACROMOLECULES, V11, P3652, DOI 10.1021/bm101106c
   Bahar E, 2012, J APPL POLYM SCI, V125, P2882, DOI 10.1002/app.36445
   BATTISTA OA, 1956, IND ENG CHEM, V48, P333, DOI 10.1021/ie50554a046
   BATTISTA OA, 1950, IND ENG CHEM, V42, P502, DOI 10.1021/ie50483a029
   Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Bonini C, 2002, LANGMUIR, V18, P3311, DOI 10.1021/la015511t
   Bordel D, 2006, LANGMUIR, V22, P4899, DOI 10.1021/la0600402
   Borges AC, 2011, ACTA BIOMATER, V7, P3412, DOI 10.1016/j.actbio.2011.05.029
   Cai J, 2012, ANGEW CHEM INT EDIT, V51, P2076, DOI 10.1002/anie.201105730
   Callister Jr JD, 1994, MAT SCI ENG INTRO, P530
   Cao X, 2008, EXPRESS POLYM LETT, V2, P502, DOI 10.3144/expresspolymlett.2008.60
   Cao XD, 2008, J APPL POLYM SCI, V109, P3804, DOI 10.1002/app.28418
   Cao XD, 2011, CURR SCI INDIA, V100, P1172
   Cao XD, 2009, J MATER CHEM, V19, P7137, DOI 10.1039/b910517d
   Cha RT, 2012, CARBOHYD POLYM, V88, P713, DOI 10.1016/j.carbpol.2012.01.026
   Chazeau L, 2000, J POLYM SCI POL PHYS, V38, P383, DOI 10.1002/(SICI)1099-0488(20000201)38:3<383::AID-POLB5>3.3.CO;2-H
   Chen WS, 2011, SOFT MATTER, V7, P10360, DOI 10.1039/c1sm06179h
   Cranston ED, 2008, COLLOID SURFACE A, V325, P44, DOI 10.1016/j.colsurfa.2008.04.042
   Cranston ED, 2006, BIOMACROMOLECULES, V7, P2522, DOI 10.1021/bm0602886
   Cranston ED, 2010, LANGMUIR, V26, P17190, DOI 10.1021/la1030729
   Dalmas F, 2006, POLYMER, V47, P2802, DOI 10.1016/j.polymer.2006.02.014
   Dalmas F, 2007, COMPOS SCI TECHNOL, V67, P829, DOI 10.1016/j.compscitech.2006.01.030
   Das K, 2009, CELLULOSE, V16, P783, DOI 10.1007/s10570-009-9280-6
   de Menezes AJ, 2009, POLYMER, V50, P4552, DOI 10.1016/j.polymer.2009.07.038
   de Paula EL, 2011, POLYM DEGRAD STABIL, V96, P1631, DOI 10.1016/j.polymdegradstab.2011.06.006
   de Rodriguez NLG, 2006, CELLULOSE, V13, P261, DOI 10.1007/s10570-005-9039-7
   Diddens I, 2008, MACROMOLECULES, V41, P9755, DOI 10.1021/ma801796u
   Ding WQ, 2006, COMPOS SCI TECHNOL, V66, P1112, DOI 10.1016/j.compscitech.2005.11.030
   Dong XM, 1996, LANGMUIR, V12, P2076, DOI 10.1021/la950133b
   Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939
   Dorris A, 2012, CELLULOSE, V19, P687, DOI 10.1007/s10570-012-9679-3
   Ebeling T, 1999, LANGMUIR, V15, P6123, DOI 10.1021/la990046+
   Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0
   Eichhorn SJ, 2001, CELLULOSE, V8, P197, DOI 10.1023/A:1013181804540
   Elazzouzi-Hafraoui S, 2008, BIOMACROMOLECULES, V9, P57, DOI 10.1021/bm700769p
   Magalhaes WLE, 2009, LANGMUIR, V25, P13250, DOI 10.1021/la901928j
   EVANS R, 1995, HOLZFORSCHUNG, V49, P498, DOI 10.1515/hfsg.1995.49.6.498
   FAVIER V, 1995, POLYM ADVAN TECHNOL, V6, P351, DOI 10.1002/pat.1995.220060514
   Fortunati E, 2012, CARBOHYD POLYM, V87, P1596, DOI 10.1016/j.carbpol.2011.09.066
   Gao ZZ, 2012, CARBOHYD POLYM, V87, P2068, DOI 10.1016/j.carbpol.2011.10.027
   GARDINER ES, 1985, CAN J CHEM, V63, P173, DOI 10.1139/v85-027
   GARDNER KH, 1974, BIOPOLYMERS, V13, P1975, DOI 10.1002/bip.1974.360131005
   Garvey CJ, 2005, MACROMOL CHEM PHYSIC, V206, P1568, DOI 10.1002/macp.200500008
   Gindl W, 2004, COMPOS PART A-APPL S, V35, P1345, DOI 10.1016/j.compositesa.2004.04.002
   Gindl W, 2005, POLYMER, V46, P10221, DOI 10.1016/j.polymer.2005.08.040
   Goffin AL, 2011, POLYMER, V52, P1532, DOI 10.1016/j.polymer.2011.02.004
   Goffin AL, 2011, BIOMACROMOLECULES, V12, P2456, DOI 10.1021/bm200581h
   Gong G, 2011, POLYM COMPOSITE, V32, P1492, DOI 10.1002/pc.21170
   Gousse C, 2002, POLYMER, V43, P2645, DOI 10.1016/S0032-3861(02)00051-4
   Grunert M, 2002, J POLYM ENVIRON, V10, P27, DOI 10.1023/A:1021065905986
   Habibi Y, 2008, J MATER CHEM, V18, P5002, DOI 10.1039/b809212e
   Habibi Y, 2008, BIOMACROMOLECULES, V9, P1974, DOI 10.1021/bm8001717
   Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y
   Hajji P, 1996, POLYM COMPOSITE, V17, P612, DOI 10.1002/pc.10651
   HAYASHI J, 1975, J POLYM SCI POL LETT, V13, P23, DOI 10.1002/pol.1975.130130104
   He JX, 2008, J APPL POLYM SCI, V107, P1029, DOI 10.1002/app.27061
   Heath L, 2010, GREEN CHEM, V12, P1448, DOI 10.1039/c0gc00035c
   Herrera NV, 2011, PLAST RUBBER COMPOS, V40, P57, DOI 10.1179/174328911X12988622800891
   Heux L, 2000, LANGMUIR, V16, P8210, DOI 10.1021/la9913957
   Hoepfner S, 2008, CELLULOSE, V15, P121, DOI 10.1007/s10570-007-9146-8
   HORII F, 1987, MACROMOLECULES, V20, P2117, DOI 10.1021/ma00175a012
   Hossain KMZ, 2012, J MATER SCI, V47, P2675, DOI 10.1007/s10853-011-6093-4
   Hult EL, 2003, CELLULOSE, V10, P103, DOI 10.1023/A:1024080700873
   Husing N, 1998, ANGEW CHEM INT EDIT, V37, P23, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<22::AID-ANIE22>3.0.CO;2-I
   Hussain F, 2006, J COMPOS MATER, V40, P1511, DOI 10.1177/0021998306067321
   Innventia, 2011, NAN
   Ioelovich M, 2010, BIORESOURCES, V5, P1393
   JASWON MA, 1968, PROC R SOC LON SER-A, V306, P389, DOI 10.1098/rspa.1968.0157
   Jean B, 2008, LANGMUIR, V24, P3452, DOI 10.1021/la703045f
   Jin H, 2004, COLLOID SURFACE A, V240, P63, DOI 10.1016/j.colsurfa.2004.03.007
   Job S, 2011, PLASTICS FRUIT DERIV
   John MJ, 2013, J APPL POLYM SCI, V127, P274, DOI 10.1002/app.37884
   Kataoka Y, 1998, MACROMOLECULES, V31, P760, DOI 10.1021/ma970768c
   Kaushik A, 2010, CARBOHYD POLYM, V82, P337, DOI 10.1016/j.carbpol.2010.04.063
   Kettunen M, 2011, ADV FUNCT MATER, V21, P510, DOI 10.1002/adfm.201001431
   Kim H, 2010, MACROMOLECULES, V43, P6515, DOI 10.1021/ma100572e
   Kimura F, 2005, LANGMUIR, V21, P2034, DOI 10.1021/la0475728
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Koo J.H., 2006, POLYM NANOCOMPOSITES
   Korhonen JT, 2011, ACS APPL MATER INTER, V3, P1813, DOI 10.1021/am200475b
   Krassig HA, 1993, CELLULOSE STRUCTURE
   Krishnamachari P, 2011, MICRON, V42, P751, DOI 10.1016/j.micron.2011.05.001
   Kvien I, 2007, APPL PHYS A-MATER, V87, P641, DOI 10.1007/s00339-007-3882-3
   Lahiji RR, 2010, LANGMUIR, V26, P4480, DOI 10.1021/la903111j
   Lam E, 2013, ACS SUSTAIN CHEM ENG, V1, P278, DOI 10.1021/sc3001367
   Lam E, 2012, TRENDS BIOTECHNOL, V30, P283, DOI 10.1016/j.tibtech.2012.02.001
   Larsson PT, 1997, CARBOHYD RES, V302, P19, DOI 10.1016/S0008-6215(97)00130-4
   Lee J, 2012, MACROMOL RES, V20, P76, DOI 10.1007/s13233-012-0008-3
   Lemke CH, 2011, THESIS U BRIT COLUMB
   Leung ACW, 2011, SMALL, V7, P302, DOI 10.1002/smll.201001715
   Leung CW, 2010, Canada Patent, Patent No. 000372
   Li RJ, 2012, J APPL POLYM SCI, V124, P2080, DOI 10.1002/app.35273
   Li W, 2012, ULTRASON SONOCHEM, V19, P479, DOI 10.1016/j.ultsonch.2011.11.007
   Li Y, 2012, RSC ADV, V2, P3347, DOI 10.1039/c2ra00646d
   Lima AMD, 2003, LANGMUIR, V19, P24, DOI 10.1021/la020475z
   Lima MMD, 2004, MACROMOL RAPID COMM, V25, P771, DOI 10.1002/marc.200300268
   Lin N, 2011, COLLOID SURFACE B, V85, P270, DOI 10.1016/j.colsurfb.2011.02.039
   Lin N, 2011, POLYM COMPOSITE, V32, P472, DOI 10.1002/pc.21066
   Lin N, 2011, CARBOHYD POLYM, V83, P1834, DOI 10.1016/j.carbpol.2010.10.047
   Lin N, 2009, J APPL POLYM SCI, V113, P3417, DOI 10.1002/app.30308
   Littunen K, 2011, CARBOHYD POLYM, V84, P1039, DOI 10.1016/j.carbpol.2010.12.064
   Liu HY, 2010, BIORESOURCE TECHNOL, V101, P5685, DOI 10.1016/j.biortech.2010.02.045
   Liu HZ, 2011, CELLULOSE, V18, P619, DOI 10.1007/s10570-011-9499-x
   Ljungberg N, 2006, POLYMER, V47, P6285, DOI 10.1016/j.polymer.2006.07.013
   Lopez-Suevos F, 2010, CELLULOSE, V17, P387, DOI 10.1007/s10570-010-9396-8
   Lu P, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/41/415604
   Majoinen J, 2011, BIOMACROMOLECULES, V12, P2997, DOI 10.1021/bm200613y
   Marchessault R H, 1967, Adv Carbohydr Chem Biochem, V22, P421
   Mark H, 1940, J PHYS CHEM-US, V44, P764, DOI 10.1021/j150402a009
   Matsumura H, 2000, J APPL POLYM SCI, V78, P2242, DOI 10.1002/1097-4628(20001220)78:13<2242::AID-APP20>3.0.CO;2-5
   Mendez J, 2011, MACROMOLECULES, V44, P6827, DOI 10.1021/ma201502k
   Meyer KH, 1937, HELV CHIM ACTA, V20, P232, DOI 10.1002/hlca.19370200134
   Miller AF, 2003, BIOMACROMOLECULES, V4, P510, DOI 10.1021/bm0200837
   Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b
   Morandi G, 2009, LANGMUIR, V25, P8280, DOI 10.1021/la900452a
   Newman RH, 2004, HOLZFORSCHUNG, V58, P91, DOI 10.1515/HF.2004.012
   Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Osorio-Madrao A, 2012, BIOMACROMOLECULES, V13, P850, DOI 10.1021/bm201764y
   Paakko M, 2008, SOFT MATTER, V4, P2492, DOI 10.1039/b810371b
   Pakzad A, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/8/085706
   Pakzad A, 2012, COMPOS SCI TECHNOL, V72, P314, DOI 10.1016/j.compscitech.2011.11.020
   Pakzad A, 2012, J MATER RES, V27, P528, DOI 10.1557/jmr.2011.288
   Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10
   Pasquini D, 2010, IND CROP PROD, V32, P486, DOI 10.1016/j.indcrop.2010.06.022
   Pei AH, 2011, MACROMOLECULES, V44, P4422, DOI 10.1021/ma200318k
   Peng BL, 2011, CAN J CHEM ENG, V89, P1191, DOI 10.1002/cjce.20554
   Peresin MS, 2010, BIOMACROMOLECULES, V11, P674, DOI 10.1021/bm901254n
   Pierre AC, 2002, CHEM REV, V102, P4243, DOI 10.1021/cr0101306
   Podsiadlo P, 2007, LANGMUIR, V23, P7901, DOI 10.1021/la700772a
   Pranger L, 2008, MACROMOLECULES, V41, P8682, DOI 10.1021/ma8020213
   Qu P, 2010, BIORESOURCES, V5, P1811
   Raquez JM, 2012, COMPOS SCI TECHNOL, V72, P544, DOI 10.1016/j.compscitech.2011.11.017
   Revol J.F., 1982, CARBOHYD POLYM, V2, P123, DOI DOI 10.1016/0144-8617(82)90058-3
   Revol JF, 1998, J PULP PAP SCI, V24, P146
   REVOL JF, 1992, INT J BIOL MACROMOL, V14, P170, DOI 10.1016/S0141-8130(05)80008-X
   Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+
   Rong MZ, 2001, COMPOS SCI TECHNOL, V61, P1437, DOI 10.1016/S0266-3538(01)00046-X
   Rowland SP, 1985, CELLULOSE CHEM ITS A
   Ruiz MM, 2000, COMPOS INTERFACE, V7, P117
   RULAND W, 1961, ACTA CRYSTALLOGR, V14, P1180, DOI 10.1107/S0365110X61003429
   Saidak T, 2012, CELLUFORCE DEBUTS WO
   SAKURADA I, 1962, J POLYM SCI, V57, P651, DOI 10.1002/pol.1962.1205716551
   Salvetat JP, 2006, J NANOSCI NANOTECHNO, V6, P1857, DOI 10.1166/jnn.2006.305
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   SARKO A, 1978, TAPPI, V61, P59
   Schenzel K, 2005, CELLULOSE, V12, P223, DOI 10.1007/s10570-004-3885-6
   Sharmin N, 2012, J AGR FOOD CHEM, V60, P623, DOI 10.1021/jf203500s
   Shim BS, 2007, NANO LETT, V7, P3266, DOI 10.1021/nl071245d
   Siqueira G, 2011, COMPOS SCI TECHNOL, V71, P1886, DOI 10.1016/j.compscitech.2011.09.002
   Siqueira G, 2011, CELLULOSE, V18, P57, DOI 10.1007/s10570-010-9463-1
   Siqueira G, 2010, POLYMERS-BASEL, V2, P728, DOI 10.3390/polym2040728
   Sjostrom E, 1981, WOOD CHEM FUNDAMENTA, P223
   Spagnol C, 2012, CELLULOSE, V19, P1225, DOI 10.1007/s10570-012-9711-7
   STIPANOVIC AJ, 1976, MACROMOLECULES, V9, P851, DOI 10.1021/ma60053a027
   SUGIYAMA J, 1992, MACROMOLECULES, V25, P4232, DOI 10.1021/ma00042a032
   SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033
   Sui L, 2010, MACROMOLECULES, V43, P9541, DOI 10.1021/ma1016488
   Tanaka F, 2006, CELLULOSE, V13, P509, DOI 10.1007/s10570-006-9068-x
   TASHIRO K, 1991, POLYMER, V32, P1516, DOI 10.1016/0032-3861(91)90435-L
   TASHIRO K, 1985, POLYM BULL, V14, P213
   TEEAAR R, 1987, POLYM BULL, V17, P231
   Teixeira ED, 2009, CARBOHYD POLYM, V78, P422, DOI 10.1016/j.carbpol.2009.04.034
   Ten E, 2012, IND ENG CHEM RES, V51, P2941, DOI 10.1021/ie2023367
   Urena-Benavides EE, 2010, LANGMUIR, V26, P14263, DOI 10.1021/la102216v
   Virozub A, 2009, LANGMUIR, V25, P12837, DOI 10.1021/la902578j
   Visakh PM, 2012, J APPL POLYM SCI, V124, P1614, DOI 10.1002/app.35176
   Wada M, 2001, CELLULOSE, V8, P183, DOI 10.1023/A:1013196220602
   Wang HZ, 2011, BIOMACROMOLECULES, V12, P1585, DOI 10.1021/bm101584c
   Wang N, 2006, ACTA POLYM SIN, P982
   Wang XH, 2009, 2009 INTERNATIONAL FORUM ON COMPUTER SCIENCE-TECHNOLOGY AND APPLICATIONS, VOL 2, PROCEEDINGS, P117, DOI 10.1109/IFCSTA.2009.356
   Wang YX, 2011, CARBOHYD POLYM, V83, P1937, DOI 10.1016/j.carbpol.2010.10.071
   Xu SH, 2012, EXPRESS POLYM LETT, V6, P14, DOI 10.3144/expresspolymlett.2012.3
   Yoshiharu N, 1997, MACROMOLECULES, V30, P6395, DOI 10.1021/ma970503y
   Yu HY, 2012, CARBOHYD POLYM, V89, P971, DOI 10.1016/j.carbpol.2012.04.053
   Zafeiropoulos NE, 2002, COMPOS PART A-APPL S, V33, P1185, DOI 10.1016/S1359-835X(02)00088-X
   Zhang H, 2011, BIORESOURCES, V6, P4430
   Zhou CJ, 2011, COLLOID POLYM SCI, V289, P247, DOI 10.1007/s00396-010-2342-3
   Zhou CJ, 2011, J COLLOID INTERF SCI, V353, P116, DOI 10.1016/j.jcis.2010.09.035
   Zoppe JO, 2010, BIOMACROMOLECULES, V11, P2683, DOI 10.1021/bm100719d
NR 188
TC 11
Z9 12
U1 6
U2 152
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD MAY
PY 2013
VL 15
IS 5
AR 1636
DI 10.1007/s11051-013-1636-z
PG 24
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 139BC
UT WOS:000318555400041
DA 2018-10-20
ER

PT J
AU Lopes, JH
   Mazali, IO
   Landers, R
   Bertran, CA
AF Lopes, Joao H.
   Mazali, Italo Odone
   Landers, Richard
   Bertran, Celso A.
TI Structural Investigation of the Surface of Bioglass 45S5 Enriched with
   Calcium Ions
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID SODA-LIME GLASSES; BIOACTIVE GLASS; HUMAN OSTEOBLASTS; EXCHANGE;
   DISSOLUTION; EXPRESSION; PRODUCTS; NMR; DIFFUSION; SILICA
AB In this article the changes on the surface of the 45S5 bioglass submitted to an enrichment with calcium ions were investigated. The method employed was the immersion of bioglass in calcium molten salt bath at 450 degrees C. Changes in composition were probed by different techniques of chemical analysis. The use of SEM-EDS allowed estimating the thickness modified, as being about 10m. X-ray photoelectron spectroscopy enabled to infer over the structural changes on the surface of 45S5 bioactive glass. The entry of calcium in the vitreous network promoted the phase separation of microdomains rich in silica and phosphate on the surface of the glass. The formation of immiscibility region was attributed a depolymerization of silica network and also, to a possible migration of phosphate species from the bulk. The results of this study indicate a great change in the surface properties of this biomaterial. In addition, the method proposed in this study proved to be very promising in the possibility of designing the surface of bioactive glasses, to modulate the desired properties, keeping the bulk unchanged.
C1 [Lopes, Joao H.; Mazali, Italo Odone; Bertran, Celso A.] Univ Estadual Campinas, Inst Chem, BR-13083862 Campinas, SP, Brazil.
   [Landers, Richard] Univ Estadual Campinas, Inst Phys Gleb Wataghin, BR-13083859 Campinas, SP, Brazil.
RP Bertran, CA (reprint author), Univ Estadual Campinas, Inst Chem, POB 6154, BR-13083862 Campinas, SP, Brazil.
EM bertran@iqm.unicamp.br
RI Inst. of Physics, Gleb Wataghin/A-9780-2017; Bertran, Celso
   Aparecido/C-1174-2013; Mazali, Italo/C-5217-2012
OI Mazali, Italo/0000-0001-5698-5273; Lopes, Joao
   Henrique/0000-0001-6872-0299
FU Sao Paulo Research Foundation - FAPESP [2010/05394-9]; PETROBRAS
FX This study was supported by the Sao Paulo Research Foundation - FAPESP
   (no. 2010/05394-9) and PETROBRAS.
CR Bellucci D, 2011, MATER LETT, V65, P1825, DOI 10.1016/j.matlet.2011.03.060
   Bellucci D, 2011, CERAM INT, V37, P1575, DOI 10.1016/j.ceramint.2011.01.023
   Bellucci D, 2011, MATERIALS, V4, P339, DOI 10.3390/ma4020339
   BENDICHO C, 1990, SPECTROCHIM ACTA B, V45, P695, DOI 10.1016/0584-8547(90)80050-S
   Bolis V, 2008, J PHYS CHEM C, V112, P16879, DOI 10.1021/jp805206z
   Catan F, 2008, J NON-CRYST SOLIDS, V354, P1026, DOI 10.1016/j.jnoncrysol.2007.08.071
   Cerruti M, 2005, J PHYS CHEM B, V109, P14496, DOI 10.1021/jp050705t
   Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   Di Nunzio S, 2004, J EUR CERAM SOC, V24, P2935, DOI 10.1016/j.jeurceramsoc.2003.11.010
   Doostmohammadi A, 2011, CERAM INT, V37, P1601, DOI 10.1016/j.ceramint.2011.03.009
   Nascimento MLF, 2007, MATER LETT, V61, P912, DOI 10.1016/j.matlet.2006.06.012
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   GREAVES GN, 1985, J NON-CRYST SOLIDS, V71, P203, DOI 10.1016/0022-3093(85)90289-3
   Grelin J, 2008, MATER SCI ENG B-ADV, V149, P190, DOI 10.1016/j.mseb.2007.11.017
   Gy R, 2008, MATER SCI ENG B-ADV, V149, P159, DOI 10.1016/j.mseb.2007.11.029
   Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027
   Hench L.L., 1999, INTRO BIOCERAMICS
   Hench LL, 2009, J EUR CERAM SOC, V29, P1257, DOI 10.1016/j.jeurceramsoc.2008.08.002
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Lee YK, 1997, J NON-CRYST SOLIDS, V222, P125, DOI 10.1016/S0022-3093(97)90104-6
   Lefebvre L, 2007, ACTA MATER, V55, P3305, DOI 10.1016/j.actamat.2007.01.029
   Linati L, 2008, J NON-CRYST SOLIDS, V354, P84, DOI 10.1016/j.jnoncrysol.2007.06.076
   LOCKYER MWG, 1995, J NON-CRYST SOLIDS, V188, P207, DOI 10.1016/0022-3093(95)00188-3
   Nesbitt HW, 2011, J NON-CRYST SOLIDS, V357, P170, DOI 10.1016/j.jnoncrysol.2010.09.031
   Njiokep EMT, 2008, J NON-CRYST SOLIDS, V354, P355, DOI 10.1016/j.jnoncrysol.2007.07.045
   O'Neil Maryadele J., 1996, MERCK INDEX
   Siqueira RL, 2011, MAT SCI ENG C-MATER, V31, P983, DOI 10.1016/j.msec.2011.02.018
   SUCOV EW, 1965, J AM CERAM SOC, V48, P426, DOI 10.1111/j.1151-2916.1965.tb14782.x
   Tilocca A, 2007, J PHYS CHEM B, V111, P14256, DOI 10.1021/jp075677o
   Tilocca A, 2010, J MATER CHEM, V20, P6848, DOI 10.1039/c0jm01081b
   Tilocca A, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3456712
   Tilocca A, 2010, LANGMUIR, V26, P545, DOI 10.1021/la902548f
   Varanasi VG, 2011, J BIOMED MATER RES A, V98A, P177, DOI 10.1002/jbm.a.33102
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamane M, 1996, J NON-CRYST SOLIDS, V203, P268, DOI 10.1016/0022-3093(96)00357-2
NR 39
TC 10
Z9 10
U1 0
U2 23
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD MAY
PY 2013
VL 96
IS 5
BP 1464
EP 1469
DI 10.1111/jace.12305
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 142ML
UT WOS:000318801400022
DA 2018-10-20
ER

PT J
AU Djaker, N
   Wulfman, C
   Sadoun, M
   de la Chapelle, ML
AF Djaker, Nadia
   Wulfman, Claudine
   Sadoun, Michael
   de la Chapelle, Marc Lamy
TI Zirconia dental implants degradation by confocal Raman
   microspectroscopy: analytical simulation and experiments
SO BIOMEDICAL OPTICS EXPRESS
LA English
DT Article
ID HYDROTHERMAL DEGRADATION; PHASE-TRANSFORMATION; DEPTH PROFILES;
   MICROSCOPY; DIFFRACTION; BIOMATERIAL; CERAMICS
AB Subsurface hydrothermal degradation of yttria stabilized tetragonal zirconia polycrystals (3Y-TZP) is presented. Evaluation of low temperature degradation (LTD) phase transformation induced by aging in 3Y-TZP is experimentally studied by Raman confocal microspectroscopy. A non-linear distribution of monoclinic volume fraction is determined in depth by using different pinhole sizes. A theoretical simulation is proposed based on the convolution of the excitation intensity profile and the Beer-Lambert law (optical properties of zirconia) to compare between experiment and theory. The calculated theoretical degradation curves matche closely to the experimental ones. Surface transformation (V-0) and transformation factor in depth (T) are obtained by comparing simulation and experience for each sample with nondestructive optical sectioning. (C) 2013 Optical Society of America
C1 [Djaker, Nadia; de la Chapelle, Marc Lamy] Univ Paris 13, Sorbonne Paris Cite, CNRS, Lab CSPBAT,UMR 7244, F-93017 Bobigny, France.
   [Wulfman, Claudine; Sadoun, Michael] Univ Paris 05, Sorbonne Paris Cite, Fac Chirurg Dent, EA4462 2URB2I, Paris, France.
RP Djaker, N (reprint author), Univ Paris 13, Sorbonne Paris Cite, CNRS, Lab CSPBAT,UMR 7244, 74 Rue Marcel Cachin, F-93017 Bobigny, France.
EM nadia.djaker@univ-paris13.fr
CR BARBILLAT J, 1994, J RAMAN SPECTROSC, V25, P3, DOI 10.1002/jrs.1250250103
   Brown SS, 2008, J BIOMED MATER RES B, V85B, P444, DOI 10.1002/jbm.b.30964
   Casellas D, 2001, J EUR CERAM SOC, V21, P765, DOI 10.1016/S0955-2219(00)00273-9
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   Gallardo A, 2007, J RAMAN SPECTROSC, V38, P880, DOI 10.1002/jrs.1736
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Jacques SL, 2012, BIOMED OPT EXPRESS, V3, P1162, DOI 10.1364/BOE.3.001162
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   Luthy H, 2005, DENT MATER, V21, P930, DOI 10.1016/j.dental.2004.11.012
   Macdonald AM, 2007, J RAMAN SPECTROSC, V38, P584, DOI 10.1002/jrs.1706
   Munoz Tabares JA, 2010, J AM CERAM SOC, V93, P1790
   Munoz-Tabares JA, 2011, ACTA MATER, V59, P473, DOI 10.1016/j.actamat.2010.09.047
   Pezzotti G, 2004, J BIOMED OPT, V9, P372, DOI 10.1117/1.1647547
   Pezzotti G, 2009, J AM CERAM SOC, V92, P1817, DOI 10.1111/j.1551-2916.2009.03114.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Presser V, 2009, APPL SPECTROSC, V63, P1288, DOI 10.1366/000370209789806975
   Salem J., 2007, CERAMIC COATINGS AND, VII
   Schley JS, 2010, EUR J ORAL SCI, V118, P443, DOI 10.1111/j.1600-0722.2010.00767.x
   Song W, 2012, OPT EXPRESS, V20, P20605, DOI 10.1364/OE.20.020605
   TORAYA H, 1984, J AM CERAM SOC, V67, pC183
   Wang Danni, 2012, Biomed Opt Express, V3, P3153, DOI 10.1364/BOE.3.003153
   Wulfman C, 2010, IRBM, V31, P257, DOI 10.1016/j.irbm.2010.10.004
   Wulfman C, 2012, J AM CERAM SOC, V95, P2347, DOI 10.1111/j.1551-2916.2012.05237.x
NR 23
TC 4
Z9 4
U1 0
U2 31
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 2156-7085
J9 BIOMED OPT EXPRESS
JI Biomed. Opt. Express
PD MAY 1
PY 2013
VL 4
IS 5
BP 725
EP 731
DI 10.1364/BOE.4.000725
PG 7
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 137FR
UT WOS:000318421400007
PM 23667788
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gu, ZP
   Xie, HX
   Li, L
   Zhang, X
   Liu, F
   Yu, XX
AF Gu, Zhipeng
   Xie, Huixu
   Li, Li
   Zhang, Xu
   Liu, Fei
   Yu, Xixun
TI Application of strontium-doped calcium polyphosphate scaffold on
   angiogenesis for bone tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HUMAN ENDOTHELIAL-CELLS; IN-VITRO; SUBSTITUTE APPLICATIONS; PHOSPHATE
   SCAFFOLDS; FACTOR DELIVERY; GROWTH; BIOMATERIALS; REPAIR; REGENERATION;
   OSTEOBLASTS
AB The key factor for regenerating large segmental bone defects through bone tissue engineering is angiogenesis in scaffolds. Attempts to overcome this problem, it is a good strategy to develop a new scaffold with bioactivity to induce angiogenesis in bone tissue engineering. In our previous research, the ability of strontium-doped calcium polyphosphate (SCPP) to stimulate the release of angiogenic growth factors from cultured osteoblasts was studied. This study was performed to determine the ability of SCPP to induce angiogenesis within in vitro co-culture model of human umbilical vein endothelial cells (HUVEC) and osteoblasts co-cultured. The bioactivity of developed scaffolds to induce angiogenesis in vivo was also researched in this paper. Co-cultured model has been developed in vitro and then cultured with SCPP scaffold as well as calcium polyphosphate (CPP) scaffold and hydroxylapatite (HA) scaffold. The results showed that the optimal ratio of HUVEC and osteoblasts co-cultured model for in vitro angiogenesis was 5:1. The model could maintain for more than 35 days when cultured with the scaffold and show the best activity at 21st day. Compared with those in CPP and HA scaffold, the formation of tube-like structure and the expression of platelet endothelial cell adhesion molecule in co-cultured model is better in SCPP scaffold. The in vivo immunohistochemistry staining for VEGF also showed that SCPP had a potential to promote the formation of angiogenesis and the regeneration of bone. SCPP scaffold could be served as a potential biomaterial with stimulating angiogenesis in bone tissue engineering and bone repair.
C1 [Gu, Zhipeng; Zhang, Xu; Liu, Fei; Yu, Xixun] Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Sichuan, Peoples R China.
   [Xie, Huixu] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610065, Sichuan, Peoples R China.
   [Li, Li] Chinese PLA, Hosp 452, Dept Oncol, Chengdu 610021, Sichuan, Peoples R China.
RP Yu, XX (reprint author), Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Sichuan, Peoples R China.
EM yuxixun1@126.com
RI Gu, Zhi peng/E-5108-2013
OI Gu, Zhi peng/0000-0003-4533-6539; Yu, Xixun/0000-0002-2301-8727
FU National Natural Science Foundation of China [30870616]; Scientific and
   technological project of Sichuan Province [2012SZ0015]
FX This work was supported by the National Natural Science Foundation of
   China (30870616) and the Scientific and technological project of Sichuan
   Province (2012SZ0015).
CR Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Cao GY, 2002, AM J PHYSIOL-CELL PH, V282, pC1181, DOI 10.1152/ajpcell.00524.2001
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Chen YW, 2008, J MATER SCI-MATER M, V19, P2655, DOI 10.1007/s10856-007-3350-9
   Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521
   Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Hofmann A, 2008, EUR CELLS MATER, V16, P79
   Hsiong SX, 2006, PERIODONTOL 2000, V41, P109, DOI 10.1111/j.1600-0757.2006.00158.x
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Laurance S, 2011, HAEMATOL-HEMATOL J, V96, P534, DOI 10.3324/haematol.2010.026740
   Liu F, 2011, J MATER SCI-MATER M, V22, P683, DOI 10.1007/s10856-011-4247-1
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   O'Brien CD, 2004, AM J PHYSIOL-CELL PH, V287, pC1103, DOI 10.1152/ajpcell.00573.2003
   Peters K, 2002, MICROVASC RES, V64, P334, DOI 10.1006/mvre.2002.2438
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sanchez-Salcedo S, 2006, TISSUE ENG, V12, P279, DOI 10.1089/ten.2006.12.279
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Marques JMS, 2009, J MATER SCI-MATER M, V20, P725, DOI 10.1007/s10856-008-3628-6
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2011, METHODS MOL BIOL, V695, P229, DOI 10.1007/978-1-60761-984-0_15
NR 28
TC 28
Z9 28
U1 1
U2 44
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2013
VL 24
IS 5
BP 1251
EP 1260
DI 10.1007/s10856-013-4891-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 138LN
UT WOS:000318510200013
PM 23430336
DA 2018-10-20
ER

PT J
AU Vargas, GE
   Durand, LAH
   Cadena, V
   Romero, M
   Mesones, RV
   Mackovic, M
   Spallek, S
   Spiecker, E
   Boccaccini, AR
   Gorustovich, AA
AF Vargas, Gabriela E.
   Haro Durand, Luis A.
   Cadena, Vanesa
   Romero, Marcela
   Vera Mesones, Rosa
   Mackovic, Mirza
   Spallek, Stefanie
   Spiecker, Erdmann
   Boccaccini, Aldo R.
   Gorustovich, Alejandro A.
TI Effect of nano-sized bioactive glass particles on the angiogenic
   properties of collagen based composites
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID QUAIL CHORIOALLANTOIC MEMBRANE; GROWTH-FACTOR; IN-VITRO; COVALENT
   INCORPORATION; PROMOTES ANGIOGENESIS; TISSUE REGENERATION; SCAFFOLDS;
   MATRICES; VEGF; VIVO
AB Angiogenesis is essential for tissue regeneration and repair. A growing body of evidence shows that the use of bioactive glasses (BG) in biomaterial-based tissue engineering (TE) strategies may improve angiogenesis and induce increased vascularization in TE constructs. This work investigated the effect of adding nano-sized BG particles (n-BG) on the angiogenic properties of bovine type I collagen/n-BG composites. Nano-sized (20-30 nm) BG particles of nominally 45S5 Bioglass(A (R)) composition were used to prepare composite films, which were characterized by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The in vivo angiogenic response was evaluated using the quail chorioallantoic membrane (CAM) as an model of angiogenesis. At 24 h post-implantation, 10 wt% n-BG containing collagen films stimulated angiogenesis by increasing by 41 % the number of blood vessels branch points. In contrast, composite films containing 20 wt% n-BG were found to inhibit angiogenesis. This experimental study provides the first evidence that addition of a limited concentration of n-BG (10 wt%) to collagen films induces an early angiogenic response making selected collagen/n-BG composites attractive matrices for tissue engineering and regenerative medicine.
C1 [Vargas, Gabriela E.; Haro Durand, Luis A.; Cadena, Vanesa; Gorustovich, Alejandro A.] INTECIN UBA CONICET, Interdisciplinary Mat Grp IESIING UCASAL, Salta, Argentina.
   [Vargas, Gabriela E.; Cadena, Vanesa; Romero, Marcela; Vera Mesones, Rosa] Natl Univ Salta, Sch Nat Sci, Salta, Argentina.
   [Mackovic, Mirza; Spallek, Stefanie; Spiecker, Erdmann; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
   [Mackovic, Mirza; Spallek, Stefanie; Spiecker, Erdmann] Univ Erlangen Nurnberg, Ctr Nanoanal & Electron Microscopy CENEM, D-91058 Erlangen, Germany.
RP Gorustovich, AA (reprint author), INTECIN UBA CONICET, Interdisciplinary Mat Grp IESIING UCASAL, A4400EDD, Salta, Argentina.
EM agorustovich@gmail.com
RI Spiecker, Erdmann/B-3902-2017; Boccaccini, Aldo/C-7905-2013
FU National Research Council of Argentina [PIP CONICET 0184]; German
   research council (Deutsche Forschungsgemeinschaft, DFG)
FX This study was supported by the National Research Council of Argentina
   (Grant PIP CONICET 0184 to A. A. G.). The authors thank the German
   research council (Deutsche Forschungsgemeinschaft, DFG) for partial
   financial support of this work.
CR Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389
   Baiguera S, 2012, J BIOMED MATER RES B, V100B, P1425, DOI 10.1002/jbm.b.32653
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332
   Brooks PC, 1999, METH MOL B, V129, P257
   Brunner TJ, 2006, CHEM COMMUN, P1384, DOI 10.1039/b517501a
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   Dorj B, 2012, MATER LETT, V73, P119, DOI 10.1016/j.matlet.2011.12.107
   Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gonzalez-Iriarte Mauricio, 2003, Angiogenesis, V6, P251, DOI 10.1023/B:AGEN.0000021388.59617.6b
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Grieb G, 2010, CELLS TISSUES ORGANS, V191, P96, DOI 10.1159/000231473
   Haag J, 2012, BIOMATERIALS, V33, P780, DOI 10.1016/j.biomaterials.2011.10.008
   Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100
   Hong SJ, 2010, J BIOMATER APPL, V24, P733, DOI 10.1177/0885328209338956
   Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Irvine SM, 2011, BIOMATERIALS, V32, P6351, DOI 10.1016/j.biomaterials.2011.05.040
   Joo NY, 2012, ACTA BIOMATER, V8, P1802, DOI 10.1016/j.actbio.2012.01.026
   Keshaw H, 2010, ACTA BIOMATER, V6, P1158, DOI 10.1016/j.actbio.2009.08.044
   Ko YG, 2010, J BIOACT COMPAT POL, V25, P360, DOI 10.1177/0883911510370002
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Lazarovici P, 2006, ENDOTHELIUM-J ENDOTH, V13, P51, DOI 10.1080/10623320600669053
   Leu A, 2008, PHARM RES, V25, P1222, DOI 10.1007/s11095-007-9508-9
   Liao S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025019
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Marelli B, 2011, BIOMATERIALS, V32, P8915, DOI 10.1016/j.biomaterials.2011.08.016
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Misra SK, 2010, J R SOC INTERFACE, V7, P453, DOI 10.1098/rsif.2009.0255
   Oates M, 2007, BIOMATERIALS, V28, P3679, DOI 10.1016/j.biomaterials.2007.04.042
   Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Parsons-Wingerter P, 1998, MICROVASC RES, V55, P201, DOI 10.1006/mvre.1998.2073
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Ribatti D, 2012, METHODS MOL BIOL, V843, P47, DOI 10.1007/978-1-61779-523-7_5
   Saito A, 2012, ACTA BIOMATER, V8, P2932, DOI 10.1016/j.actbio.2012.04.019
   Sharma AK, 2012, J BIOMED MATER RES A, V100A, P561, DOI 10.1002/jbm.a.33306
   Silva SS, 2010, CRIT REV BIOTECHNOL, V30, P200, DOI 10.3109/07388551.2010.505561
   Singh S, 2012, J BIOMED MATER RES A, V100A, P720, DOI 10.1002/jbm.a.34010
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Vila OF, 2013, J BIOMED MATER RES A, V101, P932, DOI 10.1002/jbm.a.34391
   VILLIGER W, 1990, J STRUCT BIOL, V104, P178, DOI 10.1016/1047-8477(90)90074-M
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Walton RS, 2010, J MATER SCI-MATER M, V21, P451, DOI 10.1007/s10856-009-3910-2
   Wu CT, 2011, ACTA BIOMATER, V7, P2229, DOI 10.1016/j.actbio.2010.12.019
   Yao C, 2008, BIOMATERIALS, V29, P66, DOI 10.1016/j.biomaterials.2007.08.049
NR 50
TC 28
Z9 29
U1 0
U2 46
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2013
VL 24
IS 5
BP 1261
EP 1269
DI 10.1007/s10856-013-4892-7
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 138LN
UT WOS:000318510200014
PM 23430337
DA 2018-10-20
ER

PT J
AU Qu, FN
   Lin, JMG
   Esterhai, JL
   Fisher, MB
   Mauck, RL
AF Qu, Feini
   Lin, Jung-Ming G.
   Esterhai, John L.
   Fisher, Matthew B.
   Mauck, Robert L.
TI Biomaterial-mediated delivery of degradative enzymes to improve meniscus
   integration and repair
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Drug delivery; Enzyme; Meniscus tear; Nanofibrous scaffold; Wound
   healing
ID GROWTH-FACTOR; IN-VITRO; ARTICULAR-CARTILAGE; ENZYMATIC TREATMENT;
   CELL-MIGRATION; FETAL SHEEP; KNEE-JOINT; MODEL; TRANSPLANTATION;
   SCAFFOLDS
AB Endogenous repair of fibrous connective tissues is limited, and there exist few successful strategies to improve healing after injury. As such, new methods that advance repair by promoting cell growth, extracellular matrix (ECM) production, and tissue integration would represent a marked clinical advance. Using the meniscus as a test platform, we sought to develop an enzyme-releasing scaffold that enhances integrative repair. We hypothesized that the high ECM density and low cellularity of native tissue present physical and biological barriers to endogenous healing, and that localized collagenase treatment might expedite cell migration to the wound edge and tissue remodeling. To test this hypothesis, we fabricated a delivery system in which collagenase was stored inside electrospun poly(ethylene oxide) (PEO) nanofibers and released upon hydration. In vitro results showed that partial digestion of the wound interface improved repair by creating a microenvironment that facilitated cell migration, proliferation and matrix deposition. Specifically, treatment with high-dose collagenase led to a 2-fold increase in cell density at the wound margin and a 2-fold increase in integrative tissue compared to untreated controls at 4 weeks (P <= 0.05). Furthermore, when composite scaffolds containing both collagenase-releasing and structural fiber fractions were placed inside meniscal tears in vitro, enzyme release acted locally and resulted in a positive cellular response similar to that of global treatment with aqueous collagenase. This innovative approach to targeted enzyme delivery may aid the many patients that exhibit meniscal tears by promoting integration of the defect, thereby circumventing the pathologic consequences of partial meniscus removal, and may find widespread application in the treatment of injuries to a variety of dense connective tissues. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Qu, Feini; Lin, Jung-Ming G.; Esterhai, John L.; Fisher, Matthew B.; Mauck, Robert L.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA.
   [Qu, Feini; Lin, Jung-Ming G.; Mauck, Robert L.] Univ Penn, Dept Bioengn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA.
   [Qu, Feini; Esterhai, John L.; Fisher, Matthew B.; Mauck, Robert L.] Philadelphia Vet Adm Med Ctr, Philadelphia, PA 19104 USA.
   [Qu, Feini] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.
RP Mauck, RL (reprint author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, 36th St & Hamilton Walk, Philadelphia, PA 19104 USA.
EM lemauck@mail.med.upenn.edu
RI Fisher, Matthew/M-5809-2016
OI Fisher, Matthew/0000-0002-3212-0870; Mauck, Robert/0000-0002-9537-603X
FU National Institutes of Health [R01 AR056624, MSTP T32 GM007170];
   Department of Veterans Affairs [I01 RX000174]; Penn Center for
   Musculoskeletal Disorders; Institute for Regenerative Medicine at the
   University of Pennsylvania; Musculoskeletal Transplant Foundation;
   Armour-Lewis Foundation; School of Veterinary Medicine at the University
   of Pennsylvania
FX This work was supported by the National Institutes of Health (R01
   AR056624 and MSTP T32 GM007170), the Department of Veterans Affairs (I01
   RX000174), the Penn Center for Musculoskeletal Disorders, and the
   Institute for Regenerative Medicine at the University of Pennsylvania.
   Additional funding was provided by the Musculoskeletal Transplant
   Foundation, the Armour-Lewis Foundation, and the School of Veterinary
   Medicine at the University of Pennsylvania. The views expressed in this
   article are those of the authors and do not necessarily reflect the
   position or policy of the National Institutes of Health, Department of
   Veterans Affairs, or the US government.
CR Aagaard H, 1999, SCAND J MED SCI SPOR, V9, P134
   ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931
   Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216
   CLARK CR, 1983, J BONE JOINT SURG AM, V65, P538, DOI 10.2106/00004623-198365040-00018
   D'Andrea MR, 2004, BIOTECH HISTOCHEM, V79, P55, DOI 10.1080/10520290410001728972
   DiMicco MA, 2002, OSTEOARTHR CARTILAGE, V10, P218, DOI 10.1053/joca.2001.0502
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Englund Martin, 2004, Acta Orthop Scand Suppl, V75, P1
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271
   FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19
   Hong Y, 2008, BIOMACROMOLECULES, V9, P1200, DOI 10.1021/bm701201w
   Ionescu LC, 2011, TISSUE ENG PT A, V17, P193, DOI [10.1089/ten.tea.2010.0272, 10.1089/ten.TEA.2010.0272]
   Ionescu LC, 2013, TISSUE ENG PT A, V19, P538, DOI [10.1089/ten.tea.2012.0052, 10.1089/ten.TEA.2012.0052]
   Ionescu LC, 2012, ACTA BIOMATER, V8, P3687, DOI 10.1016/j.actbio.2012.06.005
   Ionescu LC, 2012, ORTH RES SOC ANN M
   Janssen LM, 2006, ANN OTO RHINOL LARYN, V115, P461, DOI 10.1177/000348940611500611
   Kawamura S, 2003, OPER TECHN SPORT MED, V11, P68, DOI 10.1053/otsm.2003.35899
   Khetia EA, 2007, SPORTS MED ARTHROSC, V15, P114, DOI 10.1097/JSA.0b013e3180dca217
   Klompmaker Jan, 1993, Clinical Materials, V14, P1, DOI 10.1016/0267-6605(93)90041-5
   lonescu L. C., 2010, BIOMATERIALS, V31, P4113
   Maher SA, 2010, ARTHROSCOPY, V26, P1510, DOI 10.1016/j.arthro.2010.02.033
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Martinek V, 2006, ARCH ORTHOP TRAUM SU, V126, P228, DOI 10.1007/s00402-005-0025-1
   McCarty EC, 2002, CLIN ORTHOP RELAT R, P122, DOI 10.1097/01.blo.0000026963.51742.d0
   McNulty AL, 2007, ARTHRITIS RHEUM, V56, P3033, DOI 10.1002/art.22839
   Natoli RM, 2009, J ORTHOP RES, V27, P949, DOI 10.1002/jor.20821
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Ochi M, 1996, ARCH ORTHOP TRAUM SU, V115, P123, DOI 10.1007/BF00434537
   Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023
   Petersen W, 2007, ARCH ORTHOP TRAUM SU, V127, P235, DOI 10.1007/s00402-005-0024-2
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Provenzano PP, 2002, J ORTHOPAED RES, V20, P975, DOI 10.1016/S0736-0266(02)00036-0
   Rubman MH, 1998, AM J SPORT MED, V26, P87, DOI 10.1177/03635465980260013301
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Shi L, 2010, INT WOUND J, V7, P87, DOI 10.1111/j.1742-481X.2010.00659.x
   SMITH DJ, 2004, Patent No. 6821479
   Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430
   Tu K, 2003, OPER TECHN SPORT MED, V11, P127, DOI 10.1053/otsm.2003.35904
   Tumia NS, 2009, KNEE, V16, P73, DOI 10.1016/j.knee.2008.08.008
   Tumia NS, 2004, AM J SPORT MED, V32, P915, DOI 10.1177/0363546503261710
   Ye L, 2011, J BIOMAT SCI-POLYM E, V22, P389, DOI 10.1163/092050610X487710
   ZHANG ZN, 1995, AM J SPORT MED, V23, P35
NR 47
TC 24
Z9 24
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2013
VL 9
IS 5
BP 6393
EP 6402
DI 10.1016/j.actbio.2013.01.016
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134GY
UT WOS:000318199600009
PM 23376132
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Binazadeh, M
   Zeng, H
   Unsworth, LD
AF Binazadeh, M.
   Zeng, H.
   Unsworth, L. D.
TI Effect of peptide secondary structure on adsorption and adsorbed film
   properties
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Non-specific protein adsorption; Secondary structure; Poly-L-lysine;
   Circular dichroism; Quartz crystal microbalance with dissipation
ID POLY-L-LYSINE; QUARTZ-CRYSTAL-MICROBALANCE; BETA-SHEET CONFORMATIONS;
   MODEL-DRUG MACROMOLECULE; PROTEIN ADSORPTION; ALPHA-HELIX;
   CIRCULAR-DICHROISM; SURFACE-CHEMISTRY; IONIC-STRENGTH; POLYELECTROLYTE
   MULTILAYERS
AB Protein adsorption at the biomaterial-tissue interface is of utmost importance to the widespread application of engineered materials. The present study asked what role the secondary structures of peptides play in their adsorption, as well as how these structures affect the physicochemical properties of the final adsorbed layer. To this end, alpha-helices and beta-sheets were induced in poly-L-lysine, and their adsorption to Au surfaces was monitored using quartz crystal microbalance with dissipation. It was observed that secondary structures played an important role in governing both the adsorption process and the final film properties. Higher initial adsorption rates were obtained for alpha-helices compared with beta-sheets, regardless of solution salt concentration. Adsorption half-time for beta-sheets was greater than that for alpha-helices, and the final amount adsorbed on beta-sheet was significantly higher than that on alpha-helix. The adsorbed amount and adsorption half-time decreased with increasing salt concentration, suggesting that electrostatic interactions played a role. It was found that the differences in Zeta potential coupled with the apparent effect of surface contact area differences between alpha-helix and beta-sheet conformations are ultimately responsible for these different peptide adsorption behaviours at the Au interface. The initial adsorption rate of alpha-helix increased with salt concentrations up to 50 mM, whereas beta-sheet initial adsorption rates increased with salt concentrations up to 500 mM. Viscosities for films formed from alpha-helices were about twice those of beta-sheets films, regardless of solution ionic strength. It was evident that the peptide secondary structures influence all aspects of their adsorption, as well as affecting the adsorbed film properties. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Binazadeh, M.; Zeng, H.; Unsworth, L. D.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
   [Unsworth, L. D.] Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada.
RP Zeng, H (reprint author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
EM hongbo.zeng@ualberta.ca; lunswort@ualberta.ca
RI Zeng, Hongbo/C-8491-2011
OI Zeng, Hongbo/0000-0002-1432-5979
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
FX This work was supported by the Natural Sciences and Engineering Research
   Council of Canada (NSERC).
CR ABSOLOM DR, 1983, T AM SOC ART INT ORG, V29, P146
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   ANDREWS DW, 1982, ULTRAMICROSCOPY, V9, P337, DOI 10.1016/0304-3991(82)90094-8
   Arunkumar AI, 1997, INT J BIOL MACROMOL, V21, P299, DOI 10.1016/S0141-8130(97)00065-2
   Ball V, 2004, COLLOID SURFACE B, V33, P129, DOI 10.1016/j.colsurfb.2003.09.006
   BONEKAMP BC, 1989, COLLOID SURFACE, V41, P267, DOI 10.1016/0166-6622(89)80058-7
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   CHIOU JS, 1992, BIOCHIM BIOPHYS ACTA, V1119, P211, DOI 10.1016/0167-4838(92)90394-S
   Chittchang M, 2002, J PHARM PHARMACOL, V54, P315, DOI 10.1211/0022357021778556
   Chittchang M, 2002, J PHARM PHARMACOL, V54, P1497, DOI 10.1211/002235702108
   Chittchang M, 2007, PHARM RES, V24, P502, DOI 10.1007/s11095-006-9166-3
   Cocinero EJ, 2009, J AM CHEM SOC, V131, P1282, DOI 10.1021/ja808687j
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   CORREIA RJ, 1981, J CHEM ENG DATA, V26, P43, DOI 10.1021/je00023a015
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   de Kerchove AJ, 2006, MACROMOLECULES, V39, P6558, DOI 10.1021/ma0527606
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Demirdoven N, 2004, J AM CHEM SOC, V126, P7981, DOI 10.1021/ja049811j
   Drotleff S, 2006, POLYM PROTEIN CONJUG
   Dutta AK, 2007, LANGMUIR, V23, P3088, DOI 10.1021/la0624743
   ELGERSMA AV, 1992, COLLOID SURFACE, V65, P17, DOI 10.1016/0166-6622(92)80171-W
   Evans-Nguyen KM, 2006, LANGMUIR, V22, P5115, DOI 10.1021/la053070y
   FUKUSHIMA K, 1994, BBA-BIOMEMBRANES, V1191, P133, DOI 10.1016/0005-2736(94)90240-2
   Giesbers M, 2002, J COLLOID INTERF SCI, V248, P88, DOI 10.1006/jcis.2001.8144
   Gong Ping, 2007, V381, P59
   Green D. W., 2008, PERRYS CHEM ENG HDB, p[2, 2]
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Grigsby JJ, 2002, BIOPHYS CHEM, V99, P107, DOI 10.1016/S0301-4622(02)00138-2
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Jordan CE, 1997, ANAL CHEM, V69, P1449, DOI 10.1021/ac961012z
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KAISER ET, 1983, P NATL ACAD SCI USA, V80, P1137, DOI 10.1073/pnas.80.4.1137
   Kristiansen K, 2011, ADV FUNCT MATER, V21, P4555, DOI 10.1002/adfm.201101478
   Liu SX, 2009, JALA-J ASSOC LAB AUT, V14, P213, DOI 10.1016/j.jala.2009.01.003
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Martin J., 2005, INT S APPL STOCH MOD
   Meder F, 2012, ACTA BIOMATER, V8, P1221, DOI 10.1016/j.actbio.2011.09.014
   Miles AJ, 2005, PROTEIN SCI, V14, P368, DOI 10.1110/ps.041019905
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   Notley SM, 2005, J COLLOID INTERF SCI, V292, P29, DOI 10.1016/j.jcis.2005.05.057
   Ogi H, 2011, ANAL CHEM, V83, P4982, DOI 10.1021/ac2007703
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   Parson W. W., 2009, MODERN OPTICAL SPECT
   Putnam C., PROTEIN CALCULATOR V
   Ramsden J. J., 2003, BIOPOLYMERS INTERFAC
   RAMSDEN JJ, 1994, J PHYS CHEM-US, V98, P5376, DOI 10.1021/j100071a031
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   SHIBATA A, 1992, BIOCHEMISTRY-US, V31, P5728, DOI 10.1021/bi00140a006
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   SMITH T, 1980, J COLLOID INTERF SCI, V75, P51, DOI 10.1016/0021-9797(80)90348-3
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   TIFFANY ML, 1975, PHYSIOL CHEM PHYS M, V7, P191
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Van Oss C. J., 1994, INTERFACIAL FORCES A
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072
   Wang D, 2009, J COLLOID INTERF SCI, V331, P90, DOI 10.1016/j.jcis.2008.11.010
   Weber N, 2005, J BIOMED MATER RES A, V72A, P420, DOI 10.1002/jbm.a.30272
   Wells SA, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046005
   Wolkers WF, 1998, BBA-GEN SUBJECTS, V1425, P127, DOI 10.1016/S0304-4165(98)00059-2
   Wong SY, 2012, BIOMACROMOLECULES, V13, P719, DOI 10.1021/bm201637e
   Yan MQ, 2011, LANGMUIR, V27, P9860, DOI 10.1021/la1042102
   Yang Q, 2010, LANGMUIR, V26, P5746, DOI 10.1021/la903895q
NR 69
TC 6
Z9 6
U1 1
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2013
VL 9
IS 5
BP 6403
EP 6413
DI 10.1016/j.actbio.2013.01.018
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134GY
UT WOS:000318199600010
PM 23376129
DA 2018-10-20
ER

PT J
AU Wong, ML
   Wong, JL
   Athanasiou, KA
   Griffiths, LG
AF Wong, Maelene L.
   Wong, Janelle L.
   Athanasiou, Kyriacos A.
   Griffiths, Leigh G.
TI Stepwise solubilization-based antigen removal for xenogeneic scaffold
   generation in tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Antigen removal; Xenogeneic scaffold; Decellularization; Extracellular
   matrix; Heart valve tissue engineering
ID 2-DIMENSIONAL GEL-ELECTROPHORESIS; BOVINE PERICARDIUM;
   MEMBRANE-PROTEINS; CELLULAR LOCATION; AMINO ACIDS; VALVE; HEART;
   DECELLULARIZATION; XENOTRANSPLANTATION; EXTRACTION
AB The ability of residual antigens on decellularized tissue to elicit the immune response upon implantation motivates development of a more rigorous antigen removal (AR) process for xenogeneic scaffold generation. Antigen removal strategies promoting solubilization of hydrophilic proteins (predominantly cytoplasmic) enhance the reduction of hydrophilic antigenicity in bovine pericardium (BP); however, the diversity of protein antigens within a tissue necessitates development of AR strategies capable of addressing a spectrum of protein antigen solubilities. In the present study, methods for promoting solubilization of lipophilic proteins (predominantly membrane) were investigated for their ability to reduce lipophilic antigenicity of BP when applied as a second AR step following our previously described hydrophilic AR method. Bovine pericardium following AR (BP-AR) was assessed for residual hydrophilic and lipophilic antigenicity, removal of known lipophilic xenoantigens, tensile properties, and extracellular matrix structure and composition. Facilitating hydrophile solubilization (using dithiothreitol and potassium chloride) followed by lipophile solubilization (using amidosulfobetaine-14 (ASB-14)), in a two-step sequential, differential AR strategy, significantly reduces residual hydrophilic and lipophilic antigenicity of BP-AR beyond that achieved with either one-step hydrophilic AR or decellularization using 1% (w/v) sodium dodecyl sulfate. Moreover, use of 1% (w/v) ASB-14 for lipophilic AR eliminates the two most critical known barriers to xenotransplantation (galactose-alpha(1,3)-galactose and major histocompatibility complex I)) from BP-AR without compromising the structure-function properties of the biomaterial. This study demonstrates the importance of a sequential, differential protein solubilization approach to reduce biomaterial antigenicity in the production of a xenogeneic scaffold for heart valve tissue engineering. Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Wong, Maelene L.; Wong, Janelle L.; Griffiths, Leigh G.] Univ Calif Davis, Dept Vet Med Med & Epidemiol, Davis, CA 95616 USA.
   [Wong, Maelene L.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
RP Griffiths, LG (reprint author), Univ Calif Davis, Dept Vet Med Med & Epidemiol, 1 Shields Ave, Davis, CA 95616 USA.
EM lggriffiths@ucdavis.edu
FU American Heart Association [11SDG4980023]; Meadowview Foundation
FX The authors would like to acknowledge funding from the American Heart
   Association (11SDG4980023, L.G.G.) and philanthropic support from the
   Meadowview Foundation. Additionally, the authors would like to thank the
   laboratory of Dr. Clare E. Yellowley for use of their facilities.
CR BEERS MF, 1992, AM J PHYSIOL, V262, pL773
   Cascalho M, 2001, IMMUNITY, V14, P437, DOI 10.1016/S1074-7613(01)00124-8
   Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x
   Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804
   Cordwell SJ, 2000, ELECTROPHORESIS, V21, P1094, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1094::AID-ELPS1094>3.3.CO;2-S
   Cordwell Stuart J., 2008, V424, P139, DOI 10.1007/978-1-60327-064-9_12
   FRANK HS, 1968, J CHEM PHYS, V48, P4746, DOI 10.1063/1.1668057
   Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goldstein S, 2000, ANN THORAC SURG, V70, P1962, DOI 10.1016/S0003-4975(00)01812-9
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   GORDON JA, 1963, BIOCHEMISTRY-US, V2, P47, DOI 10.1021/bi00901a011
   Griffiths LG, 2008, BIOMATERIALS, V29, P3514, DOI 10.1016/j.biomaterials.2008.05.006
   Griffiths LG, 2008, ELECTROPHORESIS, V29, P4508, DOI 10.1002/elps.200800108
   HENRIQUEZ M, 1994, MACROMOLECULES, V27, P6834, DOI 10.1021/ma00101a023
   Hua L, 2008, P NATL ACAD SCI USA, V105, P16928, DOI 10.1073/pnas.0808427105
   Iwai S, 2007, J ARTIF ORGANS, V10, P29, DOI 10.1007/s10047-006-0360-1
   Krejci J., 2007, International Journal of Cosmetic Science, V29, P121, DOI 10.1111/j.1467-2494.2007.00368.x
   le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1
   Lehner I, 2003, ELECTROPHORESIS, V24, P1795, DOI 10.1002/elps.200305387
   LEIMGRUBER RM, 2005, PROTEOMICS PROTOCOLS, P1, DOI DOI 10.1385/1-59259-890-0:001
   Meyer SR, 2006, J BIOMED MATER RES A, V79A, P254, DOI 10.1002/jbm.a.30777
   Molloy MP, 1998, ELECTROPHORESIS, V19, P837, DOI 10.1002/elps.1150190539
   Nagy JM, 2011, SAMPLE PREPARATION IN BIOLOGICAL MASS SPECTROMETRY, P41, DOI 10.1007/978-94-007-0828-0_3
   National Research Council, 1996, GUIDE CARE USE LAB A
   NOZAKI Y, 1971, J BIOL CHEM, V246, P2211
   NOZAKI Y, 1963, J BIOL CHEM, V238, P4074
   Platt J, 2002, CIRCULATION, V106, P1043, DOI 10.1161/01.CIR.0000031064.67525.28
   RAMSBY ML, 1994, ELECTROPHORESIS, V15, P265, DOI 10.1002/elps.1150150146
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Vesely I, 1998, J BIOMECH, V31, P115
   Wilson R, 2008, MATRIX BIOL, V27, P709, DOI 10.1016/j.matbio.2008.07.007
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030
   Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099
   Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088
NR 37
TC 30
Z9 30
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2013
VL 9
IS 5
BP 6492
EP 6501
DI 10.1016/j.actbio.2012.12.034
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134GY
UT WOS:000318199600019
PM 23321301
DA 2018-10-20
ER

PT J
AU van Putten, SM
   Ploeger, DTA
   Popa, ER
   Bank, RA
AF van Putten, Sander M.
   Ploeger, Diana T. A.
   Popa, Eliane R.
   Bank, Ruud A.
TI Macrophage phenotypes in the collagen-induced foreign body reaction in
   rats
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Foreign body response; Rat; Macrophage phenotypes; Inflammation;
   Collagen
ID DERMAL SHEEP COLLAGEN; BIODEGRADABLE BIOMATERIAL; IFN-GAMMA; ACTIVATION;
   EXPRESSION; CELLS; MICE; POLARIZATION; CYTOKINE; DYNAMICS
AB Implantation of biomaterials into the body elicits a material-dependent inflammatory response called the foreign body reaction (FBR). Macrophages play a pivotal role in the FBR by orchestrating the pro-inflammatory microenvironment around the biomaterials by secreting cytokines, chemokines and growth factors. When the biomaterial is porous or degradable, macrophages can migrate into the material and continue the generation of a pro-inflammatory microenvironment inside the materials. They also regulate the degradation of biomaterials by secreting proteolytic enzymes and by phagocytosis. We hypothesize that macrophages present in the different microenvironments of the FBR have different phenotypes. Fundamental knowledge of the phenotypes of macrophages and their dynamics during the FBR will contribute to our overall understanding of the mechanisms involved in the FBR, and may provide us with additional tools to modulate the FBR. To investigate the phenotype of macrophages in the FBR, we validated phenotype-specific markers for rat macrophages in vitro by stimulating them with IFN gamma/LPS, IL4/IL13 or IL4/dexamethasone to induce classically activated macrophages (M1 phi) or alternatively activated macrophages (M2 phi). Gene expression analysis, Western blot and immunohistochemistry revealed that iNOS and CD206 are specifically expressed by M1 phi and M2 phi, respectively. Using these markers, we investigated the distribution of M1 phi and M2 phi in the FBR induced by subcutaneously implanted hexamethylenediisocyanate cross-linked dermal sheep collagen (HDSC) disks in AO rats. We found that part of the macrophages display an M2 phenotype, whereas the M1 phenotype was not detected. Our data suggest that many macrophages in the FBR induced by HDSC do not fit into the classical M1 or M2 dichotomy. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [van Putten, Sander M.; Ploeger, Diana T. A.; Popa, Eliane R.; Bank, Ruud A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands.
RP van Putten, SM (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
EM S.M.van.Putten@umcg.nl
OI Ploeger, Diana/0000-0002-8195-1187
FU Dutch Program for Tissue Engineering (DPTE) [6731]; Netherlands
   Institute for Regenerative Medicine (NIRM) [FES0908]
FX This work was supported by the Dutch Program for Tissue Engineering
   (DPTE, Project No. 6731), and the Netherlands Institute for Regenerative
   Medicine (NIRM, Grant No. FES0908).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bartneck M, 2010, ACTA BIOMATER, V6, P3864, DOI 10.1016/j.actbio.2010.04.025
   BEISKER W, 1987, CYTOMETRY, V8, P235, DOI 10.1002/cyto.990080218
   Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006
   Boersema M, 2009, TRANSPLANTATION, V88, P1386, DOI 10.1097/TP.0b013e3181bca1e4
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Daley JM, 2009, J LEUKOCYTE BIOL, V87, P59
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   GOERDT S, 1993, AM J PATHOL, V142, P1409
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017
   Jones JA, 2007, J BIOMED MATER RES, V84, P158
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Khouw IMSL, 2000, J BIOMED MATER RES, V49, P297, DOI 10.1002/(SICI)1097-4636(20000305)49:3<297::AID-JBM1>3.0.CO;2-0
   Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006
   Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230
   Luttikhuizen DT, 2007, J BIOMED MATER RES A, V83A, P879, DOI 10.1002/jbm.a.31420
   Luttikhuizen DT, 2007, J TISSUE ENG REGEN M, V1, P398, DOI 10.1002/term.50
   Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910
   Mueller CK, 2011, INT J ORAL MAX SURG, V40, P401, DOI 10.1016/j.ijom.2010.10.025
   Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409
   Ploeger DTA, 2012, IMMUNOBIOLOGY, V217, P299, DOI 10.1016/j.imbio.2011.10.007
   Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155
   Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561
   Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212
   Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150
   Stout RD, 2010, J LEUKOCYTE BIOL, V87, P19, DOI 10.1189/jlb.0509311
   Tolosa JM, 2007, BIOTECHNIQUES, V43, P799, DOI 10.2144/000112594
   van Putten SM, 2009, BIOMATERIALS, V30, P730, DOI 10.1016/j.biomaterials.2008.10.043
   van Putten SM, 2011, J BIOMED MATER RES A, V98A, P527, DOI 10.1002/jbm.a.33144
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
NR 38
TC 38
Z9 38
U1 2
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2013
VL 9
IS 5
BP 6502
EP 6510
DI 10.1016/j.actbio.2013.01.022
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134GY
UT WOS:000318199600020
PM 23376130
DA 2018-10-20
ER

PT J
AU Torres, AL
   Santos, SG
   Oliveira, MI
   Barbosa, MA
AF Torres, A. L.
   Santos, S. G.
   Oliveira, M. I.
   Barbosa, M. A.
TI Fibrinogen promotes resorption of chitosan by human osteoclasts
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Osteoclasts; Chitosan; Fibrinogen; Biomaterial resorption; Regeneration
ID RESISTANT ACID-PHOSPHATASE; HUMAN OSTEOBLASTIC CELLS; FORMED IN-VITRO;
   CATHEPSIN-K; TARTRATE-RESISTANT; BONE-RESORPTION; POLYELECTROLYTE
   COMPLEXES; EXTRACELLULAR-MATRIX; ALGINATE HYDROGELS; GROWTH-FACTOR
AB The osteoconductive and osteoinductive properties of materials intended for bone regeneration have been extensively tested, but the resorbability of these materials is often overlooked. Osteoclasts are responsible for bone resorption and play a crucial role in bone remodeling, which is essential for complete regeneration of bone tissue following injury. In this study we compare, for the first time, the ability of unmodified and fibrinogen (Fg)-modified chitosan (Ch) substrates to support the formation of multinucleated osteoclasts, and the potential of these cells to resorb the two substrates in vitro. Osteoclasts were differentiated from primary human peripheral blood monocytes directly on the substrates being investigated. Our results showed similar cell adhesion to unmodified and Fg-modified Ch substrates. Although the number of multinucleated osteoclasts on both Ch substrates increased throughout the culture period, by 21 days of culture significantly more highly multinucleated osteoclasts (>10 nuclei per cell) were observed on Fg-modified Ch, when compared to Ch alone. In addition, cells were tartrate-resistant acid phosphatase positive and secreted significantly more enzyme on Ch-based substrates than in control conditions. Unmodified and Fg-modified Ch resorption was investigated by fluorescence microscopy and confirmed by electron microscopy. Quantification of results obtained by fluorescence microscopy shows that Fg modification led to significantly higher substrate resorption by 17 days of culture. Our results show that osteoclasts, beyond resorbing mineralized substrates, successfully resorb a polymeric substrate (Ch), with Fg accelerating this process. Thus, in bone tissue regeneration strategies employing polymeric biomaterials, resorption may depend not only on macrophages, but also on osteoclasts. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Torres, A. L.; Santos, S. G.; Oliveira, M. I.; Barbosa, M. A.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Torres, A. L.] Univ Porto, Fac Engn, P-4150180 Oporto, Portugal.
   [Barbosa, M. A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4150180 Oporto, Portugal.
RP Santos, SG (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM susana.santos@ineb.up.pt
RI Torres, Ana Luisa/D-3983-2014; Oliveira, Marta/M-9386-2013; Santos,
   Susana/L-9351-2013; Barbosa, Mario/F-5964-2011
OI Torres, Ana Luisa/0000-0003-1338-8625; Oliveira,
   Marta/0000-0002-0578-9202; Santos, Susana/0000-0002-8604-2978; Barbosa,
   Mario/0000-0003-3568-7482
FU FEDER funds through the Programa Operacional Factores de
   Competitividade-COMPETE; FCT-Fundacao para a Ciencia e a Tecnologia
   [PEst-C/SAU/LA0002/2011, PTDC/SAU-BEB/099954/2008]; FCT-POPH
   [SFRH/BPD/37090/2007]; FCT-POPH-FSE
FX The authors would like to thank Instituto Portugues do Sangue, for
   kindly donating the buffy coats. This work was financed by FEDER funds
   through the Programa Operacional Factores de Competitividade-COMPETE and
   by Portuguese funds through FCT-Fundacao para a Ciencia e a Tecnologia
   in the framework of the projects PEst-C/SAU/LA0002/2011 and
   PTDC/SAU-BEB/099954/2008. M.I.O. is recipient of a post-doctoral
   fellowship from FCT-POPH (SFRH/BPD/37090/2007). S.G.S. has a research
   position funded by FCT-POPH-FSE (Ciencia 2007).
CR Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599
   Almeida CR, 2012, J R SOC INTERFACE, V9, P261, DOI 10.1098/rsif.2011.0357
   Amaral IF, 2007, J BIOMAT SCI-POLYM E, V18, P469, DOI 10.1163/156856207780425068
   Amaral IF, 2006, J BIOMED MATER RES A, V76A, P335, DOI 10.1002/jbm.a.30522
   Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Antunes JC, 2011, BIOMACROMOLECULES, V12, P4183, DOI 10.1021/bm2008235
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Balasundaram G, 2007, MACROMOL BIOSCI, V7, P635, DOI 10.1002/mabi.200600270
   Blair HC, 1998, BIOESSAYS, V20, P837, DOI 10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.3.CO;2-4
   BOYDE A, 1984, BRIT DENT J, V156, P216, DOI 10.1038/sj.bdj.4805313
   Chambers TJ, 2011, ANN NY ACAD SCI, V1240, P1, DOI 10.1111/j.1749-6632.2011.06249.x
   CHAMBERS TJ, 1985, J CELL SCI, V76, P155
   Chen CL, 2008, BIOMATERIALS, V29, P2173, DOI 10.1016/j.biomaterials.2008.01.023
   Cunha-Reis C, 2013, J TISSUE ENG REGEN M, V7, P39, DOI 10.1002/term.494
   Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691
   EKRYLANDER B, 1991, J BIOL CHEM, V266, P24684
   Fuller K, 2010, PLOS ONE, V5
   Fuller K, 2008, BONE, V42, P200, DOI 10.1016/j.bone.2007.09.044
   Goncalves IC, 2009, J BIOMED MATER RES A, V89A, P642, DOI 10.1002/jbm.a.32011
   Goncalves RM, 2009, BIOMATERIALS, V30, P6879, DOI 10.1016/j.biomaterials.2009.09.010
   Gorzelanny C, 2010, BIOMATERIALS, V31, P8556, DOI 10.1016/j.biomaterials.2010.07.100
   Halleen JM, 2003, J BONE MINER RES, V18, P1908, DOI 10.1359/jbmr.2003.18.10.1908
   Heinemann C, 2010, EUR CELLS MATER, V19, P96, DOI 10.22203/eCM.v019a10
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Holliday LS, 1997, J BIOL CHEM, V272, P22053, DOI 10.1074/jbc.272.35.22053
   Horwood NJ, 1999, BIOCHEM BIOPH RES CO, V265, P144, DOI 10.1006/bbrc.1999.1623
   Hsu CW, 2011, J BIOMED MATER RES A, V98A, P53, DOI 10.1002/jbm.a.33076
   Huang M, 2007, BIOMACROMOLECULES, V8, P1607, DOI 10.1021/bm061211k
   Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146
   Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039
   Ke K, 2012, AM J PHYSIOL-ENDOC M, V303, P1296
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835
   Kudo O, 2002, CALCIFIED TISSUE INT, V71, P539, DOI 10.1007/s00223-001-2128-1
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200
   Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200
   Lopes BAC, 2010, CELL NOTE PLATAFORMA
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Martin TJ, 2006, ANN NY ACAD SCI, V1068, P458, DOI 10.1196/annals.1346.043
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K
   Miyamoto Takeshi, 2003, Keio J Med, V52, P1
   Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   Nakamura I, 1996, J BONE MINER RES, V11, P1873
   Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10
   Oliveira MI, 2012, EUR CELLS MATER, V24, P152
   Park JH, 2012, BIOMATERIALS, V33, P5267, DOI 10.1016/j.biomaterials.2012.03.074
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Pires LR, 2011, NANOMEDICINE-UK, V6, P1499, DOI [10.2217/nnm.11.51, 10.2217/NNM.11.51]
   Rochet N, 2009, BIOMATERIALS, V30, P4260, DOI 10.1016/j.biomaterials.2009.04.044
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Takayanagi H, 2010, ANN NY ACAD SCI, V1192, P117, DOI 10.1111/j.1749-6632.2009.05303.x
   TAMURA T, 1993, J BONE MINER RES, V8, P953
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Troen BR, 2004, DRUG NEWS PERSPECT, V17, P19, DOI 10.1358/dnp.2004.17.1.829022
   WALSH CA, 1991, J BONE MINER RES, V6, P661
   YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0
   Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034
   Zhang ZY, 2012, ACTA BIOMATER, V8, P13, DOI 10.1016/j.actbio.2011.09.020
NR 65
TC 11
Z9 12
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2013
VL 9
IS 5
BP 6553
EP 6562
DI 10.1016/j.actbio.2013.01.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134GY
UT WOS:000318199600025
PM 23376128
DA 2018-10-20
ER

PT J
AU Kwon, H
   Sun, L
   Cairns, DM
   Rainbow, RS
   Preda, RC
   Kaplan, DL
   Zeng, L
AF Kwon, Heenam
   Sun, Lin
   Cairns, Dana M.
   Rainbow, Roshni S.
   Preda, Rucsanda C.
   Kaplan, David L.
   Zeng, Li
TI The influence of scaffold material on chondrocytes under inflammatory
   conditions
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cartilage matrix production; Scaffold; Pro-inflammatory cytokines;
   Cytokine release; Water uptake
ID MESENCHYMAL STEM-CELLS; HUMAN ARTICULAR CHONDROCYTES; TISSUE-ENGINEERED
   CARTILAGE; NECROSIS-FACTOR-ALPHA; IN-VITRO; N-CADHERIN; SILK FIBROIN;
   CHONDROGENIC DIFFERENTIATION; CULTURE-SYSTEM; 3-D SCAFFOLDS
AB Cartilage tissue engineering aims to repair damaged cartilage tissue in arthritic joints. As arthritic joints have significantly higher levels of pro-inflammatory cytokines (such as IL-1 beta and TNF alpha, that cause cartilage destruction, it is critical to engineer stable cartilage in an inflammatory environment. Biomaterial scaffolds constitute an important component of the microenvironment for chondrocytes in engineered cartilage. However, it remains unclear how the scaffold material influences the response of chondrocytes seeded in these scaffolds under inflammatory stimuli. Here we have compared the responses of articular chondrocytes seeded within three different polymeric scaffolding materials (silk, collagen and polylactic acid (PLA)) to IL-1 beta and TNF alpha. These scaffolds have different physical characteristics and yielded significant differences in the expression of genes associated with cartilage matrix production and degradation, cell adhesion and cell death. The silk and collagen scaffolds released pro-inflammatory cytokines faster and had higher uptake water abilities than PLA scaffolds. Correspondingly, chondrocytes cultured in silk and collagen scaffolds maintained higher levels of cartilage matrix than those in PLA, suggesting that these biophysical properties of scaffolds may regulate gene expression and the response to inflammatory stimuli in chondrocytes. Based on this study we conclude that selecting the proper scaffold material will aid in the engineering of more stable cartilage tissues for cartilage repair, and that silk and collagen are better scaffolds in terms of supporting the stability of three-dimensional cartilage under inflammatory conditions. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kwon, Heenam; Cairns, Dana M.; Kaplan, David L.; Zeng, Li] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Cellular Mol & Dev Biol, Boston, MA 02111 USA.
   [Kwon, Heenam; Cairns, Dana M.; Rainbow, Roshni S.; Zeng, Li] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA.
   [Sun, Lin; Preda, Rucsanda C.; Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zeng, Li] Tufts Med Ctr, Dept Orthopaed Surg, Boston, MA 02111 USA.
RP Zeng, L (reprint author), Tufts Univ, Sch Med, Dept Anat & Cellular Biol, 136 Harrison Ave, Boston, MA 02111 USA.
EM li.zeng@tufts.edu
OI Cairns, Dana/0000-0003-0574-8395
FU NSF [CBET-0966920]; NIH [1R01AR059106-01A1, P41EB002520]
FX We are grateful to Catherine Linsenmayer and Lawrence Barry at Tufts
   Imaging Facility for help with the scanning electron microscopy. This
   work has been supported by grants to L.Z. and D.L.K. from the NSF
   (CBET-0966920) and NIH (1R01AR059106-01A1 and P41EB002520).
CR Abramoff MD, 2004, J BIOPHOTONICS INT, V11, P36
   Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amin A R, 2000, Curr Rheumatol Rep, V2, P447, DOI 10.1007/s11926-000-0019-5
   Appelman TP, 2011, BIOMATERIALS, V32, P1508, DOI 10.1016/j.biomaterials.2010.10.017
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174
   Bi WM, 1999, NAT GENET, V22, P85
   Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Bruckschen B., 2005, BIOMED TECH, V50, P1609
   Burrage PS, 2006, FRONT BIOSCI, V11, P529, DOI 10.2741/1817
   Cairns DM, 2010, J ORTHOP RES, V28, P529, DOI 10.1002/jor.21014
   Cake MA, 2000, OSTEOARTHR CARTILAGE, V8, P404, DOI 10.1053/joca.2000.0315
   Carames B, 2008, OSTEOARTHR CARTILAGE, V16, P715, DOI 10.1016/j.joca.2007.10.006
   Chandran PL, 2012, ACTA BIOMATER, V8, P3, DOI 10.1016/j.actbio.2011.08.011
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Choi CK, 2010, TRENDS CELL BIOL, V20, P705, DOI 10.1016/j.tcb.2010.09.007
   CHU CR, 1995, BIOMATERIALS, V16, P1381, DOI 10.1016/0142-9612(95)96873-X
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Clouet J, 2009, DRUG DISCOV TODAY, V14, P913, DOI DOI 10.1016/J.DRUDIS.2009.07.012
   DeLise AM, 2002, J CELL BIOCHEM, V87, P342, DOI 10.1002/jcb.10308
   Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151
   Dinerman AA, 2002, BIOMATERIALS, V23, P4203, DOI 10.1016/S0142-9612(02)00164-3
   Elder SH, 2009, TISSUE ENG PT A, V15, P3025, DOI [10.1089/ten.tea.2008.0617, 10.1089/ten.TEA.2008.0617]
   Erggelet C, 2010, ARCH ORTHOP TRAUM SU, V130, P957, DOI 10.1007/s00402-009-0957-y
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Getgood A, 2009, J BONE JOINT SURG BR, V91B, P565, DOI 10.1302/0301-620X.91B5.21832
   Girish V, 2004, Indian J Cancer, V41, P47
   Glowacki J, 2000, J REHABIL RES DEV, V37, P171
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Goessler UR, 2006, INT J MOL MED, V17, P301
   GOLDRING SR, 2004, CLIN ORTHOP S, V427, pS27, DOI DOI 10.1097/01.BLO.0000144854.66565.8F
   Heinegard D, 2009, INT J EXP PATHOL, V90, P575, DOI 10.1111/j.1365-2613.2009.00695.x
   Hu JC, 2005, BIOMATERIALS, V26, P2001, DOI 10.1016/j.biomaterials.2004.06.008
   Hunziker EB, 2000, BIORHEOLOGY, V37, P163
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Ju YM, 2008, J BIOMED MATER RES B, V85B, P252, DOI 10.1002/jbm.b.30943
   Kafienah W, 2003, ARTHRITIS RHEUM, V48, P709, DOI 10.1002/art.10842
   Kanczler JM, 2007, BIOCHEM BIOPH RES CO, V352, P135, DOI 10.1016/j.bbrc.2006.10.187
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kleinheinz J, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-17
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Lee JW, 2004, BIOMATERIALS, V25, P1901, DOI 10.1016/j.biomaterials.2003.08.037
   Lima EG, 2008, TISSUE ENG PT A, V14, P1721, DOI 10.1089/ten.tea.2007.0347
   Lima EG, 2009, J BIOMED MATER RES A, V91A, P692, DOI 10.1002/jbm.a.32305
   Lima EG, 2008, J BIOMECH, V41, P3253, DOI 10.1016/j.jbiomech.2008.06.015
   Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005
   Lotz JC, 2006, J BONE JOINT SURG AM, V88A, P76, DOI 10.2106/JBJS.E.01448
   Mastbergen SC, 2002, RHEUMATOLOGY, V41, P801, DOI 10.1093/rheumatology/41.7.801
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Mohan N, 2009, J MATER SCI-MATER M, V20, P49, DOI 10.1007/s10856-008-3481-7
   Montaseri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028663
   Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020
   Mullen LM, 2010, TISSUE ENG PART C-ME, V16, P1439, DOI [10.1089/ten.tec.2009.0806, 10.1089/ten.TEC.2009.0806]
   Nakazora S, 2010, BIOCHEM BIOPH RES CO, V400, P493, DOI 10.1016/j.bbrc.2010.08.070
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Park H, 2009, BIOMACROMOLECULES, V10, P541, DOI 10.1021/bm801197m
   Park JS, 2007, J CONTROL RELEASE, V124, P51, DOI 10.1016/j.jconrel.2007,08.030
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Ronziere MC, 2005, BBA-MOL CELL RES, V1746, P55, DOI 10.1016/j.bbamcr.2005.08.003
   Schagemann JC, 2010, BIOMATERIALS, V31, P2798, DOI 10.1016/j.biomaterials.2009.12.037
   Schagemann JC, 2009, TISSUE ENG PT A, V15, P75, DOI 10.1089/ten.tea.2008.0087
   Scheuner G, 1975, Prog Histochem Cytochem, V7, P1
   Schlegel W, 2008, INT J MOL MED, V22, P691, DOI 10.3892/ijmm_00000074
   SCHUMAN L, 1995, BIOMATERIALS, V16, P809, DOI 10.1016/0142-9612(95)99644-2
   Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137
   Siclari A, 2012, CLIN ORTHOP RELAT R, V470, P910, DOI 10.1007/s11999-011-2107-4
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Stockwell RA., 1979, BIOL CARTILAGE CELLS
   Sun L, 2011, BIOMATERIALS, V32, P5581, DOI 10.1016/j.biomaterials.2011.04.028
   Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205
   Wang Y, 2009, J BIOMED MATER RES A, V92A, P693
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200
   Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110
NR 95
TC 20
Z9 20
U1 2
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2013
VL 9
IS 5
BP 6563
EP 6575
DI 10.1016/j.actbio.2013.01.004
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134GY
UT WOS:000318199600026
PM 23333441
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Muller, C
   Ma, BN
   Gust, R
   Bernkop-Schnurch, A
AF Mueller, Christiane
   Ma, Benjamin N.
   Gust, Ronald
   Bernkop-Schnuerch, Andreas
TI Thiopyrazole preactivated chitosan: Combining mucoadhesion and drug
   delivery
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Thiomers; Mucoadhesion; Biomaterials; Drug delivery; Thiol/disulfide
   exchange
ID PROTECTED THIOLATED CHITOSAN; IN-VITRO EVALUATION; GLUTATHIONE;
   DISULFIDE; POLYMERS; SYSTEMS; INTESTINE; PEPTIDES; REDOX
AB The objective of this study was to develop a preactivated chitosan derivative by the introduction of thioglycolic acid followed by 3-methyl-1-phenylpyrazole-5-thiol (MPPT) coupling via disulfide bond formation. The newly synthesized conjugate was characterized in terms of water-absorbing capacity, cohesive properties, mucoadhesion and drug release kinetics. Further in vitro characterization was conducted regarding permeation enhancement of the model compound fluorescein isothiocyanate dextran (FD4) and cytotoxic effects on Caco-2 cells. Based on the attachment of the hydrophobic residue, chitosan-S-S-MPPT test discs showed increased stability of the polymer matrix as well as improved water uptake and liberation of fluorescein isothiocyanate dextran (FD4) compared to chitosan only. The mucoadhesive qualities on porcine intestinal mucosa could be improved 38-fold based on the enhanced bonding between chitosan-S-S-MPPT and mucus through the thiol/disulfide exchange reaction of polymer and mucosal cysteine-rich domains supported by MPPT as the leaving group. This novel biomaterial presents a disulfide conjugation-based delivery system that releases the antibacterial thiopyrazole when the polymer comes into contact with the intestinal mucosa. These properties, together with the safe toxicological profile, make chitosan-S-S-MPPT a valuable carrier for mucoadhesive drug delivery systems and a promising matrix for the development of antimicrobial excipients. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mueller, Christiane; Bernkop-Schnuerch, Andreas] Univ Innsbruck, Ctr Mol Biosci Innsbruck, Inst Pharm, Dept Pharmaceut Technol,CCB, A-6020 Innsbruck, Austria.
   [Ma, Benjamin N.; Gust, Ronald] Univ Innsbruck, Dept Pharmaceut Chem, Inst Pharm, CCB, A-6020 Innsbruck, Austria.
RP Bernkop-Schnurch, A (reprint author), Univ Innsbruck, Ctr Mol Biosci Innsbruck, Inst Pharm, Dept Pharmaceut Technol,CCB, Innrain 80-82-4, A-6020 Innsbruck, Austria.
EM andreas.bemkop@uibk.ac.at
RI Ma, Benjamin/N-3054-2017
CR Bernkop-Schnurch A, 2003, J CONTROL RELEASE, V93, P95, DOI 10.1016/j.jconrel.2003.05.001
   Circu ML, 2011, FREE RADICAL RES, V45, P1245, DOI 10.3109/10715762.2011.611509
   Clausen AE, 2002, PHARMACEUT RES, V19, P602, DOI 10.1023/A:1015345827091
   DAHM LJ, 1994, AM J PHYSIOL, V267, pG292
   Dahm LJ, 2000, J NUTR, V130, P2739
   Dunnhaupt S, 2012, CARBOHYD POLYM, V90, P765, DOI 10.1016/j.carbpol.2012.05.028
   Dunnhaupt S, 2012, J CONTROL RELEASE, V160, P477, DOI 10.1016/j.jconrel.2012.04.020
   ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6
   HABEEB AFSA, 1973, ANAL BIOCHEM, V56, P60, DOI 10.1016/0003-2697(73)90169-3
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   Kafedjiiski K, 2005, PHARM RES, V22, P1480, DOI 10.1007/s11095-005-6248-6
   Kast CE, 2001, BIOMATERIALS, V22, P2345, DOI 10.1016/S0142-9612(00)00421-X
   Koo AN, 2008, CHEM COMMUN, P6570, DOI 10.1039/b815918a
   Millotti G, 2010, J DRUG DELIV SCI TEC, V20, P181, DOI 10.1016/S1773-2247(10)50027-3
   Millotti G, 2010, J MATER CHEM, V20, P2432, DOI 10.1039/b916528b
   MORRISON AB, 1965, J PHARM SCI, V54, P1, DOI 10.1002/jps.2600540102
   Muller C, 2012, J APPL POLYM SCI, V124, P5046
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Ozturk T, 2007, CHEM REV, V107, P5210, DOI 10.1021/cr040650b
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Saito G, 2003, ADV DRUG DELIVER REV, V55, P199, DOI 10.1016/S0169-409X(02)00179-5
   Sakloetsakun D, 2011, DRUG DEV IND PHARM, V37, P648, DOI 10.3109/03639045.2010.534484
   Sarti F, 2011, ADV POLYM SCI, V243, P93, DOI 10.1007/12_2011_109
   Schipper NGM, 1999, EUR J PHARM SCI, V8, P335, DOI 10.1016/S0928-0987(99)00032-9
   Sriamornsak P, 2008, CARBOHYD POLYM, V74, P458, DOI 10.1016/j.carbpol.2008.03.022
   Tagawa Y, 2002, ARCH PHARM, V335, P99, DOI 10.1002/1521-4184(200203)335:2/3<99::AID-ARDP99>3.0.CO;2-2
NR 28
TC 17
Z9 18
U1 2
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2013
VL 9
IS 5
BP 6585
EP 6593
DI 10.1016/j.actbio.2013.01.008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134GY
UT WOS:000318199600028
PM 23321304
DA 2018-10-20
ER

PT J
AU Limbert, G
   Bryan, R
   Cotton, R
   Young, P
   Hall-Stoodley, L
   Kathju, S
   Stoodley, P
AF Limbert, G.
   Bryan, R.
   Cotton, R.
   Young, P.
   Hall-Stoodley, L.
   Kathju, S.
   Stoodley, P.
TI On the mechanics of bacterial biofilms on non-dissolvable surgical
   sutures: A laser scanning confocal microscopy-based finite element study
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biofilm; Bacterial adhesion; Suture; Finite element modelling; Confocal
   microscopy
ID EXTRACELLULAR POLYMERIC SUBSTANCES; CELLULAR-AUTOMATON APPROACH; SOLUBLE
   MICROBIAL PRODUCTS; UNIFYING HYPOTHESIS; CONTINUUM MODEL; INERT BIOMASS;
   SHEAR-STRESS; DETACHMENT; GROWTH; FLOW
AB Biofilms are bacterial communities encapsulated within a self-secreted extracellular polymeric substance and are responsible for a wide range of chronic medical device related infections. Understanding and addressing the conditions that lead to the attachment and detachment of biofilms from biomedical surfaces (orthopaedic implants, sutures, intravenous catheters, cardio-vascular stents) has the potential to identify areas of the device that might be more prone to infection and predict how and when biofilms might dislodge. In this study, an integrated software methodology was devised to create image-based microscopic finite element models of real biofilm colonies of Staphylococcus aureus attached to a fragment of surgical suture. The goal was to predict how deformation of the suture may lead to the potential detachment of biofilm colonies by solving the equations of continuum mechanics using the finite element method for various loading cases. Tension, torsion and bending of the biomaterial structure were simulated, demonstrating that small strains in the suture can produce surface shear stresses sufficient to trigger the sliding of biofilms over the suture surface. Applications of this technique to other medical devices are discussed. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Limbert, G.; Stoodley, P.] Univ Southampton, Fac Engn & Environm, Natl Ctr Adv Tribol Southampton, Southampton SO17 1BJ, Hants, England.
   [Limbert, G.] Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton SO17 1BJ, Hants, England.
   [Bryan, R.; Cotton, R.; Young, P.] Simpleware Ltd, Exeter EX4 3PL, Devon, England.
   [Young, P.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England.
   [Hall-Stoodley, L.] Univ Hosp Southampton NHS Fdn Trust, Fac Med, NIHR Resp BRU Southampton, Southampton, Hants, England.
   [Kathju, S.] Univ Pittsburgh, Sch Med, Div Plast Surg, Pittsburgh, PA 15261 USA.
   [Stoodley, P.] Drexel Univ, Coll Med, Allegheny Gen Hosp, Dept Microbiol & Immunol, Pittsburgh, PA 15212 USA.
RP Limbert, G (reprint author), Univ Southampton, Fac Engn & Environm, Natl Ctr Adv Tribol Southampton, Southampton SO17 1BJ, Hants, England.
EM g.limbert@soton.ac.uk
RI Limbert, Georges/E-5658-2010; Stoodley, Paul/E-5079-2013
OI Limbert, Georges/0000-0002-4268-6106; Stoodley, Paul/0000-0001-6069-273X
FU Engineering and Physical Sciences Research Council (EPSRC)
   [EP/F034296/1]; University of Southampton; Engineering and Physical
   Sciences Research Council [EP/F034296/1]
FX Financial support from the Engineering and Physical Sciences Research
   Council (EPSRC) (Grant EP/F034296/1) and the University of Southampton
   is gratefully acknowledged. The authors thank the reviewers for their
   helpful comments and insights.
CR Alpkvist E, 2007, B MATH BIOL, V69, P765, DOI 10.1007/s11538-006-9168-7
   [Anonymous], 2011, ABAQUS THEOR MAN
   Aravas N, 2008, BIOTECHNOL BIOENG, V101, P196, DOI 10.1002/bit.21865
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Bol M, 2009, BIOTECHNOL BIOENG, V103, P177, DOI 10.1002/bit.22235
   Bohn A, 2007, WATER SCI TECHNOL, V55, P257, DOI 10.2166/wst.2007.266
   Boissy R, 2011, BMC GENOMICS, V12
   Chopp DL, 2003, B MATH BIOL, V65, P1053, DOI 10.1016/S0092-8240(03)00057-0
   Chopp DL, 2002, J IND MICROBIOL BIOT, V29, P339, DOI 10.1038/sj.jim.7000316
   Dens EJ, 2005, INT J FOOD MICROBIOL, V101, P319, DOI 10.1016/j.ijfoodmicro.2004.11.017
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Duddu R, 2008, INT J NUMER METH ENG, V74, P848, DOI 10.1002/nme.2200
   Duddu R, 2009, BIOTECHNOL BIOENG, V103, P92, DOI 10.1002/bit.22233
   Eberl HJ, 2008, J THEOR BIOL, V253, P788, DOI 10.1016/j.jtbi.2008.04.013
   Ehret AE, 2012, J ROY SOC INT
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Grijspeerdt K, 2005, INT J FOOD MICROBIOL, V100, P323, DOI 10.1016/j.ijfoodmicro.2004.10.028
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hall-Stoodley L, 2012, FEMS IMMUNOL MED MIC, V65, P127, DOI 10.1111/j.1574-695X.2012.00968.x
   Hermanowicz SW, 2001, MATH BIOSCI, V169, P1, DOI 10.1016/S0025-5564(00)00049-3
   INGLIS TJJ, 1989, J CLIN MICROBIOL, V27, P2014
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   Kathju S, 2010, FEMS IMMUNOL MED MIC, V59, P405, DOI 10.1111/j.1574-695X.2010.00691.x
   Kathju S, 2010, OBES SURG, V20, P251, DOI 10.1007/s11695-009-9921-8
   Kathju S, 2009, SURG INFECT, V10, P457, DOI 10.1089/sur.2008.062
   Khassehkhan H, 2009, DISCRETE CONT DYN-B, V12, P371, DOI 10.3934/dcdsb.2009.12.371
   Khassehkhan H, 2009, LECT NOTES COMPUT SC, V5544, P735, DOI 10.1007/978-3-642-01970-8_73
   Klapper I, 2002, BIOTECHNOL BIOENG, V80, P289, DOI 10.1002/bit.10376
   Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275
   Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897
   Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x
   Laspidou CS, 2007, WIT TRANS ECOL ENVIR, V103, P231, DOI 10.2495/WRM070221
   Laspidou CS, 2010, DESALINATION, V250, P390, DOI 10.1016/j.desal.2009.09.062
   Laspidou CS, 2005, WATER SCI TECHNOL, V52, P161
   Laspidou CS, 2002, WATER RES, V36, P1983, DOI 10.1016/S0043-1354(01)00414-6
   Laspidou CS, 2002, WATER RES, V36, P2711, DOI 10.1016/S0043-1354(01)00413-4
   Leitao A, 1996, CHEM ENG SCI, V51, P4595, DOI 10.1016/0009-2509(96)00320-X
   Limbert G, 2010, J BIOMECH, V43, P1251, DOI 10.1016/j.jbiomech.2010.01.003
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Mathias JD, 2009, BIOFOULING, V25, P695, DOI 10.1080/08927010903104984
   Mohle RB, 2007, BIOTECHNOL BIOENG, V98, P747, DOI 10.1002/bit.21448
   Najibi S, 2010, Iowa Orthop J, V30, P84
   Noguera DR, 1999, WATER SCI TECHNOL, V39, P273, DOI 10.1016/S0273-1223(99)00178-X
   Picioreanu C, 1998, BIOTECHNOL BIOENG, V57, P718, DOI 10.1002/(SICI)1097-0290(19980320)57:6<718::AID-BIT9>3.3.CO;2-U
   Picioreanu C, 2000, BIOTECHNOL BIOENG, V68, P355, DOI 10.1002/(SICI)1097-0290(20000520)68:4<355::AID-BIT1>3.0.CO;2-A
   Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M
   Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205
   Rupp CJ, 2005, APPL ENVIRON MICROB, V71, P2175, DOI 10.1128/AEM.71.4.2175-2178.2005
   Sauerland S, 2011, COCHRANE DATABASE SY
   Scherman P, 2010, J HAND SURG-AM, V35A, P780, DOI 10.1016/j.jhsa.2010.02.005
   Stoodley P, 1997, ANTIMICROB AGENTS CH, V41, P1876, DOI 10.1128/AAC.41.9.1876
   Stoodley P, 1999, J APPL MICROBIOL, V85, p19S, DOI 10.1111/j.1365-2672.1998.tb05279.x
   Taherzadeh D, 2010, BIOTECHNOL BIOENG, V105, P600, DOI 10.1002/bit.22551
   Towler BW, 2007, BIOTECHNOL BIOENG, V96, P259, DOI 10.1002/bit.21098
   van Loosdrecht MCM, 2002, ANTON LEEUW INT J G, V81, P245, DOI 10.1023/A:1020527020464
   Viinikainen A, 2006, J MATER SCI-MATER M, V17, P169, DOI 10.1007/s10856-006-6821-5
   Vizesi F, 2008, J HAND SURG-AM, V33A, P241, DOI 10.1016/j.jhsa.2007.10.011
   Wagner M, 2010, BIOTECHNOL BIOENG, V107, P172, DOI 10.1002/bit.22784
   Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520
   Wimpenny JWT, 1997, FEMS MICROBIOL ECOL, V24, P185, DOI 10.1111/j.1574-6941.1997.tb00435.x
   Wimpenny JWT, 1997, FEMS MICROBIOL ECOL, V22, P1, DOI 10.1111/j.1574-6941.1997.tb00351.x
   Xavier JB, 2005, ENVIRON MICROBIOL, V7, P1085, DOI 10.1111/j.1462-2920.2005.00787.x
   Xavier JD, 2005, BIOTECHNOL BIOENG, V91, P651, DOI 10.1002/bit.20544
   Young PG, 2008, PHILOS T R SOC A, V366, P3155, DOI 10.1098/rsta.2008.0090
   Zienkiewicz O, 1989, FINITE ELEMENT METHO
NR 66
TC 14
Z9 15
U1 2
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2013
VL 9
IS 5
BP 6641
EP 6652
DI 10.1016/j.actbio.2013.01.017
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 134GY
UT WOS:000318199600034
PM 23376125
DA 2018-10-20
ER

PT J
AU Chou, J
   Ito, T
   Otsuka, M
   Ben-Nissan, B
   Milthorpe, B
AF Chou, Joshua
   Ito, Tomoko
   Otsuka, Makoto
   Ben-Nissan, Besim
   Milthorpe, Bruce
TI Simvastatin-Loaded beta-TCP Drug Delivery System Induces Bone Formation
   and Prevents Rhabdomyolysis in OVX Mice
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE controlled drug delivery system; simvastatin; biomaterial; biomimetic
ID REGENERATION; COMBINATION
C1 [Chou, Joshua] Univ Technol Sydney, Sch Med & Mol Sci, Sydney, NSW 2007, Australia.
   [Ito, Tomoko; Otsuka, Makoto] Musashino Univ, Pharmaceut Sci Res Inst, Fac Pharm, Nishi Tokyo 2028585, Japan.
   [Ben-Nissan, Besim] Univ Technol Sydney, Sch Chem & Forens Sci, Sydney, NSW 2007, Australia.
   [Milthorpe, Bruce] Univ Technol Sydney, Fac Sci CB04 04 48H, Sydney, NSW 2007, Australia.
RP Chou, J (reprint author), Univ Technol Sydney, Sch Med & Mol Sci, Sydney, NSW 2007, Australia.
EM Joshua.chou@uts.edu.au
RI Chou, Joshua/G-7746-2013
OI Chou, Joshua/0000-0002-7472-8016
FU Endevour Cheung Kong Fellowship Award; University of Technology Sydney
   Chancellor Postdoctoral Fellowship award; Australian Academy of Science;
   Japan Fellowship award; Research Institute of Pharmaceutical Science at
   Musashino University
FX We thank the 2011 Endevour Cheung Kong Fellowship Award, University of
   Technology Sydney Chancellor Postdoctoral Fellowship award, Australian
   Academy of Science, Japan Fellowship award and Research Institute of
   Pharmaceutical Science at Musashino University for their support of this
   research. Furthermore, all authors contributed equally to this work.
CR Ayukawa Y, 2004, CLIN ORAL IMPLAN RES, V404, P343
   Basarir K, 2009, INT ORTHOP, V33, P855, DOI 10.1007/s00264-007-0490-y
   Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031
   Chou JH, 2011, ADV ENG MATER, V13, P93, DOI 10.1002/adem.201000208
   Guyton JR, 2006, AM J CARDIOL, V97, P95
   Jamal SM, 2004, AM HEART J, V147, P956, DOI 10.1016/j.ahj.2003.12.037
   Kilic E, 2008, J ORAL MAXIL SURG, V66, P2233, DOI 10.1016/j.joms.2008.05.362
   Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184
   Nyan M, 2009, CLIN ORAL IMPLAN RES, V20, P280, DOI 10.1111/j.1600-0501.2008.01639.x
   ozec, 2007, J CRANIOFAC SURG, V18, P546
   Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681
   Thylin MR, 2002, J PERIODONTOL, V73, P1141, DOI 10.1902/jop.2002.73.10.1141
   Wong RWK, 2003, BRIT J ORAL MAX SURG, V41, P244, DOI 10.1016/S0266-4356(03)00081-0
   Wu Z, 2007, INT J ORAL MAXILLOF, V37, P170
NR 14
TC 7
Z9 8
U1 0
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY
PY 2013
VL 2
IS 5
BP 678
EP 681
DI 10.1002/adhm.201200342
PG 4
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 135TU
UT WOS:000318312200006
PM 23184712
DA 2018-10-20
ER

PT J
AU Gladwin, KM
   Whitby, RLD
   Mikhalovsky, SV
   Tomlins, P
   Adu, J
AF Gladwin, Karen M.
   Whitby, Raymond L. D.
   Mikhalovsky, Sergey V.
   Tomlins, Paul
   Adu, Jimi
TI In Vitro Biocompatibility of Multiwalled Carbon Nanotubes with Sensory
   Neurons
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE biomaterial; cytotoxicity; multiwalled carbon nanotube; peripheral nerve
   repair; tissue scaffold
ID NEURITE OUTGROWTH; NANOFIBER ARRAYS; NEURAL-NETWORKS; LAMININ; GROWTH;
   FIBRONECTIN; MICROTUBULES; INTERFACE; EXTENSION; SUBSTRATE
AB Multiwalled carbon nanotubes (MWCNTs) possess unique properties rendering them a potentially useful biomaterial for neurobiological applications such as providing nanoscale contact-guidance cues for directing axon growth within peripheral nerve repair scaffolds. The in vitro biocompatibility of MWCNTs with postnatal mouse spinal sensory neurons was assessed for this application. Cell culture medium conditioned with MWCNTs was not significantly toxic to dissociated cultures of postnatal mouse dorsal root ganglia (DRG) neurons. However, exposure of DRG neurons to MWCNTs dispersed in culture medium resulted in a time- and dose-dependent reduction in neuronal viability. At 250 g mL1, dispersed MWCNTs caused significant neuronal death and unusual neurite morphologies illustrated by immunofluorescent labelling of the cytoskeletal protein beta (III) tubulin, however, at a dose of 5 g mL1 MWCNTs were nontoxic over a 14-day period. DRG neurons grown on fabricated MWCNT substrates produced neurite outgrowths with abnormal morphologies that were significantly inferior in length to neurons grown on the control substrate laminin. This evidence demonstrates that to be utilized as a biomaterial in tissue scaffolds for nerve repair, MWCNTs will require robust surface modification to enhance biocompatibility and growth promoting properties.
C1 [Gladwin, Karen M.; Whitby, Raymond L. D.; Mikhalovsky, Sergey V.; Adu, Jimi] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
   [Tomlins, Paul] Natl Phys Lab, Teddington TW11 0LW, Middx, England.
RP Adu, J (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
EM J.adu@brighton.ac.uk
RI Whitby, Raymond/F-7871-2010
OI Whitby, Raymond/0000-0002-9650-4179
FU EPSRC; National Physical Laboratory; University of Brighton
FX This work was supported by a CASE studentship award from the EPSRC and
   the National Physical Laboratory and funds from the University of
   Brighton.
CR BARONVANEVERCOOREN A, 1982, J NEUROSCI RES, V8, P179, DOI 10.1002/jnr.490080208
   Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Casey A, 2007, CARBON, V45, P1425, DOI 10.1016/j.carbon.2007.03.033
   Casey A, 2007, CARBON, V45, P34, DOI 10.1016/j.carbon.2006.08.009
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   Gabay T, 2005, PHYSICA A, V350, P611, DOI 10.1016/j.physa.2004.11.007
   Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891
   Gheith MK, 2005, ADV MATER, V17, P2663, DOI 10.1002/adma.200500366
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0
   Liopo AV, 2006, J NANOSCI NANOTECHNO, V6, P1365, DOI 10.1166/jnn.2006.155
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6
   MACCIONI RB, 1995, PHYSIOL REV, V75, P835
   MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Merkoci A, 2006, MICROCHIM ACTA, V152, P157, DOI 10.1007/s00604-005-0439-z
   Nguyen-Vu TDB, 2007, IEEE T BIO-MED ENG, V54, P1121, DOI 10.1109/TBME.2007.891169
   Nguyen-Vu TDB, 2006, SMALL, V2, P89, DOI 10.1002/smll.200500175
   Ni YC, 2005, J NANOSCI NANOTECHNO, V5, P1707, DOI 10.1166/jnn.2005.189
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   Park KH, 2003, J BIOL CHEM, V278, P50212, DOI 10.1074/jbc.M310216200
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Sargent LM, 2009, ENVIRON MOL MUTAGEN, V50, P708, DOI 10.1002/em.20529
   SMALHEISER NR, 1984, DEV BRAIN RES, V12, P136, DOI 10.1016/0165-3806(84)90184-6
   Sorkin R, 2006, J NEURAL ENG, V3, P95, DOI 10.1088/1741-2560/3/2/003
   Sorkin R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/1/015101
   Sucapane Antonietta, 2009, J Nanoneurosci, V1, P10
   TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347
   Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t
   Wu D, 2012, NEUROSCI LETT, V507, P72, DOI 10.1016/j.neulet.2011.11.056
   Xie JN, 2006, SMART MATER STRUCT, V15, pN85, DOI 10.1088/0964-1726/15/4/N02
   Yu Z, 2007, NANO LETT, V7, P2188, DOI 10.1021/nl070291a
   Zhang X, 2005, SENSOR ACTUAT B-CHEM, V106, P843, DOI 10.1016/j.snb.2004.10.039
NR 39
TC 12
Z9 12
U1 1
U2 48
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY
PY 2013
VL 2
IS 5
BP 728
EP 735
DI 10.1002/adhm.201200233
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 135TU
UT WOS:000318312200012
PM 23184463
DA 2018-10-20
ER

PT J
AU Lowenthal, MS
   Phillips, MM
   Rimmer, CA
   Rudnick, PA
   Simon-Manso, Y
   Stein, SE
   Tchekhovskoi, D
   Phinney, KW
AF Lowenthal, Mark S.
   Phillips, Melissa M.
   Rimmer, Catherine A.
   Rudnick, Paul A.
   Simon-Manso, Yamil
   Stein, Stephen E.
   Tchekhovskoi, Dmitrii
   Phinney, Karen W.
TI Developing qualitative LC-MS methods for characterization of Vaccinium
   berry Standard Reference Materials
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE Vaccinium; LC-MS; Qualitative analysis; Reference materials; Mass
   spectral library; Metabolites
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; PLANT
   METABOLOMICS; PHENOLIC-COMPOUNDS; CRANBERRY JUICE;
   ELECTROSPRAY-IONIZATION; ANTIOXIDANT PROPERTIES; CYANIDIN GLYCOSIDES;
   FUNCTIONAL GENOMICS; VITIS-IDAEA
AB Standard Reference Materials (SRMs) offer the scientific community a stable and homogenous source of material that holds countless application possibilities. Traditionally, the National Institute of Standards and Technology (NIST) has provided SRMs with associated quantitative information (certified values) for a select group of targeted analytes as measured in a solution or complex matrix. While the current needs of the SRM community are expanding to include non-quantitative data, NIST is attempting to broaden the scope of how and what information is offered to the SRM community by providing qualitative information about biomaterials, such as chromatographic fingerprints and profiles of untargeted identifications. In this work, metabolomic and proteomic profiling efforts were employed to characterize a suite of six Vaccinium berry SRMs. In the discovery phase, liquid chromatography-tandem mass spectrometry (LC-MS/MS) data was matched to mass spectral libraries; a subsequent validation phase based on multiple-reaction monitoring LC-MS/MS relied on both retention time matching of authentic standards along with fragmentation data for a qualitative overview of the most prominent organic compounds present. Definitive and putative identifications were determined for over 70 metabolites based on reporting guidelines set forth by the Metabolomics Standards Initiative (Metabolomics 3(3):211-221, 2007), and the capability of electrospray ionization mass spectrometry (ESI-MS) to profile untargeted metabolites within a complex matrix using mass spectral matching is demonstrated. Bottom-up proteomic analyses were possible using peptide databases translated from expressed sequence tags (ESTs). Homology searches provided identification of novel Vaccinium proteins based on homology to related genera. Chromatographic fingerprints of these berry materials were acquired for supplemental qualitative information to be provided to users of these SRMs. An unbounded set of qualitative data about a biomaterial is a valuable complement to quantitative information traditionally provided in NIST Certificates of Analysis.
C1 [Lowenthal, Mark S.; Phillips, Melissa M.; Rimmer, Catherine A.; Phinney, Karen W.] NIST, Div Analyt Chem, Gaithersburg, MD 20899 USA.
   [Rudnick, Paul A.; Simon-Manso, Yamil; Stein, Stephen E.; Tchekhovskoi, Dmitrii] NIST, Chem & Biochem Reference Data Div, Gaithersburg, MD 20899 USA.
RP Lowenthal, MS (reprint author), NIST, Div Analyt Chem, 100 Bur Dr,Stop 8392, Gaithersburg, MD 20899 USA.
EM mark.lowenthal@nist.gov
RI Tchekhovskoi, Dmitrii/J-2319-2014
CR Agnese AM, 2001, PHYTOMEDICINE, V8, P389, DOI 10.1078/0944-7113-00059
   Allwood JW, 2011, METHOD ENZYMOL, V500, P299, DOI 10.1016/B978-0-12-385118-5.00016-5
   Ayaz FA, 2005, J AGR FOOD CHEM, V53, P8116, DOI 10.1021/jf058057y
   Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x
   Bramati L, 2003, J AGR FOOD CHEM, V51, P7472, DOI 10.1021/jf0347721
   Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298
   Chen SN, 2008, J PHARMACEUT BIOMED, V46, P692, DOI 10.1016/j.jpba.2007.12.014
   Dastmalchi K, 2011, J AGR FOOD CHEM, V59, P3020, DOI 10.1021/jf200367j
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Famiani F, 2005, J EXP BOT, V56, P2959, DOI 10.1093/jxb/eri293
   Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137
   Guy C, 2008, PHYSIOL PLANTARUM, V132, P113, DOI 10.1111/j.1399-3054.2007.01020.x
   Hall RD, 2008, PHYSIOL PLANTARUM, V132, P162, DOI 10.1111/j.1399-3054.2007.00989.x
   Hokkanen J, 2009, J AGR FOOD CHEM, V57, P9437, DOI 10.1021/jf9022542
   Hosseinian FS, 2007, J AGR FOOD CHEM, V55, P10832, DOI 10.1021/jf072529m
   JAMES DP, 1952, BRIT J NUTR, V6, P341, DOI 10.1079/BJN19520037
   Jensen HD, 2002, J AGR FOOD CHEM, V50, P6871, DOI 10.1021/jf0205110
   Katsube N, 2003, J AGR FOOD CHEM, V51, P68, DOI 10.1021/jf025781x
   Koek MM, 2011, METABOLOMICS, V7, P307, DOI 10.1007/s11306-010-0254-3
   Kuzminski LN, 1996, NUTR REV, V54, pS87
   Latti AK, 2011, PHYTOCHEMISTRY, V72, P810, DOI 10.1016/j.phytochem.2011.02.015
   Lazze MC, 2004, CARCINOGENESIS, V25, P1427, DOI 10.1093/carcin/bgh138
   Lee JH, 2004, ARCH PHARM RES, V27, P53, DOI 10.1007/BF02980046
   Lee JS, 2005, RAPID COMMUN MASS SP, V19, P3539, DOI 10.1002/rcm.2230
   Lee YL, 2000, JAMA-J AM MED ASSOC, V283, P1691, DOI 10.1001/jama.283.13.1691
   Lei ZT, 2011, J BIOL CHEM, V286, P25435, DOI 10.1074/jbc.R111.238691
   Li Zeng-Liang, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2087
   Liu J, 2010, J FOOD SCI, V75, pH103, DOI 10.1111/j.1750-3841.2010.01546.x
   Mercuro G, 2011, J CARDIOVASC MED, V12, P800, DOI 10.2459/JCM.0b013e32834a658f
   Moze S, 2011, J AGR FOOD CHEM, V59, P6998, DOI 10.1021/jf200765n
   Nestel P, 2003, CURR OPIN LIPIDOL, V14, P3, DOI 10.1097/01.mol.0000052844.26236.9c
   Nyman NA, 2001, J AGR FOOD CHEM, V49, P4183, DOI 10.1021/jf010572i
   Parry J, 2006, J AGR FOOD CHEM, V54, P3773, DOI 10.1021/jf060325k
   Parry J, 2005, J AGR FOOD CHEM, V53, P566, DOI 10.1021/jf048615t
   Penniston KL, 2008, J ENDOUROL, V22, P567, DOI 10.1089/end.2007.0304
   Phillips MM, 2010, ANAL BIOANAL CHEM, V398, P425, DOI 10.1007/s00216-010-3916-0
   Picerno P, 2003, J AGR FOOD CHEM, V51, P6423, DOI 10.1021/jf030284h
   Radulovic N, 2010, MOLECULES, V15, P6168, DOI 10.3390/molecules15096168
   Rahman MM, 2006, FREE RADICAL RES, V40, P993, DOI 10.1080/10715760600815322
   Reed J, 2002, CRIT REV FOOD SCI, V42, P301, DOI 10.1080/10408390209351919
   Roje S, 2007, PHYTOCHEMISTRY, V68, P1904, DOI 10.1016/j.phytochem.2007.03.038
   Rumbold K, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-64
   Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007
   Seeram NP, 2001, PHYTOMEDICINE, V8, P362, DOI 10.1078/0944-7113-00053
   Seeram NP, 2001, J AGR FOOD CHEM, V49, P4924, DOI 10.1021/jf0107508
   Sellappan S, 2002, J AGR FOOD CHEM, V50, P2432, DOI 10.1021/jf011097r
   Stein S. E., 2011, NIST 11 MASS SPECTRA
   STEIN SE, 1994, J AM SOC MASS SPECTR, V5, P859, DOI 10.1016/1044-0305(94)87009-8
   STEIN SE, 1994, J AM SOC MASS SPECTR, V5, P316, DOI 10.1016/1044-0305(94)85022-4
   Stein S, 2012, ANAL CHEM, V84, P7274, DOI 10.1021/ac301205z
   Steinfath M, 2010, PLANT BIOTECHNOL J, V8, P900, DOI 10.1111/j.1467-7652.2010.00516.x
   Stevenson DE, 2007, MOL NUTR FOOD RES, V51, P939, DOI 10.1002/mnfr.200700087
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2
   Taruscio TG, 2004, J AGR FOOD CHEM, V52, P3169, DOI 10.1021/jf0307595
   Tian QG, 2005, J CHROMATOGR A, V1091, P72, DOI 10.1016/j.chroma.2005.07.036
   Tikkanen MJ, 1998, P NATL ACAD SCI USA, V95, P3106, DOI 10.1073/pnas.95.6.3106
   Ulrich, 1971, BIOCH FRUITS THEIR P
   Vazquez-Araujo L, 2010, J FOOD SCI, V75, pS398, DOI 10.1111/j.1750-3841.2010.01779.x
   White BL, 2011, J AGR FOOD CHEM, V59, P4692, DOI 10.1021/jf200149a
   Wishart DS, 2011, BIOANALYSIS, V3, P1769, DOI [10.4155/BIO.11.155, 10.4155/bio.11.155]
   Xuan JK, 2011, J PROTEOME RES, V10, P5433, DOI 10.1021/pr2006796
   Yi WG, 2005, J AGR FOOD CHEM, V53, P7320, DOI 10.1021/jf051333o
   Zadernowski R, 2005, J AGR FOOD CHEM, V53, P2118, DOI 10.1021/jf040411p
   Zhang K, 2004, J AGR FOOD CHEM, V52, P222, DOI 10.1021/jf035073r
   Zuo YG, 2002, J AGR FOOD CHEM, V50, P3789, DOI 10.1021/jf020055f
NR 66
TC 3
Z9 3
U1 2
U2 57
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD MAY
PY 2013
VL 405
IS 13
BP 4451
EP 4465
DI 10.1007/s00216-012-6346-3
PG 15
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 131DK
UT WOS:000317972200016
PM 22941178
DA 2018-10-20
ER

PT J
AU Cittadella, G
   de Mel, A
   Dee, R
   De Coppi, P
   Seifalian, AM
AF Cittadella, Giorgio
   de Mel, Achala
   Dee, Ryan
   De Coppi, Paolo
   Seifalian, Alexander M.
TI Arterial Tissue Regeneration for Pediatric Applications: Inspiration
   From Up-to-Date Tissue-Engineered Vascular Bypass Grafts
SO ARTIFICIAL ORGANS
LA English
DT Review
DE Small diameter grafts; Tissue engineering; Autologous cells;
   Regenerative
ID HUMAN BLOOD-VESSEL; IN-SITU ENDOTHELIALIZATION; BONE-MARROW-CELLS;
   PULMONARY-ARTERY; NANOCOMPOSITE BIOMATERIAL; MECHANICAL-PROPERTIES;
   PROGENITOR CELLS; SMOOTH-MUSCLE; CONSTRUCTION; AUTOGRAFTS
AB The need for a valid replacement for autologous tissues in vascular surgery has led to the development of tissue-engineered vascular grafts (TEVGs). Currently, only three kinds of TEVG have been used in clinical trials: synthetic scaffold-based TEVGs, self-assembled grafts, and decellularized exogenous tissues. This review presents the current options in the construction of TEVG and the changes that have occurred in the design following the clinical experience while focusing on the potential for pediatric applications. The emerging trend in the field, which is also pertinent for pediatric applications, is a shift from the development of vascular analogues to implants composed of scaffolds with autologous cellular components. Designs of such implants are currently being fine-tuned so that a natural, functional tissue can gradually take over the role of scaffolds to stimulate the host's regenerative capacity and maintain the physiological homeostasis.
C1 [Cittadella, Giorgio; de Mel, Achala; Dee, Ryan; Seifalian, Alexander M.] UCL, UCL Ctr Nanotechnol & Regenerat Med, London NW3 2PF, England.
   [De Coppi, Paolo] UCL, Inst Child Hlth, London NW3 2PF, England.
   [De Coppi, Paolo] UCL, Great Ormond St Hosp, London NW3 2PF, England.
   [Seifalian, Alexander M.] Royal Free NHS Fdn Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, UCL Ctr Nanotechnol & Regenerat Med, Rowland Hill St, London NW3 2PF, England.
EM a.seifalian@ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322; De Coppi,
   Paolo/0000-0002-1659-0207
CR Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Baguneid M, 2011, BIOTECHNOL APPL BIOC, V58, P14, DOI 10.1002/bab.8
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Chamiot-Clerc P, 1998, CARDIOVASC RES, V37, P811, DOI 10.1016/S0008-6363(97)00267-8
   Chemla ES, 2009, BRIT J SURG, V96, P34, DOI 10.1002/bjs.6434
   Chiesa R, 2002, ACTA CHIR BELG, V102, P238
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   Dahl SLM, 2011, SCI TRANSL MED, V3, P68
   Darby CR, 2006, EUR J VASC ENDOVASC, V31, P181, DOI 10.1016/j.ejvs.2005.07.006
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   de Mel A, 2012, J BIOMED MATER RES A, V100A, P2348, DOI 10.1002/jbm.a.34177
   de Mel A, 2011, CHEM REV, V111, P5742, DOI 10.1021/cr200008n
   de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597
   Desai M, 2011, EUR J CARDIO-THORAC, V40, P394, DOI 10.1016/j.ejcts.2010.11.050
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Fiore AC, 2011, ANN THORAC SURG, V92, P183, DOI 10.1016/j.athoracsur.2011.02.073
   Ghanbari H, 2011, INT J NANOMED, V6, P775, DOI 10.2147/IJN.S14881
   Hagensen MK, 2012, CARDIOVASC RES, V93, P223, DOI 10.1093/cvr/cvr278
   Harish A, 2011, CLIN J AM SOC NEPHRO, V6, P1739, DOI 10.2215/CJN.00490111
   Harrington JK, 2011, FASEB J, V25, P4150, DOI 10.1096/fj.11-185140
   HERRING M, 1978, SURGERY, V84, P498
   Hibino N, 2005, J THORAC CARDIOV SUR, V129, P1064, DOI 10.1016/j.jtcvs.2004.10.030
   Hibino N, 2012, J THORAC CARDIOV SUR, V143, P696, DOI 10.1016/j.jtcvs.2011.06.046
   Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585
   Hibino N, 2011, FASEB J, V25, P2731, DOI 10.1096/fj.11-182246
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Hirsch AT, 2012, CIRCULATION, V125, P1449, DOI 10.1161/CIR.0b013e31824c39ba
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052
   Kim SJ, 2008, J THORAC CARDIOV SUR, V136, P108, DOI 10.1016/j.jtcvs.2007.12.032
   Kitamura S, 2009, CIRCULATION, V120, P60, DOI 10.1161/CIRCULATIONAHA.108.840603
   Klein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020540
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   Lau Keith K, 2007, Hemodial Int, V11, P190, DOI 10.1111/j.1542-4758.2007.00167.x
   Legendre A, 2010, J THORAC CARDIOV SUR, V139, P349, DOI 10.1016/j.jtcvs.2009.07.061
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Liberski AR, 2011, MACROMOL BIOSCI, V11, P1491, DOI 10.1002/mabi.201100086
   Liu JY, 2007, CARDIOVASC RES, V75, P618, DOI 10.1016/j.cardiores.2007.04.018
   Loizidou M, 2010, BRIT J SURG, V97, P463, DOI 10.1002/bjs.7074
   Marelli B, 2010, ACTA BIOMATER, V6, P4019, DOI 10.1016/j.actbio.2010.05.008
   Mathapati S, 2011, INTERACT CARDIOV TH, V12, P360, DOI 10.1510/icvts.2010.256719
   MATSUMOTO T, 1966, SURGERY, V60, P739
   Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Mayer JE, 1997, CURR OPIN CARDIOL, V12, P528, DOI 10.1097/00001573-199711000-00005
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   McClure MJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055010
   McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Meyers RL, 2006, J PEDIATR SURG, V41, P226, DOI 10.1016/j.jpedsurg.2005.10.086
   Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545
   Neff LP, 2011, J VASC SURG, V53, P426, DOI 10.1016/j.jvs.2010.07.054
   Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406
   Rahmani B, 2012, J BIOMECH, V45, P1205, DOI 10.1016/j.jbiomech.2012.01.046
   Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389
   Riley PR, 2011, CARDIOVASC RES, V91, P260, DOI 10.1093/cvr/cvr035
   Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Saha SP, 2012, CURR VASC PHARM
   SAMANEK M, 1992, PEDIATR CARDIOL, V13, P152
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Spark JI, 2008, BRIT J SURG, V95, P582, DOI 10.1002/bjs.6052
   Sparks C H, 1969, Ann Thorac Surg, V8, P104
   Starr JP, 2010, WORLD J SURG, V34, P658, DOI 10.1007/s00268-009-0296-8
   Sundaram S, 2012, CELLS TISSUES ORGANS, V195, P15, DOI 10.1159/000331409
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Teebken OE, 2009, VASA-J VASCULAR DIS, V38, P60, DOI 10.1024/0301-1526.38.1.60
   Twine CP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001487.pub2
   Udelsman B, 2011, TISSUE ENG PART C-ME, V17, P731, DOI [10.1089/ten.tec.2010.0581, 10.1089/ten.TEC.2010.0581]
   Weber B, 2011, PLACENTA, V32, pS316, DOI 10.1016/j.placenta.2011.04.001
   Weber B, 2011, SEMIN IMMUNOPATHOL, V33, P307, DOI 10.1007/s00281-011-0258-8
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Wystrychowski W, 2011, J VASC ACCESS, V12, P67, DOI 10.5301/JVA.2011.6360
NR 83
TC 10
Z9 10
U1 0
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAY
PY 2013
VL 37
IS 5
BP 423
EP 434
DI 10.1111/aor.12022
PG 12
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 134PC
UT WOS:000318223900003
PM 23551257
DA 2018-10-20
ER

PT J
AU Pan, Z
   Qu, ZH
   Zhang, Z
   Peng, R
   Yan, C
   Ding, JD
AF Pan, Zhen
   Qu, Ze-hua
   Zhang, Zheng
   Peng, Rong
   Yan, Ce
   Ding, Jian-dong
TI Particle-collision and porogen-leaching technique to fabricate polymeric
   porous scaffolds with microscale roughness of interior surfaces
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE Tissue engineering; Porous scaffolds; Surface topography; Cell adhesion;
   Poly(lactide-co-glycolide) (PLGA)
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS; IN-VITRO
   DEGRADATION; SUBSTRATE TOPOGRAPHY; POLY(D,L-LACTIDE-CO-GLYCOLIDE)
   SCAFFOLDS; ADHESION; GROWTH; POLY(LACTIDE-CO-GLYCOLIDE);
   DIFFERENTIATION; PROLIFERATION
AB A facile technique is herein reported to fabricate three-dimensional (3D) polymeric porous scaffolds with interior surfaces of a topographic microstructure favorable for cell adhesion. As demonstration, a well-known biodegradable polymer poly(lactide-co-glycolide) (PLGA) was employed as matrix. Under the porogen-leaching strategy, the large and soft porogens of paraffin were modified by colliding with small and hard salt particles, which generated micropits on the surfaces of paraffin spheres. The eventual PLGA scaffolds after leaching the modified porogens had thus interior surfaces of microscale roughness imprinted by those micropits. The microrough scaffolds were confirmed to benefit adhesion of bone marrow stromal cells (BMSCs) of rats and meanwhile not to hamper the proliferation and osteogenic differentiation of the cells. The insight and technique might be helpful for biomaterial designing in tissue engineering and regenerative medicine.
C1 [Pan, Zhen; Qu, Ze-hua; Zhang, Zheng; Peng, Rong; Yan, Ce; Ding, Jian-dong] Fudan Univ, State Key Lab Mol Engn Polymers, Adv Mat Lab, Dept Macromol Sci, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, State Key Lab Mol Engn Polymers, Adv Mat Lab, Dept Macromol Sci, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
FU Chinese Ministry of Science and Technology [2009CB930000, 2011CB606203];
   NSF of China [21034002, 91127028, 51273046]
FX This work was financially supported by Chinese Ministry of Science and
   Technology (973 programs Nos. 2009CB930000 and 2011CB606203), and NSF of
   China (Nos. 21034002, 91127028 and 51273046).
CR Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Chung S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045001
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Ding J., 2011, BIOMATERIALS, V32, P8045, DOI DOI 10.1016/J.BI0MATERIALS.2011.07.035)
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Haque A, 2011, BIOMATERIALS, V32, P2032, DOI 10.1016/j.biomaterials.2010.11.045
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kantawong F, 2009, BIOMATERIALS, V30, P4723, DOI 10.1016/j.biomaterials.2009.05.040
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Ke JH, 2012, CHINESE J POLYM SCI, V30, P436, DOI 10.1007/s10118-012-1133-3
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim EJ, 2010, ACTA BIOMATER, V6, P160, DOI 10.1016/j.actbio.2009.06.016
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu YJ, 2008, CHINESE J POLYM SCI, V26, P63, DOI 10.1142/S0256767908002674
   Lopez-Alvarez M, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045012
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Ma ZW, 2003, J BIOMED MATER RES B, V67B, P610, DOI 10.1002/jbm.b.10049
   Mata A, 2002, J BIOMED MATER RES, V62, P499, DOI 10.1002/jbm.10353
   Mata A, 2009, BIOMATERIALS, V30, P4610, DOI 10.1016/j.biomaterials.2009.05.023
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Moroni L, 2009, J BIOMED MATER RES A, V88A, P644, DOI 10.1002/jbm.a.31915
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Odelius K, 2011, BIOMACROMOLECULES, V12, P1250, DOI 10.1021/bm1015464
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   Qu Z., 2012, CHINESE J CHEM, V30, P2257
   Reignier J, 2006, POLYMER, V47, P4703, DOI 10.1016/j.polymer.2006.04.029
   Safinia L, 2007, MACROMOL BIOSCI, V7, P315, DOI 10.1002/mabi.200600175
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Schulte VA, 2010, BIOMACROMOLECULES, V11, P3375, DOI 10.1021/bm100881y
   Schulte VA, 2009, BIOMACROMOLECULES, V10, P2795, DOI 10.1021/bm900631s
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Shi G., 2001, J FUNCT POLYM, V14, P7
   Tanaka M, 2011, BBA-GEN SUBJECTS, V1810, P251, DOI 10.1016/j.bbagen.2010.10.002
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang W, 2011, CHINESE J POLYM SCI, V29, P233, DOI 10.1007/s10118-010-1026-2
   Wang Z, 2009, CHINESE SCI BULL, V54, P2968, DOI 10.1007/s11434-009-0181-8
   Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487
   Wu LB, 2005, TISSUE ENG, V11, P1105, DOI 10.1089/ten.2005.11.1105
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078
   Yao L, 2009, ACTA BIOMATER, V5, P580, DOI 10.1016/j.actbio.2008.09.002
   Zhang C, 2006, BIOMED MATER, V1, P56, DOI 10.1088/1748-6041/1/2/002
   Zhang JC, 2005, POLYMER, V46, P4979, DOI 10.1016/j.polymer.20058.02.120
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
   Zhao YC, 2012, CHINESE SCI BULL, V57, P234, DOI 10.1007/s11434-011-4904-2
   Zorlutuna P, 2009, BIOMACROMOLECULES, V10, P814, DOI 10.1021/bm801307y
NR 58
TC 13
Z9 13
U1 1
U2 66
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7679
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD MAY
PY 2013
VL 31
IS 5
BP 737
EP 747
DI 10.1007/s10118-013-1264-1
PG 11
WC Polymer Science
SC Polymer Science
GA 131IB
UT WOS:000317985200003
DA 2018-10-20
ER

PT J
AU Marchand-Libouban, H
   Guillaume, B
   Bellaiche, N
   Chappard, D
AF Marchand-Libouban, Helene
   Guillaume, Bernard
   Bellaiche, Norbert
   Chappard, Daniel
TI Texture analysis of computed tomographic images in osteoporotic patients
   with sinus lift bone graft reconstruction
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Sinus lift; beta-TCP; Bone graft; Texture analysis; CT scan; Image
   analysis
ID BETA-TRICALCIUM PHOSPHATE; X-RAY RADIOGRAPHS; ILIAC BONE; IMPLANTS;
   AUGMENTATION; MICROARCHITECTURE; HISTOMORPHOMETRY; SURGERY; BIOLOGY;
   HUMANS
AB Bone implants are now widely used to replace missing teeth. Bone grafting (sinus lift) is a very useful way to increase the bone volume of the maxilla in patients with bone atrophy. There is a 6- to 9-month delay for the receiver grafted site to heal before the implants can be placed. Computed tomography is a useful method to measure the amount of remaining bone before implantation and to evaluate the quality of the receiver bone at the end of the healing period. Texture analysis is a non-invasive method useful to characterize bone microarchitecture on X-ray images.
   Ten patients in which a sinus lift surgery was necessary before implantation were analyzed in the present study. All had a bone reconstruction with a combination of a biomaterial (beta tricalcium phosphate) and autograft bone harvested at the chin. Computed tomographic images were obtained before grafting (t0), at mid-interval (t1, 4.2 +/- 0.7 months) and before implant placement (t2, 9.2 +/- 0.6 months). Texture analysis was done with the run-length method.
   A significant increase of texture parameters at t1 reflected a gain of homogeneity due to the graft and the beginning of bone remodeling. At t2, some parameters remained high and corresponded to the persistence of bone trabeculae while the resorption of biomaterials was identified by other parameters which tended to return to pregraft values.
   Texture analysis identified changes during the healing of the receiver site.
   The method is known to correlate with microarchitectural changes in bone and could be a useful approach to characterized osseointegrated grafts.
C1 [Marchand-Libouban, Helene; Chappard, Daniel] LUNAM Univ, GEROM LHEA, CHU Angers, IRIS IBS Inst Biol Sante, F-49933 Angers, France.
   [Guillaume, Bernard] CFI, F-75008 Paris, France.
   [Bellaiche, Norbert] Ctr Imagerie Numerisee St Germain, F-75007 Paris, France.
   [Chappard, Daniel] CHU Angers, IRIS IBS Inst Biol Sante, GEROM LHEA, F-49933 Angers, France.
RP Chappard, D (reprint author), CHU Angers, IRIS IBS Inst Biol Sante, GEROM LHEA, F-49933 Angers, France.
EM daniel.chappard@univ-angers.fr
FU Contrat de Plan Etat-Region "Pays de la Loire" Bioregos2
FX This work was made possible by grants from Contrat de Plan Etat-Region
   "Pays de la Loire" Bioregos2. The beta-TCP was provided by Kasios
   (Launaguet, France). Thanks to Mrs. L. Lechat for secretarial
   assistance.
CR Abubaker AO, 1992, MODERN PRACTICE ORTH, P975
   Askew CA, 2005, BRIT J ORAL MAX SURG, V43, P341, DOI 10.1016/j.bjoms.2004.10.016
   Bodic F, 2005, JOINT BONE SPINE, V72, P215, DOI 10.1016/j.jbspin.2004.03.007
   Bodic F, 2012, GERODONTOLOGY, V29, pE585, DOI 10.1111/j.1741-2358.2011.00527.x
   BucklandWright JC, 1996, ANN RHEUM DIS, V55, P749, DOI 10.1136/ard.55.10.749
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Chappard D, 2005, J BONE MINER METAB, V23, P24, DOI 10.1007/s00774-004-0536-9
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   CHU A, 1990, PATTERN RECOGN LETT, V11, P415, DOI 10.1016/0167-8655(90)90112-F
   Cortet B, 2004, CALCIFIED TISSUE INT, V75, P23, DOI 10.1007/s00223-004-0086-0
   Farman AG, 2005, ORAL SURG ORAL MED O, V100, P395, DOI 10.1016/j.tripleo.2005.05.055
   Galindo-Moreno P, 2007, CLIN ORAL IMPLAN RES, V18, P376, DOI 10.1111/j.1600-0501.2007.01337.x
   Galloway M. M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI [DOI 10.1016/S0146-664X(75)80008-6, 10.1016/S0146-664X(75)80008-6]
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Guerrero ME, 2006, CLIN ORAL INVEST, V10, P1, DOI 10.1007/s00784-005-0031-2
   Guggenbuhl P, 2006, OSTEOPOROSIS INT, V17, P447, DOI 10.1007/s00198-005-0007-8
   Guillaume B, 2010, TITANE, V7, P201
   Guillaume B, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015012
   Haas R, 2002, CLIN ORAL IMPLAN RES, V13, P581, DOI 10.1034/j.1600-0501.2002.130602.x
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Jung YS, 2003, INT J ORAL MAX SURG, V32, P638, DOI 10.1054/ijom.2002.0415
   Kahnberg KE, 2001, CLIN ORAL IMPLAN RES, V12, P479, DOI 10.1034/j.1600-0501.2001.120508.x
   Klijn RJ, 2010, TISSUE ENG PART B-RE, V16, P493, DOI [10.1089/ten.teb.2010.0035, 10.1089/ten.TEB.2010.0035]
   Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Linkow LI, 1976, DENT DIG, V7, P9
   Marquez S, 2008, ANAT REC, V291, P1350, DOI 10.1002/ar.20791
   Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P150, DOI 10.1111/j.1600-0501.2004.00978.x
   Nyangoga H, 2010, ACTA BIOMATER, V6, P3310, DOI 10.1016/j.actbio.2010.01.042
   Papa F, 2005, BRIT J ORAL MAX SURG, V43, P309, DOI 10.1016/j.bjoms.2004.08.027
   Pothuaud L, 2000, J BONE MINER RES, V15, P691, DOI 10.1359/jbmr.2000.15.4.691
   Schwartz Z, 2007, CLIN ORAL IMPLAN RES, V18, P204, DOI 10.1111/j.1600-0501.2006.01303.x
   SMILER D G, 1992, Dental Clinics of North America, V36, P151
   Szczypinski PM, 2009, COMPUT METH PROG BIO, V94, P66, DOI 10.1016/j.cmpb.2008.08.005
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P26
   Widmark G, 1997, INT J ORAL MAX SURG, V26, P106, DOI 10.1016/S0901-5027(05)80827-6
   Zinner Ira D., 1996, Journal of the American Dental Association, V127, P51
NR 37
TC 4
Z9 5
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD MAY
PY 2013
VL 17
IS 4
BP 1267
EP 1272
DI 10.1007/s00784-012-0808-z
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 129TZ
UT WOS:000317866800018
PM 22886459
DA 2018-10-20
ER

PT J
AU Johnson, G
   Curry, B
   Cahalan, L
   Prater, R
   Biggerstaff, J
   Hussain, A
   Gartner, M
   Cahalan, P
AF Johnson, G.
   Curry, B.
   Cahalan, L.
   Prater, R.
   Biggerstaff, J.
   Hussain, A.
   Gartner, M.
   Cahalan, P.
TI Effects of surface-bound and intravenously administered heparin on
   cell-surface interactions: inflammation and coagulation
SO PERFUSION-UK
LA English
DT Article
DE flow cytometry; platelet activation; leukocyte activation; heparin;
   anti-thrombin
ID FACTOR PATHWAY INHIBITOR; IN-VITRO; IMMOBILIZED HEPARIN; PROCOAGULANT
   ACTIVITY; PLATELET ACTIVATION; ENDOTHELIAL-CELLS; CONTACT SYSTEM;
   COMPLEMENT; BINDING; MODEL
AB Intravenous administration of heparin and heparin-bonded extracorporeal circuits are frequently used to mitigate the deleterious effects of blood contact with synthetic materials. The work described here utilized human blood in a micro-perfusion circuit to experimentally examine the effects of intravenous and surface-bound heparin on cellular activation. Activation markers of coagulation and of the inflammatory response were examined using flow cytometry; specifically, markers of platelet, monocyte, polymorphonuclear leukocyte (PMN), and lymphocyte activation were quantified. The results indicate that surface-bound heparin reduces the inflammatory response whereas systemically administered heparin does not. This finding has important implications for blood-contacting devices, particularly within the context of recently elucidated connections between inflammation pathways and coagulation disorders. Data presented indicate that surface-bound heparin and intravenously administered heparin play distinct, but vital roles in rendering biomaterial surfaces compatible with blood.
C1 [Johnson, G.; Cahalan, L.; Hussain, A.; Gartner, M.; Cahalan, P.] Ension Inc, Pittsburgh, PA 15238 USA.
   [Curry, B.; Prater, R.; Biggerstaff, J.] Univ Tennessee, Knoxville, TN USA.
RP Johnson, G (reprint author), Ension Inc, 240 William Pitt Way, Pittsburgh, PA 15238 USA.
EM gjohnson@ension.com
OI Curry, Benjamin/0000-0003-3830-1311
FU NIH/NHLBI [HHSN268201000012C, R44HL083563]
FX NIH/NHLBI Contract HHSN268201000012C and Grant R44HL083563
CR Amara U, 2008, CURRENT TOPICS COMPL, DOI 10:1007/978-0-387-78952-1_6
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   [Anonymous], 1995, CHROM PROD MON
   Barnard MR, 2005, J THROMB HAEMOST, V3, P2563, DOI 10.1111/j.1538-7836.2005.01603.x
   Blezer R, 1998, BLOOD COAGUL FIBRIN, V9, P435, DOI 10.1097/00001721-199807000-00006
   BLOCKMANS D, 1995, BLOOD REV, V9, P143, DOI 10.1016/0268-960X(95)90020-9
   Colman RW, 1997, BLOOD, V90, P3819
   Dabbagh K, 1998, EUR RESPIR J, V11, P1002, DOI 10.1183/09031936.98.11051002
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Frick IM, 2007, THROMB HAEMOSTASIS, V98, P497, DOI 10.1160/TH07-01-0051
   Garred P, 1997, ARTIF ORGANS, V21, P293
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grady RM, 1995, J AM COLL CARDIOL, V25, P325
   Hansen JB, 2000, THROMB HAEMOSTASIS, V83, P937
   Hoffman M, 2003, BLOOD REV, V17, pS1, DOI 10.1016/S0268-960X(03)90000-2
   John R, 2009, ANN THORAC SURG, V88, P1171, DOI 10.1016/j.athoracsur.2009.06.095
   Johnson G, 2013, J BIOMATER APPL, V27, P925, DOI 10.1177/0885328211428525
   Jy WC, 1995, BLOOD CELL MOL DIS, V21, P217, DOI 10.1006/bcmd.1995.0025
   KODAMA K, 1987, THROMB HAEMOSTASIS, V58, P1064
   Lappegard KT, 2004, ANN THORAC SURG, V77, P932, DOI 10.1016/S0003-4975(03)01519-4
   Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21
   Lupu C, 1999, ARTERIOSCL THROM VAS, V19, P2251, DOI 10.1161/01.ATV.19.9.2251
   Mickelson JK, 1996, J AM COLL CARDIOL, V28, P345, DOI 10.1016/0735-1097(96)00164-7
   Ovrum E, 1995, ANN THORAC SURG, V60, P1755, DOI 10.1016/0003-4975(95)00763-6
   PASCHE B, 1991, THROMB RES, V62, P531, DOI 10.1016/0049-3848(91)90026-S
   PASCHE B, 1986, THROMB RES, V44, P739, DOI 10.1016/0049-3848(86)90020-4
   Passacquale G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025595
   Reddy M, 2004, J IMMUNOL METHODS, V293, P127, DOI 10.1016/j.jim.2004.07.006
   Riddel JP, 2007, J PEDIATR ONCOL NURS, V24, P123, DOI 10.1177/1043454206298693
   Sanchez J, 1997, J BIOMED MATER RES, V37, P37, DOI 10.1002/(SICI)1097-4636(199710)37:1<37::AID-JBM5>3.3.CO;2-O
   Seizer P, 2008, CURR MED CHEM, V15, P1976, DOI 10.2174/092986708785132852
   SIMS PJ, 1995, SEMIN CELL BIOL, V6, P275, DOI 10.1006/scel.1995.0037
   Smith SA, 2009, J VET EMERG CRIT CAR, V19, P3, DOI 10.1111/j.1476-4431.2009.00389.x
   Sokolov A, 2013, J BIOMED MATER RES A, V101, P575, DOI 10.1002/jbm.a.34348
   Weber N, 2000, J BIOMATER APPL, V15, P8, DOI 10.1106/DUYU-CEL6-529C-WUL9
   Weerwind PW, 1998, INT J ARTIF ORGANS, V21, P291
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Wendel HP, 1999, PERFUSION-UK, V14, P21, DOI 10.1177/026765919901400104
   WEST RH, 1995, J MATER SCI-MATER M, V6, P63, DOI 10.1007/BF00120408
   Wilhelm CR, 1998, ANN THORAC SURG, V65, P1071, DOI 10.1016/S0003-4975(98)00111-8
   Ye A, 1998, THROMB RES, V89, P263
NR 41
TC 5
Z9 5
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PD MAY
PY 2013
VL 28
IS 3
BP 263
EP 271
DI 10.1177/0267659113475834
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 131JF
UT WOS:000317988500014
PM 23401339
DA 2018-10-20
ER

PT J
AU Cardamone, JM
   Tunick, MH
   Onwulata, C
AF Cardamone, Jeanette M.
   Tunick, Michael H.
   Onwulata, Charles
TI Keratin sponge/hydrogel: I. Fabrication and characterization
SO TEXTILE RESEARCH JOURNAL
LA English
DT Article
DE keratin; wool; sponge/hydrogel; biomaterial; structure/property
   relationships
ID DIFFERENTIAL SCANNING CALORIMETRY; MEDIATED CROSS-LINKING; WOOL KERATIN;
   FIBERS; TRANSGLUTAMINASE; SCAFFOLDS; HYDROGELS; SPONGE; MODEL
AB Keratin sponge/hydrogels formed by oxidation and reduction hydrolysis of US domestic fine-or coarse-grade wool exhibited distinctively different topologies, each with unique porous structure. These materials retained amino acids and microstructure as protein homologues of intact keratin. Amphoteric character was confirmed by differential dyeing with anionic and cationic dyes. Differential scanning calorimetry (DSC) provided evidence of molecular organization and the behavior of occluded moisture through measurements of glass transition, peak temperature, thermal degradation temperature, enthalpy of water removal, and degradation (T-g, T-w, Delta H-w, T-t, and Delta H-t). The absence of denaturation peaks indicated highly crosslinked molecular association. Low Delta H-w indicated high plasticity and the ability to absorb and retain moisture. Small amplitude strain analysis rheology to measure storage or elastic modulus, G', and shear loss or viscous modulus, G '', as a function of applied strain characterized the sponge/hydrogels as covalently crosslinked networks. With viscoelastic properties typical of both liquids and solids, they maintained their structural integrity under strain.
C1 [Cardamone, Jeanette M.; Tunick, Michael H.; Onwulata, Charles] USDA ARS Wyndmoor, Wyndmoor, PA USA.
RP Cardamone, JM (reprint author), USDA ARS ERRC Wool & Keratin From Wool Res, 600 E Mermaid Lane, Wyndmoor, PA 19038 USA.
EM jan.cardamone@ars.usda.gov
RI Tunick, Michael/C-9761-2010
CR Bendit EG, 1960, TEXT RES J, V30, P547
   Cao JN, 1997, J APPL POLYM SCI, V63, P411, DOI 10.1002/(SICI)1097-4628(19970124)63:4<411::AID-APP1>3.0.CO;2-U
   Cardamnone JM, 2007, TEXT RES J, V77, P277, DOI 10.1177/004517507078788
   Cardamone J M, 2006, US Patent, Patent No. [7,090,701, 7090701]
   Cardamone JM, 2008, INT J BIOL MACROMOL, V42, P413, DOI 10.1016/j.ijbiomac.2008.02.004
   Cardamone JM, 2007, TEXT RES J, V77, P214, DOI 10.1177/0040517507076327
   Cardamone JM, 2010, J MOL STRUCT, V969, P97, DOI 10.1016/j.molstruc.2010.01.048
   Celikiz G., 1983, COLOR TECHNOLOGY TEX
   CHAPMAN BM, 1969, TEXT RES J, V39, P1102, DOI 10.1177/004051756903901204
   COHEN SA, 1994, J CHROMATOGR A, V661, P25, DOI 10.1016/0021-9673(93)E0821-B
   CORFIELD MC, 1955, BIOCHEM J, V59, P62, DOI 10.1042/bj0590062
   Dusenbury JH, 1963, WOOL HDB, V1, P225
   FEUGHELMAN M, 1994, TEXT RES J, V64, P236, DOI 10.1177/004051759406400408
   Feughelman M, 1959, TEXT RES J, V29, P223, DOI DOI 10.1177/004051755902900305
   Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1
   Kauder OS, 1983, ENCY CHEM TECHNOLOGY, V22, P946
   Kelly RW, 2008, NATION, V287, P2
   Manich AM, 2005, J THERM ANAL CALORIM, V82, P119, DOI 10.1007/s70973-005-6922-8
   Marti M, 2007, J APPL POLYM SCI, V104, P545, DOI 10.1002/app.25586
   MENEFEE E, 1965, TEXT RES J, V35, P801, DOI 10.1177/004051756503500904
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   PHILLIPS DG, 1985, TEXT RES J, V55, P171, DOI 10.1177/004051758505500306
   Schrooyen PMM, 2001, J AGR FOOD CHEM, V49, P221, DOI 10.1021/jf0004154
   SPEI M, 1989, COLLOID POLYM SCI, V267, P549, DOI 10.1007/BF01416064
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   Timmons SF, 2003, US Patent Application, Patent No. [0035820 A1, 0035820]
   Tunick MH, 2011, J AGR FOOD CHEM, V59, P1481, DOI 10.1021/jf1016237
   Tunick MH, 2011, J AGR FOOD CHEM, V59, P1477, DOI 10.1021/jf1021994
   Van Dyke ME, 2002, US Patent, Patent No. [6,371,984 B1, 6371984]
   Van Hekken DL, 2005, J DAIRY SCI, V88, P1966, DOI 10.3168/jds.S0022-0302(05)72872-1
   WARD WH, 1954, ADV PROTEIN CHEM, V9, P243, DOI 10.1016/S0065-3233(08)60208-9
   WORTMANN FJ, 1994, TEXT RES J, V64, P737, DOI 10.1177/004051759406401206
   WORTMANN FJ, 1993, J APPL POLYM SCI, V48, P137, DOI 10.1002/app.1993.070480114
   ZAHN H, 1980, IND ENG CHEM PROD RD, V19, P496, DOI 10.1021/i360076a005
   Zhan H, 2003, ULLMANNS ENCY IND CH
   Zhang XZ, 2002, MATER LETT, V52, P5, DOI 10.1016/S0167-577X(01)00355-X
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 38
TC 4
Z9 4
U1 3
U2 62
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0040-5175
EI 1746-7748
J9 TEXT RES J
JI Text. Res. J.
PD MAY
PY 2013
VL 83
IS 7
BP 661
EP 670
DI 10.1177/0040517512468814
PG 10
WC Materials Science, Textiles
SC Materials Science
GA 130QX
UT WOS:000317935000001
DA 2018-10-20
ER

PT J
AU Macaya, DJ
   Hayakawa, K
   Arai, K
   Spector, M
AF Macaya, Daniel J.
   Hayakawa, Kazuhide
   Arai, Ken
   Spector, Myron
TI Astrocyte infiltration into injectable collagen-based hydrogels
   containing FGF-2 to treat spinal cord injury
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Fibroblast growth factor; Nerve tissue engineering;
   Chemotaxis; In vitro test; Spinal cord injury
ID FIBROBLAST-GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCAN; INTRATHECAL
   DELIVERY-SYSTEM; FACTOR BFGF; FUNCTIONAL RECOVERY; GLIAL SCAR;
   RAT-BRAIN; REACTIVE ASTROCYTES; WHITE-MATTER; REGENERATION
AB Astrocytes can play dual roles in the response to spinal cord injury (SCI) acting as both an inhibitory barrier and a trophic support for growth axons. Therefore, migration of these cells into the defect as opposed to forming a scar at the periphery, may promote axon regeneration through the lesion. However, infiltration requires the conformal filling of the cyst-like lesion, which often forms after SCI, with a biomaterial scaffold encouraging of astrocyte migration. For this application, we investigated injectable collagen-based hydrogels covalently cross-linked with genipin and incorporating fibroblast growth factor-2 (FGF-2) either freely or encapsulated within lipid microtubules (LMTs). An outgrowth assay was used to evaluate in vitro the number of primary rat astrocytes infiltrating into the collagen gels and the distance to which they infiltrated. The presence of FGF-2 within the encapsulating gel significantly increased the number of astrocytes within the gel, their penetration distance into the gel, and caused them to move out in a chain-like pattern, compared to control gels without FGF-2. Genipin cross-linking of the collagen gel decreased the number of infiltrating astrocytes, compared to the non-cross-linked control gel; however, incorporation of FGF-2-containing LMTs within genipin-cross-linked gels restored the astrocyte infiltration to levels approaching non-cross-linked gels incorporating FGF-2. Overall, injectable collagen-genipin hydrogels containing FGF-2-containing LMTs are a promising candidate for the treatment for SCI through the attraction of astrocytes into the graft. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Macaya, Daniel J.; Spector, Myron] Harvard Univ, Brigham & Womens Hosp, Sch Med, VA Boston Healthcare Syst, Boston, MA 02115 USA.
   [Macaya, Daniel J.] Harvard Massachusetts Inst Technol, Cambridge, MA USA.
   [Hayakawa, Kazuhide; Arai, Ken] Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA.
   [Hayakawa, Kazuhide; Arai, Ken] Harvard Univ, Sch Med, Charlestown, MA USA.
   [Hayakawa, Kazuhide; Arai, Ken] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA.
RP Spector, M (reprint author), 150 S Huntington Ave,MS151, Boston, MA 02130 USA.
EM mspector@rics.bwh.harvard.edu
OI Spector, Myron/0000-0003-3328-4858
FU NSF Fellowship; VA Research Career Scientist Award; U.S. Department of
   Veterans Affairs, Veterans Health Administration, Rehabilitation
   Research and Development Service
FX D.M. was supported by an NSF Fellowship, and MS by a VA Research Career
   Scientist Award. The work was supported in part by the U.S. Department
   of Veterans Affairs, Veterans Health Administration, Rehabilitation
   Research and Development Service.
CR ARD MD, 1988, J NEUROSCI, V8, P2844
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26
   Bribian A, 2006, MOL CELL NEUROSCI, V33, P2, DOI 10.1016/j.mcn.2006.05.009
   Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014
   Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85
   Davies SJA, 1997, NATURE, V390, P680
   Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999
   Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9
   FaberElman A, 1996, J CLIN INVEST, V97, P162, DOI 10.1172/JCI118385
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Goddard DR, 2002, J ANAT, V200, P57, DOI 10.1046/j.0021-8782.2001.00002.x
   Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012
   GOMEZPINILLA F, 1994, NEUROSCIENCE, V61, P911, DOI 10.1016/0306-4522(94)90412-X
   Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030
   Hayakawa K, 2010, GLIA, V58, P1007, DOI 10.1002/glia.20982
   HOU YJ, 1995, J NEUROSCI RES, V40, P359, DOI 10.1002/jnr.490400310
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Kalman M, 2003, ADV MOL CELL BIOL, P787
   Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029
   Kitano A, 2006, OPHTHAL RES, V38, P355, DOI 10.1159/000096231
   Kitano A, 2006, J CATARACT REFR SURG, V32, P1727, DOI 10.1016/j.jcrs.2006.05.015
   Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Lee TT, 1999, J NEUROTRAUM, V16, P347, DOI 10.1089/neu.1999.16.347
   Lichtenstein MP, 2012, NEUROSIGNALS, V20, P86, DOI 10.1159/000330805
   Macaya D, 2011, ADV FUNCT MATER, V21, P4788, DOI 10.1002/adfm.201101720
   Mahoney MJ, 2007, J BIOMED MATER RES A, V81A, P269, DOI 10.1002/jbm.a.30970
   Meilander NJ, 2001, J CONTROL RELEASE, V71, P141, DOI 10.1016/S0168-3659(01)00214-0
   MENON VK, 1994, EXP NEUROL, V129, P142, DOI 10.1006/exnr.1994.1155
   Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5
   National Spinal Cord Injury Statistical Center, 2012, SPIN CORD INJ FACTS
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   Parr AM, 2007, NEUROSURGERY, V60, P926, DOI 10.1227/01.NEU.0000255441.59612.98
   Polikov VS, 2009, J NEUROSCI METH, V181, P170, DOI 10.1016/j.jneumeth.2009.05.002
   Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817
   Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399
   Reilly JF, 1997, BRAIN RES, V759, P277, DOI 10.1016/S0006-8993(97)00267-9
   Renault-Mihara F, 2011, EMBO MOL MED, V3, P682, DOI 10.1002/emmm.201100179
   Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978
   Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591
   Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321
   Spyrou GE, 2002, BRIT J PLAST SURG, V55, P275, DOI 10.1054/bjps.2002.3831
   Suzuki H, 2007, J HEALTH SCI, V53, P730, DOI 10.1248/jhs.53.730
   Teng YD, 1999, J NEUROSCI, V19, P7037
   Vaccarino FM, 2007, NEUROSCIENTIST, V13, P173, DOI 10.1177/1073858406298336
   White RE, 2008, EXP NEUROL, V214, P10, DOI 10.1016/j.expneurol.2008.06.012
   White RE, 2011, J NEUROSCI, V31, P15173, DOI 10.1523/JNEUROSCI.3441-11.2011
   Yamazaki M, 2005, J HEALTH SCI, V51, P687, DOI 10.1248/jhs.51.687
   Yun YR, 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/218142
   Zai LJ, 2005, BRAIN RES, V1052, P147, DOI 10.1016/j.brainres.2005.05.071
   Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200
   Zittermann SI, 2006, AM J PATHOL, V168, P835, DOI 10.2353/ajpath.2006.050479
   Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1
NR 58
TC 26
Z9 26
U1 2
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2013
VL 34
IS 14
BP 3591
EP 3602
DI 10.1016/j.biomaterials.2012.12.050
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 125IT
UT WOS:000317534200006
PM 23414684
DA 2018-10-20
ER

PT J
AU Li, YX
   Wang, YL
   Wang, PP
   Zhang, BB
   Yan, WW
   Sun, JX
   Pan, J
AF Li, Yuxiao
   Wang, Yuanliang
   Wang, Pinpin
   Zhang, Bingbing
   Yan, Weiwei
   Sun, Jiaoxia
   Pan, Jun
TI In vitro cytocompatibility evaluation of MGF-Ct24E chemically grafted
   and physically blended with maleic anhydride modified poly(D, L-lactic
   acid)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE poly(D; L-lactic acid); MGF-Ct24E; blends; cytocompatibility; rat
   calvarial osteoblasts
ID MECHANO-GROWTH-FACTOR; POLY(D,L-LACTIC ACID); BIOMIMETIC MATERIALS;
   PROTEIN; MUSCLE; CELLS; MINERALIZATION; NANOPARTICLES; OSTEOBLASTS;
   MATURATION
AB As a growth repair factor, mechano-growth factor (MGF) and its 24 amino acid peptide analogs corresponding to the unique C-terminal E-domain (MGF-Ct24E) positively regulate bone regeneration. MGF-Ct24E was introduced into the poly(D, L-lactic acid) (PDLLA) to improve bone regeneration in our previous study. MGF-Ct24E-grafted PDLLA was chemically characterized and showed potential as a biofunctional polymer. In this study, we evaluated the cytocompatibility of MGF-Ct24E chemically grafted and physically blended with maleic anhydride modified PDLLA, relative to maleic anhydride modified PDLLA (MPLA) as the control. The surface properties of these three polymer films were characterized with scanning electron microscopy and X-ray photoelectron spectroscopy. Rat calvarial osteoblasts were seeded on the three polymer films, and cell adhesion, spreading, and proliferation were assessed with an inverted microscope, laser scanning confocal microscope, and a cell counting kit-8, respectively. The alkaline phosphatase activity and extracellular calcium production were exploited to characterize the differentiation and mineralization of rat calvarial osteoblasts on various polymer films. The results revealed that compared with MPLA, MGF-Ct24E-MPLA, and MGF-Ct24E/MPLA blends promoted adhesion, spreading, proliferation, and the later differentiation and mineralization process of rat calvarial osteoblasts. In addition, the positive effect of MGF-Ct24E-MPLA on rat calvarial osteoblasts was maintained longer than the MGF-Ct24E/MPLA blends. In conclusion, MGF-Ct24E-MPLA synthesized chemically might be a promising biomaterial for bone tissue engineering.
C1 [Li, Yuxiao; Wang, Yuanliang; Wang, Pinpin; Zhang, Bingbing; Yan, Weiwei; Sun, Jiaoxia; Pan, Jun] Chongqing Univ, Coll Bioengn, Res Ctr Bioinspired Mat Sci & Engn, Chongqing 630044, Peoples R China.
RP Wang, YL (reprint author), Chongqing Univ, Coll Bioengn, Res Ctr Bioinspired Mat Sci & Engn, Chongqing 630044, Peoples R China.
EM wyl@cqu.edu.cn; panj@cqu.edu.cn
FU National Natural Science Foundation of China [11032012, 30870609];
   Natural Science Foundation of CQ CSTC [2009BA4025, 2009BB4382,
   2010BB5225]
FX This work was supported by a grant from the National Natural Science
   Foundation of China (11032012, 30870609), the Natural Science Foundation
   of CQ CSTC (2009BA4025, 2009BB4382, 2010BB5225).
CR Alves CM, 2008, J BIOMED MATER RES B, V87B, P59, DOI 10.1002/jbm.b.31068
   Ates K, 2007, FEBS LETT, V581, P2727, DOI 10.1016/j.febslet.2007.05.030
   Bil M, 2007, BIOMED MATER, V2, P93, DOI 10.1088/1748-6041/2/2/006
   Carpenter V, 2008, HEART LUNG CIRC, V17, P33, DOI 10.1016/j.hlc.2007.04.013
   Cheddadi M, 2011, INT J PHARMACEUT, V413, P126, DOI 10.1016/j.ijpharm.2011.04.042
   Chen X, 2011, ARCH ORAL BIOL, V57, P720
   Dai ZQ, 2010, GROWTH HORM IGF RES, V20, P275, DOI 10.1016/j.ghir.2010.03.005
   Deng MY, 2011, INT ORTHOP, V35, P1099, DOI 10.1007/s00264-010-1141-2
   Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Goldspink G, 2005, PHYSIOLOGY, V20, P232, DOI 10.1152/physiol.00004.2005
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hill M, 2003, J ANAT, V203, P89, DOI 10.1046/j.1469-7580.2003.00195.x
   Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120
   Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Li YP, 2001, J CONTROL RELEASE, V71, P203, DOI 10.1016/S0168-3659(01)00218-8
   Luo YF, 2008, EUR POLYM J, V44, P1390, DOI 10.1016/j.eurpolymj.2008.01.043
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Niu XF, 2008, J BIOMED MATER RES A, V84A, P908, DOI 10.1002/jbm.a.31360
   Niu X, 2009, POLYM DEGRAD STABIL, V94, P176, DOI 10.1016/j.polymdegradstab.2008.11.008
   Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6
   Quesada A, 2009, EXP NEUROL, V220, P255, DOI 10.1016/j.expneurol.2009.08.029
   Rao S. S., 2009, FRONT NEUROENG, V2, P1, DOI 10.3389/neuro.16.006.2009
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sittichockechaiwut A, 2009, BONE, V44, P822, DOI 10.1016/j.bone.2008.12.027
   [唐丽灵 Tang Liling], 2003, [生物物理学报, Acta Biophysica Sinica], V19, P88
   Xiang Y, 2011, COLLOID SURFACE B, V85, P248, DOI 10.1016/j.colsurfb.2011.02.036
   Yonezawa T, 2011, BIOCHEM BIOPH RES CO, V409, P260, DOI 10.1016/j.bbrc.2011.05.001
   Zahm AM, 2008, BONE, V43, P25, DOI 10.1016/j.bone.2008.03.010
   ZHANG BB, 2008, CHIN J BIOTECHNOL, V24, P1180
   Zhang BB, 2009, SCI CHINA SER C, V52, P928, DOI 10.1007/s11427-009-0122-4
NR 34
TC 3
Z9 3
U1 1
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD MAY 1
PY 2013
VL 24
IS 7
BP 849
EP 864
DI 10.1080/09205063.2012.723957
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 128BL
UT WOS:000317743000007
PM 23594073
DA 2018-10-20
ER

PT J
AU Fathi, M
   Farajollahi, AR
   Entezami, AA
AF Fathi, Marziyeh
   Farajollahi, Ali Reza
   Entezami, Ali Akbar
TI Synthesis of fast response crosslinked PVA-g-NIPAAm nanohydrogels by
   very low radiation dose in dilute aqueous solution
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
DE Thermosensitive; Nanohydrogels; Dilute solution; Radiation; Oxygen
   scavenger; Crosslinking density
ID POLYMER NETWORK HYDROGELS; ACID) COPOLYMERIC HYDROGELS; ELECTRON-BEAM
   IRRADIATION; CONTROLLED DRUG-RELEASE; SEMI-IPN HYDROGELS;
   N-ISOPROPYLACRYLAMIDE; POLY(VINYL ALCOHOL); SWELLING BEHAVIOR;
   PHASE-TRANSITION; TEMPERATURE
AB Nanohydrogels of poly(vinyl alcohol)-g-N-isopropylacrylamide (PVA-g-NIPAAm) are synthesized by PVA and NIPAAm dilute aqueous solution using much less radiation dose of 1-20 Gy via intramolecular crosslinking at ambient temperature. The radiation synthesis of nanohydrogels is performed in the presence of tetrakis (hydroxymethyl) phosphonium chloride (THPC) due to its rapid oxygen scavenging abilities and hydrogen peroxide (H2O2) as a source of hydroxyl radicals. The effect of radiation dose, feed composition ratio of PVA and H2O2 is investigated on swelling properties such as temperature and pH dependence of equilibrium swelling ratio as well as deswelling kinetics. Experimental data exhibit high equilibrium swelling ratio and fast response time for the synthesized nanohydrogels. The average molecular weight between crosslinks (M-c) and crosslinking density (rho(x)) of the obtained nanohydrogels are calculated from swelling data as a function of radiation dose, H2O2 and PVA amount. Fourier transform infrared spectroscopy (FT-IR), elemental analysis of nitrogen content and thermogravimetric analysis (TGA) are used to confirm the grafting reaction. Lower critical solution temperature (LCST) is measured around 33 degrees C by differential scanning calorimetry (DSC) for PVA-g.-NIPAAm nanohydrogels. Dynamic light scattering (DLS) data demonstrate that the increase of radiation dose leads to the decreasing in dimension of nanohydrogels. Also, theological studies are confirmed an improvement in the mechanical properties of the nanohydrogels with increasing the radiation dose. A cytotoxicity study exhibits a good biocompatibility for the obtained nanohydrogels. The prepared nanohydrogels show fast swelling/deswelling behavior, high swelling ratio, dual sensitivity and good cytocompatibility, which may find potential applications as biomaterial. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Fathi, Marziyeh; Entezami, Ali Akbar] Univ Tabriz, Lab Polymer, Fac Chem, Tabriz, Iran.
   [Farajollahi, Ali Reza] Tabriz Univ Med Sci, Fac Med, Dept Med Phys, Tabriz, Iran.
RP Entezami, AA (reprint author), Univ Tabriz, Lab Polymer, Fac Chem, Tabriz, Iran.
EM aaentezami@yahoo.com
OI Farajollahi, Alireza/0000-0001-5549-9847
CR Barros JAG, 2006, POLYMER, V47, P8414, DOI 10.1016/j.polymer.2006.10.033
   Bhardwaj YK, 2003, J APPL POLYM SCI, V88, P730, DOI 10.1002/app.12023
   Calvet D, 2004, MACROMOLECULES, V37, P7762, DOI 10.1021/ma049072r
   Caykara T, 2004, J APPL POLYM SCI, V91, P2168, DOI 10.1002/app.13339
   Caykara T, 2007, POLYM INT, V56, P275, DOI 10.1002/pi.2162
   Cherian E., 2007, J AM CHEM SOC, V129, P11350
   Constantin M, 2011, EXPRESS POLYM LETT, V5, P839, DOI 10.3144/expresspolymlett.2011.83
   Constantin M, 2009, REV ROUM CHIM, V54, P1031
   Dumitriu RP, 2011, POLYM INT, V60, P1398, DOI 10.1002/pi.3093
   El-Mohdy HLA, 2008, RADIAT PHYS CHEM, V77, P273, DOI 10.1016/j.radphyschem.2007.05.006
   Flory PJ, 1959, PRINCIPLES POLYM CHE
   Gao J, 2003, LANGMUIR, V19, P5217, DOI 10.1021/la034207s
   Geever LM, 2011, J MATER SCI, V46, P509, DOI 10.1007/s10853-010-4962-x
   Ghaemy M, 2012, CARBOHYD POLYM, V90, P1265, DOI 10.1016/j.carbpol.2012.06.069
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Jabbari E, 2000, EUR POLYM J, V36, P2685, DOI 10.1016/S0014-3057(00)00044-6
   Kadlubowski S, 2003, MACROMOLECULES, V36, P2484, DOI 10.1021/ma021628s
   Kadlubowski S, 2007, POLYMER, V48, P4974, DOI 10.1016/j.polymer.2007.06.033
   Kato N, 2003, MACROMOLECULES, V36, P961, DOI 10.1021/ma0214198
   Kim SJ, 2003, J APPL POLYM SCI, V89, P2041, DOI 10.1002/app.12471
   Kim SJ, 2003, J APPL POLYM SCI, V90, P881, DOI 10.1002/app.12794
   Kim SJ, 2003, J APPL POLYM SCI, V89, P890, DOI 10.1002/app.12331
   Kim SJ, 2003, REACT FUNCT POLYM, V55, P61, DOI 10.1016/S1381-5148(02)00215-8
   Kumari M, 2012, RADIAT PHYS CHEM, V81, P1729, DOI 10.1016/j.radphyschem.2012.05.018
   Loh XJ, 2010, J CONTROL RELEASE, V143, P175, DOI 10.1016/j.jconrel.2009.12.030
   Maeda T, 2009, LANGMUIR, V25, P9510, DOI 10.1021/la9007735
   McAuley K. B., 2006, Journal of Physics: Conference Series, V56, P35, DOI 10.1088/1742-6596/56/1/004
   Mendrek S, 2009, MACROMOLECULES, V42, P9161, DOI 10.1021/ma901849j
   Molina MA, 2011, EUR POLYM J, V47, P1977, DOI 10.1016/j.eurpolymj.2011.07.015
   Morinloto N, 2008, MACROMOLECULES, V41, P5985, DOI 10.1021/ma801332x
   OGATA T, 1995, J MEMBRANE SCI, V103, P159, DOI 10.1016/0376-7388(94)00316-Q
   Panda A, 2000, RADIAT PHYS CHEM, V58, P101, DOI 10.1016/S0969-806X(99)00349-7
   Peppas N.A., 2002, MACROMOLECULES, V35, P3668
   PEPPAS NA, 1977, J APPL POLYM SCI, V21, P1763, DOI 10.1002/app.1977.070210704
   Rosiak JM, 2003, NUCL INSTRUM METH B, V208, P325, DOI 10.1016/s0168-583X(03)00672-X
   Ryu JH, 2010, J AM CHEM SOC, V132, P17227, DOI 10.1021/ja1069932
   Schmidt T, 2005, POLYMER, V46, P9908, DOI 10.1016/j.polymer.2005.07.077
   Sheikh FA, 2009, J MATER SCI-MATER M, V20, P821, DOI 10.1007/s10856-008-3637-5
   Shukla SK, 2009, J APPL POLYM SCI, V111, P1300, DOI 10.1002/app.29155
   Szilagyi A, 2005, POLYMER, V46, P10011, DOI 10.1016/j.polymer.2005.07.072
   Tan Y, 2010, SOFT MATTER, V6, P1467, DOI 10.1039/b916942c
   Tasdelen B, 2004, POLYM ADVAN TECHNOL, V15, P528, DOI 10.1002/pat.505
   Tasdelen B, 2004, RADIAT PHYS CHEM, V69, P303, DOI 10.1016/j.radphyschem.2003.07.004
   Ulalnski P, 2002, RADIAT PHYS CHEM, V63, P533
   Ulanski P, 1998, RADIAT PHYS CHEM, V52, P289, DOI 10.1016/S0969-806X(98)00155-8
   Ulanski P, 2002, POLYM ADVAN TECHNOL, V13, P951, DOI 10.1002/pat.249
   Wang Q, 2007, COLLOID POLYM SCI, V285, P515, DOI 10.1007/s00396-006-1592-6
   Wang SQ, 2011, EUR POLYM J, V47, P1168, DOI 10.1016/j.eurpolymj.2011.01.011
   Zhang JT, 2009, ADV ENG MATER, V11, pB12, DOI 10.1002/adem.200800266
   Zhang JT, 2009, ACTA BIOMATER, V5, P488, DOI 10.1016/j.actbio.2008.06.012
   Zhang JT, 2003, COLLOID POLYM SCI, V281, P580, DOI 10.1007/s00396-002-0829-2
   Zhao SP, 2010, CARBOHYD RES, V345, P425, DOI 10.1016/j.carres.2009.11.014
   Zhuang YF, 2003, J APPL POLYM SCI, V88, P724, DOI 10.1002/app.11921
NR 53
TC 13
Z9 13
U1 1
U2 42
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD MAY
PY 2013
VL 86
BP 145
EP 154
DI 10.1016/j.radphyschem.2013.02.005
PG 10
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 130AX
UT WOS:000317886200023
DA 2018-10-20
ER

PT J
AU Lam, J
   Segura, T
AF Lam, Jonathan
   Segura, Tatiana
TI The modulation of MSC integrin expression by RGD presentation
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Hyaluronic acid; RGD clustering; Mesenchymal stem cells
ID MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; TISSUE ARCHITECTURE;
   BONE-MARROW; 3-DIMENSIONAL CULTURE; DYNAMIC RECIPROCITY;
   GENE-EXPRESSION; BREAST-CANCER; IN-VITRO; HYDROGELS
AB Biomaterials designed to mimic the intricate native extracellular matrix (ECM) can use a variety of techniques to control the behavior of encapsulated cells. Common methods include controlling the mechanical properties of the material, incorporating bioactive signals, spatially patterning bioactive signals, and controlling the time-release of bioactive signals. Further design parameters like bioactive signal distribution can be used to manipulate cell behavior. Efforts on clustering adhesion peptides have focused on seeding cells on top of a biomaterial. Here we report the effect of clustering the adhesion peptide RGD on mouse mesenchymal stem cells encapsulated inside three-dimensional hyaluronic acid hydrogels. The clustered bioactive signals resulted in significant differences in both cell spreading and integrin expression. These results indicate that signal RGD peptide clustering is an additional hydrogel design parameter can be used to influence and guide the behavior of encapsulated cells. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Lam, Jonathan; Segura, Tatiana] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
   [Segura, Tatiana] Univ Calif Los Angeles, Chem & Biomol Engn Dept, Los Angeles, CA 90095 USA.
RP Segura, T (reprint author), Univ Calif Los Angeles, Chem & Biomol Engn Dept, 5531 Boelter Hall,420 Westwood Plaza, Los Angeles, CA 90095 USA.
EM tsegura@ucla.edu
FU California Institute for Regenerative Medicine [CIRM RT2-01881]; NIH
   [T32 GM067555]
FX The authors would like to thank the California Institute for
   Regenerative Medicine (CIRM RT2-01881) for funding. J.L. would also like
   to thank the NIH Funded Biotechnology Training Grant (T32 GM067555) for
   a predoctoral fellowship. Anandika Dhaliwal is thanked for help with the
   FACS experiments.
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Anderson SM, 2011, INTEGR BIOL-UK, V3, P887, DOI 10.1039/c1ib00037c
   Azab AK, 2006, J CONTROL RELEASE, V111, P281, DOI 10.1016/j.jconrel.2005.12.014
   Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z
   Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328
   Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Comisar WA, 2011, J THEOR BIOL, V274, P120, DOI 10.1016/j.jtbi.2011.01.007
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7
   DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012
   Discher DE, 2007, BIOPHYS J, p32A
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8
   Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI [10.1089/ten.tea.2010.0135, 10.1089/ten.TEA.2010.0135]
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Hagios C, 1998, PHILOS T ROY SOC B, V353, P857, DOI 10.1098/rstb.1998.0250
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Jones JL, 1999, J CLIN PATHOL-MOL PA, V52, P208
   KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150
   Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kopecek J, 2007, POLYM INT, V56, P1078, DOI 10.1002/pi.2253
   LaBarge MA, 2007, STEM CELL REV, V3, P137, DOI 10.1007/s12015-007-0024-4
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lei YG, 2011, BIOMATERIALS, V32, P39, DOI 10.1016/j.biomaterials.2010.08.103
   Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7
   Li XD, 2003, BONE, V33, P652, DOI 10.1016/S8756-3282(03)00239-4
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MAEDA T, 1994, J BIOCHEM, V115, P182, DOI 10.1093/oxfordjournals.jbchem.a124315
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Minguell JJ, 2001, EXP BIOL MED, V226, P507
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Petersen OW, 2001, BREAST CANCER RES, V3, P213
   Phelps EA, P NATL ACAD SCI US, V107, P3323
   Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005
   Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360
   Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089
   Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 67
TC 33
Z9 34
U1 4
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2013
VL 34
IS 16
BP 3938
EP 3947
DI 10.1016/j.biomaterials.2013.01.091
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122MQ
UT WOS:000317322600002
PM 23465825
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Tran, RT
   Qattan, IS
   Tsai, YT
   Tang, LP
   Liu, C
   Yang, J
AF Zhang, Yi
   Tran, Richard T.
   Qattan, Ibrahim S.
   Tsai, Yi-Ting
   Tang, Liping
   Liu, Chao
   Yang, Jian
TI Fluorescence imaging enabled urethane-doped citrate-based biodegradable
   elastomers
SO BIOMATERIALS
LA English
DT Article
DE Photoluminescence; Biodegradable; Elastomer; Tissue engineering; Drug
   delivery
ID IN-VITRO; POLYESTER ELASTOMERS; TISSUE; NANOPARTICLES; SCAFFOLD; VIVO;
   DESIGN; CELLS; DRUG; COMPOSITES
AB The field of tissue engineering and drug delivery calls for new measurement tools, non-invasive real-time assays, and design methods for the next wave of innovations. Based on our recent progress in developing intrinsically biodegradable photoluminescent polymers (BPLPs) without conjugating organic dyes or quantum dots, in this paper, we developed a new type urethane-doped biodegradable photoluminescent polymers (UBPLPs) that could potentially serve as a new tool to respond the above call for innovations. Inherited from BPLPs, UBPLPs demonstrated strong inherent photoluminescence and excellent cytocompatibility in vitro. Crosslinked UBPLPs (CUBPLPs) showed soft, elastic, but strong mechanical properties with a tensile strength as high as 49.41 +/- 6.17 MPa and a corresponding elongation at break of 334.87 +/- 26.31%. Porous triphasic CUBPLP vascular scaffolds showed a burst pressure of 76933 +/- 70.88 mmHg and a suture retention strength of 1.79 +/- 0.11 N. Stable but photoluminescent nanoparticles with average size of 103 nm were also obtained by nanoprecipitation. High loading efficiency (91.84%) and sustained release of 5-fluorouracil (up to 120 h) were achieved from UBPLP nanoparticles. With a quantum yield as high as 38.65%, both triphasic scaffold and nanoparticle solutions could be non-invasively detected in vivo. UBPLPs represent an innovation in fluorescent biomaterial design and may offer great potential in advancing the field of tissue engineering and drug delivery where bioimaging has gained increasing interest. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Zhang, Yi; Qattan, Ibrahim S.; Tsai, Yi-Ting; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76010 USA.
   [Tran, Richard T.; Liu, Chao; Yang, Jian] Penn State Univ, Huck Inst Life Sci, Mat Res Inst, Dept Bioengn, University Pk, PA 16802 USA.
RP Yang, J (reprint author), Penn State Univ, Huck Inst Life Sci, Mat Res Inst, Dept Bioengn, W340 Millennium Sci Complex, University Pk, PA 16802 USA.
EM jxy30@psu.edu
RI Yang, Jian/N-1291-2014; Zhang, Yi/K-3340-2016
OI Yang, Jian/0000-0003-0695-828X; Zhang, Yi/0000-0001-8667-7829
FU National Institute of Biomedical Imaging and Bioengineering (NIBIB)
   [EB012575]; National Science Foundation (NSF) CAREER award [DMR 1313553]
FX This work was supported in part by a R01 award EB012575 from the
   National Institute of Biomedical Imaging and Bioengineering (NIBIB) (to
   J.Y.), and a National Science Foundation (NSF) CAREER award DMR 1313553
   (to J.Y.).
CR Abraham T, 2011, RESPIROLOGY, V16, P22, DOI 10.1111/j.1440-1843.2010.01898.x
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Demchenko AP, 2002, LUMINESCENCE, V17, P19, DOI 10.1002/bio.671
   Dey J, 2011, MACROMOL MATER ENG, V296, P1149, DOI 10.1002/mame.201100074
   Dey J, 2010, J BIOMED MATER RES A, V95A, P361, DOI 10.1002/jbm.a.32846
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008
   Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767
   Jamieson T, 2007, BIOMATERIALS, V28, P4717, DOI 10.1016/j.biomaterials.2007.07.014
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Liu QY, 2012, PROG POLYM SCI, V37, P715, DOI 10.1016/j.progpolymsci.2011.11.001
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Nair LS, 2007, PROG POLYM SCI, V32, P762
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Phillips RL, 2008, J AM CHEM SOC, V130, P6952, DOI 10.1021/ja802094s
   Sodian R, 2002, TISSUE ENG, V8, P863, DOI 10.1089/10763270260424222
   Tateishi T, 2005, KEY ENG MAT, V288-289, P59, DOI 10.4028/www.scientific.net/KEM.288-289.59
   Terai T, 2008, CURR OPIN CHEM BIOL, V12, P515, DOI 10.1016/j.cbpa.2008.08.007
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   WILLIAMS ATR, 1983, ANALYST, V108, P1067, DOI 10.1039/an9830801067
   Yakimansky AV, 2009, POLYM ADVAN TECHNOL, V20, P581, DOI 10.1002/pat.1400
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2005, TISSUE ENG, V11, P1876, DOI 10.1089/ten.2005.11.1876
   Yang J, 2009, P NATL ACAD SCI USA, V106, P10086, DOI 10.1073/pnas.0900004106
   Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g
NR 34
TC 34
Z9 35
U1 1
U2 100
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2013
VL 34
IS 16
BP 4048
EP 4056
DI 10.1016/j.biomaterials.2013.02.040
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122MQ
UT WOS:000317322600012
PM 23465824
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Camilleri, J
   Sorrentino, F
   Damidot, D
AF Camilleri, Josette
   Sorrentino, Francois
   Damidot, Denis
TI Investigation of the hydration and bioactivity of radiopacified
   tricalcium silicate cement, Biodentine and MTA Angelus
SO DENTAL MATERIALS
LA English
DT Article
DE Biodentine; Characterization; Dental material; Hydration; MTA Angelus;
   Radiopacity; Root-end filling materials; Zirconium oxide
ID MINERAL TRIOXIDE AGGREGATE; IN-VITRO BIOACTIVITY; SELF-SETTING
   PROPERTIES; WHITE PORTLAND-CEMENT; COMPOSITE BONE-CEMENT; END FILLING
   MATERIALS; PHYSICAL-PROPERTIES; DENTAL BIOMATERIAL; CURING CONDITIONS;
   CALCIUM
AB Objective. Novel root-end filling materials are composed of tricalcium silicate (TCS) and radiopacifier as opposed to the traditional mineral trioxide aggregate (MTA) which is made up of clinker derived from Portland cement and bismuth oxide. The aim of this research was to characterize and investigate the hydration of a tricalcium silicate-based proprietary brand cement (Biodentine (TM)) and a laboratory manufactured cement made with a mixture of tricalcium silicate and zirconium oxide (TCS-20-Z) and compare their properties to MTA Angelus (TM).
   Methods. The materials investigated included a cement containing 80% of TCS and 20% zirconium oxide (TCS-20-Z), Biodentine (TM) and MTA Angelus (TM). The specific surface area and the particle size distribution of the un-hydrated cements and zirconium oxide were investigated using a gas adsorption method and scanning electron microscopy. Un-hydrated cements and set materials were tested for mineralogy and microstructure, assessment of bioactivity and hydration. Scanning electron microscopy, X-ray energy dispersive analysis, X-ray fluorescence spectroscopy, X-ray diffraction, Rietveld refined X-ray diffraction and calorimetry were employed. The radiopacity of the materials was investigated using ISO 6876 methods. Results. The un-hydrated cements were composed of tricalcium silicate and a radiopacifier phase; zirconium oxide for both Biodentine (TM) and TCS-20-Z whereas bismuth oxide for MTA Angelus (TM). In addition Biodentine (TM) contained calcium carbonate particles and MTA Angelus (TM) exhibited the presence of dicalcium silicate, tricalcium aluminate, calcium, aluminum and silicon oxides. TCS and MTA Angelus (TM) exhibited similar specific surface area while Biodentine (TM) had a greater specific surface area. The cements hydrated and produced some hydrates located either as reaction rim around the tricalcium silicate grain or in between the grains at the expense of volume containing the water initially present in the mixture. The rate of reaction of tricalcium calcium silicate was higher for Biodentine (TM) than for TCS-20-Z owing to its optimized particle size distribution, the presence of CaCO3 and the use of CaCl2. Tricalcium calcium silicate in MTA hydrated even more slowly than TCS-20-Z as evident from the size of reaction rim representative of calcium silicate hydrate (C-S-H) around tricalcium silicate grains and the calorimetry measurements. On the other hand, calcium oxide contained in MTA Angelus (TM) hydrated very fast inducing an intense exothermic reaction. Calcium hydroxide was produced as a by-product of reaction in all hydrated cements but in greater quantities in MTA due to the hydration of calcium oxide. This lead to less dense microstructure than the one observed for both Biodentine (TM) and TCS-20-Z. All the materials were bioactive and allowed the deposition of hydroxyapatite on the cement surface in the presence of simulated body fluid and the radiopacity was greater than 3 mm aluminum thickness. Significance. All the cement pastes tested were composed mainly of tricalcium silicate and a radiopacifier. The laboratory manufactured cement contained no other additives. Biodentine (TM) included calcium carbonate which together with the additives in the mixing liquid resulted in a material with enhanced chemical properties relative to TCS-20-Z prototype cement. On the other hand MTA Angelus (TM) displayed the presence of calcium, aluminum and silicon oxides in the un-hydrated powder. These phases are normally associated with the raw materials indicating that the clinker of MTA Angelus (TM) is incompletely sintered leading to a potential important variability in its mineralogy depending on the sintering conditions. As a consequence, the amount of tricalcium silicate is less than in the two other cements leading to a slower reaction rate and more porous microstructure. (C) 2013 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Camilleri, Josette] Univ Malta, Dept Restorat Dent, Fac Dent Surg, Msida Msd 2090, Malta.
   [Sorrentino, Francois] Mineral Res Proc, Meyzieu, France.
   [Damidot, Denis] Univ Lille Nord France, F-59000 Lille, France.
   [Damidot, Denis] LGCgE GCE, EM Douai, F-59508 Douai, France.
RP Camilleri, J (reprint author), Univ Malta, Dept Restorat Dent, Fac Dent Surg, Sch Med,Mater Dei Hosp, Msida Msd 2090, Malta.
EM josette.camilleri@um.edu.mt
RI Camilleri, Josette/N-9409-2015; Damidot, Denis/G-3215-2011
OI Camilleri, Josette/0000-0003-3556-6365; Damidot,
   Denis/0000-0001-6630-9607
FU ERDF (Malta) [012]
FX Septodont and Angelus for the materials; Dr V. Thiery of the Department
   of Civil and Environmental Engineering, Ecole de Mines, Douai, France
   and Ing. J. Camilleri of the Department of Metallurgy and Materials
   Engineering laboratory, Faculty of Engineering, University of Malta for
   their help with the analysis; ERDF (Malta) for the financing of the
   testing equipment through the project: "Developing an Interdisciplinary
   Material Testing and Rapid Prototyping R&D Facility (Ref. no. 012)".
CR Belio-Reyes IA, 2009, J ENDODONT, V35, P875, DOI 10.1016/j.joen.2009.03.004
   BENSTED J, 1976, J AM CERAM SOC, V59, P140, DOI 10.1111/j.1151-2916.1976.tb09451.x
   Ber BS, 2007, J ENDODONT, V33, P1231, DOI 10.1016/j.joen.2007.06.012
   Bortoluzzi EA, 2009, J ENDODONT, V35, P550, DOI 10.1016/j.joen.2008.12.018
   Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x
   Camilleri J, 2007, INT ENDOD J, V40, P462, DOI 10.1111/j.1365-2591.2007.01248.x
   Camilleri J, 2011, DENT MATER, V27, P836, DOI 10.1016/j.dental.2011.04.010
   Camilleri J, 2011, DENT MATER, V27, P845, DOI 10.1016/j.dental.2011.04.011
   Camilleri J, 2005, INT ENDOD J, V38, P834, DOI 10.1111/j.1365-2591.2005.01028.x
   Camilleri J, 2012, INT ENDOD J, V5, P737
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   Cutajar A, 2011, DENT MATER, V27, P879, DOI 10.1016/j.dental.2011.04.012
   DAMIDOT D, 1994, ADV CEM RES, V6, P27
   Damidot D., 1994, ADV CEM RES, V6, P83
   Darvell BW, 2011, DENT MATER, V27, P407, DOI 10.1016/j.dental.2011.02.001
   Forbes WF, 1998, EXP GERONTOL, V33, P141, DOI 10.1016/S0531-5565(97)00061-2
   Formosa LM, 2012, DENT MATER, V28, P584, DOI 10.1016/j.dental.2012.02.006
   Formosa LM, 2012, INT ENDOD J, V45, P326, DOI 10.1111/j.1365-2591.2011.01980.x
   Han L, 2011, INT ENDOD J, V44, P1081, DOI 10.1111/j.1365-2591.2011.01924.x
   Han LL, 2010, DENT MATER J, V29, P512, DOI 10.4012/dmj.2009-133
   Huan ZG, 2008, J BIOMATER APPL, V23, P247, DOI 10.1177/0885328208088714
   Huan ZG, 2008, J MATER SCI-MATER M, V19, P2913, DOI 10.1007/s10856-008-3423-4
   Huan ZG, 2007, J BIOMED MATER RES B, V82B, P352, DOI 10.1002/jbm.b.30740
   International Standards Organization, 2001, 6876 ISO
   KIDD EAM, 1978, CARIES RES, V12, P238, DOI 10.1159/000260338
   Laurent P, 2008, DENT MATER, V24, P1486, DOI 10.1016/j.dental.2008.02.020
   Lin Q, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045005
   Nagataki S, 1995, APPL ADMIXTURES CONC
   Peng WW, 2011, J ENDODONT, V37, P1240, DOI 10.1016/j.joen.2011.05.035
   R&D Department Septodont, 2010, BIOD SCI FIL ACT BIO
   RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558
   Sorrentino F, 2008, CEM WAPNO BETON, V13, P177
   Taddei P, 2009, J RAMAN SPECTROSC, V40, P1858, DOI 10.1002/jrs.2333
   Tanomaru M, 2008, J APPL ORAL SCI, V16, P376, DOI 10.1590/S1678-77572008000600004
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   Torabinejad M., 1995, US Patent, Patent No. [5769638, 5,769,638]
   Torabinejad M., 1995, U. S. Patent, Patent No. [5415547, 5,415,547]
   Vivan RR, 2009, ORAL SURG ORAL MED O, V108, pE35, DOI 10.1016/j.tripleo.2009.07.037
   Wang XH, 2008, DENT MATER, V24, P74, DOI 10.1016/j.dental.2007.02.006
   Wiltbank KB, 2007, J ENDODONT, V33, P1235, DOI 10.1016/j.joen.2007.06.016
   Zhao WY, 2008, J BIOMED MATER RES A, V85A, P336, DOI 10.1002/jbm.a.31523
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
NR 42
TC 100
Z9 109
U1 3
U2 77
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD MAY
PY 2013
VL 29
IS 5
BP 580
EP 593
DI 10.1016/j.dental.2013.03.007
PG 14
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 123KD
UT WOS:000317387100012
PM 23537569
DA 2018-10-20
ER

PT J
AU Favi, PM
   Benson, RS
   Neilsen, NR
   Hammonds, RL
   Bates, CC
   Stephens, CP
   Dhar, MS
AF Favi, Pelagie M.
   Benson, Roberto S.
   Neilsen, Nancy R.
   Hammonds, Ryan L.
   Bates, Cassandra C.
   Stephens, Christopher P.
   Dhar, Madhu S.
TI Cell proliferation, viability, and in vitro differentiation of equine
   mesenchymal stem cells seeded on bacterial cellulose hydrogel scaffolds
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Mesenchymal stem cell; Bacterial cellulose; Tissue engineering; Bone;
   Cartilage
ID MARROW STROMAL CELLS; CALCIUM-DEFICIENT HYDROXYAPATITE; BONE-MARROW;
   CHONDROGENIC DIFFERENTIATION; MECHANICAL-PROPERTIES; AGAROSE CULTURE;
   ADIPOSE-TISSUE; CARTILAGE; SUBSTRATE; MEMBRANES
AB The culture of multipotent mesenchymal stem cells on natural biopolymers holds great promise for treatments of connective tissue disorders such as osteoarthritis. The safety and performance of such therapies relies on the systematic in vitro evaluation of the developed stem cell-biomaterial constructs prior to in vivo implantation. This study evaluates bacterial cellulose (BC), a biocompatible natural polymer, as a scaffold for equine-derived bone marrow mesenchymal stem cells (EqMSCs) for application in bone and cartilage tissue engineering. An equine model was chosen due to similarities in size, load and types of joint injuries suffered by horses and humans. Lyophilized and critical point dried BC hydrogel scaffolds were characterized using scanning electron microscopy (SEM) to confirm nanostructure morphology which demonstrated that critical point drying induces fibre bundling unlike lyophilisation. EqMSCs positively expressed the undifferentiated pluripotent mesenchymal stem cell surface markers CD44 and CD90. The BC scaffolds were shown to be cytocompatible, supporting cellular adhesion and proliferation, and allowed for osteogenic and chondrogenic differentiation of EqMSCs. The cells seeded on the BC hydrogel were shown to be viable and metabolically active. These findings demonstrate that the combination of a BC hydrogel and EqMSCs are promising constructs for musculoskeletal tissue engineering applications. Published by Elsevier B.V.
C1 [Favi, Pelagie M.; Benson, Roberto S.; Hammonds, Ryan L.] Univ Tennessee, Dept Mat Sci & Engn, Coll Engn, Knoxville, TN 37996 USA.
   [Neilsen, Nancy R.] Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA.
   [Bates, Cassandra C.; Dhar, Madhu S.] Univ Tennessee, Dept Large Anim Clin Sci, Coll Vet Med, Knoxville, TN 37996 USA.
   [Stephens, Christopher P.] Univ Tennessee, Grad Sch Med, Dept Surg, Knoxville, TN 37996 USA.
   [Stephens, Christopher P.] Univ Tennessee, Ctr Mat Proc, Knoxville, TN 37996 USA.
RP Dhar, MS (reprint author), Univ Tennessee, Coll Vet Med, UT Vet Med Ctr C222, 2407 River Dr, Knoxville, TN 37996 USA.
EM mdhar@utk.edu
FU Center of Excellence in Livestock Diseases and Human Health Grant;
   Physicians Medical and Education Research Foundation (PMERF) Grant the
   Cardiothoracic Surgery Gift Fund; National Institute of Health Training
   Grant [NIH/NIGMS-IMSD: R25 GM086761]
FX This study was supported by the Center of Excellence in Livestock
   Diseases and Human Health Grant, the Physicians Medical and Education
   Research Foundation (PMERF) Grant the Cardiothoracic Surgery Gift Fund,
   and the National Institute of Health Training Grant (NIH/NIGMS-IMSD: R25
   GM086761). Thanks to William Gazzola for assisting with the SEM images
   and Anik Vasington for assistance with the color figures.
CR Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715
   [Anonymous], 2005, ADVISORY COMMITTEE M
   Arnhold SJ, 2007, AM J VET RES, V68, P1095, DOI 10.2460/ajvr.68.10.1095
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Bielecki S., 2001, BIOPOLYMERS POLYSACC, V5, P37
   Bourzac C, 2010, EQUINE VET J, V42, P519, DOI 10.1111/j.2042-3306.2010.00098.x
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102
   Czaja W. K., 2006, BIOMACROMOLECULES, V8, P1, DOI DOI 10.1021/BM060620D
   Dhar M., 2012, EQUINE VET J
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167
   Evans BR, 2003, BIOSENS BIOELECTRON, V18, P917, DOI 10.1016/S0956-5663(02)00212-9
   Fang B, 2009, TISSUE ENG PT A, V15, P1091, DOI 10.1089/ten.tea.2008.0110
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Garg HG, 2000, SCARLESS WOUND HEALI, P1
   Goodrich LR, 2007, J BONE JOINT SURG BR, V89B, P672, DOI 10.1302/0301-620X.89B5.18343
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010
   Huang WB, 2004, EXP CELL RES, V299, P325, DOI 10.1016/j.yexcr.2004.04.051
   Hutchens SA, 2007, LETT APPL MICROBIOL, V44, P175, DOI 10.1111/j.1472-765X.2006.02055.x
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Hutchens SA, 2009, CELLULOSE, V16, P887, DOI 10.1007/s10570-009-9300-6
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Koch TG, 2008, CAN VET J, V49, P1009
   Kucharzewski M., 2003, PHLEBOLOGIE, V32, P138
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liao HT, 2011, TISSUE ENG PART C-ME, V17, P1139, DOI 10.1089/ten.tec.2011.0140
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lohmander LS., 2003, TISSUE ENGINEERING O, V249, P2
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Monroe KR, 2008, FUNDAMENTALS OF THE STEM CELL DEBATE: THE SCIENTIFIC, RELIGIOUS, ETHICAL, AND POLITICAL ISSUES, P1
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366
   NISHI Y, 1990, J MATER SCI, V25, P2997, DOI 10.1007/BF00584917
   NORDESTGAARD BG, 1985, J MICROSC-OXFORD, V137, P189, DOI 10.1111/j.1365-2818.1985.tb02577.x
   Olson Jennifer L, 2011, Chonnam Med J, V47, P1, DOI 10.4068/cmj.2011.47.1.1
   P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253
   Palsson B.O., 2004, TISSUE ENG
   Paris DBBP, 2010, THERIOGENOLOGY, V74, P516, DOI 10.1016/j.theriogenology.2009.11.020
   Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PITTENGER MF, 2001, HUMAN CELL CULTURE, V5, P189
   Ranera B, 2011, VET IMMUNOL IMMUNOP, V144, P147, DOI 10.1016/j.vetimm.2011.06.033
   Saltzman WM, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P279, DOI 10.1016/B978-012370615-7/50024-X
   SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123
   Scott C.T., 2006, STEM CELL NOW FROM T
   SHAPIRO HM, 2003, PRACTICAL FLOW CYTOM
   Smith RKW, 2003, EQUINE VET J, V35, P99, DOI 10.2746/042516403775467388
   Stewart MC, 2011, VET CLIN N AM-EQUINE, V27, P243, DOI 10.1016/j.cveq.2011.06.004
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   The National Collaborating Centre for Chronic Conditions, 2008, OSTEOARTHRITIS NATIO
   Tortora G.J., 2003, PRINCIPLES ANATOMY P
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang XJ, 2011, CELL PROLIFERAT, V44, P274, DOI 10.1111/j.1365-2184.2011.00750.x
   White DG, 1989, CELLULOSE WOOD CHEM, P573
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 66
TC 30
Z9 32
U1 4
U2 148
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2013
VL 33
IS 4
BP 1935
EP 1944
DI 10.1016/j.msec.2012.12.100
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 125GQ
UT WOS:000317528700013
PM 23498215
DA 2018-10-20
ER

PT J
AU Knotek, P
   Chanova, E
   Rypacek, F
AF Knotek, Petr
   Chanova, Eliska
   Rypacek, Frantisek
TI AFM imaging and analysis of local mechanical properties for detection of
   surface pattern of functional groups
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Phase Shift Image; AFAM; Force Spectroscopy; Biomimetic structure;
   Surface pattern; Biotin-streptavidin interaction
ID FORCE ACOUSTIC MICROSCOPY; CELL-ADHESION; SPECTROSCOPY; BIOMATERIALS;
   POLYLACTIDE; COPOLYMERS; GROWTH
AB In this work we evaluate the applicability of different atomic force microscopy (AFM) modes, such as Phase Shift Imaging, Atomic Force Acoustic Microscopy (AFAM) and Force Spectroscopy, for mapping of the distribution pattern of low-molecular-weight biomimetic groups on polymer biomaterial surfaces. Patterns with either random or clustered spatial distribution of bioactive peptide group derived from fibronectin were prepared by surface deposition of functional block copolymer nano-colloids and grafted with RGDS peptide containing the sequence of amino acids arginine-glycine-aspartic acid-serine (conventionally labeled as RGDS) and carrying biotin as a tag. The biotin-tagged peptides were labeled with 40 nm streptavidin-modified Au nanospheres. The peptide molecules were localized through the detection of bound Au nanospheres by AFM, and thus, the surface distribution of peptides was revealed. AFM techniques capable of monitoring local mechanical properties of the surface were proved to be the most efficient for identification of Au nano-markers. The efficiency was successfully demonstrated on two different patterns, i.e. random and clustered distribution of RGDS peptides on structured surface of the polymer biomaterial. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Knotek, Petr] Univ Pardubice, Fac Chem Technol, Joint Lab Solid State Chem IMC ASCR, Pardubice 53210, Czech Republic.
   [Knotek, Petr] Univ Pardubice, Pardubice 53210, Czech Republic.
   [Chanova, Eliska; Rypacek, Frantisek] Acad Sci Czech Republic, Inst Macromol Chem, CR-16206 Prague, Czech Republic.
RP Knotek, P (reprint author), Univ Pardubice, Fac Chem Technol, Joint Lab Solid State Chem IMC ASCR, Studentska 573, Pardubice 53210, Czech Republic.
EM petr.knotek@upce.cz
RI Mazl Chanova, Eliska/H-6751-2014; Rypacek, Frantisek/G-7872-2014;
   Knotek, Petr/J-6608-2012
OI Mazl Chanova, Eliska/0000-0003-0240-1206; Knotek,
   Petr/0000-0003-2407-4947
FU Czech Science Foundation [GPP108/12/PO44, GPP108/11/1857,
   GPP108/12/P624]
FX The authors acknowledge the financial support from the Czech Science
   Foundation projects GPP108/12/P044, GPP108/11/1857 and GPP108/12/P624.
CR Bacakova L, 2007, J MATER SCI-MATER M, V18, P1317, DOI 10.1007/s10856-006-0074-1
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Capella B, 1997, IEEE ENG MED BIOL, V16, P58
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Garcia R, 2002, SURF SCI REP, V47, P197, DOI 10.1016/S0167-5729(02)00077-8
   Garcia-Manyes S., 2005, J CHEM PHYS, V123
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Kester E, 2000, J PHYS CHEM SOLIDS, V61, P1275, DOI 10.1016/S0022-3697(99)00412-6
   Knotek P, 2012, MATER RES BULL, V47, P4246, DOI 10.1016/j.materresbull.2012.09.024
   Knotek P, 2012, THIN SOLID FILMS, V520, P5472, DOI 10.1016/j.tsf.2012.03.116
   Popelka S, 2007, J COLLOID INTERF SCI, V308, P291, DOI 10.1016/j.jcis.2006.12.022
   Rabe U, 2002, SURF INTERFACE ANAL, V33, P65, DOI 10.1002/sia.1163
   Sahoo NK, 2005, APPL SURF SCI, V252, P1520, DOI 10.1016/j.apsusc.2005.02.136
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Tresohlava E., 2010, TERMIS EU M GALW IR
   Tresohlava E, 2010, BIOMACROMOLECULES, V11, P68, DOI 10.1021/bm900889b
NR 19
TC 14
Z9 14
U1 1
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2013
VL 33
IS 4
BP 1963
EP 1968
DI 10.1016/j.msec.2013.01.006
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 125GQ
UT WOS:000317528700017
PM 23498219
DA 2018-10-20
ER

PT J
AU N'Diaye, M
   Degeratu, C
   Bouler, JM
   Chappard, D
AF N'Diaye, Mambaye
   Degeratu, Cristinel
   Bouler, Jean-Michel
   Chappard, Daniel
TI Biomaterial porosity determined by fractal dimensions, succolarity and
   lacunarity on microcomputed tomographic images
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Porosity; Connectivity; Fractal dimension; Lacunarity; Succolarity
ID POLY 2-HYDROXYETHYL METHACRYLATE; TRABECULAR BONE; SCAFFOLDS;
   HISTOMORPHOMETRY; ARCHITECTURE; MORPHOLOGY; CT
AB Porous structures are becoming more and more important in biology and material science because they help in reducing the density of the grafted material. For biomaterials, porosity also increases the accessibility of cells and vessels inside the grafted area. However, descriptors of porosity are scanty. We have used a series of biomaterials with different types of porosity (created by various porogens: fibers, beads ...). Blocks were studied by microcomputed tomography for the measurement of 3D porosity. 2D sections were re-sliced to analyze the microarchitecture of the pores and were transferred to image analysis programs: star volumes, interconnectivity index, Minkowski-Bouligand and Kolmogorov fractal dimensions were determined. Lacunarity and succolarity, two recently described fractal dimensions, were also computed. These parameters provided a precise description of porosity and pores' characteristics. Non-linear relationships were found between several descriptors e.g. succolarity and star volume of the material. A linear correlation was found between lacunarity and succolarity. These techniques appear suitable in the study of biomaterials usable as bone substitutes. (c) 2013 Elsevier B.V. All rights reserved.
C1 [N'Diaye, Mambaye; Degeratu, Cristinel; Chappard, Daniel] LUNAM Univ, GEROM Grp Etud Remodelage Osseux & BioMat LHEA, IRIS IBS Inst Biol Sante, CHU Angers, F-49933 Angers, France.
   [Degeratu, Cristinel] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Bioresources & Polymer Sci, Bucharest 010072, Romania.
   [Bouler, Jean-Michel] Univ Nantes, LIOAD, Inserm UMR 791, F-44000 Nantes, France.
RP Chappard, D (reprint author), LUNAM Univ Nantes Angers Le Mans, GEROM LHEA, IRIS IBS Inst Biol Sante, CHU Angers, F-49933 Angers, France.
EM daniel.chappard@univ-angers.fr
OI BOULER, Jean-Michel/0000-0001-9784-5584
FU Contrat Region Pays de la Loire: Bioregos2 program
FX This work was made possible by grants from the Contrat Region Pays de la
   Loire: Bioregos2 program. Many thanks are due to Mr R.H.C de Melo for
   providing test images, Mr. Guillaume Mabilleau for reviewing the revised
   version of the manuscript and Mrs. Lechat for secretarial assistance.
CR ALLAIN C, 1991, PHYS REV A, V44, P3552, DOI 10.1103/PhysRevA.44.3552
   Anderson J.M., 2004, HOST RESPONSE BIOMAT, P293
   BAN S, 1991, BIOMATERIALS, V12, P205, DOI 10.1016/0142-9612(91)90201-K
   BLOCK A, 1990, PHYS REV A, V42, P1869, DOI 10.1103/PhysRevA.42.1869
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Chappard D, 1996, J BONE MINER RES, V11, P676
   Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205
   Chappard D, 2001, J PATHOL, V195, P515, DOI 10.1002/path.970
   Chappard D, 1999, MICROSC RES TECHNIQ, V45, P303, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<303::AID-JEMT14>3.0.CO;2-8
   De Melo R.H.C., 2011, TELECOMMUN SYST
   de Melo RHC, 2006, 13 INT C SYST SIGN I, P299
   Filmon R, 2002, J BIOMAT SCI-POLYM E, V13, P1105, DOI 10.1163/156856202320813828
   Gilmore S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007449
   GRASSBERGER P, 1981, J STAT PHYS, V26, P173, DOI 10.1007/BF01106792
   Hassan Shombe N., 2011, International Journal of Biodiversity Science Ecosystem Services & Management, V7, P122, DOI 10.1080/21513732.2011.617710
   Hernandez R, 2002, BIO-MED MATER ENG, V12, P37
   Hiu-Yan Yeung, 2005, J Biomed Mater Res B Appl Biomater, V75, P234, DOI 10.1002/jbm.b.30240
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014
   Klein M, 2009, CLIN ORAL IMPLAN RES, V20, P67, DOI 10.1111/j.1600-0501.2008.01605.x
   Kohles SS, 2002, J BIOMECH ENG-T ASME, V124, P521, DOI 10.1115/1.1503374
   LE HM, 1992, ACTA STEREOL, V11, P267
   LEVITZ P, 1992, J PHYS I, V2, P771
   MANDELBROT BB, 1977, FRACTAL GEOMETRY NAT
   Niu WJ, 2010, COMP MATER SCI, V50, P172, DOI 10.1016/j.commatsci.2010.07.022
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P1
   Schladitz K, 2011, J MICROSC-OXFORD, V243, P111, DOI 10.1111/j.1365-2818.2011.03513.x
   Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5
   Stancu IC, 2007, J OPTOELECTRON ADV M, V9, P2125
   Thomsen JS, 1998, BONE, V22, P153, DOI 10.1016/S8756-3282(97)00235-4
   Truscello S, 2012, ACTA BIOMATER, V8, P1648, DOI 10.1016/j.actbio.2011.12.021
   Vehel J.L. Levy, 1989, C VIS COMM IM PROC P, P903
NR 32
TC 13
Z9 14
U1 2
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2013
VL 33
IS 4
BP 2025
EP 2030
DI 10.1016/j.msec.2013.01.020
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 125GQ
UT WOS:000317528700026
PM 23498228
DA 2018-10-20
ER

PT J
AU Fan, J
   Qiu, X
   Niu, XD
   Tian, Z
   Sun, W
   Liu, XJ
   Li, YD
   Li, WR
   Meng, J
AF Fan, Jun
   Qiu, Xin
   Niu, Xiaodong
   Tian, Zheng
   Sun, Wei
   Liu, Xiaojuan
   Li, Yangde
   Li, Weirong
   Meng, Jian
TI Microstructure, mechanical properties, in vitro degradation and
   cytotoxicity evaluations of Mg-1.5Y-1.2Zn-0.44Zr alloys for
   biodegradable metallic implants
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Mg-Y-Zn-Zr alloys; Biomaterial; Microstructure; Mechanical properties;
   In vitro degradation; In vitro cytotoxicity evaluation
ID MAGNESIUM ALLOYS; MG-ZN; ELECTRON-MICROSCOPY; VIVO CORROSION; BONE;
   BEHAVIOR; IONS; STRENGTH; TITANIUM; RELEASE
AB Mg-1.5Y-1.2Zn-0.44Zr alloys were newly developed as degradable metallic biomaterials. A comprehensive investigation of the microstructure, mechanical properties, in vitro degradation assessments and in vitro cytotoxicity evaluations of the as-cast state, as-heat treated state and as-extruded state alloys was done. The microstructure observations show that the Mg-1.5Y-1.2Zn-0.44Zr alloys are mainly composed of the matrix alpha-Mg phases and the Mg12ZnY secondary phases (LPS structure). The hot extrusion method significantly refined the grains and eliminated the defects of both as-cast and heat treated alloys and thereby contributed to the better mechanical properties and biodegradation resistance. The values of tensile strength and tensile yield strength of the alloy in the as-extruded condition are about 236 and 178 MPa respectively, with an excellent elongation of 28%. Meanwhile, the value of compressive strength is about 471 MPa and the value of bending strength is about 501 MPa. The superior bending strength further demonstrates the excellent ductility of the hot extruded alloys. The results of immersion tests and electrochemical measurements in the SBF indicate that a protective film precipitated on the alloy's surface with the extension of degradation. The protective film contains Mg(OH)(2) and hydroxyapatite (HA) which can reinforce osteoblast activity and promote good biocompatibility. No significant cytotoxicity towards L-929 cells was detected and the immersion extracts of alloy samples could enhance the cell proliferation with time in the cytotoxicity evaluations, implying that the Mg-1.5Y-1.2Zn-0.44Zr alloys have the potential to be used for biomedical applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Fan, Jun; Qiu, Xin; Niu, Xiaodong; Tian, Zheng; Sun, Wei; Liu, Xiaojuan; Meng, Jian] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resources Utilizat, Changchun 130022, Peoples R China.
   [Li, Yangde; Li, Weirong] Dongguan E Ande Sci & Tech Co Ltd, Dongguan 523640, Peoples R China.
   [Fan, Jun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Meng, J (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resources Utilizat, Changchun 130022, Peoples R China.
EM jmeng@ciac.jl.cn
FU National Key Technologies RD Program [2012BAE01B04, 2011BAE22B01];
   Guangdong Innovative Team Program [201001C0104669453]
FX This work is supported by the National Key Technologies R&D Program
   2012BAE01B04, and 2011BAE22B01 and Guangdong Innovative Team Program
   201001C0104669453. The authors thank Dr. Peng Wan (IMR CAS) and Dr.
   Xiaomeng Li (CIAC CAS) for giving help and guide on the experiments.
CR [Anonymous], 2000, E989A ASTM
   [Anonymous], 2009, 109935 ISO
   [Anonymous], 2004, E804 ASTM
   [Anonymous], 2005, 7438 ISO
   [Anonymous], 2004, ASTMG3172
   Babkin V.M., 2004, MET SCI HEAT TREAT, V5, P543
   Boehlert CJ, 2006, MAT SCI ENG A-STRUCT, V417, P315, DOI 10.1016/j.msea.2005.11.006
   Castellani C, 2011, ACTA BIOMATER, V7, P432, DOI 10.1016/j.actbio.2010.08.020
   CLARK JB, 1965, ACTA METALL MATER, V13, P1281, DOI 10.1016/0001-6160(65)90039-8
   Genevieve B., 2001, CORROS SCI, V43, P471
   Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6
   Gu XN, 2011, MATER SCI ENG B-ADV, V176, P1778, DOI 10.1016/j.mseb.2011.05.032
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hanzi AC, 2009, ACTA BIOMATER, V5, P162, DOI 10.1016/j.actbio.2008.07.034
   He WW, 2010, MAT SCI ENG C-MATER, V30, P167, DOI 10.1016/j.msec.2009.09.014
   Huan ZG, 2010, J MATER SCI-MATER M, V21, P2623, DOI 10.1007/s10856-010-4111-8
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu K, 2010, MAT SCI ENG A-STRUCT, V527, P828, DOI 10.1016/j.msea.2009.10.031
   Luo ZP, 2000, J MATER SCI LETT, V19, P813, DOI 10.1023/A:1006793411506
   Niki Y, 2003, BIOMATERIALS, V24, P1447, DOI 10.1016/S0142-9612(02)00531-8
   Nishida M, 2004, MAT SCI ENG A-STRUCT, V375, P1217, DOI 10.1016/j.msea.2003.10.145
   PADEZHNOVA EM, 1982, RUSS METALL+, P185
   PULEO DA, 1995, J APPL BIOMATER, V6, P109, DOI 10.1002/jab.770060205
   Smola B, 2012, MAT SCI ENG C-MATER, V32, P659, DOI 10.1016/j.msec.2012.01.003
   Song G.L., 2002, J LIGHT MET, V1, P1
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   WEI LY, 1995, METALL MATER TRANS A, V26, P1705, DOI 10.1007/BF02670757
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Ye XY, 2010, J MATER SCI-MATER M, V21, P1321, DOI 10.1007/s10856-009-3954-3
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 38
TC 31
Z9 33
U1 2
U2 66
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2013
VL 33
IS 4
BP 2345
EP 2352
DI 10.1016/j.msec.2013.01.063
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 125GQ
UT WOS:000317528700066
PM 23498268
DA 2018-10-20
ER

PT J
AU Wang, Y
   Jiang, XL
   Peng, SW
   Guo, XY
   Shang, GG
   Chen, JC
   Wu, Q
   Chen, GQ
AF Wang, Yang
   Jiang, Xian-Li
   Peng, Si-Wu
   Guo, Xiao-Yong
   Shang, Guan-Guan
   Chen, Jin-Chun
   Wu, Qiong
   Chen, Guo-Qiang
TI Induced apoptosis of osteoblasts proliferating on polyhydroxyalkanoates
SO BIOMATERIALS
LA English
DT Article
DE Polyhydroxyalkanoates; Osteoblast; Apoptosis; Proliferation; Integrin;
   Caspase-8
ID FOCAL ADHESION KINASE; PROTEIN ADSORPTION; CELL-ADHESION;
   SURFACE-ROUGHNESS; STEM-CELLS; INTEGRINS; FIBROBLAST; CYCLE;
   ALPHA-V-BETA-3; TERPOLYESTER
AB The mechanism study on behaviors of cells influenced by biomaterial surface properties can provide profound guidances for functional tissue engineering scaffolds design. In this study, regulation of integrin-mediated cell substrate interactions using rat osteoblasts incubated on PHA films was investigated. Compared with tissue culture plate (TCP), poly-3-hydroxybutyrate (PHB), copolymer of 3-hydroxybutyrate and 3-hydroxyvalerate (PHBV) and copolymer of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHBHHx), osteoblasts inoculated on a terpolymer of 3-hydroxybutyrate, 3-hydroxyvalerate and 3-hydroxyhexanoate (PHBVHHx) were found to have higher apoptosis rates. Several integrin subunits in osteoblasts grown on PHBVHHx showed altered expressions. Simultaneously, extracellular matrics (ECM) were also remodeled on the material surface. Osteoblasts showed a higher expression of integrin subunit beta 3 and ay on PHBVHHx films compared with that on TCP. On the other hand, less vitronectin, osteopontin and fibronectin, the main ligands for integrin beta 3 were expressed and deposited in ECM. The unligated integrin beta 3 could recruit caspase-8 to the membrane and activate its downstream signaling which was proven by the caspase-8 activation assay. It was therefore concluded that the induced apoptosis of osteoblasts on PHBVHHx was regulated by recruitment of caspase-8 to the unligated integrin beta 3. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Wang, Yang] China Agr Univ, Coll Biol Sci, Natl Plant Gene Res Ctr, State Key Lab Plant Physiol & Biochem, Beijing 100193, Peoples R China.
   [Wang, Yang; Jiang, Xian-Li; Chen, Jin-Chun; Wu, Qiong; Chen, Guo-Qiang] Tsinghua Univ, Tsinghua Univ Peking Univ Joint Ctr Life Sci, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.
   [Peng, Si-Wu] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA.
   [Peng, Si-Wu; Guo, Xiao-Yong; Shang, Guan-Guan] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
   [Guo, Xiao-Yong] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen 518055, Guangdong, Peoples R China.
   [Chen, Guo-Qiang] Tsinghua Univ, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China.
RP Chen, GQ (reprint author), Tsinghua Univ, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China.
EM chengq@mail.tsinghua.edu.cn
RI Yan, Hua/F-4023-2015; Peng, Siwu/G-6369-2015
OI Peng, Siwu/0000-0002-2032-2352
FU State Basic Science Foundation 973 [2012CB725201]; State
   Industrialization Grant [2012BAD32B02]
FX This collaborative research project was supported by the State Basic
   Science Foundation 973 (Grant No. 2012CB725201 to CJC and GQC). GQC also
   received support from State Industrialization Grant (Zhicheng Grant No.
   2012BAD32B02) to develop process for large scale production of this
   family of new polymers.
CR Apparao KBC, 2001, J CLIN ENDOCR METAB, V86, P4991, DOI 10.1210/jc.86.10.4991
   Butler SM, 1999, J CONTROL RELEASE, V58, P335, DOI 10.1016/S0168-3659(98)00173-4
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Cheng ST, 2008, BIOMATERIALS, V29, P4187, DOI 10.1016/j.biomaterials.2008.07.022
   Cool SM, 2007, J BIOMED MATER RES A, V82A, P599, DOI 10.1002/jbm.a.31174
   Cruet S, 1999, GYNECOL ONCOL, V75, P254, DOI 10.1006/gyno.1999.5572
   Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   ffrench-Constant C, 2004, TRENDS CELL BIOL, V14, P678, DOI 10.1016/j.tcb.2004.10.005
   Gardel M, 2010, J PHYS CONDENS MATT, V22
   Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200
   Hu YJ, 2009, ACTA BIOMATER, V5, P1115, DOI 10.1016/j.actbio.2008.09.021
   Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401
   Ji GZ, 2009, J BIOMAT SCI-POLYM E, V20, P325, DOI 10.1163/156856209X412191
   Ji Y, 2008, BIOMATERIALS, V29, P3807, DOI 10.1016/j.biomaterials.2008.06.008
   Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608
   Liang YS, 2008, J BIOMED MATER RES A, V87A, P441, DOI 10.1002/jbm.a.31801
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Noti JD, 2001, INT J ONCOL, V18, P195
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peng SW, 2010, BIOMATERIALS, V32, P2546
   Persin Z, 2004, TEXT RES J, V74, P55, DOI 10.1177/004051750407400110
   Pozzi Ambra, 1998, Journal of Cell Biology, V142, P587, DOI 10.1083/jcb.142.2.587
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Schwartz MA, 2001, J CELL SCI, V114, P2553
   Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070
   TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198
   Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053
   Wang Y, 2011, BIOMATERIALS, V33, P485
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Yan C, 2011, BIOMATERIALS, V32, P6435, DOI 10.1016/j.biomaterials.2011.05.031
   Ye C, 2009, BIOMATERIALS, V30, P4401, DOI 10.1016/j.biomaterials.2009.05.001
   Zhang HF, 2009, BIOTECHNOL BIOENG, V104, P582, DOI 10.1002/bit.22409
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
NR 49
TC 5
Z9 7
U1 4
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2013
VL 34
IS 15
BP 3737
EP 3746
DI 10.1016/j.biomaterials.2013.01.088
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 120KH
UT WOS:000317168700001
PM 23433672
DA 2018-10-20
ER

PT J
AU Jain, S
   Sharma, A
   Basu, B
AF Jain, Shilpee
   Sharma, Ashutosh
   Basu, Bikramjit
TI In vitro cytocompatibility assessment of amorphous carbon structures
   using neuroblastoma and Schwann cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE carbon nanofibers; neuroblastoma cells; Schwann cells; surface
   treatments; surface free energy
ID ELECTROSPUN NANOFIBERS; INTERFACIAL PROPERTIES; OSTEOBLAST ADHESION;
   BIOMEDICAL DEVICES; PERIPHERAL-NERVE; PLASMA TREATMENT; SCAFFOLDS;
   POLYMER; GROWTH; FIBER
AB The development of scaffolds for neural tissue engineering application requires an understanding of cell adhesion, proliferation, and migration of neuronal cells. Considering the potential application of carbon as scaffold materials and the lack of understanding of compatibility of amorphous carbon with neuronal cells, the carbon-based materials in the forms of carbon films and continuous electrospun carbon nanofibers having average diameter of approximate to 200 nm are being investigated with or without ultraviolet (UV) and oxy-plasma (OP) treatments for cytocompatibility property using mouse Neuroblastoma (N2a) and rat Schwann cells (RT4-D6P2T). The use of Raman spectroscopy in combination with Fourier transform infrared (FTIR) and X-ray diffraction establishes the amorphous nature and surface-bonding characteristics of the studied carbon materials. Although both UV and OP treatments make carbon surfaces more hydrophilic, the cell viability of N2a cells is statistically more significant on OP treated fibers/films compared to UV fiber/film substrates after 4 days in culture. The electrospun carbon fibrous substrate provides the physical guidance to the cultured Schwann cells. Overall, the experimental results of this study demonstrate that the electrospun amorphous carbon nanofibrous scaffolds can be used as a suitable biomaterial substrate for supporting cell adhesion and proliferation of neuronal cells in the context of their applications as artificial nerve implants. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [Jain, Shilpee] Indian Inst Technol, Dept Mat Sci & Engn, Lab Biomat, Kanpur 208016, Uttar Pradesh, India.
   [Sharma, Ashutosh] Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.
   [Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
RI Sharma, Ashutosh/D-1034-2011
OI Sharma, Ashutosh/0000-0002-2653-0806; Jain, Shilpee/0000-0002-2909-9476
FU Department of Science and Technology
FX Contract grant sponsors: Department of Science and Technology
CR ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   BAILEY JE, 1971, NATURE, V234, P529, DOI 10.1038/234529a0
   Banwell CN, 1995, FUNDAMENTALS MOL SPE, P55
   Basu B, 2009, ADV BIOMATERIALS FUN
   BOKROS JC, 1977, CARBON, V15, P355
   Chiono V, 2009, INT REV NEUROBIOL, V87, P173, DOI 10.1016/S0074-7742(09)87009-8
   CLARKE AJ, 1973, NATURE, V243, P146, DOI 10.1038/243146a0
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Jessen KR, 2004, INT J BIOCHEM CELL B, V36, P1861, DOI 10.1016/j.biocell.2004.02.023
   Kane RS, 2007, BIOTECHNOL PROGR, V23, P316, DOI 10.1021/bp060388n
   Kaplan S, 2009, INT REV NEUROBIOL, V87, P9, DOI 10.1016/S0074-7742(09)87002-5
   Kelly S, 2008, BIOMATERIALS, V29, P2573, DOI 10.1016/j.biomaterials.2008.03.001
   Kim D, 2010, ANNU REV BIOMED ENG, V6, P12
   Ko TH, 1999, J APPL POLYM SCI, V71, P2219, DOI 10.1002/(SICI)1097-4628(19990328)71:13<2219::AID-APP12>3.0.CO;2-W
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Kubova O, 2007, THIN SOLID FILMS, V515, P6765, DOI 10.1016/j.tsf.2007.02.014
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x
   Ma KM, 2010, J APPL POLYM SCI, V118, P1606, DOI 10.1002/app.32549
   Majumdar A, 2008, J APPL PHYS, V104, DOI 10.1063/1.2990054
   Michalski MC, 1998, J COLLOID INTERF SCI, V208, P319, DOI 10.1006/jcis.1998.5814
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Mobarakeh G, 2007, J APPL POLYM SCI, V106, P2536
   Montes-Moran MA, 2002, CARBON, V40, P845, DOI 10.1016/S0008-6223(01)00212-3
   Murugan R, 2010, ADV MAT LETT, V1, P179
   Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086
   Olivares R, 2007, DIAM RELAT MATER, V16, P1858, DOI 10.1016/j.diamond.2007.08.022
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Rahaman MSA, 2007, POLYM DEGRAD STABIL, V92, P1421, DOI 10.1016/j.polymdegradstab.2007.03.023
   Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001
   Rodil SE, 2005, BIO-MED MATER ENG, V15, P101
   Sadezky A, 2005, CARBON, V43, P1731, DOI 10.1016/j.carbon.2005.02.018
   Sangsanoh P, 2007, BIOMACROMOLECULES, V8, P1587, DOI 10.1021/bm061152a
   Satnescu R, 1999, CARBON, V37, P1
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Schmidt DR, 2009, BIOL INTERACTIONS MA, P2
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Seil JT, 2010, WIRES NANOMED NANOBI, V2, P635, DOI 10.1002/wnan.109
   Selhuber C, 2006, NANO LETT, V6, P267, DOI 10.1021/nl052256e
   Sharma CS, 2010, IND ENG CHEM RES, V49, P2731, DOI 10.1021/ie901312j
   Shen JW, 2008, BIOMATERIALS, V29, P3847, DOI 10.1016/j.biomaterials.2008.06.013
   Teixidor GT, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034116
   VALLANA F, 1993, CERAM INT, V19, P169, DOI 10.1016/0272-8842(93)90038-S
   Vecitis CD, 2010, ACS NANO, V4, P5471, DOI 10.1021/nn101558x
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Yaghoub MB, 2005, BIOTECHNOL BIOENG, V92, P336
NR 50
TC 17
Z9 18
U1 1
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2013
VL 101B
IS 4
BP 520
EP 531
DI 10.1002/jbm.b.32852
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 123RL
UT WOS:000317408200004
PM 23359403
DA 2018-10-20
ER

PT J
AU Zhang, YQ
   Wang, JL
   Wang, P
   Fan, XL
   Li, XK
   Fu, J
   Li, SJ
   Fan, HB
   Guo, Z
AF Zhang, Yongquan
   Wang, Junlin
   Wang, Pan
   Fan, Xiangli
   Li, Xiaokang
   Fu, Jun
   Li, Shujun
   Fan, Hongbin
   Guo, Zheng
TI Low elastic modulus contributes to the osteointegration of titanium
   alloy plug
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cartilage repair; elastic modulus; titanium plug; osteointegration
ID CARTILAGE REPAIR; STAINLESS-STEEL; FINITE-ELEMENT; BONE; IMPLANTS;
   TI-24NB-4ZR-7.9SN; SURFACES; DEFECTS; RABBIT; PLATES
AB Resurfacing of cartilage defect with mini titanium plug is considered a promising alternative for the treatment of focal chondral defects. Elastic modulus of the metal implant plays a significant role in force transmission which influences the stability of plug. This study assessed the effects of two kinds of titanium alloy plug with different elastic modulus, that is, titanium 2448 (Ti2448) plug and titanium6 aluminum4 vanadium (TAV) plug on osteointegration. The full-thickness chondral defects were created in bilateral knees of dogs and then TAV and Ti2448 plugs were implanted, respectively. After 12 weeks, radiographic evaluation did not reveal any signs of disassembly, subsidence, or periprosthetic radiolucency in both groups. Microcomputed tomography analysis revealed that bone histomorphometric parameters in Ti2448 group were all significantly better than those of TAV group. Furthermore, the value of pullout force in Ti2448 group was also significantly higher. Histology showed that the screw threads of Ti2448 plug were well integrated into the newly formed bone. In contrast, the trabecular bone was sparsely distributed around TAV plug. In conclusion, Ti2448 plug with low elastic modulus showed more favorable characteristics in osteointegration. Ti2448 may be a promising biomaterial for fabricating mini plug applied for cartilage resurfacing. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [Zhang, Yongquan; Wang, Pan; Fan, Xiangli; Li, Xiaokang; Fu, Jun; Fan, Hongbin; Guo, Zheng] Fourth Mil Med Univ, Xi Jing Hosp, Dept Orthoped Oncol, Xian 710032, Peoples R China.
   [Wang, Junlin] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China.
   [Li, Shujun] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.
RP Fan, HB (reprint author), Fourth Mil Med Univ, Xi Jing Hosp, Dept Orthoped Oncol, Xian 710032, Peoples R China.
EM fanhb@fmmu.edu.cn; guozheng@fmmu.edu.cn
FU National Natural Science Foundation of China [30900311]; National High
   Technology Research and Development Program of China [2007AA03Z431];
   Natural Science Foundation of Shaanxi Province, China [2011JM4039]
FX Contract grant sponsor: National Natural Science Foundation of China;
   contract grant number: 30900311; Contract grant sponsor: National High
   Technology Research and Development Program of China; contract grant
   number: 2007AA03Z431; Contract grant sponsor: Natural Science Foundation
   of Shaanxi Province, China; contract grant number: 2011JM4039
CR Akpinar I, 1996, Quintessence Int, V27, P11
   Bollars P, 2012, KNEE SURG SPORT TR A, V20, P1753, DOI 10.1007/s00167-011-1757-9
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BRUNSKI J B, 1992, Clinical Materials, V10, P153, DOI 10.1016/0267-6605(92)90049-Y
   Chang MC, 2003, J BIOMECH, V36, P1209, DOI [10.1016/S0021-9290(03)00113-1, 10.1016/S0021-9290(03)001133-1]
   Cochran DL, 2000, CLIN ORAL IMPLAN RES, V11, P33, DOI 10.1034/j.1600-0501.2000.011S1033.x
   Eskitascioglu G, 2004, J PROSTHET DENT, V91, P144, DOI 10.1016/j.prosdent.2003.10.018
   Geng JP, 2001, J PROSTHET DENT, V85, P585, DOI 10.1067/mpr.2001.115251
   Guo Z, 2009, MAT SCI ENG C-BIO S, V29, P963, DOI 10.1016/j.msec.2008.08.019
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Jackson RW, 2003, ARTHROSCOPY, V19, P13, DOI 10.1053/jars.2003.50022
   Krishnan SP, 2006, J BONE JOINT SURG BR, V88B, P61, DOI 10.1302/0301-620X.88B1.16796
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Lin DJ, 2007, BIOMATERIALS, V28, P2582, DOI 10.1016/j.biomaterials.2007.02.005
   ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008
   PILLIAR RM, 1991, BIOMATERIALS, V12, P95, DOI 10.1016/0142-9612(91)90185-D
   Rosowski M, 2006, ARTIF ORGANS, V30, P775, DOI 10.1111/j.1525-1594.2006.00300.x
   Sumner DR, 1998, J BIOMECH, V31, P909, DOI 10.1016/S0021-9290(98)00096-7
   TONINO AJ, 1976, J BONE JOINT SURG BR, V58, P107
   UHTHOFF HK, 1981, J BONE JOINT SURG BR, V63, P427
   Wiskott HWA, 1999, CLIN ORAL IMPLAN RES, V10, P429, DOI 10.1034/j.1600-0501.1999.100601.x
NR 22
TC 2
Z9 2
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2013
VL 101B
IS 4
BP 584
EP 590
DI 10.1002/jbm.b.32860
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 123RL
UT WOS:000317408200011
PM 23255397
DA 2018-10-20
ER

PT J
AU Devine, DM
   Hahn, J
   Richards, RG
   Gruner, H
   Wieling, R
   Pearce, SG
AF Devine, Declan M.
   Hahn, Joachim
   Richards, R. Geoffery
   Gruner, Heiko
   Wieling, Ronald
   Pearce, Simon G.
TI Coating of carbon fiber-reinforced polyetheretherketone implants with
   titanium to improve bone apposition
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE coating; orthopedic; PEEK; titanium; in vivo
ID PLASMA-SPRAYED TITANIUM; IN-VIVO; CALCIUM-PHOSPHATE; PEEK; ROUGHNESS;
   SURFACES; REMOVAL; VITRO
AB Carbon fiber-reinforced polyetheretherketone (CF/PEEK) is a thermoplastic composite biomaterial exhibiting properties suitable for load-bearing orthopedic implants. However, the hydrophobic surface of CF/PEEK implants induces the deposition of a peri-implant fibrous tissue capsule preventing bone apposition. However, if bone apposition was improved, the use of CF/PEEK in orthopedics could be increased as it has many advantages compared with metallic implants. In this study, CF/PEEK screws were coated with titanium (Ti) using two different techniques, namely vacuum plasma spraying (VPS) and physical vapor deposition (PVD) with uncoated screws as controls. These coatings were characterized and implanted in a loaded sheep tibia model. In the characterization of the screw surfaces using microscopy techniques, the uncoated screws were seen to have an irregular surface. The PVD coating appeared smooth and consistent, whereas the VPS coating appeared to be a rough coating with some inhomogeneities, which did not cover the entire surface area. Nevertheless, in the ex vivo analysis the VPS-coated screws had a screw removal torque which was statistically greater than uncoated and PVD-coated screws (p 0.002 for both comparisons). Additionally, the VPS-coated screws had a statistically higher bone contact area than the uncoated screws (p = 0.006), whereas no statistical difference was detected between VPS and PVD coating types (p = 0.11). Thereby illustrating that Ti coating of CF/PEEK screws significantly improve bone apposition and removal torque compared with uncoated CF/PEEK screws. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
C1 [Devine, Declan M.; Hahn, Joachim; Richards, R. Geoffery; Pearce, Simon G.] AO Res Inst, Davos, Switzerland.
   [Richards, R. Geoffery] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales.
   [Gruner, Heiko] Medicoat AG, Magenwil, Switzerland.
   [Wieling, Ronald] Icotec AG, Altstatten, Swaziland.
RP Devine, DM (reprint author), Athlone Inst Technol, Mat Res Inst, Dublin Rd, Athlone, Westmeath, Ireland.
EM ddevine50@yahoo.co.uk
RI Devine, Declan/H-2340-2014; Richards, Robert/I-8235-2015
OI Devine, Declan/0000-0002-1364-5583; Richards, Robert/0000-0002-7778-2480
CR Aebli N, 2003, J BIOMED MATER RES A, V66A, P356, DOI 10.1002/jbm.a.10508
   Borsari V, 2005, J BIOMED MATER RES B, V75B, P359, DOI 10.1002/jbm.b.30313
   Borsari V, 2005, BIOMATERIALS, V26, P4948, DOI 10.1016/j.biomaterials.2005.01.010
   Converse GL, 2007, BIOMATERIALS, V28, P927, DOI 10.1016/j.biomaterials.2006.10.031
   Eschbach L., 2000, INT J CARE INJURED, V31
   Gisep A, 2009, EUR CELLS MATER, V17, P10
   GRUNER H, 2001, ENG MAT SER, P375
   Ha SW, 1997, J MATER SCI-MATER M, V8, P683, DOI 10.1023/A:1018535923173
   Ha SW, 1997, J MATER SCI-MATER M, V8, P881, DOI 10.1023/A:1018557922690
   Hallmann L, 2012, APPL SURF SCI, V258, P7213, DOI 10.1016/j.apsusc.2012.04.040
   Han CM, 2010, BIOMATERIALS, V31, P3465, DOI 10.1016/j.biomaterials.2009.12.030
   Hayes JS, 2010, EXPERT REV MED DEVIC, V7, P843, DOI [10.1586/erd.10.53, 10.1586/ERD.10.53]
   Hayes JS, 2010, EUR CELLS MATER, V20, P98
   Hayes JS, 2010, EUR CELLS MATER, V19, P117, DOI 10.22203/eCM.v019a12
   Hayes JS, 2010, EXPERT REV MED DEVIC, V7, P131, DOI 10.1586/ERD.09.55
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Liebenson C., 1996, REHABILITATION SPINE, P927
   Niemeyer P, 2010, TISSUE ENG PT A, V16, P33, DOI [10.1089/ten.tea.2009.0190, 10.1089/ten.TEA.2009.0190]
   Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pearce AI, 2008, J ORTHOP RES, V26, P1377, DOI 10.1002/jor.20665
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Riveiro A, 2012, APPL SURF SCI, V258, P9437, DOI 10.1016/j.apsusc.2012.01.154
   Schlegel P, 2009, J BIOMED MATER RES B, V90B, P26, DOI 10.1002/jbm.b.31249
   Zhang SN, 2011, COLLOID SURFACE A, V374, P88, DOI 10.1016/j.colsurfa.2010.11.013
NR 25
TC 33
Z9 33
U1 2
U2 85
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2013
VL 101B
IS 4
BP 591
EP 598
DI 10.1002/jbm.b.32861
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 123RL
UT WOS:000317408200012
PM 23281249
DA 2018-10-20
ER

PT J
AU Yang, YL
   Guo, N
AF Yang, Y. L.
   Guo, N.
TI In situ fabrication and wettability of Ca2SiO4/CaTiO3 biocoating by
   laser cladding technology on Ti-6Al-4V alloy
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Biocoating; Laser cladding; In situ fabrication; Wettability
ID CALCIUM-PHOSPHATE COATINGS; ND-YAG LASER; CERAMIC A-W; APATITE
   FORMATION; HYDROXYAPATITE; TITANIUM; SILICON; GLASS; CRYSTALLIZATION;
   MICROSTRUCTURE
AB Wetting is the first and foremost event when a biomaterial is implanted into the biological system. Hence, it is very essential to investigate the wettability of a biomaterial before further biological studies. A textured coating with different relative amounts of Ca2SiO4 and CaTiO3 was in situ fabricated by varying laser scan speed. The wettability of different coatings was investigated. The results indicate that the relative amount of Ca2SiO4 phase increased with decreasing laser scan speeds and reached the highest value of 48.17 +/- 2.10 mJ mm(-2), and the geometrically textured topography with a surface roughness of 9.17 mu m was obtained at a laser scan speed of 2 mm s(-1). The microstructure in the coating can be characterised as fine dendrites. Surface energy values varied with the relative amount of Ca2SiO4 phase. The coating obtained at the laser scan speed of 2 mm s(-1), which contains more relative amount of Ca2SiO4, presents the highest surface energy, indicating most desirable wettability. This resulted in an increase in contact angle in simulated body fluid solution for improved wettability. The microhardness presented a gradient distribution from the coating surface (1072 HV) to the substrate (260 HV).
C1 [Yang, Y. L.; Guo, N.] Northeastern Univ, Coll Sci, Shenyang 110004, Peoples R China.
RP Yang, YL (reprint author), Northeastern Univ, Coll Sci, Shenyang 110004, Peoples R China.
EM yulingyang@mail.neu.edu.cn
FU Fundamental Research Funds for the Central University [N100405001];
   Natural Science Foundation of China (NSFC) [50801012]; Natural Science
   Fund in Liaoning Province [20102072]
FX Part of the present work is supported by the Fundamental Research Funds
   for the Central University under grant no. N100405001, Natural Science
   Foundation of China (NSFC) under project no. 50801012 and Natural
   Science Fund in Liaoning Province under grant no. 20102072.
CR Arcos D, 2004, CHEM MATER, V16, P2300, DOI 10.1021/cm035337
   Assender H, 2002, SCIENCE, V297, P973, DOI 10.1126/science.1074955
   Bielby RC, 2005, TISSUE ENG, V11, P479, DOI 10.1089/ten.2005.11.479
   Cheng GJ, 2005, MAT SCI ENG C-BIO S, V25, P541, DOI 10.1016/j.msec.2005.05.002
   Chibowski E, 2003, ADV COLLOID INTERFAC, V103, P149, DOI 10.1016/S0001-8686(02)00093-3
   De Aza PN, 2004, BIOMATERIALS, V25, P1983, DOI 10.1016/j.biomaterials.2003.08.036
   Gibson IR, 2002, J AM CERAM SOC, V85, P2771
   Gou Z., 2005, J BIOMED MATER RES B, V73B, P241
   Gou ZR, 2005, J EUR CERAM SOC, V25, P1507, DOI 10.1016/j.jeurceramsoc.2004.05.029
   Greish YE, 2003, J BIOMED MATER RES B, V67B, P632, DOI 10.1002/jbm.b.10056
   Hansson S, 1999, J BIOMECH, V32, P829, DOI 10.1016/S0021-9290(99)00058-5
   Israelachvili J., 1985, INTERMOLECLAR SURFAC
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kurella A, 2006, ACTA BIOMATER, V2, P677, DOI 10.1016/j.actbio.2006.05.001
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Lusquinos F, 2003, J BIOMED MATER RES A, V64A, P630, DOI 10.1002/jbm.a.10440
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ohtsu N, 2012, SURF COAT TECH, V206, P2616, DOI 10.1016/j.surfcoat.2011.11.022
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Paital SR, 2007, BIOMED MATER, V2, P274, DOI 10.1088/1748-6041/2/4/011
   Pichugin VF, 2008, SURF COAT TECH, V202, P3913, DOI 10.1016/j.surfcoat.2008.01.038
   Pietak A, 2004, J MATER SCI, V39, P2443, DOI 10.1023/B:JMSC.0000020008.76515.bd
   Roy M, 2008, ACTA BIOMATER, V4, P324, DOI 10.1016/j.actbio.2007.09.008
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Surmenev RA, 2012, SURF COAT TECH, V206, P2035, DOI 10.1016/j.surfcoat.2011.11.002
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Wang CX, 2000, SURF COAT TECH, V130, P39, DOI 10.1016/S0257-8972(00)00705-2
   Wang DG, 2008, COLLOID SURFACE B, V66, P155, DOI 10.1016/j.colsurfb.2008.06.003
   Zhao YF, 2005, SURF REV LETT, V12, P505, DOI 10.1142/S0218625X05007347
   Zheng M, 2008, APPL SURF SCI, V255, P426, DOI 10.1016/j.apsusc.2008.06.078
   Zubair MA, 2010, J EUR CERAM SOC, V30, P107, DOI 10.1016/j.jeurceramsoc.2009.07.026
   Zuleta F, 2011, MAT SCI ENG C-MATER, V31, P377, DOI 10.1016/j.msec.2010.10.013
   Zuleta FA, 2010, J BIOMED MATER RES B, V94B, P399, DOI 10.1002/jbm.b.31667
NR 36
TC 3
Z9 3
U1 1
U2 39
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0267-0836
EI 1743-2847
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD MAY
PY 2013
VL 29
IS 5
BP 598
EP 604
DI 10.1179/1743284712Y.0000000188
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 122VG
UT WOS:000317345600014
DA 2018-10-20
ER

PT J
AU Lambert, F
   Leonard, A
   Drion, P
   Sourice, S
   Pilet, P
   Rompen, E
AF Lambert, France
   Leonard, Angelique
   Drion, Pierre
   Sourice, Sophie
   Pilet, Paul
   Rompen, Eric
TI The effect of collagenated space filling materials in sinus bone
   augmentation: a study in rabbits
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE bone regeneration; collagen; histomorphometry; hydroxyapatite;
   osteoconduction
ID EXTRACTION; XENOGRAFT; IMPLANTS; DOG
AB Aim The inclusion of biomaterial particles used for alveolar bone regeneration in a carrier or in binding agents such as collagen gel or fibers is of interest as a means to help with surgical handling. However, the possible influence of collagen on bone tissue response to biomaterials is poorly studied. The objective of the present study was to investigate, in a sub-sinus bone augmentation model in rabbits, the effect of collagen at different stages of the osteogenesis process. Histologic, histomorphometric and volumetric analyses were performed. Materials and methods Rabbits underwent a double sinus lift procedure using bovine hydroxyapatite (BHA), collagenated bovine hydroxyapatite (BHAColl), and prehydrated and collagenated porcine hydroxyapatite (PHAColl). Animals were sacrificed at 1week, 5weeks or 6months. Samples were subjected to X-ray micro-tomography and histology. Qualitative analysis was performed on the non-decalcified sections and quantitative histomorphometric analyses were conducted using scanning electron microscopy (SEM). Volume variations of bone augmentations were calculated at different time points. Results The three biomaterials allowed an optimal bone formation and were able to equally withstand sinusal reexpansion. A comparable percentage of new bone, as well as 3D volume stability, was found between the groups at each time point. However, the PHAColl resorption rate was significantly higher than the rates in other groups (P=0.0003), with only 3.6% of the particles remaining at 6months. At 1week, both collagenated groups displayed the presence of inflammatory cells although BHA did not show any sign of inflammation. At 5weeks and 6months, the inflammatory process had disappeared completely in the BHAColl groups, whereas some inflammatory-like cells could still be observed around the remaining particles of PHAColl. Conclusions and clinical implications Within the limitations of this study in rabbits, the findings showed the presence of inflammatory-like cells at the early stage of bone regeneration when collagenated xenogenic biomaterials were used compared to xenogenic granules alone. Nevertheless, similar bone formation occurred and comparable 3D volumes were found at 6months in the different groups.
C1 [Lambert, France; Rompen, Eric] Univ Liege, Dept Periodontol & Oral Surg, Fac Med, Liege, Belgium.
   [Leonard, Angelique] Univ Liege, Dept Appl Chem, Liege, Belgium.
   [Drion, Pierre] Univ Liege, Cent Anim Facil, Giga R, Liege, Belgium.
   [Sourice, Sophie; Pilet, Paul] Univ Nantes, Lab Osteoarticular & Dent Tissue Engn, INSERM, U791, Nantes, France.
   [Pilet, Paul] CHU Nantes, Serv Odontol Conservatrice Endodontie, F-44035 Nantes 01, France.
RP Lambert, F (reprint author), Serv Med Dent, Domaine Sart Tilman Bat B35, B-4000 Cointe Ougree, Belgium.
EM france.lambert@chu.ulg.ac.be
RI Paul, Pilet/A-3755-2015
CR Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Asai S, 2002, CLIN ORAL IMPLAN RES, V13, P405, DOI 10.1034/j.1600-0501.2002.130409.x
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   Busenlechner D, 2009, CLIN ORAL IMPLAN RES, V20, P1099, DOI 10.1111/j.1600-0501.2009.01743.x
   Chiapasco M, 2009, CLIN ORAL IMPLAN RES, V20, P113, DOI 10.1111/j.1600-0501.2009.01781.x
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Lambert F, 2013, CLIN IMPLANT DENT R, V15, P412, DOI 10.1111/j.1708-8208.2011.00374.x
   Lambert F, 2011, CLIN ORAL IMPLAN RES, V22, P538, DOI 10.1111/j.1600-0501.2010.02069.x
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x
   Sbordone L, 2009, INT J ORAL MAX SURG, V38, P1059, DOI 10.1016/j.ijom.2009.06.024
NR 13
TC 3
Z9 3
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2013
VL 24
IS 5
BP 505
EP 511
DI 10.1111/j.1600-0501.2011.02412.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 114PV
UT WOS:000316755400004
PM 22313247
OA Green Published
DA 2018-10-20
ER

PT J
AU Ramirez-Fernandez, MP
   Calvo-Guirado, JL
   del Val, JEMS
   Delgado-Ruiz, RA
   Negri, B
   Barona-Dorado, C
AF Piedad Ramirez-Fernandez, Maria
   Luis Calvo-Guirado, Jose
   Eduardo Mate-Sanchez del Val, Jose
   Arcesio Delgado-Ruiz, Rafael
   Negri, Bruno
   Barona-Dorado, Cristina
TI Ultrastructural study by backscattered electron imaging and elemental
   microanalysis of bone-to-biomaterial interface and mineral degradation
   of porcine xenografts used in maxillary sinus floor elevation
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE maxillary sinus lift; grafting material; porcine bone xenograft;
   back-scattered electron imaging
ID IMPLANT PLACEMENT; AUGMENTATION TECHNIQUES; AUTOGENOUS BONE; BOVINE
   BONE; DIFFERENTIATION; GRAYLEVELS; MICROSCOPY; GRAFTS; HUMANS; IMAGES
AB Objectives The aim of this study was to carry out an ultrastructural study of the biomaterial-to-bone interface and biomaterial mineral degradation in retrieved bone biopsies following maxillary sinus augmentation using collagenized porcine xenografts (Osteobiol (R) Mp3) in 15 clinical cases. Materials and methods Nine months after sinus lifting, bone cores were harvested from the maxillary sinus. The specimens were processed for observation under a scanning electron microscope with backscattered electron imaging (SEM-BSE). In addition, chemical analysis and elemental mapping of the mineral composition were generated using a microanalytical system based on energy-dispersive X-ray spectrometry (EDX). Results No clinical complications were evident during surgery. Scanning electron microscopy revealed that newly formed bone had become closely attached to the xenograft. Statistical analysis showed a significantly high Ca/P ratio in the biomaterial (2.46 +/- 0.16) and at the bone interface (2.00 +/- 0.48) compared to bone (1.97 +/- 0.36), which suggests that there may be a gradual diffusion of Ca ions from the biomaterial into the newly forming bone at the interface as part of the biomaterial's resorption process. EDX analysis of the residual porcine biomaterial at different points showed some particle categories with different mean ratios of Ca/P according to size, pointing to different stages of the resorption process. Conclusions The biomaterial proved to be biocompatible, bioreabsorbable and osteoconductive when used as a bone substitute for maxillary sinus elevation. SEM-BSE revealed that newly formed bone had become closely attached to the xenografts. EDX analysis monitored the resorption process of the porcine bone xenograft. Elemental mapping showed that there was a gradual diffusion of Ca ions from the biomaterial to the newly forming bone at the interface.
C1 [Piedad Ramirez-Fernandez, Maria; Luis Calvo-Guirado, Jose; Eduardo Mate-Sanchez del Val, Jose; Arcesio Delgado-Ruiz, Rafael; Negri, Bruno] Univ Murcia, Dept Implant Dent, Fac Med & Dent, Murcia 30007, Spain.
   [Barona-Dorado, Cristina] Univ Complutense Madrid, Dept Oral Surg, Madrid, Spain.
RP Ramirez-Fernandez, MP (reprint author), Univ Murcia, Fac Med & Dent, Hosp Morales Meseguer, 2 Planta Clin Odontol,Calle Marques de los Velez, Murcia 30007, Spain.
EM mpramirezfern@hotmail.com
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; Delgado-Ruiz,
   Rafael/0000-0003-1721-0509; calvo guirado, jose
   luis/0000-0002-4067-2253; RAMIREZ FERNANDEZ, MARIA
   PIEDAD/0000-0003-1913-9902
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Arcuri C, 2005, Minerva Stomatol, V54, P351
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   Bloebaum R D, 1990, J Biomater Appl, V5, P56
   Borie DC, 1998, INFECT CONT HOSP EP, V19, P355
   Guirado JLC, 2013, CLIN IMPLANT DENT R, V15, P143, DOI 10.1111/j.1708-8208.2011.00337.x
   Calvo-Guirado JL, 2012, CLIN ORAL IMPLAN RES, V23, P667, DOI 10.1111/j.1600-0501.2011.02193.x
   Cricchio Giovanni, 2003, Clin Implant Dent Relat Res, V5, P161, DOI 10.1111/j.1708-8208.2003.tb00198.x
   Cutter C Suzanne, 2006, J Long Term Eff Med Implants, V16, P249
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Franch J, 1998, VET COMP ORTHOPAED, V11, P105
   Haga M, 2009, ANAT REC, V292, P38, DOI 10.1002/ar.20748
   JASTY M, 1989, SCANNING MICROSCOPY, V3, P1051
   Johansson LA, 2010, J ORAL MAXIL SURG, V68, P837, DOI 10.1016/j.joms.2009.07.093
   Kim SH, 2004, J BIOMED MATER RES B, V68B, P69, DOI 10.1002/jbm.b.10084
   Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002
   Lindgren C, 2010, CLIN ORAL IMPLAN RES, V21, P924, DOI 10.1111/j.1600-0501.2010.01933.x
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Ottani V, 2002, MICRON, V33, P121, DOI 10.1016/S0968-4328(01)00008-7
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Scarano A, 2011, CLIN IMPLANT DENT R, V13, P13, DOI 10.1111/j.1708-8208.2009.00176.x
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P47, DOI 10.1002/jbm.820270107
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P57, DOI 10.1002/jbm.820270108
   Slater N, 2008, CLIN ORAL IMPLAN RES, V19, P814, DOI 10.1111/j.1600-0501.2008.01550.x
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Traini T, 2008, J PERIODONTOL, V79, P1232, DOI [10.1902/jop.2008.070504, 10.1902/jop.2008.070504 ]
   Wierzchos J, 2008, MICRON, V39, P1363, DOI 10.1016/j.micron.2008.01.022
NR 35
TC 11
Z9 12
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2013
VL 24
IS 5
BP 523
EP 530
DI 10.1111/j.1600-0501.2011.02414.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 114PV
UT WOS:000316755400007
PM 22276656
DA 2018-10-20
ER

PT J
AU Park, YS
   Chung, SH
   Shon, WJ
AF Park, Young-Seok
   Chung, Shin-Hye
   Shon, Won-Jun
TI Peri-implant bone formation and surface characteristics of rough surface
   zirconia implants manufactured by powder injection molding technique in
   rabbit tibiae
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE animal experiment; biomaterials; boneimplant interaction; powder
   induction molding technique; zirconia implant
ID IN-VIVO; TITANIUM IMPLANTS; DENTAL IMPLANTS; SINTERING BEHAVIOR; REMOVAL
   TORQUE; FOLLOW-UP; OSSEOINTEGRATION; BIOMATERIAL; HUMANS; VITRO
AB Objective To evaluate osseointegration in rabbit tibiae and to investigate surface characteristics of novel zirconia implants made by powder injection molding (PIM) technique, using molds with and without roughened inner surfaces. Material and methods A total of 20 rabbits received three types of external hex implants with identical geometry on the tibiae: machined titanium implants, PIM zirconia implants without mold etching, and PIM zirconia implants with mold etching. Surface characteristics of the three types of implant were evaluated. Removal torque tests and histomorphometric analyses were performed. Results The roughness of PIM zirconia implants was higher than that of machined titanium implants. The PIM zirconia implants exhibited significantly higher boneimplant contact and removal torque values than the machined titanium implants (P<0.001). The PIM zirconia implants using roughened mold showed significantly higher removal torque values than PIM zirconia implants without using roughened mold (P<0.001). Conclusions It is concluded that the osseointegration of PIM zirconia implant is promising and PIM using roughened mold etching technique can produce substantially rough surfaces on zirconia implants.
C1 [Park, Young-Seok] Seoul Natl Univ, Dent Res Inst, Dept Oral Anat, Seoul 110749, South Korea.
   [Park, Young-Seok; Chung, Shin-Hye; Shon, Won-Jun] Seoul Natl Univ, Sch Dent, Seoul 110749, South Korea.
   [Chung, Shin-Hye; Shon, Won-Jun] Seoul Natl Univ, Dept Conservat Dent, Dent Res Inst, Seoul 110749, South Korea.
RP Shon, WJ (reprint author), Seoul Natl Univ, Dent Res Inst, 28 Yeongeuon Dong, Seoul 110749, South Korea.
EM endoson@snu.ac.kr
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science, and Technology [2011-0026146]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science, and Technology (2011-0026146). We are much
   indebted to Soo-Hwan Kim (Graduate student, Department of Statistics,
   Korea University) for his comprehensive cooperation in statistical
   evaluation of the data.
CR Aboushelib MN, 2013, J ORAL IMPLANTOL, V39, P583, DOI 10.1563/AAID-JOI-D-11-00075
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x
   Edirisinghe M.J., 1986, INT J HIGH TECH CERA, V2, P1
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Gahlert M, 2012, CLIN ORAL IMPLAN RES, V23, P281, DOI 10.1111/j.1600-0501.2011.02157.x
   Gahlert M, 2009, CLIN ORAL IMPLAN RES, V20, P1247, DOI 10.1111/j.1600-0501.2009.01734.x
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Jung RE, 2007, INT J PERIODONT REST, V27, P251
   Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P350, DOI 10.1111/j.1600-0501.2009.01832.x
   Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P333, DOI 10.1111/j.1600-0501.2008.01656.x
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Kokubo Y, 2007, J ORAL REHABIL, V34, P503, DOI 10.1111/j.1365-2842.2007.01751.x
   Lee J, 2009, J CLIN PERIODONTOL, V36, P610, DOI 10.1111/j.1600-051X.2009.01423.x
   Lee SY, 2004, CERAM INT, V30, P579, DOI 10.1016/j.ceramint.2003.09.009
   Lin SIE, 2001, CERAM INT, V27, P205, DOI 10.1016/S0272-8842(00)00065-1
   Liu DM, 1998, CERAM INT, V24, P471, DOI 10.1016/S0272-8842(97)00039-4
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Oliva J, 2007, INT J ORAL MAX IMPL, V22, P430
   Oliva J, 2010, INT J ORAL MAX IMPL, V25, P336
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Rocchietta I, 2009, CLIN ORAL IMPLAN RES, V20, P844, DOI 10.1111/j.1600-0501.2009.01727.x
   Rompen E, 2007, J PROSTHET DENT, V97, pS119, DOI 10.1016/S0022-3913(07)60015-8
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Schliephake H, 2010, J CLIN PERIODONTOL, V37, P818, DOI 10.1111/j.1600-051X.2010.01549.x
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Shin D, 2011, CLIN ORAL IMPLAN RES, V22, P242, DOI 10.1111/j.1600-0501.2010.01980.x
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   SONG JH, 1995, CERAM INT, V21, P325, DOI 10.1016/0272-8842(95)96204-3
   Stadlinger B, 2010, INT J ORAL MAX SURG, V39, P585, DOI 10.1016/j.ijom.2010.01.015
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
   Zinelis S, 2010, DENT MATER, V26, P295, DOI 10.1016/j.dental.2009.11.079
NR 36
TC 21
Z9 23
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2013
VL 24
IS 5
BP 586
EP 591
DI 10.1111/j.1600-0501.2012.02468.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 114PV
UT WOS:000316755400016
PM 22471790
DA 2018-10-20
ER

PT J
AU Vadillo-Rodriguez, V
   Pacha-Olivenza, MA
   Gonzalez-Martin, ML
   Bruque, JM
   Gallardo-Moreno, AM
AF Vadillo-Rodriguez, Virginia
   Pacha-Olivenza, Miguel A.
   Luisa Gonzalez-Martin, M.
   Bruque, Jose M.
   Gallardo-Moreno, Amparo M.
TI Adsorption behavior of human plasma fibronectin on hydrophobic and
   hydrophilic Ti6Al4V substrata and its influence on bacterial adhesion
   and detachment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium alloy; hydrophilicity; fibronectin; protein adsorption;
   bacterial adhesion
ID STAPHYLOCOCCUS-AUREUS; CELL-ADHESION; TITANIUM SURFACES; OPTICAL
   TWEEZERS; BINDING PROTEINS; IMMUNOGLOBULIN-G; COATED SURFACES;
   EPIDERMIDIS; INTERFACE; ADHERENCE
AB Biomaterial implant-associated infections, a common cause of medical devices' failure, are initiated by bacterial adhesion to an adsorbed protein layer on the implant material surface. In this study, the influence of protein surface orientation on bacterial adhesion has been examined using three clinically relevant bacterial strains known to express specific binding sites for human plasma fibronectin (HFN). HFN was allowed to adsorb on hydrophobic Ti6Al4V and physically modified hydrophilic Ti6Al4V substrata. Ellipsometric data reveal that the characteristics of the adsorbed protein layers primary depend on solid surface tension and the initial protein concentration in solution. In particular, HFN molecules adopt a more extended conformation on hydrophobic than hydrophilic surfaces, an effect that is more pronounced at low than at high initial protein concentrations. Moreover, the extended conformation of the protein molecules on these surfaces likely facilitates the exposure of specific sites for adhesion, resulting in the higher bacterial-cell attachment observed regardless of the strain considered. Contact angle measurements and the analysis of the number of remaining adhering cells after being subjected to external forces further suggest that both specific and nonspecific (hydrophobic) interactions play an important role on bacterial attachment. This study is the first one to evaluate the influence of surface hydrophobicity on protein adsorption and its subsequent effect on bacterial adhesion using a material whose hydrophobicity was not modified using chemical treatments that potentially led to surface properties changes other than hydrophobicity. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Vadillo-Rodriguez, Virginia; Pacha-Olivenza, Miguel A.; Luisa Gonzalez-Martin, M.; Bruque, Jose M.; Gallardo-Moreno, Amparo M.] Univ Extremadura, Dept Appl Phys, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Badajoz 06006, Spain.
RP Vadillo-Rodriguez, V (reprint author), Univ Extremadura, Dept Appl Phys, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Avda Elvas S-N, Badajoz 06006, Spain.
EM vvadillo@unex.es
RI Pacha Olivenza, Miguel/M-8285-2014; Morales Bruque, Jose/N-2521-2014;
   Gonzalez Martin, Maria Luisa/L-3476-2014; Vadillo-Rodriguez,
   Virginia/I-3117-2015
OI Pacha Olivenza, Miguel/0000-0003-3505-9320; Morales Bruque,
   Jose/0000-0002-9336-4350; Gonzalez Martin, Maria
   Luisa/0000-0002-9207-444X; Vadillo-Rodriguez,
   Virginia/0000-0002-7329-712X
FU Ministerio de Ciencia e Innovacion [RYC-2008-03482,
   MAT2009-14695-C04-01]; Junta of Extremadura [PRI08A124]; FEDER
FX Contract grant sponsor: Ministerio de Ciencia e Innovacion; contract
   grant number: RYC-2008-03482; Contract grant sponsor: Ministerio de
   Ciencia e Innovacion; contract grant number: MAT2009-14695-C04-01;
   Contract grant sponsor: Junta of Extremadura; contract grant number:
   PRI08A124; Contract grant sponsor: FEDER
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Brunette D. M., 2001, TITANIUM MED
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Fortun J, 1999, CLIN MICROBIOL INFEC, V5, p2S40
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   GOMEZSUAREZ C, 1999, PHYS CHEM CHEM PHYS, V1, P4423, DOI DOI 10.1039/A905156B
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HAYMAN EG, 1982, J CELL BIOL, V94, P28, DOI 10.1083/jcb.94.1.28
   Hemmersam AG, 2008, J COLLOID INTERF SCI, V320, P110, DOI 10.1016/j.jcis.2007.11.047
   Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   IWAMOTO GK, 1985, J COLLOID INTERF SCI, V106, P459, DOI 10.1016/S0021-9797(85)80020-5
   Jarvis RA, 2005, J BIOMED MATER RES A, V75A, P41, DOI 10.1002/jbm.a.30404
   JONSSON U, 1985, J COLLOID INTERF SCI, V103, P360, DOI 10.1016/0021-9797(85)90115-8
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   JONSSON U, 1987, J COLLOID INTERF SCI, V117, P127, DOI 10.1016/0021-9797(87)90175-5
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KUUSELA P, 1978, NATURE, V276, P718, DOI 10.1038/276718a0
   LAI CS, 1993, J MOL BIOL, V230, P625, DOI 10.1006/jmbi.1993.1174
   Laterra J, 1983, J CELL BIOL, V96, P113
   Leonhardt A, 2003, J PERIODONTOL, V74, P1415, DOI 10.1902/jop.2003.74.10.1415
   MacDonald ND, 2002, BIOMATERIALS, V23, P1269
   Mohamed N, 2000, BIOTECHNOL BIOENG, V68, P628, DOI 10.1002/(SICI)1097-0290(20000620)68:6<628::AID-BIT5>3.3.CO;2-4
   MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421
   Olsson ALJ, 2012, APPL ENVIRON MICROB, V78, P99, DOI 10.1128/AEM.06912-11
   Payet V, 2010, SURF INTERFACE ANAL, V42, P457, DOI 10.1002/sia.3298
   Pompe T, 2003, J BIOMED MATER RES A, V67A, P647, DOI 10.1002/jbm.a.10130
   Poortinga AT, 2001, COLLOID SURFACE B, V20, P105, DOI 10.1016/S0927-7765(00)00182-X
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Sela MN, 2007, CLIN ORAL IMPLAN RES, V18, P630, DOI 10.1111/j.1600-0501.2007.01373.x
   Simpson KH, 2003, J BACTERIOL, V185, P2031, DOI 10.1128/JB.185.6.2031-2035.2003
   Simpson KH, 2002, LASER SURG MED, V31, P45, DOI 10.1002/lsm.10070
   SJOLLEMA J, 1989, J MICROBIOL METH, V9, P73, DOI 10.1016/0167-7012(89)90057-2
   TALAY SR, 1992, INFECT IMMUN, V60, P3837
   Vadillo-Rodriguez V, 2005, COLLOID SURFACE B, V41, P33, DOI 10.1016/j.colsurfb.2004.10.028
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   Xu CP, 2008, APPL ENVIRON MICROB, V74, P7522, DOI 10.1128/AEM.00948-08
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
NR 46
TC 9
Z9 10
U1 1
U2 41
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2013
VL 101
IS 5
BP 1397
EP 1404
DI 10.1002/jbm.a.34447
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 115MG
UT WOS:000316815700020
PM 23076738
DA 2018-10-20
ER

PT J
AU Hoss, M
   Saric, T
   Denecke, B
   Peinkofer, G
   Bovi, M
   Groll, J
   Ko, K
   Salber, J
   Halbach, M
   Scholer, HR
   Zenke, M
   Neuss, S
AF Hoss, Mareike
   Saric, Tomo
   Denecke, Bernd
   Peinkofer, Gabriel
   Bovi, Manfred
   Groll, Juergen
   Ko, Kinarm
   Salber, Jochen
   Halbach, Marcel
   Schoeler, Hans R.
   Zenke, Martin
   Neuss, Sabine
TI Expansion and Differentiation of Germline-Derived Pluripotent Stem Cells
   on Biomaterials
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID IN-VITRO; HUMAN BLASTOCYSTS; HUMAN TESTIS; CARDIOMYOCYTES; FIBROBLASTS;
   GENERATION; LINES; INDUCTION; MATRICES; GROWTH
AB Stem cells with broad differentiation potential, such as the recently described germline-derived pluripotent stem cells (gPS cells), are an appealing source for tissue engineering strategies. Biomaterials can inhibit, support, or induce proliferation and differentiation of stem cells. Here we identified (1) polymers that maintain self-renewal and differentiation potential of gPS cells for feeder-free expansion and (2) polymers supporting the cardiomyogenic fate of gPS cells by analyzing a panel of polymers of an established biomaterial bank previously used to assess growth of diverse stem cell types. Identification of cytocompatible gPS cell/biomaterial combinations required analysis of several parameters, including morphology, viability, cytotoxicity, apoptosis, proliferation, and differentiation potential. Pluripotency of gPS cells was visualized by the endogenous Oct4-promoter-driven GFP and by Sox2 and Nanog immunofluorescence. Viability assay, proliferation assay, and flow cytometry showed that gPS cells efficiently adhere and are viable on synthetic polymers, such as Resomer (R) LR704 (poly((L)-lactic-(D,L)-lactic acid), poly(tetrafluor ethylene) (PTFE), poly(vinylidene fluoride) (PVDF), and on gelatine-coated tissue culture polystyrene. Expansion experiments showed that Resomer LR704 is an alternative substrate for feeder-free gPS cell maintenance. Resomer LR704, PTFE, and PVDF were found to be suitable for gPS cell differentiation. Spontaneous beating in embryoid bodies cultured on Resomer LR704 occurred already on day 8 of differentiation, much earlier compared to the other surfaces. This indicates that Resomer LR704 supports spontaneous cardiomyogenic differentiation of gPS cells, which was also confirmed on molecular, protein and functional level.
C1 [Hoss, Mareike; Denecke, Bernd] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res Aachen IZKF Aachen, D-52074 Aachen, Germany.
   [Hoss, Mareike; Zenke, Martin] Rhein Westfal TH Aachen, Inst Biomed Engn, Dept Cell Biol, D-52074 Aachen, Germany.
   [Hoss, Mareike; Bovi, Manfred; Neuss, Sabine] Rhein Westfal TH Aachen, Inst Pathol, Fac Med, D-52074 Aachen, Germany.
   [Saric, Tomo; Peinkofer, Gabriel] Univ Cologne, Inst Neurophysiol, Med Ctr, D-50931 Cologne, Germany.
   [Bovi, Manfred] Rhein Westfal TH Aachen, Electron Microscop Facil, Fac Med, D-52074 Aachen, Germany.
   [Groll, Juergen] Rhein Westfal TH Aachen, DWI eV, D-52074 Aachen, Germany.
   [Groll, Juergen] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52074 Aachen, Germany.
   [Groll, Juergen] Univ Hosp Wurzburg, Dept Funct Mat Med & Dent, Wurzburg, Germany.
   [Ko, Kinarm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.
   [Ko, Kinarm] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea.
   [Ko, Kinarm] Konkuk Univ, SMART Inst Adv Biomed Sci, Ctr Stem Cell Res, Seoul, South Korea.
   [Salber, Jochen] Ruhr Univ Bochum, BG Univ Klinikum Bergmannsheil, Chirurg Klin & Poliklin, Bochum, Germany.
   [Halbach, Marcel] Univ Cologne, Dept Internal Med 3, D-50931 Cologne, Germany.
   [Neuss, Sabine] Rhein Westfal TH Aachen, Inst Biomed Engn, Biointerface Grp, D-52074 Aachen, Germany.
RP Hoss, M (reprint author), Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res Aachen IZKF Aachen, Pauwelsstr 30, D-52074 Aachen, Germany.
EM mareike.hoss@rwth-aachen.de
RI Saric, Tomo/B-3415-2015; Groll, Jurgen/F-4202-2012
OI Saric, Tomo/0000-0001-8344-1095; Groll, Jurgen/0000-0003-3167-8466;
   Scholer, Hans/0000-0003-2643-5136
FU Interdisciplinary Centre for Clinical Research within the Faculty of
   Medicine at the RWTH Aachen University [IZKF 520813]; Stem Cell Network
   North-Rhine Westphalia; German Ministry for Education and Research
   [01GN0937]; National Research Foundation of Korea; Korean Government
   (MEST) [NRF-2012-0005133]
FX Supported by a grant from the Interdisciplinary Centre for Clinical
   Research within the Faculty of Medicine at the RWTH Aachen University
   (IZKF 520813), by the grant from the Stem Cell Network North-Rhine
   Westphalia to S.N. and T.S.. and by the German Ministry for Education
   and Research to T.S.. (grant number 01GN0937), and by the National
   Research Foundation of Korea Grant funded by the Korean Government
   (MEST) (NRF-2012-0005133). We thank Qiong Lin, M.Sc., Institute for
   Biomedical Engineering, Department of Cell Biology, RWTH Aachen, for PCA
   and hierarchical cluster analysis (heat maps), and Nadin Lange
   (Institute for Neurophysiology, Cologne) for technical assistance.
CR Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Cohen S, 2006, TISSUE ENG, V12, P2025, DOI 10.1089/ten.2006.12.2025
   Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404
   Czyz J, 2003, BIOL CHEM, V384, P1391, DOI 10.1515/BC.2003.155
   Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697
   Guan K, 2007, CIRC RES, V100, P1615, DOI 10.1161/01.RES.0000269182.22798.d9
   Guan K, 2009, NAT PROTOC, V4, P143, DOI 10.1038/nprot.2008.242
   Igelmund P, 1999, PFLUG ARCH EUR J PHY, V437, P669, DOI 10.1007/s004240050831
   Itthichaisri C, 2007, J BIOMED MATER RES A, V82A, P777, DOI 10.1002/jbm.a.31191
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061
   Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025
   Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Neuss S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023195
   Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125
   Pfannkuche K, 2010, STEM CELLS DEV, V19, P1589, DOI 10.1089/scd.2009.0255
   Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399
   Schneider R K, 2011, Pathologe, V32 Suppl 2, P296, DOI 10.1007/s00292-011-1485-4
   SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x
   Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tapia N, 2011, STEM CELLS, V29, P1165, DOI 10.1002/stem.669
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Torok E, 2011, LIVER TRANSPLANT, V17, P104, DOI 10.1002/lt.22200
   Wang L, 1996, CIRC RES, V79, P79, DOI 10.1161/01.RES.79.1.79
   Wang Q, 2005, STEM CELLS, V23, P1221, DOI 10.1634/stemcells.2004-0347
   WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x
   Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863
   Xu Zi-xing, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P289
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 38
TC 5
Z9 5
U1 0
U2 36
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2013
VL 19
IS 9-10
BP 1067
EP 1080
DI 10.1089/ten.tea.2012.0185
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 114JK
UT WOS:000316736700003
PM 23234562
OA Green Published
DA 2018-10-20
ER

PT J
AU Andukuri, A
   Sohn, YD
   Anakwenze, CP
   Lim, DJ
   Brott, BC
   Yoon, YS
   Jun, HW
AF Andukuri, Adinarayana
   Sohn, Young-Doug
   Anakwenze, Chidinma P.
   Lim, Dong-Jin
   Brott, Brigitta C.
   Yoon, Young-Sup
   Jun, Ho-Wook
TI Enhanced Human Endothelial Progenitor Cell Adhesion and Differentiation
   by a Bioinspired Multifunctional Nanomatrix
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID ACUTE MYOCARDIAL-INFARCTION; BONE-MARROW-CELLS; PERCUTANEOUS CORONARY
   INTERVENTION; ISCHEMIC VASCULAR-DISEASE; ANTIBODY-COATED STENT;
   NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; INTIMAL HYPERPLASIA;
   THERAPEUTIC NEOVASCULARIZATION; ERYTHROCYTE CONSUMPTION
AB Endothelial progenitor cell (EPC)-capturing techniques have led to revolutionary strategies that can improve the performance of cardiovascular implant devices and engineered tissues by enhancing re-endothelialization and angiogenesis. However, these strategies are limited by controversies regarding the phenotypic identities of EPCs as well as their inability to target and prevent the other afflictions associated with current therapies, namely, thrombosis and neointimal hyperplasia. Therefore, the goal of this study was to study the efficacy of a bioinspired multifunctional nanomatrix in recruiting and promoting the differentiation of EPCs toward an endothelial lineage. The bioinspired nanomatrix combines multiple components, including self-assembled peptide amphiphiles (PAs) that include cell adhesive ligands, nitric oxide (NO)-producing donors, and enzyme-mediated degradable sequences to achieve an endothelium-mimicking character. In this study, human peripheral blood mononuclear cells (PBMNCs) were isolated and cultured on the bioinspired multifunctional nanomatrix. Initial cell adhesion, lectin staining, acetylated low-density lipoprotein uptake, and expression of endothelial markers, including CD31, CD34, von Willebrand Factor, and VEGFR2, were analyzed. The results from this study indicate that the NO releasing bioinspired multifunctional nanomatrix promotes initial adhesion of EPCs when compared to control surfaces. The expression of endothelial markers is also increased on the bioinspired multifunctional nanomatrix, suggesting that it directs the differentiation of EPCs toward an endothelial phenotype. The bioinspired nanomatrix therefore provides a novel biomaterial-based platform for capturing as well as directing EPC behavior. Therefore, this study has the potential to positively impact the patency of cardiovascular devices such as stents and vascular grafts as well as enhanced angiogenesis for ischemic or engineered tissues.
C1 [Andukuri, Adinarayana; Anakwenze, Chidinma P.; Lim, Dong-Jin; Jun, Ho-Wook] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Sohn, Young-Doug; Yoon, Young-Sup] Emory Univ, Dept Cardiol, Atlanta, GA 30322 USA.
   [Brott, Brigitta C.] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA.
RP Jun, HW (reprint author), Univ Alabama Birmingham, Dept Biomed Engn, 1825 Univ Blvd,Shelby 806, Birmingham, AL 35294 USA.
EM hwjun@uab.edu
OI Andukuri, Adinarayana/0000-0002-6909-4928
FU Wallace H Coulter Foundation (HWJ), Caroline P Ireland Research
   Scholarship; American Heart Association Predoctoral Fellowship, UAB PREP
   scholarship [10PRE3500024]; NIH [GM086256]
FX The authors express their gratitude to Joan Harshberger (RN) and Enid
   Keyser for the use of Flow cytometry facilities. This study was
   supported by the Wallace H Coulter Foundation (HWJ), Caroline P Ireland
   Research Scholarship and the American Heart Association Predoctoral
   Fellowship (10PRE3500024) (AA), UAB PREP scholarship and the NIH
   (GM086256) (CPA).
CR Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea
   Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948
   Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Andukuri A, 2010, NANOMED-NANOTECHNOL, V6, P289, DOI 10.1016/j.nano.2009.09.004
   Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048
   ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Avci-Adali M, 2011, EUR CELLS MATER, V21, P157, DOI 10.22203/eCM.v021a13
   Banerjee S, 2012, ATHEROSCLEROSIS, V225, P91, DOI 10.1016/j.atherosclerosis.2012.08.025
   Behjati M, 2013, INT J CARDIOL, V167, P1560, DOI 10.1016/j.ijcard.2012.04.094
   Belardi JA, 2011, CATHETER CARDIO INTE, V78, P196, DOI 10.1002/ccd.23284
   Blindt R, 2006, J AM COLL CARDIOL, V47, P1786, DOI 10.1016/j.jacc.2005.11.081
   Caplice NM, 2003, P NATL ACAD SCI USA, V100, P4754, DOI 10.1073/pnas.0730743100
   Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.00000097001.79750.78
   Chu L, 2008, EUR J PHARMACOL, V591, P59, DOI 10.1016/j.ejphar.2008.06.066
   Co M, 2008, AM HEART J, V155, P128, DOI 10.1016/j.ahj.2007.08.031
   den Dekker WK, 2011, ATHEROSCLEROSIS, V219, P245, DOI 10.1016/j.atherosclerosis.2011.06.032
   Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Garg S, 2010, EUR HEART J, V31, P1032, DOI 10.1093/eurheartj/ehp591
   George J, 2006, TISSUE ENG, V12, P331, DOI 10.1089/ten.2006.12.331
   Gill M, 2001, CIRC RES, V88, P167
   Harrison CB, 2010, CLIN EXP PHARMACOL P, V37, P429, DOI 10.1111/j.1440-1681.2009.05317.x
   Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hoffmann J, 2008, J BIOMED MATER RES A, V84A, P614, DOI 10.1002/jbm.a.31309
   Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5
   Huang KT, 2001, P NATL ACAD SCI USA, V98, P11771, DOI 10.1073/pnas.201276698
   Imanishi T, 2006, ATHEROSCLEROSIS, V189, P288, DOI 10.1016/j.atherosclerosis.2005.12.031
   Jeong JO, 2009, CIRCULATION, V119, P699, DOI 10.1161/CIRCULATIONAHA.108.789297
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Kalka C, 2000, ANN THORAC SURG, V70, P829, DOI 10.1016/S0003-4975(00)01633-7
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Kamihata H, 2002, ARTERIOSCL THROM VAS, V22, P1804, DOI 10.1161/01.ATV.0000039168.95670.B9
   Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50
   Kawamoto A, 2001, CIRCULATION, V103, P634
   Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396
   Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070
   Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048
   KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   Kutryk MJB, 2003, AM J CARDIOL, V92, P941
   Liao JC, 1999, P NATL ACAD SCI USA, V96, P8757, DOI 10.1073/pnas.96.15.8757
   Liu XP, 2002, J BIOL CHEM, V277, P26194, DOI 10.1074/jbc.M201939200
   Miglionico M, 2008, CATHETER CARDIO INTE, V71, P600, DOI 10.1002/ccd.21437
   Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015
   Narasipura SD, 2008, CLIN CHEM, V54, P77, DOI 10.1373/clinchem.2007.089896
   Ormiston JA, 2009, CIRC-CARDIOVASC INTE, V2, P255, DOI 10.1161/CIRCINTERVENTIONS.109.859173
   Peichev M, 2000, BLOOD, V95, P952
   Pislaru SV, 2006, CIRCULATION, V114, pI314, DOI 10.1161/CIRCULATIONAHA.105.001446
   Rossi ML, 2010, INT J CARDIOL, V141, pE20, DOI 10.1016/j.ijcard.2008.11.134
   Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407
   Saavedra J., 2000, NITRIC OXIDE CARDIOV
   Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103
   Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1
   Shi Q, 1998, BLOOD, V92, P362
   Shimizu K, 2001, NAT MED, V7, P738, DOI 10.1038/89121
   Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8
   Song JM, 2000, ATHEROSCLEROSIS, V150, P309, DOI 10.1016/S0021-9150(99)00384-6
   Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054
   Takahashi T, 1999, NAT MED, V5, P434
   Tamai H, 2000, CIRCULATION, V102, P399
   Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8
   Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699
   van Beusekom HMM, 2012, CATHETER CARDIO INTE, V79, P231, DOI 10.1002/ccd.22928
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163
   Vaughn MW, 2001, NITRIC OXIDE-BIOL CH, V5, P18, DOI 10.1006/niox.2000.0328
   Veleva AN, 2008, BIOMATERIALS, V29, P3656, DOI 10.1016/j.biomaterials.2008.05.022
   Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8
   Wojakowski W, 2008, HEART, V94, P27, DOI 10.1136/hrt.2006.103358
   Xu H, 2012, J CARDIOVASC TRANSL, V5, P519, DOI 10.1007/s12265-012-9381-8
   Yoon YS, 2004, CIRCULATION, V109, P3154, DOI 10.1161/01.CIR.0000134696.08436.65
   Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460
NR 77
TC 16
Z9 16
U1 1
U2 53
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD MAY
PY 2013
VL 19
IS 5
BP 375
EP 385
DI 10.1089/ten.tec.2012.0312
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 108QE
UT WOS:000316310300006
PM 23126402
OA Green Published
DA 2018-10-20
ER

PT J
AU Kotha, R
   Pires, M
   Chmielewski, J
AF Kotha, Raghavendhar
   Pires, Marcos
   Chmielewski, Jean
TI Probing Nano/Micro- scale Biomaterial Morphology with Collagen Mimetic
   Peptides
SO BIOPOLYMERS
LA English
DT Meeting Abstract
CT 23rd American Peptide Symposium
CY JUN 22-27, 2013
CL Waikoloa, HI
C1 [Kotha, Raghavendhar; Pires, Marcos; Chmielewski, Jean] Purdue Univ, W Lafayette, IN 47907 USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD MAY
PY 2013
VL 100
IS 3
SI SI
BP 290
EP 290
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI0IL
UT WOS:000336530200240
DA 2018-10-20
ER

PT J
AU Zhu, L
   Zhou, H
   Sun, Z
   Lou, W
   Lang, J
AF Zhu, L.
   Zhou, H.
   Sun, Z.
   Lou, W.
   Lang, J.
TI ANATOMIC AND SEXUAL OUTCOMES AFTERVAGINOPLASTY USING TISSUE-ENGINEERED
   BIOMATERIAL GRAFT IN PATIENTS WITH MAYER-ROKITANSKY-KUSTER-HAUSER
   SYNDROME: A NEW MINIMALLY INVASIVE AND EFFECTIVE SURGERY
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Meeting Abstract
C1 [Zhu, L.; Zhou, H.; Sun, Z.; Lou, W.; Lang, J.] Beijing Union Med Coll Hosp, Beijing, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD MAY
PY 2013
VL 24
SU 1
MA 102
BP S83
EP S83
PG 1
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA V41LP
UT WOS:000209548000103
DA 2018-10-20
ER

PT J
AU Dutta, S
   Talukdar, B
   Bharali, R
   Rajkhowa, R
   Devi, D
AF Dutta, Saranga
   Talukdar, Bijit
   Bharali, Rupjyoti
   Rajkhowa, Rangam
   Devi, Dipali
TI Fabrication and characterization of biomaterial film from gland silk of
   muga and eri silkworms
SO BIOPOLYMERS
LA English
DT Article
DE fibroin; liquid silk; films; biomaterials; non mulberry silkworm
ID CONFORMATION TRANSITION KINETICS; ANTHERAEA-PERNYI FIBROIN;
   AIR-WATER-INTERFACE; CYNTHIA-RICINI SILK; BOMBYX-MORI;
   PHYSICAL-PROPERTIES; CRYSTAL-STRUCTURE; PROTEIN; FIBERS; SPECTROSCOPY
AB This study discusses the possibilities of liquid silk (Silk gland silk) of Muga and Eri silk, the indigenous non mulberry silkworms of North Eastern region of India, as potential biomaterials. Silk protein fibroin of Bombyx mori, commonly known as mulberry silkworm, has been extensively studied as a versatile biomaterial. As properties of different silk-based biomaterials vary significantly, it is important to characterize the non mulberry silkworms also in this aspect. Fibroin was extracted from the posterior silk gland of full grown fifth instars larvae, and 2D film was fabricated using standard methods. The films were characterized using SEM, Dynamic contact angle test, FTIR, XRD, DSC, and TGA and compared with respective silk fibers. SEM images of films reveal presence of some globules and filamentous structure. Films of both the silkworms were found to be amorphous with random coil conformation, hydrophobic in nature, and resistant to organic solvents. Non mulberry silk films had higher thermal resistance than mulberry silk. Fibers were thermally more stable than the films. This study provides insight into the new arena of research in application of liquid silk of non mulberry silkworms as biomaterials. (c) 2012 Wiley Periodicals, Inc. Biopolymers 99: 292333, 2013.
C1 [Dutta, Saranga; Talukdar, Bijit; Devi, Dipali] Inst Adv Study Sci & Technol, Div Life Sci, Seri Biotech Lab, Gauhati 781035, Assam, India.
   [Bharali, Rupjyoti] Gauhati Univ, Dept Biotechnol, Gauhati 781014, Assam, India.
   [Rajkhowa, Rangam] Deakin Univ, Australian Future Fibres Res & Innovat Ctr, Waurn Ponds, Vic 3217, Australia.
RP Devi, D (reprint author), Inst Adv Study Sci & Technol, Div Life Sci, Seri Biotech Lab, Gauhati 781035, Assam, India.
EM dipali.devi@gmail.com
FU Department of Biotechnology, Govt. of India [BT/102/NE/ TBP/ 2010]
FX Contract grant sponsor: Department of Biotechnology, Govt. of India;
   Contract grant number: BT/102/NE/ TBP/ 2010
CR Acharaya C., 2009, ACTA BIOMATER, V5, P988
   Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arondo J. L., 1993, PROG BIOPHYS MOL BIO, V59, P23
   Asakura T, 1999, MACROMOLECULES, V32, P4940, DOI 10.1021/ma990442z
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Choudhury S. N., 1981, MUGA SILK IND GUWAHA
   Devi D, 2011, J TEXT I, V102, P527, DOI 10.1080/00405000.2010.498172
   Feng XX, 2007, INT J BIOL MACROMOL, V40, P105, DOI 10.1016/j.ijbiomac.2006.06.011
   Freddi G, 1997, J POLYM SCI POL PHYS, V35, P841, DOI 10.1002/(SICI)1099-0488(19970415)35:5<841::AID-POLB13>3.0.CO;2-A
   FREDDI G, 1994, J APPL POLYM SCI, V52, P775, DOI 10.1002/app.1994.070520608
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Helfer T. W., 1837, J ASIATIC SOC BENGAL, V6, P38
   Iizuka E., 1980, STRUCTURE SILK YARN, V1, P299
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   Kearns V, 2008, TOPICS TISSUE ENG, V4, P1
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   LUCAS F, 1958, ADV PROTEIN CHEM, V13, P107, DOI 10.1016/S0065-3233(08)60599-9
   Matsumura, 1980, STRUCTURE SILK YARN, V1, P173
   Mikos A., 2001, ELECTRON J BIOTECHN, V3, P114
   Minagawa M., 2000, STRUCTURE SILK YARN, P185
   Nakamura S., 1986, J APPL POLYM SCI, V31, P995
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Rajkhowa R, 2011, J BIOMED MATER RES A, V97A, P37, DOI 10.1002/jbm.a.33021
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Shimizu M., 1957, KYORITSU SHUPPAN CO, V5, P317
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   TASHIRO Y, 1970, J CELL BIOL, V46, P1, DOI 10.1083/jcb.46.1.1
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   TSUKADA M, 1988, J POLYM SCI POL PHYS, V26, P949, DOI 10.1002/polb.1988.090260418
   TSUKADA M, 1986, J POLYM SCI POL PHYS, V24, P457, DOI 10.1002/polb.1986.090240219
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   TSUKADA M, 1992, J APPL POLYM SCI, V44, P2203, DOI 10.1002/app.1992.070441217
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Valluzzi R, 1997, BIOPOLYMERS, V42, P705, DOI 10.1002/(SICI)1097-0282(199711)42:6<705::AID-BIP8>3.0.CO;2-Y
   Valluzzi R, 2002, PHILOS T ROY SOC B, V357, P165, DOI 10.1098/rstb.2001.1032
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   van Beek JD, 2000, NATURE, V405, P1077
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 52
TC 18
Z9 18
U1 1
U2 107
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD MAY
PY 2013
VL 99
IS 5
BP 326
EP 333
DI 10.1002/bip.22168
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 094XZ
UT WOS:000315300100005
PM 23426575
DA 2018-10-20
ER

PT J
AU Jha, N
   Mondal, DP
   Majumdar, JD
   Badkul, A
   Jha, AK
   Khare, AK
AF Jha, Nidhi
   Mondal, D. P.
   Majumdar, J. Dutta
   Badkul, Anshul
   Jha, A. K.
   Khare, A. K.
TI Highly porous open cell Ti-foam using NaCl as temporary space holder
   through powder metallurgy route
SO MATERIALS & DESIGN
LA English
DT Article
DE Powder metallurgy; Space holder; Sintering; Compression; Open cell
   Ti-foam; Biomaterial
ID COMPRESSIVE DEFORMATION-BEHAVIOR; TITANIUM FOAMS; BIOMEDICAL
   APPLICATIONS; SYNTACTIC FOAM; SHAPE; MAGNESIUM; STRENGTH; METALS; ALLOY;
   NITI
AB Open cell Titanium-foam (Ti-foam) with varying porosities (65-80%) was prepared using sodium chloride (NaCl) particles as space holder through powder metallurgy route. In order to ensure sufficient handling strength in cold compacted pallets, 2 wt.% polyvinyl alcohol (PVA) solutions (5 wt.% PVA in water) was mixed with the mixture of Ti and NaCl powders prior to cold compaction. After sintering, NaCl salt was removed by dissolving it in hot water. Detailed Energy dispersive X-ray (EDX) analysis and X-ray diffraction studies of the prepared Ti-foams were conducted to examine any physical and chemical changes in the phase constituents. The micro-architectural characteristics, density vis-a-vis porosity, and compressive deformation behavior of the synthesized foams were evaluated to examine their suitability as biomaterial and engineering applications. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Jha, Nidhi; Mondal, D. P.; Badkul, Anshul; Jha, A. K.; Khare, A. K.] CSIR Adv Mat & Proc Res Inst, Bhopal 462026, India.
   [Majumdar, J. Dutta] Indian Inst Technol, Dept Met & Mat Engn, Kharagpur 721302, W Bengal, India.
RP Mondal, DP (reprint author), CSIR Adv Mat & Proc Res Inst, Bhopal 462026, India.
EM dpmondal@ampri.res.in
CR Aktay L, 2008, MATER DESIGN, V29, P952, DOI 10.1016/j.matdes.2007.03.019
   Andrews A, 1999, MAT SCI ENG A-STRUCT, V270, P113
   Ashby M. F., 2000, METALS FOAMS DESIGN
   Aydogmus T, 2009, J ALLOY COMPD, V478, P705, DOI 10.1016/j.jallcom.2008.11.141
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P1996, DOI 10.1016/j.actbio.2008.06.005
   Barrabes A, 2008, MAT SCI ENG C-BIO S, V28, P23, DOI 10.1016/j.msec.2007.02.001
   Batchelor AW, 2004, ORTHOPAEDIC PROSTHES
   BAUMEISTER J, 1994, Patent No. 4426627
   Baumgartner F, 2000, ADV ENG MATER, V2, P168, DOI 10.1002/(SICI)1527-2648(200004)2:4<168::AID-ADEM168>3.0.CO;2-O
   Dunand DC, 2004, ADV ENG MATER, V6, P369, DOI 10.1002/adem.200405576
   Esen Z, 2007, SCRIPTA MATER, V56, P341, DOI 10.1016/j.scriptamat.2006.11.010
   Gaillard C, 2004, MAT SCI ENG A-STRUCT, V374, P250, DOI 10.1016/j.msea.2004.03.015
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gergely V, 2000, ADV ENG MATER, V2, P175, DOI 10.1002/(SICI)1527-2648(200004)2:4<175::AID-ADEM175>3.3.CO;2-N
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Greiner C, 2005, ACTA BIOMATER, V1, P705, DOI 10.1016/j.actbio.2005.07.005
   Kang SB, 2002, MATER TRANS, V43, P1045, DOI 10.2320/matertrans.43.1045
   Kotan Gueher, 2007, Turkish Journal of Engineering and Environmental Sciences, V31, P149
   Laptev A, 2005, POWDER METALL, V48, P358, DOI 10.1179/174329005X73838
   Li JP, 2002, KEY ENG MAT, V218-2, P51, DOI 10.4028/www.scientific.net/KEM.218-220.51
   Mansourighasri A, 2012, J MATER PROCESS TECH, V212, P83, DOI 10.1016/j.jmatprotec.2011.08.008
   Mondal DP, 2013, MAT SCI ENG A-STRUCT, V560, P601, DOI 10.1016/j.msea.2012.10.003
   Mondal DP, 2012, MAT SCI ENG A-STRUCT, V534, P521, DOI 10.1016/j.msea.2011.12.002
   Mondal DP, 2012, MATER DESIGN, V34, P82, DOI 10.1016/j.matdes.2011.07.055
   Mondal DP, 2009, MAT SCI ENG A-STRUCT, V507, P102, DOI 10.1016/j.msea.2009.01.019
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niu WJ, 2009, MAT SCI ENG A-STRUCT, V506, P148, DOI 10.1016/j.msea.2008.11.022
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Rajendran R, 2009, MATER DESIGN, V30, P2823, DOI 10.1016/j.matdes.2009.01.026
   Salimon A, 2005, J MATER SCI, V40, P5793, DOI 10.1007/s10853-005-4993-x
   Singh R, 2009, ACTA BIOMATER, V5, P477, DOI 10.1016/j.actbio.2008.06.014
   Spoerke ED, 2005, ACTA BIOMATER, V1, P523, DOI 10.1016/j.actbio.2005.04.005
   Stanzick H, 2002, ADV ENG MATER, V4, P814, DOI 10.1002/1527-2648(20021014)4:10<814::AID-ADEM814>3.0.CO;2-5
   Tencer AF, 1994, BIOMECHANICS ORTHOPE, P31
   Tukkanen J., 2003, BIOMATERIALS, V24, P4691
   Tuncer N, 2011, MAT SCI ENG A-STRUCT, V530, P633, DOI 10.1016/j.msea.2011.10.036
   Wen C. E., 2002, J MATER SCI-MATER M, V13, P307
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
NR 40
TC 73
Z9 77
U1 2
U2 95
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
EI 1873-4197
J9 MATER DESIGN
JI Mater. Des.
PD MAY
PY 2013
VL 47
BP 810
EP 819
DI 10.1016/j.matdes.2013.01.005
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 095LP
UT WOS:000315336200100
DA 2018-10-20
ER

PT J
AU Capone, SH
   Dufresne, M
   Rechel, M
   Fleury, MJ
   Salsac, AV
   Paullier, P
   Daujat-Chavanieu, M
   Legallais, C
AF Capone, Stephanie H.
   Dufresne, Murielle
   Rechel, Mathias
   Fleury, Marie-Jose
   Salsac, Anne-Virginie
   Paullier, Patrick
   Daujat-Chavanieu, Martine
   Legallais, Cecile
TI Impact of Alginate Composition: From Bead Mechanical Properties to
   Encapsulated HepG2/C3A Cell Activities for In Vivo Implantation
SO PLOS ONE
LA English
DT Article
ID FLUIDIZED-BED BIOREACTOR; BIOARTIFICIAL LIVER DEVICES; FULMINANT
   HEPATIC-FAILURE; C3A CELLS; MICROENCAPSULATED HEPATOCYTES; EXTRACELLULAR
   MATRICES; RAT HEPATOCYTES; MASS TRANSFERS; GEL BEADS; MICROCAPSULES
AB Recently, interest has focused on hepatocytes' implantation to provide end stage liver failure patients with a temporary support until spontaneous recovery or a suitable donor becomes available. To avoid cell damage and use of an immunosuppressive treatment, hepatic cells could be implanted after encapsulation in a porous biomaterial of bead or capsule shape. The aim of this study was to compare the production and the physical properties of the beads, together with some hepatic cell functions, resulting from the use of different material combinations for cell microencapsulation: alginate alone or combined with type I collagen with or without poly-L-lysine and alginate coatings. Collagen and poly-L-lysine increased the bead mechanical resistance but lowered the mass transfer kinetics of vitamin B12. Proliferation of encapsulated HepG2/C3A cells was shown to be improved in alginate-collagen beads. Finally, when the beads were subcutaneously implanted in mice, the inflammatory response was reduced in the case of alginate mixed with collagen. This in vitro and in vivo study clearly outlines, based on a systematic comparison, the necessity of compromising between material physical properties (mechanical stability and porosity) and cell behavior (viability, proliferation, functionalities) to define optima hepatic cell microencapsulation conditions before implantation.
C1 [Capone, Stephanie H.; Dufresne, Murielle; Rechel, Mathias; Fleury, Marie-Jose; Salsac, Anne-Virginie; Paullier, Patrick; Legallais, Cecile] Univ Technol Compiegne, Lab Biomech & Bioengn, UMR CNRS 7338, Compiegne, France.
   [Capone, Stephanie H.; Daujat-Chavanieu, Martine] CHU St Eloi, INSERM U1040, Inst Res Biotherapy, Montpellier, France.
RP Legallais, C (reprint author), Univ Technol Compiegne, Lab Biomech & Bioengn, UMR CNRS 7338, Compiegne, France.
EM cecile.legallais@utc.fr
RI Daujat-Chavanieu, Martine/T-5155-2018
OI Daujat-Chavanieu, Martine/0000-0001-5560-1610
FU Research Minister of French Government; ANR TECSAN (SUPPLIVER Project)
FX This work was supported by Research Minister of French Government, and
   also by ANR TECSAN 2011 (SUPPLIVER Project). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aoki T, 2005, TRANSPLANTATION, V79, P783, DOI 10.1097/01.TP.0000156319.47645.3B
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380
   Catapano G, 1996, INT J ARTIF ORGANS, V19, P18
   Chia SM, 2000, TISSUE ENG, V6, P481, DOI 10.1089/107632700750022134
   Coward SM, 2009, ARTIF ORGANS, V33, P1117, DOI 10.1111/j.1525-1594.2009.00821.x
   David B, 2006, INT J ARTIF ORGANS, V29, P756
   David B, 2004, BIOTECHNOL PROGR, V20, P1204, DOI 10.1021/bp034031z
   David B, 2004, INT J ARTIF ORGANS, V27, P284
   de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014
   Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44
   Fassett JT, 2003, J BIOL CHEM, V278, P31691, DOI 10.1074/jbc.M300899200
   Gao Y, 2004, WORLD J GASTROENTERO, V10, P2067, DOI 10.3748/wjg.v10.i14.2067
   Gautier A, 2011, EUR CELLS MATER, V21, P94, DOI 10.22203/eCM.v021a08
   Gillette BM, 2010, ADV MATER, V22, P686, DOI 10.1002/adma.200902265
   GRASDALEN H, 1979, CARBOHYD RES, V68, P23, DOI 10.1016/S0008-6215(00)84051-3
   Gupta S, 1997, CELL TRANSPLANT, V6, P377, DOI 10.1016/S0963-6897(97)00047-X
   HALLE JP, 1992, TRANSPL P, V24, P2930
   Harm S, 2009, INT J ARTIF ORGANS, V32, P769
   Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156
   Ijima H, 2010, J BIOSCI BIOENG, V109, P179, DOI 10.1016/j.jbiosc.2009.07.017
   Khalil M, 2001, J HEPATOL, V34, P68, DOI 10.1016/S0168-8278(00)00080-5
   Kinasiewicz A, 2008, INT J ARTIF ORGANS, V31, P340
   King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276
   Knaebel A, 1997, POLYM GELS NETW, V5, P107, DOI 10.1016/S0966-7822(96)00034-2
   KOHN R, 1972, ACTA CHEM SCAND, V26, P2455, DOI 10.3891/acta.chem.scand.26-2455
   Kulseng B, 1997, CELL TRANSPLANT, V6, P387, DOI 10.1016/S0963-6897(97)00002-X
   Lee M, 2009, BIOMATERIALS, V30, P1214, DOI 10.1016/j.biomaterials.2008.11.017
   Lewinska D, 2002, J MEMBRANE SCI, V209, P533, DOI 10.1016/S0376-7388(02)00370-8
   Li RH, 1998, ADV DRUG DELIVER REV, V33, P87, DOI 10.1016/S0169-409X(98)00022-2
   Mavri-Damelin D, 2008, BIOTECHNOL BIOENG, V99, P644, DOI 10.1002/bit.21599
   Mei J, 2009, CELL TRANSPLANT, V18, P101, DOI 10.3727/096368909788237168
   Ng S, 2005, BIOMATERIALS, V26, P3153, DOI 10.1016/j.biomaterials.2004.08.017
   Tran NM, 2013, TISSUE ENG PT A, V19, P103, DOI [10.1089/ten.tea.2012.0139, 10.1089/ten.TEA.2012.0139]
   Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7
   Qiu LY, 2012, INT J ARTIF ORGANS, V35, P458, DOI 10.5301/ijao.5000092
   Quek CH, 2004, BIOMATERIALS, V25, P3531, DOI 10.1016/j.biomaterials.2003.09.112
   Rahman TM, 2005, TRANSPL INT, V18, P1001, DOI 10.1111/j.1432-2277.2005.00156.x
   Rahman TM, 2004, ARTIF ORGANS, V28, P476, DOI 10.1111/j.1525-1594.2004.07259.x
   Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011
   Saudek F, 2010, TRANSPLANTATION, V90, P1602, DOI 10.1097/TP.0b013e3181ffba5e
   Selden C, 1999, ANN NY ACAD SCI, V875, P353, DOI 10.1111/j.1749-6632.1999.tb08517.x
   Selden C, 2004, TRANSPL IMMUNOL, V12, P273, DOI 10.1016/j.trim.2003.12.008
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   Shulman Maria, 2013, Methods Mol Biol, V945, P287, DOI 10.1007/978-1-62703-125-7_17
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Strom S, 2003, GASTROENTEROLOGY, V124, P568, DOI 10.1053/gast.2003.50072
   Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006
   Teng Y, 2010, TISSUE ENG PART C-ME, V16, P1125, DOI 10.1089/ten.TEC.2009.0374
   VANDENBOSSCHE GMR, 1993, BIOTECHNOL BIOENG, V42, P381, DOI 10.1002/bit.260420316
   Yongsunthon R, 2009, ULTRAMICROSCOPY, V109, P942, DOI 10.1016/j.ultramic.2009.03.007
   Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x
NR 52
TC 24
Z9 24
U1 2
U2 49
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 25
PY 2013
VL 8
IS 4
AR e62032
DI 10.1371/journal.pone.0062032
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 136DM
UT WOS:000318341400030
PM 23637958
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yu, L
   Li, Y
   Zhao, K
   Tang, YF
   Cheng, Z
   Chen, J
   Zang, Y
   Wu, JW
   Kong, L
   Liu, SA
   Lei, W
   Wu, ZX
AF Yu, Long
   Li, Yang
   Zhao, Kang
   Tang, Yufei
   Cheng, Zhe
   Chen, Jun
   Zang, Yuan
   Wu, Jianwei
   Kong, Liang
   Liu, Shuai
   Lei, Wei
   Wu, Zixiang
TI A Novel Injectable Calcium Phosphate Cement-Bioactive Glass Composite
   for Bone Regeneration
SO PLOS ONE
LA English
DT Article
ID MARROW STROMAL CELLS; BETA-TRICALCIUM PHOSPHATE; IN-VITRO;
   DIFFERENTIATION; SCAFFOLDS; RAT; PROLIFERATION; BIOMATERIAL;
   DEGRADATION; STRENGTH
AB Background: Calcium phosphate cement (CPC) can be molded or injected to form a scaffold in situ, which intimately conforms to complex bone defects. Bioactive glass (BG) is known for its unique ability to bond to living bone and promote bone growth. However, it was not until recently that literature was available regarding CPC-BG applied as an injectable graft. In this paper, we reported a novel injectable CPC-BG composite with improved properties caused by the incorporation of BG into CPC.
   Materials and Methods: The novel injectable bioactive cement was evaluated to determine its composition, microstructure, setting time, injectability, compressive strength and behavior in a simulated body fluid (SBF). The in vitro cellular responses of osteoblasts and in vivo tissue responses after the implantation of CPC-BG in femoral condyle defects of rabbits were also investigated.
   Results: CPC-BG possessed a retarded setting time and markedly better injectability and mechanical properties than CPC. Moreover, a new Ca-deficient apatite layer was deposited on the composite surface after immersing immersion in SBF for 7 days. CPC-BG samples showed significantly improved degradability and bioactivity compared to CPC in simulated body fluid (SBF). In addition, the degrees of cell attachment, proliferation and differentiation on CPC-BG were higher than those on CPC. Macroscopic evaluation, histological evaluation, and micro-computed tomography (micro-CT) analysis showed that CPC-BG enhanced the efficiency of new bone formation in comparison with CPC.
   Conclusions: A novel CPC-BG composite has been synthesized with improved properties exhibiting promising prospects for bone regeneration.
C1 [Yu, Long; Li, Yang; Chen, Jun; Zang, Yuan; Wu, Jianwei; Liu, Shuai; Lei, Wei; Wu, Zixiang] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped, Xian 710032, Shaanxi Provinc, Peoples R China.
   [Zhao, Kang; Tang, Yufei; Cheng, Zhe] Xian Univ Technol, Sch Mat & Engn, Xian, Shaanxi Provinc, Peoples R China.
   [Kong, Liang] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi Provinc, Peoples R China.
RP Lei, W (reprint author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped, Xian 710032, Shaanxi Provinc, Peoples R China.
EM leiwei@fmmu.edu.cn; wuzixiang@fmmu.edu.cn
FU National Science Foundation of China [31170913]
FX This study was supported by the National Science Foundation of China
   (No. 31170913). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Bodde EWH, 2008, J BIOMED MATER RES A, V87A, P780, DOI 10.1002/jbm.a.31830
   Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059
   Brown WE, 1986, CEM RES PROG, V4, P352
   Chen QZ, 2008, J BIOMED MATER RES A, V84A, P1049, DOI 10.1002/jbm.a.31512
   Chen ZG, 2011, J BIOMED MATER RES A, V99A, P554, DOI 10.1002/jbm.a.33212
   Chou SY, 2009, BIOMATERIALS, V30, P3136, DOI 10.1016/j.biomaterials.2009.02.037
   Christodoulou I, 2005, J BIOMED MATER RES B, V74B, P529, DOI 10.1002/jbm.b.30249
   Combes C, 2010, ACTA BIOMATER, V6, P920, DOI 10.1016/j.actbio.2009.08.032
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018
   He Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042525
   Heikkila JT, 1995, BIOCERAMICS, P35
   Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu GF, 2010, J MATER SCI-MATER M, V21, P627, DOI 10.1007/s10856-009-3885-z
   Huan ZG, 2009, ACTA BIOMATER, V5, P1253, DOI 10.1016/j.actbio.2008.10.006
   Huan ZG, 2009, J MATER SCI-MATER M, V20, P833, DOI 10.1007/s10856-008-3641-9
   Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542
   Julien M, 2007, BIOMATERIALS, V28, P956, DOI 10.1016/j.biomaterials.2006.10.018
   Kobayashi M, 1999, J BIOMED MATER RES, V46, P447, DOI 10.1002/(SICI)1097-4636(19990915)46:4<447::AID-JBM2>3.3.CO;2-G
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033
   Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lin Q, 2010, J MATER SCI-MATER M, V21, P3065, DOI 10.1007/s10856-010-4160-z
   Link DP, 2008, BIOMATERIALS, V29, P675, DOI 10.1016/j.biomaterials.2007.10.029
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Lu JX, 2011, J MATER SCI-MATER M, V22, P607, DOI 10.1007/s10856-011-4228-4
   Manitha B, 2009, J MATER SCI-MATER M, V20, pS251
   Miguel BS, 2010, J BIOMED MATER RES A, V94A, P1023, DOI 10.1002/jbm.a.32773
   Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022
   Pamula E, 2011, ANN BIOMED ENG, V39, P2114, DOI 10.1007/s10439-011-0307-4
   Radin S, 2005, J BIOMED MATER RES A, V73A, P21, DOI 10.1002/jbm.a.30241
   Reilly GC, 2007, BIOMATERIALS, V28, P4091, DOI 10.1016/j.biomaterials.2007.05.038
   Renno ACM, 2013, ACTA BIOMATER, V9, P5728, DOI 10.1016/j.actbio.2012.11.009
   Saboori A, 2009, MAT SCI ENG C-BIO S, V29, P335, DOI 10.1016/j.msec.2008.07.004
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   van de Watering FCJ, 2012, CLIN ORAL IMPLAN RES, V23, P151, DOI 10.1111/j.1600-0501.2011.02218.x
   Wada Y, 1998, BONE, V22, P479, DOI 10.1016/S8756-3282(98)00039-8
   Wu C, 2009, BIOMATERIALS, V30, P2199, DOI 10.1016/j.biomaterials.2009.01.029
   Wu F, 2008, ACTA BIOMATER, V4, P1873, DOI 10.1016/j.actbio.2008.06.020
   Xu HHK, 2010, TISSUE ENG PT A, V16, P2743, DOI [10.1089/ten.tea.2009.0757, 10.1089/ten.TEA.2009.0757]
   Yao J, 2005, J BIOMED MATER RES A, V75A, P794, DOI 10.1002/jbm.a.30494
   Zhang JT, 2011, MAT SCI ENG C-MATER, V31, P740, DOI 10.1016/j.msec.2010.10.014
NR 46
TC 30
Z9 30
U1 2
U2 80
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 25
PY 2013
VL 8
IS 4
AR e62570
DI 10.1371/journal.pone.0062570
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 136DM
UT WOS:000318341400060
PM 23638115
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Latifi, A
   Imani, M
   Khorasani, MT
   Joupari, MD
AF Latifi, Afrooz
   Imani, Mohammad
   Khorasani, Mohammad Taghi
   Joupari, Morteza Daliri
TI Electrochemical and chemical methods for improving surface
   characteristics of 316L stainless steel for biomedical applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE 316L stainless steel; Electropolishing; Acid dipping; Surface
   characterization; Corrosion resistance; In vitro biocompatibility
ID CORROSION-RESISTANCE; BEHAVIOR; 316-STAINLESS-STEEL; BIOMATERIAL;
   COATINGS; STENTS; NITI; FE
AB Although stainless steel is a widely used material for biomedical applications, its surface properties for long term application are still a serious concern. Here, chemical surface treatment by electropolishing and acid dipping is used for improving surface properties of 316L stainless steel to provide a homogenous, smooth and corrosion resistant surface with high biocompatibility profile. X-ray photoelectron spectroscopy (XPS) was performed to trace surface chemical composition before and after chemical treatment. Surface enrichment of corrosion resistant compounds was shown by XPS. Corrosion behavior of the treated samples was evaluated by electrochemical analysis. Surface energy was also studied through contact angle measurements. The roughness of the surface was traced by atomic force microscopy (AFM) and scanning electron microscopy (SEM) techniques. The lowest roughness (S-a: 0.96 +/- 029 nm) was observed for the highest acid dipping duration (1800 s). The surface energy was remarkably subsided by acid dipping duration. MTT assay and cell adhesion studies were conducted to evaluate in vitro biocompatibility showing high cell viability percentage with proper cell adhesion on the surface-treated samples. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Latifi, Afrooz] Islamic Azad Univ, Sci & Res Branch, Biomed Engn Fac, Tehran, Iran.
   [Imani, Mohammad] Iran Polymer & Petrochem Inst, Novel Drug Delivery Syst Dept, Tehran, Iran.
   [Khorasani, Mohammad Taghi] Iran Polymer & Petrochem Inst, Biomat Dept, Tehran, Iran.
   [Joupari, Morteza Daliri] Natl Inst Genet Engn & Biotechnol, Anim & Marine Biotechnol Dept, Tehran, Iran.
RP Imani, M (reprint author), Iran Polymer & Petrochem Inst, Novel Drug Delivery Syst Dept, POB 14965-115, Tehran, Iran.
EM M.Imani@ippi.ac.ir
CR [Anonymous], 2005, STAND PRACT CLEAN DE, pA380
   BARON A, 2006, J ACHIEV MAT MANUF E, V18, P55
   Belo MD, 1998, CORROS SCI, V40, P481, DOI 10.1016/S0010-938X(98)00016-X
   Chiu KY, 2006, SURF COAT TECH, V200, P6054, DOI 10.1016/j.surfcoat.2005.09.009
   Dahlgren L, 2010, TREATMENT SPENT PICK
   Feng ZC, 2010, CORROS SCI, V52, P3646, DOI 10.1016/j.corsci.2010.07.013
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   Haidopoulos M, 2006, J MATER SCI-MATER M, V17, P647, DOI 10.1007/s10856-006-9228-4
   Haidopoulos M, 2005, SURF COAT TECH, V197, P278, DOI 10.1016/j.surfcoat.2004.10.113
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   Hryniewicz T, 2009, MATERIALS, V2, P129, DOI 10.3390/ma2010129
   Irving C. C, 1985, ASTM SPECIAL TECH PU, V859, P136, DOI 10.1520/STP33247S
   Lee CJ., 2009, J MATER PROCESS TECH, V32, P4769
   Lee SJ, 2003, J MATER PROCESS TECH, V140, P206, DOI 10.1016/S0924-0136(03)00785-4
   Li Y, 2008, MICROELECTRONIC APPLICATIONS OF CHEMICAL MECHANICAL PLANARIZATION, P1
   Liu CL, 2006, SURF COAT TECH, V200, P4011, DOI 10.1016/j.surfcoat.2004.12.015
   Muthukumaran V, 2010, MATER DESIGN, V31, P2813, DOI 10.1016/j.matdes.2010.01.007
   Okado J, 2008, SURF COAT TECH, V202, P5595, DOI 10.1016/j.surfcoat.2008.06.033
   Okazaki Y, 2008, CORROS SCI, V50, P3429, DOI 10.1016/j.corsci.2008.09.002
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Ramsden JJ, 2007, CIRP ANN-MANUF TECHN, V56, P687, DOI 10.1016/j.cirp.2007.10.001
   Samide A, 2008, J OPTOELECTRON ADV M, V10, P1431
   SEEGER JM, 1995, J VASC SURG, V22, P327, DOI 10.1016/S0741-5214(95)70148-6
   SEO M, 1980, T JPN I MET, V21, P805, DOI 10.2320/matertrans1960.21.805
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   Shinonaga Y, 2009, DENT MATER J, V28, P735, DOI 10.4012/dmj.28.735
   Tiwari A, 2008, SURF COAT TECH, V202, P4620, DOI 10.1016/j.surfcoat.2008.03.030
   Unger F, 2007, J CONTROL RELEASE, V117, P312, DOI 10.1016/j.jconrel.2006.11.003
   Vesel A., 2008, APPL SURF SCI, V32, P1759
   Wang YB, 2012, MAT SCI ENG C-MATER, V32, P599, DOI 10.1016/j.msec.2011.12.018
   Wu W, 2008, J MATER SCI TECHNOL, V24, P926
   Yousefzadeh S., 2011, INT J HYDROGEN ENERG, V36, P13462
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
   Zhao H, 2002, J MATER SCI-MATER M, V13, P911, DOI 10.1023/A:1019831808503
NR 34
TC 34
Z9 36
U1 2
U2 52
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 25
PY 2013
VL 221
BP 1
EP 12
DI 10.1016/j.surfcoat.2013.01.020
PG 12
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 131MT
UT WOS:000317998500001
DA 2018-10-20
ER

PT J
AU Yang, GM
   Liu, LB
   Lv, FT
   Wang, S
AF Yang, Gaomai
   Liu, Libing
   Lv, Fengting
   Wang, Shu
TI Conjugated Polyelectrolyte Materials for Promoting Progenitor Cell
   Growth Without Serum
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EMBRYONIC STEM-CELLS; DNA; PROLIFERATION; CHONDROCYTES; TELOMERASE;
   PROTEINS; BIOLOGY
AB The discovery of new active biomaterials for promoting progenitor cell growth and differentiation in serum-free medium is still proving more challenging for the clinical treatments of degenerative diseases. In this work, a conjugated polyelectrolyte, polythiophene derivative (PMNT), was discovered to significantly drive the cell cycle progression from G(1) to S and G(2) phases and thus efficiently promote the cell growth without the need of serum. Furthermore, the fluorescent characteristic of PMNT makes it simultaneously able to trace its cellular uptake and localization by cell imaging. cDNA microarray study shows that PMNT can greatly regulate genes related to cell growth or differentiation. To the best of our knowledge, this is the first example of cell growth or differentiation promotion by polyelectrolyte material without the need of serum, thereby providing an important demonstration of degenerative biomaterial discovery through polymer design.
C1 [Yang, Gaomai; Liu, Libing; Lv, Fengting; Wang, Shu] Chinese Acad Sci, Inst Chem, Key Lab Organ Solids, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.
RP Wang, S (reprint author), Chinese Acad Sci, Inst Chem, Key Lab Organ Solids, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.
EM liulibing@iccas.ac.cn; wangshu@iccas.ac.cn
FU National Natural Science Foundation of China [21033010, 21003140,
   21021091]; Major Research Plan of China [2011CB808400, 2013CB932800,
   2011CB935800]
FX This work was supported by the National Natural Science Foundation of
   China (Nos. 21033010, 21003140, 21021091) and the Major Research Plan of
   China (Nos. 2011CB808400, 2013CB932800, 2011CB935800).
CR BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y
   Choi Y, 2012, ARCH PHARM RES, V35, P281, DOI 10.1007/s12272-012-0208-6
   Duan XR, 2010, ACCOUNTS CHEM RES, V43, P260, DOI 10.1021/ar9001813
   Firestone AJ, 2010, ACS CHEM BIOL, V5, P15, DOI 10.1021/cb900249y
   Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025
   Ghasemi-Mobarakeh L., 2011, J TISSUE ENG REGEN M, V5, P17
   Ho HA, 2002, ANGEW CHEM INT EDIT, V41, P1548, DOI 10.1002/1521-3773(20020503)41:9<1548::AID-ANIE1548>3.0.CO;2-I
   Imamura T, 1997, NATURE, V389, P622
   Iwata K, 2012, BIOMATERIALS, V33, P444, DOI 10.1016/j.biomaterials.2011.09.056
   King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200
   Liu LB, 2010, J MATER CHEM, V20, P6942, DOI 10.1039/c0jm01078b
   Liu WH, 1998, ONCOGENE, V17, P3055, DOI 10.1038/sj.onc.1202234
   Liu Y, 2008, CHEM COMMUN, P3729, DOI 10.1039/b804283g
   Mawad D, 2012, ADV FUNCT MATER, V22, P2692, DOI 10.1002/adfm.201102373
   McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774
   Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060
   Quigley AF, 2009, ADV MATER, V21, P4393, DOI 10.1002/adma.200901165
   Shen GF, 2012, CHEMMEDCHEM, V7, P733, DOI 10.1002/cmdc.201100603
   Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113
   Takahashi T, 2005, CELL TRANSPLANT, V14, P683, DOI 10.3727/000000005783982675
   Toriniwa H, 2011, VACCINE, V29, P1859, DOI 10.1016/j.vaccine.2010.12.038
   Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842
   Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140
   van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016
   Xing CF, 2009, J AM CHEM SOC, V131, P13117, DOI 10.1021/ja904492x
   Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042
   Yang GM, 2012, ADV FUNCT MATER, V22, P736, DOI 10.1002/adfm.201101764
NR 29
TC 4
Z9 4
U1 0
U2 58
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 23
PY 2013
VL 3
AR 1702
DI 10.1038/srep01702
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 130DI
UT WOS:000317892500005
PM 23609105
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hudson, SD
   Zhurov, V
   Grbic, V
   Grbic, M
   Hutter, JL
AF Hudson, Stephen D.
   Zhurov, Vladimir
   Grbic, Vojislava
   Grbic, Miodrag
   Hutter, Jeffrey L.
TI Measurement of the elastic modulus of spider mite silk fibers using
   atomic force microscopy
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID MECHANICAL-PROPERTIES; NANOWIRES; BIOMATERIALS; CANTILEVERS; NANOFIBERS
AB Bio-nanomaterials are one of the fastest developing sectors of industry and technology. Spider silk, a highly attractive light-weight biomaterial, has high tensile strength and elasticity and is compatible with human tissues, allowing for many areas of application. In comparison to spider silk fibers with diameters of several micrometers, spider mite silk fibers have much smaller diameters of tens of nanometers, making conventional tensile testing methods impractical. To determine the mechanical properties of adult and larval Tetranychus urticae silk fibers, we have performed three-point bending tests with an atomic force microscope. We found that because of the small diameters of these fibers, axial tension-due to both the applied force and a pre-existing strain-has a significant effect on the fiber response, even in the small-deformation limit. As a result, the typical Euler-Bernoulli-Timoshenko theory cannot be applied. We therefore follow the approach of Heidelberg et al. to develop a mechanical model of the fiber response that accounts for bending, an initial tension in the fibers, and a tension due to elongation during testing. This model provides self-consistent results, allowing us to determine that adult and larval fibers have Young's moduli of 24 +/- 3 GPa and 15 +/- 3 GPa, respectively. Both adult and larval fibers have an estimated ultimate strength of 200-300 MPa and a toughness of order 9MJ/m(3). We note that with increasing interest in the mechanical properties of very high aspect ratio nanomaterials, the influence of pre-existing tension must be considered in any measurements involving a bending test. (C) 2013 AIP Publishing LLC
C1 [Hudson, Stephen D.; Hutter, Jeffrey L.] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.
   [Zhurov, Vladimir; Grbic, Vojislava; Grbic, Miodrag] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.
   [Grbic, Miodrag] Univ La Rioja, CSIC, ICVV, Gobierno La Rioja, Logrono 26006, Spain.
RP Hutter, JL (reprint author), Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.
EM mgrbic@uwo.ca; jhutter@uwo.ca
FU NSERC (Canada); NSERC Strategic [STPGP 322206-05]; Ontario Research
   Fund-Global Leadership in Genomics and Life Sciences [GL2-01-035];
   Genome Canada and the Ontario Genomics Institute [OGI-046]
FX The authors thank NSERC (Canada) for operation funding of this project
   and the Canada Foundation for Innovation and Ontario Innovation Trust
   for the AFM infrastructure used. The authors also thank Mark Gooyers for
   designing the silicon gratings. M.G. and V.G acknowledge support from
   NSERC Strategic Grant STPGP 322206-05, Ontario Research Fund-Global
   Leadership in Genomics and Life Sciences GL2-01-035, and Genome Canada
   and the Ontario Genomics Institute grant (OGI-046).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001
   Chen CQ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.075505
   Elices M, 2005, JOM-US, V57, P60, DOI 10.1007/s11837-005-0218-7
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   Guhados G, 2007, J APPL PHYS, V101, DOI 10.1063/1.2433125
   Heidelberg A, 2006, NANO LETT, V6, P1101, DOI 10.1021/nl060028u
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hutter JL, 2005, LANGMUIR, V21, P2630, DOI 10.1021/la047670t
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n
   Kaplan D, 1994, SILK POLYM MAT SCI B
   Kim GT, 2002, APPL PHYS LETT, V80, P1815, DOI 10.1063/1.1458533
   Landau L., 1970, THEORY ELASTICITY
   Lee SH, 2005, MAT SCI ENG A-STRUCT, V398, P77, DOI 10.1016/j.msea.2005.03.014
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Ni H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2165275
   Salvetat JP, 1999, APPL PHYS A-MATER, V69, P255, DOI 10.1007/s003390050999
   Shin MK, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2402941
   Tan EPS, 2004, APPL PHYS LETT, V84, P1603, DOI 10.1063/1.1651643
   Timoshenko SP, 1921, PHILOS MAG, V41, P744, DOI 10.1080/14786442108636264
   Walters DA, 1996, REV SCI INSTRUM, V67, P3583, DOI 10.1063/1.1147177
   Wen BM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.175502
   Wu B, 2005, NAT MATER, V4, P525, DOI 10.1038/nmat1403
NR 26
TC 10
Z9 10
U1 3
U2 52
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD APR 21
PY 2013
VL 113
IS 15
AR 154307
DI 10.1063/1.4800865
PG 7
WC Physics, Applied
SC Physics
GA 134YJ
UT WOS:000318251400048
DA 2018-10-20
ER

PT J
AU Veneman, WJ
   Stockhammer, OW
   de Boer, L
   Zaat, SAJ
   Meijer, AH
   Spaink, HP
AF Veneman, Wouter J.
   Stockhammer, Oliver W.
   de Boer, Leonie
   Zaat, Sebastian A. J.
   Meijer, Annemarie H.
   Spaink, Herman P.
TI A zebrafish high throughput screening system used for Staphylococcus
   epidermidis infection marker discovery
SO BMC GENOMICS
LA English
DT Article
DE Zebrafish; Staphylococcus epidermidis; High throughput screening;
   Transcriptome analysis; RNA deep sequencing; COPAS; Host pathogen
   interaction
ID INNATE IMMUNE FUNCTION; RNA-SEQ; MODEL; EMBRYOS; HOST; TRANSCRIPTOMES;
   PATHOGENESIS; TISSUE; NICHE; DEEP
AB Background: Staphylococcus epidermidis bacteria are a major cause of biomaterial-associated infections in modern medicine. Yet there is little known about the host responses against this normally innocent bacterium in the context of infection of biomaterials. In order to better understand the factors involved in this process, a whole animal model with high throughput screening possibilities and markers for studying the host response to S. epidermidis infection are required.
   Results: We have used a zebrafish yolk injection system to study bacterial proliferation and the host response in a time course experiment of S. epidermidis infection. By combining an automated microinjection system with complex object parametric analysis and sorting (COPAS) technology we have quantified bacterial proliferation. This system was used together with transcriptome analysis at several time points during the infection period. We show that bacterial colony forming unit (CFU) counting can be replaced by high throughput flow-based fluorescence analysis of embryos enabling high throughput readout. Comparison of the host transcriptome response to S. epidermidis and Mycobacterium marinum infection in the same system showed that M. marinum has a far stronger effect on host gene regulation than S. epidermidis. However, multiple genes responded differently to S. epidermidis infection than to M. marinum, including a cell adhesion gene linked to specific infection by staphylococci in mammals.
   Conclusions: Our zebrafish embryo infection model allowed (i) quantitative assessment of bacterial proliferation, (ii) identification of zebrafish genes serving as markers for infection with the opportunistic pathogen S. epidermidis, and (iii) comparison of the transcriptome response of infection with S. epidermidis and with the pathogen M. marinum. As a result we have identified markers that can be used to distinguish common and specific responses to S. epidermidis. These markers enable the future integration of our high throughput screening technology with functional analyses of immune response genes and immune modulating factors.
C1 [Veneman, Wouter J.; Meijer, Annemarie H.; Spaink, Herman P.] Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands.
   [Stockhammer, Oliver W.; de Boer, Leonie; Zaat, Sebastian A. J.] Acad Med Ctr, Ctr Infect & Immun Amsterdam, CINIMA, Dept Med Microbiol, NL-1100 DD Amsterdam, Netherlands.
RP Veneman, WJ (reprint author), Leiden Univ, Inst Biol, POB 9502, NL-2300 RA Leiden, Netherlands.
EM w.j.veneman@biology.leidenuniv.nl; h.p.spaink@biology.leidenuniv.nl
RI Spaink, Herman/S-3586-2017
OI Spaink, Herman/0000-0003-4128-9501
FU BioMedical Materials institute [P5.03 IBIZA]; Dutch Ministry of Economic
   Affairs; Division for Earth and Life Sciences (ALW); Netherlands
   Organization for Scientific Research (NWO) [834.10.004]; EU
   [FP7-Health-2009-242048]
FX We thank Jan de Sonneville (Life Science Methods BV) for support with
   the automated microinjection system, Robert Lodder for the deep
   sequencing read count program, Rico Bongaarts, Francis Smet and Angela
   Comas (Union Biometrica) for help and advice with COPAS analyses, Mark
   de Jong (MicroArray Department - University of Amsterdam for support
   with the micro-array analysis and Hans Jansen and Ron Dirks (ZF-screens
   B.V.) for RNA-seq service. We thank Ruben Marin Juez (ZF-screens B.V.)
   for critically reading the manuscript. We thank Davy de Witt, Ulrike
   Nehrdich, and Laura van Hulst for fish caretaking, and other colleagues
   from Leiden University for helpful discussions. This research forms part
   of the Project P5.03 IBIZA of the research program of the BioMedical
   Materials institute, co-funded by the Dutch Ministry of Economic
   Affairs. The COPAS system acquisition was in part supported by the
   Division for Earth and Life Sciences (ALW) with financial aid from the
   Netherlands Organization for Scientific Research (NWO, 834.10.004).
   Additional support was obtained from the EU project ZF-Health
   (FP7-Health-2009-242048; A.H.M. and H.P.S.).
CR Al-Solaiman Y, 2011, CLIN J AM SOC NEPHRO, V6, P2247, DOI 10.2215/CJN.03900411
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Brittijn SA, 2009, INT J DEV BIOL, V53, P835, DOI 10.1387/ijdb.082615sb
   Broekhuizen CAN, 2008, CRIT CARE MED, V36, P2395, DOI 10.1097/CCM.0b013e3181818268
   Broekhuizen CAN, 2009, BIOMATERIALS, V30, P6444, DOI 10.1016/j.biomaterials.2009.08.018
   Busscher H.J., 2012, SCI TRANSL MED, V4
   Carvalho R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016779
   Cui C, 2011, METHOD CELL BIOL, V105, P273, DOI 10.1016/B978-0-12-381320-6.00012-6
   Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2
   Ellett F., 2010, BLOOD, V117, pe49, DOI DOI 10.1182/BL00D-2010-10-314120
   Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2008, NUCLEIC ACIDS RES, V37, P1, DOI [10.1093/nar/gkn923, DOI 10.1093/NAR/GKN923]
   Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005
   Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000
   Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Ordas A, 2011, FISH SHELLFISH IMMUN, V31, P716, DOI 10.1016/j.fsi.2010.08.022
   Otto M., 2011, SEMIN IMMUNOPATHOL, V34, P201
   Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184
   Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x
   Pulak Rock, 2006, V351, P275
   Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   Schlosser A, 2006, SCAND J IMMUNOL, V64, P104, DOI 10.1111/j.1365-3083.2006.01778.x
   Sever-Chroneos Z, 2010, J BIOL CHEM, V286, P4854
   Stockhammer OW, 2010, MOL IMMUNOL, V48, P179, DOI 10.1016/j.molimm.2010.08.011
   Tong SYC, 2011, SEMIN IMMUNOPATHOL, V34, P185
   van der Sar AM, 2006, INFECT IMMUN, V74, P2436, DOI 10.1128/IAI.74.4.2436-2441.2006
   van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x
   van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024
   van Soest JJ, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-58
   Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
   Zaat SAJ, 2008, EUR CELLS MATER, V16, P10
   Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 44
TC 37
Z9 37
U1 0
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD APR 15
PY 2013
VL 14
AR 255
DI 10.1186/1471-2164-14-255
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 138QB
UT WOS:000318522300005
PM 23586901
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Qiu, DF
   Liu, KC
   Jiao, ZJ
   Huang, QZ
   Shi, HZ
   Li, M
AF Qiu, Dongfang
   Liu, Kecheng
   Jiao, Zhujin
   Huang, Qunzeng
   Shi, Hengzhen
   Li, Min
TI Quercetin-sensitized TiO2 film: Photocatalytic inhibition of
   Helminthosporium maydis under visible light irradiation
SO MATERIALS LETTERS
LA English
DT Article
DE Quercetin; Anatase; Biomaterial film; H. maydis; Visible-light-driven
   photocatalysis
ID SURFACE COMPLEXATION; DEGRADATION
AB A PEG-added sol-gel chemistry approach was used to prepare the nanocrystalline TiO2 film in its anatase form. It is found that the utilization of polyethylene glycol (PEG) as additive in the preparation process benefits the uniform distribution of the TiO2 nanoparticles and the corresponding film-forming behavior. Moreover, the sensitized TiO2 biomaterial film loaded with quercetin was processed by anchoring function groups of the sensitizer onto the surface of TiO2 substrates through chemical interaction at optimized curing temperature. The as-prepared TiO2 film was characterized by X-ray diffractometry (XRD), scan electron microscopy (SEM), diffuse reflectance spectroscopy (DRS) and ultraviolet-visible (UV-vis) spectroscopy. The investigation of the anti-fungal activity of quercetin-sensitized TiO2 film suggests that such photocatalyst effectively inhibited the growth of Helminthosporium maydis (H. maydis) under visible light irradiation. Subsequently, the antimicrobial efficiency and inhibition mechanism were further illustrated and discussed by the determination of hydroxyl radicals and lipid peroxidation as well as the measurement of sensitizer redox potential. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Qiu, Dongfang; Liu, Kecheng; Huang, Qunzeng; Shi, Hengzhen] Nanyang Normal Univ, Chem & Pharmaceut Engn Coll, Nanyang 473061, Peoples R China.
   [Jiao, Zhujin] Nanyang Normal Univ, Henan Prov Key Lab Funiu Mt Insect Biol, Nanyang 473061, Peoples R China.
   [Li, Min] Henan Inst Educ, Dept Chem, Zhengzhou 450000, Peoples R China.
RP Shi, HZ (reprint author), Nanyang Normal Univ, Chem & Pharmaceut Engn Coll, Nanyang 473061, Peoples R China.
EM hzshi2011@gmail.com
FU National Natural Science Foundation of China [20943003]
FX This work is supported by the National Natural Science Foundation of
   China (No. 20943003).
CR ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   Hu C, 2007, LANGMUIR, V23, P4982, DOI 10.1021/la063626x
   Iliev V, 2002, J PHOTOCH PHOTOBIO A, V151, P195, DOI 10.1016/S1010-6030(02)00177-6
   Ishibashi K, 2000, ELECTROCHEM COMMUN, V2, P207, DOI 10.1016/S1388-2481(00)00006-0
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   MOSER J, 1991, LANGMUIR, V7, P3012, DOI 10.1021/la00060a018
   Raja P, 2005, J PHOTOCH PHOTOBIO A, V169, P271, DOI 10.1016/j.jphotochem.2004.07.009
   Regan BO, 1991, NATURE, V353, P737, DOI DOI 10.1038/353737A0
   Rodriguez R, 1996, J COLLOID INTERF SCI, V177, P122, DOI 10.1006/jcis.1996.0012
   Su C, 2004, CATAL TODAY, V96, P119, DOI 10.1016/j.cattod.2004.06.132
   Villarreal TL, 2005, J AM CHEM SOC, V127, P12601
   Zhao W, 2003, CHEM-EUR J, V9, P3292, DOI 10.1002/chem.200204559
NR 13
TC 3
Z9 3
U1 3
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 15
PY 2013
VL 97
BP 21
EP 23
DI 10.1016/j.matlet.2013.01.089
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 120IS
UT WOS:000317164600007
DA 2018-10-20
ER

PT J
AU Prawel, DA
   Kipper, MJ
   Popat, KC
   James, SP
AF Prawel, David A.
   Kipper, Matt J.
   Popat, Ketul C.
   James, Susan P.
TI Electrohydrodynamic atomization technique for applying phospholipid
   coatings to titanium implant materials
SO MATERIALS LETTERS
LA English
DT Article
DE Electrospray; Coating; Biomaterial; Orthopedic implant; Titanium;
   Phosphatidylserine
ID STAINLESS-STEEL; IN-VIVO; MINERALIZATION; DEPOSITION
AB Phospholipid coatings on titanium implants have been shown to enhance osteoblast activity, promote mineralization, and facilitate implant osseointegration in vivo. To date, dip and drip coating techniques have been used to apply these coatings. These coating techniques are easy to perform, but present difficulties in controlling the characteristics of the coating on the final surface, resulting in inconsistent, non-uniform, non-conformal coatings that are too thick for in vivo use.
   Electrohydrodynamic atomization (electro-spraying or e-spraying) is a versatile and easy method of creating thin, uniform and consistent coatings by atomizing a liquid with electrical forces. e-Spraying provides the advantage of being able to create coatings with relatively high efficiencies, while providing good control of coating morphology, especially on rough and intricately shaped surfaces, which is an important consideration for cell attachment and growth. Other advantages of this technique are low cost and easy setup. The purpose of this study was to develop an e-spraying technique for applying phospholipid coatings on commercially pure titanium implant materials. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Prawel, David A.; Popat, Ketul C.; James, Susan P.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [Kipper, Matt J.] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
   [Prawel, David A.; Kipper, Matt J.; Popat, Ketul C.; James, Susan P.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP James, SP (reprint author), Engn A101,Campus Delivery 1374, Ft Collins, CO 80523 USA.
EM sjames@engr.colostate.edu
RI Kipper, Matt/B-6941-2013
OI Kipper, Matt/0000-0002-8818-745X; Popat, Ketul C./0000-0002-2417-7789
FU Colorado State University Cancer Supercluster Translational Research
   Grant Program; Colorado Bioscience Discovery Evaluation Grant Program
FX This paper was supported by the Colorado State University Cancer
   Supercluster Translational Research Grant Program and Colorado
   Bioscience Discovery Evaluation Grant Program.
CR Alegre-Rico F, 2004, ACTA ORTOP MEX, V18, P235
   Bosetti M, 2005, BIOMATERIALS, V26, P7572, DOI 10.1016/j.biomaterials.2005.05.033
   BRAUN G, 1995, CLIN ORAL IMPLAN RES, V6, P1, DOI 10.1034/j.1600-0501.1995.060101.x
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   GRACE JM, 1994, J AEROSOL SCI, V25, P1005, DOI 10.1016/0021-8502(94)90198-8
   Hudson HK, 2012, PENETRATIVE OSSEOINT
   Kumbar SG, 2007, J BIOMED MATER RES B, V81B, P91, DOI 10.1002/jbm.b.30641
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   MAGARVEY RH, 1962, J FLUID MECH, V13, P151, DOI 10.1017/S0022112062000580
   Merolli A, 2006, J MATER SCI-MATER M, V17, P789, DOI 10.1007/s10856-006-9836-z
   RAGGIO CL, 1986, J BONE MINER RES, V1, P409
   Santin M, 2006, J R SOC INTERFACE, V3, P277, DOI 10.1098/rsif.2005.0088
   Satsangi N, 2004, J MATER SCI-MATER M, V15, P693, DOI 10.1023/B:JMSM.0000030211.32655.80
   SIEFERT W, 1984, THIN SOLID FILMS, V120, P267, DOI 10.1016/0040-6090(84)90241-4
   TRANQUILLI PL, 1994, J MATER SCI-MATER M, V5, P345, DOI 10.1007/BF00058960
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
NR 16
TC 10
Z9 10
U1 0
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 15
PY 2013
VL 97
BP 81
EP 85
DI 10.1016/j.matlet.2013.01.091
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 120IS
UT WOS:000317164600024
DA 2018-10-20
ER

PT J
AU Chomchalao, P
   Pongcharoen, S
   Sutheerawattananonda, M
   Tiyaboonchai, W
AF Chomchalao, Pratthana
   Pongcharoen, Sutatip
   Sutheerawattananonda, Manote
   Tiyaboonchai, Waree
TI Fibroin and fibroin blended three-dimensional scaffolds for rat
   chondrocyte culture
SO BIOMEDICAL ENGINEERING ONLINE
LA English
DT Article
DE Fibroin; Collagen; Gelatin; Scaffolds; Chondrocytes
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; SILK FIBROIN;
   FIBROIN/COLLAGEN SCAFFOLDS; DRUG-DELIVERY; IN-VITRO; TISSUE;
   DIFFERENTIATION; REGENERATION; BIOMATERIAL
AB Background: In our previous study, we successfully developed 3-D scaffolds prepared from silk fibroin (SF), silk fibroin/collagen (SF/C) and silk fibroin/gelatin (SF/G) using a freeze drying technique. The blended construct showed superior mechanical properties to silk fibroin construct. In addition, collagen and gelatin, contain RGD sequences that could facilitate cell attachment and proliferation. Therefore, in this study, the ability of silk fibroin and blended constructs to promote cell adhesion, proliferation and production of extracellular matrix (EMC) were compared.
   Methods: Articular chondrocytes were isolated from rat and cultured on the prepared constructs. Then, the cell viability in SF, SF/C and SF/G scaffolds was determined by MTT assay. Cell morphology and distribution were investigated by scanning electron microscopy (SEM) and histological analysis. Moreover, the secretion of extracellular matrix (ECM) by the chondrocytes in 3-D scaffolds was assessed by immunohistochemistry.
   Results: Results from MTT assay indicated that the blended SF/C and SF/G scaffolds provided a more favorable environment for chondrocytes attachment and proliferation than that of SF scaffold. In addition, scanning electron micrographs and histological images illustrated higher cell density and distribution in the SF/C and SF/G scaffolds than that in the SF scaffold. Importantly, immunohistochemistry strongly confirmed a greater production of type II collagen and aggrecan, important markers of chondrocytic phenotype, in SF blended scaffolds than that in the SF scaffold.
   Conclusion: Addition of collagen and gelatin to SF solution not only improved the mechanical properties of the scaffolds but also provided an effective biomaterial constructs for chondrocyte growth and chondrocytic phenotype maintenance. Therefore, SF/C and SF/G showed a great potential as a desirable biomaterial for cartilage tissue engineering.
C1 [Chomchalao, Pratthana; Tiyaboonchai, Waree] Naresuan Univ, Fac Pharmaceut Sci, Phitsanulok 65000, Thailand.
   [Pongcharoen, Sutatip] Naresuan Univ, Fac Med, Phitsanulok 65000, Thailand.
   [Sutheerawattananonda, Manote] Suranaree Univ Technol, Inst Agr Technol, Nakhon Ratchasima 30000, Thailand.
RP Sutheerawattananonda, M (reprint author), Suranaree Univ Technol, Inst Agr Technol, Nakhon Ratchasima 30000, Thailand.
EM msutheera@yahoo.com; wareet@nu.ac.th
FU Suranaree University of Technology; Thailand Research Fund; Center of
   Excellence for Innovation in Chemistry (PERCH-CIC); Commission on Higher
   Education, Ministry of Education
FX The authors thank Dr C. Norman Scholfield for his comments on the
   manuscript and results. This work was financially supported by Suranaree
   University of Technology, Thailand Research Fund, and the Center of
   Excellence for Innovation in Chemistry (PERCH-CIC), Commission on Higher
   Education, Ministry of Education.
CR Aigner T, 2003, ADV DRUG DELIVER REV, V55, P1569, DOI 10.1016/j.addr.2003.08.009
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Benz K, 2002, BIOCHEM BIOPH RES CO, V293, P284, DOI 10.1016/S0006-291X(02)00223-1
   Capito RM, 2006, OSTEOARTHR CARTILAGE, V14, P1203, DOI 10.1016/j.joca.2006.06.001
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Facchini A, 2006, BIORHEOLOGY, V43, P471
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   GETGOOD A, 2009, ORTHOPAEDICS TRAUMA, V23, P189
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Janjanin S, 2008, J SURG RES, V149, P47, DOI 10.1016/j.jss.2007.12.788
   Kang JY, 2009, INT J PHARMACEUT, V369, P114, DOI 10.1016/j.ijpharm.2008.11.008
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liuyun Jiang, 2009, J Biomed Sci, V16, P65, DOI 10.1186/1423-0127-16-65
   Lorenz H, 2006, PROG HISTOCHEM CYTO, V40, P135, DOI 10.1016/j.proghi.2006.02.003
   Lu Q, 2008, J MATER SCI-MATER M, V19, P629, DOI 10.1007/s10856-007-3180-9
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lu Q, 2009, MAT SCI ENG C-MATER, V29, P2239, DOI 10.1016/j.msec.2009.05.014
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   Lv Q, 2007, COMPOS SCI TECHNOL, V67, P3023, DOI 10.1016/j.compscitech.2007.05.003
   Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009
   Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001
   Matmati M, 2013, ANN BIOMED ENG, P1
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Rohanizadeh R, 2008, J MATER SCI-MATER M, V19, P1173, DOI 10.1007/s10856-007-3154-y
   Sato M, 2008, MED BIOL ENG COMPUT, V46, P735, DOI 10.1007/s11517-008-0360-9
   Schuh E, 2012, J BIOMED MATER RES A, V100A, P38, DOI 10.1002/jbm.a.33226
   Schulze-Tanzil G, 2009, ANN ANAT, V191, P325, DOI 10.1016/j.aanat.2009.05.003
   Stoop R, 2008, INJURY, V39, P77
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tiyaboonchai W, 2011, FIBER POLYM, V12, P324, DOI 10.1007/s12221-011-0324-9
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
NR 45
TC 7
Z9 10
U1 1
U2 30
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-925X
J9 BIOMED ENG ONLINE
JI Biomed. Eng. Online
PD APR 8
PY 2013
VL 12
AR 28
DI 10.1186/1475-925X-12-28
PG 12
WC Engineering, Biomedical
SC Engineering
GA 163DF
UT WOS:000320315200001
PM 23566031
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Harris, JJ
   Gabriele, P
AF Harris, Jeremy J.
   Gabriele, Peter
TI Use of FTIR imaging and scanning electron microscopy to analyze the
   effects of degradation on a resorbable polyester biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 245th National Spring Meeting of the American-Chemical-Society (ACS)
CY APR 07-11, 2013
CL New Orleans, LA
SP Amer Chem Soc
C1 [Harris, Jeremy J.; Gabriele, Peter] Secant Med Inc, Dept Emerging Technol, Perkasie, PA 18944 USA.
EM jeremy.harris@secantmedical.com
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 7
PY 2013
VL 245
MA 184-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 216SF
UT WOS:000324303604672
DA 2018-10-20
ER

PT J
AU Czaja, W
   Kyryliouk, D
   DePaula, CA
   Buechter, D
AF Czaja, Wojciech
   Kyryliouk, Dmytro
   DePaula, C. Alex
   Buechter, Douglas
TI Oxidation of gamma-irradiated microbial cellulose results in a
   bioresorbable, highly conformable novel biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 245th National Meeting of the American-Chemical-Society (ACS)
CY APR 07-11, 2013
CL New Orleans, LA
SP Amer Chem Soc
C1 [Czaja, Wojciech; Kyryliouk, Dmytro; DePaula, C. Alex; Buechter, Douglas] Synthes Inc, Biomat R&D, W Chester, PA 19380 USA.
EM czaja.wojciech@synthes.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 7
PY 2013
VL 245
MA 141-CELL
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 210RD
UT WOS:000323851301626
DA 2018-10-20
ER

PT J
AU Hong, F
AF Hong, Feng
TI Bacterial nanocellulose biomaterial for the sustainable earth: Beginning
   from development of cost-effective feedstocks
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 245th National Meeting of the American-Chemical-Society (ACS)
CY APR 07-11, 2013
CL New Orleans, LA
SP Amer Chem Soc
C1 [Hong, Feng] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
EM fhong@dhu.edu.cn
NR 0
TC 0
Z9 0
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 7
PY 2013
VL 245
MA 8-CELL
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 210RD
UT WOS:000323851301505
DA 2018-10-20
ER

PT J
AU Rohly, K
   Wheeler, A
AF Rohly, Ken
   Wheeler, Andrew
TI Effect of passivation time, temperature, and solution composition on the
   oxide film composition and electrochemical properties of metallic
   biomaterial 316L stainless steel
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 245th National Meeting of the American-Chemical-Society (ACS)
CY APR 07-11, 2013
CL New Orleans, LA
SP Amer Chem Soc
C1 [Rohly, Ken; Wheeler, Andrew] Bethel Univ, Dept Chem, St Paul, MN 55112 USA.
EM rohly@bethel.edu
NR 0
TC 0
Z9 0
U1 2
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 7
PY 2013
VL 245
MA 168-ANYL
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 210RD
UT WOS:000323851300383
DA 2018-10-20
ER

PT J
AU Bharti, S
   Mishra, S
   Sen, G
AF Bharti, Srijita
   Mishra, Sumit
   Sen, Gautam
TI Ceric ion initiated synthesis of polyacrylamide grafted oatmeal: Its
   application as flocculant for wastewater treatment
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Oatmeal; Flocculent; Conventional synthesis; Graft co polymer; Coal fine
   suspension; Wastewater treatment
ID SODIUM ALGINATE; PERFORMANCE; AGENT; POLYSACCHARIDES; METHACRYLATE;
   SUSPENSION
AB Polyacrylamide grafted oatmeal (OAT-g-PAM) was synthesized by conventional method. The grafting of the PAM chains on the biomaterial backbone was confirmed through intrinsic viscosity study, FTIR spectroscopy, elemental analysis (C, H, N, S and O), SEM morphology and TGA study. The intrinsic viscosity of oatmeal appreciably improved on grafting of PAM chains, thus resulting grafted product with potential application as superior viscosifier. Further, flocculation efficacy of the graft copolymer was studied in coal fine suspension, kaolin suspension, iron-ore suspension and then in municipal wastewater through 'jar test' procedure. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Bharti, Srijita; Mishra, Sumit; Sen, Gautam] Birla Inst Technol, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
RP Mishra, S (reprint author), Birla Inst Technol, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
EM sumitmishra1@gmail.com
RI Sen, Gautam/F-2930-2010
OI Sen, Gautam/0000-0003-0395-2878
FU Birla Institute of Technology, Mesra (BIT-Mesra); BIT-Mesra; Central
   Instrumentation Facility (CIF) of BIT-Mesra
FX Srijita Bharti acknowledges the support of Birla Institute of
   Technology, Mesra (BIT-Mesra); in form of Institute fellowship received
   by her.; Sumit Mishra and Gautam Sen acknowledge the support of
   BIT-Mesra; in form of Cumulative Professional Development Grant (CPDG).;
   All authors acknowledge the support of Central Instrumentation Facility
   (CIF) of BIT-Mesra.
CR Brostow W, 2007, MATER LETT, V61, P4381, DOI 10.1016/j.matlet.2007.02.007
   Collins E. A., 1973, EXPT POLYM SCI, P394
   Greenberg A., 1999, STANDARD METHOD EXAM, P1
   Karmakar GP, 1998, COLLOID SURFACE A, V133, P119, DOI 10.1016/S0927-7757(97)00129-5
   Kongparakul S, 2008, EUR POLYM J, V44, P1915, DOI 10.1016/j.eurpolymj.2007.09.021
   MINO G, 1958, J POLYM SCI, V31, P242, DOI 10.1002/pol.1958.1203112248
   Mishra S, 2012, CARBOHYD POLYM, V87, P2255, DOI 10.1016/j.carbpol.2011.10.057
   Mishra S, 2011, INT J BIOL MACROMOL, V49, P591, DOI 10.1016/j.ijbiomac.2011.06.015
   Pal S, 2008, CARBOHYD POLYM, V74, P590, DOI 10.1016/j.carbpol.2008.04.007
   Pal S, 2006, COLLOID SURFACE A, V289, P193, DOI 10.1016/j.colsurfa.2006.04.034
   Pal S, 2012, CARBOHYD POLYM, V87, P336, DOI 10.1016/j.carbpol.2011.07.052
   Rani GU, 2012, CARBOHYD POLYM, V90, P784, DOI 10.1016/j.carbpol.2012.05.069
   Rani P, 2013, CARBOHYD POLYM, V91, P686, DOI 10.1016/j.carbpol.2012.08.023
   Rath SK, 1998, COLLOID SURFACE A, V139, P129, DOI 10.1016/S0927-7757(98)00250-7
   RUEHRWEIN RA, 1952, SOIL SCI, V73, P485, DOI 10.1097/00010694-195206000-00007
   Schwab E., 1962, TAPPI, V45, P390
   Sen G, 2012, INT J BIOL MACROMOL, V50, P369, DOI 10.1016/j.ijbiomac.2011.12.014
   Singh R, 2013, CRIT REV FOOD SCI, V53, P126, DOI 10.1080/10408398.2010.526725
   Singh RP, 1995, POLYMER AND OTHER ADVANCED MATERIALS, P227
   Singh RP, 2000, POLYM ENG SCI, V40, P46, DOI 10.1002/pen.11138
   Tripathy T, 2001, EUR POLYM J, V37, P125, DOI 10.1016/S0014-3057(00)00089-6
   Tripathy T, 1999, EUR POLYM J, V35, P2057, DOI 10.1016/S0014-3057(98)00284-5
   Tripathy T, 2000, EUR POLYM J, V36, P1471, DOI 10.1016/S0014-3057(99)00201-3
NR 23
TC 25
Z9 26
U1 0
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 2
PY 2013
VL 93
IS 2
BP 528
EP 536
DI 10.1016/j.carbpol.2012.11.072
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 120CL
UT WOS:000317148200024
PM 23499093
DA 2018-10-20
ER

PT J
AU Kavitha, K
   Sutha, S
   Prabhu, M
   Rajendran, V
   Jayakumar, T
AF Kavitha, K.
   Sutha, S.
   Prabhu, M.
   Rajendran, V.
   Jayakumar, T.
TI In situ synthesized novel biocompatible titania-chitosan nanocomposites
   with high surface area and antibacterial activity
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Titania-chitosan; Nanocomposite; Cytotoxicity; Biocompatibility;
   Antibacterial activity; Surface area
ID DIOXIDE TIO2 NANOPARTICLES; OXIDATIVE STRESS; CELL-GROWTH;
   HYDROXYAPATITE; BONE; SCAFFOLDS; CYTOTOXICITY; COMPOSITES; MEMBRANES;
   CHITINS
AB A series of titania-chitosan nanocomposites (2:x (0.12, 0.25, 0.5, 1.0 and 2.0 g)) were synthesized using in situ sol-gel method and comprehensively characterized using conventional techniques. The resultant particles showed anatase phase, spherical and irregular morphology with particle size of 4.5-10.5 nm. Nanocomposites with higher surface area (114-265 m(2)/g) and high purity were obtained. The characterized samples were analyzed in 1.5 mM simulated body fluid (1.5 SBF) and human gastric adenocarcinoma cell line to explore the bioactivity and biocompatibility. Antibacterial activity against Staphylococcus aureus was also evaluated. The formation of apatite layer on 1.5 SBF-immersed samples confirms the bioactivity of all the nanocomposites. High surface area, appropriate hydroxyapatite formation, specific antibacterial action, increased cell viability, controlled swelling and degrading rate are favorably achieved at 2:1 nanocomposite ratio. This study shows titania-chitosan nanocomposites as the promising biomaterial for orthopedic and tissue engineering applications. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Kavitha, K.; Sutha, S.; Prabhu, M.; Rajendran, V.] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, KSR Kalvi Nagar, Tiruchengode 637215, Tamil Nadu, India.
   [Jayakumar, T.] Indira Gandhi Ctr Atom Res, Dept Met & Mat, Kalpakkam 603102, Tamil Nadu, India.
RP Rajendran, V (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, KSR Kalvi Nagar, Tiruchengode 637215, Tamil Nadu, India.
EM kkavitha07@gmail.com; suthaasridhar@gmail.com; prabhubpt16@gmail.com;
   veerajendran@gmail.com; tjk@igcar.gov.in
RI VENKATACHALAM, RAJENDRAN/H-5099-2012
OI VENKATACHALAM, RAJENDRAN/0000-0001-9471-5311
FU UGC-DAE-Consortium for Scientific Research, Kalpakkam
   [CSR/Acctts/2010-11/1136]
FX The authors would like to acknowledge the UGC-DAE-Consortium for
   Scientific Research, Kalpakkam and Dr. G. Amarendra, Head, Metal Physics
   Section, Indira Gandhi Center for Atomic Research, Kalpakkam node for
   the financial support and valuable suggestions to carry out this
   research project (CSR/Acctts/2010-11/1136 dt.06.01.2011). The authors
   are thankful to Dr. G. Kumaresan and Mr. P. Jayaprakash, Department of
   genetics, School of biological sciences, Madurai Kamaraj University for
   their technical support in the toxicity studies.
CR Al-Sagheer FA, 2011, CARBOHYD POLYM, V85, P356, DOI 10.1016/j.carbpol.2011.02.032
   Amin KAM, 2012, POLYMERS-BASEL, V4, P590, DOI 10.3390/polym4010590
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Choi D, 2006, J AM CERAM SOC, V89, P444, DOI 10.1111/j.1551-2916.2005.00738.x
   Chung YC, 2004, ACTA PHARMACOL SIN, V25, P932
   Dai SX, 2010, NANOSCALE RES LETT, V5, P1829, DOI 10.1007/s11671-010-9720-0
   Di Vona ML, 2007, J MEMBRANE SCI, V296, P156, DOI 10.1016/j.memsci.2007.03.037
   Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5
   Ghosh M, 2010, CHEMOSPHERE, V81, P1253, DOI 10.1016/j.chemosphere.2010.09.022
   Guo WL, 2003, MICROELECTRON ENG, V66, P95, DOI 10.1016/S0167-9317(03)00031-5
   He G, 2008, APPL SURF SCI, V255, P442, DOI 10.1016/j.apsusc.2008.06.088
   Hua D., 2007, T NONFERROUS METALS, V17, ps00
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Jayakumar R, 2011, INT J BIOL MACROMOL, V48, P336, DOI 10.1016/j.ijbiomac.2010.12.010
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kroll A, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-9
   Lim TY, 2009, J MATER SCI-MATER M, V20, P1, DOI 10.1007/s10856-008-3528-9
   Luo YB, 2009, APPL SURF SCI, V255, P6795, DOI 10.1016/j.apsusc.2009.02.074
   Murugan R, 2005, J CRYST GROWTH, V274, P209, DOI 10.1016/j.jcrysgro.2004.09.069
   Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nakayama N, 2007, POLYM DEGRAD STABIL, V92, P1255, DOI 10.1016/j.polymdegradstab.2007.03.026
   Ozerin AN, 2006, POLYM SCI SER A+, V48, P638, DOI 10.1134/S0965545X06060137
   Rajkumar M, 2011, DIG J NANOMATER BIOS, V6, P169
   Ramalingam S, 2009, J SOLID STATE ELECTR, V13, P1777, DOI 10.1007/s10008-009-0870-x
   Rani VVD, 2011, CARBOHYD POLYM, V83, P858, DOI 10.1016/j.carbpol.2010.08.065
   Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011
   Saravanakumar B, 2011, MATER LETT, V65, P31, DOI 10.1016/j.matlet.2010.09.053
   Singh S, 2007, TOXICOL APPL PHARM, V222, P141, DOI 10.1016/j.taap.2007.05.001
   Siriphannon P, 2002, J EUR CERAM SOC, V22, P511, DOI 10.1016/S0955-2219(01)00301-6
   Sun SQ, 2008, B MATER SCI, V31, P61, DOI 10.1007/s12034-008-0011-7
   Teodor E, 2009, NANOSCALE RES LETT, V4, P544, DOI 10.1007/s11671-009-9278-x
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Wang J, 2004, J DENT RES, V83, P296, DOI 10.1177/154405910408300405
   Wu Y. A., 2010, 103 A WMAS ANN C EXH
   Yan L, 2001, INT J INORG MATER, V3, P633, DOI 10.1016/S1466-6049(01)00164-7
   Yang D, 2009, CHEM ENG SCI, V64, P3130, DOI 10.1016/j.ces.2009.03.042
   Yuan Y, 2008, J BIOMED MATER RES B, V86B, P245, DOI 10.1002/jbm.b.31012
   Zawadzki J, 2010, CARBOHYD POLYM, V80, P394, DOI 10.1016/j.carbpol.2009.11.037
   Zhang Y, 2004, J MATER SCI-MATER M, V15, P255, DOI 10.1023/B:JMSM.0000015485.94665.25
NR 40
TC 41
Z9 42
U1 4
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 2
PY 2013
VL 93
IS 2
BP 731
EP 739
DI 10.1016/j.carbpol.2012.12.031
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 120CL
UT WOS:000317148200048
PM 23499117
DA 2018-10-20
ER

PT J
AU Muhamed, J
   Revi, D
   Joseph, R
   Anilkumar, T
AF Muhamed, Jaseer
   Revi, Deepa
   Joseph, Roy
   Anilkumar, Thapasimuthu
TI Phenotypic Modulation of Cell Types around Implanted Polyethylene
   Terephthalate Fabric in Rabbit Muscle
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE biomaterials; polyethylene terephthalate; biocompatibility;
   myofibroblast; rhabdomyocytes
ID SKELETAL-MUSCLE; TOXICOLOGIC PATHOLOGISTS; SATELLITE CELL; STEM-CELL;
   VIMENTIN; TISSUE; BIOCOMPATIBILITY; MYOFIBROBLAST; DESMIN; BIOMATERIALS
AB Whereas the nature of healing reaction in skeletal muscle following implantation of biomaterial has been extensively studied, the extent of variation in cell phenotypes is poorly known. Here, we studied the phenotypic alteration of cell types following injury in skeletal muscle of rabbits implanted with a commonly used biomaterial, polyethylene terephthalate (PET) fabric. Following implantation, histomorphological features were studied after 1, 4, and 12 weeks. Routine objective histomorphological evaluation was supplemented with histochemistry for collagen and immunohistochemistry for proliferating cell nuclear antigen (PCNA), CD34, vimentin, and alpha smooth muscle actin (alpha-SMA). The extent of reaction was quantified. The foreign body giant cells were found to comprise subpopulations, based on the variation in vimentin detectability or the presence of differentially capable proliferating nuclei (PCNA positive). Many rhabdomyocytes adjacent to the implant were PCNA-positive and some of them showed CD34 positivity. Often, the rhabdomyocytes very near to implanted PET fabric assumed a myofibroblast phenotype as evidenced by vimentin and/or alpha-SMA positivity at immunohistochemistry. Overall, the results suggested a phenotypic alteration of native cell types following implantation of PET fabric in rabbit skeletal muscle. Quantification of such cell types at the tissue-material interphase in relation to the deposition of collagen may be desirable during safety evaluation of biomaterials by histomorphology.
C1 [Muhamed, Jaseer; Revi, Deepa; Anilkumar, Thapasimuthu] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Lab Expt Pathol, Trivandrum 695012, Kerala, India.
   [Joseph, Roy] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Polymer Proc Lab, Trivandrum 695012, Kerala, India.
RP Anilkumar, T (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Lab Expt Pathol, Trivandrum 695012, Kerala, India.
EM tvanilkumar@sctimst.ac.in
OI Muhamed, Jaseer/0000-0001-5046-9438
CR Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Anilkumar TV, 2011, BIOLOGICALS, V39, P81, DOI 10.1016/j.biologicals.2011.01.003
   Anilkumar T. V., 2007, Indian Journal of Veterinary Pathology, V31, P11
   [Anonymous], 2007, 10993 ISO 6
   Bancroft JD, 2008, THEORY PRACTICE HIST
   BORNEMANN A, 1993, NEUROPATH APPL NEURO, V19, P414, DOI 10.1111/j.1365-2990.1993.tb00463.x
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Cenni E, 1996, BIOMATERIALS, V17, P2071, DOI 10.1016/0142-9612(96)00037-3
   Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90
   Duquette RA, 2005, BIOL REPROD, V72, P276, DOI 10.1095/biolreprod.104.033506
   GALLANTI A, 1992, ACTA NEUROPATHOL, V85, P88, DOI 10.1007/BF00304637
   Hagerty RD, 2000, J BIOMED MATER RES, V49, P489, DOI 10.1002/(SICI)1097-4636(20000315)49:4<489::AID-JBM7>3.0.CO;2-2
   Hao H, 2006, ARTERIOSCL THROM VAS, V26, P326, DOI 10.1161/01.ATV.000019939.74656.4c
   Helmus MN, 2008, TOXICOL PATHOL, V36, P70, DOI 10.1177/0192623307310949
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Jayo MJ, 2008, TOXICOL PATHOL, V36, P92, DOI 10.1177/0192623307311405
   LEADER M, 1987, HISTOPATHOLOGY, V11, P63
   Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2
   MISRA AK, 1992, MUSCLE NERVE, V15, P1246, DOI 10.1002/mus.880151105
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P86
   Schuh JCL, 2008, TOXICOL PATHOL, V36, P63, DOI 10.1177/0192623307309926
   Seitz H, 1998, BIOMATERIALS, V19, P189, DOI 10.1016/S0142-9612(97)00201-9
   Swathy S. S., 2007, Indian Journal of Veterinary Pathology, V31, P113
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.55.091902.103810
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   TOKUYASU KT, 1984, J CELL BIOL, V98, P1961, DOI 10.1083/jcb.98.6.1961
   TURNER JE, 1973, J BIOMED MATER RES, V7, P39, DOI 10.1002/jbm.820070104
   van Bilsen PHJ, 2004, J BIOMED MATER RES A, V68A, P423, DOI 10.1002/jbm.a.20069
   Velayudhan S, 2005, ACTA BIOMATER, V1, P201, DOI 10.1016/j.actbio.2004.11.005
   Williams D. F., 1987, DEFINITION BIOMATERI
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Williams David, 2003, Med Device Technol, V14, P10
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Zalewski A, 2002, CIRC RES, V91, P652, DOI 10.1161/01.RES.0000038996.97287.9A
   Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006
   Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x
NR 38
TC 6
Z9 6
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-6233
EI 1533-1601
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD APR
PY 2013
VL 41
IS 3
BP 497
EP 507
DI 10.1177/0192623312460922
PG 11
WC Pathology; Toxicology
SC Pathology; Toxicology
GA AB0EI
UT WOS:000331464200007
PM 22991385
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Obata, A
AF Obata, Akiko
TI Development of biomaterials with inorganic ions stimulating osteogenic
   cell functions
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Biomaterial; Polymer; Composite; Bone; Cell; Electrospinning
ID BIOACTIVE GLASS SCAFFOLD; GUIDED BONE REGENERATION; IN-VITRO; HUMAN
   OSTEOBLASTS; ACID) COMPOSITES; TISSUE; DIFFERENTIATION; MINERALIZATION;
   DEGRADATION; DISSOLUTION
AB Ceramic and polymer composite biomaterials releasing silicate and calcium ions were developed for the use in bone regeneration. Silicate and calcium ions stimulatory enhance osteogenic cell functions, such as proliferation, differentiation and mineralization. Siloxane-doped vaterite (SiV) particles were prepared using aminopropyltriethoxysilane (APTES) as a siloxane source to achieve an effective release of silicate and calcium ions in a physiological condition. Composite materials consisting of SiV and poly(lactic acid) (PLLA), which is one of the biodegradable polymers, were prepared. In this system, the amino groups and calcium ions on the SiV surface had chemical reactions with the carboxy groups in the PLLA. The composite materials showed a chronic release of trace amounts of silicate and calcium ions in a cell culture medium. Proliferation and differentiation of mouse osteoblast-like cells (MC3T3-E1 cells) were enhanced on the composite material in comparison with the material releasing no silicate ions. The composite fibremats were also developed by an electrospinning method. The fibremats had about 10 mu m in fibre-diameter and showed good flexibility. The fibre surfaces were able to be coated with hydroxyapatite by soaking in a simulated body fluid (1.5SBF) for 1 day. The fibremats showed excellent cell and tissue compatibilities in the results of in vitro and vivo tests. Thus, the inorganic ions released from bioceramics should be one of the important factors for achieving high-performance biomaterials for bone regeneration. (C)2013 The Ceramic Society of Japan. All rights reserved.
C1 Nagoya Inst Technol, Grad Sch Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Obata, A (reprint author), Nagoya Inst Technol, Grad Sch Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM obata.akiko@nitech.ac.jp
CR ASADA M, 1991, J MOL STRUCT, V244, P237, DOI 10.1016/0022-2860(91)80159-2
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   Fujikura K, 2012, J BIOMAT SCI-POLYM E, V23, P1939, DOI 10.1163/092050611X599328
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   Maeda H, 2004, MATER TRANS, V45, P989, DOI 10.2320/matertrans.45.989
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   Obata A, 2010, ACTA BIOMATER, V6, P1248, DOI 10.1016/j.actbio.2009.11.013
   Obata A, 2009, ACTA BIOMATER, V5, P57, DOI 10.1016/j.actbio.2008.08.004
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   Wakita T, 2011, DENT MATER J, V30, P232, DOI 10.4012/dmj.2010-141
   Wakita T, 2010, COMPOS SCI TECHNOL, V70, P1889, DOI 10.1016/j.compscitech.2010.05.014
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yabuta T, 2000, J SOL-GEL SCI TECHN, V19, P745, DOI 10.1023/A:1008795629804
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
NR 28
TC 0
Z9 0
U1 0
U2 8
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD APR
PY 2013
VL 121
IS 1412
BP 377
EP 381
DI 10.2109/jcersj2.121.377
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 296TV
UT WOS:000330209200013
OA Bronze
DA 2018-10-20
ER

PT J
AU Brown, EMB
   Allen, LL
   Pyles, H
   Solis, J
   Wileman, TA
   Willadsen, GB
AF Brown, Eric Michael Bratsolias
   Allen, Latoya L.
   Pyles, Harley
   Solis, Jessica
   Wileman, Traci A.
   Willadsen, Gail B.
TI Advancements in Using TiO2 Bionanoconjugates for Precision Degradation
   of Intracellular Biological Structures
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Review
DE Titanium Dioxide; TiO2; Nanoparticle; Nanoconjugate; Bionanoconjugate;
   Chemical Modification; Biological Modification; Photoreactivity
ID PEPTIDE NUCLEIC-ACID; TITANIUM-DIOXIDE; PHOTOCATALYTIC ACTIVITY;
   VISIBLE-LIGHT; CANCER-CELLS; COMPOSITE NANOPARTICLES; BIOMATERIAL
   SYSTEM; STRAND INVASION; METAL-SURFACES; ALIZARIN RED
AB Due to their low cost, photocatalytic properties, and unique surface chemistry, titanium dioxide (TiO2) nanoparticles are among the most widely used nanoparticles in industry today. Over the last decade, TiO2 nanoparticles have also been chemically and biologically enhanced to create TiO2 bionanoconjugates that can be used for biological applications such as imaging and manipulating desired biological structures. This review particularly focuses on the manner in which these specific chemical and biological modifications in TiO2 bionanoconjugates alter pre and post photoexcitation events to enable precision degradation of intracellular biological structures. Secondary emphasis is given to imaging aspects when necessary to understanding the effects that targeting these bionanoconjugates has on degradation of neighboring biological structures. The advantages of TiO2 bionanoconjugates to standard techniques, as well as future research directions, are also discussed.
C1 [Brown, Eric Michael Bratsolias; Allen, Latoya L.; Pyles, Harley; Solis, Jessica; Wileman, Traci A.; Willadsen, Gail B.] Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA.
RP Brown, EMB (reprint author), Univ Wisconsin, Dept Biol Sci, 800 W Main St,Upham Hall 357, Whitewater, WI 53190 USA.
EM browne@uww.edu
OI Allen, Latoya/0000-0003-1486-8487
FU Office of Research and Sponsored Programs at the University of
   Wisconsin-Whitewater
FX The authors would like to thank Dean Mary Pinkerton and Associate Dean
   David Travis of the College of Letter and Sciences and Dr. Daryle
   Waechter-Brulla (Chair of the Department of Biological Sciences) at the
   University of Wisconsin-Whitewater for supporting the writing of this
   review article. A Library Research Fellowship awarded to Eric Brown by
   the Office of Research and Sponsored Programs at the University of
   Wisconsin-Whitewater also supported the writing of this article.
CR Agrawal M, 2011, J MATER CHEM, V21, P615, DOI 10.1039/c0jm02631j
   Alexandrescu R, 2010, INFRARED PHYS TECHN, V53, P94, DOI 10.1016/j.infrared.2009.10.004
   Armitage B, 1997, P NATL ACAD SCI USA, V94, P12320, DOI 10.1073/pnas.94.23.12320
   Armitage B, 1997, NUCLEIC ACIDS RES, V25, P4674, DOI 10.1093/nar/25.22.4674
   Avirah RR, 2008, J ORG CHEM, V73, P274, DOI 10.1021/jo702209a
   Blatnik J., 2012, MICROSC MICROANAL, V18, P1
   Bonnett R., 2000, ASPECTS PHOTODYNAMIC
   Brown EMB, 2008, ANAL BIOCHEM, V383, P226, DOI 10.1016/j.ab.2008.08.020
   Chen DM, 2008, APPL SURF SCI, V255, P2879, DOI 10.1016/j.apsusc.2008.08.032
   Chen WJ, 2008, SMALL, V4, P485, DOI 10.1002/smll.200701164
   Chien WC, 2011, THIN SOLID FILMS, V519, P5274, DOI 10.1016/j.tsf.2011.04.001
   Contado C, 2008, ANAL CHEM, V80, P7594, DOI 10.1021/ac8012626
   Craig CF, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.163001
   Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029
   EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0
   EGHOLM M, 1992, J AM CHEM SOC, V114, P1895, DOI 10.1021/ja00031a062
   Fay F, 2011, IMMUNOTHERAPY-UK, V3, P381, DOI [10.2217/imt.11.5, 10.2217/IMT.11.5]
   Franzen S, 2011, EXPERT OPIN DRUG DEL, V8, P281, DOI 10.1517/17425247.2011.554816
   Garcia A. M. F., 2011, NANOSCALE RES LETT, V6
   Hall E. G. A., 2006, PHYS CHEM RAD ABSORP, P5
   Huber S. R. S., 2000, J PHYS CHEM B, V104, P8995
   Hurst SJ, 2011, J PHYS CHEM C, V115, P620, DOI 10.1021/jp1096162
   Ismagilov ZR, 2009, RUSS CHEM REV+, V78, P873, DOI 10.1070/RC2009v078n09ABEH004082
   Janczyk A, 2008, FREE RADICAL BIO MED, V44, P1120, DOI 10.1016/j.freeradbiomed.2007.12.019
   Janczyk A, 2008, J PHOTOCH PHOTOBIO B, V92, P54, DOI 10.1016/j.jphotobiol.2008.05.003
   Jing LQ, 2008, SOL ENERG MAT SOL C, V92, P1030, DOI 10.1016/j.solmat.2008.03.003
   Jing LQ, 2006, SCI CHINA SER B, V49, P345, DOI 10.1007/Ss11426-006-2002-0
   Jing LQ, 2006, J PHYS CHEM B, V110, P17860, DOI 10.1021/jp063148z
   Jing LQ, 2006, SOL ENERG MAT SOL C, V90, P1773, DOI 10.1016/j.solmat.2005.11.007
   Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2
   Kemp S, 2008, J MED CHEM, V51, P2787, DOI 10.1021/jm7016072
   Khan J. A., 2011, PLOS ONE, V6
   Kim J, 2010, ENVIRON POLLUT, V158, P2335, DOI 10.1016/j.envpol.2010.03.024
   Kim S, 2004, BIOCHEM ENG J, V22, P81, DOI 10.1016/j.bej.2004.08.005
   Kumar SA, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255501
   Kwon S, 2008, CRIT REV ENV SCI TEC, V38, P197, DOI 10.1080/10643380701628933
   Li J., 2005, NUCLEIC ACIDS RES, V33, P168
   Liu GM, 2000, J MOL CATAL A-CHEM, V153, P221, DOI 10.1016/S1381-1169(99)00351-9
   Liu GM, 1999, ENVIRON SCI TECHNOL, V33, P2081, DOI 10.1021/es9807643
   Liu XQ, 2010, TALANTA, V81, P1599, DOI 10.1016/j.talanta.2010.03.009
   Lo PH, 2008, COLLOID SURFACE B, V66, P266, DOI 10.1016/j.colsurfb.2008.07.003
   Lundin KE, 2004, BIOMOL ENG, V21, P51, DOI 10.1016/j.bioeng.2003.10.003
   Ma LL, 2011, LANGMUIR, V27, P7681, DOI 10.1021/la200659z
   Macwan DP, 2011, J MATER SCI, V46, P3669, DOI 10.1007/s10853-011-5378-y
   Matsui K, 2010, MEDCHEMCOMM, V1, P209, DOI 10.1039/c0md00027b
   McMahon BM, 2002, ANTISENSE NUCLEIC A, V12, P65, DOI 10.1089/108729002760070803
   Menard A, 2011, ENVIRON POLLUT, V159, P677, DOI 10.1016/j.envpol.2010.11.027
   Michelmore A, 2000, PHYS CHEM CHEM PHYS, V2, P2985, DOI 10.1039/b001213k
   Moan J. J., 1990, PHOTOCHEM PHOTOBIOL, V6, P343
   Ni M, 2007, RENEW SUST ENERG REV, V11, P401, DOI 10.1016/j.rser.2005.01.009
   Niedre M, 2002, PHOTOCHEM PHOTOBIOL, V75, P382, DOI 10.1562/0031-8655(2002)075<0382:DNILDO>2.0.CO;2
   NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210
   Nohynek GJ, 2008, SKIN PHARMACOL PHYS, V21, P136, DOI 10.1159/000131078
   Ogino C, 2007, J BIOSCI BIOENG, V104, P339, DOI 10.1263/jbb.104.339
   Ogino C, 2010, BIOORG MED CHEM LETT, V20, P5320, DOI 10.1016/j.bmcl.2010.06.124
   Ohno T, 2011, ADV POWDER TECHNOL, V22, P390, DOI 10.1016/j.apt.2010.06.003
   Paunesku T, 2003, NAT MATER, V2, P343, DOI 10.1038/nmat875
   Paunesku T, 2007, NANO LETT, V7, P596, DOI 10.1021/nl0624723
   Paunesku T, 2008, NANOMED-NANOTECHNOL, V4, P201, DOI 10.1016/j.nano.2008.04.004
   Pavlova AS, 2009, RUSS J BIOORG CHEM+, V35, P197, DOI 10.1134/S1068162009020083
   Penn SG, 2003, CURR OPIN CHEM BIOL, V7, P609, DOI 10.1016/j.cbpa.2003.08.013
   Pipelzadeh E, 2009, CHEM ENG J, V155, P660, DOI 10.1016/j.cej.2009.08.023
   Rajh T, 2002, J PHYS CHEM B, V106, P10543, DOI 10.1021/jp021235v
   Rajh T, 2004, NANO LETT, V4, P1017, DOI 10.1021/nl049684p
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Reyes-Coronado D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/14/145605
   Rozhkova EA, 2009, NANO LETT, V9, P3337, DOI 10.1021/nl901610f
   Sahu M, 2011, CHEM ENG SCI, V66, P3482, DOI 10.1016/j.ces.2011.04.003
   Sasikala R, 2009, INT J HYDROGEN ENERG, V34, P6105, DOI 10.1016/j.ijhydene.2009.05.131
   Shah SI, 2002, P NATL ACAD SCI USA, V99, P6482, DOI 10.1073/pnas.052518299
   Shimizu N, 2007, ULTRASON SONOCHEM, V14, P184, DOI 10.1016/j.ultsonch.2006.04.002
   Shown I, 2010, J COLLOID INTERF SCI, V352, P232, DOI 10.1016/j.jcis.2010.08.055
   Skocaj M, 2011, RADIOL ONCOL, V45, P227, DOI 10.2478/v10019-011-0037-0
   Stinner C, 2001, INORG CHEM, V40, P5245, DOI 10.1021/ic010376t
   Stuchinskaya T, 2011, PHOTOCH PHOTOBIO SCI, V10, P822, DOI 10.1039/c1pp05014a
   SUSLICK KS, 1988, ABSTR PAP AM CHEM S, V196, P392
   SUSLICK KS, 1988, ABSTR PAP AM CHEM S, V195, P542
   SUSLICK KS, 1988, ABSTR PAP AM CHEM S, V195, P253
   SUSLICK KS, 1988, SOLID STATE IONICS, V26, P176, DOI 10.1016/0167-2738(88)90186-5
   Szacilowski K, 2005, CHEM REV, V105, P2647, DOI 10.1021/cr030707e
   Teh CM, 2011, J ALLOY COMPD, V509, P1648, DOI 10.1016/j.jallcom.2010.10.181
   Thurn K. T., 2007, NANOSCALE RES LETT
   Thurn KT, 2009, SMALL, V5, P1318, DOI 10.1002/smll.200801458
   Tsai MC, 2009, ANAL CHEM, V81, P7590, DOI 10.1021/ac900916s
   Vasudev M, 2011, IEEE T NANOTECHNOL, V10, P35, DOI 10.1109/TNANO.2010.2064174
   Vega-Arroyo M, 2007, CHEM PHYS, V339, P164, DOI 10.1016/j.chemphys.2007.06.037
   Wu AG, 2008, NANO, V3, P27, DOI 10.1142/S1793292008000836
   Xiao HM, 2006, COMPOS SCI TECHNOL, V66, P2003, DOI 10.1016/j.compscitech.2006.01.001
   Xiao JR, 2006, J SOLID STATE CHEM, V179, P1161, DOI 10.1016/j.jssc.2006.01.008
   Xiao Q, 2008, J ALLOY COMPD, V450, P426, DOI 10.1016/j.jallcom.2006.10.137
   Xu JC, 2004, J MOL CATAL A-CHEM, V219, P351, DOI 10.1016/j.molcata.2004.05.018
   Xu J, 2007, BIOELECTROCHEMISTRY, V71, P217, DOI 10.1016/j.bioelechem.2007.06.001
   Xue CB, 2010, J NANOSCI NANOTECHNO, V10, P8500, DOI 10.1166/jnn.2010.2682
   Yang XL, 2005, J CATAL, V234, P438, DOI 10.1016/j.jcat.2005.06.035
   Zhang L, 2007, CHEM COMMUN, P1891, DOI 10.1039/b618413h
   Zhao Y, 2009, J GASTROEN HEPATOL, V24, P1775, DOI 10.1111/j.1440-1746.2009.05986.x
NR 97
TC 4
Z9 5
U1 3
U2 29
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2013
VL 9
IS 4
BP 539
EP 550
DI 10.1166/jbn.2013.1564
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 211NS
UT WOS:000323915600001
PM 23621012
DA 2018-10-20
ER

PT J
AU Steffens, D
   Lersch, M
   Rosa, A
   Scher, C
   Crestani, T
   Morais, MG
   Costa, JAV
   Pranke, P
AF Steffens, D.
   Lersch, M.
   Rosa, A.
   Scher, C.
   Crestani, T.
   Morais, M. G.
   Costa, J. A. V.
   Pranke, P.
TI A New Biomaterial of Nanofibers with the Microalga Spirulina as
   Scaffolds to Cultivate with Stem Cells for Use in Tissue Engineering
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Tissue Engineering; Stem Cells; Nanotechnology; Spirulina; Scaffolds
ID IN-VITRO CHARACTERIZATION; ELECTROSPUN NANOFIBERS; POLYLACTIDE FOAMS;
   GROWTH; REGENERATION; BIOGLASS(R); REPLACEMENT; DEGRADATION;
   FABRICATION; COMPOSITES
AB The association of stem cells (SCs) with biomaterials promises to be the protagonist for future regenerative medicine in the treatment of tissue and organ lesions. Stem cells were cultivated in scaffolds constructed by the electrospinning technique, using poly-D,L-lactic acid (PDLLA) associated or not with Spirulina biomass (PDLLA/Sp), which has bioactive components of interest for tissue engineering (TE). Physicochemical analyses were performed, such as morphology, fiber diameter, degradability, residual solvent, roughness, contact angle with water, among others. SCs adhesion, proliferation and scaffold cytotoxicity were also evaluated. Nanofibers without beads and with characteristics similar to the natural extracellular matrix (ECM) in terms of mechanical and topographical properties were obtained. In biological tests it was found that SCs adhered more and had greater viability in the PDLLA/Sp molds, when compared with the PDLLA scaffolds. The scaffolds were shown to be atoxic for the SCs. It can be concluded that the scaffolds developed in this work have the characteristics to be a new biomaterial suitable for use in TE.
C1 [Steffens, D.; Lersch, M.; Rosa, A.; Scher, C.; Pranke, P.] Univ Fed Rio Grande do Sul, Hematol & Stem Cell Lab, Fac Pharm, BR-90046900 Porto Alegre, RS, Brazil.
   [Steffens, D.; Rosa, A.; Pranke, P.] Univ Fed Rio Grande do Sul, Postgrad Course Mat Sci, BR-90046900 Porto Alegre, RS, Brazil.
   [Crestani, T.] Univ Fed Rio Grande do Sul, Postgrad Course Neurosci, BR-90046900 Porto Alegre, RS, Brazil.
   [Morais, M. G.; Costa, J. A. V.] Fed Univ Rio Grande, Coll Chem & Food Engn, Lab Biochem Engn, Rio Grande, RS, Brazil.
RP Pranke, P (reprint author), Univ Fed Rio Grande do Sul, Hematol & Stem Cell Lab, Fac Pharm, BR-90046900 Porto Alegre, RS, Brazil.
EM dani_ste@hotmail.com
RI Costa, Jorge/L-3999-2013; Morais, Michele/J-7539-2015
OI Costa, Jorge/0000-0001-8042-7642; Morais, Michele/0000-0001-8920-2896
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico);
   FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul);
   Stem Cell Research Institute (IPCT)
FX Thanks to Felipe Kessler and Professor Daniel Eduardo Weibel, both from
   the Laboratory of Photochemistry and Surfaces (LAFOS). Thanks to Dr.
   Roland Fleck for the confocal analysis to verify the presence of
   Spirulina in the PDLLA/Sp scaffolds. Thanks also to the CNPq (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico), FAPERGS (Fundacao
   de Amparo a Pesquisa do Estado do Rio Grande do Sul) and Stem Cell
   Research Institute (IPCT) for financial support.
CR Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Andrews KD, 2007, BIOMATERIALS, V28, P1014, DOI 10.1016/j.biomaterials.2006.10.014
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Catiker E, 2000, POLYM INT, V49, P728, DOI 10.1002/1097-0126(200007)49:7<728::AID-PI443>3.0.CO;2-3
   de Morais MG, 2010, BIORESOURCE TECHNOL, V101, P2872, DOI 10.1016/j.biortech.2009.11.059
   EMISIG E. M. I. S. I. G., 2010, PROT ACT CRIT PAC AE
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Huss Fredrik Rm, 2008, Organogenesis, V4, P195
   Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017
   Jin L, 2012, J BIOMED NANOTECHNOL, V8, P1, DOI 10.1166/jbn.2012.1360
   Ju Xiu-li, 2005, Zhonghua Er Ke Za Zhi, V43, P499
   Karkos P. D., 2008, EVID BASED COMPLEMEN
   Khan Z, 2005, CURR PHARM BIOTECHNO, V6, P373, DOI 10.2174/138920105774370607
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Kulshreshtha A, 2008, CURR PHARM BIOTECHNO, V9, P400, DOI 10.2174/138920108785915111
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li XQ, 2010, COLLOID SURFACE B, V75, P418, DOI 10.1016/j.colsurfb.2009.09.014
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Navarro M, 2006, ADV POLYM SCI, V200, P209, DOI 10.1007/12_068
   Nelson D. L., 2002, FOTOSSINTESE CAPTURA, P975
   Pohanish R. P., 2012, SITTIGS HDB TOXIC HA, P3
   Pohlmann A. R., 2008, TOPICOS NANOCIENCIA, VI, P243
   Qureshi MA, 1996, IMMUNOPHARM IMMUNOT, V18, P465, DOI 10.3109/08923979609052748
   Qureshi MA, 1996, IMMUNOPHARM IMMUNOT, V18, P457, DOI 10.3109/08923979609052747
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Saad B, 2006, EVID-BASED COMPL ALT, V3, P93, DOI 10.1093/ecam/nel002
   Saad B., 2003, INTRO POLYM BIOMATER, VI, P263
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sui G, 2007, J BIOMED MATER RES A, V82A, P445, DOI 10.1002/jbm.a.31166
   Teebken OE, 2009, VASA-J VASCULAR DIS, V38, P60, DOI 10.1024/0301-1526.38.1.60
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thomas V, 2006, J BIOMAT SCI-POLYM E, V17, P969, DOI 10.1163/156856206778366022
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Vunjak-Novakovic G., 2004, BIOPOLYM METHODS TIS, V238, P131
   Wang C, 2009, POLYMER, V50, P6100, DOI 10.1016/j.polymer.2009.10.025
   Wei JD, 2012, J BIOMATER APPL, V26, P963, DOI 10.1177/0885328210390401
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zanatta G, 2012, J BIOMED NANOTECHNOL, V8, P211, DOI 10.1166/jbn.2012.1382
   Zhao GQ, 2009, BIOMATERIALS, V30, P3241, DOI 10.1016/j.biomaterials.2009.02.027
   Zhao L, 2008, J BIOMED MATER RES B, V87B, P26, DOI 10.1002/jbm.b.31060
   Zheng L, 2009, TISSUE ENG PT A, V15, P2145, DOI 10.1089/ten.tea.2008.0268
NR 50
TC 26
Z9 26
U1 2
U2 36
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2013
VL 9
IS 4
BP 710
EP 718
DI 10.1166/jbn.2013.1571
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 211NS
UT WOS:000323915600022
PM 23621033
DA 2018-10-20
ER

PT J
AU Yamada, S
   Yoshizawa, Y
   Kawakubo, A
   Ikeda, T
   Yanagiguchi, K
   Hayashi, Y
AF Yamada, Shizuka
   Yoshizawa, Yuu
   Kawakubo, Atsushi
   Ikeda, Takeshi
   Yanagiguchi, Kajiro
   Hayashi, Yoshihiko
TI Early gene and protein expression associated with osteoblast
   differentiation in response to fish collagen peptides powder
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Fish collagen peptide; Osteoblast differentiation; Alkaline phosphatase
   activity; Real-time PCR; Western blot analysis
ID BONE-MARROW-CELLS; I COLLAGEN; MATRIX; OSTEOPONTIN; HYDROLYSATE;
   GELATIN; CULTURE; KINASE; BETA
AB This study was designed to investigate the biological effects of fish collagen peptide (FCP) on human osteoblasts. Human osteoblasts were treated with 0.1% FCP, which was the optimal concentration confirmed by the increase in alkaline phosphatase activity. After one, three, five and seven days of culture, the number of FCP-treated cells increased significantly compared with untreated cells. In a real-time PCR analysis, the expression of osteocalcin, osteopontin, BMP-2 and integrin beta 3 mRNAs in FCP-treated cells showed increases compared with untreated cells after three days of culture. After seven days of culture, the expression levels of osteopontin and integrin beta 3 were still higher in the FCP-treated cells than in untreated cells. The production of osteocalcin, osteopontin and integrin beta 3 proteins in FCP-treated cells also showed increases after seven days of culture. Furthermore, FCP accelerated matrix mineralization in the cultures. The present study indicates the potential utility of FCP as a biomaterial.
C1 [Yamada, Shizuka; Yoshizawa, Yuu; Kawakubo, Atsushi; Ikeda, Takeshi; Yanagiguchi, Kajiro; Hayashi, Yoshihiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan.
   [Kawakubo, Atsushi] Motohara Dent Clin, Nagasaki 8528133, Japan.
RP Yamada, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Sakamoto 1-7-1, Nagasaki 8528588, Japan.
EM shiduka@nagasaki-u.ac.jp
CR Blum JS, 2001, J CELL BIOCHEM, V80, P532, DOI 10.1002/1097-4644(20010315)80:4<532::AID-JCB1007>3.0.CO;2-B
   Chellaiah MA, 2003, CALCIFIED TISSUE INT, V72, P197, DOI 10.1007/s00223-002-1025-6
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Deal CL, 1999, RHEUM DIS CLIN N AM, V25, P379, DOI 10.1016/S0889-857X(05)70074-0
   EASTOE JE, 1957, BIOCHEM J, V65, P363, DOI 10.1042/bj0650363
   Giraud-Guille MM, 2000, BIOMATERIALS, V21, P899, DOI 10.1016/S0142-9612(99)00244-6
   Guillerminet F, 2010, BONE, V46, P827, DOI 10.1016/j.bone.2009.10.035
   Kasugai S, 1992, J CELL PHYSL, V152, P457
   Koyama Y, 2001, J NUTR SCI VITAMINOL, V47, P84
   Martinovic S, 2006, ARCH HISTOL CYTOL, V69, P23, DOI 10.1679/aohc.69.23
   Mizuno M, 2003, J CELL BIOCHEM, V88, P1112, DOI 10.1002/jcb.10466
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moskowitz RW, 2000, SEMIN ARTHRITIS RHEU, V30, P87, DOI 10.1053/sarh.2000.9622
   NAGATA T, 1991, BIOCHEM J, V274, P513, DOI 10.1042/bj2740513
   PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4
   Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tsuchiya S, 2008, CELL TISSUE RES, V331, P447, DOI 10.1007/s00441-007-0532-1
   Ueno A, 2006, J MED INVESTIG, V53, P297, DOI 10.2152/jmi.53.297
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Xiao Y, 2004, CELL TRANSPLANT, V13, P15, DOI 10.3727/000000004772664851
   Yamada S, 2003, J BIOMED MATER RES A, V66A, P500, DOI 10.1002/jbm.a.10009
   Yamada S, 2007, J BIOMED MATER RES A, V83A, P290, DOI 10.1002/jbm.a.31234
   Zhao HB, 2005, J BONE MINER RES, V20, P2116, DOI 10.1359/JBMR.050724
NR 27
TC 9
Z9 9
U1 1
U2 12
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD APR
PY 2013
VL 32
IS 2
BP 233
EP 240
DI 10.4012/dmj.2012-188
PG 8
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 205TJ
UT WOS:000323467400005
PM 23538758
OA Bronze
DA 2018-10-20
ER

PT J
AU Schulz, S
   Steinberg, T
   Beck, D
   Tomakidi, P
   Accardi, R
   Tommasino, M
   Reinhard, T
   Eberwein, P
AF Schulz, Simon
   Steinberg, Thorsten
   Beck, David
   Tomakidi, Pascal
   Accardi, Rosita
   Tommasino, Massimo
   Reinhard, Thomas
   Eberwein, Philipp
TI Generation and evaluation of a human corneal model cell system for
   ophthalmologic issues using the HPV16 E6/E7 oncogenes as uniform
   immortalization platform
SO DIFFERENTIATION
LA English
DT Article
DE Human cornea; Immortalization; Homeostasis; Corneal model cell system;
   Human papillomavirus type 16
ID HUMAN FORESKIN KERATINOCYTES; EPITHELIAL-CELLS; CHROMOSOMAL-ABERRATIONS;
   ENDOTHELIAL-CELLS; STEM-CELLS; IN-VITRO; MESENCHYMAL TRANSITION;
   CYTOGENETIC ANALYSIS; EXTENDED LIFE; NORMAL GROWTH
AB The present study aimed at employing the human papillomavirus type 16 (HPV16) E6/E7 gene platform, to create a uniform authentic in vitro model cell system of the human cornea for ophthalmologic issues and here especially for prospective biomaterial evaluations for therapeutic regenerative approaches. Therefore, HPV16 E6/E7 genes were employed as uniform platform to immortalize primary human corneal keratinocytes (IHCK), fibroblasts (IHCF), and endothelial (IHCE) cells. qPCR revealed that E6/E7 mRNA transcription persisted at rising passages and FISH detection of the chromosome portfolio 1, 8, 10 and 18 showed fairly the disomic cytogenetic status. Hot spot passages proved oscillation of aneuploidies in the entire passage spectrum under study, while hot spot aneuploidies annotated prevalence for distinct chromosomes. Though IIF revealed general endurance, tissue-innate corneal biomarkers were modulated, i.e. expressed in a temporal-confluence, temporal-spatial or passage-dependent manner. In summary, by the fairly normal chromosomal status, and expression of tissue-innate biomarkers, we created for the first time a uniform authentic in vitro model cell system of the human cornea, by application of the HPV16 E6/E7 immortalization platform only. This system renders a precious tool for prospective iterative in vitro studies on issues such as corneal tissue homeostasis, pharmaceutical generics, and/or evaluation of new biomaterials for clinical corneal applications. (C) 2013 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.
C1 [Schulz, Simon; Steinberg, Thorsten; Beck, David; Tomakidi, Pascal] Univ Med Ctr Freiburg, Sch Dent, Dept Oral Biotechnol, D-79106 Freiburg, Germany.
   [Accardi, Rosita; Tommasino, Massimo] Int Agcy Res Canc, Infect & Canc Biol Grp, F-69372 Lyon 08, France.
   [Reinhard, Thomas; Eberwein, Philipp] Univ Hosp Freiburg, Univ Eye Hosp, D-79106 Freiburg, Germany.
RP Steinberg, T (reprint author), Univ Med Ctr Freiburg, Sch Dent, Dept Oral Biotechnol, Hugstetterstr 55, D-79106 Freiburg, Germany.
EM thorsten.steinberg@uniklinik-freiburg.de
RI Schulz, Simon/A-2428-2013
OI Schulz, Simon/0000-0002-3747-3093
FU Deutsche Forschungsgemeinschaft/DFG [TO 198/10-1, EB 478/1-1]
FX This work has been supported by a Grant from the Deutsche
   Forschungsgemeinschaft/DFG, Reference numbers TO 198/10-1 and EB 478/1-1
   to Pascal Tomakidi and Philipp Eberwein.
CR Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x
   ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614
   BADEN HP, 1987, J INVEST DERMATOL, V89, P574, DOI 10.1111/1523-1747.ep12461235
   Bednarz J, 2000, ACTA OPHTHALMOL SCAN, V78, P130, DOI 10.1034/j.1600-0420.2000.078002130.x
   Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Budak MT, 2005, J CELL SCI, V118, P1715, DOI 10.1242/jcs.02279
   Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277
   Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000
   DURST M, 1987, ONCOGENE, V1, P251
   Eberwein P, 2011, EUR J CELL BIOL, V90, P1029, DOI 10.1016/j.ejcb.2011.08.005
   Engelmann K, 2001, EXP EYE RES, V73, P9, DOI 10.1006/exer.2001.0993
   Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868
   Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Guo AH, 2009, EXP DERMATOL, V18, P720, DOI 10.1111/j.1600-0625.2009.00900.x
   HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x
   KAHN CR, 1993, INVEST OPHTH VIS SCI, V34, P3429
   Kim Hyun-Ju, 2006, Korean J Ophthalmol, V20, P47
   Kimura R, 2010, GENES CELLS, V15, P385, DOI 10.1111/j.1365-2443.2010.01387.x
   Lake SL, 2011, INVEST OPHTH VIS SCI, V52, P5598, DOI 10.1167/iovs.10-6934
   Lenz CF, 1998, LARYNGOSCOPE, V108, P917, DOI 10.1097/00005537-199806000-00023
   Li Q, 2003, J LEUKOCYTE BIOL, V74, P412, DOI 10.1189/jlb.0801757
   Lu L, 2001, EXP BIOL MED, V226, P653
   Mensink HW, 2011, BRIT J OPHTHALMOL, V95, P424, DOI 10.1136/bjo.2010.181289
   Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255
   Offord EA, 1999, INVEST OPHTH VIS SCI, V40, P1091
   PATEL BKR, 1993, MOL CARCINOGEN, V8, P7, DOI 10.1002/mc.2940080105
   PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392
   Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310
   POPESCU NC, 1990, CANCER RES, V50, P1316
   Rao K, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-15
   Reichl S, 2004, BRIT J OPHTHALMOL, V88, P560, DOI 10.1136/bjo.2003.028225
   Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528
   Roesch-Ely M, 2006, DIFFERENTIATION, V74, P622, DOI 10.1111/j.1432-0436.2006.00099.x
   Ryan DG, 2003, INVEST OPHTH VIS SCI, V44, P4255, DOI 10.1167/iovs.03-0578
   Schneider M, 2008, J MOL MED-JMM, V86, P507, DOI 10.1007/s00109-007-0301-3
   Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x
   SODER AI, 1995, CANCER RES, V55, P5030
   STEINBERG ML, 1985, J CELL PHYSIOL, V123, P117, DOI 10.1002/jcp.1041230117
   Sun TT, 2010, NATURE, V463, pE10, DOI 10.1038/nature08805
   Veiga LCS, 2003, GENET MOL BIOL, V26, P121, DOI 10.1590/S1415-47572003000200003
   WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2112
   WOODWORTH CD, 1989, J VIROL, V63, P159
   WYNFORDTHOMAS D, 1990, MOL CELL BIOL, V10, P5365, DOI 10.1128/MCB.10.10.5365
   Yokoi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029677
   Zhang Z., 2010, ADV BIOINFORMATICS, V2010
   Zieske James, 2004, HUMAN CORNEAL ORGANO
   Zorn-Kruppa M, 2005, ATLA-ALTERN LAB ANIM, V33, P37
NR 50
TC 4
Z9 4
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4681
J9 DIFFERENTIATION
JI Differentiation
PD APR-JUN
PY 2013
VL 85
IS 4-5
BP 161
EP 172
DI 10.1016/j.diff.2013.06.001
PG 12
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 197KV
UT WOS:000322851000005
PM 23811495
DA 2018-10-20
ER

PT J
AU Espallargas, N
   Aune, RE
   Torres, C
   Papageorgiou, N
   Munoz, AI
AF Espallargas, N.
   Aune, R. E.
   Torres, C.
   Papageorgiou, N.
   Munoz, A. I.
TI Bulk metallic glasses (BMG) for biomedical applications-A tribocorrosion
   investigation of Zr55Cu30Ni5Al10 in simulated body fluid
SO WEAR
LA English
DT Article; Proceedings Paper
CT 19th International Conference on Wear of Materials
CY APR 14-18, 2013
CL Portland, OR
DE Biotribology; Tribocorrosion; Bulk metallic glasses
ID ROOM-TEMPERATURE; BEHAVIOR; SURFACES; ALLOYS
AB The acceptability of implants by the human body is a very important requirement in the field of biomaterials. Implants should not cause diseases or other complications to the patients. Further, biomaterials should possess enough mechanical strength, corrosion and wear resistance in order to withstand the harsh conditions of the body environment. If this is not achieved, degradation of the implant occurs and secondary effects take place leading to carcinogenicity, hypersensitivity and inflammation. In the present work a new alloy composition (bulk metallic glass) as potential biomaterial for implant bearing material has been studied. The bulk metallic glass (BMG) is a disordered solid without the long-range order of crystalline materials. This characteristic makes them free of defects such as grain boundaries, dislocations and voids. Knowledge regarding their electrochemical and tribocorrosion performance is very limited. Thus, the assessment of metallic glasses as potentially applicable in situations where wear and corrosion act simultaneously is still premature. The electrochemical and tribocorrosion performance of a Zr-based BMG has been evaluated in different solutions with and without the presence of protein. The results show that the BMG material with amorphous structure has the largest wear rates in all electrolytes tested (NaCl, phosphate buffer solution and phosphate buffer solution with protein). This is due to the passivation character of the alloy leading to wear accelerated corrosion. The amorphous structure of the alloy promotes the formation of an amorphous oxide film. On the other hand, the crystalline structure of the BMG shows negligible wear rate due to a nanocrystallization process or the presence of a new phase (Zr2Cu) leading to lack of passivation and thus minimizing wear accelerated corrosion. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Espallargas, N.; Aune, R. E.; Torres, C.; Papageorgiou, N.] NTNU, Dept Engn Design & Mat, N-7491 Trondheim, Norway.
   [Espallargas, N.; Aune, R. E.; Torres, C.; Papageorgiou, N.] NTNU, Dept Mat Sci & Engn, N-7491 Trondheim, Norway.
   [Torres, C.; Munoz, A. I.] Univ Politecn Valencia, Dept Ingn Quim & Nucl, E-46071 Valencia, Spain.
RP Espallargas, N (reprint author), NTNU, Dept Engn Design & Mat, N-7491 Trondheim, Norway.
EM nuria.espallargas@ntnu.no
RI BAI, JIE/D-7448-2016; Espallargas, Nuria/F-9346-2016; igual munoz,
   anna/K-7996-2014
OI igual munoz, anna/0000-0002-1372-621X
FU Erasmus mundus; ARGO
FX The authors would like to thank the Erasmus mundus and the ARGO global
   programs for funding the stay of the master candidate C. Torres at NTNU.
   Tohoku University (Japan) is also acknowledged for the production of the
   BMG materials. Yolanda Pena Lopez, MD (Hospital Vall D'Hebron,
   Barcelona, Spain) is acknowledged for the valuable information regarding
   protein concentration in the human body.
CR [Anonymous], 2011, LIFE EXPECTANCY INCR
   Bauer TW, 2002, CLIN ORTHOP RELAT R, P138, DOI 10.1097/01.blo.00000038467.05771.90
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Deng YF, 2004, ULTRAMICROSCOPY, V98, P201, DOI 10.1016/j.ultramic.2003.08.013
   Engester L., 2011, ANN REPORT NORWEGIAN
   Espallargas N, 2011, WEAR, V270, P464, DOI 10.1016/j.wear.2010.12.008
   Fu XY, 2001, WEAR, V250, P409, DOI 10.1016/S0043-1648(01)00605-6
   Garellick G., 2010, ANN REPORT SWEDISH H
   Gorman S.P., 2002, ANTIMICROBIAL BIOMAT
   Horbett Thomas A., 1996, P133
   Huang L, 2011, ACTA BIOMATER, V7, P395, DOI 10.1016/j.actbio.2010.08.002
   Kawashima A, 2012, MAT SCI ENG A-STRUCT, V542, P140, DOI 10.1016/j.msea.2012.02.047
   Kluess D, 2007, MED ENG PHYS, V29, P465, DOI 10.1016/j.medengphy.2006.07.001
   Landolt D., 2007, CORROSION SURFACE CH
   Le M, 2011, J ELECTROCHEM SOC, V158, pE45, DOI 10.1149/1.3561636
   Lin YC, 2012, WEAR, V280, P5, DOI 10.1016/j.wear.2012.01.014
   Migliaresi C., 2004, BIOMATERIALS SCI INT
   Passuti N, 2009, ORTHOP TRAUMATOL-SUR, V95, pS27, DOI 10.1016/j.otsr.2009.04.003
   Rothman Institute Orthopaedics, TOT HIP REPL
   STECKELBERG JM, 2000, INFECT ASS INDWELLIN
   Stojadinovic J, 2009, TRIBOL INT, V42, P575, DOI 10.1016/j.triboint.2008.04.009
   Suegama P. H., 2007, NEW RES ELECTROCHEMI, P113
   Tao PJ, 2010, INT J MIN MET MATER, V17, P327, DOI 10.1007/s12613-010-0313-9
   Tsutsumi Y, 2009, MAT SCI ENG C-BIO S, V29, P1702, DOI 10.1016/j.msec.2009.01.016
   Vidal CV, 2008, CORROS SCI, V50, P1954, DOI 10.1016/j.corsci.2008.04.002
   Wright T.M., 2001, IMPLANT WEAR TOTAL J, P61
   Wright T.M., 2001, IMPLANT WEAR TOTAL J, P31
   Yoshimi K, 2005, MATER TRANS, V46, P2870, DOI 10.2320/matertrans.46.2870
   Zander D, 2004, MAT SCI ENG A-STRUCT, V375, P53, DOI 10.1016/j.msea.2003.10.230
   Zhu SL, 2012, J MECH BEHAV BIOMED, V13, P166, DOI 10.1016/j.jmbbm.2012.04.011
NR 30
TC 21
Z9 21
U1 5
U2 42
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
EI 1873-2577
J9 WEAR
JI Wear
PD APR-MAY
PY 2013
VL 301
IS 1-2
SI SI
BP 271
EP 279
DI 10.1016/j.wear.2012.12.053
PG 9
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 193JG
UT WOS:000322555500040
DA 2018-10-20
ER

PT J
AU Lepore, S
   Milillo, L
   Trotta, T
   Castellani, S
   Porro, C
   Panaro, MA
   Santarelli, A
   Bambini, F
   Lo Muzio, L
   Conese, M
   Maffione, AB
AF Lepore, S.
   Milillo, L.
   Trotta, T.
   Castellani, S.
   Porro, C.
   Panaro, M. A.
   Santarelli, A.
   Bambini, F.
   Lo Muzio, L.
   Conese, M.
   Maffione, A. B.
TI ADHESION AND GROWTH OF OSTEOBLAST-LIKE CELLS ON LASER-ENGINEERED POROUS
   TITANIUM SURFACE: EXPRESSION AND LOCALIZATION OF N-CADHERIN AND
   beta-CATENIN
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE titanium surface; MG63; biomaterials; dental implants
ID ORAL IMPLANT SURFACES; DIFFERENTIATION; BIOMATERIAL; TOPOGRAPHY;
   PHENOTYPE; ROUGHNESS; RESPONSES; STRAINS; MODEL
AB Response of different types of cells on biomaterials is crucial for the applications of tissue engineering and regenerative medicine. It is recognized that cell behaviour depends largely on material surface characteristics. The purpose of this study was to define the biologic response of MG63 cells to the innovative patented surface SYNTHEGRA (R). MG63 morphology and distribution on the three different titanium disk surfaces (sandblasted, smooth, and laser-treated) were evaluated by microscopy analysis after staining with hematoxylin and eosin. Cell adhesion was determined by crystal violet assay at 48 h while proliferation and cytotoxicity were performed by MTT assay at 24, 48, 72 and 240 h. The expression and localization of N-cadherin and beta-catenin were studied by immunfluorescence and confocal microscopy. At 48 h the adhesion was similar in all titanium surfaces, no difference in cell viability were observed in all titanium disks when compared with controls, while the cell growth on laser-treated disks was significantly higher at 240 h than at 24 and 72 h. Morphological analysis show that cells are aligned along the grooves and inside the cavities. beta-catenin signal appeared more diffuse and localized underneath the cell membrane, while N-cadherin signal was fainter in cells grown on SYNTHEGRA (R) surface. This work put into evidence the performance of newly designed laser-micromachined surface for adhesion, growth and distribution of human osteoblast-like cells. SYNTHEGRA (R) surface inducing modification of N-cadherin and beta-catenin expression and localization, are suggestive of cells undergoing differentiation towards osteocytes and could be particularly suited for immediate load implant procedures.
C1 [Lepore, S.] IRCCS CROB, Lab Preclin & Translat Res, Rionero In Vulture, Italy.
   [Milillo, L.; Trotta, T.; Porro, C.; Lo Muzio, L.; Maffione, A. B.] Univ Foggia, Dept Clin & Expt Med, I-71122 Foggia, Italy.
   [Castellani, S.; Conese, M.] Univ Foggia, Dept Med & Surg Sci, I-71122 Foggia, Italy.
   [Panaro, M. A.] Univ Bari, Dept Basic Med Sci, I-70121 Bari, Italy.
   [Santarelli, A.; Bambini, F.] Univ Ancona, Dept Clin & Dent Sci, I-60128 Ancona, Italy.
RP Lo Muzio, L (reprint author), Univ Foggia, Dept Clin & Expt Med, Via Rovelli 48, I-71122 Foggia, Italy.
EM l.lomuzio@unifg.it
RI Santarelli, Andrea/P-6310-2014
OI Santarelli, Andrea/0000-0003-4218-3354; castellani,
   stefano/0000-0003-0201-7298; PORRO, CHIARA/0000-0002-7526-6968
CR Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Berardi D, 2009, INT J IMMUNOPATH PH, V22, P125, DOI 10.1177/039463200902200114
   Browne M, 2000, BIOMATERIALS, V21, P385, DOI 10.1016/S0142-9612(99)00200-8
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Cei S, 2011, IMPLANT DENT, V20, P285, DOI 10.1097/ID.0b013e31821bfa9f
   Cretel E, 2008, CELL MOL BIOENG, V1, P5, DOI 10.1007/s12195-008-0009-7
   Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016
   Di Palma F, 2005, BIOMATERIALS, V26, P4249, DOI 10.1016/j.biomaterials.2004.10.041
   Di Palma F, 2003, BIOMATERIALS, V24, P3139, DOI 10.1016/S0142-9612(03)00152-2
   Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198
   Glauser R., 2011, CLIN IMPLANT DENT R, V10, P1708
   Hansson S, 1999, J BIOMECH, V32, P829, DOI 10.1016/S0021-9290(99)00058-5
   Head WC, 1995, CLIN ORTHOP RELAT RE, P85
   Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013
   Kawaguchi J, 2001, J BONE MINER RES, V16, P260, DOI 10.1359/jbmr.2001.16.2.260
   Linares A, 2011, CLIN ORAL IMPLAN RES, V22, P38, DOI 10.1111/j.1600-0501.2010.01988.x
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Mangano C, 2009, J OSSEOINTEGRATION, V1, P3
   Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030
   Marie PJ, J CELL PHYSL, V190, P297
   Puleo David A, 2006, Dent Clin North Am, V50, P323, DOI 10.1016/j.cden.2006.03.001
   Ricci IL, 1991, BONE BIOMATERIAL INT, P334
   Rosa AL, 2009, CLIN ORAL IMPLAN RES, V20, P472, DOI 10.1111/j.1600-0501.2008.01662.x
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Stangl R., 2001, European Cells & Materials, V2, P1
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
   Zinger O, 2005, BIOMATERIALS, V26, P37
NR 32
TC 7
Z9 7
U1 0
U2 15
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD APR-JUN
PY 2013
VL 27
IS 2
BP 531
EP 541
PG 11
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA 189TH
UT WOS:000322290700024
PM 23830402
DA 2018-10-20
ER

PT J
AU Davis, NF
   Mooney, R
   Piterina, AV
   Callanan, A
   Flood, HD
   McGloughlin, TM
AF Davis, Niall F.
   Mooney, Rory
   Piterina, Anna V.
   Callanan, Anthony
   Flood, Hugh D.
   McGloughlin, Tim M.
TI Cell-seeded extracellular matrices for bladder reconstruction: An ex
   vivo comparative study of their biomechanical properties
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Biomechanical properties; Extracellular matrix; Urinary bladder matrix;
   Urinary bladder reconstruction; Urinary bladder augmentation; Bioreactor
ID BIAXIAL MECHANICAL-BEHAVIOR; URINARY-TRACT; CYSTOPLASTY; SCAFFOLDS;
   BIOREACTOR
AB Purpose: Autogenous ileal tissue remains the gold-standard biomaterial for bladder replacement purposes; however, cell-seeded extracellular matrix (ECM) scaffolds have shown promise. Although the biological advantages of cell-seeded ECMs in urological settings are well documented, there is a paucity of data available on their biomechanical properties. In this study, the biomechanical properties of cell-seeded ECMs are compared with autogenous ileal tissue.
   Methods: Human urothelial cells (UCs) and smooth muscle cells (SMCs) were obtained by bladder biopsy and cultured onto porcine urinary bladder matrix (UBM) scaffolds under dynamic and static growth conditions for 14 days. The biomechanical properties of cell-seeded UBM (n = 12), and porcine ileum (n = 12) were determined with uni-axial tensile testing protocols and compared with stress-strain curves. In addition, their biomechanical properties were compared with porcine bladder tissue (n = 12) and unseeded UBM (n = 12).
   Results: There were significant differences in the biomechanical properties of each biomaterial assessed. Strain to failure occurred at 92 +/- 24% for dynamically cultured cell-seeded UBM compared to 42.2 +/- 5.20% for ileal tissue (p<0.01). Values for linear stiffness at 30% strain were significantly lower in dynamically cultured cell-seeded UBM compared to Heal tissue (0.36 +/- 0.14 MPa versus 0.67 +/- 0.32 MPa respectively, p<0.01). Bladder tissue remained the most distensible biomaterial throughout, with linear stiffness measuring 0.066 +/- 0.034 MPa at 30% strain.
   Conclusions: Dynamically cultured cell-seeded ECMs are biomechanically superior to ileal tissue for bladder replacement purposes. Additional comparative in vivo studies will be necessary before their role as a reliable alternative is clearly established.
C1 [Davis, Niall F.; Flood, Hugh D.] Midwestern Reg Hosp, Dept Urol, Limerick, Ireland.
   [Davis, Niall F.; Mooney, Rory; Piterina, Anna V.; McGloughlin, Tim M.] Univ Limerick, Dept Mech & Aeronaut Engn & MSSI, Ctr Appl Biomed Engn Res, Limerick, Ireland.
RP Davis, NF (reprint author), Midwestern Reg Hosp, Dept Urol, Dooradoyle, Limerick, Ireland.
EM nialldavis2001@yahoo.com
RI McGloughlin, Tim/G-9526-2015; McGloughlin, Tim/D-3639-2009
OI McGloughlin, Tim/0000-0002-6632-2075; McGloughlin,
   Tim/0000-0002-6632-2075; McGloughlin, Tim/0000-0003-3519-8988
CR Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Davis NF, 2011, J MECH BEHAV BIOMED, V4, P375, DOI 10.1016/j.jmbbm.2010.11.005
   Davis NF, 2010, J UROLOGY, V184, P2246, DOI 10.1016/j.juro.2010.07.038
   Davis NF, 2011, UROLOGY, V78, P954, DOI 10.1016/j.urology.2011.06.036
   Davis NF, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.11.036
   FLOOD HD, 1995, NEUROUROL URODYNAM, V14, P297, DOI 10.1002/nau.1930140402
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Kanematsu A, 2007, INT J UROL, V14, P673, DOI 10.1111/j.1442-2042.2007.01768.x
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Arteaga JL, 2012, NEUROUROL URODYNAM, V31, P156, DOI 10.1002/nau.21187
   Parekh A, 2010, J BIOMECH, V43, P1708, DOI 10.1016/j.jbiomech.2010.02.034
   Pradhan S, 2010, REGEN MED, V5, P961, DOI 10.2217/RME.10.61
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sievert KD, 2000, WORLD J UROL, V18, P19, DOI 10.1007/s003450050004
   Turner A, 2011, EUR UROL, V59, P447, DOI 10.1016/j.eururo.2010.12.004
   Wallis MC, 2008, TISSUE ENG PT A, V14, P339, DOI 10.1089/tea.2006.0398
   Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005
NR 26
TC 5
Z9 5
U1 0
U2 11
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD APR
PY 2013
VL 36
IS 4
BP 251
EP 258
DI 10.5301/ijao.5000194
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 170ZQ
UT WOS:000320894500003
PM 23446760
DA 2018-10-20
ER

PT J
AU Kolodzinska, A
   Kutarski, A
   Kozlowska, M
   Grabowski, M
   Marchel, H
   Drela, N
   Opolski, G
AF Kolodzinska, Agnieszka
   Kutarski, Andrzej
   Kozlowska, Marta
   Grabowski, Marcin
   Marchel, Halina
   Drela, Nadzieja
   Opolski, Grzegorz
TI Biodegradation of the Outer Silicone Insulation of Endocardial Leads
SO CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY
LA English
DT Article
DE cardiovasular implantable electronic device infection; endocardial lead
   abrasion; endocardial lead damage; infective endocarditis; silicone
   biodegradation
ID VOICE PROSTHESES; MICROBIAL COLONIZATION; DEVICE INFECTIONS;
   BIOMATERIAL; MANAGEMENT; MACROPHAGES; DIAGNOSIS; IMPLANTS; SURFACES;
   ADHESION
AB Background-Silicone catheter insulation, larynx prostheses undergo biodegradation. The aims of the study were to verify the conviction that outer silicone lead insulation is biostable and inert in addition to determining the role of macrophages (M) and Staphylococcus aureus (S aureus) strains in the silicone lead insulation degradation.
   Methods and Results-Leads removed from 8 patients because of infective and noninfective indications were analyzed with stereomicroscope and classified according to Banacha abrasion classification, and additional analysis using scanning electron microscope was performed. The examination revealed excavations of different shape and depth in the abraded areas. Fresh silicone-insulated lead was cut into fragments. The fragments were cultured with RAW 264.7 macrophage cell line for 9 weeks. Additional lead fragments were placed with S aureus strains: ATCC 25923, ATCC 29213, and K9328H. Lead fragments were also cocultured with the bacterial strains and RAW M. In scanning electron microscope analysis, diminution in silicone was observed. All S aureus strains provoked insulation damage after 9 weeks. The lowest level of degradation of insulation concerned ATCC 25923. Silicone lead fragments in cocultures presented a further gone level of silicone biodegradation.
   Conclusions-S aureus, macrophages separately, and S aureus and macrophages cocultures initiate the biodegradation of silicone insulation. Differences in the level of biodegradation between strains of S aureus were observed, with the most aggressive reaction toward silicone visible in the cocultures. In vivo silicone biodegradation is initiated by tearing among surfaces of the lead insulation, macrophages may be the crucial cells for the process that may be aggravated by pathogen colonization.
C1 [Kolodzinska, Agnieszka; Kozlowska, Marta; Grabowski, Marcin; Opolski, Grzegorz] Med Univ Warsaw, Dept Cardiol, PL-02097 Warsaw, Poland.
   [Marchel, Halina] Med Univ Warsaw, Dept Microbiol, PL-02097 Warsaw, Poland.
   [Drela, Nadzieja] Univ Warsaw, Fac Biol, Warsaw, Poland.
   [Kutarski, Andrzej] Med Univ Lublin, Dept Cardiol, Lublin, Poland.
RP Kolodzinska, A (reprint author), Med Univ Warsaw, Dept Cardiol, 1A Banacha St, PL-02097 Warsaw, Poland.
EM aa.kolodzinska@wp.pl
RI Marchel, Halina/T-2062-2018; Grabowski, Marcin/M-3872-2018
OI Marchel, Halina/0000-0002-6754-3742; Grabowski,
   Marcin/0000-0003-3306-0301; Skowronska, Marta/0000-0002-0826-7821
FU Medical University of Warsaw
FX This work was supported by internal funds of Medical University of
   Warsaw.
CR Al-Ahmad A, 2010, PACEMAKERS IMPLANTAB, P24
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDERSON JM, 1991, J VASC SURG, V13, P750, DOI 10.1016/0741-5214(91)90375-5
   Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bongiorni MG, 2011, TRANSVENOUS LEAD EXTRACTION: FROM SIMPLE TRACTION TO INTERNAL TRANSJUGLAR APPROACH, P1, DOI 10.1007/978-88-470-1466-4
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Busscher HJ, 1997, J BIOMED MATER RES, V34, P201, DOI 10.1002/(SICI)1097-4636(199702)34:2<201::AID-JBM9>3.0.CO;2-U
   Camus C, 2010, MED MALADIES INFECT, V40, P429, DOI 10.1016/j.medmal.2009.11.005
   Chua JD, 2005, PACE, V28, P1276, DOI 10.1111/j.1540-8159.2005.00268.x
   Chua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011
   Colas A, 2004, BIOMATERIAL SCI INTR
   Dasgupta MK, 2001, PERITON DIALYSIS INT, V21, pS213
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Eerenstein SEJ, 1999, CLIN OTOLARYNGOL, V24, P398, DOI 10.1046/j.1365-2273.1999.00245.x
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Eymann R, 2012, ACTA NEUROCHIR SUPPL, V113, P87, DOI 10.1007/978-3-7091-0923-6_18
   Giangrande A, 1993, PERIT DIAL INT, V13, pS133 S135
   GUO WD, 1994, J BIOMED MATER RES, V28, P1433, DOI 10.1002/jbm.820281208
   Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Klug D, 2012, EUROPACE, V14, P776, DOI 10.1093/europace/eus072
   Kolodzinska A, 2012, EUROPACE, V14, P994, DOI 10.1093/europace/eur384
   Kolodzinska A, 2012, EUROPACE, V14, P903, DOI 10.1093/europace/eus003
   Liem BL, 2001, IMPLANTABLE CARDIOVE, P47
   Mebouta-Nkamgueu E, 2001, J MATER SCI-MATER M, V12, P351, DOI 10.1023/A:1011255406438
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   NEU TR, 1993, BIOMATERIALS, V14, P459, DOI 10.1016/0142-9612(93)90149-V
   PALMER MD, 1993, LARYNGOSCOPE, V103, P910
   Perry L, 2007, J UND RES BIOENG, V7, P13
   Pichlmaier M, 2008, EUROPACE, V10, P1067, DOI 10.1093/europace/eun191
   RICH A, 1981, J CELL SCI, V50, P1
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   Voigt A, 2006, J AM COLL CARDIOL, V48, P590, DOI 10.1016/j.jacc.2006.05.016
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Williams I, 1997, MICROBIOL-UK, V143, P2407, DOI 10.1099/00221287-143-7-2407
NR 40
TC 7
Z9 7
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1941-3149
EI 1941-3084
J9 CIRC-ARRHYTHMIA ELEC
JI Circ.-Arrhythmia Electrophysiol.
PD APR
PY 2013
VL 6
IS 2
BP 279
EP 286
DI 10.1161/CIRCEP.112.000069
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 167XB
UT WOS:000320667700015
PM 23476031
OA Bronze
DA 2018-10-20
ER

PT J
AU Li, WA
   Mooney, DJ
AF Li, Weiwei Aileen
   Mooney, David J.
TI Materials based tumor immunotherapy vaccines
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID DENDRITIC CELLS; METASTATIC MELANOMA; T-CELLS; IN-VIVO; NANOPARTICLE
   VACCINES; CANCER-IMMUNOTHERAPY; PLGA NANOPARTICLES; PROSTATE-CANCER;
   SIRNA DELIVERY; RESPONSES
AB Immunotherapy is a promising approach for treating cancer. However, there are limitations inherent to current approaches which may be addressed by integrating them with biomaterial-based strategies. Material platforms have been fabricated to interact with immune cells through spatially controlled and temporally controlled delivery of immune modulators and to promote immune cell crosstalk. Particle vaccines have been developed to specifically target and deliver agents to organs, cells and subcellular compartments. These strategies have been shown to generate antigen-specific CTL responses and, in some cases, tumor regression. Therefore, collaboration between immunology and materials engineering is likely to result in the creation of strong vaccines to combat cancer in the future.
C1 [Li, Weiwei Aileen; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Li, Weiwei Aileen; Mooney, David J.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St,319 Pierce Hall, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Li, Aileen/0000-0002-1056-5932
FU NIH [R01 DE019917]; NSF GRFP; Wyss Institute
FX The authors acknowledge support from the NIH (R01 DE019917), the NSF
   GRFP, and the Wyss Institute.
CR Ali OA, 2011, PHARM RES-DORDR, V28, P1074, DOI 10.1007/s11095-010-0361-x
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104
   Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105
   Cho NH, 2011, NAT NANOTECHNOL, V6, P675, DOI [10.1038/nnano.2011.149, 10.1038/NNANO.2011.149]
   Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107
   Donia M, 2012, J INVEST DERMATOL
   Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544
   Finn OJ, 2003, NAT REV IMMUNOL, V3, P630, DOI 10.1038/nri1150
   Flanary S, 2009, BIOCONJUGATE CHEM, V20, P241, DOI 10.1021/bc800317a
   Hirosue S, 2010, VACCINE, V28, P7897, DOI 10.1016/j.vaccine.2010.09.077
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   Hu YH, 2009, BIOMACROMOLECULES, V10, P756, DOI 10.1021/bm801199z
   Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Kim J, 2011, NANO TODAY, V6, P466, DOI 10.1016/j.nantod.2011.08.005
   Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817
   Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067
   Lee J, 2012, BIOCONJUGATE CHEM, V23, P1174, DOI 10.1021/bc2006219
   Lee J, 2012, NANO LETT, V12, P6322, DOI 10.1021/nl303421h
   Longo DL, 2010, NEW ENGL J MED, V363, P479, DOI 10.1056/NEJMe1006300
   Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]
   Nordly P, 2011, J CONTROL RELEASE, V150, P307, DOI 10.1016/j.jconrel.2010.11.021
   Park J, 2011, J CONTROL RELEASE, V156, P109, DOI 10.1016/j.jconrel.2011.06.025
   Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Scott EA, 2012, BIOMATERIALS, V33, P6211, DOI 10.1016/j.biomaterials.2012.04.060
   Selbo PK, 2010, J CONTROL RELEASE, V148, P2, DOI 10.1016/j.jconrel.2010.06.008
   Simons JW, 2006, CLIN CANCER RES, V12, P3394, DOI 10.1158/1078-0432.CCR-06-0145
   Slutter B, 2010, J CONTROL RELEASE, V148, P117, DOI 10.1016/j.jconrel.2010.06.009
   Slutter B, 2010, J CONTROL RELEASE, V143, P207, DOI 10.1016/j.jconrel.2010.01.007
   Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141
   Stephan MT, 2012, BIOMATERIALS, V33, P5776, DOI 10.1016/j.biomaterials.2012.04.029
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Swartz M, 2012, SCI TRANSL MED, V4
   Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173
   Uto T, 2011, BIOMATERIALS, V32, P5206, DOI 10.1016/j.biomaterials.2011.03.052
   Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104
   Vasdekis AE, 2012, ACS NANO, V6, P7850, DOI 10.1021/nn302122h
   Wang YN, 2011, BIOMATERIALS, V32, P4903, DOI 10.1016/j.biomaterials.2011.03.027
   Woodrow KA, 2012, ANNU REV BIOMED ENG, V14, P17, DOI 10.1146/annurev-bioeng-071811-150054
   Zhang ZP, 2011, BIOMATERIALS, V32, P3666, DOI 10.1016/j.biomaterials.2011.01.067
   Zhou J, 2012, BIOMATERIALS, V33, P583, DOI 10.1016/j.biomaterials.2011.09.061
NR 50
TC 29
Z9 29
U1 1
U2 99
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD APR
PY 2013
VL 25
IS 2
BP 238
EP 245
DI 10.1016/j.coi.2012.12.008
PG 8
WC Immunology
SC Immunology
GA 150CZ
UT WOS:000319369100017
PM 23337254
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Guidelli, EJ
   Kinoshita, A
   Ramos, AP
   Baffa, O
AF Guidelli, Eder Jose
   Kinoshita, Angela
   Ramos, Ana Paula
   Baffa, Oswaldo
TI Silver nanoparticles delivery system based on natural rubber latex
   membranes
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Natural rubber latex; Drug delivery system; Silver nanoparticles; Wound
   dressing
ID GUIDED BONE REGENERATION; HEVEA-BRASILIENSIS; MOLLUSCICIDAL SAPONIN;
   CALENDULA-OFFICINALIS; GREEN SYNTHESIS; NANOCOMPOSITES; RELEASE; GLYCOL;
   SERUM
AB The search for new materials for biomedical applications is extremely important. Here, we present results on the performance of a silver nanoparticles delivery system using natural rubber latex (NRL) as the polymeric matrix. Our aim was to obtain an optimized wound dressing by combining materials with potential healing action. The synthesis of silver nanoparticles and their characterization by UV-Vis spectroscopy, transmission electron microscopy, zeta potential, dynamic light scattering, and Fourier transform infrared spectroscopy (FTIR) are depicted. The NRL membranes are good matrix for silver nanoparticles and allow for their gradual release. The release of 30 nm silver nanoparticles by the NRL membranes depends on their mass percentage in NRL membranes. The total concentration of AgNP released by the NRL membranes was calculated. The AgNP attached to the cis-isoprene molecules in the NRL matrix remain attached to the membrane (similar to 0.1 % w/w). So, only the AgNP bound to the non-rubber molecules are released. FTIR spectra suggest that non-rubber molecules, like aminoacids and proteins, associated with the serum fraction of the NRL may be attached to the surfaces of the released nanoparticles, thereby increasing the release of such molecules. The released silver nanoparticles are sterically stabilized, more stable and well dispersed. Because the serum fraction of the NRL is responsible for the angiogenic properties of the matrix, the silver nanoparticles could increment the angiogenic properties of NRL. This biomaterial has desirable properties for the fabrication of a wound dressing with potential healing action, since it combines the angiogenic and antibacterial properties of the silver nanoparticles with the increased angiogenic properties of the NRL.
C1 [Guidelli, Eder Jose; Baffa, Oswaldo] Univ Sao Paulo FFCLRP DF, Ribeirao Preto, Brazil.
   [Kinoshita, Angela] Univ Sagrado Coracao, Bauru, Brazil.
   [Ramos, Ana Paula] Univ Sao Paulo FFCLRP DQ, Ribeirao Preto, Brazil.
RP Guidelli, EJ (reprint author), Univ Sao Paulo FFCLRP DF, Ribeirao Preto, Brazil.
EM ederguidelli@gmail.com
RI Ramos, Ana Paula/N-4426-2013; Guidelli, Eder/M-9953-2014; Baffa,
   Oswaldo/E-3251-2012; Kinoshita, Angela/C-6946-2012; Moussa,
   Luciana/M-2257-2013
OI Ramos, Ana Paula/0000-0001-6200-8989; Baffa,
   Oswaldo/0000-0002-0622-2814; Kinoshita, Angela/0000-0002-5057-1667; 
FU FAPESP; CNPq; CAPES
FX The authors are grateful to C. A. Brunello for technical assistance,
   Professor A. S. Ito for the use of his UV-Vis spectrometer, Professor.
   M. E. D. Zaniquelli for the use of the zetaSizer system, and Dr. Cynthia
   Maria de Campos Prado Manso for language revision. This study was
   supported by the Brazilian agencies: FAPESP, CNPq, and CAPES.
CR Amsden B, 2003, J CONTROL RELEASE, V93, P249, DOI 10.1016/j.conrel.2003.08.007
   Ereno C, 2010, J BIOMED MATER RES A, V95A, P932, DOI 10.1002/jbm.a.32919
   Ferreira M, 2009, BRAZ J PHYS, V39, P564, DOI 10.1590/S0103-97332009000500010
   Frade MAC, 2001, INT J DERMATOL, V40, P238, DOI 10.1046/j.1365-4362.2001.00977-2.x
   Guidelli EJ, 2012, ACS APPL MATER INTER, V4, P5844, DOI 10.1021/am3014899
   Guidelli EJ, 2012, J ELECTROCHEM SOC, V159, pJ217, DOI 10.1149/2.053206jes
   Guidelli EJ, 2012, NANOSCALE, V4, P2884, DOI 10.1039/c2nr30090g
   Guidelli EJ, 2012, RADIAT PHYS CHEM, V81, P301, DOI 10.1016/j.radphyschem.2011.10.020
   Guidelli EJ, 2011, SPECTROCHIM ACTA A, V82, P140, DOI 10.1016/j.saa.2011.07.024
   Guidelli EJ, 2011, MATER CHEM PHYS, V125, P833, DOI 10.1016/j.matchemphys.2010.09.040
   Hasma H, 2003, J RUBBER RES, V6, P9
   Helaly FM, 1999, J CONTROL RELEASE, V57, P1, DOI 10.1016/S0168-3659(98)00071-6
   Helaly FM, 2001, ADV POLYM TECH, V20, P305, DOI 10.1002/adv.10005
   Herculano RD, 2009, MATER RES-IBERO-AM J, V12, P253, DOI 10.1590/S1516-14392009000200023
   Khlebtsov NG, 2008, QUANTUM ELECTRON+, V38, P504, DOI 10.1070/QE2008v038n06ABEH013829
   Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008
   Kwan KH, 2011, NANOMEDICINE-UK, V6, P595
   Lu SY, 2008, BURNS, V34, P623, DOI 10.1016/j.burns.2007.08.020
   Medina-Ramirez I, 2009, COLLOID SURFACE B, V73, P185, DOI 10.1016/j.colsurfb.2009.05.015
   Mendonca RJ, 2010, PHYTOTHER RES, V24, P764, DOI 10.1002/ptr.3043
   MODAK SM, 1973, BIOCHEM PHARMACOL, V22, P2391, DOI 10.1016/0006-2952(73)90341-9
   Mrue F, 2004, MAT RES, V7, P6
   Neves-Junior WFP, 2006, BRAZ J PHYS, V36, P586, DOI 10.1590/S0103-97332006000400021
   Park HS, 2012, ACTA BIOMATER, V8, P2911, DOI 10.1016/j.actbio.2012.04.026
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Sadatmousavi P, 2012, ACTA BIOMATER, V8, P3241, DOI 10.1016/j.actbio.2012.05.021
   Solomon SD, 2007, J CHEM EDUC, V84, P322
   Sun RWY, 2005, CHEM COMMUN, P5059, DOI 10.1039/b510984a
   Thomazini JA, 1997, ACTA MICROSC, V6, P1
   Tian J, 2007, CHEMMEDCHEM, V2, P129, DOI 10.1002/cmdc.200600171
NR 30
TC 11
Z9 11
U1 0
U2 50
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD APR
PY 2013
VL 15
IS 4
AR UNSP 1536
DI 10.1007/s11051-013-1536-2
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 139AS
UT WOS:000318554400034
DA 2018-10-20
ER

PT J
AU Yao, SL
   Liu, X
   Wang, XM
   Merolli, A
   Chen, XB
   Cui, FZ
AF Yao, Shenglian
   Liu, Xi
   Wang, Xiumei
   Merolli, Antonio
   Chen, Xiongbiao
   Cui, Fuzhai
TI Directing neural stem cell fate with biomaterial parameters for injured
   brain regeneration
SO PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL
LA English
DT Review
DE NSCs niche; Biomaterial design; Brain tissue engineering; Nerve
   regeneration
ID HYALURONIC-ACID HYDROGEL; CENTRAL-NERVOUS-SYSTEM; PEPTIDE NANOFIBER
   SCAFFOLDS; NOGO-66 RECEPTOR ANTIBODY; SPINAL-CORD-INJURY;
   EXTRACELLULAR-MATRIX; IN-VITRO; RAT-BRAIN; HIPPOCAMPAL-NEURONS;
   ANGIOGENIC ACTIVITY
AB The discovery of neural stem cells (NSCs), which have the ability to self-renew and differentiate into all types of neural lineages, offers promising prospect for the treatment of brain neurological disorders such as stroke cerebral ischemia, traumatic brain injury and neurodegenerative disorders. However, only limited number of NSCs could survive or propagate due to tissue inflammation or blood brain barrier. Therefore, it is necessary to develop an appropriate culture system that highly mimics the natural NSCs niche to direct stem cell fate and behavior for nerve regeneration. Both biophysical and biochemical properties of the NSC niche, including topology, mechanical properties, bioactive molecules, and their spatial and temporal presentations should be considered for the design of functionalized scaffolds, which could not only serve as the delivery vehicles of NSCs but also stimulate specific cellular responses at the molecular level, such as support endogenous or exogenous cells proliferation, migration and homing, even promote the growth of axon at the injured brain site. This review attempts to outline the varieties of biomaterial parameters that are applied as biophysical and biochemical signals to direct neural stem cell fate and behavior. The understanding on the interaction of NSCs decision and biomaterial parameters is helping to advance NSCs-based clinical approaches for nerve tissue regeneration and repair. (c) 2013 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved.
C1 [Yao, Shenglian; Liu, Xi; Wang, Xiumei; Cui, Fuzhai] Tsinghua Univ, Inst Regenerat Med & Biomimet Mat, Key Lab Adv Mat, Sch Mat Sci & Engn, Beijing 100084, Peoples R China.
   [Wang, Xiumei; Cui, Fuzhai] Natl Engn Lab Regenerat Implantable Med Devices, Guangzhou 510663, Guangdong, Peoples R China.
   [Merolli, Antonio] Univ Cattolica Sacro Cuore, Sch Med, Orthopaed & Hand Surg Unit, I-00168 Rome, Italy.
   [Chen, Xiongbiao] Univ Saskatchewan, Coll Engn, Div Biomed Engn, Saskatoon, SK, Canada.
RP Wang, XM (reprint author), Tsinghua Univ, Inst Regenerat Med & Biomimet Mat, Key Lab Adv Mat, Sch Mat Sci & Engn, Beijing 100084, Peoples R China.
EM wxm@mail.tsinghua.edu.cn
OI Liu, Xi/0000-0003-4927-8292; Merolli, Antonio/0000-0001-5704-2066
FU Tsinghua University Initiative Scientific Research Program
   [20121087982]; 973 Program [2011CB606205]; National Nature Foundation of
   China [50803031]; Analysis Foundation of Tsinghua University
FX This work was supported by Tsinghua University Initiative Scientific
   Research Program (No. 20121087982), 973 Program (No. 2011CB606205),
   National Nature Foundation of China (No. 50803031), and Analysis
   Foundation of Tsinghua University.
CR Allan LE, 2010, CURR OPIN NEUROL, V23, P426, DOI 10.1097/WCO.0b013e32833b1f62
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   BANERJEE SD, 1991, DEV BIOL, V146, P186, DOI 10.1016/0012-1606(91)90459-G
   Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037
   Bellomo EG, 2004, NAT MATER, V3, P244, DOI 10.1038/nmat1093
   BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024
   Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705
   Buss A, 2005, ACTA NEUROPATHOL, V110, P113, DOI 10.1007/s00401-004-0942-z
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Cui Yan-hong, 2010, Jiepou Xuebao, V41, P41, DOI 10.3969/j.issn.0529-1356.2010.01.009
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science1136281
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Egawa EY, 2011, BIOMATERIALS, V32, P4737, DOI 10.1016/j.biomaterials.2011.03.033
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gao J, 2006, P NATL ACAD SCI USA, V103, P16681, DOI 10.1073/pnas.0606237103
   Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gumera CB, 2007, ADV MATER, V19, P4404, DOI 10.1002/adma.200701747
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039
   Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kokovay E, 2008, NEURON, V60, P420, DOI 10.1016/j.neuron.2008.10.025
   Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852
   Kreger ST, 2009, MATRIX BIOL, V28, P336, DOI 10.1016/j.matbio.2009.05.001
   Lalatsa A, 2012, J CONTROL RELEASE, V161, P523, DOI 10.1016/j.jconrel.2012.04.046
   Lee YB, 2010, EXP NEUROL, V223, P645, DOI 10.1016/j.expneurol.2010.02.014
   Li L, 2008, STEM CELLS, V26, P2193, DOI 10.1634/stemcells.2007-1022
   Li QQ, 2010, J BIOMED MATER RES A, V94A, P688, DOI 10.1002/jbm.a.32707
   Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5
   Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026029
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lin HJ, 2004, DEV BRAIN RES, V153, P163, DOI 10.1016/j.devbrainres.2004.08.010
   Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t
   Liu T, 2010, J BIOMED MATER RES A, V95A, P276, DOI 10.1002/jbm.a.32831
   Liu X., 2011, J TISSUE ENG REGENER, V10
   Liu X, 2011, FRONT MATER SCI, V5, P358, DOI 10.1007/s11706-011-0150-4
   Liu X, 2012, NANOSCALE, V4, P2720, DOI [10.1039/c2nr00001, 10.1039/c2nr00001f]
   Low HP, 2001, IN VITRO CELL DEV-AN, V37, P141
   Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Ma W, 2000, EUR J NEUROSCI, V12, P1227, DOI 10.1046/j.1460-9568.2000.00010.x
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014
   Maric D, 2000, J NEUROSCI RES, V61, P652, DOI 10.1002/1097-4547(20000915)61:6<652::AID-JNR9>3.0.CO;2-J
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Meszar Z, 2008, BRAIN RES BULL, V75, P414, DOI 10.1016/j.brainresbull.2007.10.052
   Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008
   Miller RE, 2011, CLIN ORTHOP RELAT R, V469, P2716, DOI 10.1007/s11999-011-1891-1
   Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004
   Mrksich M, 2009, ACTA BIOMATER, V5, P832, DOI 10.1016/j.actbio.2009.01.016
   Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   OOHIRA A, 1986, J NEUROCHEM, V47, P588
   Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580
   Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757
   Piquet AL, 2012, BRAIN RES BULL, V88, P320, DOI 10.1016/j.brainresbull.2012.03.001
   Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302
   Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021
   Rauch U, 2005, BIOCHEM BIOPH RES CO, V328, P608, DOI 10.1016/j.bbrc.2005.01.026
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Ren YJ, 2009, J BIOACT COMPAT POL, V24, P56, DOI 10.1177/0883911508099472
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sawamoto K., 2006, SCI SIGNAL, P311
   Schwab JM, 2005, EUR J NEUROSCI, V21, P1569, DOI 10.1111/j.1460-9568.2005.03962.x
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Shihabuddin LS, 2000, J NEUROSCI, V20, P8727
   Shiraishi T., 2010, IMECE2009 P ASM INT, V2, P467
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Waldau B, 2008, CELL MOL LIFE SCI, V65, P2372, DOI 10.1007/s00018-008-8053-y
   Wang G, 2010, ACTA BIOMATER, V6, P3630, DOI 10.1016/j.actbio.2010.03.039
   Wang XM, 2011, PROG NAT SCI, V21, P111, DOI 10.1016/S1002-0071(12)60043-4
   Wang Y., SYNAPSE REINTE UNPUB
   Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   Wei YT, 2009, J BIOACT COMPAT POL, V24, P205, DOI 10.1177/0883911509102266
   Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Zhang ZX, 2010, BIOTECHNOL BIOPROC E, V15, P545, DOI 10.1007/s12257-009-3076-2
   Zhao XB, 2008, PROG NAT SCI, V18, P653, DOI 10.1016/j.pnsc.2008.01.012
NR 109
TC 15
Z9 15
U1 2
U2 118
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1002-0071
EI 1745-5391
J9 PROG NAT SCI-MATER
JI Prog. Nat. Sci.
PD APR
PY 2013
VL 23
IS 2
BP 103
EP 112
DI 10.1016/j.pnsc.2013.02.009
PG 10
WC Materials Science, Multidisciplinary; Multidisciplinary Sciences
SC Materials Science; Science & Technology - Other Topics
GA 148RB
UT WOS:000319263200001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Budiraharjo, R
   Neoh, KG
   Kang, ET
AF Budiraharjo, Rusdianto
   Neoh, Koon Gee
   Kang, En-Tang
TI Enhancing bioactivity of chitosan film for osteogenesis and wound
   healing by covalent immobilization of BMP-2 or FGF-2
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE chitosan film; BMP-2; FGF-2; covalent immobilization; bioactivity
ID BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST GROWTH FACTOR-2; N-ACETYLATED
   CHITOSANS; IN-VITRO DEGRADATION; REGENERATIVE MEDICINE; IMPLANT
   INFECTIONS; CELL-ADHESION; DELIVERY; SCAFFOLDS; REPAIR
AB This study compares the efficacy of growth factors that are covalently immobilized to those that are adsorbed in improving the bioactivity of a biomaterial. Bone morphogenetic protein-2 (BMP-2) or fibroblast growth factor-2 (FGF-2) was covalently bonded to chitosan films using carbodiimide chemistry. For BMP-2, a growth factor loading efficiency of approximate to 64% was obtained with this method compared to approximate to 25% from adsorption. As for FGF-2, the growth factor loading efficiency of the two methods was similar at approximate to 50%. The covalently immobilized BMP-2 promoted attachment, proliferation, and differentiation of osteoblasts in a dose-dependent manner, whereas the covalently immobilized FGF-2 stimulated fibroblast attachment, proliferation, and collagen synthesis. After threeweeks immersion in phosphate buffered saline, about 80% of the covalently immobilized growth factors were retained on the films, while only approximate to 16 and approximate to 21% of the adsorbed BMP-2 and FGF-2 remained on the corresponding films. The higher retention rate of the covalently immobilized growth factors enabled their stimulatory effects to persist for a longer period than when adsorbed growth factors were used.
C1 [Budiraharjo, Rusdianto; Neoh, Koon Gee; Kang, En-Tang] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
RP Neoh, KG (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
EM chenkg@nus.edu.sg
OI Neoh, Koon Gee/0000-0002-2700-1914; Kang, En-Tang/0000-0003-0599-7834
FU Singapore Stem Cell Consortium [SSCC/09/019]
FX This work was financially supported by the Singapore Stem Cell
   Consortium Grant SSCC/09/019.
CR Abarrategi A, 2008, BIOMACROMOLECULES, V9, P711, DOI 10.1021/bm701049g
   Axelrad TW, 2007, INJURY, V38, pS49, DOI 10.1016/j.injury.2007.02.010
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   BERSCHT PC, 1994, BIOMATERIALS, V15, P593, DOI 10.1016/0142-9612(94)90209-7
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bratskaya S, 2007, BIOMACROMOLECULES, V8, P2960, DOI 10.1021/bm700620j
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Choudhary S, 2007, TISSUE ENG, V13, P1421, DOI 10.1089/ten.2006.0376
   Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P1
   Custodio CA, 2010, J TISSUE ENG REGEN M, V4, P316, DOI 10.1002/term.248
   Delgado-Rivera R, 2009, MATRIX BIOL, V28, P137, DOI 10.1016/j.matbio.2009.02.001
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Gumusderelioglu M, 2011, CARBOHYD RES, V346, P606, DOI 10.1016/j.carres.2010.12.007
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1825, DOI 10.1007/s10529-009-0100-8
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   HANKIEWICZ J, 1974, CLIN CHIM ACTA, V57, P205, DOI 10.1016/0009-8981(74)90398-2
   Harraghy N, 2006, INT J ARTIF ORGANS, V29, P368
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023
   Jones GL, 2009, BIOMATERIALS, V30, P5376, DOI 10.1016/j.biomaterials.2009.07.028
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Lala NL, 2007, BIOTECHNOL BIOENG, V97, P1357, DOI 10.1002/bit.21351
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Lefler A, 2009, J BIOMAT SCI-POLYM E, V20, P1335, DOI 10.1163/092050609X12457417534295
   Lopez-Lacomba JL, 2006, BIOMACROMOLECULES, V7, P792, DOI 10.1021/bm050859e
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Mack D, 2004, INT J MED MICROBIOL, V294, P203, DOI 10.1016/j.ijmm.2004.06.015
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   Masuoka K, 2005, BIOMATERIALS, V26, P3277, DOI 10.1016/j.biomaterials.2004.07.061
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   Nur-E-Kamal A, 2008, MOL CELL BIOCHEM, V309, P157, DOI 10.1007/s11010-007-9654-8
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Park CJ, 2009, ACTA BIOMATER, V5, P1926, DOI 10.1016/j.actbio.2009.03.002
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Son WK, 2004, MACROMOL RAPID COMM, V25, P1632, DOI 10.1002/marc.200400323
   Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Yamachika E, 2009, J BIOMED MATER RES A, V88A, P599, DOI 10.1002/jbm.a.31833
   Zhang HN, 2010, TISSUE ENG PT A, V16, P3441, DOI [10.1089/ten.tea.2010.0132, 10.1089/ten.TEA.2010.0132]
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
NR 53
TC 16
Z9 16
U1 3
U2 59
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD APR 1
PY 2013
VL 24
IS 6
BP 645
EP 662
DI 10.1080/09205063.2012.703949
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 146ME
UT WOS:000319094400001
PM 23565907
DA 2018-10-20
ER

PT J
AU Datta, P
   Chatterjee, J
   Dhara, S
AF Datta, Pallab
   Chatterjee, Jyotirmoy
   Dhara, Santanu
TI Phosphate functionalized and lactic acid containing graft copolymer:
   synthesis and evaluation as biomaterial for bone tissue engineering
   applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomaterials; hydrophilic polymers; modifications; polyesters; surfaces
ID SOLUBLE POLY(VINYL ALCOHOL); CONTACT-ANGLE HYSTERESIS; MESENCHYMAL
   STEM-CELLS; POLYVINYL-ALCOHOL; DIFFERENTIATION; HYDROGELS; ADHESION;
   POLYMER; PROLIFERATION; DEGRADATION
AB Polyvinyl alcohol (PVA) and polylactic acids (PLA) are biocompatible materials possessing some inherent contrasting limitations which have reduced the scope of their individual applicability. Specifically, overcoming strong hydrophobicity and introducing chemical groups for biofunctionalization are unmet challenges for PLA whilst chemical endeavors to render adequate aqueous stability and cell adhesion properties to PVA have not produced completely intended results. Objective of the present work is to explore synthesis of a graft polymer as an approach towards coupling biofunctional groups with PLA materials. In a two-step reaction, PPVA (phosphorylated polyvinyl alcohol or PVA pre-functionalized with phosphate) is esterified with lactic acid followed by polymerization into PLA in presence of stannous chloride as catalyst to obtain phosphorylated polyvinyl alcohol-graft-polylactic acid (PPVA-g-LA) copolymer. Product is characterized by nuclear magnetic resonance, X-ray diffraction, and thermogravimetric analysis. PPVA-g-LA shows an increase in uniaxial elongation compared to parent PPVA under condition of tensile loading. The graft copolymer also exhibits higher water contact angles compared to PPVA, but a more hydrophilic surface compared to PLA. Culture of MG-63 cells on solvent cast films of polymers demonstrates that PPVA-g-LA as a cell substrate can significantly (p<0.05) improve proliferation and differentiation of cells compared to PPVA substrate whereas in comparison to PLA can significantly ameliorate osteoblast function of cultured cells. Overall, results illustrate the feasibility of PVA to act as a carrier for biofunctional agents to be coupled to lactic acid-based biomaterials with subsequent improvement in cell response on the polymers. In this attempt, it also affords materials with tunable surface or bulk properties of relevance for tissue engineering applications.
C1 [Datta, Pallab; Chatterjee, Jyotirmoy; Dhara, Santanu] Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.
RP Dhara, S (reprint author), Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.
EM sdhara@smst.iitkgp.ernet.in
FU Council of Scientific and Industrial Research, India; IIT Kharagpur
FX Authors thank Council of Scientific and Industrial Research, India for
   financial support. P.D. thanks IIT Kharagpur for fellowship; Uttam Kumar
   Das and Amrita Pal for their help in NMR interpretations; Mr Nantu and
   Mr Debnath for their help in laboratory works.
CR Amaral IF, 2005, J BIOMAT SCI-POLYM E, V16, P1575, DOI 10.1163/156856205774576736
   AN Y, 1995, POLYMER, V36, P2297, DOI 10.1016/0032-3861(95)95310-W
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   BANKS M, 1993, POLYMER, V34, P4547, DOI 10.1016/0032-3861(93)90163-5
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Breitenbach A, 1998, POLYMER, V39, P3261, DOI 10.1016/S0032-3861(97)10077-5
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Cai KY, 2002, J BIOMED MATER RES, V62, P283, DOI 10.1002/jbm.10067
   Carlotti SJ, 2001, J APPL POLYM SCI, V80, P142, DOI 10.1002/1097-4628(20010411)80:2<142::AID-APP1082>3.3.CO;2-W
   Coates J., 2000, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A5606
   Collins JM, 2010, SMALL, V6, P355, DOI 10.1002/smll.200901757
   Datta P, 2012, COLLOID SURFACE B, V94, P177, DOI 10.1016/j.colsurfb.2012.01.033
   DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827
   Ding J., 2008, IND ENG CHEM RES, V48, P788
   Ding J, 2011, IND ENG CHEM RES, V50, P9123, DOI 10.1021/ie2003889
   Dowling DP, 2010, J BIOMATER APPL, V26, P327
   Emoto K, 1999, LANGMUIR, V15, P5212, DOI 10.1021/la980918s
   Gemeinhart RA, 2006, J BIOMED MATER RES A, V78A, P433, DOI 10.1002/jbm.a.30788
   Gopalakrishnanchettiyar SS, 2009, TISSUE ENG PT A, V15, P3061, DOI [10.1089/ten.tea.2008.0454, 10.1089/ten.TEA.2008.0454]
   Laishun S, 2000, EUR POLYM J, V36, P987
   Lam CNC, 2002, ADV COLLOID INTERFAC, V96, P169, DOI 10.1016/S0001-8686(01)00080-X
   LEE SH, 1987, J COLLOID INTERF SCI, V120, P529, DOI 10.1016/0021-9797(87)90380-8
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Liu JH, 2009, J APPL POLYM SCI, V114, P643, DOI 10.1002/app.30592
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Lopez-Perez PM, 2010, J MATER CHEM, V20, P483, DOI 10.1039/b911854c
   Mills CA, 2006, J BIOMED MATER RES A, V76A, P781, DOI 10.1002/jbm.a.30539
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   Onyari JM, 2009, J APPL POLYM SCI, V113, P2053, DOI 10.1002/app.29909
   Otsuka H, 2000, SCI TECHNOL ADV MAT, V1, P21, DOI 10.1016/S1468-6996(99)00003-0
   Park JH, 2002, MACROMOL RES, V10, P135, DOI 10.1007/BF03218262
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pramanik N, 2008, INT J APPL CERAM TEC, V5, P20, DOI 10.1111/j.1744-7402.2008.02179.x
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   Sailaja GS, 2009, ACTA BIOMATER, V5, P1647, DOI 10.1016/j.actbio.2008.12.005
   Sakakura A, 2005, ORG LETT, V7, P1999, DOI 10.1021/ol0504796
   Sarasua J-R, 2011, POLYMER, V53, P50
   Smith KE, 2010, BIOMATERIALS, V31, P6131, DOI 10.1016/j.biomaterials.2010.04.033
   Suzuki M, 1999, PHYS CHEM CHEM PHYS, V1, P2749, DOI 10.1039/a901545k
   Tadmor R, 2004, LANGMUIR, V20, P7659, DOI 10.1021/la049410h
   Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746
   Thomas LV, 2009, J MATER SCI-MATER M, V20, P259, DOI 10.1007/s10856-008-3599-7
   TRETINNIKOV ON, 1994, LANGMUIR, V10, P1606, DOI 10.1021/la00017a047
   Wan YQ, 2006, BIOMATERIALS, V27, P2699, DOI 10.1016/j.biomaterials.2005.12.007
   Wang R, 2011, MACROMOLECULES, V44, P6009, DOI 10.1021/ma200824k
   Xiang Y, 2011, COLLOID SURFACE B, V85, P248, DOI 10.1016/j.colsurfb.2011.02.036
   Zhan FL, 2004, J APPL POLYM SCI, V92, P3417, DOI 10.1002/app.20361
NR 49
TC 3
Z9 5
U1 2
U2 33
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD APR 1
PY 2013
VL 24
IS 6
BP 696
EP 713
DI 10.1080/09205063.2012.707428
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 146ME
UT WOS:000319094400004
PM 23565910
DA 2018-10-20
ER

PT J
AU Booth, BW
   Park, JP
   Burg, KJL
AF Booth, Brian W.
   Park, Jang Pyo
   Burg, Karen J. L.
TI Evaluation of normal and metastatic mammary cells grown in different
   biomaterial matrices: establishing potential tissue test systems
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE breast cancer; epithelial cells; Matrigel(TM); matrix; tissue test
   system
ID BREAST-CANCER; EPITHELIAL-CELLS; BIOLOGICAL-ACTIVITY; NEURITE EXTENSION;
   GEL STIFFNESS; 3D CULTURES; TUMOR; MATRIGEL; PROLIFERATION;
   MORPHOGENESIS
AB The in vitro growth and differentiation of normal mammalian cells is quite different than the growth of cells derived from tumors. Additionally, cells of the same origin (tissue) behave differently depending on the biomaterial matrix in or on which they are grown in vitro. We examined both Matrigel(TM) and a collagen/agarose blend and demonstrated that two murine mammary derived cells lines, 4T1 and NMuMG, derived from a metastatic mammary tumor or a normal mammary gland, respectively, exhibit different growth and differentiation patterns depending on the three-dimensional matrix in which they are grown. The shape and size of the colonies that formed were matrix dependent. The two cell lines produced different levels of growth factors and metalloproteinases, and expressed differentiation markers specific to a matrix. Through the classification of different cell behaviors in different growth matrices, we will be able to intelligently design and tune tissue test systems to ask and answer specific challenging scientific questions.
C1 [Booth, Brian W.; Park, Jang Pyo; Burg, Karen J. L.] Clemson Univ, Inst Biol Interfaces Engn, Rhodes Engn Res Ctr 401 2, Clemson, SC 29634 USA.
   [Burg, Karen J. L.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Burg, KJL (reprint author), Clemson Univ, Inst Biol Interfaces Engn, Rhodes Engn Res Ctr 401 2, Clemson, SC 29634 USA.
EM kburg@clemson.edu
FU Institute for Biological Interfaces of Engineering at Clemson
   University; Department of Defense Era of Hope [BC044778]; National
   Science Foundation Emerging Frontiers in Research and Innovation
   [CBE0736007]
FX Funding for this work was provided by the Institute for Biological
   Interfaces of Engineering at Clemson University, Department of Defense
   Era of Hope Scholars award BC044778, and National Science Foundation
   Emerging Frontiers in Research and Innovation grant CBE0736007. The
   authors gratefully acknowledge Dr. Steven Ellis and Ms. Nancy Korn of
   the Animal & Veterinary Sciences Department of Clemson University for
   their assistance in cryosectioning.
CR ASLAKSON CJ, 1992, CANCER RES, V52, P1399
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Booth BW, 2010, EXP CELL RES, V316, P422, DOI 10.1016/j.yexcr.2009.11.006
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   CC Yang, 2011, T 2011 ANN M EXP SOC
   Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20
   Gjorevski N, 2010, WIRES SYST BIOL MED, V2, P734, DOI 10.1002/wsbm.96
   Glondu M, 2001, ONCOGENE, V20, P6920, DOI 10.1038/sj.onc.1204843
   Hens J, 2009, DEV DYNAM, V238, P2713, DOI 10.1002/dvdy.22097
   Isaji M, 1997, BRIT J PHARMACOL, V122, P1061, DOI 10.1038/sj.bjp.0701493
   Jezierska A, 2009, MED SCI MONITOR, V15, pRA32
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Lee PPH, 2000, ENDOCRINOLOGY, V141, P3764, DOI 10.1210/en.141.10.3764
   Lelievre S, 1996, RECENT PROG HORM RES, V51, P417
   Marques MM, 2006, INT J EXP PATHOL, V87, P405, DOI 10.1111/j.1365-2613.2006.00498.x
   McBryan J, 2008, J MAMMARY GLAND BIOL, V13, P159, DOI 10.1007/s10911-008-9075-7
   McCarty WJ, 2007, BIORHEOLOGY, V44, P303
   Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108
   Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x
   RonnovJessen L, 1996, PHYSIOL REV, V76, P69
   Simian M, 2001, DEVELOPMENT, V128, P3117
   Swamydas M, 2010, IN VITRO CELL DEV-AN, V46, P673, DOI 10.1007/s11626-010-9323-1
   Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744
   Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Zaman GJR, 2005, COMB CHEM HIGH T SCR, V8, P283, DOI 10.2174/1386207054020750
NR 27
TC 1
Z9 2
U1 1
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD APR 1
PY 2013
VL 24
IS 6
BP 758
EP 768
DI 10.1080/09205063.2012.708189
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 146ME
UT WOS:000319094400008
PM 23565914
DA 2018-10-20
ER

PT J
AU Bayram, C
   Ahmad, Z
   Denkbas, EB
   Stride, E
   Edirisinghe, MJ
AF Bayram, Cem
   Ahmad, Zeeshan
   Denkbas, Emir B.
   Stride, Eleanor
   Edirisinghe, Mohan J.
TI Electrohydrodynamic Printing of Silk Fibroin
SO MACROMOLECULAR RESEARCH
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; BOMBYX-MORI SILK; DRUG-DELIVERY;
   CONTROLLED-RELEASE; SCAFFOLDS; MICROSPHERES; BIOMATERIAL; POLYMER;
   PROTEIN; MATRIX
C1 [Bayram, Cem; Denkbas, Emir B.] Hacettepe Univ, Nanotechnol & Nanomed Div, Inst Grad Studies Sci & Engn, TR-06800 Ankara, Turkey.
   [Ahmad, Zeeshan] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   [Stride, Eleanor] Inst Biomed Engn, Dept Engn Sci, Oxford OX3 7DQ, England.
   [Stride, Eleanor; Edirisinghe, Mohan J.] UCL, Dept Mech Engn, London WC1E 7JE, England.
RP Edirisinghe, MJ (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
EM m.edirisinghe@ucl.ac.uk
RI Bayram, Cem/D-7403-2013
OI Bayram, Cem/0000-0001-8717-4668; Ahmad, Zeeshan/0000-0001-8863-6211;
   Stride, Eleanor/0000-0003-3371-5929
FU Engineering and Physical Sciences Research Council [EP/I021795/1]
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Ahmad Z, 2010, MACROMOL MATER ENG, V295, P315, DOI 10.1002/mame.200900396
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Bayram C, 2008, J BIOACT COMPAT POL, V23, P334, DOI 10.1177/0883911508092790
   Bohr A, 2011, INT J PHARMACEUT, V412, P59, DOI 10.1016/j.ijpharm.2011.04.005
   Chang MW, 2011, J R SOC INTERFACE, V8, P451, DOI 10.1098/rsif.2010.0428
   Denkbas EB, 2006, J BIOACT COMPAT POL, V21, P351, DOI 10.1177/0883911506066930
   Ekemen Z, 2011, MACROMOL MATER ENG, V296, P8, DOI 10.1002/mame.201000308
   Enayati M, 2011, INT J PHARMACEUT, V404, P110, DOI 10.1016/j.ijpharm.2010.11.014
   Gumusderelioglu M, 2011, J BIOMED MATER RES A, V98A, P461, DOI 10.1002/jbm.a.33143
   Gupta A, 2007, J BIOACT COMPAT POL, V22, P265, DOI 10.1177/0883911507078268
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kavaz D, 2010, J BIOACT COMPAT POL, V25, P305, DOI 10.1177/0883911509360735
   Ki CS, 2009, MACROMOL RES, V17, P935, DOI 10.1007/BF03218639
   Kim HS, 2007, MACROMOL RES, V15, P65, DOI 10.1007/BF03218754
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   Lv Q, 2008, J APPL POLYM SCI, V109, P1577, DOI 10.1002/app.24546
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Nienhuijs MEL, 2011, TISSUE ENG PT A, V17, P1683, DOI [10.1089/ten.tea.2009.0349, 10.1089/ten.TEA.2009.0349]
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Rasekh M, 2011, ADV ENG MATER, V13, pB296, DOI 10.1002/adem.201080126
   Silva SS, 2008, MACROMOL BIOSCI, V8, P766, DOI 10.1002/mabi.200700300
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   Thian ES, 2011, THIN SOLID FILMS, V519, P2328, DOI 10.1016/j.tsf.2010.11.035
   Tigli RS, 2009, J MATER SCI-MATER M, V20, P699, DOI 10.1007/s10856-008-3624-x
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari C, 2010, J BIOMED MATER RES A, V93A, P595, DOI 10.1002/jbm.a.32565
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 38
TC 5
Z9 5
U1 3
U2 30
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD APR
PY 2013
VL 21
IS 4
BP 339
EP 342
DI 10.1007/s13233-013-1037-2
PG 4
WC Polymer Science
SC Polymer Science
GA 133YS
UT WOS:000318177400001
DA 2018-10-20
ER

PT J
AU Zhou, J
   Wang, XW
   Hua, K
   Duan, CE
   Zhang, W
   Ji, JH
   Yang, XB
AF Zhou, Jian
   Wang, Xiaowei
   Hua, Kun
   Duan, Chang'en
   Zhang, Wei
   Ji, Junhui
   Yang, Xiubin
TI Enhanced mechanical properties and degradability of poly(butylene
   succinate) and poly(lactic acid) blends
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE Biodegradable; Poly(butylene succinate); Poly(lactic acid); Blends;
   Hydrolysis
ID IN-VITRO DEGRADATION; HYDROLYTIC DEGRADATION; POLYMER DEGRADATION; BULK
   EROSION; PLA; BEHAVIOR; POLY(L-LACTIDE); BIOMATERIAL; BIOACTIVITY;
   MORPHOLOGY
AB To improve the tensile properties and degradability of poly(butylene succinate) (PBS) for biomedical usage, biodegradable polymer blends have been developed. A series of PBS and poly(lactic acid) (PLA) blends were prepared, and their degradation behaviors in simulated body fluid for 16 months were investigated based on morphology, tensile test, weight analysis, and molecular weight. The results showed that the incorporation of PLA into PBS increased the initial tensile strength to some extent, and the blends lost their tensile properties earlier than their parent polymers with the proceeding of hydrolysis. Both blends and parent polymers went through a plateau and subsequent rise stage in mass loss and water absorption, but the blends hydrolyzed faster than the parent polymers. The molecular weight variations also demonstrated faster hydrolysis of the blends. Moreover, both blends and their parent polymers underwent a slow-to-fast transition in their hydrolysis rates. When the M-n of PBS and PLA reached 4.0 x 10(4) and 9.0 x 10(4), the hydrolysis of parent polymers and blends began to accelerate, which is the start of auto-acceleration. The blends hydrolyzed faster in both stages. The interface between the components initiated accelerating hydrolysis in the first stage, and the reciprocal auto-acceleration effect resulted in faster hydrolysis of the blends in the second stage.
C1 [Zhou, Jian; Hua, Kun; Duan, Chang'en; Yang, Xiubin] Chinese Acad Med Sci, Dept Surg, Cardiovasc Inst, Beijing 100037, Peoples R China.
   [Zhou, Jian; Hua, Kun; Duan, Chang'en; Yang, Xiubin] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China.
   [Zhou, Jian; Hua, Kun; Duan, Chang'en; Yang, Xiubin] Peking Union Med Coll, Beijing 100037, Peoples R China.
   [Wang, Xiaowei; Zhang, Wei; Ji, Junhui] Chinese Acad Sci, Tech Inst Phys & Chem, Beijing 100190, Peoples R China.
RP Yang, XB (reprint author), Chinese Acad Med Sci, Dept Surg, Cardiovasc Inst, Beijing 100037, Peoples R China.
EM hebeizhoujian@126.com; jhji@mail.ipc.ac.cn; xiubinyang@yahoo.com
FU National Natural Science Foundation of China (NSFC) [30870620]
FX This research was financially supported by a National Natural Science
   Foundation of China (NSFC) surface project with Grant 30870620.
CR Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   Bramfeldt H, 2008, POLYM DEGRAD STABIL, V93, P877, DOI 10.1016/j.polymdegradstab.2008.01.023
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Chen GX, 2005, POLYMER, V46, P11829, DOI 10.1016/j.polymer.2005.10.056
   Chrissafis K, 2005, THERMOCHIM ACTA, V435, P142, DOI 10.1016/j.tca.2005.05.011
   Claes LE, 1996, BIOMATERIALS, V17, P1621, DOI 10.1016/0142-9612(95)00327-4
   Fan D, 2011, IRAN POLYM J, V20, P3
   Farahani TD, 2005, IRAN POLYM J, V14, P753
   Gopferich A, 1997, MACROMOLECULES, V30, P2598, DOI 10.1021/ma961627y
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Ishioka R, 2002, BIOPOLYMERS, V4
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   Lyu SP, 2007, BIOMACROMOLECULES, V8, P2301, DOI 10.1021/bm070313n
   Lyu SP, 2009, INT J MOL SCI, V10, P4033, DOI 10.3390/ijms10094033
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mobedi H, 2011, IRAN POLYM J, V20, P237
   Mohammadi Rovshandeh J, 2001, IRAN POLYM J, V10, P53
   Navarro M, 2005, ACTA BIOMATER, V1, P411, DOI 10.1016/j.actbio.2005.03.004
   Park JW, 2002, J APPL POLYM SCI, V86, P647, DOI [10.1002/app.10923, 10.1002/aoo.10923]
   Renard E, 2004, POLYM DEGRAD STABIL, V85, P779, DOI 10.1016/j.pllymdegradstab.2003.11.019
   San Roman J, 1991, BIOMATERIALS, V12, P236
   Shibata M, 2006, POLYMER, V47, P3557, DOI 10.1016/j.polymer.2006.03.065
   Shibata M, 2006, POLYMER, V47, P3357
   Siparsky GL, 1998, J ENVIRON POLYM DEGR, V6, P31, DOI 10.1023/A:1022826528673
   TAMADA JA, 1993, P NATL ACAD SCI USA, V90, P552, DOI 10.1073/pnas.90.2.552
   Tan LC, 2010, POLYM DEGRAD STABIL, V95, P1920, DOI 10.1016/j.polymdegradstab.2010.04.010
   Tsuji H, 2003, BIOMATERIALS, V24, P537, DOI 10.1016/S0142-9612(02)00365-4
   Vieira AC, 2011, J MECH BEHAV BIOMED, V4, P451, DOI 10.1016/j.jmbbm.2010.12.006
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Wang XQ, 2003, CN Patent, Patent No. [1,424,339, 1424339]
   Weiner AA, 2007, BIOMATERIALS, V28, P5259, DOI 10.1016/j.biomaterials.2007.08.022
   Yokohara T, 2008, EUR POLYM J, V44, P677, DOI 10.1016/j.eurpolymj.2008.01.008
NR 39
TC 13
Z9 14
U1 3
U2 68
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD APR
PY 2013
VL 22
IS 4
BP 267
EP 275
DI 10.1007/s13726-013-0124-8
PG 9
WC Polymer Science
SC Polymer Science
GA 140II
UT WOS:000318647300005
DA 2018-10-20
ER

PT J
AU Rong, MD
   Zhu, AD
   Guo, ZH
   Zhou, L
   Li, SB
   Lu, HB
   Zhang, XY
AF Rong, Mingdeng
   Zhu, Andi
   Guo, Zehong
   Zhou, Lei
   Li, Shaobing
   Lu, Haibin
   Zhang, Xueyang
TI The effects of early osseointegration in different implant sites in
   rabbit tibias
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TITANIUM IMPLANTS; DENTAL IMPLANTS; ANIMAL-MODELS; BIOLOGICAL
   PERFORMANCE; BONE; SURFACE; BIOMATERIAL; STABILITY; RESPONSES; TI
AB The aim of this study was to evaluate the early osseointegration of implants with the same surface treatment in different implant sites in rabbit tibias after 4 weeks. A total of 42 acid-etched implants were implanted in three different sites in the tibia: group A was 2.08 +/- 0.18 mm below epiphyseal line; group B was 7.00 +/- 0.61 mm below the epiphyseal line; group C was 13.01 +/- 1.26 mm below the epiphyseal line. After 4 weeks, the average bone-to-implant contact (BIC) values were as follows: group A, 40.02 +/- 4.82 %; group B, 28.20 +/- 5.41 %; group C, 20.76 +/- 3.10 %. The BIC measurements yielded statistically significant differences among group A, group B and group C (P < 0.01); group A demonstrated the best osseointegration. In the present study, the different implantation sites in the selected 20-mm area demonstrated different early osseointegration; the sites located 7 +/- 1.5 mm below the epiphyseal line were best suited for observing the effectiveness of early osseointegration among the three sites. The statistical results of the early osseointegration of implants are therefore affected by the location of the implant sites in this 20-mm area.
C1 [Rong, Mingdeng; Zhu, Andi; Guo, Zehong; Zhou, Lei; Li, Shaobing; Lu, Haibin; Zhang, Xueyang] Southern Med Univ, Guangdong Prov Stomatol Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510280, Guangdong, Peoples R China.
   [Zhou, Lei] Southern Med Univ, Guangdong Prov Stomatol Hosp, Dept Oral Implantol, Guangzhou 510280, Guangdong, Peoples R China.
RP Zhou, L (reprint author), Southern Med Univ, Guangdong Prov Stomatol Hosp, Dept Oral Implantol, S366 Jiangnan Blvd, Guangzhou 510280, Guangdong, Peoples R China.
EM 23554800@qq.com; zho668@263.net
FU Guangdong Provincal Stomatological Hospital (Southern Medical
   University, China); Natural Science Foundation of China [81170998]; Fund
   of Guangdong Province Medical Science Research [B2012032]
FX This work was supported by the Guangdong Provincal Stomatological
   Hospital (Southern Medical University, China), the Grants from the
   Natural Science Foundation of China (81170998) and the Fund of Guangdong
   Province Medical Science Research (2012, B2012032).
CR Abrahamsson I, 2008, CLIN ORAL IMPLAN RES, V19, P153, DOI 10.1111/j.1600-0501.2007.01454.x
   Annibali S, 2008, Oral Implantol (Rome), V1, P21
   Annibali S, 2009, INT J PERIODONT REST, V29, P325
   Botticelli D, 2004, CLIN ORAL IMPLAN RES, V15, P285, DOI 10.1046/j.1600-0501.2003.01008.x
   Cheng ZP, 2010, ORAL SURG ORAL MED O, V110, pE5, DOI 10.1016/j.tripleo.2010.03.012
   Cho SA, 2003, BIOMATERIALS, V24, P4859, DOI 10.1016/S0142-9612(03)00377-6
   Choi JW, 2006, J ORAL REHABIL, V33, P889, DOI 10.1111/j.1365-2842.2006.01669.x
   Dong-Sheng W., 2006, CHIN J PROSTHODONT C, V3, P169
   Ferguson SJ, 2008, INT J ORAL MAX IMPL, V23, P1037
   Franchi Marco, 2004, ScientificWorldJournal, V4, P1083
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Hayes JS, 2012, J BIOMED MATER RES B, V100B, P611, DOI 10.1002/jbm.b.31967
   Johansson CB, 1998, INT J ORAL MAX IMPL, V13, P315
   Kim YH, 2003, INT J ORAL MAX IMPL, V18, P349
   Lang NP, 2007, INT TEAM IMPL 2007 C
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Le Guehennec L, 2005, J BIOMED MATER RES B, V72B, P69, DOI 10.1002/jbm.b.30118
   Lee IS, 2002, BIOMATERIALS, V23, P609, DOI 10.1016/S0142-9612(01)00147-8
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Lioubavina-Hack N, 2006, CLIN ORAL IMPLAN RES, V17, P244, DOI 10.1111/j.1600-0501.2005.01201.x
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Peraire C, 2006, J BIOMED MATER RES A, V77A, P370, DOI 10.1002/jbm.a.30556
   Rong MD, 2009, J MATER SCI-MATER M, V20, P1721, DOI 10.1007/s10856-009-3730-4
   SCHIMANDLE JH, 1994, SPINE, V19, P1998, DOI 10.1097/00007632-199409000-00023
   Sennerby L, 2000, APPL OSSEOINTEGR RES, V1, P31
   Stenport VF, 2003, J MATER SCI-MATER M, V14, P247, DOI 10.1023/A:1022884724059
   Suh JY, 2007, CLIN ORAL IMPLAN RES, V18, P362, DOI 10.1111/j.1600-0501.2006.01323.x
   Yang GL, 2008, ORAL SURG ORAL MED O, V106, P516, DOI 10.1016/j.tripleo.2008.03.017
NR 30
TC 1
Z9 1
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2013
VL 24
IS 4
BP 959
EP 965
DI 10.1007/s10856-012-4847-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 138LC
UT WOS:000318509100012
PM 23430332
DA 2018-10-20
ER

PT J
AU Sun, SJ
   Yu, WQ
   Zhang, YL
   Zhang, FQ
AF Sun, ShengJun
   Yu, WeiQiang
   Zhang, YiLin
   Zhang, FuQiang
TI Increased preosteoblast adhesion and osteogenic gene expression on TiO2
   nanotubes modified with KRSR
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HEPARIN-BINDING DOMAIN; INCREASED OSTEOBLAST ADHESION; BIOMIMETIC
   PEPTIDE SURFACES; LOADED TITANIUM IMPLANTS; ACID-ETCHED SURFACE;
   BONE-DERIVED CELLS; FORMATION IN-VIVO; SIGNALING PATHWAYS; RGD PEPTIDES;
   DIFFERENTIATION
AB TiO2 anodized nanotubelayers are potentially useful for orthopedic and dental implants because they promotes bone formation. Peptide sequences, such as lysine-arginine-serine-arginine (KRSR), are often used to modify biomaterial surfaces for the selective adhesion of bone cells. The objective of this study was to functionalize TiO2 nanotube layers with KRSR to examine the responses of mouse preosteoblasts (MC3T3-E1) to this new material in vitro. SEM, AFM, XPS were used to characterize the materials. Immunofluorescence staining, SEM, ALP, RT-PCR, Wb analysis were used to detect the preosteoblast adhesion, spreading and osteogenic differentiation. KRSR peptides could be immobilized on the TiO2 nanotube layers by silane coupling. Immobilized KRSR increased preosteoblast adhesion and spreading on TiO2 nanotube layers. Moreover, osteogenic differentiation increased on the KRSR-modified TiO2 nanotube layers. KRSR-modified TiO2 nanotube layers have satisfactory biological properties and should be further investigated as medical implant materials.
C1 [Sun, ShengJun; Yu, WeiQiang; Zhang, YiLin; Zhang, FuQiang] Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200011, Peoples R China.
RP Zhang, FQ (reprint author), Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Shanghai Key Lab Stomatol,Peoples Hosp 9, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
EM fqzhang@vip.163.com
FU Shanghai Leading Academic Discipline Project [S30206, T0202]; Science
   and Technology committee of Shanghai [08DZ2271100, 1052nm04300,
   10JC1408600]; National Natural Science Foundation of China [81070866]
FX The authors would like to thank Xiu-li Zhang (Oral Bioengineering Lab,
   Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
   University) for assistance with the experiments. This work was supported
   by Shanghai Leading Academic Discipline Project (Project Number:
   S30206), the Science and Technology committee of Shanghai (08DZ2271100,
   1052nm04300, and 10JC1408600), the Shanghai Leading Academic Discipline
   Project (T0202) and the National Natural Science Foundation of China
   (81070866).
CR ALBREKTSSON T, 1990, International Journal of Prosthodontics, V3, P30
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Balasundaram G, 2006, NANOMEDICINE-UK, V1, P169, DOI 10.2217/17435889.1.2.169
   Balasundaram G, 2007, J BIOMED MATER RES A, V80A, P602, DOI 10.1002/jbm.a.30954
   Balasundaram G, 2011, J BIOMED MATER RES A, V98A, P192, DOI 10.1002/jbm.a.33105
   Bauer S, 2008, ACTA BIOMATER, V4, P1576, DOI 10.1016/j.actbio.2008.04.004
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   De Bartolo L, 2007, BIOMOL ENG, V24, P23, DOI 10.1016/j.bioeng.2006.07.001
   Matesanz MD, 2012, MACROMOL BIOSCI, V12, P446, DOI 10.1002/mabi.201100456
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Domingo-Espin J, 2012, NANOMEDICINE, DOI [10.1016/j.nano.2012.06.005., DOI 10.1016/J.NAN0.2012.06.005]
   Echtermeyer F, 1999, J CELL SCI, V112, P3433
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   Hori N, 2010, DENT MATER, V26, P275, DOI 10.1016/j.dental.2009.11.077
   Kroese-Deutman HC, 2005, TISSUE ENG, V11, P1867, DOI 10.1089/ten.2005.11.1867
   Kusano Y, 2000, EXP CELL RES, V256, P434, DOI 10.1006/excr.2000.4802
   Lee JY, 2007, J BIOMED MATER RES A, V83A, P970, DOI 10.1002/jbm.a.31351
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0
   Mas-Moruno C, 2013, J BIOMED MATER RES A, V101, P87, DOI 10.1002/jbm.a.34303
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   NAKAMURA H, 1994, J BONE MINER RES, V9, P1289, DOI 10.1002/jbmr.5650090819
   Nelson M, 2006, INT J NANOMED, V1, P339
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Palchesko RN, 2012, J BIOMED MATER RES A, V100A, P1229, DOI 10.1002/jbm.a.33303
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Sato M, 2004, EXPERT REV MED DEVIC, V1, P105, DOI 10.1586/17434440.1.1.105
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yu WQ, 2011, J BIOMED MATER RES B, V99B, P207, DOI 10.1002/jbm.b.31888
   Yu WQ, 2010, J BIOMED MATER RES A, V94A, P1012, DOI 10.1002/jbm.a.32687
   Yu WQ, 2012, COLLOID SURFACE B, V93, P135, DOI 10.1016/j.colsurfb.2011.12.025
   Zhang LJ, 2010, J BIOMED MATER RES A, V95A, P550, DOI 10.1002/jbm.a.32832
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
NR 50
TC 21
Z9 22
U1 4
U2 58
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2013
VL 24
IS 4
BP 1079
EP 1091
DI 10.1007/s10856-013-4869-6
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 138LC
UT WOS:000318509100022
PM 23371766
DA 2018-10-20
ER

PT J
AU Vlaisavljevich, E
   Holmes, HR
   Tan, EL
   Qian, Z
   Trierweiler, S
   Ong, KG
   Rajachar, RM
AF Vlaisavljevich, E.
   Holmes, H. R.
   Tan, E. L.
   Qian, Z.
   Trierweiler, S.
   Ong, K. G.
   Rajachar, R. M.
TI Magnetoelastic vibrational biomaterials for real-time monitoring and
   modulation of the host response
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FOREIGN-BODY REACTION; FLUID-FLOW VELOCITY; THICK-FILM SENSORS;
   TERFENOL-D; MECHANISMS; VISCOSITY; WIRELESS; TEMPERATURE; PRESSURE;
   FIBROSIS
AB Magnetoelastic (ME) biomaterials are ferromagnetic materials that physically deform when exposed to a magnetic field. This work describes the real-time control and monitoring capabilities of ME biomaterials in wound healing. Studies were conducted to demonstrate the capacity of the materials to monitor changes in protein adsorption and matrix stiffness. In vitro experiments demonstrated that ME biomaterials can monitor cell adhesion and growth in real-time, and a long-term in vivo study demonstrated their ability to monitor the host response (wound healing) to an implant and control local cell density and collagen matrix production at the soft tissue-implant interface. This approach represents a potentially self-aware and post-deployment activated biomaterial coating as a means to monitor an implant surface and provide an adjuvant therapy for implant fibrosis.
C1 [Vlaisavljevich, E.; Holmes, H. R.; Tan, E. L.; Qian, Z.; Trierweiler, S.; Ong, K. G.; Rajachar, R. M.] Michigan Technol Univ, Dept Biomed Engn, Houghton, MI 49931 USA.
RP Rajachar, RM (reprint author), Michigan Technol Univ, Dept Biomed Engn, 309 M&M Bldg,1400 Townsend Dr, Houghton, MI 49931 USA.
EM rupakr@mtu.edu
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Cai QY, 2000, SENSOR ACTUAT B-CHEM, V71, P112, DOI 10.1016/S0925-4005(00)00599-2
   Cai QY, 2000, J ENVIRON MONITOR, V2, P556, DOI 10.1039/b004929h
   Cai QY, 2001, SENSOR ACTUAT B-CHEM, V77, P614, DOI 10.1016/S0925-4005(01)00766-3
   Feril LB, 2012, INT J HYPERTHER, V28, P282, DOI 10.3109/02656736.2012.668640
   Grimes CA, 2000, SENSOR ACTUAT A-PHYS, V84, P205, DOI 10.1016/S0924-4247(00)00306-X
   Grimes CA, 2000, REV SCI INSTRUM, V71, P3822, DOI 10.1063/1.1315352
   Holmes HR, 2012, BIOSENSORS-BASEL, V2, P57, DOI 10.3390/bios2010057
   Jain MK, 2001, APPL ACOUST, V62, P1001, DOI 10.1016/S0003-682X(00)00091-8
   Jauregui H O, 1987, ASAIO Trans, V33, P66, DOI 10.1097/00002480-198704000-00004
   Kouzoudis D, 2000, SMART MATER STRUCT, V9, P885, DOI 10.1088/0964-1726/9/6/320
   Kouzoudis D, 2000, J APPL PHYS, V87, P6301, DOI 10.1063/1.372686
   Lekholm U, 1999, CLIN IMPLANT DENT R, V1, P2
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   Omar O, 2009, J MATER SCI-MATER M, V21, P969
   Ong K G, 2001, SENSORS, V1, P138
   Ong KG, 2006, IEEE SENS J, V6, P514, DOI 10.1109/JSEN.2006.874450
   Ong KG, 2003, IEEE T MAGN, V39, P3414, DOI 10.1109/TMAG.2003.816168
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   Ruan C, 2004, BIOSENS BIOELECTRON, V20, P589
   Ruan CM, 2003, ANAL CHEM, V75, P6494, DOI 10.1021/ac034562n
   SANDLUND L, 1994, J APPL PHYS, V75, P5656, DOI 10.1063/1.355627
   Somnath RC, 2007, SENSOR LETT, V5, P1
   Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3
   Stoyanov PG, 2000, SENSOR ACTUAT A-PHYS, V80, P8, DOI 10.1016/S0924-4247(99)00288-5
   Sullivan J, 2003, PROSTHET ORTHOT INT, V27, P114, DOI 10.1080/03093640308726667
   Teri GRC, 2009, J BIOMED MATER RES A, V999, P942
   Tsodikov SF, 1998, P INT SYMP DISCH EL, V18, P713
   Vlaisavljevich E, 2011, IEEE T BIO-MED ENG, V58, P698, DOI 10.1109/TBME.2010.2093131
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487
   Zhu HQ, 1997, J ALLOY COMPD, V258, P49, DOI 10.1016/S0925-8388(97)00068-6
NR 33
TC 4
Z9 4
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2013
VL 24
IS 4
BP 1093
EP 1104
DI 10.1007/s10856-013-4854-0
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 138LC
UT WOS:000318509100023
PM 23354739
DA 2018-10-20
ER

PT J
AU Zhou, CH
   Keeling, J
AF Zhou, Chun Hui
   Keeling, John
TI Fundamental and applied research on clay minerals: From climate and
   environment to nanotechnology
SO APPLIED CLAY SCIENCE
LA English
DT Article
DE Clay minerals; Layered structure; Functionalization; Catalyst;
   Adsorbent; Biomaterial
ID MONTMORILLONITE; WATER
AB This brief overview comments on recent trends in scientific research and development of clay minerals and was stimulated by the compilation of papers for this special issue to pay tribute to the 34th International Geological Congress held in 2012. The essentially geological context of the conference was a reminder that increased understanding of the genesis and evolution of clays and clay minerals provides insights that have applications in mining, environmental management, paleoclimate, Earth and extraterrestrial sciences. The requirement for multidisciplinary knowledge, including geology, mineralogy, chemistry and materials science, and modern instrumentation and analysis of clay minerals, is essential to a full understanding of the genesis, role and potential new uses for these fine-grained industrial minerals. Latest studies are typically focused on processing and modifying of clay minerals as adsorbents, catalysts, and biomaterials. The emphasis for future work is on advanced clay-based nanomaterials for use in new approaches to sustainable energy, green environment, and human health. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Zhou, Chun Hui] Zhejiang Univ Technol, Coll Chem Engn & Mat Sci, Res Grp Adv Mat & Sustainable Catalysis AMSC, Hangzhou 310032, Zhejiang, Peoples R China.
   [Keeling, John] Geol Survey South Australia, Dept Mfg Innovat Trade Resources & Energy, Adelaide, SA 5001, Australia.
RP Zhou, CH (reprint author), Zhejiang Univ Technol, Coll Chem Engn & Mat Sci, Res Grp Adv Mat & Sustainable Catalysis AMSC, Hangzhou 310032, Zhejiang, Peoples R China.
EM chc.zhou@yahoo.com.cn; john.Keeling@sa.gov.au
FU Zhejiang Provincial Natural Science Foundation of China [R4100436];
   Natural Scientific Foundation of Zhejiang Province [LQ12B03004]; Science
   and Technology Department of Zhejiang Provincial Government for the
   efficient use of industrial minerals [2009C14G2020021/2010C14013]
FX Our thanks also go to Sa Xiao and Ling-Yun Wang for helping with drawing
   the Figures. CHZ wishes to acknowledge the Distinguished Young Scholar
   Grant from Zhejiang Provincial Natural Science Foundation of China
   (R4100436), and the Natural Scientific Foundation of Zhejiang Province
   (LQ12B03004), and the international cooperation project
   (2009C14G2020021/2010C14013) from the Science and Technology Department
   of Zhejiang Provincial Government for the efficient use of industrial
   minerals.
CR Bergaya F, 2006, DEV CLAY SCI, V1, P1
   Bineesh K. V., 2013, APPL CLAY SCI
   Brigatta M. F., 2011, LAYERED MINERAL STRU
   Cinku K., 2000, DEV MINERAL PROCESSI, V13, pC5
   Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582
   Fatimah I., 2012, APPL CLAY SCI
   GALAN E, 2006, HDB CLAY SCI, V1, P1129
   GUGGENHEIM S, 1995, CLAY CLAY MINER, V43, P255, DOI 10.1346/CCMN.1995.0430213
   Hu P., 2013, INSIGHT PHYSICOCHEMI
   Huo C., 2013, APPL CLAY SCI
   Ikeda M, 2011, J AM CHEM SOC, V133, P1670, DOI 10.1021/ja109692z
   Jha A., 2013, APPL CLAY SCI
   Jiang W.-T., 2013, APPL CLAY SCI
   Joshi PC, 2012, NUCLEOS NUCLEOT NUCL, V31, P536, DOI 10.1080/15257770.2012.701787
   Keeling J. L., 2012, P 10 INT C APPL MIN, P351
   KONTA J, 1995, APPL CLAY SCI, V10, P275, DOI 10.1016/0169-1317(95)00029-4
   Kusuma R. I., 2013, APPL CLAY SCI
   Li C., 2013, APPL CLAY SCI
   Liang Y., 2013, APPL CLAY SCI
   Liu H., 2013, APPL CLAY SCI
   Morton O., 2005, SCIENCE, V26, P1320
   Pasbakhsh P., 2013, APPL CLAY SCI
   Pearson VK, 2002, METEORIT PLANET SCI, V37, P1829, DOI 10.1111/j.1945-5100.2002.tb01166.x
   Peng Y., 2013, APPL CLAY SCI
   Tong D. S., 2013, APPL CLAY SCI
   Wang C., 2013, APPL CLAY SCI
   Wang Q., 2013, APPL CLAY SCI
   Wu LM, 2012, EARTH-SCI REV, V115, P373, DOI 10.1016/j.earscirev.2012.10.001
   Wu Q., 2013, APPL CLAY SCI
   Xu Z. P., 2013, HIGH CAPACITANCE ELE
   Yin K., 2013, APPL CLAY SCI
   Zhao H., 2013, APPL CLAY SCI
   Zhou CH, 2011, APPL CLAY SCI, V53, P87, DOI 10.1016/j.clay.2011.04.016
   Zhou CH, 2012, CHEM ENG J, V209, P223, DOI 10.1016/j.cej.2012.07.107
   Zhou CH, 2010, APPL CLAY SCI, V48, P1, DOI 10.1016/j.clay.2009.12.018
NR 35
TC 78
Z9 81
U1 3
U2 95
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-1317
J9 APPL CLAY SCI
JI Appl. Clay Sci.
PD APR
PY 2013
VL 74
SI SI
BP 3
EP 9
DI 10.1016/j.clay.2013.02.013
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy
SC Chemistry; Materials Science; Mineralogy
GA 130UH
UT WOS:000317945100002
DA 2018-10-20
ER

PT J
AU Lombardi, G
   Banfi, G
   Lippi, G
   Sanchis-Gomar, F
AF Lombardi, Giovanni
   Banfi, Giuseppe
   Lippi, Giuseppe
   Sanchis-Gomar, Fabian
TI Ex vivo erythrocyte generation and blood doping
SO BLOOD TRANSFUSION
LA English
DT Editorial Material
ID SYNTHETIC BIOMATERIAL PARTICLES; HEMATOPOIETIC STEM-CELLS; TRANSFUSION
   MEDICINE; BIOCHEMISTRY; PHYSIOLOGY; PASSPORT; MARKERS
C1 [Lombardi, Giovanni; Banfi, Giuseppe] IRCCS Galeazzi Orthopaed Inst, Milan, Italy.
   [Banfi, Giuseppe] Univ Milan, Sch Med, Chair Clin Biochem, Milan, Italy.
   [Lippi, Giuseppe] Univ Hosp Parma, Dept Pathol & Lab Med, Unit Diagnost Blood Biochem, Parma, Italy.
   [Sanchis-Gomar, Fabian] Univ Valencia, Fac Med, Dept Physiol, Fdn Invest Hosp Clin Univ INCLIVA, Valencia, Spain.
RP Lombardi, G (reprint author), IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Via R Galeazzi 4, I-20161 Milan, Italy.
EM giovanni.lombardi@grupposandonato.it
RI Lombardi, Giovanni/I-2414-2012
OI Lombardi, Giovanni/0000-0002-8365-985X; Sanchis-Gomar,
   Fabian/0000-0003-0424-4208; Lippi, Giuseppe/0000-0001-9523-9054; Banfi,
   Giuseppe/0000-0001-9578-5338
CR Banfi G, 2011, ANAL BIOANAL CHEM, V401, P577, DOI 10.1007/s00216-011-4839-0
   Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038
   Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047
   Haghgooie R, 2010, MACROMOL RAPID COMM, V31, P128, DOI 10.1002/marc.200900302
   Jelkmann W, 2011, BLOOD, V118, P2395, DOI 10.1182/blood-2011-02-303271
   Lapillonne H, 2010, HAEMATOL-HEMATOL J, V95, P1651, DOI 10.3324/haematol.2010.023556
   Lippi G, 2011, MINI-REV MED CHEM, V11, P362, DOI 10.2174/138955711795445952
   Lippi G, 2010, INT J SPORTS MED, V31, P75, DOI 10.1055/s-0030-1247540
   Lippi G, 2006, CLIN CHEM LAB MED, V44, P1395, DOI 10.1515/CCLM.2006.262
   Lippi G, 2006, CRIT REV CL LAB SCI, V43, P349, DOI 10.1080/10408360600755313
   Lippi G, 2011, EUR J INTERN MED, V22, P16, DOI 10.1016/j.ejim.2010.08.001
   Monfort N, 2011, TRANSFUSION, V52, P647
   Morkeberg J, 2011, SCAND J MED SCI SPOR, V21, P235, DOI 10.1111/j.1600-0838.2009.01033.x
   Morkeberg J, 2012, TRANSFUS MED REV, V26, P199, DOI 10.1016/j.tmrv.2011.09.007
   Pottgiesser T, 2011, TRANSFUSION, V51, P1707, DOI 10.1111/j.1537-2995.2011.03076.x
   Robinson N, 2010, HDB EXP PHARM, V195, P295
   Sallet P, 2008, INT J HEMATOL, V88, P362, DOI 10.1007/s12185-008-0182-4
   Solymos E, 2011, DRUG TEST ANAL, V3, P892, DOI 10.1002/dta.377
   Timmins NE, 2011, TISSUE ENG PART C-ME, V17, P1131, DOI [10.1089/ten.tec.2011.0207, 10.1089/ten.TEC.2011.0207]
   Timmins NE, 2009, TRENDS BIOTECHNOL, V27, P415, DOI 10.1016/j.tibtech.2009.03.008
   WADA, WORLD ANT COD
   WADA (World Anti-Doping Agency), 2012, 2012 PROH LIST INT S
   Yachie-Kinoshita A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/642420
   Zorzoli M, 2010, DRUG TEST ANAL, V2, P542, DOI 10.1002/dta.173
NR 25
TC 2
Z9 2
U1 4
U2 16
PU SIMITI SERVIZI SRL
PI MILAN
PA VIA DESIDERIO 21, MILAN, 20131, ITALY
SN 1723-2007
J9 BLOOD TRANSFUS-ITALY
JI Blood Transf.
PD APR
PY 2013
VL 11
IS 2
BP 161
EP 163
DI 10.2450/2012.0028-12
PG 3
WC Hematology
SC Hematology
GA 132HI
UT WOS:000318058100001
PM 23114519
DA 2018-10-20
ER

PT J
AU de Olyveira, GM
   Costa, LMM
   Basmaji, P
AF de Olyveira, Gabriel Molina
   Manzine Costa, Ligia Maria
   Basmaji, Pierre
TI Physically Modified Bacterial Cellulose as Alternative Routes for
   Transdermal Drug Delivery
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Bacterial Cellulose; Gamma Irradiation; Drug Delivery; Medical
   Applications
ID SURFACE MODIFICATION; SYSTEMS; IRRADIATION; MEMBRANES; POLYMERS;
   COLLAGEN; PLASMA
AB Bacterial cellulose (BC) has established to be a remarkably versatile biomaterial and can be used in wide variety of applied scientific endeavors, especially for medical devices. In fact, biomedical devices recently have gained a significant amount of attention because of increased interesting tissue-engineered products for both wound care and the regeneration of damaged or diseased organs. The architecture of BC materials can be engineered over length scales ranging from nano to macro by controlling the biofabrication process, besides, surface modifications bring a vital role in in vivo performance of biomaterials. This work highlights the potential of gamma irradiation treatment for the modification of the BC surface properties, enhancing its potential for biomedical applications. Samples did not show significant variation in thermal properties, however, higher density of porous were produced in irradiated samples than non irradiated which produced slowly diffusion than nonirradiated membrane.
C1 [de Olyveira, Gabriel Molina; Manzine Costa, Ligia Maria] Univ Fed Abc, Dept Nanosci & Adv Mat, BR-09291210 Santo Andre, SP, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13566610 Sao Carlos, SP, Brazil.
RP de Olyveira, GM (reprint author), Univ Fed Abc, Dept Nanosci & Adv Mat, Rua Santa Adelia 166, BR-09291210 Santo Andre, SP, Brazil.
RI Manzine Costa, Ligia Maria/N-1780-2015
OI Manzine Costa, Ligia Maria/0000-0001-6483-7633
CR ALBIN G, 1986, ADV DRUG DELIVERY SY, P153
   Alvarez VA, 2006, POLYM DEGRAD STABIL, V91, P3156, DOI 10.1016/j.polymdegradstab.2006.07.011
   Basmaji P., 2011, J BIONANOSCIENCE, V5, P167
   Basmaji P., 2011, J NANOTECH ENG MED, V2, P34001
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Chan C. M, 1994, POLYM SURFACE MODIFI
   Costa L. M. M., 2012, J BIOMATER NANOBIOTE, V3, P92, DOI [10.4236/jbnb.2012.31012, DOI 10.4236/JBNB.2012.31012]
   Deepa B, 2011, BIORESOURCE TECHNOL, V102, P1988, DOI 10.1016/j.biortech.2010.09.030
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   George J, 2005, INT J BIOL MACROMOL, V37, P189, DOI 10.1016/j.ijbiomac.2005.10.007
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   HAIGLER CH, 1982, J CELL BIOL, V94, P64, DOI 10.1083/jcb.94.1.64
   Kaczmarek H, 2002, SURF SCI, V507, P883, DOI 10.1016/S0039-6028(02)01367-5
   Kofuji K, 2004, INT J PHARM, V272, P65, DOI 10.1016/j.ijpharm.2003.11.036
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Manfredi B.L., 2006, POLYM DEGRAD STABIL, V91, P255
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P48, DOI 10.1166/jbt.2012.1031
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   Olyveira G. M., 2011, J BIOMATER NANOBIOTE, V02, P239
   Olyveira G. M., 2011, J NANOTECHNOLOGY ENG, V2
   Olyveira G. M., 2011, NSTI NANOTECH, V3, P267
   Ouajai S., 2006, POLYM DEGRAD STABIL, V13, P131
   Owens DR, 2002, NAT REV DRUG DISCOV, V1, P529, DOI 10.1038/nrd836
   Pashkuleva I, 2005, J MATER SCI-MATER M, V16, P81, DOI 10.1007/s10856-005-6450-4
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Silva SS, 2008, MACROMOL BIOSCI, V8, P568, DOI 10.1002/mabi.200700264
   Stoica-Guzun A, 2007, NUCL INSTRUM METH B, V265, P434, DOI 10.1016/j.nimb.2007.09.036
   THACHARODI D, 1995, BIOMATERIALS, V16, P145, DOI 10.1016/0142-9612(95)98278-M
NR 31
TC 6
Z9 6
U1 0
U2 43
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD APR
PY 2013
VL 3
IS 2
BP 227
EP 232
DI 10.1166/jbt.2013.1079
PG 6
WC Cell & Tissue Engineering
SC Cell Biology
GA 130TG
UT WOS:000317942400008
DA 2018-10-20
ER

PT J
AU Gomes, S
   Gallego-Llamas, J
   Leonor, IB
   Mano, JF
   Reis, RL
   Kaplan, DL
AF Gomes, Silvia
   Gallego-Llamas, Jabier
   Leonor, Isabel B.
   Mano, Joao F.
   Reis, Rui L.
   Kaplan, David L.
TI In Vivo Biological Responses to Silk Proteins Functionalized with Bone
   Sialoprotein
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biocompatibility; chimeric protein; inflammation tests; spider silk;
   tissue engineering
ID SPIDER SILK; MACROPHAGE ADHESION; SIBLING PROTEINS; SERUM-PROTEINS;
   COLLAGEN; CELLS; BIOMATERIALS; LYMPHOCYTES; MATRIX; MINERALIZATION
AB Recombinant 6mer+BSP protein, combining six repeats of the consensus sequence for Nephila clavipes dragline (6mer) and bone sialoprotein sequence (BSP), shows good support for cell viability and induces the nucleation of hydroxyapatite and tricalcium phosphate during osteoblast in vitro culture. The present study is conducted to characterize this bioengineered protein-based biomaterial further for in vivo behavior related to biocompatibility. 6mer+BSP protein films are implanted in subcutaneous pouches in the back of mice and responses are evaluated by flow cytometry and histology. The results show no major differences between the inflammatory responses induced by 6mer+BSP films and the responses observed for the controls. Thus, this new chimeric protein could represent an alternative for bone regeneration applications.
C1 [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Gomes, Silvia; Gallego-Llamas, Jabier; Kaplan, David L.] Medford Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Gomes, Silvia; Gallego-Llamas, Jabier; Kaplan, David L.] Medford Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   [Gomes, Silvia; Gallego-Llamas, Jabier; Kaplan, David L.] Medford Tufts Univ, Dept Phys, Medford, MA 02155 USA.
RP Reis, RL (reprint author), Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM rgreis@dep.uminho.pt; david.kaplan@tufts.edu
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Reis, Rui
   L./A-8938-2008; Leonor, Isabel/B-5260-2011; Gomes, Silvia/J-6099-2013
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Reis,
   Rui L./0000-0002-4295-6129; Leonor, Isabel/0000-0002-4319-4883; Gomes,
   Silvia/0000-0002-4881-7808
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/28603/2006]; scope of the European NoE EXPERTISSUES, the FIND
   BIND project [NMP3-CT-2004-500283]; agency EU-EC (FP7 program); FCT R&D
   project ProteoLight [PTDC/FIS/68517/2006]; FCT agency; Chimera project
   [PTDC/EBB-EBI/109093/2008]; NIH [P41 EB002520, EB003210, DE017207];
   Tissue Engineering Resource Center
FX The authors thank Doctor Tircia Santos for her advice in this paper.
   Silvia Gomes thanks the Portuguese Foundation for Science and Technology
   (FCT) for providing her a PhD grant (SFRH/BD/28603/2006). This work was
   carried out under the scope of the European NoE EXPERTISSUES
   (NMP3-CT-2004-500283), the FIND & BIND project funded by the agency
   EU-EC (FP7 program), the FCT R&D project ProteoLight
   (PTDC/FIS/68517/2006) funded by the FCT agency, the Chimera project
   (PTDC/EBB-EBI/109093/2008) funded by the FCT agency, the NIH (P41
   EB002520) Tissue Engineering Resource Center and the NIH (EB003210 and
   DE017207).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20
   Benesch J, 2008, TISSUE ENG PART B-RE, V14, P433, DOI 10.1089/ten.teb.2008.0121
   Bergman AJ, 1999, BIOMATERIALS, V20, P2235, DOI 10.1016/S0142-9612(99)00154-4
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Chang DT, 2009, J BIOMED MATER RES A, V91A, P1210, DOI 10.1002/jbm.a.32218
   Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146
   FUJISAWA R, 1995, CALCIFIED TISSUE INT, V56, P140, DOI 10.1007/BF00296346
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Gomes S., 2010, SOFT MATTER, V7, P4964
   Graf HL, 2008, INT J ORAL MAX SURG, V37, P634, DOI 10.1016/j.ijom.2008.01.021
   GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8
   Hilbig H, 2007, EUR J MED RES, V12, P6
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kao W. J., 2008, BIOMATERIALS, V20, P2213
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071
   Mieszawska AJ, 2010, CHEM MATER, V22, P5780, DOI 10.1021/cm101940u
   Mishra Neeraj, 2008, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V7, P240, DOI 10.2174/187152308786847816
   Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078
   Montanaro F, 2003, P NATL ACAD SCI USA, V100, P9336, DOI 10.1073/pnas.1133179100
   O'Toole GC, 2004, J ORTHOPAED RES, V22, P641, DOI 10.1016/j.orthres.2003.09.005
   Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302
   Qin CL, 2001, EUR J ORAL SCI, V109, P133, DOI 10.1034/j.1600-0722.2001.00001.x
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   RUDOLPH R, 1990, CLIN PLAST SURG, V17, P457
   Ruiz JH, 2007, PARASITE IMMUNOL, V29, P671, DOI 10.1111/j.1365-3024.2007.00991.x
   Sallach RE, 2009, BIOMATERIALS, V30, P409, DOI 10.1016/j.biomaterials.2008.09.040
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822
   Tye CE, 2005, J BIOL CHEM, V280, P13487, DOI 10.1074/jbc.M408923200
   Valverde P, 2008, J BONE MINER RES, V23, P1775, DOI 10.1359/JBMR.080605
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   Wang JX, 2006, CALCIFIED TISSUE INT, V79, P179, DOI 10.1007/s00223-006-0018-2
   WEINER S, 1992, FASEB J, V6, P879
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xu L, 2007, BIOMATERIALS, V28, P750, DOI 10.1016/j.biomaterials.2006.09.022
   Yadav V, 2010, APPL ENVIRON MICROB, V76, P6257, DOI 10.1128/AEM.00698-10
   Yan SZ, 2001, J BIOL CHEM, V276, P8500, DOI 10.1074/jbc.M010361200
NR 50
TC 10
Z9 10
U1 2
U2 53
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR
PY 2013
VL 13
IS 4
BP 444
EP 454
DI 10.1002/mabi.201200372
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 132BS
UT WOS:000318043400006
PM 23359587
DA 2018-10-20
ER

PT J
AU Jagadale, PN
   Kulal, SR
   Joshi, MG
   Jagtap, PP
   Khetre, SM
   Bamane, SR
AF Jagadale, Pramod N.
   Kulal, Shivaji R.
   Joshi, Meghanath G.
   Jagtap, Pramod P.
   Khetre, Sanjay M.
   Bamane, Sambhaji R.
TI Synthesis and characterization of nanostructured CaSiO3 biomaterial
SO MATERIALS SCIENCE-POLAND
LA English
DT Article
DE biomaterials; cell viability; biocompatibility; X-ray diffraction
ID BIOCERAMICS IN-VITRO; CALCIUM SILICATE; SOL-GEL; BIOACTIVE GLASS;
   CERAMICS; HYDROXYAPATITE; NANOCOMPOSITES; BEHAVIOR; RELEASE; APATITE
AB Here we report a successful preparation of nanostructured calcium silicate by wet chemical approach. The synthesized sample was characterized by various physico-chemical methods. Thermal stability was investigated using thermo-gravimetric and differential thermal analysis (TG-DTA). Structural characterization of the sample was carried out by the X-ray diffraction technique (XRD) which confirmed its single phase hexagonal structure. Transmission electron microscopy (TEM) was used to study the nanostructure of the ceramics while homogeneous grain distribution was revealed by scanning electron microscopy studies (SEM). The elemental analysis data obtained from energy dispersive X-ray spectroscopy (EDAX) were in close agreement with the starting composition used for the synthesis. Superhydrophilic nature of CaSiO3 was investigated at room temperature by sessile drop technique. Effect of porous nanosized CaSiO3 on early adhesion and proliferation of human bone marrow mesenchymal stem cells (BMMSCs) and cord blood mesenchymal stem (CBMSCs) cells was measured in vitro. MTT cytotoxicity test and cell adhesion test showed that the material had good biocompatibility and promoted cell viability and cell proliferation. It has been stated that the cell viability and proliferation are significantly affected by time and concentration of CaSiO3. These findings indicate that the CaSiO3 ceramics has good biocompatibility and that it is promising as a biomaterial.
C1 [Jagadale, Pramod N.] Bharati Vidyapeeth Deemed Univ, YM Coll, Dept Chem, Pune 411038, Maharashtra, India.
   [Kulal, Shivaji R.; Jagtap, Pramod P.; Khetre, Sanjay M.; Bamane, Sambhaji R.] Dr Patangrao Kadam Mahavidyalaya, Dept Chem, Met Oxide Res Lab, Sangli 416416, MS, India.
   [Joshi, Meghanath G.] Stem One Biol Pvt Ltd, Pune 412108, Maharashtra, India.
RP Jagadale, PN (reprint author), Bharati Vidyapeeth Deemed Univ, YM Coll, Dept Chem, Pune 411038, Maharashtra, India.
EM pramodbioceramics@gmail.com
RI Deemed University, Bharati Vidyapeeth/A-6025-2016
FU UGC, New Delhi [34-296/2008 (SR)]
FX The authors would like to express their thanks to UGC, New Delhi for
   financial support through Major Research Project [F.No.34-296/2008 (SR)]
   and Dr. S. S. Kadam, Vice-Chancellor, Bharati Vidyapeeth Deemed
   University Pune, India, for his constant encouragement.
CR Balamurugan A, 2006, MATER LETT, V60, P3752, DOI 10.1016/j.matlet.2006.03.102
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Chang CK, 2000, CERAM INT, V26, P779, DOI 10.1016/S0272-8842(00)00019-5
   Fagerlund S, 2012, ACTA BIOMATER, V8, P2331, DOI 10.1016/j.actbio.2012.03.011
   Jia N, 2011, CARBOHYD RES, V346, P2970, DOI 10.1016/j.carres.2011.10.006
   Kulal SR, 2012, MATER LETT, V84, P169, DOI 10.1016/j.matlet.2012.06.025
   Lin KL, 2009, J EUR CERAM SOC, V29, P2937, DOI 10.1016/j.jeurceramsoc.2009.04.025
   Lin KL, 2005, J INORG MATER, V20, P692
   Lin KL, 2005, CERAM INT, V31, P323, DOI 10.1016/j.ceramint.2004.05.023
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Lynch E, 2012, DENT MATER, V28, P168, DOI 10.1016/j.dental.2011.11.021
   Lynn AK, 2005, J BIOMED MATER RES A, V74A, P447, DOI 10.1002/jbm.a.30373
   MAHADIK S, 2010, APPL SURF SCI, V25, P333
   Mansur S.H., 2008, CHEM ENG J, V137, P72
   Meiszterics A, 2008, COLLOID SURFACE A, V319, P143, DOI 10.1016/j.colsurfa.2007.08.021
   Ni SY, 2006, J BIOMED MATER RES A, V76A, P196, DOI 10.1002/jbm.a.30525
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Sainz MA, 2010, ACTA BIOMATER, V6, P2797, DOI 10.1016/j.actbio.2010.01.003
   Thompson SP, 2012, J NON-CRYST SOLIDS, V358, P885, DOI 10.1016/j.jnoncrysol.2011.12.080
   Wang C, 2012, ACTA BIOMATER, V8, P350, DOI 10.1016/j.actbio.2011.08.019
   Webster TJ, 2005, J BIOMED MATER RES A, V74A, P677, DOI 10.1002/jbm.a.30358
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Xue WC, 2009, ACTA BIOMATER, V5, P1686, DOI 10.1016/j.actbio.2009.01.012
   ZHAI W, 2012, ACTA BIOMATER, V8, P34
   Zhong HB, 2011, CERAM INT, V37, P2459, DOI 10.1016/j.ceramint.2011.03.037
NR 26
TC 2
Z9 2
U1 3
U2 40
PU OFICYNA WYDAWNICZA POLITECHNIKI WROCLAWSKIEJ
PI WROCLAW
PA WYBRZEZE WYSPIANSKIEGO 27, 50-370 WROCLAW, POLAND
SN 2083-1331
J9 MATER SCI-POLAND
JI Mater. Sci.
PD APR
PY 2013
VL 31
IS 2
BP 269
EP 275
DI 10.2478/s13536-012-0099-8
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 130YJ
UT WOS:000317956100017
DA 2018-10-20
ER

PT J
AU Iwabata, K
   Sugai, U
   Seki, Y
   Furue, H
   Sakaguchi, K
AF Iwabata, Kazuki
   Sugai, Urara
   Seki, Yasutaka
   Furue, Hirokazu
   Sakaguchi, Kengo
TI Applications of Biomaterials to Liquid Crystals
SO MOLECULES
LA English
DT Review
DE liquid crystal; biomaterial; DNA; peptide
ID FREQUENCY-MODULATION RESPONSE; HYDRATING WATER-MOLECULES; DNA PI-STACKS;
   HOLE TRANSFER; CHARGE-TRANSFER; PHYSICAL GELS; DIELECTRIC-PROPERTIES;
   DOPING NANOPARTICLES; ELECTRON-TRANSFER; AQUEOUS-SOLUTION
AB Nowadays, chemically synthesized proteins and peptides are attractive building blocks and have potential in many important applications as biomaterials. In this review, applications of biomaterials to thermotropic liquid crystals are discussed. The review covers the improvement of the performance of liquid crystal displays using liquid crystal physical gels consisting of a liquid crystal and amino acid-based gelators, and also new functionalization of liquid crystals. Moreover, the influence of DNA, which is one of the more attractive biomaterials, dispersed in thermotropic liquid crystals and its potential use in the liquid crystal industry is described. In addition, we found interesting results during electrooptical measurements of liquid crystals doped with DNA, and explain them from the point of view of biological applications. These recent approaches suggest that these biomaterials may be applicable in the electronic device industry and should be considered as an interesting material with their physical properties having the potential to create or refine an industrial product.
C1 [Iwabata, Kazuki; Sugai, Urara; Seki, Yasutaka; Sakaguchi, Kengo] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan.
   [Furue, Hirokazu] Tokyo Univ Sci, Dept Ind Chem, Noda, Chiba 2788510, Japan.
RP Iwabata, K (reprint author), Tokyo Univ Sci, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.
EM iwabata@rs.noda.tus.ac.jp; sugai.urara.63@gmail.com;
   y.seki1030@gmail.com; hfurue@rs.noda.tus.ac.jp; kengo@rs.noda.tus.ac.jp
CR Asai Y, 2003, J PHYS CHEM B, V107, P8716, DOI 10.1021/jp0307809
   Barnett RN, 2003, J PHYS CHEM A, V107, P3525, DOI 10.1021/jp022211r
   Barnett RN, 2001, SCIENCE, V294, P567, DOI 10.1126/science.1062864
   Bhargavi R, 2011, J APPL PHYS, V109, DOI 10.1063/1.3553413
   Brake JM, 2003, SCIENCE, V302, P2094, DOI 10.1126/science.1091749
   Cavalli S, 2010, CHEM SOC REV, V39, P241, DOI 10.1039/b906701a
   Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686
   Ciferri A, 2012, LIQ CRYST, V39, P1231, DOI 10.1080/02678292.2012.708441
   del Mercato LL, 2007, P NATL ACAD SCI USA, V104, P18019, DOI 10.1073/pnas.0702843104
   Eelkema R, 2006, ORG BIOMOL CHEM, V4, P3729, DOI 10.1039/b608749c
   Engels T, 1998, J MATER CHEM, V8, P1313, DOI 10.1039/a706141b
   Furue H, 2011, MOL CRYST LIQ CRYST, V540, P213, DOI 10.1080/15421406.2011.568884
   Gao BX, 2011, BEILSTEIN J ORG CHEM, V7, P198, DOI 10.3762/bjoc.7.26
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0
   Giese B, 2000, ACCOUNTS CHEM RES, V33, P631, DOI 10.1021/ar990040b
   Giese B, 2002, CURR OPIN CHEM BIOL, V6, P612, DOI 10.1016/S1367-5931(02)00364-2
   Gothelf KV, 2005, ORG BIOMOL CHEM, V3, P4023, DOI 10.1039/b510551j
   Guo AM, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061915
   Hamley IW, 2011, SOFT MATTER, V7, P4122, DOI 10.1039/c0sm01218a
   Hamley IW, 2010, SOFT MATTER, V6, P1863, DOI 10.1039/b923942a
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hirai Y, 2009, LANGMUIR, V25, P8423, DOI 10.1021/la804291j
   Inoue M, 2009, MOL CRYST LIQ CRYST, V510, P312, DOI 10.1080/15421400903070242
   Iwabata K., JPN J APPL PHY UNPUB
   Iwabata K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.087002
   Kamikawa Y, 2006, ORG LETT, V8, P2463, DOI 10.1021/ol060580q
   Kato T, 2006, ANGEW CHEM INT EDIT, V45, P38, DOI 10.1002/anie.200501384
   Kato T, 2002, SCIENCE, V295, P2414, DOI 10.1126/science.1070967
   Kawamoto H, 2002, P IEEE, V90, P460, DOI 10.1109/JPROC.2002.1002521
   Kelley SO, 1999, NUCLEIC ACIDS RES, V27, P4830, DOI 10.1093/nar/27.24.4830
   Kinsinger MI, 2010, SOFT MATTER, V6, P4095, DOI 10.1039/c0sm00080a
   Kobayashi S, 2006, J DISP TECHNOL, V2, P121, DOI 10.1109/JDT.2006.872306
   Kubar T, 2008, J PHYS CHEM B, V112, P8788, DOI 10.1021/jp803661f
   Kubar T, 2008, J PHYS CHEM B, V112, P7937, DOI 10.1021/jp801486d
   Kumar RJ, 2011, J AM CHEM SOC, V133, P8564, DOI 10.1021/ja110858k
   Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009
   Lewis JP, 2003, J PHYS CHEM B, V107, P2581, DOI 10.1021/jp026772u
   LIVOLANT F, 1991, PHYSICA A, V176, P117, DOI 10.1016/0378-4371(91)90436-G
   Livolant F, 1996, PROG POLYM SCI, V21, P1115, DOI 10.1016/S0079-6700(96)00016-0
   Lowe AM, 2012, CHEM MATER, V24, P746, DOI 10.1021/cm202632m
   Lowik DWPM, 2010, CHEM SOC REV, V39, P3394, DOI 10.1039/b914342b
   Lundgren JS, 2000, BIOSENS BIOELECTRON, V15, P417, DOI 10.1016/S0956-5663(00)00098-1
   Meggers E, 1998, J AM CHEM SOC, V120, P12950, DOI 10.1021/ja983092p
   Miyama T, 2004, JPN J APPL PHYS 1, V43, P2580, DOI 10.1143/JJAP.43.2580
   Mizoshita N, 1999, ADV MATER, V11, P392, DOI 10.1002/(SICI)1521-4095(199903)11:5<392::AID-ADMA392>3.0.CO;2-Q
   Mizoshita N, 2005, ADV MATER, V17, P692, DOI 10.1002/adma.200401401
   Mizoshita N, 2004, MOL CRYST LIQ CRYST, V409, P175, DOI 10.1080/15421400490431219
   Mizoshita N, 2003, ADV FUNCT MATER, V13, P313, DOI 10.1002/adfm.200304275
   Mizoshita N, 2002, J MATER CHEM, V12, P2197, DOI 10.1039/b201484j
   Nair GG, 2009, J PHYS CHEM B, V113, P6647, DOI 10.1021/jp900074e
   Nishii M, 2005, ORG BIOMOL CHEM, V3, P875, DOI 10.1039/b416474a
   Okada A, 2003, J MOL STRUC-THEOCHEM, V630, P283, DOI 10.1016/S0166-1280(03)00157-X
   Park JS, 2008, ADV MATER, V20, P1185, DOI 10.1002/adma.200702012
   Park JS, 2006, CHEM MATER, V18, P6147, DOI 10.1021/cm0606732
   POWELL MF, 1994, PHARMACEUT RES, V11, P1352, DOI 10.1023/A:1018963016079
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   REICH Z, 1994, SCIENCE, V264, P1460, DOI 10.1126/science.8197460
   Rey AD, 2010, SOFT MATTER, V6, P3402, DOI 10.1039/b921576j
   ROBINSON C, 1961, TETRAHEDRON, V13, P219, DOI 10.1016/S0040-4020(01)92215-X
   Roca-Sanjuan D, 2008, CHEM PHYS, V349, P188, DOI 10.1016/j.chemphys.2008.02.026
   Roche S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108101
   Sadowska-Aleksiejew A, 2006, CHEM PHYS LETT, V429, P546, DOI 10.1016/j.cplett.2006.08.050
   Safinya CR, 2011, LIQ CRYST, V38, P1715, DOI 10.1080/02678292.2011.624364
   Sawada N, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.100210
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Senthilkumar K, 2005, J AM CHEM SOC, V127, P14894, DOI 10.1021/ja054257e
   Severcan I, 2009, NANO LETT, V9, P1270, DOI 10.1021/nl900261h
   Shiraishi Y, 2002, APPL PHYS LETT, V81, P2845, DOI 10.1063/1.1511282
   Shiraki H, 2004, JPN J APPL PHYS 1, V43, P5425, DOI 10.1143/JJAP.43.5425
   Starikov EB, 2006, MOL SIMULAT, V32, P759, DOI 10.1080/08927020600835673
   Starikov EB, 2009, CHEM PHYS LETT, V467, P369, DOI 10.1016/j.cplett.2008.11.001
   Starikov EB, 2005, EUR PHYS J E, V18, P437, DOI 10.1140/epje/e2005-00047-4
   Sugiyama H, 1996, J AM CHEM SOC, V118, P7063, DOI 10.1021/ja9609821
   Suzuki Y, 2003, J MATER CHEM, V13, P2870, DOI 10.1039/b308098f
   Tada T, 2003, CHEMPHYSCHEM, V4, P1256, DOI 10.1002/cphc.200300811
   Thisayukta J, 2004, JPN J APPL PHYS 1, V43, P5430, DOI 10.1143/JJAP.43.5430
   Troisi A, 2002, J PHYS CHEM B, V106, P2093, DOI 10.1021/jp0133182
   Tsukamoto T, 2007, CHEM PHYS LETT, V441, P136, DOI 10.1016/j.cplett.2007.05.009
   Tsukamoto T, 2006, CHEM PHYS LETT, V429, P563, DOI 10.1016/j.cplett.2006.08.112
   Tsukamoto T, 2009, INT J QUANTUM CHEM, V109, P2058, DOI 10.1002/qua.22057
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   van Zalinge H, 2006, ANGEW CHEM INT EDIT, V45, P5499, DOI 10.1002/anie.200601263
   Versluis F, 2010, CHEM SOC REV, V39, P3434, DOI 10.1039/b919446k
   Voityuk AA, 2004, ANGEW CHEM INT EDIT, V43, P624, DOI 10.1002/anie.200352824
   Voityuk AA, 2006, CHEM PHYS LETT, V427, P177, DOI 10.1016/j.cplett.2006.06.101
   Woltman SJ, 2007, NAT MATER, V6, P929, DOI 10.1038/nmat2010
   Xu BQ, 2004, NANO LETT, V4, P1105, DOI 10.1021/nl0494295
   Xu MS, 2005, SMALL, V1, P1168, DOI 10.1002/smll.200500216
   Yanov I, 2008, J PHYS CHEM A, V112, P2069, DOI 10.1021/jp710956s
   Yoshikawa H, 2002, JPN J APPL PHYS 2, V41, pL1315, DOI 10.1143/JJAP.41.L1315
   Zalinge H. V., 2006, CHEMPHYSCHEM, V<IT>7</IT>, P94
   Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c
   Zidovska A, 2009, J PHYS CHEM B, V113, P3694, DOI 10.1021/jp806863z
NR 95
TC 15
Z9 15
U1 5
U2 87
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD APR
PY 2013
VL 18
IS 4
BP 4703
EP 4717
DI 10.3390/molecules18044703
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 131TV
UT WOS:000318020100072
PM 23603952
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Li, H
   Jia, Y
   Du, MC
   Fei, JB
   Zhao, J
   Cui, Y
   Li, JB
AF Li, Hong
   Jia, Yi
   Du, Mingchun
   Fei, Jinbo
   Zhao, Jie
   Cui, Yue
   Li, Junbai
TI Self-Organization of Honeycomb-like Porous TiO2 Films by means of the
   Breath-Figure Method for Surface Modification of Titanium Implants
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE breath-figure method; porosity; surface modification; thin films;
   titanium dioxide
ID PHOTONIC CRYSTALS; BLOCK-COPOLYMERS; STRUCTURED FILMS; CELL MORPHOLOGY;
   FOCAL ADHESION; POLYMER-FILMS; NANOPARTICLES; GROWTH; NANOTOPOGRAPHY;
   PHASE
AB This study describes a facile breath-figure method for the preparation of honeycomb-like porous TiO2 films with an organometallic small-molecule precursor. Multiple characterization techniques have been used to investigate the porous films and a mechanism for the formation process of porous TiO2 films through the breath-figure method is proposed. The pore size of the TiO2 films could be modulated by varying the experimental parameters, such as the concentration of titanium n-butoxide (TBT) solution, the content of cosolvent, and the air flow rate. In vitro cell-culture experiments indicate that NIH 3T3 fibroblast cells seeded on the honeycomb-like porous TiO2 films show good adhesion, spreading, and proliferation behaviors, which suggests that honeycomb-like porous TiO2 films are an attractive biomaterial for surface modification of titanium and its alloys implants in tissue engineering to enhance their biocompatibility and bioactivity.
C1 [Li, Hong; Jia, Yi; Fei, Jinbo; Zhao, Jie; Cui, Yue; Li, Junbai] Chinese Acad Sci, Inst Chem, CAS Key Lab Colloid & Interface Sci, BNLMS, Beijing 100190, Peoples R China.
   [Du, Mingchun] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed Res, Suzhou 215123, Peoples R China.
RP Li, JB (reprint author), Chinese Acad Sci, Inst Chem, CAS Key Lab Colloid & Interface Sci, BNLMS, Beijing 100190, Peoples R China.
EM jbli@iccas.ac.cn
RI Fei, Jinbo/D-5699-2013; Li, Junbai/M-4351-2016
OI Fei, Jinbo/0000-0002-8675-7412; Li, Junbai/0000-0001-9575-3125; gu,
   yi/0000-0001-9812-667X
FU National Nature Science Foundation of China [91027045, 21003136,
   21273250]; National Basic Research Program of China (973 Program)
   [2009CB930101]; Innovation Fund of the China National Petroleum
   Corporation [2010D-5006-0701]
FX We acknowledge financial support from the National Nature Science
   Foundation of China (project nos. 91027045, 21003136, and 21273250), the
   National Basic Research Program of China (973 Program, 2009CB930101),
   and the Innovation Fund of the China National Petroleum Corporation
   (2010D-5006-0701).
CR Akin FA, 2001, J BIOMED MATER RES, V57, P588, DOI 10.1002/1097-4636(20011215)57:4<588::AID-JBM1206>3.0.CO;2-Y
   Beattie D, 2006, BIOMACROMOLECULES, V7, P1072, DOI 10.1021/bm050858m
   Boker A, 2004, NAT MATER, V3, P302, DOI 10.1038/nmat1110
   Bunz UHF, 2006, ADV MATER, V18, P973, DOI 10.1002/adma.200501131
   Chen PC, 2011, LANGMUIR, V27, P12597, DOI 10.1021/la201911f
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Cozzoli PD, 2003, J AM CHEM SOC, V125, P14539, DOI 10.1021/ja036505h
   de Boer B, 2000, ADV MATER, V12, P1581, DOI 10.1002/1521-4095(200011)12:21<1581::AID-ADMA1581>3.0.CO;2-R
   Du MC, 2011, CHEM-EUR J, V17, P4238, DOI 10.1002/chem.201003021
   Englert BC, 2005, CHEM-EUR J, V11, P995, DOI 10.1002/chem.200400921
   Ferrari E, 2011, LANGMUIR, V27, P1874, DOI 10.1021/la104500j
   Fukuhira Y, 2006, BIOMATERIALS, V27, P1797, DOI 10.1016/j.biomaterials.2005.10.019
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Gray JJ, 2001, LANGMUIR, V17, P2317, DOI 10.1021/la001029j
   Haddow DB, 1996, BIOMATERIALS, V17, P501, DOI 10.1016/0142-9612(96)82724-4
   He J, 2008, J MATER SCI-MATER M, V19, P3465, DOI 10.1007/s10856-008-3505-3
   Hernandez-Guerrero M, 2012, POLYM CHEM-UK, V3, P563, DOI 10.1039/c1py00219h
   Jiang XL, 2010, LANGMUIR, V26, P2477, DOI 10.1021/la9027139
   Kato M, 2004, BIOCHEMISTRY-US, V43, P2699, DOI 10.1021/bi0352670
   Ke BB, 2010, LANGMUIR, V26, P15982, DOI 10.1021/la1030608
   Kim JK, 2009, IEEE PHOTONIC TECH L, V21, P21, DOI 10.1109/LPT.2008.2007912
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Lemons J. E., 1996, BIOMATERIALS SCI INT, P308
   Li J, 2005, LANGMUIR, V21, P2017, DOI 10.1021/la0476521
   Li L, 2010, J MATER CHEM, V20, P5446, DOI 10.1039/c0jm00405g
   Li XF, 2011, J AM CHEM SOC, V133, P3736, DOI 10.1021/ja1106767
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lu MH, 2006, ADV MATER, V18, P3094, DOI 10.1002/adma.200600744
   Ma HM, 2011, CHEM SOC REV, V40, P5457, DOI 10.1039/c1cs15059f
   Malfatti L, 2009, CHEM MATER, V21, P2763, DOI 10.1021/cm900289c
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Peng J, 2004, POLYMER, V45, P447, DOI 10.1016/j.polymer.2003.11.019
   Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279
   Srinivasarao M, 2001, SCIENCE, V292, P79, DOI 10.1126/science.1057887
   STEYER A, 1990, PHYS REV B, V42, P1086, DOI 10.1103/PhysRevB.42.1086
   Wang JX, 2011, ACCOUNTS CHEM RES, V44, P405, DOI 10.1021/ar1001236
   WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0
   Wijnhoven JEGJ, 1998, SCIENCE, V281, P802, DOI 10.1126/science.281.5378.802
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yonezawa T, 2001, ADV MATER, V13, P140, DOI 10.1002/1521-4095(200101)13:2<140::AID-ADMA140>3.0.CO;2-H
   Zhang Y, 2007, ADV MATER, V19, P913, DOI 10.1002/adma.200601169
   Zhao HJ, 2009, LANGMUIR, V25, P11032, DOI 10.1021/la901338j
   Zhu YD, 2011, ACS APPL MATER INTER, V3, P2487, DOI 10.1021/am200371c
NR 46
TC 21
Z9 21
U1 4
U2 153
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD APR
PY 2013
VL 19
IS 17
BP 5306
EP 5313
DI 10.1002/chem.201203353
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 130EA
UT WOS:000317894300013
PM 23447368
DA 2018-10-20
ER

PT J
AU Qi, C
   Zhu, YJ
   Lu, BQ
   Zhao, XY
   Zhao, J
   Chen, F
   Wu, J
AF Qi, Chao
   Zhu, Ying-Jie
   Lu, Bing-Qiang
   Zhao, Xin-Yu
   Zhao, Jing
   Chen, Feng
   Wu, Jin
TI Hydroxyapatite Hierarchically Nanostructured Porous Hollow Microspheres:
   Rapid, Sustainable Microwave-Hydrothermal Synthesis by Using Creatine
   Phosphate as an Organic Phosphorus Source and Application in Drug
   Delivery and Protein Adsorption
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE adsorption; drug delivery; microwave chemistry; nanostructures; proteins
ID SPRAY-DRYING METHOD; ASSISTED SYNTHESIS; CALCIUM ORTHOPHOSPHATES; DOPED
   HYDROXYAPATITE; BOVINE HEMOGLOBIN; NANORODS; LUMINESCENT; CARRIER;
   PARTICLES; RELEASE
AB Hierarchically nanostructured porous hollow microspheres of hydroxyapatite (HAP) are a promising biomaterial, owing to their excellent biocompatibility and porous hollow structure. Traditionally, synthetic hydroxyapatite is prepared by using an inorganic phosphorus source. Herein, we report a new strategy for the rapid, sustainable synthesis of HAP hierarchically nanostructured porous hollow microspheres by using creatine phosphate disodium salt as an organic phosphorus source in aqueous solution through a microwave-assisted hydrothermal method. The as-obtained products are characterized by powder X-ray diffraction (XRD), Fourier-transform IR (FTIR) spectroscopy, SEM, TEM, BrunauerEmmettTeller (BET) nitrogen sorptometry, dynamic light scattering (DLS), and thermogravimetric analysis (TGA). SEM and TEM micrographs show that HAP hierarchically nanostructured porous hollow microspheres consist of HAP nanosheets or nanorods as the building blocks and DLS measurements show that the diameters of HAP hollow microspheres are within the range 0.81.5m. The specific surface area and average pore size of the HAP porous hollow microspheres are 87.3m2g1 and 20.6nm, respectively. The important role of creatine phosphate disodium salt and the influence of the experimental conditions on the products were systematically investigated. This method is facile, rapid, surfactant-free and environmentally friendly. The as-prepared HAP porous hollow microspheres show a relatively high drug-loading capacity and protein-adsorption ability, as well as sustained drug and protein release, by using ibuprofen as a model drug and hemoglobin (Hb) as a model protein, respectively. These experiments indicate that the as-prepared HAP porous hollow microspheres are promising for applications in biomedical fields, such as drug delivery and protein adsorption.
C1 [Qi, Chao; Zhu, Ying-Jie; Lu, Bing-Qiang; Zhao, Xin-Yu; Zhao, Jing; Chen, Feng; Wu, Jin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
RI Qi, Chao/N-5957-2015; CHEN, Feng/E-4310-2016; Chen, Feng/D-6406-2012
OI CHEN, Feng/0000-0002-1162-1684; Chen, Feng/0000-0002-1162-1684
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [51172260, 51102258,
   51121064]; Science and Technology Commission of Shanghai [11nm0506600];
   State Key Laboratory of High Performance Ceramics and Superfine
   Microstructure
FX Financial support from the National Basic Research Program of China (973
   Program, 2012CB933600), the National Natural Science Foundation of China
   (51172260, 51102258, 51121064), the Science and Technology Commission of
   Shanghai (11nm0506600), and the State Key Laboratory of High Performance
   Ceramics and Superfine Microstructure is gratefully acknowledged.
CR Andersson J, 2004, CHEM MATER, V16, P4160, DOI 10.1021/cm0401490
   Cao SW, 2010, NANOSCALE RES LETT, V5, P781, DOI 10.1007/s11671-010-9558-5
   Chen F, 2011, BIOMATERIALS, V32, P9031, DOI 10.1016/j.biomaterials.2011.08.032
   Chen F, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-67
   Chen F, 2011, CRYSTENGCOMM, V13, P1858, DOI 10.1039/c0ce00574f
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dorozhkin SV, 2002, ANGEW CHEM, V114, P3260
   Gao W, 2011, BIOMATERIALS, V32, P9425, DOI 10.1016/j.biomaterials.2011.08.046
   GEDYE R, 1986, TETRAHEDRON LETT, V27, P279, DOI 10.1016/S0040-4039(00)83996-9
   GIGUERE RJ, 1986, TETRAHEDRON LETT, V27, P4945, DOI 10.1016/S0040-4039(00)85103-5
   Henzler K, 2007, BIOMACROMOLECULES, V8, P3674, DOI 10.1021/bm700953e
   Hou ZY, 2009, CHEM-EUR J, V15, P6973, DOI 10.1002/chem.200900269
   Jevtic M, 2008, CRYST GROWTH DES, V8, P2217, DOI 10.1021/cg7007304
   Jiang SD, 2012, J PHYS CHEM C, V116, P4484, DOI 10.1021/jp211648x
   Jiao Y, 2012, POWDER TECHNOL, V217, P581, DOI 10.1016/j.powtec.2011.11.025
   Jongpoiboonkit L, 2009, ADV MATER, V21, P1960, DOI 10.1002/adma.200801808
   Kawai T, 2009, J CERAM SOC JPN, V117, P340, DOI 10.2109/jcersj2.117.340
   Ma MG, 2009, EUR J INORG CHEM, V2009, P5522
   Ma MG, 2006, J PHYS CHEM B, V110, P14226, DOI 10.1021/jp061738r
   Ma MY, 2008, J MATER CHEM, V18, P2722, DOI 10.1039/b800389k
   Ng SX, 2010, ACTA BIOMATER, V6, P3772, DOI 10.1016/j.actbio.2010.03.017
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Qi C, 2013, CHEM-EUR J, V19, P981, DOI 10.1002/chem.201202829
   Qi C, 2012, J MATER CHEM, V22, P22642, DOI 10.1039/c2jm35280j
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun RX, 2009, MAT SCI ENG C-BIO S, V29, P1088, DOI 10.1016/j.msec.2008.08.010
   Tang QL, 2011, NANOMED-NANOTECHNOL, V7, P428, DOI 10.1016/j.nano.2010.12.005
   Tseng YH, 2009, MAT SCI ENG C-BIO S, V29, P819, DOI 10.1016/j.msec.2008.07.028
   Tsuji M, 2005, CHEM-EUR J, V11, P440, DOI 10.1002/chem.200400417
   Wang KW, 2011, MATER LETT, V65, P2361, DOI 10.1016/j.matlet.2011.04.104
   Wang KW, 2010, CHEM-ASIAN J, V5, P2477, DOI 10.1002/asia.201000463
   Wang KW, 2010, J MATER CHEM, V20, P1161, DOI 10.1039/b917441a
   Wang X, 2006, ADV MATER, V18, P2031, DOI 10.1002/adma.200600033
   Wu GJ, 2010, J COLLOID INTERF SCI, V345, P427, DOI 10.1016/j.jcis.2010.01.048
   Xia W, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/30/305610
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Zhang CM, 2010, J MATER CHEM, V20, P6674, DOI 10.1039/c0jm01036g
   Zhang CM, 2010, BIOMATERIALS, V31, P3374, DOI 10.1016/j.biomaterials.2010.01.044
   Zhang CM, 2009, CRYST GROWTH DES, V9, P2725, DOI 10.1021/cg801353n
   Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011
   Zhang HB, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/031002
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhu Y., 2004, ANGEW CHEM, V116, P1434, DOI DOI 10.1002/ANGE.200353101
   Zhu YJ, 2004, ANGEW CHEM INT EDIT, V43, P1410, DOI 10.1002/anie.200353101
NR 46
TC 97
Z9 100
U1 10
U2 204
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD APR
PY 2013
VL 19
IS 17
BP 5332
EP 5341
DI 10.1002/chem.201203886
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 130EA
UT WOS:000317894300016
PM 23460360
DA 2018-10-20
ER

PT J
AU Thasler, WE
   Thasler, RMK
   Schelcher, C
   Jauch, KW
AF Thasler, Wolfgang E.
   Thasler, Reinhard M. K.
   Schelcher, Celine
   Jauch, Karl-Walter
TI Biobanking for research in surgery: are surgeons in charge for advancing
   translational research or mere assistants in biomaterial and data
   preservation?
SO LANGENBECKS ARCHIVES OF SURGERY
LA English
DT Review
DE Translational research; Biobanking; Tissue banking; Pre-analytics;
   Informed consent; Biobank governance
ID HUMAN HEPATOCYTES; PROTEIN EXPRESSION; PROTEOMIC ANALYSIS; EMBEDDED
   TISSUES; CANCER TISSUE; PURIFICATION; EXTRACTION; ETHICS; CELLS; LEGAL
AB High-quality biospecimens of human origin with annotated clinical and procedural data are an important tool for biomedical research, not only to map physiology, pathophysiology and aetiology but also to go beyond in translational research. This has opened a new special field of research known as 'biobanking', which focuses on how to collect, store and provide these specimens and data, and which is substantially supported by national and European funding.
   An overview on biobanking is given, with a closer look on a clinical setting, concerning a necessary distinction from clinical trials and studies as well as a comparison of prospective sample collection with secondary use of archived samples from diagnostics. Based on a summary of possible use and scientific impact of human tissue in research, it is shown how surgical expertise boosts the scientific value of specimens and data. Finally, an assessment of legal and ethical issues especially from a surgical perspective is given, followed by a model of interdisciplinary biobanking within a joint 'centre' that as synergistic structure merges essential input from surgery as well as laboratory medicine, pathology and biometry.
   Within the domain of biobanking, surgeons have to develop a better awareness of their role within translational research, not only on the level of medical faculties but also as nationally and internationally funded initiatives. Therefore, the authors suggest a platform for biobanking within the German association of surgeons in analogy to the existing special interest group for clinical trials.
C1 [Thasler, Wolfgang E.; Jauch, Karl-Walter] Univ Munich, Dept Gen Visceral Transplantat Vasc & Thorac Surg, D-81377 Munich, Germany.
   [Thasler, Wolfgang E.; Thasler, Reinhard M. K.; Schelcher, Celine] Univ Munich, Tissue Bank, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Grosshadern Hosp,Med Ctr, D-81377 Munich, Germany.
   [Thasler, Reinhard M. K.] BioM Biotech Cluster Dev GmbH, Munich Biobank Alliance, D-82512 Martinsried, Germany.
RP Thasler, WE (reprint author), Univ Munich, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Marchioninistr 15, D-81377 Munich, Germany.
EM wolfgang.thasler@med.uni-muenchen.de
FU Bundesministerium fur Bildung und Forschung (BMBF) [01EX1020B]
FX Serene Lee's scientific input and support in design of Figs. 3 and 4 is
   notably appreciated. We thank Serene Lee and Geoffrey Halvorsen for the
   assistance in proof reading this manuscript. This work was partly
   carried out with financial support from the Bundesministerium fur
   Bildung und Forschung (BMBF; grant name M4 Munich Biotech Excellence
   Cluster Biobank Alliance, grant number 01EX1020B).
CR Axelrod DA, 2000, ARCH SURG-CHICAGO, V135, P55, DOI 10.1001/archsurg.135.1.55
   Bao WG, 2012, ANN SURG ONCOL
   Behne T, 2012, INT J HEPATOL, DOI 10.1155/2012/859076
   Bernini P, 2011, J BIOMOL NMR, V49, P231, DOI 10.1007/s10858-011-9489-1
   Bioethik-Kommission d.B.S, 2010, DBS BIOB STELL BIOET
   Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572
   Brisson AR, 2012, PEDIATRICS, V129, P153, DOI 10.1542/peds.2011-0134
   Bundesarztekammer, 1991, POS QUAL PATH
   Bundesarztekammer, 2011, MUST BER DEUTSCHL TA
   CHEN DS, 1984, GASTROENTEROLOGY, V86, P1404
   Christoph Revermann A. S, 2006, BIOBANKEN HUMANMEDIZ
   Conrad C, 2011, ANN SURG, V253, P566, DOI 10.1097/SLA.0b013e3181fcb5d8
   Cordell S, 2011, HEALTH CARE ANAL, V19, P282, DOI 10.1007/s10728-011-0180-1
   Demeure MJ, 2010, PANCREAS, V39, P949, DOI 10.1097/MPA.0b013e3181df27a8
   Deutsche-Forschungsgemeinschaft, 2011, STELL DFG SEN KLIN F
   DeutscherEthikrat, 2010, HUM FORSCH STELL
   Evers K, 2012, BIOPRESERV BIOBANK, V10, P476, DOI 10.1089/bio.2012.1062
   Failli A, 2009, TUMORI, V95, P343
   Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102
   Gibbons SMC, 2009, MED LAW REV, V17, P313, DOI 10.1093/medlaw/fwp016
   Giesbertz NAA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001373
   Glaysher S, 2011, METHODS MOL BIOL, V731, P135, DOI 10.1007/978-1-61779-080-5_12
   Goebel JW, 2010, EUR J HUM GENET, V18, P522, DOI 10.1038/ejhg.2009.214
   GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0
   Gomez-Lechon MJ, 2006, XENOBIOTICA, V36, P457, DOI 10.1080/00498250600674352
   Herpel E, 2012, FORUM, V27, P47
   Hoeyer K, 2008, BIOTECHNOL GENET ENG, V25, P429, DOI 10.5661/bger-25-429
   Hofler H, 2006, Verh Dtsch Ges Pathol, V90, P46
   Hofmann B, 2009, J MED ETHICS, V35, P125, DOI 10.1136/jme.2008.024851
   Hofmann B, 2009, ETHICS OF RESEARCH BIOBANKING, P3, DOI 10.1007/978-0-387-93872-1_1
   Hollands P, 2009, STEM CELL REV REP, V5, P195, DOI 10.1007/s12015-009-9082-0
   Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200
   Hoppe N, 2007, ETHICS LAW INTELLECT, P199
   Hoppe Nils, 2009, BIOEQUITY PROPERTY H
   Huss R, 2004, J VASC RES, V41, P422, DOI 10.1159/000081441
   Jiang XG, 2007, J PROTEOME RES, V6, P1038, DOI 10.1021/pr0605318
   Karlsen JR, 2009, ETHICS OF RESEARCH BIOBANKING, P331, DOI 10.1007/978-0-387-93872-1_21
   Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683
   Lee SML, 2013, MOL BIOTECHNOL, V53, P1, DOI 10.1007/s12033-011-9493-4
   Li AP, 2007, CHEM-BIOL INTERACT, V168, P16, DOI 10.1016/j.cbi.2007.01.001
   Li AP, 1999, CHEM-BIOL INTERACT, V121, P17, DOI 10.1016/S0009-2797(99)00088-5
   Lin JH, 2009, ANAL BIOCHEM, V395, P265, DOI 10.1016/j.ab.2009.08.016
   Luque JS, 2012, J CANCER EDUC, V27, P91, DOI 10.1007/s13187-011-0275-2
   McGinnity DF, 2004, DRUG METAB DISPOS, V32, P1247, DOI 10.1124/dmd.104.000026
   McKneally MF, 2009, WORLD J SURG, V33, P1341, DOI 10.1007/s00268-009-0021-7
   Moore HM, 2011, J PROTEOME RES, V10, P3429, DOI 10.1021/pr200021n
   Neumeister VM, 2012, J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438
   Nirmalan NJ, 2011, J PROTEOME RES, V10, P896, DOI 10.1021/pr100812d
   Oberlander M, 2013, LANGENBECKS ARCH SUR
   Organ. Econ. Coop. Dev. (OECD), 2009, OECD GUID HUM BIOB G
   Palmer-Toy DE, 2005, J PROTEOME RES, V4, P2404, DOI 10.1021/pr050208p
   PATH, 2012, PAT TUM BANK HOP
   Qi J, 2013, NEOPLASMA, V60, P135, DOI 10.4149/neo_2013_018
   Rentoft M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035276
   Riegman PHJ, 2011, HUM GENET, V130, P357, DOI 10.1007/s00439-011-1074-x
   Riegman PHJ, 2008, MOL ONCOL, V2, P213, DOI 10.1016/j.molonc.2008.07.004
   Robienski J, 2010, FINANCE INSURANCE LA, V3
   ROSSLER D, 1982, LANGENBECK ARCH CHIR, V358, P47, DOI 10.1007/BF01271754
   RUPP GM, 1988, BIOTECHNIQUES, V6, P56
   Schroder C, 2011, CELL TISSUE BANK, V12, P233, DOI 10.1007/s10561-010-9190-8
   Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548
   Segerdahl P, 2012, BIOBANK SWEDEN, P3
   Shickle D, 2006, STUD HIST PHI PART C, V37, P503, DOI 10.1016/j.shpsc.2006.06.007
   Shickle D, 2010, PATHOBIOLOGY, V77, P181, DOI 10.1159/000292651
   Shulman Maria, 2013, Methods Mol Biol, V945, P287, DOI 10.1007/978-1-62703-125-7_17
   Simeon-Dubach D, 2012, J PATHOL
   Simon J, 2007, EUR J HUM GENET, V15, P528, DOI 10.1038/sj.ejhg.5201810
   Simon Jurgen, 2009, J Int Bioethique, V20, P47
   Simon Jurgen, 2009, J Int Bioethique, V20, P17
   Simon JW, 2006, SCHRIFTENREIHE TELEM, V2
   Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04
   Taga M, 2013, INT J CLIN EXP PATHO, V6, P76
   Thasler WE, 2006, ATLA-ALTERN LAB ANIM, V34, P387
   Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112
   Treweek S, 2009, J HEALTH SERV RES PO, V14, P13, DOI 10.1258/jhsrp.2008.008016
   Widdows H, 2011, HEALTH CARE ANAL, V19, P207, DOI 10.1007/s10728-011-0184-x
   Wolff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016353
   Yang HK, 2011, PATHOBIOLOGY, V78, P320, DOI 10.1159/000331225
   Yuille M, 2008, BRIEF BIOINFORM, V9, P14, DOI 10.1093/bib/bbm050
   Zech E, 2007, FACULTY LAW
NR 80
TC 9
Z9 9
U1 1
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1435-2443
EI 1435-2451
J9 LANGENBECK ARCH SURG
JI Langenbecks Arch. Surg.
PD APR
PY 2013
VL 398
IS 4
BP 487
EP 499
DI 10.1007/s00423-013-1060-y
PG 13
WC Surgery
SC Surgery
GA 131EH
UT WOS:000317974800002
PM 23430290
DA 2018-10-20
ER

PT J
AU Le, DHT
   Hanamura, R
   Pham, DH
   Kato, M
   Tirrell, DA
   Okubo, T
   Sugawara-Narutaki, A
AF Le, Duc H. T.
   Hanamura, Ryo
   Dieu-Huong Pham
   Kato, Masaru
   Tirrell, David A.
   Okubo, Tatsuya
   Sugawara-Narutaki, Ayae
TI Self-Assembly of Elastin-Mimetic Double Hydrophobic Polypeptides
SO BIOMACROMOLECULES
LA English
DT Article
ID EXPRESSED HUMAN ELASTIN; HUMAN TROPOELASTIN; SUPRAMOLECULAR
   ORGANIZATION; MECHANICAL-PROPERTIES; PROTEIN; BIOPOLYMERS; BIOMATERIAL;
   DISSECTION; SEQUENCES; POLYMERS
AB We have constructed a novel class of "double-hydrophobic block polypeptides based on the hydrophobic domains found in native elastin, an extracellular matrix protein responsible for the elasticity and resilience of tissues. The block polypeptides comprise proline-rich poly(VPGXG) and glycinerich poly(VGGVG), both of which dehydrate at higher temperature but form distinct secondary structures, beta-turn and beta-sheet respectively. In water at 45 degrees C, the block polypeptides initially assemble into nanoparticles rich in beta-turn structures, which further connect into long (>10 mu m), beaded nanofibers along with the increase in the beta-sheet content The nanofibers obtained are well dispersed in water, and show thermoresponsive properties. Polypeptides comprising each block component assemble into different morphologies, showing that the conjugation of poly(VPGXG) and poly(VGGVG) plays a role for beaded fiber formation. These results may provide innovative ideas for designing peptide based materials but also opportunities for developing novel materials useful for tissue engineering and drug delivery systems.
C1 [Le, Duc H. T.; Hanamura, Ryo; Dieu-Huong Pham; Okubo, Tatsuya; Sugawara-Narutaki, Ayae] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Kato, Masaru] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.
   [Kato, Masaru] Univ Tokyo, Global COE Program, Bunkyo Ku, Tokyo 1130033, Japan.
   [Tirrell, David A.] CALTECH, Joseph J Jacobs Inst Mol Engn Med, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
RP Sugawara-Narutaki, A (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ayae@chemsys.t.u-tokyo.ac.jp
RI LE, DUC/T-2119-2018
OI LE, DUC/0000-0002-3539-0462; Sugawara-Narutaki, Ayae/0000-0003-3579-6689
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan [22107005]; Japan Society for the Promotion of Science (JSPS);
   Center for Nanobio Integration (CNBI); Center for Medical System
   Integration (CMSI); Center for Nano Lithography and Analysis; University
   of Tokyo; MEXT
FX This work was supported by a Grant-in-Aid for Scientific Research (No.
   22107005) on the Innovative Areas: "Fusion Materials" (Area No. 2206)
   from the Ministry of Education, Culture, Sports, Science and Technology
   (MEXT), Japan. D.H.T.L. is grateful to a Grant-in-Aid for Young
   Scientists from the Japan Society for the Promotion of Science (JSPS). A
   part of this work was conducted at the Center for Nanobio Integration
   (CNBI), Center for Medical System Integration (CMSI), and Center for
   Nano Lithography and Analysis, The University of Tokyo, supported by
   MEXT. We thank Profs. Yukio Yamaguchi and Teruyuki Nagamune for their
   help in the preparation of polypeptides.
CR Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   Bochicchio B, 2007, BIOMACROMOLECULES, V8, P3478, DOI 10.1021/bm700636a
   Bochicchio B, 2011, CHIRALITY, V23, P694, DOI 10.1002/chir.20979
   BRESSAN GM, 1986, J ULTRA MOL STRUCT R, V94, P209, DOI 10.1016/0889-1605(86)90068-6
   Chilkoti A, 2006, CURR OPIN CHEM BIOL, V10, P652, DOI 10.1016/j.cbpa.2006.10.010
   Chow DC, 2006, BIOTECHNOL PROGR, V22, P638, DOI 10.1021/bp0503742
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   del Mercato LL, 2008, BIOMACROMOLECULES, V9, P796, DOI 10.1021/bm7010104
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Diehl MR, 2006, SCIENCE, V311, P1468, DOI 10.1126/science.1122125
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Flamia R, 2007, BIOMACROMOLECULES, V8, P128, DOI 10.1021/bm060764s
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Kim W, 2010, ADV DRUG DELIVER REV, V62, P1468, DOI 10.1016/j.addr.2010.04.007
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Lee J, 2001, MACROMOLECULES, V34, P5968, DOI 10.1021/ma0017844
   Matsuura K, 2011, CHEM COMMUN, V47, P265, DOI 10.1039/c0cc01324b
   McMillan RA, 2000, MACROMOLECULES, V33, P4809, DOI 10.1021/ma9921091
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Muiznieks LD, 2010, J BIOL CHEM, V285, P39779, DOI 10.1074/jbc.M110.164467
   Nagapudi K, 2005, BIOMATERIALS, V26, P4695, DOI 10.1016/j.biomaterials.2004.11.027
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Pepe A, 2005, MATRIX BIOL, V24, P96, DOI 10.1016/j.matbio.2005.01.004
   Pepe A, 2007, NANOMEDICINE-UK, V2, P203, DOI 10.2217/17435889.2.2.203
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Reguera J, 2004, J AM CHEM SOC, V126, P13212, DOI 10.1021/ja047417f
   Ruan LP, 2009, P NATL ACAD SCI USA, V106, P5105, DOI 10.1073/pnas.0900026106
   Sallach RE, 2010, BIOMATERIALS, V31, P779, DOI 10.1016/j.biomaterials.2009.09.082
   Tamburro AM, 2005, J BIOL CHEM, V280, P2682, DOI 10.1074/jbc.M411617200
   Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t
   Tamburro AM, 2009, NANOMEDICINE-UK, V4, P469, DOI 10.2217/NNM.09.18
   URRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819, DOI 10.1002/anie.199308191
   URRY DW, 1985, BIOCHEM BIOPH RES CO, V130, P50, DOI 10.1016/0006-291X(85)90380-8
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Zhang KC, 2005, J AM CHEM SOC, V127, P10136, DOI 10.1021/ja051457h
   Zhang KC, 2009, CHEMBIOCHEM, V10, P2617, DOI 10.1002/cbic.200900542
NR 40
TC 29
Z9 29
U1 1
U2 109
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2013
VL 14
IS 4
BP 1028
EP 1034
DI 10.1021/bm301887m
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 123EF
UT WOS:000317370500011
PM 23495825
DA 2018-10-20
ER

PT J
AU Hessenauer, M
   Reichel, CA
   Berghaus, A
   Strieth, S
AF Hessenauer, M.
   Reichel, C. A.
   Berghaus, A.
   Strieth, S.
TI Tissue plasminogen activator and plasminogen activator inhibitor-1
   promote tissue integration of biomaterial
SO EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Meeting Abstract
C1 [Hessenauer, M.; Reichel, C. A.] Walter Brendel Ctr Expt Med, Munich, Germany.
   [Hessenauer, M.; Reichel, C. A.; Berghaus, A.] Univ Munich, Dept Otorhinolaryngol, Munich, Germany.
   [Strieth, S.] Goethe Univ Frankfurt, Dept Otorhinolaryngol, D-60054 Frankfurt, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2972
J9 EUR J CLIN INVEST
JI Eur. J. Clin. Invest.
PD APR
PY 2013
VL 43
SU 1
SI SI
BP 8
EP 8
PG 1
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA 120AE
UT WOS:000317141000024
DA 2018-10-20
ER

PT J
AU Oprenyeszk, F
   Chausson, M
   Maquet, V
   Dubuc, JE
   Henrotin, Y
AF Oprenyeszk, F.
   Chausson, M.
   Maquet, V.
   Dubuc, J-E.
   Henrotin, Y.
TI THE INTRA-ARTICULAR INJECTION OF A NEW CHITOSAN BIOMATERIAL PREVENTS THE
   PROGRESSION OF OSTEOARTHRITIS IN ACLT RABBIT MODEL
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Meeting Abstract
CT World Congress of the Osteoarthritis-Research-Society-International
   (OARSI)
CY APR 18-21, 2013
CL Philadelphia, PA
SP OsteoArthritis Res Soc Int (OARSI)
C1 [Oprenyeszk, F.; Henrotin, Y.] Univ Liege, BCRU, Liege, Belgium.
   [Chausson, M.; Maquet, V.] KitoZyme SA, Herstal, Belgium.
   [Dubuc, J-E.] Clin Univ St Luc, Dept Orthopaed, B-1200 Brussels, Belgium.
   [Henrotin, Y.] Princess Paola Hosp, Phys Therapy & Rehabil Dept, Vivalia, Marche, Belgium.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD APR
PY 2013
VL 21
SU S
BP S69
EP S69
DI 10.1016/j.joca.2013.02.150
PG 1
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 130TF
UT WOS:000317942300140
OA Bronze
DA 2018-10-20
ER

PT J
AU Peterson, RO
   Vucetich, JA
   Vucetich, LM
AF Peterson, R. O.
   Vucetich, J. A.
   Vucetich, L. M.
TI THE INTRA-ARTICULAR INJECTION OF A NEW CHITOSAN BIOMATERIAL PREVENTS THE
   PROGRESSION OF OSTEOARTHRITIS IN ACLT RABBIT MODEL
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Meeting Abstract
CT World Congress of the Osteoarthritis-Research-Society-International
   (OARSI)
CY APR 18-21, 2013
CL Philadelphia, PA
SP OsteoArthritis Res Soc Int (OARSI)
C1 [Peterson, R. O.; Vucetich, J. A.; Vucetich, L. M.] Michigan Technol Univ, Houghton, MI 49931 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD APR
PY 2013
VL 21
SU S
BP S69
EP S69
DI 10.1016/j.joca.2013.02.151
PG 1
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 130TF
UT WOS:000317942300141
OA Bronze
DA 2018-10-20
ER

PT J
AU Sreejit, P
   Verma, RS
AF Sreejit, P.
   Verma, R. S.
TI Natural ECM as Biomaterial for Scaffold Based Cardiac Regeneration Using
   Adult Bone Marrow Derived Stem Cells
SO STEM CELL REVIEWS AND REPORTS
LA English
DT Article
DE Cellular therapy; Biomaterials; Niche; Cardiac regeneration;
   Differentiation
ID ACUTE MYOCARDIAL-INFARCTION; AMERICAN-HEART-ASSOCIATION; SKELETAL-MUSCLE
   CELLS; PHENOTYPE IN-VITRO; EXTRACELLULAR-MATRIX; PROGENITOR CELLS;
   ISCHEMIC-MYOCARDIUM; STROMAL CELLS; CARDIOMYOCYTE DIFFERENTIATION;
   TISSUE-REPAIR
AB Cellular therapy using stem cells for cardiac diseases has recently gained much interest in the scientific community due to its potential in regenerating damaged and even dead tissue and thereby restoring the organ function. Stem cells from various sources and origin are being currently used for regeneration studies directly or along with differentiation inducing agents. Long term survival and minimal side effects can be attained by using autologous cells and reduced use of inducing agents. Cardiomyogenic differentiation of adult derived stem cells has been previously reported using various inducing agents but the use of a potentially harmful DNA demethylating agent 5-azacytidine (5-azaC) has been found to be critical in almost all studies. Alternate inducing factors and conditions/stimulant like physical condition including electrical stimulation, chemical inducers and biological agents have been attempted by numerous groups to induce cardiac differentiation. Biomaterials were initially used as artificial scaffold in in vitro studies and later as a delivery vehicle. Natural ECM is the ideal biological scaffold since it contains all the components of the tissue from which it was derived except for the living cells. Constructive remodeling can be performed using such natural ECM scaffolds and stem cells since, the cells can be delivered to the site of infraction and once delivered the cells adhere and are not "lost". Due to the niche like conditions of ECM, stem cells tend to differentiate into tissue specific cells and attain several characteristics similar to that of functional cells even in absence of any directed differentiation using external inducers. The development of niche mimicking biomaterials and hybrid biomaterial can further advance directed differentiation without specific induction. The mechanical and electrical integration of these materials to the functional tissue is a problem to be addressed. The search for the perfect extracellular matrix for therapeutic applications including engineering cardiac tissue structures for post ischemic cardiac tissue regeneration continues.
C1 [Sreejit, P.; Verma, R. S.] Indian Inst Technol, Dept Biotechnol, Stem Cell & Mol Biol Lab, Madras 600036, Tamil Nadu, India.
   [Verma, R. S.] Indian Inst Technol, Dept Biotechnol, Stem Cell & Mol Biol Lab, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India.
RP Verma, RS (reprint author), Indian Inst Technol, Dept Biotechnol, Stem Cell & Mol Biol Lab, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India.
EM vermars@iitm.ac.in
OI Verma, Rama/0000-0001-7287-7803
CR Adler ED, 2010, FASEB J, V24, P1073, DOI 10.1096/fj.09-135426
   American Heart Association, 1999, HEART STROK STAT UPD
   Antonitsis Polychronis, 2007, Interact Cardiovasc Thorac Surg, V6, P593, DOI 10.1510/icvts.2007.157875
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   ATALA A, 2002, METHODS TISSUE ENG
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011
   Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460
   Bartunek J, 2009, CLIN PHARMACOL THER, V85, P548, DOI 10.1038/clpt.2008.295
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Beqqali A, 2009, CELL MOL LIFE SCI, V66, P800, DOI 10.1007/s00018-009-8476-0
   Bettiol E, 2007, REV PHYSIOL BIOCH P, V157, P1, DOI 10.1007/s112_0508
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bick RJ, 1998, CELL ADHES COMMUN, V6, P301, DOI 10.3109/15419069809010789
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Boyang Z., 2011, NANOTECHNOLOGY, V22, DOI DOI 10.1088/0957-4484/22/49/494003.PMID:22101261
   Braunwald E, 2000, CIRCULATION, V102, P14
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Caplice Noel M, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS129, DOI 10.1038/ncpcardio0432
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chang W, 2007, TISSUE ENG REGEN MED, V4, P370
   Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034
   CHIU RCJ, 1995, ANN THORAC SURG, V60, P12
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   CIHAK A, 1974, ONCOLOGY, V30, P405
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Dimarakis I, 2005, EUR J CARDIO-THORAC, V28, P665, DOI 10.1016/j.ejcts.2005.08.013
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   Eschenhagen T, 1997, FASEB J, V11, P683
   Eshghi S, 2008, ENG MICROENVIRONMENT
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fukuda K, 2003, BONE MARROW TRANSPL, V32, pS25, DOI 10.1038/sj.bmt.1703940
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Gersh BJ, 2009, MAYO CLIN PROC, V84, P876, DOI 10.1016/S0025-6196(11)60505-3
   Giraud M.-N., 2012, CARDIOLOGY RES PRACT, V10
   Giraud MN, 2007, TISSUE ENG, V13, P1825, DOI 10.1089/ten.2006.0110
   Guan JJ, 2011, BIOMATERIALS, V32, P5568, DOI 10.1016/j.biomaterials.2011.04.038
   Heng BC, 2004, CARDIOVASC RES, V62, P34, DOI 10.1016/j.cardiores.2003.12.022
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Jabbari E., 2010, BIOL RESPONSIVE HYBR
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Jones DA, 2012, HEART, V98, P1626, DOI 10.1136/heartjnl-2011-301540
   Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60
   Kang H. J., 2008, EUROPEAN HEART J S, V10, pK39
   Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   KOH GY, 1993, J CLIN INVEST, V92, P1548, DOI 10.1172/JCI116734
   KONIECZNY SF, 1984, CELL, V38, P791, DOI 10.1016/0092-8674(84)90274-5
   Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2
   Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35
   Kurdi Mazen, 2010, Congest Heart Fail, V16, P132, DOI 10.1111/j.1751-7133.2010.00145.x
   Kutschka I., 2006, CIRCULATION S, V114, pI
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li RK, 1996, ANN THORAC SURG, V62, P654
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Loke WK, 1996, BIOMATERIALS, V17, P2163, DOI 10.1016/0142-9612(96)00053-1
   MacArthur BD, 2005, NATURE, V433, P19, DOI 10.1038/433019a
   Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Marelli D, 1992, Cell Transplant, V1, P383
   Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1
   Mason C, 2010, REGEN MED, V5, P307, DOI [10.2217/rme.10.37, 10.2217/RME.10.37]
   Matsuura K, 2004, J CELL BIOL, V167, P351, DOI 10.1083/jcb.200312111
   Maulik N, 2008, J MOL CELL CARDIOL, V44, P219, DOI 10.1016/j.yjmcc.2007.11.012
   McLaren A, 2001, NATURE, V414, P129, DOI 10.1038/35102194
   Melo LG, 2004, CIRCULATION, V109, P2386, DOI 10.1161/01.CIR.0000128597.37025.00
   Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023
   Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002
   Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374
   Minato A., 2011, BIOMATERIALS, V33, P515
   Miner EC, 2006, MAYO CLIN PROC, V81, P71, DOI 10.4065/81.1.71
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   National Institutes of Health, 2006, REG MED
   Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040
   O'Brien T, 2009, MAYO CLIN PROC, V84, P859, DOI 10.1016/S0025-6196(11)60501-6
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47
   Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X
   Reinecke H, 2004, CIRC RES, V94, pE56, DOI 10.1161/01.RES.0000125294.04612.81
   Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588
   Robert P. Lanza, 2000, PRINCIPLES TISSUE EN
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Rosca AM, 2011, STEM CELLS DEV, V20, P1213, DOI 10.1089/scd.2010.0433
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104
   Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530
   Sanchez P. L., 2006, NATURAL CLIN PRACTIC, V3, pS133
   Schenke-Layland K, 2011, BIOMATERIALS, V32, P2748, DOI 10.1016/j.biomaterials.2010.12.046
   Schmidt D, 2006, SWISS MED WKLY, V136, P618
   Schuleri K. H., 2007, V180, P195
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Shim W, 2011, CARDIOVASC RES, V89, P20, DOI 10.1093/cvr/cvq301
   SIMPSON DG, 1994, J CELL PHYSIOL, V161, P89, DOI 10.1002/jcp.1041610112
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Song H, 2007, STEM CELLS, V25, P1431, DOI 10.1634/stemcells.2006-0467
   Song H, 2010, EXPERT OPIN BIOL TH, V10, P309, DOI 10.1517/14712590903455997
   Sreejit P, 2011, EUR CELLS MATER, V21, P107, DOI 10.22203/eCM.v021a09
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Tathe A., 2010, INT J PHARM PHARM SC, V2, P19
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Traverse JH, 2012, J CARDIOVASC TRANSL, V5, P67, DOI 10.1007/s12265-011-9330-y
   van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X
   van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113
   van Laake LW, 2010, CELL MOL LIFE SCI, V67, P277, DOI 10.1007/s00018-009-0179-z
   van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505
   van Laake LW, 2006, J PHYSIOL-LONDON, V577, P467, DOI 10.1113/jphysiol.2006.115816
   Van Laake LW, 2005, ANN MED, V37, P499, DOI 10.1080/07853890500327843
   VanWinkle WB, 1996, IN VITRO CELL DEV-AN, V32, P478
   Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang F, 2010, ADV DRUG DELIVER REV, V62, P784, DOI 10.1016/j.addr.2010.03.001
   Wang JS, 2001, J THORAC CARDIOV SUR, V122, P699, DOI 10.1067/mtc.2001.116317
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
   Wei-xin L, 2004, J WUHAN U NAT SCI ED, V9, P513
   Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1
   Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Wong SSY, 2010, REGEN MED, V5, P763, DOI [10.2217/rme.10.52, 10.2217/RME.10.52]
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Wu KH, 2006, EUR J CARDIO-THORAC, V30, P770, DOI 10.1016/j.ejcts.2006.08.003
   Xu WR, 2004, EXP BIOL MED, V229, P623
   Yacoub Magdi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS133, DOI 10.1038/ncpcardio0401
   Yang J, 2005, MRS BULL, V30, P189, DOI 10.1557/mrs2005.51
   Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057
   Young PP, 2007, PROG CARDIOVASC DIS, V49, P421, DOI 10.1016/j.pcad.2007.02.004
   Yousef M, 2009, J AM COLL CARDIOL, V53, P2262, DOI 10.1016/j.jacc.2009.02.051
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zipori D, 2005, STEM CELLS, V23, P719, DOI 10.1634/stemcells.2005-0030
   Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885
NR 172
TC 30
Z9 32
U1 0
U2 51
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1550-8943
EI 1558-6804
J9 STEM CELL REV REP
JI Stem Cell Rev. Rep.
PD APR
PY 2013
VL 9
IS 2
BP 158
EP 171
DI 10.1007/s12015-013-9427-6
PG 14
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
SC Cell Biology; Research & Experimental Medicine
GA 119CI
UT WOS:000317074300007
PM 23319217
DA 2018-10-20
ER

PT J
AU Sahoo, NG
   Pan, YZ
   Li, L
   He, CB
AF Sahoo, Nanda Gopal
   Pan, Yong Zheng
   Li, Lin
   He, Chao Bin
TI Nanocomposites for bone tissue regeneration
SO NANOMEDICINE
LA English
DT Review
DE biodegradable; biomaterial; bone regeneration; nanocomposite; scaffold
ID BIPHASIC CALCIUM-PHOSPHATE; IN-SITU SYNTHESIS; COMPOSITE SCAFFOLDS;
   MECHANICAL-PROPERTIES; HYDROXYAPATITE COMPOSITE; ENGINEERING SCAFFOLDS;
   POLYMER SCAFFOLDS; CARBON NANOTUBES; DRUG-RELEASE; CHITOSAN
AB Natural bone tissue possesses a nanocomposite structure that provides appropriate physical and biological properties. For bone tissue regeneration, it is crucial for the biomaterial to mimic living bone tissue. Since no single type of material is able to mimic the composition, structure and properties of native bone, nanocomposites are the best choice for bone tissue regeneration as they can provide the appropriate matrix environment, integrate desirable biological properties, and provide controlled, sequential delivery of multiple growth factors for the different stages of bone tissue regeneration. This article reviews the composition, structure and properties of advanced nanocomposites for bone tissue regeneration. It covers aspects of interest such as the biomimetic synthesis of bone-like nanocomposites, guided bone regeneration from inert biomaterials and bioactive nanocomposites, and nanocomposite scaffolds for bone tissue regeneration. The design, fabrication, and in vitro and in vivo characterization of such nanocomposites are reviewed.
C1 [Sahoo, Nanda Gopal; Pan, Yong Zheng; Li, Lin] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
   [Sahoo, Nanda Gopal; Pan, Yong Zheng; He, Chao Bin] Inst Mat Res & Engn, Singapore 117602, Singapore.
RP Li, L (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mlli@ntu.edu.sg
RI He, Chaobin/G-5755-2011; Li, Lin/G-5107-2010
OI He, Chaobin/0000-0001-8200-8337; 
CR Aboudzadeh N, 2010, J BIOMED MATER RES A, V94A, P137, DOI 10.1002/jbm.a.32673
   Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Barbani N, 2012, J MATER SCI-MATER M, V23, P51, DOI 10.1007/s10856-011-4505-2
   Barone DTJ, 2011, POLYM ADVAN TECHNOL, V22, P463, DOI 10.1002/pat.1845
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Calandrelli L, 2010, J MATER SCI-MATER M, V21, P2923, DOI 10.1007/s10856-010-4156-8
   Cheng L, 2008, MATER RES INNOV, V12, P192, DOI 10.1179/143307508X362837
   Chesnutt BM, 2009, TISSUE ENG PT A, V15, P2571, DOI 10.1089/ten.tea.2008.0054
   Chesnutt BM, 2009, J BIOMED MATER RES A, V88A, P491, DOI 10.1002/jbm.a.31878
   Cunniffe GM, 2010, J MATER SCI-MATER M, V21, P2293, DOI 10.1007/s10856-009-3964-1
   Diba M, 2012, COMPOS SCI TECHNOL, V72, P716, DOI 10.1016/j.compscitech.2012.01.023
   Duan B, 2010, ACTA BIOMATER, V6, P4495, DOI 10.1016/j.actbio.2010.06.024
   Fang B, 2009, TISSUE ENG PT A, V15, P1091, DOI 10.1089/ten.tea.2008.0110
   Fang LM, 2007, COMPOS PART B-ENG, V38, P345, DOI 10.1016/j.compositesb.2006.05.004
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   Fu SZ, 2012, BIOMATERIALS, V33, P8363, DOI 10.1016/j.biomaterials.2012.08.023
   Fu SZ, 2012, BIOMATERIALS, V33, P4801, DOI 10.1016/j.biomaterials.2012.03.040
   Fu SZ, 2010, J PHYS CHEM C, V114, P18372, DOI 10.1021/jp106488t
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Huang J, 2007, J MATER SCI-MATER M, V18, P2151, DOI 10.1007/s10856-007-3201-8
   Huang YX, 2008, J BIOMATER APPL, V22, P409, DOI 10.1177/0885328207077632
   James R, 2011, FRONT MATER SCI, V5, P342, DOI 10.1007/s11706-011-0151-3
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Jeon BJ, 2012, MACROMOL RES, V20, P715, DOI 10.1007/s13233-012-0103-5
   Jiang LY, 2008, J MATER SCI-MATER M, V19, P981, DOI 10.1007/s10856-007-3208-1
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Jung Y, 2005, BIOMATERIALS, V26, P6314, DOI 10.1016/j.biomaterials.2005.04.007
   Khan YM, 2004, J BIOMED MATER RES A, V69A, P728, DOI 10.1002/jbm.a.30051
   Kharaziha M, 2010, J MECH BEHAV BIOMED, V3, P530, DOI 10.1016/j.jmbbm.2010.06.003
   Kim HW, 2007, J BIOMED MATER RES A, V83A, P169, DOI 10.1002/jbm.a.31247
   Kim HW, 2005, J BIOMED MATER RES B, V75B, P34, DOI 10.1002/jbm.b.30223
   Kim HW, 2004, J BIOMED MATER RES A, V70A, P467, DOI 10.1002/j.jbm.a.30100
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   Lee KW, 2008, BIOMATERIALS, V29, P2839, DOI 10.1016/j.biomaterials.2008.03.030
   Li K, 2012, ADV ENG MATER, V14, pB155, DOI 10.1002/adem.201080145
   Li LJ, 2008, POLYM INT, V57, P1226, DOI 10.1002/pi.2466
   Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lin CL, 2011, COLLOID SURFACE B, V83, P367, DOI 10.1016/j.colsurfb.2010.12.011
   Liu L, 2011, POLYM ADVAN TECHNOL, V22, P909, DOI 10.1002/pat.1595
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Liu Y, 2009, BIOMATERIALS, V30, P6276, DOI 10.1016/j.biomaterials.2009.08.003
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t
   Luo DM, 2011, MATER LETT, V65, P2395, DOI 10.1016/j.matlet.2011.05.011
   Luo TJM, 2010, J SOL-GEL SCI TECHN, V53, P459, DOI 10.1007/s10971-009-2114-z
   Luo XL, 2005, CHEM COMMUN, P2169, DOI 10.1039/b419197h
   Ma R, 2012, J SOL-GEL SCI TECHN, V62, P52, DOI 10.1007/s10971-012-2682-1
   Mattioli-Belmonte M, 2012, MAT SCI ENG C-MATER, V32, P152, DOI 10.1016/j.msec.2011.10.010
   Mehrabanian M, 2012, INT J POLYM MATER, V61, P558, DOI 10.1080/00914037.2011.593061
   Niu L, 2010, J NANOMATER, DOI 10.1155/2010/729457
   Notodihardjo FZ, 2012, J CRANIO MAXILL SURG, V40, P287, DOI 10.1016/j.jcms.2011.04.008
   ONO I, 1995, J CRANIOFAC SURG, V6, P238, DOI 10.1097/00001665-199505000-00011
   Ono I, 1998, J BONE MINER METAB, V16, P81, DOI 10.1007/s007740050030
   Pan LL, 2012, COLLOID SURFACE B, V93, P226, DOI 10.1016/j.colsurfb.2012.01.011
   Peter M, 2010, CHEM ENG J, V158, P353, DOI 10.1016/j.cej.2010.02.003
   Petricca SE, 2006, ACTA BIOMATER, V2, P277, DOI 10.1016/j.actbio.2005.12.004
   Pielichowska K, 2010, ADV POLYM SCI, V232, P97, DOI 10.1007/12_2010_50
   Poursamar SA, 2011, COLLOID SURFACE B, V84, P310, DOI 10.1016/j.colsurfb.2011.01.015
   Reves Benjamin T, 2012, J Funct Biomater, V3, P114, DOI 10.3390/jfb3010114
   Rogel MR, 2008, J MATER CHEM, V18, P4233, DOI 10.1039/b804692a
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Russias J, 2006, MAT SCI ENG C-BIO S, V26, P1289, DOI 10.1016/j.msec.2005.08.004
   Sahithi K, 2010, INT J BIOL MACROMOL, V46, P281, DOI 10.1016/j.ijbiomac.2010.01.006
   Saranya N, 2011, J BIOMED NANOTECHNOL, V7, P238, DOI 10.1166/jbn.2011.1283
   Saska S, 2011, INT J BIOMATER, DOI 10.1155/2011/175362
   Scholz MS, 2011, COMPOS SCI TECHNOL, V71, P1791, DOI 10.1016/j.compscitech.2011.08.017
   Sendemir-Urkmez A, 2007, J BIOMED MATER RES A, V81A, P624, DOI 10.1002/jbm.a.31010
   Serizawa T, 2003, J BIOMAT SCI-POLYM E, V14, P653, DOI 10.1163/156856203322274914
   Sharifi S, 2011, POLYM ADVAN TECHNOL, V22, P605, DOI 10.1002/pat.1553
   Stodolak-Zych E, 2012, ACTA PHYS POL A, V121, P518, DOI 10.12693/APhysPolA.121.518
   Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Tanaka T, 2007, MAT SCI ENG C-BIO S, V27, P817, DOI 10.1016/j.msec.2006.09.019
   Thein-Han WW, 2008, MATER SCI TECH-LOND, V24, P1062, DOI 10.1179/174328408X341753
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Tripathi A, 2012, INT J BIOL MACROMOL, V50, P294, DOI 10.1016/j.ijbiomac.2011.11.013
   Venkatesan J, 2012, INT J BIOL MACROMOL, V51, P1033, DOI 10.1016/j.ijbiomac.2012.08.020
   Venkatesan J, 2012, INT J BIOL MACROMOL, V50, P393, DOI 10.1016/j.ijbiomac.2011.12.032
   Venkatesan J, 2011, CARBOHYD POLYM, V83, P569, DOI 10.1016/j.carbpol.2010.08.019
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   VENUGOPAL J, 2007, NANOTECHNOLOGY, V18
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wang C, 2012, ACTA BIOMATER, V8, P350, DOI 10.1016/j.actbio.2011.08.019
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wang Y, 2008, J BIOMED MATER RES B, V86B, P29, DOI 10.1002/jbm.b.30984
   Webb AR, 2007, J MATER CHEM, V17, P900, DOI 10.1039/b611353b
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Yu NYC, 2010, J BIOMED MATER RES B, V93B, P285, DOI 10.1002/jbm.b.31588
   Zeng S, 2011, J BIOMED NANOTECHNOL, V7, P549, DOI 10.1166/jbn.2011.1316
   Zhang PB, 2009, BIOMATERIALS, V30, P58, DOI 10.1016/j.biomaterials.2008.08.041
   Zhang X, 2007, COMPOS PART A-APPL S, V38, P843, DOI 10.1016/j.compositesa.2006.08.002
NR 93
TC 30
Z9 32
U1 0
U2 155
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD APR
PY 2013
VL 8
IS 4
SI SI
BP 639
EP 653
DI 10.2217/NNM.13.44
PG 15
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 120NU
UT WOS:000317178200021
PM 23560413
DA 2018-10-20
ER

PT J
AU Persichetti, P
   Palazzolo, D
   Tenna, S
   Poccia, I
   Abbruzzese, F
   Trombetta, M
AF Persichetti, Paolo
   Palazzolo, Dario
   Tenna, Stefania
   Poccia, Igor
   Abbruzzese, Franca
   Trombetta, Marcella
TI Dermal Filler Complications from Unknown Biomaterials: Identification by
   Attenuated Total Reflectance Spectroscopy
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID SOFT-TISSUE AUGMENTATION; INJECTABLE SILICONE; BIOCOMPATIBILITY;
   ULTRASOUND; IMPLANTS; HISTORY
AB Background: In the last decade, an increase in complications related to dermal filler injections has been reported, especially in patients who underwent multiple treatments with different products. Imaging or histological examinations may suggest what kind of substance was used, but none can precisely identify the biomaterial. The aim of this study was to evaluate the use of Fourier transform infrared spectroscopy, using an attenuated total reflectance cell, in the identification of unknown dermal fillers.
   Methods: In the preclinical study, samples from different manufacturers were analyzed according to attenuated total reflectance spectroscopy using the Nicolet 8700 FT-IR spectrophotometer (resolution, 0.125 cm(-1); Thermo Fisher Scientific, Inc., Madison, Wis.). Spectra of each biomaterial were collected and included in a reference database. In the clinical study, seven patients affected by severe complications due to multiple injections with unknown fillers provided a sample of the pathological tissue for the analysis.
   Results: Two granulomas, two infiltrated tissues, and three abscesses were studied. Attenuated total reflectance/Fourier transform infrared analysis of pathological tissues revealed the presence of absorption bands absent in the healthy tissue. Comparison of these bands to the filler database made it possible to identify the dermal fillers injected.
   Conclusions: This pilot study has demonstrated the absolute validity of the application of infrared spectroscopy in attenuated total reflectance for the determination of infiltrated biomaterial. The knowledge of the previously injected fillers may be crucial to selecting the appropriate medical or surgical treatment as well as to solving medical-legal issues. (Plast. Reconstr. Surg. 131: 597e, 2013.)
C1 [Tenna, Stefania] Campus Biomed Roma Univ, Plast & Reconstruct Surg Unit, I-00128 Rome, Italy.
   Campus Biomed Roma Univ, CIR, Lab Chem & Biomat, I-00128 Rome, Italy.
RP Tenna, S (reprint author), Campus Biomed Roma Univ, Plast & Reconstruct Surg Unit, Via Alvaro Portillo 200, I-00128 Rome, Italy.
EM s.tenna@unicampus.it
OI Abbruzzese, Franca/0000-0002-8157-5193; Trombetta,
   Marcella/0000-0002-1357-4885; Persichetti, Paolo/0000-0001-8857-6060;
   Tenna, Stefania/0000-0001-7858-1528
CR Bailey SH, 2011, AESTHET SURG J, V31, P110, DOI 10.1177/1090820X10391083
   Broder KW, 2006, PLAST RECONSTR SURG, V118, P7
   Cassuto D, 2009, DERMATOL SURG, V35, P1689, DOI 10.1111/j.1524-4725.2009.01348.x
   Chasan PE, 2007, PLAST RECONSTR SURG, V120, P2034, DOI 10.1097/01.prs.0000267580.92163.33
   Cohen JL, 2008, DERMATOL SURG, V34, pS92, DOI 10.1111/j.1524-4725.2008.34249.x
   Cohen SR, 2004, PLAST RECONSTR SURG, V114, P964, DOI 10.1097/01.PRS.0000133169.16467.5F
   Fernandez-Cossio S, 2006, PLAST RECONSTR SURG, V117, P1789, DOI 10.1097/01.prs.0000214656.07273.b0
   Grippaudo FR, 2011, ANN PLAS SURG, V67, P469, DOI 10.1097/SAP.0b013e318203ebf6
   Kuptsov AH, 1998, HDB FOURIER TRANSFOR, P388
   Laeschke K, 2004, SEMIN CUTAN MED SURG, V23, P214, DOI 10.1016/j.sder.2004.09.005
   Lemperle G, 2006, PLAST RECONSTR SURG, V118, p92S, DOI 10.1097/01.prs.0000234672.69287.77
   Morris CL, 2008, OPHTHAL PLAST RECONS, V24, P117, DOI 10.1097/IOP.0b013e318166dd2a
   Narins RS, 2006, PLAST RECONSTR SURG, V118, p77S, DOI 10.1097/01.prs.0000234919.25096.67
   Nettar K, 2012, FACIAL PLAST SURG, V28, P288, DOI 10.1055/s-0032-1312695
   Persichetti P, 2009, ANN PLAS SURG, V63, P373, DOI 10.1097/SAP.0b013e3181953791
   Rallan D, 2003, CLIN EXP DERMATOL, V28, P632, DOI 10.1046/j.1365-2230.2003.01405.x
   Sachdev Mukta, 2010, J Cutan Aesthet Surg, V3, P162, DOI 10.4103/0974-2077.74493
   Sclafani AP, 2009, DERMATOL SURG, V35, P1672, DOI 10.1111/j.1524-4725.2009.01346.x
   Sherman RN, 2009, CLIN DERMATOL, V27, pS23, DOI 10.1016/j.clindermatol.2008.12.002
   Stocks D, 2011, J DRUGS DERMATOL, V10, P974
   Winslow CP, 2009, FACIAL PLAST SURG, V25, P124, DOI 10.1055/s-0029-1220653
   Young SR, 2008, SKIN RES TECHNOL, V14, P320, DOI 10.1111/j.1600-0846.2008.00297.x
NR 22
TC 4
Z9 4
U1 1
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD APR
PY 2013
VL 131
IS 4
BP 597E
EP 603E
DI 10.1097/PRS.0b013e3182827741
PG 7
WC Surgery
SC Surgery
GA 121YW
UT WOS:000317282800014
PM 23542278
DA 2018-10-20
ER

PT J
AU von der Mark, K
   Park, J
AF von der Mark, Klaus
   Park, Jung
TI Engineering biocompatible implant surfaces Part II: Cellular recognition
   of biomaterial surfaces: Lessons from cell-matrix interactions
SO PROGRESS IN MATERIALS SCIENCE
LA English
DT Review
ID GROWTH-FACTOR-BETA; FOCAL ADHESION KINASE; BASEMENT-MEMBRANE LAMININ;
   3-DIMENSIONAL COLLAGEN LATTICES; HYALURONAN-BASED SCAFFOLD;
   CAPILLARY-LIKE STRUCTURES; MAMMARY EPITHELIAL-CELLS; PROCOLLAGEN
   N-PROTEINASE; COLD-INSOLUBLE GLOBULIN; HUMAN-ENDOTHELIAL CELLS
C1 [von der Mark, Klaus] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Expt Med 1, D-91054 Erlangen, Germany.
   [Park, Jung] Univ Hosp Erlangen, Div Mol Pediat, Dept Pediat, Erlangen, Germany.
RP von der Mark, K (reprint author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Expt Med 1, D-91054 Erlangen, Germany.
EM kvdmark@molmed.uni-erlangen.de; jpark@molmed.uni-erlangen.de
CR Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554
   ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0
   Adams Josephine C., 2004, International Journal of Biochemistry & Cell Biology, V36, P961, DOI 10.1016/j.biocel.2004.01.004
   AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Aplin AE, 1998, PHARMACOL REV, V50, P197
   Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x
   Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217
   Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S095506740200371X
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   AUMAILLEY M, 1989, EXP CELL RES, V181, P463, DOI 10.1016/0014-4827(89)90103-1
   AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x
   AUMAILLEY M, 1990, EXP CELL RES, V188, P55, DOI 10.1016/0014-4827(90)90277-H
   Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   Ayad S., 1998, EXTRACELLULAR MATRIX
   BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204
   Balazs EA, 2008, CURR PHARM BIOTECHNO, V9, P236, DOI 10.2174/138920108785161596
   Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   BARD JBL, 1975, J CELL BIOL, V67, P400, DOI 10.1083/jcb.67.2.400
   Bauer S, 2006, ELECTROCHEM COMMUN, V8, P1321, DOI 10.1016/j.elecom.2006.05.030
   Bax DV, 2009, J BIOL CHEM, V18, P18
   Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3
   BECKER U, 1975, EUR J BIOCHEM, V54, P359, DOI 10.1111/j.1432-1033.1975.tb04146.x
   Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O
   BELL E, 1983, J INVEST DERMATOL, V81, pS2, DOI 10.1111/1523-1747.ep12539993
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370
   Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749
   Bottaro DP, 2002, ANN NY ACAD SCI, V961, P158, DOI 10.1111/j.1749-6632.2002.tb03071.x
   Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0
   Brinckmann J, 2005, COLLAGEN PRIMARY STR
   Brizzi MF, 2012, CURR OPIN CELL BIOL, V2012, P13
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   BRONNERFRASER M, 1986, DEV BIOL, V117, P528, DOI 10.1016/0012-1606(86)90320-9
   BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   BRUCKNER P, 1994, MICROSC RES TECHNIQ, V28, P378, DOI 10.1002/jemt.1070280504
   Bruckner-Tuderman L, 1999, J DERMATOL SCI, V20, P122, DOI 10.1016/S0923-1811(99)00018-3
   Bulleid NJ, 2000, BIOCHEM SOC T, V28, P350, DOI 10.1042/0300-5127:0280350
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, P250
   BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129
   BURGESON RE, 1988, ANNU REV CELL BIOL, V4, P551, DOI 10.1146/annurev.cellbio.4.1.551
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383
   Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Cavalcanti-Adam EA, 2008, HFSP J, V2, P276, DOI 10.2976/1.2976662
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Cavalcanti-Adam Elisabetta Ada, 2005, Prog Orthod, V6, P232
   Cavallo C, 2010, J BIOMED MATER RES A, V93A, P86, DOI 10.1002/jbm.a.32547
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b
   Chajra H, 2008, BIO-MED MATER ENG, V18, pS33
   Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868
   CHAMBARD M, 1981, J CELL BIOL, V91, P157, DOI 10.1083/jcb.91.1.157
   Chan D, 1998, MATRIX BIOL, V17, P169, DOI 10.1016/S0945-053X(98)90056-7
   Chan KT, 2007, METHOD ENZYMOL, V426, P47, DOI 10.1016/S0076-6879(07)26003-3
   CHENG S, 1994, J MED CHEM, V37, P1, DOI 10.1021/jm00027a001
   Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P986, DOI 10.1016/j.biocel.2003.12.002
   CHOI HU, 1983, J BIOL CHEM, V258, P655
   CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x
   Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098
   Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   CORY AH, 1991, CANCER COMMUN, V3, P207
   Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cunningham LW, 1987, METHOD ENZYMOL, P561
   Curtis ASG, 2006, J R SOC INTERFACE, V3, P393, DOI 10.1098/rsif.2005.0104
   Cushing MC, 2007, BIOMATERIALS, V28, P3378, DOI 10.1016/j.biomaterials.2007.04.005
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6
   DELVOYE P, 1986, BRIT J DERMATOL, V115, P139, DOI 10.1111/j.1365-2133.1986.tb05709.x
   Denault Jean-Bernard, 2008, V414, P191
   DESSAU W, 1978, BIOCHIM BIOPHYS ACTA, V533, P227, DOI 10.1016/0005-2795(78)90566-4
   DESSAU W, 1978, BIOCHEM J, V169, P55, DOI 10.1042/bj1690055
   DEUTZMANN R, 1990, EUR J BIOCHEM, V191, P513, DOI 10.1111/j.1432-1033.1990.tb19151.x
   DOEGE KJ, 1986, J BIOL CHEM, V261, P8924
   Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200
   DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219
   DUBAND JL, 1986, J CELL BIOL, V102, P160, DOI 10.1083/jcb.102.1.160
   Dubey PK, 2010, DRUG DELIV, V17, P541, DOI 10.3109/10717544.2010.490249
   Dubey PK, 2010, J DRUG TARGET, V18, P373, DOI 10.3109/10611860903483388
   Durbeej M, CELL TISSUE RES, V339, P259
   Eble JA, 2001, OSTEOARTHR CARTILAGE, V9, pS131
   Eble JN, 1998, SEMIN DIAGN PATHOL, V15, P1
   Echtermeyer F, 1996, J BIOL CHEM, V271, P2071, DOI 10.1074/jbc.271.4.2071
   Eckes B, 1998, J CELL SCI, V111, P1897
   EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x
   Ekblom M, 1998, ANN NY ACAD SCI, V857, P194, DOI 10.1111/j.1749-6632.1998.tb10117.x
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Emerich DF, 2007, J DRUG TARGET, V15, P163, DOI 10.1080/10611860701231810
   Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ergun C, 2009, J BIOMED MATER RES A, V89A, P727, DOI 10.1002/jbm.a.32035
   Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117
   EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6
   Farjanel J, 2001, OSTEOARTHR CARTILAGE, V9, pS55, DOI 10.1053/joca.2001.0445
   FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070
   Fassler R, 1996, CURR OPIN CELL BIOL, V8, P641, DOI 10.1016/S0955-0674(96)80105-0
   Feng Y, 2004, BIOCHEMISTRY-US, V43, P15811
   FESSLER JH, 1985, J CELL BIOCHEM, V28, P31, DOI 10.1002/jcb.240280106
   FESSLER JH, 1985, ANN NY ACAD SCI, V460, P181, DOI 10.1111/j.1749-6632.1985.tb51166.x
   FESSLER LI, 1981, J BIOL CHEM, V256, P9640
   FESSLER LI, 1987, J CELL BIOL, V105, P2383, DOI 10.1083/jcb.105.5.2383
   Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224
   FOLKMAN J, 1992, ADV EXP MED BIOL, V313, P355
   Fransson LA, 2003, INT J BIOCHEM CELL B, V35, P125, DOI 10.1016/S1357-2725(02)00095-X
   Fratzl P., 2008, COLLAGEN STRUCTURE M
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Friedl P, 1997, CANCER RES, V57, P2061
   Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X
   Fuerer C, 2009, DEV DYNAM, V24, P24
   Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x
   GAILIT J, 1988, J BIOL CHEM, V263, P12927
   GAILL F, 1991, J MOL BIOL, V221, P209, DOI 10.1016/0022-2836(91)80215-G
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GEHLSEN KR, 1992, J CELL BIOL, V117, P449, DOI 10.1083/jcb.117.2.449
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gelse K, 2003, ARTHRITIS RHEUM, V48, P430, DOI 10.1002/art.10759
   Genasetti A, 2008, CONNECT TISSUE RES, V49, P120, DOI 10.1080/03008200802148462
   Gerecke DR, 1997, GENOMICS, V41, P236, DOI 10.1006/geno.1997.4638
   Giancotti FG, 2003, DEV CELL, V4, P149, DOI 10.1016/S1534-5807(03)00034-0
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X
   Girotti A, 2012, BIOTECHNOL J, V6, P1174
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gokhale J, 2001, BIOCH BONE, V1, P107
   Goldmann WH, 2012, CELL BIOL INT, V36, P567, DOI 10.1042/CBI20120071
   GONZALEZ MC, 1989, J PHYS CHEM-US, V93, P3536, DOI 10.1021/j100346a035
   Goodman S. L., 1989, DEVELOPMENT CAMB, V106, P795
   GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799
   GOODMAN SL, 1987, J CELL BIOL, V105, P589, DOI 10.1083/jcb.105.1.589
   Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4
   GORDON MK, 1987, P NATL ACAD SCI USA, V84, P6040, DOI 10.1073/pnas.84.17.6040
   Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991
   Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801
   GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245
   Grigolo B, 2003, Chir Organi Mov, V88, P351
   GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x
   Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490
   Gurtu V, 1997, ANAL BIOCHEM, V251, P98, DOI 10.1006/abio.1997.2220
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Hagg PM, 1998, J BIOL CHEM, V273, P17824, DOI 10.1074/jbc.273.28.17824
   HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672
   Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208
   Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200
   Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093
   HARDINGHAM T, 1990, SEMIN ARTHRITIS RHEU, V20, P12, DOI 10.1016/0049-0172(90)90044-G
   Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   HARRIS ED, 1974, NEW ENGL J MED, V291, P557, DOI 10.1056/NEJM197409122911105
   Hartmann-Petersen S, 2009, BRIT J DERMATOL, V160, P1251, DOI 10.1111/j.1365-2133.2009.09031.x
   Hartwig B, 2007, EXP CELL RES, V313, P1575, DOI 10.1016/j.yexcr.2007.02.003
   HAUSCHKA SD, 1966, P NATL ACAD SCI USA, V55, P119, DOI 10.1073/pnas.55.1.119
   Hay E.D., 1983, Modern Cell Biology, V2, P509
   HAY ED, 1981, CELL BIOL EXTRACELLU, P379
   HECK LW, 1990, AM J PATHOL, V136, P1267
   HEDBOM E, 1993, J BIOL CHEM, V268, P27307
   Heikkila P, 2000, EXP NEPHROL, V8, P1
   HEINEGARD D, 1987, METHOD ENZYMOL, V144, P305
   Heinegard D, 2009, INT J EXP PATHOL, V90, P575, DOI 10.1111/j.1365-2613.2009.00695.x
   Hemler M E, 1995, Curr Opin Hematol, V2, P61
   Hirschfeld-Warneken VC, 2008, EUR J CELL BIOL, V87, P743, DOI 10.1016/j.ejcb.2008.03.011
   Hocking AM, 1998, MATRIX BIOL, V17, P1
   HOGAN BLM, 1980, DEV BIOL, V80, P289, DOI 10.1016/0012-1606(80)90405-4
   Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x
   HOJIMA Y, 1994, J BIOL CHEM, V269, P11381
   HOLMES DF, 1991, J MOL BIOL, V220, P111, DOI 10.1016/0022-2836(91)90385-J
   Horiguchi M, 2009, P NATL ACAD SCI USA, V106, P19029, DOI 10.1073/pnas.0908268106
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Huang CC, 2003, DEVELOPMENT, V130, P3343, DOI 10.1242/dev.00481
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9
   Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296
   Hulmes DJS, 1992, ESSAYS BIOCHEM, V27, P49
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Humphries MJ, 2004, BIOCHEM SOC T, V32, P407, DOI 10.1042/BST0320407
   Humphries MJ, 2000, METH MOL B, V139, P279
   Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9
   Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866
   Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311
   HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X
   Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074
   HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cellbio.1.1.67
   Hynes R. O., 1990, FIBRONECTIN
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369
   HYNES RO, 1973, P NATL ACAD SCI USA, V70, P3170, DOI 10.1073/pnas.70.11.3170
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5
   Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702
   Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609
   Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200
   Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998
   Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200
   Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443
   Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008
   Kao WWY, 2003, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169
   Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419
   Keeney M, 2009, TISSUE ENG PART C-ME, V15, P265, DOI 10.1089/ten.tec.2008.0365
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200
   Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564
   Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X
   Kielty Cay M., 1993, P103
   Kielty CM, 2002, CONNECTIVE TISSUE IT, P159
   Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40
   Kivirikko KI, 1998, MATRIX BIOL, V16, P355, DOI 10.1016/S0945-053X(98)90008-7
   KLEBE RJ, 1974, NATURE, V250, P248, DOI 10.1038/250248a0
   Kleinman H. K, 2001, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB1002S00
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   Knudson Cheryl B., 2003, Birth Defects Research, V69, P174, DOI 10.1002/bdrc.10013
   Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853
   Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Kuehl U, 1986, DEV BIOL, V117, P628
   KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0
   KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2
   KUHN K, 1986, RHEUMATOLOGY, V10, P29
   KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   Kusakabe M, 2008, J CELL BIOCHEM, V103, P311, DOI 10.1002/jcb.21407
   KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597
   Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311
   Lampugnani MG, 1999, METH MOL B, V96, P177
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0
   LANDER AD, 1985, J CELL BIOL, V101, P898, DOI 10.1083/jcb.101.3.898
   Landgren C, 1998, GENOMICS, V47, P84, DOI 10.1006/geno.1997.5085
   Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   LAURENT TC, 1992, FASEB J, V6, P2397
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   LEE EYHP, 1985, P NATL ACAD SCI USA, V82, P1419, DOI 10.1073/pnas.82.5.1419
   Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709
   Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Li CY, 2006, CELL TISSUE RES, V324, P369, DOI 10.1007/s00441-005-0153-5
   Li JH, 2008, J MATER SCI-MATER M, V19, P2595, DOI 10.1007/s10856-007-3354-5
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Liao E, 2007, TISSUE ENG, V13, P537, DOI 10.1089/ten.2006.0117
   LIMAT A, 1994, SKIN PHARMACOL, V7, P47
   Lin CH, 2008, TISSUE ENG PART C-ME, V14, P69, DOI 10.1089/tec.2007.0336
   Lind M, 2008, CONNECT TISSUE RES, V49, P437, DOI 10.1080/03008200802325037
   Liu CZ, 2009, ACTA BIOMATER, V5, P661, DOI 10.1016/j.actbio.2008.09.022
   Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P2100, DOI 10.1002/anie.200462459
   MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Malicev E, 2007, BIOTECHNOL BIOENG, V96, P364, DOI 10.1002/bit.21038
   MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882
   MARCHISIO PC, 1984, EXP CELL RES, V151, P332, DOI 10.1016/0014-4827(84)90384-7
   Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005
   Mark von der, 2002, CONNECTIVE TISSUE IT, P93
   Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   MAUCH C, 1989, FEBS LETT, V250, P301, DOI 10.1016/0014-5793(89)80743-4
   MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x
   MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772
   MCCARTHY RA, 1987, EMBO J, V6, P1587, DOI 10.1002/j.1460-2075.1987.tb02404.x
   MCGARVEY ML, 1984, DEV BIOL, V105, P18, DOI 10.1016/0012-1606(84)90257-4
   McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054
   McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135
   McLaughlin SH, 1998, MATRIX BIOL, V16, P369, DOI 10.1016/S0945-053X(98)90010-5
   McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343
   Millward-Sadler SJ, 2004, ANN BIOMED ENG, V32, P435, DOI 10.1023/B:ABME.0000017538.72511.48
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.00150.x
   MOHRI H, 1991, AM J HEMATOL, V37, P14, DOI 10.1002/ajh.2830370105
   Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   MORSTYN G, 1983, J CLIN INVEST, V72, P1844, DOI 10.1172/JCI111145
   Mosher D F, 1980, Prog Hemost Thromb, V5, P111
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31
   Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002
   Myllyharju J, 2000, METH MOL B, V139, P39
   Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594
   Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   NEAME PJ, 1994, J BIOL CHEM, V269, P21547
   Negoescu A, 1998, BIOMED PHARMACOTHER, V52, P252, DOI 10.1016/S0753-3322(98)80010-3
   Nettles DL, 2010, ADV DRUG DELIV REV, V2010, P10
   Ng KW, 2006, BIOMATERIALS, V27, P4591, DOI 10.1016/j.biomaterials.2006.04.020
   Nie T, 2009, ACTA BIOMATER, V5, P865, DOI 10.1016/j.actbio.2008.12.004
   NIEHAUS GD, 1981, P SOC EXP BIOL MED, V168, P15
   NISHIMURA I, 1989, J BIOL CHEM, V264, P20033
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   NOMIZU M, 1993, CANCER RES, V53, P3459
   NORO A, 1983, J BIOL CHEM, V258, P9323
   OECALAN M, 1988, Developmental Biology, V125, P158
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   OH SP, 1994, P NATL ACAD SCI USA, V91, P4229, DOI 10.1073/pnas.91.10.4229
   OLDBERG A, 1990, BIOCHEM SOC T, V18, P789, DOI 10.1042/bst0180789
   OToole EA, 1997, EXP CELL RES, V233, P330, DOI 10.1006/excr.1997.3586
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pacifici M, 2005, J BONE MINER METAB, V23, P191, DOI 10.1007/s00774-004-0584-1
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Palecek SP, 1998, J CELL SCI, V111, P929
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573
   Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x
   Park J, 2009, SMALL, V20, P20
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   PAULSSON M, 1989, J BIOL CHEM, V264, P18726
   PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x
   PEARLSTEIN E, 1976, NATURE, V262, P497, DOI 10.1038/262497a0
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   PENNYPACKER JP, 1979, EXP CELL RES, V121, P411, DOI 10.1016/0014-4827(79)90022-3
   PFAFF M, 1994, J BIOL CHEM, V269, P20233
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Piez KA, 1998, EXTRACELLULAR MATRIX
   PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P16922
   PIHLAJANIEMI T, 1995, PROG NUCLEIC ACID RE, V50, P225, DOI 10.1016/S0079-6603(08)60816-8
   POOLE CA, 1992, J CELL SCI, V103, P1101
   Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07
   PORSTMANN T, 1985, J IMMUNOL METHODS, V82, P169, DOI 10.1016/0022-1759(85)90236-4
   Prince JM, 2002, DEV DYNAM, V223, P497, DOI 10.1002/dvdy.10070
   Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0
   Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976
   Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127
   Pulsipher A, 2010, CHEMBIOCHEM, V11, P730
   PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8
   PYTELA R, 1987, METHOD ENZYMOL, V144, P475
   Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h
   Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006
   Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x
   Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005
   Ramirez F, 2009, J BIOL CHEM, V284, P14677, DOI 10.1074/jbc.R900004200
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Rapraeger AC, 2001, SEMIN CELL DEV BIOL, V12, P107, DOI 10.1006/scdb.2000.0239
   Reddi AH, 2003, ANN RHEUM DIS, V62, P73
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Responte Donald J., 2007, Critical Reviews in Biomedical Engineering, V35, P363
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   Rnjak J, 2009, BIOMATERIALS, V26, P26
   ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x
   Rotter N, 2007, J TISSUE ENG REGEN M, V1, P411, DOI 10.1002/term.52
   Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11
   ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205
   ROYCE PM, 2002, CONNECTIVE TISSUE IT
   RUCKER RB, 1978, AM J CLIN NUTR, V31, P1221
   Ruoslahti E, 1980, Prog Clin Biol Res, V41, P821
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   RUOSLAHTI E, 1985, ARTERIOSCLEROSIS, V5, P581, DOI 10.1161/01.ATV.5.6.581
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUOSLAHTI E, 1978, BIOCHIM BIOPHYS ACTA, V534, P210, DOI 10.1016/0005-2795(78)90003-X
   Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1
   Ruszczak Z, 1999, DERMATOLOGY, V199, P285, DOI 10.1159/000018305
   Ryan MC, 1996, MATRIX BIOL, V15, P369, DOI 10.1016/S0945-053X(96)90157-2
   SAGE EH, 1991, J BIOL CHEM, V266, P14831
   SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499
   Salo S, 1999, MATRIX BIOL, V18, P197, DOI 10.1016/S0945-053X(99)00012-8
   Salter DM, 1997, J BONE MINER RES, V12, P1133, DOI 10.1359/jbmr.1997.12.7.1133
   Sarfati G, 2010, BIOMATERIALS, V2010, P13
   Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058
   Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249
   Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745
   Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469
   SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423
   SAWADA H, 1990, J CELL BIOL, V110, P219, DOI 10.1083/jcb.110.1.219
   Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200
   SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3
   Scheele S, 2007, J MOL MED-JMM, V85, P825, DOI 10.1007/s00109-007-0182-5
   SCHITTNY JC, 1990, J CELL BIOL, V110, P825, DOI 10.1083/jcb.110.3.825
   Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008
   Schmid TM, 1994, EXTRACELLULAR MATRIX, P171
   SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977
   Schmidt S, 2010, CELL TISSUE RES, V339, P83, DOI 10.1007/s00441-009-0892-9
   Schober S, 2000, EXP CELL RES, V255, P303, DOI 10.1006/excr.2000.4806
   Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005
   Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4
   Secchi AG, 2007, J BIOMED MATER RES A, V83A, P577, DOI 10.1002/jbm.a.31007
   SEKIGUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P2661, DOI 10.1073/pnas.77.5.2661
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200
   SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926
   SHAPIRO HS, 1993, MATRIX, V13, P431, DOI 10.1016/S0934-8832(11)80109-5
   SHIMIZU Y, 1991, FASEB J, V5, P2292
   SHIMOKOMAKI M, 1980, FEBS LETT, V121, P51, DOI 10.1016/0014-5793(80)81265-8
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   SIMPSON DG, 1994, INT REV CYTOL, V150, P69
   Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145
   Spatz J. P., 2004, NANOBIOTECHNOLOGY, P53
   Spector DL, 2010, COLD SPRING HARB PRO, V2010
   Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004
   Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x
   Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048
   Still J, 2003, BURNS, V29, P837, DOI 10.1016/S0305-4179(03)00164-5
   Stoddart MJ, 2009, REGEN MED, V4, P81, DOI 10.2217/17460751.4.1.81
   STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591
   Stuart K, 2009, BIOMACROMOLECULES, V10, P25, DOI 10.1021/bm800888u
   Sugawara K, 2008, EXP DERMATOL, V17, P473, DOI 10.1111/j.1600-0625.2008.00721.x
   SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693
   Suzuki N, 2005, NEUROSCI RES, V51, P293, DOI 10.1016/j.neures.2004.12.001
   Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636
   Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2
   Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445
   Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x
   Tang SQ, 2007, BIOMED MATER, V2, pS135, DOI 10.1088/1748-6041/2/3/S10
   TERRANOVA VP, 1980, CELL, V22, P719, DOI 10.1016/0092-8674(80)90548-6
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Tiitu V, 2008, BIO-MED MATER ENG, V18, P225, DOI 10.3233/BME-2008-0529
   TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9
   TIMPL R, 1979, J BIOL CHEM, V254, P9933
   Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130
   TIMPL R, 1983, J BIOL CHEM, V258, P8922
   TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x
   TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x
   TIMPL R, 1987, STRUCTURE FUNCTION C, P105
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R
   Tortelli F, 2009, EUR CELLS MATER, V17, P1
   Tryggvason K, 1993, CURR OPIN CELL BIOL, V5, P877, DOI 10.1016/0955-0674(93)90038-R
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109
   Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885
   Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421
   Van Agtmael T, 2010, CELL TISSUE RES, V339, P167, DOI 10.1007/s00441-009-0866-y
   van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R
   VANDERREST M, 1985, J BIOL CHEM, V260, P220
   VAUGHAN L, 1985, J BIOL CHEM, V260, P4758
   Vaughan L, 1988, J CELL BIOL, V106, P997
   Veit G, 2006, J BIOL CHEM, V281, P27461, DOI 10.1074/jbc.M603147200
   Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564
   Volpi N, 2009, CURR MED CHEM, V16, P1718, DOI 10.2174/092986709788186138
   von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   VONDERMARK H, 1984, EUR J BIOCHEM, V142, P493
   VONDERMARK H, 1991, J BIOL CHEM, V266, P23593
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   VONDERMARK K, 1986, RHEUMATOLOGY, V10, P272
   Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang TW, 2006, BIOMATERIALS, V27, P5689, DOI 10.1016/j.biomaterials.2006.07.024
   WAYNER EA, 1992, J CELL BIOL, V116, P489, DOI 10.1083/jcb.116.2.489
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Weder G, 2010, LANGMUIR, V26, P8180, DOI 10.1021/la904526u
   Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001
   Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   WEST CM, 1979, CELL, V17, P491
   WEWER U, 1981, CANCER RES, V41, P1518
   Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200
   Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200
   WIEDEMANN H, 1975, EUR J BIOCHEM, V51, P363, DOI 10.1111/j.1432-1033.1975.tb03936.x
   Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8
   Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I
   WIGHT TN, 1991, CELL BIOL EXTRACELLU
   Wilson K, 2004, J BIOMED MATER RES A, V69A, P686, DOI 10.1002/jbm.a.30042
   Wondimu Z, 2006, MATRIX BIOL, V25, P89, DOI 10.1016/j.matbio.2005.10.001
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Wu C, 2009, NAT MED, V15, P519, DOI 10.1038/nm.1957
   Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318
   Wyllie AH, 1997, BRIT MED BULL, V53, P451
   Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   Yamada KM, 1989, CURR OPIN CELL BIOL, V1, P956, DOI 10.1016/0955-0674(89)90065-3
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yilgor P, 2010, J BIOMED MATER RES A, V93A, P528, DOI 10.1002/jbm.a.32520
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006
   Zhang L, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045012
   Zhou QH, 2009, J DRUG TARGET, V17, P364, DOI 10.1080/10611860902807046
   ZHU XY, 1995, MOL BIOL CELL, V6, P273
   Zimmermann P, 1999, FASEB J, V13, pS91
NR 535
TC 38
Z9 38
U1 4
U2 99
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6425
EI 1873-2208
J9 PROG MATER SCI
JI Prog. Mater. Sci.
PD APR
PY 2013
VL 58
IS 3
BP 327
EP 381
DI 10.1016/j.pmatsci.2012.09.002
PG 55
WC Materials Science, Multidisciplinary
SC Materials Science
GA 098GI
UT WOS:000315536200002
DA 2018-10-20
ER

PT J
AU Cano-Garrido, O
   Rodriguez-Carmona, E
   Diez-Gil, C
   Vazquez, E
   Elizondo, E
   Cubarsi, R
   Seras-Franzoso, J
   Corchero, JL
   Rinas, U
   Ratera, I
   Ventosa, N
   Veciana, J
   Villaverde, A
   Garcia-Fruitos, E
AF Cano-Garrido, Olivia
   Rodriguez-Carmona, Escarlata
   Diez-Gil, Cesar
   Vazquez, Esther
   Elizondo, Elisa
   Cubarsi, Rafael
   Seras-Franzoso, Joaquin
   Luis Corchero, Jose
   Rinas, Ursula
   Ratera, Imma
   Ventosa, Nora
   Veciana, Jaume
   Villaverde, Antonio
   Garcia-Fruitos, Elena
TI Supramolecular organization of protein-releasing functional amyloids
   solved in bacterial inclusion bodies
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanoparticles; Functional amyloid; Nanomedicine; Protein release;
   Biomaterial
ID ESCHERICHIA-COLI; CONFORMATIONAL QUALITY; RECOMBINANT PROTEINS;
   BIOLOGICAL ROLE; AGGREGATION; SOLUBILITY; PEPTIDE; CELLS; FUSION;
   NANOPARTICLES
AB Slow protein release from amyloidal materials is a molecular platform used by nature to control protein hormone secretion in the endocrine system. The molecular mechanics of the sustained protein release from amyloids remains essentially unexplored. Inclusion bodies (IBs) are natural amyloids that occur as discrete protein nanoparticles in recombinant bacteria. These protein clusters have been recently explored as protein-based functional biomaterials with diverse biomedical applications, and adapted as nanopills to deliver recombinant protein drugs into mammalian cells. Interestingly, the slow protein release from IBs does not significantly affect the particulate organization and morphology of the material, suggesting the occurrence of a tight scaffold. Here, we have determined, by using a combined set of analytical approaches, a sponge-like supramolecular organization of IBs combining differently folded protein versions (amyloid and native-like), which supports both mechanical stability and sustained protein delivery. Apart from offering structural clues about how amyloid materials release their monomeric protein components, these findings open exciting possibilities for the tailored development of smart biofunctional materials, adapted to mimic the functions of amyloid-based secretory glands of higher organisms. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Cano-Garrido, Olivia; Rodriguez-Carmona, Escarlata; Vazquez, Esther; Seras-Franzoso, Joaquin; Luis Corchero, Jose; Villaverde, Antonio; Garcia-Fruitos, Elena] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.
   [Cano-Garrido, Olivia; Rodriguez-Carmona, Escarlata; Vazquez, Esther; Seras-Franzoso, Joaquin; Luis Corchero, Jose; Villaverde, Antonio; Garcia-Fruitos, Elena] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain.
   [Cano-Garrido, Olivia; Rodriguez-Carmona, Escarlata; Diez-Gil, Cesar; Vazquez, Esther; Elizondo, Elisa; Cubarsi, Rafael; Seras-Franzoso, Joaquin; Luis Corchero, Jose; Ratera, Imma; Ventosa, Nora; Veciana, Jaume; Villaverde, Antonio; Garcia-Fruitos, Elena] CIBER Bioingn Biomat & Nanomed CIBER BBN, Barcelona 08193, Spain.
   [Diez-Gil, Cesar; Elizondo, Elisa; Ratera, Imma; Ventosa, Nora; Veciana, Jaume] CSIC, Inst Ciencia Mat Barcelona ICMAB, Dept Nanociencia Mol & Mat Organ, Barcelona 08193, Spain.
   [Cubarsi, Rafael] Univ Politecn Cataluna, Dept Matemat Aplicada 4, ES-08034 Barcelona, Spain.
   [Rinas, Ursula] Leibniz Univ Hannover, Inst Tech Chem Life Sci, D-30167 Hannover, Germany.
   [Rinas, Ursula] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.
RP Villaverde, A (reprint author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.
EM antoni.villaverde@uab.cat
RI Ventosa, Nora/C-2170-2015; Corchero, Jose/G-8413-2016; Veciana,
   Jaume/A-2147-2008; Ratera, Imma/E-2353-2014
OI Ventosa, Nora/0000-0002-8008-4974; Corchero, Jose/0000-0002-6109-144X;
   Veciana, Jaume/0000-0003-1023-9923; Ratera, Imma/0000-0002-1464-9789;
   Villaverde, Antonio/0000-0002-2615-4521; , Cesar/0000-0001-5795-2246;
   Garcia-Fruitos, Elena/0000-0001-7498-4864; Seras-Franzoso,
   Joaquin/0000-0002-7893-4773; Vazquez, Esther/0000-0003-1052-0424
FU MICINN [BFU2010-17450, CTQ2010-19501]; AGAUR [20095GR-108,
   2009SGR00516]; CIBER en Bioingenieria; Biomateriales y Nanomedicina; VI
   National R82Di Plan; Iniciativa Ingenio; CIBER; European Regional
   Development Fund; Consolider Program
FX The authors acknowledge the financial support from MICINN (BFU2010-17450
   and CTQ2010-19501), AGAUR (20095GR-108 and 2009SGR00516) and CIBER en
   Bioingenieria, Biomateriales y Nanomedicina, an initiative funded by the
   VI National R82D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider
   Program, CIBER Actions and financed by the Instituto de Salud Carlos III
   with assistance from the European Regional Development Fund. We are also
   indebted to the Protein Production Platform (CIBER-BBN) for helpful
   technical assistance and for protein production and purification
   services
   (http://www.bbn.ciber-bbn.es/programas/plataformas/equipamiento). A.V.
   has been distinguished with an ICREA ACADEMIA award (from ICREA,
   Catalonia, Spain). O.C. was granted a beca lanzadera fellowship from
   CIBER-BBN and, at present, a FPU fellowship from MECD. E.G.F. is
   supported by the Programa Personal de Tecnico de Apoyo (Modalidad
   Infraestructuras cientifico-tecnologicas, MICINN). J.S.F. is the
   recipient of a PIF doctoral fellowship from UAB.
CR Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005
   Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43
   Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029
   Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200
   BOWDEN GA, 1991, BIO-TECHNOL, V9, P725, DOI 10.1038/nbt0891-725
   Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030
   CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4
   Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133
   Curtis-Fisk J, 2008, J AM CHEM SOC, V130, P12568, DOI 10.1021/ja8039426
   de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009
   Diez-Gil C, 2010, BIOMATERIALS, V31, P5805, DOI 10.1016/j.biomaterials.2010.04.008
   Doglia Silvia Maria, 2008, Biotechnol J, V3, P193, DOI 10.1002/biot.200700238
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   Espargaro A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-89
   Fahnert B, 2012, METHODS MOL BIOL, V824, P3, DOI 10.1007/978-1-61779-433-9_1
   Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27
   Garcia-Fruitos E, 2010, Use of inclusion bodies as therapeutic agents, Patent No. [WO2010131117A1, 02010131117, 2010131117]
   Garcia-Fruitos E, 2007, J MOL BIOL, V374, P195, DOI 10.1016/j.jmb.2007.09.004
   Garcia-Fruitos E, 2007, APPL ENVIRON MICROB, V73, P289, DOI 10.1128/AEM.01952-06
   Garcia-Fruitos E, 2012, TRENDS BIOTECHNOL, V30, P65, DOI 10.1016/j.tibtech.2011.09.003
   Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x
   Garcia-Fruitos E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-80
   Garcia-Fruitos E, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/20/205101
   Garcia-Fruitos E, 2010, KOREAN J CHEM ENG, V27, P385, DOI 10.1007/s11814-010-0161-3
   Garcia-Fruitos E, 2009, ADV MATER, V21, P4249, DOI 10.1002/adma.200900283
   Gasser B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-11
   Gonzalez-Montalban N, 2008, BIOTECHNOL BIOENG, V100, P797, DOI 10.1002/bit.21797
   Gonzalez-Montalban N, 2007, NAT BIOTECHNOL, V25, P718, DOI 10.1038/nbt0707-718
   Hoffmann F, 2004, ENZYME MICROB TECH, V34, P235, DOI 10.1016/j.enzmictec.2003.10.011
   Iconomidou VA, 2008, CURR PROTEIN PEPT SC, V9, P291, DOI 10.2174/138920308784534041
   Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp[0497839
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017
   Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155
   Mankar S, 2011, NANO REV, V2
   Margreiter G, 2008, J BIOTECHNOL, V138, P67, DOI 10.1016/j.jbiotec.2008.07.1995
   MARSTON FAO, 1986, BIOCHEM J, V240, P1
   Martinez-Alonso M, 2007, FEMS MICROBIOL LETT, V273, P187, DOI 10.1111/j.1574-6968.2007.00788.x
   Martinez-Alonso M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-64
   Mitraki A, 2010, ADV PROTEIN CHEM STR, V79, P89, DOI 10.1016/S1876-1623(10)79003-9
   Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007
   Nahalka J, 2007, BIOTECHNOL BIOENG, V97, P454, DOI 10.1002/bit.21244
   Nahalka J, 2009, MOL BIOSYST, V5, P819, DOI 10.1039/b900526a
   OBERG K, 1994, BIOCHEMISTRY-US, V33, P2628, DOI 10.1021/bi00175a035
   Parra A, 2007, LANGMUIR, V23, P2747, DOI 10.1021/la062864p
   Peternel S, 2008, BIOTECHNOL APPL BIOC, V49, P239, DOI 10.1042/BA20070140
   Peternel S, 2011, INT J MOL SCI, V12, P8275, DOI 10.3390/ijms12118275
   Peternel S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-66
   Peternel S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-34
   Platas G, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-79
   Rodriguez-Carmona E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-71
   Rodriguez-Carmona E, 2010, TRENDS MICROBIOL, V18, P423, DOI 10.1016/j.tim.2010.06.007
   Sabate R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-56
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sans C, 2012, BIOTECHNOL PROGR, V28, P421, DOI 10.1002/btpr.1518
   Schrodel A, 2005, J BIOTECHNOL, V120, P2, DOI 10.1016/j.jbiotec.2005.04.028
   Seras-Franzoso J, 2012, NANOMEDICINE-UK, V7, P79, DOI [10.2217/nnm.11.83, 10.2217/NNM.11.83]
   Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1
   Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283
   Thomas JG, 1998, J BACTERIOL, V180, P5165
   Unzueta U, 2012, BIOMATERIALS, V33, P8714, DOI 10.1016/j.biomaterials.2012.08.033
   Upadhyay AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033951
   Vazquez E, 2012, ADV MATER, V24, P1742, DOI 10.1002/adma.201104330
   Vazquez E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-60
   Vazquez E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-101
   Vazquez E, 2010, NANOMEDICINE-UK, V5, P259, DOI [10.2217/nnm.09.98, 10.2217/NNM.09.98]
   Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007
   Villar-Pique A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-55
   Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862
   Villaverde A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-76
   Villaverde A, 2012, NANOMEDICINE-UK, V7, P1277, DOI 10.2217/NNM.12.100
   Villaverde A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-53
   Wang L, 2009, PRION, V3, P139, DOI 10.4161/pri.3.3.9922
   Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195
   Wu W, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-9
   Zhou BH, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-10
NR 76
TC 30
Z9 30
U1 0
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2013
VL 9
IS 4
BP 6134
EP 6142
DI 10.1016/j.actbio.2012.11.033
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 111MZ
UT WOS:000316526700025
PM 23220450
DA 2018-10-20
ER

PT J
AU Patlazhan, G
   Unukovych, D
   Pshenisnov, K
AF Patlazhan, Gennadiy
   Unukovych, Dmytro
   Pshenisnov, Kirill
TI Breast Reconstruction and Treatment Algorithm for Patients with
   Complications after Polyacrylamide Gel Injections: A 10-Year Experience
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE PAAG; Polyacrylamide gel; Biomaterial injection; Complications; Breast
   augmentation; Breast reconstruction
ID AUGMENTATION; HYDROGEL; TISSUE; MAMMAPLASTY; MANAGEMENT
AB An algorithm for breast reconstruction for patients with complications after polyacrylamide gel (PAAG) injections is presented, and the outcomes of surgery using the adopted treatment protocol are evaluated.
   We reviewed the clinical records of consecutive patients who were treated for PAAG complications with breast reconstruction at two surgical centers between 2000 and 2010 (n = 154). All patients had one or more complications from PAAG injections and underwent gel removal and breast reconstruction with implants. One hundred women who underwent conventional breast augmentation with implants matching the study cohort comprised a reference group.
   Of the total of 154 patients, 121 (79 %) women had no signs of acute inflammation and underwent a single-stage surgery comprising gel removal and immediate breast reconstruction (group I). The remaining 33 (21 %) patients had signs of acute inflammation (group II) and underwent two-stage surgery with delayed reconstruction. Subgroup analysis of group I revealed that submuscular implant placement was associated with a lower probability of capsular contracture (CC) than was subglandular placement (17 vs. 36 %, p < 0.05). The rate of CC in patients with textured implants (n = 81) was 24.8 %, whereas no CC was registered among patients with micropolyurethane surface implants (n = 40). The rate of early surgical complications in group I, group II, and the reference group was 39, 51.5, and 9 %, respectively. The probability of reoperation after breast reconstruction in group I and in group II was 34 and 42 %, respectively.
   Complications and subsequent breast reconstruction in patients after PAAG injection pose a challenge to the surgeon; however, satisfactory results can be achieved in the majority of patients. The reconstruction algorithm described here may serve as a useful tool for breast surgeons dealing with PAAG complications.
C1 [Patlazhan, Gennadiy] Ukrainian Inst Plast Surg Virtus, UA-65026 Odessa, Ukraine.
   [Unukovych, Dmytro] Karolinska Inst, Karolinska Univ Hosp R8 00, S-17176 Stockholm, Sweden.
   [Unukovych, Dmytro] Natl OO Bohomolets Med Univ, Kiev, Ukraine.
   [Pshenisnov, Kirill] Yaroslavl Med Acad, Plast Surg Ctr, Yaroslavl 150000, Russia.
RP Unukovych, D (reprint author), Karolinska Inst, Karolinska Univ Hosp R8 00, S-17176 Stockholm, Sweden.
EM unukovych@gmail.com
OI Unukovych, Dmytro/0000-0002-1357-9125
CR Cheng NX, 2011, AESTHET PLAST SURG, V35, P365, DOI 10.1007/s00266-010-9617-4
   Cheng NX, 2006, AESTHET PLAST SURG, V30, P215, DOI 10.1007/s00266-005-0081-5
   Cheng NX, 2002, AESTHET PLAST SURG, V26, P375, DOI 10.1007/s00266-002-2052
   Christensen LH, 2003, PLAST RECONSTR SURG, V111, P1883, DOI 10.1097/01.PRS.0000056873.87165.5A
   Kang GCW, 2011, AESTHET PLAST SURG, V35, P122, DOI 10.1007/s00266-010-9550-6
   Kovanskaya V, 2000, SCI PRACT C 10 YEARS
   Lui CY, 2008, AM J ROENTGENOL, V191, P677, DOI 10.2214/AJR.07.2733
   Luo SK, 2010, J PLAST RECONSTR AES, V64, P731
   Pshenisnov K, 2001, ANN PLAST RECONSTR A, V2, P41
   Qiao Q, 2005, AESTHET PLAST SURG, V29, P156, DOI 10.1007/s00266-004-0099-0
   Teo SY, 2008, AM J ROENTGENOL, V191, pW89, DOI 10.2214/AJR.07.3616
   Unukovych D, 2012, WORLD J SURG, V36, P695, DOI 10.1007/s00268-011-1273-6
   van Dam D, 2009, AESTHET PLAST SURG, V33, P479, DOI 10.1007/s00266-009-9369-1
   Xu CJ, 2012, AESTHET PLAST SURG, V36, P160, DOI 10.1007/s00266-011-9779-8
NR 14
TC 9
Z9 10
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-216X
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD APR
PY 2013
VL 37
IS 2
BP 312
EP 320
DI 10.1007/s00266-012-0045-5
PG 9
WC Surgery
SC Surgery
GA 114LU
UT WOS:000316743600016
PM 23381651
DA 2018-10-20
ER

PT J
AU Dulinska-Molak, I
   Lekka, M
   Kurzydlowski, KJ
AF Dulinska-Molak, Ida
   Lekka, Malgorzata
   Kurzydlowski, Krzysztof J.
TI Surface properties of polyurethane composites for biomedical
   applications
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Polyurethane; Composites; Calcium carbonate; Adhesion force; Surface
   free energy
ID CALCIUM-CARBONATE; NATURAL CORAL; IN-VITRO; HYDROXYAPATITE; SCAFFOLDS;
   ROUGHNESS; ENERGY; ADHESION; GROWTH; CELLS
AB The development of tissue engineering in the field of orthopedic surgery is now booming. Biocompatibility is one of the most important characteristics of a biomedical polymer and composites material whose surface is required to interact with a biological system. Since proteins are viewed as the primary and the most important substrate in mediating polymer-organism interactions, the status of the proteins on a material surface is believed to determine the ultimate biocompatibility of a given biomaterial. In order to achieve specific responses between biomaterial surfaces and the adjacent cells, the principles for designing biocompatible materials are brought forth decorating polymer surfaces with bioceramic particles (aragonite and calcite) to induce specific protein adsorption and cell responses. In this work, we describe the adhesion properties of polyurethane/calcium carbonate composites. An understanding of the phenomena of cell adhesion and, in particular, understanding of the proteins involved in osteoblast adhesion on contact with the materials is of crucial importance, the adhesion between fibronectin (FN) and composites PUR/CaCO3 surfaces were examined using atomic force microscopy (AFM). Moreover, it is found that is correlation between the detachment force and surface free energy (SFE). At the end, in order to estimate the cellular biocompatibility, the human bone derived cells (HBDC) were cultured on PUR/CaCO3 composites. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Dulinska-Molak, Ida; Kurzydlowski, Krzysztof J.] Warsaw Univ Technol, Fac Mat Sci & Engn, PL-02507 Warsaw, Poland.
   [Lekka, Malgorzata] Polish Acad Sci, Henryk Niewodniczanski Inst Nucl Phys, PL-31342 Krakow, Poland.
RP Lekka, M (reprint author), Polish Acad Sci, Henryk Niewodniczanski Inst Nucl Phys, Radzikowskiego 152, PL-31342 Krakow, Poland.
EM malgorzata.lekka@ifj.edu.pl
RI Lekka, Malgorzata/A-3706-2016
OI Lekka, Malgorzata/0000-0003-0844-8662
FU Faculty of Materials Science and Engineering, WUT;  [R1301901]
FX The cell culture were performed at the Warsaw Medical University by a
   group of Prof Malgorzata Lewandowska-Szumiel. The synthesis of
   composites was conducted in the laboratory of Dr Joanna Ryszkowska. This
   work was financially supported by grant R1301901 and by the Faculty of
   Materials Science and Engineering, WUT.
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   Gallagher J., 1996, METHODS MOL MED HUMA
   Gorna J., 2003, J BIOMEDICAL MAT R A, V67, P813
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   GUILLEMIN G, 1993, J MATER SCI-MATER M, V4, P575, DOI 10.1007/BF00125596
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   Knabe C, 2004, J BIOMED MATER RES A, V69A, P145, DOI 10.1002/jbm.a.20131
   Kudelska-Mazur Dorota, 2005, Cell and Tissue Banking, V6, P55, DOI 10.1007/s10561-005-1911-z
   Lamba N, 1997, POLYURETHANES BIOMED
   Lan PN, 1996, BIOMATERIALS, V17, P2273, DOI 10.1016/0142-9612(96)00056-7
   Lekka M, 2002, ACTA PHYS POL A, V102, P355, DOI 10.12693/APhysPolA.102.355
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Petite H, 1996, J MATER SCI-MATER M, V7, P665, DOI 10.1007/BF00123405
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Przybytniak G., 2006, NUKLEONIKA, V51, P1
   Przybytniak G., 2006, NUKLEONIKA, V51, P121
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
   Wozniak P, 2010, ACTA BIOMATER, V6, P2484, DOI 10.1016/j.actbio.2009.10.022
NR 25
TC 12
Z9 12
U1 3
U2 97
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD APR 1
PY 2013
VL 270
BP 553
EP 560
DI 10.1016/j.apsusc.2013.01.085
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 115CO
UT WOS:000316790200083
DA 2018-10-20
ER

PT J
AU Huang, Z
   Newcomb, CJ
   Zhou, Y
   Lei, YP
   Bringas, P
   Stupp, SI
   Snead, ML
AF Huang, Z.
   Newcomb, C. J.
   Zhou, Y.
   Lei, Y. P.
   Bringas, P., Jr.
   Stupp, S. I.
   Snead, M. L.
TI The role of bioactive nanofibers in enamel regeneration mediated through
   integrin signals acting upon C/EBP alpha and c-Jun
SO BIOMATERIALS
LA English
DT Article
DE RGDS; Peptide amphiphile; Artificial extracellular matrix; Integrin;
   Cell signaling; Regenerated enamel
ID FOCAL ADHESION KINASE; BINDING PROTEIN-ALPHA; MOUSE AMELOGENIN GENE;
   EPITHELIAL-MESENCHYMAL INTERACTIONS; TOOTH MORPHOGENESIS; HYDROXYAPATITE
   MINERALIZATION; AMELOBLAST DIFFERENTIATION; SEQUENTIAL EXPRESSION;
   NH2-TERMINAL KINASE; PEPTIDE AMPHIPHILES
AB Enamel formation involves highly orchestrated intracellular and extracellular events; following development, the tissue is unable to regenerate, making it a challenging target for tissue engineering. We previously demonstrated the ability to trigger enamel differentiation and regeneration in the embryonic mouse incisor using a self-assembling matrix that displayed the integrin-binding epitope RGDS (Arg-Gly-Asp-Ser). To further elucidate the intracellular signaling pathways responsible for this phenomenon, we explore here the coupling response of integrin receptors to the biomaterial and subsequent downstream gene expression profiles. We demonstrate that the artificial matrix activates focal adhesion kinase (FAR) to increase phosphorylation of both c-Jun N-terminal kinase (JNK) and its downstream transcription factor c-Jun (c-Jun). Inhibition of FAR blocked activation of the identified matrix-mediated pathways, while independent inhibition of INK nearly abolished phosphorylated-c-Jun (p-c-Jun) and attenuated the pathways identified to promote enamel regeneration. Cognate binding sites in the amelogenin promoter were identified to be transcriptionally up-regulated in response to p-c-Jun. Furthermore, the artificial matrix induced gene expression as evidenced by an increased abundance of amelogenin, the main protein expressed during enamel formation, and the CCAAT enhancer binding protein alpha (C/EBP alpha), which is the known activator of amelogenin expression. Elucidating these cues not only provides guidelines for the design of synthetic regenerative strategies and opportunities to manipulate pathways to regulate enamel regeneration, but can provide insight into the molecular mechanisms involved in tissue formation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Huang, Z.; Zhou, Y.; Lei, Y. P.; Bringas, P., Jr.; Snead, M. L.] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA.
   [Newcomb, C. J.; Stupp, S. I.] Northwestern Univ, Dept Mat Sci & Engn, Chicago, IL 60611 USA.
   [Newcomb, C. J.; Stupp, S. I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
   [Stupp, S. I.] Northwestern Univ, Dept Chem, Evanston, IL USA.
   [Stupp, S. I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
RP Snead, ML (reprint author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.
EM mlsnead@usc.edu
RI Stupp, Samuel/B-6737-2009
FU National Institute for Dental and Craniofacial Research (NIDCR) of the
   National Institutes of Health, USPHS [5R01 DE015920]; NIH, USPHS [P50
   AA11999]
FX This work was supported by the National Institute for Dental and
   Craniofacial Research (NIDCR) of the National Institutes of Health,
   USPHS, 5R01 DE015920 (SIS, MLS).; Confocal fluorescent images were
   acquired at the USC Keck Center for Liver Diseases Confocal Microscopy
   Core, supported by NIH, USPHS grant P50 AA11999.
CR Abe K, 2007, J BIOSCI BIOENG, V103, P479, DOI 10.1263/jbb.103.479
   Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741
   Bei M, 2004, DEV DYNAM, V231, P758, DOI 10.1002/dvdy.20182
   Beyeler M, 2010, EXP CELL RES, V316, P1202, DOI 10.1016/j.yexcr.2009.12.019
   Bleicher F, 1999, MATRIX BIOL, V18, P133, DOI 10.1016/S0945-053X(99)00007-4
   Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940
   Chavez MG, 2013, TISSUE ENG PART C-ME, V19, DOI [10.1089/ten.tec.2012.0232, 10.1089/ten.TEC.2012.0232]
   Chen B, 2009, J DENT RES, V88, P539, DOI 10.1177/0022034509338008
   CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T
   COUWENHOVEN RI, 1990, J HISTOCHEM CYTOCHEM, V38, P1853, DOI 10.1177/38.12.2254649
   Dalla Costa AP, 2010, CARDIOVASC RES, V86, P421, DOI 10.1093/cvr/cvp416
   Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a
   DenBesten PK, 2005, ARCH ORAL BIOL, V50, P689, DOI 10.1016/j.archoralbio.2004.12.008
   Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108
   Fincham AG, 1997, CIBA F SYMP, V205, P118
   Fincham AG, 1997, CIBA F SYMP, V205, P30
   Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061
   Fong H, 2003, J BONE MINER RES, V18, P2052, DOI 10.1359/jbmr.2003.18.11.2052
   Fukumoto S, 2005, CELLS TISSUES ORGANS, V181, P189, DOI 10.1159/000091380
   Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017
   Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Gungormus M, 2012, INT J ORAL SCI, V4, P69, DOI 10.1038/ijos.2012.40
   Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Homsy JG, 2006, DEV DYNAM, V235, P427, DOI 10.1002/dvdy.20649
   Huang Z, 2008, J BONE MINER RES, V23, P1995, DOI 10.1359/JBMR.080705
   Huang Z, 2010, BIOMATERIALS, V31, P9202, DOI 10.1016/j.biomaterials.2010.08.013
   Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585
   Kim JK, 2010, J DENT RES, V89, P1433, DOI 10.1177/0022034510384870
   Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X
   Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385
   MacDougall M, 1998, CONNECT TISSUE RES, V39, P25, DOI 10.3109/03008209809023909
   Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108
   Midwood KS, 2006, J INVEST DERM SYMP P, V11, P73, DOI 10.1038/sj.jidsymp.5650005
   Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8
   Newcomb CJ, 2012, SMALL, V8, P2195, DOI 10.1002/smll.201102150
   Nishikawa S, 2000, J HISTOCHEM CYTOCHEM, V48, P1511, DOI 10.1177/002215540004801108
   Nishikawa Sumio, 2004, Anatomical Science International, V79, P87, DOI 10.1111/j.1447-073x.2004.00073.x
   Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461
   Paine M L, 2005, Orthod Craniofac Res, V8, P239, DOI 10.1111/j.1601-6343.2005.00346.x
   Paine ML, 2005, J BIOL CHEM, V280, P31991, DOI 10.1074/jbc.M502991200
   Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x
   Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309
   Salmivirta K, 1996, DEV DYNAM, V205, P104, DOI 10.1002/(SICI)1097-0177(199602)205:2<104::AID-AJA2>3.0.CO;2-M
   Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200
   SLAVKIN HC, 1988, DIFFERENTIATION, V37, P26, DOI 10.1111/j.1432-0436.1988.tb00793.x
   Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101
   Snead ML, 2011, BIOMATERIALS, V32, P3151, DOI 10.1016/j.biomaterials.2011.01.024
   Snead ML, 1996, CONNECT TISSUE RES, V35, P41, DOI 10.3109/03008209609029173
   SNEAD ML, 1989, CONNECT TISSUE RES, V22, P727, DOI 10.3109/03008208909114125
   Storrie H, 2007, BIOMATERIALS, V28, P4608, DOI 10.1016/j.biomaterials.2007.06.026
   Sur S, 2012, ACS NANO, V6, P10776, DOI 10.1021/nn304101x
   Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200
   Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410
   Thesleff I, 1996, CURR OPIN CELL BIOL, V8, P844, DOI 10.1016/S0955-0674(96)80086-X
   Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9
   Thesleff I, 2009, STEM CELL RES COMMUN, DOI 10.3824/stembook.1.37.1
   Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006
   VOGEL BE, 1990, J BIOL CHEM, V265, P5934
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   Xu YC, 2007, J BIOL CHEM, V282, P29882, DOI 10.1074/jbc.M702097200
   Xu YC, 2007, BIOCHEM BIOPH RES CO, V354, P56, DOI 10.1016/j.bbrc.2006.12.182
   YAMADA S, 1994, INT J DEV BIOL, V38, P553
   Zhang Y, 2007, MATRIX BIOL, V26, P633, DOI 10.1016/j.matbio.2007.06.002
   Zhou YL, 2000, J BIOL CHEM, V275, P29066, DOI 10.1074/jbc.M002031200
   Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273
NR 70
TC 15
Z9 15
U1 1
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2013
VL 34
IS 13
BP 3303
EP 3314
DI 10.1016/j.biomaterials.2013.01.054
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 114VE
UT WOS:000316770100015
PM 23398885
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Assal, Y
   Mie, M
   Kobatake, E
AF Assal, Yasmine
   Mie, Masayasu
   Kobatake, Eiry
TI The promotion of angiogenesis by growth factors integrated with ECM
   proteins through coiled-coil structures
SO BIOMATERIALS
LA English
DT Article
DE Extracellular matrix (ECM); Growth factor; Endothelial cell; Cell
   proliferation; Scaffold; Angiogenesis
ID EXTRACELLULAR-MATRIX; POLY(LACTIC ACID-CO-LYSINE); IN-VITRO; PEPTIDE;
   LAMININ; VEGF; NEOVASCULARIZATION; DIFFERENTIATION; ANGIOPOIETIN-2;
   CONSTRUCTION
AB An appropriate method to bind extracellular matrix (ECM) proteins and growth factors using advanced protein engineering techniques has the potential to enhance cell proliferation and differentiation for tissue regeneration and repair. In this study we developed a method to co-immobilize non-covalently an ECM protein to three different types of growth factors: basic fibroblast growth factor (bFGF), epidermal growth factor (EGF) and single-chain vascular endothelial growth factor (scVEGF121) through a coiled-coil structure formed by helixA/helixB in order to promote angiogenesis. The designed ECM was established by fusing two repeats of elastin-derived unit (APGVGV)(12), cell-adhesive sequence (RGD), laminin-derived IKVAV sequence and collagen-binding domain (CBD) to obtain CBDEREI2. HelixA was fused to each growth factor and helixB to the engineered ECM. Human umbilical vein endothelial cells (HUVECs) were cultured on engineered ECM and growth factors connected through the coiled-coil formation between helixA and helixB. Cell proliferation and capillary tube-like formation were monitored. Moreover, the differentiated cells with high expression of Ang-2 suggested the ECM remodeling. Our approach of non-covalent coupling method should provide a protein-release control system as a new contribution in biomaterial for tissue engineering field. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Assal, Yasmine; Mie, Masayasu; Kobatake, Eiry] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268051, Japan.
RP Kobatake, E (reprint author), Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268051, Japan.
EM ekobatak@bio.titech.ac.jp
RI Mie, Masayasu/C-5995-2015
OI Mie, Masayasu/0000-0003-2255-3346
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   JSPS Institutional Program for Young Researcher Overseas Visits
FX This work was financially supported by Grants-in-aid for Scientific
   Research from the Ministry of Education, Culture, Sports, Science and
   Technology of Japan and JSPS Institutional Program for Young Researcher
   Overseas Visits.
CR Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Boesen TP, 2002, J BIOL CHEM, V277, P40335, DOI 10.1074/jbc.M204107200
   BONZON N, 1995, BIOMATERIALS, V16, P881, DOI 10.1016/0142-9612(95)94151-A
   Boucher C, 2010, BIOMATERIALS, V31, P7021, DOI 10.1016/j.biomaterials.2010.05.072
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   CHARRIERE G, 1989, J AM ACAD DERMATOL, V21, P1203, DOI 10.1016/S0190-9622(89)70330-3
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Elloumi I, 2006, BIOMATERIALS, V27, P3451
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994
   Ishikawa T, 2001, J BIOCHEM-TOKYO, V129, P627, DOI 10.1093/oxfordjournals.jbchem.a002900
   Karle IL, 2005, BIOPOLYMERS, V77, P198, DOI 10.1002/bip.20214
   KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   Kobatake E, 2000, BIOMACROMOLECULES, V1, P382, DOI 10.1021/bm000284f
   Kobatake E, 2011, BIOCONJUGATE CHEM, V22, P2038, DOI 10.1021/bc200249u
   Kvanta A, 2000, EXP EYE RES, V70, P419, DOI 10.1006/exer.1999.0790
   Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249
   Nakamura M, 2008, BIOMATERIALS, V29, P2977, DOI 10.1016/j.biomaterials.2008.04.006
   Nillesen ST, 2006, J CONTROL RELEASE, V116, P88
   Noda T, 2006, J BIOTECHNOL, V126, P230, DOI 10.1016/j.jbiotec.2006.04.021
   OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T
   OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872
   PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5
   Sakai D, 2006, BIOMATERIALS, V27, P346, DOI 10.1016/j.biomaterials.205.06.040
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   SCHNAPER HW, 1993, KIDNEY INT, V43, P20, DOI 10.1038/ki.1993.5
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Zagzag D, 1999, EXP NEUROL, V159, P391, DOI 10.1006/exnr.1999.7162
NR 30
TC 34
Z9 34
U1 1
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2013
VL 34
IS 13
BP 3315
EP 3323
DI 10.1016/j.biomaterials.2013.01.067
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 114VE
UT WOS:000316770100016
PM 23388150
DA 2018-10-20
ER

PT J
AU Mohtaram, NK
   Montgomery, A
   Willerth, SM
AF Mohtaram, Nima Khadem
   Montgomery, Amy
   Willerth, Stephanie M.
TI Biomaterial-based drug delivery systems for the controlled release of
   neurotrophic factors
SO BIOMEDICAL MATERIALS
LA English
DT Review
ID NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; HYALURONIC-ACID HYDROGELS;
   CONTROLLED PROTEIN RELEASE; FIBRIN MATRICES; ELECTROSPUN NANOFIBERS;
   SUSTAINED-RELEASE; NEURAL TISSUE; IN-VITRO; BIODEGRADABLE MICROSPHERES
AB This review highlights recent work on the use of biomaterial-based drug delivery systems to control the release of neurotrophic factors as a potential strategy for the treatment of neurological disorders. Examples of neurotrophic factors include the nerve growth factor, the glial cell line-derived neurotrophic factor, the brain-derived neurotrophic factor and neurotrophin-3. In particular, this review focuses on two methods of drug delivery: affinity-based and reservoir-based systems. We review the advantages and challenges associated with both types of drug delivery system and how these systems can be applied to neurological diseases and disorders. While a limited number of affinity-based delivery systems have been developed for the delivery of neurotrophic factors, we also examine the broad spectrum of reservoir-based delivery systems, including microspheres, electrospun nanofibers, hydrogels and combinations of these systems. Finally, conclusions are drawn about the current state of such drug delivery systems as applied to neural tissue engineering along with some thoughts on the future direction of the field.
C1 [Mohtaram, Nima Khadem; Montgomery, Amy; Willerth, Stephanie M.] Univ Victoria, Dept Mech Engn, STN CSC, Victoria, BC V8W 2Y2, Canada.
   [Willerth, Stephanie M.] Univ Victoria, Div Med Sci, STN CSC, Victoria, BC V8W 2Y2, Canada.
RP Willerth, SM (reprint author), Univ Victoria, Dept Mech Engn, STN CSC, POB 1700, Victoria, BC V8W 2Y2, Canada.
EM willerth@uvic.ca
OI Willerth, Stephanie/0000-0002-1665-7723
FU NSERC [402462]
FX We would like to thank the NSERC Discovery grant 402462 for supporting
   this work.
CR Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2
   Aliabadi Hamidreza Montazeri, 2006, Expert Opin Drug Deliv, V3, P139
   Anand P, 2004, PROG BRAIN RES, V146, P477
   Andrieu-Soler C, 2005, MOL VIS, V11
   Aubert-Pouessel A, 2004, J CONTROL RELEASE, V95, P463, DOI 10.1016/j.jconrel.2003.12.012
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0
   Belcheva N, 1999, BIOCONJUGATE CHEM, V10, P932, DOI 10.1021/bc990001k
   Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3
   Bensadoun JC, 2003, J CONTROL RELEASE, V87, P107, DOI 10.1016/S0168-3659(02)00353-X
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002
   Checa-Casalengua P, 2011, J CONTROL RELEASE, V156, P92, DOI 10.1016/j.jconrel.2011.06.023
   Chen FM, 2011, J CONTROL RELEASE, V149, P92, DOI 10.1016/j.jconrel.2010.10.021
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Davis HE, 2011, ANN BIOMED ENG, V39, P1, DOI 10.1007/s10439-010-0135-y
   de Boer R, 2010, J BIOMED MATER RES A, V95A, P1067, DOI 10.1002/jbm.a.32900
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Fu AS, 2011, ANN BIOMED ENG, V39, P2466, DOI 10.1007/s10439-011-0336-z
   Garbayo E, 2008, EUR J PHARM BIOPHARM, V69, P844, DOI 10.1016/j.ejpb.2008.02.015
   Garbayo E, 2009, J CONTROL RELEASE, V135, P119, DOI 10.1016/j.jconrel.2008.12.010
   Goraltchouk A, 2006, J CONTROL RELEASE, V110, P400, DOI 10.1016/j.jconrel.2005.10.019
   Grondin R, 1998, J NEUROL, V245, pP35, DOI 10.1007/PL00007744
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   Han D, 2011, POLYMERS-BASEL, V3, P1684, DOI 10.3390/polym3041684
   Hosseinkhani H, 2006, INT J NANOTECHNOL, V3, P416, DOI 10.1504/IJNT.2006.011172
   Hosseinkhani H, 2009, CURR DRUG SAF, V4, P79, DOI 10.2174/157488609787354477
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Jiang X, 2012, ACTA BIOMATER, V8, P1290, DOI 10.1016/j.actbio.2011.11.019
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   KERKHOFF H, 1993, CLIN NEUROL NEUROSUR, V95, pS103
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kim TG, 2007, INT J PHARM, V338, P276, DOI 10.1016/j.ijpharm.2007.01.040
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liao IC, 2006, NANOMEDICINE-UK, V1, P465, DOI 10.2217/17435889.1.4.465
   Lyons J, 2004, POLYMER, V45, P7597, DOI 10.1016/j.polymer.2004.08.071
   Madduri S, 2012, J CONTROL RELEASE, V161, P274, DOI 10.1016/j.jconrel.2011.11.036
   Madduri S, 2010, J CONTROL RELEASE, V143, P168, DOI 10.1016/j.jconrel.2009.12.017
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mahoney MJ, 1996, J PHARM SCI, V85, P1276, DOI 10.1021/js9601602
   Maretschek S, 2008, J CONTROL RELEASE, V127, P180, DOI 10.1016/j.jconrel.2008.01.011
   Maxwell DJ, 2005, ACTA BIOMATER, V1, P101, DOI 10.1016/j.actbio.2004.09.002
   Mehrotra S, 2010, ADV FUNCT MATER, V20, P247, DOI 10.1002/adfm.200901172
   Meinel AJ, 2012, EUR J PHARM BIOPHARM, V81, P1, DOI 10.1016/j.ejpb.2012.01.016
   Meng ZX, 2011, COLLOID SURFACE B, V84, P97, DOI 10.1016/j.colsurfb.2010.12.022
   Moore AM, 2010, J HAND SURG-AM, V35A, P2008, DOI 10.1016/j.jhsa.2010.08.016
   Pabari A, 2011, J CONTROL RELEASE, V156, P2, DOI 10.1016/j.jconrel.2011.07.001
   Park JH, 2005, MOLECULES, V10, P146, DOI 10.3390/10010146
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Piras AM, 2008, J BIOACT COMPAT POL, V23, P423, DOI 10.1177/0883911508093357
   POWELL EM, 1990, BRAIN RES, V515, P309, DOI 10.1016/0006-8993(90)90612-F
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Saltzman WM, 2001, ENG PRINCIPLES DRUG
   Saralidze K, 2010, MATERIALS, V3, P3537, DOI 10.3390/ma3063537
   Shi LJ, 2008, MACROMOLECULES, V41, P6546, DOI 10.1021/ma800812z
   Shidhaye S L, 2008, CURR DRUG THER, V3, P9
   Shimoke K, 2001, J NEUROSCI RES, V63, P402, DOI 10.1002/1097-4547(20010301)63:5<402::AID-JNR1035>3.0.CO;2-F
   Shukla S, 2005, POLYMER, V46, P12130, DOI 10.1016/j.polymer.2005.10.070
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024
   Stroh M, 2003, BIOPHYS J, V85, P581, DOI 10.1016/S0006-3495(03)74502-0
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Tatard VM, 2005, CURR DRUG TARGETS, V6, P81, DOI 10.2174/1389450053344885
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Thompson BC, 2006, J CONTROL RELEASE, V116, P285, DOI 10.1016/j.jconrel.2006.09.004
   Thompson BC, 2010, J CONTROL RELEASE, V141, P161, DOI 10.1016/j.jconrel.2009.09.016
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Valmikinathan CM, 2009, BIOMACROMOLECULES, V10, P1084, DOI 10.1021/bm8012499
   Venugopal J, 2005, APPL BIOCHEM BIOTECH, V125, P147, DOI 10.1385/ABAB:125:3:147
   Wang NX, 2011, MACROMOL BIOSCI, V11, P321, DOI 10.1002/mabi.201000206
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Wood MD, 2009, J BIOMED MATER RES A, V89A, P909, DOI 10.1002/jbm.a.32043
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xu XY, 2002, BIOMATERIALS, V23, P3765, DOI 10.1016/S0142-9612(02)00116-3
   Yang WW, 2012, JALA-J LAB AUTOM, V17, P50, DOI 10.1177/2211068211428189
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Ye ML, 2010, J CONTROL RELEASE, V146, P241, DOI 10.1016/j.jconrel.2010.05.011
   Yoshimura N, 2006, J NEUROSCI, V26, P10847, DOI 10.1523/JNEUROSCI.3023-06.2006
   Zanin MP, 2012, J CONTROL RELEASE, V160, P3, DOI 10.1016/j.jconrel.2012.01.021
   Zern BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011017
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
NR 101
TC 50
Z9 52
U1 2
U2 118
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2013
VL 8
IS 2
AR 022001
DI 10.1088/1748-6041/8/2/022001
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 114MS
UT WOS:000316746100003
PM 23385544
DA 2018-10-20
ER

PT J
AU Turturro, MV
   Sokic, S
   Larson, JC
   Papavasiliou, G
AF Turturro, Michael V.
   Sokic, Sonja
   Larson, Jeffery C.
   Papavasiliou, Georgia
TI Effective tuning of ligand incorporation and mechanical properties in
   visible light photopolymerized poly(ethylene glycol) diacrylate
   hydrogels dictates cell adhesion and proliferation
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID BIOMIMETIC PEGDA HYDROGELS; CLEAVAGE SITE PRESENTATION;
   SMOOTH-MUSCLE-CELLS; BIOACTIVE HYDROGELS; NEURITE EXTENSION;
   CROSS-LINKING; IN-VITRO; MIGRATION; PEPTIDES; GROWTH
AB Cell behavior is guided by the complex interplay of matrix mechanical properties as well as soluble and immobilized biochemical signals. The development of synthetic scaffolds that incorporate key functionalities of the native extracellular matrix (ECM) for support of cell proliferation and tissue regeneration requires that stiffness and immobilized concentrations of ECM signals within these biomaterials be tuned and optimized prior to in vitro and in vivo studies. A detailed experimental sensitivity analysis was conducted to identify the key polymerization conditions that result in significant changes in both elastic modulus and immobilized YRGDS within visible light photopolymerized poly(ethylene glycol) diacrylate hydrogels. Among the polymerization conditions investigated, single as well as simultaneous variations in N-vinylpyrrolidinone and precursor concentrations of acryl-PEG(3400)-YRGDS resulted in a broad range of the hydrogel elastic modulus (81-1178 kPa) and YRGDS surface concentration (0.04-1.72 pmol cm(-2)). Increasing the YRGDS surface concentration enhanced fibroblast cell adhesion and proliferation for a given stiffness, while increases in the hydrogel elastic modulus caused decreases in cell adhesion and increases in proliferation. The identification of key polymerization conditions is critical for the tuning and optimization of biomaterial properties and the controlled study of cell-substrate interactions.
C1 [Turturro, Michael V.; Sokic, Sonja; Larson, Jeffery C.; Papavasiliou, Georgia] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
RP Papavasiliou, G (reprint author), IIT, Dept Biomed Engn, Wishnick Hall 314,3255 S Dearborn St, Chicago, IL 60616 USA.
EM turtmic@hawk.iit.edu; ssokic@hawk.iit.edu; jlarson1@iit.edu;
   papavasiliou@iit.edu
RI Papavailiou, Georgia/D-2645-2014
OI Papavailiou, Georgia/0000-0002-6730-7360
FU Pritzker Institute of Biomedical Science and Engineering at IIT;
   National Institutes of Health [R21HL094916]
FX The authors are grateful to Dr Eric Brey in the Biomedical Engineering
   Department at the Illinois Institute of Technology (IIT) for his
   guidance in developing the YRGDS incorporation studies. The authors
   would also like to acknowledge Dr David Venerus and the members of his
   lab for their help with the compression experiments. This research was
   supported by funding from the Pritzker Institute of Biomedical Science
   and Engineering at IIT and the National Institutes of Health (grant no.
   R21HL094916).
CR Behravesh E, 2003, BIOMATERIALS, V24, P4365, DOI 10.1016/S0142-9612(03)00338-7
   Blewitt MJ, 2007, ANN BIOMED ENG, V35, P2159, DOI 10.1007/s10439-007-9389-4
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hoffman AS, 2001, ANN NY ACAD SCI, V944, P62
   Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974
   Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Lee SH, 2007, BIOMATERIALS, V28, P3163, DOI 10.1016/j.biomaterials.2007.03.004
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   LORENZ DH, 1977, RADIAT PHYS CHEM, V9, P843, DOI 10.1016/0146-5724(77)90195-9
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Porter AM, 2011, BIOMACROMOLECULES, V12, P242, DOI 10.1021/bm101220b
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Sokic S, 2012, TISSUE ENG PT A, V18, P2477, DOI [10.1089/ten.tea.2012.0173, 10.1089/ten.TEA.2012.0173]
   Sokic S, 2012, ACTA BIOMATER, V8, P2213, DOI 10.1016/j.actbio.2012.03.017
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   White TJ, 2007, J POLYM SCI POL CHEM, V45, P4062, DOI 10.1002/pola.22173
NR 41
TC 12
Z9 12
U1 1
U2 41
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2013
VL 8
IS 2
AR 025001
DI 10.1088/1748-6041/8/2/025001
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 114MS
UT WOS:000316746100004
PM 23343533
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhou, J
   Hao, GY
   Weng, H
   Tsai, YT
   Baker, DW
   Sun, XK
   Tang, LP
AF Zhou, Jun
   Hao, Guiyang
   Weng, Hong
   Tsai, Yi-Ting
   Baker, David W.
   Sun, Xiankai
   Tang, Liping
TI In vivo evaluation of medical device-associated inflammation using a
   macrophage-specific positron emission tomography (PET) imaging probe
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Folic acid; Biomaterial implant; Inflammation; Biocompatibility; PET
   imaging
ID RESPONSES; BIOCOMPATIBILITY; NANOPARTICLES
AB To image implant-surrounding activated macrophages, a macrophage-specific PET probe was prepared by conjugating folic acid (FA) and 2,2',2 '',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetracetic acid (DOTA) to polyethylene glycol (PEG) and then labeling the conjugate with Ga-68. In vivo PET imaging evaluations demonstrate that the probe is able to detect foreign body reactions, and more importantly, quantify the degree of inflammatory responses to an implanted medical device. These results were further validated by histological analysis. (C) 2013 Elsevier Ltd. All rights reserved,
C1 [Zhou, Jun; Weng, Hong; Tsai, Yi-Ting; Baker, David W.; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Hao, Guiyang; Sun, Xiankai] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.
   [Sun, Xiankai] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
EM ltang@uta.edu
RI Zhou, Jun/H-3484-2013
FU NIH [EB007271, EB014404, U24 CA126608]; Siemens Inveon PET-CT
   Multi-modality System
FX The research was supported by NIH Grants EB007271, EB014404 (L.T.) and
   U24 CA126608 (X.S.). The authors acknowledge the generous support of a
   private donor that allowed the purchase of the Siemens Inveon PET-CT
   Multi-modality System.
CR Aide N, 2005, AM J ROENTGENOL, V184, P1172, DOI 10.2214/ajr.184.4.01841172
   Blom E, 2012, INT J CLIN EXP MED, V5, P165
   Bouloux GF, 2009, J ORAL MAXIL SURG, V67, P2497, DOI 10.1016/j.joms.2009.04.103
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Eder M, 2010, NUCL MED BIOL, V37, P405, DOI 10.1016/j.nucmedbio.2010.02.001
   Herschman HR, 2003, CURR OPIN IMMUNOL, V15, P378, DOI 10.1016/S0952-7915(03)00066-9
   Jiang WW, 2007, J BIOMED MATER RES A, V82A, P492, DOI 10.1002/jbm.a.31175
   Lidgren L, 2008, J BONE JOINT SURG BR, V90B, P7, DOI 10.1302/0301-620X.90B1.19823
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Piemonti L, 2010, ADV EXP MED BIOL, V654, P725, DOI 10.1007/978-90-481-3271-3_32
   Requena L, 2011, J AM ACAD DERMATOL, V64, P1, DOI 10.1016/j.jaad.2010.02.064
   Sailes FC, 2010, ANN PLAS SURG, V64, P696, DOI 10.1097/SAP.0b013e3181dc8409
   Santos E, 2010, ADV EXP MED BIOL, V670, P5
   Singh P, 2008, BIOCONJUGATE CHEM, V19, P2239, DOI 10.1021/bc800125u
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Wang S, 1996, BIOCONJUGATE CHEM, V7, P56, DOI 10.1021/bc9500709
   Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106
   Zhang Y, 2005, J COLLOID INTERF SCI, V283, P352, DOI 10.1016/j.jcis.2004.09.042
   Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064
NR 21
TC 10
Z9 10
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD APR 1
PY 2013
VL 23
IS 7
BP 2044
EP 2047
DI 10.1016/j.bmcl.2013.02.004
PG 4
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA 113CD
UT WOS:000316642900025
PM 23481649
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Sanon, C
   Chevalier, J
   Douillard, T
   Kohal, RJ
   Coelho, PG
   Hjerppe, J
   Silva, NRFA
AF Sanon, Clarisse
   Chevalier, Jerome
   Douillard, Thierry
   Kohal, Ralf J.
   Coelho, Paulo G.
   Hjerppe, Jenni
   Silva, Nelson R. F. A.
TI Low temperature degradation and reliability of one-piece ceramic oral
   implants with a porous surface
SO DENTAL MATERIALS
LA English
DT Article
DE Dental implants; Zirconia; Transformation; Reliability; Fatigue; Surface
   modification; Cracks; Focused ion beam
ID IN-VIVO; ZIRCONIA; BIOMATERIAL; TITANIUM; FUTURE
AB Low temperature degradation of zirconia (3Y-TZP) oral implants and its effect on fatigue reliability is poorly documented.
   Objective. The aim of this investigation was to follow the aging process occurring at the surface of implants exhibiting a porous coating and to assess its influence on their mechanical (fatigue) properties.
   Methods. Tetragonal to monoclinic transformation (t-m) was evaluated during accelerated aging tests up to 100 h in autoclave (134 degrees C, 2 bars) by X-ray diffraction (XRD) and focused ion beam (FIB). A series of implants were steam-aged for 20 h before fatigue testing. Such temperature-time conditions would correspond roughly to 40 years in vivo. The aged specimens and a non-aged control group were step-stress fatigued until failure or survival.
   Results. The evolution of XRD surface monoclinic content was slow, i.e. 16% and 35% for 20 and 100 h respectively. However, FIB revealed a significant transformation, initiated at the interface between the porous layer and the bulk, preferentially growing towards the bulk. FIB is therefore better indicated than XRD to follow aging in such implants. Higher average fatigue strength (aged 1235 N versus non-aged 826 N) and reliability levels were observed for the 20 h aged group.
   Significance. After aging for durations compatible with clinical use, 3Y-TZP with porous surface presented higher fatigue performance. This is in contrast to previous studies where loss of strength due to aging was often reported. Generalizations must therefore be avoided when considering aging of zirconia dental products and every new material/process combination should be tested before drawing conclusions. (C) 2013 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Sanon, Clarisse; Chevalier, Jerome; Douillard, Thierry] INSA Lyon, MATEIS, CNRS, UMR 5510, F-69621 Villeurbanne, France.
   [Sanon, Clarisse] Univ Lyon 1, Fac Odontol, Dept Biomat, F-69372 Lyon 08, France.
   [Kohal, Ralf J.] Univ Freiburg, Dept Prosthodont, Sch Dent, D-79106 Freiburg, Germany.
   [Coelho, Paulo G.; Hjerppe, Jenni] NYU, Coll Dent, New York, NY USA.
   [Silva, Nelson R. F. A.] Univ Fed Minas Gerais, Sch Dent, UFMG, FO, Belo Horizonte, MG, Brazil.
RP Chevalier, J (reprint author), INSA Lyon, MATEIS, CNRS, UMR 5510, 7 Ave Jean Capelle, F-69621 Villeurbanne, France.
EM jerome.chevalier@insa-lyon.fr
RI Douillard, Thierry/G-9808-2014
OI Douillard, Thierry/0000-0001-7113-889X; Kohal, Ralf/0000-0001-7095-4190
FU CNRS; "Grand Lyon"; "Rhone-Alpes Region"
FX Thanks are due to the CLYM (Centre Lyonnais de Microscopie: www.clym.fr)
   for the access to the microscope FIB ZEISS, NVI-SION 40. CLYM is
   supported by the CNRS, the "Grand Lyon" and the "Rhone-Alpes Region".
   The authors thank Nobel Bio-care for providing the implant prototypes
   for this study. Dr. Leandro M. Martins from Federal University of Manus,
   Brazil is acknowledged for his contribution during the fatigue testing.
   The fatigue test and data calculation were performed in the Department
   of Biomaterials and Biomimetics at New York University College of
   Dentistry, USA.
CR Blaschke C, 2006, NEUROENDOCRINOL LETT, V27, P69
   Borchers L, 2010, ACTA BIOMATER, V6, P4547, DOI 10.1016/j.actbio.2010.07.025
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chevalier J, 2011, ACTA BIOMATER, V7, P2986, DOI 10.1016/j.actbio.2011.03.006
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Dunn DB, 2008, J PROSTHET DENT, V100, P415, DOI 10.1016/S0022-3913(08)00149-2
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Kohal RJ, 2012, J CLIN PERIODONTOL, V39, P590, DOI 10.1111/j.1600-051X.2012.01876.x
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Koutayas SO, 2009, INT J ESTHET DENT, V4, P348
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Marro FG, 2012, J EUR CERAM SOC, V32, P317, DOI 10.1016/j.jeurceramsoc.2011.08.019
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, P13
   Studart AR, 2007, DENT MATER, V23, P106, DOI 10.1016/j.dental.2005.12.008
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
NR 22
TC 24
Z9 25
U1 0
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD APR
PY 2013
VL 29
IS 4
BP 389
EP 397
DI 10.1016/j.dental.2013.01.007
PG 9
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 112ND
UT WOS:000316598000007
PM 23419633
DA 2018-10-20
ER

PT J
AU Leal, AI
   Caridade, SG
   Ma, JL
   Yu, N
   Gomes, ME
   Reis, RL
   Jansen, JA
   Walboomers, XF
   Mano, JF
AF Leal, Ana I.
   Caridade, Sofia G.
   Ma, Jinling
   Yu, Na
   Gomes, Manuela E.
   Reis, Rui L.
   Jansen, John A.
   Walboomers, X. Frank
   Mano, Joao F.
TI Asymmetric PDLLA membranes containing Bioglass (R) for guided tissue
   regeneration: Characterization and in vitro biological behavior
SO DENTAL MATERIALS
LA English
DT Article
DE PDLLA; Bioglass (R); Membrane; Periodontal ligament; Tissue engineering
ID BIOACTIVE GLASS; COMPOSITE SCAFFOLDS; BIOABSORBABLE POLYMER; COLLAGEN
   PRODUCTION; MATRIX PRODUCTION; 45S5 BIOGLASS(R); NODULE FORMATION; CELL
   ATTACHMENT; BONE-FORMATION; GROWTH-FACTORS
AB Objective. In the treatment of periodontal defects, composite membranes might be applied to protect the injured area and simultaneously stimulate tissue regeneration. This work describes the development and characterization of poly(D,L-lactic acid)/Bioglass (R) (PDLLA/BG) composite membranes with asymmetric bioactivity. We hypothesized that the presence of BG microparticles could enhance structural and osteoconductivity performance of pure PDLLA membranes.
   Methods. The membranes were prepared by an adjusted solvent casting method that promoted a non-uniform distribution of the inorganic component along the membrane thickness. In vitro bioactive behavior (precipitation of an apatite layer upon immersion in simulated body fluid, SBF), SEM observation, FTIR, swelling, weight loss and mechanical properties of the developed biomaterials were evaluated. Cell behavior on the membranes was assessed using both human bone marrow stromal cells and human periodontal ligament cells.
   Results. Just the BG rich face of the composite membranes induced the precipitation of bone-like apatite in SBF, indicating that this biomaterial exhibit asymmetric osteoconductive properties. SEM images, DNA content and metabolic activity quantification revealed an improved cell adhesion and proliferation on the composite membranes. Composite membranes also stimulated cell differentiation, mineralization, and production of extracellular matrix and calcium nodules, suggesting the positive effect of adding the bioactive microparticles in the PDLLA matrix.
   Significance. The results indicate that the proposed asymmetric PDLLA/BG membranes could have potential to be used in guided tissue regeneration therapies or in orthopedic applications, with improved outcomes. (C) 2013 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Leal, Ana I.; Caridade, Sofia G.; Gomes, Manuela E.; Reis, Rui L.; Mano, Joao F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, European Inst Excellence Tissue Engn & Regenerat, Guimaraes, Portugal.
   [Leal, Ana I.; Caridade, Sofia G.; Gomes, Manuela E.; Reis, Rui L.; Mano, Joao F.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Ma, Jinling; Yu, Na; Jansen, John A.; Walboomers, X. Frank] Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, UMC St Radboud, NL-6525 ED Nijmegen, Netherlands.
RP Mano, JF (reprint author), 3Bs Res Grp Biomat Biodegradables & Biomimet, AvePk,Zona Ind Gandra,S Claudio do Barco, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Jansen, John/H-8055-2014; Mano,
   Joao/A-4418-2009; Gomes, Manuela/B-6282-2009; Group, 3Bs/E-4374-2012;
   Walboomers, X.Frank/B-3692-2013; Caridade, Sofia/P-1925-2015
OI Reis, Rui L./0000-0002-4295-6129; Mano, Joao/0000-0002-2342-3765; Gomes,
   Manuela/0000-0002-2036-6291; Group, 3Bs/0000-0002-5195-3456; Caridade,
   Sofia/0000-0002-0448-1871
FU Foundation for Science and Technology (FCT) [PTDC/CTM-BPC/112774/2009]
FX This work was financially supported by Foundation for Science and
   Technology (FCT) by the project PTDC/CTM-BPC/112774/2009.
CR Alves NM, 2010, J MATER CHEM, V20, P2911, DOI 10.1039/b910960a
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Batista EL, 1999, J PERIODONTOL, V70, P1000, DOI 10.1902/jop.1999.70.9.1000
   BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205
   Blaker JJ, 2005, E-POLYMERS
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Bras AR, 2007, J THERM ANAL CALORIM, V88, P425, DOI 10.1007/s10973-006-8038-8
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009
   Demirkiran H, 2010, MAT SCI ENG C-MATER, V30, P263, DOI 10.1016/j.msec.2009.10.011
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   GHEYSEN G, 1983, BIOMATERIALS, V4, P81, DOI 10.1016/0142-9612(83)90044-3
   Gollwitzer H, 2005, J ORTHOP RES, V23, P802, DOI 10.1016/j.orthres.2005.02.003
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   Helen W, 2007, BIOMATERIALS, V28, P2010, DOI 10.1016/j.biomaterials.2007.01.011
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1991, BIOCERAMICS, V4, P156
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI 10.1089/ten.TEA.2010.0181
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P335, DOI 10.1002/jbm.a.10587
   Marelli B, 2010, BIOMACROMOLECULES, V11, P1470, DOI 10.1021/bm1001087
   Meretoja VV, 2006, J BIOMED MATER RES A, V77A, P261, DOI 10.1002/jbm.a.30630
   Niemela T, 2005, ACTA BIOMATER, V1, P235, DOI [10.1016/j.actbio.2004.11.002, 10.1016/j.actbio.2004.11002]
   Niiranen H, 2004, J BIOMED MATER RES A, V69A, P699, DOI 10.1002/jbm.a.30043
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449
   Schmidmaier G, 2001, BONE, V28, P341, DOI 10.1016/S8756-3282(00)00456-7
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Villar Cristina C, 2010, Dent Clin North Am, V54, P73, DOI 10.1016/j.cden.2009.08.011
   Wan Y, 2006, BIOMACROMOLECULES, V7, P1362, DOI 10.1021/bm0600825
   Wilda H, 2006, BIOMATERIALS, V27, P5220, DOI 10.1016/j.biomaterials.2006.06.008
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang XBB, 2006, BIOCHEM BIOPH RES CO, V342, P1098, DOI 10.1016/j.bbrc.2006.02.021
   ZELLIN G, 1995, BIOMATERIALS, V16, P601, DOI 10.1016/0142-9612(95)93857-A
NR 47
TC 20
Z9 22
U1 6
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD APR
PY 2013
VL 29
IS 4
BP 427
EP 436
DI 10.1016/j.dental.2013.01.009
PG 10
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 112ND
UT WOS:000316598000012
PM 23422419
DA 2018-10-20
ER

PT J
AU Laverty, G
   Gorman, SP
   Gilmore, BF
AF Laverty, Garry
   Gorman, Sean P.
   Gilmore, Brendan F.
TI Biomolecular mechanisms of staphylococcal biofilm formation
SO FUTURE MICROBIOLOGY
LA English
DT Review
DE adhesins; adhesion; biomaterial; ica operon; quorum sensing
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   FIBRONECTIN-BINDING PROTEINS; RNAIII-INHIBITING PEPTIDE; QUORUM-SENSING
   SYSTEM; SIGMA-FACTOR SIGMA(B); PHENOL-SOLUBLE MODULINS; GRAM-POSITIVE
   BACTERIA; WALL TEICHOIC-ACIDS; CELL-WALL
AB The multitude of biomolecular and regulatory factors involved in staphylococcal adhesion and biofilm formation owe much to their ability to colonize surfaces, allowing the biofilm form to become the preferential bacterial phenotype. Judging by total number, biomass and variety of environments colonized, bacteria can be categorized as the most successful life form on earth. This is due to the ability of bacteria and other microorganisms to respond phenotypically via biomolecular processes to the stresses of their surrounding environment. This review focuses on the specific pathways involved in the adhesion of the Gram-positive bacteria Staphylococcus epidermidis and Staphylococcus aureus with reference to the role of specific cell surface adhesins, the ica operon, accumulation-associated proteins and quorum-sensing systems and their significance in medical device-related infection.
C1 [Laverty, Garry; Gorman, Sean P.; Gilmore, Brendan F.] Queens Univ Belfast, Sch Biomed Sci, Ctr Biol, Belfast BT9 7BL, Antrim, North Ireland.
RP Laverty, G (reprint author), Queens Univ Belfast, Sch Biomed Sci, Ctr Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM garry.laverty@qub.ac.uk
OI Laverty, Garry/0000-0002-1435-2942
CR Adhikari RP, 2007, INFECT IMMUN, V75, P4534, DOI 10.1128/IAI.00679-07
   Balaban N, 2001, J BIOL CHEM, V276, P2658, DOI 10.1074/jbc.M005446200
   Baldassarri L, 1996, INFECT IMMUN, V64, P3410
   Baldassarri L, 2001, EUR J CLIN MICROBIOL, V20, P343, DOI 10.1007/s100960100495
   Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206
   Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790
   Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003
   Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057
   Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x
   Bixler GD, 2012, PHILOS T R SOC A, V370, P2381, DOI 10.1098/rsta.2011.0502
   Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052
   Bose JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042244
   Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200
   Carson L, 2009, GREEN CHEM, V11, P492, DOI 10.1039/b821842k
   Chokr A, 2006, INT J MED MICROBIOL, V296, P381, DOI 10.1016/j.ijmm.2006.02.018
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   Cirioni O, 2006, J INFECT DIS, V193, P180, DOI 10.1086/498914
   Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Conlon KM, 2002, FEMS MICROBIOL LETT, V216, P171, DOI 10.1016/S0378-1097(02)01031-5
   Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0
   Dalton HM, 1998, CURR OPIN BIOTECH, V9, P252, DOI 10.1016/S0958-1669(98)80055-4
   de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x
   Dell'Acqua G, 2004, J INFECT DIS, V190, P318, DOI 10.1086/386546
   Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006
   Dubin G, 2002, BIOL CHEM, V383, P1075, DOI 10.1515/BC.2002.116
   Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001
   Federle MJ, 2009, CONTRIB MICROBIOL, V16, P18, DOI 10.1159/000219371
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Fluckiger U, 1998, INFECT IMMUN, V66, P2871
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Giacometti A, 2003, ANTIMICROB AGENTS CH, V47, P1979, DOI 10.1128/AAC.47.6.1979-1983.2003
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gov Y, 2001, PEPTIDES, V22, P1609, DOI 10.1016/S0196-9781(01)00496-X
   Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001
   Harris Llinos G, 2006, Injury, V37 Suppl 2, pS3, DOI 10.1016/j.injury.2006.04.003
   Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545
   Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x
   Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Jager S, 2005, APPL ENVIRON MICROB, V71, P5577, DOI 10.1128/AEM.71.9.5577-5581.2005
   Jefferson KK, 2003, MOL MICROBIOL, V48, P889, DOI 10.1046/j.1365-2958.2003.03482.x
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005
   Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027
   Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387
   Kavanaugh JS, 2007, MOL MICROBIOL, V65, P780, DOI 10.1111/j.1365-2958.2007.05830.x
   Kiran MD, 2008, INT J ARTIF ORGANS, V31, P761
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P101, DOI 10.1007/s00430-002-0124-3
   Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683
   Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x
   Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042
   Kullik I, 1998, J BACTERIOL, V180, P4814
   Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08
   Laverty G, 2011, INT J MOL SCI, V12, P6566, DOI 10.3390/ijms12106566
   Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005
   Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519
   Lindsay JA, 1999, MOL GEN GENET, V262, P323, DOI 10.1007/s004380051090
   Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Maira-Litran T, 2004, VACCINE, V22, P872, DOI 10.1016/j.vaccine.2003.11.033
   Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002
   Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822
   Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110
   Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006
   Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x
   Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   Pei L, 1999, INFECT IMMUN, V67, P4525
   Pei L, 2001, MICROB PATHOGENESIS, V31, P185, DOI 10.1006/mpat.2001.0462
   Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109
   Peschel A, 2001, PEPTIDES, V22, P1651, DOI 10.1016/S0196-9781(01)00500-9
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000
   Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005
   Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104
   Rimondini L, 2005, J Appl Biomater Biomech, V3, P1
   Risley AL, 2007, J INFECT DIS, V196, P919, DOI 10.1086/520932
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005
   Sadovskaya I, 2004, CARBOHYD RES, V339, P1467, DOI 10.1016/j.carres.2004.03.017
   Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x
   SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x
   Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744
   Scott CJ, 2002, BIOCHEM J, V366, P953, DOI 10.1042/BJ20020602
   Shanks RMQ, 2008, INFECT IMMUN, V76, P2469, DOI 10.1128/IAI.01370-07
   Shaw LN, 2007, INFECT IMMUN, V75, P4519, DOI 10.1128/IAI.00491-07
   SHIRO H, 1995, CIRCULATION, V92, P2715, DOI 10.1161/01.CIR.92.9.2715
   Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005
   Trotonda MP, 2005, J BACTERIOL, V187, P5790, DOI 10.1128/JB.187.16.5790-5798.2005
   Tsang LH, 2007, INFECT IMMUN, V75, P4528, DOI 10.1128/IAI.00603-07
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Valle J, 2007, J BACTERIOL, V189, P2886, DOI 10.1128/JB.01767-06
   Veiga AS, 2012, BIOMATERIALS, V33, P8907, DOI 10.1016/j.biomaterials.2012.08.046
   Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146
   Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0
   Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x
   Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606
   Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239
   Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861
   Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6
   Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006
   Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945
   Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004
   Zelzer M, 2013, BIOMATER SCI-UK, V1, P11, DOI 10.1039/c2bm00041e
   Zhang LS, 2004, J BIOL CHEM, V279, P19448, DOI 10.1074/jbc.M311349200
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 130
TC 33
Z9 37
U1 1
U2 91
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
EI 1746-0921
J9 FUTURE MICROBIOL
JI Future Microbiol.
PD APR
PY 2013
VL 8
IS 4
BP 509
EP 524
DI 10.2217/FMB.13.7
PG 16
WC Microbiology
SC Microbiology
GA 115GA
UT WOS:000316799400012
PM 23534362
OA Green Published
DA 2018-10-20
ER

PT J
AU Pan, WM
   Cao, Z
   Li, D
   Zhang, MJ
AF Pan, Weimin
   Cao, Zheng
   Li, Dan
   Zhang, Mingjun
TI Evaluation of the potential application of three different biomaterials
   combined with bone morphological proteins for enhancing tendon-bone
   integration
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Anterior cruciate ligament reconstruction; Different biomaterials; Bone
   morphological proteins; Tendon-bone integration
ID ANTERIOR CRUCIATE LIGAMENT; CALCIUM-PHOSPHATE CEMENT; MORPHOGENETIC
   PROTEINS; IN-VITRO; RECONSTRUCTION; AUTOGRAFT; RABBITS; TUNNEL;
   REPLACEMENT; FIXATION
AB Introduction: Secure tendon-bone integration is crucial for successful anterior cruciate ligament (ACL) reconstruction. Previous studies have applied different types of biomaterial or biomaterial combined with bone-growth factors to enhance tendon-bone integration. However, which approach is better remains controversial. This comparison evaluation could help identify a suitable composite biomaterial for osteointegration of grafted tendon.
   Materials and methods: Three different composite biomaterials mixed with bone morphological proteins (BMPs) were fabricated. The in vitro study investigates cell metabolism, osteogenic gene expression and the growth behaviour of bone marrow stromal cells (BMSCs) on fibrin glue-BMPs (FGB), calcium phosphate cement-BMPs (CPCB) and recombined bone xenograft (RBX), which are commercially, clinically available biomaterials. Meanwhile, the changes in the physical, morphological and mechanical properties between the three composites and the original biomaterials were also observed. The in vivo study mainly examined the osteogenic ability of the three composites through rat ectopic testing.
   Results: The porosity structure of three biomaterials was improved after being combined with BMPs powder for SEM observation, and the setting times of the injectable composites were not significantly delayed. More importantly, there were no significant decreases in compressive strength between the three composite biomaterials and the original biomaterials. The highest proliferation rate of BMSCs was found in the RBX group, followed by the CPCB and FGB groups. BMSCs seeded onto an RBX showed the highest alkaline phosphatase (ALPase) activity and gene expression of collagen I (P < 0.05). Histological examination showed endochondral new bone formation in the specimens of all groups, but the ALPase activity of newly formed tissue in the RBX group showed the highest level (P < 0.01).
   Conclusion: Our results indicate that RBX seems to be a very good choice for accelerating tendon-bone integration, and CPCB also has a large potential ability to be used. However, these two composites still need to be modified, and we postulate that a combination of them would be more favourable for tendon osteointegration after ACL reconstruction than either composite used alone. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Pan, Weimin; Zhang, Mingjun] Xian Phys Educ Univ, Dept Human Movement Studies, Xian 710068, Peoples R China.
   [Li, Dan] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed & Traumatol, Xian 710032, Peoples R China.
   [Cao, Zheng] China Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing 100037, Peoples R China.
RP Pan, WM (reprint author), Xian Phys Educ Univ, Dept Human Movement Studies, 65 Hanguang Rd, Xian 710068, Peoples R China.
EM panweimin@163.com
FU Chinese General Administration of Sport of Science and Technology
   [10B019]
FX This study was supported by Chinese General Administration of Sport of
   Science and Technology (No. 10B019).
CR BERESFORD JN, 1992, J CELL SCI, V102, P341
   Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P1425, DOI 10.2106/00004623-200308000-00002
   Flautre B, 2001, J MATER SCI-MATER M, V12, P679, DOI 10.1023/A:1011256107282
   FORWARD AD, 1963, J BONE JOINT SURG AM, V45, P807, DOI 10.2106/00004623-196345040-00015
   Gulotta LV, 2007, CLIN SPORT MED, V26, P509, DOI 10.1016/j.csm.2007.06.007
   Hashimoto Y, 2007, J ORTHOP RES, V25, P1415, DOI 10.1002/jor.20447
   Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Mihelic R, 2004, AM J SPORT MED, V32, P1619, DOI 10.1177/0363546504263703
   Milankov M, 2007, ARTHROSCOPY, V23, DOI 10.1016/j.arthro.2006.07.043
   Moffat KL, 2009, CLIN SPORT MED, V28, P157, DOI 10.1016/j.csm.2008.08.006
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nawata K, 2002, J ORTHOPAED RES, V20, P1339, DOI 10.1016/S0736-0266(02)00048-7
   Nebelung W, 2003, ARCH ORTHOP TRAUM SU, V123, P158, DOI 10.1007/s00402-002-0463-y
   Pan WM, 2009, INT ORTHOP, V33, P1761, DOI 10.1007/s00264-008-0715-8
   Pinczewski LA, 2002, AM J SPORT MED, V30, P523, DOI 10.1177/03635465020300041201
   Robertson WJ, 2007, ARTHROSCOPY, V23, P1087, DOI 10.1016/j.arthro.2007.04.007
   Rodeo SA, 1999, AM J SPORT MED, V27, P476, DOI 10.1177/03635465990270041201
   RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009
   Tien YC, 2004, J BONE JOINT SURG BR, V86B, P1072, DOI 10.1302/0301-620X.86B7.14578
   Tyler TF, 1999, J ORTHOP SPORT PHYS, V29, P540, DOI 10.2519/jospt.1999.29.9.540
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   Wen CY, 2010, ARTHROSCOPY, V26, P58, DOI 10.1016/j.arthro.2009.06.025
   Winkler MM, 1998, J PROSTHET DENT, V79, P532, DOI 10.1016/S0022-3913(98)70174-X
   Yamazaki S, 2005, ARTHROSCOPY, V21, P1034, DOI 10.1016/j.arthro.2005.05.011
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Yu Y, 2007, ARTHROSCOPY, V23, P205, DOI 10.1016/j.arthro.2006.08.023
   Yuan Zhi, 2003, Zhonghua Yi Xue Za Zhi, V83, P128
NR 30
TC 4
Z9 5
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD APR
PY 2013
VL 44
IS 4
BP 550
EP 557
DI 10.1016/j.injury.2012.09.019
PG 8
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 114GO
UT WOS:000316729300028
PM 23062671
DA 2018-10-20
ER

PT J
AU Wu, QY
   Liu, T
   Yang, Q
AF Wu, Qingyue
   Liu, Tian
   Yang, Qing
TI Cloning, expression and biocharacterization of OfCht5, the chitinase
   from the insect Ostrinia furnacalis
SO INSECT SCIENCE
LA English
DT Article
DE chitin; chitinase; glycoside hydrolase; N-acetyl-beta-D-glucosamine;
   Ostrinia furnacalis; pest control
ID ACETYL-D-GLUCOSAMINE; FUNCTIONAL EXPRESSION; BOMBYX-MORI; CDNA;
   PROTEINS; ENZYMES; FAMILY; PURIFICATION; BACTERIAL; DOMAINS
AB Chitinase catalyzes -1,4-glycosidic linkages in chitin and has attracted research interest due to it being a potential pesticide target and an enzymatic tool for preparation of N-acetyl--D-glucosamine. An individual insect contains multiple genes encoding chitinases, which vary in domain architectures, expression patterns, physiological roles and biochemical properties. Herein, OfCht5, the glycoside hydrolase family 18 chitinase from the widespread lepidopteran pest Ostrinia furnacalis, was cloned, expressed in the yeast Pichia pastoris and biochemically characterized in an attempt to facilitate both pest control and biomaterial preparation. Complementary DNA sequence analysis indicated that OfCHT5 consisted of an open reading frame of 1665-bp nucleotides. Phylogenic analysis suggested OfCht5 belongs to the Group I insect chitinases. Expression of OfCht5 in Pichia pastoris resulted in highest specific activity after 120 h of induction with methanol. Through two steps of purification, consisting of ammonium sulfate precipitation and metal chelating chromatography, about 7 mg of the recombinant OfCht5 was purified to homogeneity from 1 L culture supernatant. OfCht5 effectively converted colloidal chitin into chitobiose, but had relatively low activity toward -chitin. When chitooligosaccharides [(GlcNAc)n, n= 36] were used as substrates, OfCht5 was observed to possess the highest catalytic efficiency parameter toward (GlcNAc)4 and predominantely hydrolyzed the second glycosidic bond from the non-reducing end. Together with -N-acetyl-D-hexosaminidase OfHex1, OfCht5 achieved its highest efficiency in chitin degradation that yielded N-acetyl--D-glucosamine, a valuable pharmacological reagent and food supplement, within a molar concentration ratio of OfCht5 versus OfHex1 in the range of 9:115:1. This work provides an alternative to existing preparation of chitinase for pesticides and other applications.
C1 [Wu, Qingyue; Liu, Tian; Yang, Qing] Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian 116024, Peoples R China.
RP Yang, Q (reprint author), Dalian Univ Technol, Dept Biosci & Biotechnol, 2 Linggong Rd, Dalian 116024, Peoples R China.
EM qingyang@dlut.edu.cn
RI Liu, Tian/E-2481-2012
FU National Key Project for Basic Research [2010CB126100]; National Natural
   Science Foundation of China [31070715, 31101671]; National High
   Technology Research and Development Program of China [2011AA10A204];
   National Key Technology RD Program [2011BAE06B05]; Fundamental Research
   Funds for the Central Universities [DUT11ZD113, DUT11RC(3)73]
FX The authors acknowledge the financial support provided by the National
   Key Project for Basic Research (2010CB126100), the National Natural
   Science Foundation of China (31070715, 31101671), the National High
   Technology Research and Development Program of China (2011AA10A204), the
   National Key Technology R&D Program (2011BAE06B05) and the Fundamental
   Research Funds for the Central Universities (DUT11ZD113, DUT11RC(3)73).
   Also thanks to Dr. Alan K. Chang at Dalian University of Technology for
   reviewing the language of this manuscript.
CR A-Banat BMA, 1999, INSECT BIOCHEM MOLEC, V29, P537, DOI 10.1016/S0965-1748(99)00028-4
   Arakane Y, 2003, INSECT BIOCHEM MOLEC, V33, P631, DOI 10.1016/S0965-1748(03)00049-3
   Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9
   Binod P, 2007, BIORESOURCE TECHNOL, V98, P2742, DOI 10.1016/j.biortech.2006.09.030
   Bokma E, 2000, FEBS LETT, V478, P119, DOI 10.1016/S0014-5793(00)01833-0
   Donzelli BGG, 2003, CARBOHYD RES, V338, P1823, DOI 10.1016/S0008-6215(03)00269-6
   Erthal M, 2007, J INSECT PHYSIOL, V53, P1101, DOI 10.1016/j.jinsphys.2007.06.014
   Filho BPD, 2002, INSECT BIOCHEM MOLEC, V32, P1723, DOI 10.1016/S0965-1748(02)00112-1
   Fitches E, 2004, INSECT BIOCHEM MOLEC, V34, P1037, DOI 10.1016/j.ibmb.2004.06.012
   Genta FA, 2006, INSECT BIOCHEM MOLEC, V36, P789, DOI 10.1016/j.ibmb.2006.07.007
   Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988
   KIMURA S, 1976, INSECT BIOCHEM, V6, P479, DOI 10.1016/0020-1790(76)90071-8
   KRISHNAN A, 1994, J BIOL CHEM, V269, P20971
   Kuk JH, 2005, APPL MICROBIOL BIOT, V68, P384, DOI 10.1007/s00253-004-1877-y
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036
   Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796
   Lu YM, 2002, INSECT BIOCHEM MOLEC, V32, P1369, DOI 10.1016/S0965-1748(02)00057-7
   Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709
   Nakabachi A, 2010, INSECT MOL BIOL, V19, P175, DOI 10.1111/j.1365-2583.2009.00985.x
   Pichyangkura R, 2002, CARBOHYD RES, V337, P557, DOI 10.1016/S0008-6215(02)00007-1
   Ramalho-Ortigao JM, 2003, INSECT BIOCHEM MOLEC, V33, P279, DOI 10.1016/S0965-1748(02)00209-6
   Royer W, 2002, BIOCHEM J, V366, P921
   Salvatore S, 2000, ALIMENT PHARM THER, V14, P1567, DOI 10.1046/j.1365-2036.2000.00883.x
   Sashiwa H, 2002, CARBOHYD RES, V337, P761, DOI 10.1016/S0008-6215(02)00034-4
   Shinoda T, 2001, INSECT BIOCHEM MOLEC, V31, P521, DOI 10.1016/S0965-1748(00)00133-8
   Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008
   Suginta Wipa, 2009, J Chem Biol, V2, P191, DOI 10.1007/s12154-009-0021-y
   Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473
   Taira T, 2011, GLYCOBIOLOGY, V21, P644, DOI 10.1093/glycob/cwq212
   Tamai Y, 2003, CARBOHYD POLYM, V54, P251, DOI 10.1016/S0144-8617(03)00170-X
   Yan J, 2002, INSECT BIOCHEM MOLEC, V32, P979, DOI 10.1016/S0965-1748(02)00034-6
   Yang Q, 2008, FEBS J, V275, P5690, DOI 10.1111/j.1742-4658.2008.06695.x
   Zhang HB, 2011, CELL BIOCHEM BIOPHYS, V61, P267, DOI 10.1007/s12013-011-9196-2
   Zhang JZ, 2011, INSECT BIOCHEM MOLEC, V41, P521, DOI 10.1016/j.ibmb.2011.03.001
   Zhang JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019899
   Zheng Y, 2002, INSECT BIOCHEM MOLEC, V32, P1813, DOI 10.1016/S0965-1748(02)00166-2
   Zhu Q, 2008, INSECT BIOCHEM MOLEC, V38, P467, DOI 10.1016/j.ibmb.2007.06.011
   Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.01
   Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105
NR 41
TC 15
Z9 22
U1 1
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1672-9609
J9 INSECT SCI
JI Insect Sci.
PD APR
PY 2013
VL 20
IS 2
BP 147
EP 157
DI 10.1111/j.1744-7917.2012.01512.x
PG 11
WC Entomology
SC Entomology
GA 113VX
UT WOS:000316698600003
PM 23955855
DA 2018-10-20
ER

PT J
AU Monier, M
   El-Mekabaty, A
AF Monier, M.
   El-Mekabaty, A.
TI Preparation of molecularly imprinted resin based on chitosan for chiral
   recognition of S-mandelic acid
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Molecular imprinting; Enantioselective resins; Biopolymers; Biosorption;
   Adsorbents; Biomaterial engineering
ID SELECTIVE SEPARATION; MAGNETIC CHITOSAN; AQUEOUS-SOLUTIONS; POLYMERS;
   REMOVAL; ADSORPTION; PHENYLALANINE; PROTEINS; WATER; ENANTIOMERS
AB An enantioselective S-mandelic acid (S-MA) imprinted chitosan (SMIC) was prepared by cross-linking of chitosan using formaldehyde cross-linker, in the presence of S-MA as an imprint template molecule and 0.5% acetic acid solution as a solvent. Non-imprinted cross-linked chitosan (NIC) as control was also prepared by the same procedure in absence of template molecules. The surface morphology of both SMIC and NIC were examined by scanning electron microscope (SEM). SMIC particles were applied to determine the optimum operational condition for S-MA separation from dilute aqueous solution. In adsorption step, optimum pH and retention time were 3.5 and 60 min, while corresponding values in extraction step were 1 and 40 min, respectively. Also, the adsorption isotherms indicated that the maximum adsorption capacities of S- and R-MA on SMIC were 100 +/- 0.5 and 64 +/- 0.8 mg/g, respectively, while in the case of NIC, both R- and S-MA present the same maximum adsorption. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Monier, M.; El-Mekabaty, A.] Mansoura Univ, Fac Sci, Dept Chem, Mansoura 35516, Egypt.
RP Monier, M (reprint author), Mansoura Univ, Fac Sci, Dept Chem, Mansoura 35516, Egypt.
EM monierchem@yahoo.com
CR Aksu Z, 2002, PROCESS BIOCHEM, V38, P89, DOI 10.1016/S0032-9592(02)00051-1
   Alvarez-Lorenzo C, 2006, BIOTECHNOL ANN REV, V12, P225, DOI 10.1016/S1387-2656(06)12007-4
   Baraka A, 2007, REACT FUNCT POLYM, V67, P585, DOI 10.1016/j.reactfunctpolym.2007.01.015
   Bossi A, 2007, BIOSENS BIOELECTRON, V22, P1131, DOI 10.1016/j.bios.2006.06.023
   Chen CY, 2011, J HAZARD MATER, V185, P430, DOI 10.1016/j.jhazmat.2010.09.051
   Chen CY, 2007, BIORESOURCE TECHNOL, V98, P2578, DOI 10.1016/j.biortech.2006.09.009
   Chen LX, 2011, CHEM SOC REV, V40, P2922, DOI 10.1039/c0cs00084a
   Dinu MV, 2008, REACT FUNCT POLYM, V68, P1346, DOI 10.1016/j.reactfunctpolym.2008.06.011
   Fan LL, 2012, COLLOID SURFACE B, V91, P250, DOI 10.1016/j.colsurfb.2011.11.014
   Fan LL, 2011, J HAZARD MATER, V194, P193, DOI 10.1016/j.jhazmat.2011.07.080
   Fu GQ, 2008, BIOMATERIALS, V29, P2138, DOI 10.1016/j.biomaterials.2008.01.019
   Fu GQ, 2007, REACT FUNCT POLYM, V67, P442, DOI 10.1016/j.reactfunctpolym.2007.02.006
   Guo HS, 2009, BIOSENS BIOELECTRON, V24, P2931, DOI 10.1016/j.bios.2009.02.002
   Guo TY, 2005, BIOMATERIALS, V26, P5737, DOI 10.1016/j.biomaterials.2005.02.017
   Hofstetter O, 2005, J BIOCHEM BIOPH METH, V63, P91, DOI 10.1016/j.jbbm.2005.03.003
   Hu SG, 2005, J CHROMATOGR A, V1062, P31, DOI 10.1016/j.chroma.2004.11.036
   Hu XJ, 2011, J HAZARD MATER, V185, P306, DOI 10.1016/j.jhazmat.2010.09.034
   Jirage KB, 1999, TRENDS BIOTECHNOL, V17, P197, DOI 10.1016/S0167-7799(98)01296-7
   Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007
   Kirsch N, 2009, J MOL CATAL B-ENZYM, V58, P110, DOI 10.1016/j.molcatb.2008.12.002
   Koesdjojo MT, 2007, SEP SCI TECHNOL-SER, V8, P479
   Li W, 2007, ADV POLYM SCI, V206, P191, DOI 10.1007/12_2006_105
   Li YH, 2005, WATER RES, V39, P605, DOI 10.1016/j.watres.2004.11.004
   Liu H. J., 2011, WATER RES, V4, P145
   Mahony JO, 2005, ANAL CHIM ACTA, V534, P31, DOI 10.1016/j.aca.2004.07.043
   Maier NM, 2001, J CHROMATOGR A, V906, P3, DOI 10.1016/S0021-9673(00)00532-X
   Matsuoka Y, 2006, J MEMBRANE SCI, V280, P116, DOI 10.1016/j.memsci.2006.01.013
   Millot MC, 2003, J CHROMATOGR B, V797, P131, DOI 10.1016/j.jchromb.2003.08.035
   Monier M, 2012, J HAZARD MATER, V209, P240, DOI 10.1016/j.jhazmat.2012.01.015
   Monier M, 2010, BIOCHEM ENG J, V51, P140, DOI 10.1016/j.bej.2010.06.007
   Monier M, 2010, INT J BIOL MACROMOL, V47, P207, DOI 10.1016/j.ijbiomac.2010.04.020
   Nishad PA, 2012, CARBOHYD POLYM, V87, P2690, DOI 10.1016/j.carbpol.2011.11.061
   Panahi R, 2007, BIOCHEM ENG J, V35, P352, DOI 10.1016/j.bej.2007.01.027
   Prasad BB, 2010, BIOSENS BIOELECTRON, V25, P2140, DOI 10.1016/j.bios.2010.02.016
   Rikken GLJA, 2000, NATURE, V405, P932, DOI 10.1038/35016043
   Sarhan AA, 2009, REACT FUNCT POLYM, V69, P358, DOI 10.1016/j.reactfunctpolym.2009.02.009
   Sergeyeva T. A., 2010, ANAL CHIM ACTA, V656, P274
   Sueyoshi Y, 2010, J MEMBRANE SCI, V357, P90, DOI 10.1016/j.memsci.2010.04.005
   Sulaiman Y, 2012, ANALYST, V137, P2386, DOI 10.1039/c2an15854j
   Sunayama H, 2010, BIOSENS BIOELECTRON, V26, P458, DOI 10.1016/j.bios.2010.07.091
   Tokonami S, 2009, ANAL CHIM ACTA, V641, P7, DOI 10.1016/j.aca.2009.03.035
   Tong Y., 2011, CARBOHYD RES, V246, P495
   Wu H, 2009, SEP PURIF TECHNOL, V68, P97, DOI 10.1016/j.seppur.2009.04.014
   Xia YQ, 2006, REACT FUNCT POLYM, V66, P1734, DOI 10.1016/j.reactfunctpolym.2006.08.001
   Zhou LM, 2012, J COLLOID INTERF SCI, V366, P165, DOI 10.1016/j.jcis.2011.09.069
NR 45
TC 11
Z9 15
U1 2
U2 88
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2013
VL 55
BP 207
EP 213
DI 10.1016/j.ijbiomac.2013.01.020
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 114YH
UT WOS:000316778400029
PM 23357795
DA 2018-10-20
ER

PT J
AU Abdelaal, MY
   Sobahi, TR
   Al-Shareef, HF
AF Abdelaal, Magdy Y.
   Sobahi, Tariq R.
   Al-Shareef, Hossa F.
TI Modification of chitosan derivatives of environmental and biological
   interest: A green chemistry approach
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan; Carbohydrate; Crosslinker; Chemical modification; Biological
   activity
ID ANTIMICROBIAL ACTIVITY; DELIVERY-SYSTEMS; CHITIN; CYCLODEXTRIN;
   HYDROGELS; RELEASE
AB Chitosan is a non-toxic polyaminosaccharide that is available in a variety of useful forms, and its chemical and biological properties make it a very attractive biomaterial that could be used in a wide variety of medicinal applications. This work focuses on the preparation of different chitosan derivatives by treatment with ethyl cellulose, cellulose triacetate and different carbohydrates in both neutral and slightly acidic media. It also addresses modification with glycidyltrimethyl ammonium chloride, phthalic anhydride and succinic acid derivatives. The obtained derivatives were crosslinked with glutaraldehyde. Thermo-gravimetric (TGA) and FT-IR spectroscopic analyses and electron scanning microscopy (SEM) were used to characterize the obtained products and demonstrate the success of the chitosan-modification process. The obtained products were tested for their ability to uptake transition metal ions from aqueous solutions, and their ion-uptake efficiency was determined with the aid of the ICP-AES technique. The bioactivity of some selected products was tested to study the effect of their concentrations on selected microorganisms. Burkholderia cepaci, Aspergillus niger, and Candida albi cans were selected as representative examples of bacteria, yeasts and fungi, respectively. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Abdelaal, Magdy Y.; Sobahi, Tariq R.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah 21589, Saudi Arabia.
   [Al-Shareef, Hossa F.] Umm Al Qura Univ, Fac Sci Appl, Dept Chem, Makkah Al Mukarramah, Saudi Arabia.
   [Abdelaal, Magdy Y.] Mansoura Univ, Fac Sci, Polymer Lab, Dept Chem, ET-35516 Mansoura, Egypt.
RP Abdelaal, MY (reprint author), King Abdulaziz Univ, Fac Sci, Dept Chem, POB 80203, Jeddah 21589, Saudi Arabia.
EM magdyabdelaal@yahoo.com
RI Faculty of, Sciences, KAU/E-7305-2017; Sobahi, Tariq/J-5801-2012
OI Abdelaal, Magdy/0000-0002-1948-6413
FU King Abdulaziz City for Science & Technology (KASCT) [AT-17-096]; King
   Abdulaziz University
FX The authors would like to acknowledge King Abdulaziz City for Science &
   Technology (KASCT) for partially financing this work (AT-17-096) through
   the collaboration with Deanship of Scientific Research (DSR) at King
   Abdulaziz University.
CR Abdelaal MY, 2007, J APPL POLYM SCI, V103, P2864, DOI 10.1002/app.25154
   Ali AEH, 2009, CARBOHYD POLYM, V78, P725, DOI 10.1016/j.carbpol.2009.06.009
   Cuero RG, 1999, EXS, V87, P315
   El-Tahlawy K, 2006, CARBOHYD POLYM, V63, P385, DOI 10.1016/j.carbpol.2005.08.057
   ELGHAOUTH A, 1992, PHYTOPATHOLOGY, V82, P398, DOI 10.1094/Phyto-82-398
   FOUDA MMG, 2005, THESIS U DUISBURG ES
   Fukuda M, 2006, INT J PHARM, V310, P90, DOI 10.1016/j.ijpharm.2005.11.042
   Gorochovceva N, 2004, EUR POLYM J, V40, P685, DOI 10.1016/j.eurpolymj.2003.12.005
   Goy RC, 2009, POLIMEROS, V19, P241, DOI 10.1590/S0104-14282009000300013
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   Juang RS, 1997, J CHEM TECHNOL BIOT, V70, P391, DOI 10.1002/(SICI)1097-4660(199712)70:4<391::AID-JCTB792>3.0.CO;2-V
   KOBAYASHI N, 1981, J CHEM SOC CHEM COMM, P340, DOI 10.1039/c39810000340
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Makki M.S.I., 2011, J ALLOY COMPD, V509, P2582
   Prabaharan M, 2006, CARBOHYD POLYM, V63, P153, DOI 10.1016/j.carbpol.2005.08.051
   Qin CQ, 2004, INT J BIOL MACROMOL, V34, P121, DOI 10.1016/j.ijbiomac.2004.03.009
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sashai A. S., 1993, FEMS MICROBIOL REV, V11, P317
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   Sobahi T.R., J SAUDI CHE IN PRESS
   Sobahi T.R., ARABIAN J C IN PRESS
   Sun LP, 2006, POLYMER, V47, P1796, DOI 10.1016/j.polymer.2006.01.073
   van de Wiel H.J., 2003, HORIZONTAL, V19, P1
   Yan CY, 2006, CHEM RES CHINESE U, V22, P589, DOI 10.1016/S1005-9040(06)60168-2
NR 25
TC 8
Z9 8
U1 1
U2 109
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2013
VL 55
BP 231
EP 239
DI 10.1016/j.ijbiomac.2013.01.013
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 114YH
UT WOS:000316778400032
PM 23376358
DA 2018-10-20
ER

PT J
AU Hoss, M
   Apel, C
   Dhanasingh, A
   Suschek, CV
   Hemmrich, K
   Salber, J
   Zenke, M
   Neuss, S
AF Hoss, Mareike
   Apel, Christian
   Dhanasingh, Anandhan
   Suschek, Christoph V.
   Hemmrich, Karsten
   Salber, Jochen
   Zenke, Martin
   Neuss, Sabine
TI Integrin 4 impacts on differential adhesion of preadipocytes and stem
   cells on synthetic polymers
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE polymers; integrins; extracellular matrix molecules; human mesenchymal
   stem cells; human dental pulp stem cells; human preadipocytes
ID TERM SELF-RENEWAL; SURFACE-PROPERTIES; STROMAL CELLS; DENTAL-PULP;
   IN-VITRO; BIOMATERIALS; COLLAGEN; GROWTH; PROLIFERATION; PHENOTYPE
AB Stem cells represent an ideal cell source for tissue engineering and regenerative medicine, because they can be readily isolated, expanded, differentiated and transplanted. For stem cell-based therapies, biomaterials are required to allow for a spatial distribution of the stem cells within a defined area in the body. In our recent studies, we analysed the interaction of a large panel of stem cell types with an array of biomaterials and demonstrated that a rational prediction of stem cell behaviour on a specific biomaterial is so far not possible. Interestingly, even ontogenetically related stem cell types, such as mesenchymal stem cells (MSCs), preadipocytes and dental pulp stem cells (DPSCs), exhibit distinct adhesion properties on the very same biomaterial surface. Therefore, we investigated integrin and extracellular matrix (ECM) protein expression of stem cells to relate gene expression to adhesion behaviour. MSCs, preadipocytes and DPSCs were cultured on selected synthetic polymers, such as Texin, a thermoplastic polyurethane, poly(dimethyl siloxane) (PDMS), poly-d,l-lactic acid (PDLLA) and l-lactic acid-trimehylene carbonate (Resomer (R) LT706). Integrins and ECM proteins were analysed by RTPCR, real-time PCR and immunohistochemistry. Analysis of several adhesion molecules yielded that only one molecule, integrin 4, might play a significant role in differential adhesion on polymers for preadipocytes compared to DPSCs and MSCs. Thus, our studies on the molecular interactions of stem cells and polymers are expected to lead to a more profound understanding of the stem cellbiomaterial interactions to eventually allow for a rational biomaterial design. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Hoss, Mareike] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res, IZKF Aachen, D-52074 Aachen, Germany.
   [Hoss, Mareike; Neuss, Sabine] Rhein Westfal TH Aachen, Inst Pathol, D-52074 Aachen, Germany.
   [Apel, Christian] Rhein Westfal TH Aachen, Dept Conservat Dent Periodontol & Prevent Dent, D-52074 Aachen, Germany.
   [Dhanasingh, Anandhan; Salber, Jochen] Rhein Westfal TH Aachen, DWI eV, D-52074 Aachen, Germany.
   [Dhanasingh, Anandhan; Salber, Jochen] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52074 Aachen, Germany.
   [Suschek, Christoph V.; Hemmrich, Karsten] Rhein Westfal TH Aachen, Dept Plast & Reconstruct Surg, Hand Surg & Burn Ctr, D-52074 Aachen, Germany.
   [Salber, Jochen] Ruhr Univ Bochum, Chirurg Klin & Poliklin, BG Univ Klinikum Bergmannsheil, Bochum, Germany.
   [Zenke, Martin] Rhein Westfal TH Aachen, Inst Biomed Engn, Dept Cell Biol, D-52074 Aachen, Germany.
   [Zenke, Martin] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
   [Neuss, Sabine] Rhein Westfal TH Aachen, Inst Biomed Engn, Biointerface Grp, D-52074 Aachen, Germany.
RP Hoss, M (reprint author), Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res, IZKF Aachen, Pauwelsstr 30, D-52074 Aachen, Germany.
EM mareike.hoss@rwth-aachen.de
FU IZKF Aachen (Interdisciplinary Centre for Clinical Research within the
   faculty of Medicine at RWTH Aachen University) [VVB-110]; Deutsche
   Forschungsgemeinschaft (DFG) [SFB-TR 37]
FX We thank P. Buttler for isolation of DPSCs, A. Fritz for isolation of
   preadipocytes and the Department of Orthopaedic Surgery (RWTH Aachen
   University) for providing bone spongiosa. Supported by the IZKF Aachen
   (Interdisciplinary Centre for Clinical Research within the faculty of
   Medicine at RWTH Aachen University; Grant No. VVB-110) and the Deutsche
   Forschungsgemeinschaft (DFG; Grant No. SFB-TR 37, Project B2, to K.H).
CR Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Coleman SR, 2006, CLIN PLAST SURG, V33, P567, DOI 10.1016/j.cps.2006.09.002
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   GLASS J, 1994, ANN NY ACAD SCI, V745, P177
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   HUMPHRIES MJ, 1995, CIBA F SYMP, V189, P177
   Itthichaisri C, 2007, J BIOMED MATER RES A, V82A, P777, DOI 10.1002/jbm.a.31191
   Karakecili A, 2007, J MATER SCI-MATER M, V18, P317, DOI 10.1007/s10856-006-0695-4
   Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564
   Kornblihtt AR, 1996, FASEB J, V10, P248
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Li B, 2006, J BIOMED MATER RES A, V79A, P989, DOI 10.1002/jbm.a.30847
   Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Nakajima I, 2002, BIOL CELL, V94, P197, DOI 10.1016/S0248-4900(02)01189-9
   Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   Schieker M, 2004, J ANAT, V204, P133, DOI 10.1111/j.1469-7580.2004.00252.x
   Shi S, 2001, BONE, V29, P532, DOI 10.1016/S8756-3282(01)00612-3
   Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0
   Yu JH, 2006, TISSUE ENG, V12, P3097, DOI 10.1089/ten.2006.12.3097
NR 32
TC 3
Z9 3
U1 1
U2 23
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2013
VL 7
IS 4
BP 312
EP 323
DI 10.1002/term.526
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 117RA
UT WOS:000316969600006
PM 22318983
DA 2018-10-20
ER

PT J
AU Balaz, P
   Calka, A
   Zorkovska, A
   Balaz, M
AF Balaz, P.
   Calka, A.
   Zorkovska, A.
   Balaz, M.
TI Processing of Eggshell Biomaterial by Electrical Discharge Assisted
   Mechanical Milling (EDAMM) and High Energy Milling (HEM) Techniques
SO MATERIALS AND MANUFACTURING PROCESSES
LA English
DT Article
DE Biomaterial; Eggshell; Mechanochemistry; Milling
ID DECOMPOSITION; CARBONATES; PVC
AB In this study, hen eggshell (ES) biomaterial was treated by two mechanochemical methods. Here we show that using of low-current high-voltage electrical impulses during electrical discharge assisted mechanical milling (EDAMM) or high-energy milling (HEM) are proper tools for ES transformation to materials suitable for the further applications. The decomposition of calcite CaCO3 (the main component of ES) into lime CaO (EDAMM treatment) or calcite-aragonite transformation (HEM treatment) were documented by X-ray diffractometry. The applied techniques bring about solid state transformation, high degree of calcite amorphization, and enhancement of specific surface area of ES samples. As examples of using the transformed ES the uptake of cadmium ions during sorption experiments and the dechlorination of polyvinyl chloride are given. In both cases, the technologically accepted recoveries and kinetics have been obtained.
C1 [Balaz, P.; Zorkovska, A.; Balaz, M.] Slovak Acad Sci, Inst Geotech, Kosice 04353, Slovakia.
   [Calka, A.] Univ Wollongong, Fac Engn, Wollongong, NSW, Australia.
RP Balaz, P (reprint author), Slovak Acad Sci, Inst Geotech, Watsonova 45, Kosice 04353, Slovakia.
EM balaz@saske.sk
FU Agency for Science and Development [APVV-0189-10]; Slovak Grant Agency
   [2/0009/11]; SAS Centre of Excellence: CFNTMVEP; Center of Excellence of
   Advanced Materials with Nano- and Submicron-Structure [nano-CEXmat
   II-ITMS 26220120035]; Operational Program "Research and Development";
   European Regional Development Fund
FX This study was supported by the Agency for Science and Development
   (project APVV-0189-10), the Slovak Grant Agency (project VEGA
   2/0009/11), and the SAS Centre of Excellence: CFNTMVEP. The support
   through the project of Center of Excellence of Advanced Materials with
   Nano- and Submicron-Structure (nano-CEXmat II-ITMS 26220120035), which
   is supported by the Operational Program "Research and Development"
   financed through European Regional Development Fund is also gratefully
   acknowledged.
CR Bala P, 2008, MECHANOCHEMISTRY NAN
   Balazsi C, 2007, J EUR CERAM SOC, V27, P1601, DOI 10.1016/j.jeurceramsoc.2006.04.016
   Calka A, 2002, NATURE, V419, P147, DOI 10.1038/nature00985
   CRIADO JM, 1979, THERMOCHIM ACTA, V32, P99, DOI 10.1016/0040-6031(79)85097-2
   Drebushchak TN, 2011, CRYSTENGCOMM, V13, P4405, DOI 10.1039/c1ce05189j
   HEDVALL JA, 1938, REACTIVITY SOLIDS
   JAMIESON JC, 1960, AM MINERAL, V45, P818
   Ji RJ, 2011, MATER MANUF PROCESS, V26, P1050, DOI 10.1080/10426914.2010.529590
   Kumar R., 2011, FRONTIERS MECHANOCHE
   MARTINEZ G, 1981, J COLLOID INTERF SCI, V81, P500, DOI 10.1016/0021-9797(81)90431-8
   Oke IA, 2008, ADSORPTION, V14, P73, DOI 10.1007/s10450-007-9047-z
   Pesenti H, 2008, Z KRISTALLOGR, P143, DOI 10.1524/zksu.2008.0019
   Tongamp W, 2008, WASTE MANAGE, V28, P484, DOI 10.1016/j.wasman.2007.01.022
   Tongamp W, 2006, J HAZARD MATER, V137, P1226, DOI 10.1016/j.jhazmat.2006.04.013
   Tsai WT, 2008, MICROPOR MESOPOR MAT, V111, P379, DOI 10.1016/j.micromeso.2007.08.010
   Zhang Q., 1999, J SOC POWDER TECHNOL, V36, P468
   Zhou J, 2011, NANO RES, V4, P171, DOI 10.1007/s12274-010-0067-8
NR 17
TC 18
Z9 18
U1 1
U2 28
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1042-6914
EI 1532-2475
J9 MATER MANUF PROCESS
JI Mater. Manuf. Process.
PD APR 1
PY 2013
VL 28
IS 4
BP 343
EP 347
DI 10.1080/10426914.2012.709294
PG 5
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 113HZ
UT WOS:000316658500001
DA 2018-10-20
ER

PT J
AU Palumbo, C
   Baldini, A
   Cavani, F
   Sena, P
   Benincasa, M
   Ferretti, M
   Zaffe, D
AF Palumbo, Carla
   Baldini, Andrea
   Cavani, Francesco
   Sena, Paola
   Benincasa, Marta
   Ferretti, Marzia
   Zaffe, Davide
TI Immunocytochemical and structural comparative study of committed versus
   multipotent stem cells cultured with different biomaterials
SO MICRON
LA English
DT Article
DE Osteoblast cells; Stem cells; Bone cell differentiation; Biomaterials;
   Titanium; 3D-Scaffold
ID DENTAL-PULP; BONE-MARROW; OSTEOBLASTS; TITANIUM; PRECURSORS; REPAIR
AB The aim of this work was the comparison of the behavior of committed (human osteoblast cells - hOB - from bone biopsies) versus multipotent (human dental pulp stem cells - hDPSC - from extracted teeth) cells, cultured on shot-peened titanium surfaces, since the kind of cell model considered has been shown to be relevant in techniques widely used in studies on composition/morphology of biomaterial surfaces. The titanium surface morphology, with different roughness, and the behavior of cells were analyzed by confocal microscope (CM), scanning electron microscope (SEM) and X-ray microanalysis. The best results, in terms of hOB adhesion/distribution, were highlighted by both CM and SEM in cultured plates having 20-mu m-depth cavities. On the contrary, CM and SEM results highlighted the hDPSC growth regardless the different surface morphology, arranged in overlapped layers due to their high proliferation rate, showing their unfitness in biomaterial surface test. Nevertheless, hDPSC cultured inside 3D-matrices reproduced an osteocyte-like three-dimensional network, potentially useful in the repair of critical size bone defects. The behavior of the two cell models suggests a different use in biomaterial cell cultures: committed osteoblast cells could be appropriate in selecting the best surfaces to improve osseointegration, while multipotent cells could be suitable to obtain in vitro osteocyte-like network for regenerative medicine. The originality of the present work consists in studying for the first time two different cell models (committed versus multipotent) compared in parallel different biomaterial cultures, thus suggesting distinct targets for each cellular model. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Palumbo, Carla; Cavani, Francesco; Sena, Paola; Benincasa, Marta; Ferretti, Marzia; Zaffe, Davide] Univ Modena & Reggio Emilia, Sect Human Morphol, Dept Biomed Sci, Modena, Italy.
   [Baldini, Andrea] Univ Modena & Reggio Emilia, Dept Mech & Civil Engn, Modena, Italy.
RP Zaffe, D (reprint author), Dipartimento Sci Biomed, Sez Morfol Umana, Via Pozzo 71, I-41124 Modena, Italy.
EM davide.zaffe@unimore.it
RI Ferretti, Marzia/F-1153-2016; Sena, Paola/G-9394-2016; Zaffe,
   Davide/G-1181-2016; Cavani, Francesco/B-2907-2016; Palumbo,
   Carla/E-5802-2012
OI Ferretti, Marzia/0000-0003-0280-3598; Sena, Paola/0000-0003-4724-8786;
   Zaffe, Davide/0000-0003-1241-385X; Cavani,
   Francesco/0000-0002-9084-3997; Palumbo, Carla/0000-0003-0587-0112;
   Baldini, Andrea/0000-0002-2427-2663
FU Fondazione di Vignola, Modena, Italy; Banca Popolare dell'Emilia
   Romagna, Modena, Italy
FX The study was supported by funds of "Fondazione di Vignola, Modena,
   Italy" and "Banca Popolare dell'Emilia Romagna, Modena, Italy".
CR Agrawal AA, 2010, BIOMATERIALS, V31, P5408, DOI 10.1016/j.biomaterials.2010.03.041
   Apostolou E, 2011, NATURE, V474, P165, DOI 10.1038/474165a
   Barclay A N, 1988, Adv Exp Med Biol, V237, P3
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Chen WH, 2009, ARTHRITIS RHEUM, V60, P450, DOI 10.1002/art.24265
   d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121
   d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07
   Docheva D, 2010, EUR CELLS MATER, V19, P228, DOI 10.22203/eCM.v019a22
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   GRONTHOS S, 1994, BLOOD, V84, P4164
   Higuchi A, 2011, CHEM REV, V111, P3021, DOI 10.1021/cr1003612
   Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI 10.1089/ten.TEA.2010.0338
   Laino G, 2006, J CELL PHYSIOL, V206, P693, DOI 10.1002/jcp.20526
   Lavenus S, 2011, ACTA BIOMATER, V7, P1525, DOI 10.1016/j.actbio.2010.12.033
   Mangano C, 2010, BIOMATERIALS, V31, P3543, DOI 10.1016/j.biomaterials.2010.01.056
   Maraldi T, 2009, MOL HUM REPROD, V15, P499, DOI 10.1093/molehr/gap048
   Marotti G, 1996, Ital J Anat Embryol, V101, P25
   Marotti G., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P133
   Necula BS, 2011, ACTA BIOMATER, V7, P2751, DOI 10.1016/j.actbio.2011.02.037
   Okada S, 2011, ACTA BIOMATER, V7, P1290, DOI 10.1016/j.actbio.2010.10.010
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Paino F, 2010, EUR CELLS MATER, V20, P295
   PALUMBO C, 1990, BONE, V11, P401, DOI 10.1016/8756-3282(90)90134-K
   Palumbo C., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P327
   Palumbo C., 2007, EUR J HISTOCHEM S2, V51, P31
   Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667
   Riccio M, 2010, EUR J HISTOCHEM, V54, P205
   Riccio M., 2010, OPT LASER TECHNOL, V43, P317
   Robey P, 1985, CALCIFIED TISSUE INT, V5, P453
   Rubinacci A, 1998, CALCIFIED TISSUE INT, V63, P331, DOI 10.1007/s002239900536
   Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x
   SIMMONS PJ, 1991, BLOOD, V78, P2848
   Song J, 2009, J BIOMED MATER RES A, V89A, P1098, DOI 10.1002/jbm.a.32110
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Wang K, 2010, BIOMACROMOLECULES, V11, P2748, DOI 10.1021/bm1008102
   Ward J, 2010, BIOMACROMOLECULES, V11, P3093, DOI 10.1021/bm100898p
   World Medical Association Declaration of Helsinki, 2002, J POSTGRAD MED, V48, P206
   Xu JW, 2009, J ORTHOP RES, V27, P1306, DOI 10.1002/jor.20890
   Xu WJ, 2010, ACTA BIOMATER, V6, P1992, DOI 10.1016/j.actbio.2009.12.003
   Yukawa H, 2011, BIOMATERIALS, V32, P3729, DOI 10.1016/j.biomaterials.2011.01.013
NR 40
TC 5
Z9 5
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD APR
PY 2013
VL 47
BP 1
EP 9
DI 10.1016/j.micron.2012.02.017
PG 9
WC Microscopy
SC Microscopy
GA 115RZ
UT WOS:000316830900001
PM 22440134
DA 2018-10-20
ER

PT J
AU Yoshimoto, Y
   Hasebe, T
   Takahashi, K
   Amari, M
   Nagashima, S
   Kamijo, A
   Hotta, A
   Takahashi, K
   Suzuki, T
AF Yoshimoto, Yukihiro
   Hasebe, Terumitsu
   Takahashi, Kei
   Amari, Masao
   Nagashima, So
   Kamijo, Aki
   Hotta, Atsushi
   Takahashi, Koki
   Suzuki, Tetsuya
TI Ultrastructural characterization of surface-induced platelet activation
   on artificial materials by transmission electron microscopy
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE transmission electron microscopy; platelet; diamond-like carbon;
   cell-material interface
ID DIAMOND-LIKE CARBON; PROTEIN ADSORPTION; IN-VITRO; DLC COATINGS;
   ADHESION; HEMOCOMPATIBILITY; ACTIN; FILMS; COMPLEXES; FLUORINE
AB Platelet adhesion is one of the most pivotal events of blood clotting for artificial surfaces. However, the mechanisms of surface-induced platelet activation have not been fully been elucidated or visualized so far. In this study, we attempted to observe the internal structures and adhesion interfaces of human platelets attached to artificial surfaces by transmission electron microscopy (TEM) during the platelet activation process. We prepared observation samples by a conventional embedding method using EPON 812 resin. The sectioning was sliced perpendicular to the a-platelet/material interface. Observation by TEM indicates that internal granules coalesce in the center of the platelet accompanied by pseudopodial growth in the early stage of platelet activation. Pseudopodia from a platelet attach to the material interface not along a plane but at a point. In addition, along with the process of platelet activation, the gap between the platelet membrane and the material surface at the interface disappeared and a-platelet/material adhesion became much tighter. In the fully activated platelet stage, the platelet becomes thinner and tightly adheres to the substrate. As a result of comparative observation of an adherent platelet on polycarbonate (PC) and on amorphous carbon (a-C:H), it was found that internal granules release was inhibited more remarkably on a-C:H coating rather than on PC. Despite numerous technical difficulties in preparing sectional samples, such a study might prove the essential mechanism of biomaterial-related thrombosis, and it might become possible to modify the surfaces of materials to minimize material-related thrombosis. Microsc. Res. Tech. 76:342349, 2013. (c) 2013 Wiley Periodicals, Inc.
C1 [Yoshimoto, Yukihiro; Hasebe, Terumitsu; Nagashima, So; Hotta, Atsushi; Suzuki, Tetsuya] Keio Univ, Grad Sch Sci & Technol, Ctr Sci Environm Resources & Energy, Yokohama, Kanagawa 2238522, Japan.
   [Hasebe, Terumitsu] Tokai Univ, Dept Radiol, Sch Med, Hachioji Hosp, Hachioji, Tokyo 1920032, Japan.
   [Takahashi, Kei; Amari, Masao] Toho Univ, Dept Pathol, Ohashi Med Ctr, Meguro Ku, Tokyo 1538515, Japan.
   [Kamijo, Aki] Yokohama City Univ Med, Dept Transfus Med, Yokohama, Kanagawa 2360004, Japan.
   [Takahashi, Koki] Tokyo Univ Hosp, Dept Transfus Med, Bunkyo Ku, Tokyo 1138655, Japan.
RP Hasebe, T (reprint author), Tokai Univ, Dept Radiol, Sch Med, Hachioji Hosp, 1838 Ishikawa Cho, Hachioji, Tokyo 1920032, Japan.
EM hasebe@hachioji-hosp.tokai.ac.jp
RI Hotta, Atsushi/E-9302-2014
OI Hotta, Atsushi/0000-0001-9516-2739; Nagashima, So/0000-0002-4073-6245
CR Ali N, 2006, THIN SOLID FILMS, V515, P59, DOI 10.1016/j.tsf.2005.12.023
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   Bearer EL, 2002, INT REV CYTOL, V217, P137
   Cartmell SH, 1998, J MATER SCI-MATER M, V9, P1, DOI 10.1023/A:1008830025416
   Cenni E, 1997, J BIOMED MATER RES, V36, P289, DOI 10.1002/(SICI)1097-4636(19970905)36:3<289::AID-JBM3>3.0.CO;2-A
   Cerecedo D, 2006, BLOOD COAGUL FIBRIN, V17, P161, DOI 10.1097/01.mbc.0000214712.96244.47
   Cerecedo D, 2002, HAEMATOLOGICA, V87, P1165
   DEPALMA VA, 1972, J BIOMED MATER RES, V6, P37, DOI 10.1002/jbm.820060406
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   ESCOLAR G, 1994, MICROSC RES TECHNIQ, V28, P308, DOI 10.1002/jemt.1070280407
   Flaumenhaft R, 2003, ARTERIOSCL THROM VAS, V23, P1152, DOI 10.1161/01.ATV.0000075965.88456.48
   Gemmell CH, 2000, J BIOMAT SCI-POLYM E, V11, P1197, DOI 10.1163/156856200744273
   Gunn J, 1999, EUR HEART J, V20, P1693, DOI 10.1053/euhj.1999.1549
   Gutensohn K, 1996, TRANSFUS SCI, V17, P489
   HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421
   Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Hasebe T, 2011, DIAM RELAT MATER, V20, P902, DOI 10.1016/j.diamond.2011.04.014
   Hasebe T, 2007, THIN SOLID FILMS, V516, P299, DOI 10.1016/j.tsf.2007.06.033
   Hasebe T, 2007, J BIOMED MATER RES A, V83A, P1192, DOI 10.1002/jbm.a.31340
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Kobayashi S, 2007, J MATER SCI-MATER M, V18, P2263, DOI 10.1007/s10856-007-3118-2
   LEISTIKOW EA, 1990, BRIT J HAEMATOL, V74, P93, DOI 10.1111/j.1365-2141.1990.tb02544.x
   Ma WJ, 2007, BIOMATERIALS, V28, P1620, DOI 10.1016/j.biomaterials.2006.12.010
   Miyashita O, 2006, THIN SOLID FILMS, V497, P218
   Nalla RK, 2005, MICRON, V36, P672, DOI 10.1016/j.micron.2005.05.011
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   Okroj W, 2009, ACTA BIOENG BIOMECH, V11, P45
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   Ren YB, 2005, MATER LETT, V59, P1785, DOI 10.1016/j.matlet.2005.01.067
   Saito T, 2005, DIAM RELAT MATER, V14, P1116, DOI 10.1016/j.diamond.2004.09.017
   SCHAKENRAAD JM, 1991, CELL MATER, V1, P35
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   Tran HS, 1999, J INVEST SURG, V12, P133
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Weisenberg BA, 2002, J BIOMED MATER RES, V60, P283, DOI 10.1002/jbm.10076
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   WHITE JG, 1967, BLOOD-J HEMATOL, V30, P625
   WHITE JG, 1995, EUR J CLIN INVEST, V25, P241, DOI 10.1111/j.1365-2362.1995.tb01555.x
NR 43
TC 7
Z9 8
U1 0
U2 52
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD APR
PY 2013
VL 76
IS 4
BP 342
EP 349
DI 10.1002/jemt.22172
PG 8
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 113WF
UT WOS:000316699400002
PM 23362044
DA 2018-10-20
ER

PT J
AU Bosworth, LA
   Turner, LA
   Cartmell, SH
AF Bosworth, Lucy A.
   Turner, Lesley-Anne
   Cartmell, Sarah H.
TI State of the art composites comprising electrospun fibres coupled with
   hydrogels: a review
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Review
DE Composites; Electrospinning; Hydrogels; Nanofibres; Tissue engineering
ID POLY(L-LACTIDE) BONE PLATES; GROWTH-FACTOR DELIVERY;
   MECHANICAL-PROPERTIES; IN-VITRO; POLY(EPSILON-CAPROLACTONE) SCAFFOLDS;
   CELLULAR INFILTRATION; INJECTABLE HYDROGELS; ARTICULAR-CARTILAGE;
   NANOFIBER SCAFFOLD; DRUG-DELIVERY
AB Research into scaffolds tailored for specific tissue engineering and biomaterial applications continues to develop as these structures are commonly impeded by their limitations. For example, electrospun fibres and hydrogels are commonly exploited because of their ability to mimic natural tissues; however, their clinical use remains restricted due to negligible cellular infiltration and poor mechanical properties, respectively. A small number of research groups are beginning to investigate composite scaffolds based on electrospun fibres and hydrogels in an attempt to overcome their individual shortcomings. This review paper discusses the various methodologies and approaches currently undertaken to create these novel composite structures and their intended applications. The combination of these two commonly used scaffold architectures to create synergistically superior structures is showing potential with regards to therapeutic use within the tissue engineering community.
   From the Clinical Editor: This review discusses methodologies to create novel electrospun nanofibers and hydrogels, and their intended applications. The combination of these two scaffold architectures has important future clinical applications, although their use is currently limited to the experimental tissue engineering community. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Bosworth, Lucy A.; Turner, Lesley-Anne; Cartmell, Sarah H.] Univ Manchester, Ctr Mat Sci, Manchester, Lancs, England.
RP Bosworth, LA (reprint author), Univ Manchester, Ctr Mat Sci, Manchester, Lancs, England.
EM lucy.bosworth@manchester.ac.uk
RI Cartmell, Sarah/J-8506-2012
OI Cartmell, Sarah/0000-0001-6864-0846; Turner,
   Lesley-Anne/0000-0002-8144-9269
FU Medical Research Council [G1000788]
CR Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
   Allen MJ, 2004, SPINE, V29, P515, DOI 10.1097/01.BRS.0000113871.67305.38
   Anderson M., 2008, J NANONEUROSCIENCE, V1, P1
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Balguid A, 2009, TISSUE ENG PT A, V15, P437, DOI 10.1089/ten.tea.2007.0294
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Boland ED, 2004, J BIOMED MATER RES B, V71B, P144, DOI 10.1002/jbm.b.30105
   Bosworth Lucy, 2008, International Journal of Nano and Biomaterials, V1, P263, DOI 10.1504/IJNBM.2008.016875
   Bosworth LA, 2010, POLYM DEGRAD STABIL, V95, P2269, DOI 10.1016/j.polymdegradstab.2010.09.007
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Chew SY, 2006, CURR PHARM DESIGN, V12, P4751, DOI 10.2174/138161206779026326
   Coburn J, 2011, SMART STRUCT SYST, V7, P213, DOI 10.12989/sss.2011.7.3.213
   Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426
   Department for Business Innovation & Skills, 2011, TAK STOCK REG MED UK
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ekaputra AK, 2008, BIOMACROMOLECULES, V9, P2097, DOI 10.1021/bm800565u
   Feingold-Leitman D, 2009, J BIONANOSCIENCE, V3, P1
   Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033
   Han N., 2011, FRONT NEUROENG, V4, P1
   HARDINGHAM T, 1990, SEMIN ARTHRITIS RHEU, V20, P12, DOI 10.1016/0049-0172(90)90044-G
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hong Y, 2011, BIOMATERIALS, V32, P3387, DOI 10.1016/j.biomaterials.2011.01.025
   Hsieh A, 2010, SOFT MATTER, V6, P2227, DOI 10.1039/b924349f
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   Kim G, 2007, J BIOMED MATER RES B, V81B, P104, DOI 10.1002/jbm.b.30642
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P643, DOI 10.1002/jbm.a.30866
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   McMahon RE, 2011, TISSUE ENG PART C-ME, V17, P451, DOI [10.1089/ten.TEC.2010.0427, 10.1089/ten.tec.2010.0427]
   Morris-Stiff GJ, 1998, J AM COLL SURGEONS, V186, P352, DOI 10.1016/S1072-7515(98)00002-7
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   Prochazka A, 2001, J PHYSIOL-LONDON, V533, P99, DOI 10.1111/j.1469-7793.2001.0099b.x
   Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182
   Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Soletti L, 2010, ACTA BIOMATER, V6, P110, DOI 10.1016/j.actbio.2009.06.026
   Song L, 2004, CYTOTHERAPY, V6, P596, DOI 10.1080/14653240410005276
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9212(03)00497-6
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Thornton AJ, 2004, J UROLOGY, V172, P763, DOI 10.1097/01.ju.0000130466.84214.f7
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   USHER FC, 1959, AM J SURG, V97, P629, DOI 10.1016/0002-9610(59)90256-9
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Wang B, 2011, J MECH BEHAV BIOMED, V4, P600, DOI 10.1016/j.jmbbm.2011.01.008
   Winter JO, 2007, J BIOMED MATER RES B, V81B, P551, DOI 10.1002/jbm.b.30696
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu WJ, 2010, ACTA BIOMATER, V6, P1992, DOI 10.1016/j.actbio.2009.12.003
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang Y, 2011, NANOMED-NANOTECHNOL, V7, P131, DOI 10.1016/j.nano.2010.12.011
NR 83
TC 45
Z9 46
U1 6
U2 161
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD APR
PY 2013
VL 9
IS 3
BP 322
EP 335
DI 10.1016/j.nano.2012.10.008
PG 14
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA 114GJ
UT WOS:000316728800003
PM 23178282
DA 2018-10-20
ER

PT J
AU Ryu, S
   Kim, BS
AF Ryu, Seungmi
   Kim, Byung-Soo
TI Culture of Neural Cells and Stem Cells on Graphene
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE graphene; neural cell; mesenchymal stem cell; induced pluripoten stem
   cell; neural stem cell; cytotoxicity
ID HYDROPHOBIC GRAPHITE SURFACE; CARBON NANOTUBES; MOLECULAR-DYNAMICS;
   OSTEOGENIC DIFFERENTIATION; NEURONAL GROWTH; OXIDE; CYTOTOXICITY;
   ADSORPTION; NANOTECHNOLOGY; FILMS
AB Graphene, as a new potential biocompatible biomaterial, retains some unique properties such as high electrical conductivity, elasticity and good molecule absorption. It has tremendous potential for a wide variety of biomedical applications. Even though studies on graphene-based nanomaterials are still at a nascent stage, graphene has been a matter of common interest in tissue engineering and regenerative medicine. In this review, we summarize the characteristics of graphene that could impose biological effects on cells. We discuss in detail the exploration of graphene when applied on neural cells and stem cells; how it affects cell behavior and differentiation. We then present the results from cytotoxicity studies on graphene and its derivatives.
C1 [Ryu, Seungmi] Seoul Natl Univ, Interdisciplinary Program Bioengn, Seoul 151744, South Korea.
   [Kim, Byung-Soo] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151744, South Korea.
   [Kim, Byung-Soo] Seoul Natl Univ, Inst Bioengn, Seoul 151744, South Korea.
RP Kim, BS (reprint author), Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151744, South Korea.
EM byungskim@snu.ac.kr
RI Kim, Byung-Soo/O-2352-2013
FU Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic
   of Korea [A100443]
FX This study was supported by a grant (A100443) from the Korean Health 21
   R&D Project, Ministry of Health and Welfare, Republic of Korea.
CR Bolotin KI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096802
   Cai WB, 2007, SMALL, V3, P1840, DOI 10.1002/smll.200700351
   Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Fan HL, 2010, BIOMACROMOLECULES, V11, P2345, DOI 10.1021/bm100470q
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   Heo C, 2011, BIOMATERIALS, V32, P19, DOI 10.1016/j.biomaterials.2010.08.095
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Huang P, 2011, THERANOSTICS, V1, P240, DOI 10.7150/thno/v01p0240
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kalbacova M, 2010, CARBON, V48, P4323, DOI 10.1016/j.carbon.2010.07.045
   Kim SJ, 2008, J MATER SCI-MATER M, V19, P2953, DOI 10.1007/s10856-008-3413-6
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lee DY, 2011, BIOMACROMOLECULES, V12, P336, DOI 10.1021/bm101031a
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Lee Y, 2010, NANO LETT, V10, P490, DOI 10.1021/nl903272n
   Li N, 2011, BIOMATERIALS, V32, P9374, DOI 10.1016/j.biomaterials.2011.08.065
   Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Lu CH, 2010, CHEM COMMUN, V46, P3116, DOI 10.1039/b926893f
   Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c
   Mucksch C, 2011, CHEM PHYS LETT, V510, P252, DOI 10.1016/j.cplett.2011.05.036
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503
   Raffaini G, 2010, LANGMUIR, V26, P5679, DOI 10.1021/la903769c
   Sanchez VC, 2011, CHEM RES TOXICOL, V25, P15, DOI DOI 10.1021/TX200339H
   Sasidharan A, 2011, NANOSCALE, V3, P2461, DOI 10.1039/c1nr10172b
   Sheng YB, 2010, PROTEIN SCI, V19, P1639, DOI 10.1002/pro.444
   Song Hongjun, 2002, Nature (London), V417, P39, DOI 10.1038/417039a
   Utesch T, 2011, LANGMUIR, V27, P13144, DOI 10.1021/la202489w
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008
   Wang Y, 2012, ADV MATER, V24, P4285, DOI 10.1002/adma.201200846
   Wheeler SE, 2013, ACCOUNTS CHEM RES, V46, P1029, DOI 10.1021/ar300109n
   Wojtoniszak M, 2012, COLLOID SURFACE B, V89, P79, DOI 10.1016/j.colsurfb.2011.08.026
   Wu ZS, 2009, ACS NANO, V3, P411, DOI 10.1021/nn900020u
   Xu GB, 2012, ANALYST, V137, P2757, DOI 10.1039/c2an35093a
   Yuan JF, 2012, TOXICOL SCI, V126, P149, DOI 10.1093/toxsci/kfr332
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang Y, 2012, SMALL, V8, P154, DOI 10.1002/smll.201101695
   Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176
NR 46
TC 41
Z9 41
U1 6
U2 128
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD APR
PY 2013
VL 10
IS 2
BP 39
EP 46
DI 10.1007/s13770-013-0384-6
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 117RN
UT WOS:000316970900001
DA 2018-10-20
ER

PT J
AU Liden, BA
   May, BCH
AF Liden, Brock A.
   May, Barnaby C. H.
TI Clinical Outcomes Following the Use of Ovine Forestomach Matrix
   (Endoform Dermal Template) to Treat Chronic Wounds
SO ADVANCES IN SKIN & WOUND CARE
LA English
DT Article
DE ovine forestomach matrix; chronic wound; venous ulcer; diabetic ulcer
ID EXTRACELLULAR-MATRIX; BIOMATERIAL
AB The suitability of the ovine forestomach matrix (OFM) for the treatment of recalcitrant wounds was evaluated in 19 patients. At 12 weeks, 50% of wounds had closed, and the average reduction in surface area was 73.4%. Promising outcomes of this initial series support the clinical consideration of OFM.
C1 [Liden, Brock A.] Reynoldsburg Podiatry Ctr, Reynoldsburg, OH 43068 USA.
   [May, Barnaby C. H.] Mesynthes Ltd, Lower Hutt, New Zealand.
RP Liden, BA (reprint author), Reynoldsburg Podiatry Ctr, Reynoldsburg, OH 43068 USA.
CR Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Floden E. W., 2010, J BIOMED MATER RES B, V96, P67
   Irvine SM, 2011, BIOMATERIALS, V32, P6351, DOI 10.1016/j.biomaterials.2011.05.040
   Lun S, 2010, BIOMATERIALS, V31, P4517, DOI 10.1016/j.biomaterials.2010.02.025
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Veves A, 2002, ARCH SURG-CHICAGO, V137, P822, DOI 10.1001/archsurg.137.7.822
NR 8
TC 14
Z9 14
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1527-7941
J9 ADV SKIN WOUND CARE
JI Adv. Skin Wound Care
PD APR
PY 2013
VL 26
IS 4
BP 164
EP 167
DI 10.1097/01.ASW.0000428862.34294.d4
PG 4
WC Dermatology; Nursing; Surgery
SC Dermatology; Nursing; Surgery
GA 110RH
UT WOS:000316462500005
PM 23507693
DA 2018-10-20
ER

PT J
AU Mehdizadeh, H
   Sumo, S
   Bayrak, ES
   Brey, EM
   Cinar, A
AF Mehdizadeh, Hamidreza
   Sumo, Sami
   Bayrak, Elif S.
   Brey, Eric M.
   Cinar, Ali
TI Three-dimensional modeling of angiogenesis in porous biomaterial
   scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Angiogenesis; Scaffolds; Hydrogels; Agent-based modeling;
   Vascularization
ID AGENT-BASED SIMULATION; PORE-SIZE; QUANTITATIVE-ANALYSIS; CELL-GROWTH;
   TISSUE; VASCULARIZATION; MIGRATION; DESIGN; MICROVASCULATURE;
   DIFFERENTIATION
AB Vascularization of biomaterial scaffolds is essential for the successful clinical application of engineered tissues. Experimental studies are often performed to investigate the role of scaffold architecture on vascularized tissue formation. However, experiments are expensive and time-consuming and synthesis protocols often do not allow for independent investigation of specific scaffold properties. Computational models allow for rapid screening of potential material designs with control over scaffold properties that is difficult in laboratory settings. We have developed and tested a three-dimensional agent-based framework for investigating the effect of scaffold pore architecture on angiogenesis. Software agents represent endothelial cells, interacting together and with their micro-environment, leading to the invasion of blood vessels into the scaffold. A rule base, driven by experimental findings, governs the behavior of individual agents. 3D scaffold models with well-defined homogeneous and heterogeneous pore architectures were simulated to investigate the impact of various design parameters. Simulation results indicate that pores of larger size with higher interconnectivity and porosity support rapid and extensive angiogenesis. The developed framework can be used to screen biomaterial scaffold designs for optimal vascularization and investigate complex interactions among invading blood vessels and their micro-environment. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Mehdizadeh, Hamidreza; Sumo, Sami; Bayrak, Elif S.; Cinar, Ali] IIT, Dept Chem & Biol Engn, ChBE Desk, Chicago, IL 60616 USA.
   [Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Brey, Eric M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.
RP Cinar, A (reprint author), IIT, Dept Chem & Biol Engn, ChBE Desk, 10 W 33rd St,Suite 127, Chicago, IL 60616 USA.
EM hamidreza@hawk.iit.edu; somosami@gmail.com; ebayrak@hawk.iit.edu;
   brey@iit.edu; cinar@iit.edu
RI Mehdizadeh, Hamidreza/D-4693-2013
OI Cinar, Ali/0000-0002-1607-9943
FU National Science Foundation [CBET-0731201]; Veterans Administration
FX This material is based upon work supported in part by the National
   Science Foundation (CBET-0731201) and the Veterans Administration. The
   authors would like to acknowledge contributions from Dr. Arsun Artel in
   the development of the initial version of the software.
CR Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]
   AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Bailey AM, 2007, ANN BIOMED ENG, V35, P916, DOI 10.1007/s10439-007-9266-1
   Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015
   Bhang SH, 2012, TISSUE ENG PT A, V18, P310, DOI [10.1089/ten.tea.2011.0193, 10.1089/ten.TEA.2011.0193]
   Brey EA, 2004, ANN BIOMED ENG, V32, P1100, DOI 10.1114/B:ABME.0000036646.17362.c4
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807
   Checa S, 2010, J BIOMECH, V43, P961, DOI 10.1016/j.jbiomech.2009.10.044
   Chen YH, 2011, BIOMATERIALS, V32, P5003, DOI 10.1016/j.biomaterials.2011.03.064
   Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   Dietmar W.H., 2000, BIOMATERIALS, V21, P2529
   Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Klenke FM, 2008, J BIOMED MATER RES A, V85A, P777, DOI 10.1002/jbm.a.31559
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liu G, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-6
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mehdizadeh H, 2011, LECT NOTES ARTIF INT, V7047, P113, DOI 10.1007/978-3-642-25044-6_11
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   North MJ, 2006, ACM T MODEL COMPUT S, V16, P1, DOI 10.1145/1122012.1122013
   Palagyi K, 1999, GRAPH MODEL IM PROC, V61, P199, DOI 10.1006/gmip.1999.0498
   Peirce SM, 2012, CURR OPIN HEMATOL, V19, P184, DOI 10.1097/MOH.0b013e3283523ea6
   Peirce SM, 2004, FASEB J, V18, P731, DOI 10.1096/fj.03-0933fje
   Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612
   Polverini Peter J, 2002, J Dent Educ, V66, P962
   Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Saltzman W. M., 2004, TISSUE ENG ENG PRINC
   Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063
   Sicchieri LG, 2012, J TISSUE ENG REGEN M, V6, P155, DOI 10.1002/term.422
   Silvestre JS, 2008, CARDIOVASC RES, V78, P201, DOI 10.1093/cvr/cvn070
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294
NR 41
TC 57
Z9 62
U1 6
U2 126
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2013
VL 34
IS 12
BP 2875
EP 2887
DI 10.1016/j.biomaterials.2012.12.047
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 105AV
UT WOS:000316038900003
PM 23357368
DA 2018-10-20
ER

PT J
AU Ben-David, D
   Srouji, S
   Shapira-Schweitzer, K
   Kossover, O
   Ivanir, E
   Kuhn, G
   Muller, R
   Seliktar, D
   Livne, E
AF Ben-David, Dror
   Srouji, Samer
   Shapira-Schweitzer, Keren
   Kossover, Olga
   Ivanir, Eran
   Kuhn, Gisela
   Mueller, Ralph
   Seliktar, Dror
   Livne, Erella
TI Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen
   hydrogel matrix
SO BIOMATERIALS
LA English
DT Article
DE MicroCT; Fluorescence imaging; Hydrogel; Contrast agents; Tissue
   regeneration; Polyethylene glycol
ID MORPHOGENETIC PROTEIN-2; POLYETHYLENE-GLYCOL; SEGMENTAL DEFECT;
   STEM-CELL; IN-VITRO; GROWTH; SCAFFOLDS; DELIVERY; FUSION; MODEL
AB Bone repair strategies utilizing resorbable biomaterial implants aim to stimulate endogenous cells in order to gradually replace the implant with functional repair tissue. These biomaterials should therefore be biodegradable, osteoconductive, osteoinductive, and maintain their integrity until the newly formed host tissue can contribute proper function. In recent years there has been impressive clinical outcomes for this strategy when using osteoconductive hydrogel biomaterials in combination with osteoinductive growth factors such as human recombinant bone morphogenic protein (hrBMP-2). However, the success of hrBMP-2 treatments is not without risks if the factor is delivered too rapidly and at very high doses because of a suboptimal biomaterial. Therefore, the aim of this study was to evaluate the use of a PEGylated fibrinogen (PF) provisional matrix as a delivery system for low-dose hrBMP-2 treatment in a critical size maxillofacial bone defect model. PP is a semi-synthetic hydrogel material that can regulate the release of physiological doses of hrBMP-2 based on its controllable physical properties and biodegradation. hrBMP-2 release from the PF material and hrBMP-2 bioactivity were validated using in vitro assays and a subcutaneous implantation model in rats. Critical size calvarial defects in mice were treated orthotopically with PF containing 8 mu g/ml hrBMP-2 to demonstrate the capacity of these bioactive implants to induce enhanced bone formation in as little as 6 weeks. Control defects treated with PF alone or left empty resulted in far less bone formation when compared to the PF/hrBMP-2 treated defects. These results demonstrate the feasibility of using a semi-synthetic biomaterial containing small doses of osteoinductive hrBMP-2 as an effective treatment for maxillofacial bone defects. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Ben-David, Dror; Srouji, Samer; Livne, Erella] Technion Israel Inst Technol, Fac Med, Dept Anat & Cell Biol, IL-32000 Haifa, Israel.
   [Shapira-Schweitzer, Keren; Kossover, Olga; Ivanir, Eran; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Kuhn, Gisela; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.
RP Ben-David, D (reprint author), Technion Israel Inst Technol, Fac Med, Dept Anat & Cell Biol, IL-32000 Haifa, Israel.
EM drorbd@tx.technion.ac.il; dror@bm.technion.ac.il
RI Muller, Ralph/A-1198-2008
OI Muller, Ralph/0000-0002-5811-7725; Seliktar, Dror/0000-0001-6964-8567
FU EC-IP FP7 grant Angioscaff; Russell Berrie Nanotechnology Institute;
   Lorry I. Lokey Interdisciplinary Center for Life Sciences and
   Engineering
FX This work was supported by EC-IP FP7 grant Angioscaff, the Russell
   Berrie Nanotechnology Institute, and the Lorry I. Lokey
   Interdisciplinary Center for Life Sciences and Engineering.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Angle SR, 2012, J MUSCULOSKEL NEURON, V12, P28
   Appelman TP, 2009, BIOMATERIALS, V30, P518, DOI 10.1016/j.biomaterials.2008.09.063
   Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003
   Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007
   Ben-David D, 2010, J TISSUE ENG REGEN M, V4, P30, DOI 10.1002/term.213
   Ben-David D, 2010, J CRANIOMAXILLOFAC S, V39, P364
   Bodde EWH, 2008, J BIOMED MATER RES A, V87A, P780, DOI 10.1002/jbm.a.31830
   Bongio M, 2010, J MATER CHEM, V20, P8747, DOI 10.1039/c0jm00795a
   Cicconetti A, 2007, ORAL SURG ORAL MED O, V104, DOI 10.1016/j.tripleo.2007.02.022
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Freilich M, 2008, BONE, V43, P781, DOI 10.1016/j.bone.2008.05.021
   Frisman I, 2010, J MATER SCI-MATER M, V21, P73, DOI 10.1007/s10856-009-3848-4
   Gottfried ON, 2008, NEUROSURGERY, V63, P91
   Gottfried ON, 2008, NEUROSURGERY, V63, P380, DOI 10.1227/01.NEU.0000324990.04818.13
   Hudalla GA, 2011, ADV FUNCT MATER, V21, P1754, DOI 10.1002/adfm.201002468
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   La WG, 2010, ARTIF ORGANS, V34, P1150, DOI 10.1111/j.1525-1594.2009.00988.x
   Liu Y, 2004, ANN BIOMED ENG, V32, P398, DOI 10.1023/B:ABME.0000017536.10767.0f
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Mironi-Harpaz I, 2012, ACTA BIOMATER, V8, P1838, DOI 10.1016/j.actbio.2011.12.034
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   Ohyama Y, 2004, ENDOCRINOLOGY, V145, P4685, DOI 10.1210/en.2003-1492
   Park K, 2011, J CONTROL RELEASE, V152, P207, DOI 10.1016/j.jconrel.2011.05.009
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4
   Schmidmaier G, 2008, INJURY, V39, pS37, DOI 10.1016/S0020-1383(08)70014-7
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Srouji S, 2005, MICROSC RES TECHNIQ, V66, P132, DOI 10.1002/jemt.20144
   Srouji S, 2010, TISSUE ENG PART A, V17, P269
   Srouji S, 2006, REGEN MED, V1, P519, DOI 10.2217/17460751.1.4.519
   Tazaki J, 2009, BIO-MED MATER ENG, V19, P141, DOI 10.3233/BME-2009-0573
   Thompson CA, 2009, AM J HEALTH-SYST PH, V66, P428, DOI 10.2146/news090019
   Torchiana DF, 2003, J CARDIAC SURG, V18, P504, DOI 10.1046/j.0886-0440.2003.00305.x
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   Villavicencio AT, 2005, J NEUROSURG-SPINE, V3, P436, DOI 10.3171/spi.2005.3.6.0436
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Xu X, 2011, ACTA BIOMATER, V7, P3050, DOI 10.1016/j.actbio.2011.04.018
   Zhao JY, 2009, J BIOSCI BIOENG, V107, P318, DOI 10.1016/j.jbiosc.2008.10.007
NR 48
TC 48
Z9 51
U1 4
U2 95
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2013
VL 34
IS 12
BP 2902
EP 2910
DI 10.1016/j.biomaterials.2013.01.035
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 105AV
UT WOS:000316038900005
PM 23375953
DA 2018-10-20
ER

PT J
AU Prodanov, L
   Lamers, E
   Domanski, M
   Luttge, R
   Jansen, JA
   Walboomers, XF
AF Prodanov, Ljupcho
   Lamers, Edwin
   Domanski, Maciej
   Luttge, Regina
   Jansen, John A.
   Walboomers, X. Frank
TI The effect of nanometric surface texture on bone contact to titanium
   implants in rabbit tibia
SO BIOMATERIALS
LA English
DT Article
DE Animal experiment; Cortical bone; Titanium; Surface roughness;
   Nano-grooves
ID OSTEOPROGENITOR RESPONSE; ATTACHMENT; TOPOGRAPHIES; ROUGHNESS; BEHAVIOR;
   ENERGY; SCALE
AB Designing biomaterial surfaces to control the reaction of the surrounding tissue is still considered to be a primary issue, which needs to be addressed systematically. Although numerous in vitro studies have described different nano-metrically textured substrates capable to influence bone cellular response, in vivo studies validating this phenomenon have not been reported. In this study, nano-grooved silicon stamps were produced by laser interference lithography (LIL) and reactive ion etching (RIE) and were subsequently transferred onto the surface of 5 mm diameter Titanium (Ti) discs by nanoimprint lithography (NIL). Patterns with pitches of 1000 nm (500 nm ridge and groove, 150 nm depth), 300 nm (150 nm ridge and groove, 120 nm depth; as well as a 1:3 ratio of 75 nm ridge and 225 nm groove, 120 nm depth) and 150 nm (75 nm ridge and groove, 30 nm depth) were created. These samples were implanted in a rabbit tibia cortical bone. Histological evaluation and histomorphometric measurements were performed, comparing each sample to conventional grit-blasted/acid-etched (GAE) titanium controls. Results showed a significantly higher bone-to-implant contact at 4 weeks for the 300 nm (1:3) specimens, compared to GAE (p = 0.006). At 8 weeks, there was overall more bone contact compared to 4 weeks. However, no significant differences between the nano-textured samples and the GAE occurred. Further studies will need to address biomechanical testing and the use of trabecular bone models. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Prodanov, Ljupcho; Lamers, Edwin; Jansen, John A.; Walboomers, X. Frank] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   [Domanski, Maciej; Luttge, Regina] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen, Med Ctr PB 309, Dept Biomat, POB 91, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Walboomers, X.Frank/B-3692-2013; Jansen, John/H-8055-2014
FU NWO-NSO [ALW-GO-MG 07-01, STW 07621]
FX Dr. Ir. Ewald, M. Bronkhorst for performing the statistical analyses.
   Grant sponsors NWO-NSO ALW-GO-MG 07-01, and STW 07621.
CR Bahat Oded, 2010, Clin Implant Dent Relat Res, V12 Suppl 1, pe2, DOI 10.1111/j.1708-8208.2010.00279.x
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Domanski M, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/6/065306
   Duyck J, 1997, Technol Health Care, V5, P253
   Ferreira AM, ACTA BIOMATERIALIA, V8, P3191
   Goto T, 2004, BIO-MED MATER ENG, V14, P537
   Hwang D, 2007, IMPLANT DENT, V16, P13, DOI 10.1097/ID.0b013e31803276c8
   Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Lamers E, 2010, EUR CELLS MATER, V20, P329
   Lamers E, 2012, NANOMED-NANOTECHNOL, V8, P308, DOI 10.1016/j.nano.2011.06.013
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Luttge R., 2009, J PHYS D, V42, P18
   Michiardi A, 2007, BIOMATERIALS, V28, P586, DOI 10.1016/j.biomaterials.2006.09.040
   Palmquist A, 2011, CLIN IMPLANT DENT R
   Prodanov L, 2011, BIOMATERIALS, V31, P7758
   Reigstad O, 2011, J BIOMED MATER RES B, V99B, P14, DOI 10.1002/jbm.b.31866
   Ronold HJ, 2002, BIOMATERIALS, V23, P2201, DOI 10.1016/S0142-9612(01)00353-2
   Ronold HJ, 2002, BIOMATERIALS, V23, P4211, DOI 10.1016/S0142-9612(02)00167-9
   Sato N, 2009, J DENT RES, V88, P812, DOI 10.1177/0022034509343101
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Ucar Y, 2011, J PROSTHET DENT, V106, P170, DOI 10.1016/S0022-3913(11)60116-9
   Ulrich SD, 2008, INT ORTHOP, V32, P597, DOI 10.1007/s00264-007-0364-3
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
NR 30
TC 31
Z9 33
U1 2
U2 80
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2013
VL 34
IS 12
BP 2920
EP 2927
DI 10.1016/j.biomaterials.2013.01.027
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 105AV
UT WOS:000316038900007
PM 23380354
DA 2018-10-20
ER

PT J
AU Bellas, E
   Panilaitis, BJB
   Glettig, DL
   Kirker-Head, CA
   Yoo, JJ
   Marra, KG
   Rubin, JP
   Kaplan, DL
AF Bellas, Evangelia
   Panilaitis, Bruce J. B.
   Glettig, Dean L.
   Kirker-Head, Carl A.
   Yoo, James J.
   Marra, Kacey G.
   Rubin, J. Peter
   Kaplan, David L.
TI Sustained volume retention in vivo with adipocyte and lipoaspirate
   seeded silk scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Adipose tissue engineering; In vivo test; Protein; Scaffold; Silk; Stem
   cell
ID CELL-ASSISTED LIPOTRANSFER; STEM-CELLS; ADIPOSE-TISSUE; SUPPORTIVE USE;
   FIBRIN GLUE; FIBROIN; AUGMENTATION; VITRO; DIFFERENTIATION; BIOMATERIALS
AB Current approaches to soft tissue regeneration include the use of fat grafts, natural or synthetic biomaterials as filler materials. Fat grafts and natural biomaterials resorb too quickly to maintain tissue regeneration, while synthetic materials do not degrade or regenerate tissue. Here, we present a simple approach to volume stable filling of soft tissue defects. In this study, we combined lipoaspirate with a silk protein matrix in a subcutaneous rat model. Silk biomaterials can be tailored to fit a variety of needs, and here were processed silk biomaterials into a porous sponge format to allow for tissue ingrowth while remaining mechanically robust. Over an 18 month period, the lipoaspirate seeded silk protein matrix regenerated subcutaneous adipose tissue while maintaining the original implanted volume. A silk protein matrix alone was not sufficient to regenerate adipose tissue, but yielded a fibrous tissue, although implanted volume was maintained. This work presents a significant improvement to the standard approaches to filling soft tissue defects by matching biomaterial degradation and tissue regeneration profiles. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Bellas, Evangelia; Panilaitis, Bruce J. B.; Glettig, Dean L.; Kaplan, David L.] Tufts Univ, Medford, MA 02155 USA.
   [Kirker-Head, Carl A.] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA 01536 USA.
   [Yoo, James J.] Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Marra, Kacey G.; Rubin, J. Peter] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI Yoo, James/L-4850-2017
OI Marra, Kacey/0000-0002-8437-4864
FU National Science Foundation [ECS-0335765]; Armed Forces Institute for
   Regenerative Medicine (AFIRM) [W81XWH-08-2-0032]; NIH [P41 EB002520]
FX The authors wish to acknowledge Eun Seok Gil, Jelena Rnyak, Rebecca S.
   Hayden and David Lange for their assistance with SEM preparation and
   imaging, Ethan Golden for histopathological insight. They also wish to
   thank Dr. Daniel Driscoll for providing surgical specimens, Marianne
   Stark and Kimberly Flink for assistance with surgeries and animal care.
   The SEM work was performed in part at the Center for Nanoscale Systems
   (CNS), a member of the National Nanotechnology Infrastructure Network
   (NNIN), which is supported by the National Science Foundation under NSF
   award no. ECS-0335765. CNS is part of Harvard University. This work was
   funded by Armed Forces Institute for Regenerative Medicine (AFIRM)
   W81XWH-08-2-0032 and the NIH - P41 EB002520.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Choi JH, 2011, METHODS MOL BIOL, V702, P319, DOI 10.1007/978-1-61737-960-4_23
   Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Matsumoto D, 2006, TISSUE ENG, V12, P3375, DOI 10.1089/ten.2006.12.3375
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Pallua N, 2009, PLAST RECONSTR SURG, V123, P826, DOI 10.1097/PRS.0b013e318199ef31
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Patrick CW, 2008, TISSUE ENG PT B-REV, V14, P167, DOI 10.1089/ten.teb.2007.0402
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   PEER LA, 1951, PLAST RECONSTR SURG, V7, P6, DOI 10.1097/00006534-195101000-00002
   PEER LA, 1951, PLAST RECONSTR SURG, V7, P73, DOI 10.1097/00006534-195102000-00001
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rubin JP, 2009, J DRUG TARGET, V17, P207, DOI 10.1080/10611860802669231
   Schoeller T, 2001, AESTHET PLAST SURG, V25, P57, DOI 10.1007/s002660010096
   Stosich MS, 2009, METHODS, V47, P116, DOI 10.1016/j.ymeth.2008.10.013
   TAKEMURA R, 1984, AM J PHYSIOL, V246, pC1
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wechselberger G, 2002, PLAST RECONSTR SURG, V110, P123, DOI 10.1097/00006534-200207000-00022
   Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636
   Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4
   Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210
NR 28
TC 24
Z9 25
U1 1
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2013
VL 34
IS 12
BP 2960
EP 2968
DI 10.1016/j.biomaterials.2013.01.058
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 105AV
UT WOS:000316038900011
PM 23374707
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Oliveros, A
   Guiseppi-Elie, A
   Saddow, SE
AF Oliveros, Alexandra
   Guiseppi-Elie, Anthony
   Saddow, Stephen E.
TI Silicon carbide: a versatile material for biosensor applications
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE Biomaterial; Biosensors; Biointerfaces; Silicon carbide
ID FIELD-EFFECT TRANSISTORS; BIOMEDICAL APPLICATIONS; SIC NANOCRYSTALS;
   THIN-FILMS; IN-VITRO; ORGANIC MONOLAYERS; FLOW-CYTOMETRY; GROWTH-FACTOR;
   SURFACES; ELECTRODE
AB Silicon carbide (SiC) has been around for more than 100 years as an industrial material and has found wide and varied applications because of its unique electrical and thermal properties. In recent years there has been increased attention to SiC as a viable material for biomedical applications. Of particular interest in this review is its potential for application as a biotransducer in biosensors. Among these applications are those where SiC is used as a substrate material, taking advantage of its surface chemical, tribological and electrical properties. In addition, its potential for integration as system on a chip and those applications where SiC is used as an active material make it a suitable substrate for micro-device fabrication. This review highlights the critical properties of SiC for application as a biosensor and reviews recent work reported on using SiC as an active or passive material in biotransducers and biosensors.
C1 [Oliveros, Alexandra; Saddow, Stephen E.] Univ S Florida, Dept Elect Engn, Tampa, FL 33620 USA.
   [Guiseppi-Elie, Anthony] Clemson Univ, Ctr Adv Mat, Ctr Bioelect Biosensors & Biochips C3B, Anderson, SC 29625 USA.
   [Guiseppi-Elie, Anthony] Clemson Univ, Dept Elect & Comp Engn, Clemson, SC 29634 USA.
   [Saddow, Stephen E.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.
RP Oliveros, A (reprint author), Univ S Florida, Dept Elect Engn, 4202 E Fowler Ave, Tampa, FL 33620 USA.
EM amolive4@mail.usf.edu; guiseppi@clemson.edu; saddow@usf.edu
FU USF; US Department of Defense (DoDPRMRP) [PR023081/DAMD17-03-1-0172]
FX A. Oliveros thanks the USF presidential doctoral fellowship for
   financial support. A. Guiseppi-Elie thanks US Department of Defense
   (DoDPRMRP) grant PR023081/DAMD17-03-1-0172 and the C3B.
CR Abraham S, 2005, BIOMATERIALS, V26, P4767, DOI 10.1016/j.biomaterials.2005.01.031
   Aghdassi N, 2012, APPL SURF SCI, V258, P7280, DOI 10.1016/j.apsusc.2012.03.104
   Aloysius S., 2010, SILICON CARBIDE GROW, V1
   Amon M, 1996, J MATER SCI-MATER M, V7, P273, DOI 10.1007/BF00058566
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Andrievski RA, 2009, REV ADV MATER SCI, V22, P1
   Andrievski RA, 2006, NANOMATERIALS HDB, P405
   Baffou G., 2007, APPL PHYS LETT, V91
   Baffou G, 2009, J AM CHEM SOC, V131, P3210, DOI 10.1021/ja806002k
   BARNES PJ, 1995, NEW ENGL J MED, V332, P868, DOI 10.1056/NEJM199503303321307
   Beheim G., 2006, MEMS DESIGN FABRICAT, P5
   Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5
   Bhowmick DK, 2012, SMALL, V8, P592, DOI 10.1002/smll.201101941
   BIERBAUM K, 1995, LANGMUIR, V11, P512, DOI 10.1021/la00002a025
   Bluet JM, 2012, SILICON CARBIDE BIOTECHNOLOGY: A BIOCOMPATIBLE SEMICONDUCTOR FOR ADVANCED BIOMEDICAL DEVICES AND APPLICATIONS, 1ST EDITION, P377
   Botsoa J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2919731
   Botsoa J., 2007, J APPL PHYS, V102
   Boucle J, 2005, J NANOPART RES, V7, P275, DOI 10.1007/s11051-005-3477-x
   Boucle J, 2002, PHYS LETT A, V302, P196, DOI 10.1016/S0375-9601(02)00965-9
   Boudrioua O., 2012, PHYS REV B, V85
   Brahim S, 2003, MICROCHIM ACTA, V143, P123, DOI 10.1007/s00604-003-0065-6
   Brown D.M., 2002, EL SOC P
   Caputo D, 2008, SENSOR LETT, V6, P542, DOI 10.1166/sl.2008.427
   Carrie D, 2001, J Interv Cardiol, V14, P1, DOI 10.1111/j.1540-8183.2001.tb00702.x
   Catellani A, 2007, J PHYS D APPL PHYS, V40, P6215, DOI 10.1088/0022-3727/40/20/S07
   Chen J, 1998, J VAC SCI TECHNOL B, V16, P1305, DOI 10.1116/1.590006
   Chong D. Y. R., 2004, 9 INT C THERM THERM, V2, P203
   CHU V, 1995, J APPL PHYS, V78, P3164, DOI 10.1063/1.360005
   Cicero G., 2005, J CHEM PHYS, V122
   Coletti C, 2007, P ANN INT IEEE EMBS, P5850
   Coletti C., 2007, APPL PHYS LETT, V91, P1
   CORASH L, 1990, BLOOD CELLS, V16, P97
   Corash L., 1990, BLOOD CELLS, V16, P7
   Deeken CR, 2011, J BIOMED MATER RES B, V97B, P334, DOI 10.1002/jbm.b.31819
   Deger C, 1998, APPL PHYS LETT, V72, P2400, DOI 10.1063/1.121368
   Deva Reddy J., 2008, MAT RES SOC M, pAA03
   Dhar S, 2009, J AM CHEM SOC, V131, P16808, DOI 10.1021/ja9053465
   Dzyadevych SV, 2006, ANAL CHIM ACTA, V568, P248, DOI 10.1016/j.aca.2005.11.057
   Ellison A, 1999, MAT SCI ENG B-SOLID, V61-2, P113, DOI 10.1016/S0921-5107(98)00482-6
   Fawcett T.J., 2006, APPL PHYS LETT, V89
   Fournier JA, 2001, REV ESP CARDIOL, V54, P567, DOI 10.1016/S0300-8932(01)76358-0
   Frewin C, 2009, THESIS U S FLORIDA T
   Frewin CL, 2009, J MOL RECOGNIT, V22, P380, DOI 10.1002/jmr.966
   Frewin CL, 2011, IEEE ENG MED BIO, P2957, DOI 10.1109/IEMBS.2011.6090582
   Fromherz P, 2005, BIOELECTRONICS: FROM THEORY TO APPLICATIONS, P339, DOI 10.1002/352760376X.ch12
   Gabriel G, 2007, MICROELECTRON J, V38, P406, DOI 10.1016/j.mejo.2006.11.008
   Ghavami R, 2011, BIOSENS BIOELECTRON, V26, P3864, DOI 10.1016/j.bios.2011.02.048
   Godignon P, 2005, MATER SCI FORUM, V483, P1009, DOI 10.4028/www.scientific.net/MSF.483-485.1009
   Godignon P, 2010, MATER SCI FORUM, V645-648, P1097, DOI 10.4028/www.scientific.net/MSF.645-648.1097
   Goldberg Y, 2001, PROPERTIES OF ADVANCED SEMICONDUCTOR MATERIALS: GAN, AIN, INN, BN, SIC, SIGE, P93
   Gomez R, 2006, BIOMED MICRODEVICES, V8, P43, DOI 10.1007/s10544-006-6381-y
   Goodman LS, 2011, GOODMAN GILMANS PHAR
   Harris G. L., 1995, PROPERTIES SILICON C
   Hehrlein C, 2009, INTERVENTIONAL CARDI, V4, P60
   Howgate J, 2010, ADV MATER, V22, P2632, DOI 10.1002/adma.200903756
   Hsu JM, 2007, THIN SOLID FILMS, V516, P34, DOI 10.1016/j.tsf.2007.04.050
   Hume DN, 1941, J AM CHEM SOC, V63, P2805, DOI 10.1021/ja01855a089
   Iliescu C, 2008, SENSOR ACTUAT B-CHEM, V129, P404, DOI 10.1016/j.snb.2007.08.043
   Iliescu C, 2007, SENSOR ACTUAT B-CHEM, V123, P168, DOI 10.1016/j.snb.2006.08.009
   Infenion-Technologies, 2012, SIL CARB SCHOTTK DIO
   Jakobson C, 1998, SOLID STATE ELECTRON, V42, P1807, DOI 10.1016/S0038-1101(98)00162-2
   Kalnins U., 2002, MED SCI MONITOR, V8, pPI16
   Kamlag Y, 2001, APPL SURF SCI, V184, P118, DOI 10.1016/S0169-4332(01)00486-X
   Kanai Y, 2005, J PHYS CHEM B, V109, P13656, DOI 10.1021/jp051260h
   Kassiba A., 2002, PHYS REV B, V66
   Kawakami Y., 2007, WIDE BANDGAP SEMICON, P146
   Kordina O, 1997, PHYS STATUS SOLIDI B, V202, P321, DOI 10.1002/1521-3951(199707)202:1<321::AID-PSSB321>3.0.CO;2-H
   Kotanen CN, 2012, BIOSENS BIOELECTRON, V35, P14, DOI 10.1016/j.bios.2012.03.016
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Kubo K, 1997, J ORAL REHABIL, V24, P70, DOI 10.1046/j.1365-2842.1997.00462.x
   LARKIN DJ, 1994, APPL PHYS LETT, V65, P1659, DOI 10.1063/1.112947
   Lazarus AH, 1995, TRANSFUS SCI, V16, P353, DOI 10.1016/0955-3886(95)00046-1
   Leconte Y, 2008, PLASMA CHEM PLASMA P, V28, P233, DOI 10.1007/s11090-007-9072-4
   Li X, 2005, J BIOMED MATER RES B, V72, P353
   Lin H., 2008, NANOTECHNOLOGY, V19, P8
   Lloyd Spetz A., 2004, ADV SILICON CARBIDE, P29
   Lloyd Spetz A., 2009, NEW TRANSDUCER MAT C, P7362
   Locke C., 2010, MAT RES SOC SPRING M
   Locke CW, 2012, SILICON CARBIDE BIOTECHNOLOGY: A BIOCOMPATIBLE SEMICONDUCTOR FOR ADVANCED BIOMEDICAL DEVICES AND APPLICATIONS, 1ST EDITION, P17
   Locke C.W., 2012, SIC BIOTECHNOLOGY, P32
   MATSUO T, 1979, IEEE T ELECTRON DEV, V26, P1856, DOI 10.1109/T-ED.1979.19780
   Mehregany M, 1998, P IEEE, V86, P1594, DOI 10.1109/5.704265
   Meier F, 1996, CHEM COMMUN, P2553, DOI 10.1039/cc9960002553
   Muller SG, 2000, J CRYST GROWTH, V211, P325, DOI 10.1016/S0022-0248(99)00835-0
   Myers RL, 2005, J CRYST GROWTH, V285, P483
   Nederberg F, 2006, J BIOMAT SCI-POLYM E, V17, P605, DOI 10.1163/156856206777346304
   NISHINO S, 1983, APPL PHYS LETT, V42, P460, DOI 10.1063/1.93970
   Oliveros A., 2012, J MAT RES
   OTOOLE RP, 1992, ANAL CHEM, V64, P1289, DOI 10.1021/ac00035a017
   Ozbek C, 1997, CATHETER CARDIO DIAG, V41, P71, DOI 10.1002/(SICI)1097-0304(199705)41:1<71::AID-CCD17>3.0.CO;2-T
   Ozpineci B, 2011, IEEE SPECTRUM, V48, P44, DOI 10.1109/MSPEC.2011.6027247
   Pandraud G, 2008, SENSOR ACTUAT A-PHYS, V142, P61, DOI 10.1016/j.sna.2007.04.030
   Pascual J, 2004, MATER SCI FORUM, V457-460, P1483, DOI 10.4028/www.scientific.net/MSF.457-460.1483
   Petoral R.M., 2007, APPL PHY LETT, V90
   Pierson H., 1999, HDB CHEM VAPOR DEPOS, P499
   Preuss M., 2006, AM PHYS SOC, V74, P1
   Qin GT, 2010, CHEM COMMUN, V46, P3289, DOI 10.1039/b925708j
   Rafiee-Pour HA, 2010, ELECTROANAL, V22, P1599, DOI 10.1002/elan.200900577
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Reboredo FA, 2004, NANO LETT, V4, P801, DOI 10.1021/nl049876k
   Reyes M, 2007, MATER SCI FORUM, V556-557, P191, DOI 10.4028/www.scientific.net/MSF.556-557.191
   Reyes M, 2006, MATER RES SOC SYMP P, V911, P79
   Rodelsperger K, 2006, INHAL TOXICOL, V18, P623, DOI 10.1080/08958370600742987
   Rosenbloom AJ, 2004, BIOMED MICRODEVICES, V6, P261, DOI 10.1023/B:BMMD.0000048558.91401.1d
   Rossi A.M., 2008, APPL PHYS LETT, V92
   Rosso M, 2008, LANGMUIR, V24, P4007, DOI 10.1021/la704002y
   Rosso M, 2009, LANGMUIR, V25, P2172, DOI 10.1021/la803094y
   Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4
   Rzany A., 2000, PROG BIOMED RES, V5, P168
   Saddow SE, 2011, MATER SCI FORUM, V679-680, P824, DOI 10.4028/www.scientific.net/MSF.679-680.824
   Saddow S.E., 2004, ADV SILICON CARBIDE, P7
   Saki M, 2009, YAKHTEH, V11, P55
   Salimi A, 2009, ELECTROCHEM COMMUN, V11, P1116, DOI 10.1016/j.elecom.2009.03.024
   Santavirta S, 1998, ARCH ORTHOP TRAUM SU, V118, P89, DOI 10.1007/s004020050319
   Schettini N, 2012, SILICON CARBIDE BIOTECHNOLOGY: A BIOCOMPATIBLE SEMICONDUCTOR FOR ADVANCED BIOMEDICAL DEVICES AND APPLICATIONS, 1ST EDITION, P153
   Schoell S.J., 2011, APPL PHYS LETT, V98
   SCHOELL SJ, 2008, APPL PHYS LETT, V92
   SenSiCAB, 2012, SENS CLEAN AIR
   Seyller T, 2004, J PHYS-CONDENS MAT, V16, pS1755, DOI 10.1088/0953-8984/16/17/016
   Singh S, 2007, MAT SCI ENG C-BIO S, V27, P551, DOI 10.1016/j.msec.2006.05.053
   Spetz AL, 2006, MATER MANUF PROCESS, V21, P253, DOI 10.1080/10426910500464495
   SPROUL AB, 1991, J APPL PHYS, V70, P846, DOI 10.1063/1.349645
   Steenackers M, 2010, CHEM MATER, V22, P272, DOI 10.1021/cm903051j
   Steinhoff G, 2005, APPL PHYS LETT, V86, DOI [10.1063/1.1853531, 10.1063/1.185331]
   Steinhoff G, 2003, ADV FUNCT MATER, V13, P841, DOI 10.1002/adfm.200304397
   Stutzmann M, 2006, PHYS STATUS SOLIDI A, V203, P3424, DOI 10.1002/pssa.200622512
   Svensson I, 1997, AM J IND MED, V31, P335, DOI 10.1002/(SICI)1097-0274(199703)31:3<335::AID-AJIM10>3.0.CO;2-1
   Syvajarvi M, 1999, J CRYST GROWTH, V197, P147, DOI 10.1016/S0022-0248(98)00878-1
   Takagi G, 2011, TISSUE ENG PT A, V17, P2787, DOI 10.1089/ten.tea.2010.0525
   Taubner T, 2006, SCIENCE, V313, P1595, DOI 10.1126/science.1131025
   Tsuchida H, 1999, J APPL PHYS, V85, P3569, DOI 10.1063/1.369716
   Ward WK, 2003, BIOSENS BIOELECTRON, V19, P155, DOI 10.1016/S0956-5663(03)00180-5
   Will J, 2010, ACTA BIOMATER, V6, P4488, DOI 10.1016/j.actbio.2010.06.036
   Williams EH, 2012, APPL SURF SCI, V258, P6056, DOI 10.1016/j.apsusc.2012.02.137
   Wilson A.N., 2012, ADV HEALTHC MAT
   Wong J, 1999, BIOMOL ENG, V16, P45, DOI 10.1016/S1050-3862(99)00035-2
   Wright NG, 2007, J PHYS D APPL PHYS, V40, P6345, DOI 10.1088/0022-3727/40/20/S17
   Wu WC, 2011, CHEM COMMUN, V47, P6458, DOI 10.1039/c1cc11162k
   Wu XL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026102
   Yakimova R, 2007, J PHYS D APPL PHYS, V40, P6435, DOI [10.1088/0022-3727/40/20/S20, 10.1088/0022-3727/40/20/s20]
   Yang NJ, 2011, ANAL CHEM, V83, P5827, DOI 10.1021/ac201315q
   Yang SK, 2011, J MATER CHEM, V21, P4432, DOI 10.1039/c0jm03475d
   Zhokhov AA, 2009, PHYS SOLID STATE+, V51, P1723, DOI 10.1134/S1063783409080344
   Zorman C. A., 2009, S DES TEST INT PACK
   Zorman CA, 2008, PHYS STATUS SOLIDI B, V245, P1404, DOI 10.1002/pssb.200844135
NR 145
TC 58
Z9 58
U1 2
U2 114
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD APR
PY 2013
VL 15
IS 2
BP 353
EP 368
DI 10.1007/s10544-013-9742-3
PG 16
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 107FV
UT WOS:000316201300014
PM 23319268
DA 2018-10-20
ER

PT J
AU Seidlits, SK
   Gower, RM
   Shepard, JA
   Shea, LD
AF Seidlits, Stephanie K.
   Gower, Robert Michael
   Shepard, Jaclyn A.
   Shea, Lonnie D.
TI Hydrogels for lentiviral gene delivery
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE gene therapy; hydrogels; lentivirus; tissue engineering
ID HYALURONIC-ACID HYDROGELS; SPINAL-CORD-INJURY; IN-VIVO; VIRAL VECTORS;
   HEMOPHILIA-B; ADENOASSOCIATED VIRUS; TRANSGENE EXPRESSION;
   PARKINSONS-DISEASE; CONTROLLED-RELEASE; FIBRIN HYDROGELS
AB Introduction: Gene delivery from hydrogel biomaterials provides a fundamental tool for a variety of clinical applications including regenerative medicine, gene therapy for inherited disorders and drug delivery. The high water content and mild gelation conditions of hydrogels support their use for gene delivery by preserving activity of lentiviral vectors and acting to shield vectors from any host immune response.
   Areas covered: Strategies to control lentiviral entrapment within and retention/release from hydrogels are reviewed. The authors discuss the ability of hydrogel design parameters to control the transgene expression profile and the capacity of hydrogels to protect vectors from (and even modulate) the host immune response.
   Expert opinion: Delivery of genetic vectors from scaffolds provides a unique opportunity to capitalize on the potential synergy between the biomaterial design for cell processes and gene delivery. Hydrogel properties can be tuned to directly control the events that determine the tissue response to controlled gene delivery, which include the extent of cell infiltration, preservation of vector activity and vector retention. While some design parameters have been identified, numerous opportunities for investigation are available in order to develop a complete model relating the biomaterial properties and host response to gene delivery.
C1 [Seidlits, Stephanie K.; Gower, Robert Michael; Shepard, Jaclyn A.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Tech Bldg E-136, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIH [R01 EB005678, R01 EB003806, R21 EB006520, F32 NS081961, PL1
   EB008542]; Oncofertility Consortium Roadmap Grant
FX The authors would like to thank the NIH (R01 EB005678, R01 EB003806, R21
   EB006520, F32 NS081961, SKS, and PL1 EB008542, a P30 Biomaterials Core
   within the Oncofertility Consortium Roadmap Grant) for support.
CR Aviles MO, 2011, DRUG DELIV TRANSL RE, V1, P91, DOI 10.1007/s13346-010-0011-1
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P374, DOI 10.1021/bm010158r
   Bowles DE, 2012, MOL THER, V20, P443, DOI 10.1038/mt.2011.237
   Brown BD, 2007, BLOOD, V109, P2797, DOI 10.1182/blood-2006-10-049312
   Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249
   Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242
   Cheung CY, 2006, BIOCONJUGATE CHEM, V17, P1036, DOI 10.1021/bc060023o
   Cho NJ, 2008, BIOMED MATER, V4
   COFFIN JM, 1997, RETROVIRUSES
   Croyle MA, 2004, J VIROL, V78, P912, DOI 10.1128/JVI.78.2.912-921.2004
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   De Laporte L, 2011, J BIOMED MATER RES A, V98A, P372, DOI 10.1002/jbm.a.33112
   De Laporte L, 2010, ACTA BIOMATER, V6, P2889, DOI 10.1016/j.actbio.2010.02.018
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   DeLaporte L, 2009, MOL THER, V80, P432
   DePolo NJ, 2000, MOL THER, V2, P218, DOI 10.1006/mthe.2000.0116
   Dull T, 1998, J VIROL, V72, P8463
   Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Gary DJ, 2011, ACS NANO, V5, P3493, DOI 10.1021/nn102540y
   Gower RM, 2012, ADV WOUND CARE, DOI [10.1089/wound2011.0325, DOI 10.1089/WOUND2011.0325]
   Humbert JM, 2012, J VIROL, V86, P5192, DOI 10.1128/JVI.06283-11
   Hwang YS, 2010, TISSUE ENG PT A, V16, P3033, DOI [10.1089/ten.tea.2010.0045, 10.1089/ten.TEA.2010.0045]
   Jang JH, 2011, MOL THER, V19, P1407, DOI 10.1038/mt.2011.111
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9
   Kasper FK, 2005, J CONTROL RELEASE, V107, P547, DOI 10.1016/j.jconrel.2005.07.005
   Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464
   Keskar V, 2010, TISSUE ENG PART A, V15, P1695
   Kidd ME, 2012, J CONTROL RELEASE, V157, P80, DOI 10.1016/j.jconrel.2011.08.036
   Kofron MD, 2006, ADV DRUG DELIVER REV, V58, P555, DOI 10.1016/j.addr.2006.03.008
   Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee HH, 2011, TISSUE ENG PT A, V17, P1969, DOI [10.1089/ten.tea.2010.0586, 10.1089/ten.TEA.2010.0586]
   Lei P, 2009, BIOMATERIALS, V30, P3790, DOI 10.1016/j.biomaterials.2009.03.049
   LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4
   Lin CC, 2010, J CONTROL RELEASE, V142, P384, DOI 10.1016/j.jconrel.2009.11.022
   Lipinski DM, 2012, PROG RETIN EYE RES, V32, P22
   Loser Peter, 2002, Curr Gene Ther, V2, P161, DOI 10.2174/1566523024605555
   Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315
   Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5
   Mah C, 2002, MOL THER, V6, P106, DOI 10.1006/mthe.2001.0636
   McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87
   McMahon SS, 2011, J GENE MED, V13, P591, DOI 10.1002/jgm.1613
   Mok H, 2007, PHARM RES, V24, P2263, DOI 10.1007/s11095-007-9441-y
   Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046
   Neumann AJ, 2012, MOL BIOTECHNOL, V53, P207
   Padmashali RM, 2011, BIOMATERIALS, V32, P3330, DOI 10.1016/j.biomaterials.2011.01.035
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Raut SD, 2010, J CONTROL RELEASE, V144, P213, DOI 10.1016/j.jconrel.2010.02.009
   Sailaja G, 2002, GENE THER, V9, P1722, DOI 10.1038/sj.gt.3301858
   Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146
   Scott EA, 2010, ACTA BIOMATER, V6, P29, DOI 10.1016/j.actbio.2009.07.009
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Shepard JA, 2012, BIOMATERIALS, V33, P7412, DOI 10.1016/j.biomaterials.2012.06.081
   Shepard JA, 2011, BIOMATERIALS, V32, P5092, DOI 10.1016/j.biomaterials.2011.03.083
   Shepard JA, 2010, J CONTROL RELEASE, V146, P128, DOI 10.1016/j.jconrel.2010.04.032
   Shin SJ, 2010, BIOMATERIALS, V31, P4353, DOI 10.1016/j.biomaterials.2010.02.013
   Shin S, 2010, MOL THER, V18, P700, DOI 10.1038/mt.2009.300
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Su J, 2010, BIOMATERIALS, V31, P308, DOI 10.1016/j.biomaterials.2009.09.045
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Vandendriessche T, 2007, J THROMB HAEMOST, V5, P16, DOI 10.1111/j.1538-7836.2006.02220.x
   Yi Y, 2011, CURR GENE THER, V11, P218
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhang LH, 2011, J GENE MED, V13, P37, DOI 10.1002/jgm.1529
   Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006
NR 70
TC 26
Z9 28
U1 2
U2 68
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5247
EI 1744-7593
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD APR
PY 2013
VL 10
IS 4
BP 499
EP 509
DI 10.1517/17425247.2013.764864
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 106FK
UT WOS:000316128100007
PM 23347508
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Amna, T
   Hassan, MS
   Yousef, A
   Mishra, A
   Barakat, NAM
   Khil, MS
   Kim, HY
AF Amna, Touseef
   Hassan, M. Shamshi
   Yousef, Ayman
   Mishra, Amrita
   Barakat, Nasser A. M.
   Khil, Myung-Seob
   Kim, Hak Yong
TI Inactivation of Foodborne Pathogens by NiO/TiO2 Composite Nanofibers: A
   Novel Biomaterial System
SO FOOD AND BIOPROCESS TECHNOLOGY
LA English
DT Article
DE Electrospinning; NiO/TiO2 composite nanofibers; Antibacterial mechanism;
   MIC foodborne pathogens
ID NICKEL-OXIDE FILM; ESCHERICHIA-COLI; ANTIMICROBIAL COATINGS;
   BACTERICIDAL ACTIVITY; TITANIUM-DIOXIDE; FABRICATION; TIO2;
   ELECTRODEPOSITION; NANOPARTICLES; LIGHT
AB This study presents the fabrication and characterization of novel NiO/TiO2 composite nanofibers and their antibacterial activity. The utilized NiO/TiO2 composite nanofibers were prepared by electrospinning of a sol-gel composed of nickel nitrate hexahydrate, titanium isopropoxide and poly(vinyl acetate). The obtained electrospun nanofiberous mat was vacuum dried at 80 A degrees C and then calcined at 600 A degrees C in air for 2 h. The physicochemical properties of the synthesized nanofibers were determined by X-ray diffraction pattern, field emission scanning electron microscopy, energy-dispersive X-ray spectroscopy, electron probe microanalysis and transmission electron microscopy. The antibacterial activity was tested against four common foodborne pathogenic bacteria viz., Staphylococcus aureus, Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae by minimum inhibitory concentration (MIC) method taking five different concentrations (5-45 mu g/ml). Our investigation reveals that the lowest concentration of NiO/TiO2 composite solution inhibiting the growth of tested strains was found to be 5 mu g/ml. TEM analysis demonstrated that the exposure of the selected microbial strains to the composite nanofibers led to disruption of cell membranes and depressed the activity of some membranous enzymes, which caused bacteria to die eventually. Furthermore, the results illustrate that the combination of NiO and TiO2 can be synergistic and resulted in superior antimicrobial activity of NiO/TiO2 composite nanofibers. To sum up, novel NiO/TiO2 composite nanofibers that possess large surface-to-volume ratio with excellent antimicrobial activity were fabricated that can be used to inhibit the microbial growth associated with food stuff.
C1 [Amna, Touseef; Yousef, Ayman; Kim, Hak Yong] Chonbuk Natl Univ, Ctr Healthcare Technol Dev, Jeonju 561756, South Korea.
   [Hassan, M. Shamshi; Barakat, Nasser A. M.; Khil, Myung-Seob; Kim, Hak Yong] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
   [Mishra, Amrita] Chonbuk Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Technol, Jeonju 561756, South Korea.
RP Kim, HY (reprint author), Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
EM khy@jbnu.ac.kr
RI Kim, Hak Yong/G-3826-2013; Barakat, Nasser/N-3507-2015
OI Kim, Hak Yong/0000-0002-4133-124X; Barakat, Nasser/0000-0003-0085-5431
FU Korean Ministry of Education, Science and Technology (The Regional Core
   Research Program/Center for Healthcare Technology & Development, Chonbuk
   National University, Jeonju, Republic of Korea)
FX This work is supported by a grant of the Korean Ministry of Education,
   Science and Technology (The Regional Core Research Program/Center for
   Healthcare Technology & Development, Chonbuk National University, Jeonju
   561-756, Republic of Korea). We would like to thank Mr. Kang Jong-Gyun,
   Center for University-wide Research Facilities, Chonbuk National
   University for his nice cooperation in transmission electron microscopy
   observations.
CR Anderson AD, 2003, MICROB DRUG RESIST, V9, P373, DOI 10.1089/107662903322762815
   Arshak K. I., 2007, P IEEE SENS, P7925
   Bajpai SK, 2012, FOOD BIOPROCESS TECH, V5, P1871, DOI 10.1007/s11947-011-0587-6
   Berry V, 2005, J AM CHEM SOC, V127, P17600, DOI 10.1021/ja056428l
   Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h
   Brody AL, 2003, FOOD TECHNOL-CHICAGO, V57, P52
   Cabrera-Vique C, 2011, SCI TOTAL ENVIRON, V409, P1584, DOI 10.1016/j.scitotenv.2010.12.035
   Callaway T R, 2008, J Anim Sci, V86, pE163
   Carter A. J., 2009, Food Science and Technology Bulletin: Functional Foods, V5, P103, DOI 10.1616/1476-2137.15682
   Chaudhry Q, 2008, FOOD ADDIT CONTAM A, V25, P241, DOI 10.1080/02652030701744538
   Cui QZ, 2008, J RARE EARTH, V26, P664, DOI 10.1016/S1002-0721(08)60158-1
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Ding B, 2004, FIBER POLYM, V5, P105, DOI 10.1007/BF02902922
   Ellis DI, 2001, TRENDS FOOD SCI TECH, V12, P414, DOI 10.1016/S0924-2244(02)00019-5
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Gadang VP, 2008, J FOOD SCI, V73, pM389, DOI 10.1111/j.1750-3841.2008.00899.x
   Gaya UI, 2008, J PHOTOCH PHOTOBIO C, V9, P1, DOI 10.1016/j.jphotochemrev.2007.12.003
   He JJ, 1999, J PHYS CHEM B, V103, P8940, DOI 10.1021/jp991681r
   Hu XL, 2010, LANGMUIR, V26, P3031, DOI 10.1021/la902142b
   IRIS, 1996, NICK SOL SALTS
   JAY JM, 1996, MODERN FOOD MICROBIO
   Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x
   Joseph CS, 2011, FOOD BIOPROCESS TECH, V4, P1179, DOI 10.1007/s11947-009-0203-1
   Kim SS, 2006, SOL ENERG MAT SOL C, V90, P283, DOI 10.1016/j.solmat.2005.03.015
   Li JF, 2008, ENERG FUEL, V22, P16, DOI 10.1021/ef700283j
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Liu Y, 2007, J PHOTOCH PHOTOBIO A, V190, P94, DOI 10.1016/j.jphotochem.2007.03.017
   Mahltig B, 2007, J MATER CHEM, V17, P2367, DOI 10.1039/b702519j
   Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174
   Neethirajan S, 2011, FOOD BIOPROCESS TECH, V4, P39, DOI 10.1007/s11947-010-0328-2
   Niklasson GA, 2007, J MATER CHEM, V17, P127, DOI 10.1039/b612174h
   Page K, 2007, J MATER CHEM, V17, P95, DOI 10.1039/b611740f
   Rengifo-Herrera JA, 2009, APPL CATAL B-ENVIRON, V88, P398, DOI 10.1016/j.apcatb.2008.10.025
   Rengifo-Herrera JA, 2008, APPL CATAL B-ENVIRON, V84, P448, DOI 10.1016/j.apcatb.2008.04.030
   Rengifo-Herrera JA, 2010, J PHYS CHEM C, V114, P2717, DOI 10.1021/jp910486f
   Schroeder CM, 2004, FOOD MICROBIOL, V21, P249, DOI 10.1016/S0740-0020(03)00074-1
   Sheikh FA, 2010, J CERAM PROCESS RES, V11, P685
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sorapong P., 2005, J SOLID STATE CHEM, V178, P3110
   Sunada K, 2003, ENVIRON SCI TECHNOL, V37, P4785, DOI 10.1021/es034106g
   Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Wittsiepe J, 2009, J TRACE ELEM MED BIO, V23, P183, DOI 10.1016/j.jtemb.2009.03.007
   Wu MS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2759270
   Xi YY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2898505
   Xi YY, 2008, ELECTROCHEM SOLID ST, V11, pD56, DOI 10.1149/1.2903345
   Zhao DD, 2008, ELECTROCHIM ACTA, V53, P2699, DOI 10.1016/j.electacta.2007.07.053
NR 47
TC 11
Z9 12
U1 3
U2 84
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1935-5130
EI 1935-5149
J9 FOOD BIOPROCESS TECH
JI Food Bioprocess Technol.
PD APR
PY 2013
VL 6
IS 4
BP 988
EP 996
DI 10.1007/s11947-011-0741-1
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA 097PQ
UT WOS:000315486400012
DA 2018-10-20
ER

PT J
AU Chung, SH
   Kim, HK
   Shon, WJ
   Park, YS
AF Chung, Shin Hye
   Kim, Hong-Kyun
   Shon, Won-Jun
   Park, Young-Seok
TI Peri-implant bone formations around (Ti,Zr)O2-coated zirconia implants
   with different surface roughness
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE (Ti; Zr)O2 coating; animal experiment; biomaterials; bone implant
   interaction; zirconia implants
ID DENTAL IMPLANTS; IN-VIVO; TITANIUM IMPLANTS; COATED IMPLANTS; REMOVAL
   TORQUE; ORAL IMPLANTS; ANIMAL-MODELS; OSSEOINTEGRATION; BIOMATERIAL;
   INTEGRATION
AB Aim The aim of this study was to evaluate and compare the osseointegration in rabbit tibiae of smooth and roughened powder injection moulded (PIM) zirconia implants with or without (Ti,Zr)O2 surface coatings. Material and Methods Twenty-five rabbits received four types of external hex implants with identical geometry on the tibiae: PIM zirconia implants, roughened PIM zirconia implants, (Ti,Zr)O2-coated PIM zirconia implants and (Ti,Zr)O2-coated roughened PIM zirconia implants. The surface characteristics of the four types of implants were evaluated. Removal torque tests and histomorphometric analyses were performed. Results The (Ti,Zr)O2 coatings substantially changed the surface topography and chemical composition of the both type of PIM zirconia implants. There were statistically significant differences in the bone to implant contact ratios and removal torque values (RT) among the tested implant types (p<0.001). The histological response favoured the coated surface at smooth PIM zirconia implants. The removal torque values favoured the rough surface whether coated or uncoated. Conclusions Within the limit of this study, the (Ti,Zr)O2 coated PIM zirconia implants, both smooth and rough, showed enhanced histological response (bone to implant contact) compared with uncoated ones. On the other hand, the mechanical anchorage (RT) was higher for rough surface implants, coated or uncoated.
C1 [Chung, Shin Hye; Shon, Won-Jun] Seoul Natl Univ, Dept Conservat Dent, Dent Res Inst, Seoul 110749, South Korea.
   [Chung, Shin Hye; Kim, Hong-Kyun; Shon, Won-Jun; Park, Young-Seok] Seoul Natl Univ, Sch Dent, Seoul 110749, South Korea.
   [Kim, Hong-Kyun; Park, Young-Seok] Seoul Natl Univ, Dept Oral Anat, Dent Res Inst, Seoul 110749, South Korea.
RP Park, YS (reprint author), Seoul Natl Univ, Dept Oral Anat, Dent Res Inst, 28 Yeongeuon Dong, Seoul 110749, South Korea.
EM ayoayo7@snu.ac.kr
FU Basic Science Research Programme through the National Research
   Foundation of Korea (NRF); Ministry of Education, Science, and
   Technology [2012001758]
FX The authors declare that they have no conflict of interests. This study
   was supported by Basic Science Research Programme through the National
   Research Foundation of Korea (NRF) funded by the Ministry of Education,
   Science, and Technology (2012001758).
CR Aboushelib M., 2011, J ORAL IMPLANTOLOGY, DOI http://dx.doi.org/10.1563/AAID-JOI-D-11-00075.
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   BARKER HW, 1995, J CLIMATE, V8, P2620, DOI 10.1175/1520-0442(1995)008<2620:IODOBC>2.0.CO;2
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Gahlert M, 2012, CLIN ORAL IMPLAN RES, V23, P281, DOI 10.1111/j.1600-0501.2011.02157.x
   Gahlert M, 2009, CLIN ORAL IMPLAN RES, V20, P1247, DOI 10.1111/j.1600-0501.2009.01734.x
   Gotfredsen K, 2000, Clin Implant Dent Relat Res, V2, P120, DOI 10.1111/j.1708-8208.2000.tb00002.x
   HEBBAR SK, 1995, J AIRCRAFT, V32, P1157, DOI 10.2514/3.46855
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Hopp M, 2003, J MATER SCI-MATER M, V14, P335, DOI 10.1023/A:1022931915709
   Jung RE, 2007, INT J PERIODONT REST, V27, P251
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P333, DOI 10.1111/j.1600-0501.2008.01656.x
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Kokubo Y, 2007, J ORAL REHABIL, V34, P503, DOI 10.1111/j.1365-2842.2007.01751.x
   Langhoff JD, 2008, INT J ORAL MAX SURG, V37, P1125, DOI 10.1016/j.ijom.2008.09.008
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee J, 2009, J CLIN PERIODONTOL, V36, P610, DOI 10.1111/j.1600-051X.2009.01423.x
   Lemons Jack E, 2004, J Oral Implantol, V30, P318, DOI 10.1563/0712.1
   Liu DM, 1998, CERAM INT, V24, P471, DOI 10.1016/S0272-8842(97)00039-4
   Neyt J G, 1998, Iowa Orthop J, V18, P118
   Oliva J, 2007, INT J ORAL MAX IMPL, V22, P430
   Oliva J, 2010, INT J ORAL MAX IMPL, V25, P336
   Ong JL, 2004, BIOMATERIALS, V25, P4601, DOI 10.1016/j.biomaterials.2003.11.053
   Ozkurt Z, 2011, J ORAL IMPLANTOL, V37, P367, DOI 10.1563/AAID-JOI-D-09-00079
   Park YS, 2012, CLIN ORAL IMPLANTS R
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   ROBERTS WE, 1984, AM J ORTHOD DENTOFAC, V86, P95, DOI 10.1016/0002-9416(84)90301-4
   Rompen E, 2007, J PROSTHET DENT, V97, pS119, DOI 10.1016/S0022-3913(07)60015-8
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Schliephake H, 2010, J CLIN PERIODONTOL, V37, P818, DOI 10.1111/j.1600-051X.2010.01549.x
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Shin D, 2011, CLIN ORAL IMPLAN RES, V22, P242, DOI 10.1111/j.1600-0501.2010.01980.x
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   SONG JH, 1995, CERAM INT, V21, P325, DOI 10.1016/0272-8842(95)96204-3
   Stadlinger B, 2010, INT J ORAL MAX SURG, V39, P585, DOI 10.1016/j.ijom.2010.01.015
   Stadlinger B, 2012, J CLIN PERIODONTOL, V39, P28, DOI 10.1111/j.1600-051X.2011.01835.x
   Tinsley D, 2001, CLIN ORAL IMPLAN RES, V12, P159, DOI 10.1034/j.1600-0501.2001.012002159.x
   Vercaigne S, 2000, CLIN ORAL IMPLAN RES, V11, P305, DOI 10.1034/j.1600-0501.2000.011004305.x
   Vignoletti F, 2012, J CLIN PERIODONTOL, V39, P6, DOI 10.1111/j.1600-051X.2011.01830.x
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wennerberg A, 2011, J ORAL REHABIL, V38, P286, DOI 10.1111/j.1365-2842.2010.02170.x
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   YU PY, 1988, NATURE, V332, P783, DOI 10.1038/332783a0
NR 48
TC 20
Z9 21
U1 0
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD APR
PY 2013
VL 40
IS 4
BP 404
EP 411
DI 10.1111/jcpe.12073
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 108XE
UT WOS:000316328800011
PM 23425208
DA 2018-10-20
ER

PT J
AU Peng, Q
   Yang, YJ
   Zhang, T
   Wu, CY
   Yang, Q
   Sun, X
   Gong, T
   Zhang, L
   Zhang, ZR
AF Peng, Qiang
   Yang, Yong-Jie
   Zhang, Ting
   Wu, Cheng-Yu
   Yang, Qin
   Sun, Xun
   Gong, Tao
   Zhang, Ling
   Zhang, Zhi-Rong
TI The Implantable and Biodegradable PHBHHx 3D Scaffolds Loaded with
   Protein-Phospholipid Complex for Sustained Delivery of Proteins
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE drug delivery; insulin; PHBHHx scaffold; phospholipid complex; tissue
   engineering
ID GROWTH-FACTORS; DRUG-DELIVERY; IN-VIVO; ORAL DELIVERY;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); INSULIN; NANOPARTICLES;
   CELLS; MICROSPHERES; REPAIR
AB PHBHHx (poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)) is an excellent biomaterial for tissue repair. Here, we aim to develop a PHBHHx-based three-dimensional (3D) scaffold system for sustained delivery of proteins (insulin serves as a model protein).
   The insulin-phospholipid complex (INS-PLC) was prepared to enhance the insulin lipophilicity. INS-PLC loaded PHBHHx 3D scaffolds (INS-PLC-SCAs) containing PEG-2000 were fabricated by lyophilization. In vitro release was performed in the medium with or without lipase. The bioactivity of INS-PLC-SCAs was measured in diabetic rats.
   In vitro release shows that the release rate of INS-PLC-SCAs was very slow (similar to 6% of total insulin was released within 120 days), and PEG-2000 or lipase had no effect on its release pattern. The bioactivity test shows that the hypoglycaemic effect of insulin was maintained after formulated into scaffolds. After subcutaneous (s.c.) implantation, its therapeutic effect lasted for over 130 h, and its bioavailability was enhanced by 4-fold.
   PHBHHx based 3D scaffold has a great potential for sustained delivery of proteins, especially growth factors. When growth factors are incorporated, it can serve as a bifunctional system that provides a porous skeleton for cells attachment and proliferation, as well as a matrix for long term release of the loaded growth factors.
C1 [Peng, Qiang; Yang, Yong-Jie; Zhang, Ting; Wu, Cheng-Yu; Yang, Qin; Sun, Xun; Gong, Tao; Zhang, Zhi-Rong] Sichuan Univ, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, West China Sch Pharm, Chengdu 610041, Peoples R China.
   [Peng, Qiang] Sichuan Univ, State Key Lab Oral Dis, West China Sch Stomatol, Chengdu 610041, Peoples R China.
   [Zhang, Ling] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.
RP Zhang, ZR (reprint author), Sichuan Univ, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, West China Sch Pharm, 17,Sect 3,South Renmin Rd, Chengdu 610041, Peoples R China.
EM ling.zhang@manchester.ac.uk; zrzzl@vip.sina.com
RI Peng, Qiang/M-5473-2014
OI Peng, Qiang/0000-0002-2268-3178
FU National S & T Major Project of China [2011ZX09501-001-01]; National
   Natural Science Foundation of China [81130060]
FX This work was funded by the National S & T Major Project of China(Grant
   No. 2011ZX09501-001-01) and the National Natural Science Foundation of
   China (No. No. 81130060).
CR Abu II H., 2010, INT J PHARMACEUT, V392, P83
   Bawa R, 2011, CURR DRUG DELIV, V8, P227, DOI 10.2174/156720111795256156
   Chalasani KB, 2007, J CONTROL RELEASE, V122, P141, DOI 10.1016/j.jconrel.2007.05.019
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Cui F, 2006, J CONTROL RELEASE, V114, P242, DOI 10.1016/j.jconrel.2006.05.013
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008
   Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608
   Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695
   Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Grdisa M, 2011, CURR MED CHEM, V18, P1373, DOI 10.2174/092986711795029591
   Huang W, 2010, BIOMATERIALS, V31, P4278, DOI 10.1016/j.biomaterials.2010.01.059
   Jaklenec A, 2008, BIOMATERIALS, V29, P185, DOI 10.1016/j.biomaterials.2007.09.017
   Kim BS, 2009, MOL PHARMACEUT, V6, P353, DOI 10.1021/mp800087t
   Ladewig K, 2011, EXPERT OPIN DRUG DEL, V8, P1175, DOI 10.1517/17425247.2011.588698
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   Moshfeghian A, 2006, J BIOMED MATER RES A, V79A, P418, DOI 10.1002/jbm.a.30849
   Moss AJ, 2009, BIOCHEM SOC T, V37, P717, DOI 10.1042/BST0370717
   Peng Q, 2008, PHARMAZIE, V63, P661, DOI 10.1691/ph.2008.8053
   Peng Q, 2012, BIOMATERIALS, V33, P1583, DOI 10.1016/j.biomaterials.2011.10.072
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Robinson SN, 2002, IN VIVO, V16, P535
   Seyednejad H, 2011, J CONTROL RELEASE, V152, P168, DOI 10.1016/j.jconrel.2010.12.016
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Thomopoulos S, 2007, J ORTHOP RES, V25, P1358, DOI 10.1002/jor.20444
   Tiwari S, 2011, INT J PHARMACEUT, V413, P211, DOI 10.1016/j.ijpharm.2011.04.029
   Wang Y, 2008, BIOMATERIALS, V29, P2858, DOI 10.1016/j.biomaterials.2008.03.021
   Wang Y, 2012, BIOMATERIALS, V33, P485, DOI 10.1016/j.biomaterials.2011.09.089
   Wang YW, 2004, POLYM DEGRAD STABIL, V85, P815, DOI 10.1016/j.polymdegradstab.2004.02.010
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   You ML, 2011, BIOMATERIALS, V32, P2305, DOI 10.1016/j.biomaterials.2010.12.009
   Yu BY, 2012, J BIOMAT SCI-POLYM E, V23, P1, DOI 10.1163/092050610X541386
   Zhou J, 2010, BIOMATERIALS, V31, P7512, DOI 10.1016/j.biomaterials.2010.06.044
NR 36
TC 5
Z9 5
U1 2
U2 41
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
J9 PHARM RES-DORDR
JI Pharm. Res.
PD APR
PY 2013
VL 30
IS 4
BP 1077
EP 1085
DI 10.1007/s11095-012-0944-9
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 107NB
UT WOS:000316223300014
PM 23224980
DA 2018-10-20
ER

PT J
AU Di Loreto, FP
   Mangione, A
   Palmisano, E
   Cerda, JI
   Dominguez, MJ
   Ponce, G
   Bernaus, M
   Gaffuri, S
   Torresi, G
   Bianco, S
AF Pomilio Di Loreto, Franco
   Mangione, Andres
   Palmisano, Ezequiel
   Ignacio Cerda, Juan
   Jose Dominguez, Maria
   Ponce, Guillermo
   Bernaus, Marianela
   Gaffuri, Silvina
   Torresi, Guillermo
   Bianco, Sergio
TI Dried human amniotic membrane as an antiadherent layer for
   intraperitoneal placing of polypropylene mesh in rats
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE Antiadhesives; Hernia repair; Human amniotic membrane; Intraperitoneal
   mesh placement; Polypropylene
ID ABDOMINAL-WALL HERNIAS; ADHESION FORMATION; INCISIONAL HERNIA; REPAIR;
   MODEL; CELLS
AB Intraabdominal peritoneal onlay polypropylene (PP) mesh repair of incisional hernia has the potential risk of adhesions, bowel obstructions, and intestinal fistulae. Fresh or cryopreserved human amniotic membrane (HAM) has been tested as an antiadherent layer in animals, with excellent outcomes. However, it has disadvantages: it is difficult to handle, and it is expensive to store. Another processing method is available: drying in a laminar flow hood and gamma irradiation. Because this method impairs the membrane's cell viability, it may affect its antiadherent properties. However, such properties may also result from the collagen matrix and its basement membrane, which remain after drying. The aim of the present study was to asses dried irradiated HAM in adhesion prophylaxis in rats.
   Twenty-four female rats were randomized into two groups. In the first group (control group), PP meshes were placed in the intraabdominal space, and in the second group (treatment group), PP meshes coated with HAM were used. Animals were killed on day 30 after surgery. Adhesions and parietal prosthetic incorporation were assessed macroscopically and expressed as the average percentage of the covered area. The portion of the abdominal wall was then resected for histological testing.
   The treatment group had a significantly higher percentage of adhesions and parietal incorporation compared with the control group (p = 0.003). Histological testing showed a higher inflammatory response in the treatment group, with an intense foreign body reaction.
   Dried irradiated HAM does not prevent adhesion formation in intraabdominal peritoneal onlay PP mesh repair in rats. Any use of this biomaterial in adhesion prophylaxis must be undertaken respecting graft cell viability as much as possible.
C1 [Pomilio Di Loreto, Franco; Mangione, Andres; Palmisano, Ezequiel; Ignacio Cerda, Juan; Jose Dominguez, Maria; Ponce, Guillermo; Bernaus, Marianela; Gaffuri, Silvina; Torresi, Guillermo; Bianco, Sergio] Sch Hosp Eva Peron, Dept Gen Surg, Granadero Baigorria, Argentina.
   [Pomilio Di Loreto, Franco; Mangione, Andres; Palmisano, Ezequiel; Ignacio Cerda, Juan; Jose Dominguez, Maria; Ponce, Guillermo; Bernaus, Marianela; Gaffuri, Silvina; Torresi, Guillermo; Bianco, Sergio] Natl Univ Rosario, Sch Med Sci, RA-2000 Rosario, Santa Fe, Argentina.
RP Di Loreto, FP (reprint author), Natl Univ Rosario, Sch Med Sci, Catamarca 1124 6 C, RA-2000 Rosario, Santa Fe, Argentina.
EM francopomilio@hotmail.com
CR Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11
   Astiz JM, 1998, REV ARGENT CIR, V74, P183
   Bauer J J, 2002, Hernia, V6, P120
   Bendavid R, 1997, HERNIA, V1, P5
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Crovella F, 2008, UPDATES SURG, P1, DOI 10.1007/978-88-470-0722-2
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Flum DR, 2003, ANN SURG, V237, P129, DOI 10.1097/00000658-200301000-00018
   Goldstein H., 1999, HERNIA, V3, P23
   Harrell AG, 2007, SURG ENDOSC, V21, P1170, DOI 10.1007/s00464-006-9147-y
   Hennerbichler Simone, 2007, Cell and Tissue Banking, V8, P1, DOI 10.1007/s10561-006-9002-3
   John Thomas, 2003, Ophthalmol Clin North Am, V16, P43, DOI 10.1016/S0896-1549(02)00110-4
   Kesting MR, 2008, ANN PLAS SURG, V60, P684, DOI 10.1097/SAP.0b013e31814fb9d2
   Kesting MR, 2009, J BIOMED MATER RES B, V90B, P930, DOI 10.1002/jbm.b.31365
   Kiudelis M, 2007, Hernia, V11, P19, DOI 10.1007/s10029-006-0139-6
   Klinge U, 1999, EUR J SURG, V165, P665
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   McGinty JJ, 2005, SURG ENDOSC, V19, P786, DOI 10.1007/s00464-004-8174-9
   Miki T, 2007, J REPROD IMMUNOL, V75, P91, DOI 10.1016/j.jri.2007.03.017
   Petter-Puchner AH, 2011, SURG ENDOSC, V25, P2125, DOI 10.1007/s00464-010-1507-y
   Rennekampff H O, 1994, J Invest Surg, V7, P187, DOI 10.3109/08941939409018285
   Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y
   Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446
   Schug-Pass C, 2009, SURG ENDOSC, V23, P487, DOI 10.1007/s00464-008-0085-8
   Singh Rita, 2004, Cell and Tissue Banking, V5, P129, DOI 10.1023/B:CATB.0000034077.05000.29
   Szabo A, 2000, EUR SURG RES, V32, P125, DOI 10.1159/000008751
   Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Vrijland WW, 2000, BRIT J SURG, V87, P348, DOI 10.1046/j.1365-2168.2000.01364.x
NR 30
TC 5
Z9 5
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD APR
PY 2013
VL 27
IS 4
BP 1435
EP 1440
DI 10.1007/s00464-012-2604-x
PG 6
WC Surgery
SC Surgery
GA 108JN
UT WOS:000316289200060
PM 23392973
DA 2018-10-20
ER

PT J
AU Hauptmann, V
   Weichert, N
   Menzel, M
   Knoch, D
   Paege, N
   Scheller, J
   Spohn, U
   Conrad, U
   Gils, M
AF Hauptmann, Valeska
   Weichert, Nicola
   Menzel, Matthias
   Knoch, Dominic
   Paege, Norman
   Scheller, Juergen
   Spohn, Uwe
   Conrad, Udo
   Gils, Mario
TI Native-sized spider silk proteins synthesized in planta via intein-based
   multimerization
SO TRANSGENIC RESEARCH
LA English
DT Article
DE Spider silk; Flagelliform protein; Intein; Protein trans-splicing;
   Microfibers; Tobacco
ID DRAGLINE SILK; MECHANICAL-PROPERTIES; POLYPEPTIDE FUSIONS; TRANSGENIC
   PLANTS; NEPHILA-CLAVIPES; EXPRESSION; ELASTIN; EVOLUTION; GENE;
   PURIFICATION
AB The synthesis of native-sized proteins is a pre-requisite for exploiting the potential of spider silk as a bio-based material. The unique properties of spider silk, such as extraordinary tensile strength and elasticity, result from the highly repetitive nature of spider silk protein motifs. The present report describes the combination of spider silk flagelliform protein (FLAG) production in the endoplasmic reticulum of tobacco plant leaf cells with an intein-based posttranslational protein fusion technology. The repeated ligation of FLAG monomers resulted in the formation of large multimers. This method avoids the need for highly repetitive transgenes, which may result in a higher genetic and transcriptional stability. Here we show, for the first time, the production of synthetic, high molecular weight spider silk proteins larger than 250 kDa based on the assembly of protein monomers via intein-mediated trans-splicing in planta. The resulting multimeric structures form microfibers, thereby demonstrating their great potential as a biomaterial.
C1 [Hauptmann, Valeska; Weichert, Nicola; Knoch, Dominic; Paege, Norman; Conrad, Udo; Gils, Mario] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Stadt Seeland, Ot Gatersleben, Germany.
   [Menzel, Matthias; Spohn, Uwe] Fraunhofer Inst Mech Mat, D-06120 Halle, Saale, Germany.
   [Scheller, Juergen] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany.
RP Conrad, U (reprint author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Corrensstr 3, D-06466 Stadt Seeland, Ot Gatersleben, Germany.
EM conradu@ipk-gatersleben.de
RI Scheller, Jurgen/K-5290-2015
OI Knoch, Dominic/0000-0002-9362-3105
CR Arias FJ, 2006, BIOTECHNOL LETT, V28, P687, DOI 10.1007/s10529-006-9045-3
   ARTSAENKO O, 1995, PLANT J, V8, P745, DOI 10.1046/j.1365-313X.1995.08050745.x
   Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Conley AJ, 2009, BIOTECHNOL BIOENG, V103, P562, DOI 10.1002/bit.22278
   Craig CL, 2004, BIOMACROMOLECULES, V5, P739, DOI 10.1021/bm034351s
   DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777
   Floss DM, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P489, DOI 10.1007/978-3-642-01144-3_31
   Gahrtz Manfred, 2009, V483, P289, DOI 10.1007/978-1-59745-407-0_17
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Phan HT, 2011, INT J MOL SCI, V12, P2808, DOI 10.3390/ijms12052808
   HORSCH RB, 1985, SCIENCE, V227, P1229
   Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4
   Kempe Katja, 2009, Plant Biotechnol J, V7, P283, DOI 10.1111/j.1467-7652.2008.00399.x
   KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102
   MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4
   Ohgo K, 2006, BIOMACROMOLECULES, V7, P1210, DOI 10.1021/bm0600522
   Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Romer L, 2008, PRION, V2, P154
   Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Sudarshana MR, 2006, PLANT BIOTECHNOL J, V4, P551, DOI 10.1111/j.1467-7652.2006.00202.x
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   Vendrely Charlotte, 2008, V474, P3, DOI 10.1007/978-1-59745-480-3_1
   VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593
   Yang JJ, 2003, P NATL ACAD SCI USA, V100, P3513, DOI 10.1073/pnas.0635899100
NR 34
TC 21
Z9 26
U1 0
U2 44
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-8819
J9 TRANSGENIC RES
JI Transgenic Res.
PD APR
PY 2013
VL 22
IS 2
BP 369
EP 377
DI 10.1007/s11248-012-9655-6
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 105KE
UT WOS:000316065900009
PM 23001519
DA 2018-10-20
ER

PT J
AU Burnett, LR
   Rahmany, MB
   Richter, JR
   Aboushwareb, TA
   Eberli, D
   Ward, CL
   Orlando, G
   Hantgan, RR
   Van Dyke, ME
AF Burnett, Luke R.
   Rahmany, Maria B.
   Richter, Jillian R.
   Aboushwareb, Tamer A.
   Eberli, Daniel
   Ward, Catherine L.
   Orlando, Giuseppe
   Hantgan, Roy R.
   Van Dyke, Mark E.
TI Hemostatic properties and the role of cell receptor recognition in human
   hair keratin protein hydrogels
SO BIOMATERIALS
LA English
DT Article
DE Keratin; Biomaterial; Hemostasis; Platelet; Integrin; Adhesion
ID HYPOTHERMIC COAGULOPATHIC SWINE; REDUCE BLOOD-LOSS; V LIVER-INJURIES;
   BIOMEDICAL APPLICATIONS; RESUSCITATION VOLUME; INTEGRIN ACTIVATION;
   IMPROVE SURVIVAL; OVINE MODEL; BIOMATERIALS; CULTIVATION
AB Driven by new discoveries in stem-cell biology and regenerative medicine, there is broad interest in biomaterials that go beyond basic interactions with cells and tissues to actively direct and sustain cellular behavior. Keratin biomaterials have the potential to achieve these goals but have been inadequately described in terms of composition, structure, and cell-instructive characteristics. In this manuscript we describe and characterize a keratin-based biomaterial, demonstrate self-assembly of cross-linked hydrogels, investigate a cell-specific interaction that is dependent on the hydrogel structure and mediated by specific biomaterial-receptor interactions, and show one potential medical application that relies on receptor binding - the ability to achieve hemostasis in a lethal liver injury model. Keratin biomaterials represent a significant advance in biotechnology as they combine the compatibility of natural materials with the chemical flexibility of synthetic materials. These characteristics allow for a system that can be formulated into several varieties of cell-instructive biomaterials with potential uses in tissue engineering, regenerative medicine, drug and cell delivery, and trauma. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Burnett, Luke R.] KeraNetics LLC, Winston Salem, NC USA.
   [Rahmany, Maria B.; Van Dyke, Mark E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Orthopaed Surg, Winston Salem, NC 27109 USA.
   [Richter, Jillian R.; Aboushwareb, Tamer A.; Eberli, Daniel; Ward, Catherine L.; Orlando, Giuseppe] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.
   [Hantgan, Roy R.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA.
RP Van Dyke, ME (reprint author), Virginia Polytech Inst & State Univ, Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Blacksburg, VA 24060 USA.
EM lburnett@wakehealth.edu; mbahawdo@wakehealth.edu;
   jrichter@wakehealth.edu; aboushwareb_tamer@allergan.com;
   daniel.eberli@usz.ch; catward@wakehealth.edu; gorlando@wakehealth.edu;
   rhantgan@wakehealth.edu; mavandyk@wakehealth.edu
RI Richter, Jillian/C-1914-2013
OI Richter, Jillian/0000-0002-2233-1711
FU KeraNetics LLC
FX The authors thank Dr. Olga Greengauz-Roberts and the Macromolecular
   Interactions Core Laboratory at Wake Forest School of Medicine for
   assistance with size exclusion chromatography, Dr. Mark Lively and the
   Wake Forest University Bioanalytical Core Laboratory for assistance with
   mass spectrometry identification of proteins, and Julie Steen and Cindy
   Andrews for assistance with animal surgeries. Partial funding for this
   project was provided by KeraNetics LLC.; Author Mark Van Dyke holds
   stock and is an officer in the company, KeraNetics LLC, who has provided
   partial funding for this research. Wake Forest School University of
   Medicine has a potential financial interest in KeraNetics through
   licensing agreements.; Author Luke Burnett is currently an employee of
   KeraNetics LLC, who has provided partial funding for this research, but
   was formerly a postdoctoral fellow at the Wake Forest School of Medicine
   when the swine experiments were conducted. Dr. Burnett had no conflict
   of interest while an employee of WFSM.
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514
   BECKERLE MC, 1989, J CELL BIOL, V109, P3333, DOI 10.1083/jcb.109.6.3333
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   BUSH JA, 1955, AM J PHYSIOL, V181, P9
   Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   Dias GJ, 2010, J BIOMED MATER RES A, V95A, P1084, DOI 10.1002/jbm.a.32908
   Dias GJ, 2010, J BIOMED MATER RES A, V92A, P513, DOI 10.1002/jbm.a.32394
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Hantgan RR, 2002, THROMB HAEMOSTASIS, V87, P910
   Hersen P, 2011, NATURE, V470, P340, DOI 10.1038/470340a
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   Holcomb JB, 1999, J TRAUMA, V47, P233, DOI 10.1097/00005373-199908000-00002
   Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1
   Howells G, 1999, J TRAUMA, V47, P240
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Leach JB, 2005, ACTA BIOMATER, V1, P155, DOI 10.1016/j.actbio.2004.12.001
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7
   Oldinski RA, 2010, J BIOMED MATER RES B, V94B, P441, DOI 10.1002/jbm.b.31672
   Parry DAD, 1998, J STRUCT BIOL, V122, P67, DOI 10.1006/jsbi.1998.3967
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Richter JR, 2012, ACTA BIOMATER, V8, P274, DOI 10.1016/j.actbio.2011.08.020
   Richter JR, 2011, BIOMATERIALS, V32, P7555, DOI 10.1016/j.biomaterials.2011.06.061
   Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   SAUK JJ, 1984, J CELL BIOL, V99, P1590, DOI 10.1083/jcb.99.5.1590
   Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161
   SHATTIL SJ, 1994, J BIOL CHEM, V269, P14738
   Shen DL, 2011, BIOMATERIALS, V32, P9290, DOI 10.1016/j.biomaterials.2011.08.057
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Stegner D, 2011, J MOL MED, V89, P109, DOI 10.1007/s00109-010-0691-5
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652
   Thilagar S, 2009, J BIOMED MATER RES B, V88B, P12, DOI 10.1002/jbm.b.31024
   THOMAS H, 1986, INT J BIOL MACROMOL, V8, P258, DOI 10.1016/0141-8130(86)90038-3
   van de Locht M, 1987, MELLIAND TEXTILBERIC, V10, P780
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   YU JL, 1993, J INVEST DERMATOL, V101, pS56, DOI 10.1111/1523-1747.ep12362635
NR 51
TC 31
Z9 32
U1 1
U2 124
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2013
VL 34
IS 11
BP 2632
EP 2640
DI 10.1016/j.biomaterials.2012.12.022
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 101AS
UT WOS:000315748200006
PM 23340195
DA 2018-10-20
ER

PT J
AU Alves, A
   Sousa, RA
   Reis, RL
AF Alves, Anabela
   Sousa, Rui A.
   Reis, Rui L.
TI A practical perspective on ulvan extracted from green algae
SO JOURNAL OF APPLIED PHYCOLOGY
LA English
DT Article
DE Green algae; Ulvan; Polysaccharide; Biopolymer; Biomaterial
ID CELL-WALL POLYSACCHARIDES; WATER-SOLUBLE POLYSACCHARIDES; VITRO
   ANTIOXIDANT ACTIVITY; RIGIDA C. AGARDH; LACTUCA L THURET; SULFATED
   POLYSACCHARIDES; CHEMICAL-STRUCTURE; IN-VITRO; ENTEROMORPHA-COMPRESSA;
   RHEOLOGICAL PROPERTIES
AB Researchers have many times turned their attention to nature and biological processes to develop novel technologies and materials. In a medical perspective, nature-based products are believed to be a strategic alternative approach to the use of fully synthetic materials, particularly in the design of medical devices. In the past decades, marine organisms have become the focus of considerable attention as potential sources of valuable materials. The sustainable exploitation and valorisation of natural marine resources constitutes a highly attractive and strategic platform for the development of novel biomaterials, with both economic and environmental benefits. In this context, algae are known to synthesise large quantities of polysaccharides and are well established sources of these particularly interesting molecules, many of which are known for their applicability in the design of biomaterials. Agar, carrageenan and alginates are some of the most known examples, and their uses can range from food to biomedical applications. However, few of the world's available seaweed species are used commercially. Among the three main divisions of macroalgae (Chlorophyta, Phaeophyta and Rhodophyta), the green algae remain largely unexploited in this biomedical arena. While the demand for novel materials and technologies increases, so does the research of unexploited marine green algae including its unique polysaccharide ulvan.
C1 [Alves, Anabela; Sousa, Rui A.; Reis, Rui L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Alves, Anabela; Sousa, Rui A.; Reis, Rui L.] ICVS 3Bs PT Associated Lab, Braga, Portugal.
RP Alves, A (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM anabela.pinto@dep.uminho.pt
RI Alves, Anabela/C-2729-2011; Group, 3Bs/E-4374-2012; Reis, Rui
   L./A-8938-2008
OI Alves, Anabela/0000-0002-6878-0766; Group, 3Bs/0000-0002-5195-3456;
   Reis, Rui L./0000-0002-4295-6129; Sousa, Rui/0000-0003-0362-7418
FU Fundacao para a Ciencia e Tecnologia [SFRH/BD/39359/2007]; project
   IBEROMARE; European Regional Development Fund (ERDF); POCTEP
FX Anabela Alves is grateful for financial support from the Fundacao para a
   Ciencia e Tecnologia through the SFRH/BD/39359/2007 grant. This work was
   partially supported by the project IBEROMARE approved by the Operational
   Programme for Cross-border Cooperation: Spain-Portugal, 2007-2013
   (POCTEP), with funding contribution through the European Regional
   Development Fund (ERDF co-funding) and POCTEP.
CR ABDELFATTAH AF, 1972, QUAL PLANT MATER VEG, V22, P15, DOI 10.1007/BF01099733
   Alves A, 2012, INT J PHARMACEUT, V426, P76, DOI 10.1016/j.ijpharm.2012.01.021
   Alves A, 2010, CARBOHYD RES, V345, P2194, DOI 10.1016/j.carres.2010.07.039
   Andrade LR, 2004, J STRUCT BIOL, V145, P216, DOI 10.1016/j.jsb.2003.11.011
   Andres E, 2006, PATHOL BIOL, V54, P420, DOI 10.1016/j.patbio.2006.07.004
   Andrieux C, 1998, J SCI FOOD AGR, V77, P25
   Araujo L, 2008, TROP PLANT PATHOL, V33, P148, DOI 10.1590/S1982-56762008000200009
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   Barcelo A, 2000, GUT, V46, P218, DOI 10.1136/gut.46.2.218
   BARSANTI L, 2006, ALGAE ANATOMY BIOCH
   Baumann L, 2009, COSMETIC DERMATOLOGY, P8
   BERESS A, 1993, J NAT PROD, V56, P478, DOI 10.1021/np50094a005
   Bernhardt A, 2009, J TISSUE ENG REGEN M, V3, P54, DOI 10.1002/term.134
   Blin X, 2007, FR Patent, Patent No. [WO 2007/007294, 2007007294]
   BobinDubigeon C, 1997, J SCI FOOD AGR, V73, P149, DOI 10.1002/(SICI)1097-0010(199702)73:2<149::AID-JSFA685>3.0.CO;2-L
   BobinDubigeon C, 1997, J SCI FOOD AGR, V75, P341, DOI 10.1002/(SICI)1097-0010(199711)75:3<341::AID-JSFA888>3.3.CO;2-2
   Bocanegra A, 2009, J MED FOOD, V12, P236, DOI 10.1089/jmf.2008.0151
   BRADING JWE, 1954, J CHEM SOC, P319, DOI 10.1039/jr9540000319
   Briand X, 2005, PCT Patent, Patent No. [WO 2005/094588, 2005094588]
   Briand X, 1991, PCT Patent, Patent No. [WO 91/07946, 9107946]
   Bruhn A, 2011, BIORESOURCE TECHNOL, V102, P2595, DOI 10.1016/j.biortech.2010.10.010
   BUERMANN CW, 1979, ARCH BIOCHEM BIOPHYS, V193, P277, DOI 10.1016/0003-9861(79)90032-8
   CANNELL RJP, 1998, METHODS BIOTECHNOLOG, V4, P343
   Castro R, 2006, AQUACULTURE, V254, P9, DOI 10.1016/j.aquaculture.2005.10.012
   Castro R, 2004, AQUACULTURE, V229, P67, DOI 10.1016/S0044-8486(03)00401-0
   Castro R, 2008, MOL IMMUNOL, V45, P428, DOI 10.1016/j.molimm.2007.05.028
   CastroGonzalez MI, 1996, CIENC MAR, V22, P205
   Charlier R.H., 2007, ENV RES ENG MANAGEME, V3, P52, DOI DOI 10.1371/JOURNAL.PONE.0033648
   Chattopadhyay K, 2007, FOOD CHEM, V104, P928, DOI 10.1016/j.foodchem.2006.12.048
   Chuda Y, 1997, PHYTOCHEMISTRY, V46, P209, DOI 10.1016/S0031-9422(97)00284-7
   Cluzet S, 2004, PLANT CELL ENVIRON, V27, P917, DOI 10.1111/j.1365-3040.2004.01197.x
   CONRAD HE, 1980, BIOCHEM J, V191, P355, DOI 10.1042/bj1910355
   Correlo VM, 2010, MACROMOL BIOSCI, V10, P1495, DOI 10.1002/mabi.201000011
   Costa C, 2012, CARBOHYD POLYM, V88, P537, DOI 10.1016/j.carbpol.2011.12.041
   Costa LS, 2010, BIOMED PHARMACOTHER, V64, P21, DOI 10.1016/j.biopha.2009.03.005
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704
   Courtois J, 2009, CURR OPIN MICROBIOL, V12, P261, DOI 10.1016/j.mib.2009.04.007
   d'Ayala GG, 2008, MOLECULES, V13, P2069, DOI 10.3390/molecules13092069
   Daniels B.A., 2004, US Patent, Patent No. [US 2004/0170645, 20040170645]
   Daniels BA, 2004, PCT Patent, Patent No. [WO 2004/103280, 2004103280]
   de Castro MDL, 1998, ANAL CHIM ACTA, V369, P1
   de Freitas MB, 2012, PHYSIOL MOL PLANT P, V78, P8, DOI 10.1016/j.pmpp.2011.12.004
   De la Fuente M, 2011, INT IMMUNOPHARMACOL, V11, P661, DOI 10.1016/j.intimp.2011.01.008
   Delattre C, 2006, APPL MICROBIOL BIOT, V70, P437, DOI 10.1007/s00253-005-0077-8
   Demais H, 2006, PCT Patent Application, Patent No. [WO2006030075, 2006030075]
   DEREVIERS B, 1993, CARBOHYD POLYM, V22, P253, DOI 10.1016/0144-8617(93)90128-Q
   Devaki T, 2009, CHEM-BIOL INTERACT, V177, P83, DOI 10.1016/j.cbi.2008.09.036
   Durand M, 1997, REPROD NUTR DEV, V37, P267, DOI 10.1051/rnd:19970303
   El-Baky H.H.A., 2009, ACAD J CANC RES, V2, P01
   Elboutachfaiti R, 2011, CARBOHYD POLYM, V84, P1, DOI 10.1016/j.carbpol.2010.10.063
   Elboutachfaiti R, 2010, US Patent, Patent No. [US 2010/0261894, 20100261894]
   Ertesvag H, 1998, POLYM DEGRAD STABIL, V59, P85, DOI 10.1016/S0141-3910(97)00179-1
   Faury G, 2011, ARCH GERONTOL GERIAT, V53, P106, DOI 10.1016/j.archger.2010.05.017
   Fialho AM, 2008, APPL MICROBIOL BIOT, V79, P889, DOI 10.1007/s00253-008-1496-0
   France M, 2009, PCT Patent, Patent No. [WO 2009/142745, 2009142745]
   Cruz DMG, 2008, J TISSUE ENG REGEN M, V2, P378, DOI 10.1002/term.106
   Ghisalberti C, 2010, PCT Patent, Patent No. [WO 2010/109256, 2010109256]
   GOSSELIN CC, 1964, J CHEM SOC, VS, P5877
   Grenha A, 2010, J BIOMED MATER RES A, V92A, P1265, DOI 10.1002/jbm.a.32466
   Harada N, 1998, BIOSCI BIOTECH BIOCH, V62, P1647, DOI 10.1271/bbb.62.1647
   Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321
   Hernandez-Garibay E, 2011, J APPL PHYCOL, V23, P537, DOI 10.1007/s10811-010-9629-0
   Jani GK, 2009, ASIAN J PHARM SCI, V4, P309
   Jaulneau V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525291
   JENSEN A, 1993, HYDROBIOLOGIA, V261, P15
   Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196
   Kaeffer B, 1999, PLANTA MED, V65, P527, DOI 10.1055/s-1999-14009
   Khotimchenko YS, 2010, MAR DRUGS, V8, P1106, DOI 10.3390/md8041106
   Kim SK, 2008, BIOTECHNOL BIOPROC E, V13, P511, DOI [10.1007/s12257-008-0113-5, 10.1007/S12257-008-0113-5]
   Kitada K, 2009, J CHEM TECHNOL BIOT, V84, P657, DOI 10.1002/jctb.2096
   Kreisman LSC, 2007, GLYCOBIOLOGY, V17, P46, DOI 10.1093/glycob/cwl056
   Kuda T, 2009, FOOD CHEM, V112, P575, DOI 10.1016/j.foodchem.2008.06.008
   LAHAYE M, 1993, J APPL PHYCOL, V5, P195, DOI 10.1007/BF00004017
   LAHAYE M, 1994, CARBOHYD RES, V262, P115, DOI 10.1016/0008-6215(94)84008-3
   LAHAYE M, 1991, J SCI FOOD AGR, V54, P587, DOI 10.1002/jsfa.2740540410
   Lahaye M, 1998, CARBOHYD RES, V314, P1, DOI 10.1016/S0008-6215(98)00293-6
   Lahaye M, 2001, CAH BIOL MAR, V42, P137
   Lahaye M, 1996, CARBOHYD RES, V283, P161, DOI 10.1016/0008-6215(95)00407-6
   Lahaye M, 1997, CARBOHYD RES, V304, P325, DOI 10.1016/S0008-6215(97)00270-X
   Lahaye M, 1998, CARBOHYD POLYM, V36, P239, DOI 10.1016/S0144-8617(98)00026-5
   LAHAYE M, 1993, CARBOHYD POLYM, V22, P261, DOI 10.1016/0144-8617(93)90129-R
   Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q
   Larraz E, 2007, J TISSUE ENG REGEN M, V1, P120, DOI 10.1002/term.10
   Lazaridou A, 2004, FOOD HYDROCOLLOID, V18, P837, DOI 10.1016/j.foodhyd.2004.01.002
   Leiro JM, 2007, INT IMMUNOPHARMACOL, V7, P879, DOI 10.1016/j.intimp.2007.02.007
   LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135
   LOVE J, 1964, J CHEM SOC, P3338, DOI 10.1039/jr9640003338
   Maeda M., 1992, Patent, Patent No. [EP 0475383, 0475383]
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mao WJ, 2006, J APPL PHYCOL, V18, P9, DOI 10.1007/s10811-005-9008-4
   Massarelli I, 2007, INT J MOL SCI, V8, P13, DOI 10.3390/i8010013
   Matsuo K-SY, 2004, US Patent, Patent No. [US 2004/0228854, 20040228854]
   MCKINNELL JP, 1962, J CHEM SOC, P3141, DOI 10.1039/jr9620003141
   MCKINNELL JP, 1962, J CHEM SOC, P2082
   Mejia-Teniente L, 2010, AFR J BIOTECHNOL, V9, P9155
   Michaud P, 2003, CRIT REV BIOTECHNOL, V23, P233, DOI 10.1080/07388550390447043
   Michel C, 1996, J APPL BACTERIOL, V80, P349, DOI 10.1111/j.1365-2672.1996.tb03230.x
   Montealegre JR, 2010, TROP PLANT PATHOL, V35, P271, DOI 10.1590/S1982-56762010000500001
   Morand P, 1996, BOT MAR, V39, P491, DOI 10.1515/botm.1996.39.1-6.491
   Morelli A, 2010, MACROMOL CHEM PHYS, V211, P821, DOI 10.1002/macp.200900562
   Msuya F, 2008, J APPL PHYCOL, V20, P1021, DOI 10.1007/s10811-007-9300-6
   Muto S., 1992, Polysaccharides and antiviral drugs containing the same as active ingredient, Patent No. [US5089481, 5089481]
   O'Mara AM, 2009, US Patent, Patent No. [US 2009/0060942, 20090060942]
   Oakes JM, 2010, LIMNOL OCEANOGR, V55, P2126, DOI 10.4319/lo.2010.55.5.2126
   Oliveira JT, 2011, J TISSUE ENG REGEN M, V5, P421, DOI 10.1002/term.335
   Ortiz J, 2006, FOOD CHEM, V99, P98, DOI 10.1016/j.foodchem.2005.07.027
   Ovodov YS, 1975, CHEM NAT COMPD, V3, P300
   Paradossi G, 1999, INT J BIOL MACROMOL, V25, P309, DOI 10.1016/S0141-8130(99)00049-5
   Paradossi G, 2002, MACROMOLECULES, V35, P6404, DOI 10.1021/ma020134s
   Paulert R, 2009, J PLANT DIS PROTECT, V116, P263, DOI 10.1007/BF03356321
   Pengzhan Y, 2003, J APPL PHYCOL, V15, P21
   PERCIVAL E, 1963, J CHEM SOC, P5459, DOI 10.1039/jr9630005459
   Pereira RC, 2009, J TISSUE ENG REGEN M, V3, P97, DOI 10.1002/term.145
   Pomponi SA, 1999, J BIOTECHNOL, V70, P5, DOI 10.1016/S0168-1656(99)00053-X
   Popa EG, 2011, BIOMACROMOLECULES, V12, P3952, DOI 10.1021/bm200965x
   Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013
   Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809
   Qi HM, 2006, BIOORG MED CHEM LETT, V16, P2441, DOI 10.1016/j.bmcl.2006.01.076
   Qi HM, 2005, INT J BIOL MACROMOL, V37, P195, DOI 10.1016/j.ijbiomac.2005.10.008
   Qi HM, 2010, J MED PLANTS RES, V4, P2445
   Quemener B, 1997, J APPL PHYCOL, V9, P179, DOI 10.1023/A:1007971023478
   Ranson M, 2007, PCT Patent, Patent No. [WO 2007/045795, 2007045795]
   RAY B, 1995, CARBOHYD RES, V274, P313, DOI 10.1016/0008-6215(95)00059-3
   RAY B, 1995, CARBOHYD RES, V274, P251, DOI 10.1016/0008-6215(95)00138-J
   Ray B, 2006, CARBOHYD POLYM, V66, P408, DOI 10.1016/j.carbpol.2006.03.027
   RENN DW, 1984, IND ENG CHEM PROD RD, V23, P17, DOI 10.1021/i300013a004
   Robic A, 2008, CARBOHYD POLYM, V74, P344, DOI 10.1016/j.carbpol.2008.02.020
   Robic A, 2009, CARBOHYD POLYM, V77, P206, DOI 10.1016/j.carbpol.2008.12.023
   Robic A, 2009, J PHYCOL, V45, P962, DOI 10.1111/j.1529-8817.2009.00699.x
   Robic A, 2009, BIOPOLYMERS, V91, P652, DOI 10.1002/bip.21195
   Rochet V, 1997, REPROD NUTR DEV, V37, P221, DOI 10.1051/rnd:19970210
   Santo VE, 2009, BIOMACROMOLECULES, V10, P1392, DOI 10.1021/bm8014973
   Santos TC, 2007, J BIOTECHNOL, V132, P218, DOI 10.1016/j.jbiotec.2007.07.497
   Sathivel A, 2008, FOOD CHEM TOXICOL, V46, P3262, DOI 10.1016/j.fct.2008.07.016
   Schijf J, 2010, ENVIRON SCI TECHNOL, V44, P1644, DOI 10.1021/es9029667
   Siddhanta AK, 2001, INDIAN J MAR SCI, V30, P166
   Silva SS, 2011, ACTA BIOMATER, V7, P1166, DOI 10.1016/j.actbio.2010.09.041
   Smit AJ, 2004, J APPL PHYCOL, V16, P245, DOI 10.1023/B:JAPH.0000047783.36600.ef
   Takemura KM, 1986, US Patent, Patent No. [US 4758283, 4758283]
   TAVERNIER M. L., 2008, BIOTECHNOL J, V2, P73
   Toskas G, 2011, CARBOHYD POLYM, V84, P1093, DOI 10.1016/j.carbpol.2010.12.075
   vanRooijen N, 1997, J LEUKOCYTE BIOL, V62, P702
   Warrand J, 2006, FOOD TECHNOL BIOTECH, V44, P355
   Webster EA, 1997, BIOMETALS, V10, P105, DOI 10.1023/A:1018379106700
   Webster EA, 1996, BIOMETALS, V9, P241, DOI 10.1007/BF00817922
   Weisberg E, 2009, COSMETIC DERMATOLOGY, P241
   Wijesekara I, 2011, CARBOHYD POLYM, V84, P14, DOI 10.1016/j.carbpol.2010.10.062
   Williams PA, 2009, STRUCT CHEM, V20, P299, DOI 10.1007/s11224-009-9420-5
   Wong KH, 2000, FOOD CHEM, V71, P475, DOI 10.1016/S0308-8146(00)00175-8
   WOOD CG, 1974, J CHEM EDUC, V51, P449, DOI 10.1021/ed051p449
   Xiong S, 2010, 4 INT C BIOINF BIOM, P1
   YAMAMOTO M, 1980, AGR BIOL CHEM TOKYO, V44, P589, DOI 10.1080/00021369.1980.10863990
   Yang LQ, 2009, CARBOHYD POLYM, V76, P349, DOI 10.1016/j.carbpol.2008.12.015
   Yapo BM, 2011, POLYM REV, V51, P391, DOI 10.1080/15583724.2011.615962
   Yu PZ, 2003, PHARMACOL RES, V48, P543, DOI 10.1016/S1043-6618(03)00215-9
   Zhang HJ, 2008, CARBOHYD POLYM, V71, P428, DOI 10.1016/j.carbpol.2007.06.012
NR 156
TC 41
Z9 42
U1 3
U2 87
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-8971
EI 1573-5176
J9 J APPL PHYCOL
JI J. Appl. Phycol.
PD APR
PY 2013
VL 25
IS 2
BP 407
EP 424
DI 10.1007/s10811-012-9875-4
PG 18
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA 104VG
UT WOS:000316023400007
DA 2018-10-20
ER

PT J
AU Borges, AMG
   Benetoli, LO
   Licinio, MA
   Zoldan, VC
   Santos-Silva, MC
   Assreuy, J
   Pasa, AA
   Debacher, NA
   Soldi, V
AF Borges, A. M. G.
   Benetoli, L. O.
   Licinio, M. A.
   Zoldan, V. C.
   Santos-Silva, M. C.
   Assreuy, J.
   Pasa, A. A.
   Debacher, N. A.
   Soldi, V.
TI Polymer films with surfaces unmodified and modified by non-thermal
   plasma as new substrates for cell adhesion
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly(styrene); Poly(methyl methaaylate); Non-thermal plasma; Cell
   proliferation; L929 fibroblasts
ID DIELECTRIC BARRIER DISCHARGE; PROLIFERATION; DIFFERENTIATION;
   FABRICATION; FIBROBLAST; ADSORPTION; IMPLANTS; ENERGY; ACID)
AB The surface properties of biomaterials, such as wettability, polar group distribution, and topography, play important roles in the behavior of cell adhesion and proliferation. Gaseous plasma discharges are among the most common means to modify the surface of a polymer without affecting its properties. Herein, we describe the surface modification of poly(styrene) (PS) and poly(methyl methacrylate) (PMMA) films using atmospheric pressure plasma processing through exposure to a dielectric barrier discharge (DBD). After treatment the film surface showed significant changes from hydrophobic to hydrophilic as the water contact angle decreasing from 95 degrees to 37 degrees. All plasma-treated films developed more hydrophilic surfaces compared to untreated films, although the reasons for the change in the surface properties of PS and PMMA differed, that is, the PS showed chemical changes and in the case of PMMA they were topographical. Excellent adhesion and cell proliferation were observed in all films. In vitro studies employing flow cytometry showed that the proliferation of L929 cells was higher in the film formed by a 1:1 mixture of PS/PMMA, which is consistent with the results of a previous study. These findings suggest better adhesion of L929 onto the 1:1 PS/PMMA modified film, indicating that this system is a new candidate biomaterial for tissue engineering. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Borges, A. M. G.; Benetoli, L. O.; Debacher, N. A.; Soldi, V.] Univ Fed Santa Catarina, Dept Chem, BR-88040900 Florianopolis, SC, Brazil.
   [Licinio, M. A.; Santos-Silva, M. C.] Univ Fed Santa Catarina, Dept Clin Anal, BR-88040900 Florianopolis, SC, Brazil.
   [Zoldan, V. C.; Pasa, A. A.] Univ Fed Santa Catarina, Dept Phys, BR-88040900 Florianopolis, SC, Brazil.
   [Assreuy, J.] Univ Fed Santa Catarina, Dept Pharmacol, BR-88040900 Florianopolis, SC, Brazil.
RP Soldi, V (reprint author), Univ Fed Santa Catarina, Dept Chem, BR-88040900 Florianopolis, SC, Brazil.
EM vsoldi@pq.cnpq.br
RI Santos-Silva, Maria/N-6564-2013; Benetoli, Luis Otavio/C-2791-2013;
   Debacher, Nito/B-2154-2016; Catalise, Inct/K-2293-2013; Pasa,
   Andre/A-4720-2008
OI Santos-Silva, Maria/0000-0003-3916-6473; Benetoli, Luis
   Otavio/0000-0001-9968-0234; Debacher, Nito/0000-0002-8809-8457; Pasa,
   Andre/0000-0002-8046-1207
FU CNPq; CAPES; FAPESC; FINEP; INES; UFSC
FX Financial support was provided by CNPq, CAPES, FAPESC, FINEP, INES and
   UFSC. The authors are particularly thankful to Giuseppe Z. Sampaio, from
   the Department of Mechanical Engineering, UFSC, for his help in contact
   angle measurements. Martinho Rau, from the Department of Chemistry,
   UFSC, is also acknowledged for his help in conducting experimental
   design. The authors are also grateful to the staff at INEP, Department
   of Electrical Engineering, represented by Prof Arnaldo J. Perin, UFSC,
   for helping with the measurement of electrical properties.
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   Artzi N, 2011, ACTA BIOMATER, V7, P67, DOI 10.1016/j.actbio.2010.07.008
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Barbanti S.H., 2001, ARTIF ORGANS, V25, P7
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Benetoli LOD, 2011, J BRAZIL CHEM SOC, V22, P1669, DOI 10.1590/S0103-50532011000900008
   Cheng N, 2010, J COLLOID INTERF SCI, V348, P71, DOI 10.1016/j.jcis.2010.04.032
   Criswell KA, 2003, MUTAT RES-FUND MOL M, V528, P1, DOI 10.1016/S0027-5107(03)00077-0
   Cui NY, 2005, SURF COAT TECH, V192, P94, DOI 10.1016/j.surfcoat.2004.03.006
   D'Sa RA, 2010, ACTA BIOMATER, V6, P2609, DOI 10.1016/j.actbio.2010.01.015
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dekeyser CM, 2004, POLYMER, V45, P2211, DOI 10.1016/j.polymer.2004.01.045
   Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001
   Dunkers JP, 2011, ACTA BIOMATER, V7, P2902, DOI 10.1016/j.actbio.2011.04.005
   Esposito A.R., 2007, REV MAT, V12, P164
   Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024
   Fujii S, 2009, LANGMUIR, V25, P9759, DOI 10.1021/la901100z
   Geng YJ, 1998, EUR J CELL BIOL, V77, P294, DOI 10.1016/S0171-9335(98)80088-5
   He B, 2004, BIOMATERIALS, V25, P5239, DOI 10.1016/j.biomaterials.2003.12.030
   Horcas I., 2007, REV SCI INSTRUM, V78
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Keen I, 2006, BIOMACROMOLECULES, V7, P427, DOI 10.1021/bm050497a
   Lee HU, 2009, CURR APPL PHYS, V9, P219, DOI 10.1016/j.cap.2008.01.014
   Liu CZ, 2008, J BIONIC ENG, V5, P204, DOI 10.1016/S1672-6529(08)60026-8
   MELO AD, 2009, J BRAZIL CHEM SOC, V20, P1753
   Ou WF, 2011, BIOMATERIALS, V32, P3178, DOI 10.1016/j.biomaterials.2011.01.031
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Ping XA, 2011, RADIAT PHYS CHEM, V80, P567, DOI 10.1016/j.radphyschem.2010.12.011
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Shimizu RN, 2000, J APPL POLYM SCI, V76, P1831, DOI 10.1002/(SICI)1097-4628(20000620)76:12<1831::AID-APP14>3.0.CO;2-Q
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Sohn EH, 2011, J COLLOID INTERF SCI, V354, P650, DOI 10.1016/j.jcis.2010.10.068
   Upadhyay DJ, 2005, J PHYS D APPL PHYS, V38, P922, DOI 10.1088/0022-3727/38/6/022
   Woodcock SE, 2005, J COLLOID INTERF SCI, V292, P99, DOI 10.1016/j.jcis.2005.05.059
   Wu S., 1971, J POLYM SCI C, V34, P19, DOI DOI 10.1002/POLC.5070340105
   Zhu X, 2005, J BIOMED MATER RES A, V73A, P264, DOI 10.1002/jbm.a.30211
NR 37
TC 22
Z9 23
U1 1
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2013
VL 33
IS 3
BP 1315
EP 1324
DI 10.1016/j.msec.2012.12.031
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 101CA
UT WOS:000315751600042
PM 23827577
DA 2018-10-20
ER

PT J
AU Carreon, H
   Barriuso, S
   Lieblich, M
   Gonzalez-Carrasco, JL
   Jimenez, JA
   Caballero, FG
AF Carreon, H.
   Barriuso, S.
   Lieblich, M.
   Gonzalez-Carrasco, J. L.
   Jimenez, J. A.
   Caballero, F. G.
TI Significance of the contacting and no contacting thermoelectric power
   measurements applied to grit blasted medical Ti6Al4V
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Grit blasting; Thermoelectric measurements; Residual stresses;
   Biomaterial; Titanium alloy
ID STAINLESS-STEEL IMPLICATIONS; SEVERE PLASTIC-DEFORMATION;
   MECHANICAL-PROPERTIES; CORROSION BEHAVIOR; RESIDUAL-STRESSES; ALLOY;
   MICROSTRUCTURE; TI-6AL-4V
AB Grit blasting is a surface plastic deformation technique aimed to increase the surface area available for bone/implant apposition, which contributes to improve fixation and mechanical stability of Ti-6Al-4V implants. Besides roughening, grit blasting also causes surface contamination with embedded grit particles and subtle subsurface microstructural changes that, although does not challenge their biocompatibility, might influence other surface dominated properties like corrosion and ion release. Additional benefits are expected due to the induced compressive residual stresses, hence enhancing fatigue strength. The net effect depends on the type of particles used for blasting, but also on the amount of the subsurface cold work associated to the severe surface plastic deformation. In this work we study the potential of the non-contacting and contacting thermoelectric power (TEP) measurements in the analysis of the global changes induced in the Ti6Al4V when blasting the alloy with Al2O3 or ZrO2 particles, which yields a coarse and a fine rough surface, respectively. To reveal the effect of residual stresses, a set of specimens were thermally treated. The study proves that the non-contacting technique is more sensitive to the presence of residual stresses, whereas the contact technique is strongly influenced by the grain size refinements, work hardening and changes in solute. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Carreon, H.] Inst Invest Met UMSNH IIM, Morelia, Michoacan, Mexico.
   [Barriuso, S.; Lieblich, M.; Gonzalez-Carrasco, J. L.; Jimenez, J. A.; Caballero, F. G.] Ctr Nacl Invest Met CENIM CSIC, E-28040 Madrid, Spain.
   [Gonzalez-Carrasco, J. L.] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Madrid, Spain.
RP Carreon, H (reprint author), Inst Invest Met UMSNH IIM, Ciudad Univ, Morelia, Michoacan, Mexico.
EM hcarreon@umich.mx
RI CABALLERO, FRANCISCA/A-4292-2008; Jimenez, Jose/H-2644-2015
OI Jimenez, Jose/0000-0003-4272-6873; Lieblich,
   Marcela/0000-0003-1887-1480; Caballero, Francisca/0000-0002-5548-7659;
   Gonzalez-Carrasco, Jose Luis/0000-0003-2004-4505; CARREON,
   HECTOR/0000-0002-4803-0650
FU CONACYT (Mexico) [CB-80883, MAT2009-14695-C04]; CONACYT (Mexico)
FX This work was performed at UMSNH (Mexico) and CENIM-CSIC (Spain) with a
   partial funding from CONACYT (Mexico) under project CB-80883 and
   MAT2009-14695-C04. The author H. Carreon wishes to thank CONACYT
   (Mexico) for the financial support during the sabbatical in CENIM-CSIC
   and S. Barriuso for the JAEPre082-3 of CSIC-UE.
CR Altenberger I, 1999, MAT SCI ENG A-STRUCT, V264, P1, DOI 10.1016/S0921-5093(98)01121-6
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Barranco V., 2001, ACTA BIOMATER, V7, P2716
   Boyer E., 1994, MAT PROPERTIES HDB T, P606
   BUNDY FP, 1961, J APPL PHYS, V32, P483, DOI 10.1063/1.1736029
   Caballero FG, 2004, SCRIPTA MATER, V50, P1061, DOI 10.1016/j.scriptamat.2003.12.017
   Carabajar S, 2000, MAT SCI ENG A-STRUCT, V281, P132, DOI 10.1016/S0921-5093(99)00737-6
   Carreon H, 2012, SURF COAT TECH, V206, P2941, DOI 10.1016/j.surfcoat.2011.12.026
   Carreon H, 2006, NDT&E INT, V39, P433, DOI 10.1016/j.ndteint.2006.01.001
   Ferrer JP, 2007, ACTA MATER, V55, P2075, DOI 10.1016/j.actamat.2006.11.010
   Frutos E, 2010, ACTA MATER, V58, P4191, DOI 10.1016/j.actamat.2010.04.010
   Galvan JC, 2012, J MATER SCI-MATER M, V23, P657, DOI 10.1007/s10856-012-4549-y
   Garcia-Alonso MC, 2000, BIOMATERIALS, V21, P79, DOI 10.1016/S0142-9612(99)00142-8
   Henry E. B., 1995, NONDESTRUCTIVE TESTI, V9, P363
   Hu JT, 1998, APPL PHYS LETT, V73, P467, DOI 10.1063/1.121902
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   Kawaguchi Y, 2002, J ALLOY COMPD, V336, P301, DOI 10.1016/S0925-8388(01)01897-7
   Kourov NI, 2007, PHYS MET METALLOGR+, V103, P270, DOI 10.1134/S0031918X07030076
   Maslov K, 2001, MATER EVAL, V59, P1081
   Multigner M, 2010, SURF COAT TECH, V205, P1830, DOI 10.1016/j.surfcoat.2010.07.126
   Multigner M, 2009, MAT SCI ENG C-BIO S, V29, P1357, DOI 10.1016/j.msec.2008.11.002
   Multigner M, 2009, SURF COAT TECH, V203, P2036, DOI 10.1016/j.surfcoat.2009.02.003
   Multigner M, 2009, REV METAL MADRID, V45, P52, DOI 10.3989/revmetalm.0803
   Nayfeh AH, 2002, J APPL PHYS, V91, P225, DOI 10.1063/1.1416852
   Ney J., 1998, METALL T A, V29, P2669
   ROWE VA, 1970, J PHYS CHEM SOLIDS, V31, P1, DOI 10.1016/0022-3697(70)90282-9
   Saldana L, 2007, J BIOMED MATER RES A, V81A, P334, DOI 10.1002/jbm.a.30994
   Stuart C. M., 1983, INT ADV NONDESTRUCTI, V9, P177
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
NR 29
TC 12
Z9 13
U1 0
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2013
VL 33
IS 3
BP 1417
EP 1422
DI 10.1016/j.msec.2012.12.045
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 101CA
UT WOS:000315751600055
PM 23827590
DA 2018-10-20
ER

PT J
AU Pacha-Olivenza, MA
   Gallardo-Moreno, AM
   Vadillo-Rodriguez, V
   Gonzalez-Martin, ML
   Perez-Giraldo, C
   Galvan, JC
AF Pacha-Olivenza, Miguel A.
   Gallardo-Moreno, Amparo M.
   Vadillo-Rodriguez, Virginia
   Luisa Gonzalez-Martin, M.
   Perez-Giraldo, Ciro
   Galvan, Juan C.
TI Electrochemical analysis of the UV treated bactericidal Ti6Al4V surfaces
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ti6Al4V; Ultraviolet; EIS; Potentiodynamic polarization plots;
   Mott-Schottky curves
ID DENTAL IMPLANT APPLICATIONS; SIMULATED BODY-FLUID; IMPEDANCE
   SPECTROSCOPY; CORROSION BEHAVIOR; TIO2 FILMS; TITANIUM-DIOXIDE; PASSIVE
   FILM; ALLOYS; TI-6AL-4V; EIS
AB This research investigates in detail the bactericidal effect exhibited by the surface of the biomaterial Ti6Al4V after being subjected to UV-C light. It has been recently hypothesized that small surface currents, occurring as a consequence of the electron-hole pair recombination taking place after the excitation process, are behind the bactericidal properties displayed by this UV-treated material. To corroborate this hypothesis we have used different electrochemical techniques, such as electrochemical impedance spectroscopy (EIS), potentiodynamic polarization plots and Mott-Schottky plots. EIS and Mott-Schottky plots have shown that UV-C treatment causes an initial increase on the surface electrical conduction of this material. In addition, EIS and polarization plots demonstrated that higher corrosion currents occur at the UV treated than at the non-irradiated samples. Despite this increase in the corrosion currents, EIS has also shown that such currents are not likely to affect the good stability of this material oxide film since the irradiated samples completely recovered the control values after being stored in dark conditions for a period not longer than 24 h. These results agree with the already-published in vitro transitory behavior of the bactericidal effect, which was shown to be present at initial times after the biomaterial implantation, a crucial moment to avoid a large number of biomaterial associated infections. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Pacha-Olivenza, Miguel A.; Gallardo-Moreno, Amparo M.; Vadillo-Rodriguez, Virginia; Luisa Gonzalez-Martin, M.] Networking Res Ctr Bioengn Biomat & Neuromed, Zaragoza, Spain.
   [Pacha-Olivenza, Miguel A.; Gallardo-Moreno, Amparo M.; Vadillo-Rodriguez, Virginia; Luisa Gonzalez-Martin, M.] Univ Extremadura, Dept Appl Phys, Badajoz 06071, Spain.
   [Galvan, Juan C.] CSIC, Natl Ctr Met Res, CENIM, E-28040 Madrid, Spain.
   [Perez-Giraldo, Ciro] Univ Extremadura, Dept Microbiol, Fac Med, E-06071 Badajoz, Spain.
RP Gallardo-Moreno, AM (reprint author), Univ Extremadura, Dept Appl Phys, Av Elvas S-N, Badajoz 06071, Spain.
EM amparogm@unex.es
RI Galvan, Juan Carlos/B-9751-2011; Gonzalez Martin, Maria
   Luisa/L-3476-2014; Vadillo-Rodriguez, Virginia/I-3117-2015; Pacha
   Olivenza, Miguel/M-8285-2014
OI Galvan, Juan Carlos/0000-0002-8841-9716; Gonzalez Martin, Maria
   Luisa/0000-0002-9207-444X; Vadillo-Rodriguez,
   Virginia/0000-0002-7329-712X; Pacha Olivenza,
   Miguel/0000-0003-3505-9320; Perez-Giraldo, Ciro/0000-0002-2358-1982
FU Ministerio de Ciencia e Innovacion [MAT2009-14695-004-01]; Junta de
   Extremadura [GRU10149]; FEDER; "Consejeria de Economia, Comercio e
   Innovacion" of the "junta de Extremadura" [GR10031]
FX This work was supported by grant MAT2009-14695-004-01 from the
   "Ministerio de Ciencia e Innovacion", GRU10149 from "Junta de
   Extremadura", and FEDER, grant GR10031 from the "Consejeria de Economia,
   Comercio e Innovacion" of the "Junta de Extremadura".
CR Alves VA, 2009, CORROS SCI, V51, P2473, DOI 10.1016/j.corsci.2009.06.035
   Antunes R.A., 2011, MATER CORROS, V62, P1
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Bao YS, 2008, ELECTROCHIM ACTA, V54, P611, DOI 10.1016/j.electacta.2008.07.041
   Baram N, 2010, J PHYS CHEM C, V114, P9781, DOI 10.1021/jp911687w
   Baron A., 2007, J ACHIEV MAT MANUF E, V21, P23
   Baumanis C, 2008, J PHYS CHEM C, V112, P19097, DOI 10.1021/jp807655a
   Bozzini B, 2008, J MATER SCI-MATER M, V19, P3443, DOI 10.1007/s10856-008-3487-1
   Byrne JA, 1998, APPL CATAL B-ENVIRON, V17, P25, DOI 10.1016/S0926-3373(97)00101-X
   Demetrescu I, 2010, BIOELECTROCHEMISTRY, V79, P122, DOI 10.1016/j.bioelechem.2010.02.001
   Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4
   Gallardo A.M., 2008, ACTA BIOMATER, V5, P181
   Gallardo-Moreno AM, 2010, BIOMATERIALS, V31, P5159, DOI 10.1016/j.biomaterials.2010.03.005
   Gaswami DY, 1997, J SOL ENERGY ENG, V119, P92
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Grosgogeat B, 2004, BIO-MED MATER ENG, V14, P323
   Hagfeldt A, 1996, J PHYS CHEM-US, V100, P8045, DOI 10.1021/jp9518567
   Harrington SP, 2008, J ELECTROCHEM SOC, V155, P381
   Hsu CH, 2001, CORROSION, V57, P747, DOI 10.5006/1.3280607
   Huang Y, 2010, MATER CORROS, V61, P302, DOI 10.1002/maco.200905385
   Ibris N, 2002, J ELECTROANAL CHEM, V526, P53, DOI 10.1016/S0022-0728(02)00814-8
   Kim B, 2003, CHEMOSPHERE, V52, P277, DOI 10.1016/S0045-6535(03)00051-1
   Lee JB, 2010, MATER CHEM PHYS, V122, P194, DOI 10.1016/j.matchemphys.2010.02.033
   Leng WH, 2005, J PHYS CHEM B, V109, P15008, DOI 10.1021/jp051821z
   Li MC, 2005, ELECTROCHIM ACTA, V50, P3401, DOI 10.1016/j.electacta.2004.12.031
   Liu HL, 2003, PROCESS BIOCHEM, V39, P475, DOI 10.1016/S0032-9592(03)00084-0
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Maneerat C, 2006, INT J FOOD MICROBIOL, V107, P99, DOI 10.1016/j.ijfoodmicro.2005.08.018
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Mindroiu M, 2010, ELECTROCHIM ACTA, V56, P193, DOI 10.1016/j.electacta.2010.08.100
   Mogoda S.A., 2004, J APPL ELECTROCHEM, V34, P873
   Nelson BP, 2000, LANGMUIR, V16, P6094, DOI 10.1021/la9911584
   Ningshen S, 2009, ELECTROCHIM ACTA, V54, P6374, DOI 10.1016/j.electacta.2009.06.003
   Nonami T, 2004, CATAL TODAY, V96, P113, DOI 10.1016/j.cattod.2004.06.112
   Pacha-Olivenza MA, 2008, J COLLOID INTERF SCI, V320, P117, DOI 10.1016/j.jcis.2007.11.060
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Paszenda Z., 2010, J ACHIEV MAT MANUFAC, V38, P24
   Paul S, 2011, J MATER ENG PERFORM, V20, P422, DOI 10.1007/s11665-010-9691-4
   Pedraza-Avella JA, 2008, CATAL TODAY, V133, P611, DOI 10.1016/j.cattod.2007.12.063
   Princeton N.J., 1989, AC1 EG G PRINC APPL
   Schiff N, 2004, BIOMATERIALS, V25, P4535, DOI 10.1016/j.biomaterials.2003.11.042
   Schmuki P., 1993, J ELECTROCHEM SOC, V140, P119
   Shukla AK, 2005, INTERMETALLICS, V13, P631, DOI 10.1016/j.intermet.2004.10.001
   Spagnol V, 2009, ELECTROCHIM ACTA, V54, P1228, DOI 10.1016/j.electacta.2008.08.070
   STERN M, 1957, J ELECTROCHEM SOC, V104, P56, DOI 10.1149/1.2428496
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Taveira L.V., 2008, J ELECTROCHEM SOC, V155, P293
   Tsuchiya H, 2007, CORROS SCI, V49, P203, DOI 10.1016/j.corsci.2006.05.009
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   VOROS J, 2001, TITANIUM MED, P87
   Wang DA, 2008, J PHYS CHEM C, V112, P16123, DOI 10.1021/jp8063323
   Wang M., 2010, MATER CORROS, V62, P320
   Xu JA, 2011, ELECTROCHEM COMMUN, V13, P102, DOI 10.1016/j.elecom.2010.11.028
   Zhang XL, 2009, CORROS SCI, V51, P581, DOI 10.1016/j.corsci.2008.12.005
   Zhou H, 2006, BIOELECTROCHEMISTRY, V69, P34, DOI 10.1016/j.bioelechem.2005.10.003
NR 55
TC 9
Z9 9
U1 6
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2013
VL 33
IS 3
BP 1789
EP 1794
DI 10.1016/j.msec.2012.12.079
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 101CA
UT WOS:000315751600102
PM 23827637
DA 2018-10-20
ER

PT J
AU Pelto, J
   Bjorninen, M
   Palli, A
   Talvitie, E
   Hyttinen, J
   Mannerstrom, B
   Seppanen, RS
   Kellomaki, M
   Miettinen, S
   Haimi, S
AF Pelto, Jani
   Bjorninen, Miina
   Palli, Aliisa
   Talvitie, Elina
   Hyttinen, Jari
   Mannerstrom, Bettina
   Seppanen, Riitta Suuronen
   Kellomaki, Minna
   Miettinen, Susanna
   Haimi, Suvi
TI Novel Polypyrrole-Coated Polylactide Scaffolds Enhance Adipose Stem Cell
   Proliferation and Early Osteogenic Differentiation
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CURRENT ELECTRIC-FIELDS; CHONDROITIN SULFATE; STROMAL CELLS; CONDUCTING
   POLYMERS; NEURITE OUTGROWTH; BIOACTIVE GLASS; MUSCLE-CELLS; FREE
   CULTURE; SERUM-FREE; IN-VITRO
AB An electrically conductive polypyrrole (PPy) doped with a bioactive agent is an emerging functional biomaterial for tissue engineering. We therefore used chondroitin sulfate (CS)-doped PPy coating to modify initially electrically insulating polylactide resulting in novel osteogenic scaffolds. In situ chemical oxidative polymerization was used to obtain electrically conductive PPy coating on poly-96L/4D-lactide (PLA) nonwoven scaffolds. The coated scaffolds were characterized and their electrical conductivity was evaluated in hydrolysis. The ability of the coated and conductive scaffolds to enhance proliferation and osteogenic differentiation of human adipose stem cells (hASCs) under electrical stimulation (ES) in three-dimensional (3D) geometry was compared to the noncoated PLA scaffolds. Electrical conductivity of PPy-coated PLA scaffolds (PLA-PPy) was evident at the beginning of hydrolysis, but decreased during the first week of incubation due to de-doping. PLA-PPy scaffolds enhanced hASC proliferation significantly compared to the plain PLA scaffolds at 7 and 14 days. Furthermore, the alkaline phosphatase (ALP) activity of the hASCs was generally higher in PLA-PPy seeded scaffolds, but due to patient variation, no statistical significance could be determined. ES did not have a significant effect on hASCs. This study highlights the potential of novel PPy-coated PLA scaffolds in bone tissue engineering.
C1 [Pelto, Jani] VTT Tech Res Ctr Finland, Tampere, Finland.
   [Bjorninen, Miina; Palli, Aliisa; Mannerstrom, Bettina; Miettinen, Susanna; Haimi, Suvi] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.
   [Bjorninen, Miina; Palli, Aliisa; Mannerstrom, Bettina; Miettinen, Susanna; Haimi, Suvi] Pirkanmaa Hosp Dist, Ctr Sci, Tampere, Finland.
   [Bjorninen, Miina; Palli, Aliisa; Talvitie, Elina; Hyttinen, Jari; Mannerstrom, Bettina; Seppanen, Riitta Suuronen; Kellomaki, Minna; Miettinen, Susanna; Haimi, Suvi] BioMediTech, Tampere, Finland.
   [Talvitie, Elina; Hyttinen, Jari; Seppanen, Riitta Suuronen; Kellomaki, Minna] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland.
   [Seppanen, Riitta Suuronen] Tampere Univ Hosp, Dept Eye Ear & Oral Dis, Tampere, Finland.
   [Haimi, Suvi] Univ Twente, Dept Biomat Sci & Technol, NL-7500 AE Enschede, Netherlands.
RP Haimi, S (reprint author), Univ Twente, Dept Biomat Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.
EM suvi.haimi@uta.fi
RI Hyttinen, Jari/G-4280-2014; Mannerstrom, Bettina/F-4002-2016; Haimi,
   Suvi/D-4966-2014; Kellomaki, Minna/G-6190-2010
OI Hyttinen, Jari/0000-0003-1850-3055; Mannerstrom,
   Bettina/0000-0001-9316-5581; Haimi, Suvi/0000-0001-8467-0252; Kellomaki,
   Minna/0000-0003-4321-1820; Miettinen, Susanna/0000-0002-0647-9556
FU Finnish Funding Agency for Technology and Innovation (TEKES); Academy of
   Finland; Competitive Research Funding of Tampere University Hospital
   [9K020]
FX The authors would like to thank Ms. Anne Rajala M.Sc, Ms. Ana Luisa
   Delgado Lima, and Ms. Hanna Juhola for the preparation and hydrolytic
   testing of the scaffolds, Ms. Anna-Maija Honkala and Ms. Minna Salomaki
   M.Sc for their assistance in the cell culture work. This study was
   financially supported by the Finnish Funding Agency for Technology and
   Innovation (TEKES), the Academy of Finland and the Competitive Research
   Funding of Tampere University Hospital (grant 9K020).
CR Andersson SR, 2010, BIOMACROMOLECULES, V11, P1067, DOI 10.1021/bm100029t
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   Blinova NV, 2007, EUR POLYM J, V43, P2331, DOI 10.1016/j.eurpolymj.2007.03.045
   Cronin EM, 2004, J BIOMED MATER RES A, V69A, P373, DOI 10.1002/jbm.a.30009
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   du Souich P, 2009, J CELL MOL MED, V13, P1451, DOI 10.1111/j.1582-4934.2009.00826.x
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Grzesik WJ, 2002, J BIOL CHEM, V277, P43638, DOI 10.1074/jbc.M202124200
   Haimi S, 2009, J BIOMED MATER RES A, V91A, P540, DOI 10.1002/jbm.a.32233
   Hammerick KE, 2010, TISSUE ENG PT A, V16, P917, DOI [10.1089/ten.tea.2009.0267, 10.1089/ten.TEA.2009.0267]
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   Jiang T, 2010, J BIOMED MATER RES A, V93A, P1193, DOI 10.1002/jbm.a.32615
   Kang SK, 2004, STEM CELLS, V22, P1356, DOI 10.1634/stemcells.2004-0023
   Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627
   Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081
   Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065
   Manton KJ, 2007, J MOL HISTOL, V38, P415, DOI 10.1007/s10735-007-9121-6
   Marino G, 2010, J MATER SCI-MATER M, V21, P353, DOI 10.1007/s10856-009-3840-z
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1377, DOI [10.1089/ten.tec.2009.0751, 10.1089/ten.TEC.2009.0751]
   Meng SY, 2011, J BONE MINER METAB, V29, P535, DOI 10.1007/s00774-010-0257-1
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Niemela T, 2005, ACTA BIOMATER, V1, P235, DOI [10.1016/j.actbio.2004.11.002, 10.1016/j.actbio.2004.11002]
   Parker AM, 2007, CYTOTHERAPY, V9, P637, DOI 10.1080/14653240701508452
   Pelto J, 2010, J BIOMED MATER RES A, V93A, P1056, DOI 10.1002/jbm.a.32603
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Rowlands AS, 2008, BIOMATERIALS, V29, P4510, DOI 10.1016/j.biomaterials.2008.07.052
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Schneiders W, 2008, J BIOMED MATER RES A, V85A, P638, DOI 10.1002/jbm.a.31611
   Shi GX, 2008, BIOMATERIALS, V29, P3792, DOI 10.1016/j.biomaterials.2008.06.010
   Shi GX, 2008, J BIOMED MATER RES A, V84A, P1026, DOI 10.1002/jbm.a.31337
   Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com
   Tandon N, 2009, IEEE ENG MED BIO, P6517, DOI 10.1109/IEMBS.2009.5333142
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Wolszczak M, 1995, RADIAT PHYS CHEM, V1, P78
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
NR 39
TC 39
Z9 41
U1 1
U2 90
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2013
VL 19
IS 7-8
BP 882
EP 892
DI 10.1089/ten.tea.2012.0111
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 103WZ
UT WOS:000315951500007
PM 23126228
OA Green Published
DA 2018-10-20
ER

PT J
AU Thomson, KS
   Korte, FS
   Giachelli, CM
   Ratner, BD
   Regnier, M
   Scatena, M
AF Thomson, Kassandra S.
   Korte, F. Steven
   Giachelli, Cecilia M.
   Ratner, Buddy D.
   Regnier, Michael
   Scatena, Marta
TI Prevascularized Microtemplated Fibrin Scaffolds for Cardiac Tissue
   Engineering Applications
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID EMBRYONIC STEM-CELLS; ENDOTHELIAL-CELLS; MUSCLE TISSUE; FACTOR-XIII;
   NEOVASCULARIZATION; MYOCARDIUM; CLOT; TRANSPLANTATION; ANGIOGENESIS;
   REGENERATION
AB Myocardial infarction (MI) causes significant cell loss and damage to myocardium. Cell-based therapies for treatment of MI aim to remuscularize the resultant scar tissue, but the majority of transplanted cells do not survive or integrate with the host tissue. Scaffolds can improve cell retention following construct implantation, but often do little to enhance host-graft integration and/or show limited biodegradation. Fibrin is an ideal biomaterial for cardiac tissue engineering as it is a natural, biodegradable polymer that can induce neovascularization, promote cell attachment, and has tunable mechanical properties. Here we describe a novel, high-density microtemplated fibrin scaffold seeded with a tri-cell mixture of cardiomyocytes, endothelial cells (ECs), and fibroblasts to mimic native cardiac tissue in structure and cellular composition to improve cell retention and promote integration with the host tissue. Scaffolds were designed with uniform architecture of parallel 60 mu m microchannels surrounded by an interconnected microporous network of 27-mu m-diameter pores and mechanical stiffness comparable to native cardiac tissues (70-90kPa). Scaffold degradation was controlled with the addition of Factor XIII (FXIII) and/or protease inhibitor (aprotinin). Unmodified scaffolds had a fast degradation profile both in vitro (19.9 +/- 3.9% stiffness retention after 10 days) and in vivo. Scaffolds treated with FXIII showed an intermediate degradation profile in vitro (45.8% +/- 5.9%), while scaffolds treated with aprotinin or both FXIII and aprotinin showed significantly slowed degradation in vitro (60.9% +/- 5.2% and 76.4% +/- 7.6%, respectively, p < 0.05). Acellular aprotinin scaffold myocardial implants showed decreased collagen deposition after 7 days. Unmodified and aprotinin implants could not be located by 14 days, while 2 of 8 FXIII implants were found, but were significantly degraded. Constructs supported seeded cell survival and organization in vitro, promoting EC-lined lumen structure formation in construct channels and colocalization of viable ECs and cardiomyocytes. In addition, constructs promoted extracellular matrix deposition by seeded cells, as shown by collagen staining within construct channels and by significant increases in construct stiffness over 10 days in vitro (209% +/- 32%, p < 0.05). The data suggest our fibrin scaffolds are ideally designed to promote graft cell survival and organization, thus improving chances of promoting construct integration with the host tissue upon implantation.
C1 [Thomson, Kassandra S.; Korte, F. Steven; Giachelli, Cecilia M.; Ratner, Buddy D.; Regnier, Michael; Scatena, Marta] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Giachelli, Cecilia M.; Regnier, Michael; Scatena, Marta] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.
   [Ratner, Buddy D.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Scatena, M (reprint author), Univ Washington, Dept Bioengn, Box 358056,UW Med South Lake Union Campus,S176, Seattle, WA 98195 USA.
EM mscatena@u.washington.edu
FU National Science Foundation; American Heart Association; NIH NHLBI
   [5R01HL064387]
FX The authors sincerely thank Sarah Dupras for performing animal implant
   surgeries, Galina Flint for performing cell isolations, Maria Razumova
   for instruction in mechanical testing, Veronica Muskheli, Kareen
   Kreutziger, Nathaniel Tulloch, and Christopher Hargrave for assistance
   with histology, Michael Linnes, Lauran Madden, and Derek Mortisen for
   instruction in scaffold construction, and Nathanial Tulloch, Anthony
   Rodriguez, Scott Lundy, Gabrielle Robinson, and Claire McLeod for useful
   discussions. This work was supported by a National Science Foundation
   Graduate Research Fellowship (K. S. T.), an award from the American
   Heart Association (K. S. T.), and by a NIH NHLBI grant 5R01HL064387
   (M.R., M.S., B.D.R.).
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Akpalo E, 2011, ACTA BIOMATER, V7, P2418, DOI 10.1016/j.actbio.2011.03.002
   Bagoly Z, 2012, THROMB RES, V129, P382, DOI 10.1016/j.thromres.2011.11.040
   Barsotti MC, 2011, BIOTECHNOL APPL BIOC, V58, P301, DOI 10.1002/bab.49
   BRAUKER J, 1992, TRANSPLANT P, V24, P2924
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Bull DA, 2003, ANN THORAC SURG, V75, pS735, DOI 10.1016/S0003-4975(02)04702-1
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chekanov V, 2003, PACE, V26, P496, DOI 10.1046/j.1460-9592.2003.00080.x
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107
   Galperin A, 2010, BIOMACROMOLECULES, V11, P2583, DOI 10.1021/bm100521x
   Gillis TE, 2007, J PHYSIOL-LONDON, V580, P561, DOI 10.1113/jphysiol.2007.128975
   Giraud MN, 2008, ARTIF ORGANS, V32, P692, DOI 10.1111/j.1525-1594.2008.00595.x
   Hickerson WL, 2011, BLOOD COAGUL FIBRIN, V22, P19, DOI 10.1097/MBC.0b013e32833fcbfb
   Huang YC, 2007, J BIOMED MATER RES A, V80A, P719, DOI 10.1002/jbm.a.31090
   Hurley JR, 2010, AM J PHYSIOL-CELL PH, V299, pC444, DOI 10.1152/ajpcell.00572.2009
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kreutziger K. L., 2007, BIOPHYS J, V92, p477a
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   MARSHALL AJ, 2004, POLYM PREPRINTS, V45, P100
   McEvoy MD, 2007, ANESTH ANALG, V105, P949, DOI 10.1213/01.ane.0000281936.04102.9f
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83
   Moreno-Gonzalez A, 2009, J MOL CELL CARDIOL, V47, P603, DOI 10.1016/j.yjmcc.2009.07.030
   Rodriguez AG, 2011, BIOPHYS J, V101, P2455, DOI 10.1016/j.bpj.2011.09.057
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036
   Standeven KF, 2007, BLOOD, V110, P902, DOI 10.1182/blood-2007-01-066837
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Stevens KR, 2009, TISSUE ENG PT A, V15, P1211, DOI 10.1089/ten.tea.2008.0151
   TAKEI A, 1995, IN VITRO CELL DEV-AN, V31, P467
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
NR 37
TC 29
Z9 30
U1 3
U2 46
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2013
VL 19
IS 7-8
BP 967
EP 977
DI 10.1089/ten.tea.2012.0286
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 103WZ
UT WOS:000315951500014
PM 23317311
OA Green Published
DA 2018-10-20
ER

PT J
AU Zustiak, SP
   Wei, YQ
   Leach, JB
AF Zustiak, Silviya P.
   Wei, Yunqian
   Leach, Jennie B.
TI Protein-Hydrogel Interactions in Tissue Engineering: Mechanisms and
   Applications
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID ENDOTHELIAL GROWTH-FACTOR; POLY(ETHYLENE GLYCOL) HYDROGELS; SUBSEQUENT
   TRIGGERED RELEASE; COLLAGEN-BASED COMPOSITE; NEURAL STEM-CELLS;
   HYALURONIC-ACID; AFFINITY-BINDING; FACTOR DELIVERY; SURFACE
   IMMOBILIZATION; ALGINATE BIOMATERIAL
AB Recent advances in our understanding of the sophistication of the cellular microenvironment and the dynamics of tissue remodeling during development, disease, and regeneration have increased our appreciation of the current challenges facing tissue engineering. As this appreciation advances, we are better equipped to approach problems in the biology and therapeutics of even more complex fields, such as stem cells and cancer. To aid in these studies, as well as the established areas of tissue engineering, including cardiovascular, musculoskeletal, and neural applications, biomaterials scientists have developed an extensive array of materials with specifically designed chemical, mechanical, and biological properties. Herein, we highlight an important topic within this area of biomaterials research, protein-hydrogel interactions. Due to inherent advantages of hydrated scaffolds for soft tissue engineering as well as specialized bioactivity of proteins and peptides, this field is well-posed to tackle major needs within emerging areas of tissue engineering. We provide an overview of the major modes of interactions between hydrogels and proteins (e.g., weak forces, covalent binding, affinity binding), examples of applications within growth factor delivery and three-dimensional scaffolds, and finally future directions within the area of hydrogel-protein interactions that will advance our ability to control the cell-biomaterial interface.
C1 [Zustiak, Silviya P.] NICHHD, NIH, Bethesda, MD 20892 USA.
   [Wei, Yunqian; Leach, Jennie B.] Univ Maryland, Dept Chem Biochem & Environm Engn, Baltimore, MD 21250 USA.
RP Leach, JB (reprint author), Univ Maryland, Dept Chem Biochem & Environm Engn, Eng 314,1000 Hilltop Circle, Baltimore, MD 21250 USA.
EM jleach@umbc.edu
FU Intramural Research Program of The Eunice Kennedy Shriver National
   Institute of Child Health and Human Development, NIH
FX We acknowledge NIH-NINDS R01NS065205 and funds from the Intramural
   Research Program of The Eunice Kennedy Shriver National Institute of
   Child Health and Human Development, NIH for supporting this work.
CR Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Annabi N, 2011, BIOMATERIALS, V32, P1517, DOI 10.1016/j.biomaterials.2010.10.024
   Backer MV, 2006, BIOMATERIALS, V27, P5452, DOI 10.1016/j.biomaterials.2006.06.025
   Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514
   Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Boucher C, 2008, TISSUE ENG PT A, V14, P2069, DOI 10.1089/ten.tea.2008.0037
   Calderon L, 2010, EUR CELLS MATER, V20, P134
   Chen GP, 2004, TISSUE ENG, V10, P323, DOI 10.1089/107632704323061681
   Chen JP, 2010, J NANOSCI NANOTECHNO, V10, P5393, DOI 10.1166/jnn.2010.1945
   Chen PR, 2005, BIOMATERIALS, V26, P6579, DOI 10.1016/j.biomaterials.2005.03.037
   Chien HW, 2012, BIOMATERIALS, V33, P5706, DOI 10.1016/j.biomaterials.2012.04.031
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Conovaloff A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056003
   Cui FY, 2009, BIOMACROMOLECULES, V10, P1253, DOI 10.1021/bm900035u
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005
   Davis HE, 2011, BIOTECHNOL BIOENG, V108, P2727, DOI 10.1002/bit.23227
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Engelhardt EM, 2011, BIOMATERIALS, V32, P3969, DOI 10.1016/j.biomaterials.2011.02.012
   Fernandes S, 2012, CELLS TISSUES ORGANS, V195, P48, DOI 10.1159/000331414
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Giraudier S, 2004, BIOMACROMOLECULES, V5, P1662, DOI 10.1021/bm049670d
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   Hachet E, 2012, BIOMACROMOLECULES, V13, P1818, DOI 10.1021/bm300324m
   Hammouche S, 2012, CURR STEM CELL RES T, V7, P134, DOI 10.2174/157488812799219018
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Hudalla GA, 2011, ADV FUNCT MATER, V21, P1754, DOI 10.1002/adfm.201002468
   Hudalla GA, 2010, LANGMUIR, V26, P6449, DOI 10.1021/la1008208
   Ito Y, 2001, J BIOCHEM-TOKYO, V129, P733, DOI 10.1093/oxfordjournals.jbchem.a002913
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Jeong KJ, 2009, BIOMACROMOLECULES, V10, P1090, DOI 10.1021/bm801270k
   Ji CD, 2011, ACTA BIOMATER, V7, P1653, DOI 10.1016/j.actbio.2010.11.043
   Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0
   Kato K, 2005, LANGMUIR, V21, P7071, DOI 10.1021/la050893e
   Kim M, 2010, BIOMATERIALS, V31, P3596, DOI 10.1016/j.biomaterials.2010.01.068
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Lai VK, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005544
   Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Lee J, 2012, ACTA BIOMATER, V8, P2549, DOI 10.1016/j.actbio.2012.03.030
   Lefler A, 2009, J BIOMAT SCI-POLYM E, V20, P1335, DOI 10.1163/092050609X12457417534295
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718
   Liao SS, 2004, J BIOACT COMPAT POL, V19, P117, DOI 10.1177/0883911504042643
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lin CC, 2008, BIOMACROMOLECULES, V9, P789, DOI 10.1021/bm700940w
   Lin CC, 2008, BIOMACROMOLECULES, V9, P75, DOI 10.1021/bm700782c
   Lin CC, 2007, J BIOMED MATER RES A, V83A, P954, DOI 10.1002/jbm.a.31282
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Lin YC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041918
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Martins GV, 2010, MACROMOL BIOSCI, V10, P1444, DOI 10.1002/mabi.201000193
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   MATSUDA T, 1995, J BIOMED MATER RES, V29, P749, DOI 10.1002/jbm.820290611
   Maynard HD, 2005, ACTA BIOMATER, V1, P451, DOI 10.1016/j.actbio.2005.04.004
   McCall JD, 2011, BIOMACROMOLECULES, V12, P1051, DOI 10.1021/bm101379v
   Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929
   Miranda SCCC, 2011, ARCH ORAL BIOL, V56, P1, DOI 10.1016/j.archoralbio.2010.08.018
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Nakaji-Hirabayashi T, 2007, BIOMATERIALS, V28, P3517, DOI 10.1016/j.biomaterials.2007.04.022
   Ngiam M, 2009, TISSUE ENG PT A, V15, P535, DOI 10.1089/ten.tea.2008.0011
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k
   Odedra D, 2011, ACTA BIOMATER, V7, P3027, DOI 10.1016/j.actbio.2011.05.002
   Ogiwara K, 2006, BIOCHEM BIOPH RES CO, V345, P255, DOI 10.1016/j.bbrc.2006.04.001
   Ogiwara K, 2005, BIOTECHNOL LETT, V27, P1633, DOI 10.1007/s10529-005-2605-0
   Oh SH, 2011, BIOMATERIALS, V32, P8254, DOI 10.1016/j.biomaterials.2011.07.027
   Oss-Ronen L, 2011, ACTA BIOMATER, V7, P163, DOI 10.1016/j.actbio.2010.07.017
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Polizzotti BD, 2008, BIOMACROMOLECULES, V9, P1084, DOI 10.1021/bm7012636
   Porter AM, 2011, AM J PHYSIOL-CELL PH, V301, pC1086, DOI 10.1152/ajpcell.00090.2011
   Rahman S, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-8
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Re'em T, 2012, BIOMATERIALS, V33, P751, DOI 10.1016/j.biomaterials.2011.10.007
   Rowe SL, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128673
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Schuppan D, 1998, GASTROENTEROLOGY, V114, P139, DOI 10.1016/S0016-5085(98)70642-0
   Scott R, 2010, J BIOMED MATER RES A, V93A, P817, DOI 10.1002/jbm.a.32775
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva SS, 2010, CRIT REV BIOTECHNOL, V30, P200, DOI 10.3109/07388551.2010.505561
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Tae G, 2006, J BIOMAT SCI-POLYM E, V17, P187, DOI 10.1163/156856206774879090
   Tan H., 2009, J BIOMED MATER RES A, V92A, P979
   Tan HP, 2012, MACROMOL BIOSCI, V12, P621, DOI 10.1002/mabi.201100502
   Tan HP, 2010, ORGANOGENESIS, V6, P173, DOI 10.4161/org.6.3.12037
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905
   Verheyen E, 2010, J CONTROL RELEASE, V148, pE18, DOI 10.1016/j.jconrel.2010.07.010
   Verheyen E, 2010, MACROMOL BIOSCI, V10, P1517, DOI 10.1002/mabi.201000168
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Wang AY, 2008, BIOMACROMOLECULES, V9, P2929, DOI 10.1021/bm800727z
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wang SD, 2011, INT J BIOL MACROMOL, V48, P345, DOI 10.1016/j.ijbiomac.2010.12.008
   Wang XL, 2011, COLLOID SURFACE B, V82, P233, DOI 10.1016/j.colsurfb.2010.08.047
   Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844
   Xie GP, 2010, J MATER SCI-MATER M, V21, P1875, DOI 10.1007/s10856-010-4038-0
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang YL, 2011, BIOMATERIALS, V32, P7932, DOI 10.1016/j.biomaterials.2011.07.018
   Yu WW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-68
   Zhang Q, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045002
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhu JM, 2012, BIOMACROMOLECULES, V13, P706, DOI 10.1021/bm201596w
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   Zustiak SP, 2010, ACTA BIOMATER, V6, P3404, DOI 10.1016/j.actbio.2010.03.040
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
NR 134
TC 23
Z9 23
U1 0
U2 174
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD APR
PY 2013
VL 19
IS 2
BP 160
EP 171
DI 10.1089/ten.teb.2012.0458
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 099VS
UT WOS:000315651800006
PM 23150926
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Vila, OF
   Bago, JR
   Navarro, M
   Alieva, M
   Aguilar, E
   Engel, E
   Planell, J
   Rubio, N
   Blanco, J
AF Vila, Olaia F.
   Bago, Juli R.
   Navarro, Melba
   Alieva, Maria
   Aguilar, Elisabeth
   Engel, Elisabeth
   Planell, Josep
   Rubio, Nuria
   Blanco, Jeronimo
TI Calcium phosphate glass improves angiogenesis capacity of poly(lactic
   acid) scaffolds and stimulates differentiation of adipose tissue-derived
   mesenchymal stromal cells to the endothelial lineage
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE scaffold; bioluminescence imaging; cell differentiation; angiogenesis;
   mesenchymal stromal cells
ID HYPOXIA-INDUCIBLE FACTOR-1; REPORTER GENE-EXPRESSION; STEM-CELLS;
   BONE-MARROW; IN-VITRO; PROMOTERS; MICE
AB The angiogenic capacity of a new biomaterial composite of poly(lactic acid) and calcium phosphate glass (PLA/CaP) was analyzed by noninvasive bioluminescence imaging (BLI) and histological procedures. Human adipose tissue-derived mesenchymal stromal cells expressing cytomegalovirus (CMV) promoter regulated Photinus pyralis luciferase (hAMSC-PLuc) grew up to 30 times the initial cell load, in vitro, when seeded in PLA/CaP scaffolds, but suffered an initial growth crisis followed by recovery when the scaffolds were subcutaneously implanted in SCID mice. To analyze changes in gene expression, hAMSC-PLuc cells were double labeled with a CMV promoter regulated Renilla reniformis luciferase and a Photinus pyralis luciferase reporter regulated by either the PECAM promoter or a hypoxia response element (HRE) artificial promoter and seeded in PLA/CaP and PLA scaffolds implanted in SCID mice. Analysis by BLI showed that hAMSCs in scaffolds were induced to differentiate to the endothelial lineage and did this faster in PLA/CaP than in PLA scaffolds. Endothelial differentiation correlated with a decrease in the activity of HRE regulated luciferase expression, indicative of a reduction of hypoxia. Histological analysis showed that PLA/CaP scaffolds were colonized by a functional host vascular system. Moreover, colonization by isolectin B4 positive host cells was more effective in PLA/CaP than in PLA scaffolds, corroborating BLI results. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Vila, Olaia F.; Bago, Juli R.; Alieva, Maria; Aguilar, Elisabeth; Rubio, Nuria; Blanco, Jeronimo] Cardiovasc Res Ctr CSIC ICCC UAB, Barcelona, Spain.
   [Vila, Olaia F.; Bago, Juli R.; Navarro, Melba; Alieva, Maria; Aguilar, Elisabeth; Engel, Elisabeth; Planell, Josep; Rubio, Nuria; Blanco, Jeronimo] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
   [Navarro, Melba; Engel, Elisabeth; Planell, Josep] Inst Bioengn Catalonia IBEC, Barcelona, Spain.
RP Blanco, J (reprint author), Cardiovasc Res Ctr CSIC ICCC UAB, Barcelona, Spain.
EM jblancof@csic-iccc.org
RI Rubio, Nuria/H-3156-2015; Blanco, Jeronimo/H-2764-2015; Engel,
   Elisabeth/D-4365-2014
OI Rubio, Nuria/0000-0003-2471-4684; Blanco, Jeronimo/0000-0003-3765-0640;
   Engel, Elisabeth/0000-0003-4855-8874; R. BAGO, JULI/0000-0002-2862-4048;
   Vila, Olaia/0000-0002-1238-2275
FU European Community [NMP-LA-2008-214402]; Spanish Government
   [SAF2009-07102]; University and Research Commission for Innovation;
   University and Company Department (Government of Catalonia)
FX Contract grant sponsor: European Community's Seventh Framework Program
   Angioscaff (Angiogenesis-inducing Bioactive and Bioresponsive Scaffolds
   in Tissue Engineering); contract grant number: NMP-LA-2008-214402;
   Contract grant sponsor: Spanish Government; contract grant number:
   SAF2009-07102; Contract grant sponsors: The University and Research
   Commission for Innovation; University and Company Department (Government
   of Catalonia)
CR Aguirre A, 2010, BIOCHEM BIOPH RES CO, V393, P156, DOI 10.1016/j.bbrc.2010.01.109
   Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934
   Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Charles-Harris M, 2008, J MATER SCI-MATER M, V19, P1503, DOI 10.1007/s10856-008-3390-9
   Chung N, 2009, MOL BIOL REP, V36, P227, DOI 10.1007/s11033-007-9171-6
   Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Degano IR, 2008, BIOMATERIALS, V29, P427, DOI 10.1016/j.biomaterials.2007.10.006
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Iyer M, 2001, P NATL ACAD SCI USA, V98, P14595, DOI 10.1073/pnas.251551098
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Navarro M, 2004, J MATER SCI-MATER M, V15, P419, DOI 10.1023/B:JMSM.0000021113.88702.9d
   NEWMAN PJ, 1992, NOUV REV FR HEMATOL, V34, pS9
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   Pansky A, 2007, CLIN LAB, V53, P81
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Polak J, 2005, GENE THER, V12, P1725, DOI 10.1038/sj.gt.3302651
   Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816
   Razorenova OV, 2005, GENE, V350, P89, DOI 10.1016/j.gene.2005.02.006
   Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529
   Vilalta M, 2009, GENE THER, V16, P547, DOI 10.1038/gt.2008.176
   Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201
   Vilalta M, 2009, BIOMATERIALS, V30, P4986, DOI 10.1016/j.biomaterials.2009.05.056
   Whyte JL, 2011, STEM CELL RES, V6, P238, DOI 10.1016/j.scr.2011.02.001
   Zippel Nina, 2010, Recent Pat Biotechnol, V4, P1, DOI 10.2174/187220810790069497
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 30
TC 17
Z9 17
U1 0
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2013
VL 101
IS 4
BP 932
EP 941
DI 10.1002/jbm.a.34391
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 096LT
UT WOS:000315406300003
PM 22962041
DA 2018-10-20
ER

PT J
AU Alves, A
   Sousa, RA
   Reis, RL
AF Alves, Anabela
   Sousa, Rui A.
   Reis, Rui L.
TI Processing of degradable ulvan 3D porous structures for biomedical
   applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE ulvan; biomaterial; porous; degradable; tissue engineering
ID NMR ANALYSIS; SCAFFOLDS; CHLOROPHYTA; HYDROGELS; DELIVERY; LINKING
AB The interest in ulvan within a biomedical framework increases as the knowledge of this polysaccharide evolves. Ulvan has been recently proposed as a potential biomaterial, and structures based on this polysaccharide are now being studied for different biomedical applications. In this work, a novel porous structure based on cross-linked ulvan was designed and characterized. Its mechanical performance, water-uptake ability and weight loss were assessed, morphology analyzed through scanning electron microscopy, and morphometric parameters quantified by microcomputed tomography. Cell viability and cell proliferation were evaluated in order to estimate the cytotoxicity of these structures and respective degradation products. Produced ulvan structures revealed remarkable ability to uptake water (up to approximate to 2000% of its initial dry weight) and are characterized by a highly porous and interconnected structure. Furthermore, these ulvan structures underwent nontoxic degradation, and cells remained viable through the time of culture. These results position ulvan structures as prospective blocks that can be further functionalized in order to acquire the desired stability and needed biological interactivity to be used as tissue-engineered structures. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Alves, Anabela; Sousa, Rui A.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3B, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Alves, Anabela; Sousa, Rui A.; Reis, Rui L.] ICVS 3Bs PT Associated Lab, Guimaraes, Portugal.
RP Alves, A (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3B, Headquarters European Inst Excellence Tissue Engn, Ave Pk, P-4806909 Taipas, Guimaraes, Portugal.
EM anabela.pinto@dep.uminho.pt
RI Alves, Anabela/C-2729-2011; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012
OI Alves, Anabela/0000-0002-6878-0766; Reis, Rui L./0000-0002-4295-6129;
   Group, 3Bs/0000-0002-5195-3456; Sousa, Rui/0000-0003-0362-7418
FU Fundacao para a Ciencia e Tecnologia [SFRH/BD/39359/2007]; European
   Regional Development Fund (ERDF); POCTEP (project IBEROMARE)
FX Contract grant sponsor: Fundacao para a Ciencia e Tecnologia; contract
   grant number: SFRH/BD/39359/2007; Contract grant sponsor: European
   Regional Development Fund (ERDF co-funding) and POCTEP (project
   IBEROMARE)
CR Alves A, 2012, INT J PHARMACEUT, V426, P76, DOI 10.1016/j.ijpharm.2012.01.021
   Alves A, 2010, CARBOHYD RES, V345, P2194, DOI 10.1016/j.carres.2010.07.039
   Autissier A, 2010, ACTA BIOMATER, V6, P3640, DOI 10.1016/j.actbio.2010.03.004
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   Baumann LS, 2009, COSMETIC DERMATOLOGY
   Delmar-Greenberg D, 2003, J MATER SCI-MATER M, V14, P833, DOI 10.1023/A:1025670323657
   Fan JY, 2010, J MATER SCI-MATER M, V21, P319, DOI 10.1007/s10856-009-3833-y
   Gomes ME, 2004, MACROMOL BIOSCI, V4, P737, DOI 10.1002/mabi.200400094
   Heber GK, 2006, US Pat, Patent No. [2010/0,035,838, 20100035838]
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Huang Y, 2006, BIOTECHNOL BIOENG, V93, P64, DOI 10.1002/bit.20703
   Janvikul W, 2007, J MATER SCI-MATER M, V18, P943, DOI 10.1007/s10856-006-0099-5
   Joy A, 2011, LANGMUIR, V27, P1891, DOI 10.1021/la103722m
   Kuo CK, 2008, J BIOMED MATER RES A, V84A, P899, DOI 10.1002/jbm.a.31375
   Kutty JK, 2007, BIOMATERIALS, V28, P4928, DOI 10.1016/j.biomaterials.2007.08.007
   Lahaye M, 1996, CARBOHYD RES, V283, P161, DOI 10.1016/0008-6215(95)00407-6
   Lahaye M, 1999, J APPL PHYCOL, V11, P1, DOI 10.1023/A:1008063600071
   Lahaye M, 1998, CARBOHYD POLYM, V36, P239, DOI 10.1016/S0144-8617(98)00026-5
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Ma PX, 2006, SCAFFOLDING TISSUE E
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malson T., 1987, Material of polysaccharides containing carboxyl groups, and a process for porducing such polysaccharides, Patent No. [US4963666, 4963666]
   Martins A, 2010, TISSUE ENG PT A, V16, P3599, DOI 10.1089/ten.TEA.2009.0779
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   Quemener B, 1997, J APPL PHYCOL, V9, P179, DOI 10.1023/A:1007971023478
   Shoichet MS, 2009, MACROMOLECULES, V43, P581
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Zawko SA, 2009, ACTA BIOMATER, V5, P14, DOI 10.1016/j.actbio.2008.09.012
   Zeeman R, 2000, J BIOMED MATER RES, V51, P541, DOI 10.1002/1097-4636(20000915)51:4<541::AID-JBM1>3.3.CO;2-G
   Zhao XB, 2002, J MATER SCI-MATER M, V13, P11, DOI 10.1023/A:1013618115163
   Zimmerman E, 1999, J STRUCT BIOL, V125, P25, DOI 10.1006/jsbi.1998.4061
NR 33
TC 14
Z9 14
U1 0
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2013
VL 101
IS 4
BP 998
EP 1006
DI 10.1002/jbm.a.34403
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 096LT
UT WOS:000315406300010
PM 22965453
DA 2018-10-20
ER

PT J
AU Chandler-Temple, A
   Kingshott, P
   Wentrup-Byrne, E
   Cassady, AI
   Grondahl, L
AF Chandler-Temple, Adrienne
   Kingshott, Peter
   Wentrup-Byrne, Edeline
   Cassady, A. Ian
   Grondahl, Lisbeth
TI Surface chemistry of grafted expanded poly(tetrafluoroethylene)
   membranes modifies the in vitro proinflammatory response in macrophages
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE immune response; macrophage; polytetrafluoroethylene; protein
   adsorption; surface-MALDI-MS; surface modification
ID MASS-SPECTROMETRY; BIOMATERIAL SURFACES; MEDICAL APPLICATIONS;
   CONTAINING POLYMERS; ALZHEIMERS-DISEASE; PROTEIN ADSORPTION;
   MOLECULAR-BASIS; CONTACT-LENSES; PTFE MEMBRANES; SERUM-ALBUMIN
AB A series of surface-modified expanded poly(tetrafluoroethylene) membranes showed varied levels of in vitro macrophage proinflammatory response. Membranes containing a mixture of phosphate and hydroxyl groups (as determined by X-ray photoelectron spectroscopy analysis) stimulate greater macrophage activation than samples containing a mixture of phosphate and carboxylic acid segments. The types of proteins that adsorbed irreversibly from serum onto the two samples with the highest and lowest cellular response were investigated using surface-matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. Distinct differences in the number and type of proteins that adsorbed were observed between these samples. A correlation was found between the main protein components adsorbed onto the surfaces and the resulting in vitro proinflammatory response. This study strongly supports the hypothesis that the cellular response is not controlled directly by surface properties but is mediated by specific protein adsorption events. This in turn highlights the importance of better understanding and controlling the properties of intelligent surface-modified biomaterials. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Chandler-Temple, Adrienne; Grondahl, Lisbeth] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.
   [Kingshott, Peter] Swinburne Univ Technol, IRIS, Fac Engn & Ind Sci, Hawthorn, Vic 3122, Australia.
   [Kingshott, Peter] Riso DTU, Danish Polymer Ctr, Roskilde, Denmark.
   [Wentrup-Byrne, Edeline] Queensland Univ Technol, IHBI, Tissue BioRegenerat & Integrat Program, Kelvin Grove Q 4059, Australia.
   [Cassady, A. Ian] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.
   [Cassady, A. Ian] Univ New England, Sch Sci & Technol, Armidale, NSW 2351, Australia.
RP Grondahl, L (reprint author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.
EM l.grondahl@uq.edu.au
OI Cassady, Alan/0000-0001-8585-5427; Kingshott, Peter/0000-0001-5882-5804;
   Grondahl, Lisbeth/0000-0001-6012-9808
FU UQ
FX Contract grant sponsors: The Francine Kroesen Travel Fellowship (UQ); A
   Graduate School Research Travel Award (UQ)
CR ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X
   Ademovic Z, 2006, J MATER SCI-MATER M, V17, P203, DOI 10.1007/s10856-006-7306-2
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Andrade J. D., 1996, INTERFACIAL PHENOMEN, P19
   BLACKLEDGE JA, 1995, ANAL CHEM, V67, P843, DOI 10.1021/ac00101a009
   Blattler TM, 2006, LANGMUIR, V22, P5760, DOI 10.1021/la0602766
   Bosker WTE, 2005, J COLLOID INTERF SCI, V286, P496, DOI 10.1016/j.jcis.2005.01.091
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   Chandler-Temple A, 2010, J APPL POLYM SCI, V117, P3331, DOI 10.1002/app.31242
   Chandler-Temple AF, 2010, LANGMUIR, V26, P15409, DOI 10.1021/la1010677
   Clarke B, 2007, ACTA BIOMATER, V3, P103, DOI 10.1016/j.actbio.2006.07.006
   de Haas CJC, 1999, FEMS IMMUNOL MED MIC, V26, P197, DOI 10.1016/S0928-8244(99)00148-0
   Dubiel EA, 2011, CHEM REV, V111, P2900, DOI 10.1021/cr9002598
   Engstrom G, 2006, J HUM HYPERTENS, V20, P581, DOI 10.1038/sj.jhh.1002037
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Garrett Q, 1999, BIOMATERIALS, V20, P1345, DOI 10.1016/S0142-9612(99)00037-X
   Godek ML, 2009, J BIOMED MATER RES A, V88A, P503, DOI 10.1002/jbm.a.31886
   Griesser H.J., 2003, BIOPOLYMERS INTERFAC, P641
   Griesser HJ, 2004, BIOMATERIALS, V25, P4861, DOI 10.1016/j.biomaterials.2004.01.049
   Grondahl L, 2003, J MATER SCI-MATER M, V14, P503, DOI 10.1023/A:1023403929496
   Grondahl L, 2002, J APPL POLYM SCI, V86, P2550, DOI 10.1002/app.11177
   Grondahl L, 2008, CHEM COMMUN, P3314, DOI 10.1039/b803223h
   Hume D A, 2001, BMC Immunol, V2, P11, DOI 10.1186/1471-2172-2-11
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   KATO K, 1995, COLLOID SURFACE B, V4, P221, DOI 10.1016/0927-7765(94)01172-2
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   Lickorish D, 2004, Eur Cell Mater, V8, P12
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200
   Monge S, 2011, BIOMACROMOLECULES, V12, P1973, DOI 10.1021/bm2004803
   Moore DF, 1997, INFLAMMATION, V21, P69, DOI 10.1023/A:1027342909423
   Moore DF, 2000, INFLAMMATION, V24, P265, DOI 10.1023/A:1007065514142
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255
   Piattelli A, 1996, BIOMATERIALS, V17, P1725, DOI 10.1016/0142-9612(96)87653-8
   Power KA, 2010, BIOMATERIALS, V31, P6667, DOI 10.1016/j.biomaterials.2010.05.029
   Reichhart C, 2009, LANGMUIR, V25, P1047, DOI 10.1021/la802905s
   Rochemonteix BGde, 1993, J LEUKOCYTE BIOL, V53, P439
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Stacey KJ, 2003, J IMMUNOL, V170, P3614, DOI 10.4049/jimmunol.170.7.3614
   Suzuki S, 2005, BIOMATERIALS, V26, P5303, DOI 10.1016/j.biomaterilas.2005.01.061
   Suzuki S, 2006, BIOMACROMOLECULES, V7, P3178, DOI 10.1021/bm060583q
   Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200
   Tolson J, 2004, LAB INVEST, V84, P845, DOI 10.1038/labinvest.3700097
   Turitto V, 1998, HDB BIOMATERIAL PROP, P114
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   Walsh W. R., 1994, Clinical Materials, V16, P201, DOI 10.1016/0267-6605(94)90118-X
   Wentrup-Byrne E, 2005, POLYM INT, V54, P1581, DOI 10.1002/pi.1902
   Wentrup-Byrne E, 2010, BIOINTEGRATION OF MEDICAL IMPLANT MATERIALS: SCIENCE AND DESIGN, P51, DOI 10.1533/9781845699802.1.51
   Wentrup-Byrne E, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045010
   Wu CKA, 2006, BIOMATERIALS, V27, P4715
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xing SM, 2002, MICROSC RES TECHNIQ, V57, P523, DOI 10.1002/jemt.10106
   Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398
NR 62
TC 7
Z9 8
U1 2
U2 46
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2013
VL 101
IS 4
BP 1047
EP 1058
DI 10.1002/jbm.a.34408
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 096LT
UT WOS:000315406300015
PM 22965526
DA 2018-10-20
ER

PT J
AU Misra, RDK
   Chaudhari, PM
AF Misra, R. D. K.
   Chaudhari, P. M.
TI Osteoblasts response to nylon 6,6 blended with single-walled carbon
   nanohorn
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polymer; nanostructured carbon; bioactivity; osteoblasts; extracellular
   matrix; proteins; actin cytoskeleton; vinculin
ID IN-VITRO; GENE-EXPRESSION; SURFACE; ADHESION; BEHAVIOR; RELEASE;
   DIFFERENTIATION; CONJUGATE; TITANIUM; CELLS
AB Bioactivity is an important aspect that can be appropriately used to tune the cellular interactions occurring at the biomaterial-physiological interface. In this regard, we explore here the nano- or quantum-size effects of a highly dispersible nanostructured carbon present in the void space between the polymers chains (Nylon 6,6) in modulating the cellular functions when osteoblasts are seeded on biocompatible substrates. The filling-up of void space in polymer facilitates filopodia to access the extracellular matrix, enabling integrin receptors to bind to the artificial biomedical device, promoting cellular interactions. In this regard, the fundamental principles of materials processing and cellular biology were combined to elucidate the mechanism of cell-substrate interactions and the molecular machinery controlling the cell response. This is accomplished by investigating cell attachment, proliferation, and morphology, including cytomorphometry evaluation and quantitative assessment of prominent proteins, actin, vinculin, and fibronectin that are sensitive to cell-substrate interactions. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Misra, R. D. K.; Chaudhari, P. M.] Univ Louisiana Lafayette, Biomat & Biomed Engn Res Lab, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ Louisiana Lafayette, Biomat & Biomed Engn Res Lab, Ctr Struct & Funct Mat, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
FU Center for Structural and Functional Materials, University of Louisiana
   at Lafayette
FX Contract grant sponsor: Center for Structural and Functional Materials,
   University of Louisiana at Lafayette
CR Ajima K, 2006, J PHYS CHEM B, V110, P5773, DOI 10.1021/jp056813x
   Ajima K, 2006, J PHYS CHEM B, V110, P19097, DOI 10.1021/jp064915x
   Ajima K, 2005, MOL PHARMACEUT, V2, P475, DOI 10.1021/mp0500566
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319
   Bodhak S, 2010, ACTA BIOMATER, V6, P641, DOI 10.1016/j.actbio.2009.08.008
   CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X
   Cheng R, 2005, BIOMATERIALS, V266, P288
   Depan D, 2012, NANOSCALE, V4, P6325, DOI 10.1039/c2nr31345f
   Diener A, 2005, BIOMATERIALS, V26, P382
   El-Warrak AO, 2004, BMC MUSCULOSKEL DIS, V3, P5
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Huang W, 2011, BIOCONJUGATE CHEM, V22, P1012, DOI 10.1021/bc200098k
   Hukkanen M, 1998, CLIN ORTHOP RELAT R, P53
   Iijima S, 1999, CHEM PHYS LETT, V309, P165, DOI 10.1016/S0009-2614(99)00642-9
   Karaca E, 2008, J BIOMED MATER RES B, V87B, P580, DOI 10.1002/jbm.b.31136
   Kilapadi KL, 2001, J BIOMED MATER RES, V57, P258
   Makropoulou M, 1995, LASER MED SCI, V10, P201, DOI 10.1007/BF02133332
   Mao C, 2005, CARBOHYD POLYM, V59, P19, DOI 10.1016/j.carbpol.2004.08.016
   Matsumura S, 2007, MOL PHARMACEUT, V4, P723, DOI 10.1021/mp070022t
   Miyawaki J, 2008, ACS NANO, V2, P213, DOI 10.1021/nn700185t
   Muralkami T, 2006, MOL PHARMACEUT, V3, P407, DOI 10.1021/mp060027a
   Muralkami T, 2004, MOL PHARMACEUT, V1, P399, DOI 10.1021/mp049928e
   Murata K, 2006, CARBON, V44, P818, DOI 10.1016/j.carbon.2005.10.034
   Myllymaa K, 2010, THESIS U E FINLAND
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Rajesh JJ, 2002, J MATER SCI, V37, P5107, DOI 10.1023/A:1021012404839
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Sendemir-Urkmez A, 2007, J BIOMED MATER RES A, V81A, P624, DOI 10.1002/jbm.a.31010
   STEIN GS, 1990, FASEB J, V4, P3111
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Thian ES, 2010, ACTA BIOMATER, V6, P750, DOI 10.1016/j.actbio.2009.08.012
   Waugh DG, 2009, MAT SCI ENG C-MATER, V29, P2514, DOI 10.1016/j.msec.2009.07.020
   WINNARD RG, 1995, J BONE MINER RES, V10, P1969
   Yuge R, 2007, J PHYS CHEM C, V111, P7348, DOI 10.1021/jp070831s
NR 36
TC 12
Z9 12
U1 1
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2013
VL 101
IS 4
BP 1059
EP 1068
DI 10.1002/jbm.a.34409
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 096LT
UT WOS:000315406300016
PM 22965545
DA 2018-10-20
ER

PT J
AU Quirk, S
AF Quirk, Stephen
TI Enhanced catalytic activity from proteinoid microspheres
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; artificial enzyme; thermal condensation; active site
   geometry
ID AMINO-ACIDS; THERMAL COPOLYMERIZATION; TRIGGERED RELEASE; ASPARTIC ACID;
   GLUTAMIC-ACID; EVOLUTION; POLYMERIZATION; PROTOCELLS; MOLECULES;
   PEPTIDES
AB Creating materials that are capable of catalyzing enzymatic reactions could be important to the treatment of both acute and chronic wounds, as well as other topical diseases. As a first step in the design of catalytic biomaterials, a new class of proteinoid microsphere (PM), that includes amino acids found in phosphatase enzyme active sites, has been constructed. This material can significantly enhance catalytic activity for phosphoester hydrolysis, with observed specific activity increases between 35- and 55-fold. Further specific activity increases occur when metal cations, notably iron or zinc, are added to the PMs. Specific activity increases between 140- and 300-fold for these metal modified systems are measured. The phosphatase activity increase is demonstrated for both aromatic phosphate esters as well as the high-energy phosphate bond of adenosine triphosphate. PMs bind substrate heterogeneously on their surfaces in an enthalpically driven reaction that is defined by an overall favorable free energy, but unfavorable entropy. The catalytic PMs have been successfully blended with polyolefin foam and extruded with PLA. These materials remain fully active. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 Kimberly Clark Inc, Roswell, GA 30076 USA.
RP Quirk, S (reprint author), Kimberly Clark Inc, 1400 Holcomb Bridge Rd, Roswell, GA 30076 USA.
EM squirk@kcc.com
OI Quirk, Stephen/0000-0002-4497-1023
CR Alhakawati MS, 2004, J ENVIRON MANAGE, V72, P195, DOI 10.1016/j.jenvman.2004.04.010
   AMES BN, 1960, J BIOL CHEM, V235, P769
   Baier G, 2011, MACROMOL BIOSCI, V11, P628, DOI 10.1002/mabi.201000395
   BERGER G, 1984, CR ACAD SCI III-VIE, V299, P333
   BROOKE S, 1977, BIOSYSTEMS, V9, P1, DOI 10.1016/0303-2647(77)90028-4
   Der BS, 2012, BIOCHEMISTRY-US, V51, P3933, DOI 10.1021/bi201881p
   FOX S W, 1976, Origins of Life, V7, P49, DOI 10.1007/BF01218513
   FOX SW, 1960, J AM CHEM SOC, V82, P3745, DOI 10.1021/ja01499a069
   FOX SW, 1980, BIOSYSTEMS, V12, P155, DOI 10.1016/0303-2647(80)90013-1
   FOX SW, 1984, ORIGINS LIFE EVOL B, V14, P485, DOI 10.1007/BF00933695
   FOX SW, 1964, NATURE, V201, P336, DOI 10.1038/201336a0
   FOX SW, 1991, Q REV BIOL, V66, P181, DOI 10.1086/417144
   Fox SW, 1974, BIOCHIM BIOPHYS ACTA, V140, P155
   FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159
   Garrabou X, 2010, CHEM-EUR J, V16, P10691, DOI 10.1002/chem.201000714
   Grossoehme NE, 2007, BIOCHEMISTRY-US, V46, P10506, DOI 10.1021/bi700171v
   HARADA K, 1958, J AM CHEM SOC, V80, P2694, DOI 10.1021/ja01544a027
   HARADA K, 1960, ARCH BIOCHEM BIOPHYS, V86, P274, DOI 10.1016/0003-9861(60)90418-5
   Hart E, 2010, J ANTIMICROB CHEMOTH, V65, P974, DOI 10.1093/jac/dkq057
   HSU L L, 1971, Currents in Modern Biology, V4, P12
   HSU LL, 1976, BIOSYSTEMS, V8, P89, DOI 10.1016/0303-2647(76)90012-5
   JUNGCK JR, 1973, NATURWISSENSCHAFTEN, V60, P425, DOI 10.1007/BF00623555
   Kawamura K, 2008, NATURWISSENSCHAFTEN, V95, P449, DOI 10.1007/s00114-008-0342-7
   KELETI T, 1984, BIOCHEM J, V223, P299, DOI 10.1042/bj2230299
   Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718
   KOKUFUTA E, 1983, BIOSYSTEMS, V16, P175, DOI 10.1016/0303-2647(83)90002-3
   Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570
   Kumar ABM, 1998, BIOMATERIALS, V19, P725, DOI 10.1016/S0142-9612(97)00188-9
   Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200
   Lopez-Alonso JP, 2010, CHEM-EUR J, V16, P5314, DOI 10.1002/chem.200903207
   LUQUEROMERO MM, 1986, BIOSYSTEMS, V19, P267
   Masinovsky Z, 1995, Cas Lek Cesk, V134, P607
   MASINOVSKY Z, 1989, BIOSYSTEMS, V22, P305, DOI 10.1016/0303-2647(89)90052-X
   MATSUNO K, 1981, BIOSYSTEMS, V14, P163, DOI 10.1016/0303-2647(81)90065-4
   MATSUNO K, 1981, BIOSYSTEMS, V13, P237, DOI 10.1016/0303-2647(81)90003-4
   MCALHANEY WW, 1976, BIOSYSTEMS, V8, P45, DOI 10.1016/0303-2647(76)90007-1
   MULLERHEROLD U, 1994, BIOSYSTEMS, V33, P215, DOI 10.1016/0303-2647(94)90006-X
   NAKASHIMA T, 1980, J MOL EVOL, V15, P161, DOI 10.1007/BF01732668
   Nakashima T, 1987, Top Curr Chem, V139, P58
   OSHIMA T, 1968, ARCH BIOCHEM BIOPHYS, V126, P478, DOI 10.1016/0003-9861(68)90432-3
   PHILLIPS RD, 1974, INT J PEPT PROT RES, V6, P309
   Pollack JD, 2010, ORIGINS LIFE EVOL B, V40, P273, DOI 10.1007/s11084-009-9188-z
   Quirk S, 2010, J BIOMED MATER RES A, V92A, P877, DOI 10.1002/jbm.a.32416
   Quirk S, 2009, J BIOMED MATER RES A, V91A, P391, DOI 10.1002/jbm.a.32241
   Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230
   ROHLFING DL, 1975, ORIGINS LIFE EVOL B, V6, P203, DOI 10.1007/BF01372406
   Ryan J W, 1973, Curr Mod Biol, V5, P115
   SNYDER WD, 1975, BIOSYSTEMS, V7, P222, DOI 10.1016/0303-2647(75)90029-5
   SYREN RM, 1985, BIOSYSTEMS, V17, P275, DOI 10.1016/0303-2647(85)90043-7
   Talbert JN, 2012, COLLOID SURFACE B, V93, P8, DOI 10.1016/j.colsurfb.2012.01.003
   Tallawi M, 2011, J BIOMED MATER RES B, V96B, P261, DOI 10.1002/jbm.b.31761
   van de Weert M, 2000, PHARM RES, V17, P1159, DOI DOI 10.1023/A:1026498209874
   Worthington V., 1993, WORTHINGTON ENZYME M
NR 53
TC 1
Z9 1
U1 2
U2 23
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2013
VL 101
IS 4
BP 1133
EP 1143
DI 10.1002/jbm.a.34421
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 096LT
UT WOS:000315406300023
PM 23023829
DA 2018-10-20
ER

PT J
AU Costa, D
   Garrain, PA
   Baaden, M
AF Costa, Dominique
   Garrain, Pierre-Alain
   Baaden, Marc
TI Understanding small biomolecule-biomaterial interactions: A review of
   fundamental theoretical and experimental approaches for biomolecule
   interactions with inorganic surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE biomolecule; biomaterial; TiO2; stainless steel; theoretical chemistry
ID MOLECULAR-DYNAMICS SIMULATIONS; STAINLESS-STEEL SURFACE;
   DENSITY-FUNCTIONAL THEORY; BOVINE BETA-LACTOGLOBULIN; SELF-ASSEMBLED
   MONOLAYERS; AB-INITIO; AQUEOUS-SOLUTION; AMINO-ACIDS; TITANIUM SURFACES;
   ADSORPTION CHARACTERISTICS
AB Interactions between biomolecules and inorganic surfaces play an important role in natural environments and in industry, including a wide variety of conditions: marine environment, ship hulls (fouling), water treatment, heat exchange, membrane separation, soils, mineral particles at the earth's surface, hospitals (hygiene), art and buildings (degradation and biocorrosion), paper industry (fouling) and more. To better control the first steps leading to adsorption of a biomolecule on an inorganic surface, it is mandatory to understand the adsorption mechanisms of biomolecules of several sizes at the atomic scale, that is, the nature of the chemical interaction between the biomolecule and the surface and the resulting biomolecule conformations once adsorbed at the surface. This remains a challenging and unsolved problem. Here, we review the state of art in experimental and theoretical approaches. We focus on metallic biomaterial surfaces such as TiO2 and stainless steel, mentioning some remarkable results on hydroxyapatite. Experimental techniques include atomic force microscopy, surface plasmon resonance, quartz crystal microbalance, X-ray photoelectron spectroscopy, fluorescence microscopy, polarization modulation infrared reflection absorption spectroscopy, sum frequency generation and time of flight secondary ion mass spectroscopy. Theoretical models range from detailed quantum mechanical representations to classical forcefield-based approaches. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
C1 [Costa, Dominique; Garrain, Pierre-Alain] Chim ParisTech, Ecole Natl Super Chim Paris, Lab Phys Chim Surfaces, UMR CNRS ENSCP 7045, F-75005 Paris, France.
   [Baaden, Marc] Univ Paris Diderot, UPR9080, CNRS, Lab Biochim Theor, F-75005 Paris, France.
RP Costa, D (reprint author), Chim ParisTech, Ecole Natl Super Chim Paris, Lab Phys Chim Surfaces, UMR CNRS ENSCP 7045, 11 Rue Pierre & Marie Curie, F-75005 Paris, France.
EM dominiquecosta@ymail.com; baaden@smplinux.de
RI Baaden, Marc/C-6623-2008
OI Baaden, Marc/0000-0001-6472-0486
FU French National Research Agency [ANR-10-BIOE-003]
FX Contract grant sponsor: French National Research Agency; contract grant
   number: ANR-10-BIOE-003
CR Abbasi A, 2009, SURF SCI, V603, P2502, DOI 10.1016/j.susc.2009.06.004
   Adeagbo WA, 2008, CHEMPHYSCHEM, V9, P994, DOI 10.1002/cphc.200700819
   Allen JP, 2009, MOL SIMULAT, V35, P584, DOI 10.1080/08927020902774570
   Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Argyris D, 2008, J PHYS CHEM C, V112, P13587, DOI 10.1021/jp803234a
   Argyris D, 2011, J PHYS CHEM C, V115, P2038, DOI 10.1021/jp109244c
   Argyris D, 2009, J PHYS CHEM C, V113, P19591, DOI 10.1021/jp906150n
   Argyris D, 2009, LANGMUIR, V25, P8025, DOI 10.1021/la9005136
   Arrouvel C, 2007, J PHYS CHEM C, V111, P18164, DOI 10.1021/jp0741408
   Bagno A, 2007, BONE, V40, P693, DOI 10.1016/j.bone.2006.10.007
   Boehme C, 2003, J AM CHEM SOC, V125, P13362, DOI 10.1021/ja0359714
   Bornstein MM, 2009, CLIN IMPLANT DENT R, V11, P338, DOI 10.1111/j.1708-8208.2009.00148.x
   Bourg IC, 2012, J PHYS CHEM C, V116, P11556, DOI 10.1021/jp301299a
   Brown GE, 1999, CHEM REV, V99, P77, DOI 10.1021/cr980011z
   Butenuth A, 2012, PHYS STATUS SOLIDI B, V249, P292, DOI 10.1002/pssb.201100786
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Capriotti LA, 2007, J AM CHEM SOC, V129, P5281, DOI 10.1021/ja070356b
   Carravetta V, 2006, J PHYS CHEM B, V110, P6160, DOI 10.1021/jp056760j
   Carravetta V, 2009, THEOR CHEM ACC, V123, P299, DOI 10.1007/s00214-009-0513-4
   Chavent M, 2011, J COMPUT CHEM, V32, P2924, DOI 10.1002/jcc.21861
   Chen W, 2010, J PHYS CHEM C, V114, P460, DOI 10.1021/jp909308k
   Cheng J, 2010, J CHEM THEORY COMPUT, V6, P880, DOI 10.1021/ct100013q
   Ciaccafava A, 2012, ANGEW CHEM INT EDIT, V51, P953, DOI 10.1002/anie.201107053
   Cole DJ, 2009, PHYS CHEM CHEM PHYS, V11, P11395, DOI 10.1039/b816125a
   Cole DJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799196
   Compere C, 2001, BIOFOULING, V17, P129, DOI 10.1080/08927010109378472
   Cooke DJ, 2004, PHYS CHEM MINER, V31, P507, DOI 10.1007/s00269-004-0396-9
   Corno M, 2010, PHYS CHEM CHEM PHYS, V12, P6309, DOI 10.1039/c002146f
   Costa D, 2011, LANGMUIR, V27, P2747, DOI 10.1021/la104317j
   Costa D, 2007, J MOL STRUC-THEOCHEM, V806, P253, DOI 10.1016/j.theochem.2006.12.006
   Costa D, 2009, SURF SCI, V603, P2484, DOI 10.1016/j.susc.2009.05.037
   Criscenti LJ, 2008, CHEM MATER, V20, P4682, DOI 10.1021/cm70278lr
   de Leeuw NH, 1999, J AM CERAM SOC, V82, P3209
   Delalande O, 2009, J COMPUT CHEM, V30, P2375, DOI 10.1002/jcc.21235
   Di Felice R, 2011, J PHYS CHEM LETT, V2, P1510, DOI 10.1021/jz200297k
   Di Foggia M, 2009, J MOL STRUCT, V924, P120, DOI 10.1016/j.molstruc.2008.11.004
   Di Tommaso D, 2009, GEOCHIM COSMOCHIM AC, V73, P5394, DOI 10.1016/j.gca.2009.06.003
   Durupthy O, 2007, CRYST GROWTH DES, V7, P2696, DOI 10.1021/cg060405g
   Fan FRF, 1999, P NATL ACAD SCI USA, V96, P14222, DOI 10.1073/pnas.96.25.14222
   Floess JK, 2011, CHEM PHYS LETT, V516, P216, DOI 10.1016/j.cplett.2011.09.085
   Fogarty JC, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3407433
   Friedrichs W, 2011, ADV ENG MATER, V13, pB334, DOI 10.1002/adem.201080123
   Friis EP, 1997, J ELECTROANAL CHEM, V431, P35, DOI 10.1016/S0022-0728(97)00178-2
   Gaigeot M-P, 2012, J PHYS COND MATTER, P24
   Gao YK, 2009, J COLLOID INTERF SCI, V338, P16, DOI 10.1016/j.jcis.2009.06.008
   Gao YK, 2011, PHYS CHEM CHEM PHYS, V13, P10709, DOI 10.1039/c0cp02295k
   Garrain PA, 2011, J PHYS CHEM C, V115, P719, DOI 10.1021/jp109704b
   Garrain PA, 2011, ETUDE INITIO ADSORPT
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495
   Hagiwara T, 2009, LANGMUIR, V25, P226, DOI 10.1021/la8024149
   Harding JH, 2006, J MATER CHEM, V16, P1105, DOI 10.1039/b511650c
   Harding JH, 2008, CHEM REV, V108, P4823, DOI 10.1021/cr078278y
   Hassanali AA, 2007, J COMPUT-AIDED MATER, V14, P53, DOI 10.1007/s10820-006-9038-5
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   Heinz H, 2009, J AM CHEM SOC, V131, P9704, DOI 10.1021/ja900531f
   Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6
   Henry M, 2003, LANGMUIR, V19, P6271, DOI 10.1021/la034081z
   Hoffmann C, 2008, ANAL BIOCHEM, V372, P62, DOI 10.1016/j.ab.2007.07.027
   Hoffmann C, 2011, ANAL BIOANAL CHEM, V399, P1653, DOI 10.1007/s00216-010-4476-z
   Imamura K, 2003, J COLLOID INTERF SCI, V267, P294, DOI 10.1016/S0021-9797(03)00700-8
   Imamura K, 2000, J COLLOID INTERF SCI, V229, P237, DOI 10.1006/jcis.2000.7016
   Imamura K, 2007, J BIOSCI BIOENG, V103, P7, DOI 10.1263/jbb.103.7
   Irrera S, 2009, J MOL STRUC-THEOCHEM, V903, P49, DOI 10.1016/j.theochem.2009.01.023
   Ithurbide A, 2007, ELECTROCHIM ACTA, V53, P1336, DOI 10.1016/j.electacta.2007.04.109
   Jackson L., 2008, MARINE BIOFOULING AS
   Jonsson CM, 2010, GEOCHIM COSMOCHIM AC, V74, P2356, DOI 10.1016/j.gca.2010.01.003
   Jonsson EO, 2011, J PHYS CHEM B, V115, P9410, DOI 10.1021/jp200893w
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kalasin S, 2009, COLLOID SURFACE B, V73, P229, DOI 10.1016/j.colsurfb.2009.05.028
   Kanagaraja S, 2001, BIOMATERIALS, V22, P1809, DOI 10.1016/S0142-9612(00)00362-8
   Kang Y, 2010, J PHYS CHEM C, V114, P14496, DOI 10.1021/jp1037156
   Kasprzyk-Hordern B, 2004, ADV COLLOID INTERFAC, V110, P19, DOI 10.1016/j.cis.2004.02.002
   Kerisit S, 2005, CHEM COMMUN, P3027, DOI 10.1039/b503899e
   Kerisit S, 2008, GEOCHIM COSMOCHIM AC, V72, P1481, DOI 10.1016/j.gca.2007.12.014
   Kerisit S, 2006, J PHYS CHEM B, V110, P20491, DOI 10.1021/jp0636569
   Khoo X, 2009, J AM CHEM SOC, V9, P3098
   Knotts TA, 2008, BIOPHYS J, V94, P4473, DOI 10.1529/biophysj.107.123158
   Koehler JA, 1997, LANGMUIR, V13, P4162, DOI 10.1021/la970010m
   KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251
   Lambert JF, 2008, ORIGINS LIFE EVOL B, V38, P211, DOI 10.1007/s11084-008-9128-3
   Langel W, 2003, SURF SCI, V538, P1, DOI 10.1016/S0039-6028(03)00723-4
   Laurent B, 2013, PURE APPL CHEM
   Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI 10.2217/NNM.10.54
   Leed EA, 2003, J NON-CRYST SOLIDS, V325, P48, DOI 10.1016/S0022-3093(03)00361-2
   Lefevre G, 2009, J COLLOID INTERF SCI, V337, P449, DOI 10.1016/j.jcis.2009.05.005
   Leopold MC, 2002, LANGMUIR, V18, P2239, DOI 10.1021/la011456c
   Leung K, 2009, J AM CHEM SOC, V131, P18358, DOI 10.1021/ja906190t
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Lojou E, 2000, J ELECTROANAL CHEM, V485, P71, DOI 10.1016/S0022-0728(00)00102-9
   Lu HY, 2006, ELECTROANAL, V18, P379, DOI 10.1002/elan.200503420
   Machesky M, 2011, LANGMUIR, V27, P4585, DOI 10.1021/la1040163
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Mahadevan TS, 2008, J PHYS CHEM C, V112, P1507, DOI 10.1021/jp076936c
   Mamontov E, 2007, J PHYS CHEM C, V111, P4328, DOI 10.1021/jp067242r
   Manivannan G, 2000, ANTIMICROBIAL ANTIIN
   Martin P, 2006, MOL SIMULAT, V32, P1079, DOI 10.1080/08927020601013817
   McCafferty E, 1998, SURF INTERFACE ANAL, V26, P549, DOI 10.1002/(SICI)1096-9918(199807)26:8<549::AID-SIA396>3.3.CO;2-H
   Monti S, 2008, LANGMUIR, V24, P3205, DOI 10.1021/la702956t
   Monti S, 2010, J PHYS CHEM C, V114, P22197, DOI 10.1021/jp107859q
   Monti S, 2007, J PHYS CHEM C, V111, P7765, DOI 10.1021/jp071095v
   Monti S, 2007, J PHYS CHEM C, V111, P6086, DOI 10.1021/jp070266t
   Monti S, 2012, J PHYS CHEM C, V116, P5141, DOI 10.1021/jp2121593
   Monti S, 2011, J PHYS CHEM C, V115, P24238, DOI 10.1021/jp207950p
   Monti S, 2009, J PHYS CHEM C, V113, P2433, DOI 10.1021/jp809297c
   Motta A, 2012, J PHYS CHEM C, V116, P12514, DOI 10.1021/jp3000812
   Motta A, J PHYS CHEM C UNPUB
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Noinville S, 2003, BIOPHYS J, V85, P1196, DOI 10.1016/S0006-3495(03)74555-X
   Nonella M, 2008, CHEMPHYSCHEM, V9, P414, DOI 10.1002/cphc.200700546
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   Panagiotou GD, 2008, ADV COLLOID INTERFAC, V142, P20, DOI 10.1016/j.cis.2008.04.003
   Parikh SJ, 2011, LANGMUIR, V27, P1778, DOI 10.1021/la103826p
   Parker SC, 2003, FARADAY DISCUSS, V124, P155, DOI 10.1039/b211988a
   Paszti Z, 2004, J PHYS CHEM B, V108, P7779, DOI 10.1021/jp0367474
   Paszti Z, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/22/224014
   Patil AV, 2011, COORDIN CHEM REV, V255, P1970, DOI 10.1016/j.ccr.2011.02.002
   Paul D, 1984, NAT WAT SUPPL IMPROV, VII, P21
   Payet V, 2010, SURF INTERFACE ANAL, V42, P457, DOI 10.1002/sia.3298
   Pegueroles M, 2010, ACTA BIOMATER, V6, P291, DOI 10.1016/j.actbio.2009.07.030
   Pradier CM, 2002, SURF INTERFACE ANAL, V34, P50, DOI 10.1002/sia.1250
   Pradier CM, 2000, SURF INTERFACE ANAL, V30, P45, DOI 10.1002/1096-9918(200008)30:1<45::AID-SIA767>3.0.CO;2-G
   Predota M, 2004, J PHYS CHEM B, V108, P12061, DOI 10.1021/jp037199x
   QUIQUAMPOIX H, 1987, BIOCHIMIE, V69, P753, DOI 10.1016/0300-9084(87)90196-9
   Raybaud P, 2001, J CATAL, V201, P236, DOI 10.1006/jcat.2001.3246
   Raymand D, 2011, J PHYS CHEM C, V115, P8573, DOI 10.1021/jp106144p
   Riganese GM, 2004, PHYS CHEM CHEM PHYS, V6, P1920
   Rimola A, 2006, LANGMUIR, V22, P6593, DOI 10.1021/la0610203
   Rimola A, 2012, J AM CHEM SOC, V134, P10899, DOI 10.1021/ja302262y
   Rimola A, 2012, PHILOS T R SOC A, V370, P1478, DOI 10.1098/rsta.2011.0236
   Rimola A, 2011, J PHYS CHEM LETT, V2, P1390, DOI 10.1021/jz200457x
   Rimola A, 2008, LANGMUIR, V24, P14027, DOI 10.1021/la8029352
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Roddick-Lanzilotta AD, 1998, LANGMUIR, V14, P6479, DOI 10.1021/la980425n
   Rosenqvist J, 2003, COLLOID SURFACE A, V220, P91, DOI 10.1016/S0927-7757(03)00063-3
   Rosenqvist J, 2009, LANGMUIR, V25, P10852, DOI 10.1021/la901396w
   Ross NL, 2009, NEUTRON SCATT APPL T, P235, DOI 10.1007/978-0-387-09416-8_8
   Sakiyama T, 2004, COLLOID SURFACE B, V33, P77, DOI 10.1016/j.colsurfb.2003.08.010
   Sakiyama T, 1999, J BIOSCI BIOENG, V88, P536, DOI 10.1016/S1389-1723(00)87672-0
   Sakiyama T, 2006, J BIOSCI BIOENG, V101, P434, DOI 10.1263/jbb.101.434
   Schneider J, 2012, J AM CHEM SOC, V134, P2407, DOI 10.1021/ja210744g
   Schneider J, 2011, J CHEM THEORY COMPUT, V7, P473, DOI 10.1021/ct1004388
   Schneider J, 2010, SURF SCI, V604, P1105, DOI 10.1016/j.susc.2010.03.021
   Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409
   Sheka EF, 2006, PHYS LOW-DIMENS STR, V1, P99
   Shumaker-Parry JS, 2004, ANAL CHEM, V76, P907, DOI 10.1021/ac034962a
   Sposito G, 1995, ADV CHEM SER, P33
   Stievano L, 2007, EUR J MINERAL, V19, P321, DOI 10.1127/0935-1221/2007/0019-1731
   Sulpizi M, 2012, J CHEM THEORY COMPUT, V8, P1037, DOI 10.1021/ct2007154
   Tamerler C, 2009, PHILOS T R SOC A, V367, P1705, DOI 10.1098/rsta.2009.0018
   Tonner R, 2010, CHEMPHYSCHEM, V11, P1053, DOI 10.1002/cphc.200900902
   Vallee A, 2010, ACCOUNTS CHEM RES, V43, P1297, DOI 10.1021/ar100017n
   van Duin ACT, 2001, J PHYS CHEM A, V105, P9396, DOI 10.1021/jp004368u
   VanNostrand W. L., 1981, FOULING HEAT TRANSFE, P619
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wang JW, 2009, J PHYS CHEM C, V113, P11077, DOI 10.1021/jp9018316
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Wei JJ, 2002, J AM CHEM SOC, V124, P9591, DOI 10.1021/ja025518c
   Wieczorek R, 2005, J AM CHEM SOC, V127, P17216, DOI 10.1021/ja052689j
   Wikesjo UME, 2009, ORTHOD CRANIOFAC RES, V12, P263, DOI 10.1111/j.1601-6343.2009.01461.x
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG
   Wu CY, 2010, J PHYS CHEM B, V114, P4692, DOI 10.1021/jp9109223
   Yamamoto S, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/18/184025
   Yue J, 2011, SOLID STATE SCI, V13, P263, DOI 10.1016/j.solidstatesciences.2010.11.026
   Zhang DQ, 2009, J APPL ELECTROCHEM, V39, P1193, DOI 10.1007/s10800-009-9784-7
   Zhang Z, 2004, LANGMUIR, V20, P4954, DOI 10.1021/la0353834
   Zhao YL, 2011, J PHYS CHEM C, V115, P9615, DOI 10.1021/jp200610p
NR 170
TC 33
Z9 34
U1 7
U2 280
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2013
VL 101
IS 4
BP 1210
EP 1222
DI 10.1002/jbm.a.34416
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 096LT
UT WOS:000315406300031
PM 23015529
DA 2018-10-20
ER

PT J
AU Khot, VM
   Salunkhe, AB
   Thorat, ND
   Phadatare, MR
   Pawar, SH
AF Khot, V. M.
   Salunkhe, A. B.
   Thorat, N. D.
   Phadatare, M. R.
   Pawar, S. H.
TI Induction heating studies of combustion synthesized MgFe2O4
   nanoparticles for hyperthermia applications
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE Combustion synthesis; Magnetic nanoparticle; Biomaterial; Induction
   heating
ID AC MAGNETIC-FIELD; INFRARED SPECTRA; FERRITES
AB The structural, magnetic and ac magnetically induced heating characteristics of combustion synthesized MgFe2O4 nanoparticles have been investigated for application in magnetic particle hyperthermia. As prepared nanoparticles showed ferrimagnetic behavior at room temperature with magnetization of about 33.83 emu/g at +/- 15 kOe. The solid state MgFe2O4 nanoparticles exhibited specific absorption rate (SAR) of about 297 W/g at physiological safe range of frequency and amplitude. The increase in SAR and heating temperature in ac magnetic field was thought to be due to enhancement in magnetic hysteresis loss caused by dipole-dipole interactions in combustion synthesized MgFe2O4 nanoparticles. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Khot, V. M.; Salunkhe, A. B.; Thorat, N. D.; Phadatare, M. R.; Pawar, S. H.] DY Patil Univ, Interdisciplinary Res Ctr, Kolhapur 416006, Maharashtra, India.
RP Pawar, SH (reprint author), DY Patil Univ, Interdisciplinary Res Ctr, Kolhapur 416006, Maharashtra, India.
EM wish_khot@yahoo.co.in
RI Thorat, Nanasaheb/C-4630-2014; Phadatare, Manisha/R-1960-2017
OI Phadatare, Manisha/0000-0002-9570-8647; Thorat,
   Nanasaheb/0000-0001-6343-527X
FU Council of Scientific and Industrial Research, India
   [09/10771(0001)/2012/EMR-1]
FX Author Mr. V.M. Khot acknowledges the Council of Scientific and
   Industrial Research, India for the award of senior research fellowship
   File No.: 09/10771(0001)/2012/EMR-1. Authors are thankful to Dr. D. Das,
   Dr. R. S. Ningthoujam and Dr. R. K Vatsa, BARC for availability of
   induction heating studies.
CR Bae S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2420769
   Bae S, 2006, IEEE T MAGN, V42, P3566, DOI 10.1109/TMAG.2006.879617
   Bae S, 2009, IEEE T NANOTECHNOL, V8, P86, DOI 10.1109/TNANO.2008.2007214
   Dutz S, 2007, J MAGN MAGN MATER, V308, P305, DOI 10.1016/j.jmmm.2006.06.005
   Franco A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3359709
   Ghosh R, 2011, J MATER CHEM, V21, P13388, DOI 10.1039/c1jm10092k
   GILCHRIST RK, 1957, ANN SURG, V146, P596, DOI 10.1097/00000658-195710000-00007
   Hergt R, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/1/015706
   Hiergeist R, 1999, J MAGN MAGN MATER, V201, P420, DOI 10.1016/S0304-8853(99)00145-6
   Jeun M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3211120
   JORDAN A, 1993, INT J HYPERTHER, V9, P51, DOI 10.3109/02656739309061478
   Khot VM, 2012, MATER CHEM PHYS, V132, P782, DOI 10.1016/j.matchemphys.2011.12.012
   Kim D., 2005, J APPL PHYS, V97
   Konishi K, 2004, J MAGN MAGN MATER, V272, P2428, DOI 10.1016/j/jmmm.2003.12.591
   Poddar P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.060403
   Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0
   Syue M., 2011, J APPL PHYS, V109
   WALDRON RD, 1955, PHYS REV, V99, P1727, DOI 10.1103/PhysRev.99.1727
   Zaki HM, 2010, PHYSICA B, V405, P4476, DOI 10.1016/j.physb.2010.08.018
NR 19
TC 31
Z9 31
U1 2
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD APR
PY 2013
VL 332
BP 48
EP 51
DI 10.1016/j.jmmm.2012.12.010
PG 4
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 086KJ
UT WOS:000314682200009
DA 2018-10-20
ER

PT J
AU Adamska, K
   Szubert, M
   Voelkel, A
   Okulus, Z
AF Adamska, Katarzyna
   Szubert, Magdalena
   Voelkel, Adam
   Okulus, Zuzanna
TI Characterisation of hydroxyapatite surface modified by poly(ethylene
   glycol) and poly(hydroxyethyl methacrylate) grafting
SO CHEMICAL PAPERS
LA English
DT Article
DE hydroxyapatite; surface modification; polyethylene glycol; infrared
   spectroscopy; X-ray photoelectron spectroscopy
ID POLYETHYLENE-GLYCOL; NANO-HYDROXYAPATITE; CALCIUM; PARTICLES
AB Hydroxyapatite (HA) has many applications in medicine as a biocompatible and bioactive biomaterial. Numerous studies have shown that modification of the HA surface can improve its biological and chemical properties. However, little is known about the surface properties of modified materials. In this paper the influence of organic polymers: polyethylene glycol (PEG) and polyhydroxyethyl methacrylate (pHEMA) on the surface properties and surface chemistry of hydroxyapatite (HA) is presented. The surface properties of modified HA were characterised by the FT-IR, XPS, BET, and zeta potential measurements. Specific surface area was determined by BET. Infrared and XPS spectra confirmed the presence of PEG and pHEMA on the surface of HA. The BET N-2 adsorption revealed slight changes in the HA surface chemistry after grafting modification. The surface chemical properties of the HA were considered to be based on the zeta potential. The decrease in zeta potential results in the increasing stability of the modified material and also in the reduction of bacterial adhesion. The reaction for surface modification of HA is proposed and described.
C1 [Adamska, Katarzyna; Szubert, Magdalena; Voelkel, Adam; Okulus, Zuzanna] Poznan Univ Tech, Inst Chem Technol & Engn, PL-60965 Poznan, Poland.
RP Okulus, Z (reprint author), Poznan Univ Tech, Inst Chem Technol & Engn, Pl M Sklodowskiej Curie 2, PL-60965 Poznan, Poland.
EM zuzanna.okulus@o2.pl
RI Voelkel, Adam/G-3436-2014; Okulus, Zuzanna/M-3323-2014; Adamska,
   Katarzyna/G-3535-2014
OI Voelkel, Adam/0000-0002-6536-8952; 
FU Poland Ministry of Science and Higher Education [N N204 137638]
FX This paper was produced with financial support from the Poland Ministry
   of Science and Higher Education (grant no. N N204 137638) and this
   support is gratefully acknowledged.
CR ARAKAKI M, 1995, CLEFT PALATE-CRAN J, V32, P282, DOI 10.1597/1545-1569(1995)032<0282:OSAHTC>2.3.CO;2
   Ciobanu CS, 2011, DIG J NANOMATER BIOS, V6, P609
   Costescu A, 2010, DIG J NANOMATER BIOS, V5, P989
   D'Andrea SC, 2003, LANGMUIR, V19, P7904, DOI 10.1021/la027000s
   Groth T, 2010, NATO SCI PEACE SEC A, P253, DOI 10.1007/978-90-481-8790-4_13
   Hong ZK, 2004, POLYMER, V45, P6699, DOI 10.1016/j.polymer.2004.07.036
   Houghton RP, 1996, J ORGANOMET CHEM, V518, P21, DOI 10.1016/0022-328X(96)06223-7
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Kinnari TJ, 2009, J MED MICROBIOL, V58, P132, DOI 10.1099/jmm.0.002758-0
   Klodzinska E, 2010, ELECTROPHORESIS, V31, P1590, DOI 10.1002/elps.200900559
   Liu Q, 1998, J BIOMED MATER RES, V40, P257, DOI 10.1002/(SICI)1097-4636(199805)40:2<257::AID-JBM10>3.0.CO;2-J
   Liu Q, 1998, BIOMATERIALS, V19, P1067, DOI 10.1016/S0142-9612(98)00033-7
   Liu Q, 1998, J BIOMED MATER RES, V40, P358
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   Luo SG, 1997, J APPL POLYM SCI, V65, P1217, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1217::AID-APP17>3.3.CO;2-L
   Park J. B., 2003, BIOMATERIALS PRINCIP
   Qiu CF, 2008, CERAM INT, V34, P1747, DOI 10.1016/j.ceramint.2007.06.001
   Salarian M, 2009, CERAM INT, V35, P2563, DOI 10.1016/j.ceramint.2009.02.031
   Shi D, 2004, BIOMATERIALS TISSUE
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   Siddharthan A., 2005, TRENDS BIOMATER ARTI, V18, P110
   Tanaka H, 1998, J COLLOID INTERF SCI, V206, P205, DOI 10.1006/jcis.1998.5634
NR 22
TC 3
Z9 3
U1 1
U2 100
PU VERSITA
PI WARSAW
PA SOLIPSKA 14A-1, 02-482 WARSAW, POLAND
SN 0366-6352
J9 CHEM PAP
JI Chem. Pap.
PD APR
PY 2013
VL 67
IS 4
BP 429
EP 436
DI 10.2478/s11696-012-0297-1
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 067LB
UT WOS:000313294700010
DA 2018-10-20
ER

PT J
AU Grotenhuis, N
   Bayon, Y
   Lange, JF
   Van Osch, GJVM
   Bastiaansen-Jenniskens, YM
AF Grotenhuis, N.
   Bayon, Y.
   Lange, J. F.
   Van Osch, G. J. V. M.
   Bastiaansen-Jenniskens, Y. M.
TI A culture model to analyze the acute biomaterial-dependent reaction of
   human primary macrophages
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Human macrophages; Acute reaction; Biomaterials; Cytokines
ID FOREIGN-BODY REACTION; HERNIA REPAIR; GENE-EXPRESSION; TISSUE REACTION;
   ABDOMINAL-WALL; POLARIZATION; MESH; PAIN; INFLAMMATION; FIBROBLASTS
AB Macrophages are important in foreign body reactions. We devised a culture model with human primary macrophages to evaluate the acute response of macrophages to biomaterials. First we selected proteins representative for pro-inflammatory (M1) or anti-inflammatory/repair (M2) response of monocytes isolated from blood of healthy human donors by exposing them to LPS+IFN gamma or IL-4. A relative M1/M2 index was calculated using IL-1 beta, IL-6, tumor necrosis factor (TNF)alpha, monocyte chemotactic protein (MCP)-3 and macrophage inflammatory protein (MIP)-1 alpha as M1 markers, and IL-1 receptor antagonist (IL-1RA), CCL18, regulated and normal T-cell expressed and secreted (RANTES), and macrophage-derived chemokine (MDC) as M2 markers. Then monocytes were cultured for 3 days on 4 materials selected for known different foreign body reactions: Permacol (TM), Parietex (TM) Composite, multifilament polyethylene terephthalate and multifilament polypropylene. Macrophages on polypropylene produced high levels of anti-inflammatory proteins with a low M1 M2 index. Macrophages on Parietex (TM) Composite produced high levels of inflammatory and anti-inflammatory proteins, with a high M1/M2 index. Macrophages on polyethylene terephthalate also resulted in a high M1/M2 index. Macrophages on Permacol (TM) produced a low amount of all proteins, with a low M1/M2 index. This model with human primary macrophages and the panel of read-out parameters can be used to evaluate the acute reaction of macrophages to biomaterials in vitro to get more insight in the foreign body reaction. (c) 2013 Elsevier Inc. All rights reserved.
C1 [Grotenhuis, N.; Van Osch, G. J. V. M.] Univ Med Ctr Rotterdam, Dept Otorhinolaryngol Head & Neck Surg, NL-3015 GE Rotterdam, Netherlands.
   [Grotenhuis, N.] Univ Med Ctr Rotterdam, Dept Gen Surg, Erasmus MC, NL-3015 GE Rotterdam, Netherlands.
   [Bayon, Y.] Covidien Sofradim Prod, F-01600 Trevoux, France.
   [Lange, J. F.] Univ Med Ctr Rotterdam, Dept Gen Surg, Erasmus MC, NL-3000 CA Rotterdam, Netherlands.
   [Van Osch, G. J. V. M.; Bastiaansen-Jenniskens, Y. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Orthopaed, NL-3015 GE Rotterdam, Netherlands.
RP Bastiaansen-Jenniskens, YM (reprint author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Orthopaed, Ee1618c,Dr Molewatoplein 50, NL-3015 GE Rotterdam, Netherlands.
EM n.grotenhuis@erasmusmc.nl; Yves.Bayon@-covidien.com;
   j.lange@erasmusmc.nl; g.vanosch@eras-musmc.nl;
   y.bastiaansen@erasmusmc.nl
OI Bastiaansen-Jenniskens, Yvonne/0000-0002-2921-1237
FU VENI fellowship from the Dutch Technology foundation STW
FX We want to acknowledge L. Falke for pilot experiments, H. vd Toom for
   the biomaterial experiments, H.J. de Wit and J.M. Wijkhuis for teaching
   us the monocyte isolation and J.G. te Marvelde and V.H.J. vd Velden for
   their help on FACS analysis. Y.M. Bastiaansen-Jenniskens is supported by
   a VENI fellowship from the Dutch Technology foundation STW.
CR Amid P K, 2004, Hernia, V8, P343, DOI 10.1007/s10029-004-0247-0
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001
   Bellon JM, 2007, J LAPAROENDOSC ADV S, V17, P160, DOI 10.1089/lap.2006.0028
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   DABROWIECKI S, 1991, EUR SURG RES, V23, P240, DOI 10.1159/000129159
   Fosnot J, 2011, AESTHET SURG J, V31, p5S, DOI 10.1177/1090820X11417576
   Frankenberger M, 2011, MOL MED, V17, P762, DOI 10.2119/molmed.2010.00202
   Gaertner WB, 2007, J GASTROINTEST SURG, V11, P1275, DOI 10.1007/s11605-007-0242-8
   Hunt J.A., 2012, SURG MAT
   Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027
   JANSON RW, 1991, J IMMUNOL, V147, P4218
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kaleya Ronald N, 2005, Hernia, V9, P269, DOI 10.1007/s10029-005-0003-0
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Laplana M, 2012, CYTOKINE, V58, P10, DOI 10.1016/j.cyto.2011.12.021
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loos M J A, 2007, Hernia, V11, P169, DOI 10.1007/s10029-007-0196-5
   Loos MJA, 2007, WORLD J SURG, V31, P1760, DOI 10.1007/s00268-007-9121-4
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Mayer A, 2011, CLIN HEMORHEOL MICRO, V48, P57, DOI 10.3233/CH-2011-1395
   Nienhuijs SW, 2005, J AM COLL SURGEONS, V200, P885, DOI 10.1016/j.jamcollsurg.2005.02.005
   Orenstein SB, 2012, J SURG RES, V176, P423, DOI 10.1016/j.jss.2011.09.031
   Popova A, 2011, IMMUNOBIOLOGY, V216, P164, DOI 10.1016/j.imbio.2010.06.003
   Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
   Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446
   Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687
   Tomida M, 2011, EUR J MED RES, V16, P249, DOI 10.1186/2047-783X-16-6-249
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
NR 35
TC 30
Z9 31
U1 0
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 29
PY 2013
VL 433
IS 1
BP 115
EP 120
DI 10.1016/j.bbrc.2013.02.054
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 123FY
UT WOS:000317375000020
PM 23485466
DA 2018-10-20
ER

PT J
AU Pecova, M
   Sebela, M
   Markova, Z
   Polakova, K
   Cuda, J
   Safarova, K
   Zboril, R
AF Pecova, M.
   Sebela, M.
   Markova, Z.
   Polakova, K.
   Cuda, J.
   Safarova, K.
   Zboril, R.
TI Thermostable trypsin conjugates immobilized to biogenic magnetite show a
   high operational stability and remarkable reusability for protein
   digestion
SO NANOTECHNOLOGY
LA English
DT Article
ID MAGNETOTACTIC BACTERIA; GLUCOSE-OXIDASE; NANOPARTICLES; ADSORPTION;
   PARTICLES; MICROSPHERES; ENZYMES; BINDING; NANO; HYDROGEL
AB In this work, magnetosomes produced by microorganisms were chosen as a suitable magnetic carrier for covalent immobilization of thermostable trypsin conjugates with an expected applicability for efficient and rapid digestion of proteins at elevated temperatures. First, a biogenic magnetite was isolated from Magnetospirillum gryphiswaldense and its free surface was coated with the natural polysaccharide chitosan containing free amino and hydroxy groups. Prior to covalent immobilization, bovine trypsin was modified by conjugating with alpha-, beta- and gamma-cyclodextrin. Modified trypsin was bound to the magnetic carriers via amino groups using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysulfosuccinimide as coupling reagents. The magnetic biomaterial was characterized by magnetometric analysis and electron microscopy. With regard to their biochemical properties, the immobilized trypsin conjugates showed an increased resistance to elevated temperatures, eliminated autolysis, had an unchanged pH optimum and a significant storage stability and reusability. Considering these parameters, the presented enzymatic system exhibits properties that are superior to those of trypsin forms obtained by other frequently used approaches. The proteolytic performance was demonstrated during in-solution digestion of model proteins (horseradish peroxidase, bovine serum albumin and hen egg white lysozyme) followed by mass spectrometry. It is shown that both magnetic immobilization and chemical modification enhance the characteristics of trypsin making it a promising tool for protein digestion.
C1 [Pecova, M.; Sebela, M.] Palacky Univ, Fac Sci, Ctr Region Hana Biotechnol & Agr Res, Dept Prot Biochem & Prote, Olomouc 78371, Czech Republic.
   [Markova, Z.; Polakova, K.; Cuda, J.; Safarova, K.; Zboril, R.] Palacky Univ, Fac Sci, Dept Phys Chem, Reg Ctr Adv Technol & Mat, Olomouc 78371, Czech Republic.
   [Markova, Z.; Polakova, K.; Cuda, J.; Safarova, K.; Zboril, R.] Palacky Univ, Fac Sci, Dept Expt Phys, Reg Ctr Adv Technol & Mat, Olomouc 78371, Czech Republic.
RP Pecova, M (reprint author), Palacky Univ, Fac Sci, Ctr Region Hana Biotechnol & Agr Res, Dept Prot Biochem & Prote, Slechtitelu 11, Olomouc 78371, Czech Republic.
EM marek.sebela@upol.cz; radek.zboril@upol.cz
RI Zboril, Radek/F-5153-2015
OI Zboril, Radek/0000-0002-3147-2196
FU OP RD&I grant (Centre of the Region Hana for Biotechnological and
   Agricultural Research) [ED0007/01/01]; Operational Program Research and
   Development for Innovations-European Regional Development Fund of the
   Ministry of Education, Youth, and Sports of the Czech Republic
   [CZ.1.05/2.1.00/03.0058]; Operational Program Research and Development
   for Innovations-KONTAKT II of the Ministry of Education, Youth, and
   Sports of the Czech Republic [LH12085]; Operational Program Research and
   Development for Innovations-European Social Fund of the Ministry of
   Education, Youth, and Sports of the Czech Republic
   [CZ.1.07/2.3.00/20.0155]; Academy of Sciences of the Czech Republic
   [KAN115600801]; Internal Grant of Palacky University in Olomouc
   [PrF_2012_013, PrF_2012_028]
FX This work was supported by OP RD&I grant no. ED0007/01/01 (Centre of the
   Region Hana for Biotechnological and Agricultural Research), the
   Operational Program Research and Development for Innovations-European
   Regional Development Fund (project no. CZ.1.05/2.1.00/03.0058) of the
   Ministry of Education, Youth, and Sports of the Czech Republic, the
   Operational Program Research and Development for Innovations-KONTAKT II
   (project no. LH12085) of the Ministry of Education, Youth, and Sports of
   the Czech Republic, the Operational Program Research and Development for
   Innovations-European Social Fund (project no. CZ.1.07/2.3.00/20.0155) of
   the Ministry of Education, Youth, and Sports of the Czech Republic, and
   by the Academy of Sciences of the Czech Republic (project no.
   KAN115600801). The authors also thank the support of the Internal Grant
   of Palacky University in Olomouc (grants no. PrF_2012_013 and no.
   PrF_2012_028).
CR Anirudhan TS, 2012, J COLLOID INTERF SCI, V381, P125, DOI 10.1016/j.jcis.2012.05.024
   Ansari SA, 2012, BIOTECHNOL ADV, V30, P512, DOI 10.1016/j.biotechadv.2011.09.005
   Bayramoglu G, 2008, BIOCHEM ENG J, V40, P262, DOI 10.1016/j.bej.2007.12.013
   Belessi V, 2008, CHEM MATER, V20, P3298, DOI 10.1021/cm702990t
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w
   Godjevargova T, 2000, J MEMBRANE SCI, V172, P279, DOI 10.1016/S0376-7388(00)00349-5
   Goradia D, 2005, J MOL CATAL B-ENZYM, V32, P231, DOI 10.1016/j.molcatb.2004.12.007
   Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004
   Hamerska-Dudra A, 2007, ENZYME MICROB TECH, V41, P197, DOI 10.1016/j.enzmictec.2007.01.008
   Han L, 2007, J MAGN MAGN MATER, V313, P236, DOI 10.1016/j.jmmm.2007.01.004
   Hernandez K, 2006, PROCESS BIOCHEM, V41, P1155, DOI 10.1016/j.prochio.2005.12.013
   Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x
   Honda H, 1998, J FERMENT BIOENG, V86, P191, DOI 10.1016/S0922-338X(98)80060-3
   Huliciak M, 2012, BIOCHEM PHARMACOL, V83, P1507, DOI 10.1016/j.bcp.2012.02.015
   Jeng JY, 2007, RAPID COMMUN MASS SP, V21, P3060, DOI 10.1002/rcm.3191
   Jha SK, 2007, J BIOL CHEM, V282, P37479, DOI 10.1074/jbc.M706714200
   Jin X, 2010, J MAGN MAGN MATER, V322, P2031, DOI 10.1016/j.jmmm.2010.01.029
   Kalkan NA, 2012, J APPL POLYM SCI, V123, P707, DOI 10.1002/app.34504
   Kim MH, 2012, J MOL CATAL B-ENZYM, V75, P68, DOI 10.1016/j.molcatb.2011.11.011
   Kluchova K, 2009, BIOMATERIALS, V30, P2855, DOI 10.1016/j.biomaterials.2009.02.023
   Kouassi G., 2005, BIOMAGN RES TECHNOL, V3, P1, DOI DOI 10.1186/1477-044X-3-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lei L, 2009, J MAGN MAGN MATER, V321, P252, DOI 10.1016/j.jmmm.2008.08.047
   Lin J, 2009, FOOD CHEM, V117, P94, DOI 10.1016/j.foodchem.2009.03.089
   Luo XL, 2005, BIOSENS BIOELECTRON, V21, P190, DOI 10.1016/j.bios.2004.07.029
   Luo Y, 2010, J AM SOC MASS SPECTR, V21, P34, DOI 10.1016/j.jasms.2009.08.026
   Ma M, 2003, COLLOID SURFACE A, V212, P219, DOI 10.1016/S0927-7757(02)00305-9
   Maciel JC, 2012, J MAGN MAGN MATER, V324, P1312, DOI 10.1016/j.jmmm.2011.11.017
   Magro M, 2012, ACTA BIOMATER, V8, P2068, DOI 10.1016/j.actbio.2012.02.005
   Markova Z, 2012, GREEN CHEM, V14, P2550, DOI 10.1039/c2gc35545k
   MORAND P, 1991, FEBS LETT, V289, P148, DOI 10.1016/0014-5793(91)81056-E
   Moreno-Garrido I, 2008, BIORESOURCE TECHNOL, V99, P3949, DOI 10.1016/j.biortech.2007.05.040
   Murphy A, 1996, J BIOTECHNOL, V49, P163, DOI 10.1016/0168-1656(96)01539-8
   Nikolic T, 2010, CARBOHYD POLYM, V82, P976, DOI 10.1016/j.carbpol.2010.06.028
   Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200
   Pan BF, 2005, J COLLOID INTERF SCI, V284, P1, DOI 10.1016/j.jcis.2004.09.073
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Peng ZG, 2004, J COLLOID INTERF SCI, V271, P277, DOI 10.1016/j.jcis.2003.12.022
   Safarik I, 2009, CHEM PAP, V63, P497, DOI 10.2478/s11696-009-0054-2
   Schueler D., 2002, International Microbiology, V5, P209
   Sebela M, 2006, PROTEOMICS, V6, P2959, DOI 10.1002/pmic.200500576
   Selim KMK, 2007, BIOMATERIALS, V28, P710, DOI 10.1016/j.biomaterials.2006.09.014
   Shaw SY, 2006, ENZYME MICROB TECH, V39, P1089, DOI 10.1016/j.enzmictec.2006.02.025
   Sun J, 2012, COLLOID SURFACE A, V414, P190, DOI 10.1016/j.colsurfa.2012.08.016
   Sun LL, 2012, J CHROMATOGR A, V1220, P68, DOI 10.1016/j.chroma.2011.11.050
   Tang ZX, 2007, MATER LETT, V61, P37, DOI 10.1016/j.matlet.2006.04.048
   Verheul RJ, 2009, BIOMATERIALS, V30, P3129, DOI 10.1016/j.biomaterials.2009.03.013
   Wei LM, 2010, TALANTA, V80, P1298, DOI 10.1016/j.talanta.2009.09.029
   Wilhelm C, 2008, BIOMATERIALS, V29, P3161, DOI 10.1016/j.biomaterials.2008.04.016
   Xi FN, 2005, PROCESS BIOCHEM, V40, P2833, DOI 10.1016/j.procbio.2004.12.013
   Xie J, 2009, NANO RES, V2, P261, DOI [10.1007/S12274-009-9025-8, 10.1007/s12274-009-9025-8]
   Xu XQ, 2007, J PROTEOME RES, V6, P3849, DOI 10.1021/pr070132s
   Yang YM, 2004, ENZYME MICROB TECH, V34, P126, DOI 10.1016/j.enzmictec.2003.09.007
   Yao GP, 2008, J CHROMATOGR A, V1215, P82, DOI 10.1016/j.chroma.2008.10.114
   Zhu XJ, 2011, J MOL CATAL B-ENZYM, V72, P145, DOI 10.1016/j.molcatb.2011.05.012
NR 56
TC 13
Z9 14
U1 2
U2 89
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD MAR 29
PY 2013
VL 24
IS 12
AR 125102
DI 10.1088/0957-4484/24/12/125102
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 103OY
UT WOS:000315929400002
PM 23466477
DA 2018-10-20
ER

PT J
AU Niu, XF
   Wang, LZ
   Chen, P
   Li, XM
   Zhou, G
   Feng, QL
   Fan, YB
AF Niu, Xufeng
   Wang, Lizhen
   Chen, Pin
   Li, Xiaoming
   Zhou, Gang
   Feng, Qingling
   Fan, Yubo
TI Emulsion Self-Assembly Synthesis of Chitosan/Poly(lactic-co-glycolic
   acid) Stimuli-Responsive Amphiphiles
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE amphiphiles; chitosan; emulsions; poly(lactic-co-lycolic acid);
   self-assembly
ID BIOMEDICAL APPLICATIONS; CHITOSAN; BIOMATERIALS; BEHAVIOR; CHEMISTRY;
   MEMBRANES; NETWORKS; POLYMERS; DELIVERY
AB An amphiphilic graft copolymer using chitosan (CS) as a hydrophilic main chain and poly(lactic-co-glycolic acid) (PLGA) as a hydrophobic side chain is prepared through an emulsion self-assembly synthesis. CS aqueous solution is used as a water phase and PLGA in chloroform is served as an oil phase. A water-in-oil (W/O) emulsion is fabricated in the presence of the surfactant span-80. The self-assembly reaction is performed between PLGA and CS under the condensation of EDC. Fourier transform IR (FTIR) spectroscopy reveals that PLGA is grafted onto the backbone of CS through the interactions between end carboxyl and amino groups of the two components. 1H NMR spectroscopy directly indicates the grafting content of PLGA in the CS-graft-PLGA (CS-g-PLGA) copolymer is close to 25%. X-ray diffraction (XRD) confirms that the copolymer exhibits an amorphous structure. The CS-g-PLGA amphiphile can self-assemble to form micelles with size in the range of approximate to 100300 nm, which makes it easy to apply in various targeted-drug-release and biomaterial fields.
C1 [Niu, Xufeng; Wang, Lizhen; Chen, Pin; Li, Xiaoming; Zhou, Gang; Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomechan & Mechanobiol, Beijing 100191, Peoples R China.
   [Feng, Qingling] Tsinghua Univ, Dept Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.
RP Niu, XF (reprint author), Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomechan & Mechanobiol, Beijing 100191, Peoples R China.
EM nxf@buaa.edu.cn; yubofan@buaa.edu.cn
FU National Natural Science Foundation of China [50803032, 11272038,
   11032012, 11202017]; State Key Laboratory of New Ceramic and Fine
   Processing Tsinghua University
FX This research was financially supported by the National Natural Science
   Foundation of China (grant Nos. 50803032, 11272038, 11032012, and
   11202017), and the State Key Laboratory of New Ceramic and Fine
   Processing Tsinghua University.
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Amidi M, 2010, ADV DRUG DELIVER REV, V62, P1, DOI 10.1016/j.addr.2009.12.006
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bajpai AK, 2008, PROG POLYM SCI, V33, P1088, DOI 10.1016/j.progpolymsci.2008.07.005
   Bao HQ, 2010, MACROMOLECULES, V43, P5679, DOI 10.1021/ma100894p
   Bhattarai N, 2009, ADV MATER, V21, P2792, DOI 10.1002/adma.200802513
   Boddohi S, 2010, ADV MATER, V22, P2998, DOI 10.1002/adma.200903790
   Espartero JL, 1996, MACROMOLECULES, V29, P3535, DOI 10.1021/ma950529u
   Fangkangwanwong J, 2006, MACROMOL RAPID COMM, V27, P1039, DOI 10.1002/marc.200600152
   Fasl H, 2012, MACROMOL CHEM PHYS, V213, P1582, DOI 10.1002/macp.201200086
   Feng H, 2007, CARBOHYD POLYM, V70, P258, DOI 10.1016/j.carbpol.2007.04.004
   Feng H, 2006, BIOMACROMOLECULES, V7, P3069, DOI 10.1021/bm060568l
   Ghosh B, 2009, SCIENCE, V323, P1458, DOI 10.1126/science.1167391
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Knight PT, 2009, MACROMOLECULES, V42, P6596, DOI 10.1021/ma901237h
   KURZER F, 1967, CHEM REV, V67, P107, DOI 10.1021/cr60246a001
   Li G, 2008, CARBOHYD POLYM, V72, P60, DOI 10.1016/j.carbpol.2007.07.042
   Luo YF, 2007, EUR POLYM J, V43, P3856, DOI 10.1016/j.eurpolymj.2007.06.022
   Niu XF, 2008, J BIOMED MATER RES A, V84A, P908, DOI 10.1002/jbm.a.31360
   Niu XF, 2012, J BIOMAT SCI-POLYM E, V23, P391, DOI 10.1163/092050610X551961
   Niu X, 2009, POLYM DEGRAD STABIL, V94, P176, DOI 10.1016/j.polymdegradstab.2008.11.008
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003
   Sakurai K, 2000, POLYMER, V41, P7051, DOI 10.1016/S0032-3861(00)00067-7
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tokarev I, 2010, ADV MATER, V22, P3446, DOI 10.1002/adma.201000165
   Wan Y, 2006, BIOMACROMOLECULES, V7, P1362, DOI 10.1021/bm0600825
   Wan Y, 2008, ACTA BIOMATER, V4, P876, DOI 10.1016/j.actbio.2008.01.001
   Wang SG, 2005, ANAL BIOANAL CHEM, V381, P547, DOI 10.1002/s00216-004-27712
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
NR 33
TC 10
Z9 10
U1 3
U2 130
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYS
JI Macromol. Chem. Phys.
PD MAR 25
PY 2013
VL 214
IS 6
BP 700
EP 706
DI 10.1002/macp.201200597
PG 7
WC Polymer Science
SC Polymer Science
GA 108LQ
UT WOS:000316295000007
DA 2018-10-20
ER

PT J
AU Chong, SF
   Smith, AAA
   Zelikin, AN
AF Chong, Siow-Feng
   Smith, Anton A. A.
   Zelikin, Alexander N.
TI Microstructured, Functional PVA Hydrogels through Bioconjugation with
   Oligopeptides under Physiological Conditions
SO SMALL
LA English
DT Article
DE microstructures; oligopeptides; hydrogels; bioconjugation; PVA
ID ALCOHOL) PHYSICAL HYDROGELS; NONVIRAL GENE DELIVERY; POLY(VINYL
   ALCOHOL); DRUG-DELIVERY; CELL-ADHESION; SUBSTRATE ELASTICITY; RAFT
   POLYMERIZATION; POLYVINYL-ALCOHOL; EPITHELIAL-CELLS; RATIONAL DESIGN
AB In this work, bioconjugation techniques are developed to achieve peptide functionalization of poly(vinyl alcohol), PVA, as both a polymer in solution and within microstructured physical hydrogels, in both cases under physiological conditions. PVA is unique in that it is one of very few polymers with excellent biocompatibility and safety and has FDA approval for clinical uses in humans. However, decades of development have documented only scant opportunities in bioconjugation with PVA. As such, materials derived thereof fail to answer the call for functional biomaterials for advanced cell culture and tissue engineering applications. To address these limitations, PVA is synthesized with terminal thiol groups and conjugated with thiolated peptides using PVA in solution. Further, microstructured, surface-adhered PVA physical hydrogels are assembled, the available conjugation sites within the hydrogels are quantified, and quantitative kinetic data are collected on peptide conjugation to the hydrogels. The success of bioconjugation in the gel phase is quantified through the use of a cell-adhesive peptide and visualization of cell adhesion on PVA hydrogels as cell culture substrates. Taken together, the presented data establish a novel paradigm in bioconjugation and functionalization of PVA physical hydrogels. Coupled with an excellent safety profile of PVA, these results deliver a superior biomaterial for diverse biomedical applications.
C1 [Chong, Siow-Feng; Smith, Anton A. A.; Zelikin, Alexander N.] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark.
RP Zelikin, AN (reprint author), Aarhus Univ, Dept Chem, Langelandsgade 140, DK-8000 Aarhus C, Denmark.
EM Zelikin@chem.au.dk
RI Zelikin, Alexander/J-3659-2012; Smith, Anton/G-1347-2017
OI Zelikin, Alexander/0000-0002-9864-321X; Smith, Anton/0000-0001-6728-5299
FU Lundbeck Foundation; Sapere Aude Starting Grant from the Danish Council
   for Independent Research, Technology and Production Sciences, Denmark
FX This work is financed by the Lundbeck Foundation and Sapere Aude
   Starting Grant from the Danish Council for Independent Research,
   Technology and Production Sciences, Denmark.
CR Adler AF, 2011, BIOMATERIALS, V32, P3611, DOI 10.1016/j.biomaterials.2011.01.040
   Ahmed WW, 2010, BIOMATERIALS, V31, P250, DOI 10.1016/j.biomaterials.2009.09.047
   Alconcel SNS, 2011, POLYM CHEM-UK, V2, P1442, DOI 10.1039/c1py00034a
   Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Aydin D., 2012, INTELLIGENT SURFACES, P291
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Bhatia SN, 1999, FASEB J, V13, P1883
   Boudou T, 2011, MACROMOL BIOSCI, V11, P77, DOI 10.1002/mabi.201000301
   Cao L, 2007, ADV DRUG DELIVER REV, V59, P1340, DOI 10.1016/j.addr.2007.08.012
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1
   Cho N.-J., 2012, BIOINTERPHASES, V7, P1
   Chong SF, 2009, BIOMATERIALS, V30, P5178, DOI 10.1016/j.biomaterials.2009.05.078
   Engler J. A., 2006, CELL, V126, P677
   Fejerskov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049619
   Fejerskov B, 2012, ACS APPL MATER INTER, V4, P4981, DOI 10.1021/am3013467
   Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Griesser H.J., 2012, INTELLIGENT SURFACES, P183
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hosta-Rigau L, 2012, ADV HEALTHC MATER, V1, P791, DOI 10.1002/adhm.201200092
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Jensen BEB, 2012, SOFT MATTER, V8, P4625, DOI 10.1039/c2sm07075h
   Jensen BEB, 2011, LANGMUIR, V27, P10216, DOI 10.1021/la201595e
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Kocgozlu L, 2012, BIOMATERIALS, V33, P798, DOI 10.1016/j.biomaterials.2011.10.024
   Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520
   KOJIMA Y, 1993, J BIOACT COMPAT POL, V8, P115, DOI 10.1177/088391159300800202
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kong HJ, 2007, NAT REV DRUG DISCOV, V6, P455, DOI 10.1038/nrd2309
   Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g
   Krsko P, 2009, BIOMATERIALS, V30, P721, DOI 10.1016/j.biomaterials.2008.10.011
   Ladewig K, 2011, EXPERT OPIN DRUG DEL, V8, P1175, DOI 10.1517/17425247.2011.588698
   Le Droumaguet B, 2010, POLYM CHEM-UK, V1, P563, DOI 10.1039/b9py00363k
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lo M., 2000, BIOPHYS J, V79, P144
   Lofthouse S, 2002, ADV DRUG DELIVER REV, V54, P863, DOI 10.1016/S0169-409X(02)00073-X
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Moad G, 2011, POLYM INT, V60, P9, DOI 10.1002/pi.2988
   Ossipov DA, 2006, MACROMOLECULES, V39, P1709, DOI 10.1021/ma052545p
   Ossipov DA, 2007, J APPL POLYM SCI, V106, P60, DOI 10.1002/app.26455
   Roth PJ, 2011, MACROMOL RAPID COMM, V32, P1123, DOI 10.1002/marc.201100127
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Saito G, 2003, ADV DRUG DELIVER REV, V55, P199, DOI 10.1016/S0169-409X(02)00179-5
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smith AAA, 2012, POLYM CHEM-UK, V3, P85, DOI 10.1039/c1py00429h
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Tong YY, 2009, J POLYM SCI POL CHEM, V47, P4494, DOI 10.1002/pola.23502
   Tong YY, 2009, J POLYM SCI POL CHEM, V47, P1901, DOI 10.1002/pola.23288
   Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Zelikin AN, 2007, BIOMACROMOLECULES, V8, P2950, DOI 10.1021/bm700498j
   Zhang XX, 2012, J CONTROL RELEASE, V159, P2, DOI 10.1016/j.jconrel.2011.10.023
NR 59
TC 22
Z9 23
U1 1
U2 55
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1613-6810
J9 SMALL
JI Small
PD MAR 25
PY 2013
VL 9
IS 6
BP 942
EP 950
DI 10.1002/smll.201201774
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 109AZ
UT WOS:000316338800019
PM 23208951
DA 2018-10-20
ER

PT J
AU Shi, JF
   Wang, XL
   Zhang, WY
   Jiang, ZY
   Liang, YP
   Zhu, YY
   Zhang, CH
AF Shi, Jiafu
   Wang, Xiaoli
   Zhang, Wenyan
   Jiang, Zhongyi
   Liang, Yanpeng
   Zhu, Yuanyuan
   Zhang, Chunhong
TI Synergy of Pickering Emulsion and Sol-Gel Process for the Construction
   of an Efficient, Recyclable Enzyme Cascade System
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE nanoparticle-stabilized capsules; Pickering emulsion; sol-gel process;
   enzyme cascade system; carbon dioxide conversion
ID FERRITE COMPOSITE NANOPARTICLES; LIQUID-LIQUID INTERFACES;
   ORGANIC-SOLVENTS; PROTEIN-DEGRADATION; BIOMATERIAL SYSTEM; IMPROVED
   STABILITY; POROUS MEMBRANES; CARBON-DIOXIDE; IMMOBILIZATION; SILICA
AB An efficient, easily recyclable enzyme cascade system based on nanoparticle-stabilized capsules (NPSCs) is constructed through a synergy of a Pickering emulsion and sol-gel process. Specifically, oligodopa-coated titania nanoparticles (biomimetic titania) containing the first enzyme (FateDH) are synthesized through a bioadhesion-assisted biomimetic mineralization approach. The biomimetic titania is then spontaneously assembled at the interface between the oil phase (hexadecane/butyl titanate (BuTi) mixture) and water phase during the formation of Pickering emulsions. The sol-gel process of BuTi can produce not only butanol for assisting the formation of Pickering emulsions but also titania gel particles (sol-gel titania) for cross-linking the biomimetic titania through catechol-titanium chelating. The NPSCs obtained, which contain the first enzyme, conjugate the second enzyme (FaldDH) onto the surface for constructing the enzyme cascade system. The system exhibits high activity and stability, particularly, superior recyclability for conversion of CO2 into formaldehyde. In detail, the system shows a formaldehyde yield of 50.0%, and can quickly float onto the air/water interface soon after stopping the agitation of reaction mixtures, which ensures that the formaldehyde yield keeps almost unaltered after 10 times recycling. This study will be useful for facile construction of a wealth of catalytic systems with efficient, recyclable attributes.
C1 [Shi, Jiafu; Wang, Xiaoli; Zhang, Wenyan; Jiang, Zhongyi; Liang, Yanpeng; Zhu, Yuanyuan; Zhang, Chunhong] Tianjin Univ, Key Lab Green Chem Technol, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
RP Shi, JF (reprint author), Tianjin Univ, Key Lab Green Chem Technol, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
EM zhyjiang@tju.edu.cn
OI Shi, Jiafu/0000-0003-4446-6163
FU National Basic Research Program of China [2009CB724705]; National
   Science Fund for Distinguished Young Scholars [21125627]; National
   Science Foundation of China [20976127]; Program of Introducing Talents
   of Discipline to Universities [B06006]
FX The authors thank the financial support from the National Basic Research
   Program of China (2009CB724705), National Science Fund for Distinguished
   Young Scholars (21125627), the National Science Foundation of China
   (20976127), and the Program of Introducing Talents of Discipline to
   Universities (B06006).
CR Alcalde M, 2006, TRENDS BIOTECHNOL, V24, P281, DOI 10.1016/j.tibtech.2005.04.002
   Ao Z, 2009, LANGMUIR, V25, P2572, DOI 10.1021/la804036m
   Avnir D, 2006, J MATER CHEM, V16, P1013, DOI [10.1039/b512706h, 10.1039/5512706h]
   Betancor L, 2008, TRENDS BIOTECHNOL, V26, P566, DOI 10.1016/j.tibtech.2008.06.009
   Binks BP, 2006, NAT MATER, V5, P865, DOI 10.1038/nmat1757
   Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0
   Burton SG, 2002, NAT BIOTECHNOL, V20, P37, DOI 10.1038/nbt0102-37
   Cao LQ, 2005, CURR OPIN CHEM BIOL, V9, P217, DOI 10.1016/j.cbpa.2005.02.014
   Cellesi F, 2006, COLLOID SURFACE A, V288, P52, DOI 10.1016/j.colsurfa.2006.05.008
   Chen T, 2007, ADV MATER, V19, P2286, DOI 10.1002/adma.200602447
   Cui Y. N., 2012, LANGMUIR, V26, P17210
   Duan HW, 2004, ANGEW CHEM INT EDIT, V43, P5639, DOI 10.1002/anie.200460920
   El-Zahab B, 2008, BIOTECHNOL BIOENG, V99, P508, DOI 10.1002/bit.21584
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263
   GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155
   GORMAN LAS, 1992, BIOTECHNOL BIOENG, V39, P392, DOI 10.1002/bit.260390405
   Jain TK, 1998, J AM CHEM SOC, V120, P11092, DOI 10.1021/ja973849x
   Jiang YJ, 2009, MAT SCI ENG C-BIO S, V29, P328, DOI 10.1016/j.msec.2008.07.006
   Jutz G, 2010, J MATER CHEM, V20, P4299, DOI 10.1039/b925018b
   Kaiser A, 2009, LANGMUIR, V25, P7335, DOI 10.1021/la900401f
   Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Li J., 2010, LANGMUIR, V19, P15554
   Li J, 2010, LANGMUIR, V26, P17926, DOI 10.1021/la102867v
   Li L, 2009, MAT SCI ENG C-MATER, V29, P2029, DOI 10.1016/j.msec.2009.03.020
   Lin Y, 2003, SCIENCE, V299, P226, DOI 10.1126/science.1078616
   Liu G, 2008, J AM CHEM SOC, V130, P6820, DOI 10.1021/ja800554t
   Luckarift HR, 2004, NAT BIOTECHNOL, V22, P211, DOI 10.1038/nbt931
   MOZHAEV VV, 1990, BIOTECHNOL BIOENG, V35, P653, DOI 10.1002/bit.260350702
   Naik RR, 2004, CHEM COMMUN, P1684, DOI 10.1039/b404586f
   Navani NK, 2006, CURR OPIN CHEM BIOL, V10, P272, DOI 10.1016/j.cbpa.2006.04.003
   Niu ZW, 2010, ANGEW CHEM INT EDIT, V49, P10052, DOI 10.1002/anie.201001623
   Obert R, 1999, J AM CHEM SOC, V121, P12192, DOI 10.1021/ja991899r
   Olofsson L, 2005, ORG BIOMOL CHEM, V3, P750, DOI 10.1039/b418040b
   Pickering SU, 1907, J CHEM SOC, V91, P2001, DOI 10.1039/ct9079102001
   Pierre AC, 2004, BIOCATAL BIOTRANSFOR, V22, P145, DOI 10.1080/10242420412331283314
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Reincke F, 2004, ANGEW CHEM INT EDIT, V43, P458, DOI 10.1002/anie.200352339
   Ren YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-63
   Russell JT, 2005, ANGEW CHEM INT EDIT, V44, P2420, DOI 10.1002/anie.200462653
   Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736
   Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082
   Shi JF, 2012, BIORESOURCE TECHNOL, V118, P359, DOI 10.1016/j.biortech.2012.04.099
   Shi JF, 2011, ACS APPL MATER INTER, V3, P881, DOI 10.1021/am101241u
   Shylesh S, 2010, ANGEW CHEM INT EDIT, V49, P3428, DOI 10.1002/anie.200905684
   Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239
   Strohm H, 2004, J MATER CHEM, V14, P2667, DOI 10.1039/b406842d
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Torres-Salas P, 2011, ADV MATER, V23, P5275, DOI 10.1002/adma.201101821
   Wehbi H, 2003, BBA-BIOMEMBRANES, V1613, P15, DOI 10.1016/S0005-2736(03)00134-2
   Whitby CP, 2010, J COLLOID INTERF SCI, V342, P205, DOI 10.1016/j.jcis.2009.10.068
   Wu CZ, 2011, ADV MATER, V23, P5694, DOI 10.1002/adma.201102693
   Yang XW, 2012, NANOSCALE, V4, P414, DOI 10.1039/c1nr11153a
   Zebda A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1365
   Zhu LP, 2009, COLLOID SURFACE B, V69, P152, DOI 10.1016/j.colsurfb.2008.11.011
   Zhu LP, 2009, ACTA POLYM SIN, P394
NR 57
TC 29
Z9 29
U1 20
U2 309
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAR 20
PY 2013
VL 23
IS 11
BP 1450
EP 1458
DI 10.1002/adfm.201202068
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 107ZY
UT WOS:000316261400010
DA 2018-10-20
ER

PT J
AU Wang, H
   Wu, Y
   Zhao, RF
   Nie, GJ
AF Wang, Hai
   Wu, Yan
   Zhao, Ruifang
   Nie, Guangjun
TI Engineering the Assemblies of Biomaterial Nanocarriers for Delivery of
   Multiple Theranostic Agents with Enhanced Antitumor Efficacy
SO ADVANCED MATERIALS
LA English
DT Article
DE combination therapy; multifunctional nanoparticles; drug delivery;
   cancer metastasis
ID COMBINATION THERAPY; CO-DELIVERY; CANCER-THERAPY; IN-VIVO; DRUG;
   NANOPARTICLES; COPOLYMER; TUMOR; BIODISTRIBUTION; BIODEGRADATION
AB The rapid development of nanotechnology holds great promise for revolutionizing the current landscape of tumor drug delivery. However, one of the biggest challenges is developing a simple nanocarrier platform to co-deliver various therapeutic agents. Here, a strategy for fabricating nanocarriers with many desirable features is demonstrated. The resulting nanoparticles achieve both high antitumor efficacy and effective inhibition of tumor metastasis with minimal side effects.
   [GRAPHICS]
   .
C1 [Wang, Hai; Wu, Yan; Zhao, Ruifang; Nie, Guangjun] Natl Ctr Nanosci & Technol NCNST, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
RP Nie, GJ (reprint author), Natl Ctr Nanosci & Technol NCNST, CAS Key Lab Biomed Effects Nanomat & Nanosafety, 11 Beiyitiao, Beijing 100190, Peoples R China.
EM niegj@nanoctr.cn
RI Wang, Hai/P-1310-2018; Wang, Hai/D-8914-2017
OI Wang, Hai/0000-0002-6999-554X; Wang, Hai/0000-0002-4639-7360; nie,
   guangjun/0000-0001-5040-9793
FU MOST 973 [2012CB934000, 2011CB933400]; NSFC [10979011, 30900278]
FX This work was supported by MOST 973 (2012CB934000 and 2011CB933400) and
   NSFC (10979011 and 30900278).
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Arai M., 2000, CIRC RES, V86, P879
   Basu S, 2009, P NATL ACAD SCI USA, V106, P7957, DOI 10.1073/pnas.0902857106
   Bendas G, 2003, BBA-BIOMEMBRANES, V1609, P63, DOI 10.1016/S0005-2736(02)00655-7
   BRILES EB, 1978, J NATL CANCER I, V60, P1217, DOI 10.1093/jnci/60.6.1217
   Chang SS, 2010, INT J FOOD MICROBIOL, V141, P236, DOI 10.1016/j.ijfoodmicro.2010.05.021
   Chen S, 2008, INT J PHARM, V352, P58, DOI 10.1016/j.ijpharm.2007.10.016
   Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108
   FIDLER IJ, 1990, CANCER RES, V50, P6130
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Gautam A, 2000, MOL THER, V2, P318, DOI 10.1006/mthe.2000.0138
   Hanson JA, 2008, NATURE, V455, P85, DOI 10.1038/nature07197
   Henningsson A, 2001, J CLIN ONCOL, V19, P4065, DOI 10.1200/JCO.2001.19.20.4065
   Kappler M, 2005, ONCOL REP, V13, P167
   Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107
   Lee CH, 2006, MOL CANCER THER, V5, P2592, DOI 10.1158/1535-7163.MCT-06-0310
   Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549
   Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010
   McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656
   Messerli FH, 2000, AM J CARDIOL, V86, P1182, DOI 10.1016/S0002-9149(00)01199-1
   Muller I, 1997, BIOCHEM BIOPH RES CO, V230, P254, DOI 10.1006/bbrc.1996.5898
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   O'Shaughnessy J, 2002, J CLIN ONCOL, V20, P2812, DOI 10.1200/JCO.2002.09.002
   Paraskar AS, 2010, P NATL ACAD SCI USA, V107, P12435, DOI 10.1073/pnas.1007026107
   Ranganath SH, 2010, BIOMATERIALS, V31, P5199, DOI 10.1016/j.biomaterials.2010.03.002
   Saad M, 2008, NANOMEDICINE-UK, V3, P761, DOI 10.2217/17435889.3.6.761
   Wang H, 2011, BIOMATERIALS, V32, P8281, DOI 10.1016/j.biomaterials.2011.07.032
   Wang X, 2008, CA-CANCER J CLIN, V58, P97, DOI 10.3322/CA.2007.0003
   Wang Y, 2006, NAT MATER, V5, P791, DOI 10.1038/nmat1737
   Wilson KD, 2007, INT IMMUNOPHARMACOL, V7, P1064, DOI 10.1016/j.intimp.2007.04.002
   Wood A.J., 2003, NEW ENGL J MED, V348, P538, DOI DOI 10.1056/NEJMRA020526
   Xie JP, 2009, J AM CHEM SOC, V131, P888, DOI 10.1021/ja806804u
   Yin C, 2010, J COLLOID INTERF SCI, V349, P153, DOI 10.1016/j.jcis.2010.05.028
   Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9
NR 34
TC 63
Z9 65
U1 5
U2 152
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD MAR 20
PY 2013
VL 25
IS 11
BP 1616
EP 1622
DI 10.1002/adma.201204750
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 107KM
UT WOS:000316215700015
PM 23341059
DA 2018-10-20
ER

PT J
AU Martino, MM
   Briquez, PS
   Ranga, A
   Lutolf, MP
   Hubbell, JA
AF Martino, Mikael M.
   Briquez, Priscilla S.
   Ranga, Adrian
   Lutolf, Matthias P.
   Hubbell, Jeffrey A.
TI Heparin-binding domain of fibrin(ogen) binds growth factors and promotes
   tissue repair when incorporated within a synthetic matrix
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE regenerative medicine; hydrogel; angiogenesis
ID EXTRACELLULAR-MATRIX; WOUND REPAIR; FIBRINOGEN; SITE; VITRONECTIN;
   HYDROGELS; ENHANCE; SULFATE; FGF-2
AB By binding growth factors (GFs), the ECM tightly regulates their activity. We recently reported that the heparin-binding domain II of fibronectin acts as a promiscuous high-affinity GF-binding domain. Here we hypothesized that fibrin, the provisional ECM during tissue repair, also could be highly promiscuous in its GF-binding capacity. Using multiple affinity-based assays, we found that fibrin(ogen) and its heparin-binding domain bind several GFs from the PDGF/VEGF and FGF families and some GFs from the TGF-beta and neurotrophin families. Overall, we identified 15 unique binding interactions. The GF binding ability of fibrinogen caused prolonged retention of many of the identified GFs within fibrin. Thus, based on the promiscuous and high-affinity interactions in fibrin, GF binding may be one of fibrin's main physiological functions, and these interactions may potentially play an important and ubiquitous role during tissue repair. To prove this role in a gain-of-function model, we incorporated the heparin-binding domain of fibrin into a synthetic fibrin-mimetic matrix. In vivo, the multifunctional synthetic matrix could fully mimic the effect of fibrin in a diabetic mouse model of impaired wound healing, demonstrating the benefits of generating a hybrid biomaterial consisting of a synthetic polymeric scaffold and recombinant bioactive ECM domains. The reproduction of GF-ECM interactions with a fibrin-mimetic matrix could be clinically useful, and has the significant benefit of a more straightforward regulatory path associated with chemical synthesis rather than human sourcing.
C1 [Martino, Mikael M.; Briquez, Priscilla S.; Ranga, Adrian; Lutolf, Matthias P.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland.
   [Martino, Mikael M.; Briquez, Priscilla S.; Ranga, Adrian; Lutolf, Matthias P.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, CH-1015 Lausanne, Switzerland.
   [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.
RP Hubbell, JA (reprint author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland.
EM jeffrey.hubbell@epfl.ch
RI Lutolf, Matthias/E-5914-2010; Martino, Mikael/N-9345-2013; Hubbell,
   Jeffrey/A-9266-2008
OI Martino, Mikael/0000-0002-5012-4605; Hubbell,
   Jeffrey/0000-0003-0276-5456
FU European Community's Seventh Framework Programme (Project Angioscaff)
   [NMP-LA-2008-214402]; Swiss National Science Foundation
FX We thank the staff at the Proteomics and Histology Core Facilities of
   Ecole Polytechnique Federale de Lausanne, as well as Miriella Pasquier,
   Xavier Quaglia, Celine Dessibourg, and Matteo T. Degiacomi for technical
   assistance and Jeffrey J. Rice for fruitful discussions and helpful
   comments. This work was funded in part by the European Community's
   Seventh Framework Programme (Project Angioscaff NMP-LA-2008-214402) and
   the Swiss National Science Foundation.
CR Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729
   Campbell PG, 1999, J BIOL CHEM, V274, P30215, DOI 10.1074/jbc.274.42.30215
   Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314
   Davidson JM, 1998, ARCH DERMATOL RES, V290, pS1, DOI 10.1007/PL00007448
   Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f
   Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027
   Gui YT, 2001, J CLIN ENDOCR METAB, V86, P2104, DOI 10.1210/jc.86.5.2104
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Martino MM, 2011, SCI TRANSL MED, V3
   Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Patterson J, 2011, BIOMATERIALS, V32, P1301, DOI 10.1016/j.biomaterials.2010.10.016
   Peng H, 2004, BLOOD, V103, P2114, DOI 10.1182/blood-2003-08-2638
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Sahni A, 2000, BLOOD, V96, P3772
   Sahni A, 2006, BLOOD, V107, P126, DOI 10.1182/blood-2005-06-2460
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schoppet M, 2002, LAB INVEST, V82, P37, DOI 10.1038/labinvest.3780393
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Smith EM, 2009, P NATL ACAD SCI USA, V106, P21683, DOI 10.1073/pnas.0902510106
   Sullivan SR, 2004, PLAST RECONSTR SURG, V113, P953, DOI 10.1097/01.PRS.0000105044.03230.F4
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79
   Yakovlev S, 2003, BIOCHEMISTRY-US, V42, P7709, DOI 10.1021/bi0344073
NR 29
TC 164
Z9 168
U1 7
U2 100
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 19
PY 2013
VL 110
IS 12
BP 4563
EP 4568
DI 10.1073/pnas.1221602110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 125EK
UT WOS:000317521600040
PM 23487783
OA Bronze, Green Published
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Moraes, ML
   Lima, LR
   Silva, RR
   Cavicchioli, M
   Ribeiro, SJL
AF Moraes, Marli L.
   Lima, Lais R.
   Silva, Robson R.
   Cavicchioli, Mauricio
   Ribeiro, Sidney J. L.
TI Immunosensor Based on Immobilization of Antigenic Peptide NS5A-1 from
   HCV and Silk Fibroin in Nanostructured Films
SO LANGMUIR
LA English
DT Article
ID BIOMATERIAL COATINGS; PHYSICAL-PROPERTIES; CONTROLLED-RELEASE; CHITOSAN;
   LAYER; ADSORPTION; PROTEIN; BIOSENSORS; OXIDASE
AB The peptide NS5A-1 (PPLLESWICDP-DYVPPWHG), derived from hepatitis C virus (HCV) NS5A protein, was immobilized into layer-by-layer (LbL) silk fibroin (SF) films. Deposition was monitored by UV-vis absorption measurements at each bilayer deposited. The interaction SF/peptide film induced secondary structure in NS5A-1 as indicated by fluorescence and circular dichroism (CD) measurements. Voltammetric sensor (SF/NS5A-1) properties were observed when the composite film was tested in the presence of anti-HCV. The peptide silk fibroin interaction studied here showed new architectures for immunosensors based on antigenic peptides and SF as a suitable immobilization matrix.
C1 [Moraes, Marli L.; Lima, Lais R.; Silva, Robson R.; Cavicchioli, Mauricio; Ribeiro, Sidney J. L.] Sao Paulo State Univ, UNESP, Inst Chem, BR-14801970 Araraquara, SP, Brazil.
RP Moraes, ML (reprint author), Sao Paulo State Univ, UNESP, Inst Chem, CP355, BR-14801970 Araraquara, SP, Brazil.
EM marli.moraes@gmail.com
RI Moraes, Marli/D-9263-2012; Ribeiro, Sidney/E-9864-2012; Cavicchioli,
   Mauricio/A-3073-2008; Rosa da Silva, Robson/N-9882-2018
OI Moraes, Marli/0000-0003-0213-3686; Ribeiro, Sidney/0000-0002-8162-6747;
   Cavicchioli, Mauricio/0000-0002-6557-7391; Rosa da Silva,
   Robson/0000-0001-6887-4749; Ribeiro, Sidney/0000-0003-3286-9440
FU FAPESP; CNPq; Nanobiotec-CAPES network (Brazil)
FX This work was supported by FAPESP, CNPq, and Nanobiotec-CAPES network
   (Brazil).
CR Ariga K, 1997, J AM CHEM SOC, V119, P2224, DOI 10.1021/ja963442c
   Ariga K, 2008, MACROMOL BIOSCI, V8, P981, DOI 10.1002/mabi.200800102
   Busquets MA, 2003, CURR DRUG TARGETS, V4, P633, DOI 10.2174/1389450033490795
   Cai K, 2007, J BIOMED MATER RES A, V82A, P927, DOI 10.1002/jbm.a.31233
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DYSON HJ, 1995, FASEB J, V9, P37
   Gotoh Y, 1997, POLYMER, V38, P487, DOI 10.1016/S0032-3861(96)00665-9
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin X, 2011, CARBOHYD POLYM, V85, P786, DOI 10.1016/j.carbpol.2011.03.048
   Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE
   Li GY, 2001, EUR J BIOCHEM, V268, P6600, DOI 10.1046/j.0014-2956.2001.02614.x
   Liu YX, 2005, COLLOID SURFACE B, V46, P117, DOI 10.1016/j.colsurfb.2005.09.005
   MAGOSHI J, 1977, POLYMER, V18, P643, DOI 10.1016/0032-3861(77)90229-4
   Mandal BB, 2009, EUR J PHARM SCI, V37, P160, DOI 10.1016/j.ejps.2009.02.005
   Moraes ML, 2009, MAT SCI ENG C-BIO S, V29, P442, DOI 10.1016/j.msec.2008.08.040
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Nogueira GM, 2010, LANGMUIR, V26, P8953, DOI 10.1021/la904741h
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Petri L, 2011, J NANOSCI NANOTECHNO, V11, P6705, DOI 10.1166/jnn.2011.4216
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Raghava G. P. S., APSSP2 COMBINATION M
   Rickert J, 1996, BIOSENS BIOELECTRON, V11, P757, DOI 10.1016/0956-5663(96)85927-6
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ronkainen NJ, 2010, CHEM SOC REV, V39, P1747, DOI 10.1039/b714449k
   SAGIV J, 1980, J AM CHEM SOC, V102, P92, DOI 10.1021/ja00521a016
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Teles FRR, 2008, MAT SCI ENG C-BIO S, V28, P1530, DOI 10.1016/j.msec.2008.04.010
   Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wu BY, 2007, BIOSENS BIOELECTRON, V22, P838, DOI 10.1016/j.bios.2006.03.009
   Xue R, 2012, APPL SURF SCI, V258, P6040, DOI 10.1016/j.apsusc.2012.02.123
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Yuan Y, 2012, ANALYST, V137, P496, DOI 10.1039/c1an15875a
   ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 39
TC 14
Z9 15
U1 0
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 19
PY 2013
VL 29
IS 11
BP 3829
EP 3834
DI 10.1021/la304404v
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 106TU
UT WOS:000316168400037
PM 23414139
DA 2018-10-20
ER

PT J
AU Berts, I
   Gerelli, Y
   Hilborn, J
   Rennie, AR
AF Berts, Ida
   Gerelli, Yuri
   Hilborn, Jons
   Rennie, Adrian R.
TI Structure of polymer and particle aggregates in hydrogel composites
SO JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS
LA English
DT Article
DE biopolymers; correlation length; hyaluronan; hydrogels; nanocomposites;
   neutron scattering
ID POLY(VINYL ALCOHOL); IN-VIVO; INJECTABLE HYDROGELS; MODIFIED CHITOSAN;
   DRUG-DELIVERY; BONE; GELS; POLYELECTROLYTE; HYALURONAN; SCATTERING
AB Knowledge of the structure of a biomaterial is usually vital to control its function. This article provides a structural characterization of a hyaluronan scaffold that has demonstrated good biocompatibility and is used to induce bone regeneration. Hyaluronan hydrogels are appealing materials that can function as a matrix to incorporate both organic and inorganic substances to enhance tissue growth. Because of the intrinsic properties of this swollen matrix, one needs a very sensitive technique that can be applied in situ to determine the organization of the polymers in a gel. Small-angle neutron scattering is used to determine the characteristics of the inhomogeneous structure of the hydrogel both with and without added particles. The results are interpreted using models of structure with two length scales that are beyond the traditional picture of homogeneous gels. The observed structure and the dimensions can explain the previously reported rheological properties of gels containing different amount of polymers. Hydroxyapatite nanoparticles added to the gel are frozen in the gel matrix. We are able to determine the distribution and shape of these particles as they aggregate around the polymer chains. We have also concluded, in this case, that the particle structure is concentration independent. Information about the nanostructure for an applicable biomaterial guides the formulation, preparation, and use that should lead to further understanding of its exploitation. (c) 2012 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys, 2013
C1 [Berts, Ida; Hilborn, Jons] Uppsala Univ, Sci Life Lab, Dept Chem, Angstrom Lab, S-75121 Uppsala, Sweden.
   [Berts, Ida; Gerelli, Yuri] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France.
   [Rennie, Adrian R.] Uppsala Univ, Dept Phys & Astron Mat Phys, S-75120 Uppsala, Sweden.
RP Berts, I (reprint author), Uppsala Univ, Sci Life Lab, Dept Chem, Angstrom Lab, Box 538, S-75121 Uppsala, Sweden.
EM berts@ill.fr
RI Gerelli, Yuri/F-4131-2010
OI Gerelli, Yuri/0000-0001-5655-8298; Hilborn, Jons/0000-0001-6947-9601
CR Baksh D, 1998, J MATER SCI-MATER M, V9, P743, DOI 10.1023/A:1008959103864
   Bergman K, 2007, BIOMACROMOLECULES, V8, P2190, DOI 10.1021/bm0701604
   Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289
   Berts I., 2009, THESIS UPPSALA U UPP
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Boyce MC, 2000, RUBBER CHEM TECHNOL, V73, P504, DOI 10.5254/1.3547602
   Buhler E, 2004, MACROMOLECULES, V37, P1600, DOI 10.1021/ma0215520
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   D'Errico G., 2007, BIOMACROMOLECULES, V9, P231
   DEBYE P, 1949, J APPL PHYS, V20, P518, DOI 10.1063/1.1698419
   deGennes PG, 1979, SCALING CONCEPTS POL
   Deiber JA, 2009, POLYMER, V50, P6065, DOI 10.1016/j.polymer.2009.10.046
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   GEISSLER E, 1993, PHYS REV LETT, V71, P645, DOI 10.1103/PhysRevLett.71.645
   Ghosh R. E., 2006, COMPUTING GUIDE SMAL
   Hansen JK, 2005, ANN OTO RHINOL LARYN, V114, P662, DOI 10.1177/000348940511400902
   Harrison A., 1995, FRACTALS CHEM
   Higgins J. S., 1994, POLYM NEUTRON SCATTE
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   HORKAY F, 1993, MACROMOLECULES, V26, P1296, DOI 10.1021/ma00058a017
   Horkay F, 2005, POLYMER, V46, P4242, DOI 10.1016/j.polymer.2005.02.054
   HORKAY F, 1991, MACROMOLECULES, V24, P2896, DOI 10.1021/ma00010a040
   Horkay F, 2002, J CHEM PHYS, V117, P9103, DOI 10.1063/1.1522399
   Horkay F, 2006, J POLYM SCI POL PHYS, V44, P3679, DOI 10.1002/polb.21008
   Horkay F, 2009, LANGMUIR, V25, P8735, DOI 10.1021/la900103j
   Hu QH, 2007, J MATER CHEM, V17, P4690, DOI 10.1039/b710936a
   Hulsart S. G., 2010, THESIS UPPSALA U UPP
   Hulsart-Billstrom G, 2011, ACTA BIOMATER, V7, P3042, DOI 10.1016/j.actbio.2011.04.021
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Kohlbrecher J, 2008, SASFIT PROGRAM FITTI
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lieutenant K, 2007, J APPL CRYSTALLOGR, V40, P1056, DOI 10.1107/S0021889807038253
   Mangiapia G, 2007, J PHYS CHEM B, V111, P2166, DOI 10.1021/jp0663107
   Monier M, 2010, POLYMER, V51, P1002, DOI 10.1016/j.polymer.2010.01.001
   Nam K, 2005, POLYMER, V46, P4704, DOI 10.1016/j.polymer.2005.03.087
   Ossipov DA, 2006, MACROMOLECULES, V39, P1709, DOI 10.1021/ma052545p
   Ossipov DA, 2008, MACROMOLECULES, V41, P3971, DOI 10.1021/ma800332c
   Ossipov DA, 2007, J APPL POLYM SCI, V106, P60, DOI 10.1002/app.26455
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Piskounova S, 2011, MACROMOL MATER ENG, V296, P944, DOI 10.1002/mame.201100008
   Sen M, 1999, POLYMER, V40, P2969, DOI 10.1016/S0032-3861(98)00251-1
   Shibayama M., 2008, SOFT MATTER CHARACTE, P787
   TEIXEIRA J, 1988, J APPL CRYSTALLOGR, V21, P781, DOI 10.1107/S0021889888000263
   Teng DY, 2010, POLYMER, V51, P639, DOI 10.1016/j.polymer.2009.12.003
   Theunissen E, 2004, POLYMER, V45, P1857, DOI 10.1016/j.polymer.2004.01.016
   Treloar L. R. G., 1975, PHYS RUBBER ELASTICI
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Van Vlierberghe S, 2010, APPL SPECTROSC, V64, P1176, DOI 10.1366/000370210792973550
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang M, 2005, POLYMER, V46, P3639, DOI 10.1016/j.polymer.2005.03.022
   Zhang YB, 2001, J CHEM PHYS, V114, P3299, DOI 10.1063/1.1336148
   ZRINYI M, 1992, POLYM BULL, V29, P445, DOI 10.1007/BF00944843
NR 55
TC 8
Z9 8
U1 0
U2 105
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-6266
EI 1099-0488
J9 J POLYM SCI POL PHYS
JI J. Polym. Sci. Pt. B-Polym. Phys.
PD MAR 15
PY 2013
VL 51
IS 6
BP 421
EP 429
DI 10.1002/polb.23230
PG 9
WC Polymer Science
SC Polymer Science
GA 091LK
UT WOS:000315050800005
DA 2018-10-20
ER

PT J
AU Zhao, Z
   Li, Y
   Chen, AZ
   Zheng, ZJ
   Hu, JY
   Li, JS
   Li, G
AF Zhao, Zheng
   Li, Yi
   Chen, Ai-Zheng
   Zheng, Zi-Jian
   Hu, Jun-Yan
   Li, Jia-Shen
   Li, Gang
TI Generation of Silk Fibroin Nanoparticles via Solution-Enhanced
   Dispersion by Supercritical CO2
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID CONTROLLED DRUG-DELIVERY; ANTISOLVENT PRECIPITATION; MICROSPHERES;
   FABRICATION; MICROPARTICLES; ATOMIZATION; BIOMATERIAL; SCAFFOLDS;
   RELEASE; DESIGN
AB A solution-enhanced dispersion by supercritical CO2 (SEDS) was employed to prepare silk fibroin (SF) nanoparticles. The results of 2(4) full factorial experiment indicated that SF nanoparticles with particle size (PS) from 52.5 to 102.3 nm and particle size distribution (PSD) from 0.32 to 0.66 can be fabricated successfully. Moreover, reducing precipitation pressure or increasing concentration of SF solution, flow rate of SF solution, or precipitation temperature can increase PS and PSD of SF nanoparticles. The nanoparticle formation mechanism was elucidated through the formation and growth of SF nuclei in the gaseous miscible phase evolved from initial droplets generated by liquid liquid phase split. Mass transfer between supercritical CO2 and SF solution superimposed on supersaturation was the most important process parameter affecting nanoparticle formation. Furthermore, Fourier transform infrared spectroscopy and X-ray powder diffraction analysis revealed that SF nanoparticles exhibited predominant random coil and a-helix structure with minor beta-sheet conformation.
C1 [Zhao, Zheng; Li, Yi; Chen, Ai-Zheng; Zheng, Zi-Jian; Hu, Jun-Yan; Li, Jia-Shen; Li, Gang] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.
   [Chen, Ai-Zheng] Huaqiao Univ, Coll Chem Engn, Xiamen 361021, Fujian, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.
EM tcliyi@polyu.edu.hk
RI LI, YI/G-4421-2012; Li, Jiashen/E-8571-2015; HU, Junyan/J-7323-2012;
   ZHENG, ZIJIAN/B-4012-2009; Li, Jiashen/J-6946-2012
OI LI, YI/0000-0002-2092-4505; ZHENG, ZIJIAN/0000-0002-6653-7594; Li,
   Jiashen/0000-0001-7333-5280
FU Hong Kong Innovation and Technology Commission and Hong Kong Research
   Institute of Textile [1TP/001/07TP, ITP/031/08TP]; Hong Kong Research
   Grant Council; Hong Kong Polytechnic University [PolyU5242/09E, G-YX1M,
   J-BB6Q, GU942]; Guangdong Provincial Department of Science and
   Technology through the Guangdong Hong Kong International Textile
   Bioengineering Joint Research Center [2011B050300023]; Hong Kong Jockey
   Club Sports Medicine and Health Science Center
FX We thank Hong Kong Innovation and Technology Commission and Hong Kong
   Research Institute of Textile and Apparel for providing funding support
   to this research through Projects 1TP/001/07TP and ITP/031/08TP and the
   Hong Kong Research Grant Council and the Hong Kong Polytechnic
   University through Projects PolyU5242/09E, G-YX1M, J-BB6Q, and GU942.
   Also, we acknowledge with thanks the support of Guangdong Provincial
   Department of Science and Technology through the Guangdong Hong Kong
   International Textile Bioengineering Joint Research Center with project
   code 2011B050300023, as well as the sponsorship from Hong Kong Jockey
   Club Sports Medicine and Health Science Center.
CR Berthold A, 1996, J CONTROL RELEASE, V39, P17, DOI 10.1016/0168-3659(95)00129-8
   Braeuer A, 2011, CHEM ENG J, V173, P258, DOI 10.1016/j.cej.2011.07.064
   Breslauer DN, 2010, BIOMACROMOLECULES, V11, P643, DOI 10.1021/bm901209u
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Chen AZ, 2011, J SUPERCRIT FLUID, V59, P92, DOI 10.1016/j.supflu.2011.08.012
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   He JX, 2010, POLYM BULL, V65, P395, DOI 10.1007/s00289-010-0293-y
   He WZ, 2010, J MATER SCI, V45, P467, DOI 10.1007/s10853-009-3963-0
   Jin H. Y., 2011, IND ENG CHEM RES, V50, P13475
   Kalani M, 2011, INT J NANOMED, V6, P1429, DOI 10.2147/IJN.S19021
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kundu J, 2008, MAT SCI ENG C-BIO S, V28, P1376, DOI 10.1016/j.msec.2008.03.004
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lee BM, 2011, IND ENG CHEM RES, V50, P9107, DOI 10.1021/ie102593p
   Magoshi J., 1977, J POLYM SCI POL PHYS, V15, P167
   MECLEAN S, 1998, EUR J PHARM SCI, V6, P153
   Montes A, 2011, IND ENG CHEM RES, V50, P2343, DOI 10.1021/ie101334v
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Rajkhowa R, 2009, POWDER TECHNOL, V191, P155, DOI 10.1016/j.powtec.2008.10.004
   Reverchon E, 2008, J SUPERCRIT FLUID, V44, P98, DOI 10.1016/j.supflu.2007.08.008
   Reverchon E, 2003, IND ENG CHEM RES, V42, P6406, DOI 10.1021/ie0302138
   Reverchon E, 2006, POWDER TECHNOL, V164, P139, DOI 10.1016/j.powtec.2006.03.018
   Reverchon E, 2011, CHEM ENG J, V169, P358, DOI 10.1016/j.cej.2011.02.064
   SCHAFER V, 1992, PHARMACEUT RES, V9, P541, DOI 10.1023/A:1015852732512
   Srisuwan Y, 2009, J MACROMOL SCI A, V46, P521, DOI 10.1080/10601320902797780
   Sundar S, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014104
   Tenorio A, 2008, J SUPERCRIT FLUID, V44, P230, DOI 10.1016/j.supflu.2007.10.009
   Wang Q, 2011, J SUPERCRIT FLUID, V56, P97, DOI 10.1016/j.supflu.2010.12.002
   Wang Q, 2010, CHEM ENG J, V159, P220, DOI 10.1016/j.cej.2010.02.004
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Zhang F, 2009, J MATER SCI, V44, P5682, DOI 10.1007/s10853-009-3800-5
   Zhang H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-117
   Zhao XH, 2012, IND ENG CHEM RES, V51, P9591, DOI 10.1021/ie3011726
   Zhao Z, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0736-5
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 40
TC 17
Z9 18
U1 3
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD MAR 13
PY 2013
VL 52
IS 10
BP 3752
EP 3761
DI 10.1021/ie301907f
PG 10
WC Engineering, Chemical
SC Engineering
GA 107TQ
UT WOS:000316244100022
DA 2018-10-20
ER

PT J
AU Manikandan, A
   Vijaya, JJ
   Kennedy, LJ
   Bououdina, M
AF Manikandan, A.
   Vijaya, J. Judith
   Kennedy, L. John
   Bououdina, M.
TI Structural, optical and magnetic properties of Zn1-xCuxFe2O4
   nanoparticles prepared by microwave combustion method
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE Microwave combustion synthesis; Nanoparticles; Spinel ferrites; Electron
   microscopy; X-ray analysis
ID FERRITE COMPOSITE NANOPARTICLES; ZINC-FERRITE; THIN-FILMS;
   PHOTOCATALYTIC PROPERTIES; ELECTRICAL-PROPERTIES; BIOMATERIAL SYSTEM;
   ASSISTED SYNTHESIS; NANO; ZNFE2O4; SIZE
AB Nano-sized copper doped zinc ferrite powders, Zn1-xCuxFe2O4 (x = 0.0, 0.1, 0.2, 0.3, 0.4 and 0.5) were synthesized by microwave combustion method. The structural, morphological and magnetic properties of the products were determined and characterized in detail by X-ray diffraction (XRD), high resolution scanning electron microscopy (HR-SEM), energy dispersive X-ray spectroscopy (EDX) and vibrating sample magnetometer (VSM). X-ray analysis showed that all compositions crystallize with a cubic spinel-type structure. The lattice parameter decreased from 8.443 to 8.413 angstrom with increasing Cu content. The average crystallite size was found in the range of 41.20-45.84 nm. Magnetic measurements revealed that for lower Cu concentration (x <= 0.2), the system shows a superparamagnetic behavior whereas for higher concentration (x >= 0.2), it becomes ferromagnetic. It has been explained in terms of random distribution of Zn2+ and Fe3+ ions at tetrahedral [A] and octahedral [B] sites. The saturation magnetization (M-s) varies considerably with Cu content to reach a maximum value for Cu0.5Zn0.5Fe2O4 composition, i.e. 58.58 emu/g. The high saturation magnetization of these samples suggests that this method is suitable for preparing high quality nanoparticles for magnetic applications. The broadband visible emission is observed in the entire photoluminescence (PL) spectrum and the estimated energy band gap is about 2.1 eV. The composition with x = 0.5 showed the highest intensity and was explained on the basis of disordered cluster model. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Manikandan, A.; Vijaya, J. Judith] Loyola Coll, Dept Chem, Catalysis & Nanomat Res Lab, Madras 600034, Tamil Nadu, India.
   [Kennedy, L. John] Vellore Inst Technol Univ, Sch Adv Sci, Div Mat, Madras 600127, Tamil Nadu, India.
   [Bououdina, M.] Univ Bahrain, Coll Sci, Dept Phys, Sakhir 32038, Bahrain.
   [Bououdina, M.] Univ Bahrain, Nanotechnol Ctr, Sakhir 32038, Bahrain.
RP Vijaya, JJ (reprint author), Loyola Coll, Dept Chem, Catalysis & Nanomat Res Lab, Madras 600034, Tamil Nadu, India.
EM jjvijayaloyola@yahoo.co.in
OI MANIKANDAN, A/0000-0001-6513-7428
CR Acharya P, 2008, PRAMANA-J PHYS, V71, P1069, DOI 10.1007/s12043-008-0225-7
   Ahmed AS, 2011, J LUMIN, V131, P1, DOI 10.1016/j.jlumin.2010.07.017
   Ashraf MA, 2010, PHYSICA B, V405, P3770, DOI 10.1016/j.physb.2010.05.084
   Ayyappan S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3374332
   Azam A, 2012, J ALLOY COMPD, V540, P145, DOI 10.1016/j.jallcom.2012.06.068
   Azam A, 2011, J ALLOY COMPD, V509, P2909, DOI 10.1016/j.jallcom.2010.11.153
   Berkowitz A.E., 1999, J MAGN MAGN MATER, V591, P196
   Bhargava R, 2010, MATER CHEM PHYS, V120, P393, DOI 10.1016/j.matchemphys.2009.11.024
   Bid S, 2003, MATER CHEM PHYS, V82, P27, DOI 10.1016/S0254-0584(03)00169-X
   Bohra M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2217253
   Borse PH, 2009, J KOREAN PHYS SOC, V55, P1472, DOI 10.3938/jkps.55.1472
   Chen NS, 2000, SENSOR ACTUAT B-CHEM, V66, P178, DOI 10.1016/S0925-4005(00)00368-3
   Chen ZC, 2007, THIN SOLID FILMS, V515, P5462, DOI 10.1016/j.tsf.2007.01.015
   Chen Z, 2009, J ALLOY COMPD, V473, pL13, DOI 10.1016/j.jallcom.2008.05.060
   Choi EJ, 2008, J KOREAN PHYS SOC, V53, P2090
   Deraz NM, 2012, J ANAL APPL PYROL, V94, P41, DOI 10.1016/j.jaap.2011.10.004
   Dijken A.V., 2000, J LUMIN, V90, P123
   Ehrhardt H, 2002, J ALLOY COMPD, V339, P255, DOI 10.1016/S0925-8388(01)02011-4
   Gabal MA, 2004, MATER CHEM PHYS, V85, P104, DOI 10.1016/j.matchemphys.2003.12.013
   Gao DQ, 2010, NANOSCALE RES LETT, V5, P1289, DOI 10.1007/s11671-010-9640-z
   Gnanaprakash G, 2007, MATER LETT, V61, P4545, DOI 10.1016/j.matlet.2007.02.048
   Goya G.F., 1999, J MAGN MAGN MATER, p[191, 196]
   Gur E, 2009, APPL PHYS A-MATER, V94, P549, DOI 10.1007/s00339-008-4960-x
   Hankare PP, 2011, APPL CATAL B-ENVIRON, V107, P333, DOI 10.1016/j.apcatb.2011.07.033
   Kale RB, 2004, APPL SURF SCI, V223, P343, DOI 10.1016/j.apsusc.2003.09.022
   Kim DH, 2009, J MAGN MAGN MATER, V321, P3899, DOI 10.1016/j.jmmm.2009.07.057
   Kislov N, 2008, MATER SCI ENG B-ADV, V153, P70, DOI 10.1016/j.mseb.2008.10.032
   Kobayashi M, 2002, IND ENG CHEM RES, V41, P2903, DOI 10.1021/ie010846r
   Kumar A, 2010, THIN SOLID FILMS, V519, P1056, DOI 10.1016/j.tsf.2010.08.043
   Kumar A, 2010, PHYSCS PROC, V9, P20, DOI 10.1016/j.phpro.2010.11.006
   Kundu A, 2003, PHYS LETT A, V311, P410, DOI 10.1016/S0375-9601(03)00509-7
   Lemine OM, 2011, PHYSICA B, V406, P1989, DOI 10.1016/j.physb.2011.02.072
   Mamiya H, 2010, J MAGN MAGN MATER, V322, P1561, DOI 10.1016/j.jmmm.2009.09.023
   Mangalaraja RV, 2009, POWDER TECHNOL, V191, P309, DOI 10.1016/j.powtec.2008.10.019
   Masala O, 2005, J AM CHEM SOC, V127, P9354, DOI 10.1021/ja051244s
   Mohai I., 2001, SOLID STATE IONICS, V163, P141
   Mohebbi H, 2008, J POWER SOURCES, V178, P64, DOI 10.1016/j.jpowsour.2007.12.054
   Mohebbi H, 2009, POWDER TECHNOL, V188, P183, DOI 10.1016/j.powtec.2008.04.095
   Mohseni H., J MAGN MAGN MAT
   Mohseni H., 2012, J MAGN MAGN MATER, V324, P3227
   Mukherjee K, 2010, SENSOR ACTUAT B-CHEM, V146, P91, DOI 10.1016/j.snb.2010.02.020
   Nakashima S, 2007, J MAGN MAGN MATER, V310, P2543, DOI 10.1016/j.jmmm.2006.11.144
   Navale S.C., 2008, MAT SCI ENG C, P1317
   Parthibavarman M, 2011, MAT SCI ENG C-MATER, V31, P840, DOI 10.1016/j.msec.2011.01.002
   Philip J, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777168
   Qiu JX, 2004, MAT SCI ENG B-SOLID, V112, P1, DOI 10.1016/j.mseb.2004.04.012
   Rajak H, 2004, J SCI IND RES INDIA, V63, P641
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Selvam NCS, 2013, J COLLOID INTERF SCI, V389, P91, DOI 10.1016/j.jcis.2012.09.014
   Selvam NCS, 2011, J ALLOY COMPD, V509, P9809, DOI 10.1016/j.jallcom.2011.08.032
   Sepelak V., 2004, MAT SCI ENG A-STRUCT, V865, P375
   Srivastava M, 2009, MATER CHEM PHYS, V118, P174, DOI 10.1016/j.matchemphys.2009.07.023
   Sultana S, 2012, J ALLOY COMPD, V535, P44, DOI 10.1016/j.jallcom.2012.04.081
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tahmasebi K, 2011, J ALLOY COMPD, V509, P1192, DOI 10.1016/j.jallcom.2010.09.176
   Tanaka K, 1998, J PHYS CHEM SOLIDS, V59, P1611, DOI 10.1016/S0022-3697(98)00078-X
   Toledo-Antonio JA, 2002, APPL CATAL A-GEN, V234, P137, DOI 10.1016/S0926-860X(02)00212-0
   Varshney D, 2011, MATER CHEM PHYS, V131, P413, DOI 10.1016/j.matchemphys.2011.09.066
   Wang WW, 2007, J NANOPART RES, V9, P419, DOI 10.1007/s11051-005-9051-8
   Wang YS, 2006, J PHYS CHEM B, V110, P21412, DOI 10.1021/jp0654415
   Yamanaka T, 2001, PHYS CHEM MINER, V28, P102, DOI 10.1007/s002690000135
   Yang H, 2010, BIOMATERIALS, V31, P3667, DOI 10.1016/j.biomaterials.2010.01.055
   Yogo T, 2005, J MATER RES, V20, P1470, DOI 10.1557/JMR.2005.0187
   Zhu HL, 2006, NANOTECHNOLOGY, V17, P2386, DOI 10.1088/0957-4484/17/9/052
NR 64
TC 69
Z9 69
U1 0
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD MAR 13
PY 2013
VL 1035
BP 332
EP 340
DI 10.1016/j.molstruc.2012.11.007
PG 9
WC Chemistry, Physical
SC Chemistry
GA 095DS
UT WOS:000315315500045
DA 2018-10-20
ER

PT J
AU Kim, MR
   Lim, YT
   Cho, KY
AF Kim, Mi Ri
   Lim, Yong Taik
   Cho, Kuk Young
TI Biodegradable Microparticles with Surface Dimples as a Bi-Modal Imaging
   Contrast Agent
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE biomaterial; bi-modal imaging; colloids; dendritic cells;
   poly(dl-lactide-co-glycolide)
ID DRUG-DELIVERY; CANCER-CELLS; PARTICLES; DESIGN
AB Fabrication of physically engineered colloids and their application to the biological fields is emerging importance because of their potential to provide an enhanced performance without altering the chemical properties of biomaterials used. A facile approach is reported to fabricate sub-10-m-sized PLGA microparticle with small dimples covering the surface by droplet imprinting. Optical and magnetic resonance bioimaging agents are easily co-encapsulated inside the microparticles to obtain a bi-modal imaging agent. Cell internalization efficacy of dimpled particles in DC 2.4 cell is enhanced compared with conventional smooth round-shaped colloids. Our result indicates that morphology-controlled microparticles show promise as a cell labeling with improved cell interaction.
C1 [Kim, Mi Ri; Cho, Kuk Young] Kongju Natl Univ, Div Adv Mat Engn, Cheonan 331717, South Korea.
   [Lim, Yong Taik] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon 305764, South Korea.
RP Lim, YT (reprint author), Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon 305764, South Korea.
EM yongtaik@cnu.ac.kr; kycho@kongju.ac.kr
RI Cho, Kuk Young/M-2164-2015
OI Cho, Kuk Young/0000-0002-8577-9767
FU National Research Foundation of Korea (NRF) [2012-0007619,
   2012M3A9C6050070]; Ministry of Education, Science and Technology, Korea
FX This research is supported by Basic Science Research Program
   (2012-0007619) and grant No. 2012M3A9C6050070 through the National
   Research Foundation of Korea (NRF) funded by the Ministry of Education,
   Science and Technology, Korea.
CR Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Hwangbo KH, 2011, SOFT MATTER, V7, P10874, DOI 10.1039/c1sm06529g
   Kim MR, 2010, CHEM COMMUN, V46, P7433, DOI 10.1039/c0cc01738h
   Kim SH, 2010, ANGEW CHEM INT EDIT, V49, P3786, DOI 10.1002/anie.201001031
   Lee H, 2009, P NATL ACAD SCI USA, V106, P12459, DOI 10.1073/pnas.0902365106
   Lee KJ, 2011, CURR OPIN COLLOID IN, V16, P195, DOI 10.1016/j.cocis.2010.11.004
   Lim YT, 2008, CHEM COMMUN, P4930, DOI 10.1039/b810240f
   Lorch M., 2009, CHEM COMMUN, V42, P6442
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Noh YW, 2008, FASEB J, V22, P3908, DOI 10.1096/fj.08-112896
   Pericet-Camara R, 2009, SOFT MATTER, V5, P3611, DOI 10.1039/b907212h
   Seth A, 2012, ADV MATER, V24, P3544, DOI 10.1002/adma.201200757
   Zhao YJ, 2008, ANAL CHEM, V80, P1598, DOI 10.1021/ac702249a
NR 18
TC 3
Z9 4
U1 0
U2 32
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD MAR 12
PY 2013
VL 34
IS 5
BP 406
EP 410
DI 10.1002/marc.201200729
PG 5
WC Polymer Science
SC Polymer Science
GA 097JS
UT WOS:000315470400004
PM 23355346
DA 2018-10-20
ER

PT J
AU Ma, Q
   Li, B
   Yu, YY
   Zhang, Y
   Wu, Y
   Ren, W
   Zheng, Y
   He, J
   Xie, YM
   Song, XR
   He, G
AF Ma, Qing
   Li, Bo
   Yu, Yiyi
   Zhang, Ying
   Wu, Yang
   Ren, Wen
   Zheng, Yu
   He, Jun
   Xie, Yongmei
   Song, Xiangrong
   He, Gu
TI Development of a novel biocompatible poly(ethylene
   glycol)-block-poly(gamma-cholesterol-l-glutamate) as hydrophobic drug
   carrier
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Poly(ethylene glycol)-block-poly(gamma-cholesterol-L-glutamate);
   Nanoparticles; Paclitaxel; Hydrophobic; Preparation method
ID LOADED PLGA NANOPARTICLES; IN-VIVO EVALUATION; ENTRAPMENT EFFICIENCY;
   POLYMERIC MICELLES; DELIVERY-SYSTEM; PARTICLE-SIZE; PACLITAXEL; TUMORS;
   VITRO; ACCUMULATION
AB A novel biomaterial poly(ethylene glycol)-block-poly(gamma-cholesterol-l-glutamate) (mPEG-PCHLG) was designed and synthesized by introducing cholesterol side chains into this pegylated poly(amino acid) copolymers to enlarge the core space to increase the drug capacity. Paclitaxel (PTX) loaded mPEG-PCHLG nanoparticles (PTX-mPEG-PCHLG-Nps) were developed for the first time. The preparation method of nanoparticles was screened and optimized systemically. The optimal PTX-mPEG-PCHLG-Nps with the average diameter of 213.71 nm were constructed through the O/W single-emulsion solvent evaporation method. The entrapment efficiency and drug loading was 38.02 +/- 4.51% and 93.90 +/- 4.56%, respectively. PTX-mPEG-PCHLG-Nps were spherical and well-dispersed and displayed a dramatic sustained-release property. The in vitro cytotoxicity experiments demonstrated that the blank mPEG-PCHLG nanoparticles had no cytotoxicities on four tumor cell lines including A549, HepG-2, MCF-7 and C26, which implied that mPEG-PCHLG might be biocompatible. PTX-mPEG-PCHLG-Nps obtained the same cell growth inhibition activities as free PTX when incubated with the above tumor cells for 48 h. It can be inferred that PTX-mPEG-PCHLG-Nps could probably have higher anticancer efficacy due to the inadequate release of PTX from nanoparticles. PTX-mPEG-PCHLG-Nps achieved the highest antitumor activity in A549 rather than HepG-2, MCF-7 and C26, thus PTX-mPEG-PCHLG-Nps could have a potential application in lung cancer therapy. All the data indicated that mPEG-PCHLG was one of biocompatible biomaterials and worth being widely investigated as hydrophobic antitumor drug carrier. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Ma, Qing; Li, Bo; Wu, Yang; Ren, Wen; Zheng, Yu; He, Jun; Xie, Yongmei; Song, Xiangrong; He, Gu] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610041, Sichuan, Peoples R China.
   [Yu, Yiyi] Sichuan Univ, West China Sch Pharm, Chengdu 610041, Sichuan, Peoples R China.
   [Zhang, Ying] Kunming Med Univ, Sch Pharmaceut Sci, Kunming 650500, Yunnan, Peoples R China.
   [Zhang, Ying] Kunming Med Univ, Yunnan Key Lab Pharmacol Nat Prod, Kunming 650500, Yunnan, Peoples R China.
RP Song, XR (reprint author), Sichuan Univ, State Key Lab Biotherapy, West China Hosp, 17 Renmin Nanlu, Chengdu 610041, Sichuan, Peoples R China.
EM songxr@scu.edu.cn; hegu@scu.edu.cn
RI He, Gu/G-5446-2015; he, gu/C-8050-2013
OI He, Gu/0000-0002-1536-8882
FU National Natural Science Foundation of China [30901868, 81001357]; Major
   National S&T Program of China [2011ZX09102-001-013]; Fundamental
   Research Funds for the Central Universities of China [2010SCU23008]
FX This research has received financial support from the National Natural
   Science Foundation of China (No. 30901868 and 81001357) and the Major
   National S&T Program of China (No. 2011ZX09102-001-013) and the
   Fundamental Research Funds for the Central Universities of China (No.
   2010SCU23008).
CR Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
   Danhier F, 2009, J CONTROL RELEASE, V133, P11, DOI 10.1016/j.jconrel.2008.09.086
   Fonseca C, 2002, J CONTROL RELEASE, V83, P273, DOI 10.1016/S0168-3659(02)00212-2
   He ZY, 2010, INT J PHARMACEUT, V397, P147, DOI 10.1016/j.ijpharm.2010.06.029
   Ji XF, 2012, INT J PHARMACEUT, V422, P390, DOI 10.1016/j.ijpharm.2011.10.003
   Jiang XY, 2011, INT J PHARMACEUT, V420, P385, DOI 10.1016/j.ijpharm.2011.08.052
   Khonkarn R, 2011, EUR J PHARM BIOPHARM, V79, P268, DOI 10.1016/j.ejpb.2011.04.011
   Li C, 1998, CANCER RES, V58, P2404
   Li JM, 2012, J BIOMED NANOTECHNOL, V8, P809, DOI 10.1166/jbn.2012.1433
   Liang N, 2012, INT J PHARMACEUT, V423, P480, DOI 10.1016/j.ijpharm.2011.12.004
   Liu P, 2009, J BIOMED NANOTECHNOL, V5, P310, DOI 10.1166/jbn.2009.1036
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Matsumura Y, 2004, BRIT J CANCER, V91, P1775, DOI 10.1038/sj.bjc.6602204
   Matsumura Y, 2011, ADV DRUG DELIVER REV, V63, P184, DOI 10.1016/j.addr.2010.05.008
   Matsumura Y, 2009, CANCER SCI, V100, P572, DOI 10.1111/j.1349-7006.2009.01103.x
   Plummer R, 2011, BRIT J CANCER, V104, P593, DOI 10.1038/bjc.2011.6
   Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794
   Shin E., 2001, INT J CLIN ONCOL, V6, P5
   Song XR, 2010, J PHARM SCI-US, V99, P4874, DOI 10.1002/jps.22200
   Song XR, 2009, EUR J PHARM SCI, V37, P300, DOI 10.1016/j.ejps.2009.02.018
   Song XR, 2008, EUR J PHARM BIOPHARM, V69, P445, DOI 10.1016/j.ejpb.2008.01.013
   Song XR, 2008, INT J PHARMACEUT, V350, P320, DOI 10.1016/j.ijpharm.2007.08.034
   Wang A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-46
   Wu Y., 2012, J POLYM SCI A
NR 24
TC 12
Z9 13
U1 2
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD MAR 10
PY 2013
VL 445
IS 1-2
BP 88
EP 92
DI 10.1016/j.ijpharm.2013.01.046
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 103VJ
UT WOS:000315947300010
PM 23376505
DA 2018-10-20
ER

PT J
AU Chang, Y
   Shih, YJ
   Lai, CJ
   Kung, HH
   Jiang, SY
AF Chang, Yung
   Shih, Yu-Ju
   Lai, Chia-Jung
   Kung, Hsiao-Han
   Jiang, Shaoyi
TI Blood-Inert Surfaces via Ion-Pair Anchoring of Zwitterionic Copolymer
   Brushes in Human Whole Blood
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE zwitterionic materials; ion-pairs; blood-inert materials; nonfouling
   materials; human whole blood
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; POLY(ETHYLENE OXIDE);
   2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE; FIBRINOGEN ADSORPTION;
   PLATELET-ADHESION; STRONG RESISTANCE; PLASMA; POLYMERS; COMPATIBILITY
AB A strategy to create blood-inert surfaces in human whole blood via ion-pair anchoring of zwitterionic copolymer brushesand a systematic study of how well-defined chain lengths and well-controlled surface packing densities of zwitterionic polymers affect blood compatibility are reported. Well-defined diblock copolymers, poly(11-mercaptoundecyl sulfonic acid)-block-poly(sulfobetaine methacrylate) (PSA-b-PSBMA) with varying zwitterionic PSBMA or negatively charged PSA lengths, are synthesized via atom-transfer radical polymerization (ATRP). PSA-b-PSBMA is grafted onto a surface covered with polycation brushes as a mimic polar/hydrophilic biomaterial surface via ion-pair anchoring at a range of copolymer concentrations. Protein adsorption from single-protein solutions, 100% blood serum, and 100% blood plasma onto the surfaces covered with PSA-b-PSBMA brushes is evaluated using a surface plasmon resonance sensor. Copolymer brushes containing a high amount of zwitterionic SBMA units are further challenged with human whole blood. Low protein-fouling surfaces with >90% reduction with respect to uncoated surfaces are achieved with longer PSA blocks and higher concentrations of PSA-b-PSBMA copolymers using the ion-pair anchoring approach. This work provides a platform to achieve the control of various surface parameters and a practical method to create blood-inert surfaces in whole blood by grafting ionic-zwitterionic copolymers to charged biomaterials via charge pairing.
C1 [Chang, Yung; Shih, Yu-Ju; Lai, Chia-Jung; Kung, Hsiao-Han] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Chungli 320, Taoyuan, Taiwan.
   [Chang, Yung; Shih, Yu-Ju; Lai, Chia-Jung; Kung, Hsiao-Han] Chung Yuan Christian Univ, Dept Chem Engn, Chungli 320, Taoyuan, Taiwan.
   [Jiang, Shaoyi] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Chang, Y (reprint author), Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Chungli 320, Taoyuan, Taiwan.
EM ychang@cycu.edu.tw; sjiang@u.washington.edu
FU Center-of-Excellence (COE) Program on Membrane Technology from the
   Ministry of Education (MOE), R.O.C.; National Science Council [NSC
   99-2628-E-033-001, NSC 100-2628-E-033-001-MY3]; Office of Naval Research
   [N000140910137]
FX The authors would like to acknowledge the Center-of-Excellence (COE)
   Program on Membrane Technology from the Ministry of Education (MOE),
   R.O.C., and the National Science Council (NSC 99-2628-E-033-001 and NSC
   100-2628-E-033-001-MY3) for their financial support. This work was also
   supported by the Office of Naval Research (N000140910137).
CR Brash J. L., 1995, ACS SYM SER, V602, P1
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chang Y, 2012, LANGMUIR, V28, P4309, DOI 10.1021/la203504h
   Chang Y, 2008, LANGMUIR, V24, P5453, DOI 10.1021/la800228c
   Chang Y, 2007, BIOMACROMOLECULES, V8, P122, DOI 10.1021/bm060739m
   Chang Y, 2011, LANGMUIR, V27, P5445, DOI 10.1021/la1048369
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   Chang Y, 2010, J BIOMED MATER RES A, V93A, P400, DOI 10.1002/jbm.a.32558
   Chang Y, 2010, LANGMUIR, V26, P3522, DOI 10.1021/la903172j
   Chang Y, 2009, J MEMBRANE SCI, V345, P160, DOI 10.1016/j.memsci.2009.08.039
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Chen SF, 2006, LANGMUIR, V22, P8186, DOI 10.1021/la061012m
   de Vos WM, 2010, SOFT MATTER, V6, P2499, DOI 10.1039/b926017j
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   Feng W, 2004, J POLYM SCI POL CHEM, V42, P2931, DOI 10.1002/pola.20095
   HAN DK, 1995, BIOMATERIALS, V16, P467, DOI 10.1016/0142-9612(95)98819-Z
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   He Y, 2008, PHYS CHEM CHEM PHYS, V10, P5539, DOI 10.1039/b807129b
   Homola J., 2006, SURFACE PLASMON RESO, V4, P251
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   Kuo WH, 2011, BIOMACROMOLECULES, V12, P4348, DOI 10.1021/bm2013185
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   Li GZ, 2008, BIOMATERIALS, V29, P4592, DOI 10.1016/j.biomaterials.2008.08.021
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2431, DOI 10.1016/S0142-9612(03)00113-3
   Nguyen AT, 2011, LANGMUIR, V27, P2587, DOI 10.1021/la104657c
   Olsson P, 2000, J BIOMAT SCI-POLYM E, V11, P1261, DOI 10.1163/156856200744192
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Shih YJ, 2010, LANGMUIR, V26, P17286, DOI 10.1021/la103186y
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Tuerk Holger, 2004, Bioconjugate Chemistry, V15, P162
   Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888
   Yang W, 2008, LANGMUIR, V24, P9211, DOI 10.1021/la801487f
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
NR 45
TC 82
Z9 82
U1 10
U2 306
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAR 6
PY 2013
VL 23
IS 9
BP 1100
EP 1110
DI 10.1002/adfm.201201386
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 100JC
UT WOS:000315693900003
DA 2018-10-20
ER

PT J
AU Bernal, A
   Kuritka, I
   Saha, P
AF Bernal, Andres
   Kuritka, Ivo
   Saha, Petr
TI Preparation and characterization of poly(vinyl alcohol)-poly(vinyl
   pyrrolidone) blend: A biomaterial with latent medical applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; mechanical properties; thermal properties; poly(vinyl
   alcohol); poly(vinyl pyrrolidone)
ID THERMAL-CHARACTERISTICS; MECHANICAL-PROPERTIES; SILVER NANOPARTICLES;
   SOLID DISPERSIONS; GLASS-TRANSITION; ALCOHOL HYDROGEL; PVP HYDROGELS;
   CROSS-LINKING; FILMS; WATER
AB Aqueous solutions of poly(vinyl alcohol) and poly(vinyl pyrrolidone) are blended and films are produced by casting method with the further intention of being used as bio-materials with latent medical application. Glutaraldehyde, 4,4'-diazido-2,2'-stilbenedisulfonic acid disodium salt tetra-hydrate are used as crosslinker agents, whereas lactic acid is the plasticizer in the blend. The obtained films are characterized by differential scanning calorimetry (DSC), mechanical properties, swelling and solubility behavior. DSC measurements show that the blends exhibit a single glass transition temperature indicating that they are miscible, even in the presence of the plasticizer and crosslinker agents. By the combination of all mentioned additives, a relevant enhancement of the swelling is observed, accompanied by a stabilization of the solubility during the tested time. Finally, mechanical properties show an appropriate performance in the studied parameters. As a consequence, the obtained films could be suitable for use as medium or long-term implants. (c) 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013
C1 [Bernal, Andres; Kuritka, Ivo; Saha, Petr] Tomas Bata Univ Zlin, Fac Technol, Polymer Ctr, Zlin 76272, Czech Republic.
   [Bernal, Andres; Kuritka, Ivo; Saha, Petr] Tomas Bata Univ Zlin, Univ Inst, Ctr Polymer Syst, Zlin 76001, Czech Republic.
RP Kuritka, I (reprint author), Tomas Bata Univ Zlin, Fac Technol, Polymer Ctr, TG Masaryka 275, Zlin 76272, Czech Republic.
EM ivo@kuritka.net
RI Saha, Petr/F-3952-2016; Kuritka, Ivo/J-2285-2016
OI Saha, Petr/0000-0002-1873-4163; Kuritka, Ivo/0000-0002-1016-5170
FU European Regional Development Fund (ERDF); national budget of Czech
   Republic, within the framework of project Centre of Polymer Systems
   [CZ.1.05/2.1.00/03.0111]; Ministry of Education, Youth and Sports of the
   Czech Republic [MSM 7088352101]
FX This article was written with support of Operational Program Research
   and Development for Innovations co-funded by the European Regional
   Development Fund (ERDF) and national budget of Czech Republic, within
   the framework of project Centre of Polymer Systems (reg. number:
   CZ.1.05/2.1.00/03.0111). The work was supported by the grant project of
   the Ministry of Education, Youth and Sports of the Czech Republic (reg.
   number: MSM 7088352101).
CR Abd El-Mohdy H. L., 2009, J POLYM RES, V16, P1, DOI DOI 10.1007/S10965-008-9196-0
   Abdelrazek EM, 2010, CURR APPL PHYS, V10, P607, DOI 10.1016/j.cap.2009.08.005
   Ahmad SI, 2008, J APPL POLYM SCI, V109, P775, DOI 10.1002/app.28140
   [Anonymous], 1995, 527 EN ISO
   [Anonymous], 1997, 291 EN ISO
   Barozzi A., 2004, BIOMATERIALS, V25, P3773, DOI [10.1016/j.biomaterials.2003.10.035, DOI 10.1016/J.BIOMATERIALS.2003.10.035]
   Bhajantri RF, 2006, POLYMER, V47, P3591, DOI 10.1016/j.polymer.2006.03.054
   Broman E, 2001, INT J PHARM, V222, P139, DOI 10.1016/S0378-5173(01)00709-8
   BUERA MD, 1992, BIOTECHNOL PROGR, V8, P144, DOI 10.1021/bp00014a008
   Can HK, 2003, ADV POLYM TECH, V22, P252, DOI 10.1002/adv.10054
   Cassu SN, 1997, POLYMER, V38, P3907, DOI 10.1016/S0032-3861(96)00959-7
   Caykara T, 2007, POLYM-PLAST TECHNOL, V46, P737, DOI 10.1080/03602550701273971
   Chan LW, 1999, CHEM PHARM BULL, V47, P1412
   de Azevedo WM, 1999, SYNTHETIC MET, V100, P241, DOI 10.1016/S0379-6779(98)01481-7
   El-Khodary A, 2009, PHYSICA B, V404, P1287, DOI 10.1016/j.physb.2008.11.238
   FAMBRI L, 2002, INTEGRATED BIOMATERI, P119
   Feldstein MM, 2000, POLYMER, V41, P5327, DOI 10.1016/S0032-3861(99)00802-2
   FENG HQ, 1993, POLYMER, V34, P2516, DOI 10.1016/0032-3861(93)90581-T
   Figueiredo KCS, 2009, J APPL POLYM SCI, V111, P3074, DOI 10.1002/app.29263
   Hari PR, 2001, J APPL POLYM SCI, V82, P143, DOI 10.1002/app.1833
   Hodge RM, 1996, POLYMER, V37, P1371, DOI 10.1016/0032-3861(96)81134-7
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   Jones SA, 2005, J APPL POLYM SCI, V98, P2290, DOI 10.1002/app.22390
   Kim GM, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/4/046003
   Kim SJ, 2003, J APPL POLYM SCI, V90, P881, DOI 10.1002/app.12794
   Kim SJ, 2002, J APPL POLYM SCI, V86, P1844, DOI 10.1002/app.11096
   Krumova M, 2000, POLYMER, V41, P9265, DOI 10.1016/S0032-3861(00)00287-1
   Lai GL, 2007, KOREA-AUST RHEOL J, V19, P81
   Lakouraj MM, 2005, IRAN POLYM J, V14, P1022
   Lewandowska K, 2005, EUR POLYM J, V41, P55, DOI 10.1016/j.eurpolymj.2004.08.016
   Li J, 2010, J REINF PLAST COMP, V29, P618, DOI 10.1177/0731684408100696
   Li L, 1998, POLYMER, V39, P2355, DOI 10.1016/S0032-3861(97)00534-X
   Li Z, 2005, APPL SURF SCI, V250, P109, DOI 10.1016/j.apsusc.2004.12.039
   Liang G., 1994, CHIN J POLYM SCI, V12, P202
   Liang S, 2011, J APPL POLYM SCI, V122, P813, DOI 10.1002/app.34060
   Lu J, 2003, J APPL POLYM SCI, V89, P2808, DOI 10.1002/app.12486
   Mano V, 2004, J APPL POLYM SCI, V92, P743, DOI 10.1002/app.20027
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Marconi W, 2002, INTEGRATED BIOMATERIALS SCIENCE, P25, DOI 10.1007/0-306-47583-9_2
   Miranda LF, 1999, RADIAT PHYS CHEM, V55, P709, DOI 10.1016/S0969-806X(99)00216-9
   Nho YC, 2002, J APPL POLYM SCI, V85, P1787, DOI 10.1002/app.10812
   Novoa GAG, 2005, EUR J PHARM BIOPHARM, V59, P343, DOI 10.1016/j.ejpb.2004.07.012
   Onyari JM, 2009, J APPL POLYM SCI, V113, P2053, DOI 10.1002/app.29909
   Park JS, 2001, J APPL POLYM SCI, V82, P1816, DOI 10.1002/app.2023
   Park YI, 2001, J APPL POLYM SCI, V80, P1785, DOI 10.1002/app.1274
   Ruan LP, 2005, J PHARMACEUT BIOMED, V38, P457, DOI 10.1016/j.jpba.2005.01.030
   Sedlarik V, 2006, INT J POLYM ANAL CH, V11, P253, DOI 10.1080/10236660600750190
   Sedlarik V, 2006, POLYM COMPOSITE, V27, P147, DOI 10.1002/pc.20197
   Shibata H, 2005, MOLECULES, V10, P162, DOI 10.3390/10010162
   Sionkowska A, 2006, APPL SURF SCI, V253, P1970, DOI 10.1016/j.apsusc.2006.03.048
   Sperling LH, 2006, INTRODUCTION TO PHYSICAL POLYMER SCIENCE, 4TH EDITION, P687
   TANIGAMI T, 1995, POLYMER, V36, P2941, DOI 10.1016/0032-3861(95)94343-R
   Thomas J, 2003, J BIOMED MATER RES A, V67A, P1329, DOI 10.1002/jbm.a.10119
   Yeom CK, 1996, J MEMBRANE SCI, V109, P257, DOI 10.1016/0376-7388(95)00196-4
   Yu HJ, 2007, J APPL POLYM SCI, V103, P125, DOI 10.1002/app.24835
   Zhang Y, 2010, J POLYM RES, V17, P725, DOI 10.1007/s10965-009-9362-z
NR 56
TC 10
Z9 10
U1 2
U2 63
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 5
PY 2013
VL 127
IS 5
BP 3560
EP 3568
DI 10.1002/app.37723
PG 9
WC Polymer Science
SC Polymer Science
GA 062QQ
UT WOS:000312936400035
DA 2018-10-20
ER

PT J
AU Critchfield, AS
   Kelley, JC
   McCabe, R
   Richey, L
   Socrate, S
   Norwitz, ER
   Kaplan, DL
   House, M
AF Critchfield, Agatha S.
   Kelley, Jeannie C.
   McCabe, Reid
   Richey, Lauren
   Socrate, Simona
   Norwitz, Errol R.
   Kaplan, David L.
   House, Michael
TI A Silk-Based Biomaterial for Cervical Injection: A Pilot Study of
   Biocompatibility in a Pregnant Rat Model
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 60th Annual Scientific Meeting of the
   Society-for-Gynecologic-Investigation (SGI)
CY MAR 20-23, 2013
CL Orlando, FL
SP Soc Gynecol Invest
C1 [Critchfield, Agatha S.; Kelley, Jeannie C.] Tufts Med Ctr, Div Maternal Fetal Med, Boston, MA USA.
   [McCabe, Reid; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Richey, Lauren] Tufts Univ, Div Lab Anim Med, Boston, MA 02111 USA.
   [Socrate, Simona] MIT, Cambridge, MA 02139 USA.
   [Norwitz, Errol R.; House, Michael] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2013
VL 20
IS S3
SU 3
BP 125A
EP 125A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 287LK
UT WOS:000329543100213
DA 2018-10-20
ER

PT J
AU Olyaee, S
   Najafgholinezhad, S
AF Olyaee, Saeed
   Najafgholinezhad, Samira
TI A High Quality Factor and Wide Measurement Range Biosensor Based on
   Photonic Crystal Nanocavity Resonator
SO SENSOR LETTERS
LA English
DT Article
DE Photonic Crystal; Biosensor; Nanocavity; Quality Factor; Measurement
   Range
ID LOW CONFINEMENT LOSS; NANO-RING RESONATOR; FIBER; MICROCAVITY;
   DISPERSION; SENSORS; AREA
AB In this paper, we describe a compact biosensor based on two-dimensional photonic crystal with hexagonal lattice of air holes in a silicon slab. This biosensor is constructed by introducing waveguides and nanocavity into the periodic photonic crystal structure. The waveguides are obtained by eliminating two groups of air holes and nanocavity is formed by changing the dimension of air holes. The simulation results show that resonant wavelength of nanocavity shifts to longer wavelengths with trapping chemicals and biomaterial like, DNA molecule, protein and so on. The biosensor is designed for wavelength range of 1.5744-1.7006 mu m with optimized Q-value which is one of the important parameters to obtain high-resolution sensor. The sensitivity of sensor equals to 63.1 nm per refractive index unit (nm/RIU), and a change in refractive index of Delta n = 0.006 can be apparent. This small size photonic crystal biosensor can be utilized to measure diversity of analytes in a wide measurement range of refractive index due to their PBG with optimized quality factor and reasonable efficiency which affect the resolution of biosensor and make the detection of bio-materials possible and easy. Two-dimensional finite-difference time-domain (FDTD) method is chosen for simulation of the proposed structure. The band diagram obtained by plane-wave expansion (PWE) method shows that solely TE mode can emit through the structure.
C1 [Olyaee, Saeed; Najafgholinezhad, Samira] SRTTU, Fac Elect & Comp Engn, Nanophoton & Optoelect Res Lab, Tehran 16788, Iran.
RP Olyaee, S (reprint author), SRTTU, Fac Elect & Comp Engn, Nanophoton & Optoelect Res Lab, Tehran 16788, Iran.
EM s_olyaee@srttu.edu
CR Chow E, 2004, OPT LETT, V29, P1093, DOI 10.1364/OL.29.001093
   Derbali J, 2011, OPT QUANT ELECTRON, V42, P463, DOI 10.1007/s11082-010-9429-4
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   Hallynck E, 2010, OPT EXPRESS, V18, P18164, DOI 10.1364/OE.18.018164
   Hsiao FL, 2010, IEEE SENS J, V10, P1185, DOI 10.1109/JSEN.2010.2040172
   Hsiao FL, 2009, PROCEDIA CHEM, V1, P417, DOI 10.1016/j.proche.2009.07.104
   Joannopoulos J, 2007, PHOTONIC CRYSTALS MO
   Lourtioz J.-M., 2008, PHOTONIC CRYSTALS NA
   Nair RV, 2010, PROG QUANT ELECTRON, V34, P89, DOI 10.1016/j.pquantelec.2010.01.001
   Olyaee S, 2012, IET OPTOELECTRON, V6, P82, DOI 10.1049/iet-opt.2011.0031
   Olyaee S., 2011, J PHYS C SERIES, V276
   Olyaee S., 2012, SENSOR LETT IN PRESS
   Olyaee S, 2012, PHOTONIC SENS, V2, P92, DOI 10.1007/s13320-011-0044-1
   Olyaee S, 2012, FIBER INTEGRATED OPT, V31, P178, DOI 10.1080/01468030.2012.658959
   Rostami A, 2011, OPTIK, V122, P1481, DOI 10.1016/j.ijleo.2010.05.036
   Saynatjoki A, 2008, PHOTONIC NANOSTRUCT, V6, P42, DOI 10.1016/j.photonics.2007.09.001
   Sun J, 2007, SENSOR ACTUAT B-CHEM, V128, P46, DOI 10.1016/j.snb.2007.05.037
   Vos K. D., 2009, BIOSENS BIOELECTRON, V24, P2528
   Wang XL, 2008, OPT COMMUN, V281, P1725, DOI 10.1016/j.optcom.2007.11.040
   Yang DQ, 2011, OPT EXPRESS, V19, P20023, DOI 10.1364/OE.19.020023
   Yun MJ, 2012, OPTIK, V123, P1920, DOI 10.1016/j.ijleo.2011.09.024
   Zhang W, 2008, SENSOR ACTUAT B-CHEM, V131, P279, DOI 10.1016/j.snb.2007.11.017
   Zhang XP, 2012, SENSORS-BASEL, V12, P12082, DOI 10.3390/s120912082
   Zhang XP, 2011, ADV FUNCT MATER, V21, P4219, DOI 10.1002/adfm.201101366
NR 24
TC 11
Z9 11
U1 0
U2 25
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1546-198X
EI 1546-1971
J9 SENSOR LETT
JI Sens. Lett.
PD MAR
PY 2013
VL 11
IS 3
BP 483
EP 488
DI 10.1166/sl.2013.2829
PG 6
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation;
   Physics, Applied
SC Chemistry; Electrochemistry; Instruments & Instrumentation; Physics
GA 202RB
UT WOS:000323236200006
DA 2018-10-20
ER

PT J
AU Ana, S
   Erika, R
   Arturo, H
   Sergio, SG
   Hugo, L
   Leticia, BO
   Lilia, S
   Hector, A
   Silvestre, GD
   Betha, V
   Xochitl, G
   Cristina, V
AF Ana, Sesman
   Erika, Ruvalcaba
   Arturo, Herrera
   Guerrero Sergio, Sanchez
   Hugo, Lecona
   Leticia, Baena-Ocampo
   Lilia, Solis
   Hector, Avila
   de la Puente Silvestre, Garcia
   Betha, Vargas
   Xochitl, Guerrero
   Cristina, Velasquillo
TI Morphological Study of Bone Cranial in Athymic Mice
SO INTERNATIONAL JOURNAL OF MORPHOLOGY
LA English
DT Article
DE Osteogenesis; Osteoinduction; Osteoconductivity
ID MORPHOGENETIC PROTEINS; POROUS HYDROXYAPATITE; ALKALINE-PHOSPHATASE;
   BIOMATERIAL; EXPRESSION; CULTURES; SURFACE; CELLS
AB The aim of our research was to create an osteogenic unit in the skulls of athymic mice; however, the first challenge we faced was to find sufficient and adequate data that would allow us to determine the morphological, immunohistochemical and microtopographical characteristics that could be used as normality standards in athymic mice skulls and, hence, a reference in the event of achieving the formation of de novo bone using the osteogenic unit we proposed. Knowing the normal bone morphology in the skull of athymic mice was a necessary precondition to develop subsequently an osteogenic unit possessing the Osteogenesis, Osteoinduction and Osteoconductivity that could be compared versus those in the normal bone during its formations and remodeling processes. Therefore, we conducted a pilot study to determine bone morphological characteristics in the skull of athymic mice by means of specific histological staining: hematoxylin-eosin and Von Kossa, for osteoid tissue and mineralized bone, and Masson Tri-chrome for ossified areas. We also use immunohistochemistry to detect bone formation markers: alkaline phosphatase resulting from osteoblastic activity stimulation, type 1 collagen a bonematrix structural protein; Osteopontine, a protein specifically synthesized by osteoblasts that favors cell proliferation and remodeling in bone defects; Osteocalcine, a peptide hormone produced by osteoblasts during bone formation; and, Runx 2, a transcription factor expressed by stem cells which stimulates bone differentiation. Likewise, we used electron microscopy on the newly formed tissue to determine the presence of organic deposits, such as calcium, phosphate and magnesium in bone tissue.
C1 [Ana, Sesman] Inst Nacl Pediat Cd, Serv Cirugia Plast, Mexico City, DF, Mexico.
   [Hector, Avila] Inst Nacl Pediat Cd, Dept Epidemiol, Mexico City, DF, Mexico.
   [de la Puente Silvestre, Garcia] Inst Nacl Pediat Cd, Dept Metodol Invest, Mexico City, DF, Mexico.
   [Ana, Sesman; Erika, Ruvalcaba; Xochitl, Guerrero; Cristina, Velasquillo] Inst Nacl Rehabil Cd, Unidad Ingn Tejidos Terapia Celular & Med Regener, Mexico City, DF, Mexico.
   [Hugo, Lecona] Bioterio Inst Nacl Rehabil Cd, Mexico City, DF, Mexico.
   [Leticia, Baena-Ocampo] Inst Nacl Rehabil Cd, Dept Patol, Mexico City, DF, Mexico.
   [Lilia, Solis; Betha, Vargas] Inst Nacl Rehabil Cd, Unidad Microscopia Elect, Mexico City, DF, Mexico.
   [Guerrero Sergio, Sanchez] Inst Nacl Cancerol Cd, Unidad Med Transfus, Mexico City, DF, Mexico.
   [Arturo, Herrera] Hosp Gen Mexico City, Dept Invest, Mexico City, DF, Mexico.
   [Arturo, Herrera] Inst Nacl Cancerol Cd, Mexico City, DF, Mexico.
RP Cristina, V (reprint author), Biotechnol Natl Inst Rehabil Mexico City, Tissue Engn Cell Therapy & Regenerat Med Unit, Mexico City, DF, Mexico.
EM mvelasquillo@inr.gob.mx
RI Ruvalcaba Paredes, Erika Karina/F-1014-2018
OI Ruvalcaba Paredes, Erika Karina/0000-0003-0293-8505
FU CONACYT Sectoriales [114359]
FX This study was partially supported by CONACYT Sectoriales with Grant
   114359.
CR Ardila M., 2005, REV FED ODONTOL COLO, P1
   Basurto R. N., 2008, VET MEXICO, V39, P1
   Boden S., 2003, PRINCIPLES PRACTICE
   Chapman MW, 1997, J BONE JOINT SURG AM, V79A, P495, DOI 10.2106/00004623-199704000-00004
   CONNOLLY J, 1989, J BONE JOINT SURG AM, V71A, P684, DOI 10.2106/00004623-198971050-00007
   Cornell CN, 1999, ORTHOP CLIN N AM, V30, P591, DOI 10.1016/S0030-5898(05)70112-7
   Dietmar W., 2005, GENE, V347, P1
   Eppley BL, 2001, PLAST RECONSTR SURG, V107, P757, DOI 10.1097/00006534-200103000-00016
   Gazdag A.R., 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Greenwald A.S., 2001, J BONE JOINT SURG, V83, pS98
   Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47
   HARRIS SE, 1994, J BONE MINER RES, V9, P855
   Inoue K, 1997, J BONE MINER RES, V12, P989, DOI 10.1359/jbmr.1997.12.6.989
   Jimenez-Palomar I, 2012, J MECH BEHAV BIOMED, V5, P149, DOI 10.1016/j.jmbbm.2011.08.018
   Lorenz H. P., 2000, PLAST RECONSTR SURG, V50, P245
   Mayer U., 2004, INT J MAXILLOFAC SUR, V33, P325
   NADE S, 1983, CLIN ORTHOP RELAT R, P255
   Nicolae C, 2011, ROM J MORPHOL EMBRYO, V52, P1255
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Safdar N., 2005, J AM ACAD ORTHOP SUR, V13, P77
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Schenk R., 1995, J CRANIOMASILLOFAC S, V23, P133
   Sonobe J, 2004, HUM GENE THER, V15, P659, DOI 10.1089/1043034041361208
   Sweeney T.M., 1994, J BONE JOINT SURG AM, V76, P922
   Sweeney T. M., 1993, ORTHOP T, V16, P785
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vaccaro AR, 2004, SPINE, V29, P1885, DOI 10.1097/01.brs.0000137062.79201.98
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
NR 30
TC 1
Z9 1
U1 2
U2 4
PU SOC CHILENA ANATOMIA
PI TEMUCO
PA CASILLA 54-D, TEMUCO, 00000, CHILE
SN 0717-9502
J9 INT J MORPHOL
JI Int. J. Morphol.
PD MAR
PY 2013
VL 31
IS 1
BP 321
EP 328
DI 10.4067/S0717-95022013000100050
PG 8
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 184DU
UT WOS:000321868400050
OA Bronze, Other Gold
DA 2018-10-20
ER

PT J
AU Lambert, F
   Leonard, A
   Lecloux, G
   Sourice, S
   Pilet, P
   Rompen, E
AF Lambert, France
   Leonard, Angelique
   Lecloux, Geoffrey
   Sourice, Sophie
   Pilet, Paul
   Rompen, Eric
TI A Comparison of Three Calcium Phosphate-Based Space Fillers in Sinus
   Elevation: A Study in Rabbits
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE biomaterials; bone regeneration; bovine hydroxyapatite; calcium
   phosphate; sinus elevation
ID BETA-TRICALCIUM PHOSPHATE; ANORGANIC BOVINE BONE; TISSUE-ENGINEERED
   BONE; MAXILLARY SINUS; FLOOR ELEVATION; HISTOMORPHOMETRIC EVALUATION;
   EXTRACTION SOCKETS; AUTOGENOUS BONE; AUGMENTATION; PARTICLES
AB Purpose: Subsinus bone regeneration procedures are reliable and known to be effective with the use of biomaterials alone. Nevertheless, many types of biomaterials are available, and the efficacy of each in terms of bone formation and resorption rate has rarely been compared. This study aimed to compare bone formation, resorption rate, osteoconductivity, and three-dimensional volume changes of three biomaterials often used for alveolar ridge augmentation. Materials and Methods: Rabbits underwent bilateral sinus elevation using three different types of space fillers: bovine hydroxyapatite (BHA), beta-tricalcium phosphate (beta-TCP), or biphasic calcium phosphate (BCP). Animals were sacrificed at 1 week, 5 weeks, and 6 months. Samples were subjected to microcomputed tomography and histologic examination. Qualitative analysis was performed on nondecalcified sections, and quantitative histomorphometric analysis was conducted using scanning electron microscopy. Volume differences in augmented bone were calculated at different time points. Results: All three particulated biomaterials promoted osteogenesis in this particular animal model. At 6 months, biomaterial resorption rates were significantly different across the three groups. The highest resorption rate was found with beta-TCP, in which only 6.7% of the baseline particle surface remained. At 6 months, bone was in close contact with the BHA particles, constituting a composite network; in contrast, BCP particles were often surrounded by soft tissue. Within each group, no significant differences in volume were found at the different time points. Conclusions: Despite the limitations of the study, the three studied biomaterials proved to be effective in promoting osteogenesis. High resorption rates and complete replacement of the biomaterials by bone seemed to withstand intrasinusal pressure. Further investigations in humans should consider longer follow-up periods.
C1 [Lambert, France; Lecloux, Geoffrey; Rompen, Eric] Univ Liege, Fac Med, Dept Periodontol & Oral Surg, B-4000 Liege, Belgium.
   [Leonard, Angelique] Univ Liege, Dept Appl Chem, B-4000 Liege, Belgium.
   [Sourice, Sophie; Pilet, Paul] Univ Nantes, Lab Osteoarticular & Dent Tissue Engn, INSERM, French Natl Inst Hlth & Med Res,U791, Nantes, France.
   [Pilet, Paul] CHU Nantes, Serv Odontol Conservatrice Endodontie, F-44035 Nantes 01, France.
RP Lambert, F (reprint author), Serv Med Dent, Domaine Sart Tilman Bat B-35, B-4000 Liege, Belgium.
EM france.lambert@chu.ulg.ac.be
RI Paul, Pilet/A-3755-2015
FU company Geistlich
FX The authors want to thank L. Seidel and Pr A. Albert for their input in
   the statistical analysis as well as the company Geistlich for their
   financial support and provision of biomaterials. The authors reported no
   conflicts of interest related to this study.
CR Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Asai S, 2002, CLIN ORAL IMPLAN RES, V13, P405, DOI 10.1034/j.1600-0501.2002.130409.x
   CHANAVAZ M, 1990, Journal of Oral Implantology, V16, P199
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   De Coster P, 2011, CLIN IMPLANT DENT R, V13, P34, DOI 10.1111/j.1708-8208.2009.00184.x
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Froum SJ, 2008, INT J PERIODONT REST, V28, P273
   Gabbert O, 2009, J CLIN PERIODONTOL, V36, P177, DOI 10.1111/j.1600-051X.2008.01357.x
   GAREY D J, 1991, Journal of Oral Implantology, V17, P404
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P107, DOI 10.1034/j.1600-0501.1998.090206.x
   Handschel J, 2002, BIOMATERIALS, V23, P1689, DOI 10.1016/S0142-9612(01)00296-4
   Hatano N, 2004, CLIN ORAL IMPLAN RES, V15, P339, DOI 10.1111/j.1600-0501.2004.00996.x
   Institute of Laboratory Animal Resources-Commission on Life Sciences NRC, 1996, GUIDE CARE USE LAB A
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Lambert F, 2011, CLIN ORAL IMPLAN RES, V22, P538, DOI 10.1111/j.1600-0501.2010.02069.x
   Nedir R, 2010, J CLIN PERIODONTOL, V37, P1023, DOI 10.1111/j.1600-051X.2010.01610.x
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Ohya M, 2005, CLIN ORAL IMPLAN RES, V16, P622, DOI 10.1111/j.1600-0501.2005.01136.x
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Scarano A, 2004, J PERIODONTOL, V75, P1161, DOI 10.1902/jop.2004.75.8.1161
   SCHARF KE, 1995, LARYNGOSCOPE, V105, P570, DOI 10.1288/00005537-199506000-00002
   Schwarz F, 2007, INT J ORAL MAX SURG, V36, P1198, DOI 10.1016/j.ijom.2007.07.014
   Sharan A, 2008, INT J ORAL MAX IMPL, V23, P48
   Sun XJ, 2008, CLIN ORAL IMPLAN RES, V19, P804, DOI 10.1111/j.1600-0501.2008.01577.x
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P40, DOI 10.1016/j.bjoms.2004.10.004
   Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x
   Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
NR 36
TC 5
Z9 6
U1 0
U2 10
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2013
VL 28
IS 2
BP 393
EP 402
DI 10.11607/jomi.2332
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 186WY
UT WOS:000322077900016
PM 23527340
OA Bronze
DA 2018-10-20
ER

PT J
AU Carlesimo, B
   Marchetti, F
   Tempesta, M
   Marcasciano, M
   Ruggiero, M
   Scuderi, N
AF Carlesimo, Bruno
   Marchetti, Francesco
   Tempesta, Massimo
   Marcasciano, Marco
   Ruggiero, Marco
   Scuderi, Nicolo
TI Muscular gastrocnemius spacer: a two stage reimplantation technique for
   infected total knee arthroplasty
SO ANNALI ITALIANI DI CHIRURGIA
LA English
DT Article
DE Arthroplasty; Autologous Spacer; Gastrocnemious Muscular Flap
ID ARTICULATING SPACER; REVISION; SALVAGE; OSTEOMYELITIS; COMPLICATIONS;
   REPLACEMENT; MANAGEMENT; FLAPS
AB Alm: We present a two stage reimplantation technique for infected total knee arthroplasv using a muscular gastrocnemious spacer that allows delivery of high local concentrations of antibiotics in absence of heterologous materials associated with high percentage of infection.
   MATERIAL OF STUDY: Between January 2009 and June 2011 we selected 8 patients with diagnosis of total knee arthroplasty deep infection. All patients underwent a surgical protocol that consisted of a two stage procedure with harvesting of medial gastrocnemious rotational flap followed by delayed reimplantation of prosthesis. All of them received 6 weeks of tailored intravenous antibiotics suggested by the infectious disease consultant and none had positive cultures at the time of reimplantation.
   ESULTS: The outcome was considered excellent for 6 of the 8 knees, good for I, fair for I, and poor for 0 joint. The reimplantion procedures were completely successfid in all cases and all patients were able to walk again after rehabilitation program. DISCUSSION: Our surgical protocol guarantees wound healing without presence of disuse osteoporosis nor joint stijfiless with scar tissue obliterating joint space. Moreover it shows a lower percentage of reinfection. This is connected to the presence of remaining microbiological organisms at the moment of closure that can develope a biofilm that adheres to biomaterial surfaces, enabling a complete bacterial eradication. The gastrocnemious muscle plays either the role of a natural spacer, either the function of coverage and protection of the new joint articulation after the reimplantation of the new device.
   CONCLUSIONS: The surgical and medical protocol used in our study resulted in clinical absence of infection in all our patients with lower postoperative complications in relation to the complete eradication of infection.
C1 [Carlesimo, Bruno; Marchetti, Francesco; Tempesta, Massimo; Marcasciano, Marco; Ruggiero, Marco; Scuderi, Nicolo] Univ Roma La Sapienza, Dept Plast & Reconstruct Surg, Rome, Italy.
RP Marcasciano, M (reprint author), Via Esquilino 38, I-00185 Rome, Italy.
EM marcomarcasciano@libero.it
RI Scuderi, Nicolo/J-2711-2018
OI Scuderi, Nicolo/0000-0002-2458-0498
CR Borden L S, 1987, J Arthroplasty, V2, P27, DOI 10.1016/S0883-5403(87)80028-1
   BRAUSE BD, 1982, ORTHOP CLIN N AM, V13, P245
   DEBURGE A, 1976, CLIN ORTHOP RELAT R, V120, P47
   Emerson Jr RH, 2002, CLIN ORTHOP RELAT R, V404, P132
   Fehring TK, 2000, CLIN ORTHOP RELAT R, P9
   Garvin Kevin L, 2012, Instr Course Lect, V61, P411
   Haddad FS, 2000, J BONE JOINT SURG BR, V82B, P689, DOI 10.1302/0301-620X.82B5.9668
   Hofmann A A, 1995, Clin Orthop Relat Res, P45
   Hofmann AA, 2005, CLIN ORTHOP RELAT R, P125, DOI 10.1097/01.blo.0000149241.77924.01
   Hsu Chi-Shiung, 2008, Chang Gung Med J, V31, P583
   INSALL JN, 1983, J BONE JOINT SURG AM, V65, P1087, DOI 10.2106/00004623-198365080-00008
   IRONS GB, 1984, ORTHOP CLIN N AM, V15, P473
   Jacobs MA, 1989, CLIN ORTHOP RELAT R, V238, P159
   JONES EC, 1979, CLIN ORTHOP RELAT R, V140, P145
   Jones RE, 1995, ORTHOPEDICS, V3, P133
   KRAUSE W, 1989, J BIOACTIVE COMPAT P, V4, P345
   Lotke PA, 1989, CLIN ORTHOP RELAT R, V248, P57
   Markovich GD, 1995, CLIN ORTHOPAEDICS, V321, P122
   MATHES SJ, 1982, PLAST RECONSTR SURG, V69, P815, DOI 10.1097/00006534-198205000-00018
   Noble PC, 2012, CLIN ORTHOP RELAT R, V470, P20, DOI 10.1007/s11999-011-2152-z
   PETTY W, 1975, ORTHOP CLIN N AM, V6, P1005
   RAND JA, 1987, J BONE JOINT SURG AM, V69A, P489, DOI 10.2106/00004623-198769040-00003
   RAND JA, 1983, J BONE JOINT SURG AM, V65, P1081, DOI 10.2106/00004623-198365080-00007
   Rorabeck CH, 2002, CLIN ORTHOP RELAT R, P113, DOI 10.1097/01.blo.0000030491.43495.b8
   ROSENBERG AG, 1988, CLIN ORTHOP RELAT R, P29
   WALKER RH, 1984, CLIN ORTHOP RELAT R, V186, P81
   WHITESIDE LA, 1994, CLIN ORTHOP RELAT R, V299, P169
   WILDE AH, 1988, CLIN ORTHOP RELAT R, V236, P23
NR 28
TC 1
Z9 1
U1 0
U2 3
PU EDIZIONI LUIGI POZZI
PI ROME
PA VIA PANAMA 68, 00198 ROME, ITALY
SN 0003-469X
EI 2239-253X
J9 ANN ITAL CHIR
JI Ann. Ital. Chir.
PD MAR-APR
PY 2013
VL 84
IS 2
BP 179
EP 185
PG 7
WC Surgery
SC Surgery
GA 162UU
UT WOS:000320292300011
PM 23698035
DA 2018-10-20
ER

PT J
AU Beenken-Rothkopf, LN
   Karfeld-Sulzer, LS
   Davis, NE
   Forster, R
   Barron, AE
   Fontaine, MJ
AF Beenken-Rothkopf, Liese N.
   Karfeld-Sulzer, Lindsay S.
   Davis, Nicolynn E.
   Forster, Ryan
   Barron, Annelise E.
   Fontaine, Magali J.
TI The Incorporation of Extracellular Matrix Proteins in Protein Polymer
   Hydrogels to Improve Encapsulated Beta-cell Function
SO ANNALS OF CLINICAL AND LABORATORY SCIENCE
LA English
DT Article
DE hydrogel; islet transplantation; extracellular matrix proteins
ID EXTRAHEPATIC ISLET TRANSPLANTATION; INSULIN-SECRETION;
   DIABETES-MELLITUS; PANCREATIC-ISLET; RATIONAL DESIGN; TISSUE; SCAFFOLDS;
   APOPTOSIS; SURVIVAL; CULTURE
AB Biomaterial encapsulation of islets has been proposed to improve the long-term success of islet transplantation by recreating a suitable microenvironment and enhancing cell-matrix interactions that affect cellular function. Protein polymer hydrogels previously showed promise as a biocompatible scaffold by maintaining high cell viability. Here, enzymatically-crosslinked protein polymers were used to investigate the effects of varying scaffold properties and of introducing ECM proteins on the viability and function of encapsulated MIN6 beta-cells. Chemical and mechanical properties of the hydrogel were modified by altering the protein concentrations while collagen IV, fibronectin, and laminin were incorporated to reestablish cell-matrix interactions lost during cell isolation. Rheology indicated all hydrogels formed quickly, resulting in robust, elastic hydrogels with Young's moduli similar to soft tissue. All hydrogels tested supported both high MIN6 beta-cell viability and function and have the potential to serve as an encapsulation platform for islet cell delivery in vivo.
C1 [Beenken-Rothkopf, Liese N.; Karfeld-Sulzer, Lindsay S.; Forster, Ryan; Barron, Annelise E.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA.
   [Beenken-Rothkopf, Liese N.; Karfeld-Sulzer, Lindsay S.; Barron, Annelise E.] Northwestern Univ, Inst BioNanotechnol Med, Evanston, IL USA.
   [Davis, Nicolynn E.; Fontaine, Magali J.] Stanford Univ, Stanford Sch Med, Dept Pathol, Stanford, CA 94305 USA.
   [Barron, Annelise E.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
RP Fontaine, MJ (reprint author), Dept Pathol, 300 Pasteur Dr H1402 M-C 5626, Stanford, CA 94305 USA.
EM magalif@stanford.edu
FU NIH/NIBIB [R01EB003806]; Northwestern University's NIH/NRSA
   Biotechnology Training Grant [2-T32-GM008449]
FX We thankfully acknowledge Victor Breedveld for modified code to analyze
   transient mircrorheology data. We thank Prof. Wes Burghardt at
   Northwestern University for the use of the rheometer. In addition, we
   thank the Institute of BioNanotechnology in Medicine (IBNAM), Integrated
   Molecular Structure Education and Research Center, The Cell Imaging
   Facility at Northwestern University, and Stanford University and the
   High-Throughput Bioscience Center (HTBC) at Stanford University for the
   use of their equipment. We thank the NIH/NIBIB (R01EB003806) and
   Northwestern University's NIH/NRSA Biotechnology Training Grant
   (2-T32-GM008449) for the generous support of this research, as well as
   the Department of Pathology at Stanford University School of Medicine.
CR Bakeine GJ, 2007, J BIOMED MATER RES A, V83A, P965, DOI 10.1002/jbm.a.31342
   Beenken-Rothkopf L, 2011, PROTEIN POLYM HYDROG
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   BRENDEL MD, 1994, CELL TRANSPLANT, V3, P427, DOI 10.1177/096368979400300510
   Bretzel RG, 2003, ADV EXP MED BIOL, V534, P69
   CAPPELLO J, 1990, TRENDS BIOTECHNOL, V8, P309, DOI 10.1016/0167-7799(90)90207-E
   Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2
   Cicuta P, 2007, SOFT MATTER, V3, P1449, DOI 10.1039/b706004c
   Collaborative Islet Transplant Registry (CITR), COLL ISL TRANSPL REG
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Davis NE, 2010, BIOMATERIALS, V31, P7288, DOI 10.1016/j.biomaterials.2010.06.003
   Davis NE, 2009, BIOMACROMOLECULES, V10, P1125, DOI 10.1021/bm801348g
   EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
   Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Garcia-Ocana A, 2001, J CLIN ENDOCR METAB, V86, P984, DOI 10.1210/jc.86.3.984
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Hamamoto Y, 2003, HORM METAB RES, V35, P460
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b
   Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200
   Kidszun A, 2006, CELL TRANSPLANT, V15, P489, DOI 10.3727/000000006783981774
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Labriola L, 2007, MOL CELL ENDOCRINOL, V263, P120, DOI 10.1016/j.mce.2006.09.011
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0
   Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   Mason MN, 2009, TISSUE ENG PT A, V15, P1343, DOI 10.1089/ten.tea.2008.0290
   Meloche RM, 2007, WORLD J GASTROENTERO, V13, P6347, DOI 10.3748/wjg.13.6347
   Nagata N, 2001, CELL TRANSPLANT, V10, P447
   Narang AS, 2006, PHARMACOL REV, V58, P194, DOI 10.1124/pr.58.2.6
   NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306
   Olsson R, 2006, TRANSPLANTATION, V82, P340, DOI 10.1097/01.tp.0000229418.60236.87
   Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106
   Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1016/S0039-6060(99)70183-2
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Schwarz US, 2005, MED ENG PHYS, V27, P763, DOI 10.1016/j.medengphy.2005.04.007
   Shapiro AMJ, 2003, IMMUNOL REV, V196, P219, DOI 10.1046/j.1600-065X.2003.00085.x
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   Tatarkiewicz K, 2001, TRANSPLANTATION, V71, P1518, DOI 10.1097/00007890-200106150-00007
   Thomas F, 2001, SURGERY, V130, P333, DOI 10.1067/msy.2001.116413
   Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1016/S0039-6060(99)70169-8
   Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208
   Vanelli M, 1997, HORM RES, V48, P71, DOI 10.1159/000191319
   Vogel WF, 2001, EUR J DERMATOL, V11, P506
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181
   Wang RN, 1999, J HISTOCHEM CYTOCHEM, V47, P499, DOI 10.1177/002215549904700408
   Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001
   Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Wilson DB, 2005, NATURE, V438, pE5, DOI 10.1038/nature04423
   Won JI, 2002, MACROMOLECULES, V35, P8281, DOI 10.1021/ma020892i
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
NR 65
TC 10
Z9 10
U1 1
U2 20
PU ASSOC CLINICAL SCIENTISTS
PI MIDDLEBURY
PA PO BOX 1287, MIDDLEBURY, VT 05753 USA
SN 0091-7370
J9 ANN CLIN LAB SCI
JI Ann. Clin. Lab. Sci.
PD SPR
PY 2013
VL 43
IS 2
BP 111
EP 121
PG 11
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 146PO
UT WOS:000319103200001
PM 23694784
DA 2018-10-20
ER

PT J
AU Alberti, C
AF Alberti, C.
TI Tissue engineering as innovative chance for organ replacement in radical
   tumor surgery
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE Trachea; Bladder; Biomatrix; Biomaterials; Nanotechnology; Stem-cells
ID NANO-STRUCTURED POLYMERS; ACELLULAR MATRIX GRAFT; REGENERATIVE MEDICINE;
   STEM-CELLS; URINARY-BLADDER; IN-VITRO; BIOMATERIALS; CHALLENGES; MODEL;
   TRANSPLANTATION
AB BACKGROUND: Different pathological conditions such as congenital organ absence, severe organ injuries, end-stage organ failure and malignancy-related organ removal, have few effective therapeutic options a part from a whole organ transplant, that, however, often meets with a serious shortage of suitable donor organs.
   AIM: The purpose of this paper consists in highlighting what the novel tissue engineering approaches might help to solve such problems.
   EMERGING CONCEPTS: A recent approach in tissue/organ engineering, particularly to build bioartificial airways, is the procedure of decellularizing a whole donor organ to obtain a complex 3D-biomatrix-scaffold mantaining the intrinsic vascular network, that is subsequently recellularized with recipient's autologous organ-specific differentiated cells or/and stem cells, to build a potentially functional biological substitute. Such strategy has been clinically used to replace organ in trachea/broncus tumor patients. In another approach, mainly used to construct a bioartificial urinary bladder tissue, different types of either biodegradable synthetic polymers or naturally-derived matrices or even polymer/biomatrix-composite materials are used as scaffold for either cell-free or autologous cell-seeded tissue engineering procedures. So far, such technique has been mainly used to make an augmentation cystoplasty in patients with end-stage poorly compliant neuropathic bladder or in exstrophic bladder subjects.
   FUTURE PROSPECTS: Intriguing developments in biomaterial science, nanotechnologies, stem cell biology, and further improvements in bioreactor manufactoring will allow to generate, in the near future, tissue engineered organs that, as for structure/function so the native one-like, might represent the optimum solution to replace organs in tumor surgery.
C1 LD Surg Semeiot, Parma, Italy.
RP Alberti, C (reprint author), LD Surg Semeiot, Parma, Italy.
EM eneide94@gmail.com
CR Adamowicz J, 2012, TRANSPL P, V44, P1429, DOI 10.1016/j.transproceed.2012.01.144
   Alberti C, 2007, EUR REV MED PHARMACO, V11, P257
   Alberti C, 2012, G CHIR, V33, P435
   Alberti C, 2012, G CHIR, V33, P234
   Alberti C, 2011, G CHIR, V32, P345
   Alberti C, 2009, G CHIR, V30, P514
   Alberti C, 1971, Minerva Urol, V23, P1
   ALBERTI C, 2002, UROLOGIA, V69, P296
   ALBERTI C., 2002, BJU INT, V89, P972
   Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 1999, UROL CLIN N AM, V26, P157, DOI 10.1016/S0094-0143(99)80013-5
   Atala A., 2012, SCI TRANSL MED, V4
   Atala Anthony, 1997, P149
   Atala A, 2006, CURR OPIN UROL, V16, P305, DOI 10.1097/01.mou.0000232055.20084.f6
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Baiguera S, 2012, BIOMATERIALS, V33, P3662, DOI 10.1016/j.biomaterials.2012.01.064
   Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   CHUN SY, 2012, UROLOGY, V79
   Cross WR, 2003, BJU INT, V92, P165, DOI 10.1046/j.1464-410X.2003.04280.x
   Curcio E, 2010, BIOMATERIALS, V31, P5131, DOI 10.1016/j.biomaterials.2010.03.013
   Davis NF, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.11.036
   Demming A, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/46/460201
   Drewa T, 2012, NAT REV UROL, V9, P561, DOI 10.1038/nrurol.2012.158
   Eberli D, 2006, METHOD ENZYMOL, V420, P287, DOI 10.1016/S0076-6879(06)20013-2
   ELLIOT MJ, 2012, LANCET, V15, P994
   Ferguson DR, 1999, BJU INT, V84, P235
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6
   Harrington DA, 2008, WORLD J UROL, V26, P315, DOI 10.1007/s00345-008-0273-0
   HE M, 2012, TISSUE EN B IN PRESS
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hyndman ME, 2012, ADV UROL, V2012
   Ilie I, 2012, INT J NANOMED, V7, P2211, DOI 10.2147/IJN.S29975
   JOHNSON TD, 2011, NANOTECHNOLOGY, V22, P494
   Jungebluth P, 2012, CLIN PHARMACOL THER, V91, P81, DOI 10.1038/clpt.2011.270
   Jungebluth P, 2012, BIOMATERIALS, V33, P4319, DOI 10.1016/j.biomaterials.2012.03.016
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Ko IK, 2012, FASEB J, V26, P158, DOI 10.1096/fj.11-182998
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Laurance J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1633
   Li W, 2011, CELL RES, V21, P550, DOI 10.1038/cr.2011.25
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   MAIOLI M, 2012, CELL TRANSP IN PRESS
   McAteer H, 2007, J TISSUE ENG REGEN M, V1, P343, DOI 10.1002/term.36
   MELLOT AJ, 2012, ANN BIOMED IN PRESS
   Mitsui Y, 2012, BJU INT, V110, pE1212, DOI 10.1111/j.1464-410X.2012.11553.x
   Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326
   Murphy SV, 2013, BIOESSAYS, V35, P163, DOI 10.1002/bies.201200062
   Nolan K, 2008, CELL TRANSPLANT, V17, P241, DOI 10.3727/096368908784153931
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   OPERPENNING F, 1999, NAT BIOTECHNOL, V17, P146
   Partington L, 2013, ACTA BIOMATER, V9, P5251, DOI 10.1016/j.actbio.2012.10.004
   Pattison M, 2007, MACROMOL BIOSCI, V7, P690, DOI 10.1002/mabi.200600297
   Peyton CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047414
   Piechota HJ, 1998, J UROLOGY, V159, P1717, DOI 10.1097/00005392-199805000-00100
   Rich JT, 2012, CURR OPIN OTOLARYNGO, V20, P246, DOI 10.1097/MOO.0b013e328355580e
   Roth CC, 2010, PEDIATR RES, V67, P509, DOI 10.1203/PDR.0b013e3181d35034
   Sharma AK, 2011, REGEN MED, V6, P583, DOI [10.2217/rme.11.47, 10.2217/RME.11.47]
   Shastri VP, 2009, ADV MATER, V21, P3246, DOI [10.1002/adma.200900608, 10.1002/adma.200990155]
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Tsang M, 2011, TISSUE ENG PT A, V17, P1879, DOI [10.1089/ten.TEA.2010.0569, 10.1089/ten.tea.2010.0569]
   YAGI H, 2012, SURG TODAY IN PRESS
   Yang Y, 2010, WIRES NANOMED NANOBI, V2, P478, DOI 10.1002/wnan.74
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
   Yoo James J, 2011, Int Neurourol J, V15, P109, DOI 10.5213/inj.2011.15.3.109
   Zang MQ, 2012, PLAST RECONSTR SURG, V130, P532, DOI 10.1097/PRS.0b013e31825dc084
   ZHANG Y, 2006, BJU INT, V88, P1100
   Zhang Yuanyuan, 2013, Methods Mol Biol, V945, P383, DOI 10.1007/978-1-62703-125-7_23
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
NR 72
TC 4
Z9 5
U1 1
U2 17
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PD MAR
PY 2013
VL 17
IS 5
BP 624
EP 631
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 148EM
UT WOS:000319225900006
PM 23543445
DA 2018-10-20
ER

PT J
AU Choi, SM
   Singh, D
   Kumar, A
   Oh, TH
   Cho, YW
   Han, SS
AF Choi, Soon Mo
   Singh, Deepti
   Kumar, Ashok
   Oh, Tae Hwan
   Cho, Yong Woo
   Han, Sung Soo
TI Porous Three-Dimensional PVA/Gelatin Sponge for Skin Tissue Engineering
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE Compression; 3-D sponge; freeze-drying; gelatin; human fibroblast; PVA;
   skin tissue engineering
ID DRUG-DELIVERY; POLYMERS; FILMS
AB A series of PVA/gelatin scaffolds in different concentrations were prepared and blended to evaluate the polymer concentration effects on the architecture of the scaffold. SEM images revealed that with increasing gelatin concentration the average pore diameters varied from 60 to 190nm. Bio-compatibility assay showed cells attached and elongated actively on the scaffolds and cyto-toxicity results of all samples were found to be in grade 1 or 0, indicating the bio-safety of PVA/gelatin as biomaterial. Results indicate the polymer concentration effects on the architecture of the scaffold and PVA/gelatin macroporous scaffolds have potential to be bio-matrices for tissue genesis.
C1 [Choi, Soon Mo; Singh, Deepti; Oh, Tae Hwan; Han, Sung Soo] Yeungnam Univ, Sch Engn, Dept Nano Med & Polymer Mat, Gyongsan 712749, Gyeonsangbukdo, South Korea.
   [Choi, Soon Mo; Singh, Deepti; Oh, Tae Hwan; Han, Sung Soo] Yeungnam Univ, Polymer Gel Res Cluster Ctr, Gyongsan 712749, Gyeonsangbukdo, South Korea.
   [Singh, Deepti; Kumar, Ashok] Indian Inst Technol Kanpur, Kanpur, Uttar Pradesh, India.
   [Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan, South Korea.
RP Han, SS (reprint author), Yeungnam Univ, Sch Engn, Dept Nano, 280 Daehak Ro, Gyongsan 712749, Gyeonsangbukdo, South Korea.
EM sshan@yu.ac.kr
RI Kumar, Ashok/G-8515-2015
FU Yeungnam University
FX This work was supported by Yeungnam University Research Grant 2009.
CR Akshay S., 2007, MAT SCI ENG A-STRUCT
   Badylak S.F., 2009, ACTA BIOMATER, V5, P13
   Buning Z., 2010, INT J POLYM MATER, V59, P1018
   Debasish S., 2009, DES MONOMERS POLYM, V12, P377
   Dilip C.D., 2011, INT J POLYM MATER, V60, P852
   Florian G., 2011, ADV DRUG DELIV REV, V63, P366
   Groeber F., 2012, CLIN PLAST SURG, V39, P58
   Guoquan Z., 2011, INT J POLYM MATER, V60, P720
   Gupta AP, 2010, DES MONOMERS POLYM, V13, P65, DOI 10.1163/138577209X12591392377810
   hao Y., 2010, CARBOHYD POLYM, V82, P1297
   Hussain T, 2011, DES MONOMERS POLYM, V14, P233, DOI 10.1163/138577211X557521
   Ismail H, 2011, POLYM-PLAST TECHNOL, V50, P1214, DOI 10.1080/03602559.2011.566241
   Jun P.Z., 2010, ACTA BIOMATER, V6, P1167
   Kumar A., 2006, J CHROM A, V1103, P42
   Kuniko H., 2007, J CONTROL RELEASE, V118, P176
   Lee S.B., 2005, BIOMATERIALS, V26, P1968
   Ma P. X, 2008, ADV DRUG DELIV REV, V60, P198
   Malafaya P.B., 2007, ADV DRUG DELIV REV, V59
   McCann J.T., 2006, J AM CHEM SOC, V128, P1437
   Mohanan A., 2012, INT J POLYM MATER, V58, P561
   Mushfiqur R, 2011, INT J POLYM MATER, V60, P1056
   Neeraj K., 2009, ACTA BIOMATER, V5, P418
   Niladri R., 2012, INT J POLYM MATER, V61, P72
   Nor A.R., 2011, INT J PHARMACEUT, V403, P73
   Orgill DP, 2009, WOODHEAD PUBL MATER, P3, DOI 10.1533/9781845695545.1.3
   Pan W., 2010, INT J POLYM MATER, V60, P223
   Papkov M.S., 2007, ADV DRUG DELIV REV, V59
   Ranjna C.D., 2009, BIOTECHNOL ADV, V27, P334
   Reverchon E., 2008, J SUPERCRIT FLUID, V45, P373
   Roy S, 2009, DES MONOMERS POLYM, V12, P483, DOI 10.1163/138577209X12478283327236
   Sahoo S, 2011, DES MONOMERS POLYM, V14, P95, DOI 10.1163/138577211X555721
   Singh D., 2010, J BIO SCI, V6, P381
   Swati S., 2012, INT J POLYM MATER, V61, P679
   Thomas W., 2007, BIOMATERIALS, V28, P147
   uirong Y., 2010, DES MONOMERS POLYM, V13, P415
   Viorica G., 2011, DES MONOMERS POLYM, V14, P57
   Wang TW, 2006, BIOMATERIALS, V27, P5689, DOI 10.1016/j.biomaterials.2006.07.024
   Yuichiro K., 2011, BIOMATERIALS, V32, P919
   Zaher K, 2009, INT J POLYM MATER, V58, P665, DOI 10.1080/00914030903146738
NR 39
TC 32
Z9 32
U1 7
U2 44
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PD MAR 1
PY 2013
VL 62
IS 7
BP 384
EP 389
DI 10.1080/00914037.2012.710862
PG 6
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA 147MI
UT WOS:000319171300003
DA 2018-10-20
ER

PT J
AU Muthumanickkam, A
   Subramanian, S
   Goweri, M
   Beaula, WS
   Ganesh, V
AF Muthumanickkam, Andiyappan
   Subramanian, Sundaramoorthy
   Goweri, Mahizhappan
   Beaula, Winfred Sofi
   Ganesh, Venkataraman
TI Comparative study on eri silk and mulberry silk fibroin scaffolds for
   biomedical applications
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE Eri silk fibroin; Mulberry silk fibroin; Tensile strength; Blood
   compatibility; Cell attachment
ID SAMIA-CYNTHIA-RICINI; IN-VITRO; BOMBYX-MORI; FILMS; NANOFIBERS;
   RESPONSES; FIBERS; CELLS; NMR
AB Mulberry silk fibroin is being used as biomaterial for tissue engineering applications. In the present work, comparisons are made between mulberry and eri silk fibroin scaffolds prepared by electrospinning method. The scaffolds are treated with ethanol to improve their dimensional stability, and the physical and chemical properties of the scaffolds are assessed using thermogravimetric analyzer (TGA), differential scanning calorimetry, Fourier transform infrared spectroscopy and X-ray diffractometry. The FTIR spectra confirm the structural change of silk fibroin from alpha-helical to beta-sheet structure when mulberry and eri silk scaffolds are treated with ethanol. The thermal stability of the eri silk scaffold is found to be better than that of mulberry silk. Ethanol-treated eri silk displays higher tensile stress than the ethanol-treated mulberry silk. The hemolysis percentages of eri silk and mulberry silk scaffolds are found to be 1 and 3 %, respectively. While the platelet adhesion on eri silk fibroin scaffold is found to be lower than that of mulberry silk fibroin scaffold, the cell attachment, binding and spreading of L6 fibroblast cells on the eri silk scaffold are better than those on the mulberry silk fibroin, and the cell viability is found to be better on eri silk fibroin scaffold.
C1 [Muthumanickkam, Andiyappan; Subramanian, Sundaramoorthy] Anna Univ, Dept Text Technol, Madras 600025, Tamil Nadu, India.
   [Goweri, Mahizhappan; Beaula, Winfred Sofi; Ganesh, Venkataraman] Sri Ramachandra Univ, Dept Human Genet, Madras 600116, Tamil Nadu, India.
RP Subramanian, S (reprint author), Anna Univ, Dept Text Technol, Madras 600025, Tamil Nadu, India.
EM ssubbu@annauniv.edu
CR Cao H, 2009, MAT SCI ENG C-MATER, V29, P2270, DOI 10.1016/j.msec.2009.05.012
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170
   Freddi G, 1999, INT J BIOL MACROMOL, V24, P251, DOI 10.1016/S0141-8130(98)00087-7
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   He JX, 2011, IRAN POLYM J, V20, P713
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Hou CJ, 2008, J BIOMED MATER RES A, V85A, P847, DOI 10.1002/jbm.a.31502
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Mai-ngam K, 2011, J BIOMAT SCI-POLYM E, V22, P2001, DOI 10.1163/092050610X530964
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MUTHUMANICKKAM A, 2010, INT J MATER RES, V12, P1548, DOI DOI 10.3139/146.110429
   Nakazawa Y, 2003, PROTEIN SCI, V12, P666, DOI 10.1110/ps.0239203
   Qu XH, 2006, J BIOMAT SCI-POLYM E, V17, P1107, DOI 10.1163/156856206778530704
   Rajkhowa R, 2011, J APPL POLYM SCI, V119, P1339, DOI 10.1002/app.31981
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sen K, 2004, J APPL POLYM SCI, V92, P1080, DOI 10.1002/app.13609
   Simchuer W, 2010, INT J APPL CHEM, V6, P373
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yang YD, 2005, CHINESE CHEM LETT, V16, P991
   Zobel HP, 1999, EUR J PHARM BIOPHARM, V48, P1, DOI 10.1016/S0939-6411(99)00003-X
NR 28
TC 11
Z9 11
U1 3
U2 26
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD MAR
PY 2013
VL 22
IS 3
BP 143
EP 154
DI 10.1007/s13726-012-0113-3
PG 12
WC Polymer Science
SC Polymer Science
GA 140ID
UT WOS:000318646800001
DA 2018-10-20
ER

PT J
AU Bastier, PL
   Bennani-Baiti, AA
   Stoll, D
   de Gabory, L
AF Bastier, Pierre-Louis
   Bennani-Baiti, Ahmed Anass
   Stoll, Dominique
   de Gabory, Ludovic
TI beta-Tricalcium Phosphate Implant to Repair Empty Nose Syndrome:
   Preliminary Results
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article
DE empty nose syndrome; inferior turbinate; nasal obstruction;
   beta-tricalcium phosphate; ceramic; biomaterial
C1 [Bastier, Pierre-Louis; Bennani-Baiti, Ahmed Anass; Stoll, Dominique; de Gabory, Ludovic] Univ Hosp Bordeaux, Ctr FX Michelet, F-33076 Bordeaux, France.
RP de Gabory, L (reprint author), Univ Hosp Bordeaux, Dept Otorhinolaryngol Head & Neck Surg, Ctr FX Michelet, Pl Amelie Raba Leon, F-33076 Bordeaux, France.
EM ludovic.de-gabory@chu-bordeaux.fr
CR Coste A, 2012, EUR ANN OTORHINOLARY, V129, P93, DOI 10.1016/j.anorl.2012.02.001
   de Gabory L, 2010, ACTA BIOMATER, V6, P909, DOI 10.1016/j.actbio.2009.08.018
   Marro M, 2011, OTOLARYNG HEAD NECK, V144, P988, DOI 10.1177/0194599811400686
   Na Y, 2012, RESP PHYSIOL NEUROBI, V180, P289, DOI 10.1016/j.resp.2011.12.005
   Saafan ME, 2013, EUR ARCH OTO-RHINO-L, V270, P527, DOI 10.1007/s00405-012-1955-1
NR 5
TC 3
Z9 3
U1 1
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0194-5998
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD MAR
PY 2013
VL 148
IS 3
BP 519
EP 522
DI 10.1177/0194599812472436
PG 4
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 136LD
UT WOS:000318362500027
PM 23300225
DA 2018-10-20
ER

PT J
AU Zafar, MN
   Wahid, A
   Ghauri, MA
   Zubair, M
   Mumtaz, MW
   Anwar, F
   Danish, M
AF Zafar, Muhammad Nadeem
   Wahid, Abdul
   Ghauri, Muhammad Afzal
   Zubair, Muhammad
   Mumtaz, Muhammad Waseem
   Anwar, Farooq
   Danish, Muhammad
TI Trichoderma harzianum: a green sorbent for Pb(II) uptake from aqueous
   solutions
SO TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY
LA English
DT Article
DE Trichoderma harzianum; Pb(II); kinetics; water treatment; toxic
ID COPPER(II) IONS; METAL-IONS; BIOMASS; BIOSORPTION; SORPTION; REMOVAL;
   BIOCONTROL; ADSORPTION; LEAD; CHROMIUM(VI)
AB This investigation describes the use of specially cultivated, nonliving biomass of Trichoderma harzianum as a biosorbent for the batch removal of Pb(II) from a stirred system under different experimental conditions. The metal removal depended upon pH, sorbent particle size, initial Pb(II) concentration, shaking speed, and sorption time. The optimal experimental conditions for the removal of Pb(II) by T. harzianum with an initial metal concentration of 100mg L-1 were obtained at a particle size of 53m, a pH of 4.5, a shaking speed of 200rpm, and a contact time of 720min. The results were analyzed in terms of adsorption isotherms and kinetic models. The Freundlich isotherm model and pseudo second-order model fitted well in the data. T. harzianum proved to be a good biomaterial for accumulating Pb(II) from aqueous solutions (q = 460mg g(1)).
C1 [Zafar, Muhammad Nadeem; Zubair, Muhammad; Mumtaz, Muhammad Waseem; Danish, Muhammad] Univ Gujrat, Dept Chem, Gujrat, Pakistan.
   [Zafar, Muhammad Nadeem; Wahid, Abdul] Univ Agr Faisalabad, Dept Chem, Faisalabad, Pakistan.
   [Wahid, Abdul; Ghauri, Muhammad Afzal] NIBGE, Bioproc Technol Div, Faisalabad, Pakistan.
   [Anwar, Farooq] Univ Sargoda, Dept Chem, Sargoda, Pakistan.
RP Zafar, MN (reprint author), Univ Gujrat, Dept Chem, Gujrat, Pakistan.
EM nadeem.zafar@uog.edu.pk
RI Zafar, Muhammad/E-8849-2010; Danish, Muhammad/J-3812-2015
OI Zafar, Muhammad/0000-0002-2109-7601; 
CR Ahalya N, 2005, ELECTRON J BIOTECHN, V8, DOI 10.2225/vol8-issue3-fulltext-10
   Altomare C, 1999, APPL ENVIRON MICROB, V65, P2926
   Ashkenazy R, 1999, APPL MICROBIOL BIOT, V52, P608, DOI 10.1007/s002530051567
   Bai RS, 2003, BIORESOURCE TECHNOL, V87, P17
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   Bhatti HN, 2007, PROCESS BIOCHEM, V42, P547, DOI 10.1016/j.procbio.2006.11.009
   Bustard M, 1997, BIOPROCESS ENG, V17, P45
   Cheryl S. S., 1995, TOXICS HLTH POTENTIA
   Choi SB, 2004, BIOTECHNOL LETT, V26, P331, DOI 10.1023/B:BILE.0000015453.20708.fc
   DARNALL DW, 1986, ENVIRON SCI TECHNOL, V20, P206, DOI 10.1021/es00144a018
   Didonato M., 2000, MOL BIOL TOXICOLOGY
   Donmez G, 1999, PROCESS BIOCHEM, V35, P135, DOI 10.1016/S0032-9592(99)00044-8
   Elad Y, 1999, EUR J PLANT PATHOL, V105, P177, DOI 10.1023/A:1008753629207
   Febriana N, 2010, J TAIWAN INST CHEM E, V41, P111, DOI 10.1016/j.jtice.2009.04.003
   Forest E., 1992, APPL MICROBIOL BIOT, V37, P399
   Freundlich H. M., 1906, J PHYS CHEM, V57, P384
   GardeaTorresdey JL, 1996, J HAZARD MATER, V48, P181, DOI 10.1016/0304-3894(95)00155-7
   Ho Y. S., 1995, ADSORPTION HEAVY MET
   Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Manju G. W., 1997, BIORESOURCE TECHNOLO, V87, P17
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   MCKAY G, 1980, WATER RES, V14, P15, DOI 10.1016/0043-1354(80)90037-8
   Muter O, 2002, PROCESS BIOCHEM, V38, P123, DOI 10.1016/S0032-9592(02)00065-1
   Nadeem R, 2008, J HAZARD MATER, V150, P335, DOI 10.1016/j.jhazmat.2007.04.110
   Naiya TK, 2008, ENVIRON PROG, V27, P313, DOI 10.1002/ep.10280
   Naiya TK, 2009, J HAZARD MATER, V163, P1254, DOI 10.1016/j.jhazmat.2008.07.119
   Nriagu JO, 1996, SCIENCE, V272, P223, DOI 10.1126/science.272.5259.223
   Priya J. Ajitha, 2007, Toxicological and Environmental Chemistry, V89, P421, DOI 10.1080/02772240601156650
   Rajfur M, 2012, BIOELECTROCHEMISTRY, V87, P65, DOI 10.1016/j.bioelechem.2011.12.007
   Riordan C, 1998, BIOPROCESS ENG, V19, P277, DOI 10.1007/s004490050519
   Shan L., 2002, ADV ENVIRON RES, V6, P523
   Singh R. S., 1995, Plant Disease Research, V10, P10
   Singha B, 2012, ENVIRON SCI POLLUT R, V19, P2212, DOI 10.1007/s11356-011-0725-8
   Singha B, 2011, COLLOID SURFACE B, V84, P221, DOI 10.1016/j.colsurfb.2011.01.004
   Sun G, 1998, IND ENG CHEM RES, V37, P1324, DOI 10.1021/ie970468j
   Volesky Bohumil, 1990, BIOSORPTION HEAVY ME
   Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061
   Zafar MN, 2009, WATER AIR SOIL POLL, V197, P1573
   Zafar MN, 2007, J HAZARD MATER, V143, P478, DOI 10.1016/j.jhazmat.2006.09.055
   ZHANG WX, 1994, ENVIRON SCI TECHNOL, V28, P1577, DOI 10.1021/es00058a007
NR 44
TC 1
Z9 1
U1 1
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0277-2248
J9 TOXICOL ENVIRON CHEM
JI Toxicol Environ. Chem.
PD MAR 1
PY 2013
VL 95
IS 3
BP 422
EP 433
DI 10.1080/02772248.2013.790973
PG 12
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 138WL
UT WOS:000318541400006
DA 2018-10-20
ER

PT J
AU Franz, S
   Scharnweber, D
   Schnabelrauch, M
   Simon, JC
   Anderegg, U
AF Franz, S.
   Scharnweber, D.
   Schnabelrauch, M.
   Simon, J. C.
   Anderegg, U.
TI Modulation of cellular functions by artificial extracellular matrices
   used as biomaterial coatings
SO EXPERIMENTAL DERMATOLOGY
LA English
DT Meeting Abstract
CT 40th Annual Meeting of the Association-of-Dermatological-Research
CY MAR 14-16, 2013
CL Dessau, GERMANY
SP Assoc Dermatolog Res
C1 [Franz, S.; Simon, J. C.; Anderegg, U.] Univ Leipzig, Dept Dermatol, D-04103 Leipzig, Germany.
   [Franz, S.; Scharnweber, D.; Schnabelrauch, M.; Simon, J. C.; Anderegg, U.] Collaborat Res Ctr SFB TRR67, Leipzig, Germany.
   [Franz, S.; Scharnweber, D.; Schnabelrauch, M.; Simon, J. C.; Anderegg, U.] Collaborat Res Ctr SFB TRR67, Dresden, Germany.
   [Scharnweber, D.] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Schnabelrauch, M.] INNOVENT EV, Biomat Dept, D-07745 Jena, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0906-6705
J9 EXP DERMATOL
JI Exp. Dermatol.
PD MAR
PY 2013
VL 22
IS 3
BP E7
EP E7
PG 1
WC Dermatology
SC Dermatology
GA 108YJ
UT WOS:000316332000034
DA 2018-10-20
ER

PT J
AU Xin, PF
   Nie, PL
   Jiang, B
   Deng, SM
   Hu, GH
   Shen, SGF
AF Xin, Pengfei
   Nie, Pulin
   Jiang, Bin
   Deng, Simin
   Hu, Guanghong
   Shen, Steve G. F.
TI Material Assignment in Finite Element Modeling: Heterogeneous Properties
   of the Mandibular Bone
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Elastic modulus; finite element modeling; heterogeneity; biomaterials
ID ELASTIC PROPERTIES; MECHANICAL-PROPERTIES; NANOINDENTATION; DENSITY;
   HARDNESS; SURGERY; STRESS; FORCES; LOAD
AB Purpose: The properties of the biomaterial are normally characterized by heterogeneity on all scales influencing the function and biomechanics. Elastic modulus (EM), which is one of the most important mechanical properties of material, is necessary for finite element modeling and needed to be determined by some methods. The aim of this study is to demonstrate the feasibility of assessment of EM from GrayValue (GV) of computed tomographic image and assignment of material properties in heterogeneous finite element modeling for studying the performance of the mandibular bones.
   Methods: Three mandibles obtained from fresh human cadavers were used in this study. All mandibular bones were scanned using computed tomography, and the original data were stored in optical disks. The finite element modeling of the 3 mandibles was meshed using Materialise Mimics 10.01 and Abaqus 6.10 software. Using the empirical expression on relationship between GV and EM, the empirical EM of the meshed mandibular elements were calculated. To verify the empirical EM, actual EM of the three was determined by nanoindentation test using Oliver and Pharr method. The dependence of EM on test regions and loading directions were also discussed.
   Results: The empirical EM of the mandible element is in the range of 3.7 to 23.4 Gpa, and EM of the cortical element is in the range of 8.6 to 13.6 Gpa. In comparison, the actual EM of cortical bone tested by nanoindentation method is in the range of 10.0 to 22.0 Gpa. The tested EM is varied with the test regions and loading directions. The difference in the values of EM determined by the empirical analysis and by the nanoindentation test is approximately 5.0 Gpa.
   Conclusions: A mandibular finite element model with heterogeneous material properties is built. By analyzing the EM value of this model, it is concluded that the actual EM in anterior-posterior direction in mandibular ramus and EM in superior-inferior direction in mandibular body match the empirical EM better than the other directions.
C1 [Xin, Pengfei; Deng, Simin; Shen, Steve G. F.] Shanghai Jiao Tong Univ, Sch Med, Dept Oral & Craniomaxillofacial Surg,Coll Stomato, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200030, Peoples R China.
   [Nie, Pulin] Shanghai Jiao Tong Univ, Shanghai Key Lab Mat Laser Proc & Modificat, Shanghai 200030, Peoples R China.
   [Jiang, Bin; Hu, Guanghong] Shanghai Jiao Tong Univ, Dept Plast Engn, Shanghai 200030, Peoples R China.
RP Shen, SGF (reprint author), 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
EM maxillofacsurg@163.com
FU National High Technology Research and Development Program of China
   [2009AA045201]; National Natural Science Foundation of China [81101131]
FX This study was supported by the National High Technology Research and
   Development Program of China (Project Number: 2009AA045201) and National
   Natural Science Foundation of China (Project Number: 81101131).
CR Bujtar P, 2010, ORAL SURG ORAL MED O, V110, P301, DOI 10.1016/j.tripleo.2010.01.025
   Choi JP, 2010, J CRANIOFAC SURG, V21, P1104, DOI 10.1097/SCS.0b013e3181e1b449
   Curtis N, 2011, J ANAT, V218, P16, DOI 10.1111/j.1469-7580.2010.01317.x
   DECHOW PC, 1993, AM J PHYS ANTHROPOL, V90, P291, DOI 10.1002/ajpa.1330900304
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   Erkmen E, 2005, INT J ORAL MAX SURG, V34, P551, DOI 10.1016/j.ijom.2004.10.009
   Gautam P, 2011, ANGLE ORTHOD, V81, P503, DOI 10.2319/070110-367.1
   Grauer D, 2009, AM J ORTHOD DENTOFAC, V136, P460, DOI 10.1016/j.ajodo.2009.04.016
   Hansen S, 2011, CALCIFIED TISSUE INT, V89, P335, DOI 10.1007/s00223-011-9523-z
   Haque F, 2003, SURF ENG, V19, P255, DOI 10.1179/026708403225007464
   Huang HL, 2010, COMPUT BIOL MED, V40, P464, DOI 10.1016/j.compbiomed.2010.02.011
   Kavanagh EP, 2008, IRISH J MED SCI, V177, P325, DOI 10.1007/s11845-008-0218-z
   Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103
   Lettry S, 2003, BONE, V32, P35, DOI 10.1016/S8756-3282(02)00921-3
   Machado Camilo, 2008, Braz. Dent. J., V19, P68, DOI 10.1590/S0103-64402008000100012
   Nickel J, 2009, ORTHOD CRANIOFAC RES, V12, P159, DOI 10.1111/j.1601-6343.2009.01449.x
   Nomura T, 2003, DENT MATER, V19, P167, DOI 10.1016/S0109-5641(02)00026-X
   O'Mahony AM, 2000, CLIN ORAL IMPLAN RES, V11, P415, DOI 10.1034/j.1600-0501.2000.011005415.x
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Oyen ML, 2011, EXP TECH, P1
   Parascandolo S, 2010, J CRANIO MAXILL SURG, V38, P385, DOI 10.1016/j.jcms.2009.10.014
   Pileicikiene Gaivile, 2007, Stomatologija, V9, P121
   Qi XD, 2012, J CRANIO MAXILL SURG, V40, pE159, DOI 10.1016/j.jcms.2011.07.024
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F
   Seong WJ, 2009, INT J ORAL MAX SURG, V38, P1088, DOI 10.1016/j.ijom.2009.06.025
   Seong WJ, 2009, J PROSTHET DENT, V101, P306, DOI 10.1016/S0022-3913(09)60062-7
   Tamatsu Yuichi, 1996, Bulletin of Tokyo Dental College, V37, P93
   Taylor WR, 2002, J BIOMECH, V35, P767, DOI 10.1016/S0021-9290(02)00022-2
   van Eijden TMGJ, 2004, CALCIFIED TISSUE INT, V75, P502, DOI 10.1007/s00223-004-0295-6
   Vollmer D, 2000, J CRANIO MAXILL SURG, V28, P91, DOI 10.1054/jcms.2000.0125
   Yua DD, 2012, J CRANIOFAC SURG, V23, P925, DOI 10.1097/SCS.0b013e318250556e
   Zwierzak I, 2009, P I MECH ENG H, V223, P913, DOI 10.1243/09544119JEIM634
NR 33
TC 3
Z9 3
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2013
VL 24
IS 2
BP 405
EP 410
DI 10.1097/SCS.0b013e31827ff137
PG 6
WC Surgery
SC Surgery
GA 113OB
UT WOS:000316676300061
PM 23524703
DA 2018-10-20
ER

PT J
AU Wu, CT
   Fan, W
   Chang, J
   Zhang, ML
   Xiao, Y
AF Wu, Chengtie
   Fan, Wei
   Chang, Jiang
   Zhang, Meili
   Xiao, Yin
TI Preparation, Characterization, and In Vitro Bioactivity of
   Nagelschmidtite Bioceramics
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID SILICON-SUBSTITUTED HYDROXYAPATITES; PERIODONTAL-LIGAMENT CELLS; IONIC
   PRODUCTS; CALCIUM-PHOSPHATE; APATITE LAYER; OSTEOGENIC DIFFERENTIATION;
   TRICALCIUM PHOSPHATE; GLASS DISSOLUTION; GENE-EXPRESSION; PROLIFERATION
AB The aim of this study is to prepare Ca, P and Si-containing ternary oxide nagelschmidtite (NAGEL, Ca7Si2P2O16) bioceramics and explore their in vitro bioactivity for potential bone tissue regeneration. We prepared dense NAGEL ceramics through high-temperature sintering of NAGEL ceramic powders. The apatite-mineralization ability, dissolution rate, and human osteoblast response (including cytotoxicity analysis, attachment, morphology, proliferation, and bone-related gene expression) to NAGEL ceramics have been systematically studied by comparing with conventional -tricalcium phosphate (-TCP) ceramics. The results showed that NAGEL ceramics possessed more obvious apatite mineralization and dissolution (degradation) and stimulated bone-related gene expression (OCN and OPN) of osteoblasts than -TCP ceramics. NAGEL ceramics also showed no significant cytotoxicity. NAGEL ceramics supported osteoblast attachment, proliferation, and osteogenic gene expression, with a comparable cell proliferation activity with -TCP ceramics. These results indicate that novel NAGEL bioceramics with the specific composition of Ca7Si2P2O16, are a promising biomaterial for bone tissue regeneration application.
C1 [Wu, Chengtie; Chang, Jiang; Zhang, Meili] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Fan, Wei; Xiao, Yin] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Peoples R China.
   [Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
RP Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM chengtiewu@mail.sic.ac.cn; yin.xiao@qut.edu.au
OI Xiao, Yin/0000-0003-1785-3491
FU Recruitment Program of Global Young Talent, China; Natural Science
   Foundation of China [81201202, 81190132]; Shanghai Municipal Natural
   Science Foundation [12ZR1435300]; ARC Discovery [DP120103697]
FX Funding for this study was provided by the Recruitment Program of Global
   Young Talent, China (Dr Wu), Natural Science Foundation of China (grant
   no. 81201202 and 81190132), Shanghai Municipal Natural Science
   Foundation (12ZR1435300), and ARC Discovery (DP120103697).
CR [Anonymous], 1999, 109935 ISOEN
   Balas F, 2003, J BIOMED MATER RES A, V66A, P364, DOI 10.1002/jbm.a.10579
   Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Gomes S, 2010, ACTA BIOMATER, V6, P3264, DOI 10.1016/j.actbio.2010.02.034
   Gu HJ, 2011, BIOMATERIALS, V32, P7023, DOI 10.1016/j.biomaterials.2011.06.003
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Langstaff S, 1999, BIOMATERIALS, V20, P1727, DOI 10.1016/S0142-9612(99)00086-1
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   Martin RA, 2009, J MATER SCI-MATER M, V20, P883, DOI 10.1007/s10856-008-3661-5
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   Misra SK, 2010, J R SOC INTERFACE, V7, P453, DOI 10.1098/rsif.2009.0255
   Ni SY, 2008, J BIOMED MATER RES A, V85A, P72, DOI 10.1002/jbm.a.31390
   Olmo N, 2003, BIOMATERIALS, V24, P3383, DOI 10.1016/S0142-9612(03)00200-X
   Peng H, 2009, BIOMACROMOLECULES, V10, P95, DOI 10.1021/bm800937g
   Peng WW, 2011, J ENDODONT, V37, P1240, DOI 10.1016/j.joen.2011.05.035
   Reid JW, 2006, BIOMATERIALS, V27, P2916, DOI 10.1016/j.biomaterials.2006.01.007
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   Wang C, 2012, ACTA BIOMATER, V8, P350, DOI 10.1016/j.actbio.2011.08.019
   Wu CT, 2008, J BIOMED MATER RES B, V87B, P346, DOI 10.1002/jbm.b.31109
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
   Wu CT, 2007, J MATER SCI-MATER M, V18, P857, DOI [10.1007/s10856-006-0083-0, 10.1007/S10856-006-0083-0]
   Wu CT, 2011, J MATER CHEM, V21, P18300, DOI 10.1039/c1jm12770e
   Wu CT, 2011, J R SOC INTERFACE, V8, P1804, DOI 10.1098/rsif.2011.0201
   Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2011, J BIOMED MATER RES A, V98A, P122, DOI 10.1002/jbm.a.33092
   Wu CT, 2009, J R SOC INTERFACE, V6, P159, DOI 10.1098/rsif.2008.0274
   Wu CT, 2006, J BIOMED MATER RES A, V76A, P73, DOI 10.1002/jbm.a.30496
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Xia LG, 2011, EUR CELLS MATER, V22, P68, DOI 10.22203/eCM.v022a06
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Xue WC, 2005, BIOMATERIALS, V26, P3455, DOI 10.1016/j.biomaterials.2004.09.027
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Zhou YH, 2012, ACTA BIOMATER, V8, P2307, DOI 10.1016/j.actbio.2012.03.012
NR 46
TC 10
Z9 10
U1 0
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD MAR
PY 2013
VL 96
IS 3
BP 928
EP 934
DI 10.1111/jace.12059
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA 112DJ
UT WOS:000316572000041
DA 2018-10-20
ER

PT J
AU Petrescu, HP
   Berceanu-Vaduva, M
   Dinu, G
   Bratu, DC
   Berceanu-Vaduva, D
AF Petrescu, Horatiu Pompiliu
   Berceanu-Vaduva, Marcel
   Dinu, Gabriel
   Bratu, Dana Cristina
   Berceanu-Vaduva, Delia
TI Influence of Implant Material on Electrical Biopotentials in Bone
   Fractures
SO MATERIALE PLASTICE
LA English
DT Article
DE biopotentials; aluminium; copper; V4A; bone callus
AB The increasingly wider scale use of various foreign materials in Orthopaedics and Traumatology require long-term study of their interaction with adjacent bone, with soft tissue, and also the integration of these materials into the bone tissue. One of the likely consequences of using implants and metal fasteners is the production of conductance disturbances of bone which are dependent on the type of material used, with major implications for its biology and by default on fracture healing. The purpose of this paper is to highlight the changes in focal bone fracture biopotentials depending on the chemical composition of biomaterials used. The study is experimental, on a group of 23 Wistar rats which were created femur bone defects that were repaired by autotransplantation of the hip bone with different wire set. The potential difference between the graft and the graft bed was measured and was correlated with the chemical composition of biomaterial. The largest potential differences were reported with aluminium wire, copper, and nickelin wire, while V4A wire (alloy of nickel, chromium and titanium) determined the smallest disturbance of these biopotentials.
C1 [Petrescu, Horatiu Pompiliu; Berceanu-Vaduva, Marcel] Victor Babes Univ Med & Pharm, Orthopaed & Trauma Dept, Timisoara 300041, Romania.
   [Dinu, Gabriel] Clin Emergency Hosp Floreasca, Orthopaed Clin 1, Bucharest 014461, Romania.
   [Bratu, Dana Cristina] Victor Babes Univ Med & Pharm, Dept Orthodont, Timisoara 300074, Romania.
   [Berceanu-Vaduva, Delia] Victor Babes Univ Med & Pharm, Dept Microbiol, Timisoara 300041, Romania.
RP Petrescu, HP (reprint author), Victor Babes Univ Med & Pharm, Orthopaed & Trauma Dept, 2 Eftimie Murgu Sq, Timisoara 300041, Romania.
EM lalusa87@yahoo.com; deliabercean@yahoo.com
CR Akca Kivanc, 2007, Head Face Med, V3, P28, DOI 10.1186/1746-160X-3-28
   BACIU C., 1957, THESIS UMF BUCURESTI
   BECKER RO, 1977, CLIN ORTHOP RELAT R, P75
   CHAMAY A., 1972, REV ORTH, V58, P26
   Eriksson C, 2007, J BIOMED MATER RES A, V83A, P1062, DOI 10.1002/jbm.a.31433
   FERRAND J., 1966, REV CHIR ORTHOP REPA, V52, P389
   Gaber S, 2009, CELL TISSUE RES, V335, P539, DOI 10.1007/s00441-008-0735-0
   GITTENS R.A., 2011, J DENT RES, V90, P1389
   JONATHAN C., 1966, AM J SURG NR, V114, P31
   Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007
   Neudert M, 2010, JARO-J ASSOC RES OTO, V11, P161, DOI 10.1007/s10162-009-0202-y
   Oshida Y, 2010, INT J MOL SCI, V11, P1580, DOI 10.3390/ijms11041580
   SORA T., 1965, TIMIS MED, VX, P409
   Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925
NR 14
TC 9
Z9 9
U1 0
U2 8
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0025-5289
J9 MATER PLAST
JI Mater. Plast.
PD MAR
PY 2013
VL 50
IS 1
BP 53
EP 54
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA 118KS
UT WOS:000317025000012
DA 2018-10-20
ER

PT J
AU Ak, F
   Oztoprak, Z
   Karakutuk, I
   Okay, O
AF Ak, Fatih
   Oztoprak, Zeynep
   Karakutuk, Ilknur
   Okay, Oguz
TI Macroporous Silk Fibroin Cryogels
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYMER SYSTEMS; SCAFFOLDS; HYDROGELS; BONE; GELS; MECHANISM;
   CRYOSTRUCTURIZATION; POLYISOBUTYLENE; BIOMATERIAL; TRANSITION
AB Silk fibroin cryogels with remarkable properties were obtained from frozen fibroin solutions (4.2-12.6%) at subzero temperatures between -5 and -22 degrees C. This was achieved by the addition of ethylene glycol diglycidyl ether (EGDE) into the cryogelation system. EGDE triggers the conformational transition of fibroin from random coil to beta-sheet structure and hence fibroin gelation. One of the unique features of fibroin cryogels is their elasticity that allows them to resist complete compression without any crack development, during which water inside the cryogel is removed. The compressed cryogel immediately swells during unloading to recover its original shape. The scaffolds obtained by freeze-drying of the cryogels consist of regular, interconnected pores of diameters ranging from 50 to 10 pin that could be regulated by the synthesis parameters. The mechanical compressive strength and the modulus of the scaffolds increase with decreasing pore diameter, that is, with decreasing gelation temperature or, with increasing filoroin or EGDE concentrations in the feed. The scaffolds produced at 12.6% fibroin exhibit a very high compressive modulus (50 MPa) making them good candidates as bone scaffold materials.
C1 [Ak, Fatih; Oztoprak, Zeynep; Karakutuk, Ilknur; Okay, Oguz] Istanbul Tech Univ, Dept Chem, TR-34469 Istanbul, Turkey.
RP Okay, O (reprint author), Istanbul Tech Univ, Dept Chem, TR-34469 Istanbul, Turkey.
RI OKAY, Oguz/G-3794-2011
OI OKAY, Oguz/0000-0003-2717-4150
FU Scientific and Technical Research Council of Turkey (TUBITAK); Russian
   Foundation for Basic Research (RFBR) [TBAG-211T044]; Turkish Academy of
   Sciences (TUBA)
FX Work was supported by the Scientific and Technical Research Council of
   Turkey (TUBITAK) and Russian Foundation for Basic Research (RFBR),
   TBAG-211T044. The authors thank Dr. V. I Lozinsky for useful
   discussions. O.O. thanks Turkish Academy of Sciences (TUBA) for the
   partial support.
CR AMIYA T, 1987, MACROMOLECULES, V20, P1162, DOI 10.1021/ma00171a050
   AYUB ZH, 1993, BIOSCI BIOTECH BIOCH, V57, P1910, DOI 10.1271/bbb.57.1910
   Ceylan D, 2007, MACROMOLECULES, V40, P8742, DOI 10.1021/ma071605j
   Chen X, 2002, BIOCHEMISTRY-US, V41, P14944, DOI 10.1021/bi026550m
   Dinu MV, 2007, POLYMER, V48, P195, DOI 10.1016/j.polymer.2006.11.022
   Gundogan N, 2002, MACROMOLECULES, V35, P5616, DOI 10.1021/ma020151h
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karakutuk I, 2012, BIOMACROMOLECULES, V13, P1122, DOI 10.1021/bm300006r
   Ki CS, 2008, BIOTECHNOL LETT, V30, P405, DOI 10.1007/s10529-007-9581-5
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kirsebom H., 2009, LANGMUIR, V25, P8426
   Kirsebom H, 2009, MACROMOLECULES, V42, P5208, DOI 10.1021/ma900566d
   Konstantinova NR, 1997, FOOD HYDROCOLLOID, V11, P113, DOI 10.1016/S0268-005X(97)80019-7
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Loo SL, 2013, SOFT MATTER, V9, P224, DOI 10.1039/c2sm26859k
   Lozinsky VI, 2003, TRENDS BIOTECHNOL, V21, P445, DOI 10.1016/j.tibtech.2003.08.002
   LOZINSKY VI, 1992, J APPL POLYM SCI, V44, P1423, DOI 10.1002/app.1992.070440813
   Lozinsky VI, 2002, USP KHIM+, V71, P559
   LOZINSKY VI, 1989, ACTA POLYM, V40, P8, DOI 10.1002/actp.1989.010400103
   Lozinsky VI, 2002, RUSS CHEM REV, V71, P489, DOI DOI 10.1070/RC2002V071N06ABEH000720
   Lu X, 2006, J CHEM TECHNOL BIOT, V81, P767
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Min SJ, 2009, J BIOMAT SCI-POLYM E, V20, P1961, DOI 10.1163/156856208X396056
   Mo CL, 2009, BIOMACROMOLECULES, V10, P2724, DOI 10.1021/bm900452u
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Okay O, 2000, PROG POLYM SCI, V25, P711, DOI 10.1016/S0079-6700(00)00015-0
   Orakdogen N, 2011, REACT FUNCT POLYM, V71, P782, DOI 10.1016/j.reactfunctpolym.2011.04.005
   Ozmen O. O., 2005, POLYMER, V46, P8119
   Plieva F, 2006, J MATER CHEM, V16, P4065, DOI 10.1039/b606734d
   Plieva FM, 2005, SOFT MATTER, V1, P303, DOI 10.1039/b510010k
   Podorozhko EA, 2012, COLLOID J+, V74, P708, DOI 10.1134/S1061933X12060117
   Sayil C, 2001, POLYMER, V42, P7639, DOI 10.1016/S0032-3861(01)00279-8
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Topuz F, 2008, MACROMOLECULES, V41, P8847, DOI 10.1021/ma801414p
   Topuz F, 2009, BIOMACROMOLECULES, V10, P2652, DOI 10.1021/bm900585v
   Tuncaboylu DC, 2010, LANGMUIR, V26, P7574, DOI 10.1021/la904369g
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vlierberghe S. V., 2011, BIOMACROMOLECULES, V12, P1387
   Vollrath F, 2009, POLYMER, V50, P5623, DOI 10.1016/j.polymer.2009.09.068
   Zhang Q, 2009, MATERIALS, V2, P2276, DOI 10.3390/ma2042276
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 49
TC 42
Z9 43
U1 10
U2 114
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2013
VL 14
IS 3
BP 719
EP 727
DI 10.1021/bm3018033
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 105DB
UT WOS:000316044700016
PM 23360211
DA 2018-10-20
ER

PT J
AU Correia, CR
   Reis, RL
   Mano, JF
AF Correia, Clara R.
   Reis, Rui L.
   Mano, Joao F.
TI Multilayered Hierarchical Capsules Providing Cell Adhesion Sites
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYELECTROLYTE MULTILAYERS; EXPONENTIAL-GROWTH; RESPONSIVE PROPERTIES;
   DRUG-DELIVERY; IN-VITRO; CHITOSAN; FILMS; MICROCAPSULES; PH; PARTICLES
AB Liquified capsules featuring (i) an external shell by layer-by-layer assembly of poly(L-lysine), alginate, and chitosan, and encapsulating (ii) surface S' functionalized poly(L-lactic acid) (PLLA) microparticles were developed. We hypothesize that, while the liquified environment enhances the diffusion of essential molecules for cell survival, microparticles dispersed in the liquified core of capsules provide the physical support required for cellular functions of anchorage-dependent cells. The influence of the incorporation of PLL on the regime growth, thickness, and stability was analyzed. Results show a more resistant and thicker film, with an, exponential build-up growth regime. Moreover, capsules ability to support cell survival was assessed. Capsules containing microparticles revealed an enhanced biological outcome in cell metabolic activity and proliferation, suggesting their potential to boost the development of innovative biomaterial designs for bioencapsulation systems and tissue engineering products.
C1 [Mano, Joao F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Mano,
   Joao/A-4418-2009; Correia, Clara/A-8824-2017
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Mano,
   Joao/0000-0002-2342-3765; Correia, Clara/0000-0002-1559-6295
FU Portuguese Foundation for Science and Technology (FCT) through the Ph.D
   [SFRH/BD/69529/2010]; Operational Human Potential Program (POPH);
   European Social Fund (FSE)
FX The present work was financial supported by the Portuguese Foundation
   for Science and Technology (FCT) through the Ph.D. Grant with the
   Reference No. SFRH/BD/69529/2010, cofinanced by the Operational Human
   Potential Program (POPH), developed under the scope of the National
   Strategic Reference Framework (QREN) from the European Social Fund
   (FSE). The authors also acknowledge the financial support from the
   MP-2008-Small-2 project (Find&Bind) developed under the scope of the EU
   7th Framework Programme.
CR Amali AJ, 2011, ANAL CHIM ACTA, V708, P75, DOI 10.1016/j.aca.2011.10.001
   Pujana MA, 2012, POLYMER, V53, P3107, DOI 10.1016/j.polymer.2012.05.027
   BODMEIER R, 1988, INT J PHARM, V43, P179, DOI 10.1016/0378-5173(88)90073-7
   BROUGHTON RL, 1989, BIOMATERIALS, V10, P462, DOI 10.1016/0142-9612(89)90087-2
   Brun-Graeppi AKAS, 2011, J CONTROL RELEASE, V149, P209, DOI 10.1016/j.jconrel.2010.09.023
   CHANG PL, 1993, HUM GENE THER, V4, P433, DOI 10.1089/hum.1993.4.4-433
   Cirone P, 2002, HUM GENE THER, V13, P1157, DOI 10.1089/104303402320138943
   Costa NL, 2011, ADV ENG MATER, V13, pB218, DOI 10.1002/adem.201080138
   Costa RR, 2011, SMALL, V7, P2640, DOI 10.1002/smll.201100875
   Dash BC, 2010, BIOMATERIALS, V31, P8188, DOI 10.1016/j.biomaterials.2010.07.067
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Dejugnat C, 2004, LANGMUIR, V20, P7265, DOI 10.1021/la049706n
   Eftat S, 2008, ADV DRUG DELIVER REV, V60, P114, DOI 10.1016/j.addr.2007.08.033
   Haque T., 2004, MOL PHARM, V2, P29
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   Jean M, 2012, EUR J PHARM SCI, V45, P138, DOI 10.1016/j.ejps.2011.10.029
   Jin R, 2009, BIOMATERIALS, V30, P2544, DOI 10.1016/j.biomaterials.2009.01.020
   Jourdainne L, 2007, MACROMOLECULES, V40, P316, DOI 10.1021/ma062201e
   Kim J, 2011, ANGEW CHEM INT EDIT, V50, P2317, DOI 10.1002/anie.201007494
   Kurayama F, 2010, J COLLOID INTERF SCI, V349, P70, DOI 10.1016/j.jcis.2010.05.039
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lavalle P, 2004, J PHYS CHEM B, V108, P635, DOI 10.1021/jp035740j
   Li C, 2012, J MATER CHEM, V22, P4623, DOI 10.1039/c2jm16702f
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lin CX, 2011, ANGEW CHEM INT EDIT, V50, P4947, DOI 10.1002/anie.201007747
   Miranda ES, 2011, TISSUE ENG PT A, V17, P2663, DOI 10.1089/ten.tea.2010.0635
   Oliveira MB, 2011, SOFT MATTER, V7, P6426, DOI 10.1039/c0sm01302a
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014
   Porcel C, 2006, LANGMUIR, V22, P4376, DOI 10.1021/la053218d
   Rokstad AM, 2002, CELL TRANSPLANT, V11, P313
   Sher P, 2010, SMALL, V6, P2644, DOI 10.1002/smll.201001066
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Sukhorukov GB, 2007, TRENDS BIOTECHNOL, V25, P93, DOI 10.1016/j.tibtech.2006.12.007
   Szarpak A, 2010, BIOMACROMOLECULES, V11, P713, DOI 10.1021/bm9012937
   Tan WH, 2007, ADV MATER, V19, P2696, DOI 10.1002/adma.200700433
   Tang M, 2012, ACTA BIOMATER, V8, P3436, DOI 10.1016/j.actbio.2012.05.016
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yuan WY, 2007, LANGMUIR, V23, P13046, DOI 10.1021/la702774a
   Yuan WY, 2011, J MATER CHEM, V21, P5148, DOI 10.1039/c0jm03925j
   Zhao QH, 2007, NANOMED-NANOTECHNOL, V3, P63, DOI 10.1016/j.nano.2006.11.007
NR 44
TC 46
Z9 46
U1 0
U2 84
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2013
VL 14
IS 3
BP 743
EP 751
DI 10.1021/bm301833z
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 105DB
UT WOS:000316044700019
PM 23330726
DA 2018-10-20
ER

PT J
AU Nguyen, VH
   Shim, JJ
AF Van Hoa Nguyen
   Shim, Jae-Jin
TI Supercritical fluid-assisted synthesis of a carbon nanotubes-grafted
   biocompatible polymer composite
SO COMPOSITE INTERFACES
LA English
DT Article
DE supercritical carbon dioxide; carbon nanotube; poly(2-hydroxylethyl
   methacrylate); nanocomposite
ID NANOCOMPOSITES; CAPACITY; CO2
AB A nanocomposite consisting of multi-wall nanotubes (MWNTs) grafted with a biocompatible polymer poly(2-hydroxyethyl methacrylate) was prepared by in situ polymerization in supercritical carbon dioxide. The surface of the MWNTs was first surface modified with hydroxyl groups in the solution of KMnO4 and a phase-transfer catalyst. MWNT-OH was then functionalized with vinyl groups using a silane coupling agent, -methacryloxypropyltrimethoxysilane. The silane groups can improve the dipersion of MWNTs in supercritical carbon dioxide, while the terminal vinyl groups help fabricate polymer chains on the MWNT surface. The as-synthesized products were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy (SEM), transmission electron microscopy (TEM), and thermo-gravimetric analysis. The SEM and TEM images showed that the nanotubes were well coated with the polymer shell. The composite had higher thermal stability than the pure polymer and dispersed well in methanol. This biocompatible polymer composite was prepared using a green method and is expected to be useful as a biomaterial composite with potential applications in the biological field.
C1 [Van Hoa Nguyen; Shim, Jae-Jin] Yeungnam Univ, Sch Chem Engn, Kyongsan 712749, Gyeongbuk, South Korea.
   [Van Hoa Nguyen] Nha Trang Univ, Dept Chem, Nha Trang, Vietnam.
RP Shim, JJ (reprint author), Yeungnam Univ, Sch Chem Engn, Kyongsan 712749, Gyeongbuk, South Korea.
EM jjshim@yu.ac.kr
OI Nguyen, Van Hoa/0000-0002-7476-2943
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science, and Technology [2012R1A1A2009529]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science, and Technology (2012R1A1A2009529).
CR Bhattacharyya S, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1883725
   Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95
   Cui J, 2004, POLYMER, V45, P8717, DOI 10.1016/j.polymer.2004.10.068
   Dai XH, 2004, CHEM COMMUN, P2190, DOI 10.1039/b407605b
   Jessop P. G., 1999, CHEM SYNTHESIS USING
   Kim MH, 2007, J POLYM SCI POL CHEM, V45, P4413, DOI 10.1002/pola.22190
   Liu P, 2005, EUR POLYM J, V41, P2693, DOI 10.1016/j.eurpolymj.2005.05.017
   Liu Z., 2004, CARBON, V42, P423
   Matsuyama K, 2009, J SUPERCRIT FLUID, V49, P256, DOI 10.1016/j.supflu.2009.03.001
   McHugh M. A., 1994, SUPERCRITICAL FLUID
   McNally T, 2005, POLYMER, V46, P8222, DOI 10.1016/j.polymer.2005.06.094
   Nie H, 1999, NANO RES, V3, P103
   Ozturk N, 2008, COLLOID SURFACE B, V67, P14, DOI 10.1016/j.colsurfb.2008.07.005
   Pham QL, 2011, B MATER SCI, V34, P37, DOI 10.1007/s12034-011-0049-9
   Rao CNR, 2001, CHEMPHYSCHEM, V2, P78, DOI 10.1002/1439-7641(20010216)2:2<78::AID-CPHC78>3.0.CO;2-7
   Shanmugharaj AM, 2007, COMPOS SCI TECHNOL, V67, P1813, DOI 10.1016/j.compscitech.2006.10.021
   Spitalsky Z, 2010, PROG POLYM SCI, V35, P357, DOI 10.1016/j.progpolymsci.2009.09.003
   Nguyen VH, 2012, SYNTH REACT INORG M, V42, P449, DOI 10.1080/15533174.2011.611851
   Nguyen VH, 2011, MATER SCI ENG B-ADV, V176, P773, DOI 10.1016/j.mseb.2011.02.020
   Wang JW, 2006, CHEM COMMUN, P1670, DOI 10.1039/b600441e
   Wu TM, 2005, CARBON, V43, P734, DOI 10.1016/j.carbon.2004.10.043
   Zhang ZW, 2008, MACROMOLECULES, V41, P2868, DOI 10.1021/ma702739n
   ZHOU O, 1994, SCIENCE, V263, P1744, DOI 10.1126/science.263.5154.1744
NR 23
TC 4
Z9 4
U1 0
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0927-6440
EI 1568-5543
J9 COMPOS INTERFACE
JI Compos. Interfaces
PD MAR 1
PY 2013
VL 20
IS 2
BP 155
EP 162
DI 10.1080/15685543.2013.765140
PG 8
WC Materials Science, Composites
SC Materials Science
GA 105JN
UT WOS:000316064200006
DA 2018-10-20
ER

PT J
AU Chebil, S
   Macauley, N
   Hianik, T
   Korri-Youssoufi, H
AF Chebil, S.
   Macauley, N.
   Hianik, T.
   Korri-Youssoufi, H.
TI Multiwalled Carbon Nanotubes Modified by NTA-Copper Complex for
   Label-Free Electrochemical Immunosensor Detection
SO ELECTROANALYSIS
LA English
DT Article
DE Biosensors; Deep vein thrombosis; Label-free detection; MWCNT; NTA;
   copper
ID DIRECT ELECTRON-TRANSFER; D-DIMER; BINDING; BIOSENSORS; PROTEINS;
   AFFINITY
AB A biomaterial based on multiwalled carbon nanotubes (MWCNTs) modified with His-tagged single chain D-dimer antibody trough nitrilo-triacetic-acid (NTA)/copper complex was designed for monitoring D-dimers, which were used as biomarkers of Deep Vein Thrombosis (DVT). The immunosensing evaluation of D-Dimer was followed by measuring the redox process of such complex. We demonstrate that using simple chemistry and exploiting the high surface area, electronic properties of MWCNTs and redox signal of the NTA/Cu2+ complex an efficient electrochemical immunosensor for the evaluation of wide range of D-dimer concentrations was obtained.
C1 [Chebil, S.; Macauley, N.; Korri-Youssoufi, H.] Univ Paris 11, CNRS UMR 8182, ICMMO, ECBB, F-91405 Orsay, France.
   [Chebil, S.; Macauley, N.; Korri-Youssoufi, H.] Univ Paris 11, F-91405 Orsay, France.
   [Macauley, N.; Hianik, T.] Comenius Univ, Fac Math Phys & Informat, Dept Nucl Phys & Biophys, Bratislava 84248, Slovakia.
RP Korri-Youssoufi, H (reprint author), Univ Paris 11, CNRS UMR 8182, ICMMO, ECBB, Bat 420, F-91405 Orsay, France.
EM hafsa.korri-youssoufi@u-psud.fr
OI Korri-Youssoufi, Hafsa/0000-0002-5858-5385
FU European Community through a STREP Grant [53086]; European Community
   [SK-FR-0025-09, APVV-0410-10]
FX The authors are grateful for the financial support of the European
   Community Sixth Framework Program through a STREP Grant to the DVT-IMP
   Consortium, Contract No. 53086 and to the Agency for Promotion Research
   and Development under the Project SK-FR-0025-09 and APVV-0410-10.
   Haptogen Company is acknowledged for providing the biological materials
   (His tag D-dimer antibody and D-dimer).
CR Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u
   Blankespoor R, 2005, LANGMUIR, V21, P3362, DOI 10.1021/la047139y
   Bourigua S, 2010, BIOSENS BIOELECTRON, V26, P1278, DOI 10.1016/j.bios.2010.07.004
   Carrara S, 2008, BIOSENS BIOELECTRON, V24, P148, DOI 10.1016/j.bios.2008.03.008
   Chebil S, 2010, BIOSENS BIOELECTRON, V26, P736, DOI 10.1016/j.bios.2010.06.048
   Ghanima W, 2007, THROMB RES, V120, P471, DOI 10.1016/j.thromres.2006.11.005
   Haddad R, 2009, ANALYST, V134, P2412, DOI 10.1039/b916774a
   Johannsson A., 1991, PRINCIPLES PRACTICE
   Kim YS, 2006, SYNTHETIC MET, V156, P938, DOI 10.1016/j.synthmet.2006.06.003
   Kronina VV, 1999, J CHROMATOGR A, V852, P261, DOI 10.1016/S0021-9673(99)00753-0
   Liu Y, 2005, BIOSENS BIOELECTRON, V21, P984, DOI 10.1016/j.bios.2005.03.003
   Lode P., 2006, THROMB RES, V118, P573
   Lugovskoy EV, 2002, THROMB RES, V107, P151, DOI 10.1016/S0049-3848(02)00204-9
   Musameh M, 2002, ELECTROCHEM COMMUN, V4, P743, DOI 10.1016/S1388-2481(02)00451-4
   Osorio AG, 2008, APPL SURF SCI, V255, P2485, DOI 10.1016/j.apsusc.2008.07.144
   Rivas GA, 2007, TALANTA, V74, P291, DOI 10.1016/j.talanta.2007.10.013
   Shen JD, 2007, MAT SCI ENG A-STRUCT, V464, P151, DOI 10.1016/j.msea.2007.02.091
   Tominaga M, 2010, CHEM LETT, V39, P976, DOI 10.1246/cl.2010.976
   Ueda EKM, 2003, J CHROMATOGR A, V988, P1, DOI 10.1016/S0021-9673(02)02057-5
   Wang J, 2003, ANALYST, V128, P912, DOI 10.1039/b303282e
   Wang J, 2008, TRAC-TREND ANAL CHEM, V27, P619, DOI 10.1016/j.trac.2008.05.009
   White CT, 1998, NATURE, V393, P240, DOI 10.1038/30420
   Yin YJ, 2005, SENSORS-BASEL, V5, P220, DOI 10.3390/s5040220
   Zhao Q, 2002, ELECTROANAL, V14, P1609, DOI 10.1002/elan.200290000
NR 25
TC 8
Z9 8
U1 3
U2 27
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1040-0397
J9 ELECTROANAL
JI Electroanalysis
PD MAR
PY 2013
VL 25
IS 3
SI SI
BP 636
EP 643
DI 10.1002/elan.201200298
PG 8
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 107JW
UT WOS:000316213900009
DA 2018-10-20
ER

PT J
AU Cui, L
   Gong, J
   Fan, XR
   Wang, P
   Wang, Q
   Qiu, YQ
AF Cui, Li
   Gong, Jun
   Fan, Xuerong
   Wang, Ping
   Wang, Qiang
   Qiu, Yaqin
TI Transglutaminase-modified wool keratin film and its potential
   application in tissue engineering
SO ENGINEERING IN LIFE SCIENCES
LA English
DT Article
DE Cell culture; Drug release; Keratin film; Properties; Transglutaminase
ID PROTEIN FILMS; CROSS-LINKING; RESISTANCE
AB Transglutaminase (TGase) catalyzes the cross-linking of many proteins and has been widely used to improve the properties of certain protein-based materials. Keratin is considered as a promising biomaterial candidate following traditional chemical modification. In this study, the effect of TGase on the properties of a wool keratin film was investigated. The TGase-modified film was applied to drug release and cell proliferation. Treatment with TGase (30 U/g keratin) for 18 h at 40 degrees C increased the tensile strength of the film from 5.18 +/- 0.15 MPa to 6.22 +/- 0.11 MPa and decreased the elongation at break from 83.47 +/- 1.79% to 72.12 +/- 3.02%. The stability of the film in PBS and in artificial gastric juice was also improved. A rougher surface and a more compact cross-section were observed by scanning electron microscopy photographs of the TGase-treated film. SDS-PAGE analysis confirmed that higher molecular weight proteins were formed in the TGase-modified keratin solution and film. The results of the drug release assay using diclofenac indicated that both films with and without TGase treatment led to a high initial release in PBS, which was more constant in artificial gastric juice. The enzyme treatment led to a lower drug release rate from the film. Cell culture experiments suggested that the TGase-mediated cross-linked keratin film shows a good biocompatibility and that it can be used for tissue engineering applications.
C1 [Cui, Li; Gong, Jun; Fan, Xuerong; Wang, Ping; Wang, Qiang; Qiu, Yaqin] Jiangnan Univ, Minist Educ, Key Lab Sci & Technol Ecotext, Wuxi 214122, Peoples R China.
RP Cui, L (reprint author), Jiangnan Univ, Sch Text & Clothing, 1800 Lihu Rd, Wuxi 214122, Peoples R China.
EM cuili2003@msn.com; qiang-wang@163.com
FU Fundamental Research Funds for the Central Universities of China
   [JUSRP21002]; National Natural Science Foundation of China [51073073];
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions [137]
FX The authors acknowledge the Fundamental Research Funds for the Central
   Universities of China (JUSRP21002), the National Natural Science
   Foundation of China (51073073), and a project funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   ((2011) 137).
CR Carvalho R. A. de, 2004, Food Hydrocolloids, V18, P717, DOI 10.1016/j.foodhyd.2003.10.005
   Cortez J, 2005, J BIOTECHNOL, V116, P379, DOI 10.1016/j.biotec.2004.12.007
   Cui L, 2011, ENG LIFE SCI, V11, P201, DOI 10.1002/elsc.201000110
   Du GC, 2007, ENZYME MICROB TECH, V40, P1753, DOI 10.1016/j.enzmictec.2006.12.001
   FEUGHELMAN M, 1985, ENCY POLYM SCI ENG, V8, P566
   Gembeh SV, 2005, J SCI FOOD AGR, V85, P418, DOI 10.1002/jsfa.1999
   Gueguen J, 1998, IND CROP PROD, V7, P149, DOI 10.1016/S0926-6690(97)00043-5
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Guzman R. C. D., 2011, BIOMATERIALS, V32, P8205
   Hernandez M. P., 2004, FOOD HYDROCOLLOID, V18, P403
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Jiang Y, 2007, INNOV FOOD SCI EMERG, V8, P218, DOI 10.1016/j.ifset.2006.11.002
   Kurimoto A, 2003, J BIOSCI BIOENG, V96, P307, DOI 10.1263/jbb.96.307
   Larre C, 2000, J AGR FOOD CHEM, V48, P5444, DOI 10.1021/jf0003505
   Lim LT, 1998, J AGR FOOD CHEM, V46, P4022, DOI 10.1021/jf980567n
   Oh JH, 2004, INT J FOOD SCI TECH, V39, P287, DOI 10.1111/j.1365-2621.2004.00783.x
   Pechter PM, 2012, WOUND REPAIR REGEN, V20, P236, DOI 10.1111/j.1524-475X.2012.00768.x
   Piotrowska B, 2008, FOOD HYDROCOLLOID, V22, P1362, DOI 10.1016/j.foodhyd.2007.07.006
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147
   Tanabe T, 2004, MAT SCI ENG C-BIO S, V24, P441, DOI 10.1016/j.msec.2003.11.004
   Tang CH, 2007, FOOD RES INT, V40, P504, DOI 10.1016/j.foodres.2006.09.010
   Tonin C, 2007, J THERM ANAL CALORIM, V89, P601, DOI 10.1007/s10973-006-7557-7
   VANDYKE ME, 2001, Patent No. 6270793
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Yamauchi K, 1997, COLLOID SURFACE B, V9, P117, DOI 10.1016/S0927-7765(96)01322-7
   Yildirim M, 1998, J FOOD SCI, V63, P248
NR 27
TC 13
Z9 14
U1 5
U2 45
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1618-0240
J9 ENG LIFE SCI
JI Eng. Life Sci.
PD MAR
PY 2013
VL 13
IS 2
BP 149
EP 155
DI 10.1002/elsc.201100206
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 108BJ
UT WOS:000316265500005
DA 2018-10-20
ER

PT J
AU Major, R
AF Major, Roman
TI Self-assembling surfaces of blood-contacting materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CELL-ADHESION; COMPATIBILITY; TITANIUM; MECHANISMS; ADSORPTION;
   RESISTANCE; COATINGS; FILMS
AB The optimal scaffold should have the self-organising property of activating the appropriate tissues surrounding the re-population. The anti-bacterial property of the coating was obtained through surface pre-treatment with coatings a few nanometres in thickness deposited using vapour-based methods. The coating's anti-thrombogenic properties were obtained by the selective mobilisation of cellular functions, which was controlled by the structure of porous coatings deposited on bulk substrates and by the small biological agent-l-arginyl-glycyl-l-aspartic acid (tripeptide Arg-Gly-Asp-RGD) protein domains. Two tests simulating arterial flow conditions were performed: Impact-R, for examining platelet function under near physiological conditions, and radial flow chamber, a cell detachment test that gives an overview of cell behaviour and shear stresses that could appear between the cell and the biomaterial. Cell structures were analysed using laser scanning confocal microscopy and flow cytometry. The performed in vitro dynamic test for the haemo-compatibility revealed the most promising surface functionalization was based on porous extracellular-like structure covered with endothelium cells simultaneously. The antibacterial function was achieved by the appropriate phase composition of the coating used for the pre-treatment stage. The coating for the pre-treatment was selected on the basis of the blood-material and bacteria-material interaction.
C1 Polish Acad Sci, Inst Met & Mat Sci, PL-30059 Krakow, Poland.
RP Major, R (reprint author), Polish Acad Sci, Inst Met & Mat Sci, 25 Reymonta St, PL-30059 Krakow, Poland.
EM rmajor1@wp.pl
FU National Centre of Research and Development [Era-Net-MNT/15/2009]
FX This research was supported financially by the project CardioBioMat MNT
   Era-Net-MNT/15/2009 "Nonstructural materials for implants and
   cardiovascular biomedical devices" under the National Centre of Research
   and Development. The experiments were executed with the cooperation of
   Jagiellonian University Medical College, Department of Medicine Cracow,
   Poland, Grenoble Institute National Polytechnique Minatec Phelma LMGP
   and JOANNEUM RESEARCH Forschungs-GmbH, MATERIALS_Functional Surfaces,
   Leoben, Austria.
CR Ballet T, 2010, B POL ACAD SCI-TECH, V58, P303, DOI 10.2478/v10175-010-0028-0
   Bergseth G, 2011, ANN THORAC SURG, V91, P527, DOI 10.1016/j.athoracsur.2010.10.084
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Chan MY, 2009, J THROMB THROMBOLYS, V28, P366, DOI 10.1007/s11239-009-0375-6
   Chen JL, 2009, APPL SURF SCI, V255, P6894, DOI 10.1016/j.apsusc.2009.03.011
   Chen L, 2011, COLLOID SURFACE B, V85, P2, DOI 10.1016/j.colsurfb.2010.10.034
   Costerton B, 2004, BIOMATERIALS SCI INT, P345
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Khait L, 2008, J CARDIOVASC TRANSL, V1, P71, DOI 10.1007/s12265-007-9005-x
   Lackner JM, 2010, B POL ACAD SCI-TECH, V58, P281
   Lackner JM, 2005, IND SCALED HYBRID PU, P1
   LACKNER JM, 2007, 50 ANN TECHN C P SOC, P113
   Lackner JM, 2006, SURF COAT TECH, V201, P4090, DOI 10.1016/j.surfcoat.2006.08.025
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Major R, 2011, ADV MATER SCI, V11, P5, DOI 10.2478/v10077-011-0007-7
   Major R., 2007, INZYNIERIA MAT, V157-156, P666
   Meng N, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/18/185101
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Sanak M, 2010, B POL ACAD SCI-TECH, V58, P317, DOI 10.2478/v10175-010-0029-z
   SEFTON MV, 2004, BIOMATERIALS SCI INT, P456
   Seo HS, 2010, APPL SURF SCI, V257, P596, DOI 10.1016/j.apsusc.2010.07.040
   Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003
   Smith Julian A, 2002, Heart Lung Circ, V11, P135, DOI 10.1046/j.1444-2892.2002.00156.x
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Varont D., 1997, THROMB RES, V85, P293
   Zhang HP, 2008, J MATER SCI-MATER M, V19, P3437, DOI 10.1007/s10856-008-3498-y
   Zhang XH, 2009, BIOMATERIALS, V30, P3213, DOI 10.1016/j.biomaterials.2009.02.002
NR 29
TC 11
Z9 11
U1 0
U2 33
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2013
VL 24
IS 3
BP 725
EP 733
DI 10.1007/s10856-012-4824-y
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 104TR
UT WOS:000316018700015
PM 23229573
DA 2018-10-20
ER

PT J
AU Bernards, DA
   Bhisitkul, RB
   Wynn, P
   Steedman, MR
   Lee, OT
   Wong, F
   Thoongsuwan, S
   Desai, TA
AF Bernards, Daniel A.
   Bhisitkul, Robert B.
   Wynn, Paula
   Steedman, Mark R.
   Lee, On-Tat
   Wong, Fergus
   Thoongsuwan, Somanus
   Desai, Tejal A.
TI Ocular Biocompatibility and Structural Integrity of Micro- and
   Nanostructured Poly(caprolactone) Films
SO JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; IN-VITRO; POSTERIOR SEGMENT; RELEASE PROFILES;
   MICROPARTICLES; POLYCAPROLACTONE; DEVICES; NANOPARTICLES; IMPLANTS;
   MICROSPHERES
AB The identification of biomaterials that are well tolerated in the eye is important for the development of new ocular drug delivery devices and implants, and the application of micro- and nanoengineered devices to biomedical treatments is predicated on the long-term preservation within the target organ or tissue of the very small functional design elements. This study assesses the ocular tolerance and durability of micro- and nanostructured biopolymer thin films injected or implanted into the rabbit eye. Structured poly(caprolactone) (PCL) thin films were placed in adult rabbit eyes for survival studies, with serial ophthalmic examinations over 6 months. Morphologic abnormalities and device/tissue reactions were evaluated by histologic studies, and scanning electron microscopy (SEM) of films was used to determine the structural integrity. Structured PCL thin films (20- to 40-mu m thick) were constructed to design specifications with 50-mu m linear microgrooves or arrays of nanopores with similar to 30-nm diameters. After up to 9 months of ocular residency, SEM on devices retrieved from the eye showed preservation of micro- and nanostructural features. In ocular safety evaluations carried out over 6 months, serial examinations in 18 implanted eyes showed no evidence of chronic inflammation, cataractogenesis, or retinal toxicity. Postoperative ocular inflammation was seen in 67% of eyes for 1 week, and persistent corneal edema occurred in 1 eye. Histology revealed no ocular inflammation or morphologic abnormalities of ocular tissues. Thin-film/tissue responses such as cellular reaction, fibrosis, or surface biodeposits were not seen. Micro- and nanostructured PCL thin films exhibited acceptable ocular tolerance and maintained the structural integrity of design features while residing in the eye. Thin-film micro- and nanostructured PCL appears to be a feasible biomaterial for intraocular therapeutic applications.
C1 [Bernards, Daniel A.; Desai, Tejal A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.
   [Bhisitkul, Robert B.; Wynn, Paula; Lee, On-Tat; Wong, Fergus; Thoongsuwan, Somanus] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94158 USA.
   [Steedman, Mark R.; Desai, Tejal A.] UC Berkeley UCSF Grad Program Bioengn, San Francisco, CA USA.
RP Desai, TA (reprint author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, 1700 4th St,Box 2520, San Francisco, CA 94158 USA.
EM tejal.desai@ucsf.edu
FU National Institutes of Health/National Eye Institute [EY021574-01A1];
   NIH/NEI [EY002162]; Wallace H. Coulter Foundation; That Man May See
   Foundation; Allergan Horizon Fellowship; Research to Prevent Blindness;
   UCSF Micro and Nanofabrication Core Grant; Genentech Postdoctoral
   Fellowship
FX The National Institutes of Health/National Eye Institute RO1 Grant
   EY021574-01A1 and the NIH/NEI Core Grant EY002162; the Wallace H.
   Coulter Foundation; the That Man May See Foundation; the Allergan
   Horizon Fellowship; the Research to Prevent Blindness unrestricted
   grant; the UCSF Micro and Nanofabrication Core Grant. DAB was funded by
   a Genentech Postdoctoral Fellowship.
CR Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Aishwarya S, 2008, J MICROENCAPSUL, V25, P298, DOI 10.1080/02652040801972004
   Allison SD, 2008, EXPERT OPIN DRUG DEL, V5, P615, DOI [10.1517/17425240802157184, 10.1517/17425247.5.6.615 ]
   Beeley NRF, 2005, J BIOMED MATER RES A, V73A, P437, DOI 10.1002/jbm.a.30294
   Bernards DA, 2010, ADV MATER, V22, P2358, DOI 10.1002/adma.200903439
   Bernards DA, 2010, SOFT MATTER, V6, P1621, DOI 10.1039/b922303g
   Budhian A, 2008, INT J PHARM, V346, P151, DOI 10.1016/j.ijpharm.2007.06.01
   Carcaboso AM, 2010, INVEST OPHTH VIS SCI, V51, P2126, DOI 10.1167/iovs.09-4050
   CHRISTIANSEN AT, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/454295
   CONTI B, 1992, J MICROENCAPSUL, V9, P153
   Edelhauser HF, 2010, INVEST OPHTH VIS SCI, V51, P5403, DOI 10.1167/iovs.10-5392
   Fialho SL, 2008, EUR J PHARM BIOPHARM, V68, P637, DOI 10.1016/j.ejpb.2007.08.004
   Giteau A, 2008, INT J PHARM, V350, P14, DOI 10.1016/j.ijpharm.2007.11.012
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Jeon G, 2012, J MATER CHEM, V22, P14814, DOI 10.1039/c2jm32430j
   Kashanian S, 2010, ACTA BIOMATER, V6, P3566, DOI 10.1016/j.actbio.2010.03.031
   Kawaguchi H, 2000, PROG POLYM SCI, V25, P1171, DOI 10.1016/S0079-6700(00)00024-1
   Kompella UB, 2003, INVEST OPHTH VIS SCI, V44, P1192, DOI 10.1167/iovs.02-0791
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   Labet M, 2009, CHEM SOC REV, V38, P3484, DOI 10.1039/b820162p
   Lassalle V, 2007, MACROMOL BIOSCI, V7, P767, DOI 10.1002/mabi.200700022
   Lee SS, 2010, PHARM RES-DORDR, V27, P2043, DOI 10.1007/s11095-010-0159-x
   Lee SS, 2009, CURR OPIN OPHTHALMOL, V20, P511, DOI 10.1097/ICU.0b013e328330ccb9
   Loftsson T, 2007, J PHARM PHARMACOL, V59, P629, DOI 10.1211/jpp.59.5.0002
   Luciani A, 2008, BIOMATERIALS, V29, P4800, DOI 10.1016/j.biomaterials.2008.09.007
   Mohammad DA, 2007, ANN PHARMACOTHER, V41, P449, DOI 10.1345/aph.1H540
   Natu MV, 2011, INT J PHARMACEUT, V415, P73, DOI 10.1016/j.ijpharm.2011.05.047
   Redenti Stephen, 2008, J Ocul Biol Dis Infor, V1, P19, DOI 10.1007/s12177-008-9005-3
   Silva-Cunha A, 2009, INVEST OPHTH VIS SCI, V50, P2312, DOI 10.1167/iovs.08-2969
   Sodha S, 2011, J BIOMAT SCI-POLYM E, V22, P443, DOI 10.1163/092050610X487738
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Steedman MR, 2010, BIOMED MICRODEVICES, V12, P363, DOI 10.1007/s10544-009-9392-7
   Wang CH, 2007, LANGMUIR, V23, P11960, DOI 10.1021/la702296q
   Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033
   Wei XW, 2009, INT J PHARMACEUT, V369, P170, DOI 10.1016/j.ijpharm.2008.10.027
   Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042
   Zarbin MA, 2010, AM J OPHTHALMOL, V150, P144, DOI 10.1016/j.ajo.2010.03.019
NR 37
TC 13
Z9 13
U1 2
U2 33
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1080-7683
J9 J OCUL PHARMACOL TH
JI J. Ocular Pharmacol. Ther.
PD MAR
PY 2013
VL 29
IS 2
SI SI
BP 249
EP 257
DI 10.1089/jop.2012.0152
PG 9
WC Ophthalmology; Pharmacology & Pharmacy
SC Ophthalmology; Pharmacology & Pharmacy
GA 106CI
UT WOS:000316118600017
PM 23391326
OA Green Published
DA 2018-10-20
ER

PT J
AU Pritchard, EM
   Hu, X
   Finley, V
   Kuo, CK
   Kaplan, DL
AF Pritchard, Eleanor M.
   Hu, Xiao
   Finley, Violet
   Kuo, Catherine K.
   Kaplan, David L.
TI Effect of Silk Protein Processing on Drug Delivery from Silk Films
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biodegradable materials; biomaterials; controlled release; drug-delivery
   systems; silk fibroin
ID POLYMER MOLECULAR-WEIGHT; IN-VITRO; CONTROLLED-RELEASE; POLY(DL-LACTIC
   ACID); GLASS-TRANSITION; FIBROIN; BIOMATERIALS; DEGRADATION; BEHAVIOR;
   ENZYMES
AB Sericin removal from the core fibroin protein of silkworm silk is a critical first step in the use of silk for biomaterial-related applications, but degumming can affect silk biomaterial properties, including molecular weight, viscosity, diffusivity and degradation behavior. Increasing the degumming time (10, 30, 60, and 90min) decreases the average molecular weight of silk protein in solution, silk solution viscosity, and silk film glass-transition temperature, and increases the rate of degradation of a silk film by protease. Model compounds spanning a range of physical-chemical properties generally show an inverse relationship between degumming time and release rate through a varied degumming time silk coating. Degumming provides a useful control point to manipulate silk's material properties.
C1 [Pritchard, Eleanor M.; Finley, Violet; Kuo, Catherine K.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Hu, Xiao] Rowan Univ, Dept Phys & Astron, Glassboro, NJ 08028 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820
FU National Institute of Neurological Disorders and Stroke [R01NS058780];
   Epilepsy Research Foundation
FX This project was supported by grant R01NS058780 from the National
   Institute of Neurological Disorders and Stroke and by the Epilepsy
   Research Foundation through the generous support of the Arlene and
   Arnold Goldstein Family Foundation. The authors would like to thank
   Lindsay Wray for advice and assistance with SDS-PAGE gels and Anthony
   Barry for discussions and technical guidance.
CR ABLETSHAUSER CB, 1993, J CONTROL RELEASE, V27, P149, DOI 10.1016/0168-3659(93)90218-T
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Arami M, 2007, J APPL POLYM SCI, V106, P267, DOI 10.1002/app.26492
   Dang WB, 1996, J CONTROL RELEASE, V42, P83, DOI 10.1016/0168-3659(96)01371-5
   Fang Jia-You, 2006, Chem Pharm Bull (Tokyo), V54, P156, DOI 10.1248/cpb.54.156
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mittal G, 2007, J CONTROL RELEASE, V119, P77, DOI 10.1016/j.jconrel.2007.01.016
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Numata K, 2010, BIOCHEMISTRY-US, V49, P3254, DOI 10.1021/bi902134p
   OMELCZUK MO, 1992, PHARMACEUT RES, V9, P26, DOI 10.1023/A:1018967424392
   PANDIT MW, 1972, ARCH BIOCHEM BIOPHYS, V149, P259, DOI 10.1016/0003-9861(72)90321-9
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1
   Pritchard E. M., 2011, EXPERT OPIN DRUG DEL, V8, P1
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rajkhowa R, 2011, J APPL POLYM SCI, V119, P1339, DOI 10.1002/app.31981
   Ramkissoon-Ganorkar C, 1999, J CONTROL RELEASE, V59, P287, DOI 10.1016/S0168-3659(99)00006-1
   Siepmann F, 2008, J CONTROL RELEASE, V125, P1, DOI 10.1016/j.jconrel.2007.09.012
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Steendam R, 2001, J CONTROL RELEASE, V70, P71, DOI 10.1016/S0168-3659(00)00342-4
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Vandamme TF, 1996, INT J PHARM, V145, P77, DOI 10.1016/S0378-5173(96)04727-8
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Yang YM, 2009, POLYM DEGRAD STABIL, V94, P2213, DOI 10.1016/j.polymdegradstab.2009.09.002
NR 49
TC 33
Z9 35
U1 6
U2 99
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAR
PY 2013
VL 13
IS 3
BP 311
EP 320
DI 10.1002/mabi.201200323
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 112XK
UT WOS:000316627800006
PM 23349062
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Chen, Q
   Huang, SP
AF Chen, Qiang
   Huang, Shiping
TI Mechanical properties of a porous bioscaffold with hierarchy
SO MATERIALS LETTERS
LA English
DT Article
DE Tissue engineering; Biomaterials; Porous materials; Mechanical
   properties; Hierarchy
ID ELASTIC-ANISOTROPY; TRABECULAR BONE; SCAFFOLDS; ARCHITECTURE;
   FABRICATION; TISSUES; DESIGN
AB In this letter, inspired by multiscale structures of natural tissues, we propose a porous bioscaffold with structural hierarchy to optimize tissue regeneration. By describing its geometric model and performing mechanical analysis, Young's modulus and strength of the scaffold, which can be formulated with given parameters of the bottom level, are derived by an iterative method. Theoretical predictions on the two mechanical parameters by the present method are compared with others by the homogenization theory and power law; the comparison shows that they agree very well. The porous scaffold could be applied in future tissue engineering as a new biomaterial. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Chen, Qiang] Southeast Univ, Sch Biol Sci & Med Engn, Lab Biomech, Nanjing 210096, Jiangsu, Peoples R China.
   [Huang, Shiping] S China Univ Technol, Sch Civil Engn & Transportat, Guangzhou 510640, Guangdong, Peoples R China.
RP Huang, SP (reprint author), S China Univ Technol, Sch Civil Engn & Transportat, Guangzhou 510640, Guangdong, Peoples R China.
EM asihuang@yahoo.cn
RI huang, shiping/K-1359-2015
CR Ahn S, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/065015
   Chen Q, 2011, ADV ENG MATER, V13, pB377, DOI 10.1002/adem.201080131
   Chen Q, 2011, COMPOS PART B-ENG, V42, P2030, DOI 10.1016/j.compositesb.2011.04.052
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   REILLY DT, 1974, J BONE JOINT SURG AM, VA 56, P1001, DOI 10.2106/00004623-197456050-00012
   Tan QG, 2011, INT J MOL SCI, V12, P890, DOI 10.3390/ijms12020890
   VanRietbergen B, 1996, J BIOMECH, V29, P1653, DOI 10.1016/0021-9290(96)00093-0
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009
   Zhang JC, 2006, J MATER SCI, V41, P1725, DOI 10.1007/s10853-06-2873-7
NR 19
TC 13
Z9 13
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD MAR 1
PY 2013
VL 95
BP 89
EP 92
DI 10.1016/j.matlet.2012.12.071
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 111GL
UT WOS:000316509700024
DA 2018-10-20
ER

PT J
AU Kannan, MB
   Wallipa, O
AF Kannan, M. Bobby
   Wallipa, O.
TI Potentiostatic pulse-deposition of calcium phosphate on magnesium alloy
   for temporary implant applications - An in vitro corrosion study
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Magnesium alloy; Biomaterial; Calcium phosphate; Corrosion
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; SODIUM-SULFATE SOLUTION;
   HYDROXYAPATITE COATINGS; MECHANICAL INTEGRITY; ELECTRODEPOSITION;
   BEHAVIOR; CA; DEGRADATION
AB In this study, a magnesium alloy (AZ91) was coated with calcium phosphate using potentiostatic pulse-potential and constant-potential methods and the in vitro corrosion behaviour of the coated samples was compared with the bare metal. In vitro corrosion studies were carried out using electrochemical impedance spectroscopy and potentiodynamic polarization in simulated body fluid (SBF) at 37 degrees C. Calcium phosphate coatings enhanced the corrosion resistance of the alloy, however, the pulse-potential coating performed better than the constant-potential coating. The pulse-potential coating exhibited similar to 3 times higher polarization resistance than that of the constant-potential coating. The corrosion current density obtained from the potentiodynamic polarization curves was significantly less (similar to 60%) for the pulse-deposition coating as compared to the constant-potential coating. Post-corrosion analysis revealed only slight corrosion on the pulse-potential coating, whereas the constant-potential coating exhibited a large number of corrosion particles attached to the coating. The better in vitro corrosion performance of the pulse-potential coating can be attributed to the closely packed calcium phosphate particles. 2012 Elsevier B.V. All rights reserved.
C1 [Kannan, M. Bobby] James Cook Univ, Sch Engn & Phys Sci, Discipline Chem Engn, Townsville, Qld 4811, Australia.
   [Wallipa, O.] King Mongkuts Univ Technol Thonburi, Fac Engn, Chem Engn Practice Sch, Bangkok 10140, Thailand.
RP Kannan, MB (reprint author), James Cook Univ, Sch Engn & Phys Sci, Discipline Chem Engn, Townsville, Qld 4811, Australia.
EM bobby.mathan@jcu.edu.au
OI Mathan, Bobby Kannan/0000-0003-0480-8587
FU NACE International, USA
FX The authors would like to thank Mr. Rhys Walter for his assistance in
   SEM analysis. One of authors (MBK) is grateful for the financial support
   from NACE International, USA.
CR Baril G, 2001, CORROS SCI, V43, P471, DOI 10.1016/S0010-938X(00)00095-0
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   Chandrasekar MS, 2008, ELECTROCHIM ACTA, V53, P3313, DOI 10.1016/j.electacta.2007.11.054
   Chen J, 2007, ELECTROCHIM ACTA, V52, P3299, DOI 10.1016/j.electacta.2006.10.007
   Dumelie H., 2008, MATER CHARACT, V59, P129
   Fleig J, 1996, J ELECTROCHEM SOC, V143, P3636, DOI 10.1149/1.1837263
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jin S, 2007, ADV ENG MATER, V9, P75, DOI 10.1002/adem.200600199
   Kannan M, 2011, BIOMED MATER, V6, P1
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kannan MB, 2010, MATER SCI FORUM, V654-656, P2196, DOI 10.4028/www.scientific.net/MSF.654-656.2196
   Kannan MB, 2010, J BIOMED MATER RES A, V93A, P1050, DOI 10.1002/jbm.a.32576
   Kannan MB, 2010, MATER LETT, V64, P739, DOI 10.1016/j.matlet.2010.01.022
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   PEBERE N, 1990, ELECTROCHIM ACTA, V35, P555, DOI 10.1016/0013-4686(90)87043-2
   Pecheva EV, 2004, APPL SURF SCI, V235, P176, DOI 10.1016/j.apsusc.2004.05.174
   Puleo D.A., 2004, APPL BIOMATER, V6, P109
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Shi D, 2004, BIOMATERIALS TISSUE
   Song Y, 2010, ACTA BIOMATER, V6, P1736, DOI 10.1016/j.actbio.2009.12.020
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Waksman R, 2007, CATHETER CARDIO INTE, V70, P407, DOI 10.1002/ccd.21176
   Walter R., 2011, MATER LETT, V64, P748
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
   Yen S.K., 2002, MAT SCI ENG C, V20, P153
NR 31
TC 27
Z9 28
U1 0
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2013
VL 33
IS 2
BP 675
EP 679
DI 10.1016/j.msec.2012.10.017
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA 101FX
UT WOS:000315761700016
PM 25427473
DA 2018-10-20
ER

PT J
AU Santos, MH
   Silva, RM
   Dumont, VC
   Neves, JS
   Mansur, HS
   Heneine, LGD
AF Santos, Maria Helena
   Silva, Rafael M.
   Dumont, Vitor C.
   Neves, Juliana S.
   Mansur, Herman S.
   Heneine, Luiz Guilherme D.
TI Extraction and characterization of highly purified collagen from bovine
   pericardium for potential bioengineering applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterials; Collagen; Protein Electrophoresis; Characterization of
   Biomaterials; Tissue replacements; Bovine collagen xenografts
ID AMIDE-I-BAND; TISSUE; BIOMATERIALS; FUNCTIONALIZATION; BIOCOMPATIBILITY;
   IMMOBILIZATION; SPECTROSCOPY
AB Bovine pericardium is widely used as a raw material in bioengineering as a source of collagen, a fundamental structural molecule. The physical, chemical, and biocompatibility characteristics of these natural fibers enable their broad use in several areas of the health sciences. For these applications, it is important to obtain collagen of the highest possible purity. The lack of a method to produce these pure biocompatible materials using simple and economically feasible techniques presents a major challenge to their production on an industrial scale. This study aimed to extract, purify, and characterize the type I collagen protein originating from bovine pericardium, considered to be an abundant tissue resource. The pericardium tissue was collected from male animals at slaughter age. Pieces of bovine pericardium were enzymatically digested, followed by a novel protocol developed for protein purification using ion-exchange chromatography. The material was extensively characterized by electrophoresis, scanning electron microscopy, energy dispersive X-ray spectroscopy, and infrared spectroscopy. The results showed a purified material with morphological properties and chemical functionalities compatible with type I collagen and similar to a highly purified commercial collagen. Thus, an innovative and relatively simple processing method was developed to extract and purify type I collagen from bovine tissue with potential applications as a biomaterial for regenerative tissue engineering. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Santos, Maria Helena; Silva, Rafael M.; Dumont, Vitor C.] Fed Univ Vales Jequitinhonha & Mucuri UFVJM, Dept Dent, BR-39100000 Diamantina, MG, Brazil.
   [Santos, Maria Helena; Silva, Rafael M.; Dumont, Vitor C.; Neves, Juliana S.] Fed Univ Vales Jequitinhonha & Mucuri UFVJM, Ctr Assessment & Dev Biomat BioMat, BR-39100000 Diamantina, MG, Brazil.
   [Mansur, Herman S.] Fed Univ Minas Gerais UFMG, Dept Met & Mat Engn, BR-31270901 Belo Horizonte, MG, Brazil.
   [Heneine, Luiz Guilherme D.] Ezequiel Dias Fdn FUNED, Dept Hlth Sci, BR-30510010 Belo Horizonte, MG, Brazil.
RP Santos, MH (reprint author), Fed Univ Vales Jequitinhonha & Mucuri UFVJM, Dept Dent, BR-39100000 Diamantina, MG, Brazil.
EM mariahelena.santos@gmail.com
RI Silva, Rafael/J-5016-2014
OI Mansur, Herman/0000-0002-3032-495X
FU CAPES; CNPq; FAPEMIG
FX The authors express their gratitude to the researchers and technicians
   of the Immunology Laboratory of Foundation Ezequiel Dias and SEM
   Microscopy Laboratory (DEMET-EEUFMG). Additionally, the authors thank
   CAPES, CNPq and FAPEMIG for financial support.
CR Aitken Alastair, 1996, P3, DOI 10.1007/978-1-60327-259-9_1
   ALMEIDA MS, 2002, BIOTECNOLOGIA CIENCI, V24, P30
   Andrade Ângela Leão, 2004, Mat. Res., V7, P631, DOI 10.1590/S1516-14392004000400018
   [Anonymous], 2004, ONL EXPASY PROT SERV
   AR Ten Cate, 1994, ORAL HISTOLOGY DEV S
   Arvanitoyannis IS, 2008, INT J FOOD SCI TECH, V43, P543, DOI 10.1111/j.1365-2621.2006.01492.x
   Caputo I, 2012, ANAL BIOCHEM, V421, P92, DOI 10.1016/j.ab.2011.10.024
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   CHARRIERE G, 1989, J AM ACAD DERMATOL, V21, P1203, DOI 10.1016/S0190-9622(89)70330-3
   Choi YH, 2006, AM J PATHOL, V169, P72, DOI 10.2353/ajpath.2006.051163
   Chu N., 1988, J HISTOCHEM CYTOCHEM, V37, P257
   Copeland R. A., 1994, METHODS PROTEIN ANAL
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Deyl Z, 2003, J CHROMATOGR B, V790, P245, DOI 10.1016/S1570-0232(03)00158-2
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Haines RJ, 2004, REPORT MEAT REGULATO
   Haralson M. A., 1995, EXTRACELLULAR MATRIX
   Ho P.L., 2000, BIOTECHNOL CIENC DES, V2, P24
   Kumudinie C., 1999, POLYM DATA HDB
   L.K.B. Pharmacia A.B. Biotechnology, 1991, ION EXCH CHROM PRINC
   Lacerda R., 1998, QUIM NOVA, V21, P267
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee WK, 2000, BIOMATERIALS, V21, P2323, DOI 10.1016/S0142-9612(00)00159-9
   LIAO KX, 1992, ARTIF ORGANS, V16, P361
   Liu DS, 2012, FOOD CHEM, V133, P1441, DOI 10.1016/j.foodchem.2012.02.032
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Manstsh H.H., 1996, INFRARED SPECTROSCOP
   Mansur H, 2002, SPECTROSC-INT J, V16, P351, DOI 10.1155/2002/183053
   Mansur HS, 2000, BIOMACROMOLECULES, V1, P789, DOI 10.1021/bm0056198
   Nagai T, 2008, FOOD CHEM, V111, P296, DOI 10.1016/j.foodchem.2008.03.087
   Nogueira GM, 2010, MAT SCI ENG C-MATER, V30, P575, DOI 10.1016/j.msec.2010.02.011
   Pachence I.M., 1996, J BIOMED MATER RES, V33, P35
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Pari L, 2003, BRAZ J MED BIOL RES, V36, P861, DOI 10.1590/S0100-879X2003000700006
   Pavia D. L., 1996, INTRO SPECTROSCOPY G
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Polak R., 2011, CRYOBIOLOGY
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Sailakshmi G, 2011, J MATER SCI-MATER M, V22, P1419, DOI 10.1007/s10856-011-4337-0
   Santos MH, 2007, BIOMED MATER, V2, P135, DOI 10.1088/1748-6041/2/2/012
   Santos MH, 2008, MAT SCI ENG C-BIO S, V28, P563, DOI 10.1016/j.msec.2007.07.002
   Sato K, 2003, J CHROMATOGR B, V790, P277, DOI 10.1016/S1570-0232(03)00083-7
   Schofer MD, 2011, J MATER SCI-MATER M, V22, P1753, DOI 10.1007/s10856-011-4341-4
   Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Tonhi E, 2002, QUIM NOVA, V25, P943, DOI 10.1590/S0100-40422002000600011
   Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010
   VIIDIK A, 1980, BIOL COLLAGEN
   Yannas I. V., 1996, BIOMATERIALS SCI INT, V1, P84
   ZIOUPOS P, 1992, MED BIOL ENG COMPUT, V30, P76, DOI 10.1007/BF02446197
NR 55
TC 16
Z9 17
U1 2
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2013
VL 33
IS 2
BP 790
EP 800
DI 10.1016/j.msec.2012.11.003
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA 101FX
UT WOS:000315761700032
PM 25427489
DA 2018-10-20
ER

PT J
AU Kolmeder, S
   Lion, A
AF Kolmeder, S.
   Lion, A.
TI Characterisation and modelling rheological properties of acrylic bone
   cement during application
SO MECHANICS RESEARCH COMMUNICATIONS
LA English
DT Article
DE Acrylic bone cement; Rheology; Vertebroplasty; Evolution equation
AB Acrylic bone cement is the most common biomaterial used in vertebral bone augmentation. The complex mechanical behaviour of this material implicates a careful handling during clinical interventions which are quite frequently accompanied with potential complications. To contribute to a more detailed understanding of the flow behaviour inside the human body, this study deals with the experimental characterisation and phenomenological modelling of the rheological properties of acrylic bone cements. Rotational and capillary rheometric measurements were carried out to investigate the time, temperature and shear rate dependent flow behaviour of acrylic bone cement. Based on these measurements a mathematical model is proposed that can describe all of the observed phenomena. Such models can be implemented in computational fluid dynamics codes to explore the flow behaviour of bone cement through more complex geometries like human vertebral bodies. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kolmeder, S.; Lion, A.] Univ Fed Armed Forces, Fac Aerosp Engn, Inst Mech, D-85577 Neubiberg, Germany.
RP Kolmeder, S (reprint author), Univ Fed Armed Forces, Fac Aerosp Engn, Inst Mech, D-85577 Neubiberg, Germany.
EM sebastian.kolmeder@unibw.de
RI Lion, Anais/G-4756-2013
OI Lion, Anais/0000-0002-4995-8637
FU German Research Foundation DFG
FX The authors would like to thank the German Research Foundation DFG for
   financial support of this work.
CR Baroud G, 2003, MED ENG PHYS, V25, P283, DOI 10.1016/S1350-4533(02)00223-0
   Boehme G., 1987, NONNEWTONIAN FLUID M
   Choon Meng J., 2007, THESIS NATL U SINGAP
   Collyer A. A., 1988, RHEOLOGICAL MEASUREM
   Farrar DF, 2001, BIOMATERIALS, V22, P3005, DOI 10.1016/S0142-9612(01)00047-3
   Grupp T., 2002, THESIS U STUTTGART
   Harris J, 1977, RHEOLOGY NONNEWTONIA
   KRAUSE WR, 1982, J BIOMED MATER RES, V16, P219, DOI 10.1002/jbm.820160305
   Kuhn K.D., 2005, ORTHOP CLIN N AM, V36, P17
   Lenk R. S., 1978, POLYM RHEOLOGY
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2011, J BIOMED MATER RES B, V98B, P171, DOI 10.1002/jbm.b.31835
   Lodge AS, 1985, VISCOELASTICITY RHEO
   Pahl M., 1995, PRAKTISCHE RHEOLOGIE
   Sarda S, 2001, J MATER SCI-MATER M, V12, P905, DOI 10.1023/A:1012832325957
   Schmidt F., 2006, THESIS FACHHOCHSCHUL
NR 16
TC 4
Z9 4
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0093-6413
J9 MECH RES COMMUN
JI Mech. Res. Commun.
PD MAR
PY 2013
VL 48
BP 93
EP 99
DI 10.1016/j.mechrescom.2012.12.010
PG 7
WC Mechanics
SC Mechanics
GA 110IG
UT WOS:000316435200014
DA 2018-10-20
ER

PT J
AU Kim, YK
   Park, IS
   Lee, SJ
   Lee, MH
AF Kim, Yu Kyoung
   Park, Il Song
   Lee, Sook Jeong
   Lee, Min Ho
TI Biodegradation and cytotoxic properties of pulse anodized Mg alloys
SO METALS AND MATERIALS INTERNATIONAL
LA English
DT Article
DE biomaterials; anodization; corrosion; surface modification; coating
ID AZ91D MAGNESIUM ALLOY; CORROSION-RESISTANCE; SURFACE CHARACTERISTICS;
   TITANIUM-ALLOYS; IN-VIVO; ALUMINUM; OXIDATION; COATINGS; NEURONS;
   PATHWAY
AB Magnesium has the potential to be used as an implant material owing to its non-toxicity. On the other hand, magnesium alloys corrode rapidly in subcutaneous gas bubbles. Consequently, the approach of using magnesium alloys as a biodegradable biomaterial is not well established. Therefore, the aim of this study was to provide corrosion protection by anodizing to surface for a biodegradable material. Micro-arc oxidation by pulsed DC was applied to AZ91D and AZ31B, and the cell bioactivity was defined. The anodic film was characterized by XRD and SEM. The specific mass loss variation from immersion test and potentiodynamic electrochemical test was performed for the quantification of corrosion resistance. Although the AZ91D had better corrosion resistance properties but the result of the in vitro tests showed low cell viability compared with the AZ31B. The results of the cell staining and agar overlay test revealed the AZ31B group had good biocompatibility and a low corrosion rate. In this study, the surfaces of AZ91D and AZ31B showed the formation of a uniform film by pulse power anodization improving corrosion resistance. Also, the cytotoxicity of the materials was examined by the aluminum content change of compound metal.
C1 [Kim, Yu Kyoung; Park, Il Song; Lee, Min Ho] Chonbuk Natl Univ, Dept Dent Biomat, Sch Dent, Jeonju 561756, South Korea.
   [Kim, Yu Kyoung; Park, Il Song; Lee, Min Ho] Chonbuk Natl Univ, Inst Oral Biosci, Sch Dent, Jeonju 561756, South Korea.
   [Kim, Yu Kyoung; Park, Il Song; Lee, Min Ho] Chonbuk Natl Univ, Post Program BK21, Jeonju 561756, South Korea.
   [Lee, Sook Jeong] Univ Ulsan, Coll Med, Neural Injury Res Lab, Dept Neurol,Asan Life Sci Inst, Seoul 138736, South Korea.
RP Park, IS (reprint author), Chonbuk Natl Univ, Dept Dent Biomat, Sch Dent, Jeonju 561756, South Korea.
EM ilsong@chonbuk.ac.kr; LMH@chonbuk.ac.kr
OI Kim, Yu Kyoung/0000-0002-7081-2907
FU OKorea Research Foundation; Korean Government (MOEHRD)
   [(KRF-2007-313-E00471)O]; ONational Research Foundation of Korea (NRF);
   Korean government (MEST) [(2011-0028709)O]
FX This work was financially supported by the OKorea Research Foundation
   Grant funded by the Korean Government (MOEHRD) (KRF-2007-313-E00471)O,
   and the ONational Research Foundation of Korea (NRF) grant funded by the
   Korean government (MEST) (No. 2011-0028709)O.
CR [Anonymous], 1984, REC STAND PRACT BIOL, P7405
   AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   Barbosa D. Peixoto, 2003, Mat. Res., V6, P103, DOI 10.1590/S1516-14392003000100018
   Canales JJ, 2001, J INORG BIOCHEM, V87, P63, DOI 10.1016/S0162-0134(01)00316-6
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   Fu HJ, 2003, BRAIN RES, V980, P11, DOI 10.1016/S0006-8993(03)02833-6
   Guo HF, 2005, THIN SOLID FILMS, V485, P53, DOI 10.1016/j.tsf.2005.03.050
   Hsiao HY, 2005, SURF COAT TECH, V190, P299, DOI 10.1016/j.surfcoat.2004.03.010
   Khaselev O, 2001, CORROS SCI, V43, P1295, DOI 10.1016/S0010-938X(00)00116-5
   Kim DH, 2011, KOREAN J MET MATER, V49, P145, DOI 10.3365/KJMM.2011.49.2.145
   Kim HS, 2004, J POWER SOURCES, V138, P14, DOI 10.1016/j.jpowsour.2004.06.012
   Kim YK, 2008, ADV MATER RES-SWITZ, V47-50, P1290, DOI 10.4028/www.scientific.net/AMR.47-50.1290
   Kuhn Anselm, 2003, MET FINISH, V101, P44
   Kuwahara H, 2003, MATER SCI FORUM, V419-4, P1007, DOI 10.4028/www.scientific.net/MSF.419-422.1007
   Lindsey R. W., 2005, ORTHOPAEDIC KNOWLEDG, P141
   McRae R., 1994, PRACTICAL FRACTURE T, P91
   MILLER PL, 1995, CORROSION, V51, P922, DOI 10.5006/1.3293568
   Mizutani Y, 2003, SURF COAT TECH, V169, P143, DOI 10.1016/S0257-8972(03)00214-7
   Park IS, 2008, SURF INTERFACE ANAL, V40, P1270, DOI 10.1002/sia.2876
   Rudnev VS, 2001, J ELECTROANAL CHEM, V497, P150, DOI 10.1016/S0022-0728(00)00483-6
   Shi ZM, 2006, CORROS SCI, V48, P1939, DOI 10.1016/j.corsci.2005.08.004
   Shi ZM, 2005, CORROS SCI, V47, P2760, DOI 10.1016/j.corsci.2004.11.004
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Voevodin AA, 1996, SURF COAT TECH, V86-7, P516, DOI 10.1016/S0257-8972(96)03069-1
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xue WB, 2000, THIN SOLID FILMS, V372, P114, DOI 10.1016/S0040-6090(00)01026-9
   Yerokhin AL, 2002, APPL SURF SCI, V200, P172, DOI 10.1016/S0169-4332(02)00848-6
NR 28
TC 6
Z9 6
U1 1
U2 57
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA POSCO CENTER, 4TH FL (EAST WING), 892 DAECHI-4-DONG, KANGNAM-KU, SEOUL
   135-777, SOUTH KOREA
SN 1598-9623
J9 MET MATER INT
JI Met. Mater.-Int.
PD MAR
PY 2013
VL 19
IS 2
BP 353
EP 360
DI 10.1007/s12540-013-2034-x
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 108IM
UT WOS:000316286200030
DA 2018-10-20
ER

PT J
AU Benders, KEM
   van Weeren, PR
   Badylak, SF
   Saris, DBF
   Dhert, WJA
   Malda, J
AF Benders, Kim E. M.
   van Weeren, P. Rene
   Badylak, Stephen F.
   Saris, Daniel B. F.
   Dhert, Wouter J. A.
   Malda, Jos
TI Extracellular matrix scaffolds for cartilage and bone regeneration
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION;
   ARTICULAR-CARTILAGE; IN-VIVO; FOLLOW-UP; TISSUE; REPAIR; DEFECTS; MODEL;
   DECELLULARIZATION
AB Regenerative medicine approaches based on decellularized extracellular matrix (ECM) scaffolds and tissues are rapidly expanding. The rationale for using ECM as a natural biomaterial is the presence of bioactive molecules that drive tissue homeostasis and regeneration. Moreover, appropriately prepared ECM is biodegradable and does not elicit adverse immune responses. Successful clinical application of decellularized tissues has been reported in cardiovascular, gastrointestinal, and breast reconstructive surgery. At present, the use of ECM for osteochondral tissue engineering is attracting interest. Recent data underscore the great promise for future application of decellularized ECM for osteochondral repair. This review describes the rationale for using ECM-based approaches for different regenerative purposes and details the application of ECM for cartilage or osteochondral repair.
C1 [Benders, Kim E. M.; Saris, Daniel B. F.; Dhert, Wouter J. A.; Malda, Jos] Univ Med Ctr Utrecht, Dept Orthoped, NL-3508 GA Utrecht, Netherlands.
   [van Weeren, P. Rene; Malda, Jos] Univ Utrecht, Dept Equine Sci, NL-3508 TD Utrecht, Netherlands.
   [Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
   [Saris, Daniel B. F.] Univ Twente, MIRA Inst, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Sci, Utrecht, Netherlands.
RP Malda, J (reprint author), Univ Med Ctr Utrecht, Dept Orthoped, POB 85500, NL-3508 GA Utrecht, Netherlands.
EM j.malda@umcutrecht.nl
OI Malda, Jos/0000-0002-9241-7676; Badylak, Stephen/0000-0003-3555-0689
CR Ahmed TAE, 2011, TISSUE ENG PT A, V17, P323, DOI [10.1089/ten.tea.2009.0773, 10.1089/ten.TEA.2009.0773]
   Armitage S, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/376251
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345
   Brittberg M, 2008, INJURY, V39, pS40, DOI 10.1016/j.injury.2008.01.040
   Bugbee WD, 1999, CLIN SPORT MED, V18, P67, DOI 10.1016/S0278-5919(05)70130-7
   Bugbee W, 2012, J KNEE SURG, V25, P109, DOI 10.1055/s-0032-1313743
   Chen CC, 2012, J ORTHOP RES, V30, P393, DOI 10.1002/jor.21541
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Cole BJ, 2011, AM J SPORT MED, V39, P1170, DOI 10.1177/0363546511399382
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   D'Onofrio A, 2011, J HEART VALVE DIS, V20, P319
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Geoffrion R, 2011, FEMALE PELVIC MED RE, V17, P174, DOI 10.1097/SPV.0b013e31821e5dcf
   Gerhardt LC, 2013, J BIOMED MATER RES A, V101, P827, DOI 10.1002/jbm.a.34373
   Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x
   Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130
   Gong J, 2008, EXP EYE RES, V86, P957, DOI 10.1016/j.exer.2008.03.014
   Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078
   Guilak F, 2011, BEST PRACT RES CL RH, V25, P815, DOI 10.1016/j.berh.2011.11.013
   Han E, 2011, BIOPHYS J, V101, P916, DOI 10.1016/j.bpj.2011.07.006
   Hangody L, 1998, ORTHOPEDICS, V21, P751
   Jeong CG, 2012, J BIOMED MATER RES A, V100A, P2088, DOI 10.1002/jbm.a.33249
   Jia SJ, 2012, J BIOSCI BIOENG, V113, P647, DOI 10.1016/j.jbiosc.2011.12.009
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Kang YQ, 2011, BIOMATERIALS, V32, P6119, DOI 10.1016/j.biomaterials.2011.05.015
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI [10.1089/ten.teb.2008.0563, 10.1089/ten.TEB.2008.0563]
   Klein TJ, 2009, MACROMOL BIOSCI, V9, P1049, DOI 10.1002/mabi.200900176
   Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091
   Lu HX, 2011, BIOMATERIALS, V32, P2489, DOI 10.1016/j.biomaterials.2010.12.016
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Malda J, 2012, OSTEOARTHR CARTILAGE, V20, P1147, DOI 10.1016/j.joca.2012.06.005
   Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001
   Martinello T., 2012, J TISSUE ENG REGEN M
   Meyer T, 2006, PEDIATR SURG INT, V22, P369, DOI 10.1007/s00383-006-1658-z
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Orthoworld, 2009, ORTH IND ANN REP, V28
   Oshima Y, 2009, TISSUE ENG PART C-ME, V15, P595, DOI [10.1089/ten.tec.2008.0487, 10.1089/ten.TEC.2008.0487]
   Padalino MA, 2012, EUR J CARDIO-THORAC, V42, pE128, DOI 10.1093/ejcts/ezs462
   Pei M, 2011, Eur Cell Mater, V22, P333
   Penolazzi L, 2012, J CELL PHYSIOL, V227, P857, DOI 10.1002/jcp.22983
   Peretti GM, 2006, CONNECT TISSUE RES, V47, P190, DOI 10.1080/03008200600809935
   Revell CM, 2009, TISSUE ENG PART B-RE, V15, P1, DOI 10.1089/ten.teb.2008.0189
   Ricchetti ET, 2012, J SHOULDER ELB SURG, V21, P251, DOI 10.1016/j.jse.2011.10.003
   Sadr N, 2012, BIOMATERIALS, V33, P5085, DOI 10.1016/j.biomaterials.2012.03.082
   Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001
   Schwarz S, 2012, J TISSUE ENG REGEN M
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437
   Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050
   Steadman J Richard, 2002, J Knee Surg, V15, P170
   Thibault RA, 2010, TISSUE ENG PT A, V16, P431, DOI [10.1089/ten.tea.2009.0583, 10.1089/ten.TEA.2009.0583]
   Tohyama H, 2009, J ORTHOP SCI, V14, P579, DOI 10.1007/s00776-009-1384-1
   Tottey S., 2012, BIOMATERIALS, V32, P128
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Turner NJ, 2012, J SURG RES, V176, P490, DOI 10.1016/j.jss.2011.11.1029
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Xue JX, 2012, BIOMATERIALS, V33, P5832, DOI 10.1016/j.biomaterials.2012.04.054
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang Q, 2011, CHINESE MED J-PEKING, V124, P3930, DOI 10.3760/cma.j.issn.0366-6999.2011.23.018
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 72
TC 200
Z9 205
U1 17
U2 305
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD MAR
PY 2013
VL 31
IS 3
SI SI
BP 169
EP 176
DI 10.1016/j.tibtech.2012.12.004
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 106RA
UT WOS:000316161200014
PM 23298610
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Masters, DB
   Meyer, RA
   Hansen, LK
AF Masters, D. B.
   Meyer, R. A.
   Hansen, L. K.
TI DERMIS REGENERATION FROM BIOMIMETIC SCAFFOLD: A CLINICALLY TRANSLATED
   THERMOPLASTIC BIOMATERIAL THAT IS A "BIO" COACERVATE OF PURIFIED
   FREEFORM ECM COMPONENTS
SO WOUND REPAIR AND REGENERATION
LA English
DT Meeting Abstract
C1 [Masters, D. B.; Meyer, R. A.] Gel Del Technol Inc, St Paul, MN USA.
   [Hansen, L. K.] WuXi AppTec Inc, St Paul, MN USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD MAR-APR
PY 2013
VL 21
IS 2
BP A33
EP A33
PG 1
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 103KI
UT WOS:000315914400081
DA 2018-10-20
ER

PT J
AU Kleinhans, C
   Barz, J
   Wurster, S
   Willig, M
   Oehr, C
   Muller, M
   Walles, H
   Hirth, T
   Kluger, PJ
AF Kleinhans, Claudia
   Barz, Jakob
   Wurster, Simone
   Willig, Marleen
   Oehr, Christian
   Mueller, Michael
   Walles, Heike
   Hirth, Thomas
   Kluger, Petra J.
TI Ammonia plasma treatment of polystyrene surfaces enhances proliferation
   of primary human mesenchymal stem cells and human endothelial cells
SO BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE Glow discharge plasma; Human dermal microvascular endothelial cells;
   Mesenchymal stem cells; Surface modification; Tissue engineering
ID OXYGEN-CONTAINING FILMS; ACRYLIC-ACID; HUMAN KERATINOCYTES; REGENERATIVE
   MEDICINE; PROTEIN ADSORPTION; TITANIUM SURFACES; ADHESION; BIOMATERIALS;
   RGD; ATTACHMENT
AB The control of surface properties is a substantial step in the development and improvement of biomaterials for clinical applications as well as for their use in tissue engineering. Interaction of the substrate surface with the biochemical or biological environment is crucial for the outcome of the applied biomaterial and therefore should meet specific requirements regarding the chemical composition, wettability, elasticity, and charge. In this study, we examined the effect of chemical groups introduced by low pressure plasma treatments of polystyrene surfaces on the cell behavior of primary human mesenchymal stem cells (hMSCs) and dermal microvascular endothelial cells (hDMECs). X-ray photoelectron spectroscopy analysis and contact angle measurements were employed to evaluate ammonia-, carbon dioxide-, and acrylic acid-plasma modifications to substrate surfaces. HMSCs and hDMECs were analyzed simultaneously to identify the most suitable surface functionalization for each cell type. Significantly higher cell proliferation was detected on ammonia plasma-treated surfaces. Cell-material interaction could be shown on all created interfaces as well as the expression of typical cell markers. Hence, the applied plasma treatment presents a suitable tool to improve culture condition on polystyrene for two important cell types (hMSCs and hDMECs) in the field of tissue engineering.
C1 [Kleinhans, Claudia; Barz, Jakob; Hirth, Thomas; Kluger, Petra J.] Univ Stuttgart, Inst Interfacial Engn, D-70569 Stuttgart, Germany.
   [Barz, Jakob; Wurster, Simone; Willig, Marleen; Oehr, Christian; Mueller, Michael; Walles, Heike; Hirth, Thomas; Kluger, Petra J.] Fraunhofer Inst Interfacial Engn & Biotechnol, Stuttgart, Germany.
   [Walles, Heike] Univ Wurzburg, Inst Tissue Engn & Regenerat Med, D-97070 Wurzburg, Germany.
RP Kleinhans, C (reprint author), Univ Stuttgart, Inst Interfacial Engn, Nobelstr 12, D-70569 Stuttgart, Germany.
EM claudia.kleinhans@igb.fraunhofer.de
RI Walles, Prof. Dr. Heike/M-1289-2015
FU University of Stuttgart; Fraunhofer Gesellschaft
FX The authors kindly thank Shannon Layland for proof reading the paper and
   Joachim Mayer for his technical support. Furthermore, we would like to
   thank the University of Stuttgart and the Fraunhofer Gesellschaft for
   financial support.
CR Alves CM, 2008, J BIOMED MATER RES B, V87B, P59, DOI 10.1002/jbm.b.31068
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Barz J, 2006, PLASMA PROCESS POLYM, V3, P540, DOI 10.1002/ppap.200600028
   Bell BF, 2011, CLIN ORAL IMPLAN RES, V22, P865, DOI 10.1111/j.1600-0501.2010.02074.x
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Bergemann C., 2011, PLASMA PROCESS POLYM, V9, P261
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   Dhayal M, 2003, SURF COAT TECH, V174, P872, DOI 10.1016/S0257-8972(03)00562-0
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   France RM, 1998, CHEM MATER, V10, P1176, DOI 10.1021/cm970761+
   France RM, 1998, J MATER CHEM, V8, P37, DOI 10.1039/a705098d
   GERENSER LJ, 1993, J ADHES SCI TECHNOL, V7, P1019, DOI 10.1163/156856193X00556
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   HAYAT U, 1992, BIOMATERIALS, V13, P801, DOI 10.1016/0142-9612(92)90022-G
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Higham MC, 2003, TISSUE ENG, V9, P919, DOI 10.1089/107632703322495565
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   HOLLANDER A, 1995, SURF COAT TECH, V74-5, P55, DOI 10.1016/0257-8972(95)08333-2
   HORBETT TA, 1987, ACS SYM SER, V343, P1
   Kirkpatrick CJ, 2011, ADV DRUG DELIVER REV, V63, P291, DOI 10.1016/j.addr.2011.01.009
   LOH IH, 1993, ABSTR PAP AM CHEM S, V205, P150
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Mwale F, 2006, BIOMATERIALS, V27, P2258, DOI 10.1016/j.biomaterials.2005.11.006
   Nakagawa M, 2006, J BIOMED MATER RES A, V77A, P112, DOI 10.1002/jbm.a.30521
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Nitschke M, 2012, COLLOID SURFACE B, V90, P41, DOI 10.1016/j.colsurfb.2011.09.034
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schenke-Layland K, 2011, BIOMATERIALS, V32, P2748, DOI 10.1016/j.biomaterials.2010.12.046
   Schenke-Layland K, 2009, BIOMATERIALS, V30, P4665, DOI 10.1016/j.biomaterials.2009.05.033
   Sciarratta V, 2003, SURF COAT TECH, V174, P805, DOI 10.1016/S0257-8972(03)00564-4
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P677, DOI 10.1016/j.cbpa.2011.04.021
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Walker NG, 2012, TISSUE ENG PART C-ME, V18, P143, DOI [10.1089/ten.tec.2011.0037, 10.1089/ten.TEC.2011.0037]
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wang MJ, 2005, SURF INTERFACE ANAL, V37, P348, DOI 10.1002/sia.2029
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
NR 52
TC 9
Z9 10
U1 1
U2 40
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1860-6768
J9 BIOTECHNOL J
JI Biotechnol. J.
PD MAR
PY 2013
VL 8
IS 3
SI SI
BP 327
EP 337
DI 10.1002/biot.201200210
PG 11
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 100OT
UT WOS:000315711300008
PM 23070995
DA 2018-10-20
ER

PT J
AU Din, MI
   Mirza, ML
AF Din, Muhammad Imran
   Mirza, Muhammad Latif
TI Biosorption potentials of a novel green biosorbent Saccharum bengalense
   containing cellulose as carbohydrate polymer for removal of Ni (II) ions
   from aqueous solutions
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Nickel; Kinetics; Saccharum bengalense; Macromolecule; Isotherm modeling
ID ADSORPTION-ISOTHERMS; NICKEL BIOSORPTION; SUGARCANE BAGASSE; ACTIVATED
   CARBON; WASTE-WATER; FLY-ASH; BIOMASS; EQUILIBRIUM; CD(II); CU(II)
AB In this research work, the potential of a novel green material obtained from Saccharum bengalense (SB) plant was investigated for the removal of Ni (II) ions from aqueous solution. Biomaterial SB composed of cellulose macromolecules and was used without any chemical treatment. Batch experiments were performed by considering the effect of contact time, SB concentration, pH of the solution and temperature. Results revealed that similar to 87% of Ni was removed from aqueous solution at optimum conditions. Three typical kinetic models namely, pseudo first order, pseudo second order and Elovich equations were applied to interpret the kinetic data. To investigate the rate determining step, the intra-particle diffusion model was applied on the experimental data. The sorption process was well explained with pseudo second-order kinetic model. Adsorption isothermal data was examined by applying classical two parameters (Langmuir, Freundlich, Timken and Dubinin-Radushkevich) and three parameters (Redlich-Peterson, Toth and Sips models) and four parameters Fritz Schlunder Isotherm models. Based on R-2 and X-2 the equilibrium sorption data was better fitted to Langmuir and Sips isotherm model than any other model. Thermodynamics parameters such as free energy change (Delta G degrees), enthalpy change (Delta H degrees) and entropy change (Delta S degrees) have been calculated respectively, which revealed the spontaneous, endothermic and feasible nature of adsorption process. The results of the present investigation suggest that S. bengalense can be used as an environmentally benign and low cost biomaterial for nickel removal from aqueous solution. (c) 2012 Elsevier BM. All rights reserved.
C1 [Din, Muhammad Imran; Mirza, Muhammad Latif] Islamia Univ Bahawalpur, Dept Chem, Bahawalpur 63100, Pakistan.
   [Din, Muhammad Imran] Univ Punjab, Inst Chem, Lahore 54590, Pakistan.
   [Mirza, Muhammad Latif] Univ Sargodha, Dept Chem, Sargodha, Pakistan.
RP Din, MI (reprint author), Islamia Univ Bahawalpur, Dept Chem, Bahawalpur 63100, Pakistan.
EM imrandin2007@gmail.com
CR Aloma I, 2012, J TAIWAN INST CHEM E, V43, P275, DOI 10.1016/j.jtice.2011.10.011
   Amini M, 2009, CHEMOSPHERE, V75, P1483, DOI 10.1016/j.chemosphere.2009.02.025
   Anayurt RA, 2009, CHEM ENG J, V151, P255, DOI 10.1016/j.cej.2009.03.002
   Bayo J, 2012, CHEM ENG J, V191, P278, DOI 10.1016/j.cej.2012.03.016
   Brdar M, 2012, CHEM ENG J, V183, P108, DOI 10.1016/j.cej.2011.12.036
   Chowdhury S, 2011, DESALINATION, V265, P159, DOI 10.1016/j.desal.2010.07.047
   Dubinin M.M., 1947, P ACAD SCI USSR PHYS, V55, P331
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gupta VK, 2003, WATER RES, V37, P4038, DOI 10.1016/S0043-1354(03)00292-6
   Hamdaoui O, 2007, J HAZARD MATER, V147, P401, DOI 10.1016/j.jhazmat.2007.01.023
   HO YS, 1995, WATER RES, V29, P1327, DOI 10.1016/0043-1354(94)00236-Z
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ho YS, 2003, PROCESS BIOCHEM, V38, P1047, DOI 10.1016/S0032-9592(02)00239-X
   Imran Din M., 2013, J CHEM, P1
   Jiang Y, 2009, J HAZARD MATER, V164, P1, DOI 10.1016/j.jhazmat.2008.07.107
   Karadag E, 1998, TURK J CHEM, V22, P227
   Khan MA, 2012, BIORESOURCE TECHNOL, V103, P35, DOI 10.1016/j.biortech.2011.09.065
   Krishnan KA, 2011, BIORESOURCE TECHNOL, V102, P10239, DOI 10.1016/j.biortech.2011.08.069
   Kumar D, 2011, BIORESOURCE TECHNOL, V102, P633, DOI 10.1016/j.biortech.2010.08.014
   Lawal OS, 2010, J HAZARD MATER, V177, P829, DOI 10.1016/j.jhazmat.2009.12.108
   Li Q, 2010, J ENVIRON MANAGE, V91, P1601, DOI 10.1016/j.jenvman.2010.03.001
   Moore J. W., 1994, INORGANIC CONTAMINAN, P178
   Nayak D, 2005, J RADIOANAL NUCL CH, V267, P59, DOI 10.1007/s10967-006-0009-9
   Ncibi MC, 2008, J HAZARD MATER, V153, P207, DOI 10.1016/j.jhazmat.2007.08.038
   Onundi Y. B., 2010, INT J ENVIRON SCI TE, P751
   Oubagaranadin JUK, 2010, APPL CLAY SCI, V50, P409, DOI 10.1016/j.clay.2010.09.008
   Padmavathy V, 2003, PROCESS BIOCHEM, V38, P1389, DOI 10.1016/S0032-9592(02)00168-1
   Rao M, 2002, WASTE MANAGE, V22, P821, DOI 10.1016/S0956-053X(02)00011-9
   Reddy DHK, 2012, CARBOHYD POLYM, V88, P1077, DOI 10.1016/j.carbpol.2012.01.073
   Rodriguez CE, 2006, BRAZ J MICROBIOL, V37, P465, DOI 10.1590/S1517-83822006000400012
   Saraydin D, 1996, TURK J CHEM, V20, P234
   Shroff KA, 2011, CHEM ENG J, V171, P1234, DOI 10.1016/j.cej.2011.05.034
   Soliman EM, 2011, ARAB J CHEM, V4, P63, DOI 10.1016/j.arabjc.2010.06.021
   Suresh S, 2011, J CHEM ENG DATA, V56, P811, DOI 10.1021/je100303x
   Tirmizi SA, 2005, J CHEM SOC PAKISTAN, V27, P186
   Tunali Akar S., 2012, CHEM ENG J, V185-186, P82
   Weber J.W., 1963, J SANIT ENG DIV ASCE, V89, P31
   Wong JPK, 2000, BIORESOURCE TECHNOL, V73, P133, DOI 10.1016/S0960-8524(99)00175-3
   Wu FC, 2009, CHEM ENG J, V150, P366, DOI 10.1016/j.cej.2009.01.014
   Zou RHW, 2006, COLLOID SURF A, V279, P238, DOI DOI 10.1016/J.COLSURFA.2006.01.008
NR 42
TC 22
Z9 23
U1 0
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR
PY 2013
VL 54
BP 99
EP 108
DI 10.1016/j.ijbiomac.2012.11.010
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 101AD
UT WOS:000315746400015
PM 23219872
DA 2018-10-20
ER

PT J
AU Seifert, P
   Regan, K
   Zani, B
   Wong, G
   Stanley, J
AF Seifert, Philip
   Regan, Kathryn
   Zani, Brett
   Wong, Gee
   Stanley, James
TI Correlative evaluation of variable pressure-scanning electron microscopy
   to histology methods for vascular tissues
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE Artery; Endothelial cell; Silver stain; Variable pressure-scanning
   electron microscopy
ID FIELD; ESEM
AB For pathological investigation, vascular tissues implanted with biomaterials or medical devices require microscopic histology and scanning electron microscopy (SEM) assessment to evaluate biocompatibility with the vascular luminal surface. However, these valuable specimens are often susceptible to SEM and histology tissue preparation artifacts. Correlative variable pressure-scanning electron microscopy (VP-SEM) and histology methods were developed and evaluated, using current SEM technology, allowing direct imaging of hydrated samples without lengthy tissue processing, labor, equipment, and their sequela artifacts. Unstained and silver-stained, fixed swine carotid arteries were assessed using a cooling stage and an environmental secondary electron detector. After VP-SEM imaging, arteries were processed for histology evaluation. Assessment of luminal endothelial surface SEM images and tissue histology of the underlying mural wall was made to determine if low vacuum, cryo-freezing, electron beam exposure, and/or staining affected tissue morphology. Conventional SEM requires lengthy tissue processing with dedicated equipment for solvent dehydration, critical point drying, and metallic sputter coating in order to image under high vacuum for secondary electron imaging. This process causes notable artifacts when samples are later processed for microscopic histology. In contrast, silver staining of swine carotid arteries, followed by aldehyde fixation, facilitated VP-SEM imaging and histology preparation with results that were comparable to conventional SEM and had acceptable tissue morphology. VP-SEM with a cooling stage and an environmental secondary electron detector allows efficient SEM imaging and correlative histological assessment of vascular tissue samples. This correlative method may be further developed and implemented for research applications with biomaterial and medical device implanted tissues.
C1 [Seifert, Philip; Zani, Brett] CBSET Inc, Dept Appl Sci, Lexington, MA USA.
   [Regan, Kathryn; Wong, Gee; Stanley, James] CBSET Inc, Dept Pathol, Lexington, MA USA.
RP Seifert, P (reprint author), CBSET Inc, Dept Appl Sci, Lexington, MA USA.
EM pseifert@cbset.org
CR DEBRUIJN WC, 1974, J CELL SCI, V16, P221
   HIRATA A, 1995, AM J PHYSIOL-LUNG C, V269, pL403
   Manero JM, 2003, MICROSC RES TECHNIQ, V61, P469, DOI 10.1002/jemt.10358
   Muscariello L, 2005, J CELL PHYSIOL, V205, P328, DOI 10.1002/jcp.20444
   Palmaz JC, 1995, J VASC INTERV RADIOL, V6, P879, DOI 10.1016/S1051-0443(95)71207-6
NR 5
TC 1
Z9 1
U1 0
U2 13
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD MAR
PY 2013
VL 36
IS 1
BP 25
EP 29
DI 10.1179/2046023613Y.0000000020
PG 5
WC Cell Biology
SC Cell Biology
GA 104NW
UT WOS:000316002000005
DA 2018-10-20
ER

PT J
AU Jones, CH
   Chen, CK
   Jiang, M
   Fang, L
   Cheng, C
   Pfeifer, BA
AF Jones, Charles H.
   Chen, Chih-Kuang
   Jiang, Ming
   Fang, Lei
   Cheng, Chong
   Pfeifer, Blaine A.
TI Synthesis of Cationic Polylactides with Tunable Charge Densities as
   Nanocarriers for Effective Gene Delivery
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE CPLA; polylactic acid; gene therapy; gene delivery; DNA
ID IN-VITRO; BIODEGRADABLE NANOPARTICLES; POLY(BETA-AMINO ESTERS); NONVIRAL
   VECTORS; SURFACE-CHARGE; VIRAL VECTORS; CROSS-LINKING; THERAPY; DNA;
   PHAGOCYTOSIS
AB Well-defined cationic polylactides (CPLAs) with tertiary amine groups were synthesized by thiol-ene click functionalization of an allyl-functionalized polylactide to yield polymers with tunable charge densities. CPLAs have not previously been utilized in the context of DNA delivery. Thus, plasmid DNA (pDNA) encoding luciferase was delivered to two physiologically distinct cell lines (macrophage and fibroblast) via formation of CPLA/pDNA polyplexes by electrostatic interaction. The formulated polyplexes demonstrated high levels of transfection with low levels of cytotoxicity when compared to a positive control. Biophysical characterization of charge densities at various CPLA/pDNA weight ratios revealed a positive correlation between surface charge and gene delivery. Overall, these results help to elucidate the influence of polyplex charge and size upon the delivery of nucleic acid and support future gene delivery applications using this next-generation biomaterial.
C1 [Jones, Charles H.; Chen, Chih-Kuang; Jiang, Ming; Fang, Lei; Cheng, Chong; Pfeifer, Blaine A.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
RP Cheng, C (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM ccheng8@buffalo.edu; blainepf@buffalo.edu
RI Cheng, Chong/K-2050-2014
FU NSF [CBET-1019227, CBET-1133737]; SUNY-Buffalo Schomburg fellowship
FX The authors thankfully acknowledge the NSF (CBET-1019227 and -1133737)
   and a SUNY-Buffalo Schomburg fellowship (C.H.J.) for financial support.
CR Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015
   Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8
   De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006
   Doshi N., 2010, PLOS ONE, DOI [10.1371/journal.-pone.0010051, DOI 10.1371/JOURNAL.-PONE.0010051]
   Giacca M, 2012, J CONTROL RELEASE, V161, P377, DOI 10.1016/j.jconrel.2012.04.008
   Gomez JMM, 2008, J CONTROL RELEASE, V130, P161, DOI 10.1016/j.jconrel.2008.06.003
   Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983
   Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e
   MUTSAERS SE, 1988, J LEUKOCYTE BIOL, V44, P17
   Nguyen J, 2008, J CONTROL RELEASE, V132, P243, DOI 10.1016/j.jconrel.2008.06.010
   Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Pochard I, 2003, POLYM INT, V52, P619, DOI 10.1002/pi.1008
   PRATTEN MK, 1986, BIOCHIM BIOPHYS ACTA, V881, P307, DOI 10.1016/0304-4165(86)90020-6
   Putnam D, 2001, P NATL ACAD SCI USA, V98, P1200, DOI 10.1073/pnas.031577698
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Rice-Ficht AC, 2010, CURR OPIN MICROBIOL, V13, P106, DOI 10.1016/j.mib.2009.12.001
   Shmueli RB, 2010, EXPERT OPIN DRUG DEL, V7, P535, DOI 10.1517/17425241003603653
   Sun XL, 2010, MINI-REV MED CHEM, V10, P108, DOI 10.2174/138955710791185109
   Thiele L, 2003, PHARM RES-DORDR, V20, P221, DOI 10.1023/A:1022271020390
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Trubetskoy VS, 2003, GENE THER, V10, P261, DOI 10.1038/sj.gt.3301888
   Wang YH, 2011, BIOMACROMOLECULES, V12, P1032, DOI 10.1021/bm101364f
   Wu J, 2001, BIOCONJUGATE CHEM, V12, P251, DOI 10.1021/bc000097e
   You JO, 2006, INT J NANOMED, V1, P173, DOI 10.2147/nano.2006.1.2.173
   Yu Y, 2013, MOL PHARMACEUT, V10, P867, DOI 10.1021/mp3004868
   Zauner W, 1998, ADV DRUG DELIVER REV, V30, P97, DOI 10.1016/S0169-409X(97)00110-5
   Zhang ZH, 2012, BIOMACROMOLECULES, V13, P3456, DOI 10.1021/bm301333w
   Zou J, 2012, J POLYM SCI POL CHEM, V50, P142, DOI 10.1002/pola.25016
   Zou J, 2011, ADV MATER, V23, P4274, DOI 10.1002/adma.201101646
NR 33
TC 44
Z9 44
U1 1
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD MAR
PY 2013
VL 10
IS 3
BP 1138
EP 1145
DI 10.1021/mp300666s
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 101GP
UT WOS:000315763500035
PM 23339525
DA 2018-10-20
ER

EF